Citrus Sinensis ID: 035713
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 491 | 2.2.26 [Sep-21-2011] | |||||||
| Q0DCT8 | 589 | Protein kinase G11A OS=Or | no | no | 0.875 | 0.730 | 0.617 | 1e-158 | |
| A2YBX5 | 589 | Protein kinase G11A OS=Or | N/A | no | 0.875 | 0.730 | 0.617 | 1e-158 | |
| P15792 | 609 | Protein kinase PVPK-1 OS= | N/A | no | 0.759 | 0.612 | 0.678 | 1e-151 | |
| Q05999 | 578 | Serine/threonine-protein | no | no | 0.775 | 0.659 | 0.655 | 1e-145 | |
| Q9LFA2 | 934 | Serine/threonine-protein | no | no | 0.780 | 0.410 | 0.579 | 1e-133 | |
| Q64FQ2 | 525 | Protein kinase PINOID 2 O | no | no | 0.773 | 0.723 | 0.456 | 1e-106 | |
| O64682 | 438 | Protein kinase PINOID OS= | no | no | 0.767 | 0.860 | 0.484 | 1e-102 | |
| Q2QM77 | 484 | Protein kinase PINOID OS= | no | no | 0.725 | 0.735 | 0.475 | 2e-99 | |
| P93025 | 915 | Phototropin-2 OS=Arabidop | no | no | 0.680 | 0.365 | 0.469 | 1e-95 | |
| Q2QYY8 | 921 | Phototropin-1A OS=Oryza s | no | no | 0.680 | 0.362 | 0.469 | 3e-92 |
| >sp|Q0DCT8|G11A_ORYSJ Protein kinase G11A OS=Oryza sativa subsp. japonica GN=Os06g0291600 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 558 bits (1439), Expect = e-158, Method: Compositional matrix adjust.
Identities = 289/468 (61%), Positives = 335/468 (71%), Gaps = 38/468 (8%)
Query: 46 NHGHGSSNC--SSRSD-----SLESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRL 98
G SS C S+ SD + S S+ KPH D RW+AI MI R +GLS+F+L
Sbjct: 138 ERGFSSSRCRPSTSSDVSDESACSSISSVTKPHKANDSRWEAIQMIRTRDGILGLSHFKL 197
Query: 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPT 158
LK+LG GDIGSVYL EL GT +YFAMKVMDKASLASR KLLRAQTE+EIL LDHPFLPT
Sbjct: 198 LKKLGCGDIGSVYLSELSGTKSYFAMKVMDKASLASRKKLLRAQTEKEILQCLDHPFLPT 257
Query: 159 LYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIV 218
LY++FETDKF CLVMEFC GG+LH+LRQ+Q KYF E A +F+ +E+LLA+EYLHMLGI+
Sbjct: 258 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAEILLAMEYLHMLGII 317
Query: 219 YRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVH 278
YRDLKPENVLVR++GHIMLSDFDLSLRC+VSPTL++SS N N Y V
Sbjct: 318 YRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSS-----NPDAEALRKNNQAYCVQ 372
Query: 279 -GCMQPS------------TFFPRIL-PSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324
C++PS F PR SKK+RK K + V PEL+AEP++ RSM
Sbjct: 373 PACVEPSCMIQPSCATPTTCFGPRFFSKSKKDRKPKPEVVNQV-SPWPELIAEPSDARSM 431
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR 384
SFVGTHEYLAPEII+GEGHGSAVDWWTFGIFLYELL G TPFKG GNRATLFNV+GQPLR
Sbjct: 432 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVIGQPLR 491
Query: 385 FPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE 444
FPE P VSF ARDLIRGLLVKEP +R+ KRGATEIKQHPFFEGVNWAL+R A PP +P
Sbjct: 492 FPEYPVVSFSARDLIRGLLVKEPQQRLGCKRGATEIKQHPFFEGVNWALIRCASPPEVPR 551
Query: 445 PVDFSVFAGKDQASAAAEKKVVAAAE-AAVDHKNGDSPKDSYVEFEYF 491
PV+ K+ V+ +E AA DSY+EF++F
Sbjct: 552 PVEIE----------RPPKQPVSTSEPAAAPSDAAQKSSDSYLEFDFF 589
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|A2YBX5|G11A_ORYSI Protein kinase G11A OS=Oryza sativa subsp. indica GN=OsI_021818 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 558 bits (1439), Expect = e-158, Method: Compositional matrix adjust.
Identities = 289/468 (61%), Positives = 335/468 (71%), Gaps = 38/468 (8%)
Query: 46 NHGHGSSNC--SSRSD-----SLESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRL 98
G SS C S+ SD + S S+ KPH D RW+AI MI R +GLS+F+L
Sbjct: 138 ERGFSSSRCRPSTSSDVSDESACSSISSVTKPHKANDSRWEAIQMIRTRDGILGLSHFKL 197
Query: 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPT 158
LK+LG GDIGSVYL EL GT +YFAMKVMDKASLASR KLLRAQTE+EIL LDHPFLPT
Sbjct: 198 LKKLGCGDIGSVYLSELNGTKSYFAMKVMDKASLASRKKLLRAQTEKEILQCLDHPFLPT 257
Query: 159 LYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIV 218
LY++FETDKF CLVMEFC GG+LH+LRQ+Q KYF E A +F+ +E+LLA+EYLHMLGI+
Sbjct: 258 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAEILLAMEYLHMLGII 317
Query: 219 YRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVH 278
YRDLKPENVLVR++GHIMLSDFDLSLRC+VSPTL++SS N N Y V
Sbjct: 318 YRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSS-----NPDAEALRKNNQAYCVQ 372
Query: 279 -GCMQPS------------TFFPRIL-PSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324
C++PS F PR SKK+RK K + V PEL+AEP++ RSM
Sbjct: 373 PACVEPSCMIQPSCATPTTCFGPRFFSKSKKDRKPKPEVVNQV-SPWPELIAEPSDARSM 431
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR 384
SFVGTHEYLAPEII+GEGHGSAVDWWTFGIFLYELL G TPFKG GNRATLFNV+GQPLR
Sbjct: 432 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVIGQPLR 491
Query: 385 FPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE 444
FPE P VSF ARDLIRGLLVKEP +R+ KRGATEIKQHPFFEGVNWAL+R A PP +P
Sbjct: 492 FPEYPVVSFSARDLIRGLLVKEPQQRLGCKRGATEIKQHPFFEGVNWALIRCASPPEVPR 551
Query: 445 PVDFSVFAGKDQASAAAEKKVVAAAE-AAVDHKNGDSPKDSYVEFEYF 491
PV+ K+ V+ +E AA DSY+EF++F
Sbjct: 552 PVEIE----------RPPKQPVSTSEPAAAPSDAAQKSSDSYLEFDFF 589
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P15792|KPK1_PHAVU Protein kinase PVPK-1 OS=Phaseolus vulgaris PE=2 SV=1 | Back alignment and function description |
|---|
Score = 533 bits (1374), Expect = e-151, Method: Compositional matrix adjust.
Identities = 264/389 (67%), Positives = 299/389 (76%), Gaps = 16/389 (4%)
Query: 69 KPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMD 128
KPH D+RW+AI + R + + +FRLLK+LG GDIGSVYL EL GT T FAMKVM+
Sbjct: 202 KPHKANDIRWEAIQAVRTRDGMLEMRHFRLLKKLGCGDIGSVYLAELSGTRTSFAMKVMN 261
Query: 129 KASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQ 188
K LA+R KLLRAQTEREIL LDHPFLPTLY++FET+ F CLVMEFC GG+LH+LRQ+Q
Sbjct: 262 KTELANRKKLLRAQTEREILQSLDHPFLPTLYTHFETEIFSCLVMEFCPGGDLHALRQRQ 321
Query: 189 PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248
P KYF+E A RF+ +EVLL+LEYLHMLGI+YRDLKPENVLVR++GHIMLSDFDLSLRCSV
Sbjct: 322 PGKYFSEHAVRFYVAEVLLSLEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCSV 381
Query: 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVH-------GCMQPSTFFPRIL----PSKKNR 297
SPTLVKSS NN G + C++PS F PR L K
Sbjct: 382 SPTLVKSS----NNLQTKSSGYCVQPSCIEPTCVMQPDCIKPSCFTPRFLSGKSKKDKKS 437
Query: 298 KSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLY 357
K K+D V LPEL+AEPTN RSMSFVGTHEYLAPEII+GEGHGSAVDWWTFGIFLY
Sbjct: 438 KPKNDMHNQV-TPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLY 496
Query: 358 ELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGA 417
ELL G TPFKG NRATLFNV+GQPLRFPE+P VSF ARDLIRGLLVKEP R+AY+RGA
Sbjct: 497 ELLFGRTPFKGSANRATLFNVIGQPLRFPESPTVSFAARDLIRGLLVKEPQHRLAYRRGA 556
Query: 418 TEIKQHPFFEGVNWALVRSALPPHIPEPV 446
TEIKQHPFF+ VNWAL+R A PP +P V
Sbjct: 557 TEIKQHPFFQNVNWALIRCATPPEVPRQV 585
|
Phaseolus vulgaris (taxid: 3885) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05999|KPK7_ARATH Serine/threonine-protein kinase AtPK7 OS=Arabidopsis thaliana GN=PK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 515 bits (1327), Expect = e-145, Method: Compositional matrix adjust.
Identities = 255/389 (65%), Positives = 301/389 (77%), Gaps = 8/389 (2%)
Query: 65 SAPVKPH-TGGDVRWDAINMISLR-GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYF 122
+A KPH D RW AI + R G + +F+L+K+LG GDIG+VYL EL GT F
Sbjct: 149 NAAYKPHRDNNDKRWVAIQEVRSRVGSSLEAKDFKLIKKLGGGDIGNVYLAELIGTGVSF 208
Query: 123 AMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLH 182
A+KVM+KA++A+R KL+RAQTE+EIL LDHPFLPTLYS+FET+ CLVMEFC GG+LH
Sbjct: 209 AVKVMEKAAIAARKKLVRAQTEKEILQSLDHPFLPTLYSHFETEMNSCLVMEFCPGGDLH 268
Query: 183 SLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242
SLRQKQ KYF E AARF+ +EVLLA+EYLHMLGI+YRDLKPENVLVR++GHIMLSDFDL
Sbjct: 269 SLRQKQRGKYFPEQAARFYVAEVLLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 328
Query: 243 SLRCSVSPTLVKSSSVSVNNGSGG----GGGILNDEYAVH-GCMQPSTFFPRILPSKKNR 297
SLRC+VSPTLV+ +++++ + S + V C+QP F PR L K+R
Sbjct: 329 SLRCAVSPTLVRFAAITLESKSSSYCIQPTCVDQSSCIVQPDCIQPVCFTPRFLSKGKHR 388
Query: 298 KSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLY 357
K +D + LPEL+AEPT+ RSMSFVGTHEYLAPEII+GEGHGSAVDWWTFGIFLY
Sbjct: 389 KKSNDMSRQI-RPLPELIAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLY 447
Query: 358 ELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGA 417
ELL G TPF+G NRATLFNVVGQPLRFPE P VSF ARDLIRGLLVKEP R+AY+RGA
Sbjct: 448 ELLFGITPFRGGDNRATLFNVVGQPLRFPEHPNVSFAARDLIRGLLVKEPQHRLAYRRGA 507
Query: 418 TEIKQHPFFEGVNWALVRSALPPHIPEPV 446
TEIKQHPFF+ VNWAL+R PP IP+PV
Sbjct: 508 TEIKQHPFFQSVNWALIRCTSPPQIPQPV 536
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFA2|KIPK_ARATH Serine/threonine-protein kinase KIPK OS=Arabidopsis thaliana GN=KIPK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 477 bits (1227), Expect = e-133, Method: Compositional matrix adjust.
Identities = 236/407 (57%), Positives = 293/407 (71%), Gaps = 24/407 (5%)
Query: 69 KPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMD 128
KPH DVRW+AI I ++ +GL +F LLK+LG GDIG+VYL EL GTN FA+KVMD
Sbjct: 511 KPHMSMDVRWEAIKHIKVQYGSLGLRHFNLLKKLGCGDIGTVYLAELIGTNCLFAIKVMD 570
Query: 129 KASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQ 188
LA R K RAQ EREIL +LDHPFLPTLY+ F +D CLVME+C GG+LH LRQKQ
Sbjct: 571 NEFLARRKKSPRAQAEREILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQKQ 630
Query: 189 PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248
+ F E AARF+ +E+LLALEYLHMLGI+YRDLKPEN+LVR++GHIML+DFDLSLRC+V
Sbjct: 631 LGRCFPEPAARFYVAEILLALEYLHMLGIIYRDLKPENILVREDGHIMLTDFDLSLRCAV 690
Query: 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQP----------STFFPRILPSKKN-R 297
+PTLV+S N+ G ++ Y C+QP S F PR+ +++ R
Sbjct: 691 NPTLVRS-----NSPPGKDPARISGPYNTSNCIQPFCITEPSCQVSCFSPRLSSNQQQGR 745
Query: 298 KSK-----SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTF 352
K K S + +LP+L+AEPT RS SFVGTHEYLAPEII+GEGHG+AVDWWTF
Sbjct: 746 KPKRGDHLSKTQQHLSRSLPQLVAEPTEARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTF 805
Query: 353 GIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIA 412
G+ LYELL+G TPFKG N TL NVV Q L+FP++P VSF A+DLIRGLLVKEP R+
Sbjct: 806 GVLLYELLYGKTPFKGYNNDETLANVVLQNLKFPDSPLVSFQAKDLIRGLLVKEPENRLG 865
Query: 413 YKRGATEIKQHPFFEGVNWALVRSALPPHIPEPVDFSVFAGKDQASA 459
++G+ EIK+HPFFEG+NWAL+R A+PP +P DF + G +A+A
Sbjct: 866 SEKGSVEIKRHPFFEGLNWALIRCAIPPELP---DFYEYGGGPEAAA 909
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q64FQ2|PID2_ARATH Protein kinase PINOID 2 OS=Arabidopsis thaliana GN=PID2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 385 bits (988), Expect = e-106, Method: Compositional matrix adjust.
Identities = 209/458 (45%), Positives = 272/458 (59%), Gaps = 78/458 (17%)
Query: 44 LTNHGHGSSNCSSRSDSLESSSAPVKPHTGGDVRWDAINMISLR---GPPIGLSNFRLLK 100
L+NHG S N S KPH V W+A M LR G +GL +FRLLK
Sbjct: 47 LSNHGLNSYNQS-------------KPHKANQVAWEA--MARLRRCCGRAVGLEHFRLLK 91
Query: 101 RLGYGDIGSVYLVELRGT--NTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPT 158
RLG GDIGSVYL ++RG+ ++AMKV+DK ++A + KL RA+ E++ILG+LDHPF PT
Sbjct: 92 RLGSGDIGSVYLCQIRGSPETAFYAMKVVDKEAVAVKKKLGRAEMEKKILGMLDHPFCPT 151
Query: 159 LYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIV 218
LY+ FE + LVME+C GG+L+++R +QP+K FT + RF+A+E L+ALEYLHM+GIV
Sbjct: 152 LYAAFEASHYSFLVMEYCPGGDLYAVRLRQPSKRFTISSTRFYAAETLVALEYLHMMGIV 211
Query: 219 YRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAV- 277
YRDLKPENVL+R++GH+MLSDFDLS +C V P + +N G +D+ ++
Sbjct: 212 YRDLKPENVLIREDGHVMLSDFDLSFKCDVVPQFLS------DNDRDRGHQEDDDDISIR 265
Query: 278 HGCMQPST-------FFPRILPSKKNRKSKSDF--------------------------- 303
C PS P+ R+ K+
Sbjct: 266 RKCSTPSCTTTPLNPVISCFSPTSSRRRKKNVVTTTIHENAAGTSDSVKSNDVSRTFSRS 325
Query: 304 -GPC---------VGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFG 353
C + G P + AEP N RS SFVGTHEYLAPE+I G+GHGSAVDWWT+G
Sbjct: 326 PSSCSRVSNGLRDISGGCPSIFAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTYG 385
Query: 354 IFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVS-------FVARDLIRGLLVKE 406
IFLYE++ G TPFKG N TL N++ PL FP+ S A+DLI LLVK
Sbjct: 386 IFLYEMIFGRTPFKGDNNEKTLVNILKAPLTFPKVIVNSPKEYEDMVNAQDLIIKLLVKN 445
Query: 407 PHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE 444
P KR+ +G+ EIK+H FFEGVNWAL+RS PP +P+
Sbjct: 446 PKKRLGSLKGSIEIKRHEFFEGVNWALIRSIKPPWVPK 483
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Plays a minor role in the regulation of cellular auxin efflux and cotyledon organogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64682|PID_ARATH Protein kinase PINOID OS=Arabidopsis thaliana GN=PID PE=1 SV=1 | Back alignment and function description |
|---|
Score = 372 bits (956), Expect = e-102, Method: Compositional matrix adjust.
Identities = 201/415 (48%), Positives = 266/415 (64%), Gaps = 38/415 (9%)
Query: 62 ESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRG---- 117
E S +KPH D + I +G + +FRL++R+G GDIG+VYL L G
Sbjct: 43 EESFLSLKPHRSSDFAYAEIRRRKKQG--LTFRDFRLMRRIGAGDIGTVYLCRLAGDEEE 100
Query: 118 -TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFC 176
++YFAMKV+DK +LA + K+ RA+ E+ IL +LDHPFLPTLY+ FE F C+VME+C
Sbjct: 101 SRSSYFAMKVVDKEALALKKKMHRAEMEKTILKMLDHPFLPTLYAEFEASHFSCIVMEYC 160
Query: 177 SGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIM 236
SGG+LHSLR +QP++ F+ +ARF+A+EVL+ALEYLHMLGI+YRDLKPEN+LVR +GHIM
Sbjct: 161 SGGDLHSLRHRQPHRRFSLSSARFYAAEVLVALEYLHMLGIIYRDLKPENILVRSDGHIM 220
Query: 237 LSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKN 296
LSDFDLSL CS S V+SSS S N + + + F R+L SKK
Sbjct: 221 LSDFDLSL-CSDSIAAVESSSSSPEN---------QQLRSPRRFTRLARLFQRVLRSKK- 269
Query: 297 RKSKSDFGPCVGGALPE--LMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGI 354
V P +AEP RS SFVGTHEY+APE+ G HG+AVDWW FG+
Sbjct: 270 ----------VQTLEPTRLFVAEPVTARSGSFVGTHEYVAPEVASGGSHGNAVDWWAFGV 319
Query: 355 FLYELLHGTTPFKGQGNRATLFNVVGQPLRFP-ETPQVSFV--ARDLIRGLLVKEPHKRI 411
FLYE+++G TPF N L N+V + L FP ++P F AR+LI GLL K+P KR+
Sbjct: 320 FLYEMIYGKTPFVAPTNDVILRNIVKRQLSFPTDSPATMFELHARNLISGLLNKDPTKRL 379
Query: 412 AYKRGATEIKQHPFFEGVNWALVRSALPPHIP-----EPVDFSVFAGKDQASAAA 461
+RGA E+K HPFF+G+N+AL+R+ PP IP +P+ + F+G+ AA
Sbjct: 380 GSRRGAAEVKVHPFFKGLNFALIRTLTPPEIPSSVVKKPMKSATFSGRSSNKPAA 434
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Acts as a positive regulator of cellular auxin efflux and regulates organ development by enhancing polar auxin transport. Phosphorylates conserved serine residues in the PIN auxin efflux carriers. Phosphorylation of PIN proteins is required and sufficient for apical-basal PIN polarity that enables directional intercellular auxin fluxes, which mediate differential growth, tissue patterning and organogenesis. Acts in association with PIN1 to control the establishment of bilateral symmetry and promotion of cotyledon outgrowth. Regulates root gravitropism through modulation of PIN2-dependent basipetal auxin transport. Required for polarization of PIN3-dependent auxin transport for hypocotyl gravitropic response. The protein kinase activity of PID is essential for its auxin efflux regulatory function. PID kinase and PP2A phosphatase activities antagonistically regulate phosphorylation of PIN proteins, affecting PIN sorting. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QM77|PID_ORYSJ Protein kinase PINOID OS=Oryza sativa subsp. japonica GN=PID PE=2 SV=1 | Back alignment and function description |
|---|
Score = 363 bits (931), Expect = 2e-99, Method: Compositional matrix adjust.
Identities = 186/391 (47%), Positives = 249/391 (63%), Gaps = 35/391 (8%)
Query: 64 SSAPVKPHTGGDVRWDAINMISL-RGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTN--- 119
+S ++PH GDV W AI S P+G +F+L++R+G GDIG+VYL LR +
Sbjct: 78 ASVLLRPHRSGDVAWAAIRAASTTSAAPLGPRDFKLVRRIGGGDIGTVYLCRLRSSPERE 137
Query: 120 --TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE-TDKFYCLVMEFC 176
+AMKV+D+ ++A + KL RA E+ IL LDHPFLPTL++ F+ T F C VMEFC
Sbjct: 138 SPCMYAMKVVDRRAVARKQKLGRAAAEKRILRQLDHPFLPTLFADFDATPHFSCAVMEFC 197
Query: 177 SGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIM 236
GG+LHSLR + P++ F +ARF+A+EVLLA+EYLHM+GIVYRDLKPENVL+R +GHIM
Sbjct: 198 PGGDLHSLRHRMPSRRFPLPSARFYAAEVLLAIEYLHMMGIVYRDLKPENVLIRADGHIM 257
Query: 237 LSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKN 296
L+DFDLSL+ + SP+L ++ + GG D +L K+
Sbjct: 258 LTDFDLSLQSTTSPSL--DGDTDTDDEASGGASCFPDH---------------LLRFKRR 300
Query: 297 RKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFL 356
R + V P +AEP + RS SFVGTHEY+APE+ G HG+AVDWW +G+FL
Sbjct: 301 RNA-------VAAPRPRFVAEPVDARSCSFVGTHEYVAPEVASGGAHGAAVDWWAYGVFL 353
Query: 357 YELLHGTTPFKGQGNRATLFNVVGQPLRFP----ETPQVSFVARDLIRGLLVKEPHKRIA 412
YEL++G TPF G N ATL N+V +PL FP ARDLI LL K+P R+
Sbjct: 354 YELIYGRTPFAGATNEATLRNIVRRPLAFPSGSGSCGPADADARDLIARLLAKDPAARLG 413
Query: 413 YKRGATEIKQHPFFEGVNWALVRSALPPHIP 443
+RGA ++K HPFF+ +N AL+RS+ PP +P
Sbjct: 414 SRRGAADVKSHPFFKSLNLALLRSSRPPVVP 444
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. May control polar auxin transport and probably plays a role in the pattern formation and organogenesis in the rice shoot. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93025|PHOT2_ARATH Phototropin-2 OS=Arabidopsis thaliana GN=PHOT2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 350 bits (899), Expect = 1e-95, Method: Compositional matrix adjust.
Identities = 177/377 (46%), Positives = 233/377 (61%), Gaps = 43/377 (11%)
Query: 70 PHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDK 129
PH W AI I G +GL +F+ +K LG GD GSV+LVEL+GT +AMK M+K
Sbjct: 551 PHNKESTSWKAIKKIQASGETVGLHHFKPIKPLGSGDTGSVHLVELKGTGELYAMKAMEK 610
Query: 130 ASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQP 189
+ +RNK RA EREI+ LLDHPFLPTLY+ F+T CL+ +FC GG L +L +QP
Sbjct: 611 TMMLNRNKAHRACIEREIISLLDHPFLPTLYASFQTSTHVCLITDFCPGGELFALLDRQP 670
Query: 190 NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249
K TED+ARF+A+EV++ LEYLH LGIVYRDLKPEN+L++ +GHI+L+DFDLS + +
Sbjct: 671 MKILTEDSARFYAAEVVIGLEYLHCLGIVYRDLKPENILLKKDGHIVLADFDLSFMTTCT 730
Query: 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGG 309
P L+ ++ PSK+ R+SKS
Sbjct: 731 PQLIIPAA----------------------------------PSKR-RRSKSQ------- 748
Query: 310 ALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQ 369
LP +AEP+ +S SFVGT EY+APEII G GH SA+DWW GI LYE+L+G TPF+G+
Sbjct: 749 PLPTFVAEPS-TQSNSFVGTEEYIAPEIITGAGHTSAIDWWALGILLYEMLYGRTPFRGK 807
Query: 370 GNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429
+ T N++ + L FP + VS V R LI LL ++P R+ K GA EIKQH FF G+
Sbjct: 808 NRQKTFANILHKDLTFPSSIPVSLVGRQLINTLLNRDPSSRLGSKGGANEIKQHAFFRGI 867
Query: 430 NWALVRSALPPHIPEPV 446
NW L+R PP + P+
Sbjct: 868 NWPLIRGMSPPPLDAPL 884
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for photo-induced movements. Mediates calcium spiking of extra- and intracellular origins in response to blue light. Involved in hypocotyl phototropism. Contributes to the chloroplast accumulation in low blue light and mediates their translocation (avoidance response) at high fluence. Regulates stomata opening and photomorphogenesis response of leaf tissue. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QYY8|PHT1A_ORYSJ Phototropin-1A OS=Oryza sativa subsp. japonica GN=PHOT1A PE=1 SV=2 | Back alignment and function description |
|---|
Score = 339 bits (869), Expect = 3e-92, Method: Compositional matrix adjust.
Identities = 177/377 (46%), Positives = 223/377 (59%), Gaps = 43/377 (11%)
Query: 70 PHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDK 129
PH W AI + G IGL +FR +K LG GD GSV+LVEL T YFAMK MDK
Sbjct: 568 PHMKDTASWRAIQKVLESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDK 627
Query: 130 ASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQP 189
+ + +RNK+ RA ER+IL LLDHPFLPTLY+ F+T CL+ ++C GG L L QP
Sbjct: 628 SIMLNRNKVHRATAERQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQP 687
Query: 190 NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249
K EDA RF+A+EV++ALEYLH GI+YRDLKPEN+L+ +GHI L+DFDLS C S
Sbjct: 688 LKVLHEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLS--CLTS 745
Query: 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGG 309
C +P F P KK RK+ G
Sbjct: 746 ------------------------------C-RPQVFLPEDADEKKGRKN---------G 765
Query: 310 ALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQ 369
+ P AEP S SFVGT EY+APEII G GH SAVDWW GI LYE+L+G TPF+G+
Sbjct: 766 SYPIFFAEPMRA-SNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFRGK 824
Query: 370 GNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429
+ T N++ + +RFP + VS AR L+ LL ++P R+ GA EIK HPFF G+
Sbjct: 825 TRQRTFANILHKDIRFPASISVSLAARQLMYRLLHRDPANRLGSYEGANEIKGHPFFRGI 884
Query: 430 NWALVRSALPPHIPEPV 446
NW L+R+ PP + P+
Sbjct: 885 NWPLIRATAPPKLEIPL 901
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 491 | ||||||
| 255572552 | 575 | serine/threonine protein kinase, putativ | 0.987 | 0.843 | 0.823 | 0.0 | |
| 224101289 | 456 | predicted protein [Populus trichocarpa] | 0.914 | 0.984 | 0.807 | 0.0 | |
| 359494615 | 634 | PREDICTED: protein kinase G11A-like [Vit | 0.955 | 0.739 | 0.769 | 0.0 | |
| 356555258 | 561 | PREDICTED: protein kinase G11A-like [Gly | 0.959 | 0.839 | 0.770 | 0.0 | |
| 449453852 | 545 | PREDICTED: protein kinase G11A-like [Cuc | 0.883 | 0.796 | 0.782 | 0.0 | |
| 356528611 | 571 | PREDICTED: protein kinase G11A-like [Gly | 0.963 | 0.828 | 0.760 | 0.0 | |
| 449508237 | 451 | PREDICTED: protein kinase G11A-like [Cuc | 0.875 | 0.953 | 0.783 | 0.0 | |
| 1360141 | 465 | protein kinase [Solanum berthaultii] | 0.861 | 0.909 | 0.820 | 0.0 | |
| 297842715 | 558 | hypothetical protein ARALYDRAFT_316818 [ | 1.0 | 0.879 | 0.708 | 0.0 | |
| 7672777 | 467 | viroid symptom modulation protein [Solan | 0.861 | 0.905 | 0.816 | 0.0 |
| >gi|255572552|ref|XP_002527210.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223533428|gb|EEF35177.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 762 bits (1967), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/492 (82%), Positives = 428/492 (86%), Gaps = 7/492 (1%)
Query: 1 MDPLTKPRTNSITNQRPLPSQKKPPNSEPSTVTMPGDIKHANSLTNHGHGSSNCSSRSDS 60
MDPLTK N+ N RP PS P S + + AN+ NH SS+ S RSDS
Sbjct: 90 MDPLTKAVGNTSANHRPSPS---PLGSSITQLQTTPPSSMANAKANHVL-SSSSSCRSDS 145
Query: 61 LESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNT 120
LESSSAP+KPHTGGDVRWDAINMI+ +G IGLSNFRLLKRLGYGDIGSVYLVELRGTN
Sbjct: 146 LESSSAPLKPHTGGDVRWDAINMINAKGS-IGLSNFRLLKRLGYGDIGSVYLVELRGTNA 204
Query: 121 YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGN 180
+FAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGN
Sbjct: 205 HFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGN 264
Query: 181 LHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240
LHSLRQ+QP K+FTE+AARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF
Sbjct: 265 LHSLRQRQPYKHFTEEAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 324
Query: 241 DLSLRCSVSPTLVKSSSVSVNNGSGGGGG-ILNDEYAVHGCMQPSTFFPRILPSKKNRKS 299
DLSLRCSVSPTLVKSSSV+V+NG G GGG IL+DE+AVHGCMQPSTFFPRILPSKKNRKS
Sbjct: 325 DLSLRCSVSPTLVKSSSVNVSNGGGNGGGGILDDEFAVHGCMQPSTFFPRILPSKKNRKS 384
Query: 300 KSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYEL 359
KSDFG VGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYEL
Sbjct: 385 KSDFGLFVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYEL 444
Query: 360 LHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATE 419
LHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATE
Sbjct: 445 LHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATE 504
Query: 420 IKQHPFFEGVNWALVRSALPPHIPEPVDFSVFAGKDQASAAAEKKVVAAAEAAVDHKNGD 479
IKQHPFFEGVNWALVRSA+PPHIPEPVDFS +A K+ A + + +
Sbjct: 505 IKQHPFFEGVNWALVRSAMPPHIPEPVDFSQYASKEPPPQANNNNKMTNIGGEKGNGSPH 564
Query: 480 SPKDSYVEFEYF 491
P DSY+EFEYF
Sbjct: 565 HP-DSYIEFEYF 575
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224101289|ref|XP_002312217.1| predicted protein [Populus trichocarpa] gi|222852037|gb|EEE89584.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 757 bits (1954), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/458 (80%), Positives = 405/458 (88%), Gaps = 9/458 (1%)
Query: 37 DIKHANSLTNHGHGSSNCSSRSDSLESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNF 96
+ K +S+TNH + S S+R++SLESS KPHTGGDVRWDAI + + RG IGLSNF
Sbjct: 5 EAKTFSSITNHANLSGRSSTRANSLESSGGANKPHTGGDVRWDAIQLATARGT-IGLSNF 63
Query: 97 RLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFL 156
RLLKRLGYGDIGSVYLVELRGTN +FAMKVMDKASLASRNK+LRAQTEREILGLLDHPFL
Sbjct: 64 RLLKRLGYGDIGSVYLVELRGTNAHFAMKVMDKASLASRNKILRAQTEREILGLLDHPFL 123
Query: 157 PTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG 216
PTLY+YFETDKFYC+VMEFCSGGNLHSLRQKQPNK+FTE+AARF+ASEVLLALEYLHMLG
Sbjct: 124 PTLYNYFETDKFYCIVMEFCSGGNLHSLRQKQPNKHFTEEAARFYASEVLLALEYLHMLG 183
Query: 217 IVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYA 276
IVYRDLKPENVLVR EGHIMLSDFDLSLRCSVSPTLVKSSS+ +N GG GIL DE
Sbjct: 184 IVYRDLKPENVLVRHEGHIMLSDFDLSLRCSVSPTLVKSSSLHASNNGSGGLGILEDESV 243
Query: 277 VHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336
V GC+QPSTFFPRILP KK+RKSKSD+G VGG++PELMAEPTNVRSMSFVGTHEYLAPE
Sbjct: 244 VQGCIQPSTFFPRILPGKKSRKSKSDYGLFVGGSMPELMAEPTNVRSMSFVGTHEYLAPE 303
Query: 337 IIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVAR 396
IIRGEGHGSAVDWWTFG+FLYELLHGTTPFKGQGNRATLFNVVGQPL+FPE PQVS VAR
Sbjct: 304 IIRGEGHGSAVDWWTFGVFLYELLHGTTPFKGQGNRATLFNVVGQPLKFPENPQVSMVAR 363
Query: 397 DLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEPVDFSVFAGKDQ 456
DLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG+NWALVRSALPPH+PEPVDFS +A K+
Sbjct: 364 DLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGMNWALVRSALPPHVPEPVDFSQYASKE- 422
Query: 457 ASAAAEKKVVAAAEAAVDHKNGDSPK---DSYVEFEYF 491
+ A+KK + D K+G SP+ +SYVEFEYF
Sbjct: 423 -APPADKKT---PDIGGDKKDGSSPENKDESYVEFEYF 456
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359494615|ref|XP_002265801.2| PREDICTED: protein kinase G11A-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 748 bits (1931), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/498 (76%), Positives = 416/498 (83%), Gaps = 29/498 (5%)
Query: 1 MDPLTKPRTNSITNQRPLPSQKKPPNSEPSTVTMPGDIKHANSLTNHGHGSSNCSSRSDS 60
+DP +K NS N PP+++ + D K + N+ G S S+RSDS
Sbjct: 159 VDPASKTNANSSMN---------PPSAKTN------DAKTSYLGPNNNRGMST-STRSDS 202
Query: 61 LESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNT 120
LESS+ P++PHTGGD+RWDAIN+ + R P+GLS+FRLLKRLGYGDIGSVYLVELRGT
Sbjct: 203 LESSTTPLRPHTGGDIRWDAINLANSRDSPLGLSHFRLLKRLGYGDIGSVYLVELRGTTA 262
Query: 121 YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGN 180
YFAMKVMDKASLASRNKLLRAQTE+EILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGN
Sbjct: 263 YFAMKVMDKASLASRNKLLRAQTEKEILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGN 322
Query: 181 LHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240
LHSLRQKQPNK+F+E+AARF+ASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF
Sbjct: 323 LHSLRQKQPNKHFSEEAARFYASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 382
Query: 241 DLSLRCSVSPTLVK------SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSK 294
DLSLRCSVSPTLVK S+V G G IL+DEYAV GC+QPSTF PRILP+K
Sbjct: 383 DLSLRCSVSPTLVKSSSGHSGSTVGGGGGGISSGAILDDEYAVQGCIQPSTFLPRILPTK 442
Query: 295 KNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGI 354
KNRKSKSDFG VGG+LPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGI
Sbjct: 443 KNRKSKSDFGLFVGGSLPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGI 502
Query: 355 FLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK 414
FLYELLHGTTPFKGQGNRATLFNVVGQPLRFP+TP VSF+ARDLIRGLLVKEP KRIAYK
Sbjct: 503 FLYELLHGTTPFKGQGNRATLFNVVGQPLRFPDTPTVSFMARDLIRGLLVKEPQKRIAYK 562
Query: 415 RGATEIKQHPFFEGVNWALVRSALPPHIPEPVDFSVFAGKDQASAAAEKKVVAAAEAAVD 474
RGATEIKQHPFFEGVNWALVRSA+PPHIPEPVDF FA K+ S AEKK +
Sbjct: 563 RGATEIKQHPFFEGVNWALVRSAMPPHIPEPVDFGHFASKE--SGHAEKK--NSDTGGDK 618
Query: 475 HKNGDSPKD-SYVEFEYF 491
HKN SP D SYV+FEYF
Sbjct: 619 HKN--SPNDASYVDFEYF 634
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555258|ref|XP_003545951.1| PREDICTED: protein kinase G11A-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 741 bits (1914), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/484 (77%), Positives = 404/484 (83%), Gaps = 13/484 (2%)
Query: 14 NQRPLPSQKKP-PNSEPSTVTMPGDIKHANSLTNHGHGSSNCSSRSDSLESSSAPVKPHT 72
Q PS KKP NS+ M + TN G GS SSRSDSLES+SAP++PHT
Sbjct: 85 QQHQSPSTKKPNSNSDHHAKAMSVSTPQTKTSTNQGQGS-GASSRSDSLESTSAPIRPHT 143
Query: 73 GGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASL 132
GGDVRW+AINMIS G + LS+FRLLKR+GYGDIGSVYLVEL+GT TYFAMKVMDKA+L
Sbjct: 144 GGDVRWEAINMISRVGS-LNLSHFRLLKRIGYGDIGSVYLVELKGTRTYFAMKVMDKAAL 202
Query: 133 ASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKY 192
SRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL+MEFCSGG+LHSLRQKQPNK
Sbjct: 203 ISRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLIMEFCSGGDLHSLRQKQPNKC 262
Query: 193 FTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252
FTE+AARF+ASEVLLALEYLHMLGIVYRDLKPEN+LVRDEGHIMLSDFDLSLRCSVSPTL
Sbjct: 263 FTEEAARFYASEVLLALEYLHMLGIVYRDLKPENLLVRDEGHIMLSDFDLSLRCSVSPTL 322
Query: 253 VKSSSVSVNNGSGGG----GGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVG 308
VKSSS N S G GGIL D+ A Q S+FFPRILPSKKNRK+KSDFG VG
Sbjct: 323 VKSSSAHAGNSSSSGNNDVGGILTDDQAAQSTTQVSSFFPRILPSKKNRKAKSDFGLLVG 382
Query: 309 GA-LPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFK 367
G LPELMAEPTNVRSMSFVGTHEYLAPEII+GEGHGSAVDWWTFGIFLYELL GTTPFK
Sbjct: 383 GGRLPELMAEPTNVRSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLLGTTPFK 442
Query: 368 GQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427
G G +ATLFNVVGQPLRFPETPQVS VARDLIRGLLVKEP KRIAYKRGATEIKQHPFFE
Sbjct: 443 GSGYKATLFNVVGQPLRFPETPQVSAVARDLIRGLLVKEPQKRIAYKRGATEIKQHPFFE 502
Query: 428 GVNWALVRSALPPHIPEPVDFSVFAGKDQASAAAEKKVVAAAEAAVDHKNGDSPKDSYVE 487
G+NWALVRSA PPHIPE +DFS +A KD A+ A +K A+ A D K+ +S DSY++
Sbjct: 503 GMNWALVRSATPPHIPEAIDFSKYASKDTATPADKK----MADIAND-KHSNSATDSYID 557
Query: 488 FEYF 491
FEYF
Sbjct: 558 FEYF 561
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449453852|ref|XP_004144670.1| PREDICTED: protein kinase G11A-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 721 bits (1860), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/456 (78%), Positives = 390/456 (85%), Gaps = 22/456 (4%)
Query: 57 RSDSLESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELR 116
R DS+E+ +KPHTGGDVRWDA+NM+S +G + LSNF+LLKRLGYGDIGSVYLVELR
Sbjct: 91 RCDSMETPGMVIKPHTGGDVRWDAVNMVS-KGGALNLSNFQLLKRLGYGDIGSVYLVELR 149
Query: 117 GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFC 176
GT+T+FAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFC
Sbjct: 150 GTDTFFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFC 209
Query: 177 SGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIM 236
SGGNLHSLRQKQPNKYFTE+AARF+ASEVLLALEYLHMLGIVYRDLKPEN+L+RDEGHIM
Sbjct: 210 SGGNLHSLRQKQPNKYFTEEAARFYASEVLLALEYLHMLGIVYRDLKPENLLIRDEGHIM 269
Query: 237 LSDFDLSLRCSVSPTLVKSSSV----------SVNNGSGGGGGILNDEYAVHGCMQPSTF 286
LSDFDLSLRCSVSPTLVKSSSV + +N G GIL+DE+ VHGCMQPS F
Sbjct: 270 LSDFDLSLRCSVSPTLVKSSSVNVNTSSTNANATSNAGLSGAGILDDEFVVHGCMQPSNF 329
Query: 287 FPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSA 346
PRILPSKKNRKSKSDFG VGG+LPELMAEPTNVRSMSFVGTHEYLAPEII+GEGHGSA
Sbjct: 330 LPRILPSKKNRKSKSDFGLFVGGSLPELMAEPTNVRSMSFVGTHEYLAPEIIQGEGHGSA 389
Query: 347 VDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406
VDWWTFGIFLYELLHGTTPFKG GNRATLFNVV QPLRFPE PQVS ARDLIRGLL+KE
Sbjct: 390 VDWWTFGIFLYELLHGTTPFKGSGNRATLFNVVEQPLRFPEAPQVSLAARDLIRGLLIKE 449
Query: 407 PHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEPVDFSVFAGKDQASAAAEKKVV 466
P KRIAY+RGATEIKQHPFF+GVNWALVRSA+PPH+PEPVDF+ FA K + A E K
Sbjct: 450 PQKRIAYRRGATEIKQHPFFDGVNWALVRSAMPPHVPEPVDFTQFARKRSGTGAVEDKRA 509
Query: 467 AAAEAAV----------DHKNGDSPKD-SYVEFEYF 491
AA ++ +G + D +YV+FEYF
Sbjct: 510 VEVAAAAAAATSTVAAGENCSGSTGSDPNYVDFEYF 545
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356528611|ref|XP_003532893.1| PREDICTED: protein kinase G11A-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 719 bits (1856), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/488 (76%), Positives = 409/488 (83%), Gaps = 15/488 (3%)
Query: 10 NSITNQRPLPSQKKPPNSEPSTVTMPGDIKHANSLTNHGHGS-SNCSSRSDSLESSSAPV 68
S + +P + PP+++ +V+ P + S TN+ G S SSRSDSLES+SAP+
Sbjct: 93 QSPSTNKPNSNSDHPPHAKAMSVSTP---QTKTSSTNNLQGQGSGASSRSDSLESTSAPI 149
Query: 69 KPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMD 128
+PHTGGDVRW+AINMIS GP + LS+FRLLKR+GYGDIGSVYLVEL+GT TYFAMKVMD
Sbjct: 150 RPHTGGDVRWEAINMISRVGP-LNLSHFRLLKRIGYGDIGSVYLVELKGTRTYFAMKVMD 208
Query: 129 KASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQ 188
KA+L SRNKLLRAQTEREILGLLDHPFLPTLYSYFET KFYCLVMEFCSGG+LHSLRQKQ
Sbjct: 209 KAALISRNKLLRAQTEREILGLLDHPFLPTLYSYFETRKFYCLVMEFCSGGDLHSLRQKQ 268
Query: 189 PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248
PNK FTE+AARF+ASEVLLALEYLHMLGIVYRDLKPEN+LVRDEGHIMLSDFDLSLRCSV
Sbjct: 269 PNKCFTEEAARFYASEVLLALEYLHMLGIVYRDLKPENLLVRDEGHIMLSDFDLSLRCSV 328
Query: 249 SPTLVKSSSVSVNNGSGGG----GGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFG 304
+PTLVKSSS +N S G G IL D+ AV Q S+FFPRILPSKKNRK+KSDFG
Sbjct: 329 NPTLVKSSSAHASNSSSGSNNDVGSILTDDQAVQSTTQVSSFFPRILPSKKNRKAKSDFG 388
Query: 305 PCVGGA-LPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGT 363
VGG LPELMAEPTNVRSMSFVGTHEYLAPEII+GEGHGSAVDWWTFGIFLYELLHGT
Sbjct: 389 ILVGGGRLPELMAEPTNVRSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLHGT 448
Query: 364 TPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423
TPFKG G +ATLFNVVGQPLRFPETPQVS VARDLIRGLLVKEP KRIAYKRGATEIKQH
Sbjct: 449 TPFKGSGYKATLFNVVGQPLRFPETPQVSAVARDLIRGLLVKEPQKRIAYKRGATEIKQH 508
Query: 424 PFFEGVNWALVRSALPPHIPEPVDFSVFAGKDQASAAAEKKVVAAAEAAVDHKNGDSPKD 483
PFFEG+NWALVRSA PPHIPE +DFS +A KD A +K A+ A D K+ +S D
Sbjct: 509 PFFEGMNWALVRSATPPHIPEVIDFSKYASKDTAPPPDKK----MADIAND-KHSNSATD 563
Query: 484 SYVEFEYF 491
SY+EFEYF
Sbjct: 564 SYIEFEYF 571
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449508237|ref|XP_004163259.1| PREDICTED: protein kinase G11A-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 713 bits (1841), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/452 (78%), Positives = 387/452 (85%), Gaps = 22/452 (4%)
Query: 61 LESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNT 120
+E+ +KPHTGGDVRWDA+NM+S +G + LSNF+LLKRLGYGDIGSVYLVELRGT+T
Sbjct: 1 METPGMVIKPHTGGDVRWDAVNMVS-KGGALNLSNFQLLKRLGYGDIGSVYLVELRGTDT 59
Query: 121 YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGN 180
+FAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGN
Sbjct: 60 FFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGN 119
Query: 181 LHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240
LHSLRQKQPNKYFTE+AARF+ASEVLLALEYLHMLGIVYRDLKPEN+L+RDEGHIMLSDF
Sbjct: 120 LHSLRQKQPNKYFTEEAARFYASEVLLALEYLHMLGIVYRDLKPENLLIRDEGHIMLSDF 179
Query: 241 DLSLRCSVSPTLVKSSSV----------SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRI 290
DLSLRCSVSPTLVKSSSV + +N G GIL+DE+ VHGCMQPS F PRI
Sbjct: 180 DLSLRCSVSPTLVKSSSVNVNTSSTNANATSNAGLSGAGILDDEFVVHGCMQPSNFLPRI 239
Query: 291 LPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWW 350
LPSKKNRKSKSDFG VGG+LPELMAEPTNVRSMSFVGTHEYLAPEII+GEGHGSAVDWW
Sbjct: 240 LPSKKNRKSKSDFGLFVGGSLPELMAEPTNVRSMSFVGTHEYLAPEIIQGEGHGSAVDWW 299
Query: 351 TFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410
TFGIFLYELLHGTTPFKG GNRATLFNVV QPLRFPE PQVS ARDLIRGLL+KEP KR
Sbjct: 300 TFGIFLYELLHGTTPFKGSGNRATLFNVVEQPLRFPEAPQVSLAARDLIRGLLIKEPQKR 359
Query: 411 IAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEPVDFSVFAGKDQASAAAEKKVVAAAE 470
IAY+RGATEIKQHPFF+GVNWALVRSA+PPH+PEPVDF+ FA K + A E K
Sbjct: 360 IAYRRGATEIKQHPFFDGVNWALVRSAMPPHVPEPVDFTQFARKRSGTGAVEDKRAVEVA 419
Query: 471 AAV----------DHKNGDSPKD-SYVEFEYF 491
AA ++ +G + D +YV+FEYF
Sbjct: 420 AAAAAATSTVAAGENCSGSTGSDPNYVDFEYF 451
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1360141|emb|CAA66616.1| protein kinase [Solanum berthaultii] | Back alignment and taxonomy information |
|---|
Score = 711 bits (1835), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/428 (82%), Positives = 380/428 (88%), Gaps = 5/428 (1%)
Query: 67 PVKPHTGGDVRWDAINMISLRG-PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMK 125
P+ PHTGGDVRWDAIN + RG PP+ LSNFRLLKRLGYGDIGSVYLVELRGTN +FAMK
Sbjct: 40 PLSPHTGGDVRWDAINSATGRGGPPLNLSNFRLLKRLGYGDIGSVYLVELRGTNAFFAMK 99
Query: 126 VMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLR 185
VMDK SLASRNKLLRAQTEREIL LLDHPFLPTLYS+FETDKFYCLVMEFCSGGNLH LR
Sbjct: 100 VMDKGSLASRNKLLRAQTEREILSLLDHPFLPTLYSHFETDKFYCLVMEFCSGGNLHQLR 159
Query: 186 QKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245
QKQPNK+FTE+A+RF+ASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR
Sbjct: 160 QKQPNKHFTEEASRFYASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 219
Query: 246 CSVSPTLVKSSSV-SVNNGSGGGGGILNDEYAVHGCMQPSTFFPR-ILPSKKNRKSKSDF 303
CSV+PTLVKSSSV G GIL+++ AV GC+QPSTFFPR ILP+KKNRKSKSDF
Sbjct: 220 CSVNPTLVKSSSVHGGGGNPSSGSGILDNDNAVQGCIQPSTFFPRNILPTKKNRKSKSDF 279
Query: 304 GPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGT 363
G VGG+LPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGT
Sbjct: 280 GLFVGGSLPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGT 339
Query: 364 TPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423
TPFKG GNRATLFNVVGQPLRFPETPQVS +ARDLIRGLLVKEPHKRIAYKRGATEIKQH
Sbjct: 340 TPFKGAGNRATLFNVVGQPLRFPETPQVSAIARDLIRGLLVKEPHKRIAYKRGATEIKQH 399
Query: 424 PFFEGVNWALVRSALPPHIPEPVDFSVFAGKDQASAAAEKKVVAAAEAAVDHKNGDSPKD 483
PFFEGVNWALVRSA+PP IPEPVDF+ +A K+ ++ ++KK+ + D S
Sbjct: 400 PFFEGVNWALVRSAVPPSIPEPVDFAQYASKEASAPCSDKKM--PDTESHDKSKNTSNDS 457
Query: 484 SYVEFEYF 491
SY++FEYF
Sbjct: 458 SYMDFEYF 465
|
Source: Solanum berthaultii Species: Solanum berthaultii Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297842715|ref|XP_002889239.1| hypothetical protein ARALYDRAFT_316818 [Arabidopsis lyrata subsp. lyrata] gi|297335080|gb|EFH65498.1| hypothetical protein ARALYDRAFT_316818 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 707 bits (1824), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/507 (70%), Positives = 403/507 (79%), Gaps = 16/507 (3%)
Query: 1 MDPLTKPRTNSITNQ-RPLPSQKKPPNSEPSTVTMPGDIKHANSLTNHGHGSSNCSSRSD 59
MD L KP +N RP+PS K P + S ++ S N + S+ S +
Sbjct: 52 MDNLIKPEPAGFSNHHRPIPSPKIPSSPGSSMAESQSNLNTKPSNNNSNNNSNMSSRSNS 111
Query: 60 SLESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTN 119
+SS P KPHTGGD+RWDA+NM++ +G +G+S+FRLLKRLGYGDIGSVYLVELRGTN
Sbjct: 112 IESTSSNPSKPHTGGDIRWDAVNMLTSKGVQLGISDFRLLKRLGYGDIGSVYLVELRGTN 171
Query: 120 TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGG 179
TYFAMKVMDKASLASRNKLLRAQTEREIL LDHPFLPTLYS+FETDKFYCLVMEFC GG
Sbjct: 172 TYFAMKVMDKASLASRNKLLRAQTEREILSQLDHPFLPTLYSHFETDKFYCLVMEFCGGG 231
Query: 180 NLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSD 239
NL+SLRQKQPNK FTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD+GHIMLSD
Sbjct: 232 NLYSLRQKQPNKCFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDDGHIMLSD 291
Query: 240 FDLSLRCSVSPTLVKSSSVSVNNGSGGGG---GILNDEYAVHGCMQPSTFFPRIL-PSKK 295
FDLSLRCSVSPTLVKSSSV G G G+++++ AV GC+QPSTFFPRIL SK+
Sbjct: 292 FDLSLRCSVSPTLVKSSSVHAAGGGSGSSRPVGLIDEDAAVQGCIQPSTFFPRILQSSKR 351
Query: 296 NRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIF 355
NRK+KSDFG V G++PELMAEPTNV+SMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIF
Sbjct: 352 NRKAKSDFGLFVNGSMPELMAEPTNVKSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIF 411
Query: 356 LYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKR 415
+YELL+G TPFKGQGNRATL NV+GQ LRFPE P VS ARDLI+GLLVKEP KRIAYKR
Sbjct: 412 IYELLYGATPFKGQGNRATLHNVIGQALRFPEVPHVSSAARDLIKGLLVKEPQKRIAYKR 471
Query: 416 GATEIKQHPFFEGVNWALVRSALPPHIPEPVDFSVFAGKDQASAAA----------EKKV 465
GATEIKQHPFFEGVNWAL+RSA PPH+PEPVDFS +A KD+ S AA
Sbjct: 472 GATEIKQHPFFEGVNWALIRSATPPHVPEPVDFSCYASKDKESMAAVDGGGKKNNIGAGG 531
Query: 466 VAAAEAAVDHK-NGDSPKDSYVEFEYF 491
++ D+K NGD Y++FEYF
Sbjct: 532 GCSSVGGGDNKSNGDCHDPDYIDFEYF 558
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7672777|gb|AAF66637.1|AF143505_1 viroid symptom modulation protein [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 707 bits (1824), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/430 (81%), Positives = 381/430 (88%), Gaps = 7/430 (1%)
Query: 67 PVKPHTGGDVRWDAINMISLRG-PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMK 125
P+KPHTGGD+RWDAIN + RG PP+ LSNFRLLKRLGYGDIGSVYLVELRGTN +FAMK
Sbjct: 40 PLKPHTGGDIRWDAINSATGRGGPPLNLSNFRLLKRLGYGDIGSVYLVELRGTNAFFAMK 99
Query: 126 VMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLR 185
VMDK SLASRNKLLRAQTEREIL LLDHPFLPTLYS+FETDKFYCLVMEFCSGGNLH+LR
Sbjct: 100 VMDKGSLASRNKLLRAQTEREILSLLDHPFLPTLYSHFETDKFYCLVMEFCSGGNLHTLR 159
Query: 186 QKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245
QKQPNK+FTE+A+RF+ASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR
Sbjct: 160 QKQPNKHFTEEASRFYASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 219
Query: 246 CSVSPTLVKSSSVSVNNGSGGGGG---ILNDEYAVHGCMQPSTFFPR-ILPSKKNRKSKS 301
CSV+PTLVKSSSV G G IL+++ AV GC+QPSTFFPR ILP+KKNRKSKS
Sbjct: 220 CSVNPTLVKSSSVHGGGGGGNPSSGSGILDNDNAVQGCIQPSTFFPRNILPTKKNRKSKS 279
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG VGG+LPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH
Sbjct: 280 DFGLFVGGSLPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 339
Query: 362 GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIK 421
GTTPFKG GNRATLFNVVGQPLRFPETPQVS +ARDLIRGLLVKEPHKRIAYKRGATEIK
Sbjct: 340 GTTPFKGAGNRATLFNVVGQPLRFPETPQVSAIARDLIRGLLVKEPHKRIAYKRGATEIK 399
Query: 422 QHPFFEGVNWALVRSALPPHIPEPVDFSVFAGKDQASAAAEKKVVAAAEAAVDHKNGDSP 481
QHPFFEGVNWALVRSA+PP IPEPVDF+ +A KD ++ ++KK+ + D
Sbjct: 400 QHPFFEGVNWALVRSAVPPSIPEPVDFAQYASKDASAPCSDKKM--PDTESHDKSKNTCT 457
Query: 482 KDSYVEFEYF 491
SY++FEYF
Sbjct: 458 DSSYIDFEYF 467
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 491 | ||||||
| TAIR|locus:2207470 | 555 | AGC1.7 "AGC kinase 1.7" [Arabi | 1.0 | 0.884 | 0.679 | 1.5e-179 | |
| TAIR|locus:2087785 | 577 | AGC1.5 "AGC kinase 1.5" [Arabi | 0.851 | 0.724 | 0.759 | 7.7e-174 | |
| TAIR|locus:2032785 | 499 | RSH3 "root hair specific 3" [A | 0.945 | 0.929 | 0.679 | 3.6e-169 | |
| TAIR|locus:2160922 | 586 | D6PKL2 "D6 protein kinase like | 0.847 | 0.709 | 0.644 | 3e-144 | |
| UNIPROTKB|Q5I6E9 | 700 | Adi3 "AvrPto-dependent Pto-int | 0.849 | 0.595 | 0.633 | 2.4e-140 | |
| TAIR|locus:2133837 | 506 | D6PKL1 "D6 protein kinase like | 0.771 | 0.749 | 0.692 | 3.9e-140 | |
| TAIR|locus:2178388 | 498 | D6PK "D6 protein kinase" [Arab | 0.771 | 0.761 | 0.689 | 1.7e-139 | |
| TAIR|locus:2174885 | 499 | AT5G40030 [Arabidopsis thalian | 0.841 | 0.827 | 0.616 | 1.8e-135 | |
| TAIR|locus:2055017 | 765 | AT2G44830 [Arabidopsis thalian | 0.769 | 0.494 | 0.664 | 3.3e-134 | |
| TAIR|locus:2091443 | 578 | ATPK7 [Arabidopsis thaliana (t | 0.847 | 0.719 | 0.607 | 1.9e-131 |
| TAIR|locus:2207470 AGC1.7 "AGC kinase 1.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1743 (618.6 bits), Expect = 1.5e-179, P = 1.5e-179
Identities = 344/506 (67%), Positives = 382/506 (75%)
Query: 1 MDPLTKPRTNSITNQ-RPLPSQKKPPNSEPSTVTMPGDIKHANSLTNHGHGXXXXXXXXX 59
MD L KP TN RP PS K P + + ++ + N +
Sbjct: 50 MDNLIKPEPAGFTNHHRPNPSPKIPSSPGSNMTESQSNLNTKPNNNNSNNNSNMSSRSNS 109
Query: 60 XXXXXXAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTN 119
P KPHTGGD+RWDA+N ++ +G +G+S+FRLLKRLGYGDIGSVYLVELRGT
Sbjct: 110 IESTSSNPSKPHTGGDIRWDAVNTLTSKGVQLGISDFRLLKRLGYGDIGSVYLVELRGTI 169
Query: 120 TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGG 179
TYFAMKVMDKASLASRNKLLRAQTEREIL LDHPFLPTLYS+FETDKFYCLVMEFC GG
Sbjct: 170 TYFAMKVMDKASLASRNKLLRAQTEREILSQLDHPFLPTLYSHFETDKFYCLVMEFCGGG 229
Query: 180 NLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSD 239
NL+SLRQKQPNK FTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD+GHIMLSD
Sbjct: 230 NLYSLRQKQPNKCFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDDGHIMLSD 289
Query: 240 FDLSLRCSVSPTLVKXXXXXXXXXXXXXXX---ILNDEYAVHGCMQPSTFFPRILPS-KK 295
FDLSLRCSVSPTLVK +++++ AV GC+QPSTFFPRIL S KK
Sbjct: 290 FDLSLRCSVSPTLVKSSSVHAAGGGSGSSRPVGLIDEDAAVQGCIQPSTFFPRILQSSKK 349
Query: 296 NRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIF 355
NRK+KSDFG V G++PELMAEPTNV+SMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIF
Sbjct: 350 NRKAKSDFGLFVNGSMPELMAEPTNVKSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIF 409
Query: 356 LYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKR 415
+YELL+G TPFKGQGNRATL NV+GQ LRFPE P VS ARDLI+GLLVKEP KRIAYKR
Sbjct: 410 IYELLYGATPFKGQGNRATLHNVIGQALRFPEVPHVSSAARDLIKGLLVKEPQKRIAYKR 469
Query: 416 GATEIKQHPFFEGVNWALVRSALPPHIPEPVDFSVFAGKDQASXXXXXXXXXX------- 468
GATEIKQHPFFEGVNWAL+RSA PPH+PEPVDFS +A KD+ S
Sbjct: 470 GATEIKQHPFFEGVNWALIRSATPPHVPEPVDFSCYASKDKESMAAVDGGGKKNNNGAGG 529
Query: 469 --XXXXXDHK-NGDSPKDSYVEFEYF 491
D+K NGD Y++FEYF
Sbjct: 530 GCSTGGGDNKPNGDCNDPDYIDFEYF 555
|
|
| TAIR|locus:2087785 AGC1.5 "AGC kinase 1.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1689 (599.6 bits), Expect = 7.7e-174, P = 7.7e-174
Identities = 326/429 (75%), Positives = 358/429 (83%)
Query: 67 PVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKV 126
P KPHTGGDVRWDAIN I+ +GP IGL NFRLLKRLGYGDIGSVYL +LRGTN FAMKV
Sbjct: 156 PFKPHTGGDVRWDAINSIASKGPQIGLDNFRLLKRLGYGDIGSVYLADLRGTNAVFAMKV 215
Query: 127 MDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQ 186
MDKASLASRNKLLRAQTEREIL LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQ
Sbjct: 216 MDKASLASRNKLLRAQTEREILSLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQ 275
Query: 187 KQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246
KQP++ FTE+AARF+ASEVLLALEYLHMLG+VYRDLKPEN+LVRDEGHIMLSDFDLSLRC
Sbjct: 276 KQPSRRFTEEAARFYASEVLLALEYLHMLGVVYRDLKPENILVRDEGHIMLSDFDLSLRC 335
Query: 247 SVSPTLVKXXXXXXXXXXXXXXXILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPC 306
+ +PTLVK ILN+E+AV+GCM PS F PR+LPSKK RK+KSD G
Sbjct: 336 TFNPTLVKSSSVCSGGGA-----ILNEEFAVNGCMHPSAFLPRLLPSKKTRKAKSDSG-- 388
Query: 307 VGG-ALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTP 365
+GG ++PELMAEPT+VRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTP
Sbjct: 389 LGGLSMPELMAEPTDVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTP 448
Query: 366 FKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425
FKGQGNRATL NVVGQPL+FP+TP VS ARDLIRGLLVK+PH+RIAY RGATEIKQHPF
Sbjct: 449 FKGQGNRATLHNVVGQPLKFPDTPHVSSAARDLIRGLLVKDPHRRIAYTRGATEIKQHPF 508
Query: 426 FEGVNWALVRSALPPHIPEPVDFSVFA---GKDQASXXXXXXXXXXXXXXXDHKNGDSPK 482
FEGVNWALVRSA PPHIP+PVD +A GK ++ G +
Sbjct: 509 FEGVNWALVRSAAPPHIPDPVDLGPYAAARGKTKSHGGGDHCNSMKPEPLVACAAGPTDD 568
Query: 483 DSYVEFEYF 491
+Y++FEYF
Sbjct: 569 TAYIDFEYF 577
|
|
| TAIR|locus:2032785 RSH3 "root hair specific 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1645 (584.1 bits), Expect = 3.6e-169, P = 3.6e-169
Identities = 328/483 (67%), Positives = 368/483 (76%)
Query: 15 QRPLPSQKKPPNSEPSTVTMPG-DIKHANSL--TNHGHGXXXXXXXXXXXXXXXAPVKPH 71
Q+ P + K E +T + IK ++L +NH + KPH
Sbjct: 30 QQQKPRKDKQKQVEQNTKKIEEHQIKSESTLLISNHNVNMSSQSNNSESTSTNNSS-KPH 88
Query: 72 TGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTN--TYFAMKVMDK 129
TGGD+RWDA+N + RG +G+S+FR+LKRLGYGDIGSVYLVEL+G N TYFAMKVMDK
Sbjct: 89 TGGDIRWDAVNSLKSRGIKLGISDFRVLKRLGYGDIGSVYLVELKGANPTTYFAMKVMDK 148
Query: 130 ASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQP 189
ASL SRNKLLRAQTEREIL LDHPFLPTLYS+FETDKFYCLVMEFCSGGNL+SLRQKQP
Sbjct: 149 ASLVSRNKLLRAQTEREILSQLDHPFLPTLYSHFETDKFYCLVMEFCSGGNLYSLRQKQP 208
Query: 190 NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249
NK FTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD+GHIMLSDFDLSLRCSV+
Sbjct: 209 NKCFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDDGHIMLSDFDLSLRCSVN 268
Query: 250 PTLVKXXXXXXXXXXXXXXXILNDEYAVHGCMQPSTFFPRILPS-KKNRKSKSDFGPCVG 308
PTLVK I++D AV GC QPS FFPR+L S KKNRKSKSDF
Sbjct: 269 PTLVKSFNGGGTTG------IIDDNAAVQGCYQPSAFFPRMLQSSKKNRKSKSDFD---- 318
Query: 309 GALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKG 368
G+LPELMAEPTNV+SMSFVGTHEYLAPEII+ EGHGSAVDWWTFGIF+YELLHG TPFKG
Sbjct: 319 GSLPELMAEPTNVKSMSFVGTHEYLAPEIIKNEGHGSAVDWWTFGIFIYELLHGATPFKG 378
Query: 369 QGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428
QGN+ATL+NV+GQPLRFPE QVS A+DLI+GLLVKEP RIAYKRGATEIKQHPFFEG
Sbjct: 379 QGNKATLYNVIGQPLRFPEYSQVSSTAKDLIKGLLVKEPQNRIAYKRGATEIKQHPFFEG 438
Query: 429 VNWALVRSALPPHIPEPVDFSVFAGKDQASXXXXXXXXXXXXXXXDHKNGDSPKDSYVEF 488
VNWAL+R PPH+PEPVDFS + K++ S +K+G P Y+ F
Sbjct: 439 VNWALIRGETPPHLPEPVDFSCYVKKEKESLPPAATEKKSKMFDEANKSGSDP--DYIVF 496
Query: 489 EYF 491
EYF
Sbjct: 497 EYF 499
|
|
| TAIR|locus:2160922 D6PKL2 "D6 protein kinase like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1386 (493.0 bits), Expect = 3.0e-144, Sum P(2) = 3.0e-144
Identities = 277/430 (64%), Positives = 317/430 (73%)
Query: 69 KPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMD 128
KPH D+RW+AI + +R +GLS+FRLLKRLG GDIGSVYL EL GT YFAMKVMD
Sbjct: 164 KPHKANDLRWEAIQAVRVRDGLLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMD 223
Query: 129 KASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQ 188
K SLASR KLLRAQTEREIL LDHPFLPTLY++FET+KF CLVMEFC GG+LH+LRQ+Q
Sbjct: 224 KTSLASRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQRQ 283
Query: 189 PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248
P K+F+E A +F+ +E LLALEYLHMLGIVYRDLKPENVLVR++GHIMLSDFDLSLRC V
Sbjct: 284 PGKHFSEQAVKFYIAESLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCLV 343
Query: 249 SPTLVKXXXXXXXXXXXXXXXI----LNDEYAVHGCMQPSTFF-PRILPSK--KNRKSKS 301
SPTLVK + + C P+T F PR+ SK K+RK K+
Sbjct: 344 SPTLVKSAAIESDPLRKNVYCVQPACIEPSCIQPSCTVPTTCFSPRLFSSKSKKDRKPKN 403
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
D V LPEL+AEPT+ RSMSFVGTHEYLAPEII+GEGHGSAVDWWTFGIFLYELL
Sbjct: 404 DTANQVR-PLPELVAEPTDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF 462
Query: 362 GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIK 421
G TPFKG GNR TLFNVVGQPLRFPETP VSF ARDLIRGLL+KEP +R+ +KRGATE+K
Sbjct: 463 GRTPFKGSGNRQTLFNVVGQPLRFPETPVVSFAARDLIRGLLMKEPQQRLGFKRGATEVK 522
Query: 422 QHPFFEGVNWALVRSALPPHIPEPVDFSVFAGKDQASXXXXXXXXXXXXXXXDHKNGDSP 481
QHPFFEGVNWAL+R A PP IP+PV+ K S N
Sbjct: 523 QHPFFEGVNWALIRCATPPEIPKPVELE----KGAVSVAEAPSSQKTAAGLV--LNAQKG 576
Query: 482 KDSYVEFEYF 491
D+Y+EF++F
Sbjct: 577 SDNYLEFDFF 586
|
|
| UNIPROTKB|Q5I6E9 Adi3 "AvrPto-dependent Pto-interacting protein 3" [Solanum lycopersicum (taxid:4081)] | Back alignment and assigned GO terms |
|---|
Score = 1373 (488.4 bits), Expect = 2.4e-140, P = 2.4e-140
Identities = 270/426 (63%), Positives = 318/426 (74%)
Query: 69 KPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMD 128
KPH G D RW AI I R +G+S+F+LLKRLG GDIGSVYL EL GT YFAMKVMD
Sbjct: 281 KPHKGNDPRWKAILAIRARDGILGMSHFKLLKRLGCGDIGSVYLSELSGTRCYFAMKVMD 340
Query: 129 KASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQ 188
KASLASR KL RAQTEREIL LLDHPFLPTLY++FETD+F CLVME+C GG+LH+LRQ+Q
Sbjct: 341 KASLASRKKLTRAQTEREILQLLDHPFLPTLYTHFETDRFSCLVMEYCPGGDLHTLRQRQ 400
Query: 189 PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248
P K+F+E AARF+A+EVLLALEYLHMLG+VYRDLKPENVLVRD+GHIMLSDFDLSLRC+V
Sbjct: 401 PGKHFSEYAARFYAAEVLLALEYLHMLGVVYRDLKPENVLVRDDGHIMLSDFDLSLRCAV 460
Query: 249 SPTLVKXXXXXXXXXXXXXXXILNDEYAVHGCMQPSTFFPRILPSKKNRKS---KSDFGP 305
SPTL++ CMQP+ F PR+ P K +K+ ++D G
Sbjct: 461 SPTLIRISSDDPSKRGAAFCVQPACIEPTTVCMQPACFLPRLFPQKSKKKTPKPRADSG- 519
Query: 306 CVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTP 365
++PEL+AEPT+ RSMSFVGTHEYLAPEII+GEGHGSAVDWWTFGIFL+ELL+G TP
Sbjct: 520 FQANSMPELVAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLHELLYGKTP 579
Query: 366 FKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425
FKG GNRATLFNVVGQ L+FP++P S+ +RDLIRGLLVKEP R+ KRGATEIKQHPF
Sbjct: 580 FKGSGNRATLFNVVGQQLKFPDSPATSYASRDLIRGLLVKEPQNRLGVKRGATEIKQHPF 639
Query: 426 FEGVNWALVRSALPPHIPEPVDFSVFAGKDQASXXXXXXXXXXXXXXXDHKNGDSPKDSY 485
FEGVNWAL+R + PP +P PV+ A Q + D K+G Y
Sbjct: 640 FEGVNWALIRCSTPPEVPRPVEPDYPAKYGQVNPVGVGNTSKRVVGA-DAKSGGK----Y 694
Query: 486 VEFEYF 491
++FE+F
Sbjct: 695 LDFEFF 700
|
|
| TAIR|locus:2133837 D6PKL1 "D6 protein kinase like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1371 (487.7 bits), Expect = 3.9e-140, P = 3.9e-140
Identities = 266/384 (69%), Positives = 306/384 (79%)
Query: 69 KPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMD 128
KPH DVRW+AI + + +GL++FRLLKRLG GDIG+V+L EL GT +FAMKVMD
Sbjct: 96 KPHKANDVRWEAIQAVRTKHGVLGLNHFRLLKRLGCGDIGTVHLAELHGTRCFFAMKVMD 155
Query: 129 KASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQ 188
K +LASR KLLRAQTEREIL LDHPFLPTLYS+FET+KF CLVMEFC GG+LH+LRQ+Q
Sbjct: 156 KGALASRKKLLRAQTEREILQCLDHPFLPTLYSHFETEKFSCLVMEFCPGGDLHTLRQRQ 215
Query: 189 PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248
P K F+E AA+F+ +EVLLA+EYLHMLGI+YRDLKPENVLVRD+GH+MLSDFDLSLRC+V
Sbjct: 216 PGKRFSEQAAKFYVAEVLLAMEYLHMLGIIYRDLKPENVLVRDDGHVMLSDFDLSLRCTV 275
Query: 249 SPTLVKXXXXXXXXXXXXXXXILNDEYAVHGCMQ-PSTFF-PRILPSK--KNRKSKSDFG 304
SPT+V+ C+ P+T F PR SK K++K K++ G
Sbjct: 276 SPTVVRSTVLASEGQKNSGYCAQPACIQQPSCISAPTTCFSPRYFSSKSKKDKKMKNETG 335
Query: 305 PCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTT 364
V LPEL+AEPT+ RSMSFVGTHEYLAPEII+GEGHGSAVDWWTFGIFLYELL G T
Sbjct: 336 NQVS-PLPELVAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKT 394
Query: 365 PFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHP 424
PFKG GNRATLFNVVGQPLRFPE+P VSF ARDLIR LLVKEP R+AYKRGATE+KQHP
Sbjct: 395 PFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRSLLVKEPQHRLAYKRGATEMKQHP 454
Query: 425 FFEGVNWALVRSALPPHIPEPVDF 448
FFEGVNWALVR A PP IP+PVD+
Sbjct: 455 FFEGVNWALVRCASPPEIPKPVDY 478
|
|
| TAIR|locus:2178388 D6PK "D6 protein kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1365 (485.6 bits), Expect = 1.7e-139, P = 1.7e-139
Identities = 266/386 (68%), Positives = 303/386 (78%)
Query: 69 KPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMD 128
KPH DVRW+AI + + +GL++FRLLKRLG GDIG+V+L EL GT YFAMKVMD
Sbjct: 82 KPHKANDVRWEAIQAVRTKHGGLGLNHFRLLKRLGCGDIGTVHLAELNGTRCYFAMKVMD 141
Query: 129 KASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQ 188
K +LASR KLLRAQTEREIL LDHPFLPTLYS+FET+KF CLVMEFC GG+LH+LRQ+Q
Sbjct: 142 KTALASRKKLLRAQTEREILQCLDHPFLPTLYSHFETEKFSCLVMEFCPGGDLHTLRQRQ 201
Query: 189 PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248
P K FTE AA+F+ +EVLLA+EYLHMLGI+YRDLKPENVLVRD+GH+MLSDFDLSLRC+V
Sbjct: 202 PGKRFTEQAAKFYVAEVLLAMEYLHMLGIIYRDLKPENVLVRDDGHVMLSDFDLSLRCTV 261
Query: 249 SPTLVKXXXXXXXXXXXXXXXILNDEYAVH--GC--MQPSTFF-PRILPSK--KNRKSKS 301
S ++V+ + C M P++ F PR SK K++K K+
Sbjct: 262 SLSIVRSANVGSEGLSKNSVSCSQQPACIQQPSCISMAPTSCFGPRFFSSKSKKDKKPKT 321
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
+ G LPEL+AEPT RSMSFVGTHEYLAPEII+GEGHGSAVDWWTFGIFLYELL
Sbjct: 322 ENGNHQVTPLPELVAEPTGARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF 381
Query: 362 GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIK 421
G TPFKG GNRATLFNVVGQPLRFPE+P VSF ARDLIR LLVKEP R+AYKRGATEIK
Sbjct: 382 GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRSLLVKEPQHRLAYKRGATEIK 441
Query: 422 QHPFFEGVNWALVRSALPPHIPEPVD 447
QHPFFEGVNWALVR A PP IP+PVD
Sbjct: 442 QHPFFEGVNWALVRCASPPEIPKPVD 467
|
|
| TAIR|locus:2174885 AT5G40030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1327 (472.2 bits), Expect = 1.8e-135, P = 1.8e-135
Identities = 265/430 (61%), Positives = 316/430 (73%)
Query: 66 APVKPHTGGDVRWDAI-NMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAM 124
AP KPH G D+RWDAI N+ + +GL +FRLLK+LG GDIGSVYL ELR +FAM
Sbjct: 83 APSKPHKGNDLRWDAIQNVKCSKNEDLGLGHFRLLKKLGCGDIGSVYLAELREMGCFFAM 142
Query: 125 KVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSL 184
KVMDK L R KL+RAQTEREILGLLDHPFLPTLYS+FET+KF CL+MEFCSGG+LH L
Sbjct: 143 KVMDKGMLIGRKKLVRAQTEREILGLLDHPFLPTLYSHFETEKFSCLLMEFCSGGDLHIL 202
Query: 185 RQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244
RQKQP K+F+E AARF+ASEVLLALEYLHM+G+VYRDLKPENV+VR++GHIMLSDFDLSL
Sbjct: 203 RQKQPGKHFSELAARFYASEVLLALEYLHMMGVVYRDLKPENVMVREDGHIMLSDFDLSL 262
Query: 245 RCSVSPTLVKXXXXXXXXXXXXXXX--ILNDEYAVH-GCMQPSTFFPRILPSKKNRKSKS 301
+ VSPTL++ ++ + C+QPS F PR L + K RK+K+
Sbjct: 263 QSFVSPTLIQSTSQPSCHIASYCIQPPCIDPSCKLPVACIQPSCFKPRFL-NNKPRKAKT 321
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
+ +LP L+AEPT RSMSFVGTHEYLAPEIIRG+GHGS+VDWWTFGIFLYELL
Sbjct: 322 E--KAGSDSLPMLIAEPTAARSMSFVGTHEYLAPEIIRGDGHGSSVDWWTFGIFLYELLT 379
Query: 362 GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIK 421
G TPFKG GNR TLFNVVGQPL+FPE +SF A+DLIRGLL K+P KR+ +K+GATEIK
Sbjct: 380 GKTPFKGNGNRETLFNVVGQPLKFPEG-SISFAAKDLIRGLLTKDPKKRLGFKKGATEIK 438
Query: 422 QHPFFEGVNWALVRSALPPHIPEPVDFSVFAGKDQASXXXXXXXXXXXXXXXDHKNGDSP 481
QHPFF VNWAL+RS PP IP+P+D S+ ++S K DS
Sbjct: 439 QHPFFNNVNWALIRSTTPPEIPKPIDLSILNETLKSSVQQQGKHS---------KQSDSS 489
Query: 482 KDSYVEFEYF 491
Y++FE+F
Sbjct: 490 SGPYLDFEFF 499
|
|
| TAIR|locus:2055017 AT2G44830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1315 (468.0 bits), Expect = 3.3e-134, P = 3.3e-134
Identities = 255/384 (66%), Positives = 302/384 (78%)
Query: 69 KPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMD 128
KPH G D W+AI I R +G+S+F+LLKRLG GDIGSVYL EL GT +FA+KVMD
Sbjct: 336 KPHKGNDPWWNAILAIRTRDGILGMSHFKLLKRLGCGDIGSVYLAELSGTRCHFAVKVMD 395
Query: 129 KASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQ 188
KASL R KL RAQTER+IL LLDHPFLPTLY++FETD+F CLVME+C GG+LH+LRQ+Q
Sbjct: 396 KASLEDRKKLNRAQTERDILQLLDHPFLPTLYTHFETDRFSCLVMEYCPGGDLHTLRQRQ 455
Query: 189 PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248
P K+F+E AARF+A+EVLLALEYLHMLG+VYRDLKPENVLVRD+GHIMLSDFDLSLRC+V
Sbjct: 456 PGKHFSEYAARFYAAEVLLALEYLHMLGVVYRDLKPENVLVRDDGHIMLSDFDLSLRCAV 515
Query: 249 SPTLVKXXXXXXXXXXXXXXXILNDEYAVHGCMQPSTFFPR-ILPSK----KNRKSKSDF 303
SPTL+K E +QPS F PR I P+K K+RK+++DF
Sbjct: 516 SPTLIKTFDSDPSRRGAFCVQPACMEPTSACIIQPSCFLPRSIFPNKNKKNKSRKTQADF 575
Query: 304 GPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGT 363
G+LPEL+AEP N RSMSFVGTHEYLAPEII+GEGHGSAVDWWTFGIF++ELL+G
Sbjct: 576 FKSHSGSLPELVAEP-NTRSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFVHELLYGK 634
Query: 364 TPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423
TPFKG GNRATLFNVVG+ L+FPE+P S+ RDLI+ LLVK+P R+ KRGATEIKQH
Sbjct: 635 TPFKGSGNRATLFNVVGEQLKFPESPATSYAGRDLIQALLVKDPKNRLGTKRGATEIKQH 694
Query: 424 PFFEGVNWALVRSALPPHIPEPVD 447
PFFEGVNWAL+R + PP +P ++
Sbjct: 695 PFFEGVNWALIRCSTPPEVPRQME 718
|
|
| TAIR|locus:2091443 ATPK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1289 (458.8 bits), Expect = 1.9e-131, P = 1.9e-131
Identities = 258/425 (60%), Positives = 304/425 (71%)
Query: 30 STVTMPG-DIKHANSLTNHGHGXXXXXXXXXXXXXXXAPVKPHT-GGDVRWDAINMISLR 87
ST+ + G D++ + G A KPH D RW AI + R
Sbjct: 113 STIGIGGIDLEKNGVMIYRGSIGSDVSDESSSSGLSNAAYKPHRDNNDKRWVAIQEVRSR 172
Query: 88 -GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE 146
G + +F+L+K+LG GDIG+VYL EL GT FA+KVM+KA++A+R KL+RAQTE+E
Sbjct: 173 VGSSLEAKDFKLIKKLGGGDIGNVYLAELIGTGVSFAVKVMEKAAIAARKKLVRAQTEKE 232
Query: 147 ILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVL 206
IL LDHPFLPTLYS+FET+ CLVMEFC GG+LHSLRQKQ KYF E AARF+ +EVL
Sbjct: 233 ILQSLDHPFLPTLYSHFETEMNSCLVMEFCPGGDLHSLRQKQRGKYFPEQAARFYVAEVL 292
Query: 207 LALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKXXXXXXXXXXXX 266
LA+EYLHMLGI+YRDLKPENVLVR++GHIMLSDFDLSLRC+VSPTLV+
Sbjct: 293 LAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLVRFAAITLESKSSS 352
Query: 267 XX---XILNDEYAV--HGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNV 321
++ + C+QP F PR L K+RK +D + LPEL+AEPT+
Sbjct: 353 YCIQPTCVDQSSCIVQPDCIQPVCFTPRFLSKGKHRKKSNDMSRQIR-PLPELIAEPTSA 411
Query: 322 RSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ 381
RSMSFVGTHEYLAPEII+GEGHGSAVDWWTFGIFLYELL G TPF+G NRATLFNVVGQ
Sbjct: 412 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGITPFRGGDNRATLFNVVGQ 471
Query: 382 PLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPH 441
PLRFPE P VSF ARDLIRGLLVKEP R+AY+RGATEIKQHPFF+ VNWAL+R PP
Sbjct: 472 PLRFPEHPNVSFAARDLIRGLLVKEPQHRLAYRRGATEIKQHPFFQSVNWALIRCTSPPQ 531
Query: 442 IPEPV 446
IP+PV
Sbjct: 532 IPQPV 536
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.VIII.1411.1 | hypothetical protein (409 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 491 | |||
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-174 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-75 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-71 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-62 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-59 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-56 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-56 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-52 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-46 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-45 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-44 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-44 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-44 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-43 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-43 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-41 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-41 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-38 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-37 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-37 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-36 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-36 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-35 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-35 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-35 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-34 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-34 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-34 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-34 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-34 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-34 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-33 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-33 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-32 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-32 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-31 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-31 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-31 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-31 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-30 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-30 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-30 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-30 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-30 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-30 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-29 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-29 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-29 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-29 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-28 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-27 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-27 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-27 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-27 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-27 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-27 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-27 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-27 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-26 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-26 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-26 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-26 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-26 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-25 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-25 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-25 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-25 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-25 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-25 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-25 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-24 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-24 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-24 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-24 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-24 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-24 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-24 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-24 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-24 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-24 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-23 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-23 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-23 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-23 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-23 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-23 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-23 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-23 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-22 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-22 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-22 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-22 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-22 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-22 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-22 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-22 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-22 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-21 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-21 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-21 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-21 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-21 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-21 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-21 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-20 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-20 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-20 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-20 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-20 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-19 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-19 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-19 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-19 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-19 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-18 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-18 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-18 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-17 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-17 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-15 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-14 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-12 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-12 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-11 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-10 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-10 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-10 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-10 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-10 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-09 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-08 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-08 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-07 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-07 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-07 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-07 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-06 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-06 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-06 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-06 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-06 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-06 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-05 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-05 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-05 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-05 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-05 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-05 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 6e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-04 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-04 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 8e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-04 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 0.001 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 0.001 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 0.001 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 0.001 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.001 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.001 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 0.001 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 0.002 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 0.002 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.002 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 0.002 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.002 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 0.002 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 0.002 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 0.003 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 0.003 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 0.003 | |
| pfam10707 | 199 | pfam10707, YrbL-PhoP_reg, PhoP regulatory network | 0.003 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 0.003 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 0.003 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 0.004 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 0.004 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 0.004 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.004 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 492 bits (1269), Expect = e-174
Identities = 181/352 (51%), Positives = 225/352 (63%), Gaps = 41/352 (11%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
F+ +K LG GD+G V+LV L+GT FA+KV+DK + RNK+ R TE+EIL LDHPF
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML 215
LPTLY+ F+T+ + CLVM++C GG L L Q+QP K +E+ ARF+A+EVLLALEYLH+L
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL 122
Query: 216 GIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEY 275
GIVYRDLKPEN+L+ + GHIMLSDFDLS + V P V +
Sbjct: 123 GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKAL------------------ 164
Query: 276 AVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAP 335
R + + S E +E + RS SFVGT EY+AP
Sbjct: 165 -------------RKGSRRSSVNS----------IPSETFSEEPSFRSNSFVGTEEYIAP 201
Query: 336 EIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVA 395
E+I G+GHGSAVDWWT GI LYE+L+GTTPFKG T N++ + + FP +P VS A
Sbjct: 202 EVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSA 261
Query: 396 RDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEPVD 447
RDLIR LLVK+P KR+ KRGA EIKQHPFF GVNWAL+R PP IP P D
Sbjct: 262 RDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPDD 313
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 241 bits (617), Expect = 1e-75
Identities = 128/402 (31%), Positives = 201/402 (50%), Gaps = 58/402 (14%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+F ++K +G G G V+LV + T +AMKV+ K+ + RN++ + ER+IL D
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
P++ LY F+ ++ LVME+ GG+L +L ++ F E+ ARF+ +E++LAL+ +H
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVH 118
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILND 273
LG ++RD+KP+N+L+ +GHI L+DF L + N + LND
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCKKM---------------NKAKDREYYLND 163
Query: 274 EYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333
+ + K R+ VR+ S VGT +Y+
Sbjct: 164 SHNLLFRDNVLVRRRD----HKQRR----------------------VRANSTVGTPDYI 197
Query: 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG--QPLRFPETPQV 391
APE++RG +G DWW+ G+ LYE+L+G PF + T ++ + LRFP P V
Sbjct: 198 APEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPV 257
Query: 392 SFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE---PVDF 448
S A DLI LL +P R+ EIK HPFF+G++W +R PP +PE P+D
Sbjct: 258 SPEAIDLICRLLC-DPEDRL---GSFEEIKSHPFFKGIDWENLRETKPPFVPELSSPLDT 313
Query: 449 SVFAGKDQASAAAEKKVVAAAEAAVDHKNGDSPKDSYVEFEY 490
S F D + K ++ + K + ++V F Y
Sbjct: 314 SNF---DDFE---DDKDLSDYLSQNSKKLNKGKQLAFVGFTY 349
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 227 bits (580), Expect = 5e-71
Identities = 98/335 (29%), Positives = 153/335 (45%), Gaps = 57/335 (17%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD- 152
+F+ K +G G +V L + + TN +A+K++DK L K+ + E+E+L L+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 153 HPFLPTLYSYFE-TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEY 211
HP + LY F+ + Y V+E+ G L +K + E RF+A+E+LLALEY
Sbjct: 61 HPGIIKLYYTFQDEENLY-FVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEY 117
Query: 212 LHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGIL 271
LH GI++RDLKPEN+L+ + HI ++DF G +L
Sbjct: 118 LHSKGIIHRDLKPENILLDKDMHIKITDF-------------------------GTAKVL 152
Query: 272 NDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331
+ + +T + + R + SFVGT E
Sbjct: 153 DPNSSPESNKGDATNIDSQIEKNRRRFA-------------------------SFVGTAE 187
Query: 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQV 391
Y++PE++ + G + D W G +Y++L G PF+G T ++ FP
Sbjct: 188 YVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPP 247
Query: 392 SFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
A+DLI LLV +P R+ G E+K HPFF
Sbjct: 248 --DAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 207 bits (530), Expect = 1e-62
Identities = 112/365 (30%), Positives = 184/365 (50%), Gaps = 45/365 (12%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+F +K +G G G V LV+ + T +AMK + K+ + + ++ + ER+IL D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
P++ LY F+ + + L+ME+ GG++ +L K+ FTE+ RF+ +E +LA++ +H
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIH 118
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLS--LRCSVSPTLVKSSSVSVNNGSGGGGGIL 271
LG ++RD+KP+N+L+ +GHI LSDF L L+ S + S
Sbjct: 119 KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYR-------ILSHALPSNF 171
Query: 272 NDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331
D + +P + + K+NR++ + S VGT +
Sbjct: 172 LDFIS-----KPMSSKRKAETWKRNRRAL----------------------AYSTVGTPD 204
Query: 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG--QPLRFPETP 389
Y+APE+ G+ DWW+ G+ +YE+L G PF + T ++ + L+FP+
Sbjct: 205 YIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEV 264
Query: 390 QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE---PV 446
+S A+DLI+ L E +R+ G EIK HPFF+GV+W +R P IPE
Sbjct: 265 PLSPEAKDLIKRLCC-EAERRLG-NNGVNEIKSHPFFKGVDWEHIRERPAPIIPELKSIT 322
Query: 447 DFSVF 451
D S F
Sbjct: 323 DTSNF 327
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 200 bits (509), Expect = 2e-59
Identities = 118/357 (33%), Positives = 182/357 (50%), Gaps = 39/357 (10%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+F +K +G G G V LV+ + T +AMK + K+ + +++L + ER++L D P
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
++ +LY F+ ++ L+MEF GG+L ++ K F+ED RF+ +E +LA+E +H
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHK 119
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLS-----LRCSVSPTLVKSSSVSVNNGSGGGGG 269
LG ++RD+KP+N+L+ GHI LSDF LS S + S N
Sbjct: 120 LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK-SNKNRIDNRNS 178
Query: 270 ILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329
+ D +++ M +I KKNR+ LMA T VGT
Sbjct: 179 VAVD--SINLTMSSKD---QIATWKKNRR---------------LMAYST-------VGT 211
Query: 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG--QPLRFPE 387
+Y+APEI +G+G DWW+ G ++E L G PF + + T ++ + L FP+
Sbjct: 212 PDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPD 271
Query: 388 TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE 444
+S A DLIR L+ R+ + GA EIK HPFF GV+W +R P IP+
Sbjct: 272 DIHLSVEAEDLIRRLIT-NAENRLG-RGGAHEIKSHPFFRGVDWDTIRQIRAPFIPQ 326
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 1e-56
Identities = 66/142 (46%), Positives = 94/142 (66%), Gaps = 2/142 (1%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYS 161
LG G G V LV + T +AMKV+ K + R ++ TER IL ++HPF+ L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 162 YFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRD 221
F+T++ LV+E+ GG L S K+ F+E+ ARF+A+E++LALEYLH LGI+YRD
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRD 118
Query: 222 LKPENVLVRDEGHIMLSDFDLS 243
LKPEN+L+ +GHI L+DF L+
Sbjct: 119 LKPENILLDADGHIKLTDFGLA 140
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 2e-56
Identities = 123/404 (30%), Positives = 189/404 (46%), Gaps = 39/404 (9%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
S F +K +G G G V LV TN +AMK + KA + RN+ + ER+IL D+
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN 60
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
++ LY F+ VM++ GG++ SL + F ED ARF+ +E+ A+E +H
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVH 118
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILND 273
+G ++RD+KP+N+L+ +GHI L+DF L C T + + S G
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGL---C----TGFRWTHDSKYYQKGD------- 164
Query: 274 EYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPEL-MAEPTNVRSMSFVGTHEY 332
+ M+PS + S+ C L + + S VGT Y
Sbjct: 165 -HHRQDSMEPSEEW-------------SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNY 210
Query: 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG--QPLRFPETPQ 390
+APE++ G+ DWW+ G+ LYE+L G PF T V+ L P +
Sbjct: 211 IAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAK 270
Query: 391 VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA-LVRSALPPHIPE---PV 446
+S A DLI L R+ K GA EIK HPFF+G+++A L+R P+IP+ P
Sbjct: 271 LSREASDLILR-LCCGAEDRLG-KNGADEIKAHPFFKGIDFASLIRRQKAPYIPKITHPT 328
Query: 447 DFSVFAGKDQASAAAEKKVVAAAEAAVDHKNGDSPKDSYVEFEY 490
D S F D ++ ++ + V N + ++ EF +
Sbjct: 329 DTSNFDPVDPEKLRSDDSGESSPDRNVKPNNRKRTEHAFYEFTF 372
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 2e-52
Identities = 63/148 (42%), Positives = 90/148 (60%), Gaps = 4/148 (2%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
+ +L++LG G G VYL + T A+KV+ K + + R E +IL L HP
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML 215
+ LY FE + LVME+C GG+L L +K +ED ARF+ ++L ALEYLH
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKK--RGRLSEDEARFYLRQILSALEYLHSK 116
Query: 216 GIVYRDLKPENVLVRDEGHIMLSDFDLS 243
GIV+RDLKPEN+L+ ++GH+ L+DF L+
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLA 144
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 1e-46
Identities = 66/149 (44%), Positives = 93/149 (62%), Gaps = 6/149 (4%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQT--EREILGLL 151
+F +K LG G G V LV +G+ Y+A+K++ KA + + K + E+ IL +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-KLKQV-EHVLNEKRILQSI 58
Query: 152 DHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEY 211
HPFL LY F+ D LVME+ GG L S +K + F E ARF+A++V+LALEY
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEY 116
Query: 212 LHMLGIVYRDLKPENVLVRDEGHIMLSDF 240
LH L IVYRDLKPEN+L+ +G+I ++DF
Sbjct: 117 LHSLDIVYRDLKPENLLLDSDGYIKITDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 6e-45
Identities = 111/362 (30%), Positives = 180/362 (49%), Gaps = 44/362 (12%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+F LK +G G G V LV+ + T +AMK++ KA + + ++ + ER+IL D
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
++ ++ F+ + L+MEF GG++ +L K+ +E+A +F+ +E +LA++ +H
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQ 119
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDE 274
LG ++RD+KP+N+L+ +GH+ LSDF L T +K + + E
Sbjct: 120 LGFIHRDIKPDNLLLDAKGHVKLSDFGLC-------TGLKKAHRT--------------E 158
Query: 275 YAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334
+ + P + F S +N SK E + + S VGT +Y+A
Sbjct: 159 FYRNLTHNPPSDF-----SFQNMNSKRK---------AETWKKNRRQLAYSTVGTPDYIA 204
Query: 335 PEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG--QPLRFPETPQVS 392
PE+ G+ DWW+ G+ +YE+L G PF + + T V+ + L FP +S
Sbjct: 205 PEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPIS 264
Query: 393 FVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVR---SALPPHIPEPVDFS 449
A+DLI + RI G EIK HPFFEGV+W +R +A+P I D S
Sbjct: 265 EKAKDLILRFCT-DSENRIG-SNGVEEIKSHPFFEGVDWGHIRERPAAIPIEIKSIDDTS 322
Query: 450 VF 451
F
Sbjct: 323 NF 324
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 3e-44
Identities = 109/374 (29%), Positives = 177/374 (47%), Gaps = 73/374 (19%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+F +LK +G G G V +V+L+ + FAMK+++K + R + + ER++L D+
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
++ TL+ F+ + LVM++ GG+L +L K ++ ED ARF+ +E+++A++ +H
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVHQ 120
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDE 274
L V+RD+KP+N+L+ GHI L+DF L+ T+ SSV+V
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV--QSSVAVGT------------ 166
Query: 275 YAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334
P P IL + ++ K K
Sbjct: 167 --------PDYISPEILQAMEDGKGK---------------------------------- 184
Query: 335 PEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFV 394
+G DWW+ G+ +YE+L+G TPF + T ++ RF QV+ V
Sbjct: 185 --------YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236
Query: 395 ---ARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE---PVDF 448
A+DLIR L+ H+ + G + KQHPFF G++W +R+ P+IPE P D
Sbjct: 237 SEDAKDLIRRLICSREHR--LGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTDT 294
Query: 449 SVFAGKDQASAAAE 462
S F D +E
Sbjct: 295 SNFDVDDDCLKNSE 308
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 3e-44
Identities = 108/352 (30%), Positives = 163/352 (46%), Gaps = 82/352 (23%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL-LDHPFLPT 158
K LG G G V L EL+GT+ +A+KV+ K + + + TE+ IL L HPFL
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 159 LYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIV 218
L+ F+T VME+ +GG+L + Q Q ++ F E +RF+A+EV LAL +LH G++
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 219 YRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVH 278
YRDLK +N+L+ EGH L+DF + C GILN
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGM---CK--------------------EGILNGVTTTT 155
Query: 279 GCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338
C P P IL + ++GP
Sbjct: 156 FCGTPDYIAPEIL-------QELEYGP--------------------------------- 175
Query: 339 RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLF-NVVGQPLRFPETPQVSFVARD 397
+VDWW G+ +YE++ G PF+ N LF +++ + +P +S A
Sbjct: 176 -------SVDWWALGVLMYEMMAGQPPFEAD-NEDDLFESILHDDVLYP--VWLSKEAVS 225
Query: 398 LIRGLLVKEPHKR---IAYKRGATEIKQHPFFEGVNWALV--RSALPPHIPE 444
+++ + K P+KR +A + G IKQHPFF+ ++W L+ R PP P+
Sbjct: 226 ILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPK 277
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 8e-44
Identities = 119/403 (29%), Positives = 193/403 (47%), Gaps = 54/403 (13%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+F LK +G G G V LV+ + T +AMK++ KA + + ++ + ER+IL D
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
++ ++ F+ L+MEF GG++ +L K+ TE+ +F+ +E +LA++ +H
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVLAIDSIHQ 119
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDE 274
LG ++RD+KP+N+L+ +GH+ LSDF L C+ L K+ LN
Sbjct: 120 LGFIHRDIKPDNLLLDSKGHVKLSDFGL---CT---GLKKAHRTEFYRN-------LNHS 166
Query: 275 YAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF--VGTHEY 332
PS F + + SK RK+++ N R ++F VGT +Y
Sbjct: 167 L-------PSDFTFQNMNSK--RKAET---------------WKRNRRQLAFSTVGTPDY 202
Query: 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG--QPLRFPETPQ 390
+APE+ G+ DWW+ G+ +YE+L G PF + + T V+ + L FP
Sbjct: 203 IAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVP 262
Query: 391 VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVR---SALPPHIPEPVD 447
+S A+DLI + H+ A G EIK +PFFEGV+W +R +A+P I D
Sbjct: 263 ISEKAKDLILRFCCEWEHRIGA--PGVEEIKTNPFFEGVDWEHIRERPAAIPIEIKSIDD 320
Query: 448 FSVFAGKDQASAAAEKKVVAAAEAAVDHKNGDSPKDSYVEFEY 490
S F + ++ A +H D +V Y
Sbjct: 321 TSNF------DEFPDSDILKPTVATSNHPETDYKNKDWVFINY 357
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 3e-43
Identities = 58/139 (41%), Positives = 87/139 (62%), Gaps = 2/139 (1%)
Query: 105 GDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE 164
G G V+L + + T +A+KV+ KA + +N++ + TER+IL P++ LY F+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 165 TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKP 224
K LVME+ GG+L SL + ED AR + +E++LALEYLH GI++RDLKP
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKP 121
Query: 225 ENVLVRDEGHIMLSDFDLS 243
+N+L+ GH+ L+DF LS
Sbjct: 122 DNILIDSNGHLKLTDFGLS 140
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 5e-43
Identities = 57/160 (35%), Positives = 88/160 (55%), Gaps = 3/160 (1%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
+ LL++LG G G+VY + +GT A+K++ K K A+ E IL L HP
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK-RSEKSKKDQTARREIRILRRLSHPN 59
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML 215
+ L FE LVME+C GG+L + +ED A+ A ++L LEYLH
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR--GGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 216 GIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKS 255
GI++RDLKPEN+L+ + G + ++DF L+ + S + + +
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT 157
|
Length = 260 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 7e-43
Identities = 123/409 (30%), Positives = 190/409 (46%), Gaps = 43/409 (10%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
S F +K LG G G V L T +AMK + K + RN++ + ER+IL D+
Sbjct: 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN 60
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
++ LY F+ VM++ GG++ SL + F ED ARF+ +E+ A+E +H
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVH 118
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILND 273
+G ++RD+KP+N+L+ +GHI L+DF L C+ G +
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGL---CT------------------GFRWTHDS 157
Query: 274 EYAVHG--CMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS--FVGT 329
+Y G Q S F N + P E A + R ++ VGT
Sbjct: 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL------ERRAARQHQRCLAHSLVGT 211
Query: 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG--QPLRFPE 387
Y+APE++ G+ DWW+ G+ LYE+L G PF Q T V+ L P
Sbjct: 212 PNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPP 271
Query: 388 TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWAL-VRSALPPHIPE-- 444
++S A DLI L + P R+ K GA EIK HPFF+ ++++ +R P+IP+
Sbjct: 272 QAKLSPEASDLIIK-LCRGPEDRLG-KNGADEIKAHPFFKTIDFSSDLRQQSAPYIPKIT 329
Query: 445 -PVDFSVFAGKDQASAAAEKKVVAAAEAAVD--HKNGDSPKDSYVEFEY 490
P D S F D ++ ++ +KNG P+ ++ EF +
Sbjct: 330 HPTDTSNFDPVDPDKLWSDDDKEGNVNDTLNGWYKNGKHPEHAFYEFTF 378
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 9e-43
Identities = 117/412 (28%), Positives = 192/412 (46%), Gaps = 50/412 (12%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
S F +K LG G G V L T+ +AMK + K + +RN++ + ER+IL D+
Sbjct: 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN 60
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
++ LY F+ VM++ GG++ SL + + F E ARF+ +E+ LA+E +H
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVH 118
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILND 273
+G ++RD+KP+N+L+ +GHI L+DF L C+ G N
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGL---CT------------------GFRWTHNS 157
Query: 274 EYAVHG------CMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM--S 325
+Y G M+PS + + + + K+ E A + R + S
Sbjct: 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKT----------LEQRATKQHQRCLAHS 207
Query: 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG--QPL 383
VGT Y+APE++ +G+ DWW+ G+ L+E+L G PF T V+ L
Sbjct: 208 LVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL 267
Query: 384 RFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWAL-VRSALPPHI 442
P ++S A DLI L + + GA +IK HPFF V+++ +R+ P++
Sbjct: 268 HIPPQVKLSPEAVDLITKLCCSAEER--LGRNGADDIKAHPFFSEVDFSSDIRTQPAPYV 325
Query: 443 PE---PVDFSVFAGKDQASA-AAEKKVVAAAEAAVDHKNGDSPKDSYVEFEY 490
P+ P+D S F ++ S + NG P+ ++ EF +
Sbjct: 326 PKISHPMDTSNFDPVEEESPWNDASGDSTRTWDTLCSPNGKHPEHAFYEFTF 377
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 4e-41
Identities = 61/155 (39%), Positives = 87/155 (56%), Gaps = 4/155 (2%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYS 161
LG G G+VYL + T A+K++ K S + L E EIL L+HP + LY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 162 YFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRD 221
FE + LVME+C GG+L L ++ K +ED ++L LEYLH GI++RD
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 222 LKPENVLV-RDEGHIMLSDFDLSLRCSVSPTLVKS 255
LKPEN+L+ D G + L+DF LS + +L+K+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 6e-41
Identities = 104/367 (28%), Positives = 173/367 (47%), Gaps = 73/367 (19%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+F ++K +G G G V +V+++ T +AMK+++K + R + + ER +L D
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
++ TL+ F+ + + LVM++ GG+L +L K ++ ED ARF+ +E++LA+ +H
Sbjct: 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQ 120
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDE 274
L V+RD+KP+NVL+ GHI L+DF L+ + T+ SSV+V
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV--QSSVAVGT------------ 166
Query: 275 YAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334
P P IL + ++ K +GP
Sbjct: 167 --------PDYISPEILQAMEDGMGK--YGP----------------------------- 187
Query: 335 PEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF---PETPQV 391
DWW+ G+ +YE+L+G TPF + T ++ RF V
Sbjct: 188 -----------ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236
Query: 392 SFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE---PVDF 448
S A+DLI+ L+ +R+ + G + K+H FFEG++W +R+ P+IP+ P D
Sbjct: 237 SEEAKDLIQRLICSR-ERRLG-QNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSSPSDT 294
Query: 449 SVFAGKD 455
S F D
Sbjct: 295 SNFDVDD 301
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 56/139 (40%), Positives = 83/139 (59%), Gaps = 2/139 (1%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYS 161
LG G G V LV+++ N FA+K + K + + +E+EIL +HPF+ LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 162 YFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRD 221
F+ K+ ++ME+C GG L ++ + F E ARF+ + V+LA EYLH GI+YRD
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARFYIACVVLAFEYLHNRGIIYRD 118
Query: 222 LKPENVLVRDEGHIMLSDF 240
LKPEN+L+ G++ L DF
Sbjct: 119 LKPENLLLDSNGYVKLVDF 137
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 7e-37
Identities = 65/155 (41%), Positives = 100/155 (64%), Gaps = 9/155 (5%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRG---TNTYFAMKVMDKASLASRNKLLR-AQTEREILGL 150
NF LL+ LG G G V+LV G +AMKV+ KA++ + K +TER++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 151 LDH-PFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLA 208
+ PFL TL+ F+TD L++++ +GG L + L Q++ +FTE R + +E++LA
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLA 117
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
L++LH LGI+YRD+K EN+L+ EGH++L+DF LS
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 9e-37
Identities = 58/127 (45%), Positives = 77/127 (60%), Gaps = 12/127 (9%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+DFG R+ +F GT EYLAPE++ G+G+G AVDWW+ G+ LYE+L
Sbjct: 135 TDFGLAK-------ELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEML 187
Query: 361 HGTTPFKGQGNRATLFN-VVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATE 419
G PF + +R ++ ++ PLRFPE +S ARDLI GLL K+P KR+ GA E
Sbjct: 188 TGKPPFYAE-DRKEIYEKILKDPLRFPEF--LSPEARDLISGLLQKDPTKRLGS-GGAEE 243
Query: 420 IKQHPFF 426
IK HPFF
Sbjct: 244 IKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 5e-36
Identities = 62/150 (41%), Positives = 94/150 (62%), Gaps = 2/150 (1%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+F +K + G G+VYLV + T FAMK ++K +L RN++ + ER+IL ++
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
PF+ +++ FET + C+VME+ GG+ +L + D AR + +E +LALEYLH
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA--LPVDMARMYFAETVLALEYLH 118
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
GIV+RDLKP+N+L+ GHI L+DF LS
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 9e-36
Identities = 101/361 (27%), Positives = 166/361 (45%), Gaps = 69/361 (19%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+F +LK +G G G V +V+++ T +AMK+++K + R + + ER++L D
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR 61
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
++ L+ F+ + LVM++ GG+L +L K ++ ED ARF+ +E++LA++ +H
Sbjct: 62 WITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVLAIDSVHQ 120
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDE 274
LG V+RD+KP+NVL+ GHI L+DF LR T+ S+V+V
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV--QSNVAVGT------------ 166
Query: 275 YAVHGCMQPSTFFPRILPSKKNRKSKSDFGP-CVGGALPELMAEPTNVRSMSFVGTHEYL 333
P P IL + ++ K + +GP C +L M E G +
Sbjct: 167 --------PDYISPEILQAMEDGKGR--YGPECDWWSLGVCMYE-------MLYGETPFY 209
Query: 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSF 393
A ++ T+G + N F E +
Sbjct: 210 AESLVE-----------TYGKIM--------------NHKEHFQFPPDVTDVSEEAK--- 241
Query: 394 VARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE---PVDFSV 450
DLIR L+ P R+ + G + K HPFFEG++W +R++ P++PE P D S
Sbjct: 242 ---DLIRRLICS-PETRLG-RNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTDTSN 296
Query: 451 F 451
F
Sbjct: 297 F 297
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 56/151 (37%), Positives = 95/151 (62%), Gaps = 6/151 (3%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+F LL+ +G G G V +V+ R T FAMK M+K + + ER IL L+HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNL--HSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
FL L+ F+ ++ LV++ GG+L H ++ + F+E+ +F+ E++LALEYL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK----FSEEQVKFWICEIVLALEYL 116
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
H GI++RD+KP+N+L+ ++GH+ ++DF+++
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHITDFNIA 147
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 51/128 (39%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 322 RSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ 381
R+ + GT EYLAPEII +G+G AVDWW GI +YE+L G PF ++
Sbjct: 154 RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG 213
Query: 382 PLRFPETPQVSFVARDLIRGLLVKEPHKRIAY-KRGATEIKQHPFFEGVNW-ALVRSALP 439
+RFP S A+DLIR LL + KR+ K G +IK HP+F G++W AL++ +
Sbjct: 214 KVRFPSF--FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIE 271
Query: 440 PHIPEPVD 447
V
Sbjct: 272 APFIPKVK 279
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 6e-35
Identities = 63/140 (45%), Positives = 85/140 (60%), Gaps = 9/140 (6%)
Query: 322 RSMSFVGTHEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG 380
R+ SF GT EY+APEIIRG+ GHG AVDWW+ GI ++ELL G +PF +G R T V
Sbjct: 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR 221
Query: 381 QPLRF--PETPQVSFVARDLIRGLLVKEPHKRI-AYKRGATEIKQHPFFEGVNWAL---- 433
+ L+ P + A+DL+ LL K+P KR+ A +GA+EIK+HPFF+G++W
Sbjct: 222 RILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALR 281
Query: 434 -VRSALPPHIPEPVDFSVFA 452
V P I +D FA
Sbjct: 282 KVNPPFRPSIRNELDVGNFA 301
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 3e-34
Identities = 69/155 (44%), Positives = 100/155 (64%), Gaps = 9/155 (5%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRG---TNTYFAMKVMDKASLASRNKLLR-AQTEREILGL 150
NF LLK LG G G V+LV T +AMKV+ KA+L + K + +TER +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 151 L-DHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLA 208
+ PFL TL+ F+T+ L++++ SGG + + L Q+ F+ED RF++ E++LA
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILA 117
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
LE+LH LGIVYRD+K EN+L+ EGH++L+DF LS
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 3e-34
Identities = 68/149 (45%), Positives = 103/149 (69%), Gaps = 8/149 (5%)
Query: 99 LKRLGYGDIGSVYLV-ELRGT--NTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
LK LG G G V+LV ++ G +AMKV+ KA+L R+++ R + ER+IL ++HPF
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV-RTKMERDILAEVNHPF 59
Query: 156 LPTLYSYFETD-KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
+ L+ F+T+ K Y L+++F GG+L + K+ FTE+ +F+ +E+ LAL++LH
Sbjct: 60 IVKLHYAFQTEGKLY-LILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS 116
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
LGI+YRDLKPEN+L+ +EGHI L+DF LS
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLS 145
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 62/147 (42%), Positives = 90/147 (61%), Gaps = 7/147 (4%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPT 158
K LG G G V L EL+GT+ +A+KV+ K + + + TE+ +L L HPFL
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 159 LYSYFETDKFYCLVMEFCSGGNL--HSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG 216
L+S F+T VME+ +GG+L H R + F E ARF+A+E++L L++LH G
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLHERG 116
Query: 217 IVYRDLKPENVLVRDEGHIMLSDFDLS 243
I+YRDLK +NVL+ EGHI ++DF +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMC 143
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 6e-34
Identities = 107/353 (30%), Positives = 155/353 (43%), Gaps = 83/353 (23%)
Query: 99 LKRLGYGDIGSVYLVE-LRGTNT--YFAMKVMDKASLASRNKLLRAQT--EREILGLLDH 153
LK LG G G V+ V + G +T FAMKV+ KA++ RN+ A T ER IL + H
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-RNQKDTAHTKAERNILEAVKH 59
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
PF+ L F+T GG L+ L LEYL
Sbjct: 60 PFIVDLIYAFQT------------GGKLY------------------------LILEYLS 83
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILND 273
G ++ L+ E + + D LS+ L+L L+
Sbjct: 84 G-GELFMHLEREGIFMEDTACFYLSEISLAL------------------------EHLHQ 118
Query: 274 EYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333
+ ++ ++P IL + +DFG C E + E + +F GT EY+
Sbjct: 119 QGIIYRDLKPEN----ILLDAQGHVKLTDFGLC-----KESIHE--GTVTHTFCGTIEYM 167
Query: 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSF 393
APEI+ GHG AVDWW+ G +Y++L G PF + + T+ ++ L P P ++
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP--PYLTP 225
Query: 394 VARDLIRGLLVKEPHKRIAYKRG-ATEIKQHPFFEGVNW--ALVRSALPPHIP 443
ARDL++ LL + P R+ G A E++ HPFF VNW L R PP P
Sbjct: 226 EARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKP 278
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 6e-34
Identities = 57/148 (38%), Positives = 82/148 (55%), Gaps = 4/148 (2%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+ +K +G G G V+LV R + Y+A+KVM + + E+ +L + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALEYL 212
PF+ L+ +F ++ME+ GG L S LR F+ F+ASE++ ALEYL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYL 117
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDF 240
H IVYRDLKPEN+L+ EGHI L+DF
Sbjct: 118 HSKEIVYRDLKPENILLDKEGHIKLTDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 7e-34
Identities = 57/146 (39%), Positives = 92/146 (63%), Gaps = 3/146 (2%)
Query: 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLP 157
LK + G GSVYL + R T YFA+KV+ K+ + ++N++ + ER I+ + + P++
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 158 TLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGI 217
LY F++ + LVME+ +GG+ SL + ED A+ + +EV+L +E LH GI
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 218 VYRDLKPENVLVRDEGHIMLSDFDLS 243
++RD+KPEN+L+ GH+ L+DF LS
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLS 144
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 54/131 (41%), Positives = 72/131 (54%), Gaps = 2/131 (1%)
Query: 302 DFG-PCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
DFG VG ++ VGT +Y+APE+I G+GH VDWW+ G LYE L
Sbjct: 136 DFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFL 195
Query: 361 HGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEI 420
G PF G+ N++ + +PE +VS A DLI LLV +P KR+ K EI
Sbjct: 196 VGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAK-SIEEI 254
Query: 421 KQHPFFEGVNW 431
K HPFF+G++W
Sbjct: 255 KNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 49/151 (32%), Positives = 85/151 (56%), Gaps = 3/151 (1%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+ ++K++G G G VYLV + + +K +D ++++ + + A E +IL L+HP
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE-DALNEVKILKKLNHP 59
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSL--RQKQPNKYFTEDAARFFASEVLLALEYL 212
+ Y FE C+VME+ GG+L +QK+ K F E+ + ++ LAL+YL
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
H I++RD+KP+N+ + G + L DF +S
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGIS 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 56/150 (37%), Positives = 86/150 (57%), Gaps = 6/150 (4%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL---GLLD 152
FR L LG G G V L E + T +A+K + K + +R+++ E+ I
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
HPFL L++ F+T+ C VME+ +GG+L + + F+E A F+A+ V+L L+YL
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDV-FSEPRAVFYAACVVLGLQYL 117
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242
H IVYRDLK +N+L+ EG + ++DF L
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 54/128 (42%), Positives = 70/128 (54%), Gaps = 14/128 (10%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+DFG + +FVGT EY+APE++ G+G+G AVD W+ G+ LYELL
Sbjct: 139 ADFGLAR--------QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELL 190
Query: 361 HGTTPFKGQGNRATLFNVVGQPLRFPETP--QVSFVARDLIRGLLVKEPHKRIAYKRGAT 418
G PF G LF +G+P P +S A+DLIR LLVK+P KR+ A
Sbjct: 191 TGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL----TAE 246
Query: 419 EIKQHPFF 426
E QHPFF
Sbjct: 247 EALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 83/334 (24%), Positives = 131/334 (39%), Gaps = 86/334 (25%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
F +L+++G G G VY + T A+KV+ S + K++ E +IL HP
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN---EIQILKKCKHPN 58
Query: 156 LPTLY-SYFETDKFYCLVMEFCSGGNLHSLRQ--KQPNKYFTEDAARFFASEVLLALEYL 212
+ Y SY + D+ + +VMEFCSGG SL+ K N+ TE + E+L LEYL
Sbjct: 59 IVKYYGSYLKKDELW-IVMEFCSGG---SLKDLLKSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILN 272
H GI++ RD +K++++ +L
Sbjct: 115 HSNGIIH----------RD---------------------IKAANI-----------LLT 132
Query: 273 DEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332
+ V ++ DFG + + VGT +
Sbjct: 133 SDGEV-----------KL----------IDFGLSAQLS--------DTKARNTMVGTPYW 163
Query: 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV-GQPLRFPETPQV 391
+APE+I G+ + D W+ GI EL G P+ LF + P +
Sbjct: 164 MAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKW 223
Query: 392 SFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425
S +D ++ L K P KR A ++ +HPF
Sbjct: 224 SDEFKDFLKKCLQKNPEKR----PTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 4e-32
Identities = 60/147 (40%), Positives = 83/147 (56%), Gaps = 16/147 (10%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRG--EGHGSAVDWWTFGIFLYE 358
+DFG L + R+ SF GT EY+APE+IRG GH AVDWW+ G+ +E
Sbjct: 147 TDFG------LSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFE 200
Query: 359 LLHGTTPFKGQGNRATLFNVVGQPLR----FPETPQVSFVARDLIRGLLVKEPHKRIAYK 414
LL G +PF G + + + + L+ FP+T +S ARD I+ LL K+P KR+
Sbjct: 201 LLTGASPFTVDGEQNSQSEISRRILKSKPPFPKT--MSAEARDFIQKLLEKDPKKRLGAN 258
Query: 415 RGATEIKQHPFFEGVNW-ALVRSALPP 440
GA EIK HPFF+G++W L +P
Sbjct: 259 -GADEIKNHPFFQGIDWDDLAAKRIPA 284
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 59/142 (41%), Positives = 88/142 (61%), Gaps = 3/142 (2%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL-LDHPFLPT 158
K LG G G V L EL+GTN +FA+K + K + + + ER +L L +HPFL
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 159 LYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIV 218
L+ F+T + VME+ +GG+L + Q + F E ARF+A+E++ L++LH GI+
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGLQFLHKKGII 118
Query: 219 YRDLKPENVLVRDEGHIMLSDF 240
YRDLK +NVL+ +GHI ++DF
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADF 140
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 59/145 (40%), Positives = 87/145 (60%), Gaps = 6/145 (4%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTL 159
K LG G G V LV + T Y+AMK++ K + +++++ TE +L HPFL L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 160 YSYFETDKFYCLVMEFCSGGNL--HSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGI 217
F+T C VME+ +GG L H R++ F+ED ARF+ +E++ AL YLH +
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSCDV 116
Query: 218 VYRDLKPENVLVRDEGHIMLSDFDL 242
VYRDLK EN+++ +GHI ++DF L
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-31
Identities = 50/154 (32%), Positives = 76/154 (49%), Gaps = 7/154 (4%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRA-QTEREILGLLDH 153
+ + LG G GSVYL + T A+K ++ + + + L A + E IL L H
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSE--EELEALEREIRILSSLQH 58
Query: 154 PFLPTLYSYF--ETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEY 211
P + Y E + +E+ SGG+L SL +K E R + ++L L Y
Sbjct: 59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAY 116
Query: 212 LHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245
LH GIV+RD+K N+LV +G + L+DF + R
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCAKR 150
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 57/145 (39%), Positives = 88/145 (60%), Gaps = 5/145 (3%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL-GLLDHPFLPT 158
K +G G G V L + + ++A+KV+ K ++ + + ER +L + HPFL
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 159 L-YSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGI 217
L YS+ DK Y V+++ +GG L Q++ + F E ARF+A+E+ AL YLH L I
Sbjct: 61 LHYSFQTADKLY-FVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNI 117
Query: 218 VYRDLKPENVLVRDEGHIMLSDFDL 242
+YRDLKPEN+L+ +GH++L+DF L
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 59/145 (40%), Positives = 88/145 (60%), Gaps = 6/145 (4%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTL 159
K LG G G V LV + T Y+AMK++ K + +++++ TE +L HPFL L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 160 YSYFETDKFYCLVMEFCSGGNL--HSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGI 217
F+T C VME+ +GG L H R++ FTE+ ARF+ +E++ ALEYLH +
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRDV 116
Query: 218 VYRDLKPENVLVRDEGHIMLSDFDL 242
VYRD+K EN+++ +GHI ++DF L
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 52/146 (35%), Positives = 80/146 (54%), Gaps = 14/146 (9%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG C G L V + +F GT +Y+APEI+ + +G AVDWW G+ LYE+L
Sbjct: 139 DFGMCKEGILG-------GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLA 191
Query: 362 GTTPFKGQGNRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI-AYKRGATE 419
G +PF+G + LF +++ +R+P +S A+ +++ L K P KR+ G +
Sbjct: 192 GQSPFEGD-DEDELFQSILEDEVRYPRW--LSKEAKSILKSFLTKNPEKRLGCLPTGEQD 248
Query: 420 IKQHPFFEGVNWALV--RSALPPHIP 443
IK HPFF ++W + + PP P
Sbjct: 249 IKGHPFFREIDWDKLERKEIKPPFKP 274
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-30
Identities = 55/156 (35%), Positives = 92/156 (58%), Gaps = 8/156 (5%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD 152
LS+F + + LG G G V + + +GT Y+A+K + K + ++ E+ IL L
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQ--KQPNKYFTEDAARFFASEVLLAL 209
HPF+ + F+ + ++EF GG L + LR+ + PN D A+F+ +E++LA
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN-----DVAKFYHAELVLAF 131
Query: 210 EYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245
EYLH I+YRDLKPEN+L+ ++GH+ ++DF + +
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK 167
|
Length = 329 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 56/150 (37%), Positives = 86/150 (57%), Gaps = 2/150 (1%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+F++L ++G G G V+L + + T A+K M K+ L N++ TER+IL
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
+L L F+ D++ L ME+ GG+ +L +ED ARF+ +E+ A++ LH
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALH 118
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
LG ++RDLKPEN L+ GHI L+DF LS
Sbjct: 119 ELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 60/165 (36%), Positives = 100/165 (60%), Gaps = 3/165 (1%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+F + +G G G V +V + T +AMKVM K+ L ++ + + ER+IL + + P
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61
Query: 155 FLPTL-YSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
++P L Y++ + D Y LVME+ GG+L SL + ++ F ED A+F+ +E++LA+ +H
Sbjct: 62 WIPQLQYAFQDKDNLY-LVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLAIHSVH 119
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258
+G V+RD+KPENVL+ GHI L+DF + R + + + V
Sbjct: 120 QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV 164
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 8e-30
Identities = 61/148 (41%), Positives = 91/148 (61%), Gaps = 2/148 (1%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
F ++K + G G VYL + + +A+KV+ KA + ++N + + Q ER+ L L PF
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML 215
+ LY ++ LVME+ GG++ SL YF E+ A + SEV LAL+YLH
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRH 123
Query: 216 GIVYRDLKPENVLVRDEGHIMLSDFDLS 243
GI++RDLKP+N+L+ +EGHI L+DF LS
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 6e-29
Identities = 51/124 (41%), Positives = 68/124 (54%), Gaps = 4/124 (3%)
Query: 322 RSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ 381
R+ + GT EYLAPE+I+ +GHG AVDWWT G+ LYE + G PF ++
Sbjct: 171 RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG 230
Query: 382 PLRFPETPQVSFVARDLIRGLLVKEPHKRI-AYKRGATEIKQHPFFEGVNW-ALVRSALP 439
L+FP ARDL++GLL + KR+ K G ++K HP+F G NW L P
Sbjct: 231 RLKFPN--WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYP 288
Query: 440 PHIP 443
IP
Sbjct: 289 APIP 292
|
Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 67/190 (35%), Positives = 88/190 (46%), Gaps = 30/190 (15%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+DFG C G E + S +F GT EYLAPE++R + + VDWW G LYE+L
Sbjct: 138 TDFGLCKEGI------EHSKTTS-TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEML 190
Query: 361 HGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEI 420
+G PF + N++ +PLR P +S AR L+ GLL K+ KR+ K EI
Sbjct: 191 YGLPPFYSRDTAEMYDNILNKPLRLK--PNISVSARHLLEGLLQKDRTKRLGAKDDFLEI 248
Query: 421 KQHPFFEGVNWA--LVRSALPPHIP-----------------EPVDFSVFAGKDQASAAA 461
K H FF +NW + + PP P EPV SV GK S
Sbjct: 249 KNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPNSV--GKSPDSVLV 306
Query: 462 EKKVVAAAEA 471
V A +A
Sbjct: 307 SASVKEADDA 316
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 8e-29
Identities = 54/142 (38%), Positives = 77/142 (54%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYS 161
LG G G V +++ T +A K +DK L R A E++IL + F+ +L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 162 YFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRD 221
FET CLVM +GG+L F E A F+A++++ LE+LH IVYRD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 222 LKPENVLVRDEGHIMLSDFDLS 243
LKPENVL+ D G++ +SD L+
Sbjct: 121 LKPENVLLDDHGNVRISDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 8e-29
Identities = 64/155 (41%), Positives = 101/155 (65%), Gaps = 9/155 (5%)
Query: 95 NFRLLKRLGYGDIGSVYLV-ELRGTNT--YFAMKVMDKASLASRNKLLR-AQTEREIL-G 149
NF LLK LG G G V+LV ++ G ++ +AMKV+ KA++ + K +TER++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 150 LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLA 208
+ PFL TL+ F+TD L++++ +GG L + L Q++ F E + ++ E++LA
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLA 117
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
LE+LH LGI+YRD+K EN+L+ GH++L+DF LS
Sbjct: 118 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 57/148 (38%), Positives = 87/148 (58%), Gaps = 5/148 (3%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+F L LG G G V L E +GT+ +A+K++ K + + + E+ +L L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 155 -FLPTLYSYFET-DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
FL L+S F+T D+ Y VME+ +GG+L + Q F E A F+A+E+ + L +L
Sbjct: 61 PFLTQLHSCFQTMDRLY-FVMEYVNGGDL--MYHIQQVGKFKEPHAVFYAAEIAIGLFFL 117
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDF 240
H GI+YRDLK +NV++ EGHI ++DF
Sbjct: 118 HSKGIIYRDLKLDNVMLDAEGHIKIADF 145
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 57/144 (39%), Positives = 87/144 (60%), Gaps = 3/144 (2%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPT 158
K LG G G V+L EL+GTN +FA+K + K + + + E+ +L L +HPFL
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 159 LYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIV 218
LY F+T + VME+ +GG+L + Q F A F+A+E++ L++LH GIV
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 219 YRDLKPENVLVRDEGHIMLSDFDL 242
YRDLK +N+L+ +GHI ++DF +
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 43/113 (38%), Positives = 67/113 (59%), Gaps = 3/113 (2%)
Query: 322 RSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKG-QGNRATLFNVVG 380
++ +F GT EY+APEII +G+ +VD+W+ GI LYELL G PF + ++N +
Sbjct: 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL 207
Query: 381 QPLRFPETPQ-VSFVARDLIRGLLVKEPHKRIAY-KRGATEIKQHPFFEGVNW 431
+ E P + A+DLI+ LL + P +R+ K G +IK+H +F G +W
Sbjct: 208 KGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 58/144 (40%), Positives = 84/144 (58%), Gaps = 12/144 (8%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG C +L + + ++ +F GT EYLAPE++ G G+ AVDWWT G+ LYE+L
Sbjct: 136 DFGLC------KLNMKDDD-KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
Query: 362 GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIK 421
G PF + ++ +PLRFP+ A+DL+ GLL ++P +R+ Y GA EIK
Sbjct: 189 GLPPFYDENVNEMYRKILQEPLRFPDG--FDRDAKDLLIGLLSRDPTRRLGYN-GAQEIK 245
Query: 422 QHPFFEGVNWA--LVRSALPPHIP 443
HPFF ++W L++ PP P
Sbjct: 246 NHPFFSQLSWKKLLMKGIQPPFKP 269
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 60/142 (42%), Positives = 87/142 (61%), Gaps = 7/142 (4%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLY 160
+G G V LVEL+ T +AMKV+ K + + QTE+ + +HPFL L+
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 161 SYFETDKFYCLVMEFCSGGNL--HSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIV 218
S F+T+ V+EF SGG+L H RQ++ E+ ARF+++E+ LAL +LH GI+
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRK----LPEEHARFYSAEISLALNFLHERGII 118
Query: 219 YRDLKPENVLVRDEGHIMLSDF 240
YRDLK +NVL+ EGHI L+D+
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDY 140
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 58/145 (40%), Positives = 88/145 (60%), Gaps = 6/145 (4%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTL 159
K LG G G V LV + + Y+AMK++ K + +++++ TE +L HPFL +L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 160 YSYFETDKFYCLVMEFCSGGNL--HSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGI 217
F+T C VME+ +GG L H R+ + F+ED RF+ +E++ AL+YLH I
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSGKI 116
Query: 218 VYRDLKPENVLVRDEGHIMLSDFDL 242
VYRDLK EN+++ +GHI ++DF L
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 4e-27
Identities = 57/136 (41%), Positives = 83/136 (61%), Gaps = 11/136 (8%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRG--EGHGSAVDWWTFGIFLYE 358
+DFG L + E R+ SF GT EY+AP+I+RG GH AVDWW+ G+ +YE
Sbjct: 147 TDFG------LSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYE 200
Query: 359 LLHGTTPFKGQGNRATLFNVVGQPLRF-PETPQ-VSFVARDLIRGLLVKEPHKRIAY-KR 415
LL G +PF G + + + + L+ P PQ +S +A+D+I+ LL+K+P KR+
Sbjct: 201 LLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPS 260
Query: 416 GATEIKQHPFFEGVNW 431
A EIK+HPFF+ +NW
Sbjct: 261 DADEIKKHPFFQKINW 276
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 62/145 (42%), Positives = 86/145 (59%), Gaps = 5/145 (3%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL---GLLDHPFLPT 158
+G G G VY V + T +AMKV+ K + ++ ++ ER IL L + PF+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 159 LYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIV 218
L F+TD LV ++ SGG L QK+ F+ED A+F+ +E++LALE+LH IV
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR--FSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 219 YRDLKPENVLVRDEGHIMLSDFDLS 243
YRDLKPEN+L+ GHI L DF LS
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLS 143
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 59/142 (41%), Positives = 84/142 (59%), Gaps = 3/142 (2%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLY 160
LG G G V L L+ + +A+KV+ K + + + TE+ IL L +HPFL LY
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 161 SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYR 220
F+T VMEF +GG+L + Q ++ F E ARF+A+E+ AL +LH GI+YR
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 221 DLKPENVLVRDEGHIMLSDFDL 242
DLK +NVL+ EGH L+DF +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-26
Identities = 59/146 (40%), Positives = 89/146 (60%), Gaps = 7/146 (4%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTL 159
K LG G G V LV+ + T Y+AMK++ K + +++++ TE +L HPFL L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 160 YSYFETDKFYCLVMEFCSGGNL--HSLRQKQPNKYFTEDAARFFASEVLLALEYLHM-LG 216
F+T C VME+ +GG L H R+ + F+ED ARF+ +E++ AL+YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEKN 116
Query: 217 IVYRDLKPENVLVRDEGHIMLSDFDL 242
+VYRDLK EN+++ +GHI ++DF L
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGL 142
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 55/152 (36%), Positives = 87/152 (57%), Gaps = 6/152 (3%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
++R+L++LG G G VYL A+KV+ K + ++ R E +IL L+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 155 -FLPTLYSYFETDKFYCLVMEFCSGGNLHSL-RQKQPNKYFTEDAARFFASEVLLALEYL 212
+ LY +F+ + LVME+ GG+L L ++ +E A F +++L ALEYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 213 HMLGIVYRDLKPENVLVRDEGH-IMLSDFDLS 243
H GI++RD+KPEN+L+ +G + L DF L+
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLA 149
|
Length = 384 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 51/152 (33%), Positives = 77/152 (50%), Gaps = 16/152 (10%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGH----GSAVDWWTFGIFL 356
+DFG C+ M VR + VGT +Y++PE+++ +G G DWW+ G+FL
Sbjct: 184 ADFGTCMK------MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237
Query: 357 YELLHGTTPFKGQGNRATLFNVVGQ--PLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK 414
YE+L G TPF T ++ L FP+ ++S A+DLI L R+ +
Sbjct: 238 YEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREV-RLG-R 295
Query: 415 RGATEIKQHPFF--EGVNWALVRSALPPHIPE 444
G EIK HPFF + + +R + P +PE
Sbjct: 296 NGVDEIKSHPFFKNDQWTFDNIRETVAPVVPE 327
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 56/167 (33%), Positives = 86/167 (51%), Gaps = 17/167 (10%)
Query: 290 ILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDW 349
+L K +DFG C E A +F GT +Y+APEI++G+ + +VDW
Sbjct: 127 VLLDKDGHIKIADFGMCKENMNGEGKAS-------TFCGTPDYIAPEILKGQKYNESVDW 179
Query: 350 WTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409
W+FG+ LYE+L G +PF G+ +++ FP +S A+D + L ++P K
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRW--ISKEAKDCLSKLFERDPTK 237
Query: 410 RIAYKRGATEIKQHPFFEGVNWALV--RSALPPHIPE---PVDFSVF 451
R+ +I+QHPFF G++W + R PP P+ P D S F
Sbjct: 238 RLGVD---GDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNF 281
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 56/150 (37%), Positives = 82/150 (54%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
FR + LG G G V ++R T +A K ++K + R A E++IL ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML 215
+ +L +ET CLV+ +GG+L N F E+ A F+A+E+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 216 GIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245
IVYRDLKPEN+L+ D GHI +SD L++
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVE 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 56/142 (39%), Positives = 83/142 (58%), Gaps = 4/142 (2%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFL-PTLY 160
+G G G V V R T +A+K + KA + SR+++ ER +L ++ PF+ P +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 161 SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYR 220
S+ +K Y LV+ F +GG L Q++ F ARF+ +E+L ALE LH ++YR
Sbjct: 61 SFQSPEKLY-LVLAFINGGELFHHLQREGR--FDLSRARFYTAELLCALENLHKFNVIYR 117
Query: 221 DLKPENVLVRDEGHIMLSDFDL 242
DLKPEN+L+ +GHI L DF L
Sbjct: 118 DLKPENILLDYQGHIALCDFGL 139
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 9e-26
Identities = 56/150 (37%), Positives = 82/150 (54%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
FR + LG G G V ++R T +A K ++K + R A E++IL ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML 215
+ L +ET CLV+ +GG+L N F E+ A F+A+E+L LE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 216 GIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245
VYRDLKPEN+L+ D GHI +SD L+++
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVK 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 2e-25
Identities = 46/152 (30%), Positives = 77/152 (50%), Gaps = 7/152 (4%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKAS-LASRNKLLRAQTEREILGLLD 152
S+ +K LG G G VY V + T +A+K + R +LLR E + L +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLR---ELKTLRSCE 57
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
P++ Y F + +V+E+ GG+L L +K E + A ++L L+YL
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDYL 115
Query: 213 H-MLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
H I++RD+KP N+L+ +G + ++DF +S
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKGEVKIADFGIS 147
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 55/144 (38%), Positives = 88/144 (61%), Gaps = 3/144 (2%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL-GLLDHPFLPT 158
K +G G G V L + + +++A+KV+ K ++ + + ER +L L HPFL
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 159 LYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIV 218
L+ F+T + V+++ +GG L Q++ + F E ARF+A+EV A+ YLH L I+
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNII 118
Query: 219 YRDLKPENVLVRDEGHIMLSDFDL 242
YRDLKPEN+L+ +GH++L+DF L
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 50/161 (31%), Positives = 91/161 (56%), Gaps = 3/161 (1%)
Query: 85 SLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTE 144
+ + +F ++K +G G G V LV + + +AMK++ K + R+ E
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 145 REILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASE 204
R+I+ + ++ L+ F+ DK+ +VME+ GG+L +L N E ARF+ +E
Sbjct: 94 RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNL---MSNYDIPEKWARFYTAE 150
Query: 205 VLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245
V+LAL+ +H +G ++RD+KP+N+L+ GH+ L+DF ++
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 49/132 (37%), Positives = 67/132 (50%), Gaps = 17/132 (12%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIR-GEGHGSAVDWWTFGIFLYEL 359
+DFG + +FVGT Y+APE++ G G+G VD W+ G+ LYEL
Sbjct: 140 ADFGLAKKLLKS-------SSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYEL 192
Query: 360 LHGTTPFKGQGNR---ATLFNVVGQPLRF--PETPQVSFVARDLIRGLLVKEPHKRIAYK 414
L G PF G+ + ++G PL F P+ S A+DLI+ L K+P KR
Sbjct: 193 LTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRP--- 249
Query: 415 RGATEIKQHPFF 426
A EI QHP+F
Sbjct: 250 -TAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 59/145 (40%), Positives = 88/145 (60%), Gaps = 5/145 (3%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL-GLLDHPFLPT 158
K +G G G V L + + +A+KV+ K + +R + ER +L + HPFL
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 159 L-YSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGI 217
L YS+ T+K Y V++F +GG L Q++ + F E ARF+A+E+ AL YLH + I
Sbjct: 61 LHYSFQTTEKLY-FVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINI 117
Query: 218 VYRDLKPENVLVRDEGHIMLSDFDL 242
VYRDLKPEN+L+ +GH++L+DF L
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 57/142 (40%), Positives = 86/142 (60%), Gaps = 3/142 (2%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL-GLLDHPFLPTLY 160
+G G V LV L+ T +AMKV+ K + + QTE+ + +HPFL L+
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 161 SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYR 220
S F+T+ V+E+ +GG+L Q+Q + E+ ARF+++E+ LAL YLH GI+YR
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 221 DLKPENVLVRDEGHIMLSDFDL 242
DLK +NVL+ EGHI L+D+ +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGM 142
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 58/145 (40%), Positives = 88/145 (60%), Gaps = 5/145 (3%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL-GLLDHPFLPT 158
K +G G G V L + ++A+KV+ K ++ + + +ER +L + HPFL
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 159 L-YSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGI 217
L +S+ DK Y V+++ +GG L Q++ + F E ARF+A+E+ AL YLH L I
Sbjct: 61 LHFSFQTADKLY-FVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNI 117
Query: 218 VYRDLKPENVLVRDEGHIMLSDFDL 242
VYRDLKPEN+L+ +GHI+L+DF L
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 49/125 (39%), Positives = 70/125 (56%), Gaps = 5/125 (4%)
Query: 322 RSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ 381
R+ + GT EYLAPE+I+ +GH AVDWW GI +YE+L G PF ++
Sbjct: 154 RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG 213
Query: 382 PLRFPETPQVSFVARDLIRGLLVKEPHKRIA-YKRGATEIKQHPFFEGVNWALV--RSAL 438
L FP + A+DLI+ LLV + +R+ K GA ++K H +F+ V+W V R
Sbjct: 214 KLEFPR--HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLK 271
Query: 439 PPHIP 443
PP +P
Sbjct: 272 PPIVP 276
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 55/144 (38%), Positives = 84/144 (58%), Gaps = 3/144 (2%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPT 158
K LG G G V L EL+G YFA+K + K + + + E+ +L L ++PFL
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 159 LYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIV 218
LY F+T + VMEF +GG+L + Q F A F+A+E++ L++LH GI+
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGII 118
Query: 219 YRDLKPENVLVRDEGHIMLSDFDL 242
YRDLK +NV++ +GHI ++DF +
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 52/145 (35%), Positives = 80/145 (55%), Gaps = 2/145 (1%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYS 161
LG G G V ++R T +A K ++K L R A E+ IL + F+ +L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 162 YFETDKFYCLVMEFCSGGNL--HSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVY 219
F+T CLVM +GG+L H + N F E A F+ ++++ LE+LH I+Y
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 220 RDLKPENVLVRDEGHIMLSDFDLSL 244
RDLKPENVL+ ++G++ +SD L++
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAV 145
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 52/150 (34%), Positives = 86/150 (57%), Gaps = 3/150 (2%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTN-TYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+F ++ LG G G V L + + A+K +K+ + + ++ +ER+IL ++H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
PF LY F+ + + LV+EF GG + ++ NK F D F+A++++L EYL
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQ 148
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
L IVYRDLKPEN+L+ +G I ++DF +
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178
|
Length = 340 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 58/170 (34%), Positives = 92/170 (54%), Gaps = 23/170 (13%)
Query: 290 ILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDW 349
IL +DFG C L + ++ +F GT +Y+APEI+ G+ + ++VDW
Sbjct: 127 ILLDTDGHIKIADFGMCKENMLGD-------AKTCTFCGTPDYIAPEILLGQKYNTSVDW 179
Query: 350 WTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF--PETPQ-VSFVARDLIRGLLVKE 406
W+FG+ LYE+L G +PF G + LF Q +R P P+ ++ A+D++ L V+E
Sbjct: 180 WSFGVLLYEMLIGQSPFHGH-DEEELF----QSIRMDNPCYPRWLTREAKDILVKLFVRE 234
Query: 407 PHKRIAYKRGATEIKQHPFFEGVNWALV--RSALPPHIPE---PVDFSVF 451
P +R+ K +I+QHPFF ++W+ + R PP P+ D S F
Sbjct: 235 PERRLGVK---GDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNF 281
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 58/150 (38%), Positives = 89/150 (59%), Gaps = 5/150 (3%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+F L LG G G V L E +GT+ +A+K++ K + + + E+ +L L D P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 155 -FLPTLYSYFET-DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
FL L+S F+T D+ Y VME+ +GG+L + Q F E A F+A+E+ + L +L
Sbjct: 61 PFLTQLHSCFQTVDRLY-FVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAEISVGLFFL 117
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242
H GI+YRDLK +NV++ EGHI ++DF +
Sbjct: 118 HRRGIIYRDLKLDNVMLDSEGHIKIADFGM 147
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 46/136 (33%), Positives = 74/136 (54%), Gaps = 8/136 (5%)
Query: 322 RSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ 381
R+ +F GT E+LAPE++ + AVDWW G+ +YE+L G +PF G ++V
Sbjct: 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND 216
Query: 382 PLRFPETPQVSFVARDLIRGLLVKEPHKRIAY-KRGATEIKQHPFFEGVNWA--LVRSAL 438
+R+P ++ ++R LL + P +R+ ++ A ++K+ PFF +NW L R
Sbjct: 217 EVRYPRFLSREAIS--IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIK 274
Query: 439 PPHIPE---PVDFSVF 451
PP +P P D S F
Sbjct: 275 PPFVPTIKGPEDVSNF 290
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 59/156 (37%), Positives = 81/156 (51%), Gaps = 14/156 (8%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+DFG C G PE E T+ +F GT EYLAPE++R E + VDWW G LYE+L
Sbjct: 138 TDFGLCKEGVEPE---ETTS----TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190
Query: 361 HGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEI 420
+G PF + N++ +PL+ P + A DL+ GLL K+ +R+ K EI
Sbjct: 191 YGLPPFYSRDVSQMYDNILHKPLQLP--GGKTVAACDLLVGLLHKDQRRRLGAKADFLEI 248
Query: 421 KQHPFFEGVNWALV--RSALPPHIPE---PVDFSVF 451
K H FF +NW + + PP+ P P D F
Sbjct: 249 KNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHF 284
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 58/150 (38%), Positives = 89/150 (59%), Gaps = 5/150 (3%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+F L LG G G V L E +GT+ +A+K++ K + + + E+ +L L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 155 -FLPTLYSYFET-DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
FL L+S F+T D+ Y VME+ +GG+L + Q Q F E A F+A+E+ + L +L
Sbjct: 61 PFLTQLHSCFQTMDRLY-FVMEYVNGGDL--MYQIQQVGRFKEPHAVFYAAEIAIGLFFL 117
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242
H GI+YRDLK +NV++ EGHI ++DF +
Sbjct: 118 HSKGIIYRDLKLDNVMLDSEGHIKIADFGM 147
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 52/143 (36%), Positives = 78/143 (54%), Gaps = 13/143 (9%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMS-FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYEL 359
+DFG C G ++ +M F GT EYLAPE++ +G AVDWW G+ +YE+
Sbjct: 137 TDFGLCKEGI--------SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188
Query: 360 LHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI-AYKRGAT 418
+ G PF Q + ++ + +RFP T +S A+ L+ GLL K+P +R+ A
Sbjct: 189 MCGRLPFYNQDHEKLFELILMEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPEDAK 246
Query: 419 EIKQHPFFEGVNW-ALVRSALPP 440
EI +H FF +NW +V+ L P
Sbjct: 247 EIMEHRFFASINWQDVVQKKLEP 269
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 48/132 (36%), Positives = 77/132 (58%), Gaps = 15/132 (11%)
Query: 321 VRSMSFVGTHEYLAPEI---IRGEG---HGSAVDWWTFGIFLYELLHGTTPFKGQGNRAT 374
V S VGT +Y+APE+ + G+G +G DWW+ G+ YE+++G +PF +G A
Sbjct: 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH-EGTSAK 216
Query: 375 LFNVV---GQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNW 431
+N + + L+FPE P+VS DLI+ LL +R+ Y+ + HPFF ++W
Sbjct: 217 TYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCG-QKERLGYEG----LCCHPFFSKIDW 271
Query: 432 ALVRSALPPHIP 443
+R++LPP +P
Sbjct: 272 NNIRNSLPPFVP 283
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 2e-23
Identities = 45/108 (41%), Positives = 60/108 (55%), Gaps = 3/108 (2%)
Query: 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF 385
FVGT +YLAPE I G G DWW+ G ++E L G PF + A N++ + + +
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212
Query: 386 PETPQ--VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNW 431
PE + S A DLI LL +P KR+ G EIK HPFF+ +NW
Sbjct: 213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGAN-GYQEIKSHPFFKSINW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 56/148 (37%), Positives = 84/148 (56%), Gaps = 14/148 (9%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSM-SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYEL 359
+DFG C G T+ +M +F GT EYLAPE++ +G AVDWW G+ +YE+
Sbjct: 137 TDFGLCKEGI--------TDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188
Query: 360 LHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI-AYKRGAT 418
+ G PF Q + ++ + ++FP T +S A+ L+ GLL+K+P+KR+ A
Sbjct: 189 MCGRLPFYNQDHEKLFELILMEDIKFPRT--LSADAKSLLSGLLIKDPNKRLGGGPDDAK 246
Query: 419 EIKQHPFFEGVNWALV--RSALPPHIPE 444
EI +H FF GVNW V + +PP P+
Sbjct: 247 EIMRHSFFTGVNWQDVYDKKLVPPFKPQ 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 50/160 (31%), Positives = 94/160 (58%), Gaps = 3/160 (1%)
Query: 86 LRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTER 145
+R + ++ ++K +G G G V LV + + +AMK++ K + R+ ER
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 146 EILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEV 205
+I+ + P++ L+ F+ DK+ +VME+ GG+L +L N E A+F+ +EV
Sbjct: 95 DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNL---MSNYDVPEKWAKFYTAEV 151
Query: 206 LLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245
+LAL+ +H +G+++RD+KP+N+L+ GH+ L+DF ++
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 61/193 (31%), Positives = 105/193 (54%), Gaps = 21/193 (10%)
Query: 79 DAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKL 138
D IN I R + ++ ++K +G G G V LV + T +AMK++ K + R+
Sbjct: 30 DTINKI--RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDS 87
Query: 139 LRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAA 198
ER+I+ + P++ L+ F+ D++ +VME+ GG+L +L N E A
Sbjct: 88 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL---MSNYDVPEKWA 144
Query: 199 RFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF--------DLSLRCS--- 247
RF+ +EV+LAL+ +H +G ++RD+KP+N+L+ GH+ L+DF + +RC
Sbjct: 145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 204
Query: 248 -----VSPTLVKS 255
+SP ++KS
Sbjct: 205 GTPDYISPEVLKS 217
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 80/341 (23%), Positives = 121/341 (35%), Gaps = 82/341 (24%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMD-KASLASRNKLLRAQTEREILGLLD 152
++ L++ +G G VY N A+K +D + S ++L + E + + +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRK---EVQAMSQCN 57
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSL-RQKQPNKYFTEDAARFFASEVLLALEY 211
HP + Y+ F LVM + SGG+L + + P E EVL LEY
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 212 LHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGIL 271
LH G ++RD+K N+L+ ++G + ++DF VS +L
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADF------GVSASLADG---------------- 155
Query: 272 NDEYAVHGCMQPSTFFPRILPSKKNRKSKSDF--GPCVGGALPELMAEPTNVRSMSFVGT 329
G RK + F PC PE+M +
Sbjct: 156 -------GDRT--------------RKVRKTFVGTPCW--MAPEVMEQ-----------V 181
Query: 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV-GQPLRFPET 388
H Y D W+FGI EL G P+ L + P
Sbjct: 182 HGY-----------DFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETG 230
Query: 389 PQV---SFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
S R +I L K+P KR A E+ +H FF
Sbjct: 231 ADYKKYSKSFRKMISLCLQKDPSKRPT----AEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 3e-23
Identities = 55/149 (36%), Positives = 80/149 (53%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
FR + LG G G V ++R T +A K ++K + R A E++IL ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML 215
+ +L +ET CLV+ +GG+L F E A F+A+E+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 216 GIVYRDLKPENVLVRDEGHIMLSDFDLSL 244
IVYRDLKPEN+L+ D GHI +SD L++
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAV 150
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 7e-23
Identities = 51/152 (33%), Positives = 79/152 (51%), Gaps = 10/152 (6%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL---D 152
++++K+LG G GSVYL + T A+K M K S + + RE+ L +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMN---LREVKSLRKLNE 56
Query: 153 HPFLPTLYSYF-ETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEY 211
HP + L F E D+ Y V E+ G NL+ L + + K F+E R ++L L +
Sbjct: 57 HPNIVKLKEVFRENDELY-FVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 212 LHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+H G +RDLKPEN+LV + ++DF L+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 8e-23
Identities = 51/128 (39%), Positives = 70/128 (54%), Gaps = 5/128 (3%)
Query: 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE 387
GT EY+APE+I +G+G VDWW GI LYE L G PF G V+ + +PE
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237
Query: 388 TPQ-VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNW-ALVR--SALPPHIP 443
+ + A+DLI LL + P +R+ GA E+KQH FF G++W L+R + P +
Sbjct: 238 GDEALPADAQDLISRLLRQNPLERLG-TGGAFEVKQHRFFLGLDWNGLLRQKAEFIPQLE 296
Query: 444 EPVDFSVF 451
D S F
Sbjct: 297 SEDDTSYF 304
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 46/125 (36%), Positives = 74/125 (59%), Gaps = 5/125 (4%)
Query: 322 RSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ 381
++ SF GT EY+APE++ GH + DWW+FG+ ++E+L G+ PF+G+ + T+ ++
Sbjct: 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA 213
Query: 382 PLRFPETPQVSFVARDLIRGLLVKEPHKRI-AYKRGATEIKQHPFFEGVNWALV--RSAL 438
L P+ +S A+ L+R L + P R+ A G EIK+HPFF ++W + R
Sbjct: 214 KLGMPQF--LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIK 271
Query: 439 PPHIP 443
PP P
Sbjct: 272 PPFKP 276
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 50/148 (33%), Positives = 79/148 (53%), Gaps = 12/148 (8%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+DFG C E + R+ F GT +Y+APEII + +G +VDWW FG+ LYE+L
Sbjct: 143 ADFGMC-----KENIFGGKTTRT--FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195
Query: 361 HGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY-KRGATE 419
G PF G+ +++ + +P++ +S A + +GLL K P KR+ G +
Sbjct: 196 AGQPPFDGEDEDELFQSIMEHNVSYPKS--LSKEAVSICKGLLTKHPAKRLGCGPTGERD 253
Query: 420 IKQHPFFEGVNWALV--RSALPPHIPEP 445
I++H FF ++W + R PP P+
Sbjct: 254 IREHAFFRRIDWEKLERREIQPPFKPKV 281
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 55/156 (35%), Positives = 82/156 (52%), Gaps = 14/156 (8%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+DFG C G ++ T +F GT EYLAPE+IR + + + VDWW G LYE+L
Sbjct: 138 TDFGLCKEGIA---QSDTTT----TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190
Query: 361 HGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEI 420
+G PF + N++ +PL P S A ++ LL K+ +R+ K EI
Sbjct: 191 YGLPPFYCRDVAEMYDNILHKPLVL--RPGASLTAWSILEELLEKDRQRRLGAKEDFLEI 248
Query: 421 KQHPFFEGVNWA-LVRSALP----PHIPEPVDFSVF 451
++HPFFE ++W L + +P P++ P D S F
Sbjct: 249 QEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNF 284
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-22
Identities = 55/150 (36%), Positives = 80/150 (53%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
FR + LG G G V ++R T +A K ++K + R A E+ IL ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML 215
+ +L +ET CLV+ +GG+L N F E A F+A+E+ LE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 216 GIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245
IVYRDLKPEN+L+ D GHI +SD L+++
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQ 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 54/142 (38%), Positives = 85/142 (59%), Gaps = 3/142 (2%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLY 160
+G G V LV L+ + +AMKV+ K + + QTE+ + +PFL L+
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 161 SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYR 220
S F+T LV+E+ +GG+L Q+Q + E+ ARF+A+E+ +AL +LH GI+YR
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 221 DLKPENVLVRDEGHIMLSDFDL 242
DLK +NVL+ +GHI L+D+ +
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGM 142
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 52/148 (35%), Positives = 81/148 (54%), Gaps = 14/148 (9%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSM-SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYEL 359
+DFG C G ++ +M +F GT EYLAPE++ +G AVDWW G+ +YE+
Sbjct: 137 TDFGLCKEGI--------SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188
Query: 360 LHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI-AYKRGAT 418
+ G PF Q + ++ + +RFP T +S A+ L+ GLL K+P +R+ A
Sbjct: 189 MCGRLPFYNQDHERLFELILMEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAK 246
Query: 419 EIKQHPFFEGVNW--ALVRSALPPHIPE 444
E+ +H FF +NW + + LPP P+
Sbjct: 247 EVMEHRFFLSINWQDVVQKKLLPPFKPQ 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 62/190 (32%), Positives = 86/190 (45%), Gaps = 30/190 (15%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+DFG C N + +F GT EYLAPE++ + + VDWW G LYE+L
Sbjct: 138 TDFGLCKENIEH-------NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190
Query: 361 HGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEI 420
+G PF + N++ +PL+ P ++ AR L+ GLL K+ KR+ K EI
Sbjct: 191 YGLPPFYSRNTAEMYDNILNKPLQL--KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248
Query: 421 KQHPFFEGVNW--ALVRSALPPHIP-----------------EPVDFSVFAGKDQASAAA 461
K H FF +NW + + PP P EPV S+ G+ S
Sbjct: 249 KNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNSI--GQSPDSILV 306
Query: 462 EKKVVAAAEA 471
V AAEA
Sbjct: 307 TASVKEAAEA 316
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 2e-22
Identities = 54/152 (35%), Positives = 82/152 (53%), Gaps = 9/152 (5%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL---DHPFLPT 158
+G G G VY T +AMK +DK + + A ER +L L+ D PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 159 LYSYFETDKFYCLVMEFCSGGNLH-SLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGI 217
+ F T +++ +GG+LH L Q + F+E RF+A+E++L LE++H +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRFV 118
Query: 218 VYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249
VYRDLKP N+L+ + GH+ +S DL L C S
Sbjct: 119 VYRDLKPANILLDEHGHVRIS--DLGLACDFS 148
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 40/127 (31%), Positives = 71/127 (55%), Gaps = 13/127 (10%)
Query: 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQG----NRATLFNVVGQP 382
GT Y+APE+++GE + +VDW+ G LYE++ G +PF+ + +
Sbjct: 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA 214
Query: 383 LRFPE--TPQVSFVARDLIRGLLVKEPHKRIAYK-RGATEIKQHPFFEGVNWALVRSAL- 438
+ +P+ +P+ A+DL LL K+P KR+ + A E+++HP F+ +NW + + +
Sbjct: 215 VEYPDKFSPE----AKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGML 270
Query: 439 -PPHIPE 444
PP IP+
Sbjct: 271 EPPFIPD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 7e-22
Identities = 52/158 (32%), Positives = 85/158 (53%), Gaps = 20/158 (12%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+D+G C G P + T+ +F GT Y+APEI+RGE +G +VDWW G+ ++E++
Sbjct: 138 TDYGMCKEGLGP---GDTTS----TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM 190
Query: 361 HGTTPFK------GQGNRATLFNVV-GQPLRFPETPQVSFVARDLIRGLLVKEPHKRIA- 412
G +PF LF V+ +P+R P +S A +++G L K+P +R+
Sbjct: 191 AGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF--LSVKASHVLKGFLNKDPKERLGC 248
Query: 413 -YKRGATEIKQHPFFEGVNWALV--RSALPPHIPEPVD 447
+ G ++IK H FF ++W L+ + PP P+ D
Sbjct: 249 QPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITD 286
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 41/124 (33%), Positives = 65/124 (52%), Gaps = 5/124 (4%)
Query: 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP 386
VGT Y+APE+++ E + + DWW G +YE++ G +PF+ + + V +
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ 221
Query: 387 ETPQVSFV--ARDLIRGLLVKEPHKRIAYKR-GATEIKQHPFFEGVNWALVRSAL--PPH 441
E F AR + R LL K+P R+ + GA E+K HPFF N+ + + + PP
Sbjct: 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPF 281
Query: 442 IPEP 445
P+P
Sbjct: 282 CPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 7/174 (4%)
Query: 320 NVRSMSFVGTHEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNV 378
N + +F GT EYLAPE++ E G+ VD+W+ G+ ++E+ G +PF + + N+
Sbjct: 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209
Query: 379 VGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSAL 438
+RFP+ +S R ++GLL + P R+ R A E+K+HPFF ++W L+
Sbjct: 210 AFGKVRFPKN-VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQ 268
Query: 439 --PPHIPE---PVDFSVFAGKDQASAAAEKKVVAAAEAAVDHKNGDSPKDSYVE 487
PP P D S F + S+ +V + +P S V+
Sbjct: 269 ITPPFKPIVDSDEDVSNFDPEFTNSSLLNAGIVPWEDVPGLPGANSTPLSSSVQ 322
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 75/309 (24%), Positives = 115/309 (37%), Gaps = 72/309 (23%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYS 161
LG G G L ++ K ++ L+ + + A E IL LL HP + Y+
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRD-ALNEIVILSLLQHPNIIAYYN 66
Query: 162 YFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRD 221
+F D + ME+ +GG L+ +Q + F E+ ++ +++ A+ Y+H GI++RD
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRD 126
Query: 222 LKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCM 281
+K N+ + G I L DF +S IL EY
Sbjct: 127 IKTLNIFLTKAGLIKLGDFGIS-------------------------KILGSEY------ 155
Query: 282 QPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGE 341
MAE + VGT Y++PE+ +G
Sbjct: 156 --------------------------------SMAE-------TVVGTPYYMSPELCQGV 176
Query: 342 GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRG 401
+ D W G LYELL F N L + Q P S L+
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTFDAT-NPLNLVVKIVQGNYTPVVSVYSSELISLVHS 235
Query: 402 LLVKEPHKR 410
LL ++P KR
Sbjct: 236 LLQQDPEKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-21
Identities = 55/152 (36%), Positives = 83/152 (54%), Gaps = 9/152 (5%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL---DHPFLPT 158
+G G G VY T +AMK +DK + + A ER +L L+ D PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 159 LYSYFETDKFYCLVMEFCSGGNLH-SLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGI 217
+ F T C +++ +GG+LH L Q + F+E RF+A+E++L LE++H +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRFV 118
Query: 218 VYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249
VYRDLKP N+L+ + GH+ +S DL L C S
Sbjct: 119 VYRDLKPANILLDEHGHVRIS--DLGLACDFS 148
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 47/126 (37%), Positives = 68/126 (53%), Gaps = 10/126 (7%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG--QP 382
S VG+ +Y+APE++RG+G+ VD+W+ G LYE L G PF G T N+ +
Sbjct: 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET 216
Query: 383 LRFPETPQ----VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSAL 438
L+ P +S A DLI L+ +P +R +IK HPFF+ V+W +R
Sbjct: 217 LQRPVYDDPRFNLSDEAWDLITKLI-NDPSRRF---GSLEDIKNHPFFKEVDWNELRELK 272
Query: 439 PPHIPE 444
PP +PE
Sbjct: 273 PPFVPE 278
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 4e-21
Identities = 53/156 (33%), Positives = 85/156 (54%), Gaps = 22/156 (14%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+D+G C G P + T+ +F GT Y+APEI+RGE +G +VDWW G+ ++E++
Sbjct: 138 TDYGMCKEGIRP---GDTTS----TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190
Query: 361 HGTTPFKGQGNRAT--------LFNVV-GQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411
G +PF G LF V+ + +R P + +S A +++G L K+P +R+
Sbjct: 191 AGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS--LSVKASSVLKGFLNKDPKERL 248
Query: 412 AYKR--GATEIKQHPFFEGVNWALV--RSALPPHIP 443
G +IK HPFF ++W L+ + LPP+ P
Sbjct: 249 GCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKP 284
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 51/157 (32%), Positives = 84/157 (53%), Gaps = 19/157 (12%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+DFG C + R+ +F GT +Y+APEI++G + +VDWW+FG+ LYE+L
Sbjct: 138 ADFGMCKENVFGD-------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEML 190
Query: 361 HGTTPFKGQGNRATLFNVVGQPLRFPETPQ-VSFVARDLIRGLLVKEPHKRIAYKRGATE 419
G +PF G + LF + P P+ ++ ++D++ L ++P +R+
Sbjct: 191 IGQSPFHGD-DEDELFESIRVDT--PHYPRWITKESKDILEKLFERDPTRRLGV---VGN 244
Query: 420 IKQHPFFEGVNWALV--RSALPPHIPE---PVDFSVF 451
I+ HPFF+ +NW + R PP P+ P D+S F
Sbjct: 245 IRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNF 281
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-21
Identities = 53/147 (36%), Positives = 81/147 (55%), Gaps = 12/147 (8%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+DFG C G + + +++ F GT EYLAPE++ +G AVDWW G+ +YE++
Sbjct: 138 TDFGLCKEG-----IKDGATMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 190
Query: 361 HGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI-AYKRGATE 419
G PF Q + ++ + +RFP T +S A+ L+ GLL K+P +R+ A E
Sbjct: 191 CGRLPFYNQDHEKLFELILMEEIRFPRT--LSPEAKSLLSGLLKKDPKQRLGGGPDDAKE 248
Query: 420 IKQHPFFEGVNWALV--RSALPPHIPE 444
I QH FF G+ W V + +PP P+
Sbjct: 249 IMQHKFFAGIVWQDVYEKKLVPPFKPQ 275
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 6e-21
Identities = 88/351 (25%), Positives = 132/351 (37%), Gaps = 86/351 (24%)
Query: 80 AINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLL 139
A+ I G P ++ L+++G G G VY R T A+K M L +NK L
Sbjct: 7 ALKDIVSEGDPR--ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKEL 61
Query: 140 RAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAA 198
E I+ HP + Y + +VME+ GG+L + Q E
Sbjct: 62 -IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN--FVRMNEPQI 118
Query: 199 RFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258
+ EVL LEYLH +++ RD +KS +
Sbjct: 119 AYVCREVLQGLEYLHSQNVIH----------RD---------------------IKSDN- 146
Query: 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEP 318
IL SK +DFG +L E
Sbjct: 147 -------------------------------ILLSKDGSVKLADFGFAA-----QLTKEK 170
Query: 319 TNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTP-FKGQGNRATLFN 377
+ S+ VGT ++APE+I+ + +G VD W+ GI E+ G P + RA LF
Sbjct: 171 SKRNSV--VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-LFL 227
Query: 378 VVGQPL-RFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427
+ + + + S +D + LVK+P KR + A E+ QHPF +
Sbjct: 228 ITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS----AEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 8e-21
Identities = 90/368 (24%), Positives = 133/368 (36%), Gaps = 121/368 (32%)
Query: 79 DAINMISLRG-PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNK 137
A+ ++ G P L NF ++G G G V + + T A+K MD
Sbjct: 6 AALQLVVDPGDPRSYLDNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMD--------- 53
Query: 138 LLRAQTERE-------ILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPN 190
LR Q RE I+ HP + +YS + +VMEF GG +L +
Sbjct: 54 -LRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGG---ALTDIVTH 109
Query: 191 KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250
E+ VL AL +LH G+++RD+K +++L+ +G + LSDF
Sbjct: 110 TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGF-------- 161
Query: 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGA 310
C Q S PR RKS VG
Sbjct: 162 -----------------------------CAQVSKEVPR-------RKS------LVG-- 177
Query: 311 LPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQG 370
P MA PE+I +G+ VD W+ GI + E++ G P+
Sbjct: 178 TPYWMA------------------PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY---- 215
Query: 371 NRATLFNVVGQPL------------RFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGAT 418
FN PL + +VS R + +LV++P +R A
Sbjct: 216 -----FNE--PPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT----AA 264
Query: 419 EIKQHPFF 426
E+ HPF
Sbjct: 265 ELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-20
Identities = 48/122 (39%), Positives = 72/122 (59%), Gaps = 5/122 (4%)
Query: 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP 386
+GT +YLAPE++ G+ HG AVDWW G+ L+E L G PF + + N++ + + +P
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 387 ETPQV-SFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEP 445
E + S A++ I LL +P KR K E+KQHP F GV+W +++ P IP+P
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLK----ELKQHPLFHGVDWENLQNQTMPFIPQP 656
Query: 446 VD 447
D
Sbjct: 657 DD 658
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 50/150 (33%), Positives = 82/150 (54%), Gaps = 12/150 (8%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+DFG C E M + V + +F GT +Y+APEII + +G +VDWW FG+ LYE+L
Sbjct: 143 ADFGMC-----KENMWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195
Query: 361 HGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY-KRGATE 419
G PF+G+ +++ + +P++ VA + +GL+ K P KR+ G +
Sbjct: 196 AGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA--ICKGLMTKHPGKRLGCGPEGERD 253
Query: 420 IKQHPFFEGVNWALV--RSALPPHIPEPVD 447
IK+H FF ++W + + PP+ P+
Sbjct: 254 IKEHAFFRYIDWEKLERKEVQPPYKPKACG 283
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 46/151 (30%), Positives = 78/151 (51%), Gaps = 3/151 (1%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+F++LK+LG G GSVY V+ N ++A+K +D S+ S+ + A E IL ++HP
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHP 59
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSL--RQKQPNKYFTEDAARFFASEVLLALEYL 212
+ + F C+VME+ G+L ++K+ K E ++L L+ L
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
H I++RDLK N+L+ + + D +S
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGIS 150
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 49/147 (33%), Positives = 80/147 (54%), Gaps = 12/147 (8%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+DFG C E M + R+ F GT +Y+APEII + +G +VDWW +G+ LYE+L
Sbjct: 143 ADFGMC-----KEHMVDGVTTRT--FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEML 195
Query: 361 HGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY-KRGATE 419
G PF G+ +++ + +P++ +S A + +GL+ K P KR+ G +
Sbjct: 196 AGQPPFDGEDEDELFQSIMEHNVSYPKS--LSKEAVSICKGLMTKHPSKRLGCGPEGERD 253
Query: 420 IKQHPFFEGVNWALV--RSALPPHIPE 444
I++H FF ++W + R PP P+
Sbjct: 254 IREHAFFRRIDWDKLENREIQPPFKPK 280
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 40/151 (26%), Positives = 70/151 (46%), Gaps = 3/151 (1%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
N++L +G G G VY T + A+K + + L E ++L L HP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEA-LKSIMQEIDLLKNLKHP 59
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
+ ET +++E+ G+L + K+ F E + +VL L YLH
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQI-IKKFGP-FPESLVAVYVYQVLQGLAYLHE 117
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245
G+++RD+K N+L +G + L+DF ++ +
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATK 148
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 4e-20
Identities = 46/152 (30%), Positives = 69/152 (45%), Gaps = 8/152 (5%)
Query: 97 RLLKRLGYGDIGSVYLVELRGTNTYFAMKV-----MDKASLASRNKLLRAQTEREILGLL 151
L K+LG G G VY L+G ++V + AS + LR E I+ L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLR---EARIMRKL 58
Query: 152 DHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEY 211
DHP + L ++ +VME+ GG+L +K K + FA ++ +EY
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 212 LHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
L ++RDL N LV + + +SDF LS
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLS 150
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 5e-20
Identities = 48/144 (33%), Positives = 78/144 (54%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYS 161
LG G G V V+++ T +A K +DK L ++ A E+EIL ++ PF+ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 162 YFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRD 221
FE+ CLVM +GG+L + + +++++ + +LH + IVYRD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 222 LKPENVLVRDEGHIMLSDFDLSLR 245
+KPENVL+ D+G+ LSD L++
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVE 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 6e-20
Identities = 54/152 (35%), Positives = 81/152 (53%), Gaps = 16/152 (10%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG----HGSAVDWWTFGIFL 356
+DFG C+ M E VR + VGT +Y++PE+++ +G +G DWW+ G+FL
Sbjct: 184 ADFGTCMK------MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237
Query: 357 YELLHGTTPFKGQGNRATLFNVVGQ--PLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK 414
+E+L G TPF T ++ L FPE ++S A++LI L + R+ +
Sbjct: 238 FEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLT-DREVRLG-R 295
Query: 415 RGATEIKQHPFFEG--VNWALVRSALPPHIPE 444
G EIKQHPFF+ NW +R P +PE
Sbjct: 296 NGVEEIKQHPFFKNDQWNWDNIRETAAPVVPE 327
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 50/149 (33%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
F LL+ +G G G VY + TN A+KV+D + +++ Q E + L P+
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPY 60
Query: 156 LPTLY-SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
+ Y S+ + K + ++ME+C GG+ L + E F EVLL LEYLH
Sbjct: 61 ITKYYGSFLKGSKLW-IIMEYCGGGSCLDLLKPGK---LDETYIAFILREVLLGLEYLHE 116
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
G ++RD+K N+L+ +EG + L+DF +S
Sbjct: 117 EGKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 85/345 (24%), Positives = 129/345 (37%), Gaps = 89/345 (25%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKAS-LASRNKLLRAQTEREILGLLD 152
+ L LG G+ G V V R T A+K + A + ++LR E +IL +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILR---ELDILHKCN 57
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
P++ Y F + + ME+ GG+L + K+ E A VL L YL
Sbjct: 58 SPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL-KEVQGRIPERILGKIAVAVLKGLTYL 116
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILN 272
+ K ++ RD VK S++ VN
Sbjct: 117 ------HEKHK---IIHRD---------------------VKPSNILVN----------- 135
Query: 273 DEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332
S+ K DFG V G L N + +FVGT Y
Sbjct: 136 --------------------SRGQIKL-CDFG--VSGQL-------VNSLAKTFVGTSSY 165
Query: 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRAT-----LFNVVGQPLRFPE 387
+APE I+G + D W+ G+ L EL G P+ + + L +V +P P
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP--PR 223
Query: 388 TPQVSFVA--RDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430
P F +D + L+K+P +R +YK E+ +HPF +
Sbjct: 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYK----ELLEHPFIKKYE 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 40/151 (26%), Positives = 78/151 (51%), Gaps = 16/151 (10%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
SD G V EL + + + GT ++APE+++GE + +VD++ G+ LYE++
Sbjct: 139 SDLGLAV-----ELKDGQSKTKG--YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMI 191
Query: 361 HGTTPFKGQG----NRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRG 416
PF+ +G N+ ++ + +P+ + S ++ LL K+P KR+ ++ G
Sbjct: 192 AARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKSFCEALLAKDPEKRLGFRDG 249
Query: 417 A-TEIKQHPFFEGVNWALVRSAL--PPHIPE 444
++ HP F +NW + + + PP +P+
Sbjct: 250 NCDGLRTHPLFRDLNWRQLEAGMLPPPFVPD 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 3e-19
Identities = 39/124 (31%), Positives = 70/124 (56%), Gaps = 5/124 (4%)
Query: 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP 386
VGT Y+APE++ + + + D+W G +YE++ G +PF+G+ + V + L
Sbjct: 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE 221
Query: 387 ETPQVSFV--ARDLIRGLLVKEPHKRIAYKR-GATEIKQHPFFEGVNWALVRSAL--PPH 441
E F A+ + + LL K+P +R+ + GA E+K+HPFF +N+ + + + PP
Sbjct: 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPF 281
Query: 442 IPEP 445
+P+P
Sbjct: 282 VPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 51/156 (32%), Positives = 83/156 (53%), Gaps = 22/156 (14%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+D+G C G P + T+ F GT Y+APEI+RGE +G +VDWW G+ ++E++
Sbjct: 138 TDYGMCKEGLRP---GDTTST----FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190
Query: 361 HGTTPFK--------GQGNRATLFNVV-GQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411
G +PF Q LF V+ + +R P + +S A +++ L K+P +R+
Sbjct: 191 AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERL 248
Query: 412 AY--KRGATEIKQHPFFEGVNWALV--RSALPPHIP 443
+ G +I+ HPFF V+W L+ + +PP P
Sbjct: 249 GCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKP 284
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-19
Identities = 42/148 (28%), Positives = 72/148 (48%), Gaps = 5/148 (3%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE--ILGLLD 152
+F +L ++G G G V+ V + +AMK +D L+ N+ R + E +L LD
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQID---LSKMNRREREEAIDEARVLAKLD 57
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
++ Y F +VME+ G+LH L + Q + ED F ++LL L +L
Sbjct: 58 SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL 117
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDF 240
H I++RD+K N+ + ++ + D
Sbjct: 118 HSKKILHRDIKSLNLFLDAYDNVKIGDL 145
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 3e-19
Identities = 48/154 (31%), Positives = 68/154 (44%), Gaps = 11/154 (7%)
Query: 96 FRLLKRLGYGDIGSVYLVELRG----TNTYFAMKVM-DKASLASRNKLLRAQTEREILGL 150
L K+LG G G VY L+G T T A+K + + AS R + L E I+
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLE---EASIMKK 57
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLAL 209
L HP + L + +V E+ GG+L LR+ T A ++ +
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK--LTLKDLLQMALQIAKGM 115
Query: 210 EYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
EYL V+RDL N LV + + +SDF LS
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLS 149
|
Length = 258 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 6e-19
Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+DFG C G + +F GT +Y+APEI++ +G +VDWW G+ LYE+L
Sbjct: 138 ADFGMCKEGIF-------NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEML 190
Query: 361 HGTTPFKGQGNRATLFN-VVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY--KRGA 417
G PF+ + N LF ++ + +P +S A D+++ + K P R+ G
Sbjct: 191 CGHAPFEAE-NEDDLFEAILNDEVVYPT--WLSQDAVDILKAFMTKNPTMRLGSLTLGGE 247
Query: 418 TEIKQHPFFEGVNWALV--RSALPPHIP 443
I +HPFF+ ++W + R PP P
Sbjct: 248 EAILRHPFFKELDWEKLNRRQIEPPFRP 275
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 8e-19
Identities = 48/161 (29%), Positives = 75/161 (46%), Gaps = 13/161 (8%)
Query: 98 LLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRA-QTEREILGLLDHPFL 156
++G G G VY T A+K + + K ++ E ++L LL HP
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEI--RIQDNDPKTIKEIADEMKVLELLKHP-- 59
Query: 157 PTLYSYF----ETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
L Y+ +K Y + ME+CSGG L L + + E R + ++L L YL
Sbjct: 60 -NLVKYYGVEVHREKVY-IFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYL 115
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253
H GIV+RD+KP N+ + G I L DF +++ + T +
Sbjct: 116 HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 43/122 (35%), Positives = 68/122 (55%), Gaps = 5/122 (4%)
Query: 327 VGTHEYLAPEII-RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF 385
VGTH Y+APE++ +G + S+ DW++ G L++LL G +PF+ +
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 215
Query: 386 PETP-QVSFVARDLIRGLLVKEPHKRIAYK-RGATEIKQHPFFEGVNWALV--RSALPPH 441
E P S R L+ GLL ++ ++R+ RGA E+K+HPFF ++W +V + PP
Sbjct: 216 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPL 275
Query: 442 IP 443
IP
Sbjct: 276 IP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 50/152 (32%), Positives = 80/152 (52%), Gaps = 16/152 (10%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG----HGSAVDWWTFGIFL 356
+DFG C+ M + VR + VGT +Y++PE+++ +G +G DWW+ G+FL
Sbjct: 184 ADFGTCMK------MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237
Query: 357 YELLHGTTPFKGQGNRATLFNVVGQ--PLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK 414
YE+L G TPF T ++ L FP+ +S A++LI L + R+ +
Sbjct: 238 YEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLT-DREVRLG-R 295
Query: 415 RGATEIKQHPFFEGVNWAL--VRSALPPHIPE 444
G EIK+H FF+ WA +R + P +P+
Sbjct: 296 NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPD 327
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 46/150 (30%), Positives = 79/150 (52%), Gaps = 2/150 (1%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+ ++ +G G G V+L + +K + + ++++ L AQ E ++L LL HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHP 59
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
+ Y F DK +VME+ GG L QK+ N ED F ++LLAL ++H
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 215 LGIVYRDLKPENVLV-RDEGHIMLSDFDLS 243
I++RDLK +N+L+ + + + + DF +S
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGIS 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 48/151 (31%), Positives = 79/151 (52%), Gaps = 6/151 (3%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+ ++ LG G G VY + + T + A K++ + S +L E +IL H
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQ---IESEEELEDFMVEIDILSECKH 61
Query: 154 PFLPTLYS-YFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
P + LY YF +K + L+ EFC GG L S+ + + TE R+ ++L AL +L
Sbjct: 62 PNIVGLYEAYFYENKLWILI-EFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFL 119
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
H +++RDLK N+L+ +G + L+DF +S
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 2e-18
Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 5/150 (3%)
Query: 97 RLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE--ILGLLDHP 154
L K+LG G G VY +L+G ++V K ++ + RE I+ LDHP
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALEYLH 213
+ L ++ +VME+ GG+L S LR+ +P + FA ++ +EYL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE 119
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++RDL N LV + + +SDF LS
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLS 149
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 46/144 (31%), Positives = 67/144 (46%), Gaps = 4/144 (2%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLLDHPFLPTL 159
LG G GSVY +FA+K + A + Q E+EI L L HP +
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 160 YSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVY 219
+ + +E GG+L L +K F E R + ++LL LEYLH V+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVH 125
Query: 220 RDLKPENVLVRDEGHIMLSDFDLS 243
RD+K N+LV G + L+DF ++
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMA 149
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 35/112 (31%), Positives = 54/112 (48%), Gaps = 7/112 (6%)
Query: 318 PTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRAT--- 374
+ + S GT Y+APE++ +G+ AVDWW+ G+ YE L G P++G
Sbjct: 151 TPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210
Query: 375 LFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
+ +P T S A D I LL ++P KR+ ++K HP+F
Sbjct: 211 RAKQETADVLYPATW--STEAIDAINKLLERDPQKRLGDN--LKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 45/132 (34%), Positives = 72/132 (54%), Gaps = 5/132 (3%)
Query: 316 AEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATL 375
A+ + R+ + GT EY+APEI+ GHG A DWWT GIF+YE+L G PF
Sbjct: 178 AKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY 237
Query: 376 FNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIA-YKRGATEIKQHPFFEGVNWA-- 432
++ + FP+ + + L++ LL + KR K+GA +K+HP+F ++W
Sbjct: 238 QKILEGIIYFPKFLDNN--CKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSL 295
Query: 433 LVRSALPPHIPE 444
L ++ P+ P+
Sbjct: 296 LHKNVEVPYKPK 307
|
Length = 340 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 8e-18
Identities = 47/148 (31%), Positives = 72/148 (48%), Gaps = 6/148 (4%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
F +L++LG G GSVY + T A+KV+ L E IL D P+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-----VEEDLQEIIKEISILKQCDSPY 59
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML 215
+ Y + + +VME+C G++ + K NK TE+ + L LEYLH
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDI-MKITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 216 GIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++RD+K N+L+ +EG L+DF +S
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 51/155 (32%), Positives = 72/155 (46%), Gaps = 10/155 (6%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE--ILGLLD 152
L RLG G GSV L+ T FA+K + N L+ Q RE I
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTI----TTDPNPDLQKQILRELEINKSCK 57
Query: 153 HPFLPTLYSYF--ETDKFYCLVMEFCSGGNLHSL--RQKQPNKYFTEDAARFFASEVLLA 208
P++ Y F E+ + ME+C GG+L S+ + K+ E A VL
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
L YLH I++RD+KP N+L+ +G + L DF +S
Sbjct: 118 LSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS 152
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 43/166 (25%), Positives = 72/166 (43%), Gaps = 28/166 (16%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNK--------LLRAQTEREI 147
+ +L+ +G G G+V V + K +D ++ + K +LR I
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 148 LGLLDHPFLP---TLYSYFETDKFYCLVMEFCSGGNLHSL--RQKQPNKYFTEDAARFFA 202
+ D TLY +VME+C GG+L L + K+ KY E+
Sbjct: 62 VRYYDRIIDRSNQTLY----------IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRIL 111
Query: 203 SEVLLALEYLHMLG-----IVYRDLKPENVLVRDEGHIMLSDFDLS 243
+++LLAL H +++RDLKP N+ + ++ L DF L+
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 40/125 (32%), Positives = 69/125 (55%), Gaps = 7/125 (5%)
Query: 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP 386
VGT Y+APE+I E + + DWW G +YE++ G +PF+ + R V + ++
Sbjct: 162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVDRRVKED 220
Query: 387 E---TPQVSFVARDLIRGLLVKEPHKRIAYK-RGATEIKQHPFFEGVNWALVRSAL--PP 440
+ + + S A+ + R LL K P +R+ + GA +KQHP F+ +N+ + + + PP
Sbjct: 221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPP 280
Query: 441 HIPEP 445
P+P
Sbjct: 281 FCPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 89/371 (23%), Positives = 134/371 (36%), Gaps = 130/371 (35%)
Query: 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDK----ASLASRN----KLLRAQTEREILGL 150
L +G G G V T A+K + + A A R +LL+ ++GL
Sbjct: 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGL 79
Query: 151 LD--HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLA 208
LD P + F+ Y LV G +L+++ + Q ++D +F ++L
Sbjct: 80 LDVFTP--ASSLEDFQD--VY-LVTHL-MGADLNNIVKCQK---LSDDHIQFLVYQILRG 130
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGG 268
L+Y+H GI++RDL K S+++VN
Sbjct: 131 LKYIHSAGIIHRDL-------------------------------KPSNIAVNE------ 153
Query: 269 GILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328
+ E +IL DFG +A T+ +V
Sbjct: 154 ---DCEL-------------KIL----------DFG----------LARHTDDEMTGYVA 177
Query: 329 THEYLAPEIIRGEGHGS-AVDWWTFGIFLYELLHGTTPFKG-----QGNRATLFNVVGQP 382
T Y APEI+ H + VD W+ G + ELL G T F G Q R + N+VG P
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKR--IMNLVGTP 235
Query: 383 LR-----------------FPETPQVSF---------VARDLIRGLLVKEPHKRIAYKRG 416
P+ P+ F +A DL+ +LV +P KRI
Sbjct: 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT---- 291
Query: 417 ATEIKQHPFFE 427
A E HP+
Sbjct: 292 AAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 2e-17
Identities = 68/281 (24%), Positives = 107/281 (38%), Gaps = 83/281 (29%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYF---AMKVM-DKASLASRNKLLRAQTEREILGLLDHPF 155
K+LG G G VY +L+G + A+K + + AS R L+ E ++ L HP
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLK---EARVMKKLGHPN 57
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAA------RFFASEVLLA 208
+ L ++ LV+E+ GG+L LR+ +P E + FA ++
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGG 268
+EYL V+RDL N LV ++ + +SDF LS
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS------------------------- 152
Query: 269 GILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328
R + + K+ GG LP +R M+
Sbjct: 153 --------------------RDVYDDDYYRKKT------GGKLP--------IRWMA--- 175
Query: 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELL-HGTTPFKG 368
PE ++ S D W+FG+ L+E+ G TP+ G
Sbjct: 176 ------PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 6/149 (4%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
+ L++R+G G G VY T A+KV+ L + Q E +L HP
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHPN 61
Query: 156 LPTLY-SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
+ + SY DK + +VME+C GG+L + Q +E + E L L YLH
Sbjct: 62 IVAYFGSYLRRDKLW-IVMEYCGGGSLQDIYQ-VTRGPLSELQIAYVCRETLKGLAYLHE 119
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
G ++RD+K N+L+ ++G + L+DF +S
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 7e-17
Identities = 41/124 (33%), Positives = 69/124 (55%), Gaps = 5/124 (4%)
Query: 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP 386
VGT Y+APE+++ E + + DWW G LYE++ G +PF+ + + V
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ 221
Query: 387 E--TPQVSFVARDLIRGLLVKEPHKRIAYK-RGATEIKQHPFFEGVNWALVRSAL--PPH 441
E + + S AR L + LL K+P +R+ + GA E+K+HP F+ +N+ + + + PP
Sbjct: 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPF 281
Query: 442 IPEP 445
P+P
Sbjct: 282 KPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 13/157 (8%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL-GLLDHP 154
F L++ +G G G VY + T A+K+MD + + + E IL +HP
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD--IIEDEEE--EIKEEYNILRKYSNHP 63
Query: 155 FLPTLY-SYFETDKFYC-----LVMEFCSGGNLHSLRQ--KQPNKYFTEDAARFFASEVL 206
+ T Y ++ + + LVME C GG++ L + ++ K E+ + E L
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL 123
Query: 207 LALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
L YLH +++RD+K +N+L+ + L DF +S
Sbjct: 124 RGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 7/151 (4%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL--LD 152
+++L R+G G G V+ + R T A+K K +L + Q REI L
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALK---KVALRRLEGGIPNQALREIKALQACQ 57
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
HP++ L F + LVME+ +L + + + E + + +L + Y+
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYM 115
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
H GI++RDLKP N+L+ +G + ++DF L+
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 48/128 (37%), Positives = 75/128 (58%), Gaps = 17/128 (13%)
Query: 327 VGTHEYLAPEII-RGEGHGSAVDWWTFGIFLYELLHGTTPF-------KGQGNRATLFNV 378
VGTH Y+APE++ +G + S+ DW++ G L++LL G +PF K + +R TL
Sbjct: 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN 215
Query: 379 VGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIA-YKRGATEIKQHPFFEGVNWALV--R 435
V P F +P++ + L+ GLL ++ KR+ RGA E+K+H FF+G++W V +
Sbjct: 216 VELPDSF--SPEL----KSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQ 269
Query: 436 SALPPHIP 443
PP IP
Sbjct: 270 KYPPPLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 52/169 (30%), Positives = 83/169 (49%), Gaps = 11/169 (6%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMD-KASLASRNKLLRAQTEREILGLLD 152
+ + LG G+ GSV V+ T T A KV+ A + R ++LR E +I+
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR---ELQIMHECR 61
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALEY 211
P++ + Y F + C+ MEF G+L ++ P + A V+ L Y
Sbjct: 62 SPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGP---IPVEILGKIAVAVVEGLTY 118
Query: 212 LH-MLGIVYRDLKPENVLVRDEGHIMLSDFDLS--LRCSVSPTLVKSSS 257
L+ + I++RD+KP N+LV G I L DF +S L S++ T V +S+
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTST 167
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (192), Expect = 6e-16
Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 24/165 (14%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLR------AQTEREI-- 147
+ L++LG G G VY + T A+K + +L + REI
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI---------RLDNEEEGIPSTALREISL 51
Query: 148 LGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQ--KQPNKYFTEDAARFFASEV 205
L L HP + L T++ LV E+C L++ + + + + ++
Sbjct: 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQL 107
Query: 206 LLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250
L L Y H I++RDLKP+N+L+ +G + L+DF L+ R P
Sbjct: 108 LRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA-RAFGIP 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 42/164 (25%), Positives = 71/164 (43%), Gaps = 35/164 (21%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE--------- 146
+ + ++G G G VY + T A+K + R + E+E
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI------------RMENEKEGFPITAIRE 48
Query: 147 --ILGLLDHPFLPTLY----SYFETDKFYCLVMEFCSGGNLHSLRQ--KQPNKYFTEDAA 198
+L L HP + L S + + +V E+ H L P FTE
Sbjct: 49 IKLLQKLRHPNIVRLKEIVTSKGKGSIY--MVFEYMD----HDLTGLLDSPEVKFTESQI 102
Query: 199 RFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242
+ + ++L L+YLH GI++RD+K N+L+ ++G + L+DF L
Sbjct: 103 KCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-15
Identities = 43/150 (28%), Positives = 83/150 (55%), Gaps = 5/150 (3%)
Query: 98 LLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLA--SRNKLLRAQTEREILGLLDHPF 155
L +RLG G G+VYLV+ + +KV+ + + + N+ ++A E ++L LDHP
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLH-SLRQ-KQPNKYFTEDAARFFASEVLLALEYLH 213
+ ++ F +C++ E+C G +L L + K K +E+ + ++LL + Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
I++RDLK +N+ +++ + + DF +S
Sbjct: 124 QRRILHRDLKAKNIFLKNN-LLKIGDFGVS 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 45/158 (28%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKV--MDKASLASRNKLLRAQTEREILGLLD 152
+ +L+ +G G G LV+ ++ +AMK + K+S A + ++ E +L +
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVED----SRKEAVLLAKMK 56
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
HP + FE D +VME+C GG+L + Q K F ED + ++ L ++++
Sbjct: 57 HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250
H +++RD+K +N+ + G + L DF S R SP
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFG-SARLLTSP 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 48/150 (32%), Positives = 80/150 (53%), Gaps = 4/150 (2%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
+ ++ LG G G VY + + T A KV++ S +L E EIL +HP+
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPY 70
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML 215
+ L F D +++EFC GG + ++ + ++ TE + ++L AL+YLH +
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAI-MLELDRGLTEPQIQVICRQMLEALQYLHSM 129
Query: 216 GIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245
I++RDLK NVL+ +G I L+DF +S +
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 47/171 (27%), Positives = 85/171 (49%), Gaps = 22/171 (12%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRG----TNTYFAMKVMDKASLASRNKLLRAQTEREILG 149
S ++ L+ +G G G+VY RG T A+K+++ + + + Q E +L
Sbjct: 1 SLYQRLELIGRGAYGAVY----RGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLS 54
Query: 150 LLDHPFLPTLYSYFET---DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVL 206
L P + Y+ + ++ME+ GG++ +L + P E EVL
Sbjct: 55 QLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP---IAEKYISVIIREVL 111
Query: 207 LALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSS 257
+AL+Y+H +G+++RD+K N+LV + G++ L DF V+ L ++SS
Sbjct: 112 VALKYIHKVGVIHRDIKAANILVTNTGNVKLCDF------GVAALLNQNSS 156
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 6e-15
Identities = 38/147 (25%), Positives = 79/147 (53%), Gaps = 2/147 (1%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+ ++K++G G G +YL + + + + +K +D + + K ++ E +L + HP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKE-ASKKEVILLAKMKHP 59
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
+ T ++ F+ + +VME+C GG+L +Q F+ED + ++ L L+++H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 215 LGIVYRDLKPENVLVRDEGHIM-LSDF 240
I++RD+K +N+ + G + L DF
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDF 146
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 9e-15
Identities = 44/128 (34%), Positives = 59/128 (46%), Gaps = 14/128 (10%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+DFG + L E T + +FVGT Y++PE I+GE + A D W+ G+ L E
Sbjct: 142 ADFG--ISKVL-----ENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECA 194
Query: 361 HGTTPFK--GQGNRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGA 417
G PF GQ + L + P + S RD I L K+P KR A
Sbjct: 195 LGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKR----PSA 250
Query: 418 TEIKQHPF 425
E+ QHPF
Sbjct: 251 AELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 53/175 (30%), Positives = 83/175 (47%), Gaps = 12/175 (6%)
Query: 84 ISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQT 143
+S R P +F L++R+G G G VY T A+KV+ L Q
Sbjct: 2 LSRRNPQ---EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQ 55
Query: 144 EREILGLLDHPFLPTLY-SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFA 202
E ++ H + + SY DK + + MEFC GG+L + +E + +
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKLW-ICMEFCGGGSLQDIYHV--TGPLSESQIAYVS 112
Query: 203 SEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSS 257
E L L YLH G ++RD+K N+L+ D GH+ L+DF +S + ++ T+ K S
Sbjct: 113 RETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQ--ITATIAKRKS 165
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-14
Identities = 47/138 (34%), Positives = 70/138 (50%), Gaps = 14/138 (10%)
Query: 105 GDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH--PFLPTLYSY 162
G I V LV T F +K + K+S SR +L ++ H P + L+ Y
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLT----------IIPHCVPNMVCLHKY 53
Query: 163 FETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDL 222
++ LV++ GG L S K N E+ + +A+E+++AL+ LH GIV RDL
Sbjct: 54 IVSEDSVFLVLQHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDL 111
Query: 223 KPENVLVRDEGHIMLSDF 240
P N+L+ D GHI L+ F
Sbjct: 112 NPNNILLDDRGHIQLTYF 129
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 50/152 (32%), Positives = 76/152 (50%), Gaps = 8/152 (5%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
+ ++ LG G G VY + + T A KV+D S +L E +IL DHP
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPN 63
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHS--LRQKQPNKYFTEDAARFFASEVLLALEYLH 213
+ L F + +++EFC+GG + + L ++P TE R + L AL YLH
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQTLEALNYLH 120
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245
I++RDLK N+L +G I L+DF +S +
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSAK 152
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 8e-14
Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 25/161 (15%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMK----VMDKASLASRNKLLRAQTEREILGLL 151
+ LLK +G G G V + T A+K V D A R +LR E ++L L
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR--ILR---EIKLLRHL 56
Query: 152 DHP--------FLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFA 202
H P F Y +V E +LH ++ QP T+D ++F
Sbjct: 57 RHENIIGLLDILRPPSPEDFND--VY-IVTEL-METDLHKVIKSPQP---LTDDHIQYFL 109
Query: 203 SEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++L L+YLH +++RDLKP N+LV + + DF L+
Sbjct: 110 YQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 37/145 (25%), Positives = 77/145 (53%), Gaps = 1/145 (0%)
Query: 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPT 158
+K++G G G LV+ + + +K ++ + ++ + + ++ E +L + HP +
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE-ESRKEVAVLSNMKHPNIVQ 63
Query: 159 LYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIV 218
FE + +VM++C GG+L+ Q F ED + ++ LAL+++H I+
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKIL 123
Query: 219 YRDLKPENVLVRDEGHIMLSDFDLS 243
+RD+K +N+ + +G I L DF ++
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIA 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 49/149 (32%), Positives = 75/149 (50%), Gaps = 9/149 (6%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMK-VMDKASLASRNKLLRAQT------EREILGLLDHP 154
+G G G VYL T A+K V A++A R+ + E E L LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
+ + T+++ + +E+ GG++ S + + F E RFF +VL L YLH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT-YGR-FEEQLVRFFTEQVLEGLAYLHS 126
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
GI++RDLK +N+LV +G +SDF +S
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGIS 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 47/154 (30%), Positives = 73/154 (47%), Gaps = 6/154 (3%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVM--DKASLASRNKLLRAQTEREILGLLD 152
N+R K LG G G VYL T A+K + D S ++ ++ + E ++L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALEY 211
H + Y D+ + ME+ GG++ L+ TE R + ++L +EY
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQILEGVEY 119
Query: 212 LHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245
LH IV+RD+K N+L G++ L DF S R
Sbjct: 120 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 45/146 (30%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL--LDHPFL 156
L ++G G G VY + T A+K K L ++ + REI L L+HP +
Sbjct: 4 LGKIGEGTYGVVYKARDKLTGEIVAIK---KIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 157 PTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG 216
L F LV EF ++ +Q + E + + ++L L + H G
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 217 IVYRDLKPENVLVRDEGHIMLSDFDL 242
I++RDLKPEN+L+ EG + L+DF L
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGL 144
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 36/123 (29%), Positives = 66/123 (53%), Gaps = 7/123 (5%)
Query: 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL---- 383
GT+ Y+APEI++ E + VDW+ G +YE++ G TPFK + + + L
Sbjct: 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV 215
Query: 384 RFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSAL--PPH 441
+F E + ++D+ R L K+P R+ + + ++H FF+ +N+ + + L PP
Sbjct: 216 KF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPF 274
Query: 442 IPE 444
+P+
Sbjct: 275 VPD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 86/342 (25%), Positives = 128/342 (37%), Gaps = 101/342 (29%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-------HP 154
LG G G V + T T A+K + +A++ S Q ++ +L LD P
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRI-RATVNS-------QEQKRLLMDLDISMRSVDCP 60
Query: 155 FLPTLYS--YFETDKFYCL-VMEFCSGGNLHSLRQK--QPNKYFTEDAARFFASEVLLAL 209
+ T Y + E D + C+ VM+ L +K ED A ++ AL
Sbjct: 61 YTVTFYGALFREGDVWICMEVMDTS----LDKFYKKVYDKGLTIPEDILGKIAVSIVKAL 116
Query: 210 EYLH-MLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGG 268
EYLH L +++RD+KP NVL+ G + L DF +S LV S + +++ G
Sbjct: 117 EYLHSKLSVIHRDVKPSNVLINRNGQVKLCDF------GISGYLVDSVAKTIDAGCK--- 167
Query: 269 GILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328
P + P + N PEL + +V+S
Sbjct: 168 -------------------PYMAPERIN---------------PELNQKGYDVKS----- 188
Query: 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR-ATLFNVVGQPLRFPE 387
D W+ GI + EL G P+ L VV +P P+
Sbjct: 189 -------------------DVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS--PQ 227
Query: 388 TPQVSFVA--RDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427
P F +D + L K +R Y E+ QHPFFE
Sbjct: 228 LPAEKFSPEFQDFVNKCLKKNYKERPNY----PELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 82/366 (22%), Positives = 123/366 (33%), Gaps = 103/366 (28%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQ---------TERE--IL 148
LG G G V T A+K + +++ R T RE I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 149 GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNK-YFTEDAARFFASEVLL 207
+ H + L + F LVM+ + L++ K TE + ++L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMAS----DLKKVVDRKIRLTESQVKCILLQILN 130
Query: 208 ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGG 267
L LH ++RDL P N+ + +G ++DF L+ R P
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPP----------------- 173
Query: 268 GGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327
+D + MQ ++ SK V
Sbjct: 174 ---YSDTLSKDETMQR----------REEMTSK--------------------------V 194
Query: 328 GTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVVGQP- 382
T Y APE++ G E + AVD W+ G ELL G F G+ L F ++G P
Sbjct: 195 VTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPN 254
Query: 383 -----------LRFPET-----------PQVSFVARDLIRGLLVKEPHKRIAYKRGATEI 420
L T P S A DL++ LL P +RI+ A E
Sbjct: 255 EDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS----AKEA 310
Query: 421 KQHPFF 426
+H +F
Sbjct: 311 LKHEYF 316
|
Length = 335 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 7e-13
Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 9/106 (8%)
Query: 325 SFVGTHEYLAPEIIRG---EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR-ATLFNV-V 379
S GT Y+APE+I G +GHG A D W+ G + E+ G P+ N +F+V
Sbjct: 162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA 221
Query: 380 GQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425
G P++ Q+S +D + L +P KR A+E+ QHPF
Sbjct: 222 GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPT----ASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 47/161 (29%), Positives = 81/161 (50%), Gaps = 6/161 (3%)
Query: 98 LLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLP 157
++ +G G G V LV R + +K ++ + ASR + A+ E ++L L HP +
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN-ASRRERKAAEQEAQLLSQLKHPNIV 62
Query: 158 TLYSYFE-TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG 216
+E D +VM FC GG+L+ ++Q K E+ + ++ +AL+YLH
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122
Query: 217 IVYRDLKPENVLVRDEGHIMLSDFD----LSLRCSVSPTLV 253
I++RDLK +NV + I + D L +C ++ TL+
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 9/155 (5%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLLD 152
+ + +K+LG G G V L +V K+ S + R+ EREI L LD
Sbjct: 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD 64
Query: 153 HPFLPTL--YSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARF--FASEVLLA 208
H + + L+ME+ G+L Q+ ++ + R F+S++
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICKG 121
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++YL ++RDL N+LV E + +SDF L+
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 16/152 (10%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKA--SLASRNKLLRAQTEREILG---L 150
+++L ++G G V + R T Y+A+K M K SL N L REI L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL------REIQALRRL 54
Query: 151 LDHPFLPTLYS--YFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLA 208
HP + L + LV E NL+ L + + + E + + ++L +
Sbjct: 55 SPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGR-KRPLPEKRVKSYMYQLLKS 112
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240
L+++H GI +RD+KPEN+L++D+ + L+DF
Sbjct: 113 LDHMHRNGIFHRDIKPENILIKDD-ILKLADF 143
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 51/173 (29%), Positives = 82/173 (47%), Gaps = 16/173 (9%)
Query: 79 DAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKL 138
D I++ +LR P G+ F L++ +G G G VY T A+KVMD + ++
Sbjct: 4 DDIDLSALRDPA-GI--FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEE 56
Query: 139 LRAQTEREILGLLDHPF-LPTLYSYF-------ETDKFYCLVMEFCSGGNLHSLRQKQPN 190
+ E +L H + T Y F D+ + LVMEFC G++ L +
Sbjct: 57 EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW-LVMEFCGAGSVTDLVKNTKG 115
Query: 191 KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
ED + E+L L +LH +++RD+K +NVL+ + + L DF +S
Sbjct: 116 NALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 46/162 (28%), Positives = 71/162 (43%), Gaps = 9/162 (5%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLLD 152
+ +L +G G G V + T A+K K S ++ ++ RE+ L L
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KES--EDDEDVKKTALREVKVLRQLR 58
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
H + L F LV E+ L L + P DA R + ++L A+ Y
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYV-ERTLLELLEASPGG-LPPDAVRSYIWQLLQAIAYC 116
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDL--SLRCSVSPTL 252
H I++RD+KPEN+LV + G + L DF +LR + L
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 4e-12
Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFN--VVGQP 382
+ VGT YL+PE+ + + + D W+ G LYEL PF+G+ N L + GQ
Sbjct: 162 TVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE-NLLELALKILKGQY 220
Query: 383 LRFPETPQVSFVARDLIRGLLVKEPHKR 410
P Q S R+L+ LL K+P +R
Sbjct: 221 PPIPS--QYSSELRNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 22/166 (13%)
Query: 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILG 149
P L++ L +G G G VY + + T A+K M + NK R + +++
Sbjct: 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK--RILMDLDVV- 67
Query: 150 LLDH--PFLPTLYSYF--ETDKFYCL-VMEFCSGGNLHSL--RQKQPNKYFTEDAARFFA 202
L H P++ Y YF ++D F C+ +M C L L R + P ED
Sbjct: 68 LKSHDCPYIVKCYGYFITDSDVFICMELMSTC----LDKLLKRIQGP---IPEDILGKMT 120
Query: 203 SEVLLALEYL---HMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245
++ AL YL H G+++RD+KP N+L+ G++ L DF +S R
Sbjct: 121 VAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGR 164
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 6e-12
Identities = 43/127 (33%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+DFG L T + S GT ++APE+IRGE +G A D W+ G + E+
Sbjct: 143 ADFGCAK-----RLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMA 197
Query: 361 HGTTPFKGQGNRATLFNVVGQPLRFPETPQ-VSFVARDLIRGLLVKEPHKRIAYKRGATE 419
G P+ GN +G PE P+ +S A+D +R L ++P KR A E
Sbjct: 198 TGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRP----TADE 253
Query: 420 IKQHPFF 426
+ QHPF
Sbjct: 254 LLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 55/186 (29%), Positives = 83/186 (44%), Gaps = 16/186 (8%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+ + + LG+G+ G+VY T A+KV+ K + +E EIL D P
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK--QIMSELEILYKCDSP 59
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
++ Y F + + EF GG+L R K P E A V+ L YL
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLDVYR-KIP-----EHVLGRIAVAVVKGLTYLWS 113
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLS--LRCSVSPTLVKSSSVSVNNGSGGGGGILN 272
L I++RD+KP N+LV G + L DF +S L S++ T V + N I
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGT------NAYMAPERISG 167
Query: 273 DEYAVH 278
++Y +H
Sbjct: 168 EQYGIH 173
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 48/168 (28%), Positives = 68/168 (40%), Gaps = 9/168 (5%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLLD 152
+ K+LG G VY + T A+K + + REI L L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQ--KQPNKYFTEDAARFFASEVLLALE 210
HP + L F LV EF L + K + T + + L LE
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET----DLEKVIKDKSIVLTPADIKSYMLMTLRGLE 116
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258
YLH I++RDLKP N+L+ +G + L+DF L+ R SP + V
Sbjct: 117 YLHSNWILHRDLKPNNLLIASDGVLKLADFGLA-RSFGSPNRKMTHQV 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 37/138 (26%), Positives = 65/138 (47%), Gaps = 1/138 (0%)
Query: 103 GYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSY 162
+ D+ V+L + + TNT A+K ++ S S+ L Q E L HP + +
Sbjct: 9 CFEDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 163 FETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDL 222
F D +V + G+ L + + E A F +VL AL+Y+H G ++R +
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSV 127
Query: 223 KPENVLVRDEGHIMLSDF 240
K ++L+ +G ++LS
Sbjct: 128 KASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 12/150 (8%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRN-----KLLRA-QTEREILGLLDHPF 155
+G G GSVYL + A+K ++ S+++ + +L A E +L L H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKY--FTEDAARFFASEVLLALEYLH 213
+ + +E+ GG++ +L N Y F E R F ++L L YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL----NNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
GI++RD+K N+LV ++G I +SDF +S
Sbjct: 124 NRGIIHRDIKGANILVDNKGGIKISDFGIS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 47/155 (30%), Positives = 78/155 (50%), Gaps = 10/155 (6%)
Query: 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVM-DKASLASRNKLLRAQTEREIL 148
LS + R+G G G+VY V R T +A+KV+ R ++ R E EIL
Sbjct: 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR---EIEIL 126
Query: 149 GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLA 208
++HP + + F+ + +++EF GG+L + F D AR ++L
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD--EQFLADVAR----QILSG 180
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ YLH IV+RD+KP N+L+ ++ ++DF +S
Sbjct: 181 IAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVS 215
|
Length = 353 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 48/164 (29%), Positives = 83/164 (50%), Gaps = 18/164 (10%)
Query: 95 NFRLLKRLGYGDIGSVYLVELR-GTNTYFAMKVMDKASLASR-NKLLRAQTEREILG--- 149
+ +L+ LG G G VY V + A+K ++ + A +K R ++ +I+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 150 ----LLDHPFLPTLYSYF-ETDKFYCLVMEFCSGGNL----HSLRQKQPNKYFTEDAARF 200
L HP + Y F E D+ Y +VM+ G L +SL++K+ FTE+
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLY-IVMDLIEGAPLGEHFNSLKEKKQR--FTEERIWN 117
Query: 201 FASEVLLALEYLHMLG-IVYRDLKPENVLVRDEGHIMLSDFDLS 243
+++LAL YLH IV+RDL P N+++ ++ + ++DF L+
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 41/148 (27%), Positives = 65/148 (43%), Gaps = 10/148 (6%)
Query: 100 KRLGYGDIGSV---YLVELRGTNTYFAMKVM-DKASLASRNKLLRAQTEREILGLLDHPF 155
K LG+G+ GSV + G A+K + + A + + LR E ++ LDHP
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLR---EASVMAQLDHPC 57
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML 215
+ L + + LVME G L +K+ + A +V + + YL
Sbjct: 58 IVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKRRE--IPVSDLKELAHQVAMGMAYLESK 114
Query: 216 GIVYRDLKPENVLVRDEGHIMLSDFDLS 243
V+RDL NVL+ + +SDF +S
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 50/173 (28%), Positives = 77/173 (44%), Gaps = 23/173 (13%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTN-----TYFAMKVM-DKASLASRNKLLRAQTE 144
I LS R L+ LG G G VY EL G N T A+K + + A + + + E
Sbjct: 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ---E 58
Query: 145 REILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTE-------- 195
E++ L HP + L ++ C++ E+ + G+LH L + P+
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 196 ---DAARFF--ASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
D + F A ++ +EYL V+RDL N LV + + +SDF LS
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
F L+R+G G G V+ T A+K++D + +++ Q E +L D P+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63
Query: 156 LPTLY-SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
+ Y SY + K + ++ME+ GG+ L + P F E E+L L+YLH
Sbjct: 64 VTKYYGSYLKGTKLW-IIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLHS 119
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++RD+K NVL+ ++G + L+DF ++
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 83/376 (22%), Positives = 133/376 (35%), Gaps = 113/376 (30%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGL 150
L ++ +L +LG G G VY T A+K K + + REI L
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALK---KILMHNEKDGFPITALREIKILKK 63
Query: 151 LDHP-FLPTLYSYFETDK--------FYCLV--MEFCSGGNLHSLRQKQPNKYFTEDAAR 199
L HP +P + E Y + M+ G L + P+ TE +
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN-----PSVKLTESQIK 118
Query: 200 FFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVS 259
+ ++L + YLH I++RD+K N+L+ ++G + ++DF L+ P
Sbjct: 119 CYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPP-------- 170
Query: 260 VNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPT 319
N GGGGG + T
Sbjct: 171 -NPKGGGGGG---------------------------------------------TRKYT 184
Query: 320 NVRSMSFVGTHEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATL--- 375
N+ V T Y PE++ GE + +AVD W G E+ +G+ + L
Sbjct: 185 NL-----VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239
Query: 376 FNVVGQP--------------------LRFPETPQVSF-----VARDLIRGLLVKEPHKR 410
F + G P +P T + F DL+ LL +P+KR
Sbjct: 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKR 299
Query: 411 IAYKRGATEIKQHPFF 426
+ A++ +HP+F
Sbjct: 300 LT----ASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 4e-11
Identities = 33/104 (31%), Positives = 48/104 (46%), Gaps = 11/104 (10%)
Query: 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNV----VGQPL 383
GT +Y +PE I+G + + DWW G+ YELL G PFK + ++ Q
Sbjct: 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK--EDEDEELDLESLLKRQQK 225
Query: 384 RFPETPQVSFVARDLIRGLLVKEPHKR-IAYKRGATEIKQHPFF 426
+ P VS A D ++ +L + R Y EI +HPF
Sbjct: 226 KLPFIKNVSKNANDFVQSMLKYNINYRLTNYN----EIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 69/263 (26%), Positives = 101/263 (38%), Gaps = 79/263 (30%)
Query: 168 FYCLVMEFCSGGNLHSL-RQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPEN 226
F+ + ME GG+L +L R K E F+ ++L L+YLH IV+
Sbjct: 79 FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH------- 131
Query: 227 VLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTF 286
RD +K +V VN SG
Sbjct: 132 ---RD---------------------IKGDNVLVNTYSG--------------------- 146
Query: 287 FPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII-RG-EGHG 344
+I SDFG A E +F GT +Y+APE+I +G G+G
Sbjct: 147 VVKI----------SDFGTSKRLAGINPCTE-------TFTGTLQYMAPEVIDKGPRGYG 189
Query: 345 SAVDWWTFGIFLYELLHGTTPFKGQGN-RATLFNVVGQPLRFPETPQ-VSFVARDLIRGL 402
+ D W+ G + E+ G PF G +A +F VG PE P+ +S A++ I
Sbjct: 190 APADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIHPEIPESLSAEAKNFILRC 248
Query: 403 LVKEPHKRIAYKRGATEIKQHPF 425
+P KR + A ++ Q PF
Sbjct: 249 FEPDPDKRAS----AHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 64.0 bits (154), Expect = 5e-11
Identities = 42/153 (27%), Positives = 60/153 (39%), Gaps = 20/153 (13%)
Query: 290 ILPSKKNRKSK-SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGH---GS 345
IL + R K DFG + VGT Y+APE++ G S
Sbjct: 132 ILLDRDGRVVKLIDFG-LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASS 190
Query: 346 AVDWWTFGIFLYELLHGTTPFKGQGNRATL-----------FNVVGQPLRFPETPQVSFV 394
+ D W+ GI LYELL G PF+G+ N + + PL +S
Sbjct: 191 SSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKA 250
Query: 395 ARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427
A DL++ LL K+P R+ ++ H
Sbjct: 251 ASDLLKKLLAKDPKNRL----SSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 53/165 (32%), Positives = 74/165 (44%), Gaps = 22/165 (13%)
Query: 99 LKRLGYGDIGSVYLVELRGTNTYFAMK----VMDKASLASRNKLLRAQTEREILGLLDHP 154
L LG G+ GSVY V R T AMK +D++ N+++ E +IL P
Sbjct: 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF---NQIIM---ELDILHKAVSP 59
Query: 155 FLPTLYSYF--ETDKFYCLVMEFCSGGNLHSLR-QKQPNKYFTEDAARFFASEVLLALEY 211
++ Y F E + C ME+ G+L L + ED R V+ L++
Sbjct: 60 YIVDFYGAFFIEGAVYMC--MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 212 L-HMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKS 255
L I++RD+KP NVLV G + L DF VS LV S
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQVKLCDF------GVSGNLVAS 156
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 7/149 (4%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
F L+R+G G G VY T A+K++D + +++ Q E +L D P+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63
Query: 156 LPTLY-SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
+ Y SY + K + ++ME+ GG+ L + P E E+L L+YLH
Sbjct: 64 ITRYYGSYLKGTKLW-IIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHS 119
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++RD+K NVL+ ++G + L+DF ++
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-11
Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 6/103 (5%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR 384
S GT +++PE+I GEG+G D W+ G + E+L P+ A +F + QP
Sbjct: 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN 225
Query: 385 FPETPQ-VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
P+ P VS AR+ +R V+ KR + A E+ +H F
Sbjct: 226 -PQLPSHVSPDARNFLRRTFVENAKKRPS----AEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 16/141 (11%)
Query: 290 ILPSKKNRKSKSDFGPC--VGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAV 347
IL + R SDFG C V +P + S VGT ++APE+I +G+ V
Sbjct: 149 ILLTSDGRIKLSDFGFCAQVSKEVP---------KRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 348 DWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ-PLRFPETPQVSFVARDLIRGLLVKE 406
D W+ GI + E++ G P+ + + + P R ++ +VS V R + +LV+E
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259
Query: 407 PHKRIAYKRGATEIKQHPFFE 427
P +R A E+ QHPF +
Sbjct: 260 PSQRAT----AQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 20/161 (12%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL---- 151
+ L +G G G+VY T + A+K K + + + T REI LL
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALK---KVRVPLSEEGIPLSTLREI-ALLKQLE 56
Query: 152 --DHPFLPTLYSYF-------ETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFA 202
+HP + L E LV E +L + K P + +
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLT--LVFEHVDQ-DLATYLSKCPKPGLPPETIKDLM 113
Query: 203 SEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++L +++LH IV+RDLKP+N+LV +G + ++DF L+
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 9e-11
Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 5/148 (3%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
F L+++G G G V+ T A+K++D + +++ Q E +L D P+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML 215
+ Y + D ++ME+ GG+ L + P E E+L L+YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSE 120
Query: 216 GIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++RD+K NVL+ + G + L+DF ++
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 7/144 (4%)
Query: 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLLDHPFL 156
L ++G G G V+ R T A+K K + + +++ REI L L HP L
Sbjct: 6 LSKIGEGSYGVVFKCRNRETGQIVAIK---KFVESEDDPVIKKIALREIRMLKQLKHPNL 62
Query: 157 PTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG 216
L F + LV E+C L+ L +K P E + + L A+ + H
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLNEL-EKNPRG-VPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 217 IVYRDLKPENVLVRDEGHIMLSDF 240
++RD+KPEN+L+ +G I L DF
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 3e-10
Identities = 37/131 (28%), Positives = 50/131 (38%), Gaps = 37/131 (28%)
Query: 329 THE-----YLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVV 379
THE Y APEI+ G H +AVD W+ G E++ G F G L F ++
Sbjct: 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQIL 215
Query: 380 GQPL------------------RFPETPQVSFV------ARDLIRGLLVKEPHKRIAYKR 415
G P +FP + DL+ +L P KRI
Sbjct: 216 GTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI---- 271
Query: 416 GATEIKQHPFF 426
A E +HP+F
Sbjct: 272 SAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 48/166 (28%), Positives = 73/166 (43%), Gaps = 23/166 (13%)
Query: 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMK--VMDKASLASRNKLLRAQTEREILG 149
+S + L ++G G G V+ + T A+K +M+ LR E +IL
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR---EIKILQ 66
Query: 150 LLDHP----------FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKY--FTEDA 197
LL H T Y+ ++ FY LV EFC H L NK FT
Sbjct: 67 LLKHENVVNLIEICRTKATPYNRYKGS-FY-LVFEFCE----HDLAGLLSNKNVKFTLSE 120
Query: 198 ARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ +L L Y+H I++RD+K N+L+ +G + L+DF L+
Sbjct: 121 IKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 50/184 (27%), Positives = 88/184 (47%), Gaps = 13/184 (7%)
Query: 83 MISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQ 142
M+ L + +++ +G G G VY V + + A+K++D S +
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE----EIE 66
Query: 143 TEREILGLL-DHPFLPTLYS-YFETDKF----YCLVMEFCSGGNLHSLRQK--QPNKYFT 194
E IL L +HP + Y +++ DK LV+E C+GG++ L + +
Sbjct: 67 AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126
Query: 195 EDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254
E + LL L++LH I++RD+K N+L+ EG + L DF +S + + S L +
Sbjct: 127 EAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT-STRLRR 185
Query: 255 SSSV 258
++SV
Sbjct: 186 NTSV 189
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 3e-10
Identities = 37/124 (29%), Positives = 59/124 (47%), Gaps = 9/124 (7%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG L + T +RS++ GT +++PE+I GEG+G D W+ G + E+L
Sbjct: 149 DFG--ASKRLQTICMSGTGIRSVT--GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT 204
Query: 362 GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIK 421
P+ A +F + QP +S ARD + + V+ H + A E+
Sbjct: 205 EKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFVEARH-----RPSAEELL 259
Query: 422 QHPF 425
+HPF
Sbjct: 260 RHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 13/106 (12%)
Query: 325 SFVGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL 383
SF G+ ++APE+I +G +G A D W+ G + E+ G P+ A +F +
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG---- 215
Query: 384 RFPETPQV----SFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425
R E P + S A+D I L ++P R A E+ +HPF
Sbjct: 216 RSKELPPIPDHLSDEAKDFILKCLQRDPSLRPT----AAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 40/137 (29%), Positives = 63/137 (45%), Gaps = 12/137 (8%)
Query: 290 ILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDW 349
IL +K +DFG V L ++ + +V VGT ++APE+I G +A D
Sbjct: 130 ILTTKDGVVKLADFG--VATKLNDVSKDDASV-----VGTPYWMAPEVIEMSGASTASDI 182
Query: 350 WTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409
W+ G + ELL G P+ A LF +V Q P +S +D + K+P+
Sbjct: 183 WSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQKDPNL 241
Query: 410 RIAYKRGATEIKQHPFF 426
R A ++ +HP+
Sbjct: 242 RPT----AKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 51/175 (29%), Positives = 79/175 (45%), Gaps = 24/175 (13%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKV--MDK-------ASLASRNKLLRAQT 143
++ F L R+G G G VY + A+K MD +SL LL +
Sbjct: 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRH 65
Query: 144 EREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFAS 203
I+ L + L S F LVME+C +L SL P F+E +
Sbjct: 66 P-NIVELKEVVVGKHLDSIF-------LVMEYCEQ-DLASLLDNMPTP-FSESQVKCLML 115
Query: 204 EVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV-----SPTLV 253
++L L+YLH I++RDLK N+L+ D+G + ++DF L+ + +P +V
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 6e-10
Identities = 28/89 (31%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQG-NRATLFNVVGQPL 383
S VGT Y++PE I G+ D W+ G LYE+ +PF G N +L + +
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-C 223
Query: 384 RFPETPQVSFVA--RDLIRGLLVKEPHKR 410
+P P + RDL+ + +P KR
Sbjct: 224 DYPPLPADHYSEELRDLVSRCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 7e-10
Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMD-KASLASRNKLLRAQTEREILGLLD 152
+F L LG G+ G V V R + A K++ + A RN+++R E ++L +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIR---ELKVLHECN 57
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQ---PNKYFTEDAARFFASEVLLAL 209
P++ Y F +D + ME GG+L + +K P + + VL L
Sbjct: 58 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGK-----ISIAVLRGL 112
Query: 210 EYLH-MLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
YL I++RD+KP N+LV G I L DF +S
Sbjct: 113 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 42/153 (27%), Positives = 64/153 (41%), Gaps = 6/153 (3%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
I +L +G G+ G V L + RG A+K + K + L E ++
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDYRGQKV--AVKCL-KDDSTAAQAFL---AEASVMTT 56
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
L HP L L +V E+ + G+L + + T FA +V +E
Sbjct: 57 LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGME 116
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
YL V+RDL NVLV ++ +SDF L+
Sbjct: 117 YLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 8e-10
Identities = 55/187 (29%), Positives = 85/187 (45%), Gaps = 16/187 (8%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVM--DKASLASRNKLLRAQTEREILGLLD 152
N+RL K LG G G VYL T A+K + D S + ++ + E ++L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 153 HPFLPTLYSYFE--TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
H + Y +K + +E+ GG++ Q + TE+ R + ++L +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKD--QLKAYGALTENVTRRYTRQILQGVS 120
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS---VSPTLVKS-------SSVSV 260
YLH IV+RD+K N+L G++ L DF S R +S T +KS S V
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 261 NNGSGGG 267
+G G G
Sbjct: 181 ISGEGYG 187
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 23/153 (15%)
Query: 290 ILPSKKNRKSKSDFGPC--VGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAV 347
IL + R SDFG C + +P + S VGT ++APE+I +G+ V
Sbjct: 148 ILLTLDGRVKLSDFGFCAQISKDVP---------KRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 348 DWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ-PLRFPETPQVSFVARDLIRGLLVKE 406
D W+ GI + E++ G P+ + + P + ++S V RD + +L +E
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTRE 258
Query: 407 PHKRIAYKRGATEIKQHPFFEGVNWALVRSALP 439
P +R A E+ HPF L+++ LP
Sbjct: 259 PQERAT----AQELLDHPF-------LLQTGLP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 8e-10
Identities = 41/155 (26%), Positives = 73/155 (47%), Gaps = 8/155 (5%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMK---VMDKASLASRNKLLRAQTEREILG 149
L+NFR+ K++G G VY A+K + D +R ++ E ++L
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLK 57
Query: 150 LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQ--KQPNKYFTEDAARFFASEVLL 207
L+HP + Y+ F D +V+E G+L + + K+ + E + ++
Sbjct: 58 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 208 ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242
ALE++H +++RD+KP NV + G + L D L
Sbjct: 118 ALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 9e-10
Identities = 41/150 (27%), Positives = 58/150 (38%), Gaps = 50/150 (33%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSK-SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAP 335
+H ++P IL N K K +DFG + + VGT Y+AP
Sbjct: 114 IHRDLKPE----NILLDSDNGKVKLADFGLSK-------LLTSDKSLLKTIVGTPAYMAP 162
Query: 336 EIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFV 394
E++ G+G+ D W+ G+ LYEL PE
Sbjct: 163 EVLLGKGYYSEKSDIWSLGVILYEL--------------------------PE------- 189
Query: 395 ARDLIRGLLVKEPHKRIAYKRGATEIKQHP 424
+DLIR +L K+P KR A EI +H
Sbjct: 190 LKDLIRKMLQKDPEKRP----SAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 40/151 (26%), Positives = 70/151 (46%), Gaps = 7/151 (4%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+ +L ++LG G G V++ GT T A+K + ++ S L+ E +I+ L H
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGTM-SPEAFLQ---EAQIMKKLRH 60
Query: 154 PFLPTLYSYF-ETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
L LY+ E + Y +V E+ S G+L + K A+++ + YL
Sbjct: 61 DKLVQLYAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL 119
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++RDL N+LV + ++DF L+
Sbjct: 120 ESRNYIHRDLAARNILVGENLVCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 39/127 (30%), Positives = 57/127 (44%), Gaps = 17/127 (13%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG V G L M+ + +FVGT ++APE+I+ G+ D W+ GI EL
Sbjct: 141 DFG--VSGQLTSTMS-----KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAK 193
Query: 362 GTTPFKGQGNRATLFNVVGQPLRFP---ETPQVSFVARDLIRGLLVKEPHKRIAYKRGAT 418
G P LF + P P E + S +D + L K+P +R + A
Sbjct: 194 GEPPLSDLHPMRVLFLI---PKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPS----AK 246
Query: 419 EIKQHPF 425
E+ +H F
Sbjct: 247 ELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 49/155 (31%), Positives = 66/155 (42%), Gaps = 41/155 (26%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSF-VGTHEYLAPEIIRGEGH-GSAVDWWTFGIFLYEL 359
DFG L L +E R S V T Y APE++ G VD W G EL
Sbjct: 142 DFG------LARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAEL 194
Query: 360 LHGTTPFKGQGNRATL---FNVVGQP----------------LRFPET---------PQV 391
L+G+ F G+ + L F +G P + FPE+ P
Sbjct: 195 LNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDA 254
Query: 392 SFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
S A DL++GLLV +P KR++ A E +HP+F
Sbjct: 255 SPEALDLLKGLLVYDPSKRLS----AAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 1e-09
Identities = 48/167 (28%), Positives = 73/167 (43%), Gaps = 25/167 (14%)
Query: 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI-- 147
P G+ F L++ +G G G VY T A+KVMD + E EI
Sbjct: 4 PAGI--FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----------VTGDEEEEIKQ 51
Query: 148 -LGLLD----HPFLPTLYSYF------ETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTED 196
+ +L H + T Y F D LVMEFC G++ L + E+
Sbjct: 52 EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 111
Query: 197 AARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ E+L L +LH +++RD+K +NVL+ + + L DF +S
Sbjct: 112 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 50/167 (29%), Positives = 75/167 (44%), Gaps = 25/167 (14%)
Query: 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE-- 146
P L +F ++G G G V + + T A+K MD LR Q RE
Sbjct: 20 PREYLDSFI---KIGEGSTGIVCIATEKHTGKQVAVKKMD----------LRKQQRRELL 66
Query: 147 -----ILGLLDHPFLPTLY-SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARF 200
I+ H + +Y SY D+ + +VMEF GG L + + E+
Sbjct: 67 FNEVVIMRDYHHENVVDMYNSYLVGDELW-VVMEFLEGGALTDIVT---HTRMNEEQIAT 122
Query: 201 FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247
VL AL YLH G+++RD+K +++L+ +G I LSDF + S
Sbjct: 123 VCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 17/168 (10%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVM-----DKASLASRNKLLRAQTEREILG 149
++ L++R+G G G VY T A+K++ D SL + + + +
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKH---- 65
Query: 150 LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLAL 209
+ SY +K + + ME+C GG+L + +E + E L L
Sbjct: 66 ---CNIVAYFGSYLSREKLW-ICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGL 119
Query: 210 EYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSS 257
YLH G ++RD+K N+L+ D G + L+DF ++ + ++ T+ K S
Sbjct: 120 AYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAK--ITATIAKRKS 165
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 42/152 (27%), Positives = 74/152 (48%), Gaps = 7/152 (4%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLLD 152
++ ++++G G G VY + T AMK K L S + + + REI L L
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMK---KIRLESEEEGVPSTAIREISLLKELQ 57
Query: 153 HPFLPTLYS-YFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEY 211
HP + L + + Y L+ EF S L +Y + + + ++L + +
Sbjct: 58 HPNIVCLQDVLMQESRLY-LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 212 LHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
H +++RDLKP+N+L+ ++G I L+DF L+
Sbjct: 117 CHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 43/146 (29%), Positives = 61/146 (41%), Gaps = 4/146 (2%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
F L+ +G+G G+VY TN A+K M + S K E L L HP
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLR-QKQPNKYFTEDAARFFASEVLLALEYLHM 214
+ + LVME+C G L K+P E L L YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKP---LQEVEIAAICHGALQGLAYLHS 133
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDF 240
++RD+K N+L+ + G + L+DF
Sbjct: 134 HERIHRDIKAGNILLTEPGTVKLADF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 6/156 (3%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVM--DKASLASRNKLLRAQTEREILGLL 151
+N+RL K LG G G VYL T A+K + D S + ++ + E ++L L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 152 DHPFLPTLYSYFE--TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLAL 209
H + Y ++ + ME GG++ Q + TE+ R + ++L +
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKD--QLKSYGALTENVTRKYTRQILEGV 119
Query: 210 EYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245
YLH IV+RD+K N+L G++ L DF S R
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKR 155
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 38/132 (28%), Positives = 54/132 (40%), Gaps = 37/132 (28%)
Query: 326 FVGTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKG-----QGNRATLFNVV 379
+V T Y APE++ G +G+ + VD W+ G ELL F G Q + +F +
Sbjct: 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK--IFRTL 215
Query: 380 GQP----------------LRFPE---------TPQVSFVARDLIRGLLVKEPHKRIAYK 414
G P FP+ P S A DL+ +L +PHKRI
Sbjct: 216 GTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT-- 273
Query: 415 RGATEIKQHPFF 426
A + HP+F
Sbjct: 274 --AEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 21/154 (13%)
Query: 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLLDHPFL 156
L+++G G G+V+ + R T+ A+K + L ++ + + REI L L H +
Sbjct: 5 LEKIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSSALREICLLKELKHKNI 61
Query: 157 PTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYF-----TEDA--ARFFASEVLLAL 209
LY +DK LV E+C + KYF D + F ++L L
Sbjct: 62 VRLYDVLHSDKKLTLVFEYC---------DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 210 EYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ H +++RDLKP+N+L+ G + L+DF L+
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 51/158 (32%), Positives = 81/158 (51%), Gaps = 19/158 (12%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDK-------ASLASRN-KLLRAQTEREI 147
+R LK++G G G+V R T A+K + + A A R +LL+ +
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 148 LGLLDHPFLPTLYSYFETDKF--YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEV 205
+GLLD F P L D+F + LVM F G +L L + + +ED +F ++
Sbjct: 77 IGLLD-VFTPDL----SLDRFHDFYLVMPFM-GTDLGKLMKHEK---LSEDRIQFLVYQM 127
Query: 206 LLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
L L+Y+H GI++RDLKP N+ V ++ + + DF L+
Sbjct: 128 LKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 3e-09
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 5/164 (3%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
++ L++LG G +VY + + A+KV+ A E +L L H
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKHA 63
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
+ L+ T + LV E+ +L K P + + F ++L L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGG-LHPENVKLFLFQLLRGLSYIHQ 121
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258
I++RDLKP+N+L+ D G + L+DF L+ R P+ S+ V
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLA-RAKSVPSHTYSNEV 164
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 37/99 (37%), Positives = 47/99 (47%), Gaps = 13/99 (13%)
Query: 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQG---NRATLFNVVGQPLRFPET 388
Y APE+ A DWW+ G L+ELL G T + N T N+ PE
Sbjct: 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNI-------PE- 199
Query: 389 PQVSFVARDLIRGLLVKEPHKRI-AYKRGATEIKQHPFF 426
VS AR L++ LL P +R+ A G +IK HPFF
Sbjct: 200 -WVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
I S +K LG G G V+L + R A+K +++ +++ + + E +++
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFI----EEAKVMMK 55
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAARFFASEVLLAL 209
L HP L LY K +V EF G L + LRQ+Q ++D +V +
Sbjct: 56 LSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGM 113
Query: 210 EYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
EYL ++RDL N LV G + +SDF ++
Sbjct: 114 EYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 100 KRLGYGDIGSVY--LVELRGTNTYFAMKVM--DKASLASRNKLLRAQTEREILGLLDHPF 155
LG G+ G+V + +++ + A+K++ D A +++LLR E ++ LD+P+
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR---EANVMQQLDNPY 57
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML 215
+ + E + + LVME G L+ QK NK+ TE +V + ++YL
Sbjct: 58 IVRMIGICEAES-WMLVMELAELGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEET 114
Query: 216 GIVYRDLKPENVLVRDEGHIMLSDFDLS 243
V+RDL NVL+ + + +SDF LS
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 12/149 (8%)
Query: 98 LLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLP 157
LK LG G G V+L + RG A+K++ + +++ + + E +++ L HP L
Sbjct: 8 FLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSEDDFI----EEAKVMMKLSHPNLV 62
Query: 158 TLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTE---DAARFFASEVLLALEYLHM 214
LY + +V E+ + G L + +++ K TE D S+V A+EYL
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC----SDVCEAMEYLES 118
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
G ++RDL N LV ++ + +SDF L+
Sbjct: 119 NGFIHRDLAARNCLVGEDNVVKVSDFGLA 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 6/149 (4%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLLDH 153
++ ++++G G G VY + T A+K K L + ++ + + REI L L+H
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALK---KIRLETEDEGVPSTAIREISLLKELNH 57
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
P + L ++ LV EF +L P + + ++L + Y H
Sbjct: 58 PNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH 116
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDL 242
+++RDLKP+N+L+ EG + L+DF L
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 29/86 (33%), Positives = 49/86 (56%), Gaps = 5/86 (5%)
Query: 171 LVMEFCSGGNLHSL-RQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLV 229
+VM+ +LH + QP TE+ R+F ++L L+Y+H +++RDLKP N+LV
Sbjct: 85 VVMDL-MESDLHHIIHSDQP---LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV 140
Query: 230 RDEGHIMLSDFDLSLRCSVSPTLVKS 255
++ + + DF ++ S SPT K
Sbjct: 141 NEDCELRIGDFGMARGLSSSPTEHKY 166
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 46/171 (26%), Positives = 85/171 (49%), Gaps = 13/171 (7%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL-GLLDHP 154
+ +++ +G G G V+ V + + A+K++D + E IL L DHP
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE----EIEAEYNILKALSDHP 75
Query: 155 FLPTLYS-YFETDKF----YCLVMEFCSGGNLHSLRQK--QPNKYFTEDAARFFASEVLL 207
+ Y Y++ D LV+E C+GG++ L + + + E + E L+
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 208 ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258
L++LH+ ++RD+K N+L+ EG + L DF +S + + S L +++SV
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT-STRLRRNTSV 185
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 7e-09
Identities = 46/167 (27%), Positives = 73/167 (43%), Gaps = 32/167 (19%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMK------VMDKASLASRNKLLRAQTERE 146
L NF++ K++G G VY A+K +MD + R L+ E +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKA---RQDCLK---EID 54
Query: 147 ILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNL-----HSLRQKQPN------KYFTE 195
+L LDHP + + F + +V+E G+L H +QK+ KYF +
Sbjct: 55 LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114
Query: 196 DAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242
+ ALE++H I++RD+KP NV + G + L D L
Sbjct: 115 LCS---------ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 7e-09
Identities = 51/158 (32%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMK-VMDKASLASRNKLLRAQ-TEREIL-- 148
L + +L++LG G G V+ R T A+K + D A RN AQ T REI+
Sbjct: 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFD----AFRNAT-DAQRTFREIMFL 60
Query: 149 -GLLDHPFLPTLYSYF--ETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEV 205
L DHP + L + E DK LV E+ +LH++ + + R+ ++
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRA---NILEDVHKRYIMYQL 116
Query: 206 LLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
L AL+Y+H +++RDLKP N+L+ + + L+DF L+
Sbjct: 117 LKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLA 154
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 8e-09
Identities = 44/151 (29%), Positives = 72/151 (47%), Gaps = 6/151 (3%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLLD 152
NF+ ++++G G G VY + T A+K K L + + + + REI L L+
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALK---KIRLDTETEGVPSTAIREISLLKELN 57
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
HP + L T+ LV EF +L P + + ++L L +
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
H +++RDLKP+N+L+ EG I L+DF L+
Sbjct: 117 HSHRVLHRDLKPQNLLINTEGAIKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 9e-09
Identities = 38/130 (29%), Positives = 62/130 (47%), Gaps = 16/130 (12%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+DFG C P + + VGT ++APE++ + +G VD W+ GI E++
Sbjct: 157 TDFGFCA-------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
Query: 361 HGTTPFKGQGNRATLFNVV--GQP-LRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGA 417
G P+ + L+ + G P L+ PE ++S + RD + L + KR A
Sbjct: 210 EGEPPYLNENPLRALYLIATNGTPELQNPE--KLSPIFRDFLNRCLEMDVEKR----GSA 263
Query: 418 TEIKQHPFFE 427
E+ QHPF +
Sbjct: 264 KELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 9e-09
Identities = 42/145 (28%), Positives = 74/145 (51%), Gaps = 8/145 (5%)
Query: 102 LGYGDIGSVY--LVELRGTNTYFAMKVMDKASLAS-RNKLLRAQTEREILGLLDHPFLPT 158
LG G+ G V + ++R A+KV+ + S R++++R E EI+ LD+P++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMR---EAEIMHQLDNPYIVR 59
Query: 159 LYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIV 218
+ E + LVME SGG L+ + ++ + +V + ++YL V
Sbjct: 60 MIGVCEAEALM-LVMEMASGGPLNKFLSGKKDEITVSNVVELM-HQVSMGMKYLEGKNFV 117
Query: 219 YRDLKPENVLVRDEGHIMLSDFDLS 243
+RDL NVL+ ++ + +SDF LS
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLS 142
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 74/338 (21%), Positives = 119/338 (35%), Gaps = 92/338 (27%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYS 161
+G G G+V + + + T A+K + K L + ++ D P++ Y
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD-VVMRSSDCPYIVKFYG 70
Query: 162 --YFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL-HMLGIV 218
+ E D + C+ + S + + E+ A + AL YL L I+
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKII 130
Query: 219 YRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVH 278
+RD+KP N+L+ G+I L DF +S LV S + + +
Sbjct: 131 HRDVKPSNILLDRNGNIKLCDF------GISGQLVDSIAKTRDA---------------- 168
Query: 279 GC---MQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAP 335
GC M P RI PS + +VRS
Sbjct: 169 GCRPYMAPE----RIDPSA---------------------RDGYDVRS------------ 191
Query: 336 EIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFN-----VVGQPLRFPETPQ 390
D W+ GI LYE+ G P+ + +F+ V G P + +
Sbjct: 192 ------------DVWSLGITLYEVATGKFPYPKWNS---VFDQLTQVVKGDPPILSNSEE 236
Query: 391 VSFVAR--DLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
F + I L+K+ KR YK + +HPF
Sbjct: 237 REFSPSFVNFINLCLIKDESKRPKYKE----LLEHPFI 270
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 1e-08
Identities = 38/130 (29%), Positives = 62/130 (47%), Gaps = 16/130 (12%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+DFG C P + + VGT ++APE++ + +G VD W+ GI E++
Sbjct: 157 TDFGFCA-------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
Query: 361 HGTTPFKGQGNRATLFNVV--GQP-LRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGA 417
G P+ + L+ + G P L+ PE ++S V RD + L + +R A
Sbjct: 210 EGEPPYLNENPLRALYLIATNGTPELQNPE--RLSAVFRDFLNRCLEMDVDRR----GSA 263
Query: 418 TEIKQHPFFE 427
E+ QHPF +
Sbjct: 264 KELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 16/140 (11%)
Query: 290 ILPSKKNRKSKSDFGPC--VGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAV 347
IL + R SDFG C V +P R S VGT ++APE+I +G V
Sbjct: 147 ILLTHDGRVKLSDFGFCAQVSKEVP---------RRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 348 DWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ-PLRFPETPQVSFVARDLIRGLLVKE 406
D W+ GI + E++ G P+ + + + P + +VS + + LLV++
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257
Query: 407 PHKRIAYKRGATEIKQHPFF 426
P +R A E+ +HPF
Sbjct: 258 PAQRAT----AAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 56/164 (34%), Positives = 76/164 (46%), Gaps = 26/164 (15%)
Query: 271 LNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330
L+ + VH ++PS ++ S KN K +DFG V L + M +P N S VGT
Sbjct: 184 LHRRHIVHRDIKPSNL---LINSAKNVKI-ADFG--VSRILAQTM-DPCN----SSVGTI 232
Query: 331 EYLAPEII-----RGEGHGSAVDWWTFGIFLYELLHGTTPFK--GQGNRATLFNVV--GQ 381
Y++PE I G G A D W+ G+ + E G PF QG+ A+L + Q
Sbjct: 233 AYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ 292
Query: 382 PLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425
P P T F R I L +EP KR A ++ QHPF
Sbjct: 293 PPEAPATASREF--RHFISCCLQREPAKR----WSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 2e-08
Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 3/93 (3%)
Query: 152 DHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEY 211
D+P LY T K + L+M++ G+L L +K +E + +++ AL
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALND 124
Query: 212 LHMLGIVYRDLKPENVL-VRDEGHIMLSDFDLS 243
LH I++ D+K ENVL R + I L D+ L
Sbjct: 125 LHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157
|
Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 28/171 (16%)
Query: 80 AINMISLRGPP-IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKL 138
A+ M+ +G P L N+ ++G G G V + + + A+K+MD
Sbjct: 9 ALRMVVDQGDPRSLLENY---IKIGEGSTGIVCIAREKHSGRQVAVKMMD---------- 55
Query: 139 LRAQTEREILGLLDHPFLPTLYSYFETDKFY---------CLVMEFCSGGNLHSLRQKQP 189
LR Q RE+L + + Y + + Y ++MEF GG L + +
Sbjct: 56 LRKQQRRELL--FNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-- 111
Query: 190 NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240
E+ VL AL YLH G+++RD+K +++L+ +G + LSDF
Sbjct: 112 -TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 41/156 (26%), Positives = 72/156 (46%), Gaps = 16/156 (10%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMD-KASLASRNKLLRAQTEREILGLLDH 153
NF+ L++LG G +VY R T A+K + A + + +R E ++ L H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKH 57
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGG-----NLHSLRQK-QPNKYFTEDAARFFASEVLL 207
+ L+ T+ LV E+ + H +R PN + F ++L
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPN------TVKSFTYQLLK 111
Query: 208 ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ + H +++RDLKP+N+L+ G + L+DF L+
Sbjct: 112 GIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 46/169 (27%), Positives = 75/169 (44%), Gaps = 23/169 (13%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTN--TYFAMKVMDKASLASRNKLLRAQTEREILGLL- 151
+ L+K LG G G V T+ A+K K + K+L + RE+ L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIK---KITNVFSKKILAKRALRELKLLRH 57
Query: 152 --DHPFLPTLYS-----YFETDKFYCL--VMEFCSGGNLHS-LRQKQPNKYFTEDAARFF 201
H + LY ++ Y +ME +LH +R QP T+ + F
Sbjct: 58 FRGHKNITCLYDMDIVFPGNFNELYLYEELMEA----DLHQIIRSGQP---LTDAHFQSF 110
Query: 202 ASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250
++L L+Y+H +++RDLKP N+LV + + + DF L+ S +P
Sbjct: 111 IYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 41/142 (28%), Positives = 61/142 (42%), Gaps = 2/142 (1%)
Query: 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPT 158
L +G+G G+VY TN A+K M + + K E + L L HP
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 159 LYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIV 218
+ + LVME+C G L + E AA L L YLH ++
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA--ITHGALQGLAYLHSHNMI 143
Query: 219 YRDLKPENVLVRDEGHIMLSDF 240
+RD+K N+L+ + G + L+DF
Sbjct: 144 HRDIKAGNILLTEPGQVKLADF 165
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 6/149 (4%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+ RL +LG G G V++ GT T A+K + +++ L AQ ++ L H
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKK----LRHE 61
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
L LY+ + Y +V E+ S G+L + + KY A+++ + Y+
Sbjct: 62 KLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ V+RDL+ N+LV + ++DF L+
Sbjct: 121 MNYVHRDLRAANILVGENLVCKVADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 7/151 (4%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMD-KASLASRNKLLRAQTEREILGLLDH 153
+F + LG G+ G V V+ + + A K++ + A RN+++R E ++L +
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIR---ELQVLHECNS 62
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL- 212
P++ Y F +D + ME GG+L + ++ K E+ + VL L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLR 120
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
I++RD+KP N+LV G I L DF +S
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 43/148 (29%), Positives = 69/148 (46%), Gaps = 22/148 (14%)
Query: 101 RLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE-------ILGLLDH 153
++G G G V + ++ + A+K MD LR Q RE I+ H
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMD----------LRKQQRRELLFNEVVIMRDYQH 76
Query: 154 PFLPTLY-SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
+ +Y SY D+ + +VMEF GG L + + E+ VL AL L
Sbjct: 77 ENVVEMYNSYLVGDELW-VVMEFLEGGALTDIVT---HTRMNEEQIAAVCLAVLKALSVL 132
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDF 240
H G+++RD+K +++L+ +G + LSDF
Sbjct: 133 HAQGVIHRDIKSDSILLTHDGRVKLSDF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 2/145 (1%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
F L+ +G+G G+VY TN A+K M + S K E + L + HP
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML 215
+ + LVME+C G L + E AA L L YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA--ITHGALQGLAYLHSH 144
Query: 216 GIVYRDLKPENVLVRDEGHIMLSDF 240
+++RD+K N+L+ + G + L+DF
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADF 169
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 69/312 (22%), Positives = 110/312 (35%), Gaps = 87/312 (27%)
Query: 94 SNFRLLKRLGYGDIGSVYL-----VELRGTNTYFAMK-VMDKASLASRNKLLRAQTEREI 147
L++ LG G G VY V T A+K V + AS+ R + L E +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN---EASV 62
Query: 148 LGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTE-----DAARFF 201
+ + + L T + +VME + G+L S LR ++P +F
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 202 --ASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVS 259
A+E+ + YL V+RDL N +V ++ + + DF ++ R
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMT-R-------------- 167
Query: 260 VNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPT 319
I +Y +K K G LP
Sbjct: 168 ---------DIYETDY-----------------YRKGGK----------GLLP------- 184
Query: 320 NVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATL-FN 377
VR M+ PE ++ + D W+FG+ L+E+ P++G N L F
Sbjct: 185 -VRWMA---------PESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234
Query: 378 VVGQPLRFPETP 389
+ G L PE
Sbjct: 235 IDGGHLDLPENC 246
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 39/127 (30%), Positives = 60/127 (47%), Gaps = 21/127 (16%)
Query: 141 AQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSG---------GNLHSLRQKQPNK 191
A E +L L H + TL+ T++ LV E+ GNL S+
Sbjct: 50 AIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHN----- 104
Query: 192 YFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251
+ F ++L L Y H I++RDLKP+N+L+ ++G + L+DF L+ SV PT
Sbjct: 105 ------VKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV-PT 157
Query: 252 LVKSSSV 258
S+ V
Sbjct: 158 KTYSNEV 164
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 39/152 (25%), Positives = 69/152 (45%), Gaps = 10/152 (6%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE---ILGLLDHPFL 156
++LG G S Y T T A+K + S + + R+ ++ L+HP +
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 157 PTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKY--FTEDAARFFASEVLLALEYLHM 214
+ D + L +E+ +GG++ L K Y F E + ++L L YLH
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 215 LGIVYRDLKPENVLVRDEGHIM-LSDFDLSLR 245
I++RD+K N+L+ G + ++DF + R
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 40/164 (24%), Positives = 70/164 (42%), Gaps = 28/164 (17%)
Query: 94 SNFRLLKRLGYGDIGSVY----LVELRGTNTYFAMKVM-DKASLASRNKLLRAQTEREIL 148
+ +K LG G G+VY + E A+KV+ ++ S + ++L E ++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILD---EAYVM 63
Query: 149 GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLL 207
+DHP + L + + L+ + G L +R + N S+ LL
Sbjct: 64 ASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDN----------IGSQYLL 112
Query: 208 --------ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ YL +V+RDL NVLV+ H+ ++DF L+
Sbjct: 113 NWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 35/129 (27%), Positives = 59/129 (45%), Gaps = 14/129 (10%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+DFG C P + + VGT ++APE++ + +G VD W+ GI E++
Sbjct: 157 TDFGFCA-------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
Query: 361 HGTTPFKGQGNRATLFNVV--GQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGAT 418
G P+ + L+ + G P ++S + RD + L + KR + A
Sbjct: 210 EGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRDFLNRCLEMDVEKRGS----AK 264
Query: 419 EIKQHPFFE 427
E+ QHPF +
Sbjct: 265 ELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 47/144 (32%), Positives = 67/144 (46%), Gaps = 7/144 (4%)
Query: 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLLDHPFL 156
L +G G G V + + T A+K K + +K+++ REI L L H L
Sbjct: 6 LGLVGEGSYGMVMKCKHKETGQIVAIK---KFLESEDDKMVKKIAMREIRMLKQLRHENL 62
Query: 157 PTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG 216
L F K LV EF L L +K PN E R + ++L +E+ H
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDL-EKYPNG-LDESRVRKYLFQILRGIEFCHSHN 120
Query: 217 IVYRDLKPENVLVRDEGHIMLSDF 240
I++RD+KPEN+LV G + L DF
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 7/102 (6%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR 384
S GT +++PE+I GEG+G D W+ + E+L P+ A +F + QP +
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK 227
Query: 385 FPETPQ-VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425
P P VS RD ++ + V+E +R + + +HPF
Sbjct: 228 -PMLPDGVSDACRDFLKQIFVEE-KRRPTAE----FLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 34/150 (22%), Positives = 63/150 (42%), Gaps = 4/150 (2%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
F L ++LG G G V+ L A+K++ L + Q E + L L H
Sbjct: 6 EEFTLERKLGSGYFGEVW-EGLWKNRVRVAIKILKSDDLLKQQDF---QKEVQALKRLRH 61
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
L +L++ + ++ E G+L + + + + A +V + YL
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++RDL N+LV ++ ++DF L+
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFGLA 151
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 9/162 (5%)
Query: 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPT 158
L++LG G +V+ + T A+K + A E +L L H + T
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVT 68
Query: 159 LYSYFETDKFYCLVMEFCSGGNLHSLRQKQPN--KYFTEDAARFFASEVLLALEYLHMLG 216
L+ TDK LV E+ L+Q + + + F ++L L Y H
Sbjct: 69 LHDIVHTDKSLTLVFEYLD----KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124
Query: 217 IVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258
+++RDLKP+N+L+ + G + L+DF L+ R PT S+ V
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLA-RAKSVPTKTYSNEV 165
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 46/151 (30%), Positives = 65/151 (43%), Gaps = 12/151 (7%)
Query: 99 LKR-LGYGDIGSVY---LVELRGTNTYFAMKVMDK-ASLASRNKLLRAQTEREILGLLDH 153
L R +G G G VY + A+K S + R K L+ E I+ DH
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ---EAYIMRQFDH 66
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAAR-FFASEVLLALEYL 212
P + L + + +VME G L S Q NKY + A+ ++ ++ AL YL
Sbjct: 67 PHIVKLIGVITENPVW-IVMELAPLGELRSYLQV--NKYSLDLASLILYSYQLSTALAYL 123
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
V+RD+ NVLV + L DF LS
Sbjct: 124 ESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 36/152 (23%), Positives = 67/152 (44%), Gaps = 2/152 (1%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD 152
L+NF++ K++G G VY A+K + + E ++L L+
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQ--KQPNKYFTEDAARFFASEVLLALE 210
HP + F D +V+E G+L + + K+ + E + ++ A+E
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242
++H +++RD+KP NV + G + L D L
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 6/149 (4%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+ RL +LG G G V++ GT T A+K + ++ L AQ I+ L H
Sbjct: 7 SLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQ----IMKKLRHD 61
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
L LY+ + Y +V EF G+L ++ KY A+++ + Y+
Sbjct: 62 KLVPLYAVVSEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ ++RDL+ N+LV D ++DF L+
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 47/153 (30%), Positives = 75/153 (49%), Gaps = 16/153 (10%)
Query: 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDK-------ASLASRNKLLRAQTERE-ILGL 150
LK++G G GSV + T A+K + + A A R L + E ++GL
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGL 79
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
LD F + S E FY LVM + + + QK +ED ++ ++L L+
Sbjct: 80 LDV-FTSAV-SGDEFQDFY-LVMPY-----MQTDLQKIMGHPLSEDKVQYLVYQMLCGLK 131
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
Y+H GI++RDLKP N+ V ++ + + DF L+
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA 164
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 46/155 (29%), Positives = 70/155 (45%), Gaps = 6/155 (3%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVM--DKASLASRNKLLRAQTEREILGLLD 152
N+R K LG G G VYL T A K + D S + ++ + E ++L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 153 HPFLPTLYSYFE--TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
H + Y +K + ME+ GG++ Q + TE R + ++L +
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKD--QLKAYGALTESVTRKYTRQILEGMS 120
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245
YLH IV+RD+K N+L G++ L DF S R
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 7/151 (4%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMD-KASLASRNKLLRAQTEREILGLLDH 153
+F + LG G+ G V+ V + + A K++ + A RN+++R E ++L +
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIR---ELQVLHECNS 62
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL- 212
P++ Y F +D + ME GG+L + +K E + V+ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLR 120
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
I++RD+KP N+LV G I L DF +S
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 9e-08
Identities = 39/125 (31%), Positives = 58/125 (46%), Gaps = 18/125 (14%)
Query: 124 MKVMDKASLASRN----KLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGG 179
MK LA R KLL+ I+ L D P YF T+ G
Sbjct: 44 MKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL---------GT 94
Query: 180 NLHSLRQKQP-NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLS 238
+LH L +P K F ++F ++L L+Y+H G+V+RDLKP N+L+ + + +
Sbjct: 95 DLHRLLTSRPLEKQF----IQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKIC 150
Query: 239 DFDLS 243
DF L+
Sbjct: 151 DFGLA 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 29/101 (28%), Positives = 47/101 (46%), Gaps = 11/101 (10%)
Query: 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP 386
+GT Y+APE+ +G + D W+ G LYE+ PF+ + + L V Q ++P
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-SMQDLRYKV-QRGKYP 219
Query: 387 ETPQVSFVARDL---IRGLLVKEPHKRIAYKRGATEIKQHP 424
P + ++DL IR +L +P R +I P
Sbjct: 220 PIPPIY--SQDLQNFIRSMLQVKPKLRP----NCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 30/102 (29%), Positives = 48/102 (47%), Gaps = 5/102 (4%)
Query: 324 MSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL 383
S GT +++PE+I GEG+G D W+ G + E+L P+ A +F + QP
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT 226
Query: 384 RFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425
P VS RD ++ + V+ + A E+ +H F
Sbjct: 227 NPVLPPHVSDHCRDFLKRIFVEA-----KLRPSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 46/176 (26%), Positives = 83/176 (47%), Gaps = 34/176 (19%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE-------IL 148
+ +++G G G+VY A+ V +A + L+ Q ++E ++
Sbjct: 21 YTRFEKIGQGASGTVYT----------AIDVATGQEVAIKQMNLQQQPKKELIINEILVM 70
Query: 149 GLLDHP-FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTE---DAARFFA-- 202
HP + L SY D+ + +VME+ +GG+L + TE D + A
Sbjct: 71 RENKHPNIVNYLDSYLVGDELW-VVMEYLAGGSLTDV--------VTETCMDEGQIAAVC 121
Query: 203 SEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258
E L ALE+LH +++RD+K +N+L+ +G + L+DF ++P K S++
Sbjct: 122 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTM 175
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 37/130 (28%), Positives = 61/130 (46%), Gaps = 16/130 (12%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+DFG C P + + VGT ++APE++ + +G VD W+ GI E++
Sbjct: 158 TDFGFCA-------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210
Query: 361 HGTTPFKGQGNRATLFNVV--GQP-LRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGA 417
G P+ + L+ + G P L+ PE ++S + RD + L + KR A
Sbjct: 211 EGEPPYLNENPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLDMDVEKR----GSA 264
Query: 418 TEIKQHPFFE 427
E+ QH F +
Sbjct: 265 KELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+ +L+K+LG G G V++ G NT A+K + +++ + L AQ I+ L H
Sbjct: 7 SLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTMSPESFLEEAQ----IMKKLRHD 61
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
L LY+ + Y +V E+ S G+L + + A++V + Y+
Sbjct: 62 KLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 120
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ ++RDL+ N+LV D ++DF L+
Sbjct: 121 MNYIHRDLRSANILVGDGLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 41/146 (28%), Positives = 60/146 (41%), Gaps = 4/146 (2%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
F L+ +G+G G+VY + A+K M + S K E L L HP
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLR-QKQPNKYFTEDAARFFASEVLLALEYLHM 214
+ + LVME+C G L K+P E L L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHS 133
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDF 240
+++RD+K N+L+ + G + L DF
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 11/152 (7%)
Query: 112 LVELRGTNTYFAMKVMDK-ASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170
V RG++ KV+ K L + A++E L DH + + F++D
Sbjct: 84 FVATRGSDP--KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL 141
Query: 171 LVMEFCSGGNLHS-----LRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPE 225
L+ME+ SGG+L+ L++ P F E +++LAL+ +H +++RDLK
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLP---FQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSA 198
Query: 226 NVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSS 257
N+ + G I L DF S + S S +L +SS
Sbjct: 199 NIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
|
Length = 478 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 2e-07
Identities = 34/134 (25%), Positives = 48/134 (35%), Gaps = 34/134 (25%)
Query: 326 FVGTHEYLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVVGQ 381
+V T Y APE++ A+D W+ G ELL F G+ L V+G
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT 225
Query: 382 P-----------------LRFPETPQVSFV---------ARDLIRGLLVKEPHKRIAYKR 415
P P+ P+ A DL+ +LV +P KRI
Sbjct: 226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT--- 282
Query: 416 GATEIKQHPFFEGV 429
A E HP+ +
Sbjct: 283 -ADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 46/175 (26%), Positives = 74/175 (42%), Gaps = 23/175 (13%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD 152
L + L +LG G +VY + T+ A+K + A E +L L
Sbjct: 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLK 62
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSG---------GNLHSLRQKQPNKYFTEDAARFFAS 203
H + TL+ T+K LV E+ GN ++ + F
Sbjct: 63 HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN-----------VKLFLF 111
Query: 204 EVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258
++L L Y H +++RDLKP+N+L+ + G + L+DF L+ R PT S+ V
Sbjct: 112 QLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYSNEV 165
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 43/147 (29%), Positives = 65/147 (44%), Gaps = 8/147 (5%)
Query: 98 LLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLP 157
LK LG G G V + RG A+K++ + S++ + A+ + L H L
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMK----LSHEKLV 62
Query: 158 TLYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG 216
LY + +V E+ S G L + LR+ K F +V + YL
Sbjct: 63 QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 217 IVYRDLKPENVLVRDEGHIMLSDFDLS 243
++RDL N LV D+G + +SDF LS
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLS 147
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 7/106 (6%)
Query: 321 VRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG 380
++SM GT ++APE+I G+G D W+ G ++E+ G P A +F +
Sbjct: 165 LKSMH--GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA 222
Query: 381 QPLRFPETPQ-VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425
P P S A D + L ++ H+R + A ++ +H F
Sbjct: 223 HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPS----ALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 39/149 (26%), Positives = 59/149 (39%), Gaps = 10/149 (6%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKA-SLASRNKLLRAQT----EREILGLLDHP 154
K+LG G G V RG + KV+ A +KL E I+ LDH
Sbjct: 1 KKLGDGSFGVVR----RGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHE 56
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
L LY T +V E G+L +K +F +A ++ + YL
Sbjct: 57 NLIRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES 115
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++RDL N+L+ + + + DF L
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLM 144
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 24/166 (14%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
S + L+ LG G G V+ + A+K K L + A E +I+ LDH
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVK---KIVLTDPQSVKHALREIKIIRRLDH 61
Query: 154 PFLPTLY---------------SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAA 198
+ +Y S E + Y +V E +L ++ ++ P +E+ A
Sbjct: 62 DNIVKVYEVLGPSGSDLTEDVGSLTELNSVY-IVQE-YMETDLANVLEQGP---LSEEHA 116
Query: 199 RFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIM-LSDFDLS 243
R F ++L L+Y+H +++RDLKP NV + E ++ + DF L+
Sbjct: 117 RLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 41/167 (24%), Positives = 68/167 (40%), Gaps = 23/167 (13%)
Query: 100 KRLGYGDIGSVYLVELRGTNTY----FAMKVMDKASLASRNKLLRAQT----------ER 145
++LG G G V+L E G + F++ V + K+LR E
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70
Query: 146 EILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSL--RQKQPNKYFTEDAA----- 198
+I+ L P + L + T C++ E+ G+L+ R + D
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 199 --RFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
F A+++ ++YL L V+RDL N LV I ++DF +S
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 4/142 (2%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYS 161
LG G+ G V+ L+ T A+K K L K+ + +E IL DHP + L
Sbjct: 3 LGKGNFGEVFKGTLK-DKTPVAVKTC-KEDLPQELKI-KFLSEARILKQYDHPNIVKLIG 59
Query: 162 YFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRD 221
+ +VME GG+ S +K+ ++ T+ +F A + + YL ++RD
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF-ALDAAAGMAYLESKNCIHRD 118
Query: 222 LKPENVLVRDEGHIMLSDFDLS 243
L N LV + + +SDF +S
Sbjct: 119 LAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 5e-07
Identities = 41/129 (31%), Positives = 65/129 (50%), Gaps = 18/129 (13%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG V G L + MA+ + +GT ++APE+I+ G+ + D W+ GI E+
Sbjct: 142 DFG--VSGQLTDTMAK-----RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAE 194
Query: 362 GTTPFKG-QGNRATLFNVVGQP---LRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGA 417
G P+ RA +F + +P L PE + S D ++ LVK+P +R + A
Sbjct: 195 GKPPYSDIHPMRA-IFMIPNKPPPTLSDPE--KWSPEFNDFVKKCLVKDPEERPS----A 247
Query: 418 TEIKQHPFF 426
++ QHPF
Sbjct: 248 IQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 34/87 (39%), Positives = 44/87 (50%), Gaps = 3/87 (3%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV-GQPL 383
SF GT YLAPE+ + + D W+ G+ LYELL PFKG R + V+ G+
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD 289
Query: 384 RFPETPQVSFVARDLIRGLLVKEPHKR 410
FP VS + L+ LL K P R
Sbjct: 290 PFP--CPVSSGMKALLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 47/166 (28%), Positives = 74/166 (44%), Gaps = 18/166 (10%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI-----LGLLDHPFL 156
+G G G+VY + + A+K + + L T RE+ L DHP +
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALK---SVRVQTNEDGLPLSTVREVALLKRLEAFDHPNI 64
Query: 157 PTLY---SYFETDK--FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEY 211
L + TD+ LV E +L + K P + + + L L++
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 212 LHMLGIVYRDLKPENVLVRDEGHIMLSDFDL----SLRCSVSPTLV 253
LH IV+RDLKPEN+LV G + L+DF L S + +++P +V
Sbjct: 124 LHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV 169
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 45/172 (26%), Positives = 74/172 (43%), Gaps = 23/172 (13%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGT-----NTYFAMKVM-DKASLASRNKLLRAQTE 144
I LS R ++ LG G VY L GT A+K + DKA R + + E
Sbjct: 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEF---KHE 58
Query: 145 REILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS---LRQKQPNKYFTED----- 196
+ L HP + L ++ ++ +CS +LH +R + T+D
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 197 ----AARFF--ASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242
A F +++ +E+L +V++DL NVLV D+ ++ +SD L
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 32/107 (29%), Positives = 58/107 (54%), Gaps = 7/107 (6%)
Query: 137 KLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTED 196
+LL+ ++GLLD F P S E + Y ++ G +L+++ + Q T+D
Sbjct: 68 RLLKHMKHENVIGLLD-VFTPA-RSLEEFNDVY--LVTHLMGADLNNIVKCQK---LTDD 120
Query: 197 AARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+F ++L L+Y+H I++RDLKP N+ V ++ + + DF L+
Sbjct: 121 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 167
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 42/173 (24%), Positives = 72/173 (41%), Gaps = 28/173 (16%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAM---------------KVMDKASLASRNKLLR 140
RL ++LG G G V+L E G + + + +RN L+
Sbjct: 7 LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLK 66
Query: 141 AQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTE---- 195
E +I+ L +P + L +D C++ E+ G+L+ L Q++ FT
Sbjct: 67 ---EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 196 -----DAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ A ++ ++YL L V+RDL N LV + I ++DF +S
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 47/170 (27%), Positives = 73/170 (42%), Gaps = 25/170 (14%)
Query: 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTE--------RE--IL 148
L +LG G +VY + T A+K +R + E RE +L
Sbjct: 10 LDKLGEGSYATVYKGRSKLTGQLVALKE------------IRLEHEEGAPFTAIREASLL 57
Query: 149 GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLA 208
L H + TL+ T K LV E+ +L + R F ++L
Sbjct: 58 KDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRG 115
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258
L Y H +++RDLKP+N+L+ + G + L+DF L+ SV P+ S+ V
Sbjct: 116 LAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV-PSKTYSNEV 164
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 44/165 (26%), Positives = 70/165 (42%), Gaps = 27/165 (16%)
Query: 271 LNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330
L+ +H ++PS IL ++K + DFG V G L +A +F GT
Sbjct: 121 LHSRKIIHRDIKPSN----ILLTRKGQVKLCDFG--VSGELVNSLA-------GTFTGTS 167
Query: 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRAT-----LFNVVGQP-LR 384
Y+APE I+G+ + D W+ G+ L E+ PF +G L +V P
Sbjct: 168 FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE 227
Query: 385 FPETPQV----SFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425
+ P S +D I+ L K+P +R + +HP+
Sbjct: 228 LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWD----MLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 9e-07
Identities = 79/312 (25%), Positives = 120/312 (38%), Gaps = 75/312 (24%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNK--------LLRAQTE 144
L+ + ++K++G G G V+LV+ + T +F K + L R K ++R
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKH 71
Query: 145 REILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKY--FTEDAARFFA 202
+ I+ +D FL K Y L MEFC G+L QK + E A
Sbjct: 72 KNIVRYIDR-FLNK-----ANQKLYIL-MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDIT 124
Query: 203 SEVLLALEYLHMLGIVYRD-LKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVN 261
++L AL Y H L +D E VL RD +K ++ ++
Sbjct: 125 RQLLHALAYCHNL----KDGPNGERVLHRD---------------------LKPQNIFLS 159
Query: 262 NGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNV 321
G G I ++G P K DFG +++ +
Sbjct: 160 TGIRHIGKITAQANNLNG-----------RPIAK----IGDFG----------LSKNIGI 194
Query: 322 RSM--SFVGTHEYLAPEIIRGE--GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFN 377
SM S VGT Y +PE++ E + D W G +YEL G TPF N + L
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL-- 252
Query: 378 VVGQPLRFPETP 389
+ + R P+ P
Sbjct: 253 -ISELKRGPDLP 263
|
Length = 1021 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 27/92 (29%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR 384
+F GT Y+APEI R + + D ++ G+ LYELL PF G+ + + R
Sbjct: 204 TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG--R 261
Query: 385 F-PETPQVSFVARDLIRGLLVKEPHKRIAYKR 415
+ P P +S ++++ LL +P +R + +
Sbjct: 262 YDPLPPSISPEMQEIVTALLSSDPKRRPSSSK 293
|
Length = 496 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 37/150 (24%), Positives = 64/150 (42%), Gaps = 21/150 (14%)
Query: 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH--PFL 156
+K L G VYL+ + + + +K+ SR K + E IL LL +
Sbjct: 3 IKLLKGGLTNRVYLLGTKDED--YVLKI-----NPSREKGADREREVAILQLLARKGLPV 55
Query: 157 PTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH--- 213
P + + E+D + L+ME+ G L ++ + E A A LH
Sbjct: 56 PKVLASGESDGWSYLLMEWIEGETL-DEVSEEEKEDIAEQLAELLAK--------LHQLP 106
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+L + + DL P N+LV D + + D++ +
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNK--LLRAQTEREILGL 150
+ F ++ ++G G G VY + T A+K K L + + + A E +IL
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIKILRQ 62
Query: 151 LDHPFLPTLYSY---------FETDK--FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAAR 199
L+H + L F+ DK FY LV E+ + L + F+ED +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFY-LVFEYMDHDLMGLLESGLVH--FSEDHIK 119
Query: 200 FFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
F ++L L Y H ++RD+K N+L+ ++G I L+DF L+
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 40/141 (28%), Positives = 56/141 (39%), Gaps = 41/141 (29%)
Query: 321 VRSM----SFVGTHEYLAPEII-RGEGHGSAVDWWTFGIFLYELLHGTTPFKG-----QG 370
+RS +V T Y APEI+ R + S VD W G + EL F G Q
Sbjct: 149 IRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQL 208
Query: 371 NRATLFNVVGQP----------------LRFPETPQVSFV---------ARDLIRGLLVK 405
+ + +V+G P RFP+ S A DLI+ +L
Sbjct: 209 YK--ICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRW 266
Query: 406 EPHKRIAYKRGATEIKQHPFF 426
+P KR A++ QHP+F
Sbjct: 267 DPKKRPT----ASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 25/96 (26%), Positives = 40/96 (41%), Gaps = 7/96 (7%)
Query: 318 PTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFN 377
+ + VGT YL+PE+ + + D W G+ LYE G PF A +
Sbjct: 153 DNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212
Query: 378 V---VGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410
+ V P+ + Q++ LI L K+ +R
Sbjct: 213 IIRGVFPPVSQMYSQQLA----QLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 27/92 (29%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 322 RSMSFVGTHEYLAPEIIR-GEGHGSAVDWWTFGIFLYELLHGTTPFKGQ-GNRATLFNVV 379
+ +FVGT ++APE+I G+ + + D W+ GI +YE+ G P+ RA +
Sbjct: 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK 216
Query: 380 GQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411
+P R + S + R+ + L +EP +R+
Sbjct: 217 SKPPRLEDN-GYSKLLREFVAACLDEEPKERL 247
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 37/142 (26%), Positives = 62/142 (43%), Gaps = 24/142 (16%)
Query: 290 ILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDW 349
+L S++ +DFG V G L + T ++ +FVGT ++APE+I+ + S D
Sbjct: 132 VLLSEQGDVKLADFG--VAGQLTD-----TQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 184
Query: 350 WTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVA------RDLIRGLL 403
W+ GI EL G P LF + P+ + ++ I L
Sbjct: 185 WSLGITAIELAKGEPPNSDMHPMRVLFLI-------PKNNPPTLTGEFSKPFKEFIDACL 237
Query: 404 VKEPHKRIAYKRGATEIKQHPF 425
K+P +++ A E+ +H F
Sbjct: 238 NKDP----SFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 39/138 (28%), Positives = 64/138 (46%), Gaps = 16/138 (11%)
Query: 290 ILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDW 349
+L S+ +DFG V G L + T ++ +FVGT ++APE+I+ + S D
Sbjct: 132 VLLSEHGEVKLADFG--VAGQLTD-----TQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 184
Query: 350 WTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVA--RDLIRGLLVKEP 407
W+ GI EL G P LF + P P T + ++ ++ + L KEP
Sbjct: 185 WSLGITAIELAKGEPPHSELHPMKVLFLI---PKNNPPTLEGNYSKPLKEFVEACLNKEP 241
Query: 408 HKRIAYKRGATEIKQHPF 425
+++ A E+ +H F
Sbjct: 242 ----SFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 45/183 (24%), Positives = 86/183 (46%), Gaps = 23/183 (12%)
Query: 82 NMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMD------KASLASR 135
+++S+ P + F +++G G G+VY T A++ M+ K + +
Sbjct: 11 SIVSVGDPKKKYTRF---EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 136 NKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTE 195
++R I+ LD SY D+ + +VME+ +GG+L + + E
Sbjct: 68 ILVMRENKNPNIVNYLD--------SYLVGDELW-VVMEYLAGGSLTDVVTET---CMDE 115
Query: 196 DAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKS 255
E L ALE+LH +++RD+K +N+L+ +G + L+DF + ++P K
Sbjct: 116 GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKR 173
Query: 256 SSV 258
S++
Sbjct: 174 STM 176
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 17/155 (10%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYS 161
LG G G+V + FA+KV+D ++ +K RAQ E L D + +
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKN-RAQAEVCCLLNCDFFSIVKCHE 98
Query: 162 YF--------ETDKFYCLVMEFCSGGNLHSLRQK-----QPNKYFTEDAARFFASEVLLA 208
F E LV+++ + G+L RQ+ + N+ F E A +VLLA
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDL---RQEIKSRAKTNRTFREHEAGLLFIQVLLA 155
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ ++H +++RD+K N+L+ G + L DF S
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190
|
Length = 496 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 12/159 (7%)
Query: 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRN-----KLLRAQTE 144
P N + YG + S Y LR + ++ + +R +LL+
Sbjct: 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKH 73
Query: 145 REILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASE 204
++GLLD F P S ++ Y LV G +L+++ + Q +++ +F +
Sbjct: 74 ENVIGLLD-VFTPAT-SIENFNEVY-LVTNLM-GADLNNIVKCQK---LSDEHVQFLIYQ 126
Query: 205 VLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+L L+Y+H GI++RDLKP NV V ++ + + DF L+
Sbjct: 127 LLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 22/167 (13%)
Query: 91 IGLSNFRLLKR------LGYGDIGSVYLVELRGTNTYFAMKVMDK-------ASLASRN- 136
+G S F +LKR +G G G V T A+K + + A A R
Sbjct: 7 VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYREL 66
Query: 137 KLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTED 196
L++ + I+GLL+ F P S E Y LVME NL + Q +
Sbjct: 67 VLMKLVNHKNIIGLLN-VFTPQ-KSLEEFQDVY-LVMELMDA-NLCQVIQMD----LDHE 118
Query: 197 AARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ ++L +++LH GI++RDLKP N++V+ + + + DF L+
Sbjct: 119 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 6/151 (3%)
Query: 97 RLLKRLGYGDIGSVYLVELR--GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+ +++LG G+ GSV L NT + V K ++ L + E EIL L H
Sbjct: 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAV-KKLQHSTAEHLRDFEREIEILKSLQHD 65
Query: 155 FLPTL--YSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
+ Y + LVME+ G+L QK + +AS++ +EYL
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLL-LYASQICKGMEYL 124
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
V+RDL N+LV E + + DF L+
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLT 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 48/174 (27%), Positives = 73/174 (41%), Gaps = 25/174 (14%)
Query: 95 NFRLLKRLGYGDIGSV---YLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL 151
N L K LG G+ G V L+G Y + V AS ++L +E +L +
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 152 DHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS---LRQKQPNKYFTEDAARF-------- 200
+HP + LY D L++E+ G+L S +K Y D R
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 201 -----------FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
FA ++ ++YL + +V+RDL NVLV + + +SDF LS
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 7/161 (4%)
Query: 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKL-LRAQTEREILGLLDHPFLP 157
L++LG G +VY R A+KV+ S+ + + A E +L L H +
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVI---SMKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 158 TLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGI 217
L+ T + V E+ +L + P + R F ++L L Y+H I
Sbjct: 67 LLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNV-RLFMFQLLRGLAYIHGQHI 124
Query: 218 VYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258
++RDLKP+N+L+ G + L+DF L+ R P+ SS V
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLA-RAKSIPSQTYSSEV 164
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 40/130 (30%), Positives = 55/130 (42%), Gaps = 17/130 (13%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII---RGEGHGSAVDWWTFGIFLYE 358
DFG V L +A + SF+GT ++APE+ R G+ D W GI E
Sbjct: 144 DFG--VSAQLTATIA-----KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
Query: 359 LLHGTTPFKGQGNRATLFNV---VGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKR 415
L P LF + P + + + S V D I+ L K+P KR
Sbjct: 197 LAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT--- 253
Query: 416 GATEIKQHPF 425
AT++ QHPF
Sbjct: 254 -ATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 3e-06
Identities = 32/102 (31%), Positives = 57/102 (55%), Gaps = 10/102 (9%)
Query: 159 LYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFA--SEVLLALEYLHMLG 216
L S+ D+ + +VME+ +GG+L + + D A+ A E L ALE+LH
Sbjct: 82 LDSFLVGDELF-VVMEYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHANQ 135
Query: 217 IVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258
+++RD+K +NVL+ +G + L+DF + ++P K S++
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQ--ITPEQSKRSTM 175
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 3e-06
Identities = 45/183 (24%), Positives = 86/183 (46%), Gaps = 23/183 (12%)
Query: 82 NMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMD------KASLASR 135
+++S+ P + F +++G G G+VY T A+K M+ K + +
Sbjct: 10 SIVSVGDPKKKYTRF---EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINE 66
Query: 136 NKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTE 195
++R I+ LD SY D+ + +VME+ +GG+L + + E
Sbjct: 67 ILVMRENKNPNIVNYLD--------SYLVGDELW-VVMEYLAGGSLTDVVTET---CMDE 114
Query: 196 DAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKS 255
E L AL++LH +++RD+K +N+L+ +G + L+DF + ++P K
Sbjct: 115 GQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKR 172
Query: 256 SSV 258
S++
Sbjct: 173 STM 175
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 28/104 (26%), Positives = 48/104 (46%), Gaps = 7/104 (6%)
Query: 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQ--GNRATLFNVVGQPL 383
+GT ++APE++RGE +G + D W+ G + E+ P+ + N L +
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227
Query: 384 RFPETPQ-VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
P P+ +S RD+ L +P R + E+ +HP F
Sbjct: 228 TAPSIPEHLSPGLRDVTLRCLELQPEDR----PPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 45/171 (26%), Positives = 72/171 (42%), Gaps = 32/171 (18%)
Query: 98 LLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL------ 151
L K LG G G V E G + ++ S + L TE+++ L+
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDN------PNETSTVAVKMLKDDATEKDLSDLVSEMEMM 69
Query: 152 ----DHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQP-NKYFTEDAARF----- 200
H + L + +V+E+ + GNL LR ++P +Y + D R
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 201 -------FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIM-LSDFDLS 243
FA +V +E+L ++RDL NVLV E H+M ++DF L+
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV-TEDHVMKIADFGLA 179
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 46/166 (27%), Positives = 65/166 (39%), Gaps = 48/166 (28%)
Query: 319 TNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKG-----QGNRA 373
TN +V T Y APE+I G G+ VD W+ G + EL+ G+ F+G Q N+
Sbjct: 175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNK- 233
Query: 374 TLFNVVGQP-LRF---------------PETPQVSFV---------------------AR 396
+ +G P F P+ P +SF AR
Sbjct: 234 -VIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQAR 292
Query: 397 DLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHI 442
DL+ +LV +P KRI+ E +HP+ A PP I
Sbjct: 293 DLLSKMLVIDPDKRISVD----EALRHPYITVWYDPAEAEAPPPQI 334
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 35/149 (23%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+L+K+LG G G V++ G +T A+K + + S++ L E ++ L HP
Sbjct: 7 TLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSMSPEAFL----AEANLMKQLQHP 61
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
L LY+ + Y ++ E+ G+L + T + A+++ + ++
Sbjct: 62 RLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER 120
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++RDL+ N+LV + ++DF L+
Sbjct: 121 KNYIHRDLRAANILVSETLCCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 36/162 (22%), Positives = 67/162 (41%), Gaps = 18/162 (11%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLLD 152
+ L+++G G G VY + T A+K K L + + REI L +L
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLS 58
Query: 153 H-PFLPTLYSYFETDK------FYCLVMEFCSG---GNLHSLRQKQPNKYFTEDAARFFA 202
++ L ++ Y LV E+ + S + + F
Sbjct: 59 ESIYIVRLLDVEHVEEKNGKPSLY-LVFEYLDSDLKKFMDSNGRGPGRP-LPAKTIKSFM 116
Query: 203 SEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIM-LSDFDLS 243
++L + + H G+++RDLKP+N+LV + ++ ++D L
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 37/131 (28%), Positives = 53/131 (40%), Gaps = 36/131 (27%)
Query: 329 THE-----YLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVV 379
THE Y APE++ G H + VD W+ G E+ F G L F ++
Sbjct: 169 THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL 228
Query: 380 GQP----------LR----FPE---------TPQVSFVARDLIRGLLVKEPHKRIAYKRG 416
G P LR FP+ P +S DL++ +L +P KRI+
Sbjct: 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS---- 284
Query: 417 ATEIKQHPFFE 427
A HP+F+
Sbjct: 285 AKAALTHPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 36/114 (31%), Positives = 51/114 (44%), Gaps = 13/114 (11%)
Query: 320 NVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPF-KGQGNRATLFN- 377
N + ++VGT+ Y+APE I GE +G D W+ GI EL G P+ + Q N+ +L
Sbjct: 147 NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL 206
Query: 378 ------VVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425
V P P Q S I + K+P +R A + HPF
Sbjct: 207 QLLQCIVDEDPPVLPVG-QFSEKFVHFITQCMRKQPKERPA----PENLMDHPF 255
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 45/159 (28%), Positives = 70/159 (44%), Gaps = 9/159 (5%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMK--VMDKAS-LASRNKLLRAQTEREILGLLDHPFLPT 158
LG G G+VY L A+K +D ++ LA+ + + Q E ++L L H +
Sbjct: 8 LGKGAYGTVYC-GLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 159 LYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALEYLHMLGI 217
D + MEF GG++ S L + P E + ++L + YLH +
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGP---LPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 218 VYRDLKPENVLVRDEGHIMLSDFDLSLR-CSVSPTLVKS 255
V+RD+K NV++ G I L DF + R V S
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHS 162
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 26/155 (16%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMK---VMDKASLASRNKLLRAQTEREILGLLDHPFL 156
+++G G+ G VY L+G NT A+K L + K L+ E EIL DHP +
Sbjct: 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDL--KRKFLQ---EAEILKQYDHPNI 54
Query: 157 PTLYSY-FETDKFYCLVMEFCSGGNLHSLRQKQPNK-------YFTEDAARFFASEVLLA 208
L + Y +VME GG+L + +K+ N+ + DAA
Sbjct: 55 VKLIGVCVQKQPIY-IVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAA--------G 105
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+EYL ++RDL N LV + + +SDF +S
Sbjct: 106 MEYLESKNCIHRDLAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 7e-06
Identities = 31/102 (30%), Positives = 53/102 (51%), Gaps = 7/102 (6%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV-GQPL 383
+F GT Y++PE ++ +G+ S D W+ G LYE+ F+GQ + + +V G
Sbjct: 164 TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP 223
Query: 384 RFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425
PET + +++ +L K+P R + A EI ++PF
Sbjct: 224 SLPETYSRQLNS--IMQSMLNKDPSLRPS----AAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 7e-06
Identities = 40/161 (24%), Positives = 71/161 (44%), Gaps = 14/161 (8%)
Query: 96 FRLLKRLGYGDIGSVYLVELR---GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD 152
+L K LG G+ GSV +L G+ A+K M K + + +++ +E + D
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD 59
Query: 153 HPFLPTLY------SYFETDKFYCLVMEFCSGGNLHSL----RQKQPNKYFTEDAARFFA 202
HP + L S + +++ F G+LHS R + F
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 203 SEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++ L +EYL ++RDL N ++R++ + ++DF LS
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 37/145 (25%), Positives = 64/145 (44%), Gaps = 5/145 (3%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMK-VMDKASLASRNKLLRAQTEREILGLLDHPFLPT 158
+R+G G+ G V+ LR NT A+K + + K L+ E IL HP +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQ---EARILKQYSHPNIVR 57
Query: 159 LYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIV 218
L + +VME GG+ + + + + ++ + +EYL +
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQM-VENAAAGMEYLESKHCI 116
Query: 219 YRDLKPENVLVRDEGHIMLSDFDLS 243
+RDL N LV ++ + +SDF +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMS 141
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 40/147 (27%), Positives = 63/147 (42%), Gaps = 5/147 (3%)
Query: 97 RLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFL 156
+LL++LG G G V+ T T A+K + K L E +I+ L HP L
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNT-TPVAVKTL-KPGTMDPKDFLA---EAQIMKKLRHPKL 63
Query: 157 PTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG 216
LY+ ++ +V E G+L Q + A++V + YL
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN 123
Query: 217 IVYRDLKPENVLVRDEGHIMLSDFDLS 243
++RDL NVLV + ++DF L+
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 8e-06
Identities = 46/179 (25%), Positives = 84/179 (46%), Gaps = 15/179 (8%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE--ILGLLDH 153
+ +++ +G G +G VYL + A+K + + S N LL+ + RE I L H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIRED--LSENPLLKKRFLREAKIAADLIH 61
Query: 154 PFLPTLYS-YFETDKFYCLVMEFCSGGNLHSL----RQKQ--PNKYFTEDAARFFAS--- 203
P + +YS + D Y M + G L SL QK+ + + + F S
Sbjct: 62 PGIVPVYSICSDGDPVY-YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 204 EVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNN 262
++ +EY+H G+++RDLKP+N+L+ G +++ D+ ++ + + V N
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
|
Length = 932 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 37/167 (22%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMK----VMDKASLASRNKLLRAQTEREILGLL 151
+++ + +G G G V T A+K V + S A+R +LR E ++L LL
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR--ILR---EIKLLRLL 56
Query: 152 DHP--------FLPT-------LYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTED 196
HP LP +Y FE +ME +LH + + N T +
Sbjct: 57 RHPDIVEIKHIMLPPSRREFKDIYVVFE-------LME----SDLHQV--IKANDDLTPE 103
Query: 197 AARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+FF ++L AL+Y+H + +RDLKP+N+L + + + DF L+
Sbjct: 104 HHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 9e-06
Identities = 31/112 (27%), Positives = 53/112 (47%), Gaps = 10/112 (8%)
Query: 320 NVRSMSFVGTHEYLAPEII--RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFN 377
N ++MS G+ ++APE+I +G+ + VD W+ G + E+ G P+ + A +F
Sbjct: 164 NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223
Query: 378 VVGQ----PLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425
+ + P+ + +S VA D + P R A E+ QHPF
Sbjct: 224 LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT----ARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 40/138 (28%), Positives = 61/138 (44%), Gaps = 16/138 (11%)
Query: 290 ILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDW 349
+L S++ +DFG V G L + T ++ +FVGT ++APE+I+ + D
Sbjct: 132 VLLSEQGDVKLADFG--VAGQLTD-----TQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184
Query: 350 WTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPET--PQVSFVARDLIRGLLVKEP 407
W+ GI EL G P LF + P P T Q S ++ + L K+P
Sbjct: 185 WSLGITAIELAKGEPPNSDLHPMRVLFLI---PKNSPPTLEGQYSKPFKEFVEACLNKDP 241
Query: 408 HKRIAYKRGATEIKQHPF 425
R A E+ +H F
Sbjct: 242 RFRPT----AKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 44/184 (23%), Positives = 73/184 (39%), Gaps = 37/184 (20%)
Query: 94 SNFRLLKRLGYGDIGSVYLVEL----------------RGTNTYFAMKVM-DKASLASRN 136
+ ++LG G G V+L E+ +G A+K++ A+ +RN
Sbjct: 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARN 64
Query: 137 KLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNL------HSLRQKQPN 190
L+ E +IL L P + L + C++ E+ G+L H L K+ N
Sbjct: 65 DFLK---EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 191 KYFTEDAAR-----------FFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSD 239
A A ++ ++YL L V+RDL N LV + I ++D
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 240 FDLS 243
F +S
Sbjct: 182 FGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 30/105 (28%), Positives = 45/105 (42%), Gaps = 17/105 (16%)
Query: 143 TEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARF-- 200
TE IL ++HP + L F +KF CL++ R K +
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILP----------RYKTDLYCYLAAKRNIAI 181
Query: 201 -----FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240
VL A++YLH I++RD+K EN+ + G + L DF
Sbjct: 182 CDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDF 226
|
Length = 391 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 35/140 (25%), Positives = 65/140 (46%), Gaps = 9/140 (6%)
Query: 103 GYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSY 162
G+ ++ SVYL T T +++ D + + L Q E + HP + T ++
Sbjct: 9 GFCNLTSVYLARHTPTGTLVTVRITDLEN-CTEEHLKALQNEVVLSHFFRHPNIMTSWTV 67
Query: 163 FETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLL----ALEYLHMLGIV 218
F T + ++ F + G+ +SL + YF E + +L L YLH G +
Sbjct: 68 FTTGSWLWVISPFMAYGSANSLLKT----YFPEGMSEALIGNILFGALRGLNYLHQNGYI 123
Query: 219 YRDLKPENVLVRDEGHIMLS 238
+R++K ++L+ +G + LS
Sbjct: 124 HRNIKASHILISGDGLVSLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 10/159 (6%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
+ + +LL+ +G G+ G V L + RG A+K + + A E ++
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCIKNDATAQA-----FLAEASVMTQ 55
Query: 151 LDHPFLPTLYSYFETDK--FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLA 208
L H L L +K Y +V E+ + G+L + + D F+ +V A
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247
+EYL V+RDL NVLV ++ +SDF L+ S
Sbjct: 115 MEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 35/127 (27%), Positives = 52/127 (40%), Gaps = 10/127 (7%)
Query: 123 AMKVMDKASLASRNKLLRAQTEREI--LGLLDHPFLPTLYSYFET-DKFYCLVMEFCSGG 179
A+K++ + A + RA+ RE L HP + L E V E+ G
Sbjct: 7 AIKLL--RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGR 64
Query: 180 NLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVR---DEGHIM 236
L + + R +VL AL H GIV+RDLKP+N++V H
Sbjct: 65 TLREVLAAD-GALPAGETGRLML-QVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAK 122
Query: 237 LSDFDLS 243
+ DF +
Sbjct: 123 VLDFGIG 129
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 39/164 (23%), Positives = 60/164 (36%), Gaps = 21/164 (12%)
Query: 98 LLKRLGYGDIGSVYLVELR-----GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD 152
L + LG G G V+L E A+K + + + K + E E+L
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDF--EREAELLTNFQ 66
Query: 153 HPFLPTLYSY-FETDKFYCLVMEFCSGGNLHS-LR-----------QKQPNKYFTEDAAR 199
H + Y E D +V E+ G+L+ LR P T
Sbjct: 67 HENIVKFYGVCTEGDPPI-MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 200 FFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
A ++ + YL V+RDL N LV + + + DF +S
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 33/136 (24%), Positives = 63/136 (46%), Gaps = 1/136 (0%)
Query: 103 GYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSY 162
G+ D+ +V L + T Y ++ ++ + + + Q E + L +HP + +
Sbjct: 9 GFEDLMTVNLARYKPTGEYVTVRRINLEA-CTNEMVTFLQGELHVSKLFNHPNIVPYRAT 67
Query: 163 FETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDL 222
F D +V F + G+ L +E A + VL AL+Y+H +G V+R +
Sbjct: 68 FIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSV 127
Query: 223 KPENVLVRDEGHIMLS 238
K ++L+ +G + LS
Sbjct: 128 KASHILISVDGKVYLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 31/110 (28%), Positives = 45/110 (40%), Gaps = 14/110 (12%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSA-----VDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV 379
+F+GT ++APE++ E D W+ GI L EL P L ++
Sbjct: 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL 221
Query: 380 GQP---LRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
L P SF D ++ LVK+P R A E+ +HPF
Sbjct: 222 KSEPPTLDQPSKWSSSF--NDFLKSCLVKDPDDRPT----AAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 41/157 (26%), Positives = 58/157 (36%), Gaps = 43/157 (27%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELL 360
DFG + +V T Y APE++ G+ +G VD W G + ELL
Sbjct: 143 DFG------FARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELL 196
Query: 361 HGTTPFKGQGNRATLF---NVVGQPL-----------------RFPETPQ---------- 390
G F G + L+ +G PL FPE Q
Sbjct: 197 DGEPLFPGDSDIDQLYLIQKCLG-PLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPG 255
Query: 391 -VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
VS A D ++ L +P +R+ E+ QHP+F
Sbjct: 256 KVSSPALDFLKACLRMDPKERLT----CDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 38/127 (29%), Positives = 50/127 (39%), Gaps = 29/127 (22%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVVGQ 381
S V T Y APE++ + + VD W+ G EL F+G L F+V+G
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGL 224
Query: 382 PLR-------------FPETPQVSFV---------ARDLIRGLLVKEPHKRIAYKRGATE 419
P FP SF DL++ +L PHKRI A E
Sbjct: 225 PSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI----SAFE 280
Query: 420 IKQHPFF 426
QHP+F
Sbjct: 281 ALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 26/90 (28%), Positives = 44/90 (48%), Gaps = 6/90 (6%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG--QP 382
S VGT Y++PE I G+ D W+ G LYE+ +PF G++ LF++ +
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLFSLCQKIEQ 222
Query: 383 LRFPETPQVSFVA--RDLIRGLLVKEPHKR 410
+P P + R+L+ + +P +R
Sbjct: 223 CDYPPLPTEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 44/173 (25%), Positives = 69/173 (39%), Gaps = 29/173 (16%)
Query: 97 RLLKRLGYGDIGSVYLVELRGTNTY----------------FAMKVM-DKASLASRNKLL 139
+++LG G G V+L E G + A+KV+ AS +R L
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 140 RAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAA 198
+ E +IL L P + L D C++ME+ G+L L++ +
Sbjct: 68 K---EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 199 RFFASEVLL--------ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ + LL + YL L V+RDL N LV I ++DF +S
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 6/153 (3%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
I S L++ +G G G V+L A+K + + +++ + + E +++
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFI----EEAQVMMK 55
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
L HP L LY CLV EF G L + Q K F+++ +V +
Sbjct: 56 LSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMA 114
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
YL +++RDL N LV + + +SDF ++
Sbjct: 115 YLESSNVIHRDLAARNCLVGENQVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 70/326 (21%), Positives = 116/326 (35%), Gaps = 77/326 (23%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELR---GTNTYFAMKVMDKA-SLASRNKLLRAQTERE 146
I +S ++ + +G G+ G V L+ + A+K + + R L +E
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFL---SEAS 57
Query: 147 ILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEV 205
I+G DHP + L + ++ EF G L S LRQ + FT +
Sbjct: 58 IMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGI 115
Query: 206 LLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSG 265
++YL + V+RDL N+LV +SDF LS
Sbjct: 116 AAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS---------------------- 153
Query: 266 GGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325
R L ++ S + +GG +P +R
Sbjct: 154 -----------------------RFL---EDDTSDPTYTSSLGGKIP--------IR--- 176
Query: 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL-HGTTPFKGQGNRATLFNVVGQPLR 384
+ APE I SA D W++GI ++E++ +G P+ N+ + N + Q R
Sbjct: 177 ------WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-NAIEQDYR 229
Query: 385 FPETPQVSFVARDLIRGLLVKEPHKR 410
P L+ K+ + R
Sbjct: 230 LPPPMDCPTALHQLMLDCWQKDRNAR 255
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 40/155 (25%), Positives = 59/155 (38%), Gaps = 38/155 (24%)
Query: 324 MSFVGTHEYLAPE-IIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQG--NRATLF-NVV 379
+V T Y APE ++ + +A+D W+ G ELL F G+ ++ L ++
Sbjct: 166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELL 225
Query: 380 GQP----LRF-------------PETPQVSFVAR---------DLIRGLLVKEPHKRIAY 413
G P L F P TP+ SF DL+ +LV +P KRI
Sbjct: 226 GSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT- 284
Query: 414 KRGATEIKQHPFFEGVNWALVRSALPPHIPEPVDF 448
E HP+ +L + P P F
Sbjct: 285 ---VEEALAHPYLA----SLHDPSDEPVCQTPFSF 312
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 45/154 (29%), Positives = 64/154 (41%), Gaps = 8/154 (5%)
Query: 97 RLLKR---LGYGDIGSVYLVEL--RGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL 151
R LKR LG G G V L G NT + V + N + + E EIL L
Sbjct: 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 63
Query: 152 DHPFLPTLYSYFETD--KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLAL 209
H + D L+MEF G+L + NK + ++ A ++ +
Sbjct: 64 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKY-AVQICKGM 122
Query: 210 EYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+YL V+RDL NVLV E + + DF L+
Sbjct: 123 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 40/168 (23%), Positives = 70/168 (41%), Gaps = 17/168 (10%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKA--SLASRNKLLRAQTEREILGL 150
LS R ++ LG G +Y L A V K + + + Q E ++
Sbjct: 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAE 63
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYF------------TEDA 197
L HP + L ++ C++ E+ + G+LH L + P+ + D
Sbjct: 64 LHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123
Query: 198 ARFF--ASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
F A ++ +EYL V++DL N+L+ ++ H+ +SD LS
Sbjct: 124 GDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 40/158 (25%), Positives = 74/158 (46%), Gaps = 13/158 (8%)
Query: 96 FRLLKRLGYGDIGSVYLV-ELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI-----LG 149
+ + +G G G V+ +L+ + A+K + + + + + T RE+ L
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALK---RVRVQTGEEGMPLSTIREVAVLRHLE 59
Query: 150 LLDHPFLPTLY---SYFETDKFYCLVMEFCS-GGNLHSLRQKQPNKYFTEDAARFFASEV 205
+HP + L+ + TD+ L + F +L + K P + + ++
Sbjct: 60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 119
Query: 206 LLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
L L++LH +V+RDLKP+N+LV G I L+DF L+
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 38/126 (30%), Positives = 52/126 (41%), Gaps = 30/126 (23%)
Query: 315 MAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRAT 374
++E +N +V T Y +PE++ G +G AVD W+ G L EL G F G+
Sbjct: 150 LSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ 209
Query: 375 LFNV--VGQPL-----------------RFPET--PQ---------VSFVARDLIRGLLV 404
LF + V PL RFP PQ +S V DL++ LL
Sbjct: 210 LFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLK 269
Query: 405 KEPHKR 410
P R
Sbjct: 270 LNPTDR 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 36/143 (25%), Positives = 64/143 (44%), Gaps = 4/143 (2%)
Query: 101 RLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLY 160
+LG G G VY + + A+K + + ++ L A +EI HP L L
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI----KHPNLVQLL 68
Query: 161 SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYR 220
+ + ++ EF + GNL ++ + + A+++ A+EYL ++R
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 128
Query: 221 DLKPENVLVRDEGHIMLSDFDLS 243
DL N LV + + ++DF LS
Sbjct: 129 DLAARNCLVGENHLVKVADFGLS 151
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 39/150 (26%), Positives = 72/150 (48%), Gaps = 11/150 (7%)
Query: 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLLDHPFL 156
++++G G G VY R TN A+K K L ++ + + REI L + H +
Sbjct: 7 VEKIGEGTYGVVYKARDRVTNETIALK---KIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 157 PTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDA--ARFFASEVLLALEYLHM 214
L ++K LV E+ +L + + F ++ + + ++L + Y H
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120
Query: 215 LGIVYRDLKPENVLV-RDEGHIMLSDFDLS 243
+++RDLKP+N+L+ R + L+DF L+
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLA 150
|
Length = 294 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 34/100 (34%), Positives = 44/100 (44%), Gaps = 5/100 (5%)
Query: 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP 386
VGT YL+PEI + + + D W+ G LYEL PF+G N L + Q P
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFAP 221
Query: 387 ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
+P S R LI L P R + T I + PF
Sbjct: 222 ISPNFSRDLRSLISQLFKVSPRDRPS----ITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 5e-05
Identities = 35/141 (24%), Positives = 48/141 (34%), Gaps = 40/141 (28%)
Query: 332 YLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGN---RATLFNVVGQP----- 382
Y APE++ G H G VD W+ G ELL G + +F +G P
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227
Query: 383 ---------LRFPETPQVSFVAR---------DLIRGLLVKEPHKRIAYKRGATEIKQHP 424
+ F P DL++ LL P+KRI A + +HP
Sbjct: 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT----ARQALEHP 283
Query: 425 FFEGVNWALVRSALPPHIPEP 445
+F S P P
Sbjct: 284 YF---------SNDPAPTPPS 295
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLLDHPFL- 156
K +G G G V + TN A+K K + A N++ +T REI L LDH +
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIK---KIANAFDNRIDAKRTLREIKLLRHLDHENVI 67
Query: 157 -------PTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLA 208
P F D + +V E +LH +R Q ++D ++F ++L
Sbjct: 68 AIKDIMPPPHREAFN-DVY--IVYELMDT-DLHQIIRSSQT---LSDDHCQYFLYQLLRG 120
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
L+Y+H +++RDLKP N+L+ + + DF L+
Sbjct: 121 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 155
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 41/160 (25%), Positives = 63/160 (39%), Gaps = 21/160 (13%)
Query: 102 LGYGDIGSVYLVELRG-----TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFL 156
LG G G V+L E A+K + +AS ++R Q E E+L +L H +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF---QREAELLTVLQHQHI 69
Query: 157 PTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARF------------FAS 203
Y + +V E+ G+L+ LR P+ AS
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 204 EVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++ + YL L V+RDL N LV + + DF +S
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 5e-05
Identities = 29/95 (30%), Positives = 42/95 (44%), Gaps = 27/95 (28%)
Query: 166 DKFYCLVMEFCSGGNLHSLR-----QKQPNKYFTEDAARFFASEV-------LLALEYLH 213
DK Y +VME+ H L+ KQP F SEV L + +LH
Sbjct: 79 DKIY-MVMEYVE----HDLKSLMETMKQP----------FLQSEVKCLMLQLLSGVAHLH 123
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248
I++RDLK N+L+ + G + + DF L+
Sbjct: 124 DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 38/138 (27%), Positives = 60/138 (43%), Gaps = 10/138 (7%)
Query: 290 ILPSKKNRKSKSDFGPCVGGAL-PELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVD 348
IL K SDFG + L ++ TN S G+ ++APE+++ + D
Sbjct: 137 ILVDNKGGIKISDFG--ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKAD 194
Query: 349 WWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQ-VSFVARDLIRGLLVKEP 407
W+ G + E+L G PF +F +G+ PE P +S A D + +
Sbjct: 195 IWSLGCLVVEMLTGKHPFPDCTQLQAIFK-IGENAS-PEIPSNISSEAIDFLEKTFEIDH 252
Query: 408 HKRIAYKRGATEIKQHPF 425
+KR A E+ +HPF
Sbjct: 253 NKRPT----AAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 43/170 (25%), Positives = 64/170 (37%), Gaps = 49/170 (28%)
Query: 315 MAEPTNVRSMSFVGTHEYLAPEI-IRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRA 373
+A + + +V T Y APEI + + + VD W+ G E+L G F G+ +
Sbjct: 154 LARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK-DHV 212
Query: 374 TLFNVV----GQP-------------LRFPET-------------PQVSFVARDLIRGLL 403
F+++ G P LRF ++ A DL+ +L
Sbjct: 213 NQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKML 272
Query: 404 VKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIP--EPVDFSVF 451
V +P KRI+ A E HP+ P H P EPV F
Sbjct: 273 VFDPQKRIS----AAEALAHPYLA-----------PYHDPTDEPVAEEKF 307
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 37/132 (28%), Positives = 53/132 (40%), Gaps = 34/132 (25%)
Query: 326 FVGTHEYLAPEI-IRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVVGQ 381
+V T Y APEI + +G+ A+D W+ G L E+L F G+ L V+G
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228
Query: 382 P----------------LR-FPETPQVSFV---------ARDLIRGLLVKEPHKRIAYKR 415
P ++ P P+V + A DL+ +L PHKRI
Sbjct: 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT--- 285
Query: 416 GATEIKQHPFFE 427
E HP+ E
Sbjct: 286 -VEEALAHPYLE 296
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 19/37 (51%), Positives = 27/37 (72%)
Query: 204 EVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240
+VL L LH +GIV+RD+KPEN+LV +G + + DF
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDF 353
|
Length = 507 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 42/144 (29%), Positives = 58/144 (40%), Gaps = 36/144 (25%)
Query: 317 EPTNVRSMSF-VGTHEYLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRAT 374
EP + M+ V T Y APEI+ G H SAVD W+ G ELL F+ Q
Sbjct: 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ 213
Query: 375 L---FNVVGQP----------------LRFPETP-----------QVSFVARDLIRGLLV 404
L +++G P LR P P Q + A L+ +LV
Sbjct: 214 LDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLV 273
Query: 405 KEPHKRIAYKRGATEIKQHPFFEG 428
+P KRI+ A + HP+ +
Sbjct: 274 FDPDKRIS----AADALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 39/156 (25%), Positives = 63/156 (40%), Gaps = 23/156 (14%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKA--SLASRNKLLRAQ------TEREILGLL 151
+ +GYG G V+ V A+K M +L S ++ R +L L
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 152 D--HPFLPTLYS--YFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLL 207
D P + Y T+ +LH + + D + F ++L
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQS---------DLHKIIVSPQP--LSSDHVKVFLYQILR 114
Query: 208 ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
L+YLH GI++RD+KP N+LV + + DF L+
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 8e-05
Identities = 37/132 (28%), Positives = 52/132 (39%), Gaps = 34/132 (25%)
Query: 326 FVGTHEYLAPEIIRGEGHGS-AVDWWTFGIFLYELLHGTTPFKGQ--------------- 369
+V T Y APEI+ G + VD W+ G L E+L G F G
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231
Query: 370 -----------GNRATLFNVVGQPLRFPET---PQVSFVARDLIRGLLVKEPHKRIAYKR 415
AT+ + + R P P+ S A DL++ LLV P+KR+
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT--- 288
Query: 416 GATEIKQHPFFE 427
A E +HP+
Sbjct: 289 -AEEALEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 8e-05
Identities = 33/153 (21%), Positives = 70/153 (45%), Gaps = 5/153 (3%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
I + +L+K+LG G G V++ +T A+K + +++ + L E ++
Sbjct: 3 IPRESIKLVKKLGAGQFGEVWM-GYYNNSTKVAVKTLKPGTMSVQAFL----EEANLMKT 57
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
L H L LY+ ++ ++ E+ + G+L + F++++ +
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
Y+ ++RDL+ NVLV + ++DF L+
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 37/143 (25%), Positives = 55/143 (38%), Gaps = 34/143 (23%)
Query: 315 MAEPTNVRSMSFVGTHEYLAPEIIRGEGHGS-AVDWWTFGIFLYELLHGTTPFKGQGNRA 373
+A T+ +V T Y APE+I H + VD W+ G + E+L G FKG +
Sbjct: 164 LARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD 223
Query: 374 TL---FNVVGQPLR-----------------FPET---------PQVSFVARDLIRGLLV 404
L V G P + P P + +A +++ +LV
Sbjct: 224 QLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLV 283
Query: 405 KEPHKRIAYKRGATEIKQHPFFE 427
+ RI A E HP+FE
Sbjct: 284 LDAESRIT----AAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 35/131 (26%), Positives = 55/131 (41%), Gaps = 34/131 (25%)
Query: 326 FVGTHEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKG-------------QGN 371
+V T Y APE++ G+ +G AVD W G + E+L G F G GN
Sbjct: 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN 219
Query: 372 ----RATLF--NVVGQPLRFPET----------PQVSFVARDLIRGLLVKEPHKRIAYKR 415
+F N + +R PE P++S + DL + L +P R +
Sbjct: 220 LIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS--- 276
Query: 416 GATEIKQHPFF 426
++++ H FF
Sbjct: 277 -SSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 9e-05
Identities = 40/154 (25%), Positives = 59/154 (38%), Gaps = 10/154 (6%)
Query: 97 RLLKR---LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLL 151
R LK+ LG G G V L N V K + + ++EI L L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63
Query: 152 DHPFLPTLYSYFET--DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLAL 209
H + K L+ME+ L SLR P FA ++ +
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQLIMEYVP---LGSLRDYLPKHKLNLAQLLLFAQQICEGM 120
Query: 210 EYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
YLH ++RDL NVL+ ++ + + DF L+
Sbjct: 121 AYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 36/131 (27%), Positives = 49/131 (37%), Gaps = 37/131 (28%)
Query: 329 THE-----YLAPEIIRGEGHGS-AVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVV 379
THE Y APEI+ G S VD W+ G E+++ F G L F +
Sbjct: 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTL 216
Query: 380 GQP---------------LRFPETPQVSF---------VARDLIRGLLVKEPHKRIAYKR 415
G P FP+ + DL+ +LV +P KRI+ K
Sbjct: 217 GTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKA 276
Query: 416 GATEIKQHPFF 426
QHP+F
Sbjct: 277 AL----QHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 37/132 (28%), Positives = 53/132 (40%), Gaps = 34/132 (25%)
Query: 326 FVGTHEYLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQ---GNRATLFNVVGQ 381
+V T Y APE+I H VD W+ G + E+L G T FKG+ + V G
Sbjct: 174 YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 233
Query: 382 P-----------------LRFPETPQVSFV---------ARDLIRGLLVKEPHKRIAYKR 415
P P+ P+ F A DL+ +L + KR+
Sbjct: 234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT--- 290
Query: 416 GATEIKQHPFFE 427
ATE +HP+F+
Sbjct: 291 -ATEALEHPYFD 301
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 37/132 (28%), Positives = 52/132 (39%), Gaps = 37/132 (28%)
Query: 327 VGTHEYLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVVGQP 382
V T Y APE++ G +A+D W+ G ELL F G+ L F ++G P
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTP 226
Query: 383 --------------------------LR--FPETPQVSFVARDLIRGLLVKEPHKRIAYK 414
LR FP +S DL+ LL +P KRI+
Sbjct: 227 TEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPAL-SLSDNGFDLLNRLLTYDPAKRIS-- 283
Query: 415 RGATEIKQHPFF 426
A + +HP+F
Sbjct: 284 --AEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 11/170 (6%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
+ L L + +G G+ G+V E G A+K + K + ++ L E ++
Sbjct: 3 LNLQKLTLGEIIGEGEFGAVLQGEYTGQKV--AVKNI-KCDVTAQAFL----EETAVMTK 55
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
L H L L + Y +VME S GNL + + + + F+ +V +E
Sbjct: 56 LHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSV 260
YL +V+RDL N+LV ++G +SDF L+ V V +S + V
Sbjct: 115 YLESKKLVHRDLAARNILVSEDGVAKVSDFGLA---RVGSMGVDNSKLPV 161
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 35/146 (23%), Positives = 62/146 (42%), Gaps = 11/146 (7%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+ ++K L G G V++ G +K+ K + LL+ ++ + D
Sbjct: 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKD-- 124
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
TL S T C+V+ S +L++ K+ D A ++L L YLH
Sbjct: 125 ---TLVSGAIT----CMVLPHYSS-DLYTYLTKRSRP-LPIDQALIIEKQILEGLRYLHA 175
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDF 240
I++RD+K EN+ + D + + D
Sbjct: 176 QRIIHRDVKTENIFINDVDQVCIGDL 201
|
Length = 357 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 42/165 (25%), Positives = 66/165 (40%), Gaps = 39/165 (23%)
Query: 290 ILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRG-EGHGSAVD 348
+L +K+ +DFG L P N S + V T Y AP+++ G + +++D
Sbjct: 131 LLINKRGELKLADFG------LARAFGIPVNTFS-NEVVTLWYRAPDVLLGSRTYSTSID 183
Query: 349 WWTFGIFLYELLHGTTPFKGQGNRATL---FNVVGQP--------LRFPE---------- 387
W+ G + E++ G F G N L F ++G P + PE
Sbjct: 184 IWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPP 243
Query: 388 ------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
P + DL+ LL P RI+ A + QHP+F
Sbjct: 244 QDLQQLFPHADPLGIDLLHRLLQLNPELRIS----AHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 44/156 (28%), Positives = 60/156 (38%), Gaps = 42/156 (26%)
Query: 326 FVGTHEYLAPEI-IRGEGHGSAVDWWTFGIFLYELLHGTTPFKG-----QGNRATLFNVV 379
+V T Y APEI + + + A+D W+ G L ELL FKG Q N+ + V+
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQ--ILQVL 226
Query: 380 GQP----LR-------------FPETPQVSFV---------ARDLIRGLLVKEPHKRIAY 413
G P L P P+ F A DL+ LL +P KRI
Sbjct: 227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRI-- 284
Query: 414 KRGATEIKQHPFFEGVNWALVRSALPPHIPEPVDFS 449
E +HP+ + P +P DFS
Sbjct: 285 --SVEEALEHPYLAIWH----DPDDEPVCQKPFDFS 314
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 38/141 (26%), Positives = 56/141 (39%), Gaps = 45/141 (31%)
Query: 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKG-----QGNRAT------ 374
+V T Y APE+I G G+ VD W+ G + E++ GT F G Q N+
Sbjct: 177 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP 236
Query: 375 ---LFNVVGQPLR-----------------FPET--PQVS--------FVARDLIRGLLV 404
+ + +R FP+ P S ARDL+ +LV
Sbjct: 237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLV 296
Query: 405 KEPHKRIAYKRGATEIKQHPF 425
+P KRI+ + QHP+
Sbjct: 297 IDPEKRIS----VDDALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 40/149 (26%), Positives = 67/149 (44%), Gaps = 7/149 (4%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLL 151
+ F +L +G G G V + T A+K K + N+ ++ T RE+ L L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIK---KFKDSEENEEVKETTLRELKMLRTL 57
Query: 152 DHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEY 211
+ L F LV E+ N+ L ++ PN + R + +++ A+ +
Sbjct: 58 KQENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGV-PPEKVRSYIYQLIKAIHW 115
Query: 212 LHMLGIVYRDLKPENVLVRDEGHIMLSDF 240
H IV+RD+KPEN+L+ + L DF
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 15/157 (9%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVM---DKASLASRN----KLLRAQTERE 146
++ L +G G G V + T A+K + + + R K+LR
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 147 ILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVL 206
I+G+LD P+ S+ + L ME +L+ L + Q + D ++F ++L
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQEL-ME----TDLYKLIKTQH---LSNDHIQYFLYQIL 116
Query: 207 LALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
L+Y+H +++RDLKP N+L+ + + DF L+
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA 153
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 38/142 (26%), Positives = 55/142 (38%), Gaps = 34/142 (23%)
Query: 315 MAEPTNVRSMSFVGTHEYLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRA 373
+A T+ +V T Y APEI+ H VD W+ G + ELL G T F G +
Sbjct: 166 LARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 225
Query: 374 TL---FNVVGQP-----------------LRFPETPQVSFV---------ARDLIRGLLV 404
L +VG P + P+++F A DL+ +LV
Sbjct: 226 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 285
Query: 405 KEPHKRIAYKRGATEIKQHPFF 426
+ KRI A + H +F
Sbjct: 286 LDSDKRIT----AAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 25/92 (27%), Positives = 42/92 (45%), Gaps = 1/92 (1%)
Query: 319 TNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNV 378
+ ++ + VGT Y++PE+ G+ + D W G LYEL F+ A + +
Sbjct: 154 SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI 213
Query: 379 VGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410
+ P + + S R LI +L +P KR
Sbjct: 214 MSGTFA-PISDRYSPDLRQLILSMLNLDPSKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 31/106 (29%), Positives = 55/106 (51%), Gaps = 8/106 (7%)
Query: 138 LLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDA 197
L++ + I+GLL+ F P S E Y +VME NL + Q + +
Sbjct: 76 LMKCVNHKNIIGLLN-VFTPQ-KSLEEFQDVY-IVMELMDA-NLCQVIQME----LDHER 127
Query: 198 ARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ ++L +++LH GI++RDLKP N++V+ + + + DF L+
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 38/157 (24%), Positives = 68/157 (43%), Gaps = 14/157 (8%)
Query: 94 SNFRLLKRLGYGDIGSVY----LVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILG 149
+ F+ +K LG G G+VY + E A+K + +A+ NK E ++
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMA 64
Query: 150 LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPN---KYFTEDAARFFASEVL 206
+D+P + L T + G L +R+ + N +Y + ++
Sbjct: 65 SVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-----WCVQIA 119
Query: 207 LALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ YL +V+RDL NVLV+ H+ ++DF L+
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 43/163 (26%), Positives = 68/163 (41%), Gaps = 20/163 (12%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRA-QTERE--- 146
I S ++ K +G G+ G V +K+ K + K L+A TE++
Sbjct: 1 IDASCIKIEKVIGAGEFGEV---------CSGRLKLPGKREIPVAIKTLKAGYTEKQRRD 51
Query: 147 ------ILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARF 200
I+G DHP + L K +V E+ G+L + +K + FT
Sbjct: 52 FLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ-FTVIQLVG 110
Query: 201 FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ ++YL +G V+RDL N+LV +SDF LS
Sbjct: 111 MLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 36/159 (22%), Positives = 63/159 (39%), Gaps = 30/159 (18%)
Query: 100 KRLGYGDIGSVYLVELRG---------------TNTYFAMKVMDKASLASRNKLLRAQTE 144
K +G G G VY + N M+ + ++ +K+ +
Sbjct: 18 KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI 77
Query: 145 REILGLLDHPFLPTLYS--YFETDKFY---CLVMEFCSGGNLHSLRQKQPNKYFTEDAAR 199
I DH +P Y F+ + Y L+ + R K NK ++ +
Sbjct: 78 HNI----DHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMK 133
Query: 200 FFASEVLLALEYLHMLGIVYRDLKPENVLV--RDEGHIM 236
++L LEY+H GI + D+KPEN++V + G+I+
Sbjct: 134 ----DMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168
|
Length = 294 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 42/194 (21%), Positives = 72/194 (37%), Gaps = 25/194 (12%)
Query: 51 SSNCSSRSDSLESSSAPVKPHTGGDVRWDAINMISLRGPPIGLS-NFRLLKRLGYGDIGS 109
+++ + +SL DV + S P + + +L L G G
Sbjct: 57 ATDYDADEESLSPQ---------TDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGE 107
Query: 110 VYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169
V++ G KV+ KA + E +IL + H + L +
Sbjct: 108 VFVCTKHGDEQ--RKKVIVKAVTGGKT----PGREIDILKTISHRAIINLIHAYRWKSTV 161
Query: 170 CLVMEFCSGGNLHSLRQKQP---NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPEN 226
C+VM + + P + T +L AL YLH GI++RD+K EN
Sbjct: 162 CMVMPKYKCDLFTYVDRSGPLPLEQAIT------IQRRLLEALAYLHGRGIIHRDVKTEN 215
Query: 227 VLVRDEGHIMLSDF 240
+ + + + +L DF
Sbjct: 216 IFLDEPENAVLGDF 229
|
Length = 392 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 41/165 (24%), Positives = 75/165 (45%), Gaps = 18/165 (10%)
Query: 91 IGLSNFRLLKR------LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTE 144
+G S F +LKR +G G G V + A+K + + ++ RA E
Sbjct: 8 VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRE 66
Query: 145 REILGLLDHPFLPTLYSYFETDKFY------CLVMEFCSGGNLHSLRQKQPNKYFTEDAA 198
++ ++H + +L + F K LVME NL + Q + +
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQME----LDHERM 121
Query: 199 RFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ ++L +++LH GI++RDLKP N++V+ + + + DF L+
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 26/90 (28%), Positives = 43/90 (47%), Gaps = 6/90 (6%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG--QP 382
S VGT Y++PE I G+ D W+ G LYE+ +PF G++ L+++ +
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLYSLCKKIEQ 222
Query: 383 LRFPETPQVSFVA--RDLIRGLLVKEPHKR 410
+P P + R L+ + +P KR
Sbjct: 223 CDYPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 39/165 (23%), Positives = 61/165 (36%), Gaps = 19/165 (11%)
Query: 95 NFRLLKRLGYGDIGSVYLVEL-----RGTNTYFAMKVMDKASLASRNKLLRAQTEREILG 149
N L + LG G G V+L E A+K + AS +R R E E+L
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR---EAELLT 62
Query: 150 LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-----------LRQKQPNKYFTEDAA 198
L H + Y +V E+ G+L+ + + T+
Sbjct: 63 NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQM 122
Query: 199 RFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
A ++ + YL V+RDL N LV + + + DF +S
Sbjct: 123 LHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMS 167
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 46/166 (27%), Positives = 66/166 (39%), Gaps = 23/166 (13%)
Query: 98 LLKR-LGYGDIGSVYLVE---LRGTN--TYFAMKVMDKASLASRNKLLRAQTEREILGLL 151
+LKR LG G G V+L E L T A+K + +LA+R Q E E+L L
Sbjct: 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF---QREAELLTNL 64
Query: 152 DHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARF---------- 200
H + Y +V E+ G+L+ LR P+ D
Sbjct: 65 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 201 ---FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
AS++ + YL V+RDL N LV + + DF +S
Sbjct: 125 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 19/39 (48%), Positives = 27/39 (69%)
Query: 202 ASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240
A ++L A++Y+H GI++RD+K ENVLV I L DF
Sbjct: 266 ARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDF 304
|
Length = 461 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 95/402 (23%), Positives = 145/402 (36%), Gaps = 126/402 (31%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQ-TEREILGLLDHP 154
F++L LG G G V R Y A+K++ +R+ + Q E+
Sbjct: 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADR 190
Query: 155 F-LPTLYSYFETDKFY-CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVL---LAL 209
F L + YF+ + + C+VM L + + P + R A + +AL
Sbjct: 191 FPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSH------RHLAQIIFQTGVAL 244
Query: 210 EYLHM-LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGG 268
+Y H L +++ DLKPEN+L+ ++S V+
Sbjct: 245 DYFHTELHLMHTDLKPENILM------------------------ETSDTVVD------- 273
Query: 269 GILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328
P T R LP R D G C + + R+ + V
Sbjct: 274 --------------PVT--NRALPPDPCRVRICDLGGC---------CDERHSRT-AIVS 307
Query: 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYEL---------------LH------GTTPFK 367
T Y +PE++ G G + D W+ G +YEL LH G P +
Sbjct: 308 TRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSE 367
Query: 368 GQGNRAT-----LFNVVGQPLRFPETPQ-VSFVAR--------------DLIRGLLVKEP 407
G T L+N GQ LR P+ ++ +AR DLI GLL +
Sbjct: 368 WAGRCGTEEARLLYNSAGQ-LRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426
Query: 408 HKRIAYKRGAT---------EIKQHPFFEGVNWALVRSALPP 440
KR+ ++ T E +QHP N+ RS L P
Sbjct: 427 QKRLNARQMTTHPYVLKYYPECRQHP-----NYPDNRSMLRP 463
|
Length = 467 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 9e-04
Identities = 39/142 (27%), Positives = 53/142 (37%), Gaps = 34/142 (23%)
Query: 315 MAEPTNVRSMSFVGTHEYLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQ---G 370
+A + +V T Y APEI+ H VD W+ G + ELL G F G
Sbjct: 164 LARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID 223
Query: 371 NRATLFNVVGQPL-----------------RFPETPQVSF---------VARDLIRGLLV 404
+ VVG P P PQ +A DL+ +LV
Sbjct: 224 QLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLV 283
Query: 405 KEPHKRIAYKRGATEIKQHPFF 426
+ KRI+ A+E HP+F
Sbjct: 284 LDSDKRIS----ASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.001
Identities = 34/115 (29%), Positives = 47/115 (40%), Gaps = 14/115 (12%)
Query: 319 TNVRSMSFVGTHEYLAPEIIRGEGHGSAV-----DWWTFGIFLYELLHGTTPFKGQGNRA 373
T R +F+GT ++APE+I + A D W+ GI EL G P
Sbjct: 166 TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR 225
Query: 374 TLFNVVGQP---LRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425
LF + P L+ PE F D I L+K +R E+ +HPF
Sbjct: 226 ALFKIPRNPPPTLKSPENWSKKF--NDFISECLIKNYEQRPF----MEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 26/87 (29%), Positives = 41/87 (47%), Gaps = 7/87 (8%)
Query: 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR-- 384
+GT YL+PEI + + D W G LYE+ F+ GN + N+V + +R
Sbjct: 162 IGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA-GN---MKNLVLKIIRGS 217
Query: 385 FPETP-QVSFVARDLIRGLLVKEPHKR 410
+P S+ R+L+ L + P R
Sbjct: 218 YPPVSSHYSYDLRNLVSQLFKRNPRDR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 36/156 (23%), Positives = 54/156 (34%), Gaps = 38/156 (24%)
Query: 325 SFVGTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKG---QGNRATLFNVVG 380
+V T Y APE++ + +A+D W+ G E+L F G + +V+G
Sbjct: 170 EYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG 229
Query: 381 QP------------LR-----FPETPQVSFV---------ARDLIRGLLVKEPHKRIAYK 414
P +R P V + A DL+ +L +P +RI
Sbjct: 230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT-- 287
Query: 415 RGATEIKQHPFFEGVNWALVRSALPPHIPEPVDFSV 450
+ QHPF P P P DF
Sbjct: 288 --VEQALQHPFLAQ----YHDPDDEPTCPPPFDFDF 317
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 24/92 (26%), Positives = 38/92 (41%), Gaps = 2/92 (2%)
Query: 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELL-HGTTPFKGQGNRATLFNVVGQPLRFPETPQ 390
++APE I SA D W FG+ ++E+L G PF+G N + + R P P
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-GRIENGERLPMPPN 232
Query: 391 VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422
L+ +P KR + ++
Sbjct: 233 CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 41/159 (25%), Positives = 58/159 (36%), Gaps = 44/159 (27%)
Query: 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQ-------------GNR 372
+V T Y APE+I G G+ VD W+ G + E++ G F G G
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 244
Query: 373 ATLFNVVGQP-----------------------LRFPETPQVSFV----ARDLIRGLLVK 405
F QP + FP + + + ARDL+ +LV
Sbjct: 245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 304
Query: 406 EPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE 444
+ KRI+ E QHP+ A PP IP+
Sbjct: 305 DASKRIS----VDEALQHPYINVWYDPSEAEAPPPKIPD 339
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 38/158 (24%), Positives = 73/158 (46%), Gaps = 13/158 (8%)
Query: 98 LLKRLGYGDIGSVYLVELRGTNTYF--AMKVMDKASLASRNKLLRAQTEREILGLLDHP- 154
L K LG G+ GSV +L ++ A+K M K ++ +R+++ +E + DHP
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 155 ---FLPTLYSYFETDKFYC--LVMEFCSGGNLHSL----RQKQPNKYFTEDAARFFASEV 205
+ E++ + +++ F G+LHS R +Y F +++
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 206 LLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+EYL ++RDL N ++ + ++ ++DF LS
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 36/155 (23%), Positives = 61/155 (39%), Gaps = 12/155 (7%)
Query: 89 PPIGLSNFRLLKRLGYGDIGSVY---LVELRGTNTYFAMKVMDKASLASRNKLLRAQTER 145
P + + LL+ LG+G G VY G + V S E
Sbjct: 1 PEVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA 60
Query: 146 EILGLLDHPFLPTLYSY-FETDKFYCLVMEFCSGGNLHSL------RQKQPNKYFTEDAA 198
I+ +H + L FE + +++E +GG+L S R ++P+ +D
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL 119
Query: 199 RFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG 233
F A +V +YL ++RD+ N L+ +G
Sbjct: 120 -FCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG 153
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 18/42 (42%), Positives = 23/42 (54%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPF 366
S VGT Y PEI++ E +G D W FG LY++ PF
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 37/131 (28%), Positives = 53/131 (40%), Gaps = 37/131 (28%)
Query: 329 THE-----YLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNV---V 379
THE Y APEI+ G + + +AVD W+ G E++ F G LF + +
Sbjct: 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 217
Query: 380 GQP---------------LRFPETPQVSFV---------ARDLIRGLLVKEPHKRIAYKR 415
G P FP+ + F RDL+ +L +P+KRI+ K
Sbjct: 218 GTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKA 277
Query: 416 GATEIKQHPFF 426
HPFF
Sbjct: 278 ALA----HPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 15/40 (37%), Positives = 29/40 (72%)
Query: 204 EVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++L +++LH GI++RDLKP N++V+ + + + DF L+
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 35/151 (23%), Positives = 70/151 (46%), Gaps = 8/151 (5%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+ +L K+LG G G V++ +T A+K M S++ L E ++ L H
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFL----AEANVMKTLQH 60
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALEYL 212
L L++ + Y ++ EF + G+L L+ + +K F ++++ + ++
Sbjct: 61 DKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDF-SAQIAEGMAFI 118
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++RDL+ N+LV ++DF L+
Sbjct: 119 EQRNYIHRDLRAANILVSASLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 35/162 (21%), Positives = 65/162 (40%), Gaps = 19/162 (11%)
Query: 96 FRLLKRLGYGDIGSVY---LVELRGTNT--YFAMKVMDKASLASRNKLLRAQTEREILGL 150
L L G G ++ L++ + F V D AS LL E +L
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLL---QESCLLYG 64
Query: 151 LDHP-FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAAR--------FF 201
L H LP L+ E + ++ + + GNL Q+ + + +
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQ--CRLGEANNPQALSTQQLVHM 122
Query: 202 ASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
A ++ + YLH G++++D+ N ++ +E + ++D LS
Sbjct: 123 AIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS 164
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 27/102 (26%), Positives = 47/102 (46%), Gaps = 9/102 (8%)
Query: 139 LRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAA 198
L A+ E E L L +P + ++ + +VME+ G L+ LR N
Sbjct: 154 LAAEREFEALQRL-YPEGVKVPKPIAWNR-HAVVMEYIEGVELYRLRLDVEN-------P 204
Query: 199 RFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240
++L + + GIV+ DL N+LV ++G I++ D+
Sbjct: 205 DEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDW 246
|
Length = 304 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 39.0 bits (92), Expect = 0.002
Identities = 20/71 (28%), Positives = 33/71 (46%), Gaps = 8/71 (11%)
Query: 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLV 229
+VME+ G L+ +R ED E+L + + GI++ DL N+LV
Sbjct: 107 AVVMEYIDGVELYRVRV-------LEDPEEVL-DEILEEIVKAYKHGIIHGDLSEFNILV 158
Query: 230 RDEGHIMLSDF 240
D+ I + D+
Sbjct: 159 DDDEKIYIIDW 169
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 35/117 (29%), Positives = 50/117 (42%), Gaps = 14/117 (11%)
Query: 319 TNVRSMSFVGTHEYLAPEIIRGE-----GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRA 373
T +R + VGT ++APE+I E + + D W+ GI EL G P
Sbjct: 181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240
Query: 374 TLFNVVGQP---LRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427
TLF + P L PE SF I L+K+ R + T + +HPF +
Sbjct: 241 TLFKIPRNPPPTLLHPEKWCRSF--NHFISQCLIKDFEARPS----VTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 29/124 (23%), Positives = 43/124 (34%), Gaps = 33/124 (26%)
Query: 332 YLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATL--------------- 375
Y APE++ G + +A+D W G L ELL G+ L
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233
Query: 376 -----------FNVVGQPLRF--PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422
F + QP + P +S L+ LL+ +P KR A E +
Sbjct: 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT----AEEALE 289
Query: 423 HPFF 426
+F
Sbjct: 290 SSYF 293
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 13/89 (14%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336
+H ++PS IL + + DFG V G L + MA SFVGT Y++PE
Sbjct: 126 MHRDVKPSN----ILVNSRGEIKLCDFG--VSGQLIDSMAN-------SFVGTRSYMSPE 172
Query: 337 IIRGEGHGSAVDWWTFGIFLYELLHGTTP 365
++G + D W+ G+ L E+ G P
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|151200 pfam10707, YrbL-PhoP_reg, PhoP regulatory network protein YrbL | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.003
Identities = 34/132 (25%), Positives = 48/132 (36%), Gaps = 26/132 (19%)
Query: 125 KVMDKASLASR-------NKLLRA----QTEREIL--------GLLDHPFLPTLYSYFET 165
KV+ A++A+R +LL Q RE+ +D +P Y + ET
Sbjct: 29 KVLRPANIAARRRFKGWLKRLLPTSRYRQNLRELKEYLRLSKRRGIDWSPIPRYYGFVET 88
Query: 166 DKFYCLVME--FCSGGNL-HSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDL 222
D LV E + GN+ +L N T A YL IV RDL
Sbjct: 89 DLGLGLVTERIRDADGNISPTLEDLLKNGGLTAALRE--ALNEFK--RYLLDNHIVARDL 144
Query: 223 KPENVLVRDEGH 234
P N++
Sbjct: 145 NPHNIVYGRRSE 156
|
This is a family of proteins that are activated by PhoP. PhoP protein controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multicomponent loop in Salmonella where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner. Length = 199 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.003
Identities = 42/155 (27%), Positives = 66/155 (42%), Gaps = 10/155 (6%)
Query: 94 SNFRLLKRLGYGDIGSVYL--VELRGTNTYF-AMKVM-DKASLASRNKLLRAQTEREILG 149
S + K +G G+ G V ++L G A+K + +S R L TE I+G
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL---TEASIMG 60
Query: 150 LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLA 208
DHP + L + ++ E+ G+L LR+ + FT +
Sbjct: 61 QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASG 118
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++YL + V+RDL N+LV +SDF LS
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 38/170 (22%), Positives = 65/170 (38%), Gaps = 15/170 (8%)
Query: 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL 148
P + ++ + +G G+ G V ++ + AS++ E E+L
Sbjct: 2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 61
Query: 149 GLL-DHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQ------PNKYFTEDAARFF 201
L HP + L E + L +E+ GNL +K P A
Sbjct: 62 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121
Query: 202 ASEVLLA--------LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+S+ LL ++YL ++RDL N+LV + ++DF LS
Sbjct: 122 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 28/109 (25%), Positives = 47/109 (43%), Gaps = 9/109 (8%)
Query: 322 RSMSFVGTHEYLAPEIIRGEGHGSAV-----DWWTFGIFLYELLHGTTPFKGQGNRATLF 376
R +F+GT ++APE+I + + A D W+ GI E+ G P LF
Sbjct: 167 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF 226
Query: 377 NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425
+ P ++ + S + I LVK +R + ++ +HPF
Sbjct: 227 LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTE----QLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 35/115 (30%), Positives = 48/115 (41%), Gaps = 14/115 (12%)
Query: 319 TNVRSMSFVGTHEYLAPEIIRGE-----GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRA 373
T +R + VGT ++APE+I E + + D W+ GI EL G P
Sbjct: 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236
Query: 374 TLFNVVGQP---LRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425
LF + P L PE F D IR L K+ KR +++ QH F
Sbjct: 237 ALFKIPRNPPPTLHQPELWSNEF--NDFIRKCLTKDYEKRPT----VSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 33/124 (26%), Positives = 51/124 (41%), Gaps = 14/124 (11%)
Query: 290 ILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGS---A 346
IL ++ + +DFG +A P N SFVGT ++APE+I G
Sbjct: 156 ILLTEPGQVKLADFGSAS-------IASPAN----SFVGTPYWMAPEVILAMDEGQYDGK 204
Query: 347 VDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406
VD W+ GI EL P + L+++ ++ + S R+ + L K
Sbjct: 205 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKI 264
Query: 407 PHKR 410
P R
Sbjct: 265 PQDR 268
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 59/256 (23%), Positives = 95/256 (37%), Gaps = 40/256 (15%)
Query: 8 RTNSITNQRPLPSQKKPPNSEPSTVTMPGDIKHANSLTNHGHGSSNCSSRSDSLESSSAP 67
R + R L P E D + S S + L+ AP
Sbjct: 73 RADPTGAHRALED--AAPAGELLVPRSNAD----LFASAGDGPSGAEDSDASHLDFDEAP 126
Query: 68 VKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELR----------G 117
P G V + L+ L++FR++ L G G +++ LR G
Sbjct: 127 --PDAAGPV---PLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRG 181
Query: 118 TNTYFAMKVMDKASLASRNK---LLRAQTEREILGL--LDHPFLPTL--------YSYFE 164
N+ K + +A R K Q E EIL L L+H + + +Y
Sbjct: 182 VNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMI 241
Query: 165 TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKP 224
T K+ + F + +P T R ++L A+EY+H +++RD+K
Sbjct: 242 TQKYDFDLYSFMYDEAFD--WKDRPLLKQT----RAIMKQLLCAVEYIHDKKLIHRDIKL 295
Query: 225 ENVLVRDEGHIMLSDF 240
EN+ + +G I+L DF
Sbjct: 296 ENIFLNCDGKIVLGDF 311
|
Length = 501 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 491 | |||
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.81 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.79 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.73 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.72 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.63 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.55 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.54 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.53 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.52 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.49 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.44 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.42 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.31 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.28 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.26 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.24 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.21 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.96 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.96 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.87 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.84 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.77 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.76 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.73 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.71 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.66 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.51 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.5 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.48 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.46 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.44 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.41 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.23 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.22 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.19 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.03 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.98 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.98 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.96 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.95 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.95 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.85 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.85 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.72 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.72 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.7 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.68 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.5 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.33 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.32 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.25 | |
| PLN02236 | 344 | choline kinase | 97.24 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.19 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.98 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.81 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.75 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.73 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.57 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.55 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.36 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.29 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.1 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.06 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.84 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.75 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.73 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.66 |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-76 Score=562.33 Aligned_cols=412 Identities=67% Similarity=1.066 Sum_probs=344.4
Q ss_pred CCCCCCCCCCCCccchhhhcc-cCCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHH
Q 035713 65 SAPVKPHTGGDVRWDAINMIS-LRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQT 143 (491)
Q Consensus 65 s~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~ 143 (491)
+...+++.+.++.|..+.... .....+.+++|+++++||.|.-|+||+|+.+.++..+|+|+|.|..+..++.+.+++.
T Consensus 47 ~~~~kph~~~d~~w~a~~~~~~~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~t 126 (459)
T KOG0610|consen 47 SSGNKPHKGNDVRWEAISSIRNSKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQT 126 (459)
T ss_pred cccCCCCCCCchhhhhhccccccCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHH
Confidence 445678888889998888666 5778899999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCccceeeeEEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCC
Q 035713 144 EREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLK 223 (491)
Q Consensus 144 E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDik 223 (491)
|.+||+.++||+++.||..|+.++..|||||||+||+|..++++++++.|++..+++|+++|+.||+|||-+|||+||||
T Consensus 127 E~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLK 206 (459)
T KOG0610|consen 127 EREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLK 206 (459)
T ss_pred HHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCEEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCC
Q 035713 224 PENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDF 303 (491)
Q Consensus 224 p~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (491)
|+||||.++|+|.|+||.|+..+...++............ .......+..-+.++.....+.+++ .+.
T Consensus 207 PENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~-----------~~~~~~~~~s~f~~r~~~~~~~~~k-~~~ 274 (459)
T KOG0610|consen 207 PENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGS-----------QPSCRSRQPSCFSPRCLSSSKKRKK-KDE 274 (459)
T ss_pred cceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCC-----------Ccccccccccccccchhcccccccc-ccc
Confidence 9999999999999999999998866666554322211110 0011112344555554444444333 333
Q ss_pred CCCCCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCC
Q 035713 304 GPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL 383 (491)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~ 383 (491)
... ..+|+..+++.+.+++++|||-.|+|||++.|..++.++|||+|||+|||||.|..||.|.++.+++.+|+.+++
T Consensus 275 ~~~--~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l 352 (459)
T KOG0610|consen 275 SAS--RSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL 352 (459)
T ss_pred ccc--ccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC
Confidence 222 677888899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhhhccCCCCCCCCCCCCCCCCCchhhHHHHH
Q 035713 384 RFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEPVDFSVFAGKDQASAAAEK 463 (491)
Q Consensus 384 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 463 (491)
.||..+.++..++|||+++|.+||.+|+++.+||.||++||||++++|+.+|...||.||.+.|................
T Consensus 353 ~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~~~~~~~~~~~~~~~ 432 (459)
T KOG0610|consen 353 KFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDGGLKPHASHKSDVKGL 432 (459)
T ss_pred cCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCccccCcccccccccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999887653111100000000
Q ss_pred HHHHHHHHHhhccCCCCCCCCCcccccC
Q 035713 464 KVVAAAEAAVDHKNGDSPKDSYVEFEYF 491 (491)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 491 (491)
. ...........+++.....+.+|+||
T Consensus 433 ~-~~~~~~~~~~~~~~~~~~~~~~F~~F 459 (459)
T KOG0610|consen 433 V-SKKLKNMPSKLSDDKVSENYNPFEYF 459 (459)
T ss_pred c-ccccccccccccCCccccCCcCcccC
Confidence 0 00011111223556667779999998
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-69 Score=532.58 Aligned_cols=344 Identities=35% Similarity=0.643 Sum_probs=277.1
Q ss_pred cccCCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeE
Q 035713 84 ISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYF 163 (491)
Q Consensus 84 ~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 163 (491)
+......+.+++|++++.||+|+||.||+|+.+.||..||+|+++|..+...+++..++.|..||...++|+||+||..|
T Consensus 131 lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF 210 (550)
T KOG0605|consen 131 LRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF 210 (550)
T ss_pred HHhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe
Confidence 34455578899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccc
Q 035713 164 ETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243 (491)
Q Consensus 164 ~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla 243 (491)
++..++||||||++||++..++.+. +.|++..+++|+++++.||+.||++|+|||||||+|+|||..||+||+||||+
T Consensus 211 QD~~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 211 QDKEYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred cCCCeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeecccccc
Confidence 9999999999999999999999875 77999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCC--ccCCcccccccccCCCCCCCCCCCCCCCccccCCCCc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPS--TFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNV 321 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (491)
.-+..... ..... ....++.. ...+...+......+. .........+......
T Consensus 289 ~gl~~~~~-~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~w~~nrr~ 343 (550)
T KOG0605|consen 289 TGLDKKHR-IESYR-------------------LDEQMQINLSEAKPSDFPKFNTPRST-----MSRREQLQTWKRNRRQ 343 (550)
T ss_pred chhhhhhh-hhhhc-------------------chhhhhhhhccCCCccccccccccch-----hhHHHHHHHHHhhhhh
Confidence 43321110 00000 00000000 0000000000000000 0000000111112222
Q ss_pred cccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC--CCcCCCCCCCCHHHHHHH
Q 035713 322 RSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ--PLRFPETPQVSFVARDLI 399 (491)
Q Consensus 322 ~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~s~~~~~li 399 (491)
...+++|||.|||||+|.+.+|+..+||||||||+||||.|.+||.+++..++..+|++- .+.+|....++++++|||
T Consensus 344 ~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI 423 (550)
T KOG0605|consen 344 LAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLI 423 (550)
T ss_pred hhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHH
Confidence 334689999999999999999999999999999999999999999999999999999854 488888888999999999
Q ss_pred HhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhhhccCCCCCCC---CCCCCCCCCCch
Q 035713 400 RGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE---PVDFSVFAGKDQ 456 (491)
Q Consensus 400 ~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~~~~~~~~~p~---~~~~~~~~~~~~ 456 (491)
.+||+ ||++|++ ..|++||++||||++|+|+.++...||++|. +.|+..|...+.
T Consensus 424 ~rll~-d~~~RLG-~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~~~~DT~yFddF~e 481 (550)
T KOG0605|consen 424 TRLLC-DPENRLG-SKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVNSELDTQYFDDFPE 481 (550)
T ss_pred HHHhc-CHHHhcC-cccHHHHhcCCccccCCcchhhcCCCCCCCCCCCcccccccccCcc
Confidence 99999 9999999 7789999999999999999999988999986 566666665443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-68 Score=502.59 Aligned_cols=290 Identities=40% Similarity=0.743 Sum_probs=260.1
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
+..++|+++++||+|+||+|++++.+.+++.||+|+++|..+........+..|..||..++||+||.++..|++.+.+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 45689999999999999999999999999999999999999998888999999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
||+||+.||.|...+++. +.|+|..++.|+++|+.||.|||++|||||||||+||||+.+|+++|+||||++....
T Consensus 102 lVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~-- 177 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK-- 177 (357)
T ss_pred EEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc--
Confidence 999999999999988875 6799999999999999999999999999999999999999999999999999864211
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
....+.++|||+
T Consensus 178 --------------------------------------------------------------------~~~~t~tfcGT~ 189 (357)
T KOG0598|consen 178 --------------------------------------------------------------------DGDATRTFCGTP 189 (357)
T ss_pred --------------------------------------------------------------------CCCccccccCCc
Confidence 112344689999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
.|||||++.+.+|+.++|||||||++|||++|.+||.+.+......+|+.++...+. ..++.++++||+++|+.||++|
T Consensus 190 eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p-~~ls~~ardll~~LL~rdp~~R 268 (357)
T KOG0598|consen 190 EYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP-GYLSEEARDLLKKLLKRDPRQR 268 (357)
T ss_pred cccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC-ccCCHHHHHHHHHHhccCHHHh
Confidence 999999999999999999999999999999999999999999999999988844432 2489999999999999999999
Q ss_pred CCcCCChHHhhcCCCcCCCChhhh--hccCCCCCCC---CCCCCCCCC
Q 035713 411 IAYKRGATEIKQHPFFEGVNWALV--RSALPPHIPE---PVDFSVFAG 453 (491)
Q Consensus 411 ~t~~~~~~ell~hpff~~~~~~~~--~~~~~~~~p~---~~~~~~~~~ 453 (491)
++...++.+|.+||||.++||+.+ +...||+.|. ..|.+.|+.
T Consensus 269 Lg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~~~~Fd~ 316 (357)
T KOG0598|consen 269 LGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLEDTSNFDN 316 (357)
T ss_pred cCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCccccccccH
Confidence 975567999999999999999977 4567777775 334444443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-67 Score=480.33 Aligned_cols=290 Identities=41% Similarity=0.758 Sum_probs=267.9
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
..+++|++++.||.|+||+|.+++++.+|..||+|++++..+.+..+.+...+|..||+.+.||++++|++.|.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 67899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
|||||++||.|..++++. ++|++..+++|++||+.||+|||+++|++|||||+|||||++|++||+|||+|++..
T Consensus 121 mvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS--- 195 (355)
T ss_pred EEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence 999999999999999885 679999999999999999999999999999999999999999999999999997642
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
.++.+.||||
T Consensus 196 ----------------------------------------------------------------------~rT~TlCGTP 205 (355)
T KOG0616|consen 196 ----------------------------------------------------------------------GRTWTLCGTP 205 (355)
T ss_pred ----------------------------------------------------------------------CcEEEecCCc
Confidence 2466889999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
.|+|||++...+|+.++|||||||++|||+.|.+||...+...++.+|+.+.+.+|.. ++.++++||+++|+.|-.+|
T Consensus 206 eYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~--fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 206 EYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSY--FSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcc--cCHHHHHHHHHHHhhhhHhh
Confidence 9999999999999999999999999999999999999999999999999999999976 99999999999999999999
Q ss_pred CC-cCCChHHhhcCCCcCCCChhhh--hccCCCCCC----CCCCCCCCCCCchh
Q 035713 411 IA-YKRGATEIKQHPFFEGVNWALV--RSALPPHIP----EPVDFSVFAGKDQA 457 (491)
Q Consensus 411 ~t-~~~~~~ell~hpff~~~~~~~~--~~~~~~~~p----~~~~~~~~~~~~~~ 457 (491)
.+ +..|..+|+.||||++++|..+ +...+|++| -+.|.++|..-.+.
T Consensus 284 ~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~gdtsnfd~y~e~ 337 (355)
T KOG0616|consen 284 FGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIHGPGDTSNFDDYEEE 337 (355)
T ss_pred hcCcCCCccccccCcccccccHHHHhhccccCCCCCccccCCcccccccccccc
Confidence 77 4668999999999999999976 445666666 25666776654433
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-65 Score=511.73 Aligned_cols=294 Identities=40% Similarity=0.771 Sum_probs=267.7
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCc
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDK 167 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~ 167 (491)
..+.+++|.++++||+|+||+|+++..+.+++.||||+++|..+..++.++..+.|.+|+.... ||++++|+.+|++.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4677899999999999999999999999999999999999999999999999999999999885 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
++|+||||+.||++..+++ .+.|++..+++|+++|+.||+|||++||||||||.+|||||.+|++||+|||+++...
T Consensus 443 ~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred eEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999999999654443 3679999999999999999999999999999999999999999999999999986421
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
....++.|+|
T Consensus 520 ----------------------------------------------------------------------~~g~~TsTfC 529 (694)
T KOG0694|consen 520 ----------------------------------------------------------------------GQGDRTSTFC 529 (694)
T ss_pred ----------------------------------------------------------------------CCCCcccccc
Confidence 0123567899
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP 407 (491)
|||.|||||++.+..|+.++|||||||+|||||.|..||.|+++.+.+..|+...+.+|.. ++.++.+++++||.+||
T Consensus 530 GTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~--ls~ea~~il~~ll~k~p 607 (694)
T KOG0694|consen 530 GTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF--LSKEAIAIMRRLLRKNP 607 (694)
T ss_pred CChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCc--ccHHHHHHHHHHhccCc
Confidence 9999999999999999999999999999999999999999999999999999999999976 99999999999999999
Q ss_pred CCCCCc-CCChHHhhcCCCcCCCChhhh--hccCCCCCCC---CCCCCCCCCCchh
Q 035713 408 HKRIAY-KRGATEIKQHPFFEGVNWALV--RSALPPHIPE---PVDFSVFAGKDQA 457 (491)
Q Consensus 408 ~~R~t~-~~~~~ell~hpff~~~~~~~~--~~~~~~~~p~---~~~~~~~~~~~~~ 457 (491)
++|+++ .+++++|++||||+.++|+.+ +...||++|. |.|.++|......
T Consensus 608 ~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt~ 663 (694)
T KOG0694|consen 608 EKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFTS 663 (694)
T ss_pred ccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcccchhhhc
Confidence 999997 467999999999999999977 5677888775 6778877765433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-64 Score=496.08 Aligned_cols=287 Identities=37% Similarity=0.641 Sum_probs=259.6
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~ 169 (491)
....||.+.+.||+|+|++|++|+++.+++.||||++.|..+.++.....+.+|.++|.+| .||.|++||..|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 4568999999999999999999999999999999999999999999999999999999999 799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+|+||+++|+|.++|++. +.|++..+++|++||+.||+|||++|||||||||+||||+.||++||+|||.|+.+...
T Consensus 150 YFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999999999999986 77999999999999999999999999999999999999999999999999999876543
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
....... ........+..++|||
T Consensus 228 ~~~~~~~---------------------------------------------------------~~~~~a~s~~~SFVGT 250 (604)
T KOG0592|consen 228 QKSQENP---------------------------------------------------------VDPNQASSRRSSFVGT 250 (604)
T ss_pred hccccCc---------------------------------------------------------cCcccccCcccceeee
Confidence 2211000 0000111123578999
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
..|.+||+|.+...++.+|||+||||||+|+.|.+||.+.++..++.+|+.-.+.||. .+++.++|||+++|..||.+
T Consensus 251 AeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~--~fp~~a~dLv~KLLv~dp~~ 328 (604)
T KOG0592|consen 251 AEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE--GFPEDARDLIKKLLVRDPSD 328 (604)
T ss_pred ecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC--CCCHHHHHHHHHHHccCccc
Confidence 9999999999999999999999999999999999999999999999999998888886 59999999999999999999
Q ss_pred CCCcCCChHHhhcCCCcCCCChhhhhccCCCCC
Q 035713 410 RIAYKRGATEIKQHPFFEGVNWALVRSALPPHI 442 (491)
Q Consensus 410 R~t~~~~~~ell~hpff~~~~~~~~~~~~~~~~ 442 (491)
|+| +.+|++||||.+|+|+.+.+..||.+
T Consensus 329 Rlt----~~qIk~HpFF~~Vdw~nlw~~~PP~l 357 (604)
T KOG0592|consen 329 RLT----SQQIKAHPFFEGVDWENLWQQTPPKL 357 (604)
T ss_pred ccc----HHHHhhCcccccCChhhhhhcCCCcc
Confidence 999 99999999999999999988877765
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-63 Score=468.61 Aligned_cols=262 Identities=31% Similarity=0.486 Sum_probs=230.6
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhH----HHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASR----NKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~----~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
..+.|.+.+.||+|+||.|.+|..+.||+.||||+|++...... .....+++|++||++|+|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 44678999999999999999999999999999999998765442 23445679999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC---CcEEEeeccccc
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE---GHIMLSDFDLSL 244 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~---g~vkL~DFGla~ 244 (491)
..||||||++||+|.+.+-.+ +.+.+..-+.+++||+.||.|||++||+||||||+||||..+ ..+||+|||+|+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 999999999999999988875 679999999999999999999999999999999999999866 789999999997
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
.... .....
T Consensus 328 ~~g~-----------------------------------------------------------------------~sfm~ 336 (475)
T KOG0615|consen 328 VSGE-----------------------------------------------------------------------GSFMK 336 (475)
T ss_pred cccc-----------------------------------------------------------------------ceehh
Confidence 5421 12344
Q ss_pred ccccccCccCcchhcCCCC---CCcccccchhhHHHhhhcCCCCCCCCCcHH-HHHHHHcCCCcC--CCCCCCCHHHHHH
Q 035713 325 SFVGTHEYLAPEIIRGEGH---GSAVDWWTFGIFLYELLHGTTPFKGQGNRA-TLFNVVGQPLRF--PETPQVSFVARDL 398 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~~~---~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~~--~~~~~~s~~~~~l 398 (491)
|+|||+.|.|||++....+ ..++|||||||+||-+|+|.+||.+..... ...+|..+.+.+ +.+..+++++.+|
T Consensus 337 TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dl 416 (475)
T KOG0615|consen 337 TLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDL 416 (475)
T ss_pred hhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHH
Confidence 7899999999999998764 448899999999999999999998876665 667788877665 3456799999999
Q ss_pred HHhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 399 IRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 399 i~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
|++||..||++|++ ++|+|+||||+.+.
T Consensus 417 I~~mL~VdP~~R~s----~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 417 INWMLVVDPENRPS----ADEALNHPWFKDAP 444 (475)
T ss_pred HHHhhEeCcccCcC----HHHHhcChhhhccc
Confidence 99999999999999 99999999999776
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-61 Score=477.76 Aligned_cols=255 Identities=32% Similarity=0.562 Sum_probs=241.8
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
.+|...+.||+|||+.||.+++..+|+.||+|++.+..+.+..+.+++.+||+|.+.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 56999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
|+|..++|.+++++. +.++|.+|+.|+.||+.||.|||+++|||||||..||+|+++.+|||+|||||..+..
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~----- 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY----- 170 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC-----
Confidence 999999999999864 6799999999999999999999999999999999999999999999999999965532
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
...+..|+||||.|+
T Consensus 171 -----------------------------------------------------------------~~Erk~TlCGTPNYI 185 (592)
T KOG0575|consen 171 -----------------------------------------------------------------DGERKKTLCGTPNYI 185 (592)
T ss_pred -----------------------------------------------------------------cccccceecCCCccc
Confidence 223556789999999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
|||++....++..+||||+||+||-||+|++||...+-.+++.+|....+.+|. .++.++++||.+||..||.+||+
T Consensus 186 APEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~--~ls~~A~dLI~~lL~~~P~~Rps- 262 (592)
T KOG0575|consen 186 APEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS--HLSAEAKDLIRKLLRPNPSERPS- 262 (592)
T ss_pred ChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc--ccCHHHHHHHHHHhcCCcccCCC-
Confidence 999999999999999999999999999999999999999999999999999987 49999999999999999999999
Q ss_pred CCChHHhhcCCCc
Q 035713 414 KRGATEIKQHPFF 426 (491)
Q Consensus 414 ~~~~~ell~hpff 426 (491)
+++||.|+||
T Consensus 263 ---l~~vL~h~Ff 272 (592)
T KOG0575|consen 263 ---LDEVLDHPFF 272 (592)
T ss_pred ---HHHHhcCHhh
Confidence 9999999999
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-59 Score=441.70 Aligned_cols=259 Identities=32% Similarity=0.490 Sum_probs=231.0
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc-eE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK-FY 169 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~-~~ 169 (491)
+.+++.+.++.||+|..|+||+|+|+.|++.+|+|+|... .+....+++.+|++|++.++||+||.+|++|..++ .+
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 5567899999999999999999999999999999999433 44566778889999999999999999999999998 59
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
+|+||||+||+|..++... ++++|.....++.+|++||.|||+ ++||||||||+||||+..|.|||||||.++.+..
T Consensus 154 sI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred EeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999999999876 679999999999999999999995 9999999999999999999999999999865321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
....+++|
T Consensus 232 ------------------------------------------------------------------------S~a~tfvG 239 (364)
T KOG0581|consen 232 ------------------------------------------------------------------------SIANTFVG 239 (364)
T ss_pred ------------------------------------------------------------------------hhcccccc
Confidence 12346899
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCC-----CcHHHHHHHHcCC-CcCCCCCCCCHHHHHHHHhh
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQ-----GNRATLFNVVGQP-LRFPETPQVSFVARDLIRGL 402 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~-----~~~~~~~~i~~~~-~~~~~~~~~s~~~~~li~~~ 402 (491)
|..|||||.+.+..|+.++||||||++++||++|+.||... +..+.+..|+.++ +.+|.. .+|+++++||..|
T Consensus 240 T~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~ef~~FV~~C 318 (364)
T KOG0581|consen 240 TSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-EFSPEFRSFVSCC 318 (364)
T ss_pred cccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-cCCHHHHHHHHHH
Confidence 99999999999999999999999999999999999999875 4566777888754 445543 6999999999999
Q ss_pred hccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 403 LVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 403 L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
|++||.+|++ +.|+++|||++...
T Consensus 319 L~Kdp~~R~s----~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 319 LRKDPSERPS----AKQLLQHPFIKKFE 342 (364)
T ss_pred hcCCcccCCC----HHHHhcCHHHhhcc
Confidence 9999999999 99999999997543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-59 Score=430.18 Aligned_cols=263 Identities=27% Similarity=0.464 Sum_probs=224.4
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
++.|+.+.++|+|+||+||+|+++.||+.||||++.... .++...+-.++|+++|++|+|+|+|.|+++|.....++||
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 367999999999999999999999999999999986542 3344555678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
+|||+.--|. -+++.+ ..++.+.++.|++|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+....
T Consensus 80 FE~~dhTvL~-eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg-- 155 (396)
T KOG0593|consen 80 FEYCDHTVLH-ELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG-- 155 (396)
T ss_pred eeecchHHHH-HHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc--
Confidence 9999765554 456654 449999999999999999999999999999999999999999999999999997653211
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
..-+.++.|.||
T Consensus 156 --------------------------------------------------------------------d~YTDYVATRWY 167 (396)
T KOG0593|consen 156 --------------------------------------------------------------------DNYTDYVATRWY 167 (396)
T ss_pred --------------------------------------------------------------------chhhhhhhhhhc
Confidence 112246899999
Q ss_pred cCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC-------------------CCcCCCC----
Q 035713 333 LAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ-------------------PLRFPET---- 388 (491)
Q Consensus 333 ~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~-------------------~~~~~~~---- 388 (491)
+|||++.| .+|+.++||||+||++.||++|.+.|+|.++.++++.|... .+.+|..
T Consensus 168 RaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~e 247 (396)
T KOG0593|consen 168 RAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPE 247 (396)
T ss_pred cChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCcc
Confidence 99999998 67999999999999999999999999999999988776531 1223321
Q ss_pred ------CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 389 ------PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 389 ------~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
+.++..+.||+++||..||++|++ .+++|.|+||+++--.
T Consensus 248 pLe~k~p~~s~~~ld~~k~cL~~dP~~R~s----c~qll~H~yFd~~~er 293 (396)
T KOG0593|consen 248 PLERKYPKISNVLLDLLKKCLKMDPDDRLS----CEQLLHHPYFDGFIER 293 (396)
T ss_pred chhhhcccchHHHHHHHHHHhcCCcccccc----HHHHhcChHHHHHHHH
Confidence 467778999999999999999999 9999999999654333
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-59 Score=429.11 Aligned_cols=291 Identities=36% Similarity=0.678 Sum_probs=261.8
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
.+.+++|..+++||+|.||+|-+|+.+.++++||||+++|..+.....+.....|-++|+..+||++..|...|+..+++
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 45779999999999999999999999999999999999999888888888889999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||++||.|+-.+.+ .+.|++..+++|.++|+.||.|||+++||+||||.+|+|++.+|++||+||||++.-..
T Consensus 244 CFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~- 320 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK- 320 (516)
T ss_pred EEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc-
Confidence 999999999999877766 46799999999999999999999999999999999999999999999999999853210
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
....+.++|||
T Consensus 321 ---------------------------------------------------------------------~g~t~kTFCGT 331 (516)
T KOG0690|consen 321 ---------------------------------------------------------------------YGDTTKTFCGT 331 (516)
T ss_pred ---------------------------------------------------------------------ccceeccccCC
Confidence 12234578999
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
|.|+|||++....|+.++|||.+||++|||++|+.||+..+....+..|+.+.++||.. ++++++.|+..+|.+||.+
T Consensus 332 PEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~--ls~eAktLLsGLL~kdP~k 409 (516)
T KOG0690|consen 332 PEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRT--LSPEAKTLLSGLLKKDPKK 409 (516)
T ss_pred hhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCcc--CCHHHHHHHHHHhhcChHh
Confidence 99999999999999999999999999999999999999999988889999999999986 9999999999999999999
Q ss_pred CCCc-CCChHHhhcCCCcCCCChhhh--hccCCCCCCC---CCCCCCCCCC
Q 035713 410 RIAY-KRGATEIKQHPFFEGVNWALV--RSALPPHIPE---PVDFSVFAGK 454 (491)
Q Consensus 410 R~t~-~~~~~ell~hpff~~~~~~~~--~~~~~~~~p~---~~~~~~~~~~ 454 (491)
|++. ...+.||.+|+||.+++|..+ +...||+.|+ ..|...|+..
T Consensus 410 RLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTryFD~E 460 (516)
T KOG0690|consen 410 RLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTRYFDEE 460 (516)
T ss_pred hcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchhhhhhh
Confidence 9984 456899999999999999854 4566777775 4555555443
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-59 Score=490.10 Aligned_cols=327 Identities=35% Similarity=0.633 Sum_probs=279.3
Q ss_pred cCCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 035713 86 LRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET 165 (491)
Q Consensus 86 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 165 (491)
.+...+..++|.|+++||+|+||.|.+++++.+++.||+|+++|....++.....|+.|..||...+.++|+.|+..|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 34455677999999999999999999999999999999999999877777777889999999999999999999999999
Q ss_pred CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
+.++|+|||||+||+|..++.+.. .+++..+++|+++|+.||.-||+.|+|||||||+||||+..|++||+|||.+-.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHh
Confidence 999999999999999999999873 799999999999999999999999999999999999999999999999998755
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
+..+. ..++..
T Consensus 225 m~~dG---------------------------------------------------------------------~V~s~~ 235 (1317)
T KOG0612|consen 225 MDADG---------------------------------------------------------------------TVRSSV 235 (1317)
T ss_pred cCCCC---------------------------------------------------------------------cEEecc
Confidence 43211 123334
Q ss_pred cccccCccCcchhcC-----CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC--CCcCCCCCCCCHHHHHH
Q 035713 326 FVGTHEYLAPEIIRG-----EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ--PLRFPETPQVSFVARDL 398 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~-----~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~s~~~~~l 398 (491)
-||||.|++||+|.. +.|+..+|||||||++|||+.|..||+.++-.+++-+|++. .+.||....+|.++++|
T Consensus 236 aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdL 315 (1317)
T KOG0612|consen 236 AVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDL 315 (1317)
T ss_pred ccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHH
Confidence 599999999999973 45899999999999999999999999999999999999876 68888777899999999
Q ss_pred HHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhhhccCCCCCCC---CCCCCCCCCCchhhHHHHHHHHHHHHHHhhc
Q 035713 399 IRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE---PVDFSVFAGKDQASAAAEKKVVAAAEAAVDH 475 (491)
Q Consensus 399 i~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~~~~~~~~~p~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 475 (491)
|.++|+ +|+.|++ +.|++++.+||||.+++|+.+|...||.+|. +.|+++|.-.+..-...+... ...+
T Consensus 316 I~~ll~-~~e~RLg-rngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTsnFd~~~dd~~~~e~~p------~~~~ 387 (1317)
T KOG0612|consen 316 IEALLC-DREVRLG-RNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTSNFDVDEDDLRDAETFP------PRIP 387 (1317)
T ss_pred HHHHhc-Chhhhcc-cccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCccccccccccccchhhccC------CCCC
Confidence 999887 7899988 6789999999999999999999999999995 788888843322222111100 0123
Q ss_pred cCCCCCCCCCcccccC
Q 035713 476 KNGDSPKDSYVEFEYF 491 (491)
Q Consensus 476 ~~~~~~~~~~~~~~~~ 491 (491)
.+=..-.=||++|+|.
T Consensus 388 ~~f~Gn~LPFIGfTy~ 403 (1317)
T KOG0612|consen 388 KAFSGNHLPFIGFTYT 403 (1317)
T ss_pred CCCcCCcCCeeeeeec
Confidence 3334455688999883
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-57 Score=431.44 Aligned_cols=259 Identities=29% Similarity=0.520 Sum_probs=228.1
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
..+|.+.++||+|+||+||+|+++.++..||||.|.+..+ ..+..+-+..|+.||+.++|||||.|++++.+++.+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999988765 345566678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC------CcEEEeeccccccc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE------GHIMLSDFDLSLRC 246 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~------g~vkL~DFGla~~~ 246 (491)
||||+||+|.+|+++. +.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+.+
T Consensus 88 MEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999999986 579999999999999999999999999999999999999864 45899999999876
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.... ...+.
T Consensus 166 ~~~~-----------------------------------------------------------------------~a~tl 174 (429)
T KOG0595|consen 166 QPGS-----------------------------------------------------------------------MAETL 174 (429)
T ss_pred Cchh-----------------------------------------------------------------------HHHHh
Confidence 5221 12257
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC-CCCCCHHHHHHHHhhhcc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE-TPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~s~~~~~li~~~L~~ 405 (491)
||++.|||||++....|+.++|+||+|+|||+|++|+.||...+..+.+..+-.+.-..+. ...++..+.+|+..+|+.
T Consensus 175 cGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~ 254 (429)
T KOG0595|consen 175 CGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQR 254 (429)
T ss_pred hCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhc
Confidence 9999999999999999999999999999999999999999999888887766544332222 234777788999999999
Q ss_pred CCCCCCCcCCChHHhhcCCCcCCC
Q 035713 406 EPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
+|.+|.+ ..+-+.|+|+..-
T Consensus 255 ~~~~~~~----~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 255 NPKDRIS----FEDFFDHPFLAAN 274 (429)
T ss_pred CccccCc----hHHhhhhhhcccC
Confidence 9999999 8888999988643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-58 Score=441.70 Aligned_cols=260 Identities=32% Similarity=0.521 Sum_probs=227.5
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCc-eE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDK-FY 169 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~-~~ 169 (491)
..++|.++++||.|+||.||+|+.+.+|..||||.+++.-...++. . -.||+.-|++|+ |||||+|++++.+.+ .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~-nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-M-NLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-H-HHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 4578999999999999999999999999999999997764443322 2 257999999998 999999999998877 99
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||| ..+|+++++.. ++.|++..++.|+.||+.||+|+|.+|++|||||||||||.....+||+||||||.....
T Consensus 86 ~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence 9999999 67999999987 788999999999999999999999999999999999999998889999999999876433
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
+. -+.++-|
T Consensus 164 pP-----------------------------------------------------------------------YTeYVST 172 (538)
T KOG0661|consen 164 PP-----------------------------------------------------------------------YTEYVST 172 (538)
T ss_pred CC-----------------------------------------------------------------------cchhhhc
Confidence 22 2246899
Q ss_pred cCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CC----------------CcCCCC-
Q 035713 330 HEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QP----------------LRFPET- 388 (491)
Q Consensus 330 ~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~----------------~~~~~~- 388 (491)
.||+|||+|+... |+.++||||+|||++|+++-++.|.|.++.+++.+|+. .+ +++|..
T Consensus 173 RWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~ 252 (538)
T KOG0661|consen 173 RWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVK 252 (538)
T ss_pred ccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCC
Confidence 9999999998765 79999999999999999999999999999999988752 22 333332
Q ss_pred --------CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 389 --------PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 389 --------~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
+.++.++.+||.+||++||.+||| |.++|+||||+.-.
T Consensus 253 ~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpT----A~~al~~pffq~~~ 298 (538)
T KOG0661|consen 253 PSPLKDLLPNASSEAASLIERLLAWDPDKRPT----ASQALQHPFFQVGR 298 (538)
T ss_pred CCChHHhCcccCHHHHHHHHHHhcCCCccCcc----HHHHhcCccccccc
Confidence 458889999999999999999999 99999999997643
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-56 Score=440.32 Aligned_cols=256 Identities=30% Similarity=0.540 Sum_probs=234.7
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
+++|.+.+.||+|+||+||+|+.+.+.+.||||.+.|.. ..++.+..+++|++|++.|+|||||.++++|++..++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 368999999999999999999999999999999998764 3456777899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
+||+.| +|+.++... +.++|+.++.++.+++.||.|||+++|+|||+||.|||+...|.+||||||+|+.+.....
T Consensus 80 te~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~- 155 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS- 155 (808)
T ss_pred ehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCce-
Confidence 999976 999999875 6799999999999999999999999999999999999999999999999999976542111
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.-+++.|||.|
T Consensus 156 ---------------------------------------------------------------------vltsikGtPlY 166 (808)
T KOG0597|consen 156 ---------------------------------------------------------------------VLTSIKGTPLY 166 (808)
T ss_pred ---------------------------------------------------------------------eeeeccCcccc
Confidence 12245799999
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCC
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIA 412 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 412 (491)
||||++.+.+|+..+|+||||||+|||++|++||...+..+....|+..+..+|. .++.++++||+.+|.+||.+|++
T Consensus 167 mAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~--~~S~~f~nfl~gLL~kdP~~Rlt 244 (808)
T KOG0597|consen 167 MAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS--TASSSFVNFLQGLLIKDPAQRLT 244 (808)
T ss_pred cCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc--cccHHHHHHHHHHhhcChhhccc
Confidence 9999999999999999999999999999999999999888888999999998887 59999999999999999999999
Q ss_pred cCCChHHhhcCCCcCC
Q 035713 413 YKRGATEIKQHPFFEG 428 (491)
Q Consensus 413 ~~~~~~ell~hpff~~ 428 (491)
-.+++.|||.++
T Consensus 245 ----W~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 245 ----WTDLLGHPFWKG 256 (808)
T ss_pred ----HHHHhcChHHhh
Confidence 899999999875
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-56 Score=430.12 Aligned_cols=286 Identities=36% Similarity=0.655 Sum_probs=255.9
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
..++..+.|+.-++||+|+||.||-|+.+.||+.||+|.+.|..+..+......++|.+||.+++.++||.|-..|++.+
T Consensus 179 ~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 179 LQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD 258 (591)
T ss_pred hhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence 35677889999999999999999999999999999999999999988888888999999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+||||..|+||+|.-.|....+..|++..+++|+++|+.||++||+.+||+||+||+|||+|+.|+|+|+|+|||..+.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999999999988877766789999999999999999999999999999999999999999999999999996543
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
.... ....+
T Consensus 339 ~g~~-----------------------------------------------------------------------~~~rv 347 (591)
T KOG0986|consen 339 EGKP-----------------------------------------------------------------------IRGRV 347 (591)
T ss_pred CCCc-----------------------------------------------------------------------ccccc
Confidence 2111 11228
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHH----HHHHHHcCCCcCCCCCCCCHHHHHHHHhhh
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRA----TLFNVVGQPLRFPETPQVSFVARDLIRGLL 403 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~s~~~~~li~~~L 403 (491)
||.+|||||++.+..|+...|||||||+||||+.|+.||....... .-.+++..+..+++ .+|+++++|+..+|
T Consensus 348 GT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~--kFS~eakslc~~LL 425 (591)
T KOG0986|consen 348 GTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSD--KFSEEAKSLCEGLL 425 (591)
T ss_pred CcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccc--ccCHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999997654432 23456667777774 59999999999999
Q ss_pred ccCCCCCCCcC-CChHHhhcCCCcCCCChhhhh--ccCCCCCCCCC
Q 035713 404 VKEPHKRIAYK-RGATEIKQHPFFEGVNWALVR--SALPPHIPEPV 446 (491)
Q Consensus 404 ~~dP~~R~t~~-~~~~ell~hpff~~~~~~~~~--~~~~~~~p~~~ 446 (491)
++||.+|++++ .+++++.+||||+.+||..+. ...||++|.|.
T Consensus 426 ~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~ 471 (591)
T KOG0986|consen 426 TKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPG 471 (591)
T ss_pred ccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCcc
Confidence 99999999997 699999999999999999874 46789999874
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-55 Score=441.80 Aligned_cols=263 Identities=31% Similarity=0.514 Sum_probs=239.6
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.+-|++.+.||.|+.|.|.+|++..||+.+|||+|.+...........+.+|+-||+.+.||||++||++|++..++|||
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 35699999999999999999999999999999999987555556667788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
+||++||.|++++.+. +.|++.+++.++.||+.|+.|||..+|+|||+||+|+||+..+.+||+|||+|......
T Consensus 91 lEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--- 165 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--- 165 (786)
T ss_pred EEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC---
Confidence 9999999999998875 67999999999999999999999999999999999999999999999999998432111
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.--.+.||++.|
T Consensus 166 --------------------------------------------------------------------klLeTSCGSPHY 177 (786)
T KOG0588|consen 166 --------------------------------------------------------------------KLLETSCGSPHY 177 (786)
T ss_pred --------------------------------------------------------------------ccccccCCCccc
Confidence 112245999999
Q ss_pred cCcchhcCCCC-CCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 333 LAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 333 ~aPE~l~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
.|||++.|.+| +.++||||.|||||.||||+.||++.+....+.++..+.+..|. .++.++.+||.+||..||++|+
T Consensus 178 A~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs--~Is~eaQdLLr~ml~VDp~~Ri 255 (786)
T KOG0588|consen 178 AAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS--NISSEAQDLLRRMLDVDPSTRI 255 (786)
T ss_pred CCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC--cCCHHHHHHHHHHhccCccccc
Confidence 99999999999 88999999999999999999999999999999999999999885 5999999999999999999999
Q ss_pred CcCCChHHhhcCCCcCCCChhhh
Q 035713 412 AYKRGATEIKQHPFFEGVNWALV 434 (491)
Q Consensus 412 t~~~~~~ell~hpff~~~~~~~~ 434 (491)
| .+||++|||+.+..-...
T Consensus 256 T----~~eI~kHP~l~g~~~~~~ 274 (786)
T KOG0588|consen 256 T----TEEILKHPFLSGYTSLPS 274 (786)
T ss_pred c----HHHHhhCchhhcCCCCCh
Confidence 9 999999999998765443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-57 Score=409.73 Aligned_cols=251 Identities=26% Similarity=0.399 Sum_probs=218.0
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceee-eEEeCc-e
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYS-YFETDK-F 168 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~-~~~~~~-~ 168 (491)
..+.+|+|+++||+|+||+||++++..+|+.+|.|.|+-.. -+....+.+..|+.+|++|+|||||++++ .|..++ .
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 35678999999999999999999999999999999998544 34556667788999999999999999998 454444 4
Q ss_pred EEEEEeccCCCchHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH--cC--cccccCCCCCEEEccCCcEEEeeccc
Q 035713 169 YCLVMEFCSGGNLHSLRQKQ--PNKYFTEDAARFFASEVLLALEYLHM--LG--IVYRDLKPENVLVRDEGHIMLSDFDL 242 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~--~g--ivHrDikp~NILl~~~g~vkL~DFGl 242 (491)
++||||||.+|+|..+++.. ..+.++|..++.|+.|+++||.++|. .. |+||||||.||+|+.+|.|||+||||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 99999999999999988753 34679999999999999999999999 44 99999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcc
Q 035713 243 SLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322 (491)
Q Consensus 243 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (491)
++.+....+ .
T Consensus 175 ~r~l~s~~t----------------------------------------------------------------------f 184 (375)
T KOG0591|consen 175 GRFLSSKTT----------------------------------------------------------------------F 184 (375)
T ss_pred HhHhcchhH----------------------------------------------------------------------H
Confidence 987643222 2
Q ss_pred ccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhh
Q 035713 323 SMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGL 402 (491)
Q Consensus 323 ~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~ 402 (491)
..+++|||+||+||++.+.+|+.++|||||||++|||+.-++||.|.+-.+.-.+|.++.+..-....+|.++..||..|
T Consensus 185 A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~c 264 (375)
T KOG0591|consen 185 AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMC 264 (375)
T ss_pred HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHH
Confidence 33679999999999999999999999999999999999999999999777777778777554222246899999999999
Q ss_pred hccCCCCCCC
Q 035713 403 LVKEPHKRIA 412 (491)
Q Consensus 403 L~~dP~~R~t 412 (491)
+..||+.||+
T Consensus 265 i~vd~~~RP~ 274 (375)
T KOG0591|consen 265 IAVDPEQRPD 274 (375)
T ss_pred ccCCcccCCC
Confidence 9999999998
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-55 Score=422.20 Aligned_cols=266 Identities=33% Similarity=0.583 Sum_probs=229.5
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhH-----------HHHHHHHHHHHHHhhcCCCCccc
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASR-----------NKLLRAQTEREILGLLDHPFLPT 158 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~-----------~~~~~~~~E~~il~~l~hp~iv~ 158 (491)
...+++|++++.||+|.||.|.+|++..+++.||||++.|...... ..++++++||.||++|.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 4567899999999999999999999999999999999987654322 23457899999999999999999
Q ss_pred eeeeEEeC--ceEEEEEeccCCCchHHHHHhCCCCC-CCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcE
Q 035713 159 LYSYFETD--KFYCLVMEFCSGGNLHSLRQKQPNKY-FTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHI 235 (491)
Q Consensus 159 l~~~~~~~--~~~~lV~E~~~gg~L~~~~~~~~~~~-l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~v 235 (491)
|+++..+. +.+|||+|||..|.+...-. ... +++.+++.|+.+++.||+|||.+|||||||||+|+||+.+|+|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence 99999764 68999999999988864322 234 9999999999999999999999999999999999999999999
Q ss_pred EEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccc
Q 035713 236 MLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELM 315 (491)
Q Consensus 236 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (491)
||+|||.+........
T Consensus 250 KIsDFGVs~~~~~~~~---------------------------------------------------------------- 265 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSD---------------------------------------------------------------- 265 (576)
T ss_pred EeeccceeeecccCCc----------------------------------------------------------------
Confidence 9999999844321100
Q ss_pred cCCCCccccccccccCccCcchhcCCC---C-CCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCC
Q 035713 316 AEPTNVRSMSFVGTHEYLAPEIIRGEG---H-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQV 391 (491)
Q Consensus 316 ~~~~~~~~~~~~gt~~y~aPE~l~~~~---~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 391 (491)
+.........+|||.|||||++.+.. + +.+.|||||||+||.|+.|+.||.++...+.+.+|++.++.+|..+.+
T Consensus 266 -~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~ 344 (576)
T KOG0585|consen 266 -EGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEI 344 (576)
T ss_pred -cccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCcccc
Confidence 00001111258999999999998732 3 789999999999999999999999999999999999999999999889
Q ss_pred CHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcC
Q 035713 392 SFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 392 s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~ 427 (491)
.++++|||++||++||++|++ +.+|+.|||..
T Consensus 345 ~e~~kDli~~lL~KdP~~Ri~----l~~ik~Hpwvt 376 (576)
T KOG0585|consen 345 NEDLKDLIKRLLEKDPEQRIT----LPDIKLHPWVT 376 (576)
T ss_pred cHHHHHHHHHHhhcChhheee----hhhheecceec
Confidence 999999999999999999999 99999999985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=434.07 Aligned_cols=260 Identities=35% Similarity=0.577 Sum_probs=232.9
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhh-h-HHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCc
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLA-S-RNKLLRAQTEREILGLLD-HPFLPTLYSYFETDK 167 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~-~-~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~ 167 (491)
...+.|.+.+.||+|+||+|++|++..+++.||+|++++.... . ......+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999999999999999988775322 1 134455678999999999 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC-CcEEEeeccccccc
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE-GHIMLSDFDLSLRC 246 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~-g~vkL~DFGla~~~ 246 (491)
.+|+||||+.||+|++++... +++.|..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 999999999999999999883 679999999999999999999999999999999999999999 99999999998543
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
. .......++
T Consensus 172 ~----------------------------------------------------------------------~~~~~l~t~ 181 (370)
T KOG0583|consen 172 P----------------------------------------------------------------------GEDGLLKTF 181 (370)
T ss_pred C----------------------------------------------------------------------CCCCcccCC
Confidence 1 011123357
Q ss_pred ccccCccCcchhcCCC-C-CCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCC-CHHHHHHHHhhh
Q 035713 327 VGTHEYLAPEIIRGEG-H-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQV-SFVARDLIRGLL 403 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~-~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~-s~~~~~li~~~L 403 (491)
|||+.|+|||++.+.. | +.++||||+||+||.|++|+.||...+....+..|....+.+|.. + +.++++||.+||
T Consensus 182 cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~--~~S~~~~~Li~~mL 259 (370)
T KOG0583|consen 182 CGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY--LLSPEARSLIEKML 259 (370)
T ss_pred CCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC--cCCHHHHHHHHHHc
Confidence 9999999999999988 8 589999999999999999999999988888888899999999876 5 999999999999
Q ss_pred ccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 404 VKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 404 ~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
..||.+|++ +.+|+.||||+.
T Consensus 260 ~~~P~~R~t----~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 260 VPDPSTRIT----LLEILEHPWFQK 280 (370)
T ss_pred CCCcccCCC----HHHHhhChhhcc
Confidence 999999999 999999999986
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-56 Score=438.43 Aligned_cols=336 Identities=33% Similarity=0.585 Sum_probs=267.1
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
.....-|..++.||-|+||+|.+++...|...||+|.++|.....++++..+..|..||...++++||+||..|++.+.+
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 34556699999999999999999999999999999999999888899999999999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||++||++..++-+. +.|+|..+++|++++.+|++++|..|+|||||||+|||||.+|++||+||||+.-+.
T Consensus 705 YFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR-- 780 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR-- 780 (1034)
T ss_pred EEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccce--
Confidence 9999999999999988774 789999999999999999999999999999999999999999999999999984221
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
+.....+.. .|+ ..-.+.|.+ .....+.+.|+-.-....+..-........+||
T Consensus 781 --WTHdskYYq-~gd----------H~RqDSmep-------------~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt 834 (1034)
T KOG0608|consen 781 --WTHDSKYYQ-EGD----------HHRQDSMEP-------------SPEWADISKCLKVLERRAMRQHQRILAHSLVGT 834 (1034)
T ss_pred --ecccccccc-CCC----------ccccccCCC-------------chhhccccccchHHHHHHHhhhhhhhhhhhcCC
Confidence 111111100 000 000000000 011122222211100000000111122357999
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc--CCCcCCCCCCCCHHHHHHHHhhhccCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG--QPLRFPETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~s~~~~~li~~~L~~dP 407 (491)
+.|+|||+|....|+..+||||.|||||||+.|++||...+..++..++++ ..+.++...+++.++.+||.+++ -++
T Consensus 835 ~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sa 913 (1034)
T KOG0608|consen 835 PNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSA 913 (1034)
T ss_pred CcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cCh
Confidence 999999999999999999999999999999999999998887777666543 44667777889999999999875 578
Q ss_pred CCCCCcCCChHHhhcCCCcCCCChhhhhccCCCCCCC---CCCCCCCCCCchh
Q 035713 408 HKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE---PVDFSVFAGKDQA 457 (491)
Q Consensus 408 ~~R~t~~~~~~ell~hpff~~~~~~~~~~~~~~~~p~---~~~~~~~~~~~~~ 457 (491)
+.|++ +.++++|+.||||++|||..+|++..|.||. |.|+++|...+..
T Consensus 914 d~RLG-kng~d~vKaHpfFkgIDfsslRkq~ApYIP~ItHptDTSNFdpvdpe 965 (1034)
T KOG0608|consen 914 DSRLG-KNGADQVKAHPFFKGIDFSSLRKQRAPYIPRITHPTDTSNFDPVDPE 965 (1034)
T ss_pred hhhhc-ccchhhhhcCccccccchHhhhhccCCcCccccCCCccccCCcCCcc
Confidence 99998 6679999999999999999999888888875 8899998887654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-54 Score=422.18 Aligned_cols=262 Identities=29% Similarity=0.439 Sum_probs=223.5
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC--c
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD--K 167 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~--~ 167 (491)
+...+.|+.+++||+|+||.||+|++..+|+.||+|.+.... .++....-+.+||.||++|+||||++|.+...+. +
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 455678999999999999999999999999999999997664 3345566678999999999999999999998766 7
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+|||+|||+ -||.-++... .-.|++.+++.|+.||+.||+|||.+||+|||||.+||||+.+|.+||+|||||+.+.
T Consensus 192 siYlVFeYMd-hDL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 192 SIYLVFEYMD-HDLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred eEEEEEeccc-chhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 8999999995 5777776653 4569999999999999999999999999999999999999999999999999998654
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
..... .-+..+
T Consensus 270 ~~~~~---------------------------------------------------------------------~~T~rV 280 (560)
T KOG0600|consen 270 PSGSA---------------------------------------------------------------------PYTSRV 280 (560)
T ss_pred CCCCc---------------------------------------------------------------------ccccce
Confidence 32210 012348
Q ss_pred cccCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHH---cCCC-------cCCC---------
Q 035713 328 GTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV---GQPL-------RFPE--------- 387 (491)
Q Consensus 328 gt~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~---~~~~-------~~~~--------- 387 (491)
-|+||+|||+|+|.. |+.++|+||.||||.||++|++.|.|.++.+++..|. +.+- .+|.
T Consensus 281 vTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~ 360 (560)
T KOG0600|consen 281 VTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQP 360 (560)
T ss_pred EEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCc
Confidence 899999999999964 8999999999999999999999999999998887764 2220 1110
Q ss_pred --------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcC
Q 035713 388 --------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 388 --------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~ 427 (491)
...++..+.+|+.+||+.||.+|.| |.++|+|+||.
T Consensus 361 y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t----A~~aL~seyF~ 404 (560)
T KOG0600|consen 361 YKRRLRETFKDFPASALDLLEKLLSLDPDKRGT----ASSALQSEYFT 404 (560)
T ss_pred ccchHHHHhccCCHHHHHHHHHHhccCcccccc----HHHHhcCcccc
Confidence 1357778999999999999999999 99999999995
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=392.13 Aligned_cols=259 Identities=29% Similarity=0.461 Sum_probs=223.2
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
.+|..+++||+|.||+||+|++..+|+.||||.|+.... ++..-....+|+.+|+.++|+||+.|+++|...+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 579999999999999999999999999999999987643 3333445678999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||| .-+|..+++.. ...|+..+++.|+.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+......
T Consensus 81 Efm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~- 157 (318)
T KOG0659|consen 81 EFM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI- 157 (318)
T ss_pred Eec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc-
Confidence 999 56899888765 467999999999999999999999999999999999999999999999999999765422111
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
...-+-|.||+
T Consensus 158 ---------------------------------------------------------------------~~~~V~TRWYR 168 (318)
T KOG0659|consen 158 ---------------------------------------------------------------------QTHQVVTRWYR 168 (318)
T ss_pred ---------------------------------------------------------------------cccceeeeecc
Confidence 11127899999
Q ss_pred CcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHH---cCCC--c---------------CCC-----
Q 035713 334 APEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV---GQPL--R---------------FPE----- 387 (491)
Q Consensus 334 aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~---~~~~--~---------------~~~----- 387 (491)
|||++.|.+ |+..+||||.|||+.||+-|.+.|.|.++-+++..|. +.+. . +|.
T Consensus 169 APELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~ 248 (318)
T KOG0659|consen 169 APELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNN 248 (318)
T ss_pred ChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcccc
Confidence 999999975 8999999999999999999999999999998886664 3321 1 111
Q ss_pred -CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 388 -TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 388 -~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
.+.++.++.||+.+||.+||.+|++ +.|+|+|+||...
T Consensus 249 lf~aas~d~ldLl~~m~~ynP~~Rit----a~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 249 LFPAASSDALDLLSKMLTYNPKKRIT----ASQALKHPYFKSL 287 (318)
T ss_pred ccccccHHHHHHHHhhhccCchhccc----HHHHhcchhhhcC
Confidence 1457788999999999999999999 9999999999853
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-55 Score=391.74 Aligned_cols=260 Identities=34% Similarity=0.577 Sum_probs=242.6
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
..+++|++.+.||+|-||.||+|+.++++-.||+|++.|..+.......++++|++|...|+||||+++|++|.+...+|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 45789999999999999999999999999999999999998887777888999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
|++||..+|+|+..++..+...+++..+..|+.|++.||.|+|..+||||||||+|+|++..|.+||+|||.+..-.
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 99999999999999997777889999999999999999999999999999999999999999999999999874311
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
..+..++|||.
T Consensus 176 ---------------------------------------------------------------------~~kR~tlcgt~ 186 (281)
T KOG0580|consen 176 ---------------------------------------------------------------------SNKRKTLCGTL 186 (281)
T ss_pred ---------------------------------------------------------------------CCCceeeeccc
Confidence 12345789999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
.|.+||...+..++..+|+|++|++.||++.|.+||...+..+++.+|..-.+.+|. .++.+++|||.+||.++|.+|
T Consensus 187 dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~--~is~~a~dlI~~ll~~~p~~r 264 (281)
T KOG0580|consen 187 DYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS--TISGGAADLISRLLVKNPIER 264 (281)
T ss_pred ccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc--ccChhHHHHHHHHhccCcccc
Confidence 999999999999999999999999999999999999999988999999988888885 599999999999999999999
Q ss_pred CCcCCChHHhhcCCCcCC
Q 035713 411 IAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 411 ~t~~~~~~ell~hpff~~ 428 (491)
.. ..|++.|||...
T Consensus 265 ~~----l~~v~~hpwI~a 278 (281)
T KOG0580|consen 265 LA----LTEVMDHPWIVA 278 (281)
T ss_pred cc----HHHHhhhHHHHh
Confidence 99 999999999753
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=434.20 Aligned_cols=362 Identities=31% Similarity=0.525 Sum_probs=257.3
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
.|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+++|+.++|+||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 69999999999999999999999999999999987766666677788999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+........
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99999999998764 5699999999999999999999999999999999999999999999999999854321110000
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCC-CCCc----cccCCCCccccccccc
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGG-ALPE----LMAEPTNVRSMSFVGT 329 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~gt 329 (491)
.. .........+.... ...+...|..+ .... ...........+++||
T Consensus 160 ~~---------------~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 211 (381)
T cd05626 160 YQ---------------KGSHIRQDSMEPSD-------------LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGT 211 (381)
T ss_pred cc---------------ccccccccccCccc-------------ccccccccccccccchhhccccccccccccccccCC
Confidence 00 00000000000000 00000000000 0000 0000011122457899
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc--CCCcCCCCCCCCHHHHHHHHhhhccC-
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG--QPLRFPETPQVSFVARDLIRGLLVKE- 406 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~s~~~~~li~~~L~~d- 406 (491)
+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....++. ..+.++....++.++++||.+||+.+
T Consensus 212 ~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~ 291 (381)
T cd05626 212 PNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAE 291 (381)
T ss_pred ccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcc
Confidence 999999999999999999999999999999999999998877766666653 33455555568999999999976554
Q ss_pred -CCCCCCcCCChHHhhcCCCcCCCChhhh-hccCCCCCCC---CCCCCCCCCCchhhHHH-HHHHHHHHHHHhhccCCCC
Q 035713 407 -PHKRIAYKRGATEIKQHPFFEGVNWALV-RSALPPHIPE---PVDFSVFAGKDQASAAA-EKKVVAAAEAAVDHKNGDS 480 (491)
Q Consensus 407 -P~~R~t~~~~~~ell~hpff~~~~~~~~-~~~~~~~~p~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 480 (491)
+..|++ +++|++||||++++|... +...+|..|. +.+...|...+..+... ........-+..-..++..
T Consensus 292 ~~~~R~~----~~~~l~hp~f~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (381)
T cd05626 292 ERLGRNG----ADDIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTRTWDTLCSPNGKH 367 (381)
T ss_pred cccCCCC----HHHHhcCcccCCCChhHHhhcCCCCccCcCCCcchhhhcCCCCcccccccCCccchhhhccccCccccc
Confidence 445999 999999999999999754 4444444443 44444454433222111 0111111111122334555
Q ss_pred CCCCCccccc
Q 035713 481 PKDSYVEFEY 490 (491)
Q Consensus 481 ~~~~~~~~~~ 490 (491)
..+.|.+|.|
T Consensus 368 ~~~~~~~~~~ 377 (381)
T cd05626 368 PEHAFYEFTF 377 (381)
T ss_pred ccccccccEe
Confidence 5788999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=431.65 Aligned_cols=302 Identities=32% Similarity=0.570 Sum_probs=237.2
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+.+++.++|+||+++++.+.+...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765555566677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.+.......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999999998764 569999999999999999999999999999999999999999999999999986543211000
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
... . .. ........ .... .... ..............+.+||+.|+
T Consensus 159 ~~~-----~---~~-~~~~~~~~-----------~~~~----~~~~-----------~~~~~~~~~~~~~~~~~Gt~~Y~ 203 (363)
T cd05628 159 FYR-----N---LN-HSLPSDFT-----------FQNM----NSKR-----------KAETWKRNRRQLAFSTVGTPDYI 203 (363)
T ss_pred ccc-----c---cc-cccccccc-----------cccc----cccc-----------ccchhhhccccccccccCCcccc
Confidence 000 0 00 00000000 0000 0000 00000001111223568999999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc--CCCcCCCCCCCCHHHHHHHHhhhccCCCCC-
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG--QPLRFPETPQVSFVARDLIRGLLVKEPHKR- 410 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R- 410 (491)
|||++.+..++.++|||||||++|||++|+.||.+.+..+.+.++.. ..+.+|....+++++++||.+|+. +|.+|
T Consensus 204 aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~ 282 (363)
T cd05628 204 APEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRI 282 (363)
T ss_pred CHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcC
Confidence 99999999999999999999999999999999998888777777775 345566555689999999999876 56655
Q ss_pred --CCcCCChHHhhcCCCcCCCChhhhhcc
Q 035713 411 --IAYKRGATEIKQHPFFEGVNWALVRSA 437 (491)
Q Consensus 411 --~t~~~~~~ell~hpff~~~~~~~~~~~ 437 (491)
|+ +++|++||||++++|+.++..
T Consensus 283 ~r~~----~~ei~~hp~f~~~~~~~~~~~ 307 (363)
T cd05628 283 GAPG----VEEIKTNPFFEGVDWEHIRER 307 (363)
T ss_pred CCCC----HHHHhCCCCCCCCCHHHHHhC
Confidence 56 999999999999999988644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=424.87 Aligned_cols=268 Identities=37% Similarity=0.743 Sum_probs=238.9
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
...++|++++.||+|+||.||+|+++.+++.||||++.+...........+.+|+++|+.++||||+++++++.+++.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 34688999999999999999999999999999999998765555556677889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
+||||+.|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 95 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-- 170 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-- 170 (329)
T ss_pred EEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC--
Confidence 999999999999988764 5699999999999999999999999999999999999999999999999999854210
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
...+.+||+
T Consensus 171 -----------------------------------------------------------------------~~~~~~gt~ 179 (329)
T PTZ00263 171 -----------------------------------------------------------------------RTFTLCGTP 179 (329)
T ss_pred -----------------------------------------------------------------------CcceecCCh
Confidence 011347999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
.|+|||++.+..++.++|||||||++|||++|+.||.+.+....+..+....+.+|.. ++..+++||.+||+.||.+|
T Consensus 180 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~~L~~dP~~R 257 (329)
T PTZ00263 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNW--FDGRARDLVKGLLQTDHTKR 257 (329)
T ss_pred hhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCC--CCHHHHHHHHHHhhcCHHHc
Confidence 9999999999999999999999999999999999999888777778888777766654 89999999999999999999
Q ss_pred CCc-CCChHHhhcCCCcCCCChhhhh
Q 035713 411 IAY-KRGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 411 ~t~-~~~~~ell~hpff~~~~~~~~~ 435 (491)
++. ...+++|++||||++++|..+.
T Consensus 258 ~~~~~~~~~~ll~hp~f~~~~~~~~~ 283 (329)
T PTZ00263 258 LGTLKGGVADVKNHPYFHGANWDKLY 283 (329)
T ss_pred CCCCCCCHHHHhcCCccCCCCHHHHH
Confidence 973 3357999999999999999763
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=433.63 Aligned_cols=322 Identities=34% Similarity=0.616 Sum_probs=243.3
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|+++++||+|+||+||+|+++.+++.||||++.+...........+.+|+++|+.++||||++++++|.+.+.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999998765555566778889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999999998764 569999999999999999999999999999999999999999999999999986442211000
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
...... . ......... ................+.....+ ...........+||+.|+
T Consensus 159 ~~~~~~--~--~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~gt~~y~ 215 (377)
T cd05629 159 YYQKLL--Q--GKSNKNRID-------NRNSVAVDSINLTMSSKDQIATW------------KKNRRLMAYSTVGTPDYI 215 (377)
T ss_pred cccccc--c--ccccccccc-------cccccccccccccccchhhhhhh------------hhcccccccccCCCcccc
Confidence 000000 0 000000000 00000000000000000000000 000011112468999999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc--CCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG--QPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
|||++.+..++.++|||||||+||||++|++||.+.+....+..+.. ..+.+|....++.++++||.+||. +|.+|+
T Consensus 216 aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~ 294 (377)
T cd05629 216 APEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRL 294 (377)
T ss_pred CHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcC
Confidence 99999999999999999999999999999999998877776666664 345556555689999999999998 788765
Q ss_pred ---CcCCChHHhhcCCCcCCCChhhhhccCCCCCCCC
Q 035713 412 ---AYKRGATEIKQHPFFEGVNWALVRSALPPHIPEP 445 (491)
Q Consensus 412 ---t~~~~~~ell~hpff~~~~~~~~~~~~~~~~p~~ 445 (491)
+ +.++++||||.+++|+.++...+|++|..
T Consensus 295 ~r~~----~~~~l~hp~~~~~~~~~~~~~~~~~~~~~ 327 (377)
T cd05629 295 GRGG----AHEIKSHPFFRGVDWDTIRQIRAPFIPQL 327 (377)
T ss_pred CCCC----HHHHhcCCCcCCCCHHHHccCCCCcccCC
Confidence 6 99999999999999999988777777653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-55 Score=415.18 Aligned_cols=282 Identities=36% Similarity=0.698 Sum_probs=255.9
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCce
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKF 168 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~ 168 (491)
.+...+|.++.+||+|+||.|.+|..+++.+.||||++++..+...+.++-.+.|.++|.... -|++++|+.+|++-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 456789999999999999999999999999999999999988777777777788999998874 6899999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
+|+||||+.||+|...++.. ++|.|..+.+|+++|+-||-+||++|||+||||.+|||++.+|++||+|||+++.-..
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 99999999999998888775 6799999999999999999999999999999999999999999999999999853110
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
....+.++||
T Consensus 503 ----------------------------------------------------------------------~~~TTkTFCG 512 (683)
T KOG0696|consen 503 ----------------------------------------------------------------------DGVTTKTFCG 512 (683)
T ss_pred ----------------------------------------------------------------------CCcceeeecC
Confidence 1224557899
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCC
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 408 (491)
|+.|+|||++...+|+.++||||+||+|||||.|++||.|+++.+.+..|......+|.. +|.++.++++.+|.+.|.
T Consensus 513 TPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKs--lSkEAv~ickg~ltK~P~ 590 (683)
T KOG0696|consen 513 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKS--LSKEAVAICKGLLTKHPG 590 (683)
T ss_pred CCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCccc--ccHHHHHHHHHHhhcCCc
Confidence 999999999999999999999999999999999999999999999999999999999976 999999999999999999
Q ss_pred CCCCc-CCChHHhhcCCCcCCCChhhh--hccCCCCCCCC
Q 035713 409 KRIAY-KRGATEIKQHPFFEGVNWALV--RSALPPHIPEP 445 (491)
Q Consensus 409 ~R~t~-~~~~~ell~hpff~~~~~~~~--~~~~~~~~p~~ 445 (491)
+|+++ ..+-.+|..||||+.++|+.+ +...||+.|..
T Consensus 591 kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~ 630 (683)
T KOG0696|consen 591 KRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKI 630 (683)
T ss_pred cccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCcc
Confidence 99996 456789999999999999987 45677777765
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-53 Score=431.81 Aligned_cols=364 Identities=32% Similarity=0.522 Sum_probs=258.9
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
+|+++++||+|+||+||+|+++.+++.||||++.+...........+.+|+++|+.++|+||++++++|.+++.+|||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 69999999999999999999999999999999987665556667788999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+........
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 99999999998764 5699999999999999999999999999999999999999999999999999854321110000
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCC---CCC--ccccCCCCccccccccc
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGG---ALP--ELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--~~~~~~~~~~~~~~~gt 329 (491)
...+..... ....... ...+...|..+ ... ............+.+||
T Consensus 160 ---------------------~~~~~~~~~-~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 211 (382)
T cd05625 160 ---------------------YQSGDHVRQ-DSMDFSN------EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGT 211 (382)
T ss_pred ---------------------ccccccccc-ccccccc------cccccccccccccccchhhhhccccccccccccccC
Confidence 000000000 0000000 00000000000 000 00000011122356899
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC--CCcCCCCCCCCHHHHHHHHhhhccCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ--PLRFPETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~s~~~~~li~~~L~~dP 407 (491)
+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+....++.. ...+|....+++++.+||.+|+ .||
T Consensus 212 ~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p 290 (382)
T cd05625 212 PNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGP 290 (382)
T ss_pred cccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCH
Confidence 9999999999999999999999999999999999999988877777776653 3445555678999999999986 599
Q ss_pred CCCCCcCCChHHhhcCCCcCCCChhh-hhccCCCCCC---CCCCCCCCCCCchhhHHHHHHHHHHHHH--HhhccCCCCC
Q 035713 408 HKRIAYKRGATEIKQHPFFEGVNWAL-VRSALPPHIP---EPVDFSVFAGKDQASAAAEKKVVAAAEA--AVDHKNGDSP 481 (491)
Q Consensus 408 ~~R~t~~~~~~ell~hpff~~~~~~~-~~~~~~~~~p---~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 481 (491)
.+|++ +.+++++++||||+.++|.. +.+..+|.+| .+.|...|...+...............+ ..-..+...+
T Consensus 291 ~~R~~-~~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (382)
T cd05625 291 EDRLG-KNGADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFDPVDPDKLWSDDDKEGNVNDTLNGWYKNGKHP 369 (382)
T ss_pred hHcCC-CCCHHHHhcCCCcCCcChHHHHhcCCCCccCcCCCcchhhhcCCCCcccccccccccccccccccccccccccc
Confidence 99997 33489999999999999985 3444444444 3555555554432211000000000011 1113556666
Q ss_pred CCCCccccc
Q 035713 482 KDSYVEFEY 490 (491)
Q Consensus 482 ~~~~~~~~~ 490 (491)
...|+.|.|
T Consensus 370 ~~~~~~~~~ 378 (382)
T cd05625 370 EHAFYEFTF 378 (382)
T ss_pred Cccccccee
Confidence 777777776
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-54 Score=401.70 Aligned_cols=263 Identities=27% Similarity=0.372 Sum_probs=224.4
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe--CceE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET--DKFY 169 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~--~~~~ 169 (491)
.+++|+.+.+|++|+||.||+|+++.|++.||+|.++... .....-....+||.+|..++|||||.+.++... -+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 4578999999999999999999999999999999997654 334444456789999999999999999998764 3579
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|||||||+ -+|..++...+ ..|...+++.++.|++.||+|||.+.|+|||||++|+|++..|.+||+|||||+.+...
T Consensus 153 y~VMe~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 153 YIVMEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeeHHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 99999995 59999998874 57999999999999999999999999999999999999999999999999999876432
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.. ..+..+-|
T Consensus 231 ~k----------------------------------------------------------------------~~T~lVVT 240 (419)
T KOG0663|consen 231 LK----------------------------------------------------------------------PYTPLVVT 240 (419)
T ss_pred cc----------------------------------------------------------------------cCcceEEE
Confidence 11 11235889
Q ss_pred cCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CC----------------CcCCCC-
Q 035713 330 HEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QP----------------LRFPET- 388 (491)
Q Consensus 330 ~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~----------------~~~~~~- 388 (491)
.||+|||+|+|.. |+.++||||+|||+.||+++++.|.|.++.+++.+|.. .+ ..++..
T Consensus 241 LWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~p 320 (419)
T KOG0663|consen 241 LWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHP 320 (419)
T ss_pred eeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCC
Confidence 9999999999976 89999999999999999999999999999988877652 21 111111
Q ss_pred ----------CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCCh
Q 035713 389 ----------PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNW 431 (491)
Q Consensus 389 ----------~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~ 431 (491)
..+++...+|+..+|.+||.+|.| |+|.|+|.||.....
T Consensus 321 yn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~t----A~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 321 YNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRIT----AEDGLKHEYFRETPL 369 (419)
T ss_pred chhhhhhccccccchhHHHHHHHHhccCcccccc----HHHhhcccccccCCC
Confidence 126688999999999999999999 999999999986543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-54 Score=399.29 Aligned_cols=284 Identities=37% Similarity=0.738 Sum_probs=251.5
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeC
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETD 166 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~ 166 (491)
.+.+++++|.++++||+|+|++|.++++++|.+.||+|+++|......+.+..++.|..+.... +||++|-|+.+|+++
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 3457889999999999999999999999999999999999999888888999999999998776 699999999999999
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
..+++|.||++||+|.-.++++ +.++++.+++|..+|+.||.|||++|||+||||.+|+||+..|++||+|+|+++.-
T Consensus 324 srlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred ceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999999998777776 66999999999999999999999999999999999999999999999999997531
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
. .....+.++
T Consensus 402 l----------------------------------------------------------------------~~gd~tstf 411 (593)
T KOG0695|consen 402 L----------------------------------------------------------------------GPGDTTSTF 411 (593)
T ss_pred C----------------------------------------------------------------------CCCcccccc
Confidence 1 012234578
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCC-------CCCcHHHHHH-HHcCCCcCCCCCCCCHHHHHH
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFK-------GQGNRATLFN-VVGQPLRFPETPQVSFVARDL 398 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~-------~~~~~~~~~~-i~~~~~~~~~~~~~s~~~~~l 398 (491)
|||+.|+|||+++|..|+..+|||+|||+++||+.|+.||. ..+.++.+++ |+...+++|.. ++-.+..+
T Consensus 412 cgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs--lsvkas~v 489 (593)
T KOG0695|consen 412 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS--LSVKASHV 489 (593)
T ss_pred cCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce--eehhhHHH
Confidence 99999999999999999999999999999999999999995 2333445544 56778888875 78888899
Q ss_pred HHhhhccCCCCCCCcC--CChHHhhcCCCcCCCChhhhh--ccCCCCCCCC
Q 035713 399 IRGLLVKEPHKRIAYK--RGATEIKQHPFFEGVNWALVR--SALPPHIPEP 445 (491)
Q Consensus 399 i~~~L~~dP~~R~t~~--~~~~ell~hpff~~~~~~~~~--~~~~~~~p~~ 445 (491)
++..|.+||.+|+++. .+..++..|+||+.++|+.+. +.+||+-|..
T Consensus 490 lkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i 540 (593)
T KOG0695|consen 490 LKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQI 540 (593)
T ss_pred HHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCcc
Confidence 9999999999999974 589999999999999999884 5678887764
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-53 Score=415.39 Aligned_cols=265 Identities=38% Similarity=0.711 Sum_probs=235.6
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++++.||+|+||.||+|+++.+++.||||++.............+.+|+++|+.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999998665544455667889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~----- 153 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD----- 153 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----
Confidence 999999999998764 5699999999999999999999999999999999999999999999999999853210
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
...+.+||+.|+
T Consensus 154 --------------------------------------------------------------------~~~~~~gt~~y~ 165 (291)
T cd05612 154 --------------------------------------------------------------------RTWTLCGTPEYL 165 (291)
T ss_pred --------------------------------------------------------------------CcccccCChhhc
Confidence 011247999999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCC-
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIA- 412 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t- 412 (491)
|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+......++.. ++..+++||++||+.||.+|++
T Consensus 166 aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~li~~~l~~dp~~R~~~ 243 (291)
T cd05612 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH--LDLYAKDLIKKLLVVDRTRRLGN 243 (291)
T ss_pred CHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCcc--CCHHHHHHHHHHcCCCHHHccCC
Confidence 9999999999999999999999999999999999988877788888777776654 7899999999999999999995
Q ss_pred cCCChHHhhcCCCcCCCChhhhh
Q 035713 413 YKRGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 413 ~~~~~~ell~hpff~~~~~~~~~ 435 (491)
+...++++++||||..++|..+.
T Consensus 244 ~~~~~~~~l~h~~~~~~~~~~~~ 266 (291)
T cd05612 244 MKNGADDVKNHRWFKSVDWDDVP 266 (291)
T ss_pred ccCCHHHHhcCccccCCCHHHHh
Confidence 23349999999999999998763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-55 Score=393.97 Aligned_cols=260 Identities=30% Similarity=0.510 Sum_probs=231.8
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.+.|++.+.||+|.|++|+++.+..+|+.+|+|+|+...+... ..+.+.+|++|.+.|+|||||+|++.+...+..|||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3689999999999999999999999999999999987766654 667788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc---CCcEEEeecccccccCCC
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD---EGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~---~g~vkL~DFGla~~~~~~ 249 (491)
+|+|.|++|..-+-.. -.++|..+-.+++||+.||.|+|.+||||||+||+|+|+-. ..-+||+|||+|..+...
T Consensus 89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 9999999997544332 45899999999999999999999999999999999999953 346999999999654311
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
. -...++||
T Consensus 167 ~-----------------------------------------------------------------------~~~G~~Gt 175 (355)
T KOG0033|consen 167 E-----------------------------------------------------------------------AWHGFAGT 175 (355)
T ss_pred c-----------------------------------------------------------------------ccccccCC
Confidence 0 00125899
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCC--CCCCCCHHHHHHHHhhhccCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP--ETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~~~~li~~~L~~dP 407 (491)
|+|||||++...+|+..+|||+.|||||-||.|++||.+.+....+++|..+.+.++ .++.+++++++||++||..||
T Consensus 176 P~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP 255 (355)
T KOG0033|consen 176 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNP 255 (355)
T ss_pred CcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccCh
Confidence 999999999999999999999999999999999999999999999999999887765 468899999999999999999
Q ss_pred CCCCCcCCChHHhhcCCCcCCCC
Q 035713 408 HKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 408 ~~R~t~~~~~~ell~hpff~~~~ 430 (491)
.+|+| +.|+|+|||+.+.+
T Consensus 256 ~kRIt----a~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 256 KKRIT----ADEALKHPWICNRE 274 (355)
T ss_pred hhhcc----HHHHhCCchhcchH
Confidence 99999 99999999998654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-53 Score=419.14 Aligned_cols=262 Identities=38% Similarity=0.712 Sum_probs=229.1
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccCCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGG 179 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~gg 179 (491)
+.||+|+||.||+|+++.+|+.||||++.+...........+.+|+++|+.++||||++++++|...+.+||||||++|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765555566667889999999999999999999999999999999999999
Q ss_pred chHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccccccc
Q 035713 180 NLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVS 259 (491)
Q Consensus 180 ~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 259 (491)
+|..++... +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~---------- 148 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD---------- 148 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC----------
Confidence 999888764 56999999999999999999999999999999999999999999999999998532100
Q ss_pred ccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhc
Q 035713 260 VNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIR 339 (491)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 339 (491)
.......+||+.|+|||++.
T Consensus 149 ------------------------------------------------------------~~~~~~~~gt~~y~aPE~~~ 168 (323)
T cd05571 149 ------------------------------------------------------------GATMKTFCGTPEYLAPEVLE 168 (323)
T ss_pred ------------------------------------------------------------CCcccceecCccccChhhhc
Confidence 00112357999999999999
Q ss_pred CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcC-CChH
Q 035713 340 GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK-RGAT 418 (491)
Q Consensus 340 ~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~-~~~~ 418 (491)
+..++.++|||||||++|||++|+.||.+.+....+..+......++. .++.++.+||.+||+.||++|++.. ..+.
T Consensus 169 ~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 246 (323)
T cd05571 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPEDAK 246 (323)
T ss_pred CCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHccCCHHHcCCCCCCCHH
Confidence 999999999999999999999999999988777777777777776665 4899999999999999999999311 1299
Q ss_pred HhhcCCCcCCCChhhhh
Q 035713 419 EIKQHPFFEGVNWALVR 435 (491)
Q Consensus 419 ell~hpff~~~~~~~~~ 435 (491)
+|++||||++++|..+.
T Consensus 247 ~ll~h~~f~~~~~~~~~ 263 (323)
T cd05571 247 EIMEHRFFASINWQDVV 263 (323)
T ss_pred HHHcCCCcCCCCHHHHH
Confidence 99999999999998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-52 Score=410.67 Aligned_cols=278 Identities=34% Similarity=0.596 Sum_probs=233.0
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
.|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+++|+.++|+||+++++++.+++.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999987655544445567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|+++|+|..++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC----
Confidence 9999999988765544569999999999999999999999999999999999999999999999999985421100
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
.....+||..|+|
T Consensus 157 -------------------------------------------------------------------~~~~~~g~~~y~a 169 (285)
T cd05631 157 -------------------------------------------------------------------TVRGRVGTVGYMA 169 (285)
T ss_pred -------------------------------------------------------------------eecCCCCCCCccC
Confidence 0112378999999
Q ss_pred cchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHH----HHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 335 PEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLF----NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 335 PE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
||++.+..++.++|||||||++|||++|+.||.+........ .+......++ ..++.++.+||.+||+.||.+|
T Consensus 170 PE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~l~~~P~~R 247 (285)
T cd05631 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYS--EKFSEDAKSICRMLLTKNPKER 247 (285)
T ss_pred HhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCC--ccCCHHHHHHHHHHhhcCHHHh
Confidence 999999999999999999999999999999998765432222 2222222333 3589999999999999999999
Q ss_pred CCcC-CChHHhhcCCCcCCCChhhhhcc--CCCCCCCC
Q 035713 411 IAYK-RGATEIKQHPFFEGVNWALVRSA--LPPHIPEP 445 (491)
Q Consensus 411 ~t~~-~~~~ell~hpff~~~~~~~~~~~--~~~~~p~~ 445 (491)
++.+ ..++++++||||++++|..+... .||+.|.+
T Consensus 248 ~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05631 248 LGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPDP 285 (285)
T ss_pred cCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCCC
Confidence 9753 24899999999999999988654 56666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=420.02 Aligned_cols=277 Identities=34% Similarity=0.705 Sum_probs=240.0
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCC-cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTN-TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
+..++|++++.||+|+||.||+|+++.++ ..||+|++.+...........+.+|+++|+.++||||+++++++.+++.+
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 45688999999999999999999987665 68999999876555556667788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence 9999999999999998874 4699999999999999999999999999999999999999999999999999853210
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
...+.+||
T Consensus 184 ------------------------------------------------------------------------~~~~~~gt 191 (340)
T PTZ00426 184 ------------------------------------------------------------------------RTYTLCGT 191 (340)
T ss_pred ------------------------------------------------------------------------CcceecCC
Confidence 01134799
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+......+|. .++..+.+||++||+.||++
T Consensus 192 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~l~~dp~~ 269 (340)
T PTZ00426 192 PEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK--FLDNNCKHLMKKLLSHDLTK 269 (340)
T ss_pred hhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHcccCHHH
Confidence 9999999999988999999999999999999999999988877777788877766665 48999999999999999999
Q ss_pred CCCc-CCChHHhhcCCCcCCCChhhhh--ccCCCCCCC
Q 035713 410 RIAY-KRGATEIKQHPFFEGVNWALVR--SALPPHIPE 444 (491)
Q Consensus 410 R~t~-~~~~~ell~hpff~~~~~~~~~--~~~~~~~p~ 444 (491)
|++. ...++++++||||.+++|..+. ...+|..|.
T Consensus 270 R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~ 307 (340)
T PTZ00426 270 RYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPK 307 (340)
T ss_pred cCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence 9732 2239999999999999998653 334455554
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-53 Score=425.42 Aligned_cols=315 Identities=34% Similarity=0.646 Sum_probs=242.9
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+++|+.++||||++++++|.+++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765555566677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+.||+|.+++... +.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+.......
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999999998764 469999999999999999999999999999999999999999999999999986543211000
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
..... ... ................... ..+.........+.+||+.|+
T Consensus 159 ~~~~~--------------~~~------~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~gt~~y~ 206 (364)
T cd05599 159 FYRIL--------------SHA------LPSNFLDFISKPMSSKRKA------------ETWKRNRRALAYSTVGTPDYI 206 (364)
T ss_pred ccccc--------------ccc------ccccccccccccccccccc------------cchhhcccccccccccCcccc
Confidence 00000 000 0000000000000000000 000000111223458999999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC--CCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ--PLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
|||++.+..++.++|||||||++|||++|+.||.+.+....+..++.. .+.++....+++++++||.+||. +|.+|+
T Consensus 207 aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~ 285 (364)
T cd05599 207 APEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRL 285 (364)
T ss_pred CHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcC
Confidence 999999999999999999999999999999999988877777776643 34455555689999999999997 999999
Q ss_pred CcCCChHHhhcCCCcCCCChhhhhccCCCCCCC
Q 035713 412 AYKRGATEIKQHPFFEGVNWALVRSALPPHIPE 444 (491)
Q Consensus 412 t~~~~~~ell~hpff~~~~~~~~~~~~~~~~p~ 444 (491)
+. ..+.++++||||++++|..++...++.+|.
T Consensus 286 ~~-~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~ 317 (364)
T cd05599 286 GN-NGVNEIKSHPFFKGVDWEHIRERPAPIIPE 317 (364)
T ss_pred CC-CCHHHHhcCCCcCCCCHHHHhhcCCCCCCC
Confidence 63 239999999999999999887666665553
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-53 Score=406.12 Aligned_cols=273 Identities=30% Similarity=0.437 Sum_probs=236.0
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
.+++..++|++..+||.|..++||+|++..++++||||+++...+... +..+++|++.|+.++||||++++..|..+.
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 345567899999999999999999999999999999999998766543 778899999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+|+||.||.+|++.++++..-...|+|..+..++++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+.
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999999999998766779999999999999999999999999999999999999999999999999874432
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
.... ....+..+++
T Consensus 178 ~~G~------------------------------------------------------------------R~~~rf~tfv 191 (516)
T KOG0582|consen 178 DSGD------------------------------------------------------------------RQVTRFNTFV 191 (516)
T ss_pred ccCc------------------------------------------------------------------eeeEeecccc
Confidence 1100 0011225789
Q ss_pred cccCccCcchhcC--CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCC--------CCCCCCHHHHH
Q 035713 328 GTHEYLAPEIIRG--EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP--------ETPQVSFVARD 397 (491)
Q Consensus 328 gt~~y~aPE~l~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--------~~~~~s~~~~~ 397 (491)
||+.|||||++.. .+|+.++||||||++..||.+|..||........+..-++..+..+ ....++..++.
T Consensus 192 gtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e 271 (516)
T KOG0582|consen 192 GTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFRE 271 (516)
T ss_pred CcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHH
Confidence 9999999999654 4589999999999999999999999998888777766665554322 22456778999
Q ss_pred HHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 398 LIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 398 li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
+|..||++||.+||| ++++|+|+||+...-.
T Consensus 272 ~i~~CL~kDP~kRpt----AskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 272 MIALCLVKDPSKRPT----ASKLLKHAFFKKAKSK 302 (516)
T ss_pred HHHHHhhcCcccCCC----HHHHhccHHHhhccch
Confidence 999999999999999 9999999999876543
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-52 Score=421.95 Aligned_cols=344 Identities=36% Similarity=0.638 Sum_probs=262.0
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++++.||+|+||+||+|++..+++.||||++++...........+.+|+++|+.++|+||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998766555566677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..........
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999999998875 569999999999999999999999999999999999999999999999999986553221100
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
........... ... ... ...............+||+.|+
T Consensus 159 ~~~~~~~~~~~----------------------~~~-----------------~~~--~~~~~~~~~~~~~~~~gt~~y~ 197 (350)
T cd05573 159 YYLNDSHNLLF----------------------RDN-----------------VLV--RRRDHKQRRVRANSTVGTPDYI 197 (350)
T ss_pred ccccccccccc----------------------ccc-----------------ccc--cccccccccccccccccCcccc
Confidence 00000000000 000 000 0000000011223457999999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc--CCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG--QPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
|||++.+..++.++|||||||+||||++|+.||.+.+......++.. ....+|....+++++.+||.+||. ||.+|+
T Consensus 198 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~ 276 (350)
T cd05573 198 APEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRL 276 (350)
T ss_pred CHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcC
Confidence 99999999999999999999999999999999998887777777776 556666666689999999999998 999999
Q ss_pred CcCCChHHhhcCCCcCCCChhhhhccCCCCCCC---CCCCCCCCCCchhhHHHHHHHHHHHHHHhhccCCCCCCCCCccc
Q 035713 412 AYKRGATEIKQHPFFEGVNWALVRSALPPHIPE---PVDFSVFAGKDQASAAAEKKVVAAAEAAVDHKNGDSPKDSYVEF 488 (491)
Q Consensus 412 t~~~~~~ell~hpff~~~~~~~~~~~~~~~~p~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 488 (491)
+. ++++++||||+.++|.......++.+|. +.+...|...+........ ......+..+.....|++|
T Consensus 277 ~s---~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 347 (350)
T cd05573 277 GS---FEEIKSHPFFKGIDWENLRETKPPFVPELSSPLDTSNFDDFEDDKDLSDY------LSQNSKKLNKGKQLAFVGF 347 (350)
T ss_pred CC---HHHHhcCCCcCCCCHHHHhhCCCCcCCCCCCchhhhhcCCCCcccccccc------cccccccccccccCccCCC
Confidence 85 8999999999999999877666666553 2222233332222111110 1111234455667788888
Q ss_pred cc
Q 035713 489 EY 490 (491)
Q Consensus 489 ~~ 490 (491)
+|
T Consensus 348 ~~ 349 (350)
T cd05573 348 TY 349 (350)
T ss_pred cc
Confidence 87
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-52 Score=417.35 Aligned_cols=318 Identities=34% Similarity=0.611 Sum_probs=255.5
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++.+.||+|+||+||+|+++.+++.||||++++...........+.+|+.+++.++|+||+++++++.+.+.+||||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765545556677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-- 157 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-- 157 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc--
Confidence 999999999998875 24699999999999999999999999999999999999999999999999999854321110
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
......+||+.|+
T Consensus 158 -------------------------------------------------------------------~~~~~~~gt~~y~ 170 (330)
T cd05601 158 -------------------------------------------------------------------VNSKLPVGTPDYI 170 (330)
T ss_pred -------------------------------------------------------------------eeeecccCCcccc
Confidence 0011237899999
Q ss_pred Ccchhc------CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC--CCcCCCCCCCCHHHHHHHHhhhcc
Q 035713 334 APEIIR------GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ--PLRFPETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 334 aPE~l~------~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~s~~~~~li~~~L~~ 405 (491)
|||++. +..++.++|||||||++|||++|+.||.+.+....+.+++.. ...++....++.++.+||.+||+
T Consensus 171 aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~- 249 (330)
T cd05601 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC- 249 (330)
T ss_pred CHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-
Confidence 999997 455789999999999999999999999988777777777643 24556656789999999999998
Q ss_pred CCCCCCCcCCChHHhhcCCCcCCCChhhhhccCCCCCCCC---CCCCCCCCCchhhHHHHHHHHHHHHHHhhccCCCCCC
Q 035713 406 EPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEP---VDFSVFAGKDQASAAAEKKVVAAAEAAVDHKNGDSPK 482 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~hpff~~~~~~~~~~~~~~~~p~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (491)
||.+|++ ++++++||||+.++|..++...|+..|.. .|...|......+..... .......+..-....
T Consensus 250 ~p~~R~t----~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 321 (330)
T cd05601 250 GQKERLG----YEGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDTSNFDEPEKNSTRRSQ----SSTTQLKPNGFSGKD 321 (330)
T ss_pred ChhhCCC----HHHHhCCCCcCCCCHHHHhhCCCCccCcCCCcchhhhcCCCccccccccc----cccccCCCcCCCCCC
Confidence 9999999 99999999999999998887766665532 223333332222211111 111222333445566
Q ss_pred CCCccccc
Q 035713 483 DSYVEFEY 490 (491)
Q Consensus 483 ~~~~~~~~ 490 (491)
.++|.|.|
T Consensus 322 ~~~~~~~~ 329 (330)
T cd05601 322 LPFVGFSF 329 (330)
T ss_pred CCccCcee
Confidence 78888766
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-54 Score=405.42 Aligned_cols=256 Identities=31% Similarity=0.545 Sum_probs=237.8
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
.+|++.+.||+|+||.|.+|+.+..|+.||||.|+|..+.++..+-++++|++||..|+||||+.+|++|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 57999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||..+|.|++|+... +.|++.+++.+++||+.|+.|||.++++|||||.+|||+|.++.+||+||||+-.+..
T Consensus 133 EYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~----- 205 (668)
T KOG0611|consen 133 EYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD----- 205 (668)
T ss_pred EecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc-----
Confidence 999999999999885 6799999999999999999999999999999999999999999999999999844321
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
....++|||++.|.
T Consensus 206 ------------------------------------------------------------------~kfLqTFCGSPLYA 219 (668)
T KOG0611|consen 206 ------------------------------------------------------------------KKFLQTFCGSPLYA 219 (668)
T ss_pred ------------------------------------------------------------------ccHHHHhcCCcccC
Confidence 11334789999999
Q ss_pred CcchhcCCCC-CCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCC
Q 035713 334 APEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIA 412 (491)
Q Consensus 334 aPE~l~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 412 (491)
+||++.|.+| ++.+|-|||||+||.|+.|.+||+|.+....+.+|..+.+.-|. -+.++.-||+.||-.||++|.|
T Consensus 220 SPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~---~PSdA~gLIRwmLmVNP~RRAT 296 (668)
T KOG0611|consen 220 SPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE---TPSDASGLIRWMLMVNPERRAT 296 (668)
T ss_pred CccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC---CCchHHHHHHHHHhcCcccchh
Confidence 9999999999 89999999999999999999999999999888999888877665 4678899999999999999999
Q ss_pred cCCChHHhhcCCCcCCCChh
Q 035713 413 YKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 413 ~~~~~~ell~hpff~~~~~~ 432 (491)
+++|-.|-|. ||.
T Consensus 297 ----ieDiAsHWWv---Nwg 309 (668)
T KOG0611|consen 297 ----IEDIASHWWV---NWG 309 (668)
T ss_pred ----HHHHhhhhee---ecc
Confidence 9999999885 565
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=416.99 Aligned_cols=262 Identities=39% Similarity=0.727 Sum_probs=227.9
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccCCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGG 179 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~gg 179 (491)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|+++|+.++||||+++++++..++.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765555566677889999999999999999999999999999999999999
Q ss_pred chHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccccccc
Q 035713 180 NLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVS 259 (491)
Q Consensus 180 ~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 259 (491)
+|..++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--------- 149 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--------- 149 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc---------
Confidence 999888764 569999999999999999999999999999999999999999999999999985321000
Q ss_pred ccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhc
Q 035713 260 VNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIR 339 (491)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 339 (491)
......+||+.|+|||++.
T Consensus 150 -------------------------------------------------------------~~~~~~~gt~~y~aPE~~~ 168 (328)
T cd05593 150 -------------------------------------------------------------ATMKTFCGTPEYLAPEVLE 168 (328)
T ss_pred -------------------------------------------------------------cccccccCCcCccChhhhc
Confidence 0111347999999999999
Q ss_pred CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcC-CChH
Q 035713 340 GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK-RGAT 418 (491)
Q Consensus 340 ~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~-~~~~ 418 (491)
+..++.++|||||||++|+|++|+.||.+.+.......+......+|. .++.++.+||.+||+.||.+|++.. ..+.
T Consensus 169 ~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 246 (328)
T cd05593 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR--TLSADAKSLLSGLLIKDPNKRLGGGPDDAK 246 (328)
T ss_pred CCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCC--CCCHHHHHHHHHHcCCCHHHcCCCCCCCHH
Confidence 999999999999999999999999999988777777777766666665 4899999999999999999998311 1299
Q ss_pred HhhcCCCcCCCChhhhh
Q 035713 419 EIKQHPFFEGVNWALVR 435 (491)
Q Consensus 419 ell~hpff~~~~~~~~~ 435 (491)
++++||||.+++|..+.
T Consensus 247 ~il~h~~~~~~~~~~~~ 263 (328)
T cd05593 247 EIMRHSFFTGVNWQDVY 263 (328)
T ss_pred HHhcCCCcCCCCHHHHH
Confidence 99999999999998663
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-52 Score=425.38 Aligned_cols=307 Identities=34% Similarity=0.576 Sum_probs=234.4
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+++|+.++|+||+++++.|.+++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765555556677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+.......
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999999999998764 569999999999999999999999999999999999999999999999999985432110000
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCC-ccccCCCCccccccccccCc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALP-ELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~gt~~y 332 (491)
.. .. ..... ........ .......+...... ............+++||+.|
T Consensus 159 ~~-----~~----~~~~~------~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 210 (376)
T cd05598 159 YY-----QK----GDHHR------QDSMEPSE-------------EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNY 210 (376)
T ss_pred cc-----cc----ccccc------cccccccc-------------cccccccccccchhhhhhhhcccccccccCCCccc
Confidence 00 00 00000 00000000 00000000000000 00000011122356899999
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC--CCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ--PLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
||||++.+..++.++|||||||++|||++|+.||.+.+..+....+... ...++....++.++.+||.+|+ .+|.+|
T Consensus 211 ~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R 289 (376)
T cd05598 211 IAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDR 289 (376)
T ss_pred cCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhc
Confidence 9999999999999999999999999999999999988877766666543 3344444568999999999976 599999
Q ss_pred C---CcCCChHHhhcCCCcCCCChhhhh
Q 035713 411 I---AYKRGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 411 ~---t~~~~~~ell~hpff~~~~~~~~~ 435 (491)
+ + +.++++||||++++|..+.
T Consensus 290 ~~~~t----~~ell~h~~~~~~~~~~~~ 313 (376)
T cd05598 290 LGKNG----ADEIKAHPFFKGIDFASLI 313 (376)
T ss_pred CCCCC----HHHHhCCCCcCCCCHHHHh
Confidence 9 6 9999999999999998773
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-53 Score=404.55 Aligned_cols=261 Identities=30% Similarity=0.471 Sum_probs=218.6
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc--eEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK--FYCL 171 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~--~~~l 171 (491)
.+|...+.||+|+||.||++.++.+|..+|||.+..... ...+.+.+|+++|++++|||||++++...... .++|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 468889999999999999999999999999999876521 12566789999999999999999999754443 7999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc-CCcEEEeecccccccCCCC
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD-EGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~-~g~vkL~DFGla~~~~~~~ 250 (491)
.|||++||+|.+++....+ .|++..++.|.+||+.||.|||++|||||||||+||||+. +|.+||+|||+++......
T Consensus 94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999998755 7999999999999999999999999999999999999999 7999999999986543200
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
. .......+.||+
T Consensus 173 ~-------------------------------------------------------------------~~~~~~~~~Gtp 185 (313)
T KOG0198|consen 173 T-------------------------------------------------------------------KSDSELSVQGTP 185 (313)
T ss_pred c-------------------------------------------------------------------cccccccccCCc
Confidence 0 001122468999
Q ss_pred CccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCC-CCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCC
Q 035713 331 EYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKG-QGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 331 ~y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 408 (491)
.|||||++... ....++|||||||++.||+||+.||.. ......+..+.......+....++.++++||.+||++||+
T Consensus 186 ~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~ 265 (313)
T KOG0198|consen 186 NYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPE 265 (313)
T ss_pred cccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcc
Confidence 99999999963 234599999999999999999999987 4555556666655422233345999999999999999999
Q ss_pred CCCCcCCChHHhhcCCCcCCC
Q 035713 409 KRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 409 ~R~t~~~~~~ell~hpff~~~ 429 (491)
+||| |+++|.|||.+..
T Consensus 266 ~Rpt----a~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 266 KRPT----AEELLEHPFLKQN 282 (313)
T ss_pred cCcC----HHHHhhChhhhcc
Confidence 9999 9999999999753
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-52 Score=420.51 Aligned_cols=282 Identities=33% Similarity=0.647 Sum_probs=240.1
Q ss_pred CCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 87 RGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 87 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
....+..++|+++++||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+|+.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 34456678999999999999999999999999999999999876544445555677899999999999999999999999
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
+.+|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999999998875 35899999999999999999999999999999999999999999999999998543
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.... .....+.
T Consensus 193 ~~~~---------------------------------------------------------------------~~~~~~~ 203 (370)
T cd05596 193 DANG---------------------------------------------------------------------MVRCDTA 203 (370)
T ss_pred cCCC---------------------------------------------------------------------cccCCCC
Confidence 2100 0011234
Q ss_pred ccccCccCcchhcCC----CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC--CcCCCCCCCCHHHHHHHH
Q 035713 327 VGTHEYLAPEIIRGE----GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP--LRFPETPQVSFVARDLIR 400 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~----~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~s~~~~~li~ 400 (491)
+||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.+....+.++.... +.++....++.++++||.
T Consensus 204 ~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 283 (370)
T cd05596 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLIC 283 (370)
T ss_pred CCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHH
Confidence 799999999999764 37889999999999999999999999988877777777543 556665578999999999
Q ss_pred hhhccCCCC--CCCcCCChHHhhcCCCcCCCChhh--hhccCCCCCCC
Q 035713 401 GLLVKEPHK--RIAYKRGATEIKQHPFFEGVNWAL--VRSALPPHIPE 444 (491)
Q Consensus 401 ~~L~~dP~~--R~t~~~~~~ell~hpff~~~~~~~--~~~~~~~~~p~ 444 (491)
+||..+|.+ |++ ++++++||||++.+|.. ++...+|.+|.
T Consensus 284 ~~L~~~p~r~~R~s----~~ell~h~~~~~~~~~~~~~~~~~~~~~p~ 327 (370)
T cd05596 284 AFLTDREVRLGRNG----VDEIKSHPFFKNDQWTFDNIRETVAPVVPE 327 (370)
T ss_pred HHccChhhccCCCC----HHHHhcCcccCCCChhhHHhcCCCcCccCc
Confidence 999999988 999 99999999999998874 45555666554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-52 Score=412.96 Aligned_cols=272 Identities=37% Similarity=0.633 Sum_probs=237.2
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+++|+.++||||+++++++...+.+||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765555556677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence 999999999999764 5699999999999999999999999999999999999999999999999999853211
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.....+||+.|+
T Consensus 154 --------------------------------------------------------------------~~~~~~gt~~y~ 165 (333)
T cd05600 154 --------------------------------------------------------------------YANSVVGSPDYM 165 (333)
T ss_pred --------------------------------------------------------------------ccCCcccCcccc
Confidence 011347999999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC--CcCCCC----CCCCHHHHHHHHhhhccCC
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP--LRFPET----PQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~----~~~s~~~~~li~~~L~~dP 407 (491)
|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+.... +..+.. ..++.++.+||.+||..+|
T Consensus 166 aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~ 245 (333)
T cd05600 166 APEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPS 245 (333)
T ss_pred ChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChh
Confidence 9999999999999999999999999999999999887766665554322 222222 2568999999999999999
Q ss_pred CCCCCcCCChHHhhcCCCcCCCChhhhhccCCCCCCC
Q 035713 408 HKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE 444 (491)
Q Consensus 408 ~~R~t~~~~~~ell~hpff~~~~~~~~~~~~~~~~p~ 444 (491)
.+|++ ++++++||||..++|..++...|+.+|.
T Consensus 246 ~rr~s----~~~ll~h~~~~~~~~~~~~~~~~~~~~~ 278 (333)
T cd05600 246 RRFGS----LEDIKNHPFFKEVDWNELRELKPPFVPE 278 (333)
T ss_pred hhcCC----HHHHHhCcccCCCCHHHHhhCCCCCCCC
Confidence 99999 9999999999999999888666766665
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-52 Score=417.68 Aligned_cols=305 Identities=33% Similarity=0.602 Sum_probs=239.0
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++++.||+|+||.||+|+++.+++.||||++.+...........+.+|+.++..++|+||++++++|.+++.+||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765555566778889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+.......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999999998764 569999999999999999999999999999999999999999999999999986543211000
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
....... ..+..........+ ...............+.+||+.|+
T Consensus 159 ~~~~~~~--------------------~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~gt~~Y~ 203 (360)
T cd05627 159 FYRNLTH--------------------NPPSDFSFQNMNSK---------------RKAETWKKNRRQLAYSTVGTPDYI 203 (360)
T ss_pred ccccccc--------------------CCcccccccccccc---------------cccccccccccccccccCCCcccc
Confidence 0000000 00000000000000 000000111112233568999999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc--CCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG--QPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
|||++.+..++.++|||||||++|||++|+.||.+.+....+.+++. ..+.+|....++.++++||.+|+. ||.+|+
T Consensus 204 APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~ 282 (360)
T cd05627 204 APEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRI 282 (360)
T ss_pred CHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcC
Confidence 99999999999999999999999999999999998888777777765 334555555689999999999874 999999
Q ss_pred CcCCChHHhhcCCCcCCCChhhhhcc
Q 035713 412 AYKRGATEIKQHPFFEGVNWALVRSA 437 (491)
Q Consensus 412 t~~~~~~ell~hpff~~~~~~~~~~~ 437 (491)
+. .+++++++||||++++|..+...
T Consensus 283 ~~-~~~~ei~~hp~f~~~~~~~~~~~ 307 (360)
T cd05627 283 GS-NGVEEIKSHPFFEGVDWGHIRER 307 (360)
T ss_pred CC-CCHHHHhcCCCCCCCCHHHHhcC
Confidence 62 23899999999999999988644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-53 Score=419.04 Aligned_cols=255 Identities=27% Similarity=0.479 Sum_probs=227.9
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
...|....+||+|+.|.||.|+...+++.||||.+........ +-+.+|+.+|+..+|+|||.+++.|..++.+|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k---eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK---ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch---hhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 4579999999999999999999999999999999987654433 3457899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
||||+||+|.+++... .++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+..
T Consensus 349 MEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~---- 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE---- 421 (550)
T ss_pred EeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc----
Confidence 9999999999998874 499999999999999999999999999999999999999999999999999854321
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......+++||++|
T Consensus 422 ------------------------------------------------------------------~~~KR~TmVGTPYW 435 (550)
T KOG0578|consen 422 ------------------------------------------------------------------EQSKRSTMVGTPYW 435 (550)
T ss_pred ------------------------------------------------------------------ccCccccccCCCCc
Confidence 11133467999999
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHH-cCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV-GQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
||||++....|++++||||||++++||+-|.+||..++....+..|- ++.+.+.....+|.+++|||.+||+.|+++|+
T Consensus 436 MAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~Ra 515 (550)
T KOG0578|consen 436 MAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRA 515 (550)
T ss_pred cchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCC
Confidence 99999999999999999999999999999999999877776666665 45566666678999999999999999999999
Q ss_pred CcCCChHHhhcCCCcC
Q 035713 412 AYKRGATEIKQHPFFE 427 (491)
Q Consensus 412 t~~~~~~ell~hpff~ 427 (491)
+ |.|||+||||+
T Consensus 516 s----A~eLL~HpFl~ 527 (550)
T KOG0578|consen 516 S----AKELLEHPFLK 527 (550)
T ss_pred C----HHHHhcChhhh
Confidence 9 99999999995
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-52 Score=415.89 Aligned_cols=262 Identities=38% Similarity=0.704 Sum_probs=228.2
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccCCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGG 179 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~gg 179 (491)
+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+++++.++||||++++++|...+.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765555556667788999999999999999999999999999999999999
Q ss_pred chHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccccccc
Q 035713 180 NLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVS 259 (491)
Q Consensus 180 ~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 259 (491)
+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--------- 149 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------- 149 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC---------
Confidence 999888764 569999999999999999999999999999999999999999999999999874321000
Q ss_pred ccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhc
Q 035713 260 VNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIR 339 (491)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 339 (491)
......+||+.|+|||++.
T Consensus 150 -------------------------------------------------------------~~~~~~~gt~~y~aPE~~~ 168 (323)
T cd05595 150 -------------------------------------------------------------ATMKTFCGTPEYLAPEVLE 168 (323)
T ss_pred -------------------------------------------------------------CccccccCCcCcCCccccc
Confidence 0011247999999999999
Q ss_pred CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcC-CChH
Q 035713 340 GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK-RGAT 418 (491)
Q Consensus 340 ~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~-~~~~ 418 (491)
+..++.++|||||||++|||++|+.||.+.+.......+......+|. .+++++.+||.+||..||.+|++.. ..+.
T Consensus 169 ~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 246 (323)
T cd05595 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAK 246 (323)
T ss_pred CCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHccCCHHHhCCCCCCCHH
Confidence 999999999999999999999999999988777777777777776665 4899999999999999999998311 1299
Q ss_pred HhhcCCCcCCCChhhhh
Q 035713 419 EIKQHPFFEGVNWALVR 435 (491)
Q Consensus 419 ell~hpff~~~~~~~~~ 435 (491)
++++||||.+++|..+.
T Consensus 247 ~~l~h~~~~~~~~~~~~ 263 (323)
T cd05595 247 EVMEHRFFLSINWQDVV 263 (323)
T ss_pred HHHcCCCcCCCCHHHHH
Confidence 99999999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-53 Score=398.13 Aligned_cols=261 Identities=28% Similarity=0.438 Sum_probs=223.1
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe-----Cce
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET-----DKF 168 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~-----~~~ 168 (491)
..|..++.||+|+||.|+.|.++.+|+.||||.|.. .+.+....++..+|+.+|+.++|+||+.+++++.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 557778999999999999999999999999998853 35667778889999999999999999999999965 357
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
+|+|+|+| +-+|..+++.+ ..|++..++.+++||++||.|+|+.+|+||||||.|+|++.++.+||||||||+....
T Consensus 101 vYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred eEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 99999999 78999999875 4499999999999999999999999999999999999999999999999999976532
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
.+ ....-+.++.
T Consensus 178 ~~--------------------------------------------------------------------~~~~mTeYVa 189 (359)
T KOG0660|consen 178 FF--------------------------------------------------------------------EDGFMTEYVA 189 (359)
T ss_pred cC--------------------------------------------------------------------cccchhccee
Confidence 10 0111234689
Q ss_pred ccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CC--------------------Cc
Q 035713 329 THEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QP--------------------LR 384 (491)
Q Consensus 329 t~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~--------------------~~ 384 (491)
|.||+|||++.. ..|+.++||||+||||.||++|++.|.|.+..+++..|+. .+ ..
T Consensus 190 TRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~ 269 (359)
T KOG0660|consen 190 TRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQ 269 (359)
T ss_pred eeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCC
Confidence 999999999876 4589999999999999999999999999988777765542 11 11
Q ss_pred CCC------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 385 FPE------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 385 ~~~------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
.|. .+++++++.||+.+||..||.+|+| ++|+|+||||+...
T Consensus 270 ~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit----a~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 270 IPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT----AEEALAHPYLAPYH 317 (359)
T ss_pred CCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC----HHHHhcChhhhhhc
Confidence 111 1578899999999999999999999 99999999998653
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-52 Score=418.74 Aligned_cols=282 Identities=34% Similarity=0.673 Sum_probs=236.6
Q ss_pred CCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 87 RGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 87 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
....+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 44556778999999999999999999999999999999999875555455556678899999999999999999999999
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
+.+|+||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999999999998753 4899999999999999999999999999999999999999999999999998543
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.... .....+.
T Consensus 193 ~~~~---------------------------------------------------------------------~~~~~~~ 203 (370)
T cd05621 193 DETG---------------------------------------------------------------------MVRCDTA 203 (370)
T ss_pred ccCC---------------------------------------------------------------------ceecccC
Confidence 2100 0011234
Q ss_pred ccccCccCcchhcCCC----CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC--CcCCCCCCCCHHHHHHHH
Q 035713 327 VGTHEYLAPEIIRGEG----HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP--LRFPETPQVSFVARDLIR 400 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~----~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~s~~~~~li~ 400 (491)
+||+.|+|||++.+.. ++.++|||||||+||||++|+.||.+.+....+.+++... +.+|....++..+++||.
T Consensus 204 ~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~ 283 (370)
T cd05621 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLIC 283 (370)
T ss_pred CCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHH
Confidence 7999999999998653 6889999999999999999999999888777777777543 555665568999999999
Q ss_pred hhhccCCCC--CCCcCCChHHhhcCCCcCCCChh--hhhccCCCCCCC
Q 035713 401 GLLVKEPHK--RIAYKRGATEIKQHPFFEGVNWA--LVRSALPPHIPE 444 (491)
Q Consensus 401 ~~L~~dP~~--R~t~~~~~~ell~hpff~~~~~~--~~~~~~~~~~p~ 444 (491)
+||..++.+ |++ +.++++||||+...|. .++...+|..|.
T Consensus 284 ~~L~~~~~r~~R~~----~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~ 327 (370)
T cd05621 284 AFLTDREVRLGRNG----VEEIKQHPFFKNDQWNWDNIRETAAPVVPE 327 (370)
T ss_pred HHccCchhccCCCC----HHHHhcCcccCCCCcChHhcCCCCCCcCCC
Confidence 999855543 778 9999999999986664 444444555543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-54 Score=418.90 Aligned_cols=291 Identities=37% Similarity=0.702 Sum_probs=263.1
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCce
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKF 168 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~ 168 (491)
..+.+++++++..||-|+||.|=+++.+.....+|+|+++|..+.+..+.+.+..|.+||..++.|+||+||-.|.++.+
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 34667899999999999999999999887666799999999999999999999999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
+|++||-|-||.|+..++.. +.|.+..+++|++.++.|++|||++|||+|||||+|+|++.+|.+||.|||+|+.+.
T Consensus 495 vYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~- 571 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG- 571 (732)
T ss_pred hhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc-
Confidence 99999999999999998875 679999999999999999999999999999999999999999999999999997653
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
...+++|+||
T Consensus 572 ----------------------------------------------------------------------~g~KTwTFcG 581 (732)
T KOG0614|consen 572 ----------------------------------------------------------------------SGRKTWTFCG 581 (732)
T ss_pred ----------------------------------------------------------------------cCCceeeecC
Confidence 2346778999
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC--CcCCCCCCCCHHHHHHHHhhhccC
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP--LRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
|+.|.|||++++..++.++|+||||+++||||+|.+||.+.+...++..|+.+- +.+| ..++..+.+||+++...+
T Consensus 582 TpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Lik~LCr~~ 659 (732)
T KOG0614|consen 582 TPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLIKKLCRDN 659 (732)
T ss_pred CcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHHHHHHhcC
Confidence 999999999999999999999999999999999999999999999998888764 4455 459999999999999999
Q ss_pred CCCCCCc-CCChHHhhcCCCcCCCChhhhhc--cCCCCCC---CCCCCCCCCCC
Q 035713 407 PHKRIAY-KRGATEIKQHPFFEGVNWALVRS--ALPPHIP---EPVDFSVFAGK 454 (491)
Q Consensus 407 P~~R~t~-~~~~~ell~hpff~~~~~~~~~~--~~~~~~p---~~~~~~~~~~~ 454 (491)
|.+|+++ ..++.||.+|-||.++||.-++. ..||.+| .|.|.++|...
T Consensus 660 P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~~ 713 (732)
T KOG0614|consen 660 PTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDNF 713 (732)
T ss_pred cHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccCC
Confidence 9999996 56899999999999999998753 4455555 47777766554
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-52 Score=419.40 Aligned_cols=282 Identities=33% Similarity=0.666 Sum_probs=238.1
Q ss_pred cCCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 035713 86 LRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET 165 (491)
Q Consensus 86 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 165 (491)
.....+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 44556677999999999999999999999999999999999987555555555667889999999999999999999999
Q ss_pred CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
++.+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 99999999999999999998753 489999999999999999999999999999999999999999999999999854
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
..... .....+
T Consensus 192 ~~~~~---------------------------------------------------------------------~~~~~~ 202 (371)
T cd05622 192 MNKEG---------------------------------------------------------------------MVRCDT 202 (371)
T ss_pred cCcCC---------------------------------------------------------------------cccccC
Confidence 32100 001123
Q ss_pred cccccCccCcchhcCCC----CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC--CcCCCCCCCCHHHHHHH
Q 035713 326 FVGTHEYLAPEIIRGEG----HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP--LRFPETPQVSFVARDLI 399 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~~~----~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~s~~~~~li 399 (491)
.+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+....+.+++... ..++....++..+++||
T Consensus 203 ~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 282 (371)
T cd05622 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 282 (371)
T ss_pred cccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHH
Confidence 47999999999998643 7889999999999999999999999888777777777543 45666667999999999
Q ss_pred HhhhccCCCC---CCCcCCChHHhhcCCCcCCCCh--hhhhccCCCCCCC
Q 035713 400 RGLLVKEPHK---RIAYKRGATEIKQHPFFEGVNW--ALVRSALPPHIPE 444 (491)
Q Consensus 400 ~~~L~~dP~~---R~t~~~~~~ell~hpff~~~~~--~~~~~~~~~~~p~ 444 (491)
.+||. +|.. |++ +++|++|+||++..| ..++...+|.+|.
T Consensus 283 ~~~L~-~~~~r~~r~~----~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~ 327 (371)
T cd05622 283 CAFLT-DREVRLGRNG----VEEIKRHLFFKNDQWAWETLRDTVAPVVPD 327 (371)
T ss_pred HHHcC-ChhhhcCCCC----HHHHhcCcccCCCChhHHhcCCCCCCCCCC
Confidence 99998 5555 556 999999999998655 4566666666654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-52 Score=411.60 Aligned_cols=264 Identities=36% Similarity=0.697 Sum_probs=229.0
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHH---hhcCCCCccceeeeEEeCceEEEE
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL---GLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il---~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
|++++.||+|+||.||+|++..+++.||||++++...........+.+|++++ +.++||||+++++++.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999876544455556677777665 456799999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||++|++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~--- 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF--- 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC---
Confidence 999999999887754 45999999999999999999999999999999999999999999999999987431100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.....+++||+.|
T Consensus 155 -------------------------------------------------------------------~~~~~~~~g~~~y 167 (324)
T cd05589 155 -------------------------------------------------------------------GDRTSTFCGTPEF 167 (324)
T ss_pred -------------------------------------------------------------------CCcccccccCccc
Confidence 0011235799999
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCC
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIA 412 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 412 (491)
+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++. .++.++.+||.+||+.||.+||+
T Consensus 168 ~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~ 245 (324)
T cd05589 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR--FLSREAISIMRRLLRRNPERRLG 245 (324)
T ss_pred cCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhhcCHhHcCC
Confidence 9999999999999999999999999999999999998888777788777666664 48999999999999999999996
Q ss_pred cCC-ChHHhhcCCCcCCCChhhh
Q 035713 413 YKR-GATEIKQHPFFEGVNWALV 434 (491)
Q Consensus 413 ~~~-~~~ell~hpff~~~~~~~~ 434 (491)
.+. .+.++++||||+.++|..+
T Consensus 246 ~~~~~~~~l~~~~~f~~~~~~~~ 268 (324)
T cd05589 246 SGEKDAEDVKKQPFFRDINWDDL 268 (324)
T ss_pred CCCCCHHHHhhCCCcCCCCHHHH
Confidence 432 4999999999999999865
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-51 Score=406.44 Aligned_cols=258 Identities=40% Similarity=0.739 Sum_probs=228.2
Q ss_pred eeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccCCCch
Q 035713 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNL 181 (491)
Q Consensus 102 iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~gg~L 181 (491)
||+|+||.||+|++..+++.||+|++.+...........+.+|+++|+.++||||+++++++...+.+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999876555556667788999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccccccccc
Q 035713 182 HSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVN 261 (491)
Q Consensus 182 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 261 (491)
.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------------ 146 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD------------ 146 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC------------
Confidence 9988764 56999999999999999999999999999999999999999999999999998532100
Q ss_pred CCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCC
Q 035713 262 NGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGE 341 (491)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 341 (491)
.......+||+.|+|||++.+.
T Consensus 147 ----------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~ 168 (312)
T cd05585 147 ----------------------------------------------------------DDKTNTFCGTPEYLAPELLLGH 168 (312)
T ss_pred ----------------------------------------------------------CCccccccCCcccCCHHHHcCC
Confidence 0011235799999999999999
Q ss_pred CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhh
Q 035713 342 GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIK 421 (491)
Q Consensus 342 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell 421 (491)
.++.++|||||||++|||++|+.||.+.+....+..++.....++. .++.++++||.+||..||.+|++... +.++|
T Consensus 169 ~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~R~~~~~-~~e~l 245 (312)
T cd05585 169 GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD--GFDRDAKDLLIGLLSRDPTRRLGYNG-AQEIK 245 (312)
T ss_pred CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCC--cCCHHHHHHHHHHcCCCHHHcCCCCC-HHHHH
Confidence 9999999999999999999999999988887777888887777765 48999999999999999999986422 89999
Q ss_pred cCCCcCCCChhhh
Q 035713 422 QHPFFEGVNWALV 434 (491)
Q Consensus 422 ~hpff~~~~~~~~ 434 (491)
+||||..++|..+
T Consensus 246 ~hp~~~~~~~~~~ 258 (312)
T cd05585 246 NHPFFSQLSWKKL 258 (312)
T ss_pred cCCCcCCCCHHHH
Confidence 9999999999765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=408.11 Aligned_cols=262 Identities=36% Similarity=0.688 Sum_probs=227.7
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceEEEEEeccCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFYCLVMEFCSG 178 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~~lV~E~~~g 178 (491)
+.||+|+||+||+|+++.+++.||||++.+...........+..|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876555555666777899888876 699999999999999999999999999
Q ss_pred CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccc
Q 035713 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258 (491)
Q Consensus 179 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 258 (491)
|+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--------- 149 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--------- 149 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC---------
Confidence 9999888764 56999999999999999999999999999999999999999999999999997432100
Q ss_pred cccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchh
Q 035713 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338 (491)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 338 (491)
.......+||+.|+|||++
T Consensus 150 -------------------------------------------------------------~~~~~~~~gt~~y~aPE~~ 168 (320)
T cd05590 150 -------------------------------------------------------------GKTTSTFCGTPDYIAPEIL 168 (320)
T ss_pred -------------------------------------------------------------CCcccccccCccccCHHHH
Confidence 0011134799999999999
Q ss_pred cCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcC--CC
Q 035713 339 RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK--RG 416 (491)
Q Consensus 339 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~--~~ 416 (491)
.+..++.++|||||||++|||++|+.||.+.+....+..+......++. .++.++++||.+||+.||.+|++.. .+
T Consensus 169 ~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~ 246 (320)
T cd05590 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--WLSQDAVDILKAFMTKNPTMRLGSLTLGG 246 (320)
T ss_pred cCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHcccCHHHCCCCCCCCC
Confidence 9999999999999999999999999999998888888888877766664 4899999999999999999999931 12
Q ss_pred hHHhhcCCCcCCCChhhhh
Q 035713 417 ATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 417 ~~ell~hpff~~~~~~~~~ 435 (491)
.+++++||||..++|..+.
T Consensus 247 ~~~~~~h~~f~~~~~~~~~ 265 (320)
T cd05590 247 EEAILRHPFFKELDWEKLN 265 (320)
T ss_pred HHHHHcCCCcCCCCHHHHH
Confidence 3899999999999998763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-51 Score=407.50 Aligned_cols=267 Identities=36% Similarity=0.693 Sum_probs=233.5
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceEEEEE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
+|++++.||+|+||.||+|+++.+++.||||++.+..............|+.++..+ +|++|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999876554455556677788888877 5899999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+++|+|..++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~---- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD---- 154 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC----
Confidence 999999999888764 56999999999999999999999999999999999999999999999999998532100
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.......+||+.|+
T Consensus 155 ------------------------------------------------------------------~~~~~~~~gt~~y~ 168 (323)
T cd05616 155 ------------------------------------------------------------------GVTTKTFCGTPDYI 168 (323)
T ss_pred ------------------------------------------------------------------CCccccCCCChhhc
Confidence 00112347999999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
|||++.+..++.++|||||||++|||++|+.||.+.+....+..+......+|. .++.++.+||.+||+.||.+|++.
T Consensus 169 aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--cCCHHHHHHHHHHcccCHHhcCCC
Confidence 999999999999999999999999999999999998888888888877777665 489999999999999999999984
Q ss_pred C-CChHHhhcCCCcCCCChhhhh
Q 035713 414 K-RGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 414 ~-~~~~ell~hpff~~~~~~~~~ 435 (491)
. ....++++||||+.++|..+.
T Consensus 247 ~~~~~~~i~~h~~~~~~~~~~~~ 269 (323)
T cd05616 247 GPEGERDIKEHAFFRYIDWEKLE 269 (323)
T ss_pred CCCCHHHHhcCCCcCCCCHHHHH
Confidence 2 346899999999999999774
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-51 Score=406.38 Aligned_cols=267 Identities=36% Similarity=0.692 Sum_probs=232.3
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCC-CccceeeeEEeCceEEEEE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP-FLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp-~iv~l~~~~~~~~~~~lV~ 173 (491)
+|++++.||+|+||.||+|+++.+++.||||++.+...........+..|++++..++|+ +|+.++++|.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876554555666788899999999764 6889999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||++||+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--- 155 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC---
Confidence 999999999988764 569999999999999999999999999999999999999999999999999974311000
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
......+||+.|+
T Consensus 156 -------------------------------------------------------------------~~~~~~~gt~~y~ 168 (324)
T cd05587 156 -------------------------------------------------------------------KTTRTFCGTPDYI 168 (324)
T ss_pred -------------------------------------------------------------------CceeeecCCcccc
Confidence 0111347999999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
|||++.+..++.++|||||||++|||++|+.||.+.+....+..+......++. .++.++.+||.+||..||.+|++.
T Consensus 169 aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK--SLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 999999999999999999999999999999999998888888888777666664 489999999999999999999984
Q ss_pred C-CChHHhhcCCCcCCCChhhhh
Q 035713 414 K-RGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 414 ~-~~~~ell~hpff~~~~~~~~~ 435 (491)
. ...+++++||||+.++|..+.
T Consensus 247 ~~~~~~~~~~hp~~~~~~~~~~~ 269 (324)
T cd05587 247 GPTGERDIREHAFFRRIDWEKLE 269 (324)
T ss_pred CCCCHHHHhcCCCcCCCCHHHHH
Confidence 2 235899999999999998763
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-51 Score=408.87 Aligned_cols=270 Identities=39% Similarity=0.721 Sum_probs=230.4
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccCCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGG 179 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~gg 179 (491)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+++++.++||||++++++|...+.+||||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765555556667788999999999999999999999999999999999999
Q ss_pred chHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccc
Q 035713 180 NLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258 (491)
Q Consensus 180 ~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 258 (491)
+|..++... +.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-------- 150 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-------- 150 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--------
Confidence 999888764 569999999999999999999997 799999999999999999999999999975321000
Q ss_pred cccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchh
Q 035713 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338 (491)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 338 (491)
......+||+.|+|||++
T Consensus 151 --------------------------------------------------------------~~~~~~~gt~~y~aPE~~ 168 (325)
T cd05594 151 --------------------------------------------------------------ATMKTFCGTPEYLAPEVL 168 (325)
T ss_pred --------------------------------------------------------------cccccccCCcccCCHHHH
Confidence 011134799999999999
Q ss_pred cCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcC-CCh
Q 035713 339 RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK-RGA 417 (491)
Q Consensus 339 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~-~~~ 417 (491)
.+..++.++|||||||++|||++|+.||.+.+.......+......++. .+++++.+||.+||+.||++|++.. ..+
T Consensus 169 ~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~ 246 (325)
T cd05594 169 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPDDA 246 (325)
T ss_pred ccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHhhcCHHHhCCCCCCCH
Confidence 9999999999999999999999999999988777777777777777665 4899999999999999999998210 129
Q ss_pred HHhhcCCCcCCCChhhhh--ccCCCCCC
Q 035713 418 TEIKQHPFFEGVNWALVR--SALPPHIP 443 (491)
Q Consensus 418 ~ell~hpff~~~~~~~~~--~~~~~~~p 443 (491)
.++++||||.++.|..+. ...++..+
T Consensus 247 ~~il~h~~~~~~~~~~~~~~~~~~~~~~ 274 (325)
T cd05594 247 KEIMQHKFFAGIVWQDVYEKKLVPPFKP 274 (325)
T ss_pred HHHhcCCCcCCCCHHHHHhCCCCCCcCC
Confidence 999999999999998663 23344443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-51 Score=405.04 Aligned_cols=262 Identities=37% Similarity=0.721 Sum_probs=228.7
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceEEEEEeccCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFYCLVMEFCSG 178 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~~lV~E~~~g 178 (491)
++||+|+||.||+|+++.+++.||||++.+...........+..|.++++.+ +||||++++++|.+.+.+||||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876555555666777899999876 799999999999999999999999999
Q ss_pred CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccc
Q 035713 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258 (491)
Q Consensus 179 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 258 (491)
++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-------- 150 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-------- 150 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--------
Confidence 9999888764 569999999999999999999999999999999999999999999999999985321100
Q ss_pred cccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchh
Q 035713 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338 (491)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 338 (491)
......+||+.|+|||++
T Consensus 151 --------------------------------------------------------------~~~~~~~gt~~y~aPE~~ 168 (321)
T cd05591 151 --------------------------------------------------------------VTTTTFCGTPDYIAPEIL 168 (321)
T ss_pred --------------------------------------------------------------ccccccccCccccCHHHH
Confidence 011134799999999999
Q ss_pred cCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCC---
Q 035713 339 RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKR--- 415 (491)
Q Consensus 339 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~--- 415 (491)
.+..++.++|||||||++|||++|+.||.+.+....+..+......+|. .++.++.+||.+||..||++|+++..
T Consensus 169 ~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~ll~~~L~~dp~~R~~~~~~~~ 246 (321)
T cd05591 169 QELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV--WLSKEAVSILKAFMTKNPNKRLGCVASQG 246 (321)
T ss_pred cCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCC
Confidence 9999999999999999999999999999999888888888887766664 48999999999999999999994322
Q ss_pred ChHHhhcCCCcCCCChhhhh
Q 035713 416 GATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 416 ~~~ell~hpff~~~~~~~~~ 435 (491)
.++++++||||..++|..+.
T Consensus 247 ~~~~~~~hp~~~~~~~~~~~ 266 (321)
T cd05591 247 GEDAIKQHPFFKEIDWVLLE 266 (321)
T ss_pred CHHHHhcCCccCCCCHHHHH
Confidence 38999999999999999774
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-51 Score=407.57 Aligned_cols=259 Identities=36% Similarity=0.588 Sum_probs=235.3
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCceEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~~l 171 (491)
...|++.+.||+|.||.||+|+++.+|+.||+|+|.+...........+.+|++||+.+. |||||.++++|++...+|+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 467999999999999999999999999999999999887766556678889999999998 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC----CcEEEeecccccccC
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE----GHIMLSDFDLSLRCS 247 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~----g~vkL~DFGla~~~~ 247 (491)
|||++.||.|.+.+... .+++..+..++.||+.++.|||+.||+||||||+|+|+... +.+|++|||++....
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 99999999999988876 39999999999999999999999999999999999999643 579999999996543
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
. ..+...+|
T Consensus 191 ~-----------------------------------------------------------------------~~~~~~~~ 199 (382)
T KOG0032|consen 191 P-----------------------------------------------------------------------GERLHTIV 199 (382)
T ss_pred C-----------------------------------------------------------------------CceEeeec
Confidence 2 11233569
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCC--CCCCCCHHHHHHHHhhhcc
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP--ETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~~~~li~~~L~~ 405 (491)
||+.|+|||++....|+..+||||+||++|.|++|.+||.+.+......+|+...+.++ .++.++..+++||++||..
T Consensus 200 Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~ 279 (382)
T KOG0032|consen 200 GTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEF 279 (382)
T ss_pred CCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhccc
Confidence 99999999999999999999999999999999999999999999999999998877654 4577999999999999999
Q ss_pred CCCCCCCcCCChHHhhcCCCcCCC
Q 035713 406 EPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
||.+|++ +.++|+|||+++.
T Consensus 280 dp~~R~t----a~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 280 DPRKRLT----AAQALQHPWIKSI 299 (382)
T ss_pred CcccCCC----HHHHhcCccccCC
Confidence 9999999 9999999998865
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=402.11 Aligned_cols=262 Identities=38% Similarity=0.692 Sum_probs=225.8
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHH-HHhhcCCCCccceeeeEEeCceEEEEEeccCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE-ILGLLDHPFLPTLYSYFETDKFYCLVMEFCSG 178 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~-il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~g 178 (491)
+.||+|+||+||+|+++.+|+.||||++.+...........+.+|.. +++.++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999999999999999998765544444455555655 56789999999999999999999999999999
Q ss_pred CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccc
Q 035713 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258 (491)
Q Consensus 179 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 258 (491)
|+|..++... +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--------- 149 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--------- 149 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC---------
Confidence 9999988764 56999999999999999999999999999999999999999999999999997432100
Q ss_pred cccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchh
Q 035713 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338 (491)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 338 (491)
.......+||+.|+|||++
T Consensus 150 -------------------------------------------------------------~~~~~~~~gt~~y~aPE~~ 168 (323)
T cd05575 150 -------------------------------------------------------------SKTTSTFCGTPEYLAPEVL 168 (323)
T ss_pred -------------------------------------------------------------CCccccccCChhhcChhhh
Confidence 0011134799999999999
Q ss_pred cCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChH
Q 035713 339 RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGAT 418 (491)
Q Consensus 339 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ 418 (491)
.+..++.++|||||||++|||++|+.||.+.+..+.+..++......+. .++..+.+||.+||+.||.+|++.+..+.
T Consensus 169 ~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (323)
T cd05575 169 RKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKP--NISVSARHLLEGLLQKDRTKRLGAKDDFL 246 (323)
T ss_pred cCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHHhCCCCCCCHH
Confidence 9999999999999999999999999999988877777778777665543 57999999999999999999999655568
Q ss_pred HhhcCCCcCCCChhhhh
Q 035713 419 EIKQHPFFEGVNWALVR 435 (491)
Q Consensus 419 ell~hpff~~~~~~~~~ 435 (491)
++++||||..++|..+.
T Consensus 247 ~il~~~~~~~~~~~~~~ 263 (323)
T cd05575 247 EIKNHVFFSSINWDDLV 263 (323)
T ss_pred HHHcCCCcCCCCHHHHh
Confidence 99999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=401.86 Aligned_cols=275 Identities=36% Similarity=0.706 Sum_probs=236.2
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCceEEEEE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~~lV~ 173 (491)
+|++.+.||+|+||+||+|+++.+|+.||||++.+...........+..|+++++.+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4889999999999999999999999999999998765545555667788999998886 577889999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||++||+|..++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--- 155 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC---
Confidence 999999999988764 569999999999999999999999999999999999999999999999999985321100
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
......+||+.|+
T Consensus 156 -------------------------------------------------------------------~~~~~~~gt~~y~ 168 (323)
T cd05615 156 -------------------------------------------------------------------VTTRTFCGTPDYI 168 (323)
T ss_pred -------------------------------------------------------------------ccccCccCCcccc
Confidence 0111347999999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
|||++.+..++.++|||||||++|||++|+.||.+.+....+..+......+|. .++.++.+||.+||+.||.+|++.
T Consensus 169 aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK--SLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHcccCHhhCCCC
Confidence 999999999999999999999999999999999998887777888877776665 489999999999999999999985
Q ss_pred C-CChHHhhcCCCcCCCChhhhhc--cCCCCCC
Q 035713 414 K-RGATEIKQHPFFEGVNWALVRS--ALPPHIP 443 (491)
Q Consensus 414 ~-~~~~ell~hpff~~~~~~~~~~--~~~~~~p 443 (491)
. ....++++||||+.++|..+.. ..+|+.|
T Consensus 247 ~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~ 279 (323)
T cd05615 247 GPEGERDIREHAFFRRIDWDKLENREIQPPFKP 279 (323)
T ss_pred CCCCHHHHhcCcccCCCCHHHHhcCCCCcCccC
Confidence 3 3468999999999999987753 3344444
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-50 Score=401.79 Aligned_cols=277 Identities=36% Similarity=0.663 Sum_probs=234.1
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|+++++||+|+||+||+++++.+++.||+|++.+...........+.+|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998765555555666788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-- 157 (332)
T cd05623 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-- 157 (332)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc--
Confidence 999999999999764 24699999999999999999999999999999999999999999999999999853211000
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
......+||+.|+
T Consensus 158 -------------------------------------------------------------------~~~~~~~gt~~y~ 170 (332)
T cd05623 158 -------------------------------------------------------------------VQSSVAVGTPDYI 170 (332)
T ss_pred -------------------------------------------------------------------ceecccccCcccc
Confidence 0111247999999
Q ss_pred CcchhcC-----CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCc--CCCC-CCCCHHHHHHHHhhhcc
Q 035713 334 APEIIRG-----EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR--FPET-PQVSFVARDLIRGLLVK 405 (491)
Q Consensus 334 aPE~l~~-----~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~--~~~~-~~~s~~~~~li~~~L~~ 405 (491)
|||++.+ ..++.++|||||||++|||++|+.||.+.+....+.++...... +|.. ..++.++++||.+||+.
T Consensus 171 aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~ 250 (332)
T cd05623 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICS 250 (332)
T ss_pred CHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccC
Confidence 9999973 45789999999999999999999999988887777777765432 3322 35899999999999987
Q ss_pred CCCC--CCCcCCChHHhhcCCCcCCCChhhhhccCCCCCCC
Q 035713 406 EPHK--RIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE 444 (491)
Q Consensus 406 dP~~--R~t~~~~~~ell~hpff~~~~~~~~~~~~~~~~p~ 444 (491)
++.+ |++ ++++++||||.+++|..++...++.+|.
T Consensus 251 ~~~r~~r~~----~~~~~~h~~f~~~~~~~~~~~~~~~~~~ 287 (332)
T cd05623 251 REHRLGQNG----IEDFKQHPFFTGIDWDNIRNCEAPYIPE 287 (332)
T ss_pred hhhhcCCCC----HHHHhCCCCcCCCCHHHHhhCCCCccCC
Confidence 5554 567 9999999999999999887766666654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=401.75 Aligned_cols=277 Identities=35% Similarity=0.644 Sum_probs=234.1
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++++.||+|+||+||+++++.+++.||+|++.+...........+.+|+.+++.++|+||+++++++.+++.+||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998755445555666788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||++||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-- 157 (331)
T cd05624 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-- 157 (331)
T ss_pred eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc--
Confidence 999999999998764 24699999999999999999999999999999999999999999999999999854321100
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
......+||+.|+
T Consensus 158 -------------------------------------------------------------------~~~~~~~gt~~y~ 170 (331)
T cd05624 158 -------------------------------------------------------------------VQSSVAVGTPDYI 170 (331)
T ss_pred -------------------------------------------------------------------eeeccccCCcccC
Confidence 0011247999999
Q ss_pred CcchhcC-----CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCC--cCCC-CCCCCHHHHHHHHhhhcc
Q 035713 334 APEIIRG-----EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL--RFPE-TPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 334 aPE~l~~-----~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~--~~~~-~~~~s~~~~~li~~~L~~ 405 (491)
|||++.+ ..++.++|||||||+||||++|+.||.+.+..+.+..+..... .++. ...++.++++||.+||+.
T Consensus 171 aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~ 250 (331)
T cd05624 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICS 250 (331)
T ss_pred CHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccC
Confidence 9999976 4578899999999999999999999998877777777765433 3332 235789999999999997
Q ss_pred CCCC--CCCcCCChHHhhcCCCcCCCChhhhhccCCCCCCC
Q 035713 406 EPHK--RIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE 444 (491)
Q Consensus 406 dP~~--R~t~~~~~~ell~hpff~~~~~~~~~~~~~~~~p~ 444 (491)
++.+ |++ ++++++||||++++|..++...+|.+|.
T Consensus 251 ~~~~~~~~~----~~~~~~h~~f~~~~~~~~~~~~~~~~p~ 287 (331)
T cd05624 251 RERRLGQNG----IEDFKKHAFFEGIDWENIRNLEAPYIPD 287 (331)
T ss_pred chhhcCCCC----HHHHhcCCCcCCCCHHHHhhCCCCccCC
Confidence 6544 345 9999999999999999988777777664
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-51 Score=386.76 Aligned_cols=262 Identities=28% Similarity=0.460 Sum_probs=221.0
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCC-ccceeeeEEeCc----
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF-LPTLYSYFETDK---- 167 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~-iv~l~~~~~~~~---- 167 (491)
...|+.+++||+|+||+||+|+.+.+|+.||+|+++..... +..-....+|+.+|+.|+|+| ||+|++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 46799999999999999999999999999999999765321 223344578999999999999 999999998877
Q ss_pred --eEEEEEeccCCCchHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccc
Q 035713 168 --FYCLVMEFCSGGNLHSLRQKQPN--KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243 (491)
Q Consensus 168 --~~~lV~E~~~gg~L~~~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla 243 (491)
.++||+||+ .-+|..++..... ..++...++.+++||+.||+|||++||+||||||+||||+.+|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 6799999987643 35888999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (491)
+........ -
T Consensus 168 ra~~ip~~~----------------------------------------------------------------------y 177 (323)
T KOG0594|consen 168 RAFSIPMRT----------------------------------------------------------------------Y 177 (323)
T ss_pred HHhcCCccc----------------------------------------------------------------------c
Confidence 743321110 1
Q ss_pred cccccccCccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHH---cCC---------------Cc
Q 035713 324 MSFVGTHEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV---GQP---------------LR 384 (491)
Q Consensus 324 ~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~---~~~---------------~~ 384 (491)
+.-++|.||+|||++.+. .|+..+||||+|||++||+++++.|.|.++.+++.+|. +.+ ..
T Consensus 178 t~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~ 257 (323)
T KOG0594|consen 178 TPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAP 257 (323)
T ss_pred cccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcccccccccc
Confidence 123899999999999998 58999999999999999999999999999988887764 222 11
Q ss_pred CCCC----------CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 385 FPET----------PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 385 ~~~~----------~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
++.. +....+..+|+.+||+++|.+|.+ ++.+|.||||+...
T Consensus 258 f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S----a~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 258 FPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS----AKGALTHPYFSELP 309 (323)
T ss_pred CcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC----HHHHhcChhhcccc
Confidence 1111 233457899999999999999999 99999999998764
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=399.89 Aligned_cols=259 Identities=35% Similarity=0.716 Sum_probs=222.0
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceEEEEEeccCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFYCLVMEFCSG 178 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~~lV~E~~~g 178 (491)
+.||+|+||.||+|+++.+|+.||+|++++..............|..++..+ +||||++++++|.+.+++|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999876443334455667788888754 899999999999999999999999999
Q ss_pred CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccc
Q 035713 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258 (491)
Q Consensus 179 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 258 (491)
|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--------- 149 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--------- 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC---------
Confidence 9999888764 56999999999999999999999999999999999999999999999999987431100
Q ss_pred cccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchh
Q 035713 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338 (491)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 338 (491)
.......+||+.|+|||++
T Consensus 150 -------------------------------------------------------------~~~~~~~~gt~~y~aPE~~ 168 (316)
T cd05620 150 -------------------------------------------------------------DNRASTFCGTPDYIAPEIL 168 (316)
T ss_pred -------------------------------------------------------------CCceeccCCCcCccCHHHH
Confidence 0011235799999999999
Q ss_pred cCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChH
Q 035713 339 RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGAT 418 (491)
Q Consensus 339 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ 418 (491)
.+..++.++|||||||++|||++|+.||.+.+....+..+......++. .++.++++||.+||+.||++|++. .+
T Consensus 169 ~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dP~~R~~~---~~ 243 (316)
T cd05620 169 QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--WITKESKDILEKLFERDPTRRLGV---VG 243 (316)
T ss_pred cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHccCCHHHcCCC---hH
Confidence 9999999999999999999999999999988777766666655555554 489999999999999999999992 36
Q ss_pred HhhcCCCcCCCChhhhh
Q 035713 419 EIKQHPFFEGVNWALVR 435 (491)
Q Consensus 419 ell~hpff~~~~~~~~~ 435 (491)
++++||||+.++|..+.
T Consensus 244 ~~~~h~~f~~~~~~~~~ 260 (316)
T cd05620 244 NIRGHPFFKTINWTALE 260 (316)
T ss_pred HHHcCCCcCCCCHHHHH
Confidence 89999999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=387.96 Aligned_cols=255 Identities=29% Similarity=0.503 Sum_probs=214.5
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC--c---eE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD--K---FY 169 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~--~---~~ 169 (491)
.|.-.+++|+|+||.||.|....+++.||||.+-.+.- . -.+|++||+.++|||||+|..+|... + ++
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----Y---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----c---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 48889999999999999999999999999998754321 1 13699999999999999999998632 2 56
Q ss_pred EEEEeccCCCchHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC-CcEEEeeccccccc
Q 035713 170 CLVMEFCSGGNLHSLRQKQ--PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE-GHIMLSDFDLSLRC 246 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~-g~vkL~DFGla~~~ 246 (491)
.|||||| ..+|..+++.. .+..++.-.++.|..||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+.+
T Consensus 98 nlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 7999999 57998888742 24569999999999999999999999999999999999999965 99999999999765
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
...+ .+.++
T Consensus 177 ~~~e-----------------------------------------------------------------------pniSY 185 (364)
T KOG0658|consen 177 VKGE-----------------------------------------------------------------------PNISY 185 (364)
T ss_pred ccCC-----------------------------------------------------------------------CceeE
Confidence 4222 23357
Q ss_pred ccccCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CC--------------CcCC--
Q 035713 327 VGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QP--------------LRFP-- 386 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~--------------~~~~-- 386 (491)
..|..|+|||++.|.. |+.++||||.||++.||+-|++.|.|++..+++..|++ .+ ..+|
T Consensus 186 icSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~i 265 (364)
T KOG0658|consen 186 ICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQI 265 (364)
T ss_pred EEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCccc
Confidence 8999999999999865 89999999999999999999999999998888876642 21 1111
Q ss_pred --------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 387 --------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 387 --------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
....+++++.+|+.++|+++|.+|.+ +.|+++||||+...-.
T Consensus 266 k~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~----~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 266 KAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS----ALEALAHPFFDELRDP 315 (364)
T ss_pred ccccceeecccCCCHHHHHHHHHHhccChhhcCC----HHHHhcchhhHHhhCc
Confidence 12467899999999999999999999 9999999999876544
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-50 Score=392.65 Aligned_cols=276 Identities=34% Similarity=0.600 Sum_probs=229.2
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
.|++.++||+|+||+||++.+..+++.||||++.+...........+.+|+++++.++|+||+++++++..++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999977655444445567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|+++|+|..++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC----
Confidence 9999999988776544569999999999999999999999999999999999999999999999999985421100
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
.....+||..|+|
T Consensus 157 -------------------------------------------------------------------~~~~~~~~~~y~a 169 (285)
T cd05605 157 -------------------------------------------------------------------TIRGRVGTVGYMA 169 (285)
T ss_pred -------------------------------------------------------------------ccccccCCCCccC
Confidence 0012368999999
Q ss_pred cchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHH----HHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 335 PEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFN----VVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 335 PE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
||++.+..++.++|||||||++|||++|+.||.+......... +......++ ..++..+.+||.+||..||++|
T Consensus 170 PE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R 247 (285)
T cd05605 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYS--EKFSEAARSICRQLLTKDPGFR 247 (285)
T ss_pred cHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccC--cccCHHHHHHHHHHccCCHHHh
Confidence 9999998899999999999999999999999988665433322 222222333 3489999999999999999999
Q ss_pred CCcC-CChHHhhcCCCcCCCChhhhhcc--CCCCCC
Q 035713 411 IAYK-RGATEIKQHPFFEGVNWALVRSA--LPPHIP 443 (491)
Q Consensus 411 ~t~~-~~~~ell~hpff~~~~~~~~~~~--~~~~~p 443 (491)
++++ ..++++++||||...+|..+... .||+.|
T Consensus 248 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05605 248 LGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCP 283 (285)
T ss_pred cCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCC
Confidence 9421 12999999999999999987543 344444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-50 Score=399.68 Aligned_cols=277 Identities=36% Similarity=0.676 Sum_probs=232.6
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+.+++.++|+||++++++|.+++++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765555556667889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||++||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 157 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-- 157 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC--
Confidence 999999999998764 35699999999999999999999999999999999999999999999999999854321100
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
......+||+.|+
T Consensus 158 -------------------------------------------------------------------~~~~~~~gt~~y~ 170 (331)
T cd05597 158 -------------------------------------------------------------------VQSNVAVGTPDYI 170 (331)
T ss_pred -------------------------------------------------------------------ccccceecccccc
Confidence 0011236999999
Q ss_pred CcchhcC-----CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC--CcCCC-CCCCCHHHHHHHHhhhcc
Q 035713 334 APEIIRG-----EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP--LRFPE-TPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 334 aPE~l~~-----~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~-~~~~s~~~~~li~~~L~~ 405 (491)
|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+.... +.++. ...++.++++||.+||+.
T Consensus 171 aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~ 250 (331)
T cd05597 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS 250 (331)
T ss_pred CHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccC
Confidence 9999974 346889999999999999999999999887777776766433 23322 235899999999999976
Q ss_pred CCCC--CCCcCCChHHhhcCCCcCCCChhhhhccCCCCCCC
Q 035713 406 EPHK--RIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE 444 (491)
Q Consensus 406 dP~~--R~t~~~~~~ell~hpff~~~~~~~~~~~~~~~~p~ 444 (491)
++++ |++ ++++++||||.+++|..+....++.+|.
T Consensus 251 ~~~r~~r~~----~~~~l~hp~~~~~~~~~~~~~~~~~~~~ 287 (331)
T cd05597 251 PETRLGRNG----LQDFKDHPFFEGIDWDNIRNSTAPYVPE 287 (331)
T ss_pred cccccCCCC----HHHHhcCCCCCCCCHHHHhhCCCCccCc
Confidence 4443 677 9999999999999999887666665553
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=399.12 Aligned_cols=259 Identities=38% Similarity=0.767 Sum_probs=222.9
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceEEEEEeccCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFYCLVMEFCSG 178 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~~lV~E~~~g 178 (491)
+.||+|+||+||+|++..+++.||||++++..............|..++..+ +||||+++++++..++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876544444555566777777654 899999999999999999999999999
Q ss_pred CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccc
Q 035713 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258 (491)
Q Consensus 179 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 258 (491)
|+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-------- 150 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-------- 150 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--------
Confidence 9999988764 469999999999999999999999999999999999999999999999999985321100
Q ss_pred cccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchh
Q 035713 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338 (491)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 338 (491)
......+||+.|+|||++
T Consensus 151 --------------------------------------------------------------~~~~~~~gt~~y~aPE~~ 168 (316)
T cd05592 151 --------------------------------------------------------------GKASTFCGTPDYIAPEIL 168 (316)
T ss_pred --------------------------------------------------------------CccccccCCccccCHHHH
Confidence 011234799999999999
Q ss_pred cCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChH
Q 035713 339 RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGAT 418 (491)
Q Consensus 339 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ 418 (491)
.+..++.++|||||||++|||++|+.||.+.+....+..+......++. .++.++.+||.+||..||.+|++. ..
T Consensus 169 ~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~ll~~~l~~~P~~R~~~---~~ 243 (316)
T cd05592 169 KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--WISKEAKDCLSKLFERDPTKRLGV---DG 243 (316)
T ss_pred cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHccCCHHHcCCC---hH
Confidence 9999999999999999999999999999998887777777766555554 489999999999999999999983 35
Q ss_pred HhhcCCCcCCCChhhhh
Q 035713 419 EIKQHPFFEGVNWALVR 435 (491)
Q Consensus 419 ell~hpff~~~~~~~~~ 435 (491)
++++||||+.++|..+.
T Consensus 244 ~l~~h~~~~~~~~~~~~ 260 (316)
T cd05592 244 DIRQHPFFRGIDWERLE 260 (316)
T ss_pred HHHcCcccCCCCHHHHH
Confidence 89999999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-51 Score=399.71 Aligned_cols=260 Identities=32% Similarity=0.500 Sum_probs=235.4
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
.-|.+.+.||+|-|++|.+|++.-+|+.||||+|.|..+..- ....+..|++.|+.++|||||+||++..+...+|||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 459999999999999999999999999999999998876543 3345677999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEc-cCCcEEEeecccccccCCCCcc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVR-DEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~-~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|+-++|+|++|+-++. ..+.|+.++.|++||+.|+.|+|...+|||||||+|+.+- .-|-|||+|||++-.+....
T Consensus 97 ELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-- 173 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-- 173 (864)
T ss_pred EecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc--
Confidence 9999999999988764 4599999999999999999999999999999999998775 67999999999985443221
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
..++.||++.|
T Consensus 174 ---------------------------------------------------------------------kL~TsCGSLAY 184 (864)
T KOG4717|consen 174 ---------------------------------------------------------------------KLTTSCGSLAY 184 (864)
T ss_pred ---------------------------------------------------------------------hhhcccchhhc
Confidence 23367999999
Q ss_pred cCcchhcCCCC-CCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 333 LAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 333 ~aPE~l~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
-|||+|+|..| .+++||||||||||.|++|++||...++.+++-.|+...+..|.. ++.+++|||..||..||.+|.
T Consensus 185 SAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPsh--vS~eCrdLI~sMLvRdPkkRA 262 (864)
T KOG4717|consen 185 SAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSH--VSKECRDLIQSMLVRDPKKRA 262 (864)
T ss_pred cCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchh--hhHHHHHHHHHHHhcCchhhc
Confidence 99999999999 568999999999999999999999999999999999999988875 999999999999999999999
Q ss_pred CcCCChHHhhcCCCcCCCChh
Q 035713 412 AYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 412 t~~~~~~ell~hpff~~~~~~ 432 (491)
+ +++|..|+|++.++-.
T Consensus 263 s----lEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 263 S----LEEIVSTSWLQAGDRG 279 (864)
T ss_pred c----HHHHhccccccCCCCC
Confidence 9 9999999999998754
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=400.29 Aligned_cols=262 Identities=38% Similarity=0.733 Sum_probs=222.9
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceEEEEEeccCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFYCLVMEFCSG 178 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~~lV~E~~~g 178 (491)
+.||+|+||.||+|+++.+++.||||++++...........+.+|+.+++.+ +||||++++++|.+.+.+||||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876655556667788999999988 699999999999999999999999999
Q ss_pred CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccc
Q 035713 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258 (491)
Q Consensus 179 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 258 (491)
|+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--------- 149 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--------- 149 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC---------
Confidence 9999888764 56999999999999999999999999999999999999999999999999997431100
Q ss_pred cccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchh
Q 035713 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338 (491)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 338 (491)
.....+.+||+.|+|||++
T Consensus 150 -------------------------------------------------------------~~~~~~~~gt~~y~aPE~~ 168 (329)
T cd05588 150 -------------------------------------------------------------GDTTSTFCGTPNYIAPEIL 168 (329)
T ss_pred -------------------------------------------------------------CCccccccCCccccCHHHH
Confidence 0011235799999999999
Q ss_pred cCCCCCCcccccchhhHHHhhhcCCCCCCCCC--------cHH-HHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 339 RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQG--------NRA-TLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 339 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~-~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
.+..++.++|||||||++|+|++|+.||.... ... ....+......+|. .++.++.+||.+||+.||.+
T Consensus 169 ~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~ 246 (329)
T cd05588 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKASSVLKGFLNKDPKE 246 (329)
T ss_pred cCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhccCHHH
Confidence 99999999999999999999999999996321 112 23445556666664 48999999999999999999
Q ss_pred CCCcC--CChHHhhcCCCcCCCChhhhh
Q 035713 410 RIAYK--RGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 410 R~t~~--~~~~ell~hpff~~~~~~~~~ 435 (491)
|++.. .+++++++||||..++|..+.
T Consensus 247 R~~~~~~~~~~~i~~hp~~~~~~~~~~~ 274 (329)
T cd05588 247 RLGCHPQTGFRDIKSHPFFRNIDWDLLE 274 (329)
T ss_pred cCCCCCCCCHHHHhcCCCCCCCCHHHHH
Confidence 99842 247899999999999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-50 Score=400.43 Aligned_cols=262 Identities=38% Similarity=0.680 Sum_probs=224.5
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHH-HHhhcCCCCccceeeeEEeCceEEEEEeccCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE-ILGLLDHPFLPTLYSYFETDKFYCLVMEFCSG 178 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~-il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~g 178 (491)
+.||+|+||+||+|++..+++.||+|++.+...........+..|.. +++.++|+||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999998765443333444444544 56889999999999999999999999999999
Q ss_pred CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccc
Q 035713 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258 (491)
Q Consensus 179 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 258 (491)
++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-------- 150 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-------- 150 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--------
Confidence 9999988764 568999999999999999999999999999999999999999999999999985321000
Q ss_pred cccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchh
Q 035713 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338 (491)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 338 (491)
......+||+.|+|||++
T Consensus 151 --------------------------------------------------------------~~~~~~~gt~~y~aPE~~ 168 (325)
T cd05602 151 --------------------------------------------------------------GTTSTFCGTPEYLAPEVL 168 (325)
T ss_pred --------------------------------------------------------------CCcccccCCccccCHHHH
Confidence 011234799999999999
Q ss_pred cCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChH
Q 035713 339 RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGAT 418 (491)
Q Consensus 339 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ 418 (491)
.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++ +.++..+.+||.+||+.||.+|++....+.
T Consensus 169 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 169 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred cCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC--CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 999999999999999999999999999998888777777777665544 358999999999999999999999766677
Q ss_pred HhhcCCCcCCCChhhhh
Q 035713 419 EIKQHPFFEGVNWALVR 435 (491)
Q Consensus 419 ell~hpff~~~~~~~~~ 435 (491)
++++|+||..++|..+.
T Consensus 247 ~i~~~~~~~~~~~~~~~ 263 (325)
T cd05602 247 EIKNHIFFSPINWDDLI 263 (325)
T ss_pred HHhcCcccCCCCHHHHH
Confidence 99999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-50 Score=399.29 Aligned_cols=262 Identities=36% Similarity=0.709 Sum_probs=221.3
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceEEEEEeccCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFYCLVMEFCSG 178 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~~lV~E~~~g 178 (491)
+.||+|+||.||+|+++.+++.||+|++++...........+.+|+.++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876555555666788899988776 799999999999999999999999999
Q ss_pred CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccc
Q 035713 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258 (491)
Q Consensus 179 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 258 (491)
|+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--------- 149 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--------- 149 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC---------
Confidence 9999887764 56999999999999999999999999999999999999999999999999998432100
Q ss_pred cccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchh
Q 035713 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338 (491)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 338 (491)
.......+||+.|+|||++
T Consensus 150 -------------------------------------------------------------~~~~~~~~gt~~y~aPE~~ 168 (329)
T cd05618 150 -------------------------------------------------------------GDTTSTFCGTPNYIAPEIL 168 (329)
T ss_pred -------------------------------------------------------------CCccccccCCccccCHHHH
Confidence 0011235799999999999
Q ss_pred cCCCCCCcccccchhhHHHhhhcCCCCCCCC--------CcHH-HHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 339 RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQ--------GNRA-TLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 339 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~--------~~~~-~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
.+..++.++|||||||++|||++|+.||... .... ....+......+|. .++..+.+||++||..||++
T Consensus 169 ~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~ll~~~L~~dP~~ 246 (329)
T cd05618 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASVLKSFLNKDPKE 246 (329)
T ss_pred cCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHhcCCHHH
Confidence 9999999999999999999999999999521 1112 23345555566664 48999999999999999999
Q ss_pred CCCcC--CChHHhhcCCCcCCCChhhhh
Q 035713 410 RIAYK--RGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 410 R~t~~--~~~~ell~hpff~~~~~~~~~ 435 (491)
|++.. .++.++++||||+.++|..+.
T Consensus 247 R~~~~~~~~~~~i~~hp~f~~~~~~~~~ 274 (329)
T cd05618 247 RLGCHPQTGFADIQGHPFFRNVDWDLME 274 (329)
T ss_pred cCCCCCCCCHHHHhcCCCCCCCCHHHHH
Confidence 99832 235899999999999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=402.64 Aligned_cols=261 Identities=39% Similarity=0.689 Sum_probs=224.5
Q ss_pred eeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc---CCCCccceeeeEEeCceEEEEEeccCC
Q 035713 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL---DHPFLPTLYSYFETDKFYCLVMEFCSG 178 (491)
Q Consensus 102 iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l---~hp~iv~l~~~~~~~~~~~lV~E~~~g 178 (491)
||+|+||+||+|+++.+++.||||++.+...........+..|..++..+ +||||+.++++|.+...+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999876555555555666777777765 699999999999999999999999999
Q ss_pred CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccc
Q 035713 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258 (491)
Q Consensus 179 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 258 (491)
|+|..++... +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--------- 149 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--------- 149 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC---------
Confidence 9999888764 56999999999999999999999999999999999999999999999999998432110
Q ss_pred cccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchh
Q 035713 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338 (491)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 338 (491)
.......+||+.|+|||++
T Consensus 150 -------------------------------------------------------------~~~~~~~~gt~~y~aPE~~ 168 (330)
T cd05586 150 -------------------------------------------------------------NKTTNTFCGTTEYLAPEVL 168 (330)
T ss_pred -------------------------------------------------------------CCCccCccCCccccCHHHH
Confidence 0011235799999999999
Q ss_pred cCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCCh
Q 035713 339 RGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGA 417 (491)
Q Consensus 339 ~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~ 417 (491)
.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+......++.. .++.++++||.+||..||.+|++....+
T Consensus 169 ~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~li~~~L~~~P~~R~~~~~~~ 247 (330)
T cd05586 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN-VLSDEGRQFVKGLLNRNPQHRLGAHRDA 247 (330)
T ss_pred cCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCc-cCCHHHHHHHHHHcCCCHHHCCCCCCCH
Confidence 8654 7999999999999999999999999888777777777766666643 5789999999999999999999765559
Q ss_pred HHhhcCCCcCCCChhhhh
Q 035713 418 TEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 418 ~ell~hpff~~~~~~~~~ 435 (491)
.++++||||..++|..+.
T Consensus 248 ~~ll~h~~~~~~~~~~~~ 265 (330)
T cd05586 248 VELKEHPFFADIDWDLLS 265 (330)
T ss_pred HHHhcCccccCCCHHHHH
Confidence 999999999999998764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-50 Score=398.63 Aligned_cols=263 Identities=37% Similarity=0.670 Sum_probs=226.0
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHH-HHhhcCCCCccceeeeEEeCceEEEEEeccCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE-ILGLLDHPFLPTLYSYFETDKFYCLVMEFCSG 178 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~-il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~g 178 (491)
+.||+|+||+||+|+++.+|+.||||++.+...........+..|.. +++.++||||+++++++..++.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999998765444444455556655 56789999999999999999999999999999
Q ss_pred CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccc
Q 035713 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258 (491)
Q Consensus 179 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 258 (491)
|+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--------- 149 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--------- 149 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC---------
Confidence 9999888764 56999999999999999999999999999999999999999999999999997432100
Q ss_pred cccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchh
Q 035713 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338 (491)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 338 (491)
.......+||+.|+|||++
T Consensus 150 -------------------------------------------------------------~~~~~~~~gt~~y~aPE~~ 168 (325)
T cd05604 150 -------------------------------------------------------------SDTTTTFCGTPEYLAPEVI 168 (325)
T ss_pred -------------------------------------------------------------CCCcccccCChhhCCHHHH
Confidence 0011234799999999999
Q ss_pred cCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChH
Q 035713 339 RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGAT 418 (491)
Q Consensus 339 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ 418 (491)
.+..++.++|||||||++|||++|+.||.+.+..+.+..++......+ +.++..+.+||.+||..||.+|++.+..+.
T Consensus 169 ~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 169 RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR--PGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred cCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC--CCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 999999999999999999999999999998887777777777665544 358899999999999999999999766678
Q ss_pred HhhcCCCcCCCChhhhhc
Q 035713 419 EIKQHPFFEGVNWALVRS 436 (491)
Q Consensus 419 ell~hpff~~~~~~~~~~ 436 (491)
++++||||..++|..+..
T Consensus 247 ~i~~h~~f~~~~~~~~~~ 264 (325)
T cd05604 247 EIQEHPFFESLSWTDLEQ 264 (325)
T ss_pred HHhcCCCcCCCCHHHHHh
Confidence 999999999999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-50 Score=396.58 Aligned_cols=258 Identities=37% Similarity=0.754 Sum_probs=221.4
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhh-cCCCCccceeeeEEeCceEEEEEeccCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL-LDHPFLPTLYSYFETDKFYCLVMEFCSG 178 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~-l~hp~iv~l~~~~~~~~~~~lV~E~~~g 178 (491)
+.||+|+||+||+|++..+++.||||++++..............|..+++. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999987644333445556678888876 4899999999999999999999999999
Q ss_pred CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccc
Q 035713 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258 (491)
Q Consensus 179 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 258 (491)
|+|..++... ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-------- 150 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-------- 150 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--------
Confidence 9999988764 469999999999999999999999999999999999999999999999999984321000
Q ss_pred cccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchh
Q 035713 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338 (491)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 338 (491)
......+||+.|+|||++
T Consensus 151 --------------------------------------------------------------~~~~~~~gt~~y~aPE~~ 168 (316)
T cd05619 151 --------------------------------------------------------------AKTCTFCGTPDYIAPEIL 168 (316)
T ss_pred --------------------------------------------------------------CceeeecCCccccCHHHH
Confidence 011134799999999999
Q ss_pred cCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChH
Q 035713 339 RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGAT 418 (491)
Q Consensus 339 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ 418 (491)
.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++. .++.++++||.+||+.||++|++ +.
T Consensus 169 ~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~----~~ 242 (316)
T cd05619 169 LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--WLTREAKDILVKLFVREPERRLG----VK 242 (316)
T ss_pred cCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHhccCHhhcCC----Ch
Confidence 9999999999999999999999999999988777666666555554544 48999999999999999999999 64
Q ss_pred -HhhcCCCcCCCChhhhh
Q 035713 419 -EIKQHPFFEGVNWALVR 435 (491)
Q Consensus 419 -ell~hpff~~~~~~~~~ 435 (491)
++++||||+.++|..+.
T Consensus 243 ~~l~~h~~~~~~~~~~~~ 260 (316)
T cd05619 243 GDIRQHPFFREIDWSALE 260 (316)
T ss_pred HHHHcCcccCCCCHHHHH
Confidence 89999999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=407.74 Aligned_cols=253 Identities=32% Similarity=0.513 Sum_probs=218.2
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CC-----CccceeeeEEeCce
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HP-----FLPTLYSYFETDKF 168 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp-----~iv~l~~~~~~~~~ 168 (491)
+|.|++.||+|+||.|-+|.+.+|++.||||+|+.. .....+...|+.||..|+ |. |||+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 689999999999999999999999999999999765 355666778999999996 32 89999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc--CCcEEEeeccccccc
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD--EGHIMLSDFDLSLRC 246 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~--~g~vkL~DFGla~~~ 246 (491)
+|||+|.+ +.+|+++++.+.-..|+...++.++.||+.||.+||++||||+|||||||||.. ...|||+|||.|...
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999999 789999999887788999999999999999999999999999999999999974 347999999998542
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
. ....++
T Consensus 342 ~-------------------------------------------------------------------------q~vytY 348 (586)
T KOG0667|consen 342 S-------------------------------------------------------------------------QRVYTY 348 (586)
T ss_pred C-------------------------------------------------------------------------Ccceee
Confidence 1 112257
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---C---------------------
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---P--------------------- 382 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~--------------------- 382 (491)
+.+..|+|||+++|.+|+.++||||||||++||++|.+.|.|.++.+++..|++- +
T Consensus 349 iQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~ 428 (586)
T KOG0667|consen 349 IQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGF 428 (586)
T ss_pred eeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCc
Confidence 8999999999999999999999999999999999999999999999988776531 0
Q ss_pred ----------------------------CcCC-CC-------C-CCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCC
Q 035713 383 ----------------------------LRFP-ET-------P-QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425 (491)
Q Consensus 383 ----------------------------~~~~-~~-------~-~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpf 425 (491)
...| .. . .-...+.|||++||.+||.+|+| +.++|+|||
T Consensus 429 ~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t----p~qal~Hpf 504 (586)
T KOG0667|consen 429 PRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT----PAQALNHPF 504 (586)
T ss_pred eeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC----HHHHhcCcc
Confidence 0001 00 0 11134789999999999999999 999999999
Q ss_pred cCCC
Q 035713 426 FEGV 429 (491)
Q Consensus 426 f~~~ 429 (491)
|.+.
T Consensus 505 l~~~ 508 (586)
T KOG0667|consen 505 LTGT 508 (586)
T ss_pred cccc
Confidence 9854
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-52 Score=375.45 Aligned_cols=266 Identities=31% Similarity=0.490 Sum_probs=230.9
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchh-----hhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeC
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASL-----ASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETD 166 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~-----~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~ 166 (491)
.+.|.-.+.||.|..++|-+|.++.+|+.+|+|+|..... .-....+....|+.||+++ .||+|+.|.++|+++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 3568888999999999999999999999999999864321 1223344567899999998 599999999999999
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
..+|+|+|.|+.|.|++++... -.++|...+.+++|++.|++|||.++||||||||+|||++++-.+||+|||+|..+
T Consensus 96 sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 9999999999999999999875 56999999999999999999999999999999999999999999999999999765
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
..... -...
T Consensus 174 ~~Gek-----------------------------------------------------------------------Lrel 182 (411)
T KOG0599|consen 174 EPGEK-----------------------------------------------------------------------LREL 182 (411)
T ss_pred CCchh-----------------------------------------------------------------------HHHh
Confidence 43221 2246
Q ss_pred ccccCccCcchhcC------CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcC--CCCCCCCHHHHHH
Q 035713 327 VGTHEYLAPEIIRG------EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF--PETPQVSFVARDL 398 (491)
Q Consensus 327 ~gt~~y~aPE~l~~------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~s~~~~~l 398 (491)
||||+|+|||.+.. .+|+..+|+||+|||||.||.|.+||........+..|+.+.++| |++..++...+||
T Consensus 183 CGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdL 262 (411)
T KOG0599|consen 183 CGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDL 262 (411)
T ss_pred cCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHH
Confidence 99999999999974 358889999999999999999999999877777778888887766 5667899999999
Q ss_pred HHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhhh
Q 035713 399 IRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 399 i~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~~ 435 (491)
|.+||+.||.+|+| ++|+|+||||..+-....+
T Consensus 263 IsrlLqVdp~~Rit----ake~LaHpff~q~~~~~~r 295 (411)
T KOG0599|consen 263 ISRLLQVDPTKRIT----AKEALAHPFFIQIAQQQAR 295 (411)
T ss_pred HHHHHeeCchhccc----HHHHhcChHHHHHHHhccc
Confidence 99999999999999 9999999999765444333
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=396.54 Aligned_cols=263 Identities=40% Similarity=0.726 Sum_probs=225.2
Q ss_pred eeeeeccCceEEEEEEEe---CCCcEEEEEEeecchhh-hHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 99 LKRLGYGDIGSVYLVELR---GTNTYFAMKVMDKASLA-SRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 99 ~~~iG~G~~g~V~~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
++.||+|+||.||+|++. .+++.||||++++.... .......+.+|+++|+.++||||++++++|..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 468999999999999874 47889999999875432 23344567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|+.|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----- 153 (323)
T cd05584 81 YLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE----- 153 (323)
T ss_pred CCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-----
Confidence 99999999988764 56899999999999999999999999999999999999999999999999998532110
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
.......+||+.|+|
T Consensus 154 -----------------------------------------------------------------~~~~~~~~gt~~y~a 168 (323)
T cd05584 154 -----------------------------------------------------------------GTVTHTFCGTIEYMA 168 (323)
T ss_pred -----------------------------------------------------------------CCcccccCCCccccC
Confidence 001113479999999
Q ss_pred cchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc-
Q 035713 335 PEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY- 413 (491)
Q Consensus 335 PE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~- 413 (491)
||++.+..++.++|||||||++|||++|+.||.+.+....+..+......++. .+++++.+||.+||+.||++|++.
T Consensus 169 PE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~ 246 (323)
T cd05584 169 PEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP--YLTPEARDLLKKLLKRNPSSRLGAG 246 (323)
T ss_pred hhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHcccCHhHcCCCC
Confidence 99999998999999999999999999999999998888778888777666554 489999999999999999999931
Q ss_pred CCChHHhhcCCCcCCCChhhhh
Q 035713 414 KRGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 414 ~~~~~ell~hpff~~~~~~~~~ 435 (491)
...++++++||||...+|..+.
T Consensus 247 ~~~~~~l~~h~~~~~~~~~~~~ 268 (323)
T cd05584 247 PGDAAEVQSHPFFRHVNWDDLL 268 (323)
T ss_pred CCCHHHHhcCCCcCCCCHHHHh
Confidence 1129999999999999998663
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=396.94 Aligned_cols=262 Identities=35% Similarity=0.702 Sum_probs=223.3
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceEEEEEeccCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFYCLVMEFCSG 178 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~~lV~E~~~g 178 (491)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..+ +||||+.+++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999887666666677788999999888 699999999999999999999999999
Q ss_pred CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccc
Q 035713 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258 (491)
Q Consensus 179 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 258 (491)
|+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--------- 149 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--------- 149 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC---------
Confidence 9999888764 46999999999999999999999999999999999999999999999999997431100
Q ss_pred cccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchh
Q 035713 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338 (491)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 338 (491)
.....+.+||+.|+|||++
T Consensus 150 -------------------------------------------------------------~~~~~~~~gt~~y~aPE~~ 168 (327)
T cd05617 150 -------------------------------------------------------------GDTTSTFCGTPNYIAPEIL 168 (327)
T ss_pred -------------------------------------------------------------CCceecccCCcccCCHHHH
Confidence 0011235799999999999
Q ss_pred cCCCCCCcccccchhhHHHhhhcCCCCCCCC------CcHH-HHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 339 RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQ------GNRA-TLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 339 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~------~~~~-~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
.+..++.++|||||||+||||++|+.||... .... ....+...+..+|. .++..+.+||.+||..||.+|+
T Consensus 169 ~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~ 246 (327)
T cd05617 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR--FLSVKASHVLKGFLNKDPKERL 246 (327)
T ss_pred CCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhccCHHHcC
Confidence 9999999999999999999999999999642 1222 33444555555554 4899999999999999999999
Q ss_pred CcC--CChHHhhcCCCcCCCChhhhh
Q 035713 412 AYK--RGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 412 t~~--~~~~ell~hpff~~~~~~~~~ 435 (491)
+.. .+++++++||||+.++|..+.
T Consensus 247 ~~~~~~~~~~i~~h~~f~~~~~~~~~ 272 (327)
T cd05617 247 GCQPQTGFSDIKSHTFFRSIDWDLLE 272 (327)
T ss_pred CCCCCCCHHHHHcCCCCCCCCHHHHH
Confidence 842 346899999999999999774
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-50 Score=396.58 Aligned_cols=262 Identities=39% Similarity=0.759 Sum_probs=227.0
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceEEEEEeccCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFYCLVMEFCSG 178 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~~lV~E~~~g 178 (491)
+.||+|+||+||+|+++.+++.||||++.+...........+.+|+++++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999877655556666778899999888 699999999999999999999999999
Q ss_pred CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccc
Q 035713 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258 (491)
Q Consensus 179 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 258 (491)
++|..++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--------- 149 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--------- 149 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC---------
Confidence 9999888764 46999999999999999999999999999999999999999999999999997431100
Q ss_pred cccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchh
Q 035713 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338 (491)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 338 (491)
.......+||+.|+|||++
T Consensus 150 -------------------------------------------------------------~~~~~~~~g~~~y~aPE~~ 168 (318)
T cd05570 150 -------------------------------------------------------------GVTTSTFCGTPDYIAPEIL 168 (318)
T ss_pred -------------------------------------------------------------CCcccceecCccccCHHHh
Confidence 0011234799999999999
Q ss_pred cCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc-CCCh
Q 035713 339 RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY-KRGA 417 (491)
Q Consensus 339 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-~~~~ 417 (491)
.+..++.++|||||||++|+|++|+.||.+.+....+..+......++. .++.++.+||.+||+.||.+|++. ....
T Consensus 169 ~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~dP~~R~s~~~~~~ 246 (318)
T cd05570 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR--WLSKEAKSILKSFLTKNPEKRLGCLPTGE 246 (318)
T ss_pred cCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC--cCCHHHHHHHHHHccCCHHHcCCCCCCCH
Confidence 9999999999999999999999999999988877777777777666664 489999999999999999999991 0112
Q ss_pred HHhhcCCCcCCCChhhhh
Q 035713 418 TEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 418 ~ell~hpff~~~~~~~~~ 435 (491)
.++++||||+.++|....
T Consensus 247 ~~ll~~~~~~~~~~~~~~ 264 (318)
T cd05570 247 QDIKGHPFFREIDWDKLE 264 (318)
T ss_pred HHHhcCCCcCCCCHHHHH
Confidence 999999999999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=394.86 Aligned_cols=262 Identities=38% Similarity=0.682 Sum_probs=225.1
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHH-HHhhcCCCCccceeeeEEeCceEEEEEeccCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE-ILGLLDHPFLPTLYSYFETDKFYCLVMEFCSG 178 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~-il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~g 178 (491)
+.||+|+||.||+|++..+++.||+|++.+...........+..|+. +++.++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765544444455555654 67889999999999999999999999999999
Q ss_pred CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccc
Q 035713 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258 (491)
Q Consensus 179 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 258 (491)
++|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-------- 150 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-------- 150 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--------
Confidence 9998887764 569999999999999999999999999999999999999999999999999974311000
Q ss_pred cccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchh
Q 035713 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338 (491)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 338 (491)
......+||+.|+|||++
T Consensus 151 --------------------------------------------------------------~~~~~~~gt~~y~aPE~~ 168 (321)
T cd05603 151 --------------------------------------------------------------ETTSTFCGTPEYLAPEVL 168 (321)
T ss_pred --------------------------------------------------------------CccccccCCcccCCHHHh
Confidence 011134799999999999
Q ss_pred cCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChH
Q 035713 339 RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGAT 418 (491)
Q Consensus 339 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ 418 (491)
.+..++.++|||||||++|||++|+.||.+.+.......++..+..++. ..+.++.+||.+||+.||.+|++....+.
T Consensus 169 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (321)
T cd05603 169 RKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPG--GKTVAACDLLVGLLHKDQRRRLGAKADFL 246 (321)
T ss_pred cCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHccCCHhhcCCCCCCHH
Confidence 9989999999999999999999999999988877777778777666654 47899999999999999999998655577
Q ss_pred HhhcCCCcCCCChhhhh
Q 035713 419 EIKQHPFFEGVNWALVR 435 (491)
Q Consensus 419 ell~hpff~~~~~~~~~ 435 (491)
++++|+||..++|..+.
T Consensus 247 ~~~~~~~~~~~~~~~~~ 263 (321)
T cd05603 247 EIKNHVFFSPINWDDLY 263 (321)
T ss_pred HHhCCCCcCCCCHHHHh
Confidence 99999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=392.24 Aligned_cols=312 Identities=57% Similarity=0.992 Sum_probs=255.3
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++.+.||+|+||.||+|.+..+++.||||.+.+...........+.+|+++|+.++|+||+++++.+..++..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998765555556677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+.|++|.+++....+..+++..++.++.||+.||.|||++|++||||||+||+|+.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999999887656679999999999999999999999999999999999999999999999999986443211100
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.... ...+... ..... ...............++||..|+
T Consensus 161 ~~~~----------------------------~~~~~~~------~~~~~-------~~~~~~~~~~~~~~~~~g~~~y~ 199 (316)
T cd05574 161 SKAL----------------------------RKGSRRS------SVNSI-------PSETFSEEPSFRSNSFVGTEEYI 199 (316)
T ss_pred cccc----------------------------ccccccc------ccccc-------chhhhcccccCCCCCCcCccCCc
Confidence 0000 0000000 00000 00001111122333568999999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
|||++.+..++.++|||||||++|+|++|+.||.+.+....+.++......++....++..+++||.+||+.||++||+.
T Consensus 200 aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~ 279 (316)
T cd05574 200 APEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGS 279 (316)
T ss_pred CHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCc
Confidence 99999998899999999999999999999999998888888888887777777665689999999999999999999998
Q ss_pred CCChHHhhcCCCcCCCChhhhhccCCCCCCCCC
Q 035713 414 KRGATEIKQHPFFEGVNWALVRSALPPHIPEPV 446 (491)
Q Consensus 414 ~~~~~ell~hpff~~~~~~~~~~~~~~~~p~~~ 446 (491)
+.+++++|+||||++++|..++...||.+|.+.
T Consensus 280 ~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (316)
T cd05574 280 KRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPD 312 (316)
T ss_pred hhhHHHHHcCchhhcCChhhcccCCCCCCCCcc
Confidence 888999999999999999999887777776654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=397.10 Aligned_cols=256 Identities=29% Similarity=0.401 Sum_probs=208.2
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
..++|+++++||+|+||.||+|++..+++.||||++.... .......+.+|+++|+.++|+||+++++++...+.+|+
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 4578999999999999999999999999999999986542 23445567899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||+++++|... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 150 v~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 150 LLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred EEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999999998642 236788889999999999999999999999999999999999999999999985432100
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
......+||..
T Consensus 223 ---------------------------------------------------------------------~~~~~~~gt~~ 233 (353)
T PLN00034 223 ---------------------------------------------------------------------DPCNSSVGTIA 233 (353)
T ss_pred ---------------------------------------------------------------------ccccccccCcc
Confidence 00112479999
Q ss_pred ccCcchhcC-----CCCCCcccccchhhHHHhhhcCCCCCCCCCcHH--HHHHHHcCCCcCCCCCCCCHHHHHHHHhhhc
Q 035713 332 YLAPEIIRG-----EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRA--TLFNVVGQPLRFPETPQVSFVARDLIRGLLV 404 (491)
Q Consensus 332 y~aPE~l~~-----~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~ 404 (491)
|+|||++.. ..++.++|||||||++|||++|+.||....... .+...+...........++.++++||.+||+
T Consensus 234 y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 313 (353)
T PLN00034 234 YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQ 313 (353)
T ss_pred ccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHcc
Confidence 999999853 223568999999999999999999997433222 1211111111222234588999999999999
Q ss_pred cCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 405 KEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 405 ~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
.||++||+ +.||++||||...
T Consensus 314 ~~P~~Rpt----~~ell~hp~~~~~ 334 (353)
T PLN00034 314 REPAKRWS----AMQLLQHPFILRA 334 (353)
T ss_pred CChhhCcC----HHHHhcCcccccC
Confidence 99999999 9999999999864
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=395.55 Aligned_cols=268 Identities=44% Similarity=0.800 Sum_probs=221.0
Q ss_pred CceEeeeeeccCceEEEEEEEe---CCCcEEEEEEeecchhh-hHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCceE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELR---GTNTYFAMKVMDKASLA-SRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKFY 169 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~ 169 (491)
+|++++.||+|+||+||+|++. .+++.||+|++.+.... .......+.+|+++|+.++ |+||++++++|..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 47899999999765432 2334556788999999994 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999988764 45999999999999999999999999999999999999999999999999998543110
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
. ......++||
T Consensus 159 ~---------------------------------------------------------------------~~~~~~~~gt 169 (332)
T cd05614 159 E---------------------------------------------------------------------KERTYSFCGT 169 (332)
T ss_pred C---------------------------------------------------------------------CCccccccCC
Confidence 0 0011235799
Q ss_pred cCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCc----HHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhc
Q 035713 330 HEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGN----RATLFNVVGQPLRFPETPQVSFVARDLIRGLLV 404 (491)
Q Consensus 330 ~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~ 404 (491)
+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ......+......++ ..++..+.+||.+||+
T Consensus 170 ~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~ 247 (332)
T cd05614 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP--SFIGPEAQDLLHKLLR 247 (332)
T ss_pred ccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHcC
Confidence 9999999998764 78899999999999999999999975332 222233444444444 3589999999999999
Q ss_pred cCCCCCCCcC-CChHHhhcCCCcCCCChhhhh
Q 035713 405 KEPHKRIAYK-RGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 405 ~dP~~R~t~~-~~~~ell~hpff~~~~~~~~~ 435 (491)
.||++|++.. ..++++++||||+..+|..+.
T Consensus 248 ~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~ 279 (332)
T cd05614 248 KDPKKRLGAGPQGASEIKEHPFFKGLDWEALA 279 (332)
T ss_pred CCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 9999999521 138999999999999998663
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=387.81 Aligned_cols=263 Identities=30% Similarity=0.609 Sum_probs=220.9
Q ss_pred eeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccCCCch
Q 035713 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNL 181 (491)
Q Consensus 102 iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~gg~L 181 (491)
||+|+||+||+|.++.+++.||+|++.+...........+..|+++|+.++|+||++++++|..+..+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999876555555566778899999999999999999999999999999999999999
Q ss_pred HHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccccccc
Q 035713 182 HSLRQKQ--PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVS 259 (491)
Q Consensus 182 ~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 259 (491)
..++... .+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--------- 151 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--------- 151 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---------
Confidence 8876432 23569999999999999999999999999999999999999999999999999985432100
Q ss_pred ccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhc
Q 035713 260 VNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIR 339 (491)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 339 (491)
.......||+.|+|||++.
T Consensus 152 -------------------------------------------------------------~~~~~~~g~~~y~aPE~~~ 170 (280)
T cd05608 152 -------------------------------------------------------------SKTKGYAGTPGFMAPELLQ 170 (280)
T ss_pred -------------------------------------------------------------ccccccCCCcCccCHHHhc
Confidence 0011246899999999999
Q ss_pred CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHH----HHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCC
Q 035713 340 GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRA----TLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKR 415 (491)
Q Consensus 340 ~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~ 415 (491)
+..++.++|||||||++|||++|+.||....... ....+......++ ..++.++.+||.+||+.||++|++.+.
T Consensus 171 ~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ 248 (280)
T cd05608 171 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYP--DKFSPASKSFCEALLAKDPEKRLGFRD 248 (280)
T ss_pred CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCc--ccCCHHHHHHHHHHhcCCHHHhcCCCC
Confidence 9999999999999999999999999998754322 2233333433333 358999999999999999999996432
Q ss_pred -ChHHhhcCCCcCCCChhhhhc
Q 035713 416 -GATEIKQHPFFEGVNWALVRS 436 (491)
Q Consensus 416 -~~~ell~hpff~~~~~~~~~~ 436 (491)
.++++++||||++++|..+..
T Consensus 249 ~~~~~~l~h~~~~~~~~~~~~~ 270 (280)
T cd05608 249 GNCDGLRTHPLFRDLNWRQLEA 270 (280)
T ss_pred CCHHHHhcChhhhcCCHhHHhh
Confidence 489999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=399.54 Aligned_cols=260 Identities=28% Similarity=0.481 Sum_probs=235.3
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCce-EEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKF-YCL 171 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~-~~l 171 (491)
+++|..+++||+|+||.+++++++..++.||+|.|+......+... ...+|+.++++++|||||.+++.|..++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~-~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERR-SAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhH-HHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 4789999999999999999999999999999999987765544433 66789999999999999999999998887 999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||+||+||+|.+.+..+++..|+++.+..|+.||+.||.|||+++|+|||||+.||+++.++.|||+|||+|+.+.....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 99999999999999988778899999999999999999999999999999999999999999999999999977643221
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
...+++||+.
T Consensus 162 ----------------------------------------------------------------------~a~tvvGTp~ 171 (426)
T KOG0589|consen 162 ----------------------------------------------------------------------LASTVVGTPY 171 (426)
T ss_pred ----------------------------------------------------------------------hhheecCCCc
Confidence 2235799999
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
||+||++.+.+|+.++|||||||++|||++-+++|.+.+-...+.+|.... -.|....++.+++.||+.||..+|..||
T Consensus 172 YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~RP 250 (426)
T KOG0589|consen 172 YMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVKSMLRKNPEHRP 250 (426)
T ss_pred ccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHHHHhhcCCccCC
Confidence 999999999999999999999999999999999999998888888888776 3455567999999999999999999999
Q ss_pred CcCCChHHhhcCCCcCC
Q 035713 412 AYKRGATEIKQHPFFEG 428 (491)
Q Consensus 412 t~~~~~~ell~hpff~~ 428 (491)
+ +.+||.+|..+.
T Consensus 251 s----a~~LL~~P~l~~ 263 (426)
T KOG0589|consen 251 S----ALELLRRPHLLR 263 (426)
T ss_pred C----HHHHhhChhhhh
Confidence 9 999999998764
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=385.27 Aligned_cols=263 Identities=30% Similarity=0.540 Sum_probs=219.4
Q ss_pred eeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccCCCch
Q 035713 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNL 181 (491)
Q Consensus 102 iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~gg~L 181 (491)
||+|+||.||+++++.+|+.||+|++.+...........+..|+++|+.++||||+++++++.++..+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765544333444556799999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccccccccc
Q 035713 182 HSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVN 261 (491)
Q Consensus 182 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 261 (491)
..++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----------- 149 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----------- 149 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-----------
Confidence 988876544569999999999999999999999999999999999999999999999999985432100
Q ss_pred CCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCC
Q 035713 262 NGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGE 341 (491)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 341 (491)
......||..|+|||++.+.
T Consensus 150 ------------------------------------------------------------~~~~~~~~~~y~aPE~~~~~ 169 (277)
T cd05607 150 ------------------------------------------------------------TITQRAGTNGYMAPEILKEE 169 (277)
T ss_pred ------------------------------------------------------------eeeccCCCCCccCHHHHccC
Confidence 00123688999999999998
Q ss_pred CCCCcccccchhhHHHhhhcCCCCCCCCCcH----HHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCCh
Q 035713 342 GHGSAVDWWTFGIFLYELLHGTTPFKGQGNR----ATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGA 417 (491)
Q Consensus 342 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~ 417 (491)
.++.++|||||||++|||++|+.||.+.... .....+......++. ..++.++++||.+||+.||++|++.++..
T Consensus 170 ~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 170 PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEH-QNFTEESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccccc-ccCCHHHHHHHHHHhccCHhhCCCCccch
Confidence 9999999999999999999999999765332 222333333333322 35899999999999999999999955445
Q ss_pred HHhhcCCCcCCCChhhhhc
Q 035713 418 TEIKQHPFFEGVNWALVRS 436 (491)
Q Consensus 418 ~ell~hpff~~~~~~~~~~ 436 (491)
+++++||||+.++|..++.
T Consensus 249 ~~~~~h~~f~~~~~~~~~~ 267 (277)
T cd05607 249 DDPRKHEFFKTINFPRLEA 267 (277)
T ss_pred hhhhcChhhcCCCHHHHhc
Confidence 8899999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=392.95 Aligned_cols=251 Identities=29% Similarity=0.459 Sum_probs=216.0
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcE-EEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc-
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTY-FAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK- 167 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~-vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~- 167 (491)
.+...+..+.+.||+|+||+||+|.+++ .. ||||++......... ...+.+|+.+|.+++|||||+++|++....
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4455677778889999999999999994 44 999999876544444 778999999999999999999999999887
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-cccccCCCCCEEEccCC-cEEEeecccccc
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG-IVYRDLKPENVLVRDEG-HIMLSDFDLSLR 245 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g-ivHrDikp~NILl~~~g-~vkL~DFGla~~ 245 (491)
.++|||||+++|+|.+++.....+.++...+..++.||++||.|||+++ ||||||||+|||++.++ ++||||||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 7999999999999999998754577999999999999999999999999 99999999999999998 999999999965
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
..... ...+.
T Consensus 194 ~~~~~----------------------------------------------------------------------~~~~~ 203 (362)
T KOG0192|consen 194 KVISK----------------------------------------------------------------------TSMTS 203 (362)
T ss_pred ecccc----------------------------------------------------------------------ccccC
Confidence 42110 00111
Q ss_pred cccccCccCcchhc--CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhh
Q 035713 326 FVGTHEYLAPEIIR--GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLL 403 (491)
Q Consensus 326 ~~gt~~y~aPE~l~--~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L 403 (491)
..||+.|||||++. ...|+.++||||||++||||+||+.||.+.........++....+.+....+++.+..||.+||
T Consensus 204 ~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW 283 (362)
T KOG0192|consen 204 VAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCW 283 (362)
T ss_pred CCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhC
Confidence 47999999999999 5689999999999999999999999999998866666666565555544559999999999999
Q ss_pred ccCCCCCCCc
Q 035713 404 VKEPHKRIAY 413 (491)
Q Consensus 404 ~~dP~~R~t~ 413 (491)
..||++||++
T Consensus 284 ~~dp~~RP~f 293 (362)
T KOG0192|consen 284 LVDPSRRPSF 293 (362)
T ss_pred CCCCCcCCCH
Confidence 9999999994
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=395.49 Aligned_cols=258 Identities=27% Similarity=0.437 Sum_probs=227.3
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
..|+.+++||+|+||.||+|.+..+++.||+|++.... ....+..++.|+.+|..++++||.++|+.|..+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 46888999999999999999999999999999998663 3455667889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
|||.||++.++++.. ..+.+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||++..+..
T Consensus 91 ey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~----- 163 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN----- 163 (467)
T ss_pred HHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec-----
Confidence 999999999999874 4469999999999999999999999999999999999999999999999999854321
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
+..+..+++||+.||
T Consensus 164 -----------------------------------------------------------------~~~rr~tfvGTPfwM 178 (467)
T KOG0201|consen 164 -----------------------------------------------------------------TVKRRKTFVGTPFWM 178 (467)
T ss_pred -----------------------------------------------------------------hhhcccccccccccc
Confidence 122336789999999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
|||++.+..|+.++||||||++.+||++|.+|+........++.|-...++... ..+++.+++||..||.+||+.||+
T Consensus 179 APEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~-~~~S~~~kEFV~~CL~k~P~~Rps- 256 (467)
T KOG0201|consen 179 APEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLD-GDFSPPFKEFVEACLDKNPEFRPS- 256 (467)
T ss_pred chhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccc-cccCHHHHHHHHHHhhcCcccCcC-
Confidence 999999989999999999999999999999999988776555555544333333 279999999999999999999999
Q ss_pred CCChHHhhcCCCcCCCC
Q 035713 414 KRGATEIKQHPFFEGVN 430 (491)
Q Consensus 414 ~~~~~ell~hpff~~~~ 430 (491)
|.+||+|+|.+...
T Consensus 257 ---A~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 257 ---AKELLKHKFIKRAK 270 (467)
T ss_pred ---HHHHhhhHHHHhcC
Confidence 99999999998754
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=388.96 Aligned_cols=262 Identities=26% Similarity=0.402 Sum_probs=211.2
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.++|+++++||+|+||.||+|+++.+++.||||++...... .....+.+|+++++.++||||+++++++.++..+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 37899999999999999999999999999999998754321 2233466899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+ +++|.+++... .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 157 (303)
T cd07869 82 FEYV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-- 157 (303)
T ss_pred EECC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence 9999 46787777654 3568999999999999999999999999999999999999999999999999984321100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......+||+.|
T Consensus 158 --------------------------------------------------------------------~~~~~~~~~~~y 169 (303)
T cd07869 158 --------------------------------------------------------------------HTYSNEVVTLWY 169 (303)
T ss_pred --------------------------------------------------------------------ccCCCCcccCCC
Confidence 000123689999
Q ss_pred cCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcH-HHHHHHH---cCCCc----------------C----CC
Q 035713 333 LAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNR-ATLFNVV---GQPLR----------------F----PE 387 (491)
Q Consensus 333 ~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~---~~~~~----------------~----~~ 387 (491)
+|||++.+. .++.++|||||||++|+|++|+.||.+.... ..+..+. ..+.. + +.
T Consensus 170 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T cd07869 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPK 249 (303)
T ss_pred CChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCc
Confidence 999998764 4788999999999999999999999876443 2222221 11100 0 00
Q ss_pred -------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 388 -------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 388 -------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
....+.++.+||.+||+.||++|+| +.++|+||||+.+++.
T Consensus 250 ~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s----~~~~l~h~~f~~~~~~ 297 (303)
T cd07869 250 NLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS----AQAALSHEYFSDLPPR 297 (303)
T ss_pred cHHHHhhccCCChHHHHHHHHHhccCchhccC----HHHHhcCcccccCChh
Confidence 0124578899999999999999999 9999999999987653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=386.72 Aligned_cols=256 Identities=27% Similarity=0.444 Sum_probs=212.5
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
+++|+++++||+|+||.||+|+++.+++.||+|+++.... ......+.+|+++++.++||||+++++++.+++.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 5789999999999999999999999999999999865422 12234567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+. ++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-- 157 (288)
T cd07871 82 FEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-- 157 (288)
T ss_pred EeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence 99996 5898888764 3458999999999999999999999999999999999999999999999999985321100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.......||+.|
T Consensus 158 --------------------------------------------------------------------~~~~~~~~~~~y 169 (288)
T cd07871 158 --------------------------------------------------------------------KTYSNEVVTLWY 169 (288)
T ss_pred --------------------------------------------------------------------ccccCceecccc
Confidence 000123689999
Q ss_pred cCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CC----------------CcCCC-----
Q 035713 333 LAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QP----------------LRFPE----- 387 (491)
Q Consensus 333 ~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~----------------~~~~~----- 387 (491)
+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.. .+ ..++.
T Consensus 170 ~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
T cd07871 170 RPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQP 249 (288)
T ss_pred cChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCc
Confidence 99999876 4589999999999999999999999998876665544431 11 00111
Q ss_pred ----CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 388 ----TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 388 ----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
...++.++++||++||+.||.+|+| ++|+|+||||
T Consensus 250 ~~~~~~~~~~~~~dll~~mL~~dp~~R~t----~~~~l~hp~f 288 (288)
T cd07871 250 LINHAPRLDTDGIDLLSSLLLYETKSRIS----AEAALRHSYF 288 (288)
T ss_pred hHHhCCCCCHHHHHHHHHhcCcCcccCCC----HHHHhcCCCC
Confidence 1356889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=385.28 Aligned_cols=257 Identities=28% Similarity=0.411 Sum_probs=213.3
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++++.||+|+||.||+|+++.+++.||+|++..... .......+.+|+++++.++|+||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999976532 2334556778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||++++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 154 (287)
T cd07848 80 EYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS--- 154 (287)
T ss_pred ecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc---
Confidence 99988777655443 2469999999999999999999999999999999999999999999999999985432100
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.......+||+.|+
T Consensus 155 ------------------------------------------------------------------~~~~~~~~~~~~y~ 168 (287)
T cd07848 155 ------------------------------------------------------------------NANYTEYVATRWYR 168 (287)
T ss_pred ------------------------------------------------------------------cccccccccccccC
Confidence 00111247899999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC-------------------CcCCC-------
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP-------------------LRFPE------- 387 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~-------------------~~~~~------- 387 (491)
|||++.+..++.++|||||||++|||++|++||.+.+....+..+.... ..++.
T Consensus 169 aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (287)
T cd07848 169 SPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSL 248 (287)
T ss_pred CcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccH
Confidence 9999999899999999999999999999999999876655444332110 01111
Q ss_pred ----CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 388 ----TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 388 ----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
...++.++.+||++||++||++|++ ++++|+||||
T Consensus 249 ~~~~~~~~s~~~~dll~~~L~~~P~~R~s----~~~~l~hp~f 287 (287)
T cd07848 249 ERRYLGILSGVLLDLMKNLLKLNPTDRYL----TEQCLNHPAF 287 (287)
T ss_pred HHhhhcccCHHHHHHHHHHccCCcccCCC----HHHHhcCCCC
Confidence 0136788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=381.99 Aligned_cols=279 Identities=34% Similarity=0.603 Sum_probs=229.8
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48889999999999999999999999999999977654444445567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|++|++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc----
Confidence 9999999998876545569999999999999999999999999999999999999999999999999874321000
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
.....+||..|+|
T Consensus 157 -------------------------------------------------------------------~~~~~~g~~~y~a 169 (285)
T cd05630 157 -------------------------------------------------------------------TIKGRVGTVGYMA 169 (285)
T ss_pred -------------------------------------------------------------------cccCCCCCccccC
Confidence 0012368999999
Q ss_pred cchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcH---HHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 335 PEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR---ATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 335 PE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
||++.+..++.++|||||||++|+|++|+.||.+.... .....++.. ........++.++.+||.+||+.||++|+
T Consensus 170 PE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 248 (285)
T cd05630 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSEKFSPDARSLCKMLLCKDPKERL 248 (285)
T ss_pred hHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcCccCCHHHHHHHHHHhhcCHHHcc
Confidence 99999999999999999999999999999999865432 222222211 11112235889999999999999999999
Q ss_pred CcC-CChHHhhcCCCcCCCChhhhhc--cCCCCCCCC
Q 035713 412 AYK-RGATEIKQHPFFEGVNWALVRS--ALPPHIPEP 445 (491)
Q Consensus 412 t~~-~~~~ell~hpff~~~~~~~~~~--~~~~~~p~~ 445 (491)
++. ..++++++||||+.++|..+.. ..|++.|.|
T Consensus 249 s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05630 249 GCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPDP 285 (285)
T ss_pred CCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCCC
Confidence 842 2478999999999999997754 445666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=405.02 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=203.9
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCC------CCccceeeeE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH------PFLPTLYSYF 163 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h------p~iv~l~~~~ 163 (491)
.+..++|+++++||+|+||+||+|++..+++.||||+++... ........|+++++.++| .+|+.++++|
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 345688999999999999999999999999999999996532 122334567777776654 4588999998
Q ss_pred EeC-ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCCEEEccCC--------
Q 035713 164 ETD-KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEG-------- 233 (491)
Q Consensus 164 ~~~-~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~NILl~~~g-------- 233 (491)
..+ +++|||||++ |++|.+++... +.+++..++.|+.||+.||.|||+ .|||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccc
Confidence 764 6899999998 88898888764 569999999999999999999998 5999999999999998765
Q ss_pred --------cEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCC
Q 035713 234 --------HIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGP 305 (491)
Q Consensus 234 --------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (491)
.+||+|||++....
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~---------------------------------------------------------- 299 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDER---------------------------------------------------------- 299 (467)
T ss_pred cccCCCCceEEECCCCccccCc----------------------------------------------------------
Confidence 49999999863210
Q ss_pred CCCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcC
Q 035713 306 CVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF 385 (491)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 385 (491)
.....++||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+......+
T Consensus 300 ---------------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~ 364 (467)
T PTZ00284 300 ---------------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364 (467)
T ss_pred ---------------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence 01123589999999999999999999999999999999999999999877655444332110000
Q ss_pred C------------------------C----------------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCC
Q 035713 386 P------------------------E----------------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425 (491)
Q Consensus 386 ~------------------------~----------------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpf 425 (491)
| . .....+.+.|||.+||++||++|++ ++|||+|||
T Consensus 365 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t----a~e~L~Hp~ 440 (467)
T PTZ00284 365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN----ARQMTTHPY 440 (467)
T ss_pred CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC----HHHHhcCcc
Confidence 0 0 0011356789999999999999999 999999999
Q ss_pred cCCC
Q 035713 426 FEGV 429 (491)
Q Consensus 426 f~~~ 429 (491)
|...
T Consensus 441 ~~~~ 444 (467)
T PTZ00284 441 VLKY 444 (467)
T ss_pred cccc
Confidence 9854
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-49 Score=389.33 Aligned_cols=262 Identities=40% Similarity=0.771 Sum_probs=225.6
Q ss_pred eeeeeccCceEEEEEEEe---CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEec
Q 035713 99 LKRLGYGDIGSVYLVELR---GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEF 175 (491)
Q Consensus 99 ~~~iG~G~~g~V~~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~ 175 (491)
++.||+|+||.||++++. .+|+.||+|++.+.... ......+.+|+++|+.++||||+++++++.+++.+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 367999999999999873 57899999999865433 23344567899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccc
Q 035713 176 CSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKS 255 (491)
Q Consensus 176 ~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 255 (491)
+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~----- 152 (318)
T cd05582 80 LRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE----- 152 (318)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-----
Confidence 9999999988764 569999999999999999999999999999999999999999999999999985321100
Q ss_pred ccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCc
Q 035713 256 SSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAP 335 (491)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 335 (491)
......+||+.|+||
T Consensus 153 -----------------------------------------------------------------~~~~~~~g~~~y~aP 167 (318)
T cd05582 153 -----------------------------------------------------------------KKAYSFCGTVEYMAP 167 (318)
T ss_pred -----------------------------------------------------------------CceecccCChhhcCH
Confidence 011234799999999
Q ss_pred chhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcC-
Q 035713 336 EIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK- 414 (491)
Q Consensus 336 E~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~- 414 (491)
|++.+..++.++|||||||++|||++|+.||.+.+....+..+......++. .++.++.+||.+||+.||++|++..
T Consensus 168 E~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 168 EVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ--FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 9999988999999999999999999999999988887777777777666654 4899999999999999999999953
Q ss_pred CChHHhhcCCCcCCCChhhhh
Q 035713 415 RGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 415 ~~~~ell~hpff~~~~~~~~~ 435 (491)
..+.++++||||+.++|..+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T cd05582 246 DGVEEIKRHPFFSTIDWNKLY 266 (318)
T ss_pred CCHHHHhCCCCcCCCCHHHHH
Confidence 247889999999999998764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=378.64 Aligned_cols=278 Identities=33% Similarity=0.599 Sum_probs=232.4
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
.|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+++|+.++|+||+.+++++..++.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37889999999999999999999999999999987655555555567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|+.+++|..++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---- 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---- 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC----
Confidence 9999999988876544569999999999999999999999999999999999999999999999999874321100
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
......|+..|+|
T Consensus 157 -------------------------------------------------------------------~~~~~~g~~~~~a 169 (285)
T cd05632 157 -------------------------------------------------------------------SIRGRVGTVGYMA 169 (285)
T ss_pred -------------------------------------------------------------------cccCCCCCcCccC
Confidence 0012368999999
Q ss_pred cchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHH----cCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 335 PEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV----GQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 335 PE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
||++.+..++.++|+|||||++|+|++|..||.+.........+. .....+ ...++.++.+||.+||+.||++|
T Consensus 170 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R 247 (285)
T cd05632 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY--SAKFSEEAKSICKMLLTKDPKQR 247 (285)
T ss_pred hHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccccc--CccCCHHHHHHHHHHccCCHhHc
Confidence 999999889999999999999999999999998776544333322 222222 24588999999999999999999
Q ss_pred CCcC-CChHHhhcCCCcCCCChhhhh--ccCCCCCCCC
Q 035713 411 IAYK-RGATEIKQHPFFEGVNWALVR--SALPPHIPEP 445 (491)
Q Consensus 411 ~t~~-~~~~ell~hpff~~~~~~~~~--~~~~~~~p~~ 445 (491)
+++. .++.++++|+||+.++|+.++ +..|++.|.|
T Consensus 248 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05632 248 LGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPDP 285 (285)
T ss_pred CCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCCC
Confidence 9964 358899999999999998764 3456666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=395.98 Aligned_cols=255 Identities=23% Similarity=0.333 Sum_probs=207.6
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
.+...+|+++++||+|+||.||+|++..+++.||||+... ..+.+|+++|+.|+||||++++++|..+...
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 3556789999999999999999999999999999997532 2356799999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+|||++ +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 159 ~lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 159 CLILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred EEEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 9999999 57888887664 45899999999999999999999999999999999999999999999999998532100
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
........+||
T Consensus 236 ---------------------------------------------------------------------~~~~~~~~~gt 246 (391)
T PHA03212 236 ---------------------------------------------------------------------NANKYYGWAGT 246 (391)
T ss_pred ---------------------------------------------------------------------cccccccccCc
Confidence 00011234799
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCC-------cHHHHHHHHc----------------------
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQG-------NRATLFNVVG---------------------- 380 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-------~~~~~~~i~~---------------------- 380 (491)
+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ....+..++.
T Consensus 247 ~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~ 326 (391)
T PHA03212 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYI 326 (391)
T ss_pred cCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHH
Confidence 99999999999999999999999999999999998875432 1111211111
Q ss_pred ----CCCcCCC-------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 381 ----QPLRFPE-------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 381 ----~~~~~~~-------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
.....+. ...++.++.+||.+||+.||.+||| ++|+|+||||+.+
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt----a~elL~hp~f~~~ 382 (391)
T PHA03212 327 GLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS----AEALLDFAAFQDI 382 (391)
T ss_pred HHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC----HHHHhcChhhccC
Confidence 0000000 0135678999999999999999999 9999999999753
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=385.55 Aligned_cols=260 Identities=26% Similarity=0.393 Sum_probs=217.5
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
+..++|++++.||+|+||.||+|++..++..||+|++.... .......+.+|+++|+.++||||+++++++..++.++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 34589999999999999999999999999999999987542 2344567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML-GIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
+||||++|++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999999998764 4599999999999999999999986 6999999999999999999999999997532110
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.....+||
T Consensus 158 ------------------------------------------------------------------------~~~~~~g~ 165 (331)
T cd06649 158 ------------------------------------------------------------------------MANSFVGT 165 (331)
T ss_pred ------------------------------------------------------------------------ccccCCCC
Confidence 01124689
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC---------------------------
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP--------------------------- 382 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~--------------------------- 382 (491)
+.|+|||++.+..++.++|||||||++|||++|+.||...+..+ +..++...
T Consensus 166 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (331)
T cd06649 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHG 244 (331)
T ss_pred cCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCccccCcccccccccccccc
Confidence 99999999999999999999999999999999999997654432 22222110
Q ss_pred --------------------CcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCCh
Q 035713 383 --------------------LRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNW 431 (491)
Q Consensus 383 --------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~ 431 (491)
........++.++++||.+||++||++||+ +++|++||||+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt----~~ell~h~~~~~~~~ 309 (331)
T cd06649 245 MDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERAD----LKMLMNHTFIKRSEV 309 (331)
T ss_pred cccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCC----HHHHhcChHHhhccc
Confidence 000011247889999999999999999999 999999999976443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=357.56 Aligned_cols=254 Identities=31% Similarity=0.480 Sum_probs=218.3
Q ss_pred CCCceEe-eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEe----C
Q 035713 93 LSNFRLL-KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFET----D 166 (491)
Q Consensus 93 ~~~y~~~-~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~----~ 166 (491)
.++|.+- ++||-|-.|.|..|.++.||+.+|+|++... .+.++|+++.-.. .|||||.++++|+. .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 4778876 5789999999999999999999999987533 2456788876555 59999999999863 4
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc---CCcEEEeecccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD---EGHIMLSDFDLS 243 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~---~g~vkL~DFGla 243 (491)
..+.+|||.|+||.|+..++.++...|+|.++..|+.||+.|+.|||+.+|.||||||+|+|... |..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 67889999999999999999987888999999999999999999999999999999999999974 557999999999
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (491)
+.-... ...
T Consensus 212 K~t~~~-----------------------------------------------------------------------~~L 220 (400)
T KOG0604|consen 212 KETQEP-----------------------------------------------------------------------GDL 220 (400)
T ss_pred cccCCC-----------------------------------------------------------------------ccc
Confidence 653211 112
Q ss_pred cccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCc----HHHHHHHHcCCCcCCC--CCCCCHHHHH
Q 035713 324 MSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGN----RATLFNVVGQPLRFPE--TPQVSFVARD 397 (491)
Q Consensus 324 ~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~--~~~~s~~~~~ 397 (491)
.+.|-|++|.|||++....|+..+|+|||||++|-||+|.+||+.... .....+|..+.+.||. +..+|++++|
T Consensus 221 ~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKd 300 (400)
T KOG0604|consen 221 MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKD 300 (400)
T ss_pred cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHH
Confidence 245899999999999999999999999999999999999999986543 2345677788887765 4679999999
Q ss_pred HHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 398 LIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 398 li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
+|++||..+|++|+| +++++.|||..+.
T Consensus 301 lIR~LLkt~PteRlT----I~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 301 LIRKLLKTEPTERLT----IEEVMDHPWINQY 328 (400)
T ss_pred HHHHHhcCCchhhee----HHHhhcCchhccc
Confidence 999999999999999 9999999999753
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=386.87 Aligned_cols=263 Identities=25% Similarity=0.397 Sum_probs=211.5
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC-----ceE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD-----KFY 169 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~-----~~~ 169 (491)
+|++.++||+|+||.||+|++..+++.||||++.... .......++.+|+++|+.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5999999999999999999999999999999986432 2223345678899999999999999999988543 358
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 80 YVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999999 57898888764 45999999999999999999999999999999999999999999999999998543210
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.. ........+||
T Consensus 157 ~~-------------------------------------------------------------------~~~~~~~~~~t 169 (338)
T cd07859 157 TP-------------------------------------------------------------------TAIFWTDYVAT 169 (338)
T ss_pred cC-------------------------------------------------------------------ccccccCCCCC
Confidence 00 00011134799
Q ss_pred cCccCcchhcC--CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHH---c-----------------------C
Q 035713 330 HEYLAPEIIRG--EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV---G-----------------------Q 381 (491)
Q Consensus 330 ~~y~aPE~l~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~---~-----------------------~ 381 (491)
+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+....+..+. + .
T Consensus 170 ~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 249 (338)
T cd07859 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRK 249 (338)
T ss_pred CCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcc
Confidence 99999999876 568999999999999999999999998766443322111 0 0
Q ss_pred CCcC---CCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 382 PLRF---PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 382 ~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
.... ...+.++.++.+||.+||+.||++||+ ++++++||||+++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~e~l~hp~f~~~~~~ 299 (338)
T cd07859 250 KQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT----AEEALADPYFKGLAKV 299 (338)
T ss_pred cCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC----HHHHhcCchhhhcCcc
Confidence 0000 011356788999999999999999999 9999999999877653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=373.31 Aligned_cols=265 Identities=43% Similarity=0.778 Sum_probs=233.1
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+++|+.++||||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998766555566778889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||+|+||||+.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 999999999998875 56999999999999999999999999999999999999999999999999997543110
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
....+|++.|+
T Consensus 155 ---------------------------------------------------------------------~~~~~~~~~y~ 165 (290)
T cd05580 155 ---------------------------------------------------------------------TYTLCGTPEYL 165 (290)
T ss_pred ---------------------------------------------------------------------CCCCCCCcccc
Confidence 11236889999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
|||.+.+..++.++|||||||++|+|++|+.||...+......++......++. .++..++++|.+||..||.+|++.
T Consensus 166 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~R~~~ 243 (290)
T cd05580 166 APEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS--FFSPDAKDLIRNLLQVDLTKRLGN 243 (290)
T ss_pred ChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc--cCCHHHHHHHHHHccCCHHHccCc
Confidence 999999888899999999999999999999999887766666677766665554 478999999999999999999932
Q ss_pred -CCChHHhhcCCCcCCCChhhhh
Q 035713 414 -KRGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 414 -~~~~~ell~hpff~~~~~~~~~ 435 (491)
...++++++||||+.++|..+.
T Consensus 244 ~~~~~~~l~~~~~~~~~~~~~~~ 266 (290)
T cd05580 244 LKNGVNDIKNHPWFAGIDWIALL 266 (290)
T ss_pred ccCCHHHHHcCcccccCCHHHHh
Confidence 2239999999999999998664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=375.21 Aligned_cols=256 Identities=26% Similarity=0.410 Sum_probs=209.2
Q ss_pred CCceEeeeeeccCceEEEEEEEeC-CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc---CCCCccceeeeEE-----
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRG-TNTYFAMKVMDKASLASRNKLLRAQTEREILGLL---DHPFLPTLYSYFE----- 164 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l---~hp~iv~l~~~~~----- 164 (491)
++|++++.||+|+||+||+|++.. +++.||+|+++..... ......+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999864 4688999998754322 22223445677777665 6999999999885
Q ss_pred eCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 165 TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 165 ~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
....+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3457899999995 689998877655669999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
..... ....
T Consensus 159 ~~~~~-----------------------------------------------------------------------~~~~ 167 (290)
T cd07862 159 IYSFQ-----------------------------------------------------------------------MALT 167 (290)
T ss_pred eccCC-----------------------------------------------------------------------cccc
Confidence 43210 0111
Q ss_pred ccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCC-----cCC-------------
Q 035713 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL-----RFP------------- 386 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-----~~~------------- 386 (491)
...||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..++.... .++
T Consensus 168 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (290)
T cd07862 168 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSK 247 (290)
T ss_pred cccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCC
Confidence 24789999999999998999999999999999999999999999887777666643110 000
Q ss_pred -------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 387 -------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 387 -------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
..+.++..+++||.+||+.||++||+ +.++|+||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~~~l~hp~f 290 (290)
T cd07862 248 SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYF 290 (290)
T ss_pred CCCCHHHHccCCCHHHHHHHHHHhccCchhcCC----HHHHhcCCCC
Confidence 01347788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=397.09 Aligned_cols=258 Identities=27% Similarity=0.429 Sum_probs=209.1
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC-----
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD----- 166 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~----- 166 (491)
...+|+++++||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++|||||+++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 4468999999999999999999999999999999886432 1234699999999999999999987432
Q ss_pred ---ceEEEEEeccCCCchHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC-cEEEeec
Q 035713 167 ---KFYCLVMEFCSGGNLHSLRQK--QPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG-HIMLSDF 240 (491)
Q Consensus 167 ---~~~~lV~E~~~gg~L~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g-~vkL~DF 240 (491)
..+++||||++ ++|.+++.. .....+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 25789999996 577666653 2245699999999999999999999999999999999999999665 6999999
Q ss_pred ccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCC
Q 035713 241 DLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTN 320 (491)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (491)
|+|+.+...
T Consensus 216 Gla~~~~~~----------------------------------------------------------------------- 224 (440)
T PTZ00036 216 GSAKNLLAG----------------------------------------------------------------------- 224 (440)
T ss_pred ccchhccCC-----------------------------------------------------------------------
Confidence 998643210
Q ss_pred ccccccccccCccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---C--------------
Q 035713 321 VRSMSFVGTHEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---P-------------- 382 (491)
Q Consensus 321 ~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~-------------- 382 (491)
......+||+.|+|||++.+. .|+.++|||||||+||||++|++||.+.+..+.+.+++.. +
T Consensus 225 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~ 304 (440)
T PTZ00036 225 QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD 304 (440)
T ss_pred CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhc
Confidence 011134789999999998875 5899999999999999999999999998777666555421 1
Q ss_pred CcCCC----------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 383 LRFPE----------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 383 ~~~~~----------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
+.++. ....+.++++||.+||++||.+|++ +.|+|+||||+.+.+.
T Consensus 305 ~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t----a~e~l~hp~f~~~~~~ 360 (440)
T PTZ00036 305 IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN----PIEALADPFFDDLRDP 360 (440)
T ss_pred ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcC----HHHHhCChhHHhhhcc
Confidence 11111 1246789999999999999999999 9999999999876553
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-47 Score=372.14 Aligned_cols=294 Identities=38% Similarity=0.659 Sum_probs=240.1
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++++.||+|+||.||++++..+++.||+|.+.+...........+.+|+++++.++||||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998765444555667889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||++|++|.+++... +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.........
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999999999765 569999999999999999999999999999999999999999999999999885321110000
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.. . . ...............|+..|+
T Consensus 159 ~~-----------------~---------------~-----------------------~~~~~~~~~~~~~~~~~~~y~ 183 (305)
T cd05609 159 LY-----------------E---------------G-----------------------HIEKDTREFLDKQVCGTPEYI 183 (305)
T ss_pred cc-----------------c---------------c-----------------------ccccchhhccccCCccCcccc
Confidence 00 0 0 000000000111246889999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCC-CCCCHHHHHHHHhhhccCCCCCCC
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPET-PQVSFVARDLIRGLLVKEPHKRIA 412 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~t 412 (491)
|||.+.+..++.++|+|||||++|||++|..||.+....+.+..+.......+.. ..++.++.+||.+||+.||++||+
T Consensus 184 aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~ 263 (305)
T cd05609 184 APEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLG 263 (305)
T ss_pred CchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccC
Confidence 9999998889999999999999999999999999887777677766655444433 257899999999999999999998
Q ss_pred cCCChHHhhcCCCcCCCChhhhhccCCCCCCCC
Q 035713 413 YKRGATEIKQHPFFEGVNWALVRSALPPHIPEP 445 (491)
Q Consensus 413 ~~~~~~ell~hpff~~~~~~~~~~~~~~~~p~~ 445 (491)
.. .+.++++||||...+|+...+.....+|..
T Consensus 264 ~~-~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~ 295 (305)
T cd05609 264 TG-GAFEVKQHRFFLGLDWNGLLRQKAEFIPQL 295 (305)
T ss_pred cc-CHHHHHhCccccCCCHHHHhhcCCCCCCCC
Confidence 53 279999999999999998766666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-47 Score=384.38 Aligned_cols=261 Identities=27% Similarity=0.385 Sum_probs=214.1
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc-----eE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK-----FY 169 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~-----~~ 169 (491)
+|++++.||+|+||.||+|++..+++.||||++.... .......++.+|+++|+.++|+||+++++++...+ .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 5889999999999999999999999999999986532 22334557789999999999999999999998776 89
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 99999995 6788777653 56999999999999999999999999999999999999999999999999998542210
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.. ......++|
T Consensus 157 ~~---------------------------------------------------------------------~~~~~~~~~ 167 (372)
T cd07853 157 ES---------------------------------------------------------------------KHMTQEVVT 167 (372)
T ss_pred cc---------------------------------------------------------------------ccCCCCCcC
Confidence 00 001123688
Q ss_pred cCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc-----------------------CCCcC
Q 035713 330 HEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG-----------------------QPLRF 385 (491)
Q Consensus 330 ~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~-----------------------~~~~~ 385 (491)
+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+....+..+.. .....
T Consensus 168 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (372)
T cd07853 168 QYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKP 247 (372)
T ss_pred CCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCC
Confidence 9999999998854 78999999999999999999999988776655444321 11111
Q ss_pred C-------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 386 P-------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 386 ~-------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
+ .....++++.+||.+||+.||++||+ +.++|+||||++..+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~~~~~ 297 (372)
T cd07853 248 PSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS----AADALAHPYLDEGRLR 297 (372)
T ss_pred CchHHhcccCCCCCHHHHHHHHHhCCCChhhCcC----HHHHhcCHhhCCCcch
Confidence 1 12346789999999999999999999 9999999999986543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=379.84 Aligned_cols=258 Identities=25% Similarity=0.385 Sum_probs=214.8
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
+..++|++.++||+|+||.||+|++..++..+|+|++.... .......+.+|+++|+.++|+||++++++|.+++.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 34578999999999999999999999999999999987542 2334556789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML-GIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
+||||+++++|.+++... +.+++..+..++.||+.||.|||+. +|+||||||+|||++.+|.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999999998764 4589999999999999999999975 7999999999999999999999999998432110
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.....+||
T Consensus 158 ------------------------------------------------------------------------~~~~~~~~ 165 (333)
T cd06650 158 ------------------------------------------------------------------------MANSFVGT 165 (333)
T ss_pred ------------------------------------------------------------------------ccccCCCC
Confidence 00123689
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHH------------------------------
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV------------------------------ 379 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~------------------------------ 379 (491)
..|+|||++.+..++.++|||||||++|+|++|+.||........ ..++
T Consensus 166 ~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (333)
T cd06650 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL-ELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPD 244 (333)
T ss_pred ccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH-HHHhcCcccCCccccccCcccCCccchhhhhccc
Confidence 999999999998899999999999999999999999976543322 1111
Q ss_pred ---------------cCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 380 ---------------GQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 380 ---------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
...........++.++++||.+||++||++||+ +.++++||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt----~~ell~h~~~~~~ 305 (333)
T cd06650 245 SRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRS 305 (333)
T ss_pred ccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcC----HHHHhhCHHHhcC
Confidence 111000011236788999999999999999999 9999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=383.21 Aligned_cols=255 Identities=28% Similarity=0.420 Sum_probs=209.8
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC------
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD------ 166 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~------ 166 (491)
.++|++++.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 578999999999999999999999999999999987542 2334455677899999999999999999988543
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
..+|+||||+. ++|..++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 46899999995 567766654 3889999999999999999999999999999999999999999999999998542
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.... .....
T Consensus 177 ~~~~-----------------------------------------------------------------------~~~~~ 185 (364)
T cd07875 177 GTSF-----------------------------------------------------------------------MMTPY 185 (364)
T ss_pred CCCC-----------------------------------------------------------------------cccCC
Confidence 1100 01123
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC----------------------Cc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP----------------------LR 384 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~----------------------~~ 384 (491)
+||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.+++... ..
T Consensus 186 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (364)
T cd07875 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 265 (364)
T ss_pred cccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCC
Confidence 78999999999999999999999999999999999999999887666555443210 00
Q ss_pred --------------CC----CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 385 --------------FP----ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 385 --------------~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
++ .....+.++++||.+||+.||.+||| ++++|+||||..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t----~~e~L~hp~~~~ 323 (364)
T cd07875 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS----VDEALQHPYINV 323 (364)
T ss_pred cCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCC----HHHHhcCccccc
Confidence 00 00123467899999999999999999 999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-47 Score=381.11 Aligned_cols=255 Identities=28% Similarity=0.434 Sum_probs=207.8
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc-----
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK----- 167 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~----- 167 (491)
.++|++++.||+|+||.||+|++..+|+.||||++.+.. ........+.+|+.+++.++||||++++++|...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 478999999999999999999999999999999987542 23344566778999999999999999999986543
Q ss_pred -eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 168 -FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 168 -~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
.+|+||||+.+ +|...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 57999999965 56665543 3899999999999999999999999999999999999999999999999998532
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.... .....
T Consensus 174 ~~~~-----------------------------------------------------------------------~~~~~ 182 (359)
T cd07876 174 CTNF-----------------------------------------------------------------------MMTPY 182 (359)
T ss_pred ccCc-----------------------------------------------------------------------cCCCC
Confidence 1100 01123
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc----------------------CCCc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG----------------------QPLR 384 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~----------------------~~~~ 384 (491)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..++. ....
T Consensus 183 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (359)
T cd07876 183 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQ 262 (359)
T ss_pred cccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCC
Confidence 789999999999999999999999999999999999999987765443322211 1111
Q ss_pred CC------------------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 385 FP------------------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 385 ~~------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
++ .....+.++++||.+||+.||++||| +.|+|+||||..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~ 320 (359)
T cd07876 263 YPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRIS----VDEALRHPYITV 320 (359)
T ss_pred CCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCC----HHHHhcCchhhh
Confidence 10 00124678999999999999999999 999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=385.08 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=204.1
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
...|.+.+.||+|+||.||+|++..+++.||||.... ..+.+|+++|+.|+|+|||++++++..++..|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999996432 1345799999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
||++ .++|..++... ...+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.......
T Consensus 239 ~e~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~- 315 (461)
T PHA03211 239 LPKY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS- 315 (461)
T ss_pred EEcc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc-
Confidence 9999 57888887654 24699999999999999999999999999999999999999999999999999854321000
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......++||+.|
T Consensus 316 -------------------------------------------------------------------~~~~~~~~GT~~Y 328 (461)
T PHA03211 316 -------------------------------------------------------------------TPFHYGIAGTVDT 328 (461)
T ss_pred -------------------------------------------------------------------cccccccCCCcCC
Confidence 0001134799999
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCC-------cHHHHHHHHcC-CC---cCC---------------
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQG-------NRATLFNVVGQ-PL---RFP--------------- 386 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-------~~~~~~~i~~~-~~---~~~--------------- 386 (491)
+|||++.+..++.++|||||||+||||++|..++.... ....+.+++.. .. .++
T Consensus 329 ~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~ 408 (461)
T PHA03211 329 NAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRA 408 (461)
T ss_pred cCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhh
Confidence 99999999999999999999999999999876543221 11223333221 00 000
Q ss_pred --------------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 387 --------------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 387 --------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
....++.++.+||.+||+.||.+||+ +.|||+||||+.
T Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs----a~elL~hp~f~~ 460 (461)
T PHA03211 409 ARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS----AAELLRLPLFQS 460 (461)
T ss_pred hcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcC----HHHHhhCcccCC
Confidence 01135568999999999999999999 999999999974
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=379.20 Aligned_cols=251 Identities=25% Similarity=0.412 Sum_probs=217.3
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
.+.+..+.+++++.||+|-||+||+|++..+ ..||+|.++......+ .+.+|++||++|+|+|||+|++++..++
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~----~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPE----AFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChh----HHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 4456667788999999999999999999954 3699999977644433 4558999999999999999999999988
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+|||||||+.|+|.++++...++.+...+...++.|||.||+||+++++|||||...||||+++..+||+|||||+...
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999999998666789999999999999999999999999999999999999999999999999998433
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
.+. |.... |+ -
T Consensus 355 d~~------------------------Y~~~~----------------------------~~-----------------k 365 (468)
T KOG0197|consen 355 DDE------------------------YTASE----------------------------GG-----------------K 365 (468)
T ss_pred CCc------------------------eeecC----------------------------CC-----------------C
Confidence 221 11110 00 1
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
-...|+|||.+....++.+||||||||+||||+| |+.||.+.+..+.+..+ ....+.|.+..+|+++.+++..||+.+
T Consensus 366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l-e~GyRlp~P~~CP~~vY~lM~~CW~~~ 444 (468)
T KOG0197|consen 366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL-ERGYRLPRPEGCPDEVYELMKSCWHED 444 (468)
T ss_pred CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH-hccCcCCCCCCCCHHHHHHHHHHhhCC
Confidence 2467999999999999999999999999999999 99999999888776654 566888888899999999999999999
Q ss_pred CCCCCCc
Q 035713 407 PHKRIAY 413 (491)
Q Consensus 407 P~~R~t~ 413 (491)
|++|||+
T Consensus 445 P~~RPtF 451 (468)
T KOG0197|consen 445 PEDRPTF 451 (468)
T ss_pred cccCCCH
Confidence 9999993
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=370.44 Aligned_cols=255 Identities=29% Similarity=0.441 Sum_probs=207.5
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc---CCCCccceeeeEEe-----C
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL---DHPFLPTLYSYFET-----D 166 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l---~hp~iv~l~~~~~~-----~ 166 (491)
+|++++.||+|+||+||+|+++.+++.||+|++...... ......+.+|+++++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 599999999999999999999999999999998754222 11222344677777665 69999999998864 3
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
..+++||||+. ++|..++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 56899999996 58888887755556999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.... .....
T Consensus 159 ~~~~-----------------------------------------------------------------------~~~~~ 167 (288)
T cd07863 159 SCQM-----------------------------------------------------------------------ALTPV 167 (288)
T ss_pred cCcc-----------------------------------------------------------------------cCCCc
Confidence 1100 00123
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---C--CcCC---------------
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---P--LRFP--------------- 386 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~--~~~~--------------- 386 (491)
.||..|+|||++.+..++.++|||||||++|+|++|++||.+......+.++... + ..++
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
T cd07863 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGP 247 (288)
T ss_pred cccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCC
Confidence 6899999999999999999999999999999999999999887776655554321 0 0000
Q ss_pred -----CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 387 -----ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 387 -----~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
..+.++.++.+||.+||+.||++||+ +.+++.||||
T Consensus 248 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~~~l~hp~f 288 (288)
T cd07863 248 RPVQSVVPEIEESGAQLLLEMLTFNPHKRIS----AFRALQHPFF 288 (288)
T ss_pred CchHHhCcCcCHHHHHHHHHHhccCcccCCC----HHHHhcCCCC
Confidence 01357788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=387.72 Aligned_cols=261 Identities=29% Similarity=0.480 Sum_probs=230.0
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
+.|+|+..||.|+||.||+|..+.++...|.|+|.. .+.+.+..++-||+||..++||+||+|++.|..++.++|+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 568999999999999999999999999999999864 34566777888999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
|||.||-...++-.. ++.|.+.+++.+++|++.||.|||+++|||||||..|||++.+|.++|+|||.+....
T Consensus 109 EFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~------ 181 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK------ 181 (1187)
T ss_pred eecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch------
Confidence 999999998887665 4679999999999999999999999999999999999999999999999999873210
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.+..+..+|+|||+||
T Consensus 182 ----------------------------------------------------------------~t~qkRDsFIGTPYWM 197 (1187)
T KOG0579|consen 182 ----------------------------------------------------------------STRQKRDSFIGTPYWM 197 (1187)
T ss_pred ----------------------------------------------------------------hHHhhhccccCCcccc
Confidence 0112334689999999
Q ss_pred Ccchhc-----CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC-CCcCCCCCCCCHHHHHHHHhhhccCC
Q 035713 334 APEIIR-----GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ-PLRFPETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 334 aPE~l~-----~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~~~~li~~~L~~dP 407 (491)
|||++. ..+|++++||||||++|.||.-+.+|-...+....+.+|... ++.+.....++..+.||+++||.+||
T Consensus 198 APEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp 277 (1187)
T KOG0579|consen 198 APEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNP 277 (1187)
T ss_pred cchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCC
Confidence 999975 467999999999999999999999999988888888887654 44455556789999999999999999
Q ss_pred CCCCCcCCChHHhhcCCCcCCCChh
Q 035713 408 HKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 408 ~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
..||+ +.+||+||||++++-+
T Consensus 278 ~~Rp~----aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 278 RNRPP----AAQLLKHPFVQNAPSN 298 (1187)
T ss_pred ccCCC----HHHHhhCcccccCCcc
Confidence 99999 9999999999987755
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=380.16 Aligned_cols=258 Identities=32% Similarity=0.512 Sum_probs=234.6
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
....|.+++.||+|.|++|.+|++..++..||||+|.+....... ...+.+|+++|+.|+|||||+|+.+.+....+|+
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 446799999999999999999999999999999999988655443 3448899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||+.+|.+++++.+. +++.+..++.++.|+++|++|||+++|||||||.+||||+.+-.+||+|||++..+...
T Consensus 133 V~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-- 208 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-- 208 (596)
T ss_pred EEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc--
Confidence 99999999999999986 66888999999999999999999999999999999999999999999999998654321
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
....++||++.
T Consensus 209 ---------------------------------------------------------------------~~lqt~cgspp 219 (596)
T KOG0586|consen 209 ---------------------------------------------------------------------LMLQTFCGSPP 219 (596)
T ss_pred ---------------------------------------------------------------------ccccccCCCCC
Confidence 12235799999
Q ss_pred ccCcchhcCCCC-CCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 332 YLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 332 y~aPE~l~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
|.|||++.+..| ++.+|+||||++||-|+.|.+||+|.+..+.-.+++.+.+++|.. ++.++++||+++|.++|.+|
T Consensus 220 yAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~--ms~dce~lLrk~lvl~Pskr 297 (596)
T KOG0586|consen 220 YAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFY--MSCDCEDLLRKFLVLNPSKR 297 (596)
T ss_pred ccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccce--eechhHHHHHHhhccCcccc
Confidence 999999999998 789999999999999999999999998888888888888888876 89999999999999999999
Q ss_pred CCcCCChHHhhcCCCcCCC
Q 035713 411 IAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 411 ~t~~~~~~ell~hpff~~~ 429 (491)
++ +++++.|.|....
T Consensus 298 ~~----~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 298 GP----CDQIMKDRWRNDL 312 (596)
T ss_pred CC----HHHhhhhcccchh
Confidence 99 9999999998643
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=374.09 Aligned_cols=259 Identities=26% Similarity=0.430 Sum_probs=212.8
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
+++|.++++||+|+||.||+|+++.+++.||+|+++..... .....+.+|+++++.++|+||+++++++..++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 47899999999999999999999999999999998754322 2233466899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+. ++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 83 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 83 FEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred EeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 99996 4888877654 34589999999999999999999999999999999999999999999999999853211000
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......+|+.|
T Consensus 160 ---------------------------------------------------------------------~~~~~~~~~~y 170 (309)
T cd07872 160 ---------------------------------------------------------------------TYSNEVVTLWY 170 (309)
T ss_pred ---------------------------------------------------------------------ccccccccccc
Confidence 00123678999
Q ss_pred cCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CC----------------CcCC------
Q 035713 333 LAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QP----------------LRFP------ 386 (491)
Q Consensus 333 ~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~----------------~~~~------ 386 (491)
+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.. .+ ..++
T Consensus 171 ~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (309)
T cd07872 171 RPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQP 250 (309)
T ss_pred cCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCc
Confidence 999998764 578999999999999999999999988766554443321 11 0111
Q ss_pred ---CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 387 ---ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 387 ---~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
....++.++++||.+||..||.+|+| +.|+|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l~h~~~~~~ 292 (309)
T cd07872 251 LINHAPRLDTEGIELLTKFLQYESKKRIS----AEEAMKHAYFRSL 292 (309)
T ss_pred hhhhccCCCHHHHHHHHHhccCChhhCCC----HHHHhcChhhhhc
Confidence 11357889999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=356.59 Aligned_cols=261 Identities=31% Similarity=0.501 Sum_probs=218.9
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCceEEEEEeccCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKFYCLVMEFCSG 178 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~~lV~E~~~g 178 (491)
+.||+|+|+.|--|....+|..||||+|.|... ....++.+|++++..++ |+||++|+++|+++..+|||||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g---HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG---HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCc---hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 578999999999999999999999999988633 34457788999999996 99999999999999999999999999
Q ss_pred CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC---cEEEeecccccccCCCCccccc
Q 035713 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG---HIMLSDFDLSLRCSVSPTLVKS 255 (491)
Q Consensus 179 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g---~vkL~DFGla~~~~~~~~~~~~ 255 (491)
|.|...++++ ..|+|.++..+..+|+.||.|||.+||.||||||+|||..... -||||||.|..-+...
T Consensus 161 GplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~------ 232 (463)
T KOG0607|consen 161 GPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN------ 232 (463)
T ss_pred chHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccC------
Confidence 9999888875 5699999999999999999999999999999999999997654 4899999886221100
Q ss_pred ccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCc
Q 035713 256 SSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAP 335 (491)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 335 (491)
+.|.-..+| ...+.||+..||||
T Consensus 233 ------------------------------------------------~~~spastP---------~L~tPvGSAEfMAP 255 (463)
T KOG0607|consen 233 ------------------------------------------------NDCSPASTP---------ELLTPVGSAEFMAP 255 (463)
T ss_pred ------------------------------------------------CCCCCCCCc---------cccCcccchhhcch
Confidence 000000111 22345999999999
Q ss_pred chhcC-----CCCCCcccccchhhHHHhhhcCCCCCCCCC---------------cHHHHHHHHcCCCcCCCC--CCCCH
Q 035713 336 EIIRG-----EGHGSAVDWWTFGIFLYELLHGTTPFKGQG---------------NRATLFNVVGQPLRFPET--PQVSF 393 (491)
Q Consensus 336 E~l~~-----~~~~~~~DiwSlG~il~elltg~~Pf~~~~---------------~~~~~~~i~~~~~~~~~~--~~~s~ 393 (491)
|++.- ..|+.++|.||||||||-||+|.+||.|.- ....+..|..+.+.||+. ..+|.
T Consensus 256 EVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~ 335 (463)
T KOG0607|consen 256 EVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISS 335 (463)
T ss_pred hHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhH
Confidence 98742 348999999999999999999999997642 134567788899999875 56999
Q ss_pred HHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 394 VARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 394 ~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
+++|||..+|..|+.+|++ +.++++|||++.+.-+
T Consensus 336 eakdlisnLlvrda~~rls----a~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 336 EAKDLISNLLVRDAKQRLS----AAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHHHHHHhccHHhhhh----hhhccCCccccccchh
Confidence 9999999999999999999 9999999999877544
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=377.12 Aligned_cols=259 Identities=20% Similarity=0.317 Sum_probs=208.8
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEe-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELR-----GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYF 163 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~ 163 (491)
.+..++|++.++||+|+||.||+|++. .+++.||||++.... .......+.+|+.+|+.+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 456689999999999999999999863 345689999987542 223445678999999999 899999999988
Q ss_pred EeC-ceEEEEEeccCCCchHHHHHhCC-----------------------------------------------------
Q 035713 164 ETD-KFYCLVMEFCSGGNLHSLRQKQP----------------------------------------------------- 189 (491)
Q Consensus 164 ~~~-~~~~lV~E~~~gg~L~~~~~~~~----------------------------------------------------- 189 (491)
... +.+|+||||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 754 56899999999999999887532
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccccccC
Q 035713 190 -------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNN 262 (491)
Q Consensus 190 -------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~ 262 (491)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~---------- 230 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---------- 230 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch----------
Confidence 124788899999999999999999999999999999999999999999999998643211100
Q ss_pred CCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCC
Q 035713 263 GSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG 342 (491)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 342 (491)
....+..++..|+|||++.+..
T Consensus 231 ----------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~ 252 (338)
T cd05102 231 ----------------------------------------------------------VRKGSARLPLKWMAPESIFDKV 252 (338)
T ss_pred ----------------------------------------------------------hcccCCCCCccccCcHHhhcCC
Confidence 0111224678899999999999
Q ss_pred CCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhh
Q 035713 343 HGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIK 421 (491)
Q Consensus 343 ~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell 421 (491)
++.++|||||||+||||++ |..||.+......+...+...........++.++.+||.+||+.||++||+ +.+|+
T Consensus 253 ~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs----~~el~ 328 (338)
T cd05102 253 YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPT----FSALV 328 (338)
T ss_pred CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcC----HHHHH
Confidence 9999999999999999997 999998866554444444333333333468899999999999999999999 88877
Q ss_pred c
Q 035713 422 Q 422 (491)
Q Consensus 422 ~ 422 (491)
+
T Consensus 329 ~ 329 (338)
T cd05102 329 E 329 (338)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=378.30 Aligned_cols=256 Identities=28% Similarity=0.421 Sum_probs=208.4
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC-----
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD----- 166 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~----- 166 (491)
..++|++++.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3578999999999999999999999999999999987543 2334455677899999999999999999998643
Q ss_pred -ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 167 -KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 167 -~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
..+|+||||+++ +|...+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 357999999965 66666654 389999999999999999999999999999999999999999999999999854
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
..... ....
T Consensus 169 ~~~~~-----------------------------------------------------------------------~~~~ 177 (355)
T cd07874 169 AGTSF-----------------------------------------------------------------------MMTP 177 (355)
T ss_pred CCCcc-----------------------------------------------------------------------ccCC
Confidence 21100 0112
Q ss_pred cccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC----------------------CC
Q 035713 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ----------------------PL 383 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~----------------------~~ 383 (491)
.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..++.. ..
T Consensus 178 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (355)
T cd07874 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 257 (355)
T ss_pred ccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCC
Confidence 47899999999999999999999999999999999999999887654443322211 00
Q ss_pred c-----CC-------------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 384 R-----FP-------------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 384 ~-----~~-------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
. ++ .....+.++++||.+||..||++||| +.|+|+||||..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps----~~ell~hp~~~~ 316 (355)
T cd07874 258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDEALQHPYINV 316 (355)
T ss_pred ccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCC----HHHHhcCcchhc
Confidence 0 00 01124567899999999999999999 999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=380.64 Aligned_cols=261 Identities=22% Similarity=0.346 Sum_probs=212.2
Q ss_pred cCCCceEeeeeeccCceEEEEEEEe--CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELR--GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
...+|++++.||+|+||.||+|... .+++.||+|.+.... ...+|+++|+.++||||++++++|.....+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3468999999999999999999865 356789999886532 234799999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+|||++ +++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 162 ~lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 162 CMVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9999999 57888888543 56999999999999999999999999999999999999999999999999998543211
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.. ......++||
T Consensus 239 ~~--------------------------------------------------------------------~~~~~~~~gt 250 (392)
T PHA03207 239 PD--------------------------------------------------------------------TPQCYGWSGT 250 (392)
T ss_pred cc--------------------------------------------------------------------cccccccccc
Confidence 00 0011235799
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCc---HHHHHHHHc----CCCc------------------
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGN---RATLFNVVG----QPLR------------------ 384 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~~----~~~~------------------ 384 (491)
+.|+|||++.+..|+.++|||||||++|||++|+.||.+... ...+..++. .+..
T Consensus 251 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (392)
T PHA03207 251 LETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAI 330 (392)
T ss_pred cCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcc
Confidence 999999999999999999999999999999999999977542 222222221 0000
Q ss_pred -------CCC---CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhhh
Q 035713 385 -------FPE---TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 385 -------~~~---~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~~ 435 (491)
.+. ...++.++.+||.+||..||++||+ +.++|+||||....|+.++
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rps----a~e~l~~p~f~~~~~~~~~ 387 (392)
T PHA03207 331 VLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS----AQDILSLPLFTKEPINLLN 387 (392)
T ss_pred cccCCccccchhhccCcchhHHHHHHHHhccChhhCCC----HHHHhhCchhhccchhhhc
Confidence 110 1235678899999999999999999 9999999999999888765
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=362.62 Aligned_cols=262 Identities=34% Similarity=0.605 Sum_probs=219.2
Q ss_pred eeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccCCCch
Q 035713 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNL 181 (491)
Q Consensus 102 iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~gg~L 181 (491)
||+|+||+||+|.+..+|+.||+|++.+...........+.+|+++|+.++||||+++++++...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999876544444555667899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccccccccc
Q 035713 182 HSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVN 261 (491)
Q Consensus 182 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 261 (491)
.+++.......+++..++.++.||+.||.|||++|++||||+|+|||++.++.+||+|||++.......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----------- 149 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----------- 149 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-----------
Confidence 999877644569999999999999999999999999999999999999999999999999875432100
Q ss_pred CCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCC
Q 035713 262 NGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGE 341 (491)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 341 (491)
......++..|+|||++.+.
T Consensus 150 ------------------------------------------------------------~~~~~~~~~~y~~PE~~~~~ 169 (277)
T cd05577 150 ------------------------------------------------------------KIKGRAGTPGYMAPEVLQGE 169 (277)
T ss_pred ------------------------------------------------------------ccccccCCCCcCCHHHhcCC
Confidence 00112578899999999988
Q ss_pred CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHH----HHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCC-C
Q 035713 342 GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLF----NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKR-G 416 (491)
Q Consensus 342 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~-~ 416 (491)
.++.++|||||||++|+|++|+.||.......... .+.......+ ..+++.+.+||.+||+.||.+|++.++ .
T Consensus 170 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 247 (277)
T cd05577 170 VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYP--DKFSPEAKDLCEALLQKDPEKRLGCRGGS 247 (277)
T ss_pred CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCC--ccCCHHHHHHHHHHccCChhHccCCCccc
Confidence 89999999999999999999999997765422222 2222222222 357899999999999999999996544 5
Q ss_pred hHHhhcCCCcCCCChhhhhc
Q 035713 417 ATEIKQHPFFEGVNWALVRS 436 (491)
Q Consensus 417 ~~ell~hpff~~~~~~~~~~ 436 (491)
+.++++||||..++|.....
T Consensus 248 ~~~ll~h~~~~~~~~~~~~~ 267 (277)
T cd05577 248 ADEVREHPLFKDLNWRRLEA 267 (277)
T ss_pred HHHHHhChhhhcCChhhhhc
Confidence 99999999999999987743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=399.02 Aligned_cols=152 Identities=40% Similarity=0.673 Sum_probs=141.0
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
+++|+++++||+|+||.||+|++..+++.||||++++...........+.+|+.+++.++|+||+++++++....++|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 47899999999999999999999999999999999876555556667788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
|||+.|++|..++... +.+++..++.|+.||+.||.|||.+|||||||||+||||+.++.+||+|||+++..
T Consensus 83 mEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 83 MEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 9999999999998764 46899999999999999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=342.27 Aligned_cols=261 Identities=26% Similarity=0.408 Sum_probs=219.8
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCce
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKF 168 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~ 168 (491)
....++.+++..||.|+.|.||+++.+.+|...|||.+.+... .+..+++...++++.... .|+||+.+++|..+..
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N--kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC--HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 4566788899999999999999999999999999999987643 345566777777776664 8999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
+++.||.| +..+..++++. .+.++|..+-.+...++.||.||.+ +|||||||||+|||+|..|.+||||||++.++.
T Consensus 166 V~IcMelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 166 VFICMELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHHHHHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee
Confidence 99999999 55666676665 4669999999999999999999986 589999999999999999999999999986653
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
.+.-. +.-.
T Consensus 244 dSkAh-----------------------------------------------------------------------trsA 252 (391)
T KOG0983|consen 244 DSKAH-----------------------------------------------------------------------TRSA 252 (391)
T ss_pred ccccc-----------------------------------------------------------------------cccc
Confidence 32111 1126
Q ss_pred cccCccCcchhcCC---CCCCcccccchhhHHHhhhcCCCCCCCC-CcHHHHHHHHcC-CCcCCCCCCCCHHHHHHHHhh
Q 035713 328 GTHEYLAPEIIRGE---GHGSAVDWWTFGIFLYELLHGTTPFKGQ-GNRATLFNVVGQ-PLRFPETPQVSFVARDLIRGL 402 (491)
Q Consensus 328 gt~~y~aPE~l~~~---~~~~~~DiwSlG~il~elltg~~Pf~~~-~~~~~~~~i~~~-~~~~~~~~~~s~~~~~li~~~ 402 (491)
|.+.|||||.+.-. .|+.++||||||++|+||.||+.||.+. .+.+.+-++++. +..++....+|+++.+|+..|
T Consensus 253 GC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~C 332 (391)
T KOG0983|consen 253 GCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDC 332 (391)
T ss_pred CCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHH
Confidence 88999999999753 5899999999999999999999999984 456666777754 344555567999999999999
Q ss_pred hccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 403 LVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 403 L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
|.+|+.+||. -.++|+|||....
T Consensus 333 L~kd~r~RP~----Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 333 LTKDHRKRPK----YNKLLEHPFIKRY 355 (391)
T ss_pred hhcCcccCcc----hHHHhcCcceeec
Confidence 9999999999 8999999998654
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=390.54 Aligned_cols=260 Identities=27% Similarity=0.380 Sum_probs=221.2
Q ss_pred CCceEeeeeeccCceEEEEEEEeCC-CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGT-NTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
..|.+.+.||+|+||.||+|.+..+ ++.||+|.+... .......+++|+++|+.++|||||+++++|..++.+|||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 3599999999999999999998877 788999976443 234445677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 173 MEFCSGGNLHSLRQKQ--PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
|||++||+|.+++... ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999999877542 23468999999999999999999999999999999999999999999999999986432110
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
. .....+.+||+
T Consensus 224 ~--------------------------------------------------------------------~~~~~~~~gt~ 235 (478)
T PTZ00267 224 S--------------------------------------------------------------------LDVASSFCGTP 235 (478)
T ss_pred c--------------------------------------------------------------------cccccccCCCc
Confidence 0 00112357999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..++..... +....++.++++||.+||..||++|
T Consensus 236 ~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R 314 (478)
T PTZ00267 236 YYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPALR 314 (478)
T ss_pred cccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCccCCHHHHHHHHHHhccChhhC
Confidence 999999999999999999999999999999999999988877777777665443 2223588999999999999999999
Q ss_pred CCcCCChHHhhcCCCcCCC
Q 035713 411 IAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 411 ~t~~~~~~ell~hpff~~~ 429 (491)
|+ +++++.|+|++.+
T Consensus 315 ps----~~~~l~~~~~~~~ 329 (478)
T PTZ00267 315 PT----TQQLLHTEFLKYV 329 (478)
T ss_pred cC----HHHHHhCHHHHHH
Confidence 99 9999999998654
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=360.76 Aligned_cols=256 Identities=25% Similarity=0.437 Sum_probs=224.8
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
-|.++.+||+|+||.||+|.++.+|+.+|||.+.-. ..++++..|+.||++++.|+||++|+.+.....+|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 389999999999999999999999999999987533 456677889999999999999999999998899999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
||--|+..++++.. +..|++.++..++...+.||+|||...-||||||..|||++.+|+.||+|||.|..+..
T Consensus 109 YCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD------ 181 (502)
T KOG0574|consen 109 YCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD------ 181 (502)
T ss_pred hcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh------
Confidence 99999999998875 46799999999999999999999999999999999999999999999999999843311
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
+....+++.||+.|||
T Consensus 182 ----------------------------------------------------------------TMAKRNTVIGTPFWMA 197 (502)
T KOG0574|consen 182 ----------------------------------------------------------------TMAKRNTVIGTPFWMA 197 (502)
T ss_pred ----------------------------------------------------------------hHHhhCccccCccccc
Confidence 1113346799999999
Q ss_pred cchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC-CCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 335 PEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ-PLRFPETPQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 335 PE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
||++..-.|+..+||||||++..||..|++||..-.....++.|-.. +..|.....++.++.|||++||.++|++|-|
T Consensus 198 PEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~T- 276 (502)
T KOG0574|consen 198 PEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKT- 276 (502)
T ss_pred HHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHH-
Confidence 99999999999999999999999999999999877665555555433 3445555678999999999999999999999
Q ss_pred CCChHHhhcCCCcCCCC
Q 035713 414 KRGATEIKQHPFFEGVN 430 (491)
Q Consensus 414 ~~~~~ell~hpff~~~~ 430 (491)
|.++++|||.++..
T Consensus 277 ---A~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 277 ---ALRLCEHTFIKNAP 290 (502)
T ss_pred ---HHHHhhhhhhcCCC
Confidence 99999999998754
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=390.68 Aligned_cols=264 Identities=25% Similarity=0.419 Sum_probs=223.7
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc----
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK---- 167 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~---- 167 (491)
..++|++.+.||+|+||+||+|++..+++.||||++...... ......+.+|+.+|..++|+||+++++.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 347999999999999999999999999999999999765433 345567789999999999999999998875332
Q ss_pred ----eEEEEEeccCCCchHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecc
Q 035713 168 ----FYCLVMEFCSGGNLHSLRQKQ--PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFD 241 (491)
Q Consensus 168 ----~~~lV~E~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFG 241 (491)
.+++||||+++|+|.+++... ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 478999999999999988643 23569999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCc
Q 035713 242 LSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNV 321 (491)
Q Consensus 242 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (491)
+++.+..... ..
T Consensus 189 ls~~~~~~~~--------------------------------------------------------------------~~ 200 (496)
T PTZ00283 189 FSKMYAATVS--------------------------------------------------------------------DD 200 (496)
T ss_pred cCeecccccc--------------------------------------------------------------------cc
Confidence 9864321000 00
Q ss_pred cccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHh
Q 035713 322 RSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRG 401 (491)
Q Consensus 322 ~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 401 (491)
...+.+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+....+..++..... +....+++++.+||.+
T Consensus 201 ~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~ 279 (496)
T PTZ00283 201 VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD-PLPPSISPEMQEIVTA 279 (496)
T ss_pred ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHH
Confidence 112358999999999999999999999999999999999999999988777777776655432 2334689999999999
Q ss_pred hhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 402 LLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 402 ~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
||+.||.+||+ +.++++|||++..
T Consensus 280 ~L~~dP~~RPs----~~ell~~p~~~~~ 303 (496)
T PTZ00283 280 LLSSDPKRRPS----SSKLLNMPICKLF 303 (496)
T ss_pred HcccChhhCcC----HHHHHhCHHHHHh
Confidence 99999999999 9999999998764
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=375.53 Aligned_cols=251 Identities=24% Similarity=0.409 Sum_probs=202.5
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
..+|++++.||+|+||.||+|++..+++.||+|+..+.. ...|+.+|+.++|+||+++++++......|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 357999999999999999999999999999999864432 23589999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+ .++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 210 (357)
T PHA03209 136 LPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--- 210 (357)
T ss_pred EEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence 9999 56888877654 356999999999999999999999999999999999999999999999999998432100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.......||..|
T Consensus 211 --------------------------------------------------------------------~~~~~~~gt~~y 222 (357)
T PHA03209 211 --------------------------------------------------------------------PAFLGLAGTVET 222 (357)
T ss_pred --------------------------------------------------------------------cccccccccccc
Confidence 001124689999
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhcCC-CCCCCCCcH---------HHHHHHHcC----CCcCC------------
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGT-TPFKGQGNR---------ATLFNVVGQ----PLRFP------------ 386 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~elltg~-~Pf~~~~~~---------~~~~~i~~~----~~~~~------------ 386 (491)
+|||++.+..++.++|||||||++|||+++. .+|...... ..+..++.. +..++
T Consensus 223 ~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (357)
T PHA03209 223 NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFI 302 (357)
T ss_pred cCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHH
Confidence 9999999999999999999999999999854 444432111 111121110 01111
Q ss_pred ----------------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 387 ----------------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 387 ----------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
....++.++.+||.+||+.||.+||| +.|||+||||+.+
T Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpt----a~e~l~hp~f~~~ 357 (357)
T PHA03209 303 EYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPS----AEEILNYPMFAQL 357 (357)
T ss_pred hhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcC----HHHHhcCchhccC
Confidence 01246778889999999999999999 9999999999853
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=375.08 Aligned_cols=255 Identities=27% Similarity=0.430 Sum_probs=210.2
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC------
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD------ 166 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~------ 166 (491)
.++|++++.||+|+||+||+|.+..+++.||||++.+.. ........+.+|+++|+.++|+||++++++|...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 378999999999999999999999999999999987643 2233445677899999999999999999988643
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
..+|++||++ +++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 4579999998 8899887764 45999999999999999999999999999999999999999999999999998532
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.. .....
T Consensus 169 ~~-------------------------------------------------------------------------~~~~~ 175 (343)
T cd07878 169 DD-------------------------------------------------------------------------EMTGY 175 (343)
T ss_pred CC-------------------------------------------------------------------------CcCCc
Confidence 10 01124
Q ss_pred ccccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---C--------------------
Q 035713 327 VGTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---P-------------------- 382 (491)
Q Consensus 327 ~gt~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~-------------------- 382 (491)
+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+... .
T Consensus 176 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (343)
T cd07878 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSL 255 (343)
T ss_pred cccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhcc
Confidence 78999999999987 46799999999999999999999999877655444433211 0
Q ss_pred CcCCC------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 383 LRFPE------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 383 ~~~~~------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
...+. ...+++.+.+||.+||..||.+||+ +.++|+||||...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s----~~ell~hp~~~~~ 304 (343)
T cd07878 256 PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS----ASEALAHPYFSQY 304 (343)
T ss_pred ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCcchhcc
Confidence 00000 1235677899999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=376.63 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=226.8
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
.|.-++.||.|+||.||.|++..+.+.||||.+....-.+.+....+..|+..|+.|+|||+|.+.+||..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 48888999999999999999999999999999988777778888889999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|| -|+-.+++.-.+ .++.+-++..|+.+.+.||.|||+++.||||||..|||++..|.|||+|||.|....
T Consensus 107 YC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------- 177 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------- 177 (948)
T ss_pred HH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-------
Confidence 99 667778877653 569999999999999999999999999999999999999999999999999874321
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
..++|+|||+|||
T Consensus 178 -------------------------------------------------------------------PAnsFvGTPywMA 190 (948)
T KOG0577|consen 178 -------------------------------------------------------------------PANSFVGTPYWMA 190 (948)
T ss_pred -------------------------------------------------------------------chhcccCCccccc
Confidence 2236899999999
Q ss_pred cchhcC---CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 335 PEIIRG---EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 335 PE~l~~---~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
||+++. +.|+-++||||||++..||.-.++|+...+....++.|.....+-.....+++.+++||..||++-|.+||
T Consensus 191 PEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRp 270 (948)
T KOG0577|consen 191 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERP 270 (948)
T ss_pred hhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCC
Confidence 999975 56899999999999999999999999988888888887655443333457899999999999999999999
Q ss_pred CcCCChHHhhcCCCcCC
Q 035713 412 AYKRGATEIKQHPFFEG 428 (491)
Q Consensus 412 t~~~~~~ell~hpff~~ 428 (491)
| .+++|+|+|...
T Consensus 271 t----se~ll~H~fv~R 283 (948)
T KOG0577|consen 271 T----SEELLKHRFVLR 283 (948)
T ss_pred c----HHHHhhcchhcc
Confidence 9 999999999753
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=355.55 Aligned_cols=260 Identities=29% Similarity=0.436 Sum_probs=220.8
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhh--hHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLA--SRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
++|++.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+++++.++||||+++++++..+..+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999999999999998754322 22345578899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||++|++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||+++.......
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999999988764 4589999999999999999999999999999999999999999999999999854321000
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
. ........|+..
T Consensus 160 ~-------------------------------------------------------------------~~~~~~~~~~~~ 172 (263)
T cd06625 160 S-------------------------------------------------------------------GTGMKSVTGTPY 172 (263)
T ss_pred c-------------------------------------------------------------------cccccCCCcCcc
Confidence 0 000012368899
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
|+|||++.+..++.++|||||||++|||++|+.||...+......++............++..+.+||.+||..+|.+||
T Consensus 173 y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 252 (263)
T cd06625 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRP 252 (263)
T ss_pred ccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCC
Confidence 99999999998999999999999999999999999877666666665554443333346899999999999999999999
Q ss_pred CcCCChHHhhcCCCc
Q 035713 412 AYKRGATEIKQHPFF 426 (491)
Q Consensus 412 t~~~~~~ell~hpff 426 (491)
+ +.++++||||
T Consensus 253 t----~~~ll~~~~~ 263 (263)
T cd06625 253 S----AEELLRHFFV 263 (263)
T ss_pred C----HHHHhhCCCC
Confidence 9 9999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=359.37 Aligned_cols=258 Identities=34% Similarity=0.646 Sum_probs=206.2
Q ss_pred eeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHh---hcCCCCccceeeeEEeCceEEEEEeccC
Q 035713 101 RLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILG---LLDHPFLPTLYSYFETDKFYCLVMEFCS 177 (491)
Q Consensus 101 ~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~---~l~hp~iv~l~~~~~~~~~~~lV~E~~~ 177 (491)
.||+|+||.||++.+..+++.||+|++.+.............+|..+++ ..+|+||+.+++++..++..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997654433322223344544444 4479999999999999999999999999
Q ss_pred CCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccccc
Q 035713 178 GGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSS 257 (491)
Q Consensus 178 gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 257 (491)
|++|..++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-------- 150 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------- 150 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--------
Confidence 99999888764 46999999999999999999999999999999999999999999999999987432100
Q ss_pred ccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcch
Q 035713 258 VSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEI 337 (491)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 337 (491)
......||..|+|||+
T Consensus 151 ----------------------------------------------------------------~~~~~~~~~~y~aPE~ 166 (279)
T cd05633 151 ----------------------------------------------------------------KPHASVGTHGYMAPEV 166 (279)
T ss_pred ----------------------------------------------------------------CccCcCCCcCccCHHH
Confidence 0001268999999999
Q ss_pred hcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCc--HHHHHHH-HcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 338 IRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGN--RATLFNV-VGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 338 l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~i-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
+.+ ..++.++|||||||++|+|++|+.||.+... ...+... .......+ ..++.++.+||.+||..||.+|++.
T Consensus 167 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~ 244 (279)
T cd05633 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELP--DSFSPELKSLLEGLLQRDVSKRLGC 244 (279)
T ss_pred hcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCc--cccCHHHHHHHHHHhcCCHHHhcCC
Confidence 874 5689999999999999999999999975432 2222221 22222333 3588999999999999999999942
Q ss_pred -CCChHHhhcCCCcCCCChhhh
Q 035713 414 -KRGATEIKQHPFFEGVNWALV 434 (491)
Q Consensus 414 -~~~~~ell~hpff~~~~~~~~ 434 (491)
...+.++++||||++++|...
T Consensus 245 ~~~~~~~~~~h~~~~~~~~~~~ 266 (279)
T cd05633 245 LGRGAQEVKEHVFFKGIDWQQV 266 (279)
T ss_pred CCCCHHHHHhCccccCCCHhHH
Confidence 123999999999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=400.75 Aligned_cols=269 Identities=26% Similarity=0.399 Sum_probs=222.8
Q ss_pred cCCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 035713 86 LRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET 165 (491)
Q Consensus 86 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 165 (491)
+...+..+++|+++++||+|+||+||+|+++.++..||+|++...... ......+..|+.+|+.|+|||||+++++|..
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 344566778999999999999999999999999999999999765433 3445678899999999999999999999854
Q ss_pred --CceEEEEEeccCCCchHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHc-------CcccccCCCCCEEEcc---
Q 035713 166 --DKFYCLVMEFCSGGNLHSLRQKQ--PNKYFTEDAARFFASEVLLALEYLHML-------GIVYRDLKPENVLVRD--- 231 (491)
Q Consensus 166 --~~~~~lV~E~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-------givHrDikp~NILl~~--- 231 (491)
...+||||||+.+++|..++... ....+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 46799999999999999988753 234699999999999999999999985 4999999999999964
Q ss_pred --------------CCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCccccccccc
Q 035713 232 --------------EGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNR 297 (491)
Q Consensus 232 --------------~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (491)
.+.+||+|||++..+....
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----------------------------------------------- 196 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIES----------------------------------------------- 196 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccc-----------------------------------------------
Confidence 2358999999985431100
Q ss_pred CCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCC--CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHH
Q 035713 298 KSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGE--GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATL 375 (491)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~ 375 (491)
.....+||+.|+|||++.+. .++.++||||||||||||++|+.||........+
T Consensus 197 ------------------------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ql 252 (1021)
T PTZ00266 197 ------------------------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL 252 (1021)
T ss_pred ------------------------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHH
Confidence 01124799999999999753 4789999999999999999999999877776666
Q ss_pred HHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCCh
Q 035713 376 FNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNW 431 (491)
Q Consensus 376 ~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~ 431 (491)
...+.....++. ...+.++.+||..||..+|.+||+ +.++|.|+||+.+..
T Consensus 253 i~~lk~~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPS----a~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 253 ISELKRGPDLPI-KGKSKELNILIKNLLNLSAKERPS----ALQCLGYQIIKNVGP 303 (1021)
T ss_pred HHHHhcCCCCCc-CCCCHHHHHHHHHHhcCChhHCcC----HHHHhccHHHhhcCC
Confidence 666655444433 357899999999999999999999 999999999987654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=370.40 Aligned_cols=259 Identities=22% Similarity=0.356 Sum_probs=215.4
Q ss_pred ccCCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEE
Q 035713 85 SLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE 164 (491)
Q Consensus 85 ~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 164 (491)
+...++|..+++.+..+||+|+||+||+|++.++ ||||+++..... .++.+.|++|+.+|++-+|.||+-+.|++.
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt-~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPT-PEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCC-HHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 4467788889999999999999999999999964 999999877655 458889999999999999999999999999
Q ss_pred eCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 165 TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 165 ~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
.+.. .||+-+|+|.+|+.+++... ..|.....+.|+.||++||.|||.++|||||||..||+|.+++.|||+||||+.
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred CCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEeccccee
Confidence 8887 89999999999999988653 569999999999999999999999999999999999999999999999999983
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
.-.. + .......
T Consensus 537 vk~~------------------------------------------------------------------w--~g~~q~~ 548 (678)
T KOG0193|consen 537 VKTR------------------------------------------------------------------W--SGEQQLE 548 (678)
T ss_pred eeee------------------------------------------------------------------e--ccccccC
Confidence 2110 0 0000111
Q ss_pred ccccccCccCcchhcC---CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC----CCCCCHHHHH
Q 035713 325 SFVGTHEYLAPEIIRG---EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE----TPQVSFVARD 397 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~---~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~s~~~~~ 397 (491)
...|...|||||+++. .+|++.+|||||||++|||++|..||........++. +++.+-.++ ...++.++++
T Consensus 549 qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm-VGrG~l~pd~s~~~s~~pk~mk~ 627 (678)
T KOG0193|consen 549 QPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM-VGRGYLMPDLSKIRSNCPKAMKR 627 (678)
T ss_pred CCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE-ecccccCccchhhhccCHHHHHH
Confidence 2357889999999985 4689999999999999999999999995544444444 444432222 2467889999
Q ss_pred HHHhhhccCCCCCCCcCCChHHhhc
Q 035713 398 LIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 398 li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
|+..||.+++++||. +.+||.
T Consensus 628 Ll~~C~~~~~~eRP~----F~~il~ 648 (678)
T KOG0193|consen 628 LLSDCWKFDREERPL----FPQLLS 648 (678)
T ss_pred HHHHHHhcCcccCcc----HHHHHH
Confidence 999999999999999 666664
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=363.72 Aligned_cols=261 Identities=27% Similarity=0.433 Sum_probs=213.7
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
.+++|+++++||+|+||.||+|+++.+++.||+|.+...... .....+.+|+++++.++|+||+++++++..++.+|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 357899999999999999999999999999999998654321 223345689999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||+. ++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 82 v~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 82 VFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred EEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 999996 6888887764 34589999999999999999999999999999999999999999999999999843211000
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
......+++.
T Consensus 160 ----------------------------------------------------------------------~~~~~~~~~~ 169 (301)
T cd07873 160 ----------------------------------------------------------------------TYSNEVVTLW 169 (301)
T ss_pred ----------------------------------------------------------------------cccccceeec
Confidence 0011257899
Q ss_pred ccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CC----------------CcCCC----
Q 035713 332 YLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QP----------------LRFPE---- 387 (491)
Q Consensus 332 y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~----------------~~~~~---- 387 (491)
|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+.. .+ ..++.
T Consensus 170 y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (301)
T cd07873 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRAD 249 (301)
T ss_pred ccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccc
Confidence 9999998765 478899999999999999999999988776554433321 10 11111
Q ss_pred -----CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 388 -----TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 388 -----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
...+++++++||.+||+.||.+|+| ++++|+||||+.+.
T Consensus 250 ~~~~~~~~~~~~~~~li~~ml~~dp~~R~t----~~eil~h~~f~~~~ 293 (301)
T cd07873 250 CLHNHAPRLDSDGAELLSKLLQFEGRKRIS----AEEAMKHPYFHCLG 293 (301)
T ss_pred cHHhhcCCCCHHHHHHHHHHhcCCcccCcC----HHHHhcCccccccc
Confidence 1357889999999999999999999 99999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=361.92 Aligned_cols=265 Identities=29% Similarity=0.461 Sum_probs=222.2
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.+.|+++++||.|+||.||+|++..+++.||+|++... .......+.+|+++++.++|+||+++++++..++.+|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 36799999999999999999999999999999998654 234456678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||++|++|..++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 88 IEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred EecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 9999999998877654 2459999999999999999999999999999999999999999999999999874321100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.......++..|
T Consensus 165 --------------------------------------------------------------------~~~~~~~~~~~y 176 (292)
T cd06644 165 --------------------------------------------------------------------QRRDSFIGTPYW 176 (292)
T ss_pred --------------------------------------------------------------------cccceecCCccc
Confidence 001123688899
Q ss_pred cCcchhcC-----CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCC-cCCCCCCCCHHHHHHHHhhhccC
Q 035713 333 LAPEIIRG-----EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL-RFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 333 ~aPE~l~~-----~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~~~~li~~~L~~d 406 (491)
+|||++.+ ..++.++|||||||++|||++|+.||...+....+.++..... .......++.++.+||.+||..|
T Consensus 177 ~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 256 (292)
T cd06644 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKH 256 (292)
T ss_pred cCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCC
Confidence 99999853 4467899999999999999999999987766555555543322 22233457889999999999999
Q ss_pred CCCCCCcCCChHHhhcCCCcCCCChhhhh
Q 035713 407 PHKRIAYKRGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 407 P~~R~t~~~~~~ell~hpff~~~~~~~~~ 435 (491)
|++||+ ++++++||||..++|....
T Consensus 257 p~~Rp~----~~~il~~~~~~~~~~~~~~ 281 (292)
T cd06644 257 PETRPS----AAQLLEHPFVSSVTSNRPL 281 (292)
T ss_pred cccCcC----HHHHhcCccccccccchhH
Confidence 999999 9999999999999887543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=353.87 Aligned_cols=264 Identities=27% Similarity=0.411 Sum_probs=217.0
Q ss_pred cccCCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-C-C----Ccc
Q 035713 84 ISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-H-P----FLP 157 (491)
Q Consensus 84 ~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h-p----~iv 157 (491)
+-+........+|.++..||+|+||.|..|.+..++..||||+|+.. ....+..+.|+++|+++. + | .+|
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 44555566678999999999999999999999999999999998643 344556678999999994 2 2 378
Q ss_pred ceeeeEEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC----
Q 035713 158 TLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG---- 233 (491)
Q Consensus 158 ~l~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g---- 233 (491)
.+.+||...++.|||+|.+ |-++++++..+....++..+++.+++||+.+++|||+.+++|.||||+|||+.+..
T Consensus 155 ~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 155 QMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred eeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEE
Confidence 9999999999999999999 88999999998778899999999999999999999999999999999999985332
Q ss_pred ----------------cEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCccccccccc
Q 035713 234 ----------------HIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNR 297 (491)
Q Consensus 234 ----------------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (491)
.|+|+|||.|..-
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~--------------------------------------------------- 262 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFD--------------------------------------------------- 262 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCccee---------------------------------------------------
Confidence 4677777766331
Q ss_pred CCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHH---H
Q 035713 298 KSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRA---T 374 (491)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~ 374 (491)
.....+++.|..|+|||++++.+|+.++||||+||||+||.+|...|.+.++.+ .
T Consensus 263 ----------------------~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaM 320 (415)
T KOG0671|consen 263 ----------------------HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAM 320 (415)
T ss_pred ----------------------ccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHH
Confidence 112246789999999999999999999999999999999999999999988776 3
Q ss_pred HHHHHcCC------------------CcCCCC-----------------------CCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 375 LFNVVGQP------------------LRFPET-----------------------PQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 375 ~~~i~~~~------------------~~~~~~-----------------------~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
+++|++.. +.+++. ..-..++.|||++||..||.+|+|
T Consensus 321 MerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT- 399 (415)
T KOG0671|consen 321 MERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT- 399 (415)
T ss_pred HHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc-
Confidence 44555421 122211 001123679999999999999999
Q ss_pred CCChHHhhcCCCcCCC
Q 035713 414 KRGATEIKQHPFFEGV 429 (491)
Q Consensus 414 ~~~~~ell~hpff~~~ 429 (491)
+.|+|.||||+..
T Consensus 400 ---l~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 400 ---LREALSHPFFARL 412 (415)
T ss_pred ---HHHHhcCHHhhcC
Confidence 9999999999753
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-47 Score=322.20 Aligned_cols=259 Identities=28% Similarity=0.476 Sum_probs=218.1
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
.+|...++||+|.||+|++|+++.+++.||+|.++... .++..-....+|+-+|+.++|.|||+++++...++.+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 46788899999999999999999999999999987653 22333445678999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||| ..+|..+.... ++.++.+.++.++.|+++||.|+|++++.|||+||.|+||+.+|.+||+|||+++.+...-.
T Consensus 81 e~c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr-- 156 (292)
T KOG0662|consen 81 EFC-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-- 156 (292)
T ss_pred HHh-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE--
Confidence 999 67888887776 56799999999999999999999999999999999999999999999999999975532110
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
|. ..-+-|.||+
T Consensus 157 ----------------------------------------------------cy----------------saevvtlwyr 168 (292)
T KOG0662|consen 157 ----------------------------------------------------CY----------------SAEVVTLWYR 168 (292)
T ss_pred ----------------------------------------------------ee----------------eceeeeeecc
Confidence 00 0126799999
Q ss_pred CcchhcCCC-CCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHc---CCC--cCCC---------------C---
Q 035713 334 APEIIRGEG-HGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVG---QPL--RFPE---------------T--- 388 (491)
Q Consensus 334 aPE~l~~~~-~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~---~~~--~~~~---------------~--- 388 (491)
+|.++.|.. |+..+|+||.|||+.|+.. |++.|.|.+-.+++.+|.. .+- .+|. .
T Consensus 169 ppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattsw 248 (292)
T KOG0662|consen 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSW 248 (292)
T ss_pred CcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchH
Confidence 999999976 7999999999999999987 9999999998888877642 210 1111 0
Q ss_pred ----CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 389 ----PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 389 ----~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
+.++...+||+.++|.-+|.+|++ ++.+++||||...
T Consensus 249 sqivp~lns~grdllqkll~cnp~qris----aeaalqhpyf~d~ 289 (292)
T KOG0662|consen 249 SQIVPKLNSTGRDLLQKLLKCNPAQRIS----AEAALQHPYFSDF 289 (292)
T ss_pred HHHhhhhcchhHHHHHHHhccCcccccC----HHHHhcCcccccc
Confidence 234455789999999999999999 9999999999753
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=368.11 Aligned_cols=265 Identities=23% Similarity=0.356 Sum_probs=210.6
Q ss_pred Eeeeeecc--CceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEec
Q 035713 98 LLKRLGYG--DIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEF 175 (491)
Q Consensus 98 ~~~~iG~G--~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~ 175 (491)
++++||+| +|++||+++++.+|+.||||++..... .......+.+|+++++.++||||++++++|..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 57889999 789999999999999999999876532 234455677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccc
Q 035713 176 CSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKS 255 (491)
Q Consensus 176 ~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 255 (491)
+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||.+..........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~-- 158 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL-- 158 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc--
Confidence 999999999876544569999999999999999999999999999999999999999999999998653221000000
Q ss_pred ccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCc
Q 035713 256 SSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAP 335 (491)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 335 (491)
.... ......+++..|+||
T Consensus 159 ------------------------------------------~~~~-------------------~~~~~~~~~~~y~aP 177 (327)
T cd08227 159 ------------------------------------------RVVH-------------------DFPKYSVKVLPWLSP 177 (327)
T ss_pred ------------------------------------------cccc-------------------cccccccceecccCh
Confidence 0000 000112577889999
Q ss_pred chhcC--CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCc-----------------------------
Q 035713 336 EIIRG--EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR----------------------------- 384 (491)
Q Consensus 336 E~l~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~----------------------------- 384 (491)
|++.+ ..++.++|||||||++|||++|+.||..................
T Consensus 178 E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T cd08227 178 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGES 257 (327)
T ss_pred HHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcc
Confidence 99986 45899999999999999999999999876554433333222110
Q ss_pred ---------------CCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 385 ---------------FPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 385 ---------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
.+....+++++.+||.+||+.||++||| +++|++||||+.+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~ell~~p~f~~~~ 314 (327)
T cd08227 258 TTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPS----ASTLLNHSFFKQIK 314 (327)
T ss_pred cccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCC----HHHHhcChhhhhcc
Confidence 0011235678999999999999999999 99999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=353.89 Aligned_cols=256 Identities=39% Similarity=0.746 Sum_probs=220.7
Q ss_pred eeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccCCCch
Q 035713 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNL 181 (491)
Q Consensus 102 iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~gg~L 181 (491)
||.|+||.||+|++..+++.||+|++.+...........+.+|+++++.++||||+++++++.++..+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999876555555667788999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccccccccc
Q 035713 182 HSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVN 261 (491)
Q Consensus 182 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 261 (491)
.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----------- 147 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----------- 147 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----------
Confidence 9998764 458999999999999999999999999999999999999999999999999985432100
Q ss_pred CCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCC
Q 035713 262 NGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGE 341 (491)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 341 (491)
.....+|+..|++||.+.+.
T Consensus 148 ------------------------------------------------------------~~~~~~~~~~~~~PE~~~~~ 167 (262)
T cd05572 148 ------------------------------------------------------------KTWTFCGTPEYVAPEIILNK 167 (262)
T ss_pred ------------------------------------------------------------ccccccCCcCccChhHhcCC
Confidence 01123688999999999988
Q ss_pred CCCCcccccchhhHHHhhhcCCCCCCCCC--cHHHHHHHHc--CCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc-CCC
Q 035713 342 GHGSAVDWWTFGIFLYELLHGTTPFKGQG--NRATLFNVVG--QPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY-KRG 416 (491)
Q Consensus 342 ~~~~~~DiwSlG~il~elltg~~Pf~~~~--~~~~~~~i~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-~~~ 416 (491)
.++.++|+|||||++|+|++|..||.... ....+..+.. ....+|. .++.++.+||.+||+.||++|+++ +.+
T Consensus 168 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~~~p~~R~~~~~~~ 245 (262)
T cd05572 168 GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN--YIDKAAKDLIKQLLRRNPEERLGNLKGG 245 (262)
T ss_pred CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCc--ccCHHHHHHHHHHccCChhhCcCCcccC
Confidence 89999999999999999999999998776 4455555653 3333443 468999999999999999999995 346
Q ss_pred hHHhhcCCCcCCCChh
Q 035713 417 ATEIKQHPFFEGVNWA 432 (491)
Q Consensus 417 ~~ell~hpff~~~~~~ 432 (491)
+.|+++||||++.+|+
T Consensus 246 ~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 246 IKDIKKHKWFNGFDWE 261 (262)
T ss_pred HHHHhcChhhhCCCCC
Confidence 8999999999999996
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=349.41 Aligned_cols=256 Identities=26% Similarity=0.427 Sum_probs=220.7
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
+|.+.+.||+|+||.||+|+++.+++.|++|.+...... ......+.+|+++++.++||||+++++++...+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 589999999999999999999999999999998765433 3445678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|++|++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--- 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--- 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc---
Confidence 99999999998876556799999999999999999999999999999999999999999999999998754321100
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
......|++.|+|
T Consensus 157 -------------------------------------------------------------------~~~~~~~~~~y~a 169 (256)
T cd08529 157 -------------------------------------------------------------------FANTIVGTPYYLS 169 (256)
T ss_pred -------------------------------------------------------------------hhhccccCccccC
Confidence 0112368899999
Q ss_pred cchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcC
Q 035713 335 PEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK 414 (491)
Q Consensus 335 PE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ 414 (491)
||++.+..++.++|+|||||++|+|++|+.||...+.......+....... ....++..+.++|.+||+.+|++||+
T Consensus 170 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~-- 246 (256)
T cd08529 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP-VSQMYSQQLAQLIDQCLTKDYRQRPD-- 246 (256)
T ss_pred HHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-CccccCHHHHHHHHHHccCCcccCcC--
Confidence 999999999999999999999999999999998887666666665543322 11258899999999999999999999
Q ss_pred CChHHhhcCCCc
Q 035713 415 RGATEIKQHPFF 426 (491)
Q Consensus 415 ~~~~ell~hpff 426 (491)
+.++++|||+
T Consensus 247 --~~~ll~~~~~ 256 (256)
T cd08529 247 --TFQLLRNPSL 256 (256)
T ss_pred --HHHHhhCCCC
Confidence 9999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=349.75 Aligned_cols=256 Identities=25% Similarity=0.431 Sum_probs=217.7
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe-CceEEEEE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET-DKFYCLVM 173 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~-~~~~~lV~ 173 (491)
+|++++.||+|++|.||+++++.+++.||+|.+..... .......+.+|+++++.++|+||+++++.+.. +..+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 49999999999999999999999999999999875432 23345567889999999999999999998864 45789999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+++++|.+++.......+++.+++.++.||+.||.+||++||+||||||+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-- 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC--
Confidence 999999999998875556699999999999999999999999999999999999999999999999999854321000
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
......|++.|+
T Consensus 158 --------------------------------------------------------------------~~~~~~~~~~y~ 169 (257)
T cd08223 158 --------------------------------------------------------------------MASTLIGTPYYM 169 (257)
T ss_pred --------------------------------------------------------------------ccccccCCcCcc
Confidence 011236889999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
|||++.+..++.++|||||||++|+|++|+.||.+.+.......+....... ....++.++.+||.+||+.||++||+
T Consensus 170 aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~- 247 (257)
T cd08223 170 SPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP-MPKDYSPELGELIATMLSKRPEKRPS- 247 (257)
T ss_pred ChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-CccccCHHHHHHHHHHhccCcccCCC-
Confidence 9999999989999999999999999999999998877666666665544321 22358899999999999999999999
Q ss_pred CCChHHhhcCCCc
Q 035713 414 KRGATEIKQHPFF 426 (491)
Q Consensus 414 ~~~~~ell~hpff 426 (491)
+.++++||||
T Consensus 248 ---~~~~l~~~~~ 257 (257)
T cd08223 248 ---VKSILRQPYI 257 (257)
T ss_pred ---HHHHhcCCCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=356.48 Aligned_cols=255 Identities=27% Similarity=0.434 Sum_probs=213.3
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeC------
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETD------ 166 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~------ 166 (491)
+.|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.+ +|+||++++++|...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 56999999999999999999999999999999986542 1224567899999998 699999999998752
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
..+|+||||+.+++|.+++.......+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 46899999999999999988765567999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.... ......
T Consensus 162 ~~~~----------------------------------------------------------------------~~~~~~ 171 (272)
T cd06637 162 DRTV----------------------------------------------------------------------GRRNTF 171 (272)
T ss_pred cccc----------------------------------------------------------------------ccCCcc
Confidence 1100 011234
Q ss_pred ccccCccCcchhc-----CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHh
Q 035713 327 VGTHEYLAPEIIR-----GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRG 401 (491)
Q Consensus 327 ~gt~~y~aPE~l~-----~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 401 (491)
.|+..|+|||++. +..++.++|||||||++|||++|+.||...........+............++.++.+||.+
T Consensus 172 ~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (272)
T cd06637 172 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIES 251 (272)
T ss_pred cccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHH
Confidence 7899999999987 34578899999999999999999999987665555554444333333334688999999999
Q ss_pred hhccCCCCCCCcCCChHHhhcCCCc
Q 035713 402 LLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 402 ~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
||..||.+||+ +.+++.||||
T Consensus 252 ~l~~~p~~Rpt----~~~il~~~~~ 272 (272)
T cd06637 252 CLVKNHSQRPT----TEQLMKHPFI 272 (272)
T ss_pred HcCCChhhCCC----HHHHhhCCCC
Confidence 99999999999 9999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=356.33 Aligned_cols=253 Identities=30% Similarity=0.426 Sum_probs=210.3
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++++.||+|+||.||+|++..+++.||+|++.+.. .......+.+|+++|+.++||||+++++++..++..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 46899999999999999999999999999999987542 2334456788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+++++|..+ ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 79 e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---- 148 (279)
T cd06619 79 EFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---- 148 (279)
T ss_pred ecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence 99999999654 23789999999999999999999999999999999999999999999999998532110
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.....+||..|+
T Consensus 149 --------------------------------------------------------------------~~~~~~~~~~y~ 160 (279)
T cd06619 149 --------------------------------------------------------------------IAKTYVGTNAYM 160 (279)
T ss_pred --------------------------------------------------------------------cccCCCCChhhc
Confidence 011247899999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcH-------HHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR-------ATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
|||++.+..++.++|||||||++|+|++|+.||...... .....+.............+.++.+||.+||+.|
T Consensus 161 aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 240 (279)
T cd06619 161 APERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQ 240 (279)
T ss_pred CceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCC
Confidence 999999999999999999999999999999999653221 1112222221111112347889999999999999
Q ss_pred CCCCCCcCCChHHhhcCCCcCCCC
Q 035713 407 PHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 407 P~~R~t~~~~~~ell~hpff~~~~ 430 (491)
|++||+ ++++++||||...+
T Consensus 241 P~~Rp~----~~eil~~~~~~~~~ 260 (279)
T cd06619 241 PKERPA----PENLMDHPFIVQYN 260 (279)
T ss_pred hhhCCC----HHHHhcCccccccc
Confidence 999999 99999999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=360.92 Aligned_cols=253 Identities=29% Similarity=0.444 Sum_probs=212.5
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++.++||+|+||.||++++..++..||+|.+.... .......+.+|+++++.++||||++++++|.+++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999986542 2344556788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
||++|++|.+++... +.+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 79 ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 79 EHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred eccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 999999999998875 569999999999999999999997 69999999999999999999999999987432100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.....+|+..|
T Consensus 154 ---------------------------------------------------------------------~~~~~~~~~~~ 164 (308)
T cd06615 154 ---------------------------------------------------------------------MANSFVGTRSY 164 (308)
T ss_pred ---------------------------------------------------------------------ccccCCCCcCc
Confidence 01124789999
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC------------------------------
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP------------------------------ 382 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~------------------------------ 382 (491)
+|||++.+..++.++|||||||++|+|++|+.||...+... ...+....
T Consensus 165 ~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (308)
T cd06615 165 MSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELL 243 (308)
T ss_pred cChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccCCCCCccchhhHHHHH
Confidence 99999998889999999999999999999999997654322 22222111
Q ss_pred --------CcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 383 --------LRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 383 --------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
...+. ..++.++++||.+||..||++||+ +.+|++||||..
T Consensus 244 ~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~~~~~~ 292 (308)
T cd06615 244 DYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERAD----LKELTKHPFIKR 292 (308)
T ss_pred HHHhcCCCccCcC-cccCHHHHHHHHHHccCChhhCcC----HHHHhcChhhhh
Confidence 00111 136788999999999999999999 999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-46 Score=355.55 Aligned_cols=254 Identities=37% Similarity=0.651 Sum_probs=212.1
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEec
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEF 175 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~ 175 (491)
|++++.||+|+||+||+|++..+++.||+|++......... .....+|+.+++.++|+||+++++++.....+|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 88999999999999999999999999999999877544333 33345699999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccc
Q 035713 176 CSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKS 255 (491)
Q Consensus 176 ~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 255 (491)
+.+++|.+++... ..+++..+..++.||+.||.+||++||+|+||||+|||++.++.++|+|||++......
T Consensus 80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~------ 151 (260)
T PF00069_consen 80 CPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN------ 151 (260)
T ss_dssp ETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST------
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------
Confidence 9999999999843 56999999999999999999999999999999999999999999999999998542100
Q ss_pred ccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCc
Q 035713 256 SSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAP 335 (491)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 335 (491)
........+|..|+||
T Consensus 152 ----------------------------------------------------------------~~~~~~~~~~~~y~aP 167 (260)
T PF00069_consen 152 ----------------------------------------------------------------NENFNPFVGTPEYMAP 167 (260)
T ss_dssp ----------------------------------------------------------------TSEBSSSSSSGGGSCH
T ss_pred ----------------------------------------------------------------cccccccccccccccc
Confidence 0011234789999999
Q ss_pred chhc-CCCCCCcccccchhhHHHhhhcCCCCCCCCC---cHHHHHHHHcCCCcCCCC--CCCCHHHHHHHHhhhccCCCC
Q 035713 336 EIIR-GEGHGSAVDWWTFGIFLYELLHGTTPFKGQG---NRATLFNVVGQPLRFPET--PQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 336 E~l~-~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~ 409 (491)
|++. +..++.++||||||+++|+|++|..||.... ....+.+........... ...+..+.+||.+||+.||++
T Consensus 168 E~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 247 (260)
T PF00069_consen 168 EVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQ 247 (260)
T ss_dssp HHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGG
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhH
Confidence 9998 7788999999999999999999999999873 233333333322221111 123489999999999999999
Q ss_pred CCCcCCChHHhhcCCCc
Q 035713 410 RIAYKRGATEIKQHPFF 426 (491)
Q Consensus 410 R~t~~~~~~ell~hpff 426 (491)
||+ +.++++||||
T Consensus 248 R~~----~~~l~~~~~~ 260 (260)
T PF00069_consen 248 RPS----AEELLKHPWF 260 (260)
T ss_dssp STT----HHHHHTSGGG
T ss_pred CcC----HHHHhcCCCC
Confidence 999 9999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=357.32 Aligned_cols=256 Identities=27% Similarity=0.440 Sum_probs=209.8
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
+|++++.||+|+||.||+|+++.+++.||||++..... .......+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999999999999999865422 22334566789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 175 FCSGGNLHSLRQKQP-NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
|+. ++|.+++.... +..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-- 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--
Confidence 996 68888876543 35699999999999999999999999999999999999999999999999999854321000
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
......+++.|+
T Consensus 157 --------------------------------------------------------------------~~~~~~~~~~y~ 168 (285)
T cd07861 157 --------------------------------------------------------------------VYTHEVVTLWYR 168 (285)
T ss_pred --------------------------------------------------------------------cccCCccccccc
Confidence 001125788999
Q ss_pred CcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---CC---------------cC---------
Q 035713 334 APEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---PL---------------RF--------- 385 (491)
Q Consensus 334 aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~~---------------~~--------- 385 (491)
|||++.+. .++.++|||||||++|+|++|++||.+......+..+... .. .+
T Consensus 169 aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (285)
T cd07861 169 APEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLR 248 (285)
T ss_pred ChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhH
Confidence 99998765 4688999999999999999999999887655444332210 00 00
Q ss_pred CCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 386 PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 386 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
.....++.++++||.+||+.||.+||+ +.+|+.||||
T Consensus 249 ~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~~ll~~~~~ 285 (285)
T cd07861 249 SAVKNLDEDGLDLLEKMLIYDPAKRIS----AKKALNHPYF 285 (285)
T ss_pred HhcCCCCHHHHHHHHHHhcCChhhCCC----HHHHhcCCCC
Confidence 011347889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=363.83 Aligned_cols=251 Identities=25% Similarity=0.404 Sum_probs=193.4
Q ss_pred eeeeeccCceEEEEEEEe--CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe--CceEEEEEe
Q 035713 99 LKRLGYGDIGSVYLVELR--GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET--DKFYCLVME 174 (491)
Q Consensus 99 ~~~iG~G~~g~V~~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~--~~~~~lV~E 174 (491)
.++||+|+||+||+|+++ .+++.||+|.+...... ..+.+|+++|+.++||||++++++|.. +..+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999976 46789999998654321 235679999999999999999999854 567899999
Q ss_pred ccCCCchHHHHHhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEE----ccCCcEEEeecccc
Q 035713 175 FCSGGNLHSLRQKQ-------PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLV----RDEGHIMLSDFDLS 243 (491)
Q Consensus 175 ~~~gg~L~~~~~~~-------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl----~~~g~vkL~DFGla 243 (491)
|+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 99 56888776532 12358999999999999999999999999999999999999 45678999999998
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (491)
+........ ....
T Consensus 160 ~~~~~~~~~-------------------------------------------------------------------~~~~ 172 (317)
T cd07868 160 RLFNSPLKP-------------------------------------------------------------------LADL 172 (317)
T ss_pred eccCCCCcc-------------------------------------------------------------------cccc
Confidence 643211000 0011
Q ss_pred cccccccCccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcH---------HHHHHHH---cCCC-------
Q 035713 324 MSFVGTHEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNR---------ATLFNVV---GQPL------- 383 (491)
Q Consensus 324 ~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---------~~~~~i~---~~~~------- 383 (491)
...+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.... ..+.++. +.+.
T Consensus 173 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (317)
T cd07868 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDI 252 (317)
T ss_pred CCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHH
Confidence 134789999999999875 4799999999999999999999999754321 1222211 1000
Q ss_pred -cCC-------------------------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 384 -RFP-------------------------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 384 -~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
..+ .....+.++.+||.+||+.||.+|+| ++|+|+||||
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07868 253 KKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT----SEQAMQDPYF 317 (317)
T ss_pred hhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCC----HHHHhcCCCC
Confidence 000 00123567899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=364.88 Aligned_cols=261 Identities=31% Similarity=0.509 Sum_probs=223.8
Q ss_pred ceEe--eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 96 FRLL--KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 96 y~~~--~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
|+|. +.||+|.||+||-|+++++|+.||||+|.|..+... +...+++|+.||+.+.||.||.|...|++.+.+|+||
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 5554 689999999999999999999999999999877653 3467899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC---CcEEEeecccccccCCCC
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE---GHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~---g~vkL~DFGla~~~~~~~ 250 (491)
|-+ .|++.+++-....++|++...++++.||+.||.|||-++|+|.||||+|||+... -++||||||+|+.+...+
T Consensus 643 EKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 643 EKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 999 5566666655556889999999999999999999999999999999999999754 369999999997653211
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
...+++||+
T Consensus 722 -----------------------------------------------------------------------FRrsVVGTP 730 (888)
T KOG4236|consen 722 -----------------------------------------------------------------------FRRSVVGTP 730 (888)
T ss_pred -----------------------------------------------------------------------hhhhhcCCc
Confidence 122569999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC--CCCCCHHHHHHHHhhhccCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE--TPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~ 408 (491)
.|+|||+|+.+.|+..-||||.|||+|--|+|..||... ++.-.+|.+..+-+|. +..++.++.|||..+|+..-.
T Consensus 731 AYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~ 808 (888)
T KOG4236|consen 731 AYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMR 808 (888)
T ss_pred cccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999654 3344556666555554 357999999999999999999
Q ss_pred CCCCcCCChHHhhcCCCcCCCC-hhhhh
Q 035713 409 KRIAYKRGATEIKQHPFFEGVN-WALVR 435 (491)
Q Consensus 409 ~R~t~~~~~~ell~hpff~~~~-~~~~~ 435 (491)
+|.+ ++..|.|||+++.. |..+|
T Consensus 809 kRys----vdk~lsh~Wlq~yq~w~DLR 832 (888)
T KOG4236|consen 809 KRYS----VDKSLSHPWLQDYQTWLDLR 832 (888)
T ss_pred Hhcc----hHhhccchhhhcchHHHHHH
Confidence 9999 99999999999863 65554
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=383.60 Aligned_cols=270 Identities=21% Similarity=0.320 Sum_probs=201.8
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCC-cEEEEEE--------------eecchhhhHHHHHHHHHHHHHHhhcCCCC
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTN-TYFAMKV--------------MDKASLASRNKLLRAQTEREILGLLDHPF 155 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~-~~vaiK~--------------i~~~~~~~~~~~~~~~~E~~il~~l~hp~ 155 (491)
...++|+++++||+|+||+||+|..+... ..+++|. +.+...........+.+|+++|+.++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999999876432 2222221 11111112234456789999999999999
Q ss_pred ccceeeeEEeCceEEEEEeccCCCchHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC
Q 035713 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQP---NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE 232 (491)
Q Consensus 156 iv~l~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~ 232 (491)
||++++++...+..|+|||++ +++|..++.... ........++.|+.||+.||.|||++|||||||||+||||+.+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 999999999999999999999 567777665321 1224567788999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCC
Q 035713 233 GHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALP 312 (491)
Q Consensus 233 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (491)
|.+||+|||+++.+....
T Consensus 304 ~~vkL~DFGla~~~~~~~-------------------------------------------------------------- 321 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKER-------------------------------------------------------------- 321 (501)
T ss_pred CCEEEEeCCCceecCccc--------------------------------------------------------------
Confidence 999999999986432110
Q ss_pred ccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCC-C--CcHHHHHHHHcC----CCcC
Q 035713 313 ELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKG-Q--GNRATLFNVVGQ----PLRF 385 (491)
Q Consensus 313 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~--~~~~~~~~i~~~----~~~~ 385 (491)
.......+||..|+|||++.+..++.++|||||||+||||++|..++.+ . .....+.+++.. ...+
T Consensus 322 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (501)
T PHA03210 322 -------EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEF 394 (501)
T ss_pred -------ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhc
Confidence 0011234799999999999999999999999999999999998765432 2 122223222210 0001
Q ss_pred C--------------------------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhh
Q 035713 386 P--------------------------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALV 434 (491)
Q Consensus 386 ~--------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~ 434 (491)
+ ....++.++.++|.+||+.||.+||+ +.|+|+||||....+..+
T Consensus 395 p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rps----a~elL~hp~f~~~~~~~~ 465 (501)
T PHA03210 395 PDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPG----AAELLALPLFSAEEEEEI 465 (501)
T ss_pred CCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcC----HHHHhhChhhhcCCchHH
Confidence 1 01235677889999999999999999 999999999998776543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=355.88 Aligned_cols=248 Identities=15% Similarity=0.204 Sum_probs=209.4
Q ss_pred CCceEe--eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe----Cc
Q 035713 94 SNFRLL--KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET----DK 167 (491)
Q Consensus 94 ~~y~~~--~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~----~~ 167 (491)
++++.. ..||+|++|.||+|.+ +|+.||||++++...........+.+|+++|++++||||+++++++.+ ..
T Consensus 18 ~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~ 95 (283)
T PHA02988 18 DDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95 (283)
T ss_pred HHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCC
Confidence 344444 6799999999999988 588999999987654444456778899999999999999999999876 35
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
.+++||||++||+|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.+
T Consensus 96 ~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~ 173 (283)
T PHA02988 96 RLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKIL 173 (283)
T ss_pred ceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence 789999999999999998764 468999999999999999999998 59999999999999999999999999998543
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
... ....
T Consensus 174 ~~~-------------------------------------------------------------------------~~~~ 180 (283)
T PHA02988 174 SSP-------------------------------------------------------------------------PFKN 180 (283)
T ss_pred ccc-------------------------------------------------------------------------cccc
Confidence 110 0012
Q ss_pred ccccCccCcchhcC--CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhc
Q 035713 327 VGTHEYLAPEIIRG--EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLV 404 (491)
Q Consensus 327 ~gt~~y~aPE~l~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~ 404 (491)
+||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..++.....++....++.++.+||.+||+
T Consensus 181 ~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~ 260 (283)
T PHA02988 181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTS 260 (283)
T ss_pred cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhc
Confidence 68899999999987 6789999999999999999999999998877777766665544444434689999999999999
Q ss_pred cCCCCCCCcCCChHHhhc
Q 035713 405 KEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 405 ~dP~~R~t~~~~~~ell~ 422 (491)
.||++||+ +.++++
T Consensus 261 ~dp~~Rps----~~ell~ 274 (283)
T PHA02988 261 HDSIKRPN----IKEILY 274 (283)
T ss_pred CCcccCcC----HHHHHH
Confidence 99999999 888875
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=360.68 Aligned_cols=259 Identities=29% Similarity=0.455 Sum_probs=208.0
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCceEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~~ 170 (491)
.-..|+++++||+||.+.||++...+.+ .||+|.+... ..+...+.-+.+|+.+|.+|+ |.+||+|++|-..++.+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 3467999999999999999999987554 5666655332 245566778899999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
|||||- ..+|..+++... ..++...+++|..||+.|+.++|.+||||.||||.|+|+- .|.+||+|||+|..+..+.
T Consensus 437 mvmE~G-d~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred EEeecc-cccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 999986 679999988753 4456568999999999999999999999999999999985 6899999999996554333
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
+. ....+-+||+
T Consensus 514 Ts--------------------------------------------------------------------I~kdsQvGT~ 525 (677)
T KOG0596|consen 514 TS--------------------------------------------------------------------IVKDSQVGTV 525 (677)
T ss_pred cc--------------------------------------------------------------------eeeccccCcc
Confidence 22 1222459999
Q ss_pred CccCcchhcCCC-----------CCCcccccchhhHHHhhhcCCCCCCCCCc-HHHHHHHHcC--CCcCCCCCCCCHHHH
Q 035713 331 EYLAPEIIRGEG-----------HGSAVDWWTFGIFLYELLHGTTPFKGQGN-RATLFNVVGQ--PLRFPETPQVSFVAR 396 (491)
Q Consensus 331 ~y~aPE~l~~~~-----------~~~~~DiwSlG~il~elltg~~Pf~~~~~-~~~~~~i~~~--~~~~~~~~~~s~~~~ 396 (491)
.||+||.+.... .+.++||||||||||+|+.|++||..-.+ ...+..|..- .+.||..+. ..++.
T Consensus 526 NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~-~~~li 604 (677)
T KOG0596|consen 526 NYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPE-NDELI 604 (677)
T ss_pred cccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCC-chHHH
Confidence 999999997533 35789999999999999999999975432 2233344433 235665432 23499
Q ss_pred HHHHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 397 DLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 397 ~li~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
++++.||+.||++||+ +.+||+|||++.
T Consensus 605 ~~mK~CL~rdPkkR~s----i~eLLqhpFl~~ 632 (677)
T KOG0596|consen 605 DVMKCCLARDPKKRWS----IPELLQHPFLQI 632 (677)
T ss_pred HHHHHHHhcCcccCCC----cHHHhcCccccc
Confidence 9999999999999999 999999999975
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=354.43 Aligned_cols=257 Identities=29% Similarity=0.432 Sum_probs=213.6
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEE------
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFE------ 164 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~------ 164 (491)
..+.|++.+.||.|+||.||+|++..+++.||+|++.... .....+..|+.+++.+ +|+||++++++|.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 4478999999999999999999999999999999986542 2334567899999988 6999999999985
Q ss_pred eCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 165 TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 165 ~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
....+|+||||+.+|+|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 34688999999999999999887656679999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
...... ....
T Consensus 170 ~~~~~~----------------------------------------------------------------------~~~~ 179 (282)
T cd06636 170 QLDRTV----------------------------------------------------------------------GRRN 179 (282)
T ss_pred hhhccc----------------------------------------------------------------------cCCC
Confidence 321100 0011
Q ss_pred ccccccCccCcchhc-----CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHH
Q 035713 325 SFVGTHEYLAPEIIR-----GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLI 399 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li 399 (491)
..+|+..|+|||++. +..++.++|||||||++|||++|+.||........+..+............++.++.+||
T Consensus 180 ~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (282)
T cd06636 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFI 259 (282)
T ss_pred cccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHH
Confidence 247899999999986 345788999999999999999999999876655555444433222222345889999999
Q ss_pred HhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 400 RGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 400 ~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
.+||..||.+||+ +.+|++||||
T Consensus 260 ~~cl~~~p~~Rp~----~~ell~~~~~ 282 (282)
T cd06636 260 EGCLVKNYLSRPS----TEQLLKHPFI 282 (282)
T ss_pred HHHhCCChhhCcC----HHHHhcCCCC
Confidence 9999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=352.62 Aligned_cols=260 Identities=33% Similarity=0.620 Sum_probs=208.0
Q ss_pred eeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHH---HHHhhcCCCCccceeeeEEeCceEEEEEeccC
Q 035713 101 RLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTER---EILGLLDHPFLPTLYSYFETDKFYCLVMEFCS 177 (491)
Q Consensus 101 ~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~---~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~ 177 (491)
.||+|+||.||+|++..+++.||+|++.+..............|. ++++...||+|+.+++++...+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999999765433222222233343 44555679999999999999999999999999
Q ss_pred CCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccccc
Q 035713 178 GGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSS 257 (491)
Q Consensus 178 gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 257 (491)
|++|..++... +.+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++......
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-------- 150 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------- 150 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--------
Confidence 99999888754 56999999999999999999999999999999999999999999999999987432100
Q ss_pred ccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcch
Q 035713 258 VSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEI 337 (491)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 337 (491)
.....+|+..|+|||+
T Consensus 151 ----------------------------------------------------------------~~~~~~~~~~y~aPE~ 166 (278)
T cd05606 151 ----------------------------------------------------------------KPHASVGTHGYMAPEV 166 (278)
T ss_pred ----------------------------------------------------------------CCcCcCCCcCCcCcHH
Confidence 0012368999999999
Q ss_pred hcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCc---HHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 338 IRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGN---RATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 338 l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
+.+. .++.++|||||||++|+|++|+.||.+... ......+......++. .++.++.+||.+||..||.+|+..
T Consensus 167 ~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~li~~~l~~~p~~R~~~ 244 (278)
T cd05606 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD--SFSPELRSLLEGLLQRDVNRRLGC 244 (278)
T ss_pred hcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCC--cCCHHHHHHHHHHhhcCHHhccCC
Confidence 9754 589999999999999999999999986632 2222223233333333 478999999999999999999921
Q ss_pred C-CChHHhhcCCCcCCCChhhhhc
Q 035713 414 K-RGATEIKQHPFFEGVNWALVRS 436 (491)
Q Consensus 414 ~-~~~~ell~hpff~~~~~~~~~~ 436 (491)
. ..+.++++||||+.++|+.+..
T Consensus 245 ~~~~~~~ll~~~~~~~~~~~~~~~ 268 (278)
T cd05606 245 LGRGAQEVKEHPFFRSLDWQMVFL 268 (278)
T ss_pred CCCCHHHHHhCccccCCCchHhhh
Confidence 1 1199999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=349.99 Aligned_cols=265 Identities=41% Similarity=0.739 Sum_probs=225.2
Q ss_pred eeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccCCCch
Q 035713 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNL 181 (491)
Q Consensus 102 iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~gg~L 181 (491)
||.|+||.||+|++..+|+.||+|++.+...........+.+|+++++.++|+||+++++.+..+...|+||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999876655556677888999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccccccccc
Q 035713 182 HSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVN 261 (491)
Q Consensus 182 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 261 (491)
.+++... +.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~------- 151 (265)
T cd05579 81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL------- 151 (265)
T ss_pred HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc-------
Confidence 9998875 3699999999999999999999999999999999999999999999999999854321110000
Q ss_pred CCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCC
Q 035713 262 NGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGE 341 (491)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 341 (491)
...........++..|+|||.+.+.
T Consensus 152 -------------------------------------------------------~~~~~~~~~~~~~~~~~~Pe~~~~~ 176 (265)
T cd05579 152 -------------------------------------------------------NDDEKEDKRIVGTPDYIAPEVILGQ 176 (265)
T ss_pred -------------------------------------------------------ccccccccCcccCccccCHHHhcCC
Confidence 0000011124688899999999988
Q ss_pred CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhh
Q 035713 342 GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIK 421 (491)
Q Consensus 342 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell 421 (491)
.++.++|||||||++|+|++|..||...........+..+...++....++..+.+||.+||+.+|.+||++.. +.++|
T Consensus 177 ~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~-~~~~l 255 (265)
T cd05579 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKS-IEEIK 255 (265)
T ss_pred CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCcc-HHHHh
Confidence 89999999999999999999999999887777777777666666655446999999999999999999999211 39999
Q ss_pred cCCCcCCCCh
Q 035713 422 QHPFFEGVNW 431 (491)
Q Consensus 422 ~hpff~~~~~ 431 (491)
+||||+.++|
T Consensus 256 ~~~~~~~~~~ 265 (265)
T cd05579 256 NHPFFKGIDW 265 (265)
T ss_pred cCccccCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=350.01 Aligned_cols=256 Identities=39% Similarity=0.713 Sum_probs=215.4
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHH-hhcCCCCccceeeeEEeCceEEEEEeccCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL-GLLDHPFLPTLYSYFETDKFYCLVMEFCSG 178 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il-~~l~hp~iv~l~~~~~~~~~~~lV~E~~~g 178 (491)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++ ..++|+||+++++++..++.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999999765544334444455565554 445899999999999999999999999999
Q ss_pred CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccc
Q 035713 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258 (491)
Q Consensus 179 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 258 (491)
++|..++... ..+++..+..++.||+.||.|||+.|++||||+|+||+++.++.+||+|||++.....
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---------- 149 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---------- 149 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----------
Confidence 9999998764 4699999999999999999999999999999999999999999999999998743210
Q ss_pred cccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchh
Q 035713 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338 (491)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 338 (491)
.....|+..|+|||.+
T Consensus 150 ----------------------------------------------------------------~~~~~~~~~y~~pe~~ 165 (260)
T cd05611 150 ----------------------------------------------------------------NKKFVGTPDYLAPETI 165 (260)
T ss_pred ----------------------------------------------------------------cccCCCCcCccChhhh
Confidence 0123678899999999
Q ss_pred cCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC--CCCCCHHHHHHHHhhhccCCCCCCCcCCC
Q 035713 339 RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE--TPQVSFVARDLIRGLLVKEPHKRIAYKRG 416 (491)
Q Consensus 339 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~R~t~~~~ 416 (491)
.+..++.++|||||||++|+|++|..||...+....+..+......++. ...++.++.++|.+||+.||++|++.. .
T Consensus 166 ~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~-~ 244 (260)
T cd05611 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGAN-G 244 (260)
T ss_pred cCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCC-c
Confidence 9888899999999999999999999999888777666666555444332 235789999999999999999999721 1
Q ss_pred hHHhhcCCCcCCCChh
Q 035713 417 ATEIKQHPFFEGVNWA 432 (491)
Q Consensus 417 ~~ell~hpff~~~~~~ 432 (491)
++|++.||||+.++|+
T Consensus 245 ~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 245 YQEIKSHPFFKSINWD 260 (260)
T ss_pred HHHHHcChHhhcCCCC
Confidence 6899999999999995
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=354.38 Aligned_cols=262 Identities=27% Similarity=0.464 Sum_probs=221.3
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.++|+++++||.|+||.||+|.+..++..||+|++... .......+.+|+++++.++|+||+++++++..+..+|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 36799999999999999999999989999999998643 234456677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+++++|..++... ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--- 156 (280)
T cd06611 81 IEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--- 156 (280)
T ss_pred eeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc---
Confidence 9999999999988764 346999999999999999999999999999999999999999999999999987432110
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
........||..|
T Consensus 157 -------------------------------------------------------------------~~~~~~~~~~~~y 169 (280)
T cd06611 157 -------------------------------------------------------------------LQKRDTFIGTPYW 169 (280)
T ss_pred -------------------------------------------------------------------ccccceeecchhh
Confidence 0011124689999
Q ss_pred cCcchhcC-----CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCC-cCCCCCCCCHHHHHHHHhhhccC
Q 035713 333 LAPEIIRG-----EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL-RFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 333 ~aPE~l~~-----~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~~~~li~~~L~~d 406 (491)
+|||++.. ..++.++|||||||++|+|++|+.||.+.+....+.++..... .+.....++.++.+||.+||+.|
T Consensus 170 ~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 249 (280)
T cd06611 170 MAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKD 249 (280)
T ss_pred cCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccC
Confidence 99999853 4467899999999999999999999988776666666655432 22333468899999999999999
Q ss_pred CCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 407 PHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 407 P~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
|.+||+ +.++++||||.....+
T Consensus 250 p~~Rps----~~~il~~~~~~~~~~~ 271 (280)
T cd06611 250 PDDRPT----AAELLKHPFVSDQSDN 271 (280)
T ss_pred hhhCcC----HHHHhcChhhcccchh
Confidence 999999 9999999999876443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=352.11 Aligned_cols=254 Identities=28% Similarity=0.459 Sum_probs=213.0
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 368999999999999999999999999999999986542 22334567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+++++|.+++... +.+++.+++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 85 MEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred EeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 9999999999998764 569999999999999999999999999999999999999999999999999985432100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.......|+..|
T Consensus 161 --------------------------------------------------------------------~~~~~~~~~~~y 172 (267)
T cd06645 161 --------------------------------------------------------------------AKRKSFIGTPYW 172 (267)
T ss_pred --------------------------------------------------------------------cccccccCcccc
Confidence 001123689999
Q ss_pred cCcchhc---CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC---CCCCCHHHHHHHHhhhccC
Q 035713 333 LAPEIIR---GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE---TPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 333 ~aPE~l~---~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~s~~~~~li~~~L~~d 406 (491)
+|||++. ...++.++|||||||++|+|++|..||........+..........+. ...++..+.+||.+||+.|
T Consensus 173 ~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 252 (267)
T cd06645 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKN 252 (267)
T ss_pred cChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCC
Confidence 9999985 445788999999999999999999999766554444444333332222 2347789999999999999
Q ss_pred CCCCCCcCCChHHhhcCCC
Q 035713 407 PHKRIAYKRGATEIKQHPF 425 (491)
Q Consensus 407 P~~R~t~~~~~~ell~hpf 425 (491)
|++||+ +++|++|||
T Consensus 253 P~~R~~----~~~ll~~~~ 267 (267)
T cd06645 253 PKKRPT----AEKLLQHPF 267 (267)
T ss_pred chhCcC----HHHHhcCCC
Confidence 999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=348.69 Aligned_cols=253 Identities=36% Similarity=0.696 Sum_probs=218.5
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
+|++.+.||.|+||.||+|++..+++.||+|++.+...........+.+|+++++.++||||+++++++..+..+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999987655554566788899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|+.|++|..++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc----
Confidence 99999999998764 469999999999999999999999999999999999999999999999999875422100
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
......|+..|+|
T Consensus 155 -------------------------------------------------------------------~~~~~~~~~~y~~ 167 (258)
T cd05578 155 -------------------------------------------------------------------LTTSTSGTPGYMA 167 (258)
T ss_pred -------------------------------------------------------------------cccccCCChhhcC
Confidence 0012357889999
Q ss_pred cchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCc--HHHHHHHHc-CCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 335 PEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGN--RATLFNVVG-QPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 335 PE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~i~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
||++.+..++.++|+|||||++|+|++|+.||...+. ...+..... ....++ ..++.++.++|.+||..||.+|+
T Consensus 168 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~ 245 (258)
T cd05578 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP--ATWSTEAIDAINKLLERDPQKRL 245 (258)
T ss_pred HHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCc--ccCcHHHHHHHHHHccCChhHcC
Confidence 9999998899999999999999999999999987764 333333333 333333 35889999999999999999999
Q ss_pred CcCCCh--HHhhcCCCc
Q 035713 412 AYKRGA--TEIKQHPFF 426 (491)
Q Consensus 412 t~~~~~--~ell~hpff 426 (491)
+ + .|+++||||
T Consensus 246 ~----~~~~~l~~~~~~ 258 (258)
T cd05578 246 G----DNLKDLKNHPYF 258 (258)
T ss_pred C----ccHHHHhcCCCC
Confidence 9 7 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=351.39 Aligned_cols=259 Identities=31% Similarity=0.491 Sum_probs=219.8
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++++.||.|+||.||+|++..+++.||+|++.... .......+.+|+++++.++|+||+++++++.++..+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 47999999999999999999999999999999987543 2334456778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+.+++|.+++... .+++..++.++.||+.||.|||+++++||||+|+||+++.++.++|+|||+++......
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 152 (274)
T cd06609 79 EYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--- 152 (274)
T ss_pred EeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc---
Confidence 999999999998763 69999999999999999999999999999999999999999999999999986542110
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.......|+..|+
T Consensus 153 -------------------------------------------------------------------~~~~~~~~~~~y~ 165 (274)
T cd06609 153 -------------------------------------------------------------------SKRNTFVGTPFWM 165 (274)
T ss_pred -------------------------------------------------------------------cccccccCCcccc
Confidence 0111236889999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
|||++.+..++.++|||||||++|+|++|+.||...+.......+............++.++.++|.+||..||++||+
T Consensus 166 ~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt- 244 (274)
T cd06609 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPS- 244 (274)
T ss_pred ChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcC-
Confidence 9999999889999999999999999999999998766555544444332222112237889999999999999999999
Q ss_pred CCChHHhhcCCCcCCCCh
Q 035713 414 KRGATEIKQHPFFEGVNW 431 (491)
Q Consensus 414 ~~~~~ell~hpff~~~~~ 431 (491)
++++++||||....-
T Consensus 245 ---~~~il~~~~~~~~~~ 259 (274)
T cd06609 245 ---AKELLKHKFIKKAKK 259 (274)
T ss_pred ---HHHHhhChhhcCCCc
Confidence 999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=351.14 Aligned_cols=257 Identities=29% Similarity=0.448 Sum_probs=216.0
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
-|++++.||+|+||.||+|.+..++..+++|.+.... ......+.+|+++++.++|+||+++++++..++..|+|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 3789999999999999999999999999999986542 3345567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|+.+++|..++... ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~---- 157 (282)
T cd06643 83 FCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 157 (282)
T ss_pred ecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc----
Confidence 99999998877653 3469999999999999999999999999999999999999999999999999985421100
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
.......||..|+|
T Consensus 158 ------------------------------------------------------------------~~~~~~~~~~~y~a 171 (282)
T cd06643 158 ------------------------------------------------------------------QRRDSFIGTPYWMA 171 (282)
T ss_pred ------------------------------------------------------------------cccccccccccccC
Confidence 00112368899999
Q ss_pred cchhc-----CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC-CcCCCCCCCCHHHHHHHHhhhccCCC
Q 035713 335 PEIIR-----GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP-LRFPETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 335 PE~l~-----~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~ 408 (491)
||++. +..++.++|||||||++|||++|++||...+.......+.... ...+....++.++.+||.+||+.||.
T Consensus 172 PE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 251 (282)
T cd06643 172 PEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVD 251 (282)
T ss_pred HhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChh
Confidence 99984 3457889999999999999999999998877666666654432 22233345889999999999999999
Q ss_pred CCCCcCCChHHhhcCCCcCCC
Q 035713 409 KRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 409 ~R~t~~~~~~ell~hpff~~~ 429 (491)
+||+ ++++++||||...
T Consensus 252 ~Rp~----~~~il~~~~~~~~ 268 (282)
T cd06643 252 ARWT----TTQLLQHPFVTVN 268 (282)
T ss_pred hCcC----HHHHhcCCCEecc
Confidence 9999 9999999999743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=343.41 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=222.2
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
+|++++.||.|+||.||.+++..+++.+++|.+...... ......+.+|+++|+.++|+||+++++++.+.+.+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 599999999999999999999999999999998765433 3445567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--- 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--- 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---
Confidence 99999999999876556799999999999999999999999999999999999999999999999999854321000
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
......|++.|+|
T Consensus 157 -------------------------------------------------------------------~~~~~~~~~~y~a 169 (256)
T cd08221 157 -------------------------------------------------------------------MAETVVGTPYYMS 169 (256)
T ss_pred -------------------------------------------------------------------cccccCCCccccC
Confidence 0012368899999
Q ss_pred cchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcC
Q 035713 335 PEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK 414 (491)
Q Consensus 335 PE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ 414 (491)
||++.+..++.++|||||||++|+|++|..||......+....+....... ....++.++.++|.+||..+|.+||+
T Consensus 170 pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~s-- 246 (256)
T cd08221 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-VVSVYSSELISLVHSLLQQDPEKRPT-- 246 (256)
T ss_pred HhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-CccccCHHHHHHHHHHcccCcccCCC--
Confidence 999998888999999999999999999999999887777777776554432 22468899999999999999999999
Q ss_pred CChHHhhcCCCc
Q 035713 415 RGATEIKQHPFF 426 (491)
Q Consensus 415 ~~~~ell~hpff 426 (491)
+.++++|+|+
T Consensus 247 --~~~ll~~~~l 256 (256)
T cd08221 247 --ADEVLDQPLL 256 (256)
T ss_pred --HHHHhhCcCC
Confidence 9999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=346.70 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=217.3
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhh------hHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCce
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLA------SRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKF 168 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~------~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~ 168 (491)
+|.+...||.|+||.||+|.+..+++.||+|.+...... .......+.+|+++++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 478889999999999999999989999999988754322 22344678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
.++||||+++++|..++... +.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999999775 5589999999999999999999999999999999999999999999999999865421
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
..... ........+.|
T Consensus 159 ~~~~~----------------------------------------------------------------~~~~~~~~~~~ 174 (267)
T cd06628 159 NSLST----------------------------------------------------------------KTNGARPSLQG 174 (267)
T ss_pred ccccC----------------------------------------------------------------CccccccccCC
Confidence 10000 00001112468
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCC
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 408 (491)
+..|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.++.... .......++..+.+||.+||+.||.
T Consensus 175 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~ 253 (267)
T cd06628 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA-SPEIPSNISSEAIDFLEKTFEIDHN 253 (267)
T ss_pred CcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC-CCcCCcccCHHHHHHHHHHccCCch
Confidence 899999999999889999999999999999999999998876655555544421 1122235889999999999999999
Q ss_pred CCCCcCCChHHhhcCCCc
Q 035713 409 KRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 409 ~R~t~~~~~~ell~hpff 426 (491)
+||+ +.++++||||
T Consensus 254 ~Rp~----~~~il~~~~~ 267 (267)
T cd06628 254 KRPT----AAELLKHPFL 267 (267)
T ss_pred hCcC----HHHHhhCCCC
Confidence 9999 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=345.98 Aligned_cols=261 Identities=27% Similarity=0.410 Sum_probs=220.0
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++.+.||.|+||+||+|.+..++..+|+|++....... ....+.+|+++|+.++|+||+++++.+..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999999899999999987654332 5567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 174 EFCSGGNLHSLRQKQPN-KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
||++|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999876432 56999999999999999999999999999999999999999999999999998554221100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
. .......+|+..|
T Consensus 159 ~------------------------------------------------------------------~~~~~~~~~~~~y 172 (267)
T cd06610 159 T------------------------------------------------------------------RKVRKTFVGTPCW 172 (267)
T ss_pred c------------------------------------------------------------------ccccccccCChhh
Confidence 0 0011234789999
Q ss_pred cCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCC-cCCCC---CCCCHHHHHHHHhhhccCC
Q 035713 333 LAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL-RFPET---PQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 333 ~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~---~~~s~~~~~li~~~L~~dP 407 (491)
+|||++... .++.++|+|||||++|+|++|+.||...+....+.+++.... .++.. ..++..+.+||.+||..||
T Consensus 173 ~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 252 (267)
T cd06610 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDP 252 (267)
T ss_pred cChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCCh
Confidence 999999877 689999999999999999999999988776666666554432 12221 2578899999999999999
Q ss_pred CCCCCcCCChHHhhcCCCc
Q 035713 408 HKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 408 ~~R~t~~~~~~ell~hpff 426 (491)
++||+ +.+|++||||
T Consensus 253 ~~Rp~----~~~ll~~p~~ 267 (267)
T cd06610 253 SKRPT----AEELLKHKFF 267 (267)
T ss_pred hhCcC----HHHHhhCCCC
Confidence 99999 9999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=351.29 Aligned_cols=256 Identities=28% Similarity=0.472 Sum_probs=211.1
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++++.||+|+||.||+|+++.+++.||+|++..... .......+.+|+++++.++|+||+++++++..+..+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999999999999999865421 2223345678999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||++++.|..++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07847 80 EYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-- 155 (286)
T ss_pred eccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--
Confidence 999998888776543 4599999999999999999999999999999999999999999999999999854321000
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
......++..|+
T Consensus 156 --------------------------------------------------------------------~~~~~~~~~~~~ 167 (286)
T cd07847 156 --------------------------------------------------------------------DYTDYVATRWYR 167 (286)
T ss_pred --------------------------------------------------------------------cccCcccccccC
Confidence 001235788999
Q ss_pred CcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC-------------------CCcCCC------
Q 035713 334 APEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ-------------------PLRFPE------ 387 (491)
Q Consensus 334 aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~-------------------~~~~~~------ 387 (491)
|||++.+ ..++.++|||||||++|+|++|++||.+....+.+..+... ....+.
T Consensus 168 aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (286)
T cd07847 168 APELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREP 247 (286)
T ss_pred CHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccC
Confidence 9999887 45789999999999999999999999987765555443210 000111
Q ss_pred ----CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 388 ----TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 388 ----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
...++..+.+||.+||+.||++||+ +.+++.||||
T Consensus 248 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~eil~~~~f 286 (286)
T cd07847 248 LESKFPNISSPALSFLKGCLQMDPTERLS----CEELLEHPYF 286 (286)
T ss_pred HHHHhccCCHHHHHHHHHHhcCCccccCC----HHHHhcCCCC
Confidence 1346788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=351.30 Aligned_cols=267 Identities=22% Similarity=0.313 Sum_probs=216.4
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE 164 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 164 (491)
++..++|++.++||+|+||.||+|.++. .+..||+|.+..... ......+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4566899999999999999999998652 355799998865422 223345778999999999999999999999
Q ss_pred eCceEEEEEeccCCCchHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEE
Q 035713 165 TDKFYCLVMEFCSGGNLHSLRQKQP--------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIM 236 (491)
Q Consensus 165 ~~~~~~lV~E~~~gg~L~~~~~~~~--------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vk 236 (491)
..+..|+||||+.+|+|.+++.... ...++...+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999999987532 12356778899999999999999999999999999999999999999
Q ss_pred EeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCcccc
Q 035713 237 LSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMA 316 (491)
Q Consensus 237 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (491)
|+|||+++........
T Consensus 160 L~Dfg~~~~~~~~~~~---------------------------------------------------------------- 175 (288)
T cd05061 160 IGDFGMTRDIYETDYY---------------------------------------------------------------- 175 (288)
T ss_pred ECcCCccccccccccc----------------------------------------------------------------
Confidence 9999998543211000
Q ss_pred CCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHH
Q 035713 317 EPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVA 395 (491)
Q Consensus 317 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~ 395 (491)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+..... .+....++..+
T Consensus 176 ----~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 250 (288)
T cd05061 176 ----RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY-LDQPDNCPERV 250 (288)
T ss_pred ----cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHHH
Confidence 00011245678999999999889999999999999999998 8999988776665555554432 22223578999
Q ss_pred HHHHHhhhccCCCCCCCcCCChHHhhc------CCCcCCCCh
Q 035713 396 RDLIRGLLVKEPHKRIAYKRGATEIKQ------HPFFEGVNW 431 (491)
Q Consensus 396 ~~li~~~L~~dP~~R~t~~~~~~ell~------hpff~~~~~ 431 (491)
.+||.+||+.||++||+ +.++++ ||||++++|
T Consensus 251 ~~li~~~l~~~p~~Rps----~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 251 TDLMRMCWQFNPKMRPT----FLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HHHHHHHcCCChhHCcC----HHHHHHHHHhhcCCCCCCCCC
Confidence 99999999999999999 666665 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=355.04 Aligned_cols=255 Identities=27% Similarity=0.459 Sum_probs=205.6
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
+|++++.||+|+||.||+|++..+|+.||+|++..... .......+.+|+++++.++|+||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 58999999999999999999999999999999875422 22233456689999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 80 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--- 154 (284)
T cd07839 80 YCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--- 154 (284)
T ss_pred cCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC---
Confidence 996 5787777654 35699999999999999999999999999999999999999999999999999854311000
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
......++..|+|
T Consensus 155 -------------------------------------------------------------------~~~~~~~~~~y~a 167 (284)
T cd07839 155 -------------------------------------------------------------------CYSAEVVTLWYRP 167 (284)
T ss_pred -------------------------------------------------------------------CcCCCccccCCcC
Confidence 0011257889999
Q ss_pred cchhcCCC-CCCcccccchhhHHHhhhcCCCCC-CCCCcHHHHHHHHc---CC--------------CcC----------
Q 035713 335 PEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPF-KGQGNRATLFNVVG---QP--------------LRF---------- 385 (491)
Q Consensus 335 PE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf-~~~~~~~~~~~i~~---~~--------------~~~---------- 385 (491)
||++.+.. ++.++|||||||++|+|++|..|| .+.+....+..+.. .. ..+
T Consensus 168 PE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (284)
T cd07839 168 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLV 247 (284)
T ss_pred hHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhh
Confidence 99998754 689999999999999999988885 44443333332211 00 000
Q ss_pred CCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 386 PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 386 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
...+.++.++++||.+||+.||.+||| ++++++||||
T Consensus 248 ~~~~~~~~~~~~li~~~l~~~P~~R~t----~~~il~h~~f 284 (284)
T cd07839 248 NVVPKLNSTGRDLLQNLLVCNPVQRIS----AEEALQHPYF 284 (284)
T ss_pred hhcccCCHHHHHHHHHHhcCChhhcCC----HHHHhcCCCC
Confidence 011357889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=346.30 Aligned_cols=261 Identities=25% Similarity=0.372 Sum_probs=215.3
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecch---hhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKAS---LASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~---~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
+|++.+.||.|+||.||+|.+. +++.+|+|.+.... .........+.+|+++|+.++|+||+++++++.+.+.+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5889999999999999999874 78899999986542 1223445678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||++|++|.+++.+. ..+++..++.++.||+.||+|||+.||+|+||||+||+++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999998764 4589999999999999999999999999999999999999999999999999854321000
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
... .........|+..
T Consensus 158 ~~~----------------------------------------------------------------~~~~~~~~~~~~~ 173 (265)
T cd06631 158 HGT----------------------------------------------------------------HSNMLKSMHGTPY 173 (265)
T ss_pred ccc----------------------------------------------------------------ccccccccCCCcc
Confidence 000 0000112468999
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC-CcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP-LRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.... ...+....++.++.+||.+||..+|.+|
T Consensus 174 ~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 253 (265)
T cd06631 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHER 253 (265)
T ss_pred ccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccC
Confidence 999999999889999999999999999999999998766555444444331 1112234588999999999999999999
Q ss_pred CCcCCChHHhhcCCCc
Q 035713 411 IAYKRGATEIKQHPFF 426 (491)
Q Consensus 411 ~t~~~~~~ell~hpff 426 (491)
|+ +.++++||||
T Consensus 254 p~----~~~~l~~~~~ 265 (265)
T cd06631 254 PS----ALQLLRHDFL 265 (265)
T ss_pred CC----HHHHhcCCCC
Confidence 99 9999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=346.77 Aligned_cols=260 Identities=29% Similarity=0.439 Sum_probs=214.2
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchh--hhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe--CceE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASL--ASRNKLLRAQTEREILGLLDHPFLPTLYSYFET--DKFY 169 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~--~~~~ 169 (491)
.+|++.+.||+|+||.||+|.+..++..||+|++..... ........+.+|+++++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 369999999999999999999999999999999865432 223455678899999999999999999999875 4678
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
+++|||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 9999999999999988764 45899999999999999999999999999999999999999999999999998543210
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
... ........|+
T Consensus 160 ~~~-------------------------------------------------------------------~~~~~~~~~~ 172 (266)
T cd06651 160 CMS-------------------------------------------------------------------GTGIRSVTGT 172 (266)
T ss_pred ccc-------------------------------------------------------------------CCccccCCcc
Confidence 000 0000123588
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
..|+|||++.+..++.++|||||||++|||++|+.||...........+............++..+++|| +||..+|++
T Consensus 173 ~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~ 251 (266)
T cd06651 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARH 251 (266)
T ss_pred ccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhh
Confidence 9999999999988999999999999999999999999877666555555443322222234788899999 577789999
Q ss_pred CCCcCCChHHhhcCCCcC
Q 035713 410 RIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 410 R~t~~~~~~ell~hpff~ 427 (491)
||+ +++|++||||+
T Consensus 252 Rp~----~~eil~hp~~~ 265 (266)
T cd06651 252 RPS----AEELLRHPFAQ 265 (266)
T ss_pred CcC----HHHHhcCcccc
Confidence 999 99999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=368.20 Aligned_cols=259 Identities=21% Similarity=0.299 Sum_probs=211.9
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCC-----cEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTN-----TYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYF 163 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~ 163 (491)
.+..++|++.+.||+|+||.||+|++...+ ..||||+++.... ......+.+|+++|+.+ +|+|||++++++
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 455678999999999999999999975443 5799999975432 23455678899999999 899999999999
Q ss_pred EeCceEEEEEeccCCCchHHHHHhCC------------------------------------------------------
Q 035713 164 ETDKFYCLVMEFCSGGNLHSLRQKQP------------------------------------------------------ 189 (491)
Q Consensus 164 ~~~~~~~lV~E~~~gg~L~~~~~~~~------------------------------------------------------ 189 (491)
...+.+|+||||+.+|+|.+++....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 99999999999999999999876421
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccc
Q 035713 190 --------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKS 255 (491)
Q Consensus 190 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 255 (491)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~--- 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY--- 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce---
Confidence 124788999999999999999999999999999999999999999999999998543211000
Q ss_pred ccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCc
Q 035713 256 SSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAP 335 (491)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 335 (491)
....+..++..||||
T Consensus 269 -----------------------------------------------------------------~~~~~~~~~~~y~aP 283 (374)
T cd05106 269 -----------------------------------------------------------------VVKGNARLPVKWMAP 283 (374)
T ss_pred -----------------------------------------------------------------eeccCCCCccceeCH
Confidence 000112356789999
Q ss_pred chhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcC
Q 035713 336 EIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK 414 (491)
Q Consensus 336 E~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ 414 (491)
|++.+..++.++|||||||++|||++ |+.||........+..++...........++.++.+||.+||+.||.+||+
T Consensus 284 E~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-- 361 (374)
T cd05106 284 ESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPT-- 361 (374)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcC--
Confidence 99999899999999999999999997 999998776655555555554444444457899999999999999999999
Q ss_pred CChHHhhc
Q 035713 415 RGATEIKQ 422 (491)
Q Consensus 415 ~~~~ell~ 422 (491)
+.+|++
T Consensus 362 --~~~l~~ 367 (374)
T cd05106 362 --FSQISQ 367 (374)
T ss_pred --HHHHHH
Confidence 777765
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=345.31 Aligned_cols=260 Identities=29% Similarity=0.438 Sum_probs=215.6
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecch--hhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC--ceE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKAS--LASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD--KFY 169 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~--~~~ 169 (491)
.+|++.+.||+|+||.||+|++..+++.||||++.... .........+.+|+++++.++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999999999999999886432 12234556788999999999999999999998763 578
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||++|++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 8999999999999998764 45899999999999999999999999999999999999999999999999988543110
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.. .........|+
T Consensus 160 ~~-------------------------------------------------------------------~~~~~~~~~~~ 172 (265)
T cd06652 160 CL-------------------------------------------------------------------SGTGMKSVTGT 172 (265)
T ss_pred cc-------------------------------------------------------------------cccccccCCCC
Confidence 00 00001123688
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
..|+|||++.+..++.++|||||||++|||++|+.||........+.++............++..+.++|.+||. +|++
T Consensus 173 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~ 251 (265)
T cd06652 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKL 251 (265)
T ss_pred ccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-Chhh
Confidence 999999999988899999999999999999999999987766666655554433322234577889999999995 9999
Q ss_pred CCCcCCChHHhhcCCCcC
Q 035713 410 RIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 410 R~t~~~~~~ell~hpff~ 427 (491)
||+ ++++++|||+.
T Consensus 252 Rp~----~~~il~~~~~~ 265 (265)
T cd06652 252 RPS----ADELLRHTFVH 265 (265)
T ss_pred CCC----HHHHhcCcccC
Confidence 999 99999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=382.78 Aligned_cols=262 Identities=29% Similarity=0.407 Sum_probs=216.9
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeE-E---
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYF-E--- 164 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~-~--- 164 (491)
.++..+++|.+.|.+|||+.||+|++...|..||+|++... ++.....+++|+++|+.|+ |+|||.+++.. .
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 35567899999999999999999999988899999987543 5677788899999999997 99999999932 1
Q ss_pred e---CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccccCCCCCEEEccCCcEEEee
Q 035713 165 T---DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG--IVYRDLKPENVLVRDEGHIMLSD 239 (491)
Q Consensus 165 ~---~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~g~vkL~D 239 (491)
. .-.++|.||||.||.|-+++...-..+|++.++..|+.|+++|+.+||.++ |||||||-|||||+.+|+.||||
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence 1 135789999999999999998655566999999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCC
Q 035713 240 FDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPT 319 (491)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (491)
||.|.......+..... ..
T Consensus 190 FGSatt~~~~~~~~~e~------------~~------------------------------------------------- 208 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEV------------NY------------------------------------------------- 208 (738)
T ss_pred ccccccccCCCccHHHH------------HH-------------------------------------------------
Confidence 99984332211100000 00
Q ss_pred CccccccccccCccCcchhc---CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHH
Q 035713 320 NVRSMSFVGTHEYLAPEIIR---GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVAR 396 (491)
Q Consensus 320 ~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~ 396 (491)
-........|+.|+|||++. +.+.+.++|||||||+||.|+....||.+... ..|+...+.+|..+.++..++
T Consensus 209 ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng~Y~~P~~p~ys~~l~ 284 (738)
T KOG1989|consen 209 VEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNGNYSFPPFPNYSDRLK 284 (738)
T ss_pred HHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEeccccCCCCccHHHHHH
Confidence 00011236799999999974 66789999999999999999999999987643 568899999999999999999
Q ss_pred HHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 397 DLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 397 ~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
+||+.||+.||++||+ +-+++.+
T Consensus 285 ~LI~~mL~~nP~~RPn----I~Qv~~~ 307 (738)
T KOG1989|consen 285 DLIRTMLQPNPDERPN----IYQVLEE 307 (738)
T ss_pred HHHHHHhccCcccCCC----HHHHHHH
Confidence 9999999999999999 7766654
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=352.63 Aligned_cols=256 Identities=24% Similarity=0.410 Sum_probs=217.2
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
..+|++++.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++|+||+++++.|..+...|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 36899999999999999999999999999999998764322 235577899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||++|++|.+++.. ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-- 170 (296)
T cd06654 96 MEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (296)
T ss_pred ecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc--
Confidence 999999999998865 358999999999999999999999999999999999999999999999999875321100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.......|++.|
T Consensus 171 --------------------------------------------------------------------~~~~~~~~~~~y 182 (296)
T cd06654 171 --------------------------------------------------------------------SKRSTMVGTPYW 182 (296)
T ss_pred --------------------------------------------------------------------cccCcccCCccc
Confidence 001123688999
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC-CcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP-LRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
+|||.+.+..++.++|||||||++|+|++|+.||........+..+.... ...+....++..+.+||.+||..||++||
T Consensus 183 ~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 262 (296)
T cd06654 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRG 262 (296)
T ss_pred cCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCc
Confidence 99999999889999999999999999999999998876655544443322 22222345888999999999999999999
Q ss_pred CcCCChHHhhcCCCcCC
Q 035713 412 AYKRGATEIKQHPFFEG 428 (491)
Q Consensus 412 t~~~~~~ell~hpff~~ 428 (491)
+ +.++++||||..
T Consensus 263 t----~~eil~~~~~~~ 275 (296)
T cd06654 263 S----AKELLQHQFLKI 275 (296)
T ss_pred C----HHHHhhChhhhc
Confidence 9 999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=343.26 Aligned_cols=256 Identities=23% Similarity=0.443 Sum_probs=220.0
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
+|++++.||+|+||.||++++..+++.||+|.+...... ......+.+|+++++.++|+||+++++++...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 599999999999999999999999999999998754333 2344567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|+.+++|.+++.......+++.++..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 155 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV---- 155 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch----
Confidence 9999999998876545568999999999999999999999999999999999999999999999999885321100
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
.......|++.|+|
T Consensus 156 ------------------------------------------------------------------~~~~~~~~~~~~~~ 169 (256)
T cd08218 156 ------------------------------------------------------------------ELARTCIGTPYYLS 169 (256)
T ss_pred ------------------------------------------------------------------hhhhhccCCccccC
Confidence 00012357889999
Q ss_pred cchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcC
Q 035713 335 PEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK 414 (491)
Q Consensus 335 PE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ 414 (491)
||++.+..++.++|+|||||++|+|++|+.||......+....++.+... +....++.++.++|.+||..+|++||+
T Consensus 170 pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~-- 246 (256)
T cd08218 170 PEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP-PVSSHYSYDLRNLVSQLFKRNPRDRPS-- 246 (256)
T ss_pred HHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC-CCcccCCHHHHHHHHHHhhCChhhCcC--
Confidence 99999988999999999999999999999999887777766666654432 223458899999999999999999999
Q ss_pred CChHHhhcCCCc
Q 035713 415 RGATEIKQHPFF 426 (491)
Q Consensus 415 ~~~~ell~hpff 426 (491)
+.++++||||
T Consensus 247 --~~~vl~~~~~ 256 (256)
T cd08218 247 --VNSILEKNFI 256 (256)
T ss_pred --HHHHhhCcCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=348.53 Aligned_cols=254 Identities=25% Similarity=0.420 Sum_probs=211.0
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
..+|++++.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++++..++.+|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 4689999999999999999999999999999999865422 2334567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..+....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06646 85 MEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-- 160 (267)
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc--
Confidence 9999999999988764 468999999999999999999999999999999999999999999999999985432100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.......|+..|
T Consensus 161 --------------------------------------------------------------------~~~~~~~~~~~y 172 (267)
T cd06646 161 --------------------------------------------------------------------AKRKSFIGTPYW 172 (267)
T ss_pred --------------------------------------------------------------------cccCccccCccc
Confidence 001123688999
Q ss_pred cCcchhc---CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCC---CCCCCCHHHHHHHHhhhccC
Q 035713 333 LAPEIIR---GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP---ETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 333 ~aPE~l~---~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~~s~~~~~li~~~L~~d 406 (491)
+|||.+. ...++.++|||||||++|||++|+.||...........+....+..+ ....++..+.+||.+||+.|
T Consensus 173 ~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 252 (267)
T cd06646 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKN 252 (267)
T ss_pred cCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCC
Confidence 9999985 34478899999999999999999999976554443333333322222 22357889999999999999
Q ss_pred CCCCCCcCCChHHhhcCCC
Q 035713 407 PHKRIAYKRGATEIKQHPF 425 (491)
Q Consensus 407 P~~R~t~~~~~~ell~hpf 425 (491)
|++||+ +++|++|+|
T Consensus 253 P~~Rp~----~~~il~~l~ 267 (267)
T cd06646 253 PKKRPT----AERLLTHLF 267 (267)
T ss_pred hhhCcC----HHHHhcCCC
Confidence 999999 999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=346.76 Aligned_cols=255 Identities=21% Similarity=0.289 Sum_probs=211.3
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEe---CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELR---GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
+...+|++.+.||+|+||.||+|.++ ..+..||+|+++... .......+.+|+.+|+.++||||+++++++..++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 34578999999999999999999875 456789999987642 2334456788999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+|+||||+++|+|.+++... ...+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999999998764 3469999999999999999999999999999999999999999999999999763311
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
.... .......
T Consensus 159 ~~~~---------------------------------------------------------------------~~~~~~~ 169 (266)
T cd05064 159 SEAI---------------------------------------------------------------------YTTMSGK 169 (266)
T ss_pred ccch---------------------------------------------------------------------hcccCCC
Confidence 0000 0000124
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+....+..+.. ....+....++..+.+++.+||+.+
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~c~~~~ 248 (266)
T cd05064 170 SPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED-GFRLPAPRNCPNLLHQLMLDCWQKE 248 (266)
T ss_pred CceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 5678999999999999999999999999999775 9999998877665555543 3344445568999999999999999
Q ss_pred CCCCCCcCCChHHhhc
Q 035713 407 PHKRIAYKRGATEIKQ 422 (491)
Q Consensus 407 P~~R~t~~~~~~ell~ 422 (491)
|.+||+ +++|++
T Consensus 249 p~~RP~----~~~i~~ 260 (266)
T cd05064 249 RGERPR----FSQIHS 260 (266)
T ss_pred chhCCC----HHHHHH
Confidence 999999 777765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=341.90 Aligned_cols=252 Identities=26% Similarity=0.472 Sum_probs=215.7
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
+|++.+.||+|+||.||++++..+++.||+|.++.... ....+.+.+|+.+++.++|+||+++++.+.+++.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999865432 2345567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|+++++|.+++.......+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~---- 154 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---- 154 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc----
Confidence 9999999998876555678999999999999999999999999999999999999999999999999875432100
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
.......|+..|+|
T Consensus 155 ------------------------------------------------------------------~~~~~~~~~~~~~a 168 (255)
T cd08219 155 ------------------------------------------------------------------AYACTYVGTPYYVP 168 (255)
T ss_pred ------------------------------------------------------------------cccccccCCccccC
Confidence 00112468899999
Q ss_pred cchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcC
Q 035713 335 PEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK 414 (491)
Q Consensus 335 PE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ 414 (491)
||++.+..++.++|+|||||++|+|++|+.||...+.......+...... +....++..+.+||.+||..||++||+
T Consensus 169 PE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~-- 245 (255)
T cd08219 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-PLPSHYSYELRSLIKQMFKRNPRSRPS-- 245 (255)
T ss_pred HHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-CCCcccCHHHHHHHHHHHhCCcccCCC--
Confidence 99999988999999999999999999999999987766666666544332 222458899999999999999999999
Q ss_pred CChHHhhcC
Q 035713 415 RGATEIKQH 423 (491)
Q Consensus 415 ~~~~ell~h 423 (491)
+.+|++-
T Consensus 246 --~~~il~~ 252 (255)
T cd08219 246 --ATTILSR 252 (255)
T ss_pred --HHHHhhc
Confidence 9998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=366.65 Aligned_cols=261 Identities=19% Similarity=0.279 Sum_probs=213.0
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEE-----eCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeee
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVEL-----RGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSY 162 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~ 162 (491)
..+..++|++.++||+|+||.||+|++ ..++..||||+++.... ......+.+|+++|+.+ +||||++++++
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 345567899999999999999999975 34567899999865422 23345678899999999 89999999999
Q ss_pred EEeCceEEEEEeccCCCchHHHHHhCC-----------------------------------------------------
Q 035713 163 FETDKFYCLVMEFCSGGNLHSLRQKQP----------------------------------------------------- 189 (491)
Q Consensus 163 ~~~~~~~~lV~E~~~gg~L~~~~~~~~----------------------------------------------------- 189 (491)
+...+..|+||||++||+|.+++....
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 999999999999999999999886532
Q ss_pred --------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 190 --------------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 190 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 124788899999999999999999999999999999999999999999999998543211
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
... .......++
T Consensus 268 ~~~--------------------------------------------------------------------~~~~~~~~~ 279 (375)
T cd05104 268 SNY--------------------------------------------------------------------VVKGNARLP 279 (375)
T ss_pred ccc--------------------------------------------------------------------cccCCCCCC
Confidence 000 000112456
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 408 (491)
..|+|||++.+..++.++|||||||++|||++ |..||.+......+.+.+............+.++.+||.+||+.||+
T Consensus 280 ~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 359 (375)
T cd05104 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPL 359 (375)
T ss_pred cceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChh
Confidence 78999999999999999999999999999998 99999887666566666555444443345788999999999999999
Q ss_pred CCCCcCCChHHhhcC
Q 035713 409 KRIAYKRGATEIKQH 423 (491)
Q Consensus 409 ~R~t~~~~~~ell~h 423 (491)
+||+ +.+|++.
T Consensus 360 ~RPs----~~eil~~ 370 (375)
T cd05104 360 KRPT----FKQIVQL 370 (375)
T ss_pred HCcC----HHHHHHH
Confidence 9999 8888764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=353.97 Aligned_cols=256 Identities=24% Similarity=0.423 Sum_probs=216.2
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
.+|++++.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++|+||++++++|..++.+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 7899999999999999999999999999999998654322 3345678999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+++++|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--- 169 (297)
T cd06656 96 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (297)
T ss_pred cccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc---
Confidence 99999999999865 358999999999999999999999999999999999999999999999999875321100
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.......|++.|+
T Consensus 170 -------------------------------------------------------------------~~~~~~~~~~~y~ 182 (297)
T cd06656 170 -------------------------------------------------------------------SKRSTMVGTPYWM 182 (297)
T ss_pred -------------------------------------------------------------------cCcCcccCCcccc
Confidence 0001236889999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC-CCcCCCCCCCCHHHHHHHHhhhccCCCCCCC
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ-PLRFPETPQVSFVARDLIRGLLVKEPHKRIA 412 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 412 (491)
|||.+.+..++.++|+|||||++|+|++|+.||.+.+....+..+... .........++..+++||.+||..||++||+
T Consensus 183 aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 262 (297)
T cd06656 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGS 262 (297)
T ss_pred CHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcC
Confidence 999999988999999999999999999999999877654444333222 2222223457889999999999999999999
Q ss_pred cCCChHHhhcCCCcCCC
Q 035713 413 YKRGATEIKQHPFFEGV 429 (491)
Q Consensus 413 ~~~~~~ell~hpff~~~ 429 (491)
++++++||||+..
T Consensus 263 ----~~~il~~~~~~~~ 275 (297)
T cd06656 263 ----AKELLQHPFLKLA 275 (297)
T ss_pred ----HHHHhcCchhccc
Confidence 9999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=351.68 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=218.8
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
.+|++++.||.|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++|+||+++++++.....+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 579999999999999999999999999999999865432 23456778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+++++|..++.. ..+++.++..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 96 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--- 169 (296)
T cd06655 96 EYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--- 169 (296)
T ss_pred EecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc---
Confidence 99999999998865 358999999999999999999999999999999999999999999999999875321100
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.......|+..|+
T Consensus 170 -------------------------------------------------------------------~~~~~~~~~~~y~ 182 (296)
T cd06655 170 -------------------------------------------------------------------SKRSTMVGTPYWM 182 (296)
T ss_pred -------------------------------------------------------------------ccCCCcCCCcccc
Confidence 0011236889999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC-CcCCCCCCCCHHHHHHHHhhhccCCCCCCC
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP-LRFPETPQVSFVARDLIRGLLVKEPHKRIA 412 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 412 (491)
|||.+.+..++.++|||||||++|+|++|+.||.+.+....+..+.... ..+.....++..+.+||.+||..||.+||+
T Consensus 183 aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt 262 (296)
T cd06655 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGS 262 (296)
T ss_pred CcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCC
Confidence 9999999889999999999999999999999999887766555554322 222233468899999999999999999999
Q ss_pred cCCChHHhhcCCCcCCC
Q 035713 413 YKRGATEIKQHPFFEGV 429 (491)
Q Consensus 413 ~~~~~~ell~hpff~~~ 429 (491)
+.++++||||+..
T Consensus 263 ----~~~il~~~~~~~~ 275 (296)
T cd06655 263 ----AKELLQHPFLKLA 275 (296)
T ss_pred ----HHHHhhChHhhhc
Confidence 9999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=341.99 Aligned_cols=255 Identities=29% Similarity=0.469 Sum_probs=219.0
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
+|++++.||+|+||.||+|.+..+++.+|||++...... ......+.+|+++|+.++||||+++++.+..++.+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 589999999999999999999999999999999765433 3345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC-CcEEEeecccccccCCCCccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE-GHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~-g~vkL~DFGla~~~~~~~~~~ 253 (491)
|+++++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--- 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---
Confidence 9999999999987655569999999999999999999999999999999999999865 457999999985432100
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
......|+..|+
T Consensus 157 --------------------------------------------------------------------~~~~~~~~~~y~ 168 (256)
T cd08220 157 --------------------------------------------------------------------KAYTVVGTPCYI 168 (256)
T ss_pred --------------------------------------------------------------------cccccccCCccc
Confidence 011236889999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
|||.+.+..++.++|||||||++|+|++|+.||.+.+.......+...... +....++.++.+||.+||..||++||+
T Consensus 169 aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt- 246 (256)
T cd08220 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA-PISDRYSPDLRQLILSMLNLDPSKRPQ- 246 (256)
T ss_pred CchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC-CCCCCcCHHHHHHHHHHccCChhhCCC-
Confidence 999999888899999999999999999999999888777666666544322 222358899999999999999999999
Q ss_pred CCChHHhhcCCCc
Q 035713 414 KRGATEIKQHPFF 426 (491)
Q Consensus 414 ~~~~~ell~hpff 426 (491)
+.++++||||
T Consensus 247 ---~~~ll~~p~~ 256 (256)
T cd08220 247 ---LSQIMAQPIC 256 (256)
T ss_pred ---HHHHhhCCCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=351.71 Aligned_cols=256 Identities=30% Similarity=0.463 Sum_probs=211.9
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
+|++++.||.|+||.||+|+++.+++.||||++..... .......+.+|+++++.++||||+++++++.+++..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999999865432 22334567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|+. ++|..++.......+++..++.++.||+.||+|||++|++||||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--- 155 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--- 155 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc---
Confidence 995 6898888776566799999999999999999999999999999999999999999999999998753311000
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
......++..|+|
T Consensus 156 -------------------------------------------------------------------~~~~~~~~~~y~a 168 (284)
T cd07860 156 -------------------------------------------------------------------TYTHEVVTLWYRA 168 (284)
T ss_pred -------------------------------------------------------------------ccccccccccccC
Confidence 0011256889999
Q ss_pred cchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---CC---------------cCCC--------
Q 035713 335 PEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---PL---------------RFPE-------- 387 (491)
Q Consensus 335 PE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~~---------------~~~~-------- 387 (491)
||++.+.. ++.++|||||||++|||++|+.||.+.+....+.++... +. .++.
T Consensus 169 PE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (284)
T cd07860 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSK 248 (284)
T ss_pred CeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHH
Confidence 99988755 588999999999999999999999887766555443321 00 0110
Q ss_pred -CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 388 -TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 388 -~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
.+.++.++++||.+||+.||.+||+ ++++++||||
T Consensus 249 ~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~l~~~~f 284 (284)
T cd07860 249 VVPPLDEDGRDLLSQMLHYDPNKRIS----AKAALAHPFF 284 (284)
T ss_pred HcccCCHHHHHHHHHhcCCCcccCCC----HHHHhcCCCC
Confidence 1247788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=364.67 Aligned_cols=249 Identities=29% Similarity=0.472 Sum_probs=216.5
Q ss_pred CCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 87 RGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 87 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
..++|..+...-++-||.|+.|.||+|+.+ ++.||||+++.-. ..+|.-|++|+|+||+.+.++|...
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~elk----------ETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK----------ETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhhh----------hhhHHHHHhccCcceeeEeeeecCC
Confidence 345667777778899999999999999988 7789999774211 1477789999999999999999999
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
-.+|||||||..|.|+.+++.. +.+.......|..+|+.||.|||.+.|||||||.-||||+.+..|||+|||.++.+
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred ceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhh
Confidence 9999999999999999999874 67899999999999999999999999999999999999999999999999988654
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
... ...++|
T Consensus 263 ~~~-----------------------------------------------------------------------STkMSF 271 (904)
T KOG4721|consen 263 SDK-----------------------------------------------------------------------STKMSF 271 (904)
T ss_pred hhh-----------------------------------------------------------------------hhhhhh
Confidence 321 123468
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
+||..|||||+++..+.+.++|||||||+|||||||..||..-+...++.-+-...+.+|-...+++.++-||+.||.-.
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sK 351 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSK 351 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcC
Confidence 99999999999999999999999999999999999999998776655554444455666666779999999999999999
Q ss_pred CCCCCCcCCChHHhhcCC
Q 035713 407 PHKRIAYKRGATEIKQHP 424 (491)
Q Consensus 407 P~~R~t~~~~~~ell~hp 424 (491)
|..||+ +.+||.|-
T Consensus 352 pRNRPS----Frqil~Hl 365 (904)
T KOG4721|consen 352 PRNRPS----FRQILLHL 365 (904)
T ss_pred CCCCcc----HHHHHHHH
Confidence 999999 89999984
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=347.25 Aligned_cols=259 Identities=28% Similarity=0.436 Sum_probs=213.0
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeC---
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETD--- 166 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~--- 166 (491)
...++|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 34688999999999999999999999999999999986532 1223556799999998 799999999998643
Q ss_pred --ceEEEEEeccCCCchHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccc
Q 035713 167 --KFYCLVMEFCSGGNLHSLRQKQ--PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242 (491)
Q Consensus 167 --~~~~lV~E~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGl 242 (491)
+.+|+||||++|++|.++++.. ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 4689999999999999987632 235689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcc
Q 035713 243 SLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322 (491)
Q Consensus 243 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (491)
+....... ..
T Consensus 175 ~~~~~~~~----------------------------------------------------------------------~~ 184 (291)
T cd06639 175 SAQLTSTR----------------------------------------------------------------------LR 184 (291)
T ss_pred chhccccc----------------------------------------------------------------------cc
Confidence 75432100 00
Q ss_pred ccccccccCccCcchhcCCC-----CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCC-cCCCCCCCCHHHH
Q 035713 323 SMSFVGTHEYLAPEIIRGEG-----HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL-RFPETPQVSFVAR 396 (491)
Q Consensus 323 ~~~~~gt~~y~aPE~l~~~~-----~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~~~ 396 (491)
.....|+..|+|||++.... ++.++|||||||++|||++|+.||........+..+..... .......++..+.
T Consensus 185 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 264 (291)
T cd06639 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFN 264 (291)
T ss_pred ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHH
Confidence 11236889999999986543 67899999999999999999999988766666666544322 2222335778899
Q ss_pred HHHHhhhccCCCCCCCcCCChHHhhcCCCcC
Q 035713 397 DLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 397 ~li~~~L~~dP~~R~t~~~~~~ell~hpff~ 427 (491)
+||.+||+.||++||+ +.+|++||||+
T Consensus 265 ~li~~~l~~~p~~Rps----~~~il~~~~~~ 291 (291)
T cd06639 265 HFISQCLIKDFEARPS----VTHLLEHPFIK 291 (291)
T ss_pred HHHHHHhhcChhhCcC----HHHHhcCcccC
Confidence 9999999999999999 99999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=352.84 Aligned_cols=260 Identities=28% Similarity=0.412 Sum_probs=211.8
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC--ceE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD--KFY 169 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~--~~~ 169 (491)
..++|++++.||+|+||.||+|.++.+|+.||+|++...... ......+.+|+++++.++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 457899999999999999999999999999999998654322 22223456799999999999999999999755 578
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+. ++|.+++.... ..+++.+++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999995 58888877642 56999999999999999999999999999999999999999999999999998543210
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.. ......++
T Consensus 162 ~~----------------------------------------------------------------------~~~~~~~~ 171 (309)
T cd07845 162 AK----------------------------------------------------------------------PMTPKVVT 171 (309)
T ss_pred cC----------------------------------------------------------------------CCCccccc
Confidence 00 00012457
Q ss_pred cCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC-------------------CCcCCC--
Q 035713 330 HEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ-------------------PLRFPE-- 387 (491)
Q Consensus 330 ~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~-------------------~~~~~~-- 387 (491)
..|+|||++.+ ..++.++|||||||++|||++|++||.+.+....+..+... .+..+.
T Consensus 172 ~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (309)
T cd07845 172 LWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQP 251 (309)
T ss_pred ccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCC
Confidence 88999999976 45789999999999999999999999988777666555431 011110
Q ss_pred -------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 388 -------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 388 -------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
...+++++.+||.+||+.||++||+ ++++++||||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t----~~~il~h~~f~~ 295 (309)
T cd07845 252 YNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT----AEEALESSYFKE 295 (309)
T ss_pred CCchHHhccccCHHHHHHHHHHhcCChhhCcC----HHHHhcChhhcc
Confidence 0235888999999999999999999 999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=350.41 Aligned_cols=258 Identities=28% Similarity=0.401 Sum_probs=215.8
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
+..++|++++.||+|+||+||++.+..+++.||+|++.... .......+.+|+++++.++||||+++++++...+.+|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 34578999999999999999999999999999999986542 2344567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
+||||+++++|..++... +.+++..++.++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++......
T Consensus 80 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999999988764 469999999999999999999997 69999999999999999999999999987432100
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.....+|+
T Consensus 158 ------------------------------------------------------------------------~~~~~~~~ 165 (284)
T cd06620 158 ------------------------------------------------------------------------IADTFVGT 165 (284)
T ss_pred ------------------------------------------------------------------------ccCccccC
Confidence 00123689
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcH-----------HHHHHHHcCCCcCCCCCCCCHHHHHH
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR-----------ATLFNVVGQPLRFPETPQVSFVARDL 398 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-----------~~~~~i~~~~~~~~~~~~~s~~~~~l 398 (491)
..|+|||++.+..++.++|||||||++|+|++|+.||...... ..+..+............++.++.+|
T Consensus 166 ~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 245 (284)
T cd06620 166 STYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDF 245 (284)
T ss_pred cccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHH
Confidence 9999999999888999999999999999999999999865442 22233332222111122377899999
Q ss_pred HHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 399 IRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 399 i~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
|.+||..||++||+ ++++++|+||..
T Consensus 246 i~~~l~~dp~~Rpt----~~e~~~~~~~~~ 271 (284)
T cd06620 246 VDACLLKDPTERPT----PQQLCAMPPFIQ 271 (284)
T ss_pred HHHHhcCCcccCcC----HHHHhcCccccc
Confidence 99999999999999 999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=347.03 Aligned_cols=260 Identities=28% Similarity=0.387 Sum_probs=209.3
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHH-HhhcCCCCccceeeeEEeCceEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI-LGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~i-l~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
++|++++.||+|+||.||+|+++.+|+.||||++++..... . ...+..|+.+ ++.++||||+++++++..++.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-E-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-H-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 47999999999999999999999999999999987653222 2 2334456554 6677899999999999999999999
Q ss_pred EeccCCCchHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 173 MEFCSGGNLHSLRQKQ--PNKYFTEDAARFFASEVLLALEYLHML-GIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|||++ ++|.+++... ....+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99995 6887776542 235699999999999999999999997 9999999999999999999999999998543110
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
. ......|+
T Consensus 158 ~-----------------------------------------------------------------------~~~~~~~~ 166 (283)
T cd06617 158 V-----------------------------------------------------------------------AKTIDAGC 166 (283)
T ss_pred c-----------------------------------------------------------------------ccccccCC
Confidence 0 00113578
Q ss_pred cCccCcchhcC----CCCCCcccccchhhHHHhhhcCCCCCCCC-CcHHHHHHHHcCC-CcCCCCCCCCHHHHHHHHhhh
Q 035713 330 HEYLAPEIIRG----EGHGSAVDWWTFGIFLYELLHGTTPFKGQ-GNRATLFNVVGQP-LRFPETPQVSFVARDLIRGLL 403 (491)
Q Consensus 330 ~~y~aPE~l~~----~~~~~~~DiwSlG~il~elltg~~Pf~~~-~~~~~~~~i~~~~-~~~~~~~~~s~~~~~li~~~L 403 (491)
..|+|||++.+ ..++.++|+|||||++|+|++|+.||... ...+.+..+.... ..++. ..++.++.+||.+||
T Consensus 167 ~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l 245 (283)
T cd06617 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA-EKFSPEFQDFVNKCL 245 (283)
T ss_pred ccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCc-cccCHHHHHHHHHHc
Confidence 89999999875 45688999999999999999999999753 3334444444332 22222 358899999999999
Q ss_pred ccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 404 VKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 404 ~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
..+|++||+ ++++++||||+...+.
T Consensus 246 ~~~p~~Rp~----~~~il~~~~~~~~~~~ 270 (283)
T cd06617 246 KKNYKERPN----YPELLQHPFFELHLSK 270 (283)
T ss_pred cCChhhCcC----HHHHhcCchhhhcccc
Confidence 999999999 9999999999877654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=366.55 Aligned_cols=252 Identities=30% Similarity=0.463 Sum_probs=213.1
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccCCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGG 179 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~gg 179 (491)
-+||+|+||+||.|++..+....|||.|.... ....+.+..||.+.+.|+|.|||+++|.+..++++-|.||.++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 37999999999999999999999999986432 345556788999999999999999999999999999999999999
Q ss_pred chHHHHHhCCCCCC--CHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEc-cCCcEEEeecccccccCCCCcccccc
Q 035713 180 NLHSLRQKQPNKYF--TEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVR-DEGHIMLSDFDLSLRCSVSPTLVKSS 256 (491)
Q Consensus 180 ~L~~~~~~~~~~~l--~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~-~~g~vkL~DFGla~~~~~~~~~~~~~ 256 (491)
+|..+++..- +++ +|..+-+|..||+.||.|||++.|||||||-+|+||+ -.|.+||+|||.++++.-
T Consensus 658 SLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-------- 728 (1226)
T KOG4279|consen 658 SLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-------- 728 (1226)
T ss_pred cHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc--------
Confidence 9999988642 446 8999999999999999999999999999999999997 478999999999866421
Q ss_pred cccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcc
Q 035713 257 SVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336 (491)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 336 (491)
-+..+.++.||..|||||
T Consensus 729 --------------------------------------------------------------inP~TETFTGTLQYMAPE 746 (1226)
T KOG4279|consen 729 --------------------------------------------------------------INPCTETFTGTLQYMAPE 746 (1226)
T ss_pred --------------------------------------------------------------CCccccccccchhhhChH
Confidence 011344688999999999
Q ss_pred hhcCC--CCCCcccccchhhHHHhhhcCCCCCCCCCcHH-HHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 337 IIRGE--GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRA-TLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 337 ~l~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
++..+ +|+.++|||||||++.||.||++||....... .++++---....|....++.+++.||.+|+..||.+||+
T Consensus 747 vIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~s- 825 (1226)
T KOG4279|consen 747 VIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPS- 825 (1226)
T ss_pred hhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCcc-
Confidence 99865 48999999999999999999999997665543 333332112223333458899999999999999999999
Q ss_pred CCChHHhhcCCCcCCC
Q 035713 414 KRGATEIKQHPFFEGV 429 (491)
Q Consensus 414 ~~~~~ell~hpff~~~ 429 (491)
|.++|..||++.-
T Consensus 826 ---A~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 826 ---AKDLLQDPFLQHN 838 (1226)
T ss_pred ---HHHhccCcccccC
Confidence 9999999999865
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=342.19 Aligned_cols=254 Identities=30% Similarity=0.492 Sum_probs=216.3
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++.+.||.|+||.||+|.+..+++.+|+|++..... .....+.+|+++++.++||||+++++++...+.+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 689999999999999999999999999999999875432 24567789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+.+++|.+++... ...+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 155 (262)
T cd06613 80 EYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--- 155 (262)
T ss_pred eCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh---
Confidence 999999999988764 2469999999999999999999999999999999999999999999999999985421100
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.......|+..|+
T Consensus 156 -------------------------------------------------------------------~~~~~~~~~~~y~ 168 (262)
T cd06613 156 -------------------------------------------------------------------AKRKSFIGTPYWM 168 (262)
T ss_pred -------------------------------------------------------------------hccccccCCcccc
Confidence 0011236888999
Q ss_pred CcchhcCC---CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCC---CCCCCCHHHHHHHHhhhccCC
Q 035713 334 APEIIRGE---GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP---ETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 334 aPE~l~~~---~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~~s~~~~~li~~~L~~dP 407 (491)
|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....+..+ ....++.++.+||.+||..||
T Consensus 169 ~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 248 (262)
T cd06613 169 APEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDP 248 (262)
T ss_pred CchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCCh
Confidence 99999877 788999999999999999999999988776665555544422221 223467889999999999999
Q ss_pred CCCCCcCCChHHhhcCCC
Q 035713 408 HKRIAYKRGATEIKQHPF 425 (491)
Q Consensus 408 ~~R~t~~~~~~ell~hpf 425 (491)
.+||+ +.+++.|+|
T Consensus 249 ~~Rpt----~~~il~~~~ 262 (262)
T cd06613 249 KKRPT----ATKLLQHPF 262 (262)
T ss_pred hhCCC----HHHHhcCCC
Confidence 99999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=341.47 Aligned_cols=263 Identities=29% Similarity=0.436 Sum_probs=207.7
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCC----cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe-Cc
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTN----TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET-DK 167 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~-~~ 167 (491)
+..|+++..||+|+||.||+|..+.++ +.||||.++.... ....-....+|+.+++.|+||||+.|..+|.. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 467999999999999999999765543 3699999865421 12233456789999999999999999999977 88
Q ss_pred eEEEEEeccCCCchHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC----CcEEEeec
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQ---PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE----GHIMLSDF 240 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~----g~vkL~DF 240 (491)
.++|++||++ -+|.++++.. ..+.++...++.++.||+.|+.|||++-|+||||||.|||+..+ |.|||+||
T Consensus 102 ~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 9999999995 5888887643 23469999999999999999999999999999999999999987 99999999
Q ss_pred ccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCC
Q 035713 241 DLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTN 320 (491)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (491)
|+++.+...-...
T Consensus 181 GlaR~~~~plkpl------------------------------------------------------------------- 193 (438)
T KOG0666|consen 181 GLARLFNNPLKPL------------------------------------------------------------------- 193 (438)
T ss_pred cHHHHhhcccccc-------------------------------------------------------------------
Confidence 9998764321100
Q ss_pred ccccccccccCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcH---------HHH---HHHHcCCC--cC
Q 035713 321 VRSMSFVGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNR---------ATL---FNVVGQPL--RF 385 (491)
Q Consensus 321 ~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~---------~~~---~~i~~~~~--~~ 385 (491)
.....++-|.||+|||+|+|.. |+.++||||+|||+.||++..+.|.+.... +++ +++++.+- .+
T Consensus 194 ~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~W 273 (438)
T KOG0666|consen 194 ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDW 273 (438)
T ss_pred ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccc
Confidence 0011358899999999999976 799999999999999999999999875321 223 33444331 11
Q ss_pred C------CC------------------------CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 386 P------ET------------------------PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 386 ~------~~------------------------~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
| +. ..-++.+.+|+.+||.+||.+|+| ++++|+|+||..
T Consensus 274 p~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIt----a~qAleh~yF~~ 342 (438)
T KOG0666|consen 274 PDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRIT----AEQALEHPYFTE 342 (438)
T ss_pred hhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhcc----HHHHhccccccc
Confidence 1 10 112344779999999999999999 999999999974
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=344.00 Aligned_cols=261 Identities=24% Similarity=0.399 Sum_probs=213.9
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhh---hHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLA---SRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~---~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
+|+..+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+++|+.++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 488899999999999999999999999999998754321 22345678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC-cEEEeecccccccCCCC
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG-HIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g-~vkL~DFGla~~~~~~~ 250 (491)
||||++|++|.+++... +.+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999998764 4689999999999999999999999999999999999998776 59999999985542110
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
.. ........+||.
T Consensus 159 ~~------------------------------------------------------------------~~~~~~~~~~~~ 172 (268)
T cd06630 159 TG------------------------------------------------------------------AGEFQGQLLGTI 172 (268)
T ss_pred cc------------------------------------------------------------------CCcccccccccc
Confidence 00 000011246899
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHH---HHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRA---TLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP 407 (491)
.|+|||++.+..++.++|||||||++|+|++|+.||....... ...++............++.++.++|.+||..||
T Consensus 173 ~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 252 (268)
T cd06630 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQP 252 (268)
T ss_pred ceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCc
Confidence 9999999998889999999999999999999999997544322 2222222222222223578999999999999999
Q ss_pred CCCCCcCCChHHhhcCCCcC
Q 035713 408 HKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 408 ~~R~t~~~~~~ell~hpff~ 427 (491)
++||+ +.++++||||+
T Consensus 253 ~~R~~----~~~ll~~~~~~ 268 (268)
T cd06630 253 EDRPP----SRELLKHPVFR 268 (268)
T ss_pred ccCcC----HHHHhcCcccC
Confidence 99999 99999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=346.59 Aligned_cols=261 Identities=27% Similarity=0.425 Sum_probs=211.5
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEE--
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFE-- 164 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~-- 164 (491)
......++|++++.||+|+||.||+|++..+++.||+|++..... ....+.+|+.+++.+ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 344456899999999999999999999999999999998764321 223466799999999 6999999999873
Q ss_pred ---eCceEEEEEeccCCCchHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEee
Q 035713 165 ---TDKFYCLVMEFCSGGNLHSLRQKQ--PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSD 239 (491)
Q Consensus 165 ---~~~~~~lV~E~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~D 239 (491)
.+..+|+||||++|++|.+++... ....+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEcc
Confidence 456799999999999999887532 235689999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCC
Q 035713 240 FDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPT 319 (491)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (491)
||++.......
T Consensus 168 fg~~~~~~~~~--------------------------------------------------------------------- 178 (286)
T cd06638 168 FGVSAQLTSTR--------------------------------------------------------------------- 178 (286)
T ss_pred CCceeecccCC---------------------------------------------------------------------
Confidence 99985432100
Q ss_pred CccccccccccCccCcchhcC-----CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC-CcCCCCCCCCH
Q 035713 320 NVRSMSFVGTHEYLAPEIIRG-----EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP-LRFPETPQVSF 393 (491)
Q Consensus 320 ~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~ 393 (491)
.......|++.|+|||++.. ..++.++|||||||++|||++|+.||........+..+.... ........++.
T Consensus 179 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (286)
T cd06638 179 -LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSN 257 (286)
T ss_pred -CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCH
Confidence 00112368999999999863 447889999999999999999999998776555444433221 12222234678
Q ss_pred HHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 394 VARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 394 ~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
.+.+||.+||+.||++||+ +.+|++|+||
T Consensus 258 ~~~~li~~~l~~~p~~Rps----~~ell~~~~~ 286 (286)
T cd06638 258 EFNDFIRKCLTKDYEKRPT----VSDLLQHVFI 286 (286)
T ss_pred HHHHHHHHHccCCcccCCC----HHHHhhcccC
Confidence 9999999999999999999 9999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=348.12 Aligned_cols=258 Identities=25% Similarity=0.378 Sum_probs=214.8
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCC-----cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTN-----TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET 165 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 165 (491)
+..++|++++.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+++|+.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 34578999999999999999999987655 679999986542 23445568899999999999999999999999
Q ss_pred CceEEEEEeccCCCchHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPN--------------KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD 231 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~--------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~ 231 (491)
.+..|++|||+++++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 9999999999999999999876421 45889999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCC
Q 035713 232 EGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGAL 311 (491)
Q Consensus 232 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (491)
++.+||+|||+++.......
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~------------------------------------------------------------ 179 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADY------------------------------------------------------------ 179 (283)
T ss_pred CCcEEECCCcceeecccccc------------------------------------------------------------
Confidence 99999999999854321000
Q ss_pred CccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCC
Q 035713 312 PELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQ 390 (491)
Q Consensus 312 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 390 (491)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+..... .+....
T Consensus 180 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~ 250 (283)
T cd05048 180 --------YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL-LPCPED 250 (283)
T ss_pred --------ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-CCCccc
Confidence 000112257889999999998889999999999999999998 9999998877666655554432 233356
Q ss_pred CCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 391 VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 391 ~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
++.++.+|+.+||+.||.+||+ +.+|+++
T Consensus 251 ~~~~~~~l~~~c~~~~p~~Rp~----~~~i~~~ 279 (283)
T cd05048 251 CPARVYALMIECWNEIPARRPR----FKDIHTR 279 (283)
T ss_pred CCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 8999999999999999999999 8898875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=348.80 Aligned_cols=256 Identities=28% Similarity=0.429 Sum_probs=212.1
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++++.||+|+||.||+|++..+++.||+|.+.... .......+.+|+++++.++|+||+++++++...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47999999999999999999999999999999886532 2334567788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 174 EFCSGGNLHSLRQKQP-NKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||++|++|..++.... ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 9999999998887531 2369999999999999999999997 59999999999999999999999999987432100
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
......|+..
T Consensus 157 ----------------------------------------------------------------------~~~~~~~~~~ 166 (286)
T cd06622 157 ----------------------------------------------------------------------LAKTNIGCQS 166 (286)
T ss_pred ----------------------------------------------------------------------ccccCCCccC
Confidence 0012357889
Q ss_pred ccCcchhcCCC------CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHH---HHHcCC-CcCCCCCCCCHHHHHHHHh
Q 035713 332 YLAPEIIRGEG------HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLF---NVVGQP-LRFPETPQVSFVARDLIRG 401 (491)
Q Consensus 332 y~aPE~l~~~~------~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~---~i~~~~-~~~~~~~~~s~~~~~li~~ 401 (491)
|+|||++.+.. ++.++|||||||++|+|++|+.||.......... .+.... ...+ ..++.++.+||.+
T Consensus 167 y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~ 244 (286)
T cd06622 167 YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLP--SGYSDDAQDFVAK 244 (286)
T ss_pred ccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCC--cccCHHHHHHHHH
Confidence 99999986543 4789999999999999999999997654433222 223222 2222 3489999999999
Q ss_pred hhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 402 LLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 402 ~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
||..+|++||+ +++++.||||...
T Consensus 245 ~l~~~p~~Rp~----~~~l~~~~~~~~~ 268 (286)
T cd06622 245 CLNKIPNRRPT----YAQLLEHPWLVKY 268 (286)
T ss_pred HcccCcccCCC----HHHHhcChhhhhc
Confidence 99999999999 9999999999644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=346.75 Aligned_cols=257 Identities=32% Similarity=0.518 Sum_probs=213.9
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
+|++.+.||+|+||.||+|++..+|+.||+|++...... ......+.+|+.+++.++|+||+++++++..+..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 589999999999999999999999999999998765432 2345567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--- 154 (286)
T cd07832 80 YM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP--- 154 (286)
T ss_pred cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC---
Confidence 99 999999887653 5699999999999999999999999999999999999999999999999999854321100
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
.......|+..|+|
T Consensus 155 ------------------------------------------------------------------~~~~~~~~~~~y~a 168 (286)
T cd07832 155 ------------------------------------------------------------------RLYSHQVATRWYRA 168 (286)
T ss_pred ------------------------------------------------------------------CccccccCcccccC
Confidence 00012368999999
Q ss_pred cchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---C----------------CcCCC-------
Q 035713 335 PEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---P----------------LRFPE------- 387 (491)
Q Consensus 335 PE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~----------------~~~~~------- 387 (491)
||++.+.. ++.++|||||||++|||++|.++|.+......+..++.. + ..++.
T Consensus 169 PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (286)
T cd07832 169 PELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLE 248 (286)
T ss_pred ceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHH
Confidence 99987654 589999999999999999999999887766555444321 0 01111
Q ss_pred --CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcC
Q 035713 388 --TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 388 --~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~ 427 (491)
.+..+.++.+||.+||..||.+||+ ++++++||||.
T Consensus 249 ~~~~~~~~~~~~li~~~l~~~p~~R~~----~~~~l~h~~~~ 286 (286)
T cd07832 249 EIFPDASPEALDLLKGLLVYDPSKRLS----AAEALRHPYFT 286 (286)
T ss_pred HhCCCccHHHHHHHHHHhccChhhCCC----HHHHhhCcCcC
Confidence 1246788999999999999999999 99999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=343.86 Aligned_cols=257 Identities=29% Similarity=0.460 Sum_probs=213.6
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeC----
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETD---- 166 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~---- 166 (491)
..++|++.+.||+|+||.||+|.++.+++.|++|++..... ....+.+|+++++.+ +|+||+++++++...
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 34789999999999999999999998999999999876532 234677899999999 699999999999754
Q ss_pred --ceEEEEEeccCCCchHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccc
Q 035713 167 --KFYCLVMEFCSGGNLHSLRQKQP--NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242 (491)
Q Consensus 167 --~~~~lV~E~~~gg~L~~~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGl 242 (491)
..+|+||||+++++|.+++.... +..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 45899999999999999887543 45799999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcc
Q 035713 243 SLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322 (491)
Q Consensus 243 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (491)
+....... ..
T Consensus 160 ~~~~~~~~----------------------------------------------------------------------~~ 169 (275)
T cd06608 160 SAQLDSTL----------------------------------------------------------------------GR 169 (275)
T ss_pred ceecccch----------------------------------------------------------------------hh
Confidence 75421100 00
Q ss_pred ccccccccCccCcchhcCC-----CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCC-cCCCCCCCCHHHH
Q 035713 323 SMSFVGTHEYLAPEIIRGE-----GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL-RFPETPQVSFVAR 396 (491)
Q Consensus 323 ~~~~~gt~~y~aPE~l~~~-----~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~~~ 396 (491)
.....|+..|+|||++... .++.++|||||||+||+|++|+.||........+.++..... .......++.+++
T Consensus 170 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (275)
T cd06608 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFN 249 (275)
T ss_pred hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHH
Confidence 1123688999999998643 367889999999999999999999987666666666654432 2222234788999
Q ss_pred HHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 397 DLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 397 ~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
+||.+||..||++||+ +.++++|||+
T Consensus 250 ~li~~~l~~dp~~Rpt----~~~ll~~~~~ 275 (275)
T cd06608 250 DFISECLIKNYEQRPF----MEELLEHPFI 275 (275)
T ss_pred HHHHHHhhcChhhCcC----HHHHhcCCCC
Confidence 9999999999999999 9999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=350.23 Aligned_cols=257 Identities=21% Similarity=0.284 Sum_probs=205.1
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeC----------------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCC
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRG----------------TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~----------------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~ 155 (491)
..++|++.++||+|+||.||+|++.. ++..||+|++.... .......+.+|+++|+.++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 34689999999999999999998642 34579999987542 2334566889999999999999
Q ss_pred ccceeeeEEeCceEEEEEeccCCCchHHHHHhCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 035713 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQP-----------------NKYFTEDAARFFASEVLLALEYLHMLGIV 218 (491)
Q Consensus 156 iv~l~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~-----------------~~~l~~~~~~~~~~qi~~aL~~LH~~giv 218 (491)
|+++++++.+.+.+|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999886531 12367888999999999999999999999
Q ss_pred cccCCCCCEEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccC
Q 035713 219 YRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRK 298 (491)
Q Consensus 219 HrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (491)
||||||+|||++.++.+||+|||+++........
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~---------------------------------------------- 194 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY---------------------------------------------- 194 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCcee----------------------------------------------
Confidence 9999999999999999999999998543211000
Q ss_pred CCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc--CCCCCCCCCcHHHHH
Q 035713 299 SKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH--GTTPFKGQGNRATLF 376 (491)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt--g~~Pf~~~~~~~~~~ 376 (491)
.......++..|+|||++.+..++.++|||||||++|||++ +..||.+.+....+.
T Consensus 195 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~ 252 (304)
T cd05096 195 ----------------------RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIE 252 (304)
T ss_pred ----------------------EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHH
Confidence 00112356789999999998889999999999999999986 668888766554443
Q ss_pred HHHc------CCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 377 NVVG------QPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 377 ~i~~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
.+.. ........+.++..+.+||.+||..||++||+ +.+|.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs----~~~i~~ 300 (304)
T cd05096 253 NAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPS----FSDIHA 300 (304)
T ss_pred HHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcC----HHHHHH
Confidence 3211 11112223457899999999999999999999 888843
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=349.18 Aligned_cols=256 Identities=29% Similarity=0.450 Sum_probs=211.4
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|+++++||+|+||.||+|.++.+++.||+|++.+.... ......+.+|+++|+.++||||+++++++..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 4799999999999999999999989999999998654322 234456778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||++++.|..+.... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--- 154 (286)
T cd07846 80 EFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--- 154 (286)
T ss_pred ecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc---
Confidence 999999998876543 348999999999999999999999999999999999999999999999999985431100
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.......++..|+
T Consensus 155 -------------------------------------------------------------------~~~~~~~~~~~y~ 167 (286)
T cd07846 155 -------------------------------------------------------------------EVYTDYVATRWYR 167 (286)
T ss_pred -------------------------------------------------------------------cccCcccceeecc
Confidence 0011236889999
Q ss_pred CcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC-------------------CCcCCC------
Q 035713 334 APEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ-------------------PLRFPE------ 387 (491)
Q Consensus 334 aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~-------------------~~~~~~------ 387 (491)
|||++.+. .++.++|||||||++|||++|++||.+....+.+..+... ....+.
T Consensus 168 aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (286)
T cd07846 168 APELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEP 247 (286)
T ss_pred CcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcch
Confidence 99999764 4688999999999999999999999877655444333310 001111
Q ss_pred ----CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 388 ----TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 388 ----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
.+.++..+.+||.+||..||++||+ +.++++||||
T Consensus 248 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~~~~ 286 (286)
T cd07846 248 LEKRFPKLSGLVLDLAKQCLRIDPDDRPS----SSQLLHHEFF 286 (286)
T ss_pred HHHhCCCcCHHHHHHHHHHhcCCcccchh----HHHHhcCCCC
Confidence 1357889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=340.49 Aligned_cols=253 Identities=29% Similarity=0.496 Sum_probs=215.6
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++.+.||+|+||.||+|++..+++.||+|.+..... ...+.+|+++++.++|+||+++++++.++..+|++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 679999999999999999999998899999999865421 567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+.+++|.+++... ...+++..++.++.||+.||.|||..||+||||+|+||+++.++.+||+|||++........
T Consensus 78 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 78 EYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred ecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 999999999998764 35699999999999999999999999999999999999999999999999999854321000
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
......|+..|+
T Consensus 155 --------------------------------------------------------------------~~~~~~~~~~y~ 166 (256)
T cd06612 155 --------------------------------------------------------------------KRNTVIGTPFWM 166 (256)
T ss_pred --------------------------------------------------------------------ccccccCCcccc
Confidence 011235788999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCC-cCCCCCCCCHHHHHHHHhhhccCCCCCCC
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL-RFPETPQVSFVARDLIRGLLVKEPHKRIA 412 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t 412 (491)
|||++.+..++.++|||||||++|+|++|+.||...........+..... .+.....++.++.+||.+||+.||++||+
T Consensus 167 ~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps 246 (256)
T cd06612 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPS 246 (256)
T ss_pred CHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcC
Confidence 99999999899999999999999999999999987766554444332211 22222357789999999999999999999
Q ss_pred cCCChHHhhcCCCc
Q 035713 413 YKRGATEIKQHPFF 426 (491)
Q Consensus 413 ~~~~~~ell~hpff 426 (491)
+.++|+||||
T Consensus 247 ----~~~il~~~~~ 256 (256)
T cd06612 247 ----AIQLLQHPFI 256 (256)
T ss_pred ----HHHHhcCCCC
Confidence 9999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=345.71 Aligned_cols=279 Identities=34% Similarity=0.611 Sum_probs=226.6
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCceEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~~lV 172 (491)
++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+++++.++ |+||+++++++..++.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765555555677889999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+++++|.+++... +.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999999999998875 46999999999999999999999999999999999999999999999999998654321110
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
..... ... . ..............+.|+..|
T Consensus 159 ~~~~~----------~~~------------------------------~----------~~~~~~~~~~~~~~~~~~~~~ 188 (280)
T cd05581 159 ESNKG----------DAT------------------------------N----------IDSQIEKNRRRFASFVGTAEY 188 (280)
T ss_pred ccCCC----------CCc------------------------------c----------ccccccccccccccccCCccc
Confidence 00000 000 0 000000011122345789999
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCC
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIA 412 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 412 (491)
+|||++.+..++.++|||||||++|+|++|+.||...+....+..+......++. .+++.+.+||.+||..||.+||+
T Consensus 189 ~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~ 266 (280)
T cd05581 189 VSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLG 266 (280)
T ss_pred cCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCCC--ccCHHHHHHHHHHhcCCHhhCCC
Confidence 9999999888899999999999999999999999988766666666655555553 47999999999999999999999
Q ss_pred cCCChHHhhcCCCc
Q 035713 413 YKRGATEIKQHPFF 426 (491)
Q Consensus 413 ~~~~~~ell~hpff 426 (491)
...+.+++|+||||
T Consensus 267 ~~~~~~~ll~~~~~ 280 (280)
T cd05581 267 VNEGYDELKAHPFF 280 (280)
T ss_pred cccCHHHHhcCCCC
Confidence 11111999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=348.09 Aligned_cols=259 Identities=29% Similarity=0.390 Sum_probs=213.2
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhh--hHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLA--SRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
+|++++.||+|+||.||+|.+..+++.||||.+...... .......+.+|+++++.++|+||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999999765433 122344567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR- 157 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc-
Confidence 9999 999999987653 3699999999999999999999999999999999999999999999999999854321100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......++..|
T Consensus 158 ---------------------------------------------------------------------~~~~~~~~~~y 168 (298)
T cd07841 158 ---------------------------------------------------------------------KMTHQVVTRWY 168 (298)
T ss_pred ---------------------------------------------------------------------cccccccceee
Confidence 00012467889
Q ss_pred cCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCC-----------------------cCC--
Q 035713 333 LAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL-----------------------RFP-- 386 (491)
Q Consensus 333 ~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-----------------------~~~-- 386 (491)
+|||++.+. .++.++|||||||++|||++|.++|.+.+....+.++..... ..+
T Consensus 169 ~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
T cd07841 169 RAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLK 248 (298)
T ss_pred eCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchh
Confidence 999998654 568999999999999999999999988776655544432100 000
Q ss_pred -CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 387 -ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 387 -~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
.....+..+.+||.+||..||++||+ +.+++.|+||++.
T Consensus 249 ~~~~~~~~~~~~li~~~l~~~P~~R~s----~~e~l~~~~~~~~ 288 (298)
T cd07841 249 QIFPAASDDALDLLQRLLTLNPNKRIT----ARQALEHPYFSND 288 (298)
T ss_pred hhcccccHHHHHHHHHHhcCCcccCcC----HHHHhhCccccCC
Confidence 01245788999999999999999999 9999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=346.83 Aligned_cols=256 Identities=29% Similarity=0.474 Sum_probs=205.5
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
+++|++++.||+|+||.||+|+++.+++.||||.+...... .....+.+|+++++.++|+||+++++++.+++..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 47899999999999999999999999999999998754221 1223456799999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 82 FEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred EecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 99996 58998887653 4689999999999999999999999999999999999999999999999998743210000
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......++..|
T Consensus 159 ---------------------------------------------------------------------~~~~~~~~~~~ 169 (291)
T cd07844 159 ---------------------------------------------------------------------TYSNEVVTLWY 169 (291)
T ss_pred ---------------------------------------------------------------------ccccccccccc
Confidence 00012467899
Q ss_pred cCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCc-HHHHHHHH---cCC----------------CcCC-----
Q 035713 333 LAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGN-RATLFNVV---GQP----------------LRFP----- 386 (491)
Q Consensus 333 ~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-~~~~~~i~---~~~----------------~~~~----- 386 (491)
+|||++.+ ..++.++|||||||++|+|++|+.||.+... .+.+..+. ..+ ..++
T Consensus 170 ~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (291)
T cd07844 170 RPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPR 249 (291)
T ss_pred CCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCCh
Confidence 99999876 4578999999999999999999999976652 22222111 110 0000
Q ss_pred ----CCCCCC--HHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 387 ----ETPQVS--FVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 387 ----~~~~~s--~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
....++ .++.+||.+||+.||++||+ +.++++||||
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps----~~e~l~~~~f 291 (291)
T cd07844 250 PLINHAPRLDRIPHGEELALKFLQYEPKKRIS----AAEAMKHPYF 291 (291)
T ss_pred hHHHhCcCCCCchhHHHHHHHHhccCcccccC----HHHHhcCCCC
Confidence 001234 78899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=357.01 Aligned_cols=254 Identities=29% Similarity=0.464 Sum_probs=207.9
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC------
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD------ 166 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~------ 166 (491)
..+|++++.||+|+||.||+|++..+++.||||++.+.. ........+.+|+.+++.++|+||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 478999999999999999999999999999999986542 2333445677899999999999999999998643
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
..+|+||||+. ++|.+++... +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 35799999995 5888777643 899999999999999999999999999999999999999999999999998543
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.... .....
T Consensus 169 ~~~~-----------------------------------------------------------------------~~~~~ 177 (353)
T cd07850 169 GTSF-----------------------------------------------------------------------MMTPY 177 (353)
T ss_pred CCCC-----------------------------------------------------------------------CCCCC
Confidence 1100 01123
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CC-------------------Cc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QP-------------------LR 384 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~-------------------~~ 384 (491)
.||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..++. .+ ..
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (353)
T cd07850 178 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPK 257 (353)
T ss_pred cccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCC
Confidence 688999999999999999999999999999999999999987765444333321 00 00
Q ss_pred --------------CCC-----CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcC
Q 035713 385 --------------FPE-----TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 385 --------------~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~ 427 (491)
++. ....+..+++||.+||+.||.+||+ +.++|+||||+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~eiL~~~~~~ 315 (353)
T cd07850 258 YAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS----VDDALQHPYIN 315 (353)
T ss_pred CCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcC----HHHHhcChhHh
Confidence 000 1124667899999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=340.17 Aligned_cols=254 Identities=21% Similarity=0.308 Sum_probs=213.4
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
+...+|.+.++||+|+||.||+|.++.+++.||+|++.+.. .....+.+|+++|+.++|+||+++++++..+..++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 45578999999999999999999999999999999986542 23446778999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
+||||+++++|.+++.......+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999999999877655669999999999999999999999999999999999999999999999999985432100
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
.. ......++.
T Consensus 159 ~~---------------------------------------------------------------------~~~~~~~~~ 169 (263)
T cd05052 159 YT---------------------------------------------------------------------AHAGAKFPI 169 (263)
T ss_pred ee---------------------------------------------------------------------ccCCCCCcc
Confidence 00 000113467
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+. .....+....++.++.+||.+||..||++
T Consensus 170 ~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~ 248 (263)
T cd05052 170 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKVYELMRACWQWNPSD 248 (263)
T ss_pred ccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHccCCccc
Confidence 8999999999999999999999999999998 999998876655544443 33344444568999999999999999999
Q ss_pred CCCcCCChHHhhc
Q 035713 410 RIAYKRGATEIKQ 422 (491)
Q Consensus 410 R~t~~~~~~ell~ 422 (491)
||+ +.++++
T Consensus 249 Rp~----~~~l~~ 257 (263)
T cd05052 249 RPS----FAEIHQ 257 (263)
T ss_pred CCC----HHHHHH
Confidence 999 787765
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=344.61 Aligned_cols=255 Identities=31% Similarity=0.468 Sum_probs=215.1
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++.+.||+|+||.||+|.++.+++.||+|++..... ......+.+|+++++.++||||+++++++..++.+|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 368899999999999999999999999999999876532 244566788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
||+.+++|.+++.... ..+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~--- 154 (265)
T cd06605 79 EYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS--- 154 (265)
T ss_pred EecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH---
Confidence 9999999999988653 569999999999999999999999 99999999999999999999999999987432110
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......|+..|
T Consensus 155 ---------------------------------------------------------------------~~~~~~~~~~y 165 (265)
T cd06605 155 ---------------------------------------------------------------------LAKTFVGTSSY 165 (265)
T ss_pred ---------------------------------------------------------------------HhhcccCChhc
Confidence 00013688899
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCC-----cHHHHHHHHcCCC-cCCCCCCCCHHHHHHHHhhhccC
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQG-----NRATLFNVVGQPL-RFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----~~~~~~~i~~~~~-~~~~~~~~s~~~~~li~~~L~~d 406 (491)
+|||.+.+..++.++|||||||++|+|++|+.||.... ....+..+..... ..+. ..++.++.+||.+||..|
T Consensus 166 ~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~ 244 (265)
T cd06605 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS-GKFSPDFQDFVNLCLIKD 244 (265)
T ss_pred cCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh-hhcCHHHHHHHHHHcCCC
Confidence 99999999999999999999999999999999997542 2233333333322 2221 127889999999999999
Q ss_pred CCCCCCcCCChHHhhcCCCcCC
Q 035713 407 PHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 407 P~~R~t~~~~~~ell~hpff~~ 428 (491)
|++||+ +.+++.||||+.
T Consensus 245 p~~Rpt----~~~ll~~~~~~~ 262 (265)
T cd06605 245 PRERPS----YKELLEHPFIKK 262 (265)
T ss_pred chhCcC----HHHHhhCchhhc
Confidence 999999 999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=380.79 Aligned_cols=268 Identities=21% Similarity=0.326 Sum_probs=209.8
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
+++|+++++||+|+||.||+|++..+++.||||++............++.+|+++++.++||||+++++++.+++..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 36899999999999999999999999999999999765444445566788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccc
Q 035713 173 MEFCSGGNLHSLRQKQP---------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~---------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla 243 (491)
|||++|++|.+++.... ...++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 99999999999886421 123566778899999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (491)
+............. ....+.+ .......
T Consensus 161 k~i~~~~~~~~~l~------------------------------------------~~~~~s~----------~s~~t~~ 188 (932)
T PRK13184 161 IFKKLEEEDLLDID------------------------------------------VDERNIC----------YSSMTIP 188 (932)
T ss_pred eecccccccccccc------------------------------------------ccccccc----------ccccccC
Confidence 65421110000000 0000000 0000111
Q ss_pred cccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHH-HHcCCCcCCCCCCCCHHHHHHHHhh
Q 035713 324 MSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFN-VVGQPLRFPETPQVSFVARDLIRGL 402 (491)
Q Consensus 324 ~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~-i~~~~~~~~~~~~~s~~~~~li~~~ 402 (491)
...+||+.|||||++.+..++.++|||||||++|||++|+.||........... .+..+........+++.+.+++.+|
T Consensus 189 g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rc 268 (932)
T PRK13184 189 GKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKA 268 (932)
T ss_pred CCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHH
Confidence 235899999999999999999999999999999999999999987654433322 2222222222346889999999999
Q ss_pred hccCCCCCCC
Q 035713 403 LVKEPHKRIA 412 (491)
Q Consensus 403 L~~dP~~R~t 412 (491)
|+.||++|++
T Consensus 269 L~~DP~kR~s 278 (932)
T PRK13184 269 LAVDPAERYS 278 (932)
T ss_pred ccCChhhCcC
Confidence 9999999988
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=341.05 Aligned_cols=258 Identities=29% Similarity=0.481 Sum_probs=213.4
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhh-------hHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLA-------SRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~-------~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
+|.+.+.||.|+||.||+|.+..+|+.||+|.++..... .....+.+.+|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588999999999999999999999999999988643211 1123456788999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+++||||+.+++|.+++... +.+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999998775 569999999999999999999999999999999999999999999999999985321
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
... .........
T Consensus 160 ~~~--------------------------------------------------------------------~~~~~~~~~ 171 (272)
T cd06629 160 DIY--------------------------------------------------------------------DNDQNMSMQ 171 (272)
T ss_pred ccc--------------------------------------------------------------------ccccccccc
Confidence 100 000111236
Q ss_pred cccCccCcchhcCCC--CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC--CcCCC--CCCCCHHHHHHHHh
Q 035713 328 GTHEYLAPEIIRGEG--HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP--LRFPE--TPQVSFVARDLIRG 401 (491)
Q Consensus 328 gt~~y~aPE~l~~~~--~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~~~s~~~~~li~~ 401 (491)
|+..|+|||++.... ++.++|+|||||++|+|++|..||........+..+.... ..++. ...++.++.+||.+
T Consensus 172 ~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (272)
T cd06629 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNA 251 (272)
T ss_pred CCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHH
Confidence 889999999998765 7899999999999999999999997665555554443322 22222 13568999999999
Q ss_pred hhccCCCCCCCcCCChHHhhcCCCc
Q 035713 402 LLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 402 ~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
||..||++||+ ++++++||||
T Consensus 252 ~l~~~p~~Rps----~~~il~~~~~ 272 (272)
T cd06629 252 CFTINPDNRPT----ARELLQHPFI 272 (272)
T ss_pred HhcCChhhCCC----HHHHhhCCCC
Confidence 99999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=347.08 Aligned_cols=262 Identities=25% Similarity=0.401 Sum_probs=213.1
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
+++|++.+.||+|++|.||+|+++.+++.||+|++..... .......+.+|+++++.++|+||+++++++.++..+|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 3689999999999999999999999999999999865432 223345577899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc-CCcEEEeecccccccCCCCc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD-EGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~-~g~vkL~DFGla~~~~~~~~ 251 (491)
|||++ ++|..++.......+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++........
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 99995 58887776654455789999999999999999999999999999999999985 56799999999854321000
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
......|++.
T Consensus 159 ----------------------------------------------------------------------~~~~~~~~~~ 168 (294)
T PLN00009 159 ----------------------------------------------------------------------TFTHEVVTLW 168 (294)
T ss_pred ----------------------------------------------------------------------ccccCceeec
Confidence 0011257899
Q ss_pred ccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CCC------------------cCC---
Q 035713 332 YLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QPL------------------RFP--- 386 (491)
Q Consensus 332 y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~~------------------~~~--- 386 (491)
|+|||++.+. .++.++|||||||++|+|++|++||...+..+.+.++.. .+. .++
T Consensus 169 y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (294)
T PLN00009 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKD 248 (294)
T ss_pred ccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCC
Confidence 9999998774 478999999999999999999999988766655554432 110 000
Q ss_pred ---CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 387 ---ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 387 ---~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
..+.++.++.+||.+||+.||++||+ +.+++.||||++++
T Consensus 249 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps----~~~~l~~~~~~~~~ 291 (294)
T PLN00009 249 LATVVPTLEPAGVDLLSKMLRLDPSKRIT----ARAALEHEYFKDLG 291 (294)
T ss_pred HHHhCcCCChHHHHHHHHHccCChhhCcC----HHHHhcCchHhHHh
Confidence 01357888999999999999999999 99999999998654
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=337.37 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=215.5
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchh--hhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASL--ASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
+|+..+.||+|+||.||+|.+..+++.|++|++..... ........+.+|+++++.++|+||+++++++..+..+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47888999999999999999998999999999865432 2234556788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 9999999999998765 458999999999999999999999999999999999999999999999999875432100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......|+..|
T Consensus 157 ---------------------------------------------------------------------~~~~~~~~~~y 167 (258)
T cd06632 157 ---------------------------------------------------------------------FAKSFKGSPYW 167 (258)
T ss_pred ---------------------------------------------------------------------cccccCCCcce
Confidence 01123688999
Q ss_pred cCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 333 LAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 333 ~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
+|||.+.... ++.++|+|||||++|+|++|+.||...........+............++.++.+||.+||..+|.+||
T Consensus 168 ~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 247 (258)
T cd06632 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRP 247 (258)
T ss_pred eCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCc
Confidence 9999998777 899999999999999999999999876655555554432222122245789999999999999999999
Q ss_pred CcCCChHHhhcCCCc
Q 035713 412 AYKRGATEIKQHPFF 426 (491)
Q Consensus 412 t~~~~~~ell~hpff 426 (491)
+ +.+++.|||+
T Consensus 248 ~----~~~~l~~~~~ 258 (258)
T cd06632 248 T----AAELLEHPFV 258 (258)
T ss_pred C----HHHHhcCCCC
Confidence 9 9999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=327.07 Aligned_cols=265 Identities=22% Similarity=0.309 Sum_probs=213.6
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC----
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD---- 166 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~---- 166 (491)
+..++|+|.++||+|||+-||+++...+++.||+|+|... +.+.++..++|++..++++||||++++++...+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 5668999999999999999999999999999999988644 356677888999999999999999999876432
Q ss_pred -ceEEEEEeccCCCchHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccccCCCCCEEEccCCcEEEeecc
Q 035713 167 -KFYCLVMEFCSGGNLHSLRQKQ--PNKYFTEDAARFFASEVLLALEYLHMLG--IVYRDLKPENVLVRDEGHIMLSDFD 241 (491)
Q Consensus 167 -~~~~lV~E~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~g~vkL~DFG 241 (491)
...||+++|...|+|.+.++.. ++..++|.++..|+.+|++||++||+.. +.||||||.|||++..+.++|.|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 3589999999999999987753 3447999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCc
Q 035713 242 LSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNV 321 (491)
Q Consensus 242 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (491)
.+......-. +...+. .. +
T Consensus 175 S~~~a~i~i~--------------------~~~~a~---------------------~l---------------Q----- 193 (302)
T KOG2345|consen 175 SATQAPIQIE--------------------GSRQAL---------------------RL---------------Q----- 193 (302)
T ss_pred CccccceEee--------------------chHHHH---------------------HH---------------H-----
Confidence 8743211000 000000 00 0
Q ss_pred cccccccccCccCcchhcCCC---CCCcccccchhhHHHhhhcCCCCCCCCCc--HHHHHHHHcCCCcCCCCCCCCHHHH
Q 035713 322 RSMSFVGTHEYLAPEIIRGEG---HGSAVDWWTFGIFLYELLHGTTPFKGQGN--RATLFNVVGQPLRFPETPQVSFVAR 396 (491)
Q Consensus 322 ~~~~~~gt~~y~aPE~l~~~~---~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~s~~~~ 396 (491)
.-..-..|..|+|||++.-+. .+.++|||||||+||+|+.|..||...-. ......+++..+.+|+...+|+.+.
T Consensus 194 e~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~ 273 (302)
T KOG2345|consen 194 EWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALH 273 (302)
T ss_pred HHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHH
Confidence 000124788999999997543 48899999999999999999999963211 0112335566788998888999999
Q ss_pred HHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 397 DLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 397 ~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
+||+.||+.||.+||+ +.+++.+
T Consensus 274 ~lik~mlqvdP~qRP~----i~~ll~~ 296 (302)
T KOG2345|consen 274 QLIKSMLQVDPNQRPT----IPELLSK 296 (302)
T ss_pred HHHHHHhcCCcccCCC----HHHHHHH
Confidence 9999999999999999 9998865
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=339.67 Aligned_cols=254 Identities=20% Similarity=0.327 Sum_probs=213.5
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
.+..++|+++++||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.+++.++|+||+++++++...+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 356689999999999999999999976 556799998865432 245678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+++++|.+++.......+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 99999999999999988765567999999999999999999999999999999999999999999999999998543211
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
... ......++
T Consensus 157 ~~~---------------------------------------------------------------------~~~~~~~~ 167 (261)
T cd05072 157 EYT---------------------------------------------------------------------AREGAKFP 167 (261)
T ss_pred cee---------------------------------------------------------------------ccCCCccc
Confidence 000 00012456
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 408 (491)
..|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+... ..++....++.++.+||.+||..||+
T Consensus 168 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~ 246 (261)
T cd05072 168 IKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMPRMENCPDELYDIMKTCWKEKAE 246 (261)
T ss_pred eecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHccCCcc
Confidence 78999999998889999999999999999998 99999887766655555433 44555556899999999999999999
Q ss_pred CCCCcCCChHHhhc
Q 035713 409 KRIAYKRGATEIKQ 422 (491)
Q Consensus 409 ~R~t~~~~~~ell~ 422 (491)
+||+ ++++.+
T Consensus 247 ~Rp~----~~~i~~ 256 (261)
T cd05072 247 ERPT----FDYLQS 256 (261)
T ss_pred cCcC----HHHHHH
Confidence 9999 777764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=350.58 Aligned_cols=250 Identities=24% Similarity=0.390 Sum_probs=191.5
Q ss_pred eeeeccCceEEEEEEEeC--CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEE--eCceEEEEEec
Q 035713 100 KRLGYGDIGSVYLVELRG--TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE--TDKFYCLVMEF 175 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~--~~~~~~lV~E~ 175 (491)
.+||+|+||+||+|+++. ++..||+|.+..... ...+.+|+++|+.++||||+++++++. .+..+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 689999999999999764 567899999865432 224568999999999999999999985 45688999999
Q ss_pred cCCCchHHHHHhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEE----ccCCcEEEeeccccc
Q 035713 176 CSGGNLHSLRQKQ-------PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLV----RDEGHIMLSDFDLSL 244 (491)
Q Consensus 176 ~~gg~L~~~~~~~-------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl----~~~g~vkL~DFGla~ 244 (491)
+. ++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 95 5777776532 12358999999999999999999999999999999999999 566799999999986
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
........ .....
T Consensus 161 ~~~~~~~~-------------------------------------------------------------------~~~~~ 173 (317)
T cd07867 161 LFNSPLKP-------------------------------------------------------------------LADLD 173 (317)
T ss_pred ccCCCccc-------------------------------------------------------------------ccccC
Confidence 53211000 00111
Q ss_pred ccccccCccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcH---------HHHHHHH---cCC---------
Q 035713 325 SFVGTHEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNR---------ATLFNVV---GQP--------- 382 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---------~~~~~i~---~~~--------- 382 (491)
..+||+.|+|||++.+. .++.++|||||||++|||++|++||...... ..+.++. +.+
T Consensus 174 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (317)
T cd07867 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIR 253 (317)
T ss_pred cceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhh
Confidence 34789999999999875 4799999999999999999999999754321 1111111 000
Q ss_pred --CcC----------------------CCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 383 --LRF----------------------PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 383 --~~~----------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
..+ ......+..+.+||.+||+.||.+||| +.|+|+||||
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07867 254 KMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRIT----SEQALQDPYF 317 (317)
T ss_pred hcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccC----HHHHhcCCCC
Confidence 000 001124567889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=360.94 Aligned_cols=261 Identities=22% Similarity=0.288 Sum_probs=212.7
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCC-----CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceee
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGT-----NTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYS 161 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~ 161 (491)
...+..++|+++++||+|+||.||+|++... +..||||++.... .....+.+.+|+++|+.+. ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 3455678899999999999999999997533 3469999996542 2334457889999999996 999999999
Q ss_pred eEEeCceEEEEEeccCCCchHHHHHhCC----------------------------------------------------
Q 035713 162 YFETDKFYCLVMEFCSGGNLHSLRQKQP---------------------------------------------------- 189 (491)
Q Consensus 162 ~~~~~~~~~lV~E~~~gg~L~~~~~~~~---------------------------------------------------- 189 (491)
++...+.+||||||+++|+|.+++....
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 9999999999999999999998876431
Q ss_pred ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCE
Q 035713 190 ------------------------------------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENV 227 (491)
Q Consensus 190 ------------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NI 227 (491)
...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 12478888999999999999999999999999999999
Q ss_pred EEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCC
Q 035713 228 LVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCV 307 (491)
Q Consensus 228 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (491)
|++.++.+||+|||+++........
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~------------------------------------------------------- 293 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNY------------------------------------------------------- 293 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccc-------------------------------------------------------
Confidence 9999999999999998543211000
Q ss_pred CCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCC
Q 035713 308 GGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFP 386 (491)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 386 (491)
.......++..|+|||++.+..++.++|||||||++|||++ |..||........+...+......+
T Consensus 294 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~ 360 (400)
T cd05105 294 -------------VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA 360 (400)
T ss_pred -------------cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCC
Confidence 00112357788999999999999999999999999999997 9999987655555555555545555
Q ss_pred CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 387 ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 387 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
....++.++.+||.+||+.||++||+ +.+|.+
T Consensus 361 ~~~~~~~~l~~li~~cl~~dP~~RPt----~~~l~~ 392 (400)
T cd05105 361 KPDHATQEVYDIMVKCWNSEPEKRPS----FLHLSD 392 (400)
T ss_pred CCccCCHHHHHHHHHHCccCHhHCcC----HHHHHH
Confidence 55578999999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=338.62 Aligned_cols=258 Identities=30% Similarity=0.488 Sum_probs=219.0
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++.+.||+|++|.||+|++..+++.||+|++...... .....+.+|+++++.++|+||+++++++...+.+|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4699999999999999999999999999999998765322 44567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
||+++++|.+++... ..+++..+..++.||+.||.|||+ +|++||||+|+||+++.++.++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~- 155 (264)
T cd06623 79 EYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD- 155 (264)
T ss_pred EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-
Confidence 999999999998864 569999999999999999999999 9999999999999999999999999998754321000
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......++..|
T Consensus 156 ---------------------------------------------------------------------~~~~~~~~~~y 166 (264)
T cd06623 156 ---------------------------------------------------------------------QCNTFVGTVTY 166 (264)
T ss_pred ---------------------------------------------------------------------cccceeecccc
Confidence 00123688999
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCC--c-HHHHHHHHcCCCcCCCCCC-CCHHHHHHHHhhhccCCC
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQG--N-RATLFNVVGQPLRFPETPQ-VSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--~-~~~~~~i~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~ 408 (491)
+|||.+.+..++.++|+|||||++|+|++|+.||.... . .+....+.... ....... ++..+.++|.+||..+|+
T Consensus 167 ~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~ 245 (264)
T cd06623 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP-PPSLPAEEFSPEFRDFISACLQKDPK 245 (264)
T ss_pred cCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCC-CCCCCcccCCHHHHHHHHHHccCChh
Confidence 99999999889999999999999999999999998774 3 33333444332 2222234 789999999999999999
Q ss_pred CCCCcCCChHHhhcCCCcCCCC
Q 035713 409 KRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 409 ~R~t~~~~~~ell~hpff~~~~ 430 (491)
+||+ +.++++||||+.++
T Consensus 246 ~R~~----~~~ll~~~~~~~~~ 263 (264)
T cd06623 246 KRPS----AAELLQHPFIKKAD 263 (264)
T ss_pred hCCC----HHHHHhCHHHHhcc
Confidence 9999 99999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=340.05 Aligned_cols=256 Identities=25% Similarity=0.359 Sum_probs=211.4
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++.+.||+|+||.||+|+++.+++.||||.+.............+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999987654444555667888999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 174 EFCSGGNLHSLRQKQ--PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 174 E~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||+++++|.+++... ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 999999999887642 234589999999999999999999999999999999999999999999999998754321000
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
......|++.
T Consensus 162 ----------------------------------------------------------------------~~~~~~~~~~ 171 (267)
T cd08228 162 ----------------------------------------------------------------------AAHSLVGTPY 171 (267)
T ss_pred ----------------------------------------------------------------------HHhcCCCCcc
Confidence 0012368889
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCc-HHHHHHHHcC-CCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGN-RATLFNVVGQ-PLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-~~~~~~i~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
|+|||.+.+..++.++|+|||||++|||++|+.||..... ...+...+.. .........++..+.+||.+||..+|++
T Consensus 172 ~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~ 251 (267)
T cd08228 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQ 251 (267)
T ss_pred ccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCccc
Confidence 9999999988899999999999999999999999975532 2223333322 2211112357789999999999999999
Q ss_pred CCCcCCChHHhhcC
Q 035713 410 RIAYKRGATEIKQH 423 (491)
Q Consensus 410 R~t~~~~~~ell~h 423 (491)
||+ +.++++.
T Consensus 252 Rp~----~~~vl~~ 261 (267)
T cd08228 252 RPD----IGYVHQI 261 (267)
T ss_pred CcC----HHHHHHH
Confidence 999 8898874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=342.87 Aligned_cols=268 Identities=41% Similarity=0.769 Sum_probs=218.2
Q ss_pred CceEeeeeeccCceEEEEEEEe---CCCcEEEEEEeecchhh-hHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELR---GTNTYFAMKVMDKASLA-SRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~ 169 (491)
+|++.+.||.|+||.||+|++. .+|+.||+|++...... .......+.+|+++|+.+ +|+||+.++++|+.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999985 47899999999764332 223345677899999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999999998764 45899999999999999999999999999999999999999999999999998543210
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
. ........|+
T Consensus 159 ~---------------------------------------------------------------------~~~~~~~~~~ 169 (290)
T cd05613 159 E---------------------------------------------------------------------VERAYSFCGT 169 (290)
T ss_pred c---------------------------------------------------------------------ccccccccCC
Confidence 0 0011134688
Q ss_pred cCccCcchhcCC--CCCCcccccchhhHHHhhhcCCCCCCCCCcH----HHHHHHHcCCCcCCCCCCCCHHHHHHHHhhh
Q 035713 330 HEYLAPEIIRGE--GHGSAVDWWTFGIFLYELLHGTTPFKGQGNR----ATLFNVVGQPLRFPETPQVSFVARDLIRGLL 403 (491)
Q Consensus 330 ~~y~aPE~l~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L 403 (491)
..|+|||.+.+. .++.++|||||||++|+|++|+.||...... .....+......++ ..++..+.+||.+||
T Consensus 170 ~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~l 247 (290)
T cd05613 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDIIQRLL 247 (290)
T ss_pred cccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC--ccCCHHHHHHHHHHh
Confidence 999999999763 4678999999999999999999999754322 22233333333333 348899999999999
Q ss_pred ccCCCCCCCc-CCChHHhhcCCCcCCCChhhhh
Q 035713 404 VKEPHKRIAY-KRGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 404 ~~dP~~R~t~-~~~~~ell~hpff~~~~~~~~~ 435 (491)
..||++|++. ...+++++.||||+.++|+.+.
T Consensus 248 ~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~ 280 (290)
T cd05613 248 MKDPKKRLGCGPSDADEIKKHPFFQKINWDDLA 280 (290)
T ss_pred cCCHHHhcCCCCCCHHHHHcCcccccCCHHHHh
Confidence 9999999853 2349999999999999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=337.76 Aligned_cols=256 Identities=27% Similarity=0.495 Sum_probs=217.8
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
+|++.+.||+|+||.||+|.++.+|..||+|.+....... .....+.+|+++++.++|+||+++++.+..+..+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 5899999999999999999999999999999987643322 334567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCc-EEEeecccccccCCCCccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGH-IMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~-vkL~DFGla~~~~~~~~~~ 253 (491)
|+.+++|.+++.......+++..+..++.||+.||.|||+++++|+||||+||+++.++. +||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-- 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--
Confidence 999999999988765556899999999999999999999999999999999999998864 69999998754321000
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
......|++.|+
T Consensus 158 --------------------------------------------------------------------~~~~~~~~~~~~ 169 (257)
T cd08225 158 --------------------------------------------------------------------LAYTCVGTPYYL 169 (257)
T ss_pred --------------------------------------------------------------------cccccCCCcccc
Confidence 001235889999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
|||++.+..++.++|+|||||++|||++|..||...+.......+...... +..+.++.++.++|.+||..+|++||+
T Consensus 170 ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt- 247 (257)
T cd08225 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-PISPNFSRDLRSLISQLFKVSPRDRPS- 247 (257)
T ss_pred CHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC-CCCCCCCHHHHHHHHHHhccChhhCcC-
Confidence 999999888999999999999999999999999887766666665554332 223457889999999999999999999
Q ss_pred CCChHHhhcCCCc
Q 035713 414 KRGATEIKQHPFF 426 (491)
Q Consensus 414 ~~~~~ell~hpff 426 (491)
+.++++||||
T Consensus 248 ---~~~ll~~~~~ 257 (257)
T cd08225 248 ---ITSILKRPFL 257 (257)
T ss_pred ---HHHHhhCCCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=354.99 Aligned_cols=260 Identities=20% Similarity=0.312 Sum_probs=210.1
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYF 163 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~ 163 (491)
.+..++|++.+.||+|+||.||+|++.. +++.||+|+++... .......+.+|+++++.+ +|+||+++++++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 3455789999999999999999997543 45789999986542 223445677899999999 799999999988
Q ss_pred Ee-CceEEEEEeccCCCchHHHHHhCCC----------------------------------------------------
Q 035713 164 ET-DKFYCLVMEFCSGGNLHSLRQKQPN---------------------------------------------------- 190 (491)
Q Consensus 164 ~~-~~~~~lV~E~~~gg~L~~~~~~~~~---------------------------------------------------- 190 (491)
.. +..+++||||+++++|.+++.....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 4678999999999999998864321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccccccCC
Q 035713 191 -------KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNG 263 (491)
Q Consensus 191 -------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 263 (491)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~------------ 228 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------------ 228 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc------------
Confidence 2588999999999999999999999999999999999999999999999999865321110
Q ss_pred CCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCCC
Q 035713 264 SGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGH 343 (491)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 343 (491)
........++..|+|||++.+..+
T Consensus 229 --------------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~ 252 (337)
T cd05054 229 --------------------------------------------------------YVRKGDARLPLKWMAPESIFDKVY 252 (337)
T ss_pred --------------------------------------------------------hhhccCCCCCccccCcHHhcCCCC
Confidence 001112356788999999999999
Q ss_pred CCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 344 GSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 344 ~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
+.++|||||||+||||++ |..||.+....+.+...+...........++.++.+++.+||+.+|++||+ +.+|++
T Consensus 253 ~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs----~~ell~ 328 (337)
T cd05054 253 TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT----FSELVE 328 (337)
T ss_pred CccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC----HHHHHH
Confidence 999999999999999998 999998765555554444443333333457899999999999999999999 899987
Q ss_pred C
Q 035713 423 H 423 (491)
Q Consensus 423 h 423 (491)
|
T Consensus 329 ~ 329 (337)
T cd05054 329 I 329 (337)
T ss_pred H
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=346.69 Aligned_cols=256 Identities=27% Similarity=0.375 Sum_probs=214.9
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
...|++.+.||+|+||.||+|++..+++.||+|++.............+.+|+++++.++||||+++++++.+++..|+|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35699999999999999999999999999999998765444445566788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+. |+|.+++... ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~---- 167 (307)
T cd06607 94 MEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---- 167 (307)
T ss_pred HHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC----
Confidence 99996 5777666543 24599999999999999999999999999999999999999999999999998743210
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.....|+..|
T Consensus 168 ----------------------------------------------------------------------~~~~~~~~~y 177 (307)
T cd06607 168 ----------------------------------------------------------------------ANSFVGTPYW 177 (307)
T ss_pred ----------------------------------------------------------------------CCCccCCccc
Confidence 0123578899
Q ss_pred cCcchhc---CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 333 LAPEIIR---GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 333 ~aPE~l~---~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
+|||++. ...++.++|||||||++|||++|+.||.+.+.......+............++..+.+||.+||..||++
T Consensus 178 ~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 257 (307)
T cd06607 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQD 257 (307)
T ss_pred cCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhh
Confidence 9999985 3457889999999999999999999998876666555554332222122347889999999999999999
Q ss_pred CCCcCCChHHhhcCCCcCC
Q 035713 410 RIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 410 R~t~~~~~~ell~hpff~~ 428 (491)
||+ +.+|+.||||..
T Consensus 258 Rp~----~~~il~~~~~~~ 272 (307)
T cd06607 258 RPS----SEELLKHRFVLR 272 (307)
T ss_pred CcC----HHHHhcChhhcc
Confidence 999 999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=349.31 Aligned_cols=255 Identities=20% Similarity=0.278 Sum_probs=210.9
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcE----EEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTY----FAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
...+|++++.||+|+||.||+|++..+++. ||+|+++.. ........+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 457899999999999999999998766654 899998643 2234455678899999999999999999998765
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
..++|+||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 4679999999999999988653 458999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
...... ......
T Consensus 161 ~~~~~~--------------------------------------------------------------------~~~~~~ 172 (316)
T cd05108 161 ADEKEY--------------------------------------------------------------------HAEGGK 172 (316)
T ss_pred CCCcce--------------------------------------------------------------------eccCCc
Confidence 211000 000113
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+ +..++.....++....++.++.++|.+||..|
T Consensus 173 ~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 251 (316)
T cd05108 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMVKCWMID 251 (316)
T ss_pred cceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCC
Confidence 5678999999999999999999999999999998 999998765443 45555555555555678899999999999999
Q ss_pred CCCCCCcCCChHHhhcC
Q 035713 407 PHKRIAYKRGATEIKQH 423 (491)
Q Consensus 407 P~~R~t~~~~~~ell~h 423 (491)
|.+||+ +.+++.+
T Consensus 252 p~~Rps----~~~l~~~ 264 (316)
T cd05108 252 ADSRPK----FRELIIE 264 (316)
T ss_pred hhhCcC----HHHHHHH
Confidence 999999 8888876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=348.68 Aligned_cols=256 Identities=29% Similarity=0.475 Sum_probs=214.9
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
+.|.....||+|+||.||++.+..++..||||.+.... ......+.+|+.+++.++|+||+++++.+..++..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 45666788999999999999999999999999986532 234456778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 99 e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--- 172 (292)
T cd06658 99 EFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--- 172 (292)
T ss_pred eCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc---
Confidence 99999999998764 358999999999999999999999999999999999999999999999999874321100
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.......|+..|+
T Consensus 173 -------------------------------------------------------------------~~~~~~~~~~~y~ 185 (292)
T cd06658 173 -------------------------------------------------------------------PKRKSLVGTPYWM 185 (292)
T ss_pred -------------------------------------------------------------------ccCceeecCcccc
Confidence 0011246899999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC-CCcCCCCCCCCHHHHHHHHhhhccCCCCCCC
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ-PLRFPETPQVSFVARDLIRGLLVKEPHKRIA 412 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 412 (491)
|||++.+..++.++|||||||++|||++|+.||.+.+....+..+... ....+....++..+.+||.+||..||.+||+
T Consensus 186 aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 265 (292)
T cd06658 186 APEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRAT 265 (292)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcC
Confidence 999999888999999999999999999999999877665554443322 1222333457889999999999999999999
Q ss_pred cCCChHHhhcCCCcCCC
Q 035713 413 YKRGATEIKQHPFFEGV 429 (491)
Q Consensus 413 ~~~~~~ell~hpff~~~ 429 (491)
++++++||||+..
T Consensus 266 ----~~~il~~~~~~~~ 278 (292)
T cd06658 266 ----AQELLQHPFLKLA 278 (292)
T ss_pred ----HHHHhhChhhhcc
Confidence 9999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=348.01 Aligned_cols=263 Identities=24% Similarity=0.327 Sum_probs=210.9
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCceEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~~l 171 (491)
.++|+..+.||+|+||.||++++..+++.||+|.+.+.... .....+.+|+.++.++. |+||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 45788899999999999999999999999999998764322 34556788999999996 9999999999999999999
Q ss_pred EEeccCCCchHHHH---HhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 172 VMEFCSGGNLHSLR---QKQPNKYFTEDAARFFASEVLLALEYLHML-GIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 172 V~E~~~gg~L~~~~---~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
+|||+. ++|..+. .......+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 999985 4554432 233345699999999999999999999974 99999999999999999999999999985432
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
... ......
T Consensus 160 ~~~-----------------------------------------------------------------------~~~~~~ 168 (288)
T cd06616 160 DSI-----------------------------------------------------------------------AKTRDA 168 (288)
T ss_pred cCC-----------------------------------------------------------------------cccccc
Confidence 100 001225
Q ss_pred cccCccCcchhcCC---CCCCcccccchhhHHHhhhcCCCCCCCCCcH-HHHHHHHcCC-CcCCC--CCCCCHHHHHHHH
Q 035713 328 GTHEYLAPEIIRGE---GHGSAVDWWTFGIFLYELLHGTTPFKGQGNR-ATLFNVVGQP-LRFPE--TPQVSFVARDLIR 400 (491)
Q Consensus 328 gt~~y~aPE~l~~~---~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~-~~~~~--~~~~s~~~~~li~ 400 (491)
|+..|+|||++.+. .++.++|||||||++|+|++|+.||...... +.+.++.... ...+. ...++.++.+||.
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 248 (288)
T cd06616 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFIN 248 (288)
T ss_pred CccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHH
Confidence 78899999999876 5899999999999999999999999765422 2223333221 12211 1348899999999
Q ss_pred hhhccCCCCCCCcCCChHHhhcCCCcCCCChhh
Q 035713 401 GLLVKEPHKRIAYKRGATEIKQHPFFEGVNWAL 433 (491)
Q Consensus 401 ~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~ 433 (491)
+||+.||++||+ +++|++||||+...|..
T Consensus 249 ~~l~~~p~~Rpt----~~~i~~~~~~~~~~~~~ 277 (288)
T cd06616 249 LCLIKDESKRPK----YKELLEHPFIKDYEERN 277 (288)
T ss_pred HHccCChhhCcC----HHHHhcChhhhchhhcc
Confidence 999999999999 99999999998766543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=345.38 Aligned_cols=258 Identities=25% Similarity=0.418 Sum_probs=208.4
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCce----
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKF---- 168 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~---- 168 (491)
++|++.+.||+|+||.||+|++..+++.||||++.... ........+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 46999999999999999999999999999999986542 22233446778999999995 6999999999987655
Q ss_pred -EEEEEeccCCCchHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc-CCcEEEeecccc
Q 035713 169 -YCLVMEFCSGGNLHSLRQKQP---NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD-EGHIMLSDFDLS 243 (491)
Q Consensus 169 -~~lV~E~~~gg~L~~~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~-~g~vkL~DFGla 243 (491)
.|+||||+++ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999975 7888776532 245899999999999999999999999999999999999998 899999999998
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (491)
........ ..
T Consensus 159 ~~~~~~~~----------------------------------------------------------------------~~ 168 (295)
T cd07837 159 RAFSIPVK----------------------------------------------------------------------SY 168 (295)
T ss_pred eecCCCcc----------------------------------------------------------------------cc
Confidence 54321000 00
Q ss_pred cccccccCccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---CC--c------------C
Q 035713 324 MSFVGTHEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---PL--R------------F 385 (491)
Q Consensus 324 ~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~~--~------------~ 385 (491)
....+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+....+..+... +. . +
T Consensus 169 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (295)
T cd07837 169 THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEF 248 (295)
T ss_pred CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhc
Confidence 012568899999998764 4789999999999999999999999987766655544321 00 0 0
Q ss_pred C---------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcC
Q 035713 386 P---------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 386 ~---------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~ 427 (491)
+ ..+.++.++.+||.+||..||.+||+ +++++.||||+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~----~~eil~~~~~~ 295 (295)
T cd07837 249 PQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS----AKAALTHPYFD 295 (295)
T ss_pred CcccchhHHHhccccCHHHHHHHHHHccCChhhcCC----HHHHhcCCCcC
Confidence 0 01357889999999999999999999 99999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=341.81 Aligned_cols=266 Identities=42% Similarity=0.766 Sum_probs=217.1
Q ss_pred CceEeeeeeccCceEEEEEEEe---CCCcEEEEEEeecchhh-hHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELR---GTNTYFAMKVMDKASLA-SRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~ 169 (491)
+|++.+.||+|+||.||+|++. .+++.||||++++.... .......+.+|+++++.+ +|+||+++++++..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46788999999764332 233445678899999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+.+++|..++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999988754 46999999999999999999999999999999999999999999999999997543211
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.. .......|+
T Consensus 159 ~~---------------------------------------------------------------------~~~~~~~~~ 169 (288)
T cd05583 159 EE---------------------------------------------------------------------ERAYSFCGT 169 (288)
T ss_pred cc---------------------------------------------------------------------cccccccCC
Confidence 00 001124688
Q ss_pred cCccCcchhcCCC--CCCcccccchhhHHHhhhcCCCCCCCCCc----HHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhh
Q 035713 330 HEYLAPEIIRGEG--HGSAVDWWTFGIFLYELLHGTTPFKGQGN----RATLFNVVGQPLRFPETPQVSFVARDLIRGLL 403 (491)
Q Consensus 330 ~~y~aPE~l~~~~--~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L 403 (491)
..|+|||.+.+.. ++.++||||||+++|||++|..||..... .+....+.......+ ..++.++.+||.+||
T Consensus 170 ~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l 247 (288)
T cd05583 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP--KTMSAEARDFIQKLL 247 (288)
T ss_pred ccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCC--cccCHHHHHHHHHHh
Confidence 9999999998765 68899999999999999999999964432 222233333333333 348899999999999
Q ss_pred ccCCCCCCCcCCChHHhhcCCCcCCCChhhh
Q 035713 404 VKEPHKRIAYKRGATEIKQHPFFEGVNWALV 434 (491)
Q Consensus 404 ~~dP~~R~t~~~~~~ell~hpff~~~~~~~~ 434 (491)
+.||++|||.. .+.++|+||||+.++|+.+
T Consensus 248 ~~~p~~R~t~~-~~~~~l~~~~~~~~~~~~~ 277 (288)
T cd05583 248 EKDPKKRLGAN-GADEIKNHPFFQGIDWDDL 277 (288)
T ss_pred cCCHhhccCcc-hHHHHhcCcccccCCHHHH
Confidence 99999999843 3778899999999999866
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=342.84 Aligned_cols=256 Identities=21% Similarity=0.308 Sum_probs=213.0
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
..++|.+++.||+|+||.||+|++.. +++.||||+++... .......+.+|+++|+.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 35789999999999999999998753 36789999987542 233456788999999999999999999999999
Q ss_pred ceEEEEEeccCCCchHHHHHhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQP------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGH 234 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~ 234 (491)
...|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999987542 235889999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCcc
Q 035713 235 IMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPEL 314 (491)
Q Consensus 235 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (491)
+||+|||++.........
T Consensus 161 ~kl~d~g~~~~~~~~~~~-------------------------------------------------------------- 178 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYY-------------------------------------------------------------- 178 (280)
T ss_pred EEECCcccceecccCcce--------------------------------------------------------------
Confidence 999999998542110000
Q ss_pred ccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCH
Q 035713 315 MAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSF 393 (491)
Q Consensus 315 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 393 (491)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+.......+ ...++.
T Consensus 179 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 251 (280)
T cd05049 179 ------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR-PRTCPS 251 (280)
T ss_pred ------ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCC-CCCCCH
Confidence 00012246788999999999999999999999999999998 9999988777766666664443322 245889
Q ss_pred HHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 394 VARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 394 ~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
.+.+||.+||+.||++||+ +.|++.
T Consensus 252 ~~~~li~~~l~~~p~~Rp~----~~eil~ 276 (280)
T cd05049 252 EVYDIMLGCWKRDPQQRIN----IKDIHE 276 (280)
T ss_pred HHHHHHHHHcCCCcccCCC----HHHHHH
Confidence 9999999999999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=356.29 Aligned_cols=259 Identities=25% Similarity=0.378 Sum_probs=224.0
Q ss_pred cccCCCCccCCCceEeeeeeccCceEEEEEEEeCCCc---E-EEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccce
Q 035713 84 ISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNT---Y-FAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTL 159 (491)
Q Consensus 84 ~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~---~-vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 159 (491)
+....+++..++-.+.++||+|+||.||+|+.+..+. . ||+|..+........++..+++|+++|+.++|||||++
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 3445566777888888999999999999999876432 3 89999876555667888899999999999999999999
Q ss_pred eeeEEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEee
Q 035713 160 YSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSD 239 (491)
Q Consensus 160 ~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~D 239 (491)
||+.....-+|||||+|+||+|.+++++.++ .++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+|
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCc
Confidence 9999999999999999999999999998743 699999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCC
Q 035713 240 FDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPT 319 (491)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (491)
|||++.........
T Consensus 306 FGLs~~~~~~~~~~------------------------------------------------------------------ 319 (474)
T KOG0194|consen 306 FGLSRAGSQYVMKK------------------------------------------------------------------ 319 (474)
T ss_pred cccccCCcceeecc------------------------------------------------------------------
Confidence 99985432000000
Q ss_pred CccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHH
Q 035713 320 NVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDL 398 (491)
Q Consensus 320 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~l 398 (491)
...--...|+|||.+....|+.++|||||||++||+++ |..||.+....+...+|+...++.+.....+.++..+
T Consensus 320 ----~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~ 395 (474)
T KOG0194|consen 320 ----FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKV 395 (474)
T ss_pred ----ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHH
Confidence 00013468999999999999999999999999999999 8999999999988888877777777777889999999
Q ss_pred HHhhhccCCCCCCCc
Q 035713 399 IRGLLVKEPHKRIAY 413 (491)
Q Consensus 399 i~~~L~~dP~~R~t~ 413 (491)
+.+|+..||++|+++
T Consensus 396 ~~~c~~~~p~~R~tm 410 (474)
T KOG0194|consen 396 MKQCWKKDPEDRPTM 410 (474)
T ss_pred HHHhccCChhhccCH
Confidence 999999999999994
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=343.56 Aligned_cols=256 Identities=28% Similarity=0.411 Sum_probs=203.6
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.++|++++.||+|+||.||+|.+..+++.||+|++...... .....+.+|+++|+.++|+||+++++++..++..|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999998654322 2223456799999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+. ++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 157 (291)
T cd07870 82 FEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-- 157 (291)
T ss_pred Eeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC--
Confidence 99995 67776665442 458899999999999999999999999999999999999999999999999885321100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.......++..|
T Consensus 158 --------------------------------------------------------------------~~~~~~~~~~~y 169 (291)
T cd07870 158 --------------------------------------------------------------------QTYSSEVVTLWY 169 (291)
T ss_pred --------------------------------------------------------------------CCCCCccccccc
Confidence 000112578899
Q ss_pred cCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcH-HHHHHHHc---CCC--------c--------C----C-
Q 035713 333 LAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNR-ATLFNVVG---QPL--------R--------F----P- 386 (491)
Q Consensus 333 ~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~---~~~--------~--------~----~- 386 (491)
+|||++.+. .++.++|||||||++|+|++|+.||.+.... +.+.++.. .+. . + +
T Consensus 170 ~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (291)
T cd07870 170 RPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQ 249 (291)
T ss_pred cCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCc
Confidence 999999764 4788999999999999999999999865442 22222211 000 0 0 0
Q ss_pred ------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 387 ------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 387 ------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
.....+.++.+||.+||..||.+||| +.+++.||||
T Consensus 250 ~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t----~~~~l~h~~~ 291 (291)
T cd07870 250 QLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS----AQDALLHPYF 291 (291)
T ss_pred chhhhccccCCChHHHHHHHHHhCcCcccCcC----HHHHhcCCCC
Confidence 00123568899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=335.66 Aligned_cols=259 Identities=28% Similarity=0.435 Sum_probs=216.9
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecch--hhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC--ceE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKAS--LASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD--KFY 169 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~--~~~ 169 (491)
.+|++.+.||+|+||.||+|++..+++.||+|++.... .........+.+|+++++.++|+||+++++++.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999885431 12234556788999999999999999999998764 568
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 9999999999999988764 45899999999999999999999999999999999999999999999999998543210
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.. .......+.|+
T Consensus 160 ~~-------------------------------------------------------------------~~~~~~~~~~~ 172 (264)
T cd06653 160 CM-------------------------------------------------------------------SGTGIKSVTGT 172 (264)
T ss_pred cc-------------------------------------------------------------------cCccccccCCc
Confidence 00 00001124688
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
..|+|||++.+..++.++|||||||++|+|++|+.||........+.++...+........+++.+.++|.+||. +|..
T Consensus 173 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~ 251 (264)
T cd06653 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKR 251 (264)
T ss_pred ccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-Cccc
Confidence 999999999998899999999999999999999999988776666666665544333345688999999999999 5799
Q ss_pred CCCcCCChHHhhcCCCc
Q 035713 410 RIAYKRGATEIKQHPFF 426 (491)
Q Consensus 410 R~t~~~~~~ell~hpff 426 (491)
||+ +.+++.|||.
T Consensus 252 r~~----~~~~~~~~~~ 264 (264)
T cd06653 252 RPT----AEFLLRHPFV 264 (264)
T ss_pred Ccc----HHHHhcCCCC
Confidence 999 9999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=342.75 Aligned_cols=258 Identities=27% Similarity=0.414 Sum_probs=217.2
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
+.|+.+++||.|+||.||+|.+..++..||||++..... ......+.+|+.+++.+.|+||+++++++.++..+|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 468899999999999999999999999999999875432 344567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+.|++|.+++.. +.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06640 82 EYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred ecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc---
Confidence 99999999998865 358999999999999999999999999999999999999999999999999985431100
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.......++..|+
T Consensus 156 -------------------------------------------------------------------~~~~~~~~~~~y~ 168 (277)
T cd06640 156 -------------------------------------------------------------------IKRNTFVGTPFWM 168 (277)
T ss_pred -------------------------------------------------------------------cccccccCccccc
Confidence 0011235788999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
|||++.+..++.++|+|||||++|||++|..||.+.........+.... .......++..+.+||.+||..+|++||+
T Consensus 169 apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~- 246 (277)
T cd06640 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-PPTLTGEFSKPFKEFIDACLNKDPSFRPT- 246 (277)
T ss_pred CHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC-CCCCchhhhHHHHHHHHHHcccCcccCcC-
Confidence 9999998889999999999999999999999998776555444432221 11112347788999999999999999999
Q ss_pred CCChHHhhcCCCcCCCCh
Q 035713 414 KRGATEIKQHPFFEGVNW 431 (491)
Q Consensus 414 ~~~~~ell~hpff~~~~~ 431 (491)
+.++++|+||.....
T Consensus 247 ---~~~il~~~~~~~~~~ 261 (277)
T cd06640 247 ---AKELLKHKFIVKNAK 261 (277)
T ss_pred ---HHHHHhChHhhhcch
Confidence 999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=334.95 Aligned_cols=259 Identities=31% Similarity=0.535 Sum_probs=217.1
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
+|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+++++.++|+||+++++.+...+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 589999999999999999999989999999999766433 4567788999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~- 156 (264)
T cd06626 80 YCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM- 156 (264)
T ss_pred cCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc-
Confidence 99999999998764 458999999999999999999999999999999999999999999999999985432111000
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
........++..|+|
T Consensus 157 -----------------------------------------------------------------~~~~~~~~~~~~~~~ 171 (264)
T cd06626 157 -----------------------------------------------------------------GEEVQSLAGTPAYMA 171 (264)
T ss_pred -----------------------------------------------------------------cccccCCcCCcCccC
Confidence 000012367889999
Q ss_pred cchhcCCC---CCCcccccchhhHHHhhhcCCCCCCCCCcHHH-HHHHHc-CCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 335 PEIIRGEG---HGSAVDWWTFGIFLYELLHGTTPFKGQGNRAT-LFNVVG-QPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 335 PE~l~~~~---~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-~~~i~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
||++.+.. ++.++|||||||++|+|++|+.||........ ...+.. ....++....++..+.+||.+||+.||.+
T Consensus 172 PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 251 (264)
T cd06626 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKK 251 (264)
T ss_pred hhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCccc
Confidence 99998876 78999999999999999999999976543332 233332 23345555556899999999999999999
Q ss_pred CCCcCCChHHhhcCCCc
Q 035713 410 RIAYKRGATEIKQHPFF 426 (491)
Q Consensus 410 R~t~~~~~~ell~hpff 426 (491)
||+ +.++++|||+
T Consensus 252 R~~----~~~i~~~~~~ 264 (264)
T cd06626 252 RPT----ASELLQHPFV 264 (264)
T ss_pred CCC----HHHHhcCCCC
Confidence 999 9999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=340.75 Aligned_cols=258 Identities=20% Similarity=0.283 Sum_probs=210.6
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET 165 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 165 (491)
+..++|++.+.||+|+||.||+|.++. ++..||||++.... .......+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 455789999999999999999998753 35679999986532 22334567889999999999999999999999
Q ss_pred CceEEEEEeccCCCchHHHHHhCCC--------CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEE
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPN--------KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIML 237 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL 237 (491)
+...++||||+.+++|.+++..... ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999999875321 23678889999999999999999999999999999999999999999
Q ss_pred eecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccC
Q 035713 238 SDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAE 317 (491)
Q Consensus 238 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (491)
+|||++..........
T Consensus 161 ~dfg~~~~~~~~~~~~---------------------------------------------------------------- 176 (277)
T cd05062 161 GDFGMTRDIYETDYYR---------------------------------------------------------------- 176 (277)
T ss_pred CCCCCccccCCcceee----------------------------------------------------------------
Confidence 9999985432110000
Q ss_pred CCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHH
Q 035713 318 PTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVAR 396 (491)
Q Consensus 318 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~ 396 (491)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+......+..+...... +....++..+.
T Consensus 177 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 251 (277)
T cd05062 177 ----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL-DKPDNCPDMLF 251 (277)
T ss_pred ----cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-CCCCCCCHHHH
Confidence 0001246788999999999889999999999999999999 79999888776666555554332 22245888999
Q ss_pred HHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 397 DLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 397 ~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
+||.+||+.||++||+ +.+++++
T Consensus 252 ~li~~~l~~~p~~Rps----~~e~l~~ 274 (277)
T cd05062 252 ELMRMCWQYNPKMRPS----FLEIISS 274 (277)
T ss_pred HHHHHHcCCChhhCcC----HHHHHHH
Confidence 9999999999999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=347.16 Aligned_cols=259 Identities=26% Similarity=0.408 Sum_probs=216.7
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
+.|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+++++.++|+||+++++++..+..+|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 458889999999999999999999999999999875432 234567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+++++|.+++.. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06642 82 EYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred EccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc---
Confidence 99999999988764 458999999999999999999999999999999999999999999999999985432100
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.......|+..|+
T Consensus 156 -------------------------------------------------------------------~~~~~~~~~~~y~ 168 (277)
T cd06642 156 -------------------------------------------------------------------IKRNTFVGTPFWM 168 (277)
T ss_pred -------------------------------------------------------------------hhhhcccCccccc
Confidence 0011235788999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
|||++.+..++.++|+|||||++|||++|+.||...........+..... ......++.++.+||.+||..+|++||+
T Consensus 169 aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~- 246 (277)
T cd06642 169 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-PTLEGQYSKPFKEFVEACLNKDPRFRPT- 246 (277)
T ss_pred CHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCC-CCCCcccCHHHHHHHHHHccCCcccCcC-
Confidence 99999998899999999999999999999999976655444443332221 1112347889999999999999999999
Q ss_pred CCChHHhhcCCCcCCCChh
Q 035713 414 KRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 414 ~~~~~ell~hpff~~~~~~ 432 (491)
+.++++||||....+.
T Consensus 247 ---~~~il~~~~~~~~~~~ 262 (277)
T cd06642 247 ---AKELLKHKFITRYTKK 262 (277)
T ss_pred ---HHHHHHhHHHHHHhhh
Confidence 9999999999765543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=336.30 Aligned_cols=256 Identities=26% Similarity=0.444 Sum_probs=215.3
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe--CceEEEE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET--DKFYCLV 172 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~--~~~~~lV 172 (491)
+|++++.||.|+||.||+|.+..+++.||+|++...... .....++.+|+++++.++|+||+++++++.. ...+|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 589999999999999999999999999999998765433 3445677889999999999999999998754 4578999
Q ss_pred EeccCCCchHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHH-----HcCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 173 MEFCSGGNLHSLRQKQ--PNKYFTEDAARFFASEVLLALEYLH-----MLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH-----~~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
|||+++++|.+++... ....+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999999988753 2356999999999999999999999 88999999999999999999999999999854
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
...... ....
T Consensus 160 ~~~~~~----------------------------------------------------------------------~~~~ 169 (265)
T cd08217 160 LGHDSS----------------------------------------------------------------------FAKT 169 (265)
T ss_pred ccCCcc----------------------------------------------------------------------cccc
Confidence 321100 0112
Q ss_pred cccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhcc
Q 035713 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~ 405 (491)
..|+..|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+...... .....++..+.+||.+||..
T Consensus 170 ~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~l~~ 248 (265)
T cd08217 170 YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR-RIPYRYSSELNEVIKSMLNV 248 (265)
T ss_pred cccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC-CCccccCHHHHHHHHHHccC
Confidence 36889999999999988999999999999999999999999987755544444443322 22246889999999999999
Q ss_pred CCCCCCCcCCChHHhhcCCCc
Q 035713 406 EPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~hpff 426 (491)
+|++||+ +.+|++|||+
T Consensus 249 ~p~~Rp~----~~~il~~~~~ 265 (265)
T cd08217 249 DPDKRPS----TEELLQLPLI 265 (265)
T ss_pred CcccCCC----HHHHhhCCCC
Confidence 9999999 9999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=345.71 Aligned_cols=255 Identities=23% Similarity=0.329 Sum_probs=208.6
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcE--EEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCc
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTY--FAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDK 167 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~--vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~ 167 (491)
+..++|++.+.||+|+||.||+|+++.++.. +|+|.+... ........+.+|++++.++ +|+||+++++++..++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 4568999999999999999999999877764 566665432 2334456778899999999 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQP--------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG 233 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g 233 (491)
.+|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999987542 13589999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCc
Q 035713 234 HIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPE 313 (491)
Q Consensus 234 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (491)
.+||+|||++.......
T Consensus 162 ~~kl~dfg~~~~~~~~~--------------------------------------------------------------- 178 (303)
T cd05088 162 VAKIADFGLSRGQEVYV--------------------------------------------------------------- 178 (303)
T ss_pred cEEeCccccCcccchhh---------------------------------------------------------------
Confidence 99999999873210000
Q ss_pred cccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCC
Q 035713 314 LMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVS 392 (491)
Q Consensus 314 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 392 (491)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+. ..........++
T Consensus 179 --------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 249 (303)
T cd05088 179 --------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNCD 249 (303)
T ss_pred --------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCcCCCCCCCC
Confidence 0001134567999999988889999999999999999998 999998776665554443 333333334578
Q ss_pred HHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 393 FVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 393 ~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
.++.+||.+||+.+|++||+ +++++++
T Consensus 250 ~~~~~li~~~l~~~p~~Rp~----~~~il~~ 276 (303)
T cd05088 250 DEVYDLMRQCWREKPYERPS----FAQILVS 276 (303)
T ss_pred HHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 99999999999999999999 8888876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=350.07 Aligned_cols=260 Identities=27% Similarity=0.417 Sum_probs=207.5
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC-----ce
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD-----KF 168 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~-----~~ 168 (491)
++|++.++||+|+||.||+|++..+|+.||||++... ........+.+|+.+++.++|+||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 6899999999999999999999999999999998642 2233445677899999999999999999987543 36
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
+|+||||+. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 899999995 588777754 4599999999999999999999999999999999999999999999999999854321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
.... .......+|
T Consensus 159 ~~~~-------------------------------------------------------------------~~~~~~~~~ 171 (336)
T cd07849 159 EHDH-------------------------------------------------------------------TGFLTEYVA 171 (336)
T ss_pred cccc-------------------------------------------------------------------cCCcCCcCc
Confidence 0000 000112478
Q ss_pred ccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHH---cCC-------------------C--
Q 035713 329 THEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV---GQP-------------------L-- 383 (491)
Q Consensus 329 t~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~---~~~-------------------~-- 383 (491)
|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+. ..+ .
T Consensus 172 ~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (336)
T cd07849 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPF 251 (336)
T ss_pred CCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCc
Confidence 999999998765 457899999999999999999999998765433332221 110 0
Q ss_pred --cCC---CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 384 --RFP---ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 384 --~~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
..+ ..+.++.++.+||.+||+.||++||+ +.++++||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~e~l~hp~~~~~~ 299 (336)
T cd07849 252 KPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT----VEEALAHPYLEQYH 299 (336)
T ss_pred CCcccHHHHhcccCcHHHHHHHHHcCCChhhCcC----HHHHhcCccccccC
Confidence 000 01346788999999999999999999 99999999998653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=341.37 Aligned_cols=258 Identities=21% Similarity=0.347 Sum_probs=211.3
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEe----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELR----GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
+.+.+|++.+.||+|+||+||+|++. .++..||+|.+.... .......+.+|+++++.++||||+++++++..+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 34578999999999999999999863 456789999987532 234456778899999999999999999999999
Q ss_pred ceEEEEEeccCCCchHHHHHhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQP---------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD 231 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~ 231 (491)
...|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 99999999999999999885321 124789999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCC
Q 035713 232 EGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGAL 311 (491)
Q Consensus 232 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (491)
++.+||+|||+++........
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~----------------------------------------------------------- 180 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYY----------------------------------------------------------- 180 (283)
T ss_pred CCcEEeccccccccccCCcce-----------------------------------------------------------
Confidence 999999999998543211000
Q ss_pred CccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCC
Q 035713 312 PELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQ 390 (491)
Q Consensus 312 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 390 (491)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+.... ..+....
T Consensus 181 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 250 (283)
T cd05090 181 ---------RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ-LLPCSED 250 (283)
T ss_pred ---------ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cCCCCCC
Confidence 00112346778999999998889999999999999999998 999998876655444444332 3333446
Q ss_pred CCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 391 VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 391 ~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
++..+.+||.+||+.||++||+ +.+|+++
T Consensus 251 ~~~~~~~li~~cl~~~p~~Rp~----~~~i~~~ 279 (283)
T cd05090 251 CPPRMYSLMTECWQEGPSRRPR----FKDIHTR 279 (283)
T ss_pred CCHHHHHHHHHHcccCcccCcC----HHHHHHH
Confidence 8999999999999999999999 8888765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=342.20 Aligned_cols=257 Identities=29% Similarity=0.470 Sum_probs=211.7
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++.+.||+|+||.||+|.+..+++.||+|+++... ........+.+|+++++.++|+||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 36999999999999999999999999999999986543 22344567789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||++++.+..+.... ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-- 155 (288)
T cd07833 80 EYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-- 155 (288)
T ss_pred ecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--
Confidence 999887776655443 4589999999999999999999999999999999999999999999999999854321110
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
......+++..|+
T Consensus 156 -------------------------------------------------------------------~~~~~~~~~~~~~ 168 (288)
T cd07833 156 -------------------------------------------------------------------SPLTDYVATRWYR 168 (288)
T ss_pred -------------------------------------------------------------------ccccCcccccCCc
Confidence 0111246889999
Q ss_pred CcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC-------------------CCcCC-------
Q 035713 334 APEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ-------------------PLRFP------- 386 (491)
Q Consensus 334 aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~-------------------~~~~~------- 386 (491)
|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+... ...++
T Consensus 169 ~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
T cd07833 169 APELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPES 248 (288)
T ss_pred CCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHH
Confidence 99999988 7899999999999999999999999877665544332210 00000
Q ss_pred ----CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 387 ----ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 387 ----~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
....++.++++||++||..||++||+ ++++++||||
T Consensus 249 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~f 288 (288)
T cd07833 249 LERRYPGKVSSPALDFLKACLRMDPKERLT----CDELLQHPYF 288 (288)
T ss_pred HHHhcCCccchHHHHHHHHHhccCchhccc----HHHHhcCCCC
Confidence 01135888999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=344.92 Aligned_cols=257 Identities=27% Similarity=0.402 Sum_probs=210.4
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC--ceEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD--KFYC 170 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~--~~~~ 170 (491)
.++|++.+.||.|+||.||+|++..+++.||+|.++..... +.....+.+|+++++.++||||+++++++... +.+|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 46899999999999999999999999999999999755332 23334567899999999999999999999877 8999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9999996 59988887643 369999999999999999999999999999999999999999999999999985432110
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
. ......++.
T Consensus 161 ~----------------------------------------------------------------------~~~~~~~~~ 170 (293)
T cd07843 161 K----------------------------------------------------------------------PYTQLVVTL 170 (293)
T ss_pred c----------------------------------------------------------------------ccccccccc
Confidence 0 001125788
Q ss_pred CccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---C----------------Cc-----C
Q 035713 331 EYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---P----------------LR-----F 385 (491)
Q Consensus 331 ~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~----------------~~-----~ 385 (491)
.|+|||++.+.. ++.++|||||||++|+|++|+.||.+......+.++... + .. +
T Consensus 171 ~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (293)
T cd07843 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPY 250 (293)
T ss_pred cccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccc
Confidence 999999998754 588999999999999999999999887665554443210 0 00 0
Q ss_pred ----CCCCC--CCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 386 ----PETPQ--VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 386 ----~~~~~--~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
...+. +++.+.+||.+||+.||++||+ +.|++.||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t----~~ell~~~~f 293 (293)
T cd07843 251 NQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS----AEDALKHPYF 293 (293)
T ss_pred hhhhccccccCCChHHHHHHHHHhccCccccCC----HHHHhcCCCC
Confidence 00111 5888999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=344.29 Aligned_cols=260 Identities=20% Similarity=0.310 Sum_probs=216.2
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEe-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeee
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELR-----GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSY 162 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~ 162 (491)
..+..++|.+.+.||+|+||.||+|.+. .++..||+|++++.. .......+.+|+++++++ +|+||++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 3456678999999999999999999863 345689999987542 233455778999999999 79999999999
Q ss_pred EEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccc
Q 035713 163 FETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242 (491)
Q Consensus 163 ~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGl 242 (491)
+...+.+|+||||+.+|+|.++++......+++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999999998865445589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcc
Q 035713 243 SLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322 (491)
Q Consensus 243 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (491)
++........ ..
T Consensus 188 ~~~~~~~~~~--------------------------------------------------------------------~~ 199 (302)
T cd05055 188 ARDIMNDSNY--------------------------------------------------------------------VV 199 (302)
T ss_pred cccccCCCce--------------------------------------------------------------------ee
Confidence 8543211000 00
Q ss_pred ccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHh
Q 035713 323 SMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRG 401 (491)
Q Consensus 323 ~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 401 (491)
.....++..|+|||++.+..++.++|||||||++|||++ |..||.+......+.+.+......+.....+.++.+||.+
T Consensus 200 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 279 (302)
T cd05055 200 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKT 279 (302)
T ss_pred cCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 011246788999999999999999999999999999998 9999988777666666665554444445678999999999
Q ss_pred hhccCCCCCCCcCCChHHhhc
Q 035713 402 LLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 402 ~L~~dP~~R~t~~~~~~ell~ 422 (491)
||..+|++||+ +.++++
T Consensus 280 cl~~~p~~Rpt----~~ell~ 296 (302)
T cd05055 280 CWDADPLKRPT----FKQIVQ 296 (302)
T ss_pred HcCCCchhCcC----HHHHHH
Confidence 99999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=351.77 Aligned_cols=257 Identities=30% Similarity=0.453 Sum_probs=212.1
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc-----
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK----- 167 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~----- 167 (491)
.++|++++.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+++|+.++|+||+++++++..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 468999999999999999999999999999999986542 23334456778999999999999999999997653
Q ss_pred -eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 168 -FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 168 -~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
.+|+||||+ |++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 468999999 8899888764 45999999999999999999999999999999999999999999999999998532
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.. .....
T Consensus 169 ~~-------------------------------------------------------------------------~~~~~ 175 (343)
T cd07880 169 DS-------------------------------------------------------------------------EMTGY 175 (343)
T ss_pred cc-------------------------------------------------------------------------Ccccc
Confidence 11 00123
Q ss_pred ccccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcC--------------------
Q 035713 327 VGTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF-------------------- 385 (491)
Q Consensus 327 ~gt~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~-------------------- 385 (491)
.+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+....+..++......
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (343)
T cd07880 176 VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKL 255 (343)
T ss_pred ccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhc
Confidence 57889999999976 357899999999999999999999998776655444433211100
Q ss_pred C---------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCCh
Q 035713 386 P---------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNW 431 (491)
Q Consensus 386 ~---------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~ 431 (491)
+ ....++.++.+||.+||+.||.+||+ +.+++.||||+...-
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t----~~~~l~~~~~~~~~~ 306 (343)
T cd07880 256 PRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT----AAEALAHPYFEEFHD 306 (343)
T ss_pred cccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC----HHHHhcCccHhhhcC
Confidence 0 01357888999999999999999999 999999999986643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=340.08 Aligned_cols=251 Identities=27% Similarity=0.462 Sum_probs=202.9
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeC--ceEEEE
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETD--KFYCLV 172 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~--~~~~lV 172 (491)
|+++++||+|+||.||+|.+..+++.||+|++++.... .... ...+|+.+++++. |+||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-LEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC-chhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 78899999999999999999999999999998754222 1222 3346888888885 99999999999987 899999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+. ++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++. +.+||+|||++.......
T Consensus 79 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-- 153 (282)
T cd07831 79 FELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-- 153 (282)
T ss_pred EecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC--
Confidence 99996 57777776542 46999999999999999999999999999999999999999 999999999985432100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......++..|
T Consensus 154 ---------------------------------------------------------------------~~~~~~~~~~y 164 (282)
T cd07831 154 ---------------------------------------------------------------------PYTEYISTRWY 164 (282)
T ss_pred ---------------------------------------------------------------------CcCCCCCCccc
Confidence 00123578899
Q ss_pred cCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---C---------------CCcCCC------
Q 035713 333 LAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---Q---------------PLRFPE------ 387 (491)
Q Consensus 333 ~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~---------------~~~~~~------ 387 (491)
+|||++.. ..++.++|||||||++|||++|..||.+.+..+.+..+.. . ...++.
T Consensus 165 ~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (282)
T cd07831 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGL 244 (282)
T ss_pred CChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccH
Confidence 99998765 4468899999999999999999999988766554433321 1 111111
Q ss_pred ---CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 388 ---TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 388 ---~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
...++.++.+||.+||..||++||+ ++++++||||
T Consensus 245 ~~~~~~~~~~~~~li~~~l~~~P~~R~~----~~~~l~~~~~ 282 (282)
T cd07831 245 RKLLPNASAEGLDLLKKLLAYDPDERIT----AKQALRHPYF 282 (282)
T ss_pred HHHcccccHHHHHHHHHHhccCcccccC----HHHHhhCCCC
Confidence 1246889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=340.86 Aligned_cols=257 Identities=25% Similarity=0.455 Sum_probs=212.9
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC---CCCccceeeeEEeCceEEE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD---HPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~---hp~iv~l~~~~~~~~~~~l 171 (491)
.|++++.||+|+||.||+|.+..+++.||+|++.... .......+.+|+++++.++ ||||+++++++..+...|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4888999999999999999999999999999987542 2234456778999999996 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||++|++|.++++. +.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred EEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 9999999999998865 369999999999999999999999999999999999999999999999999985432110
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
.......|+..
T Consensus 156 ---------------------------------------------------------------------~~~~~~~~~~~ 166 (277)
T cd06917 156 ---------------------------------------------------------------------SKRSTFVGTPY 166 (277)
T ss_pred ---------------------------------------------------------------------cccccccCCcc
Confidence 00112368899
Q ss_pred ccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 332 YLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 332 y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.........+............++.++.+||.+||..||++|
T Consensus 167 y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 246 (277)
T cd06917 167 WMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKER 246 (277)
T ss_pred eeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccC
Confidence 9999998754 468999999999999999999999987655444433322211111112378899999999999999999
Q ss_pred CCcCCChHHhhcCCCcCCCC
Q 035713 411 IAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 411 ~t~~~~~~ell~hpff~~~~ 430 (491)
|+ +.+++.|+||+...
T Consensus 247 ~~----~~~il~~~~~~~~~ 262 (277)
T cd06917 247 LS----AEELLKSKWIKAHS 262 (277)
T ss_pred cC----HHHHhhChHhhccc
Confidence 99 99999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=334.65 Aligned_cols=251 Identities=22% Similarity=0.333 Sum_probs=208.9
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
..++|++++.||+|+||.||+++++. +..+|+|.+...... ...+.+|+++|+.++||||+++++++...+.+|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence 34679999999999999999998864 567999988654322 2356789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999999999887543 4589999999999999999999999999999999999999999999999998854321000
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
. ......++..
T Consensus 156 ~---------------------------------------------------------------------~~~~~~~~~~ 166 (256)
T cd05114 156 T---------------------------------------------------------------------SSSGAKFPVK 166 (256)
T ss_pred e---------------------------------------------------------------------ccCCCCCchh
Confidence 0 0001235678
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
|+|||++.+..++.++|||||||++|||++ |+.||...+..+.+..+..... .......+.++.+||.+||+.||++|
T Consensus 167 y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~li~~c~~~~p~~R 245 (256)
T cd05114 167 WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR-LYRPKLASMTVYEVMYSCWHEKPEGR 245 (256)
T ss_pred hCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-CCCCCCCCHHHHHHHHHHccCCcccC
Confidence 999999998889999999999999999999 9999998877777666665432 22233478899999999999999999
Q ss_pred CCcCCChHHhhc
Q 035713 411 IAYKRGATEIKQ 422 (491)
Q Consensus 411 ~t~~~~~~ell~ 422 (491)
|+ ++++++
T Consensus 246 ps----~~~l~~ 253 (256)
T cd05114 246 PT----FAELLR 253 (256)
T ss_pred cC----HHHHHH
Confidence 99 888875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=338.02 Aligned_cols=255 Identities=25% Similarity=0.370 Sum_probs=210.8
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++.+.||+|+||.||+|+++.+++.||||.+.+...........+.+|+++++.++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999999999999999987655445555667889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 174 EFCSGGNLHSLRQKQ--PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 174 E~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||+++++|.+++... ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 999999999988642 234689999999999999999999999999999999999999999999999998754321000
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
.....+|+..
T Consensus 162 ----------------------------------------------------------------------~~~~~~~~~~ 171 (267)
T cd08229 162 ----------------------------------------------------------------------AAHSLVGTPY 171 (267)
T ss_pred ----------------------------------------------------------------------ccccccCCcC
Confidence 0012368899
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcH--HHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR--ATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
|+|||++.+..++.++|||||||++|+|++|..||.+.... .....+............++..+.+||.+||..||++
T Consensus 172 ~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 251 (267)
T cd08229 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEK 251 (267)
T ss_pred ccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCccc
Confidence 99999999988999999999999999999999999765432 2222333222221122357889999999999999999
Q ss_pred CCCcCCChHHhhc
Q 035713 410 RIAYKRGATEIKQ 422 (491)
Q Consensus 410 R~t~~~~~~ell~ 422 (491)
||| +.+|++
T Consensus 252 Rpt----~~~i~~ 260 (267)
T cd08229 252 RPD----ITYVYD 260 (267)
T ss_pred CCC----HHHHHH
Confidence 999 776653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=339.32 Aligned_cols=255 Identities=27% Similarity=0.460 Sum_probs=215.3
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
+|...+.||+|++|.||++.+..+++.||+|++.... ......+.+|+.+++.++|+||+++++++...+..|+|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4666789999999999999999999999999886432 2334457789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|+.|++|.+++.. ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~---- 169 (285)
T cd06648 97 FLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV---- 169 (285)
T ss_pred ccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC----
Confidence 9999999998876 358999999999999999999999999999999999999999999999999874321100
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
.......|+..|+|
T Consensus 170 ------------------------------------------------------------------~~~~~~~~~~~y~a 183 (285)
T cd06648 170 ------------------------------------------------------------------PRRKSLVGTPYWMA 183 (285)
T ss_pred ------------------------------------------------------------------cccccccCCccccC
Confidence 00112368899999
Q ss_pred cchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCc-CCCCCCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 335 PEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR-FPETPQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 335 PE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
||++.+..++.++|||||||++|+|++|+.||...+....+..+...... ......++..+.+||.+||..||++||+
T Consensus 184 PE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt- 262 (285)
T cd06648 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT- 262 (285)
T ss_pred HHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcC-
Confidence 99999988999999999999999999999999887666655555544222 2222347889999999999999999999
Q ss_pred CCChHHhhcCCCcCCC
Q 035713 414 KRGATEIKQHPFFEGV 429 (491)
Q Consensus 414 ~~~~~ell~hpff~~~ 429 (491)
+.++++||||+..
T Consensus 263 ---~~~il~~~~~~~~ 275 (285)
T cd06648 263 ---AAELLNHPFLAKA 275 (285)
T ss_pred ---HHHHccCcccccC
Confidence 9999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=344.59 Aligned_cols=258 Identities=25% Similarity=0.428 Sum_probs=217.1
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
..+|++++.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 478999999999999999999999899999999986432 22345677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+++++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 95 ~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-- 169 (293)
T cd06647 95 MEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 169 (293)
T ss_pred EecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc--
Confidence 999999999998875 348999999999999999999999999999999999999999999999999874321100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.......|++.|
T Consensus 170 --------------------------------------------------------------------~~~~~~~~~~~y 181 (293)
T cd06647 170 --------------------------------------------------------------------SKRSTMVGTPYW 181 (293)
T ss_pred --------------------------------------------------------------------cccccccCChhh
Confidence 001123688999
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHH-cCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV-GQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
+|||.+.+..++.++|||||||++|+|++|+.||...+....+..+. .....+.....++..+++||.+||..+|++||
T Consensus 182 ~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 261 (293)
T cd06647 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRG 261 (293)
T ss_pred cCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCc
Confidence 99999998889999999999999999999999998776554443332 22223333345788999999999999999999
Q ss_pred CcCCChHHhhcCCCcCCCC
Q 035713 412 AYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 412 t~~~~~~ell~hpff~~~~ 430 (491)
+ +++++.|+||+..+
T Consensus 262 ~----~~~il~h~~~~~~~ 276 (293)
T cd06647 262 S----AKELLQHPFLKIAK 276 (293)
T ss_pred C----HHHHhcCHHHhcCc
Confidence 9 99999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=342.32 Aligned_cols=255 Identities=27% Similarity=0.395 Sum_probs=215.5
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
.|..+++||+|+||+||+|++..+++.||+|++.............+.+|+++++.++|+||+++++++.+....|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 47788899999999999999999999999999976544445556678889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|+. ++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 102 ~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------- 172 (313)
T cd06633 102 YCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------- 172 (313)
T ss_pred cCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-------
Confidence 995 5777776654 3469999999999999999999999999999999999999999999999999873210
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
......|+..|+|
T Consensus 173 -------------------------------------------------------------------~~~~~~~~~~y~a 185 (313)
T cd06633 173 -------------------------------------------------------------------PANSFVGTPYWMA 185 (313)
T ss_pred -------------------------------------------------------------------CCCCccccccccC
Confidence 0012368899999
Q ss_pred cchhc---CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 335 PEIIR---GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 335 PE~l~---~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
||++. ...++.++|||||||++|+|++|..||...+....+..+............++..+++||.+||+.+|.+||
T Consensus 186 PE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp 265 (313)
T cd06633 186 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERP 265 (313)
T ss_pred hhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCc
Confidence 99985 355788999999999999999999999887766666665544333222345778899999999999999999
Q ss_pred CcCCChHHhhcCCCcCCC
Q 035713 412 AYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 412 t~~~~~~ell~hpff~~~ 429 (491)
+ +.++++||||+..
T Consensus 266 ~----~~~~l~~~~~~~~ 279 (313)
T cd06633 266 A----SAELLRHDFVRRD 279 (313)
T ss_pred C----HHHHhcCcccCCC
Confidence 9 9999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=337.94 Aligned_cols=258 Identities=21% Similarity=0.279 Sum_probs=211.8
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCC-----cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTN-----TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE 164 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 164 (491)
++..++|++.+.||+|+||.||+|.++..+ ..||+|.+.... .......+.+|+++|+.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 355689999999999999999999987543 789999986542 2233456778999999999999999999999
Q ss_pred eCceEEEEEeccCCCchHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEE
Q 035713 165 TDKFYCLVMEFCSGGNLHSLRQKQP--------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIM 236 (491)
Q Consensus 165 ~~~~~~lV~E~~~gg~L~~~~~~~~--------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vk 236 (491)
.....|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 9999999999999999999986532 22478889999999999999999999999999999999999999999
Q ss_pred EeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCcccc
Q 035713 237 LSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMA 316 (491)
Q Consensus 237 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (491)
|+|||+++........
T Consensus 160 l~dfg~~~~~~~~~~~---------------------------------------------------------------- 175 (277)
T cd05032 160 IGDFGMTRDIYETDYY---------------------------------------------------------------- 175 (277)
T ss_pred ECCcccchhhccCccc----------------------------------------------------------------
Confidence 9999998543211000
Q ss_pred CCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHH
Q 035713 317 EPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVA 395 (491)
Q Consensus 317 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~ 395 (491)
.......+|..|+|||.+.+..++.++|||||||++|||++ |..||.+.+.......+... ...+....++..+
T Consensus 176 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 250 (277)
T cd05032 176 ----RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG-GHLDLPENCPDKL 250 (277)
T ss_pred ----ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC-CCCCCCCCCCHHH
Confidence 00112256789999999998889999999999999999998 99999887766655555432 2223334578999
Q ss_pred HHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 396 RDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 396 ~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
.+||.+||+.+|++||+ +.+|++
T Consensus 251 ~~li~~~l~~~p~~Rpt----~~~l~~ 273 (277)
T cd05032 251 LELMRMCWQYNPKMRPT----FLEIVS 273 (277)
T ss_pred HHHHHHHcCCChhhCCC----HHHHHH
Confidence 99999999999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=345.09 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=214.6
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
..|.....||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++..++..|+||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 346666789999999999999999999999999865432 23345678999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 98 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--- 171 (297)
T cd06659 98 EFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--- 171 (297)
T ss_pred ecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc---
Confidence 99999999987765 358999999999999999999999999999999999999999999999999874321100
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
......+|+..|+
T Consensus 172 -------------------------------------------------------------------~~~~~~~~~~~y~ 184 (297)
T cd06659 172 -------------------------------------------------------------------PKRKSLVGTPYWM 184 (297)
T ss_pred -------------------------------------------------------------------ccccceecCcccc
Confidence 0011246899999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCc-CCCCCCCCHHHHHHHHhhhccCCCCCCC
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR-FPETPQVSFVARDLIRGLLVKEPHKRIA 412 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t 412 (491)
|||++.+..++.++|||||||++|||++|+.||...+....+..+...... ......++..+.+||.+||+.+|.+||+
T Consensus 185 aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps 264 (297)
T cd06659 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERAT 264 (297)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcC
Confidence 999999988999999999999999999999999877666655554433221 2223457889999999999999999999
Q ss_pred cCCChHHhhcCCCcCC
Q 035713 413 YKRGATEIKQHPFFEG 428 (491)
Q Consensus 413 ~~~~~~ell~hpff~~ 428 (491)
++++++||||..
T Consensus 265 ----~~~ll~~~~~~~ 276 (297)
T cd06659 265 ----AQELLDHPFLLQ 276 (297)
T ss_pred ----HHHHhhChhhcc
Confidence 999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=338.38 Aligned_cols=246 Identities=29% Similarity=0.492 Sum_probs=201.4
Q ss_pred CCceEeeee--eccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceEE
Q 035713 94 SNFRLLKRL--GYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 94 ~~y~~~~~i--G~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~~ 170 (491)
++|++.+.+ |+|+||.||+++++.++..+|+|++.+..... .|+.+...+ +|+||++++++|...+.+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 467777776 99999999999999999999999987643221 122222222 6999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC-cEEEeecccccccCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG-HIMLSDFDLSLRCSVS 249 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g-~vkL~DFGla~~~~~~ 249 (491)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 999999999999998875 3699999999999999999999999999999999999999988 999999998743210
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.....|+
T Consensus 163 -------------------------------------------------------------------------~~~~~~~ 169 (267)
T PHA03390 163 -------------------------------------------------------------------------PSCYDGT 169 (267)
T ss_pred -------------------------------------------------------------------------CccCCCC
Confidence 0012578
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHH----HHHHHHcCCCcCCCCCCCCHHHHHHHHhhhcc
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRA----TLFNVVGQPLRFPETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~ 405 (491)
..|+|||++.+..++.++|||||||++|+|++|+.||....... .+........ +....++..+.+||.+||+.
T Consensus 170 ~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~ 247 (267)
T PHA03390 170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL--PFIKNVSKNANDFVQSMLKY 247 (267)
T ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccC--CcccccCHHHHHHHHHHhcc
Confidence 89999999999899999999999999999999999998654332 1222222222 22235899999999999999
Q ss_pred CCCCCCCcCCChHHhhcCCCcCC
Q 035713 406 EPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~hpff~~ 428 (491)
||.+|++. ++++|+||||+.
T Consensus 248 ~p~~R~~~---~~~~l~h~~~~~ 267 (267)
T PHA03390 248 NINYRLTN---YNEIIKHPFLKI 267 (267)
T ss_pred ChhhCCch---HHHHhcCCcccC
Confidence 99999961 599999999963
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=338.57 Aligned_cols=259 Identities=30% Similarity=0.454 Sum_probs=211.2
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe--CceEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET--DKFYCL 171 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~--~~~~~l 171 (491)
++|+++++||.|++|.||+|.+..+++.||+|++..... .....++.+|+++++.++||||++++++|.. .+.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 469999999999999999999999999999999875422 2445667889999999999999999999864 457899
Q ss_pred EEeccCCCchHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 172 VMEFCSGGNLHSLRQK--QPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
||||++|++|.+++.. .....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999987653 22356899999999999999999999999999999999999999999999999997432100
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
. .....++
T Consensus 159 ~------------------------------------------------------------------------~~~~~~~ 166 (287)
T cd06621 159 L------------------------------------------------------------------------AGTFTGT 166 (287)
T ss_pred c------------------------------------------------------------------------cccccCC
Confidence 0 0013577
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCC-----cHHHHHHHHcCC-CcCCCC----CCCCHHHHHHH
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQG-----NRATLFNVVGQP-LRFPET----PQVSFVARDLI 399 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----~~~~~~~i~~~~-~~~~~~----~~~s~~~~~li 399 (491)
..|+|||.+.+..++.++|||||||++|+|++|+.||.... ..+....+.... ..++.. ..+++.+.+||
T Consensus 167 ~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 246 (287)
T cd06621 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFI 246 (287)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHH
Confidence 88999999999999999999999999999999999998652 122233333211 111111 23567899999
Q ss_pred HhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 400 RGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 400 ~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
.+||..||.+||+ +.|++.||||+...
T Consensus 247 ~~~l~~~p~~Rpt----~~eil~~~~~~~~~ 273 (287)
T cd06621 247 KQCLEKDPTRRPT----PWDMLEHPWIKAQM 273 (287)
T ss_pred HHHcCCCcccCCC----HHHHHhCccccccc
Confidence 9999999999999 99999999997543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=340.58 Aligned_cols=255 Identities=27% Similarity=0.449 Sum_probs=209.3
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
+|+++++||.|++|.||+|++..+|+.||||++..... ......+.+|+++++.++|+||+++++++.+.+.+|||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999876432 2233456689999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 175 FCSGGNLHSLRQKQP-NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
|+.+ +|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-- 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--
Confidence 9974 8888776542 24589999999999999999999999999999999999999999999999999853311000
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
......+|..|+
T Consensus 156 --------------------------------------------------------------------~~~~~~~~~~y~ 167 (284)
T cd07836 156 --------------------------------------------------------------------TFSNEVVTLWYR 167 (284)
T ss_pred --------------------------------------------------------------------cccccccccccc
Confidence 001125788999
Q ss_pred CcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---C---------------CcCCC-------
Q 035713 334 APEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---P---------------LRFPE------- 387 (491)
Q Consensus 334 aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~---------------~~~~~------- 387 (491)
+||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+.++... + ..++.
T Consensus 168 ~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (284)
T cd07836 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQ 247 (284)
T ss_pred ChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHH
Confidence 99998765 4688999999999999999999999987766555443321 0 00010
Q ss_pred --CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 388 --TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 388 --~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
.+.++.+++++|.+||+.||.+||+ +.++++||||
T Consensus 248 ~~~~~~~~~~~~~i~~~l~~~p~~R~~----~~~~l~~~~f 284 (284)
T cd07836 248 QLFPHADPLGIDLLHRLLQLNPELRIS----AHDALQHPWF 284 (284)
T ss_pred HHhhhcCcHHHHHHHHHhcCCcccCCC----HHHHhcCCCC
Confidence 0245788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=351.11 Aligned_cols=263 Identities=23% Similarity=0.349 Sum_probs=208.1
Q ss_pred eeeecc--CceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccC
Q 035713 100 KRLGYG--DIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCS 177 (491)
Q Consensus 100 ~~iG~G--~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~ 177 (491)
..||+| +||+||+|++..+|+.||+|++...... ....+.+.+|+.+++.++||||++++++|..++.+|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 9999999999999999999998754322 3445678899999999999999999999999999999999999
Q ss_pred CCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccccc
Q 035713 178 GGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSS 257 (491)
Q Consensus 178 gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 257 (491)
+++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~---- 158 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA---- 158 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc----
Confidence 9999999887655569999999999999999999999999999999999999999999999998653211000000
Q ss_pred ccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcch
Q 035713 258 VSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEI 337 (491)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 337 (491)
.. .........++..|+|||+
T Consensus 159 -----------~~------------------------------------------------~~~~~~~~~~~~~y~aPE~ 179 (328)
T cd08226 159 -----------KV------------------------------------------------VYDFPQFSTSVLPWLSPEL 179 (328)
T ss_pred -----------cc------------------------------------------------cccccccccCccCccChhh
Confidence 00 0000001235677999999
Q ss_pred hcCC--CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCc-------------------------------
Q 035713 338 IRGE--GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR------------------------------- 384 (491)
Q Consensus 338 l~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~------------------------------- 384 (491)
+.+. .++.++|||||||++|+|++|+.||.+......+..++.....
T Consensus 180 ~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (328)
T cd08226 180 LRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVV 259 (328)
T ss_pred hcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchh
Confidence 9874 4789999999999999999999999877655554444332111
Q ss_pred --------------CCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 385 --------------FPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 385 --------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
.+....++..+.+||.+||+.||++||| ++++|+||||..+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----a~e~l~~~~~~~~~ 315 (328)
T cd08226 260 AAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS----ASSLLSHAFFKQVK 315 (328)
T ss_pred ccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCC----HHHHhhCHHHHHHH
Confidence 1111235678999999999999999999 99999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=343.78 Aligned_cols=255 Identities=27% Similarity=0.391 Sum_probs=217.2
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
..|..++.||+|+||.||+|++..++..||+|++.+...........+.+|+++++.++|+|++++++++..+...|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 44899999999999999999999999999999987654444455667889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+. |+|.+++... ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 105 EYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred eCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 9996 5777766543 35599999999999999999999999999999999999999999999999998742110
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.....|+..|+
T Consensus 178 ---------------------------------------------------------------------~~~~~~~~~y~ 188 (317)
T cd06635 178 ---------------------------------------------------------------------ANSFVGTPYWM 188 (317)
T ss_pred ---------------------------------------------------------------------cccccCCcccc
Confidence 01236888999
Q ss_pred Ccchhc---CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 334 APEIIR---GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 334 aPE~l~---~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
|||++. ...++.++|||||||++|||++|+.||........+..+............++..+++||.+||+.+|.+|
T Consensus 189 aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 268 (317)
T cd06635 189 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDR 268 (317)
T ss_pred ChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccC
Confidence 999984 34578899999999999999999999988776666666665544433344688899999999999999999
Q ss_pred CCcCCChHHhhcCCCcCC
Q 035713 411 IAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 411 ~t~~~~~~ell~hpff~~ 428 (491)
|+ +.++++|+|+..
T Consensus 269 pt----~~~il~~~~~~~ 282 (317)
T cd06635 269 PT----SEELLKHMFVLR 282 (317)
T ss_pred cC----HHHHHhChhhhc
Confidence 99 999999999953
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=338.44 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=215.6
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
-|+++++||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 48899999999999999999999999999999865432 2345677899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|+.+++|..++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~---- 155 (277)
T cd06641 83 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---- 155 (277)
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch----
Confidence 9999999998865 358999999999999999999999999999999999999999999999999875432100
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
.......|+..|+|
T Consensus 156 ------------------------------------------------------------------~~~~~~~~~~~y~~ 169 (277)
T cd06641 156 ------------------------------------------------------------------IKRNTFVGTPFWMA 169 (277)
T ss_pred ------------------------------------------------------------------hhhccccCCccccC
Confidence 00112367889999
Q ss_pred cchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcC
Q 035713 335 PEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK 414 (491)
Q Consensus 335 PE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ 414 (491)
||.+.+..++.++|+|||||++|+|++|..||...........+...... .....++.++.++|.+||+.+|.+||+
T Consensus 170 PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~-- 246 (277)
T cd06641 170 PEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP-TLEGNYSKPLKEFVEACLNKEPSFRPT-- 246 (277)
T ss_pred hhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC-CCCcccCHHHHHHHHHHccCChhhCcC--
Confidence 99999888899999999999999999999999876655555544333221 122357889999999999999999999
Q ss_pred CChHHhhcCCCcCCC
Q 035713 415 RGATEIKQHPFFEGV 429 (491)
Q Consensus 415 ~~~~ell~hpff~~~ 429 (491)
+.++++||||...
T Consensus 247 --~~~~l~~~~~~~~ 259 (277)
T cd06641 247 --AKELLKHKFIVRF 259 (277)
T ss_pred --HHHHHhCHHHhhh
Confidence 9999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=345.74 Aligned_cols=260 Identities=25% Similarity=0.372 Sum_probs=205.3
Q ss_pred CceEeeeeeccCceEEEEEEEeC--CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC--ceEE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRG--TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD--KFYC 170 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~--~~~~ 170 (491)
+|+++++||+|+||.||+|.+.. +++.||||++.............+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48999999999999999999988 8999999999874322333445567899999999999999999999988 8899
Q ss_pred EEEeccCCCchHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc----CCcEEEeecccc
Q 035713 171 LVMEFCSGGNLHSLRQKQP---NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD----EGHIMLSDFDLS 243 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~----~g~vkL~DFGla 243 (491)
+||||++ ++|..++.... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999996 46766654321 236899999999999999999999999999999999999999 999999999998
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (491)
..+...... ....
T Consensus 160 ~~~~~~~~~-------------------------------------------------------------------~~~~ 172 (316)
T cd07842 160 RLFNAPLKP-------------------------------------------------------------------LADL 172 (316)
T ss_pred cccCCCccc-------------------------------------------------------------------cccc
Confidence 643211100 0011
Q ss_pred cccccccCccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHH---------HHHHHH---c----------
Q 035713 324 MSFVGTHEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRA---------TLFNVV---G---------- 380 (491)
Q Consensus 324 ~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---------~~~~i~---~---------- 380 (491)
...++|..|+|||++.+. .++.++|||||||++|+|++|++||.+..... .+..++ .
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 252 (316)
T cd07842 173 DPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDI 252 (316)
T ss_pred CCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHH
Confidence 124689999999998775 47899999999999999999999998654322 111111 0
Q ss_pred -------------CCCcCCC---------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 381 -------------QPLRFPE---------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 381 -------------~~~~~~~---------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
....++. ....+.++.++|.+||+.||++||+ +.++++||||
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps----~~eil~~~~f 316 (316)
T cd07842 253 KKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT----AEEALEHPYF 316 (316)
T ss_pred hhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcC----HHHHhcCCCC
Confidence 0001110 0146678999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=334.15 Aligned_cols=256 Identities=28% Similarity=0.422 Sum_probs=207.5
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
+..+.+.....||+|+||.||+|++..++..||+|.+.... ......+.+|+++++.++|+||+++++++..++..|
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34455666679999999999999999999999999886543 234456788999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCC--CHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc-CCcEEEeecccccccC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYF--TEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD-EGHIMLSDFDLSLRCS 247 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l--~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~-~g~vkL~DFGla~~~~ 247 (491)
+||||+++++|.+++.... ..+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 9999999999999887642 234 88899999999999999999999999999999999986 6799999999874321
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
... .......
T Consensus 161 ~~~----------------------------------------------------------------------~~~~~~~ 170 (268)
T cd06624 161 GIN----------------------------------------------------------------------PCTETFT 170 (268)
T ss_pred cCC----------------------------------------------------------------------CccccCC
Confidence 100 0001125
Q ss_pred cccCccCcchhcCCC--CCCcccccchhhHHHhhhcCCCCCCCCCcHHH-HHHH--HcCCCcCCCCCCCCHHHHHHHHhh
Q 035713 328 GTHEYLAPEIIRGEG--HGSAVDWWTFGIFLYELLHGTTPFKGQGNRAT-LFNV--VGQPLRFPETPQVSFVARDLIRGL 402 (491)
Q Consensus 328 gt~~y~aPE~l~~~~--~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-~~~i--~~~~~~~~~~~~~s~~~~~li~~~ 402 (491)
|+..|+|||++.+.. ++.++|||||||++|+|++|+.||........ ...+ ......++ ..+++++.+||.+|
T Consensus 171 ~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~ 248 (268)
T cd06624 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIP--ESLSAEAKNFILRC 248 (268)
T ss_pred CCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCC--cccCHHHHHHHHHH
Confidence 788999999997654 78899999999999999999999976543222 1111 12222223 35889999999999
Q ss_pred hccCCCCCCCcCCChHHhhcCCCc
Q 035713 403 LVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 403 L~~dP~~R~t~~~~~~ell~hpff 426 (491)
|..+|.+||+ +.+++.||||
T Consensus 249 l~~~p~~Rpt----~~~ll~~~~~ 268 (268)
T cd06624 249 FEPDPDKRAS----AHDLLQDPFL 268 (268)
T ss_pred cCCCchhCCC----HHHHHhCCCC
Confidence 9999999999 9999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=343.11 Aligned_cols=261 Identities=29% Similarity=0.415 Sum_probs=205.0
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc-----
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK----- 167 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~----- 167 (491)
.++|+++++||+|+||.||+|++..+++.||||++..... .......+.+|+++++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4789999999999999999999999999999999865422 2222334567999999999999999999886543
Q ss_pred ---eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 168 ---FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 168 ---~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
..|+||||+. ++|..++... ...+++.+++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 4699999995 5888777654 2469999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
......... .....
T Consensus 168 ~~~~~~~~~------------------------------------------------------------------~~~~~ 181 (310)
T cd07865 168 AFSLSKNSK------------------------------------------------------------------PNRYT 181 (310)
T ss_pred cccCCcccC------------------------------------------------------------------CCCcc
Confidence 432110000 00011
Q ss_pred ccccccCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc--CCC-----------------c
Q 035713 325 SFVGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG--QPL-----------------R 384 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~--~~~-----------------~ 384 (491)
...++..|+|||++.+.. ++.++|||||||++|||++|+.||.+.+....+..+.. +.. .
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (310)
T cd07865 182 NRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKME 261 (310)
T ss_pred CcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhcc
Confidence 236789999999987754 68899999999999999999999987765443322211 100 0
Q ss_pred CCCC-----------CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 385 FPET-----------PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 385 ~~~~-----------~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
++.. ...+..+.+||.+||..||.+||+ ++++++||||
T Consensus 262 ~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t----~~e~l~h~~f 310 (310)
T cd07865 262 LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID----ADTALNHDFF 310 (310)
T ss_pred CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccC----HHHHhcCCCC
Confidence 1100 113567889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=336.80 Aligned_cols=252 Identities=22% Similarity=0.321 Sum_probs=214.2
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
...+|+++++||.|+||.||+|++.. ++.+|+|++..... .....+.+|+++++.++|+||+++++++......|+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 44689999999999999999999987 88999999876532 223456789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999999876566799999999999999999999999999999999999999999999999999854321000
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
......++..
T Consensus 160 ----------------------------------------------------------------------~~~~~~~~~~ 169 (261)
T cd05148 160 ----------------------------------------------------------------------LSSDKKIPYK 169 (261)
T ss_pred ----------------------------------------------------------------------cccCCCCceE
Confidence 0001235678
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+.+..+.. ....+....++..+.++|.+||+.||.+|
T Consensus 170 ~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 248 (261)
T cd05148 170 WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA-GYRMPCPAKCPQEIYKIMLECWAAEPEDR 248 (261)
T ss_pred ecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh-CCcCCCCCCCCHHHHHHHHHHcCCCchhC
Confidence 999999998889999999999999999998 8999988776666666553 34444455789999999999999999999
Q ss_pred CCcCCChHHhhc
Q 035713 411 IAYKRGATEIKQ 422 (491)
Q Consensus 411 ~t~~~~~~ell~ 422 (491)
|+ +.+|++
T Consensus 249 pt----~~~l~~ 256 (261)
T cd05148 249 PS----FKALRE 256 (261)
T ss_pred cC----HHHHHH
Confidence 99 777764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=340.19 Aligned_cols=255 Identities=28% Similarity=0.433 Sum_probs=210.3
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEec
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEF 175 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~ 175 (491)
|++++.||.|++|.||+|.++.+|..||+|++..... .......+.+|+++++.++|+||+++++++.+++..|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6789999999999999999999999999999875432 223334567899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccc
Q 035713 176 CSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKS 255 (491)
Q Consensus 176 ~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 255 (491)
+ +++|.+++.......+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++........
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---- 154 (283)
T cd07835 80 L-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR---- 154 (283)
T ss_pred c-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc----
Confidence 9 56899988876545699999999999999999999999999999999999999999999999999854311000
Q ss_pred ccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCc
Q 035713 256 SSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAP 335 (491)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 335 (491)
......++..|+||
T Consensus 155 ------------------------------------------------------------------~~~~~~~~~~~~aP 168 (283)
T cd07835 155 ------------------------------------------------------------------TYTHEVVTLWYRAP 168 (283)
T ss_pred ------------------------------------------------------------------ccCccccccCCCCC
Confidence 00012568899999
Q ss_pred chhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCC------------------cCC---------C
Q 035713 336 EIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL------------------RFP---------E 387 (491)
Q Consensus 336 E~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~------------------~~~---------~ 387 (491)
|++.+. .++.++|||||||++|+|++|++||.+.+....+.++..... .++ .
T Consensus 169 E~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (283)
T cd07835 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKV 248 (283)
T ss_pred ceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhh
Confidence 988765 468899999999999999999999988776555444332100 000 1
Q ss_pred CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 388 TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 388 ~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
...++.++.+||.+||+.||.+||+ +++++.||||
T Consensus 249 ~~~~~~~~~~li~~~l~~~P~~Rpt----~~~il~~~~~ 283 (283)
T cd07835 249 VPNLDEDGLDLLSKMLVYDPAKRIS----AKAALQHPYF 283 (283)
T ss_pred cCCCCHHHHHHHHHHhcCChhhCcC----HHHHhcCCCC
Confidence 2457789999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=333.73 Aligned_cols=255 Identities=25% Similarity=0.323 Sum_probs=211.9
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCC---CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGT---NTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
.++|++.+.||+|+||+||+|+++.+ ...||||++.... .......+.+|+.+++.++|+||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 46899999999999999999998754 4579999986543 233445678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+++++|.+++.... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 81 MIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999987653 46999999999999999999999999999999999999999999999999998654210
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.... ......++
T Consensus 160 ~~~~--------------------------------------------------------------------~~~~~~~~ 171 (266)
T cd05033 160 EATY--------------------------------------------------------------------TTKGGKIP 171 (266)
T ss_pred ccce--------------------------------------------------------------------eccCCCCC
Confidence 0000 00011356
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 408 (491)
..|+|||.+.+..++.++|||||||++|+|++ |..||...........+... ...+....++..+.+|+.+||+.||+
T Consensus 172 ~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~ 250 (266)
T cd05033 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-YRLPPPMDCPSALYQLMLDCWQKDRN 250 (266)
T ss_pred ccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCCcc
Confidence 78999999999889999999999999999998 99999877666555555433 33344456899999999999999999
Q ss_pred CCCCcCCChHHhhcC
Q 035713 409 KRIAYKRGATEIKQH 423 (491)
Q Consensus 409 ~R~t~~~~~~ell~h 423 (491)
+||+ +.+|+++
T Consensus 251 ~Rp~----~~ei~~~ 261 (266)
T cd05033 251 ERPT----FSQIVST 261 (266)
T ss_pred cCcC----HHHHHHH
Confidence 9999 8888764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=349.50 Aligned_cols=263 Identities=27% Similarity=0.417 Sum_probs=211.2
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe----CceE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET----DKFY 169 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~----~~~~ 169 (491)
++|++.+.||+|+||.||+|.++.+|+.||+|++.... ........+.+|+.+|+.++||||++++++|.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF-DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc-ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 68999999999999999999999999999999987543 222345567789999999999999999998863 3578
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 99999994 6898888654 45999999999999999999999999999999999999999999999999998543211
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
... ........+|+
T Consensus 161 ~~~------------------------------------------------------------------~~~~~~~~~~~ 174 (334)
T cd07855 161 PTE------------------------------------------------------------------HKYFMTEYVAT 174 (334)
T ss_pred CcC------------------------------------------------------------------CCccccccccc
Confidence 000 00011134789
Q ss_pred cCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CC-----------------------
Q 035713 330 HEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QP----------------------- 382 (491)
Q Consensus 330 ~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~----------------------- 382 (491)
..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+.. .+
T Consensus 175 ~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (334)
T cd07855 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRK 254 (334)
T ss_pred ccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccC
Confidence 99999999876 4578999999999999999999999987765443322211 00
Q ss_pred CcCC---CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 383 LRFP---ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 383 ~~~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
...+ ..+.++.++.+||++||+.||++||+ +++++.||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~l~~~~~~~~~ 301 (334)
T cd07855 255 QPVPWSKIFPKASPEALDLLSQMLQFDPEERIT----VEQALQHPFLAQYH 301 (334)
T ss_pred CCCCHHHHcccCCHHHHHHHHHHccCChhhCcC----HHHHHhChhhhhcc
Confidence 0000 01346889999999999999999999 99999999998554
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=332.40 Aligned_cols=253 Identities=24% Similarity=0.311 Sum_probs=211.2
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
+..++|++.+.||+|+||.||+|.+.. ++.||+|.++..... ...+.+|+++++.++|+||+++++++...+.+|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 456789999999999999999999764 568999998754322 345678999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
+||||+.+++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999999999887655569999999999999999999999999999999999999999999999999986542100
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
.. ......++.
T Consensus 158 ~~---------------------------------------------------------------------~~~~~~~~~ 168 (261)
T cd05068 158 YE---------------------------------------------------------------------AREGAKFPI 168 (261)
T ss_pred cc---------------------------------------------------------------------ccCCCcCce
Confidence 00 000012346
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
.|+|||++.+..++.++|||||||++|||++ |+.||.+......+..+... ...+....++..+.+||.+||..||.+
T Consensus 169 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~ 247 (261)
T cd05068 169 KWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMPCPPGCPKELYDIMLDCWKEDPDD 247 (261)
T ss_pred eccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHHHhhcCccc
Confidence 8999999999889999999999999999999 99999987766666555433 333444568899999999999999999
Q ss_pred CCCcCCChHHhhc
Q 035713 410 RIAYKRGATEIKQ 422 (491)
Q Consensus 410 R~t~~~~~~ell~ 422 (491)
||+ +.+|++
T Consensus 248 Rp~----~~~l~~ 256 (261)
T cd05068 248 RPT----FETLQW 256 (261)
T ss_pred CCC----HHHHHH
Confidence 999 777764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=386.85 Aligned_cols=258 Identities=29% Similarity=0.493 Sum_probs=219.9
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
+++-..+||.|.||.||-|.+..+|+..|+|.|+..... ......+.+|..+|..|+|||+|++|++-.+.+.++|.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 577778999999999999999999999999988755433 4555667889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
||+||+|.++++.. +-.+|...+.|..|++.||.|||++|||||||||+|||++.+|.+|++|||.|..+...-...
T Consensus 1315 yC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~- 1391 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM- 1391 (1509)
T ss_pred HhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC-
Confidence 99999999999874 568899999999999999999999999999999999999999999999999997654221000
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
+ ..-..++||+.|||
T Consensus 1392 -------------------------------------------------~----------------~el~~~~GT~~YMA 1406 (1509)
T KOG4645|consen 1392 -------------------------------------------------P----------------GELQSMMGTPMYMA 1406 (1509)
T ss_pred -------------------------------------------------C----------------HHHHhhcCCchhcC
Confidence 0 01124689999999
Q ss_pred cchhcCCC---CCCcccccchhhHHHhhhcCCCCCCCCCcH-HHHHHHH-cCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 335 PEIIRGEG---HGSAVDWWTFGIFLYELLHGTTPFKGQGNR-ATLFNVV-GQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 335 PE~l~~~~---~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
||++.+.. ..-+.|||||||++.||+||+.||...++. ..++.+- +..+++|.. ++.+.+|||..||..||++
T Consensus 1407 PEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~--ls~~g~dFle~Cl~~dP~~ 1484 (1509)
T KOG4645|consen 1407 PEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER--LSSEGRDFLEHCLEQDPKM 1484 (1509)
T ss_pred chhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh--hhHhHHHHHHHHHhcCchh
Confidence 99998754 577999999999999999999999765544 4444443 344566665 9999999999999999999
Q ss_pred CCCcCCChHHhhcCCCcC
Q 035713 410 RIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 410 R~t~~~~~~ell~hpff~ 427 (491)
|++ +.|||.|.|-+
T Consensus 1485 Rw~----~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1485 RWT----ASQLLEHAFGK 1498 (1509)
T ss_pred hhH----HHHHHHhhccc
Confidence 999 99999999875
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=338.39 Aligned_cols=259 Identities=21% Similarity=0.339 Sum_probs=212.3
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCC-----CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGT-----NTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYF 163 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~ 163 (491)
.+..++|++.+.||+|+||.||++.+... ...+|+|++.... .......+.+|+++++.+ +|+||+++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 45668899999999999999999998744 3789999987542 223445678899999999 799999999999
Q ss_pred EeCceEEEEEeccCCCchHHHHHhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEE
Q 035713 164 ETDKFYCLVMEFCSGGNLHSLRQKQ--------------PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLV 229 (491)
Q Consensus 164 ~~~~~~~lV~E~~~gg~L~~~~~~~--------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl 229 (491)
..++.+|+||||+++|+|..+++.. ....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 9999999999999999999998652 23568999999999999999999999999999999999999
Q ss_pred ccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCC
Q 035713 230 RDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGG 309 (491)
Q Consensus 230 ~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (491)
+.++.+||+|||+++.........
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~-------------------------------------------------------- 189 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYR-------------------------------------------------------- 189 (293)
T ss_pred cCCCeEEeCcccccccccccccee--------------------------------------------------------
Confidence 999999999999986432110000
Q ss_pred CCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCC
Q 035713 310 ALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPET 388 (491)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 388 (491)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ........
T Consensus 190 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 256 (293)
T cd05053 190 ------------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK-EGYRMEKP 256 (293)
T ss_pred ------------ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCC
Confidence 0001134678999999999889999999999999999998 999998776555444443 33333444
Q ss_pred CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 389 PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 389 ~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
..++.++.+||.+||..||++||+ +.+++++
T Consensus 257 ~~~~~~~~~li~~~l~~~p~~Rps----~~eil~~ 287 (293)
T cd05053 257 QNCTQELYHLMRDCWHEVPSQRPT----FKQLVED 287 (293)
T ss_pred CCCCHHHHHHHHHHcccCcccCcC----HHHHHHH
Confidence 468899999999999999999999 8888865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=336.62 Aligned_cols=258 Identities=21% Similarity=0.304 Sum_probs=210.6
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET 165 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 165 (491)
+..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 345789999999999999999999987 77889999886432 22333457789999999999999999999999
Q ss_pred CceEEEEEeccCCCchHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC---cEEE
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPN-----KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG---HIML 237 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g---~vkL 237 (491)
.+..|+||||++|++|.+++..... ..+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 8899999999999999999876532 2589999999999999999999999999999999999998765 5999
Q ss_pred eecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccC
Q 035713 238 SDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAE 317 (491)
Q Consensus 238 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (491)
+|||+++.+......
T Consensus 161 ~dfg~~~~~~~~~~~----------------------------------------------------------------- 175 (277)
T cd05036 161 ADFGMARDIYRASYY----------------------------------------------------------------- 175 (277)
T ss_pred ccCccccccCCccce-----------------------------------------------------------------
Confidence 999998643210000
Q ss_pred CCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHH
Q 035713 318 PTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVAR 396 (491)
Q Consensus 318 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~ 396 (491)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+.......+... ........++..+.
T Consensus 176 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 251 (277)
T cd05036 176 ---RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GRLDPPKGCPGPVY 251 (277)
T ss_pred ---ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHH
Confidence 00001134568999999999889999999999999999997 99999987766655444432 22233345889999
Q ss_pred HHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 397 DLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 397 ~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
+||.+||+.||++||+ +.++++|
T Consensus 252 ~~i~~cl~~~p~~Rps----~~~vl~~ 274 (277)
T cd05036 252 RIMTDCWQHTPEDRPN----FATILER 274 (277)
T ss_pred HHHHHHcCCCcccCcC----HHHHHHH
Confidence 9999999999999999 9999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=337.89 Aligned_cols=255 Identities=23% Similarity=0.332 Sum_probs=210.8
Q ss_pred cCCCceEeeeeeccCceEEEEEEEe-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELR-----GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
...+|.+.+.||+|+||.||++.+. .++..||+|.+.... ......+.+|+++|+.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 3468999999999999999999863 345679999886542 33455678899999999999999999999999
Q ss_pred ceEEEEEeccCCCchHHHHHhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcE
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQP-----------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHI 235 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~-----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~v 235 (491)
+.+|+||||+++++|.+++.... ...+++..+..++.||+.||+|||++|++||||||+|||++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999987542 1348999999999999999999999999999999999999999999
Q ss_pred EEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccc
Q 035713 236 MLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELM 315 (491)
Q Consensus 236 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (491)
||+|||++.........
T Consensus 160 kl~dfg~~~~~~~~~~~--------------------------------------------------------------- 176 (288)
T cd05093 160 KIGDFGMSRDVYSTDYY--------------------------------------------------------------- 176 (288)
T ss_pred EeccCCccccccCCcee---------------------------------------------------------------
Confidence 99999998543211000
Q ss_pred cCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHH
Q 035713 316 AEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFV 394 (491)
Q Consensus 316 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 394 (491)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||........+..+...... +....++.+
T Consensus 177 -----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~~ 250 (288)
T cd05093 177 -----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL-QRPRTCPKE 250 (288)
T ss_pred -----ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC-CCCCCCCHH
Confidence 00011246788999999999889999999999999999998 99999888777766666655432 222358899
Q ss_pred HHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 395 ARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 395 ~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
+.+||.+||+.||.+||+ +.++++
T Consensus 251 l~~li~~~l~~~p~~Rpt----~~~v~~ 274 (288)
T cd05093 251 VYDLMLGCWQREPHMRLN----IKEIHS 274 (288)
T ss_pred HHHHHHHHccCChhhCCC----HHHHHH
Confidence 999999999999999999 777754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=328.76 Aligned_cols=256 Identities=32% Similarity=0.544 Sum_probs=219.5
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
+|++.+.||+|+||.||++.+..+++.||+|++..... .......+.+|+++++.++|+|++++++.+..+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58999999999999999999999999999999876533 23445567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 175 FCSGGNLHSLRQKQP--NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|+++++|.+++.... +..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 999999999887653 3669999999999999999999999999999999999999999999999999885432100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......+|++.|
T Consensus 158 --------------------------------------------------------------------~~~~~~~~~~~y 169 (258)
T cd08215 158 --------------------------------------------------------------------DLAKTVVGTPYY 169 (258)
T ss_pred --------------------------------------------------------------------ceecceeeeecc
Confidence 011123688999
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCC
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIA 412 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 412 (491)
+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+...... +....++..+.++|.+||..+|++||+
T Consensus 170 ~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 248 (258)
T cd08215 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP-PIPSQYSSELRNLVSSLLQKDPEERPS 248 (258)
T ss_pred cChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 9999999988999999999999999999999999887766555555544322 222368899999999999999999999
Q ss_pred cCCChHHhhcCCCc
Q 035713 413 YKRGATEIKQHPFF 426 (491)
Q Consensus 413 ~~~~~~ell~hpff 426 (491)
+.++|+||||
T Consensus 249 ----~~~ll~~~~~ 258 (258)
T cd08215 249 ----IAQILQSPFI 258 (258)
T ss_pred ----HHHHhcCCCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=349.27 Aligned_cols=256 Identities=29% Similarity=0.463 Sum_probs=208.5
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC------c
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD------K 167 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~------~ 167 (491)
.+|.+.+.||+|+||.||+|++..+|+.||||++.+.. ........+.+|+++++.++|+||+++++++... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 68999999999999999999999999999999987642 2233345677899999999999999999998754 3
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+|+||||+. .+|..++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 5699999995 57766542 359999999999999999999999999999999999999999999999999974321
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
. ......
T Consensus 169 ~-------------------------------------------------------------------------~~~~~~ 175 (342)
T cd07879 169 A-------------------------------------------------------------------------EMTGYV 175 (342)
T ss_pred C-------------------------------------------------------------------------CCCCce
Confidence 0 001236
Q ss_pred cccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC-----------------------C
Q 035713 328 GTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP-----------------------L 383 (491)
Q Consensus 328 gt~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~-----------------------~ 383 (491)
||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..++... .
T Consensus 176 ~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (342)
T cd07879 176 VTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLP 255 (342)
T ss_pred eeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcC
Confidence 7899999999877 457899999999999999999999999876554444332210 0
Q ss_pred cCCC------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 384 RFPE------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 384 ~~~~------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
..+. .+.++.++.+||.+||+.||++||+ +++++.||||+.+.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~----~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 256 KYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT----ATEALEHPYFDSFRDA 306 (342)
T ss_pred CcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcC----HHHHhcCcchhhcccc
Confidence 0110 1246788999999999999999999 9999999999987653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=348.19 Aligned_cols=259 Identities=27% Similarity=0.411 Sum_probs=209.3
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC-----ce
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD-----KF 168 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~-----~~ 168 (491)
.+|++++.||+|+||+||+|++..+++.||||.+.... ........+.+|+.+++.++|+||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 57999999999999999999999999999999987542 2223345667899999999999999999988644 35
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
+|+||||+ +++|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 89999999 57898888764 5699999999999999999999999999999999999999999999999999854311
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
.. .......|
T Consensus 161 ~~----------------------------------------------------------------------~~~~~~~~ 170 (337)
T cd07858 161 KG----------------------------------------------------------------------DFMTEYVV 170 (337)
T ss_pred Cc----------------------------------------------------------------------cccccccc
Confidence 00 00112367
Q ss_pred ccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHH---cCC--------------------Cc
Q 035713 329 THEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV---GQP--------------------LR 384 (491)
Q Consensus 329 t~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~---~~~--------------------~~ 384 (491)
+..|+|||++.. ..++.++|||||||++|+|++|+.||.+.+....+..+. +.+ ..
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (337)
T cd07858 171 TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPY 250 (337)
T ss_pred ccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCc
Confidence 899999999875 458899999999999999999999998765432222111 000 00
Q ss_pred C------CCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 385 F------PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 385 ~------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
. ...+.++.++.+||.+||+.||++||+ ++++++||||+.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps----~~ell~h~~~~~~~ 298 (337)
T cd07858 251 TPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT----VEEALAHPYLASLH 298 (337)
T ss_pred ccccCHHHHcccCCHHHHHHHHHHhcCChhhccC----HHHHHcCcchhhhc
Confidence 0 012357889999999999999999999 99999999998764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=332.95 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=207.7
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
+..++|++.++||+|+||.||+|++..++ .||+|++.+.... ...+.+|+++++.++|+||+++++.+.. ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 44578999999999999999999987654 5999998754321 2356789999999999999999998754 5678
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
+||||+.+++|.+++.......+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999999987545568999999999999999999999999999999999999999999999999985432110
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
.. ......++.
T Consensus 157 ~~---------------------------------------------------------------------~~~~~~~~~ 167 (262)
T cd05071 157 YT---------------------------------------------------------------------ARQGAKFPI 167 (262)
T ss_pred cc---------------------------------------------------------------------cccCCcccc
Confidence 00 000124677
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
.|+|||++.+..++.++|||||||++|+|++ |..||.+......+..+... ...+....++..+.+||.+||+.||++
T Consensus 168 ~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~ 246 (262)
T cd05071 168 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCWRKEPEE 246 (262)
T ss_pred eecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC-CCCCCccccCHHHHHHHHHHccCCccc
Confidence 8999999998889999999999999999999 89999887766666555433 233334568899999999999999999
Q ss_pred CCCcCCChHHhhc
Q 035713 410 RIAYKRGATEIKQ 422 (491)
Q Consensus 410 R~t~~~~~~ell~ 422 (491)
||+ +.++++
T Consensus 247 Rp~----~~~~~~ 255 (262)
T cd05071 247 RPT----FEYLQA 255 (262)
T ss_pred CCC----HHHHHH
Confidence 999 777654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=336.01 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=208.6
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc---CCCCccceeeeEEeCce----
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL---DHPFLPTLYSYFETDKF---- 168 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l---~hp~iv~l~~~~~~~~~---- 168 (491)
|++++.||+|+||.||+|+++.+++.||+|++..... .......+.+|+.+++.+ +|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7899999999999999999998899999999975432 222334456788777766 59999999999987776
Q ss_pred -EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 169 -YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 169 -~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
+|++|||+. ++|.+++.......+++..++.++.||+.||.|||+.|++|+||+|+|||++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999996 589888877544569999999999999999999999999999999999999999999999999885432
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
... ......
T Consensus 159 ~~~-----------------------------------------------------------------------~~~~~~ 167 (287)
T cd07838 159 FEM-----------------------------------------------------------------------ALTSVV 167 (287)
T ss_pred CCc-----------------------------------------------------------------------cccccc
Confidence 110 001125
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC-----CcCC-----------C----
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP-----LRFP-----------E---- 387 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~-----~~~~-----------~---- 387 (491)
++..|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+.++...- ..++ .
T Consensus 168 ~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (287)
T cd07838 168 VTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPR 247 (287)
T ss_pred ccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhccccccc
Confidence 7889999999999999999999999999999999999999888776666554310 0000 0
Q ss_pred -----CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 388 -----TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 388 -----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
.+.++..+.+||.+||+.||.+||+ +.++++||||
T Consensus 248 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~----~~~il~~~~~ 287 (287)
T cd07838 248 SFKSFVPEICEEGLDLLKKMLTFNPHKRIS----AFEALQHPYF 287 (287)
T ss_pred chhhhhhhhhHHHHHHHHHHhccCCccCCC----HHHHhcCcCC
Confidence 0235678899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=331.66 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=210.5
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++.+.||+|+||.||+|.+..+|+.||+|.++............+.+|+++++.++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999999999999999987654444555677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 174 EFCSGGNLHSLRQKQ--PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 174 E~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||+++++|..++... ....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 999999999988643 234589999999999999999999999999999999999999999999999998754321000
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
......|+..
T Consensus 162 ----------------------------------------------------------------------~~~~~~~~~~ 171 (267)
T cd08224 162 ----------------------------------------------------------------------AAHSLVGTPY 171 (267)
T ss_pred ----------------------------------------------------------------------ccceecCCcc
Confidence 0012368889
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcH--HHHHHHHcCCCc-CCCCCCCCHHHHHHHHhhhccCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR--ATLFNVVGQPLR-FPETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~i~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~ 408 (491)
|+|||.+.+..++.++|||||||++|+|++|+.||...... .....+...... .+ ...++..+.++|.+||..+|+
T Consensus 172 y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~cl~~~p~ 250 (267)
T cd08224 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP-ADHYSEELRDLVSRCINPDPE 250 (267)
T ss_pred ccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCC-hhhcCHHHHHHHHHHcCCCcc
Confidence 99999999988999999999999999999999999654321 222222222221 12 125788999999999999999
Q ss_pred CCCCcCCChHHhhc
Q 035713 409 KRIAYKRGATEIKQ 422 (491)
Q Consensus 409 ~R~t~~~~~~ell~ 422 (491)
+||+ +.+|++
T Consensus 251 ~Rp~----~~~il~ 260 (267)
T cd08224 251 KRPD----ISYVLQ 260 (267)
T ss_pred cCCC----HHHHHH
Confidence 9999 887764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=339.14 Aligned_cols=258 Identities=21% Similarity=0.314 Sum_probs=212.3
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCC-----CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGT-----NTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET 165 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 165 (491)
+...+|+++++||+|+||.||+|++..+ ++.||||+++... .......+.+|+.++..++||||+++++++..
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 3456799999999999999999998643 5789999987542 22344567889999999999999999999999
Q ss_pred CceEEEEEeccCCCchHHHHHhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQ--------------PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD 231 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~--------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~ 231 (491)
....++++||+.+++|..++... ....+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 99999999999999999987532 1234888999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCC
Q 035713 232 EGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGAL 311 (491)
Q Consensus 232 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (491)
++.+||+|||+++.......
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~------------------------------------------------------------ 179 (283)
T cd05091 160 KLNVKISDLGLFREVYAADY------------------------------------------------------------ 179 (283)
T ss_pred CCceEecccccccccccchh------------------------------------------------------------
Confidence 99999999999854321000
Q ss_pred CccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCC
Q 035713 312 PELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQ 390 (491)
Q Consensus 312 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 390 (491)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+...... +....
T Consensus 180 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~ 250 (283)
T cd05091 180 --------YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL-PCPDD 250 (283)
T ss_pred --------eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-CCCCC
Confidence 000112246789999999998889999999999999999998 89999888777666666555432 22346
Q ss_pred CCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 391 VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 391 ~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
++..+.+||.+||+.+|.+||+ +.+|++.
T Consensus 251 ~~~~~~~li~~cl~~~p~~RP~----~~~i~~~ 279 (283)
T cd05091 251 CPAWVYTLMLECWNEFPSRRPR----FKDIHSR 279 (283)
T ss_pred CCHHHHHHHHHHhCCCcccCCC----HHHHHHH
Confidence 8999999999999999999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=365.52 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=220.8
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeee
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSY 162 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 162 (491)
..++...+.+..+.||+|+||+||+|+... ....||||.++.. .+....+.|++|+++|..++|||||+|+|+
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 345677889999999999999999999643 3467999999765 344467789999999999999999999999
Q ss_pred EEeCceEEEEEeccCCCchHHHHHhCC--------C----CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEc
Q 035713 163 FETDKFYCLVMEFCSGGNLHSLRQKQP--------N----KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVR 230 (491)
Q Consensus 163 ~~~~~~~~lV~E~~~gg~L~~~~~~~~--------~----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~ 230 (491)
+..++-+|+|+|||..|||.+++.... + ..|+..+...|+.||+.||+||-++.+|||||...|+||.
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG 637 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec
Confidence 999999999999999999999987542 1 2288899999999999999999999999999999999999
Q ss_pred cCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCC
Q 035713 231 DEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGA 310 (491)
Q Consensus 231 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (491)
++-.|||+||||++..-... -|+. .|
T Consensus 638 e~l~VKIsDfGLsRdiYssD-----------------------YYk~-----------------------------~~-- 663 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSD-----------------------YYKV-----------------------------RG-- 663 (774)
T ss_pred cceEEEecccccchhhhhhh-----------------------hhcc-----------------------------cC--
Confidence 99999999999997542111 0110 00
Q ss_pred CCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCC
Q 035713 311 LPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETP 389 (491)
Q Consensus 311 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 389 (491)
...-...||+||.+...+|+.+|||||+||+|||+++ |+.||.+.++++.+..|..+.+ ++...
T Consensus 664 --------------~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~~Pe 728 (774)
T KOG1026|consen 664 --------------NTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LSCPE 728 (774)
T ss_pred --------------CceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-ccCCC
Confidence 1134578999999999999999999999999999999 9999999999999999988887 77777
Q ss_pred CCCHHHHHHHHhhhccCCCCCCCc
Q 035713 390 QVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 390 ~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
.+|.++.+|+..||+.+|.+||++
T Consensus 729 ~CP~~vY~LM~~CW~~~P~~RPsF 752 (774)
T KOG1026|consen 729 NCPTEVYSLMLECWNENPKRRPSF 752 (774)
T ss_pred CCCHHHHHHHHHHhhcCcccCCCH
Confidence 899999999999999999999993
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=329.65 Aligned_cols=250 Identities=48% Similarity=0.848 Sum_probs=216.0
Q ss_pred eeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccCCCch
Q 035713 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNL 181 (491)
Q Consensus 102 iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~gg~L 181 (491)
||.|+||.||++.+..+++.||+|++.+...........+.+|+++++.++|+||+++++.+..+..+|+||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999989999999999887666556777888999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccccccccc
Q 035713 182 HSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVN 261 (491)
Q Consensus 182 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 261 (491)
.+++... ..+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----------- 147 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----------- 147 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-----------
Confidence 9998875 459999999999999999999999999999999999999999999999999875432100
Q ss_pred CCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCC
Q 035713 262 NGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGE 341 (491)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 341 (491)
.......++..|++||.+.+.
T Consensus 148 -----------------------------------------------------------~~~~~~~~~~~~~~Pe~~~~~ 168 (250)
T cd05123 148 -----------------------------------------------------------SRTNTFCGTPEYLAPEVLLGK 168 (250)
T ss_pred -----------------------------------------------------------CcccCCcCCccccChHHhCCC
Confidence 001123688899999999988
Q ss_pred CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhh
Q 035713 342 GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIK 421 (491)
Q Consensus 342 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell 421 (491)
.++.++|+|||||++|+|++|..||...+.......+......++. .++..+.+||++||..||++||+.+. +++++
T Consensus 169 ~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~~i~~~l~~~p~~R~~~~~-~~~l~ 245 (250)
T cd05123 169 GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE--FLSPEARDLISGLLQKDPTKRLGSGG-AEEIK 245 (250)
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHhcCCHhhCCCccc-HHHHH
Confidence 8899999999999999999999999877665556666655444444 47899999999999999999999211 29999
Q ss_pred cCCCc
Q 035713 422 QHPFF 426 (491)
Q Consensus 422 ~hpff 426 (491)
+||||
T Consensus 246 ~~~~f 250 (250)
T cd05123 246 AHPFF 250 (250)
T ss_pred hCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=336.80 Aligned_cols=262 Identities=28% Similarity=0.449 Sum_probs=222.6
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
..+.|++.+.||+|+||.||+|.+..++..||+|++..... ....+.+|+++++.++|+||+++++++......|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 34679999999999999999999998999999999975432 44567789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||++|++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 999999999999998753 369999999999999999999999999999999999999999999999999874321100
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
.......++..
T Consensus 171 ---------------------------------------------------------------------~~~~~~~~~~~ 181 (286)
T cd06614 171 ---------------------------------------------------------------------SKRNSVVGTPY 181 (286)
T ss_pred ---------------------------------------------------------------------hhhccccCCcc
Confidence 00012357889
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCC-cCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL-RFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+..... .......++.++.+||.+||+.+|.+|
T Consensus 182 y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 261 (286)
T cd06614 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKR 261 (286)
T ss_pred cCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhC
Confidence 9999999988899999999999999999999999987766655555543332 223333488999999999999999999
Q ss_pred CCcCCChHHhhcCCCcCCCChh
Q 035713 411 IAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 411 ~t~~~~~~ell~hpff~~~~~~ 432 (491)
|+ +.+++.|+||....|.
T Consensus 262 pt----~~~il~~~~~~~~~~~ 279 (286)
T cd06614 262 PS----AEELLQHPFLKKACPK 279 (286)
T ss_pred cC----HHHHhhChHhhccCch
Confidence 99 9999999999987664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=353.13 Aligned_cols=262 Identities=19% Similarity=0.277 Sum_probs=214.7
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEe-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceee
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELR-----GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYS 161 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~ 161 (491)
.+.+..++|.+.++||+|+||.||+|+++ .+++.||||+++... .......+.+|+++|..+. ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 34566678999999999999999999964 345689999997542 2233456788999999997 999999999
Q ss_pred eEEeCceEEEEEeccCCCchHHHHHhCCC---------------------------------------------------
Q 035713 162 YFETDKFYCLVMEFCSGGNLHSLRQKQPN--------------------------------------------------- 190 (491)
Q Consensus 162 ~~~~~~~~~lV~E~~~gg~L~~~~~~~~~--------------------------------------------------- 190 (491)
++...+.+|+||||+.+|+|.++++....
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 99999999999999999999999875321
Q ss_pred ---------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCC
Q 035713 191 ---------------------------------------------KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPE 225 (491)
Q Consensus 191 ---------------------------------------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~ 225 (491)
..+++..+..|+.||+.||.|||+.||+||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 23677888999999999999999999999999999
Q ss_pred CEEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCC
Q 035713 226 NVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGP 305 (491)
Q Consensus 226 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (491)
|||++.++.+||+|||+++........
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~----------------------------------------------------- 295 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNY----------------------------------------------------- 295 (401)
T ss_pred eEEEeCCCEEEEEecCcceeccccccc-----------------------------------------------------
Confidence 999999999999999998543211000
Q ss_pred CCCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCc
Q 035713 306 CVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLR 384 (491)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~ 384 (491)
....+.+++..|+|||++.+..++.++|||||||++|||++ |..||......+.+...+.....
T Consensus 296 ---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~ 360 (401)
T cd05107 296 ---------------ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR 360 (401)
T ss_pred ---------------ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCC
Confidence 00112357889999999999889999999999999999998 89999877666666665555444
Q ss_pred CCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 385 FPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 385 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
.+....++.++.+||.+||..+|.+||+ +++|++.
T Consensus 361 ~~~p~~~~~~l~~li~~cl~~~P~~RPs----~~ell~~ 395 (401)
T cd05107 361 MAKPAHASDEIYEIMQKCWEEKFEIRPD----FSQLVHL 395 (401)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 4444568999999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=330.27 Aligned_cols=247 Identities=23% Similarity=0.319 Sum_probs=202.3
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccCCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGG 179 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~gg 179 (491)
+.||+|+||.||+|+++.+++.||+|.+.... .......+.+|+++|+.++||||+++++++.....+|+||||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46899999999999999999999999876432 2344556889999999999999999999999999999999999999
Q ss_pred chHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccccccc
Q 035713 180 NLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVS 259 (491)
Q Consensus 180 ~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 259 (491)
+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 79 ~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~------ 151 (252)
T cd05084 79 DFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS------ 151 (252)
T ss_pred cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc------
Confidence 999998754 3458999999999999999999999999999999999999999999999999975321100000
Q ss_pred ccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhc
Q 035713 260 VNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIR 339 (491)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 339 (491)
......++..|+|||.+.
T Consensus 152 --------------------------------------------------------------~~~~~~~~~~y~aPE~~~ 169 (252)
T cd05084 152 --------------------------------------------------------------TGGMKQIPVKWTAPEALN 169 (252)
T ss_pred --------------------------------------------------------------cCCCCCCceeecCchhhc
Confidence 000012346799999999
Q ss_pred CCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChH
Q 035713 340 GEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGAT 418 (491)
Q Consensus 340 ~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ 418 (491)
+..++.++|||||||++|||++ |..||...........+.. ....+....++..+.+||.+||+.||++||+ +.
T Consensus 170 ~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~ 244 (252)
T cd05084 170 YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-GVRLPCPELCPDAVYRLMERCWEYDPGQRPS----FS 244 (252)
T ss_pred CCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCCCCCcccCCHHHHHHHHHHcCCChhhCcC----HH
Confidence 9889999999999999999998 9999987665544444433 2233333457899999999999999999999 88
Q ss_pred Hhhc
Q 035713 419 EIKQ 422 (491)
Q Consensus 419 ell~ 422 (491)
++++
T Consensus 245 ~~~~ 248 (252)
T cd05084 245 TVHQ 248 (252)
T ss_pred HHHH
Confidence 8764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=346.52 Aligned_cols=258 Identities=24% Similarity=0.357 Sum_probs=206.4
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC-------
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD------- 166 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~------- 166 (491)
.+|++++.||.|+||.||+|++..+++.||+|++..... .....+.+|+++|+.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 689999999999999999999999999999999865432 3445677899999999999999999876543
Q ss_pred -------ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc-CCcEEEe
Q 035713 167 -------KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD-EGHIMLS 238 (491)
Q Consensus 167 -------~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~-~g~vkL~ 238 (491)
..+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 36899999996 688887764 35999999999999999999999999999999999999974 5678999
Q ss_pred ecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCC
Q 035713 239 DFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEP 318 (491)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (491)
|||++..........
T Consensus 158 dfg~~~~~~~~~~~~----------------------------------------------------------------- 172 (342)
T cd07854 158 DFGLARIVDPHYSHK----------------------------------------------------------------- 172 (342)
T ss_pred CcccceecCCccccc-----------------------------------------------------------------
Confidence 999985432100000
Q ss_pred CCccccccccccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC---------------
Q 035713 319 TNVRSMSFVGTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP--------------- 382 (491)
Q Consensus 319 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~--------------- 382 (491)
......+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......++...
T Consensus 173 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (342)
T cd07854 173 --GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVI 250 (342)
T ss_pred --cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhh
Confidence 00011257889999998765 457889999999999999999999998776655544433211
Q ss_pred ----------CcCC---CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 383 ----------LRFP---ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 383 ----------~~~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
...+ ....++.++.+||.+||+.||.+||+ ++++++||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~ell~h~~~~~~ 306 (342)
T cd07854 251 PSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT----AEEALMHPYMSCY 306 (342)
T ss_pred hhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC----HHHHhCCCccccc
Confidence 0000 01247789999999999999999999 9999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=331.47 Aligned_cols=251 Identities=23% Similarity=0.309 Sum_probs=208.8
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.++|++++.||+|+||+||+|++.. +..||+|.+...... ...+.+|+++++.++||||+++++++.....+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4679999999999999999998764 456999998754332 24567899999999999999999999988899999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+.+++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+|||++.++.+||+|||+++........
T Consensus 78 ~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 78 TEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999999999987643 36899999999999999999999999999999999999999999999999987543211000
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......++..|
T Consensus 157 ---------------------------------------------------------------------~~~~~~~~~~y 167 (256)
T cd05113 157 ---------------------------------------------------------------------SSVGSKFPVRW 167 (256)
T ss_pred ---------------------------------------------------------------------ecCCCccChhh
Confidence 00011356789
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
+|||++.+..++.++|||||||++|+|++ |+.||...........+..... .+.....+..+.++|.+||..||++||
T Consensus 168 ~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp 246 (256)
T cd05113 168 SPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR-LYRPHLASEKVYAIMYSCWHEKAEERP 246 (256)
T ss_pred CCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCCcccCC
Confidence 99999998889999999999999999998 9999987776666666654432 223345789999999999999999999
Q ss_pred CcCCChHHhhcC
Q 035713 412 AYKRGATEIKQH 423 (491)
Q Consensus 412 t~~~~~~ell~h 423 (491)
+ +.+|+.+
T Consensus 247 ~----~~~ll~~ 254 (256)
T cd05113 247 T----FQQLLSS 254 (256)
T ss_pred C----HHHHHHh
Confidence 9 8998864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=353.25 Aligned_cols=244 Identities=32% Similarity=0.487 Sum_probs=206.5
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~~ 170 (491)
..+.|.+...||.|+|+.|..|.+..+++.+++|++.+... ...+|+.++... +||||+++++.+.++.+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence 35789999999999999999999999999999999977621 123577666555 6999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEE-ccCCcEEEeecccccccCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLV-RDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl-~~~g~vkL~DFGla~~~~~~ 249 (491)
+|||++.|+.|.+.+... ..+. ..+..|++||+.|+.|||++|||||||||+|||+ +..|+++|+|||.++....+
T Consensus 393 ~v~e~l~g~ell~ri~~~--~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSK--PEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eeehhccccHHHHHHHhc--chhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999999998776654 2233 7888999999999999999999999999999999 58999999999998543211
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
..+.|-|
T Consensus 470 -------------------------------------------------------------------------~~tp~~t 476 (612)
T KOG0603|consen 470 -------------------------------------------------------------------------CDTPALT 476 (612)
T ss_pred -------------------------------------------------------------------------hcccchh
Confidence 1123678
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHH-HHHcCCCcCCCCCCCCHHHHHHHHhhhccCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~-~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 408 (491)
..|.|||++....|+.++||||||++||+||+|+.||........+. ++....+. ..+|+++++||.+||+.||.
T Consensus 477 ~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s----~~vS~~AKdLl~~LL~~dP~ 552 (612)
T KOG0603|consen 477 LQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS----ECVSDEAKDLLQQLLQVDPA 552 (612)
T ss_pred hcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc----cccCHHHHHHHHHhccCChh
Confidence 99999999999999999999999999999999999998776663333 33322222 56999999999999999999
Q ss_pred CCCCcCCChHHhhcCCCc
Q 035713 409 KRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 409 ~R~t~~~~~~ell~hpff 426 (491)
+|++ +++++.||||
T Consensus 553 ~Rl~----~~~i~~h~w~ 566 (612)
T KOG0603|consen 553 LRLG----ADEIGAHPWF 566 (612)
T ss_pred hCcC----hhhhccCcch
Confidence 9999 9999999999
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=333.92 Aligned_cols=255 Identities=20% Similarity=0.299 Sum_probs=207.9
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCc----EEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNT----YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
+...+|+++++||+|+||+||+|++..+++ .||+|+++... .......+.+|+.+++.++|+||+++++++...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 345789999999999999999999887776 48999986542 233445678899999999999999999998754
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
..+++|||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 467999999999999998764 346999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
....... .....
T Consensus 160 ~~~~~~~--------------------------------------------------------------------~~~~~ 171 (279)
T cd05109 160 DIDETEY--------------------------------------------------------------------HADGG 171 (279)
T ss_pred cccccee--------------------------------------------------------------------ecCCC
Confidence 2111000 00011
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhcc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~ 405 (491)
.++..|+|||.+.+..++.++|||||||++|||++ |..||......... ..+......+....++.++.++|.+||..
T Consensus 172 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 250 (279)
T cd05109 172 KVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-DLLEKGERLPQPPICTIDVYMIMVKCWMI 250 (279)
T ss_pred ccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcCCCCccCCHHHHHHHHHHcCC
Confidence 35678999999999899999999999999999998 99999876554433 34434334444456899999999999999
Q ss_pred CCCCCCCcCCChHHhhc
Q 035713 406 EPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~ 422 (491)
||++||+ +.+++.
T Consensus 251 dp~~Rp~----~~~l~~ 263 (279)
T cd05109 251 DSECRPR----FRELVD 263 (279)
T ss_pred ChhhCcC----HHHHHH
Confidence 9999999 888884
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=331.68 Aligned_cols=252 Identities=24% Similarity=0.350 Sum_probs=208.1
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
+..++|+++++||+|+||.||+|.+. ++..||+|.+...... ...+.+|+.+++.++|+||+++++++. ....|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 45578999999999999999999877 5567999998764332 235778999999999999999999885 45688
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
+||||+.+++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999999999887555669999999999999999999999999999999999999999999999999985432100
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
.. ......++.
T Consensus 157 ~~---------------------------------------------------------------------~~~~~~~~~ 167 (260)
T cd05070 157 YT---------------------------------------------------------------------ARQGAKFPI 167 (260)
T ss_pred cc---------------------------------------------------------------------cccCCCCCc
Confidence 00 000123567
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+... ...+.....+..+.+||.+||..||++
T Consensus 168 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~ 246 (260)
T cd05070 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMPCPQDCPISLHELMLQCWKKDPEE 246 (260)
T ss_pred cccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHHHcccCccc
Confidence 8999999998889999999999999999999 99999887766666555433 333444568899999999999999999
Q ss_pred CCCcCCChHHhhc
Q 035713 410 RIAYKRGATEIKQ 422 (491)
Q Consensus 410 R~t~~~~~~ell~ 422 (491)
||+ +++++.
T Consensus 247 Rpt----~~~l~~ 255 (260)
T cd05070 247 RPT----FEYLQS 255 (260)
T ss_pred CcC----HHHHHH
Confidence 999 777653
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=332.10 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=211.0
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCc---EEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCce
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNT---YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKF 168 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~ 168 (491)
..++|++.+.||+|+||.||+|+++.++. .+|+|.++.... ......+.+|+.+++.++||||+++++++..++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 34689999999999999999999875543 799999865432 2345577889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
+|+||||+++++|.+++.... ..+++.++..++.||+.||.|||++|++||||||+|||++.++.++|+|||++..+..
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999999987653 4689999999999999999999999999999999999999999999999999854321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
..... .......+
T Consensus 159 ~~~~~-------------------------------------------------------------------~~~~~~~~ 171 (267)
T cd05066 159 DPEAA-------------------------------------------------------------------YTTRGGKI 171 (267)
T ss_pred cccee-------------------------------------------------------------------eecCCCcc
Confidence 11000 00001134
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCC
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP 407 (491)
+..|+|||++.+..++.++|+|||||++|||++ |..||.+....+....+... ...+....++..+.+|+.+||+.+|
T Consensus 172 ~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p 250 (267)
T cd05066 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPMDCPAALHQLMLDCWQKDR 250 (267)
T ss_pred ceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCCCCCCCCHHHHHHHHHHcccCc
Confidence 568999999998889999999999999999886 99999877666555555433 4455556688999999999999999
Q ss_pred CCCCCcCCChHHhhc
Q 035713 408 HKRIAYKRGATEIKQ 422 (491)
Q Consensus 408 ~~R~t~~~~~~ell~ 422 (491)
.+||+ +.++++
T Consensus 251 ~~Rp~----~~~i~~ 261 (267)
T cd05066 251 NERPK----FEQIVS 261 (267)
T ss_pred hhCCC----HHHHHH
Confidence 99999 777764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=337.05 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=210.0
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCC----------------cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCC
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTN----------------TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~----------------~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~ 155 (491)
..++|+++++||+|+||.||+|++...+ ..||+|++..... ......+.+|+++|+.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 3578999999999999999999876543 5689999876532 244567789999999999999
Q ss_pred ccceeeeEEeCceEEEEEeccCCCchHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCC
Q 035713 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQP---------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPEN 226 (491)
Q Consensus 156 iv~l~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~---------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~N 226 (491)
|+++++++..++.+++||||+.+++|..++.... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999987643 1258999999999999999999999999999999999
Q ss_pred EEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCC
Q 035713 227 VLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPC 306 (491)
Q Consensus 227 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (491)
||++.++.++|+|||+++.......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~------------------------------------------------------- 185 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDY------------------------------------------------------- 185 (296)
T ss_pred eeecCCCceEEccccceeecccCcc-------------------------------------------------------
Confidence 9999999999999999854321100
Q ss_pred CCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc--CCCCCCCCCcHHHHHHHHcC---
Q 035713 307 VGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH--GTTPFKGQGNRATLFNVVGQ--- 381 (491)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt--g~~Pf~~~~~~~~~~~i~~~--- 381 (491)
........++..|+|||++.+..++.++|||||||++|||++ |..||...+....+..+...
T Consensus 186 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~ 252 (296)
T cd05051 186 -------------YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRD 252 (296)
T ss_pred -------------eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccc
Confidence 000112356789999999998889999999999999999998 78899876666555444321
Q ss_pred ---CCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 382 ---PLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 382 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
....+....++.++.+||.+||+.||.+||+ +.+|++
T Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt----~~el~~ 292 (296)
T cd05051 253 DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPT----FREIHL 292 (296)
T ss_pred ccccccCCCccCCCHHHHHHHHHHhccChhcCCC----HHHHHH
Confidence 2223333457899999999999999999999 888865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=346.60 Aligned_cols=261 Identities=27% Similarity=0.375 Sum_probs=215.1
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc-----eE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK-----FY 169 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~-----~~ 169 (491)
+|++.+.||.|+||.||+|++..+++.||||++.+.. ........+.+|+++++.++|+||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5899999999999999999999999999999987642 22344566788999999999999999999998765 89
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 80 YIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99999996 5888888764 47999999999999999999999999999999999999999999999999998543211
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
... ........+|
T Consensus 157 ~~~-------------------------------------------------------------------~~~~~~~~~~ 169 (330)
T cd07834 157 EDE-------------------------------------------------------------------KGFLTEYVVT 169 (330)
T ss_pred ccc-------------------------------------------------------------------cccccccccc
Confidence 100 0001123688
Q ss_pred cCccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCC----------------------
Q 035713 330 HEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP---------------------- 386 (491)
Q Consensus 330 ~~y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---------------------- 386 (491)
..|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.......+
T Consensus 170 ~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (330)
T cd07834 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKK 249 (330)
T ss_pred cCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccC
Confidence 999999999988 789999999999999999999999998876655544432110000
Q ss_pred -------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 387 -------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 387 -------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
..+.++.++.+||.+||+.||.+||+ ++++++||||+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~~~~~~~~ 296 (330)
T cd07834 250 PKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT----ADEALAHPYLAQLH 296 (330)
T ss_pred CcchhHHhcccCCHHHHHHHHHHccCChhhCCC----HHHHHhCccHHhhc
Confidence 01346888999999999999999999 99999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=331.24 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=208.3
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
..+|++.+.||+|+||.||+|+++ ++..+|+|++.+..... ..+.+|+++++.++|+||+++++++...+..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCH----HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 467999999999999999999987 46689999986543322 3466799999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++........
T Consensus 78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 78 TEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred EecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999999999987643 36899999999999999999999999999999999999999999999999988543210000
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......++..|
T Consensus 157 ---------------------------------------------------------------------~~~~~~~~~~y 167 (256)
T cd05059 157 ---------------------------------------------------------------------SSQGTKFPVKW 167 (256)
T ss_pred ---------------------------------------------------------------------ccCCCCCCccc
Confidence 00001245679
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+.. ....+....++..+.+|+.+||..+|++||
T Consensus 168 ~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 246 (256)
T cd05059 168 APPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA-GYRLYRPKLAPTEVYTIMYSCWHEKPEDRP 246 (256)
T ss_pred cCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHhcCChhhCc
Confidence 99999999899999999999999999999 8999988776665555543 333344445899999999999999999999
Q ss_pred CcCCChHHhhcC
Q 035713 412 AYKRGATEIKQH 423 (491)
Q Consensus 412 t~~~~~~ell~h 423 (491)
+ +.++++.
T Consensus 247 t----~~~~l~~ 254 (256)
T cd05059 247 A----FKKLLSQ 254 (256)
T ss_pred C----HHHHHHH
Confidence 9 8888864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=338.93 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=214.8
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
..|..++.||+|+||.||+|+++.+++.||+|.+.............+.+|+++++.++|+|++++++++......|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45889999999999999999999999999999987544444455567788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+. |+|.+++... ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----- 167 (308)
T cd06634 95 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (308)
T ss_pred EccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC-----
Confidence 9995 6787766543 34589999999999999999999999999999999999999999999999998743210
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.....|+..|+
T Consensus 168 ---------------------------------------------------------------------~~~~~~~~~y~ 178 (308)
T cd06634 168 ---------------------------------------------------------------------ANXFVGTPYWM 178 (308)
T ss_pred ---------------------------------------------------------------------cccccCCcccc
Confidence 01236788999
Q ss_pred CcchhcC---CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 334 APEIIRG---EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 334 aPE~l~~---~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
|||++.+ ..++.++|||||||++|+|++|+.||...........+............++..+.+||.+||..+|++|
T Consensus 179 aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~R 258 (308)
T cd06634 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 258 (308)
T ss_pred CHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccC
Confidence 9999853 4578899999999999999999999987766555555554443332334588899999999999999999
Q ss_pred CCcCCChHHhhcCCCcCC
Q 035713 411 IAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 411 ~t~~~~~~ell~hpff~~ 428 (491)
|+ ++++++|||+..
T Consensus 259 p~----~~~ll~~~~~~~ 272 (308)
T cd06634 259 PT----SEVLLKHRFVLR 272 (308)
T ss_pred CC----HHHHhhCccccc
Confidence 99 999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=336.51 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=207.1
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCc--EEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNT--YFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~~ 170 (491)
++|++.+.||+|+||.||+|+++.++. .+++|.++.. ........+.+|+++++++ +||||+++++++...+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 689999999999999999999987765 4688887632 2233445678899999999 7999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEE
Q 035713 171 LVMEFCSGGNLHSLRQKQP--------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIM 236 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vk 236 (491)
+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999987532 13588999999999999999999999999999999999999999999
Q ss_pred EeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCcccc
Q 035713 237 LSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMA 316 (491)
Q Consensus 237 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (491)
|+|||++.......
T Consensus 160 l~dfg~~~~~~~~~------------------------------------------------------------------ 173 (297)
T cd05089 160 IADFGLSRGEEVYV------------------------------------------------------------------ 173 (297)
T ss_pred ECCcCCCcccccee------------------------------------------------------------------
Confidence 99999874211000
Q ss_pred CCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHH
Q 035713 317 EPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVA 395 (491)
Q Consensus 317 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~ 395 (491)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+... ...+....++.++
T Consensus 174 -----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 247 (297)
T cd05089 174 -----KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRMEKPRNCDDEV 247 (297)
T ss_pred -----ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCCHHH
Confidence 0000123457999999999889999999999999999997 99999887776666555443 3333334589999
Q ss_pred HHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 396 RDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 396 ~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
.+||.+||..||.+||+ ++++++.
T Consensus 248 ~~li~~~l~~~p~~Rp~----~~~i~~~ 271 (297)
T cd05089 248 YELMRQCWRDRPYERPP----FAQISVQ 271 (297)
T ss_pred HHHHHHHcCCChhhCcC----HHHHHHH
Confidence 99999999999999999 8888765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=325.19 Aligned_cols=254 Identities=28% Similarity=0.475 Sum_probs=218.3
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
+|++.+.||+|++|.||++++..+++.||+|.+...... ......+.+|+++++.++|+||+++++++.+++..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999999999999999876433 3455678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (254)
T cd06627 80 YAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--- 154 (254)
T ss_pred cCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc---
Confidence 99999999998875 5699999999999999999999999999999999999999999999999999855321100
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
......++..|+|
T Consensus 155 -------------------------------------------------------------------~~~~~~~~~~y~~ 167 (254)
T cd06627 155 -------------------------------------------------------------------DDASVVGTPYWMA 167 (254)
T ss_pred -------------------------------------------------------------------cccccccchhhcC
Confidence 0012367889999
Q ss_pred cchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcC
Q 035713 335 PEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK 414 (491)
Q Consensus 335 PE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ 414 (491)
||.+.+..++.++||||||+++|+|++|+.||..........++..... .+....++..+.++|.+||..+|++||+
T Consensus 168 pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~-- 244 (254)
T cd06627 168 PEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH-PPLPEGISPELKDFLMQCFQKDPNLRPT-- 244 (254)
T ss_pred HhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC-CCCCCCCCHHHHHHHHHHHhCChhhCcC--
Confidence 9999888889999999999999999999999987765555555442222 2223458899999999999999999999
Q ss_pred CChHHhhcCCCc
Q 035713 415 RGATEIKQHPFF 426 (491)
Q Consensus 415 ~~~~ell~hpff 426 (491)
+.++++||||
T Consensus 245 --~~~~l~~~~~ 254 (254)
T cd06627 245 --AKQLLKHPWI 254 (254)
T ss_pred --HHHHhcCCCC
Confidence 9999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=330.57 Aligned_cols=252 Identities=21% Similarity=0.338 Sum_probs=209.1
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
+..++|+++++||+|+||.||+|.++ +++.||+|.+...... ...+.+|+++++.++|+||+++++++. .+.+|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 45678999999999999999999876 5678999998765432 235678999999999999999999874 45689
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
+||||+.+++|.+++....+..+++.++..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999999999877655679999999999999999999999999999999999999999999999999985432100
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
. .......++.
T Consensus 157 ~---------------------------------------------------------------------~~~~~~~~~~ 167 (260)
T cd05067 157 Y---------------------------------------------------------------------TAREGAKFPI 167 (260)
T ss_pred c---------------------------------------------------------------------ccccCCcccc
Confidence 0 0000124567
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
.|+|||++.+..++.++|||||||++|||++ |+.||.+.+.......+. .....+....++.++.+||.+||..+|++
T Consensus 168 ~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 246 (260)
T cd05067 168 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELYELMRLCWKEKPEE 246 (260)
T ss_pred cccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence 8999999998889999999999999999999 999998877665555443 33344444568899999999999999999
Q ss_pred CCCcCCChHHhhc
Q 035713 410 RIAYKRGATEIKQ 422 (491)
Q Consensus 410 R~t~~~~~~ell~ 422 (491)
||+ +++++.
T Consensus 247 Rp~----~~~l~~ 255 (260)
T cd05067 247 RPT----FEYLRS 255 (260)
T ss_pred CCC----HHHHHH
Confidence 999 787765
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=345.97 Aligned_cols=259 Identities=22% Similarity=0.322 Sum_probs=207.0
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEe-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELR-----GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFE 164 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~ 164 (491)
+..++|++.+.||+|+||+||+|++. .+++.||||+++... .......+.+|+.+|..+ +|+||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 45578999999999999999999853 467889999997542 223455678899999999 6899999999876
Q ss_pred e-CceEEEEEeccCCCchHHHHHhCC------------------------------------------------------
Q 035713 165 T-DKFYCLVMEFCSGGNLHSLRQKQP------------------------------------------------------ 189 (491)
Q Consensus 165 ~-~~~~~lV~E~~~gg~L~~~~~~~~------------------------------------------------------ 189 (491)
. +..+++||||+++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4 457899999999999999886532
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccc
Q 035713 190 -----------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258 (491)
Q Consensus 190 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 258 (491)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~------ 235 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------ 235 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch------
Confidence 123678888999999999999999999999999999999999999999999998543211000
Q ss_pred cccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchh
Q 035713 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338 (491)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 338 (491)
.......++..|+|||++
T Consensus 236 --------------------------------------------------------------~~~~~~~~~~~y~aPE~~ 253 (343)
T cd05103 236 --------------------------------------------------------------VRKGDARLPLKWMAPETI 253 (343)
T ss_pred --------------------------------------------------------------hhcCCCCCCcceECcHHh
Confidence 001112456789999999
Q ss_pred cCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCCh
Q 035713 339 RGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGA 417 (491)
Q Consensus 339 ~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~ 417 (491)
.+..++.++|||||||++|+|++ |..||.+......+...+......+....+++++.+++.+||+.||++||+ +
T Consensus 254 ~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps----~ 329 (343)
T cd05103 254 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----F 329 (343)
T ss_pred cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcC----H
Confidence 99899999999999999999997 999998765444444444333333333357889999999999999999999 9
Q ss_pred HHhhcC
Q 035713 418 TEIKQH 423 (491)
Q Consensus 418 ~ell~h 423 (491)
.+|++|
T Consensus 330 ~eil~~ 335 (343)
T cd05103 330 SELVEH 335 (343)
T ss_pred HHHHHH
Confidence 999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=342.12 Aligned_cols=254 Identities=27% Similarity=0.400 Sum_probs=207.8
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC------
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD------ 166 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~------ 166 (491)
.++|++++.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+++++.++|+||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 478999999999999999999999999999999987542 2233445677899999999999999999988643
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
..+|++++++ |++|.++++. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 3578999987 8899888765 35999999999999999999999999999999999999999999999999987432
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.. .....
T Consensus 171 ~~-------------------------------------------------------------------------~~~~~ 177 (345)
T cd07877 171 DD-------------------------------------------------------------------------EMTGY 177 (345)
T ss_pred cc-------------------------------------------------------------------------ccccc
Confidence 10 00123
Q ss_pred ccccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC-----------------------
Q 035713 327 VGTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP----------------------- 382 (491)
Q Consensus 327 ~gt~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~----------------------- 382 (491)
.||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..++...
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (345)
T cd07877 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 257 (345)
T ss_pred ccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHh
Confidence 67899999999877 457889999999999999999999998766544433322110
Q ss_pred CcCCC------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 383 LRFPE------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 383 ~~~~~------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
...+. ....+.++.+||.+||+.||.+|++ +.+++.||||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l~h~~f~~ 305 (345)
T cd07877 258 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQ 305 (345)
T ss_pred cccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCC----HHHHhcChhhhh
Confidence 00010 1135788999999999999999999 999999999985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=328.94 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=205.6
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeE-EeCceE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYF-ETDKFY 169 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~-~~~~~~ 169 (491)
+...+|++.+.||+|+||.||++... |..||+|.++... ....+.+|+.+++.++|+||+++++++ ..+...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 45678999999999999999999776 6789999986432 234577899999999999999999976 455679
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999999988765556899999999999999999999999999999999999999999999999987532110
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.....++
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (256)
T cd05082 156 -------------------------------------------------------------------------QDTGKLP 162 (256)
T ss_pred -------------------------------------------------------------------------CCCCccc
Confidence 0012345
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 408 (491)
..|+|||++.+..++.++|||||||++|||++ |+.||...........+.. .........++..+.+||.+||..||+
T Consensus 163 ~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~ 241 (256)
T cd05082 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPVVYDVMKQCWHLDAA 241 (256)
T ss_pred eeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHhcCChh
Confidence 67999999999889999999999999999997 9999987665554444433 233333356899999999999999999
Q ss_pred CCCCcCCChHHhhc
Q 035713 409 KRIAYKRGATEIKQ 422 (491)
Q Consensus 409 ~R~t~~~~~~ell~ 422 (491)
+||+ +.++++
T Consensus 242 ~Rpt----~~~l~~ 251 (256)
T cd05082 242 TRPS----FLQLRE 251 (256)
T ss_pred hCcC----HHHHHH
Confidence 9999 888765
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=324.61 Aligned_cols=263 Identities=27% Similarity=0.416 Sum_probs=212.3
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe------
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET------ 165 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~------ 165 (491)
..+.|+.+.+||+|.||.||+|+.+.+|+.||+|++-... .++..-....+|+.||..|+|+|++.+++.+..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 3467999999999999999999999999999999654321 233344456789999999999999999988742
Q ss_pred --CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccc
Q 035713 166 --DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243 (491)
Q Consensus 166 --~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla 243 (491)
...+||||.+|+ -+|.-++... ..+|+..+++.++.+++.||.|+|+..|+|||+|++|+||+.+|.+||+|||++
T Consensus 94 r~r~t~ylVf~~ce-hDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 94 RDRATFYLVFDFCE-HDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred cccceeeeeHHHhh-hhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 345999999995 4777777653 456999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (491)
+.+....+.... +-
T Consensus 172 r~fs~~~n~~kp------------------------------------------------------------------ry 185 (376)
T KOG0669|consen 172 RAFSTSKNVVKP------------------------------------------------------------------RY 185 (376)
T ss_pred cceecccccCCC------------------------------------------------------------------Cc
Confidence 776543332211 11
Q ss_pred cccccccCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc--CCC---cCCCC---------
Q 035713 324 MSFVGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG--QPL---RFPET--------- 388 (491)
Q Consensus 324 ~~~~gt~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~--~~~---~~~~~--------- 388 (491)
+..+-|.+|++||.++|.+ |++++|||..|||+.||+++.+.|.++++..++..|.. +.+ .+|..
T Consensus 186 tnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~si 265 (376)
T KOG0669|consen 186 TNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSI 265 (376)
T ss_pred ccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhc
Confidence 1237899999999999865 89999999999999999999999999998887765531 110 11110
Q ss_pred -------------------CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcC
Q 035713 389 -------------------PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 389 -------------------~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~ 427 (491)
-.-.+++.||+.+||..||.+|++ ++++|+|.||.
T Consensus 266 e~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~----ad~alnh~~F~ 319 (376)
T KOG0669|consen 266 ELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRID----ADQALNHDFFW 319 (376)
T ss_pred cCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcc----hHhhhchhhhh
Confidence 011346889999999999999999 99999999995
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=327.37 Aligned_cols=254 Identities=28% Similarity=0.449 Sum_probs=216.8
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
+|++.++||+|+||.||+++++.+++.||+|.+.+.... ......+.+|+++++.++|+||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 589999999999999999999999999999998765433 3445567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 175 FCSGGNLHSLRQKQ--PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 175 ~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|+++++|..++... ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 99999999987652 1246899999999999999999999999999999999999999999999999998543210
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......|+..|
T Consensus 157 ---------------------------------------------------------------------~~~~~~~~~~~ 167 (256)
T cd08530 157 ---------------------------------------------------------------------MAKTQIGTPHY 167 (256)
T ss_pred ---------------------------------------------------------------------CcccccCCccc
Confidence 00012578899
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCC
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIA 412 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 412 (491)
++||.+.+..++.++|+||||+++|+|++|+.||...+.......+...... +....++.+++++|.+||..+|++||+
T Consensus 168 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~ 246 (256)
T cd08530 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP-PIPPIYSQDLQNFIRSMLQVKPKLRPN 246 (256)
T ss_pred cCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CCchhhCHHHHHHHHHHcCCCcccCCC
Confidence 9999999988999999999999999999999999988766555555444332 222368899999999999999999999
Q ss_pred cCCChHHhhcCCCc
Q 035713 413 YKRGATEIKQHPFF 426 (491)
Q Consensus 413 ~~~~~~ell~hpff 426 (491)
+.++++||++
T Consensus 247 ----~~~~l~~p~~ 256 (256)
T cd08530 247 ----CDKILASPAV 256 (256)
T ss_pred ----HHHHhcCCCC
Confidence 9999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=353.49 Aligned_cols=253 Identities=25% Similarity=0.398 Sum_probs=213.8
Q ss_pred eEeeeeeccCceEEEEEEEeCCCcEEEEEEeecc-hhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc--eEEEEE
Q 035713 97 RLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKA-SLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK--FYCLVM 173 (491)
Q Consensus 97 ~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~--~~~lV~ 173 (491)
+.-.+||+|+|-+||+|.+..+|..||--.++.. ...+....+++..|+.+|+.|+|||||++|++|.+.. .+.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 3446899999999999999999999986655433 2345667789999999999999999999999998765 488999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccccCCCCCEEEcc-CCcEEEeecccccccCCCC
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG--IVYRDLKPENVLVRD-EGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~NILl~~-~g~vkL~DFGla~~~~~~~ 250 (491)
|++..|+|+.|+++. +.++.+.++.|++||+.||.|||++. |||||||.+||+|+. .|.|||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~-- 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK-- 198 (632)
T ss_pred ecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc--
Confidence 999999999999987 56999999999999999999999986 999999999999984 69999999999954321
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
....+++|||
T Consensus 199 ----------------------------------------------------------------------s~aksvIGTP 208 (632)
T KOG0584|consen 199 ----------------------------------------------------------------------SHAKSVIGTP 208 (632)
T ss_pred ----------------------------------------------------------------------cccceeccCc
Confidence 1122468999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCC-CCCHHHHHHHHhhhccCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETP-QVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~ 409 (491)
.|||||++. ..|+..+||||||++|+||+|+..||..-.+..++++-+.......... --.+++++||.+||.. ..+
T Consensus 209 EFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~ 286 (632)
T KOG0584|consen 209 EFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSE 286 (632)
T ss_pred cccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chh
Confidence 999999998 6799999999999999999999999988777777766554444322211 1357899999999999 999
Q ss_pred CCCcCCChHHhhcCCCcCCC
Q 035713 410 RIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 410 R~t~~~~~~ell~hpff~~~ 429 (491)
|++ +.|||+||||+.-
T Consensus 287 R~s----a~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 287 RLS----AKELLKDPFFDED 302 (632)
T ss_pred ccC----HHHHhhChhhccc
Confidence 999 9999999999874
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=341.25 Aligned_cols=257 Identities=25% Similarity=0.343 Sum_probs=203.2
Q ss_pred CceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccCCCchHHHH
Q 035713 106 DIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLR 185 (491)
Q Consensus 106 ~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~~ 185 (491)
++|.||++++..+++.||||+++... ........+.+|+++++.++|+||++++++|...+..|++|||+++++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 55677777777789999999997653 23346677899999999999999999999999999999999999999999999
Q ss_pred HhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccccccCCCC
Q 035713 186 QKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSG 265 (491)
Q Consensus 186 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~ 265 (491)
.......+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||.+...........
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~----------- 159 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR----------- 159 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc-----------
Confidence 875556699999999999999999999999999999999999999999999999998754321100000
Q ss_pred CCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCC--CC
Q 035713 266 GGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGE--GH 343 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~ 343 (491)
..........++..|+|||++.+. .+
T Consensus 160 ----------------------------------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 187 (314)
T cd08216 160 ----------------------------------------------------VVHDFPKSSVKNLPWLSPEVLQQNLQGY 187 (314)
T ss_pred ----------------------------------------------------ccccccccccccccccCHHHhcCCCCCC
Confidence 000011123678899999999764 57
Q ss_pred CCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCc--------------------------------CCCCCCC
Q 035713 344 GSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR--------------------------------FPETPQV 391 (491)
Q Consensus 344 ~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~--------------------------------~~~~~~~ 391 (491)
+.++|||||||++|||++|+.||........+......... ......+
T Consensus 188 ~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (314)
T cd08216 188 NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTF 267 (314)
T ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHH
Confidence 89999999999999999999999876554433322211100 0001123
Q ss_pred CHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 392 SFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 392 s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
+.++.+||.+||..||++||+ ++++|+||||+.+.
T Consensus 268 ~~~~~~li~~~l~~~P~~Rpt----~~~ll~~p~~~~~~ 302 (314)
T cd08216 268 SEHFHQFVELCLQRDPESRPS----ASQLLNHSFFKQCK 302 (314)
T ss_pred HHHHHHHHHHHhhcCCCcCcC----HHHHhcCchHhhhc
Confidence 467889999999999999999 99999999998664
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=339.40 Aligned_cols=268 Identities=25% Similarity=0.399 Sum_probs=208.1
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC------
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD------ 166 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~------ 166 (491)
.++|+++++||+|+||.||+|+++.+++.||||++....... .....+.+|+++++.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 578999999999999999999999999999999986543222 2223456899999999999999999987543
Q ss_pred --ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 167 --KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 167 --~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
..+|+||||+. ++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 86 KRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred cCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 35799999995 4676666543 3469999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
........... ..........
T Consensus 164 ~~~~~~~~~~~-----------------------------------------------------------~~~~~~~~~~ 184 (311)
T cd07866 164 PYDGPPPNPKG-----------------------------------------------------------GGGGGTRKYT 184 (311)
T ss_pred hccCCCccccc-----------------------------------------------------------CCcccccccc
Confidence 53221100000 0000011122
Q ss_pred ccccccCccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---CC--c--------------
Q 035713 325 SFVGTHEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---PL--R-------------- 384 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~~--~-------------- 384 (491)
...|++.|+|||++.+. .++.++|||||||++|||++|++||.+.+.......+... .. .
T Consensus 185 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (311)
T cd07866 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVH 264 (311)
T ss_pred cceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccc
Confidence 35789999999998764 4789999999999999999999999987776555443321 00 0
Q ss_pred ----CC-----CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 385 ----FP-----ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 385 ----~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
.+ ....++.++.+||.+||..||++||+ +.+++.||||
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t----~~ell~~~~f 311 (311)
T cd07866 265 SFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT----ASDALEHPYF 311 (311)
T ss_pred cCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcC----HHHHhcCCCC
Confidence 00 00234567899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=329.88 Aligned_cols=258 Identities=22% Similarity=0.317 Sum_probs=211.8
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCc---EEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCce
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNT---YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKF 168 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~ 168 (491)
...+|++.+.||+|+||.||+|+++.+++ .||||++.+.. .......+.+|+.+++.++||||+++++++..+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence 34679999999999999999999987665 59999986542 24455678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
+++||||+++++|.+++... .+.+++.+++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 80 VMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred eEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999999988764 34689999999999999999999999999999999999999999999999999754321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
...... .........
T Consensus 159 ~~~~~~-----------------------------------------------------------------~~~~~~~~~ 173 (269)
T cd05065 159 DTSDPT-----------------------------------------------------------------YTSSLGGKI 173 (269)
T ss_pred Cccccc-----------------------------------------------------------------cccccCCCc
Confidence 100000 000000022
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCC
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP 407 (491)
+..|+|||++.+..++.++|||||||++|||++ |..||...+.......+. .....+....++..+.+++.+||..+|
T Consensus 174 ~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~~l~~~p 252 (269)
T cd05065 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPTALHQLMLDCWQKDR 252 (269)
T ss_pred ceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCCHHHHHHHHHHcCCCh
Confidence 467999999999999999999999999999886 999998877665555553 334445555688999999999999999
Q ss_pred CCCCCcCCChHHhhc
Q 035713 408 HKRIAYKRGATEIKQ 422 (491)
Q Consensus 408 ~~R~t~~~~~~ell~ 422 (491)
.+||+ +.+|++
T Consensus 253 ~~Rp~----~~~i~~ 263 (269)
T cd05065 253 NARPK----FGQIVS 263 (269)
T ss_pred hhCcC----HHHHHH
Confidence 99999 888875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=325.61 Aligned_cols=257 Identities=33% Similarity=0.495 Sum_probs=215.9
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC--ceEEEE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD--KFYCLV 172 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~--~~~~lV 172 (491)
+|++.+.||+|++|.||+|.+..+++.|++|++...... ......+.+|++++++++|+||+++++.+... ..+++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999999999999998765432 45567788999999999999999999999988 899999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999999999988753 7999999999999999999999999999999999999999999999999998543211000
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.......++..|
T Consensus 158 --------------------------------------------------------------------~~~~~~~~~~~y 169 (260)
T cd06606 158 --------------------------------------------------------------------EGTGSVRGTPYW 169 (260)
T ss_pred --------------------------------------------------------------------ccccCCCCCccc
Confidence 001123688999
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcH-HHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR-ATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
+|||.+.+..++.++|||||||++|+|++|..||...... .....+............++..+.+||.+||..||.+||
T Consensus 170 ~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp 249 (260)
T cd06606 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRP 249 (260)
T ss_pred cCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCC
Confidence 9999999888999999999999999999999999877633 223333321222222235789999999999999999999
Q ss_pred CcCCChHHhhcCCCc
Q 035713 412 AYKRGATEIKQHPFF 426 (491)
Q Consensus 412 t~~~~~~ell~hpff 426 (491)
+ +.++++||||
T Consensus 250 ~----~~~ll~~~~~ 260 (260)
T cd06606 250 T----ADELLQHPFL 260 (260)
T ss_pred C----HHHHhhCCCC
Confidence 9 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=330.82 Aligned_cols=254 Identities=22% Similarity=0.288 Sum_probs=206.1
Q ss_pred ceEeeeeeccCceEEEEEEEeCC---CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc-----
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGT---NTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK----- 167 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~----- 167 (491)
|++.+.||+|+||.||+|.+..+ +..||||+++.... .......+.+|+++|+.++|+||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 67889999999999999998653 47899999875432 2345567889999999999999999999886544
Q ss_pred -eEEEEEeccCCCchHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccc
Q 035713 168 -FYCLVMEFCSGGNLHSLRQKQ----PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242 (491)
Q Consensus 168 -~~~lV~E~~~gg~L~~~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGl 242 (491)
..++||||+++++|..++... ....+++..+..++.||+.||.|||++||+||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 379999999999999887543 123589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcc
Q 035713 243 SLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322 (491)
Q Consensus 243 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (491)
++......... .
T Consensus 160 ~~~~~~~~~~~--------------------------------------------------------------------~ 171 (273)
T cd05035 160 SKKIYSGDYYR--------------------------------------------------------------------Q 171 (273)
T ss_pred eeecccccccc--------------------------------------------------------------------c
Confidence 86432111000 0
Q ss_pred ccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHh
Q 035713 323 SMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRG 401 (491)
Q Consensus 323 ~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 401 (491)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+..+.... .......++.++.++|.+
T Consensus 172 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~ 250 (273)
T cd05035 172 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-RLKQPEDCLDELYDLMYS 250 (273)
T ss_pred cccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCcCCCHHHHHHHHH
Confidence 001135678999999988889999999999999999999 999998877666655554432 233334688999999999
Q ss_pred hhccCCCCCCCcCCChHHhhcC
Q 035713 402 LLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 402 ~L~~dP~~R~t~~~~~~ell~h 423 (491)
||+.||++||+ +.+++++
T Consensus 251 ~l~~~p~~Rp~----~~e~~~~ 268 (273)
T cd05035 251 CWRADPKDRPT----FTKLREV 268 (273)
T ss_pred HcCCChhhCcC----HHHHHHH
Confidence 99999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=338.10 Aligned_cols=259 Identities=21% Similarity=0.314 Sum_probs=208.7
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeC-------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceee
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRG-------TNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYS 161 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~ 161 (491)
.+..++|.+.+.||+|+||.||+|++.. ++..+|+|++.... .......+.+|+++++.+ +|+||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 3445789999999999999999998753 23569999987542 233445677899999999 7999999999
Q ss_pred eEEeCceEEEEEeccCCCchHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCE
Q 035713 162 YFETDKFYCLVMEFCSGGNLHSLRQKQP--------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENV 227 (491)
Q Consensus 162 ~~~~~~~~~lV~E~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NI 227 (491)
++...+.+|+||||+.+++|.+++.... ...+++.++..++.||+.||+|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 9999999999999999999999987642 13488999999999999999999999999999999999
Q ss_pred EEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCC
Q 035713 228 LVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCV 307 (491)
Q Consensus 228 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (491)
|++.++.+||+|||++.........
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~------------------------------------------------------- 196 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYY------------------------------------------------------- 196 (307)
T ss_pred EEcCCCcEEECCCcccccccccchh-------------------------------------------------------
Confidence 9999999999999998543210000
Q ss_pred CCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCC
Q 035713 308 GGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFP 386 (491)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 386 (491)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.. ..+......+
T Consensus 197 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~ 262 (307)
T cd05098 197 -------------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF-KLLKEGHRMD 262 (307)
T ss_pred -------------hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH-HHHHcCCCCC
Confidence 00001134578999999999889999999999999999998 89999876554433 3333333333
Q ss_pred CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 387 ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 387 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
....++.++.+||.+||..+|++||+ +.+++++
T Consensus 263 ~~~~~~~~~~~li~~~l~~~p~~Rps----~~evl~~ 295 (307)
T cd05098 263 KPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVED 295 (307)
T ss_pred CCCcCCHHHHHHHHHHcccChhhCcC----HHHHHHH
Confidence 34468899999999999999999999 7887764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=323.21 Aligned_cols=252 Identities=33% Similarity=0.543 Sum_probs=215.3
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
+|.+.+.||+|++|.||++.+..+++.|++|++..... .....+.+|+++++.++|+||+++++++..+...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58899999999999999999999999999999976543 345677889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|++|++|.+++.... ..+++..+..++.|++.||.+||++|++||||+|+||+++.++.++|+|||++........
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 78 FCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred cCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 999999999987753 5699999999999999999999999999999999999999999999999998754321100
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
.....|+..|+|
T Consensus 154 --------------------------------------------------------------------~~~~~~~~~~~~ 165 (253)
T cd05122 154 --------------------------------------------------------------------RNTMVGTPYWMA 165 (253)
T ss_pred --------------------------------------------------------------------ccceecCCcccC
Confidence 112468899999
Q ss_pred cchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC-CCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 335 PEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ-PLRFPETPQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 335 PE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
||++.+..++.++|||||||++|+|++|+.||...+.......+... ....+....++..+.+||.+||..||++||+
T Consensus 166 PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t- 244 (253)
T cd05122 166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPT- 244 (253)
T ss_pred HHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCC-
Confidence 99999888899999999999999999999999877555544444332 2223333335889999999999999999999
Q ss_pred CCChHHhhcCCC
Q 035713 414 KRGATEIKQHPF 425 (491)
Q Consensus 414 ~~~~~ell~hpf 425 (491)
+.++++|||
T Consensus 245 ---~~~~l~~~~ 253 (253)
T cd05122 245 ---AEQLLKHPF 253 (253)
T ss_pred ---HHHHhcCCC
Confidence 999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=344.68 Aligned_cols=255 Identities=28% Similarity=0.422 Sum_probs=211.5
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCce----
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKF---- 168 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~---- 168 (491)
.++|++++.||+|+||.||+|++..+++.||||++.... ........+.+|+.+++.++|+||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 468999999999999999999999999999999986542 223344567789999999999999999998876554
Q ss_pred --EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 169 --YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 169 --~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
+|+|+||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 7899998875 45999999999999999999999999999999999999999999999999998432
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
... ....
T Consensus 169 ~~~-------------------------------------------------------------------------~~~~ 175 (343)
T cd07851 169 DDE-------------------------------------------------------------------------MTGY 175 (343)
T ss_pred ccc-------------------------------------------------------------------------ccCC
Confidence 100 0123
Q ss_pred ccccCccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCc---------------------
Q 035713 327 VGTHEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR--------------------- 384 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~--------------------- 384 (491)
.+|..|+|||++.+. .++.++|||||||++|+|++|+.||.+......+..+....-.
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (343)
T cd07851 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSL 255 (343)
T ss_pred cccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhc
Confidence 678899999998764 5788999999999999999999999887766555544321100
Q ss_pred -------C-CCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 385 -------F-PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 385 -------~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
+ .....++.++.+||.+||..||++||| +.+|++||||+..
T Consensus 256 ~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt----~~ell~h~~~~~~ 304 (343)
T cd07851 256 PQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT----AAEALAHPYLAEY 304 (343)
T ss_pred cccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC----HHHHhcCCCcccc
Confidence 0 001246889999999999999999999 9999999999854
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=328.85 Aligned_cols=257 Identities=21% Similarity=0.284 Sum_probs=211.4
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCc---EEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNT---YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
+...+|+..+.||+|+||.||+|+++.++. .+|+|.+.... .......+.+|+++++.++|+||+++++++...+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 345689999999999999999999986654 69999886542 2233456788999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
..|+||||+++++|.+++... .+.+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||++....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999999998764 3569999999999999999999999999999999999999999999999999985432
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
...... .......
T Consensus 159 ~~~~~~-------------------------------------------------------------------~~~~~~~ 171 (268)
T cd05063 159 DDPEGT-------------------------------------------------------------------YTTSGGK 171 (268)
T ss_pred cccccc-------------------------------------------------------------------eeccCCC
Confidence 111000 0000112
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
.+..|+|||++.+..++.++|||||||++|||++ |+.||...+.......+.. ....+....++.++.+||.+||+.|
T Consensus 172 ~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~c~~~~ 250 (268)
T cd05063 172 IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLPAPMDCPSAVYQLMLQCWQQD 250 (268)
T ss_pred cCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 3467999999998889999999999999999997 9999987776665555543 3444555568899999999999999
Q ss_pred CCCCCCcCCChHHhhc
Q 035713 407 PHKRIAYKRGATEIKQ 422 (491)
Q Consensus 407 P~~R~t~~~~~~ell~ 422 (491)
|++||+ +.+|++
T Consensus 251 p~~Rp~----~~~i~~ 262 (268)
T cd05063 251 RARRPR----FVDIVN 262 (268)
T ss_pred cccCcC----HHHHHH
Confidence 999999 777765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=335.63 Aligned_cols=254 Identities=27% Similarity=0.463 Sum_probs=212.0
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEec
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEF 175 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~ 175 (491)
|....+||+|+||.||++.++.+++.||||++.... ......+.+|+.+++.++|+||++++++|...+..|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 444578999999999999999999999999875432 23445678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccc
Q 035713 176 CSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKS 255 (491)
Q Consensus 176 ~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 255 (491)
+++++|.+++.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~----- 170 (292)
T cd06657 99 LEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----- 170 (292)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-----
Confidence 999999988754 358999999999999999999999999999999999999999999999999874321100
Q ss_pred ccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCc
Q 035713 256 SSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAP 335 (491)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 335 (491)
.......|+..|+||
T Consensus 171 -----------------------------------------------------------------~~~~~~~~~~~y~~p 185 (292)
T cd06657 171 -----------------------------------------------------------------PRRKSLVGTPYWMAP 185 (292)
T ss_pred -----------------------------------------------------------------ccccccccCccccCH
Confidence 001123688999999
Q ss_pred chhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC-CCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcC
Q 035713 336 EIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ-PLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK 414 (491)
Q Consensus 336 E~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ 414 (491)
|.+.+..++.++|+|||||++|+|++|..||.+......+..+... +..+.....++..+.++|.+||..||.+||+
T Consensus 186 E~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~-- 263 (292)
T cd06657 186 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT-- 263 (292)
T ss_pred HHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcC--
Confidence 9998888899999999999999999999999877655444433221 2223333457899999999999999999999
Q ss_pred CChHHhhcCCCcCCC
Q 035713 415 RGATEIKQHPFFEGV 429 (491)
Q Consensus 415 ~~~~ell~hpff~~~ 429 (491)
+.++++||||...
T Consensus 264 --~~~ll~~~~~~~~ 276 (292)
T cd06657 264 --AAELLKHPFLAKA 276 (292)
T ss_pred --HHHHhcChHHhcc
Confidence 9999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=326.52 Aligned_cols=249 Identities=25% Similarity=0.376 Sum_probs=210.5
Q ss_pred eeeeccCceEEEEEEEeCC---CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEecc
Q 035713 100 KRLGYGDIGSVYLVELRGT---NTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFC 176 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~ 176 (491)
+.||+|+||.||+|.+... +..||+|++....... ....+.+|+++++.++|+||+++++++.....+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999866 8899999997654322 4667889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhCC-------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 177 SGGNLHSLRQKQP-------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 177 ~gg~L~~~~~~~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 9999999988742 256999999999999999999999999999999999999999999999999998654211
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.. ........++
T Consensus 159 ~~--------------------------------------------------------------------~~~~~~~~~~ 170 (262)
T cd00192 159 DY--------------------------------------------------------------------YRKKTGGKLP 170 (262)
T ss_pred cc--------------------------------------------------------------------cccccCCCcC
Confidence 10 0001123578
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 408 (491)
..|+|||.+....++.++|||||||++|+|++ |..||...........+.. ....+....++.++.++|.+||..||.
T Consensus 171 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~ 249 (262)
T cd00192 171 IRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDELYELMLSCWQLDPE 249 (262)
T ss_pred ccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChHHHHHHHHHccCCcc
Confidence 89999999998889999999999999999999 6999998866665555554 333344456899999999999999999
Q ss_pred CCCCcCCChHHhhcC
Q 035713 409 KRIAYKRGATEIKQH 423 (491)
Q Consensus 409 ~R~t~~~~~~ell~h 423 (491)
+||+ +.+++++
T Consensus 250 ~Rps----~~~l~~~ 260 (262)
T cd00192 250 DRPT----FSELVER 260 (262)
T ss_pred cCcC----HHHHHHh
Confidence 9999 9999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=331.39 Aligned_cols=255 Identities=16% Similarity=0.245 Sum_probs=205.0
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcE----EEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTY----FAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
+..++|++++.||+|+||+||+|.+..+++. |++|.+... ........+..|+.+++.++||||+++++++. +
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 3457899999999999999999999877764 666766432 22334456778888999999999999999875 4
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
...++||||+++|+|.+++... .+.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 5578999999999999998764 346999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
...... ......
T Consensus 160 ~~~~~~--------------------------------------------------------------------~~~~~~ 171 (279)
T cd05111 160 YPDDKK--------------------------------------------------------------------YFYSEH 171 (279)
T ss_pred cCCCcc--------------------------------------------------------------------cccCCC
Confidence 211000 001123
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhcc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~ 405 (491)
.++..|+|||++.+..++.++|||||||++|||++ |+.||.+..... +..++......+....++.++.+++.+||..
T Consensus 172 ~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~ 250 (279)
T cd05111 172 KTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDLLEKGERLAQPQICTIDVYMVMVKCWMI 250 (279)
T ss_pred CCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHCCCcCCCCCCCCHHHHHHHHHHcCC
Confidence 57788999999998889999999999999999998 999998775544 3344443333333345788999999999999
Q ss_pred CCCCCCCcCCChHHhhc
Q 035713 406 EPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~ 422 (491)
||++||+ +.++++
T Consensus 251 ~p~~Rps----~~el~~ 263 (279)
T cd05111 251 DENVRPT----FKELAN 263 (279)
T ss_pred CcccCcC----HHHHHH
Confidence 9999999 888765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.21 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=207.3
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
+..++|++.+.||+|+||.||+|.+..++ .+|+|++..... ....+.+|+++++.++|+||+++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 34478999999999999999999987654 599998865432 2245678999999999999999999875 45688
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
+||||+.+++|.+++.......+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999999999987555568999999999999999999999999999999999999999999999999985432100
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
.. ......++.
T Consensus 157 ~~---------------------------------------------------------------------~~~~~~~~~ 167 (260)
T cd05069 157 YT---------------------------------------------------------------------ARQGAKFPI 167 (260)
T ss_pred cc---------------------------------------------------------------------ccCCCccch
Confidence 00 000124567
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
.|+|||.+.+..++.++|||||||++|||++ |+.||.+....+....+... ...+....++..+.+||.+||.+||++
T Consensus 168 ~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~ 246 (260)
T cd05069 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-YRMPCPQGCPESLHELMKLCWKKDPDE 246 (260)
T ss_pred hhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCcccCHHHHHHHHHHccCCccc
Confidence 8999999998889999999999999999999 99999987776666555443 333334468899999999999999999
Q ss_pred CCCcCCChHHhhc
Q 035713 410 RIAYKRGATEIKQ 422 (491)
Q Consensus 410 R~t~~~~~~ell~ 422 (491)
||+ ++++++
T Consensus 247 Rp~----~~~i~~ 255 (260)
T cd05069 247 RPT----FEYIQS 255 (260)
T ss_pred CcC----HHHHHH
Confidence 999 777764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=333.47 Aligned_cols=255 Identities=21% Similarity=0.307 Sum_probs=209.1
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
...+|.+.+.||+|+||.||+|++.. ++..+++|.+.... ......+.+|+++++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 34679999999999999999998643 45679999886543 23335677899999999999999999999999
Q ss_pred ceEEEEEeccCCCchHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQP--------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE 232 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~ 232 (491)
+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999987542 2348999999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCC
Q 035713 233 GHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALP 312 (491)
Q Consensus 233 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (491)
+.+||+|||++........
T Consensus 160 ~~~~l~dfg~a~~~~~~~~------------------------------------------------------------- 178 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDY------------------------------------------------------------- 178 (291)
T ss_pred CcEEECCCCcccccCCCce-------------------------------------------------------------
Confidence 9999999999854321100
Q ss_pred ccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCC
Q 035713 313 ELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQV 391 (491)
Q Consensus 313 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 391 (491)
........|+..|+|||++.+..++.++|||||||++|||++ |+.||...+....+..+...... .....+
T Consensus 179 -------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 250 (291)
T cd05094 179 -------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL-ERPRVC 250 (291)
T ss_pred -------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCC-CCCccC
Confidence 000112357889999999999999999999999999999999 99999887776655555443322 223357
Q ss_pred CHHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 392 SFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 392 s~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
+..+.+||.+||+.||++||+ +.++++
T Consensus 251 ~~~~~~li~~~l~~~P~~Rpt----~~~v~~ 277 (291)
T cd05094 251 PKEVYDIMLGCWQREPQQRLN----IKEIYK 277 (291)
T ss_pred CHHHHHHHHHHcccChhhCcC----HHHHHH
Confidence 889999999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=327.69 Aligned_cols=254 Identities=24% Similarity=0.325 Sum_probs=212.8
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
++..++|++.++||+|+||.||+|.+. +++.||||.+...... ...+.+|+.+++.++|+||+++++++......
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 456789999999999999999999976 4577999998754322 24567899999999999999999999998999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
++||||+++++|.+++....+..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++..+...
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999999999998765567999999999999999999999999999999999999999999999999998543210
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
... ......++
T Consensus 157 ~~~---------------------------------------------------------------------~~~~~~~~ 167 (261)
T cd05034 157 EYT---------------------------------------------------------------------AREGAKFP 167 (261)
T ss_pred hhh---------------------------------------------------------------------hhhccCCC
Confidence 000 00011345
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 408 (491)
..|+|||.+.+..++.++|||||||++|+|++ |+.||.+.+....+..+... ...+....++.++.++|.+||..||.
T Consensus 168 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~ 246 (261)
T cd05034 168 IKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRMPRPPNCPEELYDLMLQCWDKDPE 246 (261)
T ss_pred ccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcccCcc
Confidence 68999999998889999999999999999998 99999887776666665543 33344445789999999999999999
Q ss_pred CCCCcCCChHHhhc
Q 035713 409 KRIAYKRGATEIKQ 422 (491)
Q Consensus 409 ~R~t~~~~~~ell~ 422 (491)
+||+ ++++++
T Consensus 247 ~Rp~----~~~l~~ 256 (261)
T cd05034 247 ERPT----FEYLQS 256 (261)
T ss_pred cCCC----HHHHHH
Confidence 9999 787764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=342.82 Aligned_cols=273 Identities=26% Similarity=0.354 Sum_probs=211.9
Q ss_pred CCceE-eeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHH-----------HHHHHHHHHHHHhhcCCCCccceee
Q 035713 94 SNFRL-LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRN-----------KLLRAQTEREILGLLDHPFLPTLYS 161 (491)
Q Consensus 94 ~~y~~-~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~-----------~~~~~~~E~~il~~l~hp~iv~l~~ 161 (491)
++|.. .+.||.|+||+||+|++..+++.||||++......... ....+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 56765 46799999999999999999999999998754322211 1124678999999999999999999
Q ss_pred eEEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecc
Q 035713 162 YFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFD 241 (491)
Q Consensus 162 ~~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFG 241 (491)
++..++.+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9999999999999996 6898888763 459999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCc
Q 035713 242 LSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNV 321 (491)
Q Consensus 242 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (491)
++............. .+ . ......
T Consensus 165 ~~~~~~~~~~~~~~~---------------~~-----------------------------~------------~~~~~~ 188 (335)
T PTZ00024 165 LARRYGYPPYSDTLS---------------KD-----------------------------E------------TMQRRE 188 (335)
T ss_pred ceeeccccccccccc---------------cc-----------------------------c------------cccccc
Confidence 986543211000000 00 0 000000
Q ss_pred cccccccccCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CCCc--CC---------
Q 035713 322 RSMSFVGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QPLR--FP--------- 386 (491)
Q Consensus 322 ~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~~~--~~--------- 386 (491)
......++..|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+.+..+.. .+.. ++
T Consensus 189 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 268 (335)
T PTZ00024 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYT 268 (335)
T ss_pred cccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhccccc
Confidence 111235788999999998754 68999999999999999999999998877666554432 1110 00
Q ss_pred ------------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 387 ------------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 387 ------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
.....+.++.+||.+||..||++||+ ++++|.||||+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~~~l~~~~~~~~ 319 (335)
T PTZ00024 269 EFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS----AKEALKHEYFKSD 319 (335)
T ss_pred ccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC----HHHHhcCcccCCC
Confidence 01245788999999999999999999 9999999999854
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=334.52 Aligned_cols=261 Identities=27% Similarity=0.404 Sum_probs=210.9
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCc
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDK 167 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~ 167 (491)
..+..++|++.+.||+|+||.||+|.+..+++.||||++++.... .....+.+|+.++..+. |+||+++++++.++.
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 345678999999999999999999999999999999999764322 23344556777666664 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
.+|+||||+ +++|..++.... ..+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++...
T Consensus 88 ~~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 88 DVFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eEEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999999998 557877776642 469999999999999999999997 59999999999999999999999999987543
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.... .....
T Consensus 166 ~~~~-----------------------------------------------------------------------~~~~~ 174 (296)
T cd06618 166 VDSK-----------------------------------------------------------------------AKTRS 174 (296)
T ss_pred cCCC-----------------------------------------------------------------------cccCC
Confidence 1100 00012
Q ss_pred ccccCccCcchhcCCC----CCCcccccchhhHHHhhhcCCCCCCCCCc-HHHHHHHHcCC-CcCCCCCCCCHHHHHHHH
Q 035713 327 VGTHEYLAPEIIRGEG----HGSAVDWWTFGIFLYELLHGTTPFKGQGN-RATLFNVVGQP-LRFPETPQVSFVARDLIR 400 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~----~~~~~DiwSlG~il~elltg~~Pf~~~~~-~~~~~~i~~~~-~~~~~~~~~s~~~~~li~ 400 (491)
.++..|+|||++.+.. ++.++|||||||++|+|++|+.||..... .+.+..++... ...+....++.++.+||.
T Consensus 175 ~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 254 (296)
T cd06618 175 AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVD 254 (296)
T ss_pred CCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Confidence 5778999999997654 78899999999999999999999976433 33444444433 223333357899999999
Q ss_pred hhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 401 GLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 401 ~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
+||..||.+||+ ++++++||||..
T Consensus 255 ~~l~~~p~~Rp~----~~~il~~~~~~~ 278 (296)
T cd06618 255 LCLTKDHRKRPK----YRELLQHPFIRR 278 (296)
T ss_pred HHccCChhhCCC----HHHHhcChhhhc
Confidence 999999999999 999999999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=335.23 Aligned_cols=260 Identities=20% Similarity=0.283 Sum_probs=211.6
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEe-------CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCcccee
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELR-------GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLY 160 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~ 160 (491)
..+...+|.+.+.||+|+||.||+|++. .++..||+|++.... .......+.+|+.+++.+ +||||++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 3456689999999999999999999863 234579999886542 233456778999999999 899999999
Q ss_pred eeEEeCceEEEEEeccCCCchHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCC
Q 035713 161 SYFETDKFYCLVMEFCSGGNLHSLRQKQP--------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPEN 226 (491)
Q Consensus 161 ~~~~~~~~~~lV~E~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~N 226 (491)
+++.....+|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 99999999999999999999999987642 2347888999999999999999999999999999999
Q ss_pred EEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCC
Q 035713 227 VLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPC 306 (491)
Q Consensus 227 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (491)
||++.++.+||+|||+++.+......
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~------------------------------------------------------ 193 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYY------------------------------------------------------ 193 (304)
T ss_pred EEEcCCCcEEECCCccceeccccccc------------------------------------------------------
Confidence 99999999999999998654211100
Q ss_pred CCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcC
Q 035713 307 VGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRF 385 (491)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 385 (491)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.. ....
T Consensus 194 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~ 258 (304)
T cd05101 194 --------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE-GHRM 258 (304)
T ss_pred --------------ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-CCcC
Confidence 00011245678999999999889999999999999999998 8999988766655554433 3333
Q ss_pred CCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 386 PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 386 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
.....++.++.+||.+||..+|.+||+ +.++++.
T Consensus 259 ~~~~~~~~~~~~li~~cl~~~p~~Rps----~~e~l~~ 292 (304)
T cd05101 259 DKPANCTNELYMMMRDCWHAIPSHRPT----FKQLVED 292 (304)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCCC----HHHHHHH
Confidence 334568899999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=330.54 Aligned_cols=257 Identities=21% Similarity=0.349 Sum_probs=215.2
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
..++|++++.||+|+||.||+|+++. +.+.|++|.+.... .......+.+|+++|+.++|+||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 34789999999999999999999764 34679999876432 233556788999999999999999999999999
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEee
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNK-------YFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSD 239 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~D 239 (491)
...|+||||+++++|.+++...... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999998865421 589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCC
Q 035713 240 FDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPT 319 (491)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (491)
||++........
T Consensus 161 ~~~~~~~~~~~~-------------------------------------------------------------------- 172 (275)
T cd05046 161 LSLSKDVYNSEY-------------------------------------------------------------------- 172 (275)
T ss_pred cccccccCcccc--------------------------------------------------------------------
Confidence 998743211000
Q ss_pred CccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHH
Q 035713 320 NVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDL 398 (491)
Q Consensus 320 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~l 398 (491)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||........+..+......++....++..+.++
T Consensus 173 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 251 (275)
T cd05046 173 -YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKL 251 (275)
T ss_pred -cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHH
Confidence 00011256788999999998888999999999999999998 8899987776666666666666665556789999999
Q ss_pred HHhhhccCCCCCCCcCCChHHhhcC
Q 035713 399 IRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 399 i~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
|.+||+.||.+||+ +.+++++
T Consensus 252 i~~~l~~~p~~Rp~----~~~~l~~ 272 (275)
T cd05046 252 MTRCWAVNPKDRPS----FSELVSA 272 (275)
T ss_pred HHHHcCCCcccCCC----HHHHHHH
Confidence 99999999999999 9998864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=336.14 Aligned_cols=258 Identities=21% Similarity=0.300 Sum_probs=208.8
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeC-------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceee
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRG-------TNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYS 161 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~ 161 (491)
.+..++|.+.++||+|+||.||+|++.. ....||+|+++... .......+.+|+++++.+ +||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 3455789999999999999999998642 34579999987542 233455678899999999 6999999999
Q ss_pred eEEeCceEEEEEeccCCCchHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCE
Q 035713 162 YFETDKFYCLVMEFCSGGNLHSLRQKQP--------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENV 227 (491)
Q Consensus 162 ~~~~~~~~~lV~E~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NI 227 (491)
++...+.+|+||||+.+|+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 9999999999999999999999987632 23588999999999999999999999999999999999
Q ss_pred EEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCC
Q 035713 228 LVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCV 307 (491)
Q Consensus 228 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (491)
|++.++.+||+|||+++.........
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~------------------------------------------------------ 191 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYK------------------------------------------------------ 191 (314)
T ss_pred EEcCCCcEEEcccccccccccccccc------------------------------------------------------
Confidence 99999999999999985432110000
Q ss_pred CCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCC
Q 035713 308 GGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFP 386 (491)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 386 (491)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+......+..+... ....
T Consensus 192 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~ 256 (314)
T cd05099 192 --------------KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREG-HRMD 256 (314)
T ss_pred --------------ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCC
Confidence 0001124567999999999889999999999999999999 89999887665555544433 2223
Q ss_pred CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 387 ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 387 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
....++.++++||.+||..||++||+ +.++++
T Consensus 257 ~~~~~~~~l~~li~~cl~~~p~~Rps----~~~ll~ 288 (314)
T cd05099 257 KPSNCTHELYMLMRECWHAVPTQRPT----FKQLVE 288 (314)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcC----HHHHHH
Confidence 33468889999999999999999999 888775
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=331.00 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=209.6
Q ss_pred cCCCceEeeeeeccCceEEEEEEEe-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELR-----GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
...+|.+.++||+|+||.||+|... .++..+|+|.+.... ......+.+|+++++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 3468999999999999999999753 356789999876542 33445678899999999999999999999999
Q ss_pred ceEEEEEeccCCCchHHHHHhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPN-------------KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG 233 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~-------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g 233 (491)
...|+||||+.+++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 999999999999999999876421 3489999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCc
Q 035713 234 HIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPE 313 (491)
Q Consensus 234 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (491)
.+||+|||++.........
T Consensus 160 ~~kL~dfg~~~~~~~~~~~------------------------------------------------------------- 178 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYY------------------------------------------------------------- 178 (280)
T ss_pred CEEECCCCceeEcCCCcee-------------------------------------------------------------
Confidence 9999999998543210000
Q ss_pred cccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCC
Q 035713 314 LMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVS 392 (491)
Q Consensus 314 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 392 (491)
.......+++.|+|||++.+..++.++|||||||++|||++ |.+||........+..+.... .......++
T Consensus 179 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 250 (280)
T cd05092 179 -------RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR-ELERPRTCP 250 (280)
T ss_pred -------ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc-cCCCCCCCC
Confidence 00012246788999999999999999999999999999998 999998776666665554432 223334688
Q ss_pred HHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 393 FVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 393 ~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
..+.+||.+||+.||.+||+ +.+|++
T Consensus 251 ~~~~~li~~cl~~~P~~Rp~----~~~l~~ 276 (280)
T cd05092 251 PEVYAIMQGCWQREPQQRMV----IKDIHS 276 (280)
T ss_pred HHHHHHHHHHccCChhhCCC----HHHHHH
Confidence 99999999999999999999 888764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=329.42 Aligned_cols=254 Identities=21% Similarity=0.307 Sum_probs=204.6
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCc--EEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe------Cc
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNT--YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET------DK 167 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~------~~ 167 (491)
|.+.++||+|+||.||+|++..++. .||+|.++... ........+.+|+++|+.++|+||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567899999999999999987765 59999886542 334556678889999999999999999997642 13
Q ss_pred eEEEEEeccCCCchHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccc
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQ----PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla 243 (491)
..++||||+.+|+|..++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 578999999999999877432 1245899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (491)
+........ ...
T Consensus 160 ~~~~~~~~~--------------------------------------------------------------------~~~ 171 (272)
T cd05075 160 KKIYNGDYY--------------------------------------------------------------------RQG 171 (272)
T ss_pred cccCcccce--------------------------------------------------------------------ecC
Confidence 643211000 000
Q ss_pred cccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhh
Q 035713 324 MSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGL 402 (491)
Q Consensus 324 ~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~ 402 (491)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+.... ..+....++..+.++|.+|
T Consensus 172 ~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~ 250 (272)
T cd05075 172 RIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-RLKQPPDCLDGLYSLMSSC 250 (272)
T ss_pred CcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHH
Confidence 11246678999999999999999999999999999999 899998876666555555433 2333346889999999999
Q ss_pred hccCCCCCCCcCCChHHhhcC
Q 035713 403 LVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 403 L~~dP~~R~t~~~~~~ell~h 423 (491)
|+.||++||+ +.+|+++
T Consensus 251 l~~~p~~Rps----~~~l~~~ 267 (272)
T cd05075 251 WLLNPKDRPS----FETLRCE 267 (272)
T ss_pred cCCCcccCcC----HHHHHHH
Confidence 9999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=325.80 Aligned_cols=249 Identities=22% Similarity=0.308 Sum_probs=207.5
Q ss_pred eeeeccCceEEEEEEEeC-CCc--EEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEecc
Q 035713 100 KRLGYGDIGSVYLVELRG-TNT--YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFC 176 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~-~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~ 176 (491)
+.||+|+||.||+|.+.. +++ .||||.+...... .....+.+|++++++++|+||+++++.+.. ..+++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999876543 556678899999999999999999999988 8999999999
Q ss_pred CCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccc
Q 035713 177 SGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSS 256 (491)
Q Consensus 177 ~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 256 (491)
++++|.+++.......+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++..+.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~--- 154 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY--- 154 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce---
Confidence 99999999887543568999999999999999999999999999999999999999999999999986542111000
Q ss_pred cccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcc
Q 035713 257 SVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336 (491)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 336 (491)
.......++..|+|||
T Consensus 155 ----------------------------------------------------------------~~~~~~~~~~~y~~pE 170 (257)
T cd05040 155 ----------------------------------------------------------------VMEEHLKVPFAWCAPE 170 (257)
T ss_pred ----------------------------------------------------------------ecccCCCCCceecCHH
Confidence 0000125778899999
Q ss_pred hhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCC
Q 035713 337 IIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKR 415 (491)
Q Consensus 337 ~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~ 415 (491)
++.+..++.++|||||||++|||++ |+.||...+..+....+.......+....++..+.+||.+||+.+|++||+
T Consensus 171 ~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps--- 247 (257)
T cd05040 171 SLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPT--- 247 (257)
T ss_pred HhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCC---
Confidence 9999999999999999999999998 999998777766666665444444444467899999999999999999999
Q ss_pred ChHHhhc
Q 035713 416 GATEIKQ 422 (491)
Q Consensus 416 ~~~ell~ 422 (491)
+.++++
T Consensus 248 -~~~~~~ 253 (257)
T cd05040 248 -FAALRE 253 (257)
T ss_pred -HHHHHH
Confidence 888775
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=324.39 Aligned_cols=253 Identities=21% Similarity=0.295 Sum_probs=209.0
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
.+..++|++.++||+|+||.||+|.+. .+..+|+|++.... .....+.+|+++++.++|+||+++++++.. ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 345689999999999999999999866 45569999886542 234567789999999999999999999887 778
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+++++|.+++.......+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 99999999999999998765567899999999999999999999999999999999999999999999999988543211
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
... ......++
T Consensus 156 ~~~---------------------------------------------------------------------~~~~~~~~ 166 (260)
T cd05073 156 EYT---------------------------------------------------------------------AREGAKFP 166 (260)
T ss_pred Ccc---------------------------------------------------------------------cccCCccc
Confidence 000 00011356
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 408 (491)
..|+|||++.+..++.++|+|||||++|+|++ |+.||.+.+.......+.. ....+.....+.++.+++.+||+.||+
T Consensus 167 ~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~ 245 (260)
T cd05073 167 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPENCPEELYNIMMRCWKNRPE 245 (260)
T ss_pred ccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC-CCCCCCcccCCHHHHHHHHHHcccCcc
Confidence 77999999998889999999999999999998 9999998766655554443 334444456889999999999999999
Q ss_pred CCCCcCCChHHhhc
Q 035713 409 KRIAYKRGATEIKQ 422 (491)
Q Consensus 409 ~R~t~~~~~~ell~ 422 (491)
+||+ +.++++
T Consensus 246 ~Rp~----~~~l~~ 255 (260)
T cd05073 246 ERPT----FEYIQS 255 (260)
T ss_pred cCcC----HHHHHH
Confidence 9999 776653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=329.90 Aligned_cols=251 Identities=30% Similarity=0.473 Sum_probs=203.6
Q ss_pred eEeeeeeccCceEEEEEEEe----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 97 RLLKRLGYGDIGSVYLVELR----GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 97 ~~~~~iG~G~~g~V~~a~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
++.+.||.|.||.||+|.+. ..+..|+||+++.. ........+.+|+++|+.++||||+++++++...+.+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 57899999999999999998 45678999999543 2334467788999999999999999999999988889999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+++|+|.+++.......+++..+..++.||+.||.|||+++|+|+||+++|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999864567999999999999999999999999999999999999999999999999998543111000
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.......+...|
T Consensus 160 --------------------------------------------------------------------~~~~~~~~~~~~ 171 (259)
T PF07714_consen 160 --------------------------------------------------------------------KNDSSQQLPLRY 171 (259)
T ss_dssp --------------------------------------------------------------------EESTTSESGGGG
T ss_pred --------------------------------------------------------------------cccccccccccc
Confidence 001112467889
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+ ......+....++..+.+||.+||..||++||
T Consensus 172 ~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RP 250 (259)
T PF07714_consen 172 LAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRP 250 (259)
T ss_dssp S-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHHHHHHcCCChhhCc
Confidence 99999999989999999999999999999 78999888776666666 44344444456899999999999999999999
Q ss_pred CcCCChHHhhc
Q 035713 412 AYKRGATEIKQ 422 (491)
Q Consensus 412 t~~~~~~ell~ 422 (491)
+ +.+|++
T Consensus 251 s----~~~i~~ 257 (259)
T PF07714_consen 251 S----FQEILQ 257 (259)
T ss_dssp -----HHHHHH
T ss_pred C----HHHHHh
Confidence 9 888864
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=326.14 Aligned_cols=246 Identities=23% Similarity=0.317 Sum_probs=199.8
Q ss_pred eeeccCceEEEEEEE--eCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccCC
Q 035713 101 RLGYGDIGSVYLVEL--RGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSG 178 (491)
Q Consensus 101 ~iG~G~~g~V~~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~g 178 (491)
+||+|+||.||+|.+ ..++..||+|+++... ........+.+|+.+++.++|+||+++++++.. ...++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 689999999999975 4567899999986543 233455678899999999999999999998764 467899999999
Q ss_pred CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccc
Q 035713 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258 (491)
Q Consensus 179 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 258 (491)
++|.+++... ..+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++...........
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~---- 153 (257)
T cd05116 80 GPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK---- 153 (257)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee----
Confidence 9999998764 4699999999999999999999999999999999999999999999999999854321110000
Q ss_pred cccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchh
Q 035713 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338 (491)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 338 (491)
......++..|+|||.+
T Consensus 154 ---------------------------------------------------------------~~~~~~~~~~y~aPE~~ 170 (257)
T cd05116 154 ---------------------------------------------------------------AKTHGKWPVKWYAPECM 170 (257)
T ss_pred ---------------------------------------------------------------ecCCCCCCccccCHhHh
Confidence 00011356789999999
Q ss_pred cCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCCh
Q 035713 339 RGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGA 417 (491)
Q Consensus 339 ~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~ 417 (491)
....++.++|||||||++|||++ |..||.+.........+... ...+....++.++.+||.+||+.||++||+ +
T Consensus 171 ~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~----~ 245 (257)
T cd05116 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG-ERMECPQRCPPEMYDLMKLCWTYGVDERPG----F 245 (257)
T ss_pred ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHHhccCchhCcC----H
Confidence 88889999999999999999998 99999887666555555433 233333468999999999999999999999 6
Q ss_pred HHhhc
Q 035713 418 TEIKQ 422 (491)
Q Consensus 418 ~ell~ 422 (491)
++|..
T Consensus 246 ~~i~~ 250 (257)
T cd05116 246 AVVEL 250 (257)
T ss_pred HHHHH
Confidence 66543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=334.28 Aligned_cols=257 Identities=21% Similarity=0.305 Sum_probs=205.6
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCC--------------cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCcc
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTN--------------TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLP 157 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~--------------~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 157 (491)
...+|++.++||+|+||.||+|++..++ ..||+|+++... .......+.+|+++|+.++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 3468999999999999999999886532 359999987542 233445688999999999999999
Q ss_pred ceeeeEEeCceEEEEEeccCCCchHHHHHhCC----------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCE
Q 035713 158 TLYSYFETDKFYCLVMEFCSGGNLHSLRQKQP----------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENV 227 (491)
Q Consensus 158 ~l~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NI 227 (491)
++++++...+..|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999886531 12368889999999999999999999999999999999
Q ss_pred EEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCC
Q 035713 228 LVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCV 307 (491)
Q Consensus 228 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (491)
|++.++.+||+|||++........
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~-------------------------------------------------------- 184 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDY-------------------------------------------------------- 184 (295)
T ss_pred EEcCCCcEEecccccccccccCcc--------------------------------------------------------
Confidence 999999999999999854321000
Q ss_pred CCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc--CCCCCCCCCcHHHHHHHHc-----
Q 035713 308 GGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH--GTTPFKGQGNRATLFNVVG----- 380 (491)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt--g~~Pf~~~~~~~~~~~i~~----- 380 (491)
........++..|+|||++.+..++.++|||||||++|+|++ |..||...+....+..+..
T Consensus 185 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 252 (295)
T cd05097 185 ------------YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQ 252 (295)
T ss_pred ------------eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhc
Confidence 000011246788999999999889999999999999999988 6789987766554443321
Q ss_pred -CCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 381 -QPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 381 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
..........++..+.+||.+||+.||++||+ +++|++
T Consensus 253 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs----~~~i~~ 291 (295)
T cd05097 253 GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT----FNKIHH 291 (295)
T ss_pred cccccCCCCCCCCHHHHHHHHHHcCCCchhCcC----HHHHHH
Confidence 11122233457899999999999999999999 788764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=335.69 Aligned_cols=260 Identities=27% Similarity=0.401 Sum_probs=208.8
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc---
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK--- 167 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~--- 167 (491)
...++|++.+.||+|+||.||+|.++.+|+.||+|+++.... .......+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345789999999999999999999999999999999875432 2223345668999999999999999999987654
Q ss_pred -------eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeec
Q 035713 168 -------FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240 (491)
Q Consensus 168 -------~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DF 240 (491)
.+|+||||+++ +|..++... ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 89999999975 676666654 346999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCC
Q 035713 241 DLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTN 320 (491)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (491)
|++........
T Consensus 161 g~~~~~~~~~~--------------------------------------------------------------------- 171 (302)
T cd07864 161 GLARLYNSEES--------------------------------------------------------------------- 171 (302)
T ss_pred cccccccCCcc---------------------------------------------------------------------
Confidence 99854321100
Q ss_pred ccccccccccCccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CCCc--CC--------
Q 035713 321 VRSMSFVGTHEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QPLR--FP-------- 386 (491)
Q Consensus 321 ~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~~~--~~-------- 386 (491)
.......++..|+|||++.+. .++.++|||||||++|||++|++||...+....+..+.. .+.. ++
T Consensus 172 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T cd07864 172 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYF 251 (302)
T ss_pred cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccc
Confidence 000012467889999998764 468899999999999999999999987766555443322 1110 00
Q ss_pred ---------------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 387 ---------------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 387 ---------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
....++..+.+||.+||..||.+||+ +++++.||||
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~~~~ 302 (302)
T cd07864 252 NTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT----AEEALNSPWL 302 (302)
T ss_pred cccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCC----HHHHhcCCCC
Confidence 11246889999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=324.44 Aligned_cols=248 Identities=24% Similarity=0.336 Sum_probs=209.3
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
+..++|++.+.||.|+||.||+|... |+.||+|.+..... ...++.+|+.+++.++|+||+++++++.+....|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 34578999999999999999999876 78899999875532 4567788999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
+||||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999999999987654579999999999999999999999999999999999999999999999999985431000
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
....++.
T Consensus 157 -------------------------------------------------------------------------~~~~~~~ 163 (256)
T cd05039 157 -------------------------------------------------------------------------DSGKLPV 163 (256)
T ss_pred -------------------------------------------------------------------------ccCCCcc
Confidence 0013456
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
.|+|||++....++.++|||||||++|||++ |+.||...........+. ..........+++.+.+||.+||..+|++
T Consensus 164 ~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 242 (256)
T cd05039 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYKVMKDCWELDPAK 242 (256)
T ss_pred cccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCccCCCHHHHHHHHHHhccChhh
Confidence 7999999998889999999999999999997 999998776555444433 33333333458899999999999999999
Q ss_pred CCCcCCChHHhhc
Q 035713 410 RIAYKRGATEIKQ 422 (491)
Q Consensus 410 R~t~~~~~~ell~ 422 (491)
||+ ++++++
T Consensus 243 Rp~----~~~l~~ 251 (256)
T cd05039 243 RPT----FKQLRE 251 (256)
T ss_pred CcC----HHHHHH
Confidence 999 888875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=331.18 Aligned_cols=256 Identities=24% Similarity=0.312 Sum_probs=204.4
Q ss_pred CCceEeeeeeccCceEEEEEEE----eCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC--c
Q 035713 94 SNFRLLKRLGYGDIGSVYLVEL----RGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD--K 167 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~--~ 167 (491)
..|++++.||+|+||.||+|+. ..++..||+|.++... .......+.+|+++|+.++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 4589999999999999999985 4568899999986542 234456788999999999999999999998765 6
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
..++||||++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 7899999999999999987642 358999999999999999999999999999999999999999999999999986432
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
...... .......
T Consensus 161 ~~~~~~-------------------------------------------------------------------~~~~~~~ 173 (284)
T cd05079 161 TDKEYY-------------------------------------------------------------------TVKDDLD 173 (284)
T ss_pred cCccce-------------------------------------------------------------------eecCCCC
Confidence 111000 0001235
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCC--------------CcHHHHHHHHcCCCcCCCCCCCCH
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQ--------------GNRATLFNVVGQPLRFPETPQVSF 393 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~--------------~~~~~~~~i~~~~~~~~~~~~~s~ 393 (491)
|+..|+|||++.+..++.++|||||||++|||++++.|+... .........+......+....++.
T Consensus 174 ~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (284)
T cd05079 174 SPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPE 253 (284)
T ss_pred CCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCH
Confidence 778899999999888999999999999999999987765321 111122222333333444456899
Q ss_pred HHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 394 VARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 394 ~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
.+.+||.+||+.||++||+ +.+++++
T Consensus 254 ~~~~li~~~l~~~p~~Rpt----~~~il~~ 279 (284)
T cd05079 254 EVYQLMRKCWEFQPSKRTT----FQNLIEG 279 (284)
T ss_pred HHHHHHHHHccCCcccCcC----HHHHHHH
Confidence 9999999999999999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=331.48 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=206.7
Q ss_pred CceEeeeeeccCceEEEEEEEeC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
+|++.+.||+|+||.||+|++.. ....+|+|++..... ......+.+|+++++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999999753 235699998865432 23446788899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCE
Q 035713 170 CLVMEFCSGGNLHSLRQKQP----------------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENV 227 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NI 227 (491)
|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 99999999999999876421 13488999999999999999999999999999999999
Q ss_pred EEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCC
Q 035713 228 LVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCV 307 (491)
Q Consensus 228 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (491)
|++.++.+||+|||+++........
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~------------------------------------------------------- 183 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSY------------------------------------------------------- 183 (290)
T ss_pred EEcCCCcEEeccccccccccCccch-------------------------------------------------------
Confidence 9999999999999998543211000
Q ss_pred CCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCC
Q 035713 308 GGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFP 386 (491)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 386 (491)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+...... .+.+......+
T Consensus 184 -------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~ 249 (290)
T cd05045 184 -------------VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL-FNLLKTGYRME 249 (290)
T ss_pred -------------hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHhCCCCCC
Confidence 00011245678999999998889999999999999999998 9999987765543 44444444554
Q ss_pred CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 387 ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 387 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
....++.++.+||.+||+.||++||+ +.++++
T Consensus 250 ~~~~~~~~~~~~i~~cl~~~P~~Rp~----~~~i~~ 281 (290)
T cd05045 250 RPENCSEEMYNLMLTCWKQEPDKRPT----FADISK 281 (290)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCC----HHHHHH
Confidence 45568999999999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=331.26 Aligned_cols=255 Identities=28% Similarity=0.457 Sum_probs=208.8
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC--ceEEEEE
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD--KFYCLVM 173 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~--~~~~lV~ 173 (491)
|+++++||+|+||.||+|++..+++.||+|++.... ........+.+|+++++.++|+||+++++++... +..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 789999999999999999999999999999998653 2334445677899999999999999999999988 8999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+. ++|..++... ...+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++........
T Consensus 80 e~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 80 EYMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred cccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9996 5888887654 24699999999999999999999999999999999999999999999999999854321100
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.......++..|+
T Consensus 156 -------------------------------------------------------------------~~~~~~~~~~~y~ 168 (287)
T cd07840 156 -------------------------------------------------------------------ADYTNRVITLWYR 168 (287)
T ss_pred -------------------------------------------------------------------ccccccccccccC
Confidence 0001125678999
Q ss_pred CcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---C--CcCCC--------------------
Q 035713 334 APEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---P--LRFPE-------------------- 387 (491)
Q Consensus 334 aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~--~~~~~-------------------- 387 (491)
|||.+.+. .++.++|||||||++|||++|+.||...+....+..+... . ..++.
T Consensus 169 ~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (287)
T cd07840 169 PPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRL 248 (287)
T ss_pred CceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHH
Confidence 99988764 5789999999999999999999999887765555444321 0 00000
Q ss_pred ---CCC-CCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 388 ---TPQ-VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 388 ---~~~-~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
... ++..+.++|.+||..||.+||+ +.+++.||||
T Consensus 249 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~~l~~~~~ 287 (287)
T cd07840 249 REFFKHLIDPSALDLLDKLLTLDPKKRIS----ADQALQHEYF 287 (287)
T ss_pred HHHhcccCCHHHHHHHHHHcCCChhhCcC----HHHHhhCcCC
Confidence 011 3888999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=327.78 Aligned_cols=256 Identities=28% Similarity=0.506 Sum_probs=210.9
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhh--hHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLA--SRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
+|.+.+.||+|+||.||++++..++..+++|+++..... .......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 589999999999999999999988777888877643221 122334566799999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 173 MEFCSGGNLHSLRQK--QPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
|||+++++|..++.. .....+++..++.++.||+.||.|||++|++|+||||+||+++. +.+||+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988764 22356999999999999999999999999999999999999975 679999999875432110
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
. ......|+.
T Consensus 160 ~----------------------------------------------------------------------~~~~~~~~~ 169 (260)
T cd08222 160 D----------------------------------------------------------------------LATTFTGTP 169 (260)
T ss_pred c----------------------------------------------------------------------cccCCCCCc
Confidence 0 011235788
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
.|+|||.+.+..++.++|+||||+++|+|++|..||.+.........+....... ....++.++.+||.+||..||++|
T Consensus 170 ~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R 248 (260)
T cd08222 170 YYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS-LPETYSRQLNSIMQSMLNKDPSLR 248 (260)
T ss_pred CccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC-CcchhcHHHHHHHHHHhcCChhhC
Confidence 9999999988888999999999999999999999998776666555555443221 123578899999999999999999
Q ss_pred CCcCCChHHhhcCCCc
Q 035713 411 IAYKRGATEIKQHPFF 426 (491)
Q Consensus 411 ~t~~~~~~ell~hpff 426 (491)
|+ +.++++||||
T Consensus 249 p~----~~~il~~~~~ 260 (260)
T cd08222 249 PS----AAEILRNPFI 260 (260)
T ss_pred cC----HHHHhhCCCC
Confidence 99 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=337.62 Aligned_cols=255 Identities=27% Similarity=0.413 Sum_probs=207.2
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe-CceEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET-DKFYC 170 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~-~~~~~ 170 (491)
..++|++++.||.|+||.||+|++..+++.||||++.+.. ........+.+|+++++.++||||++++++|.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 4578999999999999999999999999999999886542 222334556789999999999999999999875 56789
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
+||||+ +++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 87 lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-- 160 (328)
T ss_pred EEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--
Confidence 999999 6789888764 3589999999999999999999999999999999999999999999999998743210
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
......++.
T Consensus 161 -----------------------------------------------------------------------~~~~~~~~~ 169 (328)
T cd07856 161 -----------------------------------------------------------------------QMTGYVSTR 169 (328)
T ss_pred -----------------------------------------------------------------------CcCCCcccc
Confidence 001236788
Q ss_pred CccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHH---HHcC-----------------------CC
Q 035713 331 EYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFN---VVGQ-----------------------PL 383 (491)
Q Consensus 331 ~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~---i~~~-----------------------~~ 383 (491)
.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......... .++. ..
T Consensus 170 ~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (328)
T cd07856 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKRE 249 (328)
T ss_pred cccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccC
Confidence 9999999876 5689999999999999999999999987654322111 1110 00
Q ss_pred cCC---CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 384 RFP---ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 384 ~~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
..+ ..+.++.++.++|.+||+.+|++||+ +++++.||||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~ell~~~~~~~ 293 (328)
T cd07856 250 PVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS----AAEALAHPYLAP 293 (328)
T ss_pred CCcHHHHcCCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCCcccc
Confidence 111 11347789999999999999999999 999999999963
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=340.79 Aligned_cols=264 Identities=30% Similarity=0.430 Sum_probs=211.3
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeC--ceE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETD--KFY 169 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~--~~~ 169 (491)
.++|++.+.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+.+++.+ +|+||++++++|... ..+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 478999999999999999999999899999999886532 2223344567899999999 999999999998653 468
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+. ++|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 99999996 5998887653 6899999999999999999999999999999999999999999999999998543211
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.... .......+.||
T Consensus 161 ~~~~-----------------------------------------------------------------~~~~~~~~~~~ 175 (337)
T cd07852 161 EENP-----------------------------------------------------------------ENPVLTDYVAT 175 (337)
T ss_pred cccc-----------------------------------------------------------------cCcchhccccc
Confidence 1000 00011234789
Q ss_pred cCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCC-------------------------
Q 035713 330 HEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL------------------------- 383 (491)
Q Consensus 330 ~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~------------------------- 383 (491)
..|+|||++.+ ..++.++|||||||++|+|++|+.||.+........++.....
T Consensus 176 ~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (337)
T cd07852 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSR 255 (337)
T ss_pred ccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccc
Confidence 99999998865 4578899999999999999999999987765554433321100
Q ss_pred c----CCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 384 R----FPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 384 ~----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
. ....+.++.++.+||.+||+.||.+||+ +.++++||||+.+.
T Consensus 256 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps----~~~il~~~~~~~~~ 302 (337)
T cd07852 256 PRKPLDELLPKASDDALDLLKKLLVFNPNKRLT----AEEALEHPYVAQFH 302 (337)
T ss_pred cccchhhhccCCCHHHHHHHHHhccCCcccccC----HHHHhhChhhhhhc
Confidence 0 0011346889999999999999999999 99999999998763
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=334.23 Aligned_cols=270 Identities=29% Similarity=0.447 Sum_probs=224.1
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecc----hhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKA----SLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET 165 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~----~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 165 (491)
+...++|-++..||+|+|+.||+|-+...+++||+|+-... .-.++...+...+|.+|.+.|+||.||++|++|.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 44567899999999999999999999999999999985432 12334566778999999999999999999999974
Q ss_pred -CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccccCCCCCEEEc---cCCcEEEee
Q 035713 166 -DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG--IVYRDLKPENVLVR---DEGHIMLSD 239 (491)
Q Consensus 166 -~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~NILl~---~~g~vkL~D 239 (491)
.+.+|-|+|||+|.+|.-|++.+ +.+++.+++.|+.||+.||.||.+.. |||-||||.|||+- ..|.+||+|
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence 56789999999999999999875 56999999999999999999999874 99999999999995 458899999
Q ss_pred cccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCC
Q 035713 240 FDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPT 319 (491)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (491)
|||++.+..++..... .
T Consensus 617 FGLSKIMdddSy~~vd---------------------------------------------------------------G 633 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVD---------------------------------------------------------------G 633 (775)
T ss_pred cchhhhccCCccCccc---------------------------------------------------------------c
Confidence 9999877544322110 1
Q ss_pred CccccccccccCccCcchhcCC----CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHH---HH-cCCCcCCCCCCC
Q 035713 320 NVRSMSFVGTHEYLAPEIIRGE----GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFN---VV-GQPLRFPETPQV 391 (491)
Q Consensus 320 ~~~~~~~~gt~~y~aPE~l~~~----~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~---i~-~~~~~~~~~~~~ 391 (491)
..-+....||.||++||.+.-. ..+.++||||+|||+|.++.|+.||..+.....+.+ |+ ...+.||..+.+
T Consensus 634 meLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvV 713 (775)
T KOG1151|consen 634 MELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVV 713 (775)
T ss_pred eeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCcc
Confidence 1123345899999999998643 358899999999999999999999976544433322 33 356789999999
Q ss_pred CHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 392 SFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 392 s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
+.++++||++||++--++|.. +.+|-.||||..
T Consensus 714 sseAkaFIRRCLaYRKeDR~D----V~qLA~dpyllP 746 (775)
T KOG1151|consen 714 SSEAKAFIRRCLAYRKEDRID----VQQLACDPYLLP 746 (775)
T ss_pred CHHHHHHHHHHHHhhhhhhhh----HHHHccCccccc
Confidence 999999999999999999999 999999999964
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=329.25 Aligned_cols=253 Identities=33% Similarity=0.516 Sum_probs=207.0
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCceEEEEEe
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~~lV~E 174 (491)
|++.+.||+|+||+||+|++..+++.||||.+.+..... ......+|+..++.++ |+||+++++++..++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 788999999999999999999899999999986543221 1223346899999999 9999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|+ +++|.+++.......+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---- 153 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---- 153 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC----
Confidence 99 8899988877644578999999999999999999999999999999999999999999999999875321100
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
......|+..|+|
T Consensus 154 -------------------------------------------------------------------~~~~~~~~~~~~a 166 (283)
T cd07830 154 -------------------------------------------------------------------PYTDYVSTRWYRA 166 (283)
T ss_pred -------------------------------------------------------------------CcCCCCCcccccC
Confidence 0012367889999
Q ss_pred cchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CCC----------------cCC--------
Q 035713 335 PEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QPL----------------RFP-------- 386 (491)
Q Consensus 335 PE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~~----------------~~~-------- 386 (491)
||++.+ ..++.++|+|||||++|||++|++||.+......+..+.. .+. .++
T Consensus 167 PE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (283)
T cd07830 167 PEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLH 246 (283)
T ss_pred ceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHH
Confidence 998865 4478999999999999999999999988776655544321 100 000
Q ss_pred -CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 387 -ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 387 -~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
.....+.++.+||.+||+.||++||+ +.|++.||||
T Consensus 247 ~~~~~~~~~~~~li~~cl~~~p~~Rpt----~~ei~~~~~~ 283 (283)
T cd07830 247 QLIPNASPEAIDLIKDMLRWDPKKRPT----ASQALQHPYF 283 (283)
T ss_pred HHcccCCHHHHHHHHHhcccCcccCCC----HHHHhhCCCC
Confidence 01124678999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=330.74 Aligned_cols=256 Identities=22% Similarity=0.348 Sum_probs=209.2
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
..++|++++.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45789999999999999999999753 67889999986542 223345678899999999999999999999999
Q ss_pred ceEEEEEeccCCCchHHHHHhCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCC
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQP--------------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPEN 226 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~--------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~N 226 (491)
..+|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999987431 1247888999999999999999999999999999999
Q ss_pred EEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCC
Q 035713 227 VLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPC 306 (491)
Q Consensus 227 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (491)
||++.++.+||+|||++.........
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~------------------------------------------------------ 186 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYY------------------------------------------------------ 186 (288)
T ss_pred eEecCCCceEECccccceecccCccc------------------------------------------------------
Confidence 99999999999999987532110000
Q ss_pred CCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcC
Q 035713 307 VGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRF 385 (491)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 385 (491)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+..... .
T Consensus 187 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~-~ 251 (288)
T cd05050 187 --------------KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNV-L 251 (288)
T ss_pred --------------cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-C
Confidence 00001134567999999999899999999999999999997 8899988777666665554433 2
Q ss_pred CCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 386 PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 386 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
+....++.++.+||.+||+.||++||+ +.||++
T Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~el~~ 284 (288)
T cd05050 252 SCPDNCPLELYNLMRLCWSKLPSDRPS----FASINR 284 (288)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCC----HHHHHH
Confidence 223458899999999999999999999 787764
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=328.39 Aligned_cols=253 Identities=21% Similarity=0.289 Sum_probs=198.9
Q ss_pred CCc-eEeeeeeccCceEEEEEEE----eCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe--C
Q 035713 94 SNF-RLLKRLGYGDIGSVYLVEL----RGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET--D 166 (491)
Q Consensus 94 ~~y-~~~~~iG~G~~g~V~~a~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~--~ 166 (491)
++| ++++.||+|+||+||++.. ..++..||+|++..... ......+.+|+++|+.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 345 9999999999999988753 45688999999875421 2334567789999999999999999998865 3
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
..+|+||||+++++|.+++... .+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 4689999999999999998763 4999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
....... ......
T Consensus 158 ~~~~~~~-------------------------------------------------------------------~~~~~~ 170 (283)
T cd05080 158 PEGHEYY-------------------------------------------------------------------RVREDG 170 (283)
T ss_pred CCcchhh-------------------------------------------------------------------ccCCCC
Confidence 2110000 000011
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcH--------------HHHHHHHcCCCcCCCCCCCC
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR--------------ATLFNVVGQPLRFPETPQVS 392 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------------~~~~~i~~~~~~~~~~~~~s 392 (491)
.++..|+|||++.+..++.++|||||||++|||++|+.||...... ..+...+......+....++
T Consensus 171 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (283)
T cd05080 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCP 250 (283)
T ss_pred CCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCC
Confidence 3566799999999888999999999999999999999998643221 01111122222233334578
Q ss_pred HHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 393 FVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 393 ~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
.++.+|+.+||+.||++||+ +++++.
T Consensus 251 ~~~~~li~~cl~~~p~~Rps----~~~i~~ 276 (283)
T cd05080 251 QEVYILMKNCWETEAKFRPT----FRSLIP 276 (283)
T ss_pred HHHHHHHHHHhccChhhCCC----HHHHHH
Confidence 99999999999999999999 788775
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=337.37 Aligned_cols=259 Identities=21% Similarity=0.310 Sum_probs=210.2
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCC-------CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceee
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGT-------NTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYS 161 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~-------~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~ 161 (491)
.+...+|++++.||+|+||.||+|++... +..||+|+++.. ........+.+|+++++++ +|+||+++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 44556899999999999999999987532 236899988643 2233456778899999999 7999999999
Q ss_pred eEEeCceEEEEEeccCCCchHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCE
Q 035713 162 YFETDKFYCLVMEFCSGGNLHSLRQKQP--------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENV 227 (491)
Q Consensus 162 ~~~~~~~~~lV~E~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NI 227 (491)
++..++.+|+||||+.+|+|.+++.... ...++...+..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 9999999999999999999999987532 23478889999999999999999999999999999999
Q ss_pred EEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCC
Q 035713 228 LVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCV 307 (491)
Q Consensus 228 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (491)
|++.++.+||+|||+++........
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~------------------------------------------------------- 190 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYY------------------------------------------------------- 190 (334)
T ss_pred EEcCCCcEEECCcccceeccccccc-------------------------------------------------------
Confidence 9999999999999998543211000
Q ss_pred CCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCC
Q 035713 308 GGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFP 386 (491)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 386 (491)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+....+..+... ...+
T Consensus 191 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~ 256 (334)
T cd05100 191 -------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG-HRMD 256 (334)
T ss_pred -------------ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCC
Confidence 00001134568999999999999999999999999999998 89999887666555554433 3333
Q ss_pred CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 387 ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 387 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
....++.++.+||.+||+.+|++||+ +.+++++
T Consensus 257 ~~~~~~~~l~~li~~cl~~~p~~Rps----~~ell~~ 289 (334)
T cd05100 257 KPANCTHELYMIMRECWHAVPSQRPT----FKQLVED 289 (334)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCcC----HHHHHHH
Confidence 34467899999999999999999999 8888876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=330.93 Aligned_cols=256 Identities=22% Similarity=0.325 Sum_probs=205.0
Q ss_pred CCCceEeeeeeccCceEEEEEEEeC----------------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCc
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRG----------------TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFL 156 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~----------------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~i 156 (491)
.++|++.++||+|+||.||+|++.. ++..||+|++.... .......+.+|+++|+.++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4679999999999999999996543 34579999986542 23345577889999999999999
Q ss_pred cceeeeEEeCceEEEEEeccCCCchHHHHHhCCC---------CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCE
Q 035713 157 PTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPN---------KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENV 227 (491)
Q Consensus 157 v~l~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~~---------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NI 227 (491)
+++++++..++.+|+||||+.+++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 9999999999999999999999999998876421 2477889999999999999999999999999999999
Q ss_pred EEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCC
Q 035713 228 LVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCV 307 (491)
Q Consensus 228 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (491)
|++.++.++|+|||++..+.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~-------------------------------------------------------- 185 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDY-------------------------------------------------------- 185 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcc--------------------------------------------------------
Confidence 999999999999999854321100
Q ss_pred CCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc--CCCCCCCCCcHHHHHHHH------
Q 035713 308 GGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH--GTTPFKGQGNRATLFNVV------ 379 (491)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt--g~~Pf~~~~~~~~~~~i~------ 379 (491)
........++..|+|||++.+..++.++|||||||++|||++ |..||...+..+.+....
T Consensus 186 ------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 253 (296)
T cd05095 186 ------------YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQ 253 (296)
T ss_pred ------------eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhc
Confidence 000111245678999999988889999999999999999998 789998766554443221
Q ss_pred cCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 380 GQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 380 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
.....++....++..+.+||.+||+.||++||+ +.+|++
T Consensus 254 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~i~~ 292 (296)
T cd05095 254 GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPS----FQEIHA 292 (296)
T ss_pred cccccCCCCCCCCHHHHHHHHHHcCCCcccCCC----HHHHHH
Confidence 112233444568899999999999999999999 777754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=337.23 Aligned_cols=260 Identities=28% Similarity=0.397 Sum_probs=205.6
Q ss_pred CceEeeeeeccCceEEEEEEEeCC--CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEe----Cc
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGT--NTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFET----DK 167 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~----~~ 167 (491)
+|++.+.||+|+||.||+|++..+ +..||||++.... ........+.+|+++++.+ +|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999988 8999999986432 2233345667899999999 59999999987543 25
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+|++|||+ +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 80 ~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 80 ELYLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred cEEEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 688999999 57898888653 569999999999999999999999999999999999999999999999999986532
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
..... ........+
T Consensus 157 ~~~~~------------------------------------------------------------------~~~~~~~~~ 170 (332)
T cd07857 157 ENPGE------------------------------------------------------------------NAGFMTEYV 170 (332)
T ss_pred ccccc------------------------------------------------------------------ccccccCcc
Confidence 11000 000112347
Q ss_pred cccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC-------------------------
Q 035713 328 GTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ------------------------- 381 (491)
Q Consensus 328 gt~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~------------------------- 381 (491)
||..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..++..
T Consensus 171 g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (332)
T cd07857 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLP 250 (332)
T ss_pred cCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhcc
Confidence 8999999998876 46899999999999999999999999876544333322210
Q ss_pred ---CCcCC-CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 382 ---PLRFP-ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 382 ---~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
...+. ..+.++..+.+||.+||+.||.+||+ +.+++.||||+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~~ll~~~~~~~ 297 (332)
T cd07857 251 NIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS----VEEALEHPYLAI 297 (332)
T ss_pred ccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC----HHHHhcChhhhh
Confidence 00011 11346789999999999999999999 999999999963
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=322.60 Aligned_cols=246 Identities=22% Similarity=0.315 Sum_probs=200.6
Q ss_pred eeeeccCceEEEEEEEeCCC---cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEecc
Q 035713 100 KRLGYGDIGSVYLVELRGTN---TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFC 176 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~ 176 (491)
++||+|+||.||+|.+..++ ..||+|.+...... .....+.+|+++++.++|+||+++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876655 78999998765433 34456788999999999999999999876 44679999999
Q ss_pred CCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccc
Q 035713 177 SGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSS 256 (491)
Q Consensus 177 ~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 256 (491)
.+++|.+++... ..+++..+..++.||+.||.|||.+|++||||||+|||++.++.+||+|||+++.+........
T Consensus 78 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~-- 153 (257)
T cd05060 78 PLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR-- 153 (257)
T ss_pred CCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc--
Confidence 999999999875 3699999999999999999999999999999999999999999999999999864321110000
Q ss_pred cccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcc
Q 035713 257 SVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336 (491)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 336 (491)
......++..|+|||
T Consensus 154 -----------------------------------------------------------------~~~~~~~~~~y~aPE 168 (257)
T cd05060 154 -----------------------------------------------------------------ATTAGRWPLKWYAPE 168 (257)
T ss_pred -----------------------------------------------------------------cccCccccccccCHH
Confidence 000012456899999
Q ss_pred hhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCC
Q 035713 337 IIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKR 415 (491)
Q Consensus 337 ~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~ 415 (491)
.+.+..++.++|||||||++|+|++ |..||...+..+....+. .....+....++..+.+||.+||..||++||+
T Consensus 169 ~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~--- 244 (257)
T cd05060 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIMLSCWKYRPEDRPT--- 244 (257)
T ss_pred HhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcC---
Confidence 9999899999999999999999998 999998776655444443 33333444568899999999999999999999
Q ss_pred ChHHhhc
Q 035713 416 GATEIKQ 422 (491)
Q Consensus 416 ~~~ell~ 422 (491)
+.++++
T Consensus 245 -~~~l~~ 250 (257)
T cd05060 245 -FSELES 250 (257)
T ss_pred -HHHHHH
Confidence 777764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=326.52 Aligned_cols=257 Identities=18% Similarity=0.220 Sum_probs=210.8
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeC----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe-
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRG----TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET- 165 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~- 165 (491)
+..++|++.+.||+|+||.||+|.+.. ++..|++|++... ........+.+|+++|+.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 456789999999999999999999886 3578999988643 234456678899999999999999999998765
Q ss_pred CceEEEEEeccCCCchHHHHHhCCC------CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEee
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPN------KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSD 239 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~D 239 (491)
+...++++||+.+++|..++..... ..+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 5778999999999999999876422 4589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCC
Q 035713 240 FDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPT 319 (491)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (491)
||+++.+.......
T Consensus 161 ~g~~~~~~~~~~~~------------------------------------------------------------------ 174 (280)
T cd05043 161 NALSRDLFPMDYHC------------------------------------------------------------------ 174 (280)
T ss_pred CCCcccccCCceEE------------------------------------------------------------------
Confidence 99986542211000
Q ss_pred CccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHH
Q 035713 320 NVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDL 398 (491)
Q Consensus 320 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~l 398 (491)
......++..|+|||++.+..++.++|||||||++|||++ |+.||...+..... ..+.....++....+++++.++
T Consensus 175 --~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l 251 (280)
T cd05043 175 --LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-AYLKDGYRLAQPINCPDELFAV 251 (280)
T ss_pred --eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH-HHHHcCCCCCCCCcCCHHHHHH
Confidence 0001235678999999999889999999999999999999 99999877555443 3343444444455688999999
Q ss_pred HHhhhccCCCCCCCcCCChHHhhc
Q 035713 399 IRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 399 i~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
|.+||..||++||+ +.++++
T Consensus 252 i~~~l~~~p~~Rps----~~~~~~ 271 (280)
T cd05043 252 MACCWALDPEERPS----FSQLVQ 271 (280)
T ss_pred HHHHcCCChhhCCC----HHHHHH
Confidence 99999999999999 888774
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=330.41 Aligned_cols=254 Identities=32% Similarity=0.500 Sum_probs=210.4
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEec
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEF 175 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~ 175 (491)
|++++.||.|++|.||+|.+..+++.+|+|.+..... .......+.+|+++|+.++|+||+++++++.++..+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6788999999999999999999999999999876532 223455677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccc
Q 035713 176 CSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKS 255 (491)
Q Consensus 176 ~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 255 (491)
+.+ +|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||.+........
T Consensus 80 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~---- 153 (283)
T cd05118 80 MDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR---- 153 (283)
T ss_pred cCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc----
Confidence 965 8887776642 5699999999999999999999999999999999999999999999999998854321100
Q ss_pred ccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCc
Q 035713 256 SSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAP 335 (491)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 335 (491)
......++..|+||
T Consensus 154 ------------------------------------------------------------------~~~~~~~~~~~~~P 167 (283)
T cd05118 154 ------------------------------------------------------------------PYTHYVVTRWYRAP 167 (283)
T ss_pred ------------------------------------------------------------------cccCccCcccccCc
Confidence 00012578899999
Q ss_pred chhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---C----------------CcCC---------
Q 035713 336 EIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---P----------------LRFP--------- 386 (491)
Q Consensus 336 E~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~----------------~~~~--------- 386 (491)
|.+.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+... + ..++
T Consensus 168 E~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (283)
T cd05118 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPK 247 (283)
T ss_pred HHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHH
Confidence 999877 6899999999999999999999999887766555444321 0 0000
Q ss_pred CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 387 ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 387 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
..+.++.++++||.+||..||.+||+ +.++++||||
T Consensus 248 ~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~ll~~~~~ 283 (283)
T cd05118 248 LFPNASPQALDLLSQMLHYDPHKRIT----AEQALAHPYF 283 (283)
T ss_pred hhhhhCHHHHHHHHHHhccCcccCcC----HHHHhhCCCC
Confidence 01246788999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=336.17 Aligned_cols=273 Identities=27% Similarity=0.402 Sum_probs=221.4
Q ss_pred CCccchhh-hcccCCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-
Q 035713 75 DVRWDAIN-MISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD- 152 (491)
Q Consensus 75 ~~~~~~~~-~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~- 152 (491)
.-+|+... .+.+.-.++.-.+|.+....|+|-|++|.+|.+..-|..||||+|....+- .+.-+.|++||++|+
T Consensus 412 ~DNWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~ 487 (752)
T KOG0670|consen 412 QDNWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLND 487 (752)
T ss_pred ccCcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhc
Confidence 34576544 456666677778999999999999999999999999999999999865332 233457999999995
Q ss_pred -----CCCccceeeeEEeCceEEEEEeccCCCchHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCC
Q 035713 153 -----HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQP-NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPEN 226 (491)
Q Consensus 153 -----hp~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~N 226 (491)
--|+++|+-.|...+++|||+|-+ ..+|.+++++.+ +-.|....++.|+.|++.||..|...||+|.||||+|
T Consensus 488 AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDN 566 (752)
T KOG0670|consen 488 ADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDN 566 (752)
T ss_pred cCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccc
Confidence 348999999999999999999988 789999998763 3459999999999999999999999999999999999
Q ss_pred EEEccC-CcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCC
Q 035713 227 VLVRDE-GHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGP 305 (491)
Q Consensus 227 ILl~~~-g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (491)
||++.. ..+||||||.|......
T Consensus 567 iLVNE~k~iLKLCDfGSA~~~~en-------------------------------------------------------- 590 (752)
T KOG0670|consen 567 ILVNESKNILKLCDFGSASFASEN-------------------------------------------------------- 590 (752)
T ss_pred eEeccCcceeeeccCccccccccc--------------------------------------------------------
Confidence 999864 56899999988443210
Q ss_pred CCCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcC
Q 035713 306 CVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF 385 (491)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 385 (491)
.-+-+.-+..|+|||+++|.+|+...|+||+||+||||.||+..|+|.++..++...+...-.|
T Consensus 591 ----------------eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 591 ----------------EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred ----------------cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 0112456788999999999999999999999999999999999999998877664332111000
Q ss_pred C---------------------------------------------------CCCCCC-------HHHHHHHHhhhccCC
Q 035713 386 P---------------------------------------------------ETPQVS-------FVARDLIRGLLVKEP 407 (491)
Q Consensus 386 ~---------------------------------------------------~~~~~s-------~~~~~li~~~L~~dP 407 (491)
| ....++ ..+++||.+||..||
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP 734 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP 734 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence 0 001122 247899999999999
Q ss_pred CCCCCcCCChHHhhcCCCcCC
Q 035713 408 HKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 408 ~~R~t~~~~~~ell~hpff~~ 428 (491)
++|++ +.++|+||||..
T Consensus 735 ~KRit----~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 735 EKRIT----VNQALKHPFITE 751 (752)
T ss_pred hhcCC----HHHHhcCCcccC
Confidence 99999 999999999974
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=322.76 Aligned_cols=246 Identities=23% Similarity=0.317 Sum_probs=197.5
Q ss_pred eeeccCceEEEEEEEe--CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccCC
Q 035713 101 RLGYGDIGSVYLVELR--GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSG 178 (491)
Q Consensus 101 ~iG~G~~g~V~~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~g 178 (491)
.||+|+||.||+|.+. .++..||+|++.... .......+.+|+++++.++|+||+++++++.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999875 445679999986542 23445678899999999999999999998864 478999999999
Q ss_pred CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccc
Q 035713 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258 (491)
Q Consensus 179 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 258 (491)
++|.+++... ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++...........
T Consensus 79 ~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~---- 153 (257)
T cd05115 79 GPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK---- 153 (257)
T ss_pred CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee----
Confidence 9999988754 34699999999999999999999999999999999999999999999999999854321110000
Q ss_pred cccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchh
Q 035713 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338 (491)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 338 (491)
......++..|+|||++
T Consensus 154 ---------------------------------------------------------------~~~~~~~~~~y~aPE~~ 170 (257)
T cd05115 154 ---------------------------------------------------------------ARSAGKWPLKWYAPECI 170 (257)
T ss_pred ---------------------------------------------------------------ccCCCCCCcccCCHHHH
Confidence 00001245789999999
Q ss_pred cCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCCh
Q 035713 339 RGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGA 417 (491)
Q Consensus 339 ~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~ 417 (491)
.+..++.++|||||||++|||++ |..||.+.........+... ...+....+++++.+||.+||..||++||+ +
T Consensus 171 ~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~----~ 245 (257)
T cd05115 171 NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG-KRLDCPAECPPEMYALMKDCWIYKWEDRPN----F 245 (257)
T ss_pred ccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcC----H
Confidence 98889999999999999999996 99999887666555444332 233333458899999999999999999999 6
Q ss_pred HHhhc
Q 035713 418 TEIKQ 422 (491)
Q Consensus 418 ~ell~ 422 (491)
.+|++
T Consensus 246 ~~i~~ 250 (257)
T cd05115 246 AKVEE 250 (257)
T ss_pred HHHHH
Confidence 66654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=363.07 Aligned_cols=258 Identities=23% Similarity=0.356 Sum_probs=221.2
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCc-----EEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNT-----YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE 164 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 164 (491)
.+.....++.+.||+|.||.||.|....-.. .||||.+++. .+...+..|.+|..+|+.++|||||+++|++.
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 3556788999999999999999999865332 3889988654 56677888999999999999999999999999
Q ss_pred eCceEEEEEeccCCCchHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEee
Q 035713 165 TDKFYCLVMEFCSGGNLHSLRQKQP-----NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSD 239 (491)
Q Consensus 165 ~~~~~~lV~E~~~gg~L~~~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~D 239 (491)
+....+|++|||+||+|..++++.+ ...++......++.||+.|+.||+++++|||||...|+||+....|||+|
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 9999999999999999999998752 23588999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCC
Q 035713 240 FDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPT 319 (491)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (491)
||+|+.+........ ++
T Consensus 846 FGlArDiy~~~yyr~-----------------------~~---------------------------------------- 862 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRK-----------------------HG---------------------------------------- 862 (1025)
T ss_pred cchhHhhhhchheec-----------------------cC----------------------------------------
Confidence 999985432111100 00
Q ss_pred CccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHH
Q 035713 320 NVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDL 398 (491)
Q Consensus 320 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~l 398 (491)
.-.-...|||||.+....++.++|||||||+|||++| |..||.+.++.+.+..++.+. +++....+++.+.++
T Consensus 863 -----~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P~~CP~~ly~l 936 (1025)
T KOG1095|consen 863 -----EAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPPSYCPEKLYQL 936 (1025)
T ss_pred -----ccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCCCCCChHHHHH
Confidence 0012367999999999999999999999999999999 999999999999888777666 777777899999999
Q ss_pred HHhhhccCCCCCCCcCCChHHhhc
Q 035713 399 IRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 399 i~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
|..||+.+|++||+ +..|++
T Consensus 937 M~~CW~~~pe~RP~----F~~i~~ 956 (1025)
T KOG1095|consen 937 MLQCWKHDPEDRPS----FRTIVE 956 (1025)
T ss_pred HHHHccCChhhCcc----HHHHHh
Confidence 99999999999999 666665
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=328.96 Aligned_cols=254 Identities=30% Similarity=0.486 Sum_probs=210.2
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEec
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEF 175 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~ 175 (491)
|++.+.||+|+||.||+|++..+++.||+|++.... ........+.+|+++++.++|+||+++++++.+.+.+|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999997653 2233445667899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccc
Q 035713 176 CSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKS 255 (491)
Q Consensus 176 ~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 255 (491)
+. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++........
T Consensus 80 ~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---- 153 (282)
T cd07829 80 CD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR---- 153 (282)
T ss_pred cC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc----
Confidence 96 58999988753 4699999999999999999999999999999999999999999999999998854321000
Q ss_pred ccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCc
Q 035713 256 SSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAP 335 (491)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 335 (491)
......++..|+||
T Consensus 154 ------------------------------------------------------------------~~~~~~~~~~~~aP 167 (282)
T cd07829 154 ------------------------------------------------------------------TYTHEVVTLWYRAP 167 (282)
T ss_pred ------------------------------------------------------------------ccCccccCcCcCCh
Confidence 00112467889999
Q ss_pred chhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC------------------CCcCCC---------
Q 035713 336 EIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ------------------PLRFPE--------- 387 (491)
Q Consensus 336 E~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~------------------~~~~~~--------- 387 (491)
|.+.+. .++.++|||||||++|||++|++||.+......+.++... ...++.
T Consensus 168 E~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (282)
T cd07829 168 EILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKV 247 (282)
T ss_pred HHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHh
Confidence 999877 7899999999999999999999999887765554443320 000111
Q ss_pred CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 388 TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 388 ~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
.+.++..+.++|.+||..||++||+ +++++.||||
T Consensus 248 ~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~~l~~p~~ 282 (282)
T cd07829 248 LPRLDPEGIDLLSKMLQYNPAKRIS----AKEALKHPYF 282 (282)
T ss_pred cccccHHHHHHHHHhhccCcccCCC----HHHHhhCcCC
Confidence 1235778999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=348.55 Aligned_cols=262 Identities=28% Similarity=0.449 Sum_probs=226.7
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEE---
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFE--- 164 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~--- 164 (491)
.+...+.|+|+..||.|.+|.||+++++.+++.+|+|++......+ +++..|.+||+.+ .|||++.+|++|.
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3444577999999999999999999999999999999987654222 2445688899887 5999999999985
Q ss_pred --eCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccc
Q 035713 165 --TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242 (491)
Q Consensus 165 --~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGl 242 (491)
.++.+|||||||.||+.-++++...+.++.|..+..|++.++.||.+||.+.++|||||-.|||++.+|.|||+|||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence 357899999999999999999988788899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcc
Q 035713 243 SLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322 (491)
Q Consensus 243 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (491)
+..+. .+-.+
T Consensus 170 SaQld----------------------------------------------------------------------sT~gr 179 (953)
T KOG0587|consen 170 SAQLD----------------------------------------------------------------------STVGR 179 (953)
T ss_pred eeeee----------------------------------------------------------------------ccccc
Confidence 74331 12235
Q ss_pred ccccccccCccCcchhcCC-----CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCC-cCCCCCCCCHHHH
Q 035713 323 SMSFVGTHEYLAPEIIRGE-----GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL-RFPETPQVSFVAR 396 (491)
Q Consensus 323 ~~~~~gt~~y~aPE~l~~~-----~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~~~ 396 (491)
.++++||+.|||||++... .|+.++|+||||++..||.-|.+|+........++.|...+. .+..+...+.++.
T Consensus 180 RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~Fn 259 (953)
T KOG0587|consen 180 RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFN 259 (953)
T ss_pred ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHHH
Confidence 5678999999999999753 368899999999999999999999999888888888765543 3344567899999
Q ss_pred HHHHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 397 DLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 397 ~li~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
+||..||.+|-++||+ ..++|+|||...
T Consensus 260 dFIs~cL~Kd~e~RP~----~~~ll~hpFi~e 287 (953)
T KOG0587|consen 260 DFISTCLVKDYEQRPS----TEELLKHPFITE 287 (953)
T ss_pred HHHHHHHhhccccCcc----hhhhccCCcccc
Confidence 9999999999999999 999999999963
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=323.94 Aligned_cols=254 Identities=19% Similarity=0.255 Sum_probs=208.1
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCc----EEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNT----YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
...+|++++.||+|+||+||+|.++.+|+ .||+|.+.+... ......+.+|+++|+.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 44789999999999999999999877665 589998865532 3445667889999999999999999999887 7
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
..++||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 8899999999999999987653 459999999999999999999999999999999999999999999999999986542
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
....... .....
T Consensus 161 ~~~~~~~--------------------------------------------------------------------~~~~~ 172 (279)
T cd05057 161 VDEKEYH--------------------------------------------------------------------AEGGK 172 (279)
T ss_pred Cccccee--------------------------------------------------------------------cCCCc
Confidence 1110000 00012
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
++..|+|||.+....++.++|||||||++|||++ |+.||.+....+....+.. ....+.....+.++.++|.+||..|
T Consensus 173 ~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~ 251 (279)
T cd05057 173 VPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-GERLPQPPICTIDVYMVLVKCWMID 251 (279)
T ss_pred ccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC-CCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 4568999999988889999999999999999998 9999988766554444443 3333444457889999999999999
Q ss_pred CCCCCCcCCChHHhhc
Q 035713 407 PHKRIAYKRGATEIKQ 422 (491)
Q Consensus 407 P~~R~t~~~~~~ell~ 422 (491)
|.+||+ +.++++
T Consensus 252 p~~Rp~----~~~l~~ 263 (279)
T cd05057 252 AESRPT----FKELIN 263 (279)
T ss_pred hhhCCC----HHHHHH
Confidence 999999 776654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=325.74 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=202.5
Q ss_pred CCceEeeeeeccCceEEEEEEE----eCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe--Cc
Q 035713 94 SNFRLLKRLGYGDIGSVYLVEL----RGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET--DK 167 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~--~~ 167 (491)
.+|++++.||+|+||.||+|.. ..+++.||+|++.... ......+.+|+++|+.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 5799999999999999999984 4578899999986542 3445677899999999999999999998753 35
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 7899999999999999987642 458999999999999999999999999999999999999999999999999986542
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
....... ......
T Consensus 160 ~~~~~~~-------------------------------------------------------------------~~~~~~ 172 (284)
T cd05081 160 QDKEYYK-------------------------------------------------------------------VREPGE 172 (284)
T ss_pred CCCccee-------------------------------------------------------------------ecCCCC
Confidence 1110000 000012
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcH---------------HHHHHHHcCCCcCCCCCCCC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR---------------ATLFNVVGQPLRFPETPQVS 392 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~s 392 (491)
++..|+|||++.+..++.++|||||||++|||++|..++...... ..+..++.....++....++
T Consensus 173 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (284)
T cd05081 173 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCP 252 (284)
T ss_pred CceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCC
Confidence 445699999999988999999999999999999987776432211 11223333344445455688
Q ss_pred HHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 393 FVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 393 ~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
.++.+||.+||..+|++||| +.+|++
T Consensus 253 ~~~~~li~~cl~~~p~~Rpt----~~ei~~ 278 (284)
T cd05081 253 AEIYAIMKECWNNDPSQRPS----FSELAL 278 (284)
T ss_pred HHHHHHHHHHccCChhhCCC----HHHHHH
Confidence 99999999999999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=316.14 Aligned_cols=261 Identities=24% Similarity=0.350 Sum_probs=211.7
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHh-hcCCCCccceeeeEEeCceE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILG-LLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~-~l~hp~iv~l~~~~~~~~~~ 169 (491)
+..++.+-+..||.|+||+|++..++.+|+..|||.|+.... +....+++.|.+... .-+.||||++||....++..
T Consensus 61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc 138 (361)
T KOG1006|consen 61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC 138 (361)
T ss_pred cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence 445678888999999999999999999999999999987654 445567777887654 45799999999999999999
Q ss_pred EEEEeccCCCchHHHHH---hCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 170 CLVMEFCSGGNLHSLRQ---KQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~---~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
||.||+| ..+|..+.+ ......++|+.+-.|....+.||.||.+ +.||||||||+|||++..|.|||||||++..
T Consensus 139 WiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 139 WICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred eeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence 9999999 567765433 2224569999999999999999999985 6899999999999999999999999999854
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
+..+-- .+.
T Consensus 218 Lv~SiA-----------------------------------------------------------------------kT~ 226 (361)
T KOG1006|consen 218 LVDSIA-----------------------------------------------------------------------KTV 226 (361)
T ss_pred HHHHHH-----------------------------------------------------------------------hhh
Confidence 321100 001
Q ss_pred cccccCccCcchhcC--CCCCCcccccchhhHHHhhhcCCCCCCCCCc-HHHHHHHHcCCCcC-CC---CCCCCHHHHHH
Q 035713 326 FVGTHEYLAPEIIRG--EGHGSAVDWWTFGIFLYELLHGTTPFKGQGN-RATLFNVVGQPLRF-PE---TPQVSFVARDL 398 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-~~~~~~i~~~~~~~-~~---~~~~s~~~~~l 398 (491)
-.|...|||||.+.. .+|+.++|+||||++|||+.||+.|+.+-+. .+++..++.+.++. .. ...++..++.|
T Consensus 227 daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~f 306 (361)
T KOG1006|consen 227 DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRF 306 (361)
T ss_pred ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHH
Confidence 268899999999974 4589999999999999999999999987654 45555666554332 11 13588999999
Q ss_pred HHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 399 IRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 399 i~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
|..||.+|-..||. ..+++++||++..
T Consensus 307 intCl~Kd~~~Rpk----y~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 307 INTCLIKDRSDRPK----YDDLKKFPFYRMY 333 (361)
T ss_pred HHHHhhcccccCcc----hhhhhcCchhhhh
Confidence 99999999999999 8999999999743
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=321.18 Aligned_cols=245 Identities=24% Similarity=0.322 Sum_probs=204.0
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
..++|++.+.||+|+||.||++.. +++.||+|++.... ....+.+|+.+++.++||||+++++++..+. .|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEE
Confidence 457899999999999999999874 57789999986532 2245778999999999999999999987654 789
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||+.+++|.+++.......+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999998765556899999999999999999999999999999999999999999999999987432100
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
......+..
T Consensus 154 -----------------------------------------------------------------------~~~~~~~~~ 162 (254)
T cd05083 154 -----------------------------------------------------------------------VDNSKLPVK 162 (254)
T ss_pred -----------------------------------------------------------------------CCCCCCCce
Confidence 001123567
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
|+|||.+.+..++.++|||||||++|||++ |+.||.+.+..+....+.. ....+....++..+.+||.+||+.+|++|
T Consensus 163 y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R 241 (254)
T cd05083 163 WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-GYRMEPPEGCPADVYVLMTSCWETEPKKR 241 (254)
T ss_pred ecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-CCCCCCCCcCCHHHHHHHHHHcCCChhhC
Confidence 999999998889999999999999999997 9999988776655544433 33443345688999999999999999999
Q ss_pred CCcCCChHHhhc
Q 035713 411 IAYKRGATEIKQ 422 (491)
Q Consensus 411 ~t~~~~~~ell~ 422 (491)
|+ +++++.
T Consensus 242 p~----~~~l~~ 249 (254)
T cd05083 242 PS----FHKLRE 249 (254)
T ss_pred cC----HHHHHH
Confidence 99 777764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=319.73 Aligned_cols=251 Identities=22% Similarity=0.351 Sum_probs=207.4
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
..+|++.+.||+|+||.||+|.+. ++..+|+|++....... ..+.+|+++++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCH----HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 468999999999999999999886 46789999987543322 3466899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+.+++|.+++.... ..++++.++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 155 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY- 155 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-
Confidence 99999999999887642 4589999999999999999999999999999999999999999999999998754311000
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.......++..|
T Consensus 156 --------------------------------------------------------------------~~~~~~~~~~~~ 167 (256)
T cd05112 156 --------------------------------------------------------------------TSSTGTKFPVKW 167 (256)
T ss_pred --------------------------------------------------------------------cccCCCccchhh
Confidence 000012356789
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
+|||++.+..++.++|||||||++|||++ |+.||........+..+... .........+..+.+|+.+||+.+|++||
T Consensus 168 ~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp 246 (256)
T cd05112 168 SSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYKPRLASQSVYELMQHCWKERPEDRP 246 (256)
T ss_pred cCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC-CCCCCCCCCCHHHHHHHHHHcccChhhCC
Confidence 99999998889999999999999999998 99999877666555554432 22222334789999999999999999999
Q ss_pred CcCCChHHhhcC
Q 035713 412 AYKRGATEIKQH 423 (491)
Q Consensus 412 t~~~~~~ell~h 423 (491)
+ +.+++++
T Consensus 247 ~----~~~~l~~ 254 (256)
T cd05112 247 S----FSLLLHQ 254 (256)
T ss_pred C----HHHHHHh
Confidence 9 8888864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=323.40 Aligned_cols=245 Identities=24% Similarity=0.332 Sum_probs=199.0
Q ss_pred eeeeccCceEEEEEEEeCCCc--EEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceEEEEEecc
Q 035713 100 KRLGYGDIGSVYLVELRGTNT--YFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFYCLVMEFC 176 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~~lV~E~~ 176 (491)
+.||+|+||.||+|+++.++. .+|+|.++.. ........+.+|+++++++ +||||+++++++...+.+|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999988775 4688887643 2233445677899999999 7999999999999999999999999
Q ss_pred CCCchHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccc
Q 035713 177 SGGNLHSLRQKQP--------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242 (491)
Q Consensus 177 ~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGl 242 (491)
++++|.+++.... ...+++.+++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999987532 13488999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcc
Q 035713 243 SLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322 (491)
Q Consensus 243 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (491)
+...... ..
T Consensus 159 ~~~~~~~-----------------------------------------------------------------------~~ 167 (270)
T cd05047 159 SRGQEVY-----------------------------------------------------------------------VK 167 (270)
T ss_pred ccccchh-----------------------------------------------------------------------hh
Confidence 7321000 00
Q ss_pred ccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHh
Q 035713 323 SMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRG 401 (491)
Q Consensus 323 ~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 401 (491)
......+..|+|||++.+..++.++|||||||++|||++ |..||.+.+....+..+... ...+....++.++.+||.+
T Consensus 168 ~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 246 (270)
T cd05047 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQ 246 (270)
T ss_pred ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC-CCCCCCCcCCHHHHHHHHH
Confidence 001134567999999998889999999999999999997 99999877665555544332 3333334578899999999
Q ss_pred hhccCCCCCCCcCCChHHhhc
Q 035713 402 LLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 402 ~L~~dP~~R~t~~~~~~ell~ 422 (491)
||..||.+||+ +.++++
T Consensus 247 ~l~~~p~~Rps----~~~il~ 263 (270)
T cd05047 247 CWREKPYERPS----FAQILV 263 (270)
T ss_pred HcccChhhCCC----HHHHHH
Confidence 99999999999 788765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=363.63 Aligned_cols=271 Identities=28% Similarity=0.420 Sum_probs=207.9
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe-------
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET------- 165 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~------- 165 (491)
..+|+.++.||+||||.||+|+++-+|+.||||+|.... ......++.+|+.+|.+|+|||||++|..|.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 478999999999999999999999999999999997664 56677788999999999999999999854400
Q ss_pred -----------------------------------------------------------------------C--------
Q 035713 166 -----------------------------------------------------------------------D-------- 166 (491)
Q Consensus 166 -----------------------------------------------------------------------~-------- 166 (491)
.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------ceEEEEEeccCCCchHHHHHhCCCCCC-CHHHHHHHHHHHHHHHHHH
Q 035713 167 ---------------------------------KFYCLVMEFCSGGNLHSLRQKQPNKYF-TEDAARFFASEVLLALEYL 212 (491)
Q Consensus 167 ---------------------------------~~~~lV~E~~~gg~L~~~~~~~~~~~l-~~~~~~~~~~qi~~aL~~L 212 (491)
..+||-||||+.-.|++++..+. .. ....++.+++||+.||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~--~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH--FNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc--cchhhHHHHHHHHHHHHHHHHH
Confidence 14799999999888888887742 22 4788999999999999999
Q ss_pred HHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccc
Q 035713 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILP 292 (491)
Q Consensus 213 H~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (491)
|++|||||||||.||+++.++.|||+|||+|..................
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~------------------------------- 762 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFST------------------------------- 762 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccc-------------------------------
Confidence 9999999999999999999999999999999653210000000000000
Q ss_pred cccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCC---CCCcccccchhhHHHhhhcCCCCCCCC
Q 035713 293 SKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG---HGSAVDWWTFGIFLYELLHGTTPFKGQ 369 (491)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~~DiwSlG~il~elltg~~Pf~~~ 369 (491)
..........++.+||..|+|||++.+.. |+.++||||||+|||||+. ||...
T Consensus 763 ---------------------~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts 818 (1351)
T KOG1035|consen 763 ---------------------NRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS 818 (1351)
T ss_pred ---------------------cccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch
Confidence 00001111334569999999999998765 9999999999999999984 58766
Q ss_pred CcHHHHHHHHc-CCCcCC---CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcC
Q 035713 370 GNRATLFNVVG-QPLRFP---ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 370 ~~~~~~~~i~~-~~~~~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~ 427 (491)
.++.....-++ ..++.+ ..+.. +.-..+|..||++||.+||| |.|+|++.||.
T Consensus 819 MERa~iL~~LR~g~iP~~~~f~~~~~-~~e~slI~~Ll~hdP~kRPt----A~eLL~s~llp 875 (1351)
T KOG1035|consen 819 MERASILTNLRKGSIPEPADFFDPEH-PEEASLIRWLLSHDPSKRPT----ATELLNSELLP 875 (1351)
T ss_pred HHHHHHHHhcccCCCCCCcccccccc-hHHHHHHHHHhcCCCccCCC----HHHHhhccCCC
Confidence 55544443333 333333 11222 34568999999999999999 99999999996
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=336.46 Aligned_cols=258 Identities=25% Similarity=0.283 Sum_probs=200.1
Q ss_pred cccCCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeE
Q 035713 84 ISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYF 163 (491)
Q Consensus 84 ~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 163 (491)
+++.+.....++|.--.+||+|+||.||+|.... |..||||.+....... ..+|.+|+++|.+++|||+|+|+|||
T Consensus 65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred eeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 4444445566899999999999999999999885 4889999876543221 34589999999999999999999999
Q ss_pred EeCc-eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC---cccccCCCCCEEEccCCcEEEee
Q 035713 164 ETDK-FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG---IVYRDLKPENVLVRDEGHIMLSD 239 (491)
Q Consensus 164 ~~~~-~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~g~vkL~D 239 (491)
.+.+ ..+||+|||++|+|.+++.......++|.....|+.+++.||+|||+.. |||||||++|||||.+...||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9888 5999999999999999988754327999999999999999999999853 99999999999999999999999
Q ss_pred cccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCC
Q 035713 240 FDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPT 319 (491)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (491)
||+|+......
T Consensus 221 FGLa~~~~~~~--------------------------------------------------------------------- 231 (361)
T KOG1187|consen 221 FGLAKLGPEGD--------------------------------------------------------------------- 231 (361)
T ss_pred ccCcccCCccc---------------------------------------------------------------------
Confidence 99994421100
Q ss_pred Ccccccc-ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCC---c---HHHHHHHHcC-CC---cCCCC
Q 035713 320 NVRSMSF-VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQG---N---RATLFNVVGQ-PL---RFPET 388 (491)
Q Consensus 320 ~~~~~~~-~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~---~~~~~~i~~~-~~---~~~~~ 388 (491)
....+. .||.+|+|||++.....+.++|||||||+|.||++|+.+..... . .+.....+.. .+ --+..
T Consensus 232 -~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l 310 (361)
T KOG1187|consen 232 -TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRL 310 (361)
T ss_pred -cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCc
Confidence 000011 69999999999998889999999999999999999998887432 1 1111111111 10 00110
Q ss_pred --CCCC-----HHHHHHHHhhhccCCCCCCCcCC
Q 035713 389 --PQVS-----FVARDLIRGLLVKEPHKRIAYKR 415 (491)
Q Consensus 389 --~~~s-----~~~~~li~~~L~~dP~~R~t~~~ 415 (491)
...+ ..+..+..+|++.+|.+||+|.+
T Consensus 311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~ 344 (361)
T KOG1187|consen 311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQ 344 (361)
T ss_pred cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHH
Confidence 1222 22567888999999999999543
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=318.97 Aligned_cols=251 Identities=25% Similarity=0.391 Sum_probs=209.9
Q ss_pred ceEeeeeeccCceEEEEEEEeCCC----cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTN----TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
+++++.||.|+||.||+|++...+ ..||+|++..... ......+..|+++++.++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467899999999999999998766 8999999865532 2255677889999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||+++++|.+++.......+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999998875433399999999999999999999999999999999999999999999999999854321100
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
. ......++..
T Consensus 159 ~---------------------------------------------------------------------~~~~~~~~~~ 169 (258)
T smart00219 159 Y---------------------------------------------------------------------KKKGGKLPIR 169 (258)
T ss_pred c---------------------------------------------------------------------ccccCCCccc
Confidence 0 0000136788
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
|+|||.+.+..++.++|||||||++|+|++ |+.||...+.......+.... ..+....++.++.++|.+||..||++|
T Consensus 170 y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R 248 (258)
T smart00219 170 WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-RLPKPENCPPEIYKLMLQCWAEDPEDR 248 (258)
T ss_pred ccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCCCcCCHHHHHHHHHHCcCChhhC
Confidence 999999988889999999999999999998 899998876666665555443 233334589999999999999999999
Q ss_pred CCcCCChHHhhc
Q 035713 411 IAYKRGATEIKQ 422 (491)
Q Consensus 411 ~t~~~~~~ell~ 422 (491)
|+ +.++++
T Consensus 249 pt----~~~ll~ 256 (258)
T smart00219 249 PT----FSELVE 256 (258)
T ss_pred cC----HHHHHh
Confidence 99 899875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=317.04 Aligned_cols=245 Identities=23% Similarity=0.326 Sum_probs=201.4
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccCCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGG 179 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~gg 179 (491)
+.||+|+||.||+|... ++..||+|+++... .......+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999865 68899999987543 2233446788999999999999999999999999999999999999
Q ss_pred chHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccccccc
Q 035713 180 NLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVS 259 (491)
Q Consensus 180 ~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 259 (491)
+|.+++.... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 78 ~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-------- 148 (250)
T cd05085 78 DFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-------- 148 (250)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc--------
Confidence 9999887643 4589999999999999999999999999999999999999999999999999743211000
Q ss_pred ccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhc
Q 035713 260 VNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIR 339 (491)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 339 (491)
.......++..|+|||++.
T Consensus 149 -------------------------------------------------------------~~~~~~~~~~~y~aPE~~~ 167 (250)
T cd05085 149 -------------------------------------------------------------SSSGLKQIPIKWTAPEALN 167 (250)
T ss_pred -------------------------------------------------------------ccCCCCCCcccccCHHHhc
Confidence 0000113457799999999
Q ss_pred CCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChH
Q 035713 340 GEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGAT 418 (491)
Q Consensus 340 ~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ 418 (491)
+..++.++|||||||++|+|++ |..||.+.........+... ........++..+.+||.+||..+|++||+ +.
T Consensus 168 ~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~ 242 (250)
T cd05085 168 YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG-YRMSCPQKCPDDVYKVMQRCWDYKPENRPK----FS 242 (250)
T ss_pred cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcccCcccCCC----HH
Confidence 8889999999999999999998 99999887666555554433 333333458899999999999999999999 88
Q ss_pred Hhhc
Q 035713 419 EIKQ 422 (491)
Q Consensus 419 ell~ 422 (491)
++++
T Consensus 243 ~l~~ 246 (250)
T cd05085 243 ELQK 246 (250)
T ss_pred HHHH
Confidence 8765
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=321.46 Aligned_cols=254 Identities=26% Similarity=0.342 Sum_probs=207.7
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCC---CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCce
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGT---NTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKF 168 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~ 168 (491)
...+|.+.+.||+|+||.||+|.+... ...||||.+.... .....+.+.+|+++++.++|+||+++++++.+. .
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-P 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-C
Confidence 446799999999999999999998644 3469999886542 133455778899999999999999999988754 5
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
.|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 789999999999999987643 3589999999999999999999999999999999999999999999999999854321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
.... ......+
T Consensus 160 ~~~~---------------------------------------------------------------------~~~~~~~ 170 (270)
T cd05056 160 ESYY---------------------------------------------------------------------KASKGKL 170 (270)
T ss_pred ccce---------------------------------------------------------------------ecCCCCc
Confidence 1000 0001134
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCC
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP 407 (491)
+..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+..+..+ ...+....++..+.+||.+||..+|
T Consensus 171 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P 249 (270)
T cd05056 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG-ERLPMPPNCPPTLYSLMTKCWAYDP 249 (270)
T ss_pred cccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCCh
Confidence 568999999998889999999999999999986 99999888776666555443 2333345689999999999999999
Q ss_pred CCCCCcCCChHHhhcC
Q 035713 408 HKRIAYKRGATEIKQH 423 (491)
Q Consensus 408 ~~R~t~~~~~~ell~h 423 (491)
.+||+ +.+++..
T Consensus 250 ~~Rpt----~~~~~~~ 261 (270)
T cd05056 250 SKRPR----FTELKAQ 261 (270)
T ss_pred hhCcC----HHHHHHH
Confidence 99999 8887754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=304.97 Aligned_cols=253 Identities=25% Similarity=0.416 Sum_probs=210.2
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeC--ce
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETD--KF 168 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~--~~ 168 (491)
..++|++++++|+|.|++|+.|.+..+++.++||+++.. ..+.+.+|+.||+.|. ||||++|+++..+. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 457899999999999999999999999999999998753 3346778999999997 99999999998764 56
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc-CCcEEEeecccccccC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD-EGHIMLSDFDLSLRCS 247 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~-~g~vkL~DFGla~~~~ 247 (491)
..||+||+++.++..+... |+.-.++.|+.|++.||.|||++||+|||+||.|++|+. .-.++|+|+|||.+..
T Consensus 110 paLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred chhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 7899999999888877554 889999999999999999999999999999999999995 4679999999997654
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
...... -.+
T Consensus 185 p~~eYn-----------------------------------------------------------------------VRV 193 (338)
T KOG0668|consen 185 PGKEYN-----------------------------------------------------------------------VRV 193 (338)
T ss_pred CCceee-----------------------------------------------------------------------eee
Confidence 322111 126
Q ss_pred cccCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCC-CCCCcHHHHHHHH---cC---------------------
Q 035713 328 GTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPF-KGQGNRATLFNVV---GQ--------------------- 381 (491)
Q Consensus 328 gt~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf-~~~~~~~~~~~i~---~~--------------------- 381 (491)
.+..|--||+|..-+ |+.+-|+|||||+|..|+..+-|| .|.++.+++.+|. +.
T Consensus 194 ASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i 273 (338)
T KOG0668|consen 194 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDI 273 (338)
T ss_pred ehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhH
Confidence 788999999998765 799999999999999999987775 6777777765542 11
Q ss_pred ---CCcC-------C-CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 382 ---PLRF-------P-ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 382 ---~~~~-------~-~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
..+- + ....+++++.|||.++|.+|-.+|+| |.|++.||||..+.
T Consensus 274 ~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT----akEam~HpyF~~~~ 329 (338)
T KOG0668|consen 274 LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT----AKEAMAHPYFAPVR 329 (338)
T ss_pred hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc----hHHHhcCchHHHHH
Confidence 0000 0 11246799999999999999999999 99999999998654
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=317.71 Aligned_cols=246 Identities=26% Similarity=0.352 Sum_probs=203.5
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccCCC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGG 179 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~gg 179 (491)
++||+|+||.||+|.+.. ++.||+|++...... .....+.+|+++++.++|+||+++++++......|+||||+.|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999999987 999999998765332 34557788999999999999999999999999999999999999
Q ss_pred chHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccccccc
Q 035713 180 NLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVS 259 (491)
Q Consensus 180 ~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 259 (491)
+|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++..........
T Consensus 78 ~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~------ 150 (251)
T cd05041 78 SLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV------ 150 (251)
T ss_pred cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee------
Confidence 999998764 2458999999999999999999999999999999999999999999999999985432100000
Q ss_pred ccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhc
Q 035713 260 VNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIR 339 (491)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 339 (491)
......++..|+|||++.
T Consensus 151 --------------------------------------------------------------~~~~~~~~~~y~~PE~~~ 168 (251)
T cd05041 151 --------------------------------------------------------------SDGLKQIPIKWTAPEALN 168 (251)
T ss_pred --------------------------------------------------------------ccccCcceeccCChHhhc
Confidence 000113456799999999
Q ss_pred CCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChH
Q 035713 340 GEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGAT 418 (491)
Q Consensus 340 ~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ 418 (491)
+..++.++|||||||++|||++ |..||.+.........+.. ....+....++..+.+||.+||..+|.+||+ +.
T Consensus 169 ~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~ 243 (251)
T cd05041 169 YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-GYRMPAPQLCPEEIYRLMLQCWAYDPENRPS----FS 243 (251)
T ss_pred cCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHhccChhhCcC----HH
Confidence 8889999999999999999999 8999987765554444433 2333333468899999999999999999999 88
Q ss_pred Hhhc
Q 035713 419 EIKQ 422 (491)
Q Consensus 419 ell~ 422 (491)
++++
T Consensus 244 ell~ 247 (251)
T cd05041 244 EIYN 247 (251)
T ss_pred HHHH
Confidence 8886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=323.80 Aligned_cols=239 Identities=22% Similarity=0.299 Sum_probs=193.6
Q ss_pred eeeeccCceEEEEEEEeCCCcE-------EEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 100 KRLGYGDIGSVYLVELRGTNTY-------FAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~-------vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
+.||+|+||.||+|.++..+.. ||+|++.... ......+.+|+.+|+.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 4689999999999998765443 8888875432 33445677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCc--------EEEeeccccc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGH--------IMLSDFDLSL 244 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~--------vkL~DFGla~ 244 (491)
|||+.+|+|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++.
T Consensus 78 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999987653 36899999999999999999999999999999999999987765 6899998863
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
.... ..
T Consensus 157 ~~~~--------------------------------------------------------------------------~~ 162 (258)
T cd05078 157 TVLP--------------------------------------------------------------------------KE 162 (258)
T ss_pred ccCC--------------------------------------------------------------------------ch
Confidence 2110 01
Q ss_pred ccccccCccCcchhcCC-CCCCcccccchhhHHHhhhcC-CCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhh
Q 035713 325 SFVGTHEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHG-TTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGL 402 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~-~~~~~~DiwSlG~il~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~ 402 (491)
...++..|+|||++.+. .++.++|||||||++|||++| ..||...+.... ..+......++. ..+.++.+||.+|
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~li~~~ 239 (258)
T cd05078 163 ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRHQLPA--PKWTELANLINQC 239 (258)
T ss_pred hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccccCCC--CCcHHHHHHHHHH
Confidence 23678899999999874 478999999999999999998 466665544333 333444444443 3668899999999
Q ss_pred hccCCCCCCCcCCChHHhhcC
Q 035713 403 LVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 403 L~~dP~~R~t~~~~~~ell~h 423 (491)
|+.||++||+ +++|++.
T Consensus 240 l~~~p~~Rps----~~~il~~ 256 (258)
T cd05078 240 MDYEPDFRPS----FRAIIRD 256 (258)
T ss_pred hccChhhCCC----HHHHHHh
Confidence 9999999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=327.83 Aligned_cols=255 Identities=20% Similarity=0.305 Sum_probs=207.1
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCc----EEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNT----YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
..++|++++.||+|+||.||+|++..++. .||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 45789999999999999999999987776 46888876542 223344678899999999999999999998754
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
..++|+||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred CceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 467999999999999998764 3458999999999999999999999999999999999999999999999999986432
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
..... .......
T Consensus 161 ~~~~~--------------------------------------------------------------------~~~~~~~ 172 (303)
T cd05110 161 GDEKE--------------------------------------------------------------------YNADGGK 172 (303)
T ss_pred Ccccc--------------------------------------------------------------------cccCCCc
Confidence 11000 0001124
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
++..|+|||++.+..++.++|||||||++|||++ |..||.+..... +..++.....++....++.++.++|.+||..|
T Consensus 173 ~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~ 251 (303)
T cd05110 173 MPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGERLPQPPICTIDVYMVMVKCWMID 251 (303)
T ss_pred cccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 6778999999999889999999999999999997 999998765433 34444444444545568899999999999999
Q ss_pred CCCCCCcCCChHHhhcC
Q 035713 407 PHKRIAYKRGATEIKQH 423 (491)
Q Consensus 407 P~~R~t~~~~~~ell~h 423 (491)
|++||+ ++++++.
T Consensus 252 p~~Rp~----~~~l~~~ 264 (303)
T cd05110 252 ADSRPK----FKELAAE 264 (303)
T ss_pred hhhCcC----HHHHHHH
Confidence 999999 7777764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=319.64 Aligned_cols=233 Identities=33% Similarity=0.458 Sum_probs=191.1
Q ss_pred cCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccCCCchHHH
Q 035713 105 GDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSL 184 (491)
Q Consensus 105 G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~ 184 (491)
|.||.||+|+++.+++.||+|++.+... ..+|...+....||||+++++++...+.+|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976431 22344455556799999999999999999999999999999998
Q ss_pred HHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccccccCCC
Q 035713 185 RQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGS 264 (491)
Q Consensus 185 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~ 264 (491)
+... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 76 l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--------------- 138 (237)
T cd05576 76 ISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--------------- 138 (237)
T ss_pred HHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---------------
Confidence 8764 35999999999999999999999999999999999999999999999999986432110
Q ss_pred CCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCCCC
Q 035713 265 GGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHG 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 344 (491)
.....++..|+|||++.+..++
T Consensus 139 ----------------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~ 160 (237)
T cd05576 139 ----------------------------------------------------------CDGEAVENMYCAPEVGGISEET 160 (237)
T ss_pred ----------------------------------------------------------cccCCcCccccCCcccCCCCCC
Confidence 0012456789999999888899
Q ss_pred CcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc-CCChHHhhcC
Q 035713 345 SAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY-KRGATEIKQH 423 (491)
Q Consensus 345 ~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-~~~~~ell~h 423 (491)
.++|||||||++|||++|+.||....... .. ...+.+| ..++..+++||.+||+.||++|++. ...++++++|
T Consensus 161 ~~~DvwslG~il~el~~g~~~~~~~~~~~--~~--~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 161 EACDWWSLGAILFELLTGKTLVECHPSGI--NT--HTTLNIP--EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred chhhHHHHHHHHHHHHHCcchhhcCchhc--cc--ccccCCc--ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence 99999999999999999999886432210 00 1112233 3588999999999999999999993 1235999999
Q ss_pred CCc
Q 035713 424 PFF 426 (491)
Q Consensus 424 pff 426 (491)
|||
T Consensus 235 ~~~ 237 (237)
T cd05576 235 PFF 237 (237)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=321.10 Aligned_cols=248 Identities=21% Similarity=0.328 Sum_probs=193.8
Q ss_pred eeeeccCceEEEEEEEeC--CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccC
Q 035713 100 KRLGYGDIGSVYLVELRG--TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCS 177 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~ 177 (491)
++||+|+||+||+|.... ....+|+|.+.... .......+.+|+++++.++|+||+++++.+.....+|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 468999999999997643 34568888775432 23344567789999999999999999999999999999999999
Q ss_pred CCchHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 178 GGNLHSLRQKQPN---KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 178 gg~L~~~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
+|+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-- 156 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY-- 156 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe--
Confidence 9999999876432 23578889999999999999999999999999999999999999999999997432110000
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
.......++..|+|
T Consensus 157 ------------------------------------------------------------------~~~~~~~~~~~y~a 170 (269)
T cd05042 157 ------------------------------------------------------------------ITKDCHAVPLRWLA 170 (269)
T ss_pred ------------------------------------------------------------------eccCCCCCcccccC
Confidence 00011246778999
Q ss_pred cchhcC-------CCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcC-CCcCCC---CCCCCHHHHHHHHhh
Q 035713 335 PEIIRG-------EGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQ-PLRFPE---TPQVSFVARDLIRGL 402 (491)
Q Consensus 335 PE~l~~-------~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~---~~~~s~~~~~li~~~ 402 (491)
||++.. ..++.++|||||||++|||++ |..||......+.+..++.. ...++. ...++..+.+++..|
T Consensus 171 PE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (269)
T cd05042 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFC 250 (269)
T ss_pred HHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHH
Confidence 999753 346789999999999999999 88999877766666554433 222222 235788899999999
Q ss_pred hccCCCCCCCcCCChHHhhc
Q 035713 403 LVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 403 L~~dP~~R~t~~~~~~ell~ 422 (491)
+ .||++||+ +++|+.
T Consensus 251 ~-~dp~~Rpt----~~~v~~ 265 (269)
T cd05042 251 W-LDPETRPT----AEEVHE 265 (269)
T ss_pred h-cCcccccC----HHHHHH
Confidence 8 59999999 777764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.00 Aligned_cols=248 Identities=21% Similarity=0.326 Sum_probs=200.8
Q ss_pred eeeeccCceEEEEEEEeCCC------cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 100 KRLGYGDIGSVYLVELRGTN------TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~------~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
+.||+|+||.||+|+++... +.||||.+.+.. .......+.+|+++|+.++||||+++++++...+..|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999986544 689999886542 1234456788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC-----CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC-----cEEEeecccc
Q 035713 174 EFCSGGNLHSLRQKQ-----PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG-----HIMLSDFDLS 243 (491)
Q Consensus 174 E~~~gg~L~~~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g-----~vkL~DFGla 243 (491)
||+++++|.+++... ....+++..+..++.||+.||.|||+++++|+||||+|||++.++ .+||+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999988753 223488999999999999999999999999999999999999887 8999999998
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (491)
.......... ..
T Consensus 159 ~~~~~~~~~~--------------------------------------------------------------------~~ 170 (269)
T cd05044 159 RDIYKSDYYR--------------------------------------------------------------------KE 170 (269)
T ss_pred cccccccccc--------------------------------------------------------------------cC
Confidence 5432110000 00
Q ss_pred cccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhh
Q 035713 324 MSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGL 402 (491)
Q Consensus 324 ~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~ 402 (491)
....++..|+|||++.+..++.++|||||||++|||++ |+.||...+.......+... ..+.....++..+.+||.+|
T Consensus 171 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~ 249 (269)
T cd05044 171 GEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GRLQKPENCPDKIYQLMTNC 249 (269)
T ss_pred cccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-CccCCcccchHHHHHHHHHH
Confidence 01245678999999999889999999999999999998 99999877666555444332 23333346889999999999
Q ss_pred hccCCCCCCCcCCChHHhhc
Q 035713 403 LVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 403 L~~dP~~R~t~~~~~~ell~ 422 (491)
|..+|.+||+ ++++++
T Consensus 250 l~~~p~~Rp~----~~~i~~ 265 (269)
T cd05044 250 WAQDPSERPT----FDRIQE 265 (269)
T ss_pred cCCCcccCCC----HHHHHH
Confidence 9999999999 777764
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=320.85 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=207.3
Q ss_pred CCceEeeeeeccCceEEEEEEEe----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe--Cc
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELR----GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET--DK 167 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~--~~ 167 (491)
++|++++.||+|+||.||+|++. .+++.||||++...... .....+.+|+++++.++|+||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 57899999999999999999965 34889999999765332 455678899999999999999999999887 56
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
..|+||||+++++|.+++.... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 8999999999999999988753 359999999999999999999999999999999999999999999999999986542
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
....... ......
T Consensus 161 ~~~~~~~-------------------------------------------------------------------~~~~~~ 173 (284)
T cd05038 161 EDKDYYY-------------------------------------------------------------------VKEPGE 173 (284)
T ss_pred cCCccee-------------------------------------------------------------------ccCCCC
Confidence 1110000 000113
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcH--------------HHHHHHHcCCCcCCCCCCCCH
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR--------------ATLFNVVGQPLRFPETPQVSF 393 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------------~~~~~i~~~~~~~~~~~~~s~ 393 (491)
++..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+...+......+....++.
T Consensus 174 ~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (284)
T cd05038 174 SPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPD 253 (284)
T ss_pred CcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCH
Confidence 456799999999888999999999999999999999998654221 222334444444554456788
Q ss_pred HHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 394 VARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 394 ~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
++.+|+.+||..+|.+||+ +.+|+.
T Consensus 254 ~~~~li~~cl~~~p~~Rpt----~~ei~~ 278 (284)
T cd05038 254 EVYDLMKLCWEAEPQDRPS----FADLIL 278 (284)
T ss_pred HHHHHHHHHhccChhhCCC----HHHHHH
Confidence 9999999999999999999 888775
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=318.04 Aligned_cols=137 Identities=28% Similarity=0.446 Sum_probs=121.4
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-----C---CCccceeee
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-----H---PFLPTLYSY 162 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----h---p~iv~l~~~ 162 (491)
+...+|.++++||.|-|++||+|.+..+.++||+|+++.. +...+....||.+|++++ | .+||+|++.
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 4458999999999999999999999999999999999754 455566778999999883 2 379999999
Q ss_pred EEe----CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCCEEEccC
Q 035713 163 FET----DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDE 232 (491)
Q Consensus 163 ~~~----~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~NILl~~~ 232 (491)
|.. +.++|||+|++ |.+|..+|+....+.++...++.|++||+.||.|||+ .||||.||||+|||+..+
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST 224 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence 964 56999999999 9999999998888889999999999999999999996 699999999999999543
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=315.98 Aligned_cols=250 Identities=18% Similarity=0.257 Sum_probs=196.6
Q ss_pred eeeeccCceEEEEEEEeC---CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEE-eCceEEEEEec
Q 035713 100 KRLGYGDIGSVYLVELRG---TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE-TDKFYCLVMEF 175 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~-~~~~~~lV~E~ 175 (491)
+.||+|+||.||+|.+.. .+..||||.+... ........+.+|+.+++.++||||+++++++. .++..|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999999754 3457999987542 22334567788999999999999999999765 45678999999
Q ss_pred cCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccc
Q 035713 176 CSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKS 255 (491)
Q Consensus 176 ~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 255 (491)
+.+++|.+++.... ..+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||+++.........
T Consensus 79 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~-- 155 (262)
T cd05058 79 MKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS-- 155 (262)
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee--
Confidence 99999999987643 347788888999999999999999999999999999999999999999999985432110000
Q ss_pred ccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCc
Q 035713 256 SSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAP 335 (491)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 335 (491)
........++..|+||
T Consensus 156 ----------------------------------------------------------------~~~~~~~~~~~~y~aP 171 (262)
T cd05058 156 ----------------------------------------------------------------VHNHTGAKLPVKWMAL 171 (262)
T ss_pred ----------------------------------------------------------------ecccccCcCCccccCh
Confidence 0000012467789999
Q ss_pred chhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcC
Q 035713 336 EIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK 414 (491)
Q Consensus 336 E~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ 414 (491)
|.+.+..++.++|||||||++|||++ |.+||...+.......+... ...+....++..+.+++.+||..+|++||+
T Consensus 172 E~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~-- 248 (262)
T cd05058 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG-RRLLQPEYCPDPLYEVMLSCWHPKPEMRPT-- 248 (262)
T ss_pred hHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCCCcCCHHHHHHHHHHcCCChhhCCC--
Confidence 99998889999999999999999999 56778766655544444433 222223357899999999999999999999
Q ss_pred CChHHhhcC
Q 035713 415 RGATEIKQH 423 (491)
Q Consensus 415 ~~~~ell~h 423 (491)
+.++++.
T Consensus 249 --~~~il~~ 255 (262)
T cd05058 249 --FSELVSR 255 (262)
T ss_pred --HHHHHHH
Confidence 8888753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=318.35 Aligned_cols=248 Identities=22% Similarity=0.301 Sum_probs=193.3
Q ss_pred eeeeccCceEEEEEEEe--CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccC
Q 035713 100 KRLGYGDIGSVYLVELR--GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCS 177 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~ 177 (491)
+.||+|+||.||+|.+. .++..+|+|.++.... ......+.+|+.+++.++||||+++++++.+...+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999865 3456799998865432 2233467789999999999999999999999999999999999
Q ss_pred CCchHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 178 GGNLHSLRQKQP---NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 178 gg~L~~~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
+|+|.+++.... ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~--- 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY--- 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce---
Confidence 999999987532 22467788889999999999999999999999999999999999999999998743211000
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
........|+..|+|
T Consensus 156 -----------------------------------------------------------------~~~~~~~~~~~~y~a 170 (269)
T cd05087 156 -----------------------------------------------------------------YVTPDQLWVPLRWIA 170 (269)
T ss_pred -----------------------------------------------------------------eecCCCcCCcccccC
Confidence 000112367889999
Q ss_pred cchhcCC-------CCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHH-cCCCcCCCC---CCCCHHHHHHHHhh
Q 035713 335 PEIIRGE-------GHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVV-GQPLRFPET---PQVSFVARDLIRGL 402 (491)
Q Consensus 335 PE~l~~~-------~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~-~~~~~~~~~---~~~s~~~~~li~~~ 402 (491)
||++.+. .++.++|||||||++|||++ |+.||......+...... .....++.. ...++.+.+++..|
T Consensus 171 PE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 250 (269)
T cd05087 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFC 250 (269)
T ss_pred HhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHH
Confidence 9998643 35789999999999999996 999998766555443322 222222221 24678899999999
Q ss_pred hccCCCCCCCcCCChHHhhc
Q 035713 403 LVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 403 L~~dP~~R~t~~~~~~ell~ 422 (491)
+ .+|++||+ +++|+.
T Consensus 251 ~-~~P~~Rpt----~~~l~~ 265 (269)
T cd05087 251 W-LQPEQRPS----AEEVHL 265 (269)
T ss_pred h-cCcccCCC----HHHHHH
Confidence 8 68999999 888874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=319.20 Aligned_cols=254 Identities=25% Similarity=0.396 Sum_probs=208.7
Q ss_pred CceEeeeeeccCceEEEEEEEeC-CCcEEEEEEeecchh-------hhHHHHHHHHHHHHHHhh-cCCCCccceeeeEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRG-TNTYFAMKVMDKASL-------ASRNKLLRAQTEREILGL-LDHPFLPTLYSYFET 165 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~-~~~~vaiK~i~~~~~-------~~~~~~~~~~~E~~il~~-l~hp~iv~l~~~~~~ 165 (491)
+|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.++.. ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 688999998864321 223445567788888865 799999999999999
Q ss_pred CceEEEEEeccCCCchHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCCEEEccCCcEEEeeccc
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQ--PNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEGHIMLSDFDL 242 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~NILl~~~g~vkL~DFGl 242 (491)
++..|+||||++|++|.+++... ....+++..++.++.|++.||.|||. .|++|+||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999999887532 23569999999999999999999996 7899999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcc
Q 035713 243 SLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322 (491)
Q Consensus 243 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (491)
+....... .
T Consensus 161 ~~~~~~~~-----------------------------------------------------------------------~ 169 (269)
T cd08528 161 AKQKQPES-----------------------------------------------------------------------K 169 (269)
T ss_pred eeeccccc-----------------------------------------------------------------------c
Confidence 85422100 0
Q ss_pred ccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhh
Q 035713 323 SMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGL 402 (491)
Q Consensus 323 ~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~ 402 (491)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+............++.++.+||.+|
T Consensus 170 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 249 (269)
T cd08528 170 LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSC 249 (269)
T ss_pred cccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHH
Confidence 11236889999999999888999999999999999999999999877666555555554443322335789999999999
Q ss_pred hccCCCCCCCcCCChHHhhcC
Q 035713 403 LVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 403 L~~dP~~R~t~~~~~~ell~h 423 (491)
|+.||++||+ +.|+..+
T Consensus 250 l~~~p~~Rp~----~~e~~~~ 266 (269)
T cd08528 250 LTPDAEARPD----IIQVSAM 266 (269)
T ss_pred CCCCCccCCC----HHHHHHH
Confidence 9999999999 7776543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=320.50 Aligned_cols=238 Identities=24% Similarity=0.301 Sum_probs=191.1
Q ss_pred eeeccCceEEEEEEEeCC------------------------CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCc
Q 035713 101 RLGYGDIGSVYLVELRGT------------------------NTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFL 156 (491)
Q Consensus 101 ~iG~G~~g~V~~a~~~~~------------------------~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~i 156 (491)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+++++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 699999999999986422 2358899886432 2334567789999999999999
Q ss_pred cceeeeEEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC---
Q 035713 157 PTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG--- 233 (491)
Q Consensus 157 v~l~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g--- 233 (491)
+++++++..+...|+||||+++|+|..++... .+.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999888654 35689999999999999999999999999999999999997644
Q ss_pred ----cEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCC
Q 035713 234 ----HIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGG 309 (491)
Q Consensus 234 ----~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (491)
.+||+|||++.....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~------------------------------------------------------------- 176 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALS------------------------------------------------------------- 176 (274)
T ss_pred CccceeeecCCcccccccc-------------------------------------------------------------
Confidence 489999998632110
Q ss_pred CCCccccCCCCccccccccccCccCcchhcC-CCCCCcccccchhhHHHhhh-cCCCCCCCCCcHHHHHHHHcCCCcCCC
Q 035713 310 ALPELMAEPTNVRSMSFVGTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELL-HGTTPFKGQGNRATLFNVVGQPLRFPE 387 (491)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlG~il~ell-tg~~Pf~~~~~~~~~~~i~~~~~~~~~ 387 (491)
.....++..|+|||++.+ ..++.++|||||||++|||+ +|+.||.+...... ..........+.
T Consensus 177 -------------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~~ 242 (274)
T cd05076 177 -------------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-ERFYEKKHRLPE 242 (274)
T ss_pred -------------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-HHHHHhccCCCC
Confidence 001246788999999876 45799999999999999995 69999987655433 233333333443
Q ss_pred CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 388 TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 388 ~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
..+.++.+||.+||+.+|++||+ +.+|+++
T Consensus 243 --~~~~~~~~li~~cl~~~p~~Rps----~~~il~~ 272 (274)
T cd05076 243 --PSCKELATLISQCLTYEPTQRPS----FRTILRD 272 (274)
T ss_pred --CCChHHHHHHHHHcccChhhCcC----HHHHHHh
Confidence 25678999999999999999999 8998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=317.08 Aligned_cols=239 Identities=22% Similarity=0.285 Sum_probs=191.0
Q ss_pred eeeeccCceEEEEEEEeCC------------CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 100 KRLGYGDIGSVYLVELRGT------------NTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~------------~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
+.||+|+||.||+|+.... ...||+|++.... ......+.+|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4689999999999985422 3358888875432 334456778999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCc-------EEEeec
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGH-------IMLSDF 240 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~-------vkL~DF 240 (491)
..++||||+++++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +|++||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999999887754 345999999999999999999999999999999999999987664 899999
Q ss_pred ccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCC
Q 035713 241 DLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTN 320 (491)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (491)
|++.....
T Consensus 157 g~~~~~~~------------------------------------------------------------------------ 164 (262)
T cd05077 157 GIPITVLS------------------------------------------------------------------------ 164 (262)
T ss_pred CCCccccC------------------------------------------------------------------------
Confidence 98743210
Q ss_pred ccccccccccCccCcchhc-CCCCCCcccccchhhHHHhhh-cCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHH
Q 035713 321 VRSMSFVGTHEYLAPEIIR-GEGHGSAVDWWTFGIFLYELL-HGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDL 398 (491)
Q Consensus 321 ~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwSlG~il~ell-tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~l 398 (491)
.....|+..|+|||++. +..++.++|||||||++|||+ .|+.||......+. ........... ...+.++.+|
T Consensus 165 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~l 239 (262)
T cd05077 165 --RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYEGQCMLV--TPSCKELADL 239 (262)
T ss_pred --cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHhcCccCC--CCChHHHHHH
Confidence 00125788899999987 456899999999999999998 58999876543332 23333322222 2356789999
Q ss_pred HHhhhccCCCCCCCcCCChHHhhcC
Q 035713 399 IRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 399 i~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
|.+||+.||++||+ +.+|+++
T Consensus 240 i~~cl~~dp~~Rp~----~~~il~~ 260 (262)
T cd05077 240 MTHCMNYDPNQRPF----FRAIMRD 260 (262)
T ss_pred HHHHcCCChhhCcC----HHHHHHh
Confidence 99999999999999 8998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=312.73 Aligned_cols=255 Identities=27% Similarity=0.461 Sum_probs=214.5
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC------
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD------ 166 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~------ 166 (491)
..+|.-++.+|.|.- .|..|-+.-.++.||+|.+... ........+..+|..++..++|+||++++.+|...
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 357899999999998 8888999999999999988665 45455667788999999999999999999999643
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
..+|+||||| ..+|..++... +.-+.+..++.|+++|+.|||+.||+||||||+||++..++.+||.|||+|+..
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVILME----LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHHHh----cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 3689999999 67898888743 888999999999999999999999999999999999999999999999999643
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
... -+.+.+
T Consensus 169 ~~~-----------------------------------------------------------------------~~mtpy 177 (369)
T KOG0665|consen 169 DTD-----------------------------------------------------------------------FMMTPY 177 (369)
T ss_pred Ccc-----------------------------------------------------------------------cccCch
Confidence 211 123346
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---C---------------------
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---P--------------------- 382 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~--------------------- 382 (491)
+.|..|+|||++.+..|...+||||+||++.||++|+..|.|.+..+++.+++.. +
T Consensus 178 VvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~ 257 (369)
T KOG0665|consen 178 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQ 257 (369)
T ss_pred hheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChH
Confidence 8999999999999999999999999999999999999999998877777665421 0
Q ss_pred ---C----cCCCC---------CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCCh
Q 035713 383 ---L----RFPET---------PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNW 431 (491)
Q Consensus 383 ---~----~~~~~---------~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~ 431 (491)
. .+|+. ..-+..+++|+.+||..||++|.+ ++++|+||||+ -|
T Consensus 258 y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ris----v~daL~HPY~~--vw 316 (369)
T KOG0665|consen 258 YQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRIS----VDDALRHPYIK--VW 316 (369)
T ss_pred hhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhccc----HHHHhcCCeee--ee
Confidence 0 11111 122346899999999999999999 99999999998 56
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=319.72 Aligned_cols=259 Identities=17% Similarity=0.222 Sum_probs=191.8
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCC---CcEEEEEEeecchhh--hHHH------HHHHHHHHHHHhhcCCCCccce
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGT---NTYFAMKVMDKASLA--SRNK------LLRAQTEREILGLLDHPFLPTL 159 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~---~~~vaiK~i~~~~~~--~~~~------~~~~~~E~~il~~l~hp~iv~l 159 (491)
+...+|++.++||+|+||+||+|++..+ +..+|+|+....... .+.. ......+...+..+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3447899999999999999999999877 677888864322111 1110 0111223344566789999999
Q ss_pred eeeEEeCc----eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcE
Q 035713 160 YSYFETDK----FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHI 235 (491)
Q Consensus 160 ~~~~~~~~----~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~v 235 (491)
++++.... ..+++||++ ..++.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 99876543 457889987 45677666653 347889999999999999999999999999999999999999999
Q ss_pred EEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccc
Q 035713 236 MLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELM 315 (491)
Q Consensus 236 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (491)
+|+|||+|+.+........
T Consensus 166 ~l~DFGla~~~~~~~~~~~------------------------------------------------------------- 184 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIE------------------------------------------------------------- 184 (294)
T ss_pred EEEEcCCceeeccCCcccc-------------------------------------------------------------
Confidence 9999999865432110000
Q ss_pred cCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHH---------HHHHcCCCcCC
Q 035713 316 AEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---------FNVVGQPLRFP 386 (491)
Q Consensus 316 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---------~~i~~~~~~~~ 386 (491)
..........||+.|+|||++.+..++.++|||||||+||||++|+.||.+......+ .++......+
T Consensus 185 --~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 261 (294)
T PHA02882 185 --YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKI- 261 (294)
T ss_pred --cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhcc-
Confidence 0000111246999999999999999999999999999999999999999877432221 2222222222
Q ss_pred CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 387 ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 387 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
..+++.+.++++.|+..+|++||+ .++|++
T Consensus 262 --~~~~~~~~~~~~~~~~~~~~~rp~----~~~l~~ 291 (294)
T PHA02882 262 --KNANKFIYDFIECVTKLSYEEKPD----YDALIK 291 (294)
T ss_pred --CCCCHHHHHHHHHHHhCCCCCCCC----HHHHHH
Confidence 346899999999999999999999 777764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=340.12 Aligned_cols=245 Identities=32% Similarity=0.482 Sum_probs=196.7
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc------e
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK------F 168 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~------~ 168 (491)
.|..-+.||+|+||.||+++++.+|+.||||.+++.. .....++..+|+++|++|+|+|||+++++-++.. .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 3667789999999999999999999999999998764 3345567789999999999999999999866543 5
Q ss_pred EEEEEeccCCCchHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc--CCc--EEEeecccc
Q 035713 169 YCLVMEFCSGGNLHSLRQKQP-NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD--EGH--IMLSDFDLS 243 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~--~g~--vkL~DFGla 243 (491)
..+|||||.||+|+.+++.-. ...|++.+...++..++.||.|||++|||||||||+||++-. +|. .||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 679999999999999988643 346999999999999999999999999999999999999853 343 699999999
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (491)
+.+...+ ..
T Consensus 172 rel~d~s-----------------------------------------------------------------------~~ 180 (732)
T KOG4250|consen 172 RELDDNS-----------------------------------------------------------------------LF 180 (732)
T ss_pred ccCCCCC-----------------------------------------------------------------------ee
Confidence 7654322 23
Q ss_pred cccccccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCC----cHHHHHHHHcCC---------------C
Q 035713 324 MSFVGTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQG----NRATLFNVVGQP---------------L 383 (491)
Q Consensus 324 ~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~----~~~~~~~i~~~~---------------~ 383 (491)
.+++||..|.+||++.. ..|+..+|.|||||++|+++||..||.... ..+....++.++ +
T Consensus 181 ~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv 260 (732)
T KOG4250|consen 181 TSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPV 260 (732)
T ss_pred eeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCce
Confidence 46799999999999995 778999999999999999999999995432 233444443221 1
Q ss_pred ----cCCCCCCCCH----HHHHHHHhhhccCCCCCCC
Q 035713 384 ----RFPETPQVSF----VARDLIRGLLVKEPHKRIA 412 (491)
Q Consensus 384 ----~~~~~~~~s~----~~~~li~~~L~~dP~~R~t 412 (491)
.+|....++. .+..++..+|..+|.+|.+
T Consensus 261 ~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 261 EWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH 297 (732)
T ss_pred eeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence 2232223333 3457788899999999993
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=322.21 Aligned_cols=258 Identities=22% Similarity=0.319 Sum_probs=212.7
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
++..+...+.++||+|-||.|.+|.... +..||+|+++.... ......|.+|+++|.+|+|||||+|+++|..++.+
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 3556778899999999999999998874 68999999987643 33456789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+|||||+.|+|.+++.++.-..+.......++.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++.+-..
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999999999998763333455566679999999999999999999999999999999999999999999754321
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.. |++ ....+-.
T Consensus 691 ~y-----------------------y~v---------------------------------------------qgr~vlp 702 (807)
T KOG1094|consen 691 DY-----------------------YRV---------------------------------------------QGRAVLP 702 (807)
T ss_pred Cc-----------------------eee---------------------------------------------ecceeee
Confidence 11 111 1123667
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhc--CCCCCCCCCcHHHHHHHH---cC---CCcCCCCCCCCHHHHHHHHh
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH--GTTPFKGQGNRATLFNVV---GQ---PLRFPETPQVSFVARDLIRG 401 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt--g~~Pf~~~~~~~~~~~i~---~~---~~~~~~~~~~s~~~~~li~~ 401 (491)
..|||+|.+...+++.++|+|+||++|||+++ ...||...++++...+.. .. ...++..+.++..+.+||.+
T Consensus 703 iRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~ 782 (807)
T KOG1094|consen 703 IRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLR 782 (807)
T ss_pred eeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHH
Confidence 89999999999999999999999999999877 778998877766655432 11 12334456799999999999
Q ss_pred hhccCCCCCCCcCCChHHhhc
Q 035713 402 LLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 402 ~L~~dP~~R~t~~~~~~ell~ 422 (491)
||..|-++||+ .+++-.
T Consensus 783 Cw~~es~~RPs----Fe~lh~ 799 (807)
T KOG1094|consen 783 CWRRESEQRPS----FEQLHL 799 (807)
T ss_pred HhchhhhcCCC----HHHHHH
Confidence 99999999999 777643
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=312.71 Aligned_cols=236 Identities=23% Similarity=0.280 Sum_probs=191.3
Q ss_pred eeeeccCceEEEEEEEeCCC----------cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 100 KRLGYGDIGSVYLVELRGTN----------TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~----------~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
+.||+|+||.||+|.+..++ ..+++|++.... .....+.+|+.+|+.++|+||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999998776 347888765432 114667789999999999999999999988 778
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC-------cEEEeeccc
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG-------HIMLSDFDL 242 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g-------~vkL~DFGl 242 (491)
|+||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999999988753 2689999999999999999999999999999999999999887 799999999
Q ss_pred ccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcc
Q 035713 243 SLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322 (491)
Q Consensus 243 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (491)
+.....
T Consensus 155 a~~~~~-------------------------------------------------------------------------- 160 (259)
T cd05037 155 PITVLS-------------------------------------------------------------------------- 160 (259)
T ss_pred cccccc--------------------------------------------------------------------------
Confidence 853211
Q ss_pred ccccccccCccCcchhcCC--CCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHH
Q 035713 323 SMSFVGTHEYLAPEIIRGE--GHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLI 399 (491)
Q Consensus 323 ~~~~~gt~~y~aPE~l~~~--~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li 399 (491)
.....++..|+|||++.+. .++.++|||||||++|||++ |..||...+......... .....+.. ....+.+||
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~li 237 (259)
T cd05037 161 REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP--DCAELANLI 237 (259)
T ss_pred ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC--CchHHHHHH
Confidence 0012566789999999887 68999999999999999999 688887665433322222 22222221 237899999
Q ss_pred HhhhccCCCCCCCcCCChHHhhc
Q 035713 400 RGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 400 ~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
.+||..+|.+||+ +.++++
T Consensus 238 ~~~l~~~p~~Rpt----~~~il~ 256 (259)
T cd05037 238 NQCWTYDPTKRPS----FRAILR 256 (259)
T ss_pred HHHhccChhhCCC----HHHHHH
Confidence 9999999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=314.85 Aligned_cols=254 Identities=20% Similarity=0.313 Sum_probs=202.9
Q ss_pred ceEeeeeeccCceEEEEEEEeC---CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc-----
Q 035713 96 FRLLKRLGYGDIGSVYLVELRG---TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK----- 167 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~----- 167 (491)
|++.+.||+|+||.||+|.+.. +++.||||++.... ........+.+|+++|+.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6788999999999999998653 57899999986543 33445667889999999999999999999886432
Q ss_pred -eEEEEEeccCCCchHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccc
Q 035713 168 -FYCLVMEFCSGGNLHSLRQKQP----NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242 (491)
Q Consensus 168 -~~~lV~E~~~gg~L~~~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGl 242 (491)
..++++||+.+|+|..++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 3578999999999988765321 12478999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcc
Q 035713 243 SLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322 (491)
Q Consensus 243 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (491)
++........ ..
T Consensus 160 ~~~~~~~~~~--------------------------------------------------------------------~~ 171 (273)
T cd05074 160 SKKIYSGDYY--------------------------------------------------------------------RQ 171 (273)
T ss_pred cccccCCcce--------------------------------------------------------------------ec
Confidence 8643211000 00
Q ss_pred ccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHh
Q 035713 323 SMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRG 401 (491)
Q Consensus 323 ~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 401 (491)
.....++..|++||.+.+..++.++|||||||++|||++ |+.||.+.+.......+.... ........+..+.+|+.+
T Consensus 172 ~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~ 250 (273)
T cd05074 172 GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RLKQPPDCLEDVYELMCQ 250 (273)
T ss_pred CCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHH
Confidence 011245678999999998889999999999999999999 999998776655554444332 222334578999999999
Q ss_pred hhccCCCCCCCcCCChHHhhcC
Q 035713 402 LLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 402 ~L~~dP~~R~t~~~~~~ell~h 423 (491)
||+.+|++||+ +.+++++
T Consensus 251 ~l~~~p~~Rps----~~~~~~~ 268 (273)
T cd05074 251 CWSPEPKCRPS----FQHLRDQ 268 (273)
T ss_pred HcCCChhhCcC----HHHHHHH
Confidence 99999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=311.95 Aligned_cols=248 Identities=18% Similarity=0.267 Sum_probs=192.7
Q ss_pred eeeeccCceEEEEEEEeCCC--cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccC
Q 035713 100 KRLGYGDIGSVYLVELRGTN--TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCS 177 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~--~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~ 177 (491)
+.||+|+||.||+|+....+ ..+++|.+.... .......+.+|+.+++.++||||+++++.+.....+|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 36999999999999865433 346667665432 22345678899999999999999999999999999999999999
Q ss_pred CCchHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccc
Q 035713 178 GGNLHSLRQKQP--NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKS 255 (491)
Q Consensus 178 gg~L~~~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 255 (491)
+|+|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~---- 154 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY---- 154 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh----
Confidence 999999887542 23467788899999999999999999999999999999999999999999998742110000
Q ss_pred ccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCc
Q 035713 256 SSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAP 335 (491)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 335 (491)
.......+|+..|+||
T Consensus 155 ----------------------------------------------------------------~~~~~~~~~~~~y~aP 170 (268)
T cd05086 155 ----------------------------------------------------------------IETEDDKCVPLRWLAP 170 (268)
T ss_pred ----------------------------------------------------------------hhcccCCcCcccccCc
Confidence 0001123688999999
Q ss_pred chhcC-------CCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCC-CcCC---CCCCCCHHHHHHHHhhh
Q 035713 336 EIIRG-------EGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQP-LRFP---ETPQVSFVARDLIRGLL 403 (491)
Q Consensus 336 E~l~~-------~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~---~~~~~s~~~~~li~~~L 403 (491)
|++.. ..++.++|||||||++|||++ |..||...+..+.+..++... ...+ ....+++.+.++|..||
T Consensus 171 E~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 250 (268)
T cd05086 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW 250 (268)
T ss_pred hhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh
Confidence 99853 235779999999999999997 678998777666666654332 2111 12347888999999999
Q ss_pred ccCCCCCCCcCCChHHhhc
Q 035713 404 VKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 404 ~~dP~~R~t~~~~~~ell~ 422 (491)
.+|++||+ +++|++
T Consensus 251 -~~P~~Rp~----~~~i~~ 264 (268)
T cd05086 251 -LSPEKRAT----AEEVHR 264 (268)
T ss_pred -hCcccCCC----HHHHHH
Confidence 68999999 888864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.50 Aligned_cols=263 Identities=20% Similarity=0.243 Sum_probs=183.6
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCC----CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeee--
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGT----NTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSY-- 162 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~----~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~-- 162 (491)
..+..++|++.++||+|+||.||+|++..+ +..||||++...... ....+| .++...+.++..++..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFL 199 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhh
Confidence 345678999999999999999999999988 899999987643211 111111 1222222233322222
Q ss_pred ----EEeCceEEEEEeccCCCchHHHHHhCCCC------------------CCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 035713 163 ----FETDKFYCLVMEFCSGGNLHSLRQKQPNK------------------YFTEDAARFFASEVLLALEYLHMLGIVYR 220 (491)
Q Consensus 163 ----~~~~~~~~lV~E~~~gg~L~~~~~~~~~~------------------~l~~~~~~~~~~qi~~aL~~LH~~givHr 220 (491)
...+..++|||||+.+++|.+++...... ...+..++.++.||+.||.|||++||+||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 23566899999999999999988754211 12244577899999999999999999999
Q ss_pred cCCCCCEEEcc-CCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCC
Q 035713 221 DLKPENVLVRD-EGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKS 299 (491)
Q Consensus 221 Dikp~NILl~~-~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (491)
||||+|||++. ++.+||+|||+|+.+....
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~------------------------------------------------- 310 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGI------------------------------------------------- 310 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCcccccccc-------------------------------------------------
Confidence 99999999985 6899999999985432110
Q ss_pred CCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCC----------------------CCCcccccchhhHHH
Q 035713 300 KSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG----------------------HGSAVDWWTFGIFLY 357 (491)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----------------------~~~~~DiwSlG~il~ 357 (491)
.....+++||+.|||||++.... ++.++|||||||+||
T Consensus 311 --------------------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~ 370 (566)
T PLN03225 311 --------------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370 (566)
T ss_pred --------------------ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHH
Confidence 00112357899999999765332 344669999999999
Q ss_pred hhhcCCCCCCCCCcHHHHHHHHcC-CCc-------------------CCCCCCCCHHHHHHHHhhhccCCCCCCCcCCCh
Q 035713 358 ELLHGTTPFKGQGNRATLFNVVGQ-PLR-------------------FPETPQVSFVARDLIRGLLVKEPHKRIAYKRGA 417 (491)
Q Consensus 358 elltg~~Pf~~~~~~~~~~~i~~~-~~~-------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~ 417 (491)
||+++..++.. ....+.+++.. ... +.........+.+||.+||++||.+||| +
T Consensus 371 el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t----a 444 (566)
T PLN03225 371 QMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS----A 444 (566)
T ss_pred HHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC----H
Confidence 99997766542 22222222211 000 0000112334669999999999999999 9
Q ss_pred HHhhcCCCcCCCChhh
Q 035713 418 TEIKQHPFFEGVNWAL 433 (491)
Q Consensus 418 ~ell~hpff~~~~~~~ 433 (491)
.++|+||||++..+..
T Consensus 445 ~e~L~Hpff~~~~~~~ 460 (566)
T PLN03225 445 KAALAHPYFDREGLLG 460 (566)
T ss_pred HHHhCCcCcCCCCccc
Confidence 9999999999988763
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=307.38 Aligned_cols=261 Identities=28% Similarity=0.410 Sum_probs=212.0
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc-----eE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK-----FY 169 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~-----~~ 169 (491)
+.+--+-||.|+||+||.+++.++|+.||+|.+.. .+.+-...+++.+|+.+|...+|.||+..+++.+... .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 34455789999999999999999999999998743 3444455667889999999999999999999887543 57
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+|+|+| ..+|..++-. ...++...++.+++||++||.|||+.||.||||||.|+|++.+..+||||||||+..+.+
T Consensus 133 YV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 8999999 5688877665 356999999999999999999999999999999999999999999999999999764322
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
... ..+.-+-|
T Consensus 210 ~~~---------------------------------------------------------------------hMTqEVVT 220 (449)
T KOG0664|consen 210 DRL---------------------------------------------------------------------NMTHEVVT 220 (449)
T ss_pred hhh---------------------------------------------------------------------hhHHHHHH
Confidence 111 11123789
Q ss_pred cCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHH-----------------------cCCCcC
Q 035713 330 HEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV-----------------------GQPLRF 385 (491)
Q Consensus 330 ~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~-----------------------~~~~~~ 385 (491)
.+|+|||++.|.+ |+.++||||.|||+.||+-.+..|...+..+++..|. +...+.
T Consensus 221 QYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~ 300 (449)
T KOG0664|consen 221 QYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRA 300 (449)
T ss_pred HHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCC
Confidence 9999999999976 7999999999999999999999999887776665442 122222
Q ss_pred CCC---------CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 386 PET---------PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 386 ~~~---------~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
|.. ..-.-+..+++.+||..||++|.+ .++++.|++....+..
T Consensus 301 Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris----~~~A~~~~~~~e~R~r 352 (449)
T KOG0664|consen 301 PDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS----VEEALQHRYLEEGRLR 352 (449)
T ss_pred CCccceeeecCCcccchHHHHHHHHHhCCCCccccc----Hhhhccccccccccee
Confidence 221 123346789999999999999999 9999999999776543
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=329.82 Aligned_cols=252 Identities=22% Similarity=0.308 Sum_probs=215.2
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCC-C--cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGT-N--TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~-~--~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
|..++.++.++||+|.||+||+|.++.. | ..||||+++...... ....|++|+.+|.+|+|+|+++||++..+ .
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 4457788899999999999999998753 2 359999997665432 56778999999999999999999999987 6
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+.||||++++|+|.+.+++.....|.......|+.||+.||.||.++++|||||...|||+-....||||||||.+-+.
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 77899999999999999888666779999999999999999999999999999999999999999999999999987654
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
........ +. ..-
T Consensus 264 ~ned~Yvm--------------------------~p-----------------------------------------~rk 276 (1039)
T KOG0199|consen 264 ENEDMYVM--------------------------AP-----------------------------------------QRK 276 (1039)
T ss_pred CCCcceEe--------------------------cC-----------------------------------------CCc
Confidence 32221110 00 001
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
-...|.|||.|+...++.++|+|++||+||||++ |..||.|......+.+|- ..-+++....+++++.++++.||+.+
T Consensus 277 vPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~csedIY~imk~cWah~ 355 (1039)
T KOG0199|consen 277 VPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCSEDIYQIMKNCWAHN 355 (1039)
T ss_pred CcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCChHHHHHHHHHhccCC
Confidence 2467999999999999999999999999999999 999999998888777776 55677777789999999999999999
Q ss_pred CCCCCCc
Q 035713 407 PHKRIAY 413 (491)
Q Consensus 407 P~~R~t~ 413 (491)
|.+||++
T Consensus 356 paDRptF 362 (1039)
T KOG0199|consen 356 PADRPTF 362 (1039)
T ss_pred ccccccH
Confidence 9999994
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=332.42 Aligned_cols=260 Identities=24% Similarity=0.346 Sum_probs=227.0
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCCCc---EEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNT---YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET 165 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 165 (491)
.+|......|.++||.|.||.|++|+.+..|+ .||||.++.. ..+++...|+.|+.||-+.+||||++|.++...
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 35677788999999999999999999987664 5999999755 345667789999999999999999999999999
Q ss_pred CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
.+-+.||+|||++|+|..+++.+. +.|+.-++..+++.|+.||.||-++|+|||||...|||++.+-.+|++||||++.
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence 999999999999999999999875 5699999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
++.++.... .+.||+.
T Consensus 781 ledd~~~~y--------------------------------------------------tt~GGKI-------------- 796 (996)
T KOG0196|consen 781 LEDDPEAAY--------------------------------------------------TTLGGKI-------------- 796 (996)
T ss_pred cccCCCccc--------------------------------------------------cccCCcc--------------
Confidence 765442110 0112211
Q ss_pred cccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhc
Q 035713 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLV 404 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~ 404 (491)
...|.|||.+...+++.++||||+|++|||.++ |..||...++++.+..| .+.+++|....++..+..|+..||+
T Consensus 797 ---PiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI-e~gyRLPpPmDCP~aL~qLMldCWq 872 (996)
T KOG0196|consen 797 ---PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-EQGYRLPPPMDCPAALYQLMLDCWQ 872 (996)
T ss_pred ---ceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH-HhccCCCCCCCCcHHHHHHHHHHHH
Confidence 368999999999999999999999999999888 99999999888877665 5668888888999999999999999
Q ss_pred cCCCCCCCcCCChHHhhcC
Q 035713 405 KEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 405 ~dP~~R~t~~~~~~ell~h 423 (491)
+|-.+||. +.+|..+
T Consensus 873 kdR~~RP~----F~qiV~~ 887 (996)
T KOG0196|consen 873 KDRNRRPK----FAQIVST 887 (996)
T ss_pred HHhhcCCC----HHHHHHH
Confidence 99999999 7777664
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=326.62 Aligned_cols=265 Identities=21% Similarity=0.252 Sum_probs=194.2
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEe----------------CCCcEEEEEEeecchhhhHHH-----------HHHHH
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELR----------------GTNTYFAMKVMDKASLASRNK-----------LLRAQ 142 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~----------------~~~~~vaiK~i~~~~~~~~~~-----------~~~~~ 142 (491)
.+..++|++.++||+|+||+||+|.+. ..++.||||.++......... .+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 456789999999999999999999752 345679999986432111111 11233
Q ss_pred HHHHHHhhcCCCCc-----cceeeeEEe--------CceEEEEEeccCCCchHHHHHhCC--------------------
Q 035713 143 TEREILGLLDHPFL-----PTLYSYFET--------DKFYCLVMEFCSGGNLHSLRQKQP-------------------- 189 (491)
Q Consensus 143 ~E~~il~~l~hp~i-----v~l~~~~~~--------~~~~~lV~E~~~gg~L~~~~~~~~-------------------- 189 (491)
.|+.++.+++|.++ ++++++|.. .+..||||||+.+++|.++++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 46777777776554 677777642 356899999999999999886421
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccccccCCCCCC
Q 035713 190 --NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGG 267 (491)
Q Consensus 190 --~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 267 (491)
...+++..++.++.||+.+|.|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~--------------- 365 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF--------------- 365 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc---------------
Confidence 112466788999999999999999999999999999999999999999999998543210000
Q ss_pred CCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCC-----
Q 035713 268 GGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG----- 342 (491)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----- 342 (491)
......+|+.|+|||++....
T Consensus 366 ------------------------------------------------------~~~~g~~tp~Y~aPE~l~~~~~~~~~ 391 (507)
T PLN03224 366 ------------------------------------------------------NPLYGMLDPRYSPPEELVMPQSCPRA 391 (507)
T ss_pred ------------------------------------------------------CccccCCCcceeChhhhcCCCCCCcc
Confidence 000114578999999986432
Q ss_pred ---------------CC--CcccccchhhHHHhhhcCCC-CCCCCCcH-----------HHHHHHHcCCCcCCCCCCCCH
Q 035713 343 ---------------HG--SAVDWWTFGIFLYELLHGTT-PFKGQGNR-----------ATLFNVVGQPLRFPETPQVSF 393 (491)
Q Consensus 343 ---------------~~--~~~DiwSlG~il~elltg~~-Pf~~~~~~-----------~~~~~i~~~~~~~~~~~~~s~ 393 (491)
|+ ...||||+||++|+|++|.. ||.+.... ..+..+....+.++....+++
T Consensus 392 ~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~ 471 (507)
T PLN03224 392 PAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKE 471 (507)
T ss_pred chhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccCh
Confidence 11 24799999999999999885 77542111 111223344556666667899
Q ss_pred HHHHHHHhhhccCC---CCCCCcCCChHHhhcCCCcC
Q 035713 394 VARDLIRGLLVKEP---HKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 394 ~~~~li~~~L~~dP---~~R~t~~~~~~ell~hpff~ 427 (491)
.++|||.+||..+| .+|++ ++|+|+||||.
T Consensus 472 ~~~dLi~~LL~~~~~~~~~RlS----a~eaL~Hp~f~ 504 (507)
T PLN03224 472 AGWDLACKLITKRDQANRGRLS----VGQALSHRFFL 504 (507)
T ss_pred HHHHHHHHHhccCCCCcccCCC----HHHHhCCCCcC
Confidence 99999999999876 68999 99999999995
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=322.03 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=210.2
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeC----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEE
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRG----TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE 164 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 164 (491)
..+..+...+.++||.|-||.||.|.... ..-.||||..+... ..+..+.|+.|..+|+.++|||||+|+|++.
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 34555666777899999999999998642 23459999987643 2334677889999999999999999999997
Q ss_pred eCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 165 TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 165 ~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
+. -.|||||+++-|.|..|++..+ ..|+......|+.||+.||.|||+..+|||||...|||+.....|||+||||++
T Consensus 462 e~-P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 462 EQ-PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred cc-ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhh
Confidence 55 5789999999999999999874 569999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
.+..+.....+
T Consensus 540 ~~ed~~yYkaS--------------------------------------------------------------------- 550 (974)
T KOG4257|consen 540 YLEDDAYYKAS--------------------------------------------------------------------- 550 (974)
T ss_pred hccccchhhcc---------------------------------------------------------------------
Confidence 76543321110
Q ss_pred ccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhh
Q 035713 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLL 403 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L 403 (491)
...-..-|||||-+.-.+++.++|||-|||++||+++ |..||.|-.+.+.+..+-+ .-++|..+++++.+..|+.+||
T Consensus 551 ~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn-GeRlP~P~nCPp~LYslmskcW 629 (974)
T KOG4257|consen 551 RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN-GERLPCPPNCPPALYSLMSKCW 629 (974)
T ss_pred ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC-CCCCCCCCCCChHHHHHHHHHh
Confidence 1123467999999999999999999999999999998 9999999877776655433 3456666789999999999999
Q ss_pred ccCCCCCCCc
Q 035713 404 VKEPHKRIAY 413 (491)
Q Consensus 404 ~~dP~~R~t~ 413 (491)
++||.+||.+
T Consensus 630 ayeP~kRPrf 639 (974)
T KOG4257|consen 630 AYEPSKRPRF 639 (974)
T ss_pred ccCcccCCcH
Confidence 9999999994
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=315.55 Aligned_cols=252 Identities=21% Similarity=0.333 Sum_probs=220.0
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
.+++...+..+..+||-|.||.||.|.+++-.-.||||.++.+ ...+.+|+.|..+|+.++|||+|+|+++|..+-
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 3445556777889999999999999999999999999998754 345678889999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
-+|||+|||..|+|.+|+++.....++.-...+++.||..||+||..+++|||||...|+|+.++..||++||||++.+.
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999999999999998766668888888999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
.+.... |. |. -
T Consensus 417 gDTYTA------------------------HA----------------------------GA-----------------K 427 (1157)
T KOG4278|consen 417 GDTYTA------------------------HA----------------------------GA-----------------K 427 (1157)
T ss_pred CCceec------------------------cc----------------------------Cc-----------------c
Confidence 322111 10 00 1
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
-.+.|.|||-|....++.++|||+|||+|||+.| |..||.|-+. .+.+.++...++......|++...+|+..||+++
T Consensus 428 FPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~Ws 506 (1157)
T KOG4278|consen 428 FPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWS 506 (1157)
T ss_pred CcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCC
Confidence 2467999999999999999999999999999999 9999998744 4566778888888888899999999999999999
Q ss_pred CCCCCCc
Q 035713 407 PHKRIAY 413 (491)
Q Consensus 407 P~~R~t~ 413 (491)
|.+||++
T Consensus 507 PsDRPsF 513 (1157)
T KOG4278|consen 507 PSDRPSF 513 (1157)
T ss_pred cccCccH
Confidence 9999994
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=292.05 Aligned_cols=242 Identities=46% Similarity=0.791 Sum_probs=203.6
Q ss_pred CceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccCCCchHHHH
Q 035713 106 DIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLR 185 (491)
Q Consensus 106 ~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~~ 185 (491)
+||.||+|.+..+++.+|+|++........ ...+.+|+++++.++|+||+++++++......++||||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999999999999999876543221 567789999999999999999999999999999999999999999998
Q ss_pred HhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccccccCCCC
Q 035713 186 QKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSG 265 (491)
Q Consensus 186 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~ 265 (491)
.... .++...+..++.+++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 ~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--------------- 141 (244)
T smart00220 79 KKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--------------- 141 (244)
T ss_pred Hhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---------------
Confidence 7753 38999999999999999999999999999999999999999999999999985432110
Q ss_pred CCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCCCCC
Q 035713 266 GGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGS 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ 345 (491)
......++..|++||.+.+..++.
T Consensus 142 --------------------------------------------------------~~~~~~~~~~~~~pE~~~~~~~~~ 165 (244)
T smart00220 142 --------------------------------------------------------LLTTFVGTPEYMAPEVLLGKGYGK 165 (244)
T ss_pred --------------------------------------------------------ccccccCCcCCCCHHHHccCCCCc
Confidence 011236788999999999888899
Q ss_pred cccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC-CcCCCCCC-CCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 346 AVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP-LRFPETPQ-VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 346 ~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~-~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
++||||||+++|+|++|..||........+.+.+... ........ ++.++.+++.+||..||++||+ +.++++|
T Consensus 166 ~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~----~~~~~~~ 241 (244)
T smart00220 166 AVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT----AEEALQH 241 (244)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC----HHHHhhC
Confidence 9999999999999999999998744444444444333 22222211 8899999999999999999999 9999999
Q ss_pred CCc
Q 035713 424 PFF 426 (491)
Q Consensus 424 pff 426 (491)
|||
T Consensus 242 ~~~ 244 (244)
T smart00220 242 PFF 244 (244)
T ss_pred CCC
Confidence 997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=302.30 Aligned_cols=302 Identities=24% Similarity=0.342 Sum_probs=210.7
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeC---CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEe
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRG---TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFET 165 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~ 165 (491)
+...+.|.++++||+|+|++||++.+.. .+++||+|.|...... .++.+|+++|..+. +.||+.+.+++..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 3345789999999999999999999887 7889999998765333 35778999999995 8999999999999
Q ss_pred CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEc-cCCcEEEeeccccc
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVR-DEGHIMLSDFDLSL 244 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~-~~g~vkL~DFGla~ 244 (491)
++.+++||||++.....++... ++..+++.|++.++.||.++|.+|||||||||+|+|.+ ..+.-.|+|||||.
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 9999999999999999988765 78999999999999999999999999999999999998 46788999999996
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
.............+..+......+..... ++- .+ .....|... ..........-
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~--------------------~~~-~~---~~~p~g~~~--~~~~~r~~~~a 235 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHC--------------------QSV-AT---ASKPAGYYR--RCNDGRPSERA 235 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccc--------------------ccc-cc---ccCCCCcee--ccCCCccceec
Confidence 42221111111100000000000000000 000 00 000000000 00001111122
Q ss_pred ccccccCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCc-HHHHHHHH---------------cC------
Q 035713 325 SFVGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGN-RATLFNVV---------------GQ------ 381 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~-~~~~~~i~---------------~~------ 381 (491)
...||++|+|||++...+ .++++||||.|||+..+++++.||..... ...+..|. +.
T Consensus 236 nrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~k 315 (418)
T KOG1167|consen 236 NRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQK 315 (418)
T ss_pred ccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeecc
Confidence 358999999999999876 48999999999999999999999853221 11111110 00
Q ss_pred --------------CC------c--------CCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCCh
Q 035713 382 --------------PL------R--------FPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNW 431 (491)
Q Consensus 382 --------------~~------~--------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~ 431 (491)
.+ . .......+..+.+|+.+||..||.+|.+ |+++|+||||...+-
T Consensus 316 sn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRit----AEeALkHpFF~~~~~ 389 (418)
T KOG1167|consen 316 SNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRIT----AEDALKHPFFDEADR 389 (418)
T ss_pred ccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhccc----HHHHhcCcCCcchhh
Confidence 00 0 0011234457899999999999999999 999999999985543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=273.83 Aligned_cols=224 Identities=25% Similarity=0.346 Sum_probs=183.6
Q ss_pred CCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEe
Q 035713 87 RGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFET 165 (491)
Q Consensus 87 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~ 165 (491)
+..++..++...+..||+|+||.|-+.++..+|...|+|.+.... . .+...++.+|+.+..+. .+|++|++|+....
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-N-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-C-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 335566678888899999999999999999999999999986542 3 34445677888876655 69999999999999
Q ss_pred CceEEEEEeccCCCchHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccccCCCCCEEEccCCcEEEeeccc
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQK--QPNKYFTEDAARFFASEVLLALEYLHML-GIVYRDLKPENVLVRDEGHIMLSDFDL 242 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~NILl~~~g~vkL~DFGl 242 (491)
++.++|.||.| .-+|..+.++ ..++.++|..+-.++..++.||.|||++ .|||||+||+||||+.+|+||+||||+
T Consensus 117 egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 117 EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccc
Confidence 99999999999 5677766442 2357799999999999999999999975 899999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcc
Q 035713 243 SLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322 (491)
Q Consensus 243 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (491)
+..+..+--.
T Consensus 196 sG~L~dSiAk---------------------------------------------------------------------- 205 (282)
T KOG0984|consen 196 SGYLVDSIAK---------------------------------------------------------------------- 205 (282)
T ss_pred ceeehhhhHH----------------------------------------------------------------------
Confidence 8654321100
Q ss_pred ccccccccCccCcchhcC----CCCCCcccccchhhHHHhhhcCCCCCCC-CCcHHHHHHHHcCCCc
Q 035713 323 SMSFVGTHEYLAPEIIRG----EGHGSAVDWWTFGIFLYELLHGTTPFKG-QGNRATLFNVVGQPLR 384 (491)
Q Consensus 323 ~~~~~gt~~y~aPE~l~~----~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~i~~~~~~ 384 (491)
+--.|...|||||.+.. ..|+.++||||||+++.||.+++.||.. .+..+++.+++..+.+
T Consensus 206 -t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P 271 (282)
T KOG0984|consen 206 -TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP 271 (282)
T ss_pred -HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence 00257889999999864 3689999999999999999999999965 4567778888877644
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.91 Aligned_cols=250 Identities=28% Similarity=0.405 Sum_probs=197.8
Q ss_pred ceEeeeeeccCceE-EEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCceEEEEE
Q 035713 96 FRLLKRLGYGDIGS-VYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 96 y~~~~~iG~G~~g~-V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~~lV~ 173 (491)
|.-.+.+|.|+.|+ ||+|... |+.||||.+-. +....+++|+.+|+..+ |||||++|+.-++.+.+||+.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 33446789999986 8999987 77999998643 34446678999999985 999999999999999999999
Q ss_pred eccCCCchHHHHHhC-CC-CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc---C--CcEEEeeccccccc
Q 035713 174 EFCSGGNLHSLRQKQ-PN-KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD---E--GHIMLSDFDLSLRC 246 (491)
Q Consensus 174 E~~~gg~L~~~~~~~-~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~---~--g~vkL~DFGla~~~ 246 (491)
|.| ..+|.++++.. .. .....-..+.++.|++.||++||+.+||||||||.||||+. + ..++|+|||+++++
T Consensus 583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999 67999999874 11 11122456788999999999999999999999999999986 3 46899999999876
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
....... .+..+.
T Consensus 662 ~~~~sS~-------------------------------------------------------------------~r~s~~ 674 (903)
T KOG1027|consen 662 AGGKSSF-------------------------------------------------------------------SRLSGG 674 (903)
T ss_pred CCCcchh-------------------------------------------------------------------hcccCC
Confidence 5322111 112234
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCC-CCCCHHHHHHHHhhhc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPET-PQVSFVARDLIRGLLV 404 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~s~~~~~li~~~L~ 404 (491)
.||-+|+|||++....-..++||+||||++|..++ |..||...-. .-.+|+.+....-.. +....+++|||.+||.
T Consensus 675 sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~ 752 (903)
T KOG1027|consen 675 SGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTLVHLEPLPDCEAKDLISRMLN 752 (903)
T ss_pred CCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccceeeeccCchHHHHHHHHHhcC
Confidence 79999999999999988899999999999999999 5999976433 335666665443221 1111289999999999
Q ss_pred cCCCCCCCcCCChHHhhcCCCcC
Q 035713 405 KEPHKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 405 ~dP~~R~t~~~~~~ell~hpff~ 427 (491)
+||..||+ |.++|.||||-
T Consensus 753 ~dP~~RPs----a~~VL~HPlFW 771 (903)
T KOG1027|consen 753 PDPQLRPS----ATDVLNHPLFW 771 (903)
T ss_pred CCcccCCC----HHHHhCCCccC
Confidence 99999999 99999999994
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=304.02 Aligned_cols=203 Identities=32% Similarity=0.503 Sum_probs=178.3
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHH-----HHHHHHHHHHHHhhcC---CCCccceeeeE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRN-----KLLRAQTEREILGLLD---HPFLPTLYSYF 163 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~-----~~~~~~~E~~il~~l~---hp~iv~l~~~~ 163 (491)
...+|..++.||+|+||.||+|.++.+...|+||.|.|.++--.. .+-.+-.|++||..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 346799999999999999999999999999999999887654332 2334567999999997 99999999999
Q ss_pred EeCceEEEEEecc-CCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccc
Q 035713 164 ETDKFYCLVMEFC-SGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242 (491)
Q Consensus 164 ~~~~~~~lV~E~~-~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGl 242 (491)
++++++||+||-- +|.+|++++... ..++|.+++.|+.||+.|+++||++||||||||-+|++++.+|.+||+|||.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 9999999999964 567999999986 4599999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcc
Q 035713 243 SLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322 (491)
Q Consensus 243 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (491)
|..... -.
T Consensus 717 aa~~ks------------------------------------------------------------------------gp 724 (772)
T KOG1152|consen 717 AAYTKS------------------------------------------------------------------------GP 724 (772)
T ss_pred hhhhcC------------------------------------------------------------------------CC
Confidence 743211 11
Q ss_pred ccccccccCccCcchhcCCCC-CCcccccchhhHHHhhhcCCCCCCC
Q 035713 323 SMSFVGTHEYLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKG 368 (491)
Q Consensus 323 ~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlG~il~elltg~~Pf~~ 368 (491)
...++||..|.|||+|.|..| +..-|||+||++||.++....||+.
T Consensus 725 fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 725 FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 235799999999999999998 8899999999999999999999863
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=312.66 Aligned_cols=258 Identities=28% Similarity=0.466 Sum_probs=221.2
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.++|++++++|.|+||.||+|+++.+++..|+|+++... ...+.-++.|+-+++.++|||||.+++.+-....++++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 378999999999999999999999999999999997653 23445567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
||||.||+|.+..+-. +.+++.++..++++.+.||+|||++|-+|||||-.|||++..|.+||+|||.+..+..
T Consensus 91 MEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita---- 164 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA---- 164 (829)
T ss_pred EEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh----
Confidence 9999999999877654 6799999999999999999999999999999999999999999999999998743210
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
+-.+..++.||++|
T Consensus 165 ------------------------------------------------------------------ti~KrksfiGtpyw 178 (829)
T KOG0576|consen 165 ------------------------------------------------------------------TIAKRKSFIGTPYW 178 (829)
T ss_pred ------------------------------------------------------------------hhhhhhcccCCccc
Confidence 11123357999999
Q ss_pred cCcchhc---CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcC---CCCCCCCHHHHHHHHhhhccC
Q 035713 333 LAPEIIR---GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF---PETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 333 ~aPE~l~---~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~s~~~~~li~~~L~~d 406 (491)
||||+-. ...|...+|||++|++..|+--.++|.........++......++. .+....++.+.+|++.+|.++
T Consensus 179 mapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altkn 258 (829)
T KOG0576|consen 179 MAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKN 258 (829)
T ss_pred cchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCC
Confidence 9999864 4568999999999999999999999877666666555555444443 344578899999999999999
Q ss_pred CCCCCCcCCChHHhhcCCCcCCC
Q 035713 407 PHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 407 P~~R~t~~~~~~ell~hpff~~~ 429 (491)
|++||+ ++.+|+|||...-
T Consensus 259 pKkRpt----aeklL~h~fvs~~ 277 (829)
T KOG0576|consen 259 PKKRPT----AEKLLQHPFVSQT 277 (829)
T ss_pred CccCCC----hhhheeceeeccc
Confidence 999999 9999999998654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=335.58 Aligned_cols=239 Identities=20% Similarity=0.285 Sum_probs=186.8
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
..|...+.||+|+||.||+|+++.++..||||++...... ...|+++|++++|||||++++++.+.+..|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 3566778999999999999999999999999998643211 124688999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH---MLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
||+++|+|.++++. +++..+..++.||+.||+||| +.+|+||||||+|||++.++..++. ||......
T Consensus 763 Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~--- 833 (968)
T PLN00113 763 EYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC--- 833 (968)
T ss_pred eCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc---
Confidence 99999999999863 889999999999999999999 6699999999999999998888775 65542110
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
...+..||+
T Consensus 834 -----------------------------------------------------------------------~~~~~~~t~ 842 (968)
T PLN00113 834 -----------------------------------------------------------------------TDTKCFISS 842 (968)
T ss_pred -----------------------------------------------------------------------cCCCccccc
Confidence 001126889
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCc----HHHHHHHHc----------CCCc--CCCCCCCCHH
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGN----RATLFNVVG----------QPLR--FPETPQVSFV 394 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~~~~i~~----------~~~~--~~~~~~~s~~ 394 (491)
.|||||++.+..++.++|||||||++|||++|+.||..... .....+... .... .+.......+
T Consensus 843 ~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (968)
T PLN00113 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVE 922 (968)
T ss_pred cccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHH
Confidence 99999999999999999999999999999999999954311 111111110 0000 0000011235
Q ss_pred HHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 395 ARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 395 ~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
+.+++.+||+.||++||+ +.++++.
T Consensus 923 ~~~l~~~Cl~~~P~~RPt----~~evl~~ 947 (968)
T PLN00113 923 VMNLALHCTATDPTARPC----ANDVLKT 947 (968)
T ss_pred HHHHHHhhCcCCchhCcC----HHHHHHH
Confidence 678999999999999999 7888764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=283.94 Aligned_cols=249 Identities=25% Similarity=0.336 Sum_probs=189.2
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhh--cCCCCccceeeeEEeC----
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL--LDHPFLPTLYSYFETD---- 166 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~--l~hp~iv~l~~~~~~~---- 166 (491)
..+..+++.||+|.||.||+|+++ |+.||||++.... .....+|.+|.+. |+|+||+.+++.-..+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hheeEEEEEecCccccceeecccc--CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 367899999999999999999999 7789999996432 2234567777765 5999999999876543
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc--------CcccccCCCCCEEEccCCcEEEe
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML--------GIVYRDLKPENVLVRDEGHIMLS 238 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------givHrDikp~NILl~~~g~vkL~ 238 (491)
..+|||++|.+.|+|++|+.+. .++.+....++..++.||+|||.. .|.|||||..|||+.++|.+-|+
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 3799999999999999999984 599999999999999999999963 39999999999999999999999
Q ss_pred ecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCC
Q 035713 239 DFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEP 318 (491)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (491)
|+|||..........+
T Consensus 359 DLGLAv~h~~~t~~id---------------------------------------------------------------- 374 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTID---------------------------------------------------------------- 374 (513)
T ss_pred eceeeEEecccCCccc----------------------------------------------------------------
Confidence 9999966433221111
Q ss_pred CCccccccccccCccCcchhcCCC----C--CCcccccchhhHHHhhhcC----------CCCCCC----CCcHHHHHHH
Q 035713 319 TNVRSMSFVGTHEYLAPEIIRGEG----H--GSAVDWWTFGIFLYELLHG----------TTPFKG----QGNRATLFNV 378 (491)
Q Consensus 319 ~~~~~~~~~gt~~y~aPE~l~~~~----~--~~~~DiwSlG~il~elltg----------~~Pf~~----~~~~~~~~~i 378 (491)
...+..+||..|||||+|...- + -..+||||||.++||++.. ++||++ +...+.+.++
T Consensus 375 --i~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkV 452 (513)
T KOG2052|consen 375 --IPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKV 452 (513)
T ss_pred --CCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcc
Confidence 1112349999999999997642 2 3478999999999998752 468864 2334445444
Q ss_pred H-cCCCcCCCCC-CCC----HHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 379 V-GQPLRFPETP-QVS----FVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 379 ~-~~~~~~~~~~-~~s----~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
+ -+.++..... +-+ ..+..|++.||..||.-|+| |-.|++
T Consensus 453 VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRlt----ALriKK 498 (513)
T KOG2052|consen 453 VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLT----ALRIKK 498 (513)
T ss_pred eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhH----HHHHHH
Confidence 3 2333222111 111 23568899999999999999 655554
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=286.49 Aligned_cols=244 Identities=25% Similarity=0.344 Sum_probs=188.2
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc--CCCCccceeeeEEeCc-
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL--DHPFLPTLYSYFETDK- 167 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l--~hp~iv~l~~~~~~~~- 167 (491)
+.+...++++.||+|.||.||+|+.. ++.||||++.. ...+.+++|.+|.+.. +|+||++++++-....
T Consensus 207 ~~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 207 LELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred ccCCchhhHHHhhcCccceeehhhcc--CceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 34567888999999999999999988 58999999864 3445677888888764 7999999999876554
Q ss_pred ---eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc---------CcccccCCCCCEEEccCCcE
Q 035713 168 ---FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML---------GIVYRDLKPENVLVRDEGHI 235 (491)
Q Consensus 168 ---~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---------givHrDikp~NILl~~~g~v 235 (491)
.++||+||.+.|+|.+|++.+ .+++.....++..|++||+|||+. .|+|||||..||||..|+..
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc 355 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC 355 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence 789999999999999999984 599999999999999999999963 49999999999999999999
Q ss_pred EEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccc
Q 035713 236 MLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELM 315 (491)
Q Consensus 236 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (491)
-|+|||||.++.....-.+
T Consensus 356 cIaDFGLAl~~~p~~~~~d------------------------------------------------------------- 374 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKPQGD------------------------------------------------------------- 374 (534)
T ss_pred EeeccceeEEecCCCCCcc-------------------------------------------------------------
Confidence 9999999977642111000
Q ss_pred cCCCCccccccccccCccCcchhcCCC-CC-----CcccccchhhHHHhhhcCCCCCC-CC----------------CcH
Q 035713 316 AEPTNVRSMSFVGTHEYLAPEIIRGEG-HG-----SAVDWWTFGIFLYELLHGTTPFK-GQ----------------GNR 372 (491)
Q Consensus 316 ~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-----~~~DiwSlG~il~elltg~~Pf~-~~----------------~~~ 372 (491)
+-.-+||..|||||+|.+.. +. .++||||+|.+||||++...-+. +. +..
T Consensus 375 -------~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e 447 (534)
T KOG3653|consen 375 -------THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE 447 (534)
T ss_pred -------hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence 00138999999999998753 22 37999999999999998644332 11 111
Q ss_pred HHHHHHHcC--CCcCCCC---CCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 373 ATLFNVVGQ--PLRFPET---PQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 373 ~~~~~i~~~--~~~~~~~---~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
+....++.. .+.+|.. -.....+++.|..||..|++.|+|.
T Consensus 448 ~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA 493 (534)
T KOG3653|consen 448 EMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA 493 (534)
T ss_pred HHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence 222223322 2333321 1233468899999999999999993
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.03 Aligned_cols=256 Identities=26% Similarity=0.370 Sum_probs=211.6
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeC-------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccce
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRG-------TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTL 159 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l 159 (491)
.+++..++..+.+.||+|.||.||+|.... ....||||.++..... .....+..|+++|+.+. |+||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhh
Confidence 345556667788899999999999998542 1456999998765333 56677889999999995 9999999
Q ss_pred eeeEEeCceEEEEEeccCCCchHHHHHhCC------------C--CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCC
Q 035713 160 YSYFETDKFYCLVMEFCSGGNLHSLRQKQP------------N--KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPE 225 (491)
Q Consensus 160 ~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~------------~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~ 225 (491)
++++...+.+++|+||+..|+|..+++..+ . ..++......++.||+.|++||++.++|||||-..
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999998764 0 13889999999999999999999999999999999
Q ss_pred CEEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCC
Q 035713 226 NVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGP 305 (491)
Q Consensus 226 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (491)
||||..+..+||+|||+|+...........
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~-------------------------------------------------- 477 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTK-------------------------------------------------- 477 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEec--------------------------------------------------
Confidence 999999999999999999754322211100
Q ss_pred CCCCCCCccccCCCCcccccccc--ccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCC
Q 035713 306 CVGGALPELMAEPTNVRSMSFVG--THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQP 382 (491)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~ 382 (491)
.-.| ...|||||.+....|+.++||||+|++||||++ |..||.+-.....+.+.+...
T Consensus 478 -------------------~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G 538 (609)
T KOG0200|consen 478 -------------------SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEG 538 (609)
T ss_pred -------------------CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcC
Confidence 0012 245999999999999999999999999999999 999999865344445567777
Q ss_pred CcCCCCCCCCHHHHHHHHhhhccCCCCCCCcC
Q 035713 383 LRFPETPQVSFVARDLIRGLLVKEPHKRIAYK 414 (491)
Q Consensus 383 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ 414 (491)
.+...+..++.++.++++.||..+|++||++.
T Consensus 539 ~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~ 570 (609)
T KOG0200|consen 539 NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFS 570 (609)
T ss_pred CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHH
Confidence 77777777999999999999999999999943
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=297.24 Aligned_cols=247 Identities=22% Similarity=0.319 Sum_probs=208.2
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCc----EEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNT----YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
..+..++||.|+||+||+|.+...|+ +||||++... ...+....+..|+-+|..|+|||+++|++++.... +.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 35566899999999999999876654 5899988655 33445567889999999999999999999998776 78
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
||++||++|.|.++++.++ ..+-.+....|+.||+.||.|||++++|||||-..|||+..-.++|++|||+|+....+.
T Consensus 774 lvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999999998864 558889999999999999999999999999999999999999999999999997654332
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
..... .|+ .-.+
T Consensus 853 ~ey~~---------------------------------------------------~~g-----------------K~pi 864 (1177)
T KOG1025|consen 853 KEYSA---------------------------------------------------PGG-----------------KVPI 864 (1177)
T ss_pred ccccc---------------------------------------------------ccc-----------------ccCc
Confidence 21110 011 2246
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
.|||-|.+....|+.++||||+||++||++| |..|+.+....+ +..+++.+-+++..+.++.++.-++.+||..|++.
T Consensus 865 kwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-I~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~ 943 (1177)
T KOG1025|consen 865 KWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-IPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADS 943 (1177)
T ss_pred HHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-hhHHHhccccCCCCCCccHHHHHHHHHHhccCccc
Confidence 7999999999999999999999999999999 999999886544 55666666677777889999999999999999999
Q ss_pred CCCcC
Q 035713 410 RIAYK 414 (491)
Q Consensus 410 R~t~~ 414 (491)
||+++
T Consensus 944 rp~fk 948 (1177)
T KOG1025|consen 944 RPTFK 948 (1177)
T ss_pred CccHH
Confidence 99943
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=290.09 Aligned_cols=258 Identities=43% Similarity=0.728 Sum_probs=220.5
Q ss_pred eeeccCceEEEEEEE---eCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCceEEEEEecc
Q 035713 101 RLGYGDIGSVYLVEL---RGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKFYCLVMEFC 176 (491)
Q Consensus 101 ~iG~G~~g~V~~a~~---~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~~lV~E~~ 176 (491)
.+|+|+||.|++++- ...|..||+|+.++......... ....|..++..++ ||++|+++..|+.+..++++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 379999999998763 44678899999988765544433 5667888999997 999999999999999999999999
Q ss_pred CCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccc
Q 035713 177 SGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSS 256 (491)
Q Consensus 177 ~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 256 (491)
.||+|...+... ..+.+..++.+.++++.+++++|+.||+|||+|++||+++.+|++++.|||+++..-..
T Consensus 80 rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~------- 150 (612)
T KOG0603|consen 80 RGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE------- 150 (612)
T ss_pred ccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh-------
Confidence 999997766553 56999999999999999999999999999999999999999999999999998543110
Q ss_pred cccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcc
Q 035713 257 SVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336 (491)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 336 (491)
...|||..|||||
T Consensus 151 -------------------------------------------------------------------~~~cgt~eymApE 163 (612)
T KOG0603|consen 151 -------------------------------------------------------------------KIACGTYEYRAPE 163 (612)
T ss_pred -------------------------------------------------------------------hhcccchhhhhhH
Confidence 0118999999999
Q ss_pred hhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcC-C
Q 035713 337 IIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK-R 415 (491)
Q Consensus 337 ~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~-~ 415 (491)
++. ++..++|+||||+++|||++|..||.+ +...+|+...+..|.. ++..+++++..|+..+|..|+... +
T Consensus 164 I~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~--l~~~a~~~~~~l~~r~p~nrLg~~~~ 235 (612)
T KOG0603|consen 164 IIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRE--LSAEARSLFRQLFKRNPENRLGAGPD 235 (612)
T ss_pred hhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchh--hhHHHHHHHHHHHhhCHHHHhccCcc
Confidence 998 678899999999999999999999988 6777888877777754 899999999999999999999863 6
Q ss_pred ChHHhhcCCCcCCCChhhh--hccCCCCCC
Q 035713 416 GATEIKQHPFFEGVNWALV--RSALPPHIP 443 (491)
Q Consensus 416 ~~~ell~hpff~~~~~~~~--~~~~~~~~p 443 (491)
++.++++|+||+.++|+.+ +...||+.|
T Consensus 236 ~~~eik~h~f~~~i~~~~l~~r~~~~~fkp 265 (612)
T KOG0603|consen 236 GVDEIKQHEFFQSIDWNELEARSRPPPFKP 265 (612)
T ss_pred hhHHHhccchheeeeHhhHhhcCCCCCCCC
Confidence 8999999999999999966 344455544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-31 Score=246.25 Aligned_cols=213 Identities=40% Similarity=0.641 Sum_probs=184.9
Q ss_pred eeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccCCCch
Q 035713 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNL 181 (491)
Q Consensus 102 iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~gg~L 181 (491)
||+|++|.||++++..+++.+++|++....... ....+.+|+++++.++|++|+++++++......+++|||+.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999999889999999987653321 345678999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc-CCcEEEeecccccccCCCCcccccccccc
Q 035713 182 HSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD-EGHIMLSDFDLSLRCSVSPTLVKSSSVSV 260 (491)
Q Consensus 182 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~-~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 260 (491)
.+++.... ..++...++.++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 79 ~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--------- 148 (215)
T cd00180 79 KDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--------- 148 (215)
T ss_pred HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---------
Confidence 99987642 35899999999999999999999999999999999999999 89999999998854321100
Q ss_pred cCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcC
Q 035713 261 NNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRG 340 (491)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 340 (491)
......+...|++||.+..
T Consensus 149 -------------------------------------------------------------~~~~~~~~~~~~~pe~~~~ 167 (215)
T cd00180 149 -------------------------------------------------------------LLKTIVGTPAYMAPEVLLG 167 (215)
T ss_pred -------------------------------------------------------------hhhcccCCCCccChhHhcc
Confidence 0111357788999999988
Q ss_pred C-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHH
Q 035713 341 E-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATE 419 (491)
Q Consensus 341 ~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~e 419 (491)
. .++.+.|+|+||+++|+| ..+.++|.+||+.||++||+ +.+
T Consensus 168 ~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~R~~----~~~ 210 (215)
T cd00180 168 KGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEKRPS----AKE 210 (215)
T ss_pred cCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcccCcC----HHH
Confidence 7 778999999999999999 67889999999999999999 999
Q ss_pred hhcCC
Q 035713 420 IKQHP 424 (491)
Q Consensus 420 ll~hp 424 (491)
+++|+
T Consensus 211 l~~~~ 215 (215)
T cd00180 211 ILEHL 215 (215)
T ss_pred HhhCC
Confidence 99875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=255.30 Aligned_cols=261 Identities=21% Similarity=0.252 Sum_probs=212.1
Q ss_pred cCCCCccCCCceEeeeeeccCceEEEEEEEeCCC-----cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCcccee
Q 035713 86 LRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTN-----TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLY 160 (491)
Q Consensus 86 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 160 (491)
..+..+...+++....+-+|.||.||+|.++... +.|-+|.++. ..++.+...+..|.-+|..+.|||+..+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~--~AS~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ--HASQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh--cccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 3445566678999999999999999999776433 3466666543 25667888899999999999999999999
Q ss_pred eeEE-eCceEEEEEeccCCCchHHHHHhCC------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC
Q 035713 161 SYFE-TDKFYCLVMEFCSGGNLHSLRQKQP------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG 233 (491)
Q Consensus 161 ~~~~-~~~~~~lV~E~~~gg~L~~~~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g 233 (491)
++.. +....++++.++.-|+|..++...+ .+.++..+...++.|++.|++|||++||||.||...|.+|++.-
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe
Confidence 9875 4567889999999999999988321 23477888889999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCc
Q 035713 234 HIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPE 313 (491)
Q Consensus 234 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (491)
+|||+|=.|++.+.+.. | .|.|..
T Consensus 434 qVkltDsaLSRDLFP~D------------------------Y-----------------------------hcLGDn--- 457 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGD------------------------Y-----------------------------HCLGDN--- 457 (563)
T ss_pred eEEeccchhccccCccc------------------------c-----------------------------cccCCC---
Confidence 99999999987654221 1 122220
Q ss_pred cccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCC
Q 035713 314 LMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVS 392 (491)
Q Consensus 314 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 392 (491)
-.....||+||.+....|+.++|+|||||+||||+| |+.|+..-+..+. ...+...+++...-+++
T Consensus 458 ------------EnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm-~~ylkdGyRlaQP~NCP 524 (563)
T KOG1024|consen 458 ------------ENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM-EHYLKDGYRLAQPFNCP 524 (563)
T ss_pred ------------CCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-HHHHhccceecCCCCCc
Confidence 023467999999999999999999999999999999 9999987766654 45556667777777899
Q ss_pred HHHHHHHHhhhccCCCCCCCcCCChHHhh
Q 035713 393 FVARDLIRGLLVKEPHKRIAYKRGATEIK 421 (491)
Q Consensus 393 ~~~~~li~~~L~~dP~~R~t~~~~~~ell 421 (491)
+++-.++..||+.+|++||+ .+|+.
T Consensus 525 DeLf~vMacCWallpeeRPs----f~Qlv 549 (563)
T KOG1024|consen 525 DELFTVMACCWALLPEERPS----FSQLV 549 (563)
T ss_pred HHHHHHHHHHHhcCcccCCC----HHHHH
Confidence 99999999999999999999 66654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-31 Score=247.82 Aligned_cols=212 Identities=42% Similarity=0.670 Sum_probs=177.8
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEec
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEF 175 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~ 175 (491)
|.+.+.||.|++|.||++.+..+++.+|+|.+...... .....+.+|++.++.++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999988999999999765432 2456778899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccc
Q 035713 176 CSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKS 255 (491)
Q Consensus 176 ~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 255 (491)
+.+++|.+++..... .+++..+..++.+++.+|.+||+++++|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~----- 152 (225)
T smart00221 79 CEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL----- 152 (225)
T ss_pred cCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-----
Confidence 999999999887532 18999999999999999999999999999999999999999999999999885432110
Q ss_pred ccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCc
Q 035713 256 SSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAP 335 (491)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 335 (491)
........++..|++|
T Consensus 153 ----------------------------------------------------------------~~~~~~~~~~~~~~~p 168 (225)
T smart00221 153 ----------------------------------------------------------------AALLKTVKGTPFYLAP 168 (225)
T ss_pred ----------------------------------------------------------------cccccceeccCCcCCH
Confidence 0001123678899999
Q ss_pred chh-cCCCCCCcccccchhhHHHhhhcCCCCCCC-CCcHHHHHHHH
Q 035713 336 EII-RGEGHGSAVDWWTFGIFLYELLHGTTPFKG-QGNRATLFNVV 379 (491)
Q Consensus 336 E~l-~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~i~ 379 (491)
|.+ ....++.++|||+||+++|+|++|+.||.. .+....+.+.+
T Consensus 169 e~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 169 EVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred hHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 999 666678899999999999999999999987 44443444433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=303.54 Aligned_cols=227 Identities=16% Similarity=0.212 Sum_probs=161.1
Q ss_pred hcCC-CCccceeeeE-------EeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 035713 150 LLDH-PFLPTLYSYF-------ETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRD 221 (491)
Q Consensus 150 ~l~h-p~iv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrD 221 (491)
.++| .||++++++| .....++++|||+ +++|.+++... ...+++.+++.|+.||+.||.|||++||||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 4455 5788888887 2334678889988 77999999753 35699999999999999999999999999999
Q ss_pred CCCCCEEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCC
Q 035713 222 LKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKS 301 (491)
Q Consensus 222 ikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (491)
|||+||||+..|.+|++|||++....... ....+..
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~--------------------------------------------~~~~ki~ 141 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDE--------------------------------------------DATTKSR 141 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccc--------------------------------------------cCccccc
Confidence 99999999999999999999875321100 0112233
Q ss_pred CCCCCCCCCC-C--------ccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcH
Q 035713 302 DFGPCVGGAL-P--------ELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR 372 (491)
Q Consensus 302 ~~~~~~~~~~-~--------~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~ 372 (491)
|||.+..... . .....+........+||++|||||++.+..|+.++|||||||+||||++|.+||.....
T Consensus 142 DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~- 220 (793)
T PLN00181 142 EIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR- 220 (793)
T ss_pred ccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-
Confidence 3333211000 0 00000001112235799999999999999999999999999999999999998764321
Q ss_pred HHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 373 ATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 373 ~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
.+..+..... .+..........+++.+||+.||.+||+ +.+|++||||...
T Consensus 221 -~~~~~~~~~~-~~~~~~~~~~~~~~~~~~L~~~P~~Rps----~~eil~h~~~~~~ 271 (793)
T PLN00181 221 -TMSSLRHRVL-PPQILLNWPKEASFCLWLLHPEPSCRPS----MSELLQSEFINEP 271 (793)
T ss_pred -HHHHHHHhhc-ChhhhhcCHHHHHHHHHhCCCChhhCcC----hHHHhhchhhhhh
Confidence 2222211111 1111123456779999999999999999 9999999999764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=246.86 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=190.0
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceee-eEEeCceEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYS-YFETDKFYCL 171 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~-~~~~~~~~~l 171 (491)
+.|.|.+.||+|-||.+.+|+++.++..+++|.+.+... .+..|.+|...--.| .|.||+.-|+ .|++.+.+++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 679999999999999999999999999999999976643 334566676544444 4899998887 4788899999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc--CCcEEEeecccccccCCC
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD--EGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~--~g~vkL~DFGla~~~~~~ 249 (491)
+|||++.|+|..-+.. ..+-|...+.++.|+++||.|||++++||||||.+||||-. ...|||||||+.+....-
T Consensus 100 ~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred eeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 9999999999876665 34889999999999999999999999999999999999953 347999999987432100
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
-...--+
T Consensus 177 -------------------------------------------------------------------------V~~~~~~ 183 (378)
T KOG1345|consen 177 -------------------------------------------------------------------------VKYLEYV 183 (378)
T ss_pred -------------------------------------------------------------------------ehhhhhh
Confidence 0001235
Q ss_pred cCccCcchhcCC---C--CCCcccccchhhHHHhhhcCCCCCCCCCcH----HHHHHHHcC-CCcCCC-CCCCCHHHHHH
Q 035713 330 HEYLAPEIIRGE---G--HGSAVDWWTFGIFLYELLHGTTPFKGQGNR----ATLFNVVGQ-PLRFPE-TPQVSFVARDL 398 (491)
Q Consensus 330 ~~y~aPE~l~~~---~--~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~i~~~-~~~~~~-~~~~s~~~~~l 398 (491)
..|.+||++... . ..+.+|+|.||+++|.+|||++||...... -.+.+.+++ ....|. ...+++.+..+
T Consensus 184 ~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~ 263 (378)
T KOG1345|consen 184 NNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRL 263 (378)
T ss_pred cccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHH
Confidence 678899987643 2 378899999999999999999999743221 122333322 223332 24588899999
Q ss_pred HHhhhccCCCCC---CCcCCChHHhhcCCCc
Q 035713 399 IRGLLVKEPHKR---IAYKRGATEIKQHPFF 426 (491)
Q Consensus 399 i~~~L~~dP~~R---~t~~~~~~ell~hpff 426 (491)
.++-|..++++| .+ +......-|.
T Consensus 264 Fkk~lt~~~~drcki~~----~kk~rk~~w~ 290 (378)
T KOG1345|consen 264 FKKSLTPRFKDRCKIWT----AKKMRKCLWK 290 (378)
T ss_pred HHHhcCCcccccchhHH----HHHHHHHHHH
Confidence 999999999999 44 4444444443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=282.56 Aligned_cols=252 Identities=38% Similarity=0.666 Sum_probs=195.7
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
.+|+.|+.|-.|+||.||+++|+.+.+.+|+| |++..+.- ++ ||.....|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lil-------Rn---ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLIL-------RN---ILTFAGNPFVV---------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchhh-------hc---cccccCCccee----------------
Confidence 68999999999999999999999999999995 44432211 11 55555666665
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
|+...+++.. +.++.. ++.+++|||+.||+|||+||+|+||+.-|++||+|||+++...-.....
T Consensus 136 -----gDc~tllk~~--g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -----GDCATLLKNI--GPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -----chhhhhcccC--CCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 6677666654 345533 3889999999999999999999999999999999999986532111100
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.. . |+ ...+........+|||+.|+
T Consensus 201 l~-----------------e----------------------------------g~----I~k~t~Ef~dKqvcgTPeyi 225 (1205)
T KOG0606|consen 201 LK-----------------E----------------------------------GH----IEKDTHEFQDKQVCGTPEYI 225 (1205)
T ss_pred hh-----------------h----------------------------------cc----hHHHHHHhhhccccCCcccc
Confidence 00 0 00 00000111122469999999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCC-CCCCHHHHHHHHhhhccCCCCCCC
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPET-PQVSFVARDLIRGLLVKEPHKRIA 412 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~t 412 (491)
|||++....|+..+|||++|+|+||++.|+.||.|++.++.+-.++...+.+|+. ..++.+++++|.++|..+|..|..
T Consensus 226 aPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 226 APEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred ChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 9999999999999999999999999999999999999999999998888887765 458899999999999999999987
Q ss_pred cCCChHHhhcCCCcCCCChhhh-hccCCCCCCC
Q 035713 413 YKRGATEIKQHPFFEGVNWALV-RSALPPHIPE 444 (491)
Q Consensus 413 ~~~~~~ell~hpff~~~~~~~~-~~~~~~~~p~ 444 (491)
-. ++-++++|+||+..||..+ |+. ..++|.
T Consensus 306 t~-ga~evk~h~ff~~LDw~~llRqk-aefvpq 336 (1205)
T KOG0606|consen 306 TG-GALEVKQHGFFQLLDWKSLLRQK-AEFVPQ 336 (1205)
T ss_pred cc-hhhhhhhccceeecccchhhhhh-cccccc
Confidence 44 6899999999999999854 544 445554
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=227.37 Aligned_cols=161 Identities=22% Similarity=0.214 Sum_probs=128.6
Q ss_pred CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccc
Q 035713 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258 (491)
Q Consensus 179 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 258 (491)
|+|.+++... +..+++.+++.++.||+.||.|||+++ ||+|||++.++.+|+ ||+++....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~---------- 61 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP---------- 61 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc----------
Confidence 6899998764 356999999999999999999999998 999999999999999 998753210
Q ss_pred cccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchh
Q 035713 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338 (491)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 338 (491)
....||+.|||||++
T Consensus 62 -----------------------------------------------------------------~~~~g~~~y~aPE~~ 76 (176)
T smart00750 62 -----------------------------------------------------------------EQSRVDPYFMAPEVI 76 (176)
T ss_pred -----------------------------------------------------------------ccCCCcccccChHHh
Confidence 011588999999999
Q ss_pred cCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHH-HHHHHHcCCCcC-----CCCCCCCH--HHHHHHHhhhccCCCCC
Q 035713 339 RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRA-TLFNVVGQPLRF-----PETPQVSF--VARDLIRGLLVKEPHKR 410 (491)
Q Consensus 339 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~~-----~~~~~~s~--~~~~li~~~L~~dP~~R 410 (491)
.+..|+.++|||||||++|||++|+.||....... .+..+....... +....++. .+++||.+||..||.+|
T Consensus 77 ~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~R 156 (176)
T smart00750 77 QGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRR 156 (176)
T ss_pred cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccc
Confidence 99999999999999999999999999997654432 233333222111 11112333 69999999999999999
Q ss_pred CCcCCChHHhhcCCCcC
Q 035713 411 IAYKRGATEIKQHPFFE 427 (491)
Q Consensus 411 ~t~~~~~~ell~hpff~ 427 (491)
|+ +.++++|+|+.
T Consensus 157 p~----~~~ll~~~~~~ 169 (176)
T smart00750 157 EA----ANHYLAHCRAL 169 (176)
T ss_pred cC----HHHHHHHHHHH
Confidence 99 99999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=266.63 Aligned_cols=261 Identities=26% Similarity=0.347 Sum_probs=202.6
Q ss_pred eEeeeeeccCceEEEEEEEeCCCcEEEEEEeec---chhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 97 RLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDK---ASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 97 ~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~---~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
.....+|.|++|.|+.+......+.++.|.+.. ...........+..|.-+-..+.|+|++..+..+.+....+.+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 466789999999999988877777677775542 22222333333667777788899999988888877766666669
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
|||++ +|+.++... +.+....+..++.|++.||.|||..||.|||||++|+|++.+|.+||+|||.+..+...-.
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e-- 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE-- 475 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc--
Confidence 99999 999988874 4699999999999999999999999999999999999999999999999998854321110
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
........++|+..|+
T Consensus 476 ----------------------------------------------------------------~~~~~~~g~~gS~pY~ 491 (601)
T KOG0590|consen 476 ----------------------------------------------------------------KNIHESSGIVGSDPYL 491 (601)
T ss_pred ----------------------------------------------------------------hhhhhhcCcccCCcCc
Confidence 0011223468999999
Q ss_pred CcchhcCCCCCC-cccccchhhHHHhhhcCCCCCCCCCcHHHH-HHH--------HcCCCcCCCCCCCCHHHHHHHHhhh
Q 035713 334 APEIIRGEGHGS-AVDWWTFGIFLYELLHGTTPFKGQGNRATL-FNV--------VGQPLRFPETPQVSFVARDLIRGLL 403 (491)
Q Consensus 334 aPE~l~~~~~~~-~~DiwSlG~il~elltg~~Pf~~~~~~~~~-~~i--------~~~~~~~~~~~~~s~~~~~li~~~L 403 (491)
|||++.+..|++ .+||||.|+++..|.+|+.||.-....+.. ... ..++.. ....++...+.+|.+||
T Consensus 492 apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~--~~~~lp~~~~~~~~~~l 569 (601)
T KOG0590|consen 492 APEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR--LLSLLPRETRIIIYRML 569 (601)
T ss_pred CcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH--HHHhchhhHHHHHHHHc
Confidence 999999999955 799999999999999999999765443332 111 111111 11357788899999999
Q ss_pred ccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 404 VKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 404 ~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
+.||.+|.| +++|++.+||+.++-.
T Consensus 570 ~~~P~~R~t----i~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 570 QLDPTKRIT----IEQILNDEWIRSIECC 594 (601)
T ss_pred cCChhheec----HHHHhhChHhhhcceE
Confidence 999999999 9999999999987543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=215.16 Aligned_cols=277 Identities=19% Similarity=0.268 Sum_probs=208.3
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCC-CCccceeeeEEeCceE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH-PFLPTLYSYFETDKFY 169 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~l~~~~~~~~~~ 169 (491)
+....|+++++||.|+||.+|+|....+|+.||||+-.... ..-.+..|..+.+.|++ ..|..+..++.+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 44578999999999999999999999999999999864431 12245579999999974 7889999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc---CCcEEEeeccccccc
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD---EGHIMLSDFDLSLRC 246 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~---~g~vkL~DFGla~~~ 246 (491)
.|||+++ |-+|.++..-. .+.|+..++..++-|++.-|+|+|.+++|||||||+|+|+.- ...+.|+|||||+.+
T Consensus 87 vlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 9999999 99999988765 466999999999999999999999999999999999999963 346899999999876
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
-+..+.... ........
T Consensus 165 ~d~~t~~HI---------------------------------------------------------------pyre~r~l 181 (341)
T KOG1163|consen 165 RDIRTRQHI---------------------------------------------------------------PYREDRNL 181 (341)
T ss_pred ccccccccC---------------------------------------------------------------ccccCCcc
Confidence 543322111 11122245
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCC---cHHHHHHHHcCCCcCCC---CCCCCHHHHHHHH
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQG---NRATLFNVVGQPLRFPE---TPQVSFVARDLIR 400 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~~---~~~~s~~~~~li~ 400 (491)
.||..|.+--...+...+.+.|+-|+|.+|..+.-|..||.|.. ..+..++|.......+. ...+|.++.-.|.
T Consensus 182 tGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~ 261 (341)
T KOG1163|consen 182 TGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLN 261 (341)
T ss_pred ceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHH
Confidence 79999999988888888999999999999999999999998753 34445566655444332 2456777777777
Q ss_pred hhhccCCCCCCCcC---CCh---HHhhcCCCcCCCChhhhhcc
Q 035713 401 GLLVKEPHKRIAYK---RGA---TEIKQHPFFEGVNWALVRSA 437 (491)
Q Consensus 401 ~~L~~dP~~R~t~~---~~~---~ell~hpff~~~~~~~~~~~ 437 (491)
-|-..-=++-|.+. +.. -.-|+|-+=--.||..+++.
T Consensus 262 Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk 304 (341)
T KOG1163|consen 262 YCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQK 304 (341)
T ss_pred HHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHH
Confidence 66555555555421 101 11233433334678877644
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-27 Score=229.63 Aligned_cols=262 Identities=35% Similarity=0.599 Sum_probs=205.9
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCC-CccceeeeEEeCceEEEEEe
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP-FLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp-~iv~l~~~~~~~~~~~lV~E 174 (491)
|.+.+.||.|+||.||++.+. ..+++|.+.+...........+.+|+.+++.+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999998 67999999876544434567788999999999988 79999999988888899999
Q ss_pred ccCCCchHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC-cEEEeecccccccCCCCcc
Q 035713 175 FCSGGNLHSLRQKQPN-KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG-HIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g-~vkL~DFGla~~~~~~~~~ 252 (491)
|+.++++.+++..... ..+++..+..++.|++.+|.|+|+.|++||||||+|||++..+ .++++|||+++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999977765421 2699999999999999999999999999999999999999988 7999999998532211000
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.. ........+||..|
T Consensus 159 ~~----------------------------------------------------------------~~~~~~~~~~t~~~ 174 (384)
T COG0515 159 SS----------------------------------------------------------------IPALPSTSVGTPGY 174 (384)
T ss_pred cc----------------------------------------------------------------cccccccccccccc
Confidence 00 00012245899999
Q ss_pred cCcchhcC---CCCCCcccccchhhHHHhhhcCCCCCCCCCc---HHHHHH-HHcCCCc-CC--CCCCC----CHHHHHH
Q 035713 333 LAPEIIRG---EGHGSAVDWWTFGIFLYELLHGTTPFKGQGN---RATLFN-VVGQPLR-FP--ETPQV----SFVARDL 398 (491)
Q Consensus 333 ~aPE~l~~---~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~-i~~~~~~-~~--~~~~~----s~~~~~l 398 (491)
+|||.+.+ ..+....|+||+|++++++++|..||..... ...... +...... .. ..... ...+.++
T Consensus 175 ~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (384)
T COG0515 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDL 254 (384)
T ss_pred CCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHH
Confidence 99999998 5678999999999999999999999887764 233333 3332222 11 11111 2578999
Q ss_pred HHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 399 IRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 399 i~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
+.+++..+|..|.+ ..+...++|...
T Consensus 255 ~~~~~~~~~~~r~~----~~~~~~~~~~~~ 280 (384)
T COG0515 255 LKKLLAKDPKNRLS----SSSDLSHDLLAH 280 (384)
T ss_pred HHHHHhcCchhcCC----HHHHhhchHhhC
Confidence 99999999999999 777777755543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=239.23 Aligned_cols=143 Identities=22% Similarity=0.116 Sum_probs=116.2
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeC-CCcEEEEEEeecchh--hhHHHHHHHHHHHHHHhhcCCCCccc-eeeeEEeCc
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRG-TNTYFAMKVMDKASL--ASRNKLLRAQTEREILGLLDHPFLPT-LYSYFETDK 167 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~-~~~~vaiK~i~~~~~--~~~~~~~~~~~E~~il~~l~hp~iv~-l~~~~~~~~ 167 (491)
..++|.+.+.||+|+||+||+|+++. +++.||||++..... ........+.+|+++|+.++|+||+. ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 45789999999999999999999886 678889998753311 12334556889999999999999985 4432 4
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccC-CCCCEEEccCCcEEEeeccccccc
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDL-KPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDi-kp~NILl~~~g~vkL~DFGla~~~ 246 (491)
..||||||++|++|... .. .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|+.+
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred CcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 57999999999999632 11 11 1467899999999999999999999 999999999999999999999765
Q ss_pred C
Q 035713 247 S 247 (491)
Q Consensus 247 ~ 247 (491)
.
T Consensus 163 ~ 163 (365)
T PRK09188 163 R 163 (365)
T ss_pred c
Confidence 3
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=222.30 Aligned_cols=215 Identities=23% Similarity=0.395 Sum_probs=178.2
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCceEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~~lV 172 (491)
-+|++.++||+|+||+.++|++.-+++.||||.-.... ..-+++.|.+..+.|. .++|...|.+.+.+.+-.||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 36999999999999999999999999999999743321 1224556888888885 78999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC-----cEEEeecccccccC
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG-----HIMLSDFDLSLRCS 247 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g-----~vkL~DFGla~~~~ 247 (491)
||++ |-+|.++..-. ++.|+..++..++.||+.-++|+|++.+|+|||||+|+||..-+ .|.|+|||+|+...
T Consensus 103 idLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 9999 99999988765 57799999999999999999999999999999999999997533 58899999998765
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
+..+.... ......+..
T Consensus 181 Dp~TkqHI---------------------------------------------------------------PYrE~KSLs 197 (449)
T KOG1165|consen 181 DPKTKQHI---------------------------------------------------------------PYREHKSLS 197 (449)
T ss_pred CccccccC---------------------------------------------------------------ccccccccc
Confidence 43332211 112223457
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCC---CcHHHHHHH
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQ---GNRATLFNV 378 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~---~~~~~~~~i 378 (491)
||..||+--..+|..-+.+.|+-|||-+++.+|-|..||.|. +..+.+++|
T Consensus 198 GTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 198 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred cceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 999999999999999999999999999999999999999874 344455554
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-27 Score=231.68 Aligned_cols=255 Identities=25% Similarity=0.302 Sum_probs=193.7
Q ss_pred CceEeeeeeccCceEEEEEEEeCCC-cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCC----CCccceeeeE-EeCce
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTN-TYFAMKVMDKASLASRNKLLRAQTEREILGLLDH----PFLPTLYSYF-ETDKF 168 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h----p~iv~l~~~~-~~~~~ 168 (491)
+|++.++||+|+||.||+|.+..++ ..+|+|+.......... .+..|+.+|..+.. .++..+++.+ ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~---~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS---VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc---cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999998774 67999987654222111 45578888988863 6899999999 58889
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC-----CcEEEeecccc
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE-----GHIMLSDFDLS 243 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~-----g~vkL~DFGla 243 (491)
.||||+.+ |.+|.++......+.|+..++..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 9999999887766889999999999999999999999999999999999999865 35899999999
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (491)
+.......... . ....+ ...
T Consensus 175 r~~~~~~~~~~---------------~----------------------~~~~r-----------------------~~~ 194 (322)
T KOG1164|consen 175 RRFKYVGDSGG---------------N----------------------LRPPR-----------------------PQK 194 (322)
T ss_pred ccccccCCCCc---------------c----------------------cccCC-----------------------CCc
Confidence 73221000000 0 00000 001
Q ss_pred cccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHH---HHcCCCcCCCCCCCCHHHHHHHH
Q 035713 324 MSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFN---VVGQPLRFPETPQVSFVARDLIR 400 (491)
Q Consensus 324 ~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~---i~~~~~~~~~~~~~s~~~~~li~ 400 (491)
..+.||..|.++.+..+...+.+.|+||++.++.||+.|..||.+......... ..............+.++.++..
T Consensus 195 ~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (322)
T KOG1164|consen 195 GLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILE 274 (322)
T ss_pred cCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHH
Confidence 134699999999999999999999999999999999999999977654322222 22111111112235677888888
Q ss_pred hhhccCCCCCCCc
Q 035713 401 GLLVKEPHKRIAY 413 (491)
Q Consensus 401 ~~L~~dP~~R~t~ 413 (491)
.+-..+...+|.+
T Consensus 275 ~~~~~~~~~~Pdy 287 (322)
T KOG1164|consen 275 YIDSLDYEDKPDY 287 (322)
T ss_pred HhhccCCcCCCCH
Confidence 7777888889984
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-25 Score=204.74 Aligned_cols=140 Identities=19% Similarity=0.244 Sum_probs=116.0
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHH------HHHHHHHHhhcCCCCccceeeeEEe
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLR------AQTEREILGLLDHPFLPTLYSYFET 165 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~------~~~E~~il~~l~hp~iv~l~~~~~~ 165 (491)
...+|++++.||.|+||.||++.. ++..+|||++.......+..... +.+|++.+.++.|++|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 357899999999999999999765 36679999997655444444444 5789999999999999999998764
Q ss_pred C--------ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEE
Q 035713 166 D--------KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIML 237 (491)
Q Consensus 166 ~--------~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL 237 (491)
. +..+|||||++|.+|.++.. +++. ...+|+.+|..||+.|++||||||+||+++.+| ++|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence 3 35889999999999987632 3332 456999999999999999999999999999988 999
Q ss_pred eeccccc
Q 035713 238 SDFDLSL 244 (491)
Q Consensus 238 ~DFGla~ 244 (491)
+|||...
T Consensus 176 iDfg~~~ 182 (232)
T PRK10359 176 IDLSGKR 182 (232)
T ss_pred EECCCcc
Confidence 9999763
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=203.08 Aligned_cols=141 Identities=22% Similarity=0.228 Sum_probs=110.5
Q ss_pred eeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHH-----------------------HHHHHHHHHHHHhhcCCCC
Q 035713 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRN-----------------------KLLRAQTEREILGLLDHPF 155 (491)
Q Consensus 99 ~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~-----------------------~~~~~~~E~~il~~l~hp~ 155 (491)
...||+|+||.||+|.+. +|+.||||+++........ ......+|+++|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 8999999999765321111 0123346999999998887
Q ss_pred ccceeeeEEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCcccccCCCCCEEEccCCc
Q 035713 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL-HMLGIVYRDLKPENVLVRDEGH 234 (491)
Q Consensus 156 iv~l~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L-H~~givHrDikp~NILl~~~g~ 234 (491)
+.....+.. .. .+|||||++|+++...+.. ...+++..+..++.||+.+|.+| |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILL-KS-HVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEe-cC-CEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 744333322 22 3799999998877654332 24699999999999999999999 799999999999999998 588
Q ss_pred EEEeecccccc
Q 035713 235 IMLSDFDLSLR 245 (491)
Q Consensus 235 vkL~DFGla~~ 245 (491)
++|+|||+|..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.3e-25 Score=207.90 Aligned_cols=236 Identities=26% Similarity=0.329 Sum_probs=155.1
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCC----------CCccceeee--
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH----------PFLPTLYSY-- 162 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h----------p~iv~l~~~-- 162 (491)
.+...+.||.|+++.||.+++..||+.+|+|++..........++.+++|.-....+.+ -.++--++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46778899999999999999999999999999876655566677777777654444322 122222222
Q ss_pred -------EEeC---c-----eEEEEEeccCCCchHHHHHh---CCCC--CCCHHHHHHHHHHHHHHHHHHHHcCcccccC
Q 035713 163 -------FETD---K-----FYCLVMEFCSGGNLHSLRQK---QPNK--YFTEDAARFFASEVLLALEYLHMLGIVYRDL 222 (491)
Q Consensus 163 -------~~~~---~-----~~~lV~E~~~gg~L~~~~~~---~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDi 222 (491)
+... . ..+++|+-+ .++|..++.. .... .+.......+..|++..+++||+.||||+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1211 1 347889888 6788877542 1111 1222333445589999999999999999999
Q ss_pred CCCCEEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCC
Q 035713 223 KPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSD 302 (491)
Q Consensus 223 kp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (491)
||+|+|++.+|.++|+||+.......
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~------------------------------------------------------ 197 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGT------------------------------------------------------ 197 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTE------------------------------------------------------
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCc------------------------------------------------------
Confidence 99999999999999999987643210
Q ss_pred CCCCCCCCCCccccCCCCccccccccccCccCcchhcCC--------CCCCcccccchhhHHHhhhcCCCCCCCCCcHHH
Q 035713 303 FGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGE--------GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRAT 374 (491)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--------~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~ 374 (491)
.......+..|.+||..... .++.+.|.|+||+++|.|++|+.||........
T Consensus 198 -------------------~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~ 258 (288)
T PF14531_consen 198 -------------------RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEAD 258 (288)
T ss_dssp -------------------EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGST
T ss_pred -------------------eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccc
Confidence 00001345779999987542 468899999999999999999999986533211
Q ss_pred HHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 375 LFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 375 ~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
. ...|.....+++.+++||..||.+||.+|
T Consensus 259 ~------~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 259 P------EWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S------GGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred c------cccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 1 11344445789999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-24 Score=193.69 Aligned_cols=143 Identities=20% Similarity=0.212 Sum_probs=113.4
Q ss_pred EeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhh-----------------------HHHHHHHHHHHHHHhhcCCC
Q 035713 98 LLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLAS-----------------------RNKLLRAQTEREILGLLDHP 154 (491)
Q Consensus 98 ~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~-----------------------~~~~~~~~~E~~il~~l~hp 154 (491)
+.+.||+|+||.||+|++. +|+.||||+++...... ......+.+|.+.+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999988 89999999998652110 00122346899999999999
Q ss_pred CccceeeeEEeCceEEEEEeccCCCchHHH-HHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCCEEEccC
Q 035713 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSL-RQKQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDE 232 (491)
Q Consensus 155 ~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~-~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~NILl~~~ 232 (491)
+|.....+.... .||||||++|+++... +.. ..+++..+..++.|++.+|.+||. +||+||||||+|||++ +
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C
Confidence 885544443332 4799999988865433 332 458899999999999999999999 9999999999999998 8
Q ss_pred CcEEEeecccccccC
Q 035713 233 GHIMLSDFDLSLRCS 247 (491)
Q Consensus 233 g~vkL~DFGla~~~~ 247 (491)
+.++|+|||++....
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-25 Score=233.54 Aligned_cols=252 Identities=23% Similarity=0.292 Sum_probs=181.6
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecch-hhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKAS-LASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
+|...+.||++.|=+|.+|++.+ | .|+||++-+.. ...-..+.+..+|++ ...++|||++.+.-+-..++..|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 78889999999999999999884 4 49999986643 222333344445665 67779999999999988899999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
+|+ ..+|++.+... ..+..-+.++|+.||+.||.-+|+.||+|+|||.+||||+.-.-+.|+||..-+..-
T Consensus 101 qyv-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtY------ 171 (1431)
T KOG1240|consen 101 QYV-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTY------ 171 (1431)
T ss_pred HHH-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCcc------
Confidence 999 66898887764 458888999999999999999999999999999999999999999999996421110
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
+| .....||+ +. ..|-..-..|+
T Consensus 172 -------------------------------------LP----eDNPadf~---------fF-------FDTSrRRtCYi 194 (1431)
T KOG1240|consen 172 -------------------------------------LP----EDNPADFT---------FF-------FDTSRRRTCYI 194 (1431)
T ss_pred -------------------------------------CC----CCCcccce---------EE-------EecCCceeeec
Confidence 00 00011110 00 00001113699
Q ss_pred CcchhcCC----------C-CCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCC---CCCCCHHHHHH
Q 035713 334 APEIIRGE----------G-HGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPE---TPQVSFVARDL 398 (491)
Q Consensus 334 aPE~l~~~----------~-~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~s~~~~~l 398 (491)
|||.+... . .+++.||||+||+++||++ |++||.-. ++...-.+.-..++ ..--+..+++|
T Consensus 195 APERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~~~~~~e~~Le~Ied~~~Rnl 270 (1431)
T KOG1240|consen 195 APERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSGNADDPEQLLEKIEDVSLRNL 270 (1431)
T ss_pred ChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhccCccCHHHHHHhCcCccHHHH
Confidence 99998642 2 5678999999999999999 89999521 11111111000000 00012368999
Q ss_pred HHhhhccCCCCCCCcCCChHHhhcC
Q 035713 399 IRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 399 i~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
|..|++.||++|++ |++.|+-
T Consensus 271 il~Mi~rdPs~RlS----AedyL~~ 291 (1431)
T KOG1240|consen 271 ILSMIQRDPSKRLS----AEDYLQK 291 (1431)
T ss_pred HHHHHccCchhccC----HHHHHHh
Confidence 99999999999999 9999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=188.55 Aligned_cols=204 Identities=20% Similarity=0.209 Sum_probs=143.1
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhH-HHHHHHHHHHHHHhhcC-CCCccceeeeEEeCceEEEEE
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASR-NKLLRAQTEREILGLLD-HPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~-~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~~lV~ 173 (491)
+.+...|++|+||+|+++.. .+..++.+.+.....-.. .....+.+|+++|++|. |++|++++++ +..|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 44678899999999998776 466788776654432111 12235789999999995 5889999886 3468999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccC-CCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDL-KPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDi-kp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
||+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 78 eyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 78 SYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99999998653321 1 1357789999999999999999999 799999999999999999998532210000
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
. +.+. ..+..+....-...++.|
T Consensus 149 ~-----------------------------------r~L~----------------------~rDl~~llk~~~~y~~~~ 171 (218)
T PRK12274 149 M-----------------------------------RLLA----------------------REDLRHLLKHKRMYCPAA 171 (218)
T ss_pred H-----------------------------------HHHH----------------------HHHHHHHHHHHHhcCCCC
Confidence 0 0000 000000000011367888
Q ss_pred cCcchhcCC-CCC-CcccccchhhHHHhhhcCCCCCCCCCc
Q 035713 333 LAPEIIRGE-GHG-SAVDWWTFGIFLYELLHGTTPFKGQGN 371 (491)
Q Consensus 333 ~aPE~l~~~-~~~-~~~DiwSlG~il~elltg~~Pf~~~~~ 371 (491)
+.|+...-. ..+ .+.++++.|+-+|.++|++.++.++++
T Consensus 172 l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 172 LTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred CCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 888876543 233 577999999999999999999876543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.7e-24 Score=201.94 Aligned_cols=272 Identities=23% Similarity=0.302 Sum_probs=183.8
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCC-----------------------------------cEEEEEEeecchh--
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTN-----------------------------------TYFAMKVMDKASL-- 132 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~-----------------------------------~~vaiK~i~~~~~-- 132 (491)
.+.+++|+|.+.||+|-...||.|+...+| -+.|||.+-.-..
T Consensus 153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s 232 (598)
T KOG4158|consen 153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS 232 (598)
T ss_pred ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence 356789999999999999999998764311 1256665432111
Q ss_pred hhHHHHHHHHHHHH------HH--------hh--------cCCCCccceeeeEEe-------------------------
Q 035713 133 ASRNKLLRAQTERE------IL--------GL--------LDHPFLPTLYSYFET------------------------- 165 (491)
Q Consensus 133 ~~~~~~~~~~~E~~------il--------~~--------l~hp~iv~l~~~~~~------------------------- 165 (491)
.+......+-+|.- .+ +. -+|||||+++.+|.+
T Consensus 233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~ 312 (598)
T KOG4158|consen 233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA 312 (598)
T ss_pred chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence 11222333333321 11 11 259999999988732
Q ss_pred --CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEc--cCC--cEEEee
Q 035713 166 --DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVR--DEG--HIMLSD 239 (491)
Q Consensus 166 --~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~--~~g--~vkL~D 239 (491)
+..+|+||..+ ..+|+.|+-.+ ..+....+.++.|+++|+.|||++||.|||+|.+||||. .|+ .+.|+|
T Consensus 313 g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaD 388 (598)
T KOG4158|consen 313 GEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVAD 388 (598)
T ss_pred CCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcc
Confidence 23689999988 56999988764 378888999999999999999999999999999999985 333 478999
Q ss_pred cccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCC
Q 035713 240 FDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPT 319 (491)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (491)
||.+--...-..-. +-
T Consensus 389 FGCcLAd~~hGlql----------------------------------------------------------------py 404 (598)
T KOG4158|consen 389 FGCCLADDNHGLQL----------------------------------------------------------------PY 404 (598)
T ss_pred cceeeecccccccc----------------------------------------------------------------cc
Confidence 99873221100000 00
Q ss_pred CccccccccccCccCcchhcCCC-----C-CCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCC-CCCCCC
Q 035713 320 NVRSMSFVGTHEYLAPEIIRGEG-----H-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP-ETPQVS 392 (491)
Q Consensus 320 ~~~~~~~~gt~~y~aPE~l~~~~-----~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~s 392 (491)
.......-|...-||||+....+ . ..++|.|+.|.+.||++....||++..+...-.+- .+.-++| -...++
T Consensus 405 ~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-Yqe~qLPalp~~vp 483 (598)
T KOG4158|consen 405 ESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-YQESQLPALPSRVP 483 (598)
T ss_pred ccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-hhhhhCCCCcccCC
Confidence 00111224677889999987532 1 34899999999999999999999985432111110 1111222 224599
Q ss_pred HHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCCh
Q 035713 393 FVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNW 431 (491)
Q Consensus 393 ~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~ 431 (491)
+.+++|+..+|+.||.+|++- +.+..+++.--|..-+|
T Consensus 484 p~~rqlV~~lL~r~pskRvsp-~iAANvl~LsLw~~~~~ 521 (598)
T KOG4158|consen 484 PVARQLVFDLLKRDPSKRVSP-NIAANVLNLSLWRMGED 521 (598)
T ss_pred hHHHHHHHHHhcCCccccCCc-cHHHhHHHHHHhcCchH
Confidence 999999999999999999983 34667777665555555
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-24 Score=194.62 Aligned_cols=242 Identities=20% Similarity=0.329 Sum_probs=198.5
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
+...+..++.+|.+.-.|+.|+|++.++ .+++|+++-.....+ .-..|..|.--|+...||||+.+++.+...-++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~r-isrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTAR-ISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchh-hcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 4556788889999999999999999955 477888765543332 3335677888899999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-cc-cccCCCCCEEEccCCcEEEe--eccccccc
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG-IV-YRDLKPENVLVRDEGHIMLS--DFDLSLRC 246 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g-iv-HrDikp~NILl~~~g~vkL~--DFGla~~~ 246 (491)
++..||+-|+|+.+++.+.+-..+..++..++.+|++|+.|||+.. ++ ---|....++|+++-..+|. |--++..
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq- 342 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ- 342 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-
Confidence 9999999999999999887777889999999999999999999975 33 33577888999988766653 3221100
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
|+| .
T Consensus 343 -----------------------------------------------------------e~g-----------------r 346 (448)
T KOG0195|consen 343 -----------------------------------------------------------EVG-----------------R 346 (448)
T ss_pred -----------------------------------------------------------ccc-----------------c
Confidence 000 1
Q ss_pred ccccCccCcchhcCCCCC---CcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhh
Q 035713 327 VGTHEYLAPEIIRGEGHG---SAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLL 403 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~---~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L 403 (491)
.-.+.||+||.+...+-+ .++|+|||+++||||.|...||...+..+.-.+|.-+.++....+.++..+..|++-|+
T Consensus 347 ~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icm 426 (448)
T KOG0195|consen 347 AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICM 426 (448)
T ss_pred ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHh
Confidence 346889999999987753 47999999999999999999999999988888887777777777889999999999999
Q ss_pred ccCCCCCCC
Q 035713 404 VKEPHKRIA 412 (491)
Q Consensus 404 ~~dP~~R~t 412 (491)
..||.+||.
T Consensus 427 nedpgkrpk 435 (448)
T KOG0195|consen 427 NEDPGKRPK 435 (448)
T ss_pred cCCCCcCCC
Confidence 999999999
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-23 Score=219.56 Aligned_cols=313 Identities=31% Similarity=0.498 Sum_probs=238.5
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
..+.+.+++-+-+|+++.+..+.-..+|...++|+..+............+.+..++-...+|.++.....|......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 45778888999999999999999888888888887765544433444455556555555667888877777767778999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||+|+.|++|...++.. +..+++-++.+...++.+++|||...++|||++|.|+|+..+|+.+++|||+......-+.
T Consensus 882 ~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred hhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 99999999999988875 4688889999999999999999999999999999999999999999999996543321111
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
..... + +......+.......+ +.. ......+....+||+.
T Consensus 960 ~~~~s-----------g-------------~~~~~~~~~~~~~~~~--------------~~l-~~~~~~~~~~~~~t~~ 1000 (1205)
T KOG0606|consen 960 TTDLS-----------G-------------PSSSGTPRRLSRSERR--------------PQL-SADEARRKHAVVGTPD 1000 (1205)
T ss_pred cCCcc-----------c-------------ccccCccccccccccc--------------ccc-ccchhhccccccCCCc
Confidence 11000 0 0000000000000000 000 0012233456789999
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCC-CCCCHHHHHHHHhhhccCCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPET-PQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R 410 (491)
|.+||.+.+......+|||++|++++|.++|.+||........+.+|++....+|.- ...+.++.+++..+|..+|.+|
T Consensus 1001 ~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr 1080 (1205)
T KOG0606|consen 1001 YLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQR 1080 (1205)
T ss_pred ccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhc
Confidence 999999999999999999999999999999999999999999999999888877764 4578899999999999999999
Q ss_pred CCcCCChHHhhcCCCcCCCChhhhhccCCCCCCCCC
Q 035713 411 IAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEPV 446 (491)
Q Consensus 411 ~t~~~~~~ell~hpff~~~~~~~~~~~~~~~~p~~~ 446 (491)
.+. .++.++..|+||+.++|+.+......++|.+.
T Consensus 1081 ~~a-~~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~~ 1115 (1205)
T KOG0606|consen 1081 LGA-KGAAEVKGHPFFQDVDWENLALQKAEFVPQPE 1115 (1205)
T ss_pred cCc-ccccccccCCccCCCCccccccccCccCCCCC
Confidence 993 23559999999999999999877777777654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=183.98 Aligned_cols=136 Identities=21% Similarity=0.219 Sum_probs=107.7
Q ss_pred eEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-----CCCCccceeeeEEeCc---e
Q 035713 97 RLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-----DHPFLPTLYSYFETDK---F 168 (491)
Q Consensus 97 ~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-----~hp~iv~l~~~~~~~~---~ 168 (491)
.-.+.||+|+||.||. +..++.. +||++..... .....+.+|+.+++.+ .||||++++++++++. .
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 3357899999999995 6666655 6998865422 2335678999999999 5799999999999873 4
Q ss_pred EE-EEEec--cCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHH-HHHHHcCcccccCCCCCEEEccC----CcEEEeec
Q 035713 169 YC-LVMEF--CSGGNLHSLRQKQPNKYFTEDAARFFASEVLLAL-EYLHMLGIVYRDLKPENVLVRDE----GHIMLSDF 240 (491)
Q Consensus 169 ~~-lV~E~--~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL-~~LH~~givHrDikp~NILl~~~----g~vkL~DF 240 (491)
++ +|||| +.+++|.++++.. .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 44 78999 5579999999763 36666 35678888888 99999999999999999999743 37999995
Q ss_pred ccc
Q 035713 241 DLS 243 (491)
Q Consensus 241 Gla 243 (491)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-22 Score=215.91 Aligned_cols=198 Identities=25% Similarity=0.351 Sum_probs=160.6
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC---CCCccceeeeEEeC
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD---HPFLPTLYSYFETD 166 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~---hp~iv~l~~~~~~~ 166 (491)
++..+.|.|-+.||+|+||.||+|.... |+.||||+-+... ..+ +..-.+++.+|+ -+.|+.+..++...
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~-~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPN-PWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCC-cee-----eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 4567789999999999999999999987 9999999865432 222 222344555665 34566666666666
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc-------CCcEEEee
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD-------EGHIMLSD 239 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~-------~g~vkL~D 239 (491)
+.-+||+||.+-|+|.+++.. .+.+++..+..+..||+.-|++||..||||+||||+|+||.. .--++|+|
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred CcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 777899999999999999984 577999999999999999999999999999999999999953 33589999
Q ss_pred cccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCC
Q 035713 240 FDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPT 319 (491)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (491)
||-+..+.. .+.
T Consensus 845 fG~siDm~l--------------------------------------------------------------------fp~ 856 (974)
T KOG1166|consen 845 FGRSIDMKL--------------------------------------------------------------------FPD 856 (974)
T ss_pred cccceeeeE--------------------------------------------------------------------cCC
Confidence 998865432 112
Q ss_pred CccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCC
Q 035713 320 NVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTT 364 (491)
Q Consensus 320 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~ 364 (491)
..+....++|-.+-++|+..|..|++.+|.|.|+.+++-||.|+.
T Consensus 857 ~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 857 GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 233445689999999999999999999999999999999998873
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=183.95 Aligned_cols=146 Identities=24% Similarity=0.257 Sum_probs=114.7
Q ss_pred CceEeeeeeccCceEEEEEE-EeCCCcEEEEEEeecchhhh---------------------HHHHHHHHHHHHHHhhcC
Q 035713 95 NFRLLKRLGYGDIGSVYLVE-LRGTNTYFAMKVMDKASLAS---------------------RNKLLRAQTEREILGLLD 152 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~-~~~~~~~vaiK~i~~~~~~~---------------------~~~~~~~~~E~~il~~l~ 152 (491)
.|.+.+.||+|+||.||+|. +..+|+.||||+++...... ......+.+|+++++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999999 67789999999987542110 011234578999999997
Q ss_pred CCC--ccceeeeEEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-cccccCCCCCEEE
Q 035713 153 HPF--LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG-IVYRDLKPENVLV 229 (491)
Q Consensus 153 hp~--iv~l~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g-ivHrDikp~NILl 229 (491)
+.+ +++++++ . ..||||||+.|++|..+.... ..+....+..++.||+.+|.+||.+| |+||||||+|||+
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 532 3344432 2 348999999998887654322 34677778899999999999999999 9999999999999
Q ss_pred ccCCcEEEeecccccccC
Q 035713 230 RDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 230 ~~~g~vkL~DFGla~~~~ 247 (491)
+ ++.++|+|||++....
T Consensus 183 ~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred E-CCCEEEEEChhhhccC
Confidence 9 8899999999986543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-20 Score=172.97 Aligned_cols=138 Identities=22% Similarity=0.282 Sum_probs=115.5
Q ss_pred eeeeeccCceEEEEEEEeCCCcEEEEEEeecchhh-----hHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLA-----SRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 99 ~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++.||+|++|.||+|.+ .|..|++|+....... ......++.+|++++..+.|++|+....++.+.+..++||
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36799999999999987 5677999986543221 1223346788999999999999988777777778889999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
||++|++|.+++... .. ....++.+|+.+|.+||+.|++|||++|+|||++ ++.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999988753 12 7888999999999999999999999999999999 88999999999854
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-21 Score=192.77 Aligned_cols=184 Identities=26% Similarity=0.404 Sum_probs=137.0
Q ss_pred ceEEEEEeccCCCchHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQ-PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
.++||.|++|.-.+|.+++.+. .....+......++.|++.|++| +|.+|||+||.||....++.+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 3689999999999999999743 33457788899999999999999 9999999999999999999999999999754
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
....++.. +.....+.
T Consensus 406 ~~~~~~~~----------------------------------------------------------------~~~a~~t~ 421 (516)
T KOG1033|consen 406 QDKDETVA----------------------------------------------------------------PAAASHTQ 421 (516)
T ss_pred cccCCccc----------------------------------------------------------------chhhhhhh
Confidence 33222000 01112334
Q ss_pred cccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHc-CCCcCCCCCCCCHHHHHHHHhhh
Q 035713 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVG-QPLRFPETPQVSFVARDLIRGLL 403 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~s~~~~~li~~~L 403 (491)
-+||.+||+||++.+..|+.++||||||+|||||++ -...|. .......+. +.++....... ++-.+|+..||
T Consensus 422 ~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----r~~t~~d~r~g~ip~~~~~d~-p~e~~ll~~ll 496 (516)
T KOG1033|consen 422 QVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----RIATLTDIRDGIIPPEFLQDY-PEEYTLLQQLL 496 (516)
T ss_pred cccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----HHHhhhhhhcCCCChHHhhcC-cHHHHHHHHhc
Confidence 589999999999999999999999999999999997 333332 222222222 22221111222 34568999999
Q ss_pred ccCCCCCCCcCCChHHhhcCCCc
Q 035713 404 VKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 404 ~~dP~~R~t~~~~~~ell~hpff 426 (491)
...|.+||+ +.+.--|.|.
T Consensus 497 s~~p~~RP~----~~~~~~~~~~ 515 (516)
T KOG1033|consen 497 SPSPEERPS----AIEVALHEFL 515 (516)
T ss_pred CCCcccCch----HHHHhhhhhc
Confidence 999999998 7777677664
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6e-22 Score=209.26 Aligned_cols=263 Identities=23% Similarity=0.353 Sum_probs=206.9
Q ss_pred CCceEeeeeeccCceEEEEEEEeCC-CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCceEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGT-NTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~~l 171 (491)
..|.+++.||+|+|+.|-++....+ ...+|+|.+.... .......++..|..+-+.+. |.|++.+++.....+..++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4588888899999999999887543 4457777776543 33445556667888888887 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCcccccCCCCCEEEccCC-cEEEeecccccccCCC
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH-MLGIVYRDLKPENVLVRDEG-HIMLSDFDLSLRCSVS 249 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~givHrDikp~NILl~~~g-~vkL~DFGla~~~~~~ 249 (491)
+++|..|+++...+........+...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .++++|||+|......
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999999988773222225788889999999999999999 99999999999999999999 9999999998543210
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc-
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG- 328 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g- 328 (491)
. .........+|
T Consensus 179 ~-------------------------------------------------------------------g~~~~~~~~~g~ 191 (601)
T KOG0590|consen 179 N-------------------------------------------------------------------GAERSLKDRCGS 191 (601)
T ss_pred C-------------------------------------------------------------------CcceeeecccCC
Confidence 0 00001112478
Q ss_pred ccCccCcchhcCCCC-CCcccccchhhHHHhhhcCCCCCCCCCcHHHH-HHHHcC--CCcCCCCCCCCHHHHHHHHhhhc
Q 035713 329 THEYLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATL-FNVVGQ--PLRFPETPQVSFVARDLIRGLLV 404 (491)
Q Consensus 329 t~~y~aPE~l~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-~~i~~~--~~~~~~~~~~s~~~~~li~~~L~ 404 (491)
++.|+|||.+.+..| ....|+||+|+++.-|++|..|+......... ...... ......+..++....+++.++|.
T Consensus 192 s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~ 271 (601)
T KOG0590|consen 192 SPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILK 271 (601)
T ss_pred CCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhccccccc
Confidence 999999999999655 78999999999999999999998654433322 112211 11233345688899999999999
Q ss_pred cCCCCCCCcCCChHHhhcCCCcCC
Q 035713 405 KEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 405 ~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
.+|..|.+ .+++..++|+..
T Consensus 272 ~~~~~r~s----~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 272 ENPSNRLS----IEELKLDNWLSS 291 (601)
T ss_pred CCchhccc----cccccccccccc
Confidence 99999999 999999999987
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.9e-20 Score=168.98 Aligned_cols=140 Identities=24% Similarity=0.221 Sum_probs=109.7
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhH-------------------HHHHHHHHHHHHHhhcCCCC
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASR-------------------NKLLRAQTEREILGLLDHPF 155 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~-------------------~~~~~~~~E~~il~~l~hp~ 155 (491)
.|.+.+.||+|+||.||+|.+. +|+.||||++........ .......+|..++..+.|.+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888899999999999999885 799999999765321000 01123567899999998774
Q ss_pred --ccceeeeEEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC
Q 035713 156 --LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG 233 (491)
Q Consensus 156 --iv~l~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g 233 (491)
++..++ ....++||||++|++|..+... .....++.+|+.++.++|+.||+||||||+||+++.++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 444443 2345899999999998765321 34567889999999999999999999999999999999
Q ss_pred cEEEeecccccccC
Q 035713 234 HIMLSDFDLSLRCS 247 (491)
Q Consensus 234 ~vkL~DFGla~~~~ 247 (491)
.++|+|||++..+.
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 99999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=167.39 Aligned_cols=133 Identities=23% Similarity=0.251 Sum_probs=107.8
Q ss_pred eeeccCceEEEEEEEeCCCcEEEEEEeecchh-----hhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEec
Q 035713 101 RLGYGDIGSVYLVELRGTNTYFAMKVMDKASL-----ASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEF 175 (491)
Q Consensus 101 ~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~-----~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~ 175 (491)
.||+|+||.||+|.. ++..|++|+...... .......++.+|+++++.+.|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 467899998654321 1222345678999999999988765555555566677899999
Q ss_pred cCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 176 CSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 176 ~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
++|++|.+++.... . .++.+|+.+|.+||+.|++|+|++|+|||++ ++.++|+|||++..
T Consensus 79 ~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998875521 1 7889999999999999999999999999999 89999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=190.80 Aligned_cols=141 Identities=23% Similarity=0.221 Sum_probs=114.5
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecch-----hhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKAS-----LASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~-----~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
...|...+.||+|+||+||++.+... .+++|+..... ........++.+|+++++.++|++|+..+.++....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 35567789999999999999987644 34444432211 112233456889999999999999998887777777
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
..++||||++|++|.+++. ....++.||+.+|.+||++||+||||||+|||+ .++.++|+|||+++..
T Consensus 410 ~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 7899999999999998775 346789999999999999999999999999999 6889999999999653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.1e-19 Score=160.58 Aligned_cols=139 Identities=21% Similarity=0.226 Sum_probs=101.1
Q ss_pred eeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHH---------------------HHHHHHHHHhhcCCCC--
Q 035713 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLL---------------------RAQTEREILGLLDHPF-- 155 (491)
Q Consensus 99 ~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~---------------------~~~~E~~il~~l~hp~-- 155 (491)
.+.||+|+||.||+|.+. +++.||||+++........... ....|.+.+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999987 8899999998764322111111 1135666666665433
Q ss_pred ccceeeeEEeCceEEEEEeccCCCchHH-HHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCCEEEccCC
Q 035713 156 LPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEG 233 (491)
Q Consensus 156 iv~l~~~~~~~~~~~lV~E~~~gg~L~~-~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~NILl~~~g 233 (491)
+.+.+++ ...++||||++|+.+.. .+... .....++.++.+++.++.++|. +||+||||||+||+++ ++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh----hhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 4445443 23589999999855432 12211 1116788899999999999999 9999999999999999 99
Q ss_pred cEEEeecccccccC
Q 035713 234 HIMLSDFDLSLRCS 247 (491)
Q Consensus 234 ~vkL~DFGla~~~~ 247 (491)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.1e-18 Score=159.22 Aligned_cols=138 Identities=20% Similarity=0.263 Sum_probs=106.1
Q ss_pred eeee-ccCceEEEEEEEeCCCcEEEEEEeecchh----hh------HHHHHHHHHHHHHHhhcCCCCc--cceeeeEEeC
Q 035713 100 KRLG-YGDIGSVYLVELRGTNTYFAMKVMDKASL----AS------RNKLLRAQTEREILGLLDHPFL--PTLYSYFETD 166 (491)
Q Consensus 100 ~~iG-~G~~g~V~~a~~~~~~~~vaiK~i~~~~~----~~------~~~~~~~~~E~~il~~l~hp~i--v~l~~~~~~~ 166 (491)
..|| .|+.|+||++... +..++||.+..... .. .....++.+|++++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 7888888888765 67899998865322 11 1233567889999999998875 6777765432
Q ss_pred -ce---EEEEEeccCC-CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecc
Q 035713 167 -KF---YCLVMEFCSG-GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFD 241 (491)
Q Consensus 167 -~~---~~lV~E~~~g-g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFG 241 (491)
.. .+|||||++| .+|.+++.. ..+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE---APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc---CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 22 3599999997 689888765 3466543 5689999999999999999999999999999999999999
Q ss_pred ccccc
Q 035713 242 LSLRC 246 (491)
Q Consensus 242 la~~~ 246 (491)
.+...
T Consensus 188 ~~~~~ 192 (239)
T PRK01723 188 RGELR 192 (239)
T ss_pred CcccC
Confidence 98653
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-17 Score=167.18 Aligned_cols=196 Identities=23% Similarity=0.282 Sum_probs=150.4
Q ss_pred HhhcCCCCccceeeeEEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCc-ccccCCCCC
Q 035713 148 LGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGI-VYRDLKPEN 226 (491)
Q Consensus 148 l~~l~hp~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~gi-vHrDikp~N 226 (491)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+... .-.+++.-...++++|+.||.|||.-.| .|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 46789999999999999999999999999999999998874 3558888888899999999999998765 999999999
Q ss_pred EEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCC
Q 035713 227 VLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPC 306 (491)
Q Consensus 227 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (491)
.+++....+||+|||+........ +
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~-----------------------~-------------------------------- 104 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETA-----------------------E-------------------------------- 104 (484)
T ss_pred ceeeeeEEEEechhhhcccccccc-----------------------c--------------------------------
Confidence 999999999999999974321100 0
Q ss_pred CCCCCCccccCCCCccccccccccCccCcchhcCCC-------CCCcccccchhhHHHhhhcCCCCCCCCC----cHHHH
Q 035713 307 VGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG-------HGSAVDWWTFGIFLYELLHGTTPFKGQG----NRATL 375 (491)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-------~~~~~DiwSlG~il~elltg~~Pf~~~~----~~~~~ 375 (491)
........-...|.|||++.+.. -+.+.||||+|++++|+++..-||.... ..+.+
T Consensus 105 -------------~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii 171 (484)
T KOG1023|consen 105 -------------PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEII 171 (484)
T ss_pred -------------ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHH
Confidence 00000112346799999998742 3567999999999999999999997532 22344
Q ss_pred HHHHcCCCc--CCC---CCCCCHHHHHHHHhhhccCCCCCCC
Q 035713 376 FNVVGQPLR--FPE---TPQVSFVARDLIRGLLVKEPHKRIA 412 (491)
Q Consensus 376 ~~i~~~~~~--~~~---~~~~s~~~~~li~~~L~~dP~~R~t 412 (491)
..+...... -|. ...+.+++..++..||..+|.+||+
T Consensus 172 ~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs 213 (484)
T KOG1023|consen 172 LRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPS 213 (484)
T ss_pred HHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCcc
Confidence 444331111 111 1145667999999999999999999
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.6e-17 Score=143.89 Aligned_cols=132 Identities=26% Similarity=0.330 Sum_probs=112.4
Q ss_pred EeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCC--CCccceeeeEEeCceEEEEEec
Q 035713 98 LLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH--PFLPTLYSYFETDKFYCLVMEF 175 (491)
Q Consensus 98 ~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h--p~iv~l~~~~~~~~~~~lV~E~ 175 (491)
+++.||.|.++.||++.... ..+++|++..... ...+.+|+.+++.++| .++++++.++...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 46789999999999999864 6799999865432 3456789999999976 5899999998888899999999
Q ss_pred cCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc---CcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 176 CSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML---GIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 176 ~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
+.|+.+..+ +......++.+++.+|.+||.. +++|+|++|+|||++..+.++|+|||++..
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 998887543 5566677889999999999985 799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.2e-17 Score=167.25 Aligned_cols=261 Identities=21% Similarity=0.208 Sum_probs=197.2
Q ss_pred CCCceEeeeeec--cCceEEEEEEE--eCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCc
Q 035713 93 LSNFRLLKRLGY--GDIGSVYLVEL--RGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDK 167 (491)
Q Consensus 93 ~~~y~~~~~iG~--G~~g~V~~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~ 167 (491)
-..|.+.+.+|. |.+|.||.+++ ..++..+|+|.-+.. ......-.+-.+|..-.+.++ |+|.++.+..++..+
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCcccccCC
Confidence 356788899999 99999999999 889999999974322 121122222345666666664 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHH----HHHHHHHcCcccccCCCCCEEEccC-CcEEEeeccc
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLL----ALEYLHMLGIVYRDLKPENVLVRDE-GHIMLSDFDL 242 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~----aL~~LH~~givHrDikp~NILl~~~-g~vkL~DFGl 242 (491)
.+|+-+|++ +.+|..+.... ...+++..++.++.++.. ||.++|..+++|-|+||+||++..+ ..++++|||+
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred cceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence 999999999 68888877654 455899999999999999 9999999999999999999999999 8899999999
Q ss_pred ccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcc
Q 035713 243 SLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322 (491)
Q Consensus 243 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (491)
...+....-.... . .
T Consensus 270 v~~i~~~~~~~~~-----------------------------------------~------------------------~ 284 (524)
T KOG0601|consen 270 VSKISDGNFSSVF-----------------------------------------K------------------------V 284 (524)
T ss_pred eEEccCCccccce-----------------------------------------e------------------------e
Confidence 8655432210000 0 0
Q ss_pred ccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCC--CcHHHHHHHHcCCCcCCCCCCCCHHHHHHHH
Q 035713 323 SMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQ--GNRATLFNVVGQPLRFPETPQVSFVARDLIR 400 (491)
Q Consensus 323 ~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~ 400 (491)
.....|...|++||++.+. ++...||++||.++.+-.++..++... +....+.+. .++.......+.++...+.
T Consensus 285 ~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~---~ip~e~~~~~s~~l~~~~~ 360 (524)
T KOG0601|consen 285 SKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG---YIPLEFCEGGSSSLRSVTS 360 (524)
T ss_pred eecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc---cCchhhhcCcchhhhhHHH
Confidence 0011456789999998764 788999999999999999887766543 333222221 1222333456677778999
Q ss_pred hhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 401 GLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 401 ~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
.|+..+|-.|++ +..+++|++....
T Consensus 361 ~~~d~~~~~~~~----~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 361 QMLDEDPRLRLT----AQILTALNVIHSK 385 (524)
T ss_pred HhcCcchhhhhH----HHHHhccccccch
Confidence 999999999999 9999999998743
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=4e-16 Score=162.05 Aligned_cols=146 Identities=17% Similarity=0.221 Sum_probs=98.2
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhh-------------------------------HHHHHHHH
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLAS-------------------------------RNKLLRAQ 142 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~-------------------------------~~~~~~~~ 142 (491)
.+|.. +.||+|++|.||+|+.+.+|+.||||++++..... .+....+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 78999999999999999889999999997542100 01122233
Q ss_pred HHHHHHh------hc----CCCCccceeeeEEe-CceEEEEEeccCCCchHHHHHhCCCC----CCCHHHHHHHHHHHHH
Q 035713 143 TEREILG------LL----DHPFLPTLYSYFET-DKFYCLVMEFCSGGNLHSLRQKQPNK----YFTEDAARFFASEVLL 207 (491)
Q Consensus 143 ~E~~il~------~l----~hp~iv~l~~~~~~-~~~~~lV~E~~~gg~L~~~~~~~~~~----~l~~~~~~~~~~qi~~ 207 (491)
+|+++++ ++ .+...+.+-.++.+ .+..+|||||+.|+.+.++......+ .+.+..+..++.||+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 3443333 33 13333333333322 34556999999999998753211112 255555666666654
Q ss_pred HHHHHHHcCcccccCCCCCEEEccCC----cEEEeecccccccC
Q 035713 208 ALEYLHMLGIVYRDLKPENVLVRDEG----HIMLSDFDLSLRCS 247 (491)
Q Consensus 208 aL~~LH~~givHrDikp~NILl~~~g----~vkL~DFGla~~~~ 247 (491)
..|++|+|+||+||+++.+| .++++|||++..+.
T Consensus 278 ------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 ------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 58999999999999999888 99999999987654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=9.4e-15 Score=150.09 Aligned_cols=143 Identities=21% Similarity=0.203 Sum_probs=97.3
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhh---H----------------------------HHH------HHHH
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLAS---R----------------------------NKL------LRAQ 142 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~---~----------------------------~~~------~~~~ 142 (491)
+.||.|++|.||+|+.+ +|+.||||+.+...... + +.. ..+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999986 78999999986532100 0 000 0134
Q ss_pred HHHHHHhhc----CCCCccceeeeE-EeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHH-HHHHHHHcC
Q 035713 143 TEREILGLL----DHPFLPTLYSYF-ETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLL-ALEYLHMLG 216 (491)
Q Consensus 143 ~E~~il~~l----~hp~iv~l~~~~-~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~-aL~~LH~~g 216 (491)
+|.+.+.++ +|.+-+.+-.++ ...+..+|||||++|++|.++......+ +. ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-LD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-CC---HHHHHHHHHHHHHHHHHhCC
Confidence 455555554 232222322222 2234468999999999998876542111 22 2345555555 467899999
Q ss_pred cccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 217 IVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 217 ivHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
++|+|+||.||+++.+|.++|+|||++..+.
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.2e-15 Score=150.14 Aligned_cols=251 Identities=21% Similarity=0.289 Sum_probs=186.4
Q ss_pred cCCCceEeeeeeccCceEEEEEEEe-CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELR-GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~ 169 (491)
...+|..+..||.|.|+.|+.+... .++..|++|.+.+.....-.++. -..|+.+...+ .|.+++.++..|....+.
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCccccccc
Confidence 4568999999999999999998755 67888999987665433333332 34577777666 489999999988888888
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC-CcEEEeecccccccCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE-GHIMLSDFDLSLRCSV 248 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~-g~vkL~DFGla~~~~~ 248 (491)
|+-.|||+++++...+.. ...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||++..+..
T Consensus 342 ~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence 899999999998765432 2458889999999999999999999999999999999999886 7789999998743211
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
.. ....+
T Consensus 420 ~~-------------------------------------------------------------------------~~~~~ 426 (524)
T KOG0601|consen 420 SS-------------------------------------------------------------------------GVFHH 426 (524)
T ss_pred ec-------------------------------------------------------------------------ccccc
Confidence 11 01122
Q ss_pred ccCcc--CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 329 THEYL--APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 329 t~~y~--aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
.-++. +++.+....+..+.|++|||..+.+.+++.+.-.... ....|..+ ..+..+....++..+.+.++..|
T Consensus 427 ~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~--~~p~~~~~~~~~q~~~kv~~~~~ 501 (524)
T KOG0601|consen 427 IDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSG--DTPNLPGLKLQLQVLLKVMINPD 501 (524)
T ss_pred cccccccchhhccccccccccccccccccccccccCcccCcccc---cceeeecc--cccCCCchHHhhhhhhhhhcCCc
Confidence 33344 5555555667899999999999999999876543221 22222222 23333445578889999999999
Q ss_pred CCCCCCcCCChHHhhcCCCcC
Q 035713 407 PHKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 407 P~~R~t~~~~~~ell~hpff~ 427 (491)
+..|+. +.++..|.=|.
T Consensus 502 ~~~~~l----~~~l~~~~~~~ 518 (524)
T KOG0601|consen 502 RKRRPS----AVELSLHSEFY 518 (524)
T ss_pred cccchh----hhhhcccchhh
Confidence 999999 77777776553
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=8.8e-14 Score=126.16 Aligned_cols=140 Identities=19% Similarity=0.154 Sum_probs=102.5
Q ss_pred eeeeeccCceEEEEEEEeC------CCcEEEEEEeecchh---------------h----hHHHHH----HHHHHHHHHh
Q 035713 99 LKRLGYGDIGSVYLVELRG------TNTYFAMKVMDKASL---------------A----SRNKLL----RAQTEREILG 149 (491)
Q Consensus 99 ~~~iG~G~~g~V~~a~~~~------~~~~vaiK~i~~~~~---------------~----~~~~~~----~~~~E~~il~ 149 (491)
...||.|--+.||.|.... .+..+|||+.+-... . +..... ...+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 357899998852110 0 011122 2348999999
Q ss_pred hcCC--CCccceeeeEEeCceEEEEEeccCCCchHH-HHHhCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCcccccCCCC
Q 035713 150 LLDH--PFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALEYL-HMLGIVYRDLKPE 225 (491)
Q Consensus 150 ~l~h--p~iv~l~~~~~~~~~~~lV~E~~~gg~L~~-~~~~~~~~~l~~~~~~~~~~qi~~aL~~L-H~~givHrDikp~ 225 (491)
++.. -+++..+++ ...+|||||+.+..+.. .++. ..+++..+..+..+++.+|..| |+.||||+||++.
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 9853 566777765 35679999996654422 2222 2366677788889999999998 8999999999999
Q ss_pred CEEEccCCcEEEeeccccccc
Q 035713 226 NVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 226 NILl~~~g~vkL~DFGla~~~ 246 (491)
|||+. ++.+.|+|||.+...
T Consensus 155 NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HEEEE-CCcEEEEECCCceeC
Confidence 99996 578999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.5e-13 Score=140.93 Aligned_cols=138 Identities=16% Similarity=0.176 Sum_probs=110.4
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEec
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEF 175 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~ 175 (491)
|.+ ....-++.+..-.|..+.++.+|.|++.+...- .....+.+-+.-|+.++||||+++++.++.++.+|||+|-
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTEr 90 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTER 90 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeec
Confidence 444 333334443332577788899999998865432 3444556778889999999999999999999999999998
Q ss_pred cCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 176 CSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH-MLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 176 ~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
+. .|..+++. +....+..-+.||+.||.||| ..+++|++|.-+-|+++..|+.||++|.++.
T Consensus 91 V~--Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~ 153 (690)
T KOG1243|consen 91 VR--PLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVS 153 (690)
T ss_pred cc--cHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEe
Confidence 85 66667776 447788888999999999998 5689999999999999999999999998864
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.9e-14 Score=126.32 Aligned_cols=128 Identities=23% Similarity=0.326 Sum_probs=96.1
Q ss_pred eeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCc-cceeeeEEeCceEEEEEeccC
Q 035713 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFL-PTLYSYFETDKFYCLVMEFCS 177 (491)
Q Consensus 99 ~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~i-v~l~~~~~~~~~~~lV~E~~~ 177 (491)
++.|+.|.++.||+++.. ++.|++|+...... ....+.+|..+++.+.+.++ .+++.+.. ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999875 67899998754321 11234578999998865554 45555443 23479999999
Q ss_pred CCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCc-----ccccCCCCCEEEccCCcEEEeecccccc
Q 035713 178 GGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGI-----VYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 178 gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~gi-----vHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
|.++... . . ....++.+++.+|..||..++ +|+|++|.||+++ ++.++|+|||.+..
T Consensus 75 G~~l~~~--~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE--D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc--c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9888643 0 1 123456799999999999885 9999999999998 67899999999853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.9e-14 Score=133.10 Aligned_cols=249 Identities=18% Similarity=0.227 Sum_probs=160.7
Q ss_pred EEEEEEEeCCCcEEEEEEeecchhhhHH-HHHHHHHHHHHHhhcCCCCccceeeeEEeCc-----eEEEEEeccCCCchH
Q 035713 109 SVYLVELRGTNTYFAMKVMDKASLASRN-KLLRAQTEREILGLLDHPFLPTLYSYFETDK-----FYCLVMEFCSGGNLH 182 (491)
Q Consensus 109 ~V~~a~~~~~~~~vaiK~i~~~~~~~~~-~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~-----~~~lV~E~~~gg~L~ 182 (491)
.||++-+...|..|+--.+......... +......-..-|-.+.|.|||+++.|+.+.+ ...+++|||..|+|.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 5677777666655543322211000000 0011111223344567999999999986544 478999999999999
Q ss_pred HHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcC--cccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccc
Q 035713 183 SLRQKQP--NKYFTEDAARFFASEVLLALEYLHMLG--IVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258 (491)
Q Consensus 183 ~~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 258 (491)
.++++.+ ...+.....++|+.||+.||.|||+.. |+|+++..+-|++..+|-+|+.--.-.
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~--------------- 225 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPD--------------- 225 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCcc---------------
Confidence 9988542 245888899999999999999999975 999999999999999998887421100
Q ss_pred cccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchh
Q 035713 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII 338 (491)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 338 (491)
...+..-.... +. ...-.+-++|.+||.=
T Consensus 226 --------------------------s~h~s~~~~~~-~E------------------------k~~~~~~~g~~a~~sg 254 (458)
T KOG1266|consen 226 --------------------------STHPSVNSTRE-AE------------------------KSVNTSLPGFSAPESG 254 (458)
T ss_pred --------------------------ccchhhhhhhH-hh------------------------hhccccCCccccCCcC
Confidence 00000000000 00 0001356788999876
Q ss_pred cCCCCCCcccccchhhHHHhhhcCCCC-CCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCCh
Q 035713 339 RGEGHGSAVDWWTFGIFLYELLHGTTP-FKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGA 417 (491)
Q Consensus 339 ~~~~~~~~~DiwSlG~il~elltg~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~ 417 (491)
.....+.++|||++|....||..|..- -.+.+....-..+.+..+... ...-+++|.+||.-.|..||+ +
T Consensus 255 ~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-----n~lqr~~i~kcl~~eP~~rp~----a 325 (458)
T KOG1266|consen 255 TTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-----NGLQRGSITKCLEGEPNGRPD----A 325 (458)
T ss_pred cccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-----CccccCcCcccccCCCCCCcc----h
Confidence 666667899999999999999988754 333322222222222212111 122357899999999999999 9
Q ss_pred HHhhcCCCcCCCChh
Q 035713 418 TEIKQHPFFEGVNWA 432 (491)
Q Consensus 418 ~ell~hpff~~~~~~ 432 (491)
.+++.||-+-.+.-.
T Consensus 326 r~llfHpllfeVhsl 340 (458)
T KOG1266|consen 326 RLLLFHPLLFEVHSL 340 (458)
T ss_pred hhhhcCceeeecchH
Confidence 999999988776654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.3e-12 Score=114.62 Aligned_cols=134 Identities=22% Similarity=0.221 Sum_probs=101.7
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeec-----chhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDK-----ASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~-----~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
..|++|+-+.++++.+. |..+++|.=.+ ..+...-...+..+|.++|..++--.|..-+-++.+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999999775 44577774322 233344455677899999999875555444444556666679999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
|++|..|.+++... ...++..+-.-+.-||..||||+||.++||++..++ +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999888764 145667777888889999999999999999997654 99999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.2e-12 Score=111.56 Aligned_cols=145 Identities=20% Similarity=0.184 Sum_probs=109.1
Q ss_pred EeeeeeccCceEEEEEEEeCCCcEEEEEEe-----ecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 98 LLKRLGYGDIGSVYLVELRGTNTYFAMKVM-----DKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 98 ~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i-----~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.+..|-+|+-+.|+++.+. |+.+.||.- +...+...-...+..+|+++|.++.--.|.--.-+|.+...-+|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 6678889999999999887 777788842 223333444556778999999998755554444456666667799
Q ss_pred EeccCC-CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC---cEEEeeccccc
Q 035713 173 MEFCSG-GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG---HIMLSDFDLSL 244 (491)
Q Consensus 173 ~E~~~g-g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g---~vkL~DFGla~ 244 (491)
|||++| .++.+++...-......+....++.+|-..|.-||..+|||+||..+||++..+| .+.|+|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 999977 4777777765333344444478899999999999999999999999999997655 35899999984
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=9.9e-12 Score=116.27 Aligned_cols=140 Identities=21% Similarity=0.253 Sum_probs=106.0
Q ss_pred eeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCC--CCccceeeeEEeC---ceEEEEE
Q 035713 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH--PFLPTLYSYFETD---KFYCLVM 173 (491)
Q Consensus 99 ~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h--p~iv~l~~~~~~~---~~~~lV~ 173 (491)
++.||.|.++.||+++... |+.|++|+....... .....+.+|.++++.+.+ ..+.+++.+.... +..++||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 3678999999999998753 678999987654221 123456789999999975 3467777776653 3678999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM--------------------------------------- 214 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--------------------------------------- 214 (491)
||++|.++...+.. ..+++.....++.+++.+|..||+
T Consensus 80 e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 80 ERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99999988765431 236777777778888888888873
Q ss_pred -----------------cCcccccCCCCCEEEcc--CCcEEEeeccccc
Q 035713 215 -----------------LGIVYRDLKPENVLVRD--EGHIMLSDFDLSL 244 (491)
Q Consensus 215 -----------------~givHrDikp~NILl~~--~g~vkL~DFGla~ 244 (491)
..++|+|+++.|||++. ++.+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23699999999999998 6678999999874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=8.9e-12 Score=128.49 Aligned_cols=169 Identities=19% Similarity=0.312 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHH-cCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCC
Q 035713 203 SEVLLALEYLHM-LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCM 281 (491)
Q Consensus 203 ~qi~~aL~~LH~-~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (491)
.+++.||.|+|. .++||++|.|++|.++.+|..||+.|+.+........ | .|.
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~-----------------------~---p~~ 159 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE-----------------------Y---PFS 159 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc-----------------------c---ccc
Confidence 455699999996 5899999999999999999999999998743211000 0 000
Q ss_pred CCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhh-
Q 035713 282 QPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL- 360 (491)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ell- 360 (491)
... ....-...-...|.|||++.+...+.++|++||||++|.+.
T Consensus 160 ~yd-----------------------------------~~lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~ 204 (700)
T KOG2137|consen 160 EYD-----------------------------------PPLPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYN 204 (700)
T ss_pred cCC-----------------------------------CCCChhhccCcccccchhhccccccccccceeeeeEEEEEec
Confidence 000 00000123457899999999988899999999999999999
Q ss_pred cCCCCCCCCCcHHHHHHH--HcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhhhc
Q 035713 361 HGTTPFKGQGNRATLFNV--VGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRS 436 (491)
Q Consensus 361 tg~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~~~ 436 (491)
.|+..|.+.+........ ..+-..+-....++.++++=|.++|..++..||+ +..++..|||++.....++.
T Consensus 205 ~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~----~~~l~~~~ff~D~~~~aLrf 278 (700)
T KOG2137|consen 205 GGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT----LDLLLSIPFFSDPGLKALRF 278 (700)
T ss_pred CCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcc----hhhhhcccccCCchhhhhhh
Confidence 577777766443332221 1111222233579999999999999999999998 99999999999887776653
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.1e-10 Score=116.57 Aligned_cols=136 Identities=19% Similarity=0.152 Sum_probs=109.1
Q ss_pred CceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEE----eCceEEEEEeccCC-Cc
Q 035713 106 DIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE----TDKFYCLVMEFCSG-GN 180 (491)
Q Consensus 106 ~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~----~~~~~~lV~E~~~g-g~ 180 (491)
--.+.|+|....+|..|++|+++.......... ..-+++++++.|+|||++.++|. .+..++||++|.++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~---t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKD---TSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccc---hHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 346789999999999999999965544433222 23567899999999999999997 34579999999876 56
Q ss_pred hHHHHHhC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 181 LHSLRQKQ-------------PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 181 L~~~~~~~-------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
|.++.-.. .+...+|+.+|.|+.||..||.++|+.|+.-+-|.|.+||++.+-+++|...|+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEeccccee
Confidence 76653221 13457899999999999999999999999999999999999988888888777653
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.2e-11 Score=107.71 Aligned_cols=127 Identities=25% Similarity=0.286 Sum_probs=85.3
Q ss_pred EEEEEEEeCCCcEEEEEEeecch-----------------------hhhHHHHHHHHHHHHHHhhcCCC--CccceeeeE
Q 035713 109 SVYLVELRGTNTYFAMKVMDKAS-----------------------LASRNKLLRAQTEREILGLLDHP--FLPTLYSYF 163 (491)
Q Consensus 109 ~V~~a~~~~~~~~vaiK~i~~~~-----------------------~~~~~~~~~~~~E~~il~~l~hp--~iv~l~~~~ 163 (491)
.||.|... +|..+|||+.+... ...........+|.+.|..+..- ++.+.+++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48888875 57799999885321 01112334568999999999765 567776542
Q ss_pred EeCceEEEEEeccC--CCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHH-HHHcCcccccCCCCCEEEccCCcEEEeec
Q 035713 164 ETDKFYCLVMEFCS--GGNLHSLRQKQPNKYFTEDAARFFASEVLLALEY-LHMLGIVYRDLKPENVLVRDEGHIMLSDF 240 (491)
Q Consensus 164 ~~~~~~~lV~E~~~--gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~-LH~~givHrDikp~NILl~~~g~vkL~DF 240 (491)
..+|||||+. |..+..+.... ++.+....++.+++..+.. +|+.||||+|+.+.|||++.+ .+.|+||
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ----CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 2359999998 66666554432 3345567788888886665 579999999999999999876 8999999
Q ss_pred ccccc
Q 035713 241 DLSLR 245 (491)
Q Consensus 241 Gla~~ 245 (491)
|.+..
T Consensus 151 ~qav~ 155 (188)
T PF01163_consen 151 GQAVD 155 (188)
T ss_dssp TTEEE
T ss_pred Cccee
Confidence 98854
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.3e-10 Score=107.79 Aligned_cols=135 Identities=15% Similarity=0.080 Sum_probs=96.7
Q ss_pred eEEEEEEEeCCCcEEEEEEeecchhhh---H-----HHHHHHHHHHHHHhhcCCCC--ccceeeeEEe-----CceEEEE
Q 035713 108 GSVYLVELRGTNTYFAMKVMDKASLAS---R-----NKLLRAQTEREILGLLDHPF--LPTLYSYFET-----DKFYCLV 172 (491)
Q Consensus 108 g~V~~a~~~~~~~~vaiK~i~~~~~~~---~-----~~~~~~~~E~~il~~l~hp~--iv~l~~~~~~-----~~~~~lV 172 (491)
..|.++.. .|+.|.||......... . .....+.+|.+.+..|..-+ ++..+.+++. ...-+||
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 34556544 46789999764332110 0 11113678999888885433 3455555543 2357899
Q ss_pred EeccCCC-chHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc-------CCcEEEeeccccc
Q 035713 173 MEFCSGG-NLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD-------EGHIMLSDFDLSL 244 (491)
Q Consensus 173 ~E~~~gg-~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~-------~g~vkL~DFGla~ 244 (491)
||++++- +|.+++........+......++.+|+..+.-||.+||+|+|+++.|||++. ++.+.|+||+.++
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999875 7988876432344667788899999999999999999999999999999975 4679999999874
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=6e-09 Score=97.09 Aligned_cols=136 Identities=24% Similarity=0.277 Sum_probs=102.0
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhh-----------------h--HHHHHHHHHHHHHHhhcCCC--
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLA-----------------S--RNKLLRAQTEREILGLLDHP-- 154 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~-----------------~--~~~~~~~~~E~~il~~l~hp-- 154 (491)
+.+...||-|--+.||.|.+. .|..+|||.-+....+ + .......++|.++|+.|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456789999999999999988 6889999965421110 0 01233457899999998754
Q ss_pred CccceeeeEEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCc
Q 035713 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGH 234 (491)
Q Consensus 155 ~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~ 234 (491)
.|.+-+++ +...+||||++|-.|.... +..+....++..|+.-+..+-..||||+|+.+=|||++.+|.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 66666654 4567999999998876432 234555666777777777777899999999999999999999
Q ss_pred EEEeecccc
Q 035713 235 IMLSDFDLS 243 (491)
Q Consensus 235 vkL~DFGla 243 (491)
+.++||--+
T Consensus 241 ~~vIDwPQ~ 249 (304)
T COG0478 241 IVVIDWPQA 249 (304)
T ss_pred EEEEeCccc
Confidence 999999654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=6.7e-09 Score=96.20 Aligned_cols=105 Identities=27% Similarity=0.274 Sum_probs=84.5
Q ss_pred HHHHHHHHHHhhcCCC--CccceeeeEEeC----ceEEEEEeccCCC-chHHHHHhCCCCCCCHHHHHHHHHHHHHHHHH
Q 035713 139 LRAQTEREILGLLDHP--FLPTLYSYFETD----KFYCLVMEFCSGG-NLHSLRQKQPNKYFTEDAARFFASEVLLALEY 211 (491)
Q Consensus 139 ~~~~~E~~il~~l~hp--~iv~l~~~~~~~----~~~~lV~E~~~gg-~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 211 (491)
.+..+|.+.+..|..- .++..+.+.+.. ..-+||||++++. +|.+++..... ++......++.+++..+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 3567888888887533 346666666542 2458999999884 79998886422 6777888999999999999
Q ss_pred HHHcCcccccCCCCCEEEccCC---cEEEeecccccc
Q 035713 212 LHMLGIVYRDLKPENVLVRDEG---HIMLSDFDLSLR 245 (491)
Q Consensus 212 LH~~givHrDikp~NILl~~~g---~vkL~DFGla~~ 245 (491)
||.+||+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999999887 899999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.87 E-value=4e-08 Score=89.86 Aligned_cols=140 Identities=21% Similarity=0.263 Sum_probs=92.4
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHH------HHHHHHHhhcC---CCCccceee
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRA------QTEREILGLLD---HPFLPTLYS 161 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~------~~E~~il~~l~---hp~iv~l~~ 161 (491)
+...+|++++++-.....-|.+..- +|+.+++|..+......+..+..+ .+++..+..+. ......++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3457899999998877776766554 477899998765432222222222 23444344443 223333333
Q ss_pred eEE-----eCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEE
Q 035713 162 YFE-----TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIM 236 (491)
Q Consensus 162 ~~~-----~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vk 236 (491)
+.+ -....+|||||++|..|.++.. +++. +...|+.+|.-||+.|++|+|.+|.|++++.+ .++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~ 174 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIR 174 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEE
Confidence 322 2234568999999998876532 3332 44567788999999999999999999999855 599
Q ss_pred Eeecccc
Q 035713 237 LSDFDLS 243 (491)
Q Consensus 237 L~DFGla 243 (491)
++||+..
T Consensus 175 iID~~~k 181 (229)
T PF06176_consen 175 IIDTQGK 181 (229)
T ss_pred EEECccc
Confidence 9999865
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=5.1e-08 Score=88.84 Aligned_cols=140 Identities=16% Similarity=0.143 Sum_probs=101.5
Q ss_pred eccCceEEEEEEEeCCCcEEEEEEeecch---hhhHHHHHHHHHHHHHHhhcCCCC--ccceeeeEE---e--CceEEEE
Q 035713 103 GYGDIGSVYLVELRGTNTYFAMKVMDKAS---LASRNKLLRAQTEREILGLLDHPF--LPTLYSYFE---T--DKFYCLV 172 (491)
Q Consensus 103 G~G~~g~V~~a~~~~~~~~vaiK~i~~~~---~~~~~~~~~~~~E~~il~~l~hp~--iv~l~~~~~---~--~~~~~lV 172 (491)
|+||.+-|++.... |+.|-+|.-.... .........+.+|...|+.|..-+ +.+.. ++. . .-.-+||
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 57899999987765 3368888754111 111223456788999998885332 45554 332 1 1246799
Q ss_pred EeccCC-CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCc--EEEeecccccc
Q 035713 173 MEFCSG-GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGH--IMLSDFDLSLR 245 (491)
Q Consensus 173 ~E~~~g-g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~--vkL~DFGla~~ 245 (491)
+|-+.| .+|.+++....-...+......++.+|+..|.-||..|+.|+|+-+.|||++.+|. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997743 68888876643345678888899999999999999999999999999999987777 99999987654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=9.8e-10 Score=112.35 Aligned_cols=244 Identities=17% Similarity=0.173 Sum_probs=165.1
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCC-ccceeeeEEeCceEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF-LPTLYSYFETDKFYCLV 172 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~-iv~l~~~~~~~~~~~lV 172 (491)
..|...+.+++|+++++++.+...+...+ .+++... ....-++++|.+++||| .+..++-++.+...+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 34677788899999999999988776555 6766432 23345889999999999 77777778888899999
Q ss_pred EeccCCC-chHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 173 MEFCSGG-NLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 173 ~E~~~gg-~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
|+++.++ +....+... .-.|.+-+...+.+.-+.+|++||+.-=+||| |||..+ +..|+.||+....+...
T Consensus 313 ~~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~-- 384 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT-- 384 (829)
T ss_pred hhhhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc--
Confidence 9999877 222211111 11244445555667778899999988779998 887754 67899999876332110
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
....+..+|+.
T Consensus 385 ---------------------------------------------------------------------~~~~t~~~~~~ 395 (829)
T KOG0576|consen 385 ---------------------------------------------------------------------MKPRTAIGTPE 395 (829)
T ss_pred ---------------------------------------------------------------------cccccCCCCCC
Confidence 01224579999
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCC--CCCCCCHH-HHHHHHhhhccCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP--ETPQVSFV-ARDLIRGLLVKEPH 408 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~-~~~li~~~L~~dP~ 408 (491)
++|||+..+..+....|.|++|+-..+|.-|-+|-... ......+-.++-.+. .....+.. -+++...|+..-|.
T Consensus 396 ~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~ 473 (829)
T KOG0576|consen 396 PLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPP 473 (829)
T ss_pred CCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCCCCccccchhhhcCcccccCCcccccCCCCC
Confidence 99999999999999999999999777787777765431 111111101100000 00011111 12477788888888
Q ss_pred CCCCcCCChHHhhcCCCcCCC
Q 035713 409 KRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 409 ~R~t~~~~~~ell~hpff~~~ 429 (491)
.|+. ...++.|.+|.+-
T Consensus 474 ~pkv----~mgacfsKvfngC 490 (829)
T KOG0576|consen 474 TPKV----HMGACFSKVFNGC 490 (829)
T ss_pred CCcc----hhhHHHHHHhccC
Confidence 8888 8888888888653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.2e-08 Score=101.15 Aligned_cols=144 Identities=20% Similarity=0.212 Sum_probs=91.3
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhh-------------------------------HHHHHH------HH
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLAS-------------------------------RNKLLR------AQ 142 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~-------------------------------~~~~~~------~~ 142 (491)
.-|+.++-|.||+|+.+ +|+.||||+.+..-... ++..+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56889999999999999 49999999986431100 011111 23
Q ss_pred HHHHHHhhcC-----CCCccceeeeE-EeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 035713 143 TEREILGLLD-----HPFLPTLYSYF-ETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG 216 (491)
Q Consensus 143 ~E~~il~~l~-----hp~iv~l~~~~-~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g 216 (491)
+|..-+.+++ .++| .+=.++ +-.+.-.|+|||++|-.+.++..... ..++...+.....++. +..+-..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 4444444432 2332 222222 33344569999999999988743322 3355433333332222 22333489
Q ss_pred cccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 217 IVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 217 ivHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
++|.|.+|.||+++.+|.+.+.|||+...+..
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999866543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.6e-07 Score=92.11 Aligned_cols=233 Identities=20% Similarity=0.238 Sum_probs=148.4
Q ss_pred EeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeE-------EeCceE
Q 035713 98 LLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYF-------ETDKFY 169 (491)
Q Consensus 98 ~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~-------~~~~~~ 169 (491)
..+.||+|+-+.+|-.-.-. ..+.|++.+.......+ .+..|... .||-+-.-+.|= .....+
T Consensus 15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~aq------k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQAQ------KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecchhh---chhheeecCCCchHHHH------HHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 45779999999999654332 24678887764433222 22233333 566443311111 122337
Q ss_pred EEEEeccCCCch-HHHHH----hCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 170 CLVMEFCSGGNL-HSLRQ----KQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 170 ~lV~E~~~gg~L-~~~~~----~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
-+.|..+.|..- ..++. ++....+.+.-+...++.|+.+...||+.|.+-+|+.++|+|+++++.|.|.|=..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 788998877532 22221 2222347788999999999999999999999999999999999999999998743211
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
.+ . .....-
T Consensus 166 i~------------------------------------------------------------~-----------ng~~~~ 174 (637)
T COG4248 166 IN------------------------------------------------------------A-----------NGTLHL 174 (637)
T ss_pred ec------------------------------------------------------------c-----------CCceEe
Confidence 00 0 001111
Q ss_pred ccccccCccCcchhc-----CCCCCCcccccchhhHHHhhhcC-CCCCCCCC-------cHHHHHHHHc----------C
Q 035713 325 SFVGTHEYLAPEIIR-----GEGHGSAVDWWTFGIFLYELLHG-TTPFKGQG-------NRATLFNVVG----------Q 381 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlG~il~elltg-~~Pf~~~~-------~~~~~~~i~~----------~ 381 (491)
.-+|...|.+||.-. +..-+...|.|.||+++|++|.| +.||.|-. ..+. .|-. .
T Consensus 175 cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~--~Ia~g~f~ya~~~~~ 252 (637)
T COG4248 175 CPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET--DIAHGRFAYASDQRR 252 (637)
T ss_pred cccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh--hhhcceeeechhccC
Confidence 238999999999865 33346789999999999999995 99997631 1110 1111 1
Q ss_pred CCcC----CCCCCCCHHHHHHHHhhhcc--CCCCCCC
Q 035713 382 PLRF----PETPQVSFVARDLIRGLLVK--EPHKRIA 412 (491)
Q Consensus 382 ~~~~----~~~~~~s~~~~~li~~~L~~--dP~~R~t 412 (491)
++.. +....+++++..|..+|+.. ++.-||+
T Consensus 253 g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~ 289 (637)
T COG4248 253 GLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPT 289 (637)
T ss_pred CCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCC
Confidence 1111 11235778888888888874 3567887
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.9e-07 Score=86.38 Aligned_cols=137 Identities=22% Similarity=0.236 Sum_probs=94.0
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhH---------------------HHHHHHHHHHHHHhhcC--CCCc
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASR---------------------NKLLRAQTEREILGLLD--HPFL 156 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~---------------------~~~~~~~~E~~il~~l~--hp~i 156 (491)
..|..|--+.||+|... ++..+|+|+++.....-. ........|..-|+++. +=.+
T Consensus 54 g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 36777888899999874 678999999864322111 11223456777777764 3344
Q ss_pred cceeeeEEeCceEEEEEeccCCCch-HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCCEEEccCCc
Q 035713 157 PTLYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEGH 234 (491)
Q Consensus 157 v~l~~~~~~~~~~~lV~E~~~gg~L-~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~NILl~~~g~ 234 (491)
.+-+.+. ...|||||+....+ .-.++. -.+..+++..+..+++..+.-|-. .|+||+||..=|||+. ++.
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence 4444443 24599999943311 111221 224444788888999999998876 8999999999999998 889
Q ss_pred EEEeecccccc
Q 035713 235 IMLSDFDLSLR 245 (491)
Q Consensus 235 vkL~DFGla~~ 245 (491)
+.|+|||-|..
T Consensus 205 p~iID~~QaV~ 215 (268)
T COG1718 205 PYIIDVSQAVT 215 (268)
T ss_pred EEEEECccccc
Confidence 99999998854
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.66 E-value=3e-07 Score=86.28 Aligned_cols=135 Identities=13% Similarity=0.094 Sum_probs=84.1
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCC--ccceeeeEEeCceEEEEEeccC
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF--LPTLYSYFETDKFYCLVMEFCS 177 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~--iv~l~~~~~~~~~~~lV~E~~~ 177 (491)
..||.|..+.||+. .+..+++|+..... ....+.+|.++++.+..-. +.+.+++....+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999984 24457889876432 1223578999999986433 5778888888888899999999
Q ss_pred CCc-hH--------------HH-------HHhCCCCCCCHHH-HHHHHH----------HHHH-HHHHHHH----cCccc
Q 035713 178 GGN-LH--------------SL-------RQKQPNKYFTEDA-ARFFAS----------EVLL-ALEYLHM----LGIVY 219 (491)
Q Consensus 178 gg~-L~--------------~~-------~~~~~~~~l~~~~-~~~~~~----------qi~~-aL~~LH~----~givH 219 (491)
|.+ +. .. ++..+........ ...+.. .+.. ...+|.. ..++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 11 10 1111001111110 001100 1111 1222221 24789
Q ss_pred ccCCCCCEEEccCCcEEEeeccccc
Q 035713 220 RDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 220 rDikp~NILl~~~g~vkL~DFGla~ 244 (491)
+|+.|.||+++.++ +.|+||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999888 9999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.6e-06 Score=81.49 Aligned_cols=139 Identities=24% Similarity=0.319 Sum_probs=83.8
Q ss_pred eeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCC--CccceeeeEE---eCceEEEEE
Q 035713 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP--FLPTLYSYFE---TDKFYCLVM 173 (491)
Q Consensus 99 ~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp--~iv~l~~~~~---~~~~~~lV~ 173 (491)
++.|+.|..+.||++.... ..+++|+.... .....+.+|..+++.+... .+.+++.+.. .....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999999875 47999987543 3344566888888888533 3567776443 334679999
Q ss_pred eccCCCchHH----------------HHH---hC--CCCCCCHHH---H---HHH---------------HHHHHH-HHH
Q 035713 174 EFCSGGNLHS----------------LRQ---KQ--PNKYFTEDA---A---RFF---------------ASEVLL-ALE 210 (491)
Q Consensus 174 E~~~gg~L~~----------------~~~---~~--~~~~l~~~~---~---~~~---------------~~qi~~-aL~ 210 (491)
++++|..+.. ++. .. ....+.... . ... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987776 111 11 111111100 0 000 111222 334
Q ss_pred HHHH-------cCcccccCCCCCEEEc-cCCcEEEeeccccc
Q 035713 211 YLHM-------LGIVYRDLKPENVLVR-DEGHIMLSDFDLSL 244 (491)
Q Consensus 211 ~LH~-------~givHrDikp~NILl~-~~g~vkL~DFGla~ 244 (491)
.+++ ..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 4442 3599999999999999 66777899999874
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=6.8e-07 Score=78.28 Aligned_cols=130 Identities=28% Similarity=0.341 Sum_probs=93.3
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCc-cceeeeEEeCceEEEEE
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFL-PTLYSYFETDKFYCLVM 173 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~i-v~l~~~~~~~~~~~lV~ 173 (491)
..++.+.||+|.+|.||+|.+. |..+|+|+-+.+ .....+..|+++|..++.-++ .++|.+..+ ++.|
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~m 91 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRM 91 (201)
T ss_pred hhhhhhhhhcccccEEEEeecc--CceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhh
Confidence 3566788999999999999988 558999986543 233456789999999987666 456665443 3559
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCC-CCCEEEccCCcEEEeeccccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLK-PENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDik-p~NILl~~~g~vkL~DFGla~ 244 (491)
||+.|-.|.++-.. .+.++ ...++..---|-..||-|..|. |..++|..++.+.|+||.-|.
T Consensus 92 e~i~G~~L~~~~~~-----~~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 92 EYIDGRPLGKLEIG-----GDRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhcCcchhhhhhc-----ccHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 99999888765332 12222 2345555555677899999994 555555566699999999885
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=8.2e-07 Score=91.98 Aligned_cols=141 Identities=19% Similarity=0.204 Sum_probs=89.4
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhH-----------------------------HHHHH------HHHH
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASR-----------------------------NKLLR------AQTE 144 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~-----------------------------~~~~~------~~~E 144 (491)
+.||.-+.|.||+|+.+. |+.||||+-+..- ... +..+. +.+|
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l-~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGL-EKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcCh-HHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 578999999999999995 9999999976431 111 11111 1222
Q ss_pred HH----HHhhcCCCC------ccceeeeEEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 035713 145 RE----ILGLLDHPF------LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214 (491)
Q Consensus 145 ~~----il~~l~hp~------iv~l~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~ 214 (491)
.+ +.+.++|-+ |.++|..+. ..-.|+||||+|..+.++-... ...++...+...+.++..-+ +=.
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~-~~gi~~~~i~~~l~~~~~~q--If~ 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAID-KRGISPHDILNKLVEAYLEQ--IFK 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHH-HcCCCHHHHHHHHHHHHHHH--HHh
Confidence 22 223334544 344443332 3456999999998887653322 13366654444433333222 234
Q ss_pred cCcccccCCCCCEEEcc----CCcEEEeecccccccC
Q 035713 215 LGIVYRDLKPENVLVRD----EGHIMLSDFDLSLRCS 247 (491)
Q Consensus 215 ~givHrDikp~NILl~~----~g~vkL~DFGla~~~~ 247 (491)
.|++|.|-+|.||++.. ++.+.|-|||+...+.
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 68999999999999984 6789999999986553
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.6e-06 Score=82.56 Aligned_cols=135 Identities=19% Similarity=0.125 Sum_probs=83.0
Q ss_pred eeccCc-eEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCceEEEEEeccCCC
Q 035713 102 LGYGDI-GSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKFYCLVMEFCSGG 179 (491)
Q Consensus 102 iG~G~~-g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~~lV~E~~~gg 179 (491)
|-.|.+ +.||++... +..+.||+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 444555 789998764 3578888875432 223557899988884 444668888877777788999999998
Q ss_pred chHHHH-------------------HhCCC--CCCCHH------HHHHHHH----------------HHHHHHHHHH---
Q 035713 180 NLHSLR-------------------QKQPN--KYFTED------AARFFAS----------------EVLLALEYLH--- 213 (491)
Q Consensus 180 ~L~~~~-------------------~~~~~--~~l~~~------~~~~~~~----------------qi~~aL~~LH--- 213 (491)
+|.... +..+. ..+... .....+. .+...+..|-
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 775331 11110 011100 0000000 0111122221
Q ss_pred ----HcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 214 ----MLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 214 ----~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
...++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 1248999999999999987778899999874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.3e-06 Score=77.56 Aligned_cols=128 Identities=27% Similarity=0.330 Sum_probs=91.5
Q ss_pred CCceEeeeeeccCc-eEEEEEEEeCCCcEEEEEEeecch----------hhh--------HHHHHHHHHHHHHHhhcC--
Q 035713 94 SNFRLLKRLGYGDI-GSVYLVELRGTNTYFAMKVMDKAS----------LAS--------RNKLLRAQTEREILGLLD-- 152 (491)
Q Consensus 94 ~~y~~~~~iG~G~~-g~V~~a~~~~~~~~vaiK~i~~~~----------~~~--------~~~~~~~~~E~~il~~l~-- 152 (491)
.+++.++.||.|.- |.||+++.. |+.||||++..-. ... .....-+..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 999999877 6799999943210 010 023345678888777774
Q ss_pred -CCCc--cceeeeEEeC------------------ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHH
Q 035713 153 -HPFL--PTLYSYFETD------------------KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEY 211 (491)
Q Consensus 153 -hp~i--v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 211 (491)
+.++ |+.++|..-. -...||.||++... .+... -+.+|++-|..
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~~~~dl~~ 179 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQMLRDLKI 179 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh----HHHHHHHHHHH
Confidence 4456 8999987311 12457888775443 12322 24678888999
Q ss_pred HHHcCcccccCCCCCEEEccCCcEEEeecccc
Q 035713 212 LHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243 (491)
Q Consensus 212 LH~~givHrDikp~NILl~~~g~vkL~DFGla 243 (491)
+|..||+-+|+|+.|.. .-||+|||.+
T Consensus 180 ~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999999975 3489999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.1e-06 Score=95.77 Aligned_cols=81 Identities=17% Similarity=0.326 Sum_probs=57.6
Q ss_pred EeeeeeccCceEEEEEEEeCCC--cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCc--cceeeeEEeC---ceE
Q 035713 98 LLKRLGYGDIGSVYLVELRGTN--TYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFL--PTLYSYFETD---KFY 169 (491)
Q Consensus 98 ~~~~iG~G~~g~V~~a~~~~~~--~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~i--v~l~~~~~~~---~~~ 169 (491)
.++.|+.|.++.+|+......+ ..+++|+........ ....+.+|.++|+.+. |.+| ++++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 4678899999999998775432 467788754322111 1234668999999996 6665 7888877654 467
Q ss_pred EEEEeccCCCc
Q 035713 170 CLVMEFCSGGN 180 (491)
Q Consensus 170 ~lV~E~~~gg~ 180 (491)
|+||||++|..
T Consensus 120 flVME~v~G~~ 130 (822)
T PLN02876 120 FYIMEYLEGRI 130 (822)
T ss_pred eEEEEecCCcc
Confidence 89999998864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.8e-05 Score=71.03 Aligned_cols=131 Identities=24% Similarity=0.320 Sum_probs=91.5
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchh-------------hhHHHHHHHHHHHHHHhhcC------CCCcccee
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASL-------------ASRNKLLRAQTEREILGLLD------HPFLPTLY 160 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~-------------~~~~~~~~~~~E~~il~~l~------hp~iv~l~ 160 (491)
..||+|+.-.||.- .......||++..... ..........+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 56899999999952 3445578999876650 00112344556666555554 78999999
Q ss_pred eeEEeCceEEEEEeccCC------CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC--
Q 035713 161 SYFETDKFYCLVMEFCSG------GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE-- 232 (491)
Q Consensus 161 ~~~~~~~~~~lV~E~~~g------g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~-- 232 (491)
|+.+++.-+-+|+|.+.. .+|.+++.. +.+++ .+. ..+-.-..||-+++|+.+|++|.||++...
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 999999888999998753 357777755 34666 333 334444567889999999999999999743
Q ss_pred C--cEEEeec
Q 035713 233 G--HIMLSDF 240 (491)
Q Consensus 233 g--~vkL~DF 240 (491)
+ .+.|+|-
T Consensus 157 ~~~~lvlIDG 166 (199)
T PF10707_consen 157 GEFRLVLIDG 166 (199)
T ss_pred CceEEEEEeC
Confidence 2 4777774
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.22 E-value=5.3e-06 Score=90.98 Aligned_cols=203 Identities=24% Similarity=0.284 Sum_probs=138.7
Q ss_pred HHHHHHHHHHhhcCCCCccceeeeEEeCc----eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 035713 139 LRAQTEREILGLLDHPFLPTLYSYFETDK----FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214 (491)
Q Consensus 139 ~~~~~E~~il~~l~hp~iv~l~~~~~~~~----~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~ 214 (491)
.....|+..+..+.|+|++.++.|..... .+.+..|++...++...++.. +..+...++.+..+++.||.|+|+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHH
Confidence 33456777788889999999999875432 234556888888998888775 668999999999999999999999
Q ss_pred cCcccccCCCC---CEEEccCCcEEEe--ecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCc
Q 035713 215 LGIVYRDLKPE---NVLVRDEGHIMLS--DFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPR 289 (491)
Q Consensus 215 ~givHrDikp~---NILl~~~g~vkL~--DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (491)
+...|.-+... +-..+..+.+.++ ||+.++......
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~--------------------------------------- 345 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE--------------------------------------- 345 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcc---------------------------------------
Confidence 96555544433 3333445555555 776553322100
Q ss_pred ccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCCCCCc--ccccchhhHHHhhhcCCCCCC
Q 035713 290 ILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSA--VDWWTFGIFLYELLHGTTPFK 367 (491)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~--~DiwSlG~il~elltg~~Pf~ 367 (491)
......-+..+.++|.+....+..+ .|+|.+|..+..+..|..+-.
T Consensus 346 --------------------------------~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~ 393 (1351)
T KOG1035|consen 346 --------------------------------KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISE 393 (1351)
T ss_pred --------------------------------cchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccc
Confidence 0111234566778888877766544 699999999999988765422
Q ss_pred CCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 368 GQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 368 ~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
-. .....++.. .......+++.+|+.-++++|+. +.+++.|+|.+.-
T Consensus 394 ~~---~~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~----~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 394 KS---AVPVSLLDV--------LSTSELLDALPKCLDEDSEERLS----ALELLTHPFLRFP 440 (1351)
T ss_pred cc---cchhhhhcc--------ccchhhhhhhhhhcchhhhhccc----hhhhhhchhcccc
Confidence 11 111111111 11126778999999999999999 9999999998643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.1e-05 Score=76.43 Aligned_cols=74 Identities=12% Similarity=0.134 Sum_probs=46.4
Q ss_pred eeeeeccCce-EEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCC---CccceeeeEEeC---ceEEE
Q 035713 99 LKRLGYGDIG-SVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP---FLPTLYSYFETD---KFYCL 171 (491)
Q Consensus 99 ~~~iG~G~~g-~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp---~iv~l~~~~~~~---~~~~l 171 (491)
++.|+.|+.. .||+.. ..+++|+..... ....+.+|.++|+.|... -+..+++..... ...|+
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3567766666 599762 247788754321 223577899999888632 345555443332 24589
Q ss_pred EEeccCCCchH
Q 035713 172 VMEFCSGGNLH 182 (491)
Q Consensus 172 V~E~~~gg~L~ 182 (491)
||++++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999997763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=5.9e-07 Score=100.09 Aligned_cols=255 Identities=11% Similarity=-0.072 Sum_probs=163.5
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhh--HHHHHHHHHHHHHHhhcCCCCccceeeeEE--eCc
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLAS--RNKLLRAQTEREILGLLDHPFLPTLYSYFE--TDK 167 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~E~~il~~l~hp~iv~l~~~~~--~~~ 167 (491)
.++++++.=-||.|.+++--.-+.+..+ +-+|+.+.-.+.. +-..+....|+..++...|+++...+.-.. +..
T Consensus 1227 ~~e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1227 AMEHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred HhhhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence 4566777777777666543222222222 4556554322221 122334455666677788998877766553 345
Q ss_pred eEEEEEeccCCCchHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHcC-----cccccCCCCCEEEccCCcEEEeec
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPN--KYFTEDAARFFASEVLLALEYLHMLG-----IVYRDLKPENVLVRDEGHIMLSDF 240 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDikp~NILl~~~g~vkL~DF 240 (491)
..|.+++|+.+|.+.+.+-+.-. ..+.+.-+.....+.+.+..-+|++. .+|+++|+-|.+|..+..+|++++
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence 67899999999999998765322 22444444444445477777777642 799999999999999999999999
Q ss_pred ccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCC
Q 035713 241 DLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTN 320 (491)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (491)
|+.+..... .
T Consensus 1385 gLdKIknp~----------------------------------------------------------------------~ 1394 (2724)
T KOG1826|consen 1385 GLDKIKNPV----------------------------------------------------------------------L 1394 (2724)
T ss_pred ccccccCch----------------------------------------------------------------------H
Confidence 998521110 0
Q ss_pred ccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcC----CCCCCCCHHHH
Q 035713 321 VRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF----PETPQVSFVAR 396 (491)
Q Consensus 321 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~----~~~~~~s~~~~ 396 (491)
...+..++++.|+.+++...-.++.++|+|.+|+.+|++.-|..+|-. .+..++.+..+. ...-..|.++.
T Consensus 1395 sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~-----flq~~Lkgiidn~tf~sIe~l~pgdaN 1469 (2724)
T KOG1826|consen 1395 SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIF-----FLQPALKGIIDNHTFFSIEKLKPGDAN 1469 (2724)
T ss_pred hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHH-----HHHHHHcCcccccccccccccCCCccc
Confidence 112245789999999999988898889999999999999988887742 233333332221 11112344455
Q ss_pred HHHHhhhccCCCCCCCcCCChHHhhcCCCcC
Q 035713 397 DLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 397 ~li~~~L~~dP~~R~t~~~~~~ell~hpff~ 427 (491)
.+...+|-..-..||. -...+.-+.|.
T Consensus 1470 ve~~~~Ll~K~~~rp~----q~isls~d~~a 1496 (2724)
T KOG1826|consen 1470 VEALHRLLWKYMERPG----QYISLSRDHFA 1496 (2724)
T ss_pred HHHHHHHHHHhhhcch----hhhhccccccc
Confidence 5555556666678888 66667666663
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.98 E-value=6.5e-05 Score=73.30 Aligned_cols=140 Identities=21% Similarity=0.234 Sum_probs=94.9
Q ss_pred EeeeeeccCceEEEEEEEeCCCcEEEEEEeecchh-----------------------hhHHHHHHHHHHHHHHhhcCCC
Q 035713 98 LLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASL-----------------------ASRNKLLRAQTEREILGLLDHP 154 (491)
Q Consensus 98 ~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~-----------------------~~~~~~~~~~~E~~il~~l~hp 154 (491)
|-..|..|--+.||.|... +|..+|||+++-..+ ...........|.+-|.+|...
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4457788999999999876 677899999862211 0011112234677777777655
Q ss_pred CccceeeeEEeCceEEEEEeccCCCchHH--HHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCcccccCCCCCEEEcc
Q 035713 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHS--LRQKQPNKYFTEDAARFFASEVLLALEYLH-MLGIVYRDLKPENVLVRD 231 (491)
Q Consensus 155 ~iv~l~~~~~~~~~~~lV~E~~~gg~L~~--~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~givHrDikp~NILl~~ 231 (491)
.|. .-.-..-.+ ..|||+|+ |.+-+- .++ ...++...+..+-.|++.-|.-|- ..++||.||.-=|+|+ .
T Consensus 227 GIP-~PePIlLk~-hVLVM~Fl-Grdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-h 299 (520)
T KOG2270|consen 227 GIP-CPEPILLKN-HVLVMEFL-GRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-H 299 (520)
T ss_pred CCC-CCCceeeec-ceEeeeec-cCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-E
Confidence 532 222222222 35999999 444332 222 245888889999889988888774 5799999999999988 5
Q ss_pred CCcEEEeecccccc
Q 035713 232 EGHIMLSDFDLSLR 245 (491)
Q Consensus 232 ~g~vkL~DFGla~~ 245 (491)
+|.+.|+|-+-+..
T Consensus 300 dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVE 313 (520)
T ss_pred CCEEEEEEcccccc
Confidence 78999999987643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.98 E-value=4.8e-05 Score=71.85 Aligned_cols=75 Identities=24% Similarity=0.375 Sum_probs=49.1
Q ss_pred eeeeeccCceEEEEEEEeC-CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCC-CCccceeeeEEeCceEEEEEecc
Q 035713 99 LKRLGYGDIGSVYLVELRG-TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH-PFLPTLYSYFETDKFYCLVMEFC 176 (491)
Q Consensus 99 ~~~iG~G~~g~V~~a~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~l~~~~~~~~~~~lV~E~~ 176 (491)
++.|..|-...||++.... .++.|++|+...... . .....+|..+++.+.. ...++++..+. + .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---L-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---c-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEee
Confidence 4677888899999997653 356788997654211 1 1122368888888853 33455555433 2 3899999
Q ss_pred CCCch
Q 035713 177 SGGNL 181 (491)
Q Consensus 177 ~gg~L 181 (491)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 99765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00011 Score=74.38 Aligned_cols=81 Identities=22% Similarity=0.241 Sum_probs=55.8
Q ss_pred EeeeeeccCceEEEEEEEeCCCcEEEEEEeecchh---h-hHHHHHHHHHHHHHHhhcC---CCCccceeeeEEeCceEE
Q 035713 98 LLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASL---A-SRNKLLRAQTEREILGLLD---HPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 98 ~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~---~-~~~~~~~~~~E~~il~~l~---hp~iv~l~~~~~~~~~~~ 170 (491)
-.+.||.|.+..||++.....++.|+||.-....- . ......+...|.+.|+.+. -.++++++.+ +....+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 35789999999999999875446899997431100 0 1224456777888888863 3467778776 335567
Q ss_pred EEEeccCCCc
Q 035713 171 LVMEFCSGGN 180 (491)
Q Consensus 171 lV~E~~~gg~ 180 (491)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998643
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00014 Score=71.37 Aligned_cols=80 Identities=15% Similarity=0.076 Sum_probs=56.7
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCC---CCccceeeeEEe---Cce
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH---PFLPTLYSYFET---DKF 168 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h---p~iv~l~~~~~~---~~~ 168 (491)
...-++.||.|..+.||+..... + .+.+|..+... ....+.+|.+.|+.|.- -.|+++++++.. .+.
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~ 87 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQ-G-NPMPLMARSFS-----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP 87 (297)
T ss_pred hhheeeecCCccceeEEEEEcCC-C-CEEEEEecccc-----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence 34456789999999999986542 3 46777743210 11356689999998853 367888887754 366
Q ss_pred EEEEEeccCCCch
Q 035713 169 YCLVMEFCSGGNL 181 (491)
Q Consensus 169 ~~lV~E~~~gg~L 181 (491)
.+||||+++|+++
T Consensus 88 ~~LVmE~i~G~~~ 100 (297)
T PRK10593 88 DVLLLERLRGVSV 100 (297)
T ss_pred eEEEEeccCCEec
Confidence 8999999998764
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.95 E-value=1.3e-05 Score=76.74 Aligned_cols=135 Identities=20% Similarity=0.285 Sum_probs=96.2
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhh------H-----------HH--HHHHHHHHHHHhhcC-CC-
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLAS------R-----------NK--LLRAQTEREILGLLD-HP- 154 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~------~-----------~~--~~~~~~E~~il~~l~-hp- 154 (491)
+.+.+.||-|.-+.||.+-+. .|...++|+-+.....- + .. .....+|...|+.|. |-
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 667899999999999999887 57788998643221110 0 01 123457888888774 22
Q ss_pred CccceeeeEEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCc
Q 035713 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGH 234 (491)
Q Consensus 155 ~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~ 234 (491)
-|.+.++ .+..|+|||++.|-.|..+.+.. + +..+...+..-+--|-.+|+||+|+.-=||+|..++.
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~-----d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHVE-----D---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeecC-----C---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence 2444444 34578999999998887654321 2 3345556666777888999999999999999999999
Q ss_pred EEEeecccc
Q 035713 235 IMLSDFDLS 243 (491)
Q Consensus 235 vkL~DFGla 243 (491)
++++||--.
T Consensus 241 i~vIDFPQm 249 (465)
T KOG2268|consen 241 IVVIDFPQM 249 (465)
T ss_pred EEEeechHh
Confidence 999999543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.85 E-value=4.9e-05 Score=69.05 Aligned_cols=97 Identities=25% Similarity=0.266 Sum_probs=78.0
Q ss_pred HHHHHHHhhcCC-CCccceeeeEEeCceEEEEEeccCCCchHHH---HHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---
Q 035713 142 QTEREILGLLDH-PFLPTLYSYFETDKFYCLVMEFCSGGNLHSL---RQKQPNKYFTEDAARFFASEVLLALEYLHM--- 214 (491)
Q Consensus 142 ~~E~~il~~l~h-p~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~---~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--- 214 (491)
..|.-+|+.+.+ +++++++|++- .++|.||...+++... +... ..-++..+..++.+++..+++|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 358888888876 69999999883 2578999987766421 1111 236899999999999999999997
Q ss_pred cCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 215 ~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
..+.-.|++++|+-++.+|++|++|...+.
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 348889999999999999999999998764
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.0002 Score=70.66 Aligned_cols=144 Identities=17% Similarity=0.190 Sum_probs=84.8
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCC--ccceeee------EEe
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF--LPTLYSY------FET 165 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~--iv~l~~~------~~~ 165 (491)
+....++.|+.|....||++... +| .+++|+.+... . ...+..|.+++..|.... +++++.. ...
T Consensus 22 ~~~~~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~ 94 (307)
T TIGR00938 22 GELLSLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL 94 (307)
T ss_pred CCceeccccCCccccceEEEEeC-CC-cEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence 44556788888888999998643 34 57889875421 1 123345677777774222 3444432 123
Q ss_pred CceEEEEEeccCCCchH-----------HH---HHhCCCC---------CCCH-HH--HH----------HHHHHHHHHH
Q 035713 166 DKFYCLVMEFCSGGNLH-----------SL---RQKQPNK---------YFTE-DA--AR----------FFASEVLLAL 209 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~-----------~~---~~~~~~~---------~l~~-~~--~~----------~~~~qi~~aL 209 (491)
.+..++||||++|..+. .. ++....+ .++. .. .. .....+...+
T Consensus 95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~ 174 (307)
T TIGR00938 95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL 174 (307)
T ss_pred CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence 46788999999986532 11 1110000 0000 00 00 0111233445
Q ss_pred HHHHH-------cCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 210 EYLHM-------LGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 210 ~~LH~-------~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
+++.. .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 55542 579999999999999988877899999873
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00039 Score=66.62 Aligned_cols=134 Identities=19% Similarity=0.216 Sum_probs=77.1
Q ss_pred eeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCc-cceeeeEEeCceEEEEEeccCCC
Q 035713 101 RLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFL-PTLYSYFETDKFYCLVMEFCSGG 179 (491)
Q Consensus 101 ~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~i-v~l~~~~~~~~~~~lV~E~~~gg 179 (491)
.+..|-.+.+|+.. .+++.+++|+..... ........+|.++|+.+....+ .+++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~---~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVC---KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccc---ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 34568888999887 346678888754321 1110123568889988864333 45554432 25899999987
Q ss_pred chHH--------------HHH---hCC--CCCCCH-HHHHHHHHHH---------HHHHHHHHH--------cCcccccC
Q 035713 180 NLHS--------------LRQ---KQP--NKYFTE-DAARFFASEV---------LLALEYLHM--------LGIVYRDL 222 (491)
Q Consensus 180 ~L~~--------------~~~---~~~--~~~l~~-~~~~~~~~qi---------~~aL~~LH~--------~givHrDi 222 (491)
.+.. .+. ..+ ...++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 6531 111 111 111221 1222322222 111222222 14899999
Q ss_pred CCCCEEEccCCcEEEeeccccc
Q 035713 223 KPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 223 kp~NILl~~~g~vkL~DFGla~ 244 (491)
.|.|||++.++ +.|+||+.|.
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccC
Confidence 99999999877 7899998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.0002 Score=70.36 Aligned_cols=76 Identities=21% Similarity=0.315 Sum_probs=49.6
Q ss_pred eeeeeccCceEEEEEEEeC------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCC-ccceeeeEEeCceEEE
Q 035713 99 LKRLGYGDIGSVYLVELRG------TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF-LPTLYSYFETDKFYCL 171 (491)
Q Consensus 99 ~~~iG~G~~g~V~~a~~~~------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~-iv~l~~~~~~~~~~~l 171 (491)
++.|..|-...||++.... .++.|++|+..... .......+|.++++.+.... ..++++++.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 4566677778999987653 25789999865432 11223457888888885333 4566666542 26
Q ss_pred EEeccCCCchH
Q 035713 172 VMEFCSGGNLH 182 (491)
Q Consensus 172 V~E~~~gg~L~ 182 (491)
|+||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999987663
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.0006 Score=66.77 Aligned_cols=141 Identities=16% Similarity=0.131 Sum_probs=84.5
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCC--ccceeee------EEeCc
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF--LPTLYSY------FETDK 167 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~--iv~l~~~------~~~~~ 167 (491)
..-++.|..|....+|+.... +..+++|+.... . ...+..|++++..|.+.+ +++++.. ...++
T Consensus 16 ~~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~ 87 (296)
T cd05153 16 LLSFEGISAGIENTNYFVTTD--SGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG 87 (296)
T ss_pred hhheecccCccccceEEEEeC--CCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence 344677888888999998654 346899987541 1 123556888888775332 4444432 23455
Q ss_pred eEEEEEeccCCCchHH-----------H---HHhC----CCC-----CCCHHH--HH--------HHHHHHHHHHHHHHH
Q 035713 168 FYCLVMEFCSGGNLHS-----------L---RQKQ----PNK-----YFTEDA--AR--------FFASEVLLALEYLHM 214 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~-----------~---~~~~----~~~-----~l~~~~--~~--------~~~~qi~~aL~~LH~ 214 (491)
..++|++|++|..+.. . ++.. ... ...+.. .. .....+..++.++.+
T Consensus 88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~ 167 (296)
T cd05153 88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA 167 (296)
T ss_pred ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence 6789999999876521 0 1100 000 000000 00 011123334445443
Q ss_pred -------cCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 215 -------LGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 215 -------~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999987777899998874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00089 Score=66.34 Aligned_cols=140 Identities=14% Similarity=0.130 Sum_probs=76.9
Q ss_pred eEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCC--ccceee------eEEeCce
Q 035713 97 RLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF--LPTLYS------YFETDKF 168 (491)
Q Consensus 97 ~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~--iv~l~~------~~~~~~~ 168 (491)
.-++.|+.|....+|+.... +| .+++|++... . .. .+..|.++++.|...+ +.+.+. +....+.
T Consensus 25 ~~~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~~--~-~~---~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~ 96 (319)
T PRK05231 25 LSLKGIAEGIENSNFFLTTT-QG-EYVLTLFERL--T-AE---DLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGK 96 (319)
T ss_pred hccchhccccccceEEEEeC-CC-cEEEEEeccC--C-hH---HhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCE
Confidence 34566778888899998754 33 6899987521 1 11 2234556666653222 334332 1233567
Q ss_pred EEEEEeccCCCchH-----------HHHH---hCCCC---------CCCH--HHHHH-----------HHHH-HHHHHHH
Q 035713 169 YCLVMEFCSGGNLH-----------SLRQ---KQPNK---------YFTE--DAARF-----------FASE-VLLALEY 211 (491)
Q Consensus 169 ~~lV~E~~~gg~L~-----------~~~~---~~~~~---------~l~~--~~~~~-----------~~~q-i~~aL~~ 211 (491)
.+++|||++|..+. ..+. ..... .+.+ ..... .+.+ +...+..
T Consensus 97 ~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 176 (319)
T PRK05231 97 PAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAF 176 (319)
T ss_pred EEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHh
Confidence 88999999987431 1111 10000 0101 00000 1111 1112233
Q ss_pred HH-------HcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 212 LH-------MLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 212 LH-------~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
+. ..|+||+|+.|.|||++.+...-|+||+.+.
T Consensus 177 ~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 177 LASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred hhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 32 2379999999999999866556899999874
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00051 Score=68.15 Aligned_cols=76 Identities=21% Similarity=0.194 Sum_probs=49.8
Q ss_pred eeeccCceEEEEEEEeCCCcEEEEEEeecc-h---hhhHHHHHHHHHHHHHHhhcC--CC-CccceeeeEEeCceEEEEE
Q 035713 101 RLGYGDIGSVYLVELRGTNTYFAMKVMDKA-S---LASRNKLLRAQTEREILGLLD--HP-FLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 101 ~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~-~---~~~~~~~~~~~~E~~il~~l~--hp-~iv~l~~~~~~~~~~~lV~ 173 (491)
.||.|....||++.....++.|+||.-... . ........+...|.+.|+... -| .++++|.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999998644467999954211 1 112334556677888887764 34 45555543 444556999
Q ss_pred eccCC
Q 035713 174 EFCSG 178 (491)
Q Consensus 174 E~~~g 178 (491)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99954
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.00097 Score=67.00 Aligned_cols=78 Identities=26% Similarity=0.352 Sum_probs=52.9
Q ss_pred eeeeeccCceEEEEEEEeCCCcEEEEEEeec---chhhhHHHHHHHHHHHHHHhhcC--CC-CccceeeeEEeCceEEEE
Q 035713 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDK---ASLASRNKLLRAQTEREILGLLD--HP-FLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 99 ~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~---~~~~~~~~~~~~~~E~~il~~l~--hp-~iv~l~~~~~~~~~~~lV 172 (491)
++.||.|--.-||++.+...++-|+||.-.. ..-...-...+...|.++|+.+. -| +++++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 7889999999999999854456799985321 11122345667778999998774 34 45556543 34455699
Q ss_pred EeccCC
Q 035713 173 MEFCSG 178 (491)
Q Consensus 173 ~E~~~g 178 (491)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999964
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0019 Score=62.51 Aligned_cols=29 Identities=24% Similarity=0.415 Sum_probs=24.7
Q ss_pred CcccccCCCCCEEEccCCc-EEEeeccccc
Q 035713 216 GIVYRDLKPENVLVRDEGH-IMLSDFDLSL 244 (491)
Q Consensus 216 givHrDikp~NILl~~~g~-vkL~DFGla~ 244 (491)
.++|+|+++.|||++.++. +-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 3899999999999997565 4699999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0042 Score=61.19 Aligned_cols=29 Identities=28% Similarity=0.521 Sum_probs=25.5
Q ss_pred cCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 215 ~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
.+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999763
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0014 Score=65.62 Aligned_cols=140 Identities=15% Similarity=0.177 Sum_probs=83.2
Q ss_pred eEeeeeeccCceEEEEEEEeC----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCc-cceeeeEEeCceEEE
Q 035713 97 RLLKRLGYGDIGSVYLVELRG----TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFL-PTLYSYFETDKFYCL 171 (491)
Q Consensus 97 ~~~~~iG~G~~g~V~~a~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~i-v~l~~~~~~~~~~~l 171 (491)
.-+..|-.|-...+|++.... .++.|++|+..... ...+.+ .+|..+++.+..-++ .++++.+..+ .
T Consensus 39 ~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~ 110 (344)
T PLN02236 39 LQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----R 110 (344)
T ss_pred EEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----e
Confidence 334456558889999987542 24679999875431 222222 568999988864444 5666766433 5
Q ss_pred EEeccCCCchHHH--------------HH---hCC--CC--CCCHHHHHHHHHHH-----------------HHHHHHHH
Q 035713 172 VMEFCSGGNLHSL--------------RQ---KQP--NK--YFTEDAARFFASEV-----------------LLALEYLH 213 (491)
Q Consensus 172 V~E~~~gg~L~~~--------------~~---~~~--~~--~l~~~~~~~~~~qi-----------------~~aL~~LH 213 (491)
|+||++|.+|..- +. ... .. ....+.+..+..++ ...+..|.
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 8999988776421 11 110 01 11123333333221 11122221
Q ss_pred --------HcCcccccCCCCCEEEcc-CCcEEEeeccccc
Q 035713 214 --------MLGIVYRDLKPENVLVRD-EGHIMLSDFDLSL 244 (491)
Q Consensus 214 --------~~givHrDikp~NILl~~-~g~vkL~DFGla~ 244 (491)
...++|+|+++.|||++. ++.+.|+||..|.
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 125899999999999986 4789999999874
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0023 Score=63.71 Aligned_cols=142 Identities=15% Similarity=0.217 Sum_probs=81.7
Q ss_pred CCceEeeeeeccCceEEEEEEEeCC---CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCc-cceeeeEEeCceE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGT---NTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFL-PTLYSYFETDKFY 169 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~i-v~l~~~~~~~~~~ 169 (491)
++.++.. |..|-...+|++..... +..|++|+..... ...+ .-.+|..+++.+..-++ +++++++. .+
T Consensus 15 ~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G-- 86 (330)
T PLN02421 15 SDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVI-DRERELQAIKYLSAAGFGAKLLGVFG-NG-- 86 (330)
T ss_pred CceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeEe-chHHHHHHHHHHHhcCCCCceeEEeC-Cc--
Confidence 3455444 44488888999876532 3378899875431 1112 22468889988865454 56676663 22
Q ss_pred EEEEeccCCCchHH--------------HHHhCCC------CCC-CHHHHHHHHHHH----------------------H
Q 035713 170 CLVMEFCSGGNLHS--------------LRQKQPN------KYF-TEDAARFFASEV----------------------L 206 (491)
Q Consensus 170 ~lV~E~~~gg~L~~--------------~~~~~~~------~~l-~~~~~~~~~~qi----------------------~ 206 (491)
+|.+|++|..|.. .+++... ..+ -...+..|..++ .
T Consensus 87 -~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~ 165 (330)
T PLN02421 87 -MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELR 165 (330)
T ss_pred -EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHH
Confidence 5899998876521 1111101 001 122333332222 1
Q ss_pred HHHHHHH----HcC----cccccCCCCCEEEcc-CCcEEEeeccccc
Q 035713 207 LALEYLH----MLG----IVYRDLKPENVLVRD-EGHIMLSDFDLSL 244 (491)
Q Consensus 207 ~aL~~LH----~~g----ivHrDikp~NILl~~-~g~vkL~DFGla~ 244 (491)
.-+..+. ..+ ++|.|+.+.|||++. ++.++|+||..|.
T Consensus 166 ~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 166 DEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1122222 112 799999999999974 5789999999874
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.001 Score=67.71 Aligned_cols=81 Identities=20% Similarity=0.160 Sum_probs=58.9
Q ss_pred CcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC----------CCCCCHHHHHHHHhhhccCCCCCCCcC
Q 035713 345 SAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE----------TPQVSFVARDLIRGLLVKEPHKRIAYK 414 (491)
Q Consensus 345 ~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~----------~~~~s~~~~~li~~~L~~dP~~R~t~~ 414 (491)
+++|||++|.++.|+..|...+......+.+..++.-...... .-.++....++..+|+-..|..||.
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l-- 187 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPL-- 187 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccc--
Confidence 3999999999999999999888765555544433321110000 0135566789999999999999998
Q ss_pred CChHHhhcCCCcCCC
Q 035713 415 RGATEIKQHPFFEGV 429 (491)
Q Consensus 415 ~~~~ell~hpff~~~ 429 (491)
..++++++-|..+
T Consensus 188 --~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 188 --PMELSKRCSFTEV 200 (725)
T ss_pred --hhHHhcCccHHHH
Confidence 8899999988765
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.012 Score=59.59 Aligned_cols=77 Identities=21% Similarity=0.202 Sum_probs=52.3
Q ss_pred EeeeeeccCceEEEEEEEeCCCcEEEEEEeecchh-h---hHHHHHHHHHHHHHHhhcC---CCCccceeeeEEeCceEE
Q 035713 98 LLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASL-A---SRNKLLRAQTEREILGLLD---HPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 98 ~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~-~---~~~~~~~~~~E~~il~~l~---hp~iv~l~~~~~~~~~~~ 170 (491)
..+.||.|....||+..+. +..|+||.-..... . ......+...|.+.|+.+. -.++++++.++.+ ..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence 4778999999999999874 44688996431111 1 1123445566777777664 2478888888773 356
Q ss_pred EEEeccCC
Q 035713 171 LVMEFCSG 178 (491)
Q Consensus 171 lV~E~~~g 178 (491)
+||||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.0051 Score=62.32 Aligned_cols=77 Identities=17% Similarity=0.259 Sum_probs=46.8
Q ss_pred EeeeeeccCceEEEEEEEeCC-CcE-----EEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCc-cceeeeEEeCceEE
Q 035713 98 LLKRLGYGDIGSVYLVELRGT-NTY-----FAMKVMDKASLASRNKLLRAQTEREILGLLDHPFL-PTLYSYFETDKFYC 170 (491)
Q Consensus 98 ~~~~iG~G~~g~V~~a~~~~~-~~~-----vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~i-v~l~~~~~~~~~~~ 170 (491)
.++.|..|-...+|++..... +.. |.+++... .....+ .-.+|+++++.|...++ .++++.|.. +
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~----g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST---YNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD----F 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC---CCceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence 445565699999999976433 122 33333211 111111 22468999999975544 677777753 4
Q ss_pred EEEeccCCCchH
Q 035713 171 LVMEFCSGGNLH 182 (491)
Q Consensus 171 lV~E~~~gg~L~ 182 (491)
+|.||++|..|.
T Consensus 126 ~l~efIeGr~l~ 137 (383)
T PTZ00384 126 TIQEWVEGNTMG 137 (383)
T ss_pred EEEEEeccccCC
Confidence 999999998764
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.027 Score=54.74 Aligned_cols=76 Identities=22% Similarity=0.242 Sum_probs=47.3
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC---CCCccceeeeEEeCceEEEE
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD---HPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~---hp~iv~l~~~~~~~~~~~lV 172 (491)
.+-++.|+-|....+|+.. .+++.+.||+-... ....+..|.+-|+.|. --.+++.+.+....+.-|||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 4556788899999999987 66788999986522 1224556787777773 44678999998877777999
Q ss_pred EeccCCC
Q 035713 173 MEFCSGG 179 (491)
Q Consensus 173 ~E~~~gg 179 (491)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.061 Score=53.02 Aligned_cols=29 Identities=14% Similarity=0.124 Sum_probs=26.9
Q ss_pred CcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 216 GIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 216 givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
+++|+|+.+.|||++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 69999999999999999999999998774
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.024 Score=55.64 Aligned_cols=149 Identities=11% Similarity=0.145 Sum_probs=86.7
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCC--CccceeeeEEeCc--eE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP--FLPTLYSYFETDK--FY 169 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp--~iv~l~~~~~~~~--~~ 169 (491)
....+++.+-.|..-.+|..... ++.+++. ... ............+|.++|+.+.-- -+...++++.++. ..
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~p 100 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTP 100 (321)
T ss_pred CCCceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCc
Confidence 44556666655555556666554 6778887 221 112223344556788888877532 3345556665554 77
Q ss_pred EEEEeccCCCch---------H---------HHHHhC---C-------C--CCCCHHHHHHHHHH--------------H
Q 035713 170 CLVMEFCSGGNL---------H---------SLRQKQ---P-------N--KYFTEDAARFFASE--------------V 205 (491)
Q Consensus 170 ~lV~E~~~gg~L---------~---------~~~~~~---~-------~--~~l~~~~~~~~~~q--------------i 205 (491)
|.||+|++|..+ . +++..- . + ..+...++..+..+ +
T Consensus 101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 999999988322 1 111110 0 0 00111222222222 2
Q ss_pred HHHHHHHHHc--------CcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 206 LLALEYLHML--------GIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 206 ~~aL~~LH~~--------givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
..-..+|+.+ .++|+|+++.||||+.++.+-+.||+++..-
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 3335566654 3899999999999999988999999998543
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.011 Score=58.06 Aligned_cols=72 Identities=22% Similarity=0.269 Sum_probs=55.6
Q ss_pred CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML-GIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
..+.|++|++- |+.+.. ++. -..+++..++.+.+.-|.-+... ..=|||+...||||+ +|.|.|+||-+++
T Consensus 298 ~~y~yl~~kdh-gt~is~-ik~-----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-IKA-----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred ceEEEEEEecC-Cceeee-eec-----ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeee
Confidence 34678888886 777642 222 45677778888877777666654 689999999999999 9999999999997
Q ss_pred c
Q 035713 245 R 245 (491)
Q Consensus 245 ~ 245 (491)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 3
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.0082 Score=55.62 Aligned_cols=29 Identities=31% Similarity=0.594 Sum_probs=20.9
Q ss_pred CcccccCCCCCEEE-ccCCcEEEeeccccc
Q 035713 216 GIVYRDLKPENVLV-RDEGHIMLSDFDLSL 244 (491)
Q Consensus 216 givHrDikp~NILl-~~~g~vkL~DFGla~ 244 (491)
-++|.|+.+.|||+ +.++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 48999999999999 889999999998874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.05 Score=56.29 Aligned_cols=79 Identities=15% Similarity=0.220 Sum_probs=50.8
Q ss_pred CCceEeeeeeccCceEEEEEEEeCC--------CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCc-cceeeeEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGT--------NTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFL-PTLYSYFE 164 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~--------~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~i-v~l~~~~~ 164 (491)
++. -++.|..|-.-.+|++..... ++.|.+++.-... ...+ .-..|..+++.+..-+| .++++.|.
T Consensus 106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~ 180 (442)
T PTZ00296 106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLNTFS 180 (442)
T ss_pred ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEEEeC
Confidence 445 667777788889999986522 4678899864421 1122 22458888888864444 46666653
Q ss_pred eCceEEEEEeccCCCch
Q 035713 165 TDKFYCLVMEFCSGGNL 181 (491)
Q Consensus 165 ~~~~~~lV~E~~~gg~L 181 (491)
-+.|.||++|..|
T Consensus 181 ----gg~I~efi~g~~l 193 (442)
T PTZ00296 181 ----GGRIEEWLYGDPL 193 (442)
T ss_pred ----CCEEEEeeCCccC
Confidence 2357999988744
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.11 Score=51.66 Aligned_cols=71 Identities=11% Similarity=0.002 Sum_probs=42.0
Q ss_pred cCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCC--cccee---e--eEEeCceEEEEEeccC
Q 035713 105 GDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF--LPTLY---S--YFETDKFYCLVMEFCS 177 (491)
Q Consensus 105 G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~--iv~l~---~--~~~~~~~~~lV~E~~~ 177 (491)
+.-..||+.... ++..+++|+.+..... ...+..|++++..|.... |+... + ....++..+.|+++++
T Consensus 36 s~eN~vy~v~~~-~~~~~vlKv~r~~~~~----~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGDE-DGRRVVAKFYRPERWS----DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEecC-CCCEEEEEEcCcccCC----HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 444678988764 4567999987643221 223445777777663211 22211 1 2234567889999998
Q ss_pred CCc
Q 035713 178 GGN 180 (491)
Q Consensus 178 gg~ 180 (491)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 864
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.15 Score=58.55 Aligned_cols=30 Identities=27% Similarity=0.397 Sum_probs=25.5
Q ss_pred cCcccccCCCCCEEEccCC--cEE-Eeeccccc
Q 035713 215 LGIVYRDLKPENVLVRDEG--HIM-LSDFDLSL 244 (491)
Q Consensus 215 ~givHrDikp~NILl~~~g--~vk-L~DFGla~ 244 (491)
.++||.|+.+.|||++.++ .+. |+|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4799999999999999775 555 99999863
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.046 Score=50.52 Aligned_cols=78 Identities=22% Similarity=0.264 Sum_probs=50.8
Q ss_pred eEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC---CCCccceeeeEEeCceEEEEE
Q 035713 97 RLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD---HPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 97 ~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~---hp~iv~l~~~~~~~~~~~lV~ 173 (491)
+..+.+--|-.-..|...+- ...|-+|+- .......+..|+.-|+.|. --.|.+++.+....++.||||
T Consensus 19 ~er~~v~gG~inea~~v~dg--~~~~FvK~n------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVl 90 (286)
T COG3001 19 KEREEVSGGDINEAWRLRDG--TDPFFVKCN------QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVL 90 (286)
T ss_pred hcccccCCccccceeEeecC--CcceEEEec------chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEE
Confidence 33344444444444544333 345778863 2344556777877776664 456788888889999999999
Q ss_pred eccCCCchH
Q 035713 174 EFCSGGNLH 182 (491)
Q Consensus 174 E~~~gg~L~ 182 (491)
||++-+.+.
T Consensus 91 e~L~~~~~d 99 (286)
T COG3001 91 EYLPTGPLD 99 (286)
T ss_pred eeccCCCCC
Confidence 999886554
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.12 Score=51.22 Aligned_cols=138 Identities=23% Similarity=0.279 Sum_probs=79.5
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCc---cc---eee----eEEeCceE
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFL---PT---LYS----YFETDKFY 169 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~i---v~---l~~----~~~~~~~~ 169 (491)
..|.+ .-..||+..... |+ +++|+.+.. .. . ..+..|..+|+.|.-..| +. +=| ......+.
T Consensus 32 ~~l~s-~eN~~f~~~~~~-g~-~iLki~~~~-~~-~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~ 103 (331)
T COG2334 32 RGLNS-EENSNFRVQTED-GR-YILKIYRPG-WT-R---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRP 103 (331)
T ss_pred ccccc-ccCceEEEEecC-CC-eEEEEecCC-CC-H---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCcee
Confidence 34444 556788887763 43 499998765 22 2 233457777777732221 22 211 11222378
Q ss_pred EEEEeccCCCchHH------------H---HHh----CC----CC--CCCHH----HH---------HHHHHHHHHHHHH
Q 035713 170 CLVMEFCSGGNLHS------------L---RQK----QP----NK--YFTED----AA---------RFFASEVLLALEY 211 (491)
Q Consensus 170 ~lV~E~~~gg~L~~------------~---~~~----~~----~~--~l~~~----~~---------~~~~~qi~~aL~~ 211 (491)
+-|++|++|..+.. + ++. .+ +. ...+. .. .....++...++.
T Consensus 104 a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~ 183 (331)
T COG2334 104 AALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDR 183 (331)
T ss_pred EEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHH
Confidence 89999999987762 0 110 00 00 11111 00 0123445555555
Q ss_pred HHHc--------C--cccccCCCCCEEEccCCc-EEEeecccccc
Q 035713 212 LHML--------G--IVYRDLKPENVLVRDEGH-IMLSDFDLSLR 245 (491)
Q Consensus 212 LH~~--------g--ivHrDikp~NILl~~~g~-vkL~DFGla~~ 245 (491)
+.+. + +||.|+.|.|||++.+.. +.++|||-+..
T Consensus 184 ~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 184 LLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred HHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 5542 3 999999999999998875 88999998743
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.038 Score=55.22 Aligned_cols=62 Identities=24% Similarity=0.169 Sum_probs=46.4
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCcccccCCCCCEEEccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH-MLGIVYRDLKPENVLVRDE 232 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~givHrDikp~NILl~~~ 232 (491)
...|+-+|..|.++..+++.. ..+++..+.++.-.+.||--+- -.+++|.|+.|.||++.-+
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred cceeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 345777899999998888763 3667677777776677765443 4689999999999999643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 491 | ||||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-34 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-34 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-30 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-30 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-30 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-30 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-30 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-30 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-18 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-30 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-29 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-29 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-29 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-29 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-28 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-18 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-28 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-28 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-28 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-28 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-28 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-28 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-28 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-28 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-28 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-28 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-28 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-28 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-28 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-27 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-27 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-27 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-27 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-19 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-26 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-19 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-26 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-19 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-26 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-19 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-26 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-19 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-26 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-19 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-26 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-19 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-26 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-18 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-26 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-18 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-26 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-17 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-26 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-18 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-26 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-23 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-26 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-18 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-25 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-18 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-25 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-18 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-25 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-18 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-25 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-25 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-18 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-25 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-25 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-25 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-24 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-19 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-24 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-24 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-24 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-24 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-24 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-24 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-24 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-24 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-15 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-24 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-24 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-24 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-24 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-24 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-24 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-24 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-14 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-24 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-24 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-24 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-24 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-24 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-24 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-24 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-24 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-24 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-24 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-24 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-15 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-24 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-24 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-24 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-24 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-24 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-24 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-24 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-24 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-24 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-24 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-24 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-24 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-24 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-24 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-24 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-24 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-24 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-24 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-23 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-15 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-23 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-23 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-20 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-23 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-23 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-23 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-20 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-23 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-23 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-18 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-23 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-15 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-23 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-22 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-22 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-22 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-22 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-22 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-17 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-22 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-17 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-22 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-17 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-22 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-16 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-22 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-21 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-21 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-18 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-20 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-19 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-19 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-19 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-19 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-18 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-18 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-18 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-16 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-16 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-16 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-16 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-16 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-15 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-11 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-10 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 8e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 9e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-05 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-05 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-07 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-04 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-06 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-06 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 1e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-06 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-06 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-06 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-06 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-06 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 4e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-06 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-06 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-06 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 6e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 6e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-06 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-06 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-06 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-06 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 7e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-06 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-06 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-05 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-05 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-05 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-05 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-05 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 5e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 5e-05 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-05 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-04 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-04 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-04 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-04 |
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 8e-59
Identities = 55/187 (29%), Positives = 105/187 (56%), Gaps = 1/187 (0%)
Query: 59 DSLESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGT 118
L +S + ++W ++ L+ + +F +LK +G G V +V+++ T
Sbjct: 26 QELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQT 85
Query: 119 NTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSG 178
+AMK+M+K + R ++ + ER++L D ++ L+ F+ + + LVME+ G
Sbjct: 86 GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG 145
Query: 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLS 238
G+L +L K + + ARF+ +E+++A++ +H LG V+RD+KP+N+L+ GHI L+
Sbjct: 146 GDLLTLLSKFGER-IPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLA 204
Query: 239 DFDLSLR 245
DF L+
Sbjct: 205 DFGSCLK 211
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 8e-40
Identities = 58/164 (35%), Positives = 84/164 (51%), Gaps = 21/164 (12%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG-------HGSAVDWWTFG 353
+DFG C+ +L A+ T VRS+ VGT +YL+PEI++ G +G DWW G
Sbjct: 204 ADFGSCL-----KLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG 257
Query: 354 IFLYELLHGTTPFKGQGNRATLFNVVG--QPLRFPETPQ-VSFVARDLIRGLLVKEPHKR 410
+F YE+ +G TPF T +V + L P + V ARD I+ LL P R
Sbjct: 258 VFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETR 316
Query: 411 IAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE---PVDFSVF 451
+ GA + + HPFF G++W +R ++PP P+ D F
Sbjct: 317 LGR-GGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFEGATDTCNF 359
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-58
Identities = 55/183 (30%), Positives = 93/183 (50%), Gaps = 6/183 (3%)
Query: 61 LESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNT 120
++ ++A +P G + +F+ K LG G +V L T+
Sbjct: 1 MDGTAAEPRPGAGSL----QHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSR 56
Query: 121 YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGN 180
+A+K+++K + NK+ ER+++ LDHPF LY F+ D+ + + G
Sbjct: 57 EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 116
Query: 181 LHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240
L +K F E RF+ +E++ ALEYLH GI++RDLKPEN+L+ ++ HI ++DF
Sbjct: 117 LLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 174
Query: 241 DLS 243
+
Sbjct: 175 GTA 177
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-45
Identities = 46/145 (31%), Positives = 68/145 (46%), Gaps = 11/145 (7%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG L E R+ SFVGT +Y++PE++ + + D W G +Y+L+
Sbjct: 173 DFGTA-----KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
Query: 362 GTTPFKGQGNRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY--KRGAT 418
G PF+ N +F ++ FP + ARDL+ LLV + KR+ G
Sbjct: 228 GLPPFRAG-NEYLIFQKIIKLEYDFP--EKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 284
Query: 419 EIKQHPFFEGVNWALVRSALPPHIP 443
+K HPFFE V W + PP +
Sbjct: 285 PLKAHPFFESVTWENLHQQTPPKLT 309
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 5e-58
Identities = 50/170 (29%), Positives = 94/170 (55%), Gaps = 3/170 (1%)
Query: 76 VRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASR 135
+ + +R + ++ ++K +G G G V LV + T +AMK++ K + R
Sbjct: 51 LSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 110
Query: 136 NKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTE 195
+ ER+I+ + P++ L+ F+ D++ +VME+ GG+L +L E
Sbjct: 111 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPE 167
Query: 196 DAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245
ARF+ +EV+LAL+ +H +G ++RD+KP+N+L+ GH+ L+DF ++
Sbjct: 168 KWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-42
Identities = 53/162 (32%), Positives = 84/162 (51%), Gaps = 19/162 (11%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG----HGSAVDWWTFGIFL 356
+DFG C+ M + VR + VGT +Y++PE+++ +G +G DWW+ G+FL
Sbjct: 210 ADFGTCMK------MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 263
Query: 357 YELLHGTTPFKGQGNRATLFNVVG--QPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK 414
YE+L G TPF T ++ L FP+ +S A++LI L + R+ +
Sbjct: 264 YEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLG-R 321
Query: 415 RGATEIKQHPFFEGVNWA--LVRSALPPHIPE---PVDFSVF 451
G EIK+H FF+ WA +R + P +P+ +D S F
Sbjct: 322 NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNF 363
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 6e-58
Identities = 72/364 (19%), Positives = 123/364 (33%), Gaps = 84/364 (23%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
I ++ +++LG G V LVE ++A+K + R + R E ++ L
Sbjct: 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQR---EADMHRL 82
Query: 151 LDHPFLPTLYSYFETDKF----YCLVMEFCSGGNLHSL--RQKQPNKYFTEDAARFFASE 204
+HP + L +Y ++ L++ F G L + R K + TED +
Sbjct: 83 FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 205 VLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGS 264
+ LE +H G +RDLKP N+L+ DEG +L D + + + +
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL------- 195
Query: 265 GGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324
L D A
Sbjct: 196 -----TLQDWAAQRC--------------------------------------------- 205
Query: 325 SFVGTHEYLAPEIIRGEGH---GSAVDWWTFGIFLYELLHGTTPFKGQGNRA-TLFNVVG 380
T Y APE+ + H D W+ G LY ++ G P+ + ++ V
Sbjct: 206 ----TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261
Query: 381 QPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPP 440
L P++P+ S L+ ++ +PH+R + AL A
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRP----HIPLLLSQL------EALQPPAPGQ 311
Query: 441 HIPE 444
H +
Sbjct: 312 HTTQ 315
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-56
Identities = 59/155 (38%), Positives = 93/155 (60%), Gaps = 2/155 (1%)
Query: 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL 148
P L +F++L+ LG G G V+L+ R Y+AMKV+ K + ++ ER +L
Sbjct: 1 PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60
Query: 149 GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLA 208
++ HPF+ ++ F+ + ++M++ GG L SL +K + F A+F+A+EV LA
Sbjct: 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLA 118
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
LEYLH I+YRDLKPEN+L+ GHI ++DF +
Sbjct: 119 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-41
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 21/158 (13%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG A+ + + GT +Y+APE++ + + ++DWW+FGI +YE+L
Sbjct: 149 DFG----------FAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
Query: 362 GTTPFKGQGNRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI-AYKRGATE 419
G TPF N + ++ LRFP P + +DL+ L+ ++ +R+ + G +
Sbjct: 199 GYTPFYDS-NTMKTYEKILNAELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTED 255
Query: 420 IKQHPFFEGVNWALV--RSALPPHIPE----PVDFSVF 451
+K HP+F+ V W + R+ P+ P D S F
Sbjct: 256 VKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQF 293
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 4e-55
Identities = 55/156 (35%), Positives = 86/156 (55%), Gaps = 2/156 (1%)
Query: 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILG 149
P+G F + LG G G V+ +++ T +A K ++K L R A E++IL
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 150 LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNL--HSLRQKQPNKYFTEDAARFFASEVLL 207
+ F+ +L FET CLVM +GG++ H + N F E A F+ ++++
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 208 ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
LE+LH I+YRDLKPENVL+ D+G++ +SD L+
Sbjct: 301 GLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA 336
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-40
Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 16/162 (9%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
SD G V EL A ++ + GT ++APE++ GE + +VD++ G+ LYE++
Sbjct: 331 SDLGLAV-----ELKAG--QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383
Query: 361 HGTTPFKGQGNRAT---LF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI-AYKR 415
PF+ +G + L V+ Q + +P + S ++D LL K+P KR+
Sbjct: 384 AARGPFRARGEKVENKELKQRVLEQAVTYP--DKFSPASKDFCEALLQKDPEKRLGFRDG 441
Query: 416 GATEIKQHPFFEGVNWALV--RSALPPHIPEPVDFSVFAGKD 455
++ HP F ++W + PP +P+ +D
Sbjct: 442 SCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQD 483
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 4e-55
Identities = 53/161 (32%), Positives = 97/161 (60%), Gaps = 1/161 (0%)
Query: 85 SLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTE 144
++ + +F +LK +G G G V +V+L+ + FAMK+++K + R + + E
Sbjct: 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 145 REILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASE 204
R++L D ++ TL+ F+ D LVM++ GG+L +L K ++ E+ ARF+ +E
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAE 183
Query: 205 VLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245
+++A++ +H L V+RD+KP+N+L+ GHI L+DF L+
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 57/161 (35%), Positives = 86/161 (53%), Gaps = 19/161 (11%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGE-----GHGSAVDWWTFGIFL 356
DFG C+ +LM + T V+S VGT +Y++PEI++ +G DWW+ G+ +
Sbjct: 218 DFGSCL-----KLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCM 271
Query: 357 YELLHGTTPFKGQGNRATLFNVVGQPLRFP---ETPQVSFVARDLIRGLLVKEPHKRIAY 413
YE+L+G TPF + T ++ RF + VS A+DLIR L+ R+
Sbjct: 272 YEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSRE-HRLGQ 330
Query: 414 KRGATEIKQHPFFEGVNWALVRSALPPHIPE---PVDFSVF 451
G + K+HPFF G++W +R+ P+IPE P D S F
Sbjct: 331 -NGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNF 370
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 7e-55
Identities = 59/153 (38%), Positives = 93/153 (60%), Gaps = 2/153 (1%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
+ +++F LK LG G G V LV + T Y+AMK++ K + +++++ TE +L
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
HPFL L F+T C VME+ +GG L ++ + FTE+ ARF+ +E++ ALE
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALE 119
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
YLH +VYRD+K EN+++ +GHI ++DF L
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 56/157 (35%), Positives = 83/157 (52%), Gaps = 17/157 (10%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG C E +++ +F GT EYLAPE++ +G AVDWW G+ +YE++
Sbjct: 148 DFGLC-----KEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 362 GTTPFKGQGNRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI-AYKRGATE 419
G PF Q + LF ++ + +RFP +S A+ L+ GLL K+P +R+ A E
Sbjct: 201 GRLPFYNQ-DHERLFELILMEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 257
Query: 420 IKQHPFFEGVNWALV--RSALPPHIPE---PVDFSVF 451
+ +H FF +NW V + LPP P+ VD F
Sbjct: 258 VMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYF 294
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 9e-55
Identities = 49/155 (31%), Positives = 92/155 (59%), Gaps = 2/155 (1%)
Query: 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL 148
+ +F +L+ +G G G V +V+ T +AMK M+K RN++ E +I+
Sbjct: 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIM 69
Query: 149 GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLA 208
L+HPFL L+ F+ ++ +V++ GG+L Q+ N +F E+ + F E+++A
Sbjct: 70 QGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMA 127
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
L+YL I++RD+KP+N+L+ + GH+ ++DF+++
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA 162
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 38/158 (24%), Positives = 64/158 (40%), Gaps = 22/158 (13%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII---RGEGHGSAVDWWTFGIFLYE 358
DF L P + + GT Y+APE+ +G G+ AVDWW+ G+ YE
Sbjct: 158 DFNIAA-----ML---PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYE 209
Query: 359 LLHGTTPF--KGQGNRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKR 415
LL G P+ + + + + +P S L++ LL P +R +
Sbjct: 210 LLRGRRPYHIRSSTSSKEIVHTFETTVVTYP--SAWSQEMVSLLKKLLEPNPDQRFS--- 264
Query: 416 GATEIKQHPFFEGVNWALV--RSALPPHIPEPVDFSVF 451
++++ P+ +NW V + +P IP
Sbjct: 265 QLSDVQNFPYMNDINWDAVFQKRLIPGFIP-NKGRLNC 301
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 2e-54
Identities = 65/190 (34%), Positives = 100/190 (52%), Gaps = 7/190 (3%)
Query: 55 SSRSDSLESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVE 114
S + ++ P P IN+ P S+F LK +G G G V L
Sbjct: 3 SQPQEPELMNANPAPPPAPSQ----QINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLAR 58
Query: 115 LRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL-LDHPFLPTLYSYFETDKFYCLVM 173
+ ++A+KV+ K ++ + + +ER +L + HPFL L+ F+T V+
Sbjct: 59 HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118
Query: 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG 233
++ +GG L Q++ + F E ARF+A+E+ AL YLH L IVYRDLKPEN+L+ +G
Sbjct: 119 DYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG 176
Query: 234 HIMLSDFDLS 243
HI+L+DF L
Sbjct: 177 HIVLTDFGLC 186
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-42
Identities = 57/156 (36%), Positives = 81/156 (51%), Gaps = 16/156 (10%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG C E + N + +F GT EYLAPE++ + + VDWW G LYE+L+
Sbjct: 182 DFGLC-----KENIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 234
Query: 362 GTTPFKGQGNRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEI 420
G PF + N A ++ N++ +PL+ P ++ AR L+ GLL K+ KR+ K EI
Sbjct: 235 GLPPFYSR-NTAEMYDNILNKPLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291
Query: 421 KQHPFFEGVNWALV--RSALPPHIPE---PVDFSVF 451
K H FF +NW + + PP P P D F
Sbjct: 292 KSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHF 327
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-54
Identities = 57/158 (36%), Positives = 83/158 (52%)
Query: 86 LRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTER 145
L P+ + FR + LG G G V ++R T +A K ++K + R A E+
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 146 EILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEV 205
+IL ++ F+ +L +ET CLV+ +GG+L F E A F+A+E+
Sbjct: 236 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEI 295
Query: 206 LLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
LE LH IVYRDLKPEN+L+ D GHI +SD L+
Sbjct: 296 CCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA 333
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-39
Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 17/152 (11%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
SD G V + P VGT Y+APE+++ E + + DWW G LYE++
Sbjct: 328 SDLGLAV-----HV---PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379
Query: 361 HGTTPFKGQGNRATL----FNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK-R 415
G +PF+ + + V P + E S AR L LL K+P +R+ +
Sbjct: 380 AGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FSPQARSLCSQLLCKDPAERLGCRGG 437
Query: 416 GATEIKQHPFFEGVNWALV--RSALPPHIPEP 445
A E+K+HP F+ +N+ + PP P+P
Sbjct: 438 SAREVKEHPLFKKLNFKRLGAGMLEPPFKPDP 469
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-54
Identities = 54/155 (34%), Positives = 91/155 (58%), Gaps = 2/155 (1%)
Query: 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL 148
L F +K LG G G V LV+ + + ++AMK++DK + ++ E+ IL
Sbjct: 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 149 GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLA 208
++ PFL L F+ + +VME+ +GG + S ++ F+E ARF+A++++L
Sbjct: 96 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLT 153
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
EYLH L ++YRDLKPEN+L+ +G+I ++DF +
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-40
Identities = 53/157 (33%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG A+ R+ + GT E LAPEII +G+ AVDWW G+ +YE+
Sbjct: 184 DFG----------FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 362 GTTPFKGQGNRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY-KRGATE 419
G PF ++ +V +RFP S +DL+R LL + KR K G +
Sbjct: 234 GYPPFFAD-QPIQIYEKIVSGKVRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVND 290
Query: 420 IKQHPFFEGVNWALV--RSALPPHIPE---PVDFSVF 451
IK H +F +W + R P IP+ P D S F
Sbjct: 291 IKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNF 327
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 7e-54
Identities = 63/156 (40%), Positives = 96/156 (61%), Gaps = 3/156 (1%)
Query: 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL 148
P+GL +F LL+ +G G V LV L+ T+ +AMKV+ K + + QTE+ +
Sbjct: 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVF 63
Query: 149 GL-LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLL 207
+HPFL L+S F+T+ V+E+ +GG+L Q+Q + E+ ARF+++E+ L
Sbjct: 64 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISL 121
Query: 208 ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
AL YLH GI+YRDLK +NVL+ EGHI L+D+ +
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 25/166 (15%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
D+G C E + + +F GT Y+APEI+RGE +G +VDWW G+ ++E++
Sbjct: 153 DYGMC-----KEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 205
Query: 362 GTTPFKGQG--------NRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI- 411
G +PF G LF ++ + +R P +S A +++ L K+P +R+
Sbjct: 206 GRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLSVKAASVLKSFLNKDPKERLG 263
Query: 412 -AYKRGATEIKQHPFFEGVNWALV--RSALPPHIPE---PVDFSVF 451
+ G +I+ HPFF V+W ++ + +PP P F
Sbjct: 264 CHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNF 309
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 9e-54
Identities = 65/199 (32%), Positives = 104/199 (52%), Gaps = 4/199 (2%)
Query: 46 NHGHGSSNCSSRSDSLESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYG 105
+H H +++L A + +GL +F LL+ +G G
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAM-GSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRG 63
Query: 106 DIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL-LDHPFLPTLYSYFE 164
V LV L+ T+ +AM+V+ K + + QTE+ + +HPFL L+S F+
Sbjct: 64 SYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 123
Query: 165 TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKP 224
T+ V+E+ +GG+L Q+Q + E+ ARF+++E+ LAL YLH GI+YRDLK
Sbjct: 124 TESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKL 181
Query: 225 ENVLVRDEGHIMLSDFDLS 243
+NVL+ EGHI L+D+ +
Sbjct: 182 DNVLLDSEGHIKLTDYGMC 200
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 25/166 (15%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
D+G C E + + +F GT Y+APEI+RGE +G +VDWW G+ ++E++
Sbjct: 196 DYGMC-----KEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 248
Query: 362 GTTPFKGQG--------NRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI- 411
G +PF G LF ++ + +R P +S A +++ L K+P +R+
Sbjct: 249 GRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLSVKAASVLKSFLNKDPKERLG 306
Query: 412 -AYKRGATEIKQHPFFEGVNWALV--RSALPPHIPE---PVDFSVF 451
+ G +I+ HPFF V+W ++ + +PP P F
Sbjct: 307 CHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNF 352
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-53
Identities = 61/164 (37%), Positives = 89/164 (54%), Gaps = 6/164 (3%)
Query: 84 ISLRGPPIGLSNFRLLKRLGYGDIGSVYLVE---LRGTNTYFAMKVMDKASLASRNKLL- 139
++ I F LL+ LG G G V+ V T FAMKV+ KA + K
Sbjct: 7 VNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTA 66
Query: 140 RAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAAR 199
+ ER IL + HPF+ L F+T L++E+ SGG L +++ F ED A
Sbjct: 67 HTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTAC 124
Query: 200 FFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
F+ +E+ +AL +LH GI+YRDLKPEN+++ +GH+ L+DF L
Sbjct: 125 FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 4e-42
Identities = 56/157 (35%), Positives = 79/157 (50%), Gaps = 17/157 (10%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG C E + + + +F GT EY+APEI+ GH AVDWW+ G +Y++L
Sbjct: 164 DFGLC-----KESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLT 216
Query: 362 GTTPFKGQGNRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI-AYKRGATE 419
G PF G+ NR ++ L P P ++ ARDL++ LL + R+ A A E
Sbjct: 217 GAPPFTGE-NRKKTIDKILKCKLNLP--PYLTQEARDLLKKLLKRNAASRLGAGPGDAGE 273
Query: 420 IKQHPFFEGVNWALV--RSALPPHIPE---PVDFSVF 451
++ HPFF +NW + R PP P D S F
Sbjct: 274 VQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQF 310
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 181 bits (463), Expect = 2e-53
Identities = 68/156 (43%), Positives = 102/156 (65%), Gaps = 6/156 (3%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVE---LRGTNTYFAMKVMDKASLASRNKLLRAQTEREI 147
S F LLK LG G G V+LV+ +AMKV+ KA+L R+++ R + ER+I
Sbjct: 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV-RTKMERDI 79
Query: 148 LGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLL 207
L ++HPF+ L+ F+T+ L+++F GG+L + K+ FTE+ +F+ +E+ L
Sbjct: 80 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELAL 137
Query: 208 ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
AL++LH LGI+YRDLKPEN+L+ +EGHI L+DF LS
Sbjct: 138 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-42
Identities = 53/157 (33%), Positives = 79/157 (50%), Gaps = 17/157 (10%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG E + ++ SF GT EY+APE++ GH + DWW+FG+ ++E+L
Sbjct: 169 DFGLSK-----ESIDH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221
Query: 362 GTTPFKGQGNRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI-AYKRGATE 419
GT PF+G+ +R ++ L P +S A+ L+R L + P R+ A G E
Sbjct: 222 GTLPFQGK-DRKETMTMILKAKLGMP--QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEE 278
Query: 420 IKQHPFFEGVNWALV--RSALPPHIPE---PVDFSVF 451
IK+H FF ++W + R PP P P D F
Sbjct: 279 IKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYF 315
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 4e-53
Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 3/158 (1%)
Query: 87 RGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE 146
+ + +F L K LG G G V+L E + TN +FA+K + K + + + E+
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 147 ILGL-LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEV 205
+L L +HPFL ++ F+T + VME+ +GG+L Q F A F+A+E+
Sbjct: 70 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEI 127
Query: 206 LLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+L L++LH GIVYRDLK +N+L+ +GHI ++DF +
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 165
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-37
Identities = 56/156 (35%), Positives = 85/156 (54%), Gaps = 19/156 (12%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG C E M + ++ +F GT +Y+APEI+ G+ + +VDWW+FG+ LYE+L
Sbjct: 161 DFGMC-----KENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 213
Query: 362 GTTPFKGQGNRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEI 420
G +PF GQ + LF ++ +P + A+DL+ L V+EP KR+ +I
Sbjct: 214 GQSPFHGQ-DEEELFHSIRMDNPFYP--RWLEKEAKDLLVKLFVREPEKRLG---VRGDI 267
Query: 421 KQHPFFEGVNWALV--RSALPPHIPE---PVDFSVF 451
+QHP F +NW + + PP P+ P D S F
Sbjct: 268 RQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNF 303
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 4e-53
Identities = 69/207 (33%), Positives = 113/207 (54%), Gaps = 8/207 (3%)
Query: 43 SLTNHGHGSSNCSSRSDSLESSSAPVKPHTGGDVRWDA-INMISLRGPPIGLSNFRLLKR 101
+ +H H SS + S+ V+ + ++ +G+ NF LLK
Sbjct: 2 AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKV 61
Query: 102 LGYGDIGSVYLVE---LRGTNTYFAMKVMDKASLASRNKLL-RAQTEREILGLLDH-PFL 156
LG G G V+LV T +AMKV+ KA++ + K +TER++L + PFL
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 157 PTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG 216
TL+ F+T+ L++++ +GG L + ++ + FTE + + E++LALE+LH LG
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG 179
Query: 217 IVYRDLKPENVLVRDEGHIMLSDFDLS 243
I+YRD+K EN+L+ GH++L+DF LS
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLS 206
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-40
Identities = 60/162 (37%), Positives = 90/162 (55%), Gaps = 20/162 (12%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGE--GHGSAVDWWTFGIFLYEL 359
DFG E +A+ R+ F GT EY+AP+I+RG GH AVDWW+ G+ +YEL
Sbjct: 202 DFGLS-----KEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 255
Query: 360 LHGTTPFKGQG---NRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI-AYK 414
L G +PF G ++A + ++ +P ++S +A+DLI+ LL+K+P KR+
Sbjct: 256 LTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGP 313
Query: 415 RGATEIKQHPFFEGVNWALV--RSALPPHIPE---PVDFSVF 451
R A EIK+H FF+ +NW + + P P +D S F
Sbjct: 314 RDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNF 355
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 1e-52
Identities = 71/254 (27%), Positives = 124/254 (48%), Gaps = 13/254 (5%)
Query: 1 MDPLTKPRTN-SITNQRPLPSQKKPPN----SEPSTVTMPGDIKHANSLTNHGHGSSNCS 55
+D P N S+ + + +++ PN T+ H + ++
Sbjct: 45 VDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQ 104
Query: 56 SRSDSLESSSAPVKPHTGGDVRWDAINM-----ISLRGPPIGLSNFRLLKRLGYGDIGSV 110
+ +D L+ +A G ++ ++ + ++ F LK LG G G V
Sbjct: 105 TVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKV 164
Query: 111 YLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170
LV+ + T Y+AMK++ K + +++++ TE +L HPFL L F+T C
Sbjct: 165 ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224
Query: 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLV 229
VME+ +GG L ++ + F+ED ARF+ +E++ AL+YLH +VYRDLK EN+++
Sbjct: 225 FVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML 282
Query: 230 RDEGHIMLSDFDLS 243
+GHI ++DF L
Sbjct: 283 DKDGHIKITDFGLC 296
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 55/157 (35%), Positives = 79/157 (50%), Gaps = 17/157 (10%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG C E + + +F GT EYLAPE++ +G AVDWW G+ +YE++
Sbjct: 292 DFGLC-----KEGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 344
Query: 362 GTTPFKGQGNRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI-AYKRGATE 419
G PF Q + LF ++ + +RFP + A+ L+ GLL K+P +R+ A E
Sbjct: 345 GRLPFYNQ-DHEKLFELILMEEIRFP--RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKE 401
Query: 420 IKQHPFFEGVNWALV--RSALPPHIPE---PVDFSVF 451
I QH FF G+ W V + PP P+ D F
Sbjct: 402 IMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYF 438
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-52
Identities = 60/159 (37%), Positives = 92/159 (57%), Gaps = 5/159 (3%)
Query: 87 RGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE 146
+G+ NF ++ LG G G V L ++ T +A+KV+ K + + + TE+
Sbjct: 16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75
Query: 147 ILGL-LDHPFLPTLYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAARFFASE 204
IL L +HPFL L+ F+T VMEF +GG+L +++ + F E ARF+A+E
Sbjct: 76 ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR---FDEARARFYAAE 132
Query: 205 VLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++ AL +LH GI+YRDLK +NVL+ EGH L+DF +
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 51/158 (32%), Positives = 79/158 (50%), Gaps = 18/158 (11%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG C E + V + +F GT +Y+APEI++ +G AVDWW G+ LYE+L
Sbjct: 167 DFGMC-----KEGICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC 219
Query: 362 GTTPFKGQGNRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY--KRGAT 418
G PF+ + N LF ++ + +P + A +++ + K P R+ + G
Sbjct: 220 GHAPFEAE-NEDDLFEAILNDEVVYP--TWLHEDATGILKSFMTKNPTMRLGSLTQGGEH 276
Query: 419 EIKQHPFFEGVNWALV--RSALPPHIPE---PVDFSVF 451
I +HPFF+ ++WA + R PP P D S F
Sbjct: 277 AILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNF 314
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-52
Identities = 55/158 (34%), Positives = 88/158 (55%), Gaps = 7/158 (4%)
Query: 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL 148
+ L++F L LG G G V L E +GT+ +A+K++ K + + + E+ +L
Sbjct: 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVL 74
Query: 149 GLLD-HPFLPTLYSYFETDKFYCLVMEFCSGGNL--HSLRQKQPNKYFTEDAARFFASEV 205
L PFL L+S F+T VME+ +GG+L H + + F E A F+A+E+
Sbjct: 75 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEI 130
Query: 206 LLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ L +L GI+YRDLK +NV++ EGHI ++DF +
Sbjct: 131 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-39
Identities = 51/147 (34%), Positives = 83/147 (56%), Gaps = 14/147 (9%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG C E + + V + +F GT +Y+APEII + +G +VDWW FG+ LYE+L
Sbjct: 164 DFGMC-----KENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 216
Query: 362 GTTPFKGQGNRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI-AYKRGATE 419
G PF+G+ + LF +++ + +P +S A + +GL+ K P KR+ G +
Sbjct: 217 GQAPFEGE-DEDELFQSIMEHNVAYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEGERD 273
Query: 420 IKQHPFFEGVNWALV--RSALPPHIPE 444
IK+H FF ++W + + PP+ P+
Sbjct: 274 IKEHAFFRYIDWEKLERKEIQPPYKPK 300
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 7e-52
Identities = 50/160 (31%), Positives = 85/160 (53%), Gaps = 5/160 (3%)
Query: 87 RGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE 146
+ +++F + + +G G G VY T +AMK +DK + + A ER
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 147 ILGLL---DHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFAS 203
+L L+ D PF+ + F T +++ +GG+LH + F+E RF+A+
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAA 299
Query: 204 EVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
E++L LE++H +VYRDLKP N+L+ + GH+ +SD L+
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-38
Identities = 45/162 (27%), Positives = 80/162 (49%), Gaps = 18/162 (11%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII-RGEGHGSAVDWWTFGIFLYEL 359
SD G + + + + VGTH Y+APE++ +G + S+ DW++ G L++L
Sbjct: 334 SDLGLAC-----DFSKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384
Query: 360 LHGTTPFKGQG--NRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI-AYKR 415
L G +PF+ ++ + + + P S R L+ GLL ++ ++R+ R
Sbjct: 385 LRGHSPFRQHKTKDKHEIDRMTLTMAVELP--DSFSPELRSLLEGLLQRDVNRRLGCLGR 442
Query: 416 GATEIKQHPFFEGVNWALV--RSALPPHIPEPVDFSVFAGKD 455
GA E+K+ PFF ++W +V + PP IP + + D
Sbjct: 443 GAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFD 484
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-50
Identities = 52/364 (14%), Positives = 97/364 (26%), Gaps = 75/364 (20%)
Query: 57 RSDSLESSSAPVKPHTGGDVRWDAINMISLRGP-PIGLSNFRLLKRLGYGDIGSVYLVEL 115
L S PV + + I + +G + LG G VY
Sbjct: 27 IFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQ 86
Query: 116 RGTNT-----YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170
N F +KV A+ + E L YS
Sbjct: 87 GDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV 143
Query: 171 LVMEFCSGGNLHSL---RQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENV 227
LV E S G L + + P K + FA +L +E +H I++ D+KP+N
Sbjct: 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNF 203
Query: 228 LVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFF 287
++ + + ++ G+
Sbjct: 204 ------------------------ILGNGFLEQDDEDDLSAGL----------------- 222
Query: 288 PRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAV 347
+ D G + ++ P + T + E++ + +
Sbjct: 223 -----------ALIDLGQSI-----DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQI 266
Query: 348 DWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEP 407
D++ +Y +L GT + + R P + + +L
Sbjct: 267 DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR--RLPHLDMWN----EFFHVMLNIPD 320
Query: 408 HKRI 411
+
Sbjct: 321 CHHL 324
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 3e-49
Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 3/229 (1%)
Query: 16 RPLPSQKKPPNSEPSTVTMPGDIKHANSLTNHGHGSSNCSSRSDSLESSSAPVKPHTGGD 75
QK + ++ + G + + K
Sbjct: 263 GISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKT 322
Query: 76 VRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASR 135
+ + + L++F L LG G G V L E +GT+ +A+K++ K +
Sbjct: 323 ANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD 382
Query: 136 NKLLRAQTEREILGL-LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFT 194
+ + E+ +L L PFL L+S F+T VME+ +GG+L + Q F
Sbjct: 383 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFK 440
Query: 195 EDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
E A F+A+E+ + L +L GI+YRDLK +NV++ EGHI ++DF +
Sbjct: 441 EPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-37
Identities = 51/146 (34%), Positives = 82/146 (56%), Gaps = 14/146 (9%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG C E + + V + +F GT +Y+APEII + +G +VDWW FG+ LYE+L
Sbjct: 485 DFGMC-----KENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 537
Query: 362 GTTPFKGQGNRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI-AYKRGATE 419
G PF+G+ + LF +++ + +P +S A + +GL+ K P KR+ G +
Sbjct: 538 GQAPFEGE-DEDELFQSIMEHNVAYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEGERD 594
Query: 420 IKQHPFFEGVNWALV--RSALPPHIP 443
IK+H FF ++W + + PP+ P
Sbjct: 595 IKEHAFFRYIDWEKLERKEIQPPYKP 620
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-48
Identities = 49/155 (31%), Positives = 79/155 (50%), Gaps = 2/155 (1%)
Query: 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL 148
+ +F + + LG G G+VYL + A+KV+ K+ L + + E EI
Sbjct: 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQ 68
Query: 149 GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLA 208
L HP + +Y+YF K L++EF G L+ QK + F E + F E+ A
Sbjct: 69 SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK--HGRFDEQRSATFMEELADA 126
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
L Y H +++RD+KPEN+L+ +G + ++DF S
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS 161
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-32
Identities = 44/144 (30%), Positives = 64/144 (44%), Gaps = 19/144 (13%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+DFG ++R + GT +YL PE+I G+ H VD W G+ YE L
Sbjct: 156 ADFG---------WSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL 206
Query: 361 HGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEI 420
G PF + T +V L+FP P +S ++DLI LL P +R+ +
Sbjct: 207 VGMPPFDSPSHTETHRRIVNVDLKFP--PFLSDGSKDLISKLLRYHPPQRL----PLKGV 260
Query: 421 KQHPFFEGVNWALVRSALPPHIPE 444
+HP+ + A R LPP
Sbjct: 261 MEHPWVK----ANSRRVLPPVYQS 280
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 9e-48
Identities = 65/374 (17%), Positives = 113/374 (30%), Gaps = 84/374 (22%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL-G 149
+G R+ + L G VY + G+ +A+K + +++ E +
Sbjct: 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ---EVCFMKK 81
Query: 150 LLDHPFLPTLYSYFETDK--------FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFF 201
L HP + S K + L+ E C G + L++ + + D
Sbjct: 82 LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141
Query: 202 ASEVLLALEYLHMLG--IVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVS 259
+ A++++H I++RDLK EN+L+ ++G I L DF + S P S+
Sbjct: 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ-- 199
Query: 260 VNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPT 319
++ +E +
Sbjct: 200 -------RRALVEEEITRNTTPM------------------------------------- 215
Query: 320 NVRSMSFVGTHEYLAPEII---RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLF 376
Y PEII G D W G LY L PF+
Sbjct: 216 ------------YRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--- 260
Query: 377 NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF-FEGVNWALVR 435
+V P V LIR +L P +R+ E+ +
Sbjct: 261 -IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL----SIAEVVHQLQEIAAARNVNPK 315
Query: 436 SALPPHIPEPVDFS 449
S + + + +
Sbjct: 316 SPITELLEQNGGYG 329
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-47
Identities = 48/151 (31%), Positives = 76/151 (50%), Gaps = 2/151 (1%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD 152
L +F + + LG G G+VYL + + A+KV+ KA L + + E EI L
Sbjct: 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
HP + LY YF L++E+ G ++ QK F E + +E+ AL Y
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYC 125
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
H +++RD+KPEN+L+ G + ++DF S
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-31
Identities = 39/126 (30%), Positives = 53/126 (42%), Gaps = 15/126 (11%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+DFG + R GT +YL PE+I G H VD W+ G+ YE L
Sbjct: 151 ADFG---------WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 201
Query: 361 HGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEI 420
G PF+ + T + FP V+ ARDLI LL P +R E+
Sbjct: 202 VGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRP----MLREV 255
Query: 421 KQHPFF 426
+HP+
Sbjct: 256 LEHPWI 261
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 9e-45
Identities = 54/337 (16%), Positives = 109/337 (32%), Gaps = 68/337 (20%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD 152
+ F L+++G G+ GSV+ R +A+K K S ++ + L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSL--RQKQPNKYFTEDAARFFASEVLLALE 210
H + +S + D + E+C+GG+L + YF E + +V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGI 270
Y+H + +V+ D+KP N+ + + + S+ V G
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEE------GDEDDWASNKVMFKIG------- 176
Query: 271 LNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330
D G + ++ G
Sbjct: 177 -------------------------------DLG---------HVTRISS--PQVEEGDS 194
Query: 331 EYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV-GQPLRFPET 388
+LA E+++ H D + + + + N + G+ R P+
Sbjct: 195 RFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR---NGDQWHEIRQGRLPRIPQ- 250
Query: 389 PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425
+S +L++ ++ +P +R A + +H
Sbjct: 251 -VLSQEFTELLKVMIHPDPERRP----SAMALVKHSV 282
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-42
Identities = 45/203 (22%), Positives = 71/203 (34%), Gaps = 13/203 (6%)
Query: 42 NSLTNHGHGSSNCSSRSDSLESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKR 101
+ + R S ++ G D R +F+ L R
Sbjct: 14 GTENLYFQSMHQLQPRRVSFRGEASETLQSPGYD---------PSRPESFFQQSFQRLSR 64
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL-GLLDHPFLPTLY 160
LG+G G V+ V + +A+K +++ R E + HP L
Sbjct: 65 LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA-RKLAEVGSHEKVGQHPCCVRLE 123
Query: 161 SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYR 220
+E L E C G +L + E + + LLAL +LH G+V+
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHL 181
Query: 221 DLKPENVLVRDEGHIMLSDFDLS 243
D+KP N+ + G L DF L
Sbjct: 182 DVKPANIFLGPRGRCKLGDFGLL 204
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 22/102 (21%), Positives = 39/102 (38%), Gaps = 8/102 (7%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR 384
G Y+APE+++G +G+A D ++ G+ + E+ G L P
Sbjct: 215 VQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY-LPPE 272
Query: 385 FPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
F +S R ++ +L +P R A + P
Sbjct: 273 FT--AGLSSELRSVLVMMLEPDPKLRA----TAEALLALPVL 308
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-42
Identities = 72/351 (20%), Positives = 115/351 (32%), Gaps = 84/351 (23%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILG-LLD 152
+ K LGYG G+V A+K M A E ++L D
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLID------FCDIALMEIKLLTESDD 67
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSL-----RQKQPNKYFTEDAARFFASEVLL 207
HP + Y TD+F + +E C NL L + K E ++
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 208 ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGG 267
+ +LH L I++RDLKP+N+LV
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVST------------------------------------ 150
Query: 268 GGILNDEYAVHGCMQPSTFFPRILPSKKNRKSK-SDFGPCVGGALPELMAEPTNVRSMSF 326
S F +N + SDFG C L + +
Sbjct: 151 ---------------SSRFTADQQTGAENLRILISDFGLCK--KLDSGQSSFRT-NLNNP 192
Query: 327 VGTHEYLAPEIIRGEGH-------GSAVDWWTFGIFLYELL-HGTTPFKGQGNRATLF-- 376
GT + APE++ + ++D ++ G Y +L G PF + +R +
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIR 252
Query: 377 -NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
++ + A DLI ++ +P KR A ++ +HP F
Sbjct: 253 GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT----AMKVLRHPLF 299
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-42
Identities = 32/172 (18%), Positives = 69/172 (40%), Gaps = 23/172 (13%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASL--------------ASRNKL 138
++++R+++ L G + L N ++A+K +K+ L + ++K
Sbjct: 30 INDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 139 LRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNL------HSLRQKQPNKY 192
+ E +I+ + + + T ++ E+ ++ + K +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 193 FTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ VL + Y+H I +RD+KP N+L+ G + LSDF S
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 34/156 (21%), Positives = 59/156 (37%), Gaps = 33/156 (21%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG--HGSAVDWWTFGIFLYE 358
SDFG + + GT+E++ PE E +G+ VD W+ GI LY
Sbjct: 194 SDFG---------ESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYV 244
Query: 359 LLHGTTPFKGQGNRATLF-NVVGQPLRFPET-----------------PQVSFVARDLIR 400
+ + PF + + LF N+ + + +P +S D ++
Sbjct: 245 MFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLK 304
Query: 401 GLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRS 436
L K P +RI + + +H + N +R
Sbjct: 305 LFLRKNPAERI----TSEDALKHEWLADTNIEDLRE 336
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 68/344 (19%), Positives = 114/344 (33%), Gaps = 85/344 (24%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
+G +F LG+G G++ + N A+K + + A E ++L
Sbjct: 21 VGKISFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECFSF------ADREVQLLRE 73
Query: 151 LD-HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLAL 209
D HP + + + +F + +E C L +Q + + L
Sbjct: 74 SDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQE-YVEQKDFAHLGLEPITLLQQTTSGL 131
Query: 210 EYLHMLGIVYRDLKPENVLVRDEGH-----IMLSDFDLSLRCSVSPTLVKSSSVSVNNGS 264
+LH L IV+RDLKP N+L+ M+SDF L + +V S S +G
Sbjct: 132 AHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG-----RHSFSRRSGV 186
Query: 265 GGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324
G G PE+++E
Sbjct: 187 PGT---------------------------------------EGWIAPEMLSEDCKEN-- 205
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL-HGTTPFKGQGNRATLFNVVGQPL 383
VD ++ G Y ++ G+ PF R + L
Sbjct: 206 ------------------PTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL 247
Query: 384 RFPETPQ-VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
+ +AR+LI ++ +P KR + A + +HPFF
Sbjct: 248 DCLHPEKHEDVIARELIEKMIAMDPQKRPS----AKHVLKHPFF 287
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-40
Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 18/164 (10%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD 152
S+F + LG G G V + Y+A+K + + KL +E +L L+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLN 60
Query: 153 HPFLPTLYSYF-------------ETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAAR 199
H ++ Y+ + + + ME+C G L+ L + N D
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYW 119
Query: 200 FFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++L AL Y+H GI++RDLKP N+ + + ++ + DF L+
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA 163
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 30/137 (21%), Positives = 53/137 (38%), Gaps = 18/137 (13%)
Query: 301 SDFG-------PCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGH-GSAVDWWTF 352
DFG L ++ S +GT Y+A E++ G GH +D ++
Sbjct: 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSL 217
Query: 353 GIFLYELLHGTTPFKGQGNRATLFNVV-GQPLRFPET--PQVSFVARDLIRGLLVKEPHK 409
GI +E+++ G R + + + FP V + +IR L+ +P+K
Sbjct: 218 GIIFFEMIYP--FSTGM-ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNK 274
Query: 410 RIAYKRGATEIKQHPFF 426
R GA + +
Sbjct: 275 RP----GARTLLNSGWL 287
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-40
Identities = 37/164 (22%), Positives = 82/164 (50%), Gaps = 1/164 (0%)
Query: 80 AINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLL 139
+++ + + + L+++G G G LV+ + +K ++ + ++S+ +
Sbjct: 10 GVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE- 68
Query: 140 RAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAAR 199
++ E +L + HP + FE + +VM++C GG+L Q F ED
Sbjct: 69 ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL 128
Query: 200 FFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ ++ LAL+++H I++RD+K +N+ + +G + L DF ++
Sbjct: 129 DWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIA 172
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 35/184 (19%), Positives = 61/184 (33%), Gaps = 17/184 (9%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG + L T + + +GT YL+PEI + + + D W G LYEL
Sbjct: 168 DFG--IARVL-----NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220
Query: 362 GTTPFKGQGNRATLFNVV-GQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEI 420
F+ + + ++ G S+ R L+ L + P R + I
Sbjct: 221 LKHAFEAGSMKNLVLKIISGSFPPVSL--HYSYDLRSLVSQLFKRNPRDRPS----VNSI 274
Query: 421 KQHPFFEGVNWALVRSALPPHIPEPVDFSVFAGKDQASAAAEKKVVAAAEAAVDHKNGDS 480
+ F + + P I E F+ A++ +V +
Sbjct: 275 LEKGFIAK---RIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKIT 331
Query: 481 PKDS 484
+
Sbjct: 332 KPAA 335
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 5e-39
Identities = 50/223 (22%), Positives = 89/223 (39%), Gaps = 7/223 (3%)
Query: 26 NSEPSTVTMPGDIKHANSLTNHGHGSSNCSSRSDSLESSSAPVKPHTGGDVRWDAINMIS 85
S+P T P I G+ + S+ + + +
Sbjct: 90 QSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149
Query: 86 LRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTER 145
++ + ++ + + LG G G V+ V R T FA K + + + + + E
Sbjct: 150 IKHDHVL-DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EI 205
Query: 146 EILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEV 205
+ + +L HP L L+ FE D ++ EF SGG L + + +ED A + +V
Sbjct: 206 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE-KVADEHNKMSEDEAVEYMRQV 264
Query: 206 LLALEYLHMLGIVYRDLKPENVLV--RDEGHIMLSDFDLSLRC 246
L ++H V+ DLKPEN++ + + L DF L+
Sbjct: 265 CKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 7e-20
Identities = 35/123 (28%), Positives = 54/123 (43%), Gaps = 12/123 (9%)
Query: 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP 386
GT E+ APE+ G+ G D W+ G+ Y LL G +PF G+ + TL NV
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 376
Query: 387 ET--PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE 444
++ +S +D IR LL+ +P+ R+ + +HP W +A
Sbjct: 377 DSAFSGISEDGKDFIRKLLLADPNTRMT----IHQALEHP------WLTPGNAPGRDSQI 426
Query: 445 PVD 447
P
Sbjct: 427 PSS 429
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 46/153 (30%), Positives = 81/153 (52%), Gaps = 5/153 (3%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGL 150
+ +F++ LG G VY E T A+K++DK ++ + + + E+
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAG--MVQRVQNEVKIHCQ 67
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
L HP + LY+YFE + LV+E C G ++ + + K F+E+ AR F +++ +
Sbjct: 68 LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGML 126
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
YLH GI++RDL N+L+ +I ++DF L+
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 39/126 (30%), Positives = 52/126 (41%), Gaps = 13/126 (10%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
+DFG L + P + GT Y++PEI HG D W+ G Y LL
Sbjct: 154 ADFG------LATQLKMPHEKH-YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLL 206
Query: 361 HGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEI 420
G PF + TL VV P +S A+DLI LL + P R++ +
Sbjct: 207 IGRPPFDTDTVKNTLNKVVLADYEMP--SFLSIEAKDLIHQLLRRNPADRLSLS----SV 260
Query: 421 KQHPFF 426
HPF
Sbjct: 261 LDHPFM 266
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-38
Identities = 53/232 (22%), Positives = 85/232 (36%), Gaps = 16/232 (6%)
Query: 19 PSQKKPPNSEPSTVTMPGDIKHANSLTNHGHGSSNCSSRSDSLESSSAPVKPHTGGDVRW 78
+ P + ++ S + + + + + + + + D
Sbjct: 25 EIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELP 84
Query: 79 DAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKL 138
D + +G G V R T FA+K+M+ + +
Sbjct: 85 DWAAAKEFY------QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQ 138
Query: 139 L---RAQTEREI---LGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNK 191
L R T RE + HP + TL +E+ F LV + G L L +K
Sbjct: 139 LEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK---V 195
Query: 192 YFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+E R +L A+ +LH IV+RDLKPEN+L+ D I LSDF S
Sbjct: 196 ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS 247
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 36/111 (32%), Positives = 53/111 (47%), Gaps = 14/111 (12%)
Query: 326 FVGTHEYLAPEIIRG------EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV 379
GT YLAPEI++ G+G VD W G+ L+ LL G+ PF + + + ++
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR-RQILMLRMI 317
Query: 380 GQ-PLRFPETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427
+ +F S +DLI LL +P R+ A + QHPFFE
Sbjct: 318 MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLT----AEQALQHPFFE 364
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-37
Identities = 39/154 (25%), Positives = 74/154 (48%), Gaps = 2/154 (1%)
Query: 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILG 149
P + + LG G + + T FA K++ K+ L ++ + E I
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 150 LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLAL 209
L H + + +FE + F +V+E C +L L ++ K TE AR++ +++L
Sbjct: 71 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGC 128
Query: 210 EYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+YLH +++RDLK N+ + ++ + + DF L+
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 35/124 (28%), Positives = 54/124 (43%), Gaps = 10/124 (8%)
Query: 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE 387
GT Y+APE++ +GH VD W+ G +Y LL G PF+ + T + P
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP- 235
Query: 388 TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPH-IPEPV 446
++ VA LI+ +L +P R E+ FF + + LP + P
Sbjct: 236 -KHINPVAASLIQKMLQTDPTARPTIN----ELLNDEFF---TSGYIPARLPITCLTIPP 287
Query: 447 DFSV 450
FS+
Sbjct: 288 RFSI 291
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 51/243 (20%), Positives = 96/243 (39%), Gaps = 15/243 (6%)
Query: 10 NSITNQRPLPSQKKPPNSEPSTVTMP--GDIKHANSLTNHGHGSSNCSSRSDSLESSSAP 67
+ ++ L ++ S ++ A + ++ + +S + +
Sbjct: 6 HHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVD 65
Query: 68 VKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKR--LGYGDIGSVYLVELRGTNTYFAMK 125
+ +++ + + S + + K LG G G V+ E T A K
Sbjct: 66 IPAPPAPFDHR----IVTAKQGAVN-SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAK 120
Query: 126 VMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLR 185
++ + + ++ E ++ LDH L LY FE+ LVME+ GG L R
Sbjct: 121 IIKTRGMKDKEEVKN---EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD-R 176
Query: 186 QKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLV--RDEGHIMLSDFDLS 243
+ TE F ++ + ++H + I++ DLKPEN+L RD I + DF L+
Sbjct: 177 IIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLA 236
Query: 244 LRC 246
R
Sbjct: 237 RRY 239
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 33/100 (33%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP 386
GT E+LAPE++ + D W+ G+ Y LL G +PF G + TL N++
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE 308
Query: 387 ET--PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHP 424
+ +S A++ I LL+KE RI+ A+E +HP
Sbjct: 309 DEEFQDISEEAKEFISKLLIKEKSWRIS----ASEALKHP 344
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 9/156 (5%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+ L LG G +V+ + T FA+KV + S + E E+L L+H
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM--REFEVLKKLNHK 67
Query: 155 FLPTLYSYFE--TDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALEY 211
+ L++ E T + L+MEFC G+L++ L + E +V+ + +
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 212 LHMLGIVYRDLKPENVLVR----DEGHIMLSDFDLS 243
L GIV+R++KP N++ + L+DF +
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 23/138 (16%), Positives = 49/138 (35%), Gaps = 39/138 (28%)
Query: 324 MSFVGTHEYLAPEIIRG--------EGHGSAVDWWTFGIFLYELLHGTTPFK----GQGN 371
+S GT EYL P++ + +G+ VD W+ G+ Y G+ PF+ + N
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 372 RATLFNVV---------------GQPLRF----PETPQVSFVARD----LIRGLLVKEPH 408
+ ++ ++ P+ + P + +S + ++ +L +
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
Query: 409 KRIAYKRGATEIKQHPFF 426
K G +
Sbjct: 293 KCW----GFDQFFAETSD 306
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 5/164 (3%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
++ + LG G G V L + + T A+KV+ K + + E ++L LDH
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
P + LY +FE ++ LV E +GG L + K F+E A +VL + Y+H
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMH 143
Query: 214 MLGIVYRDLKPENVLVR---DEGHIMLSDFDLSLRCSVSPTLVK 254
IV+RDLKPEN+L+ + +I + DF LS S +
Sbjct: 144 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 187
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 34/108 (31%), Positives = 48/108 (44%), Gaps = 7/108 (6%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR 384
+GT Y+APE++ G + D W+ G+ LY LL G PF G L V
Sbjct: 187 DKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 245
Query: 385 FPETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430
F +VS A+DLIR +L P RI+ A + H + +
Sbjct: 246 FELPQWKKVSESAKDLIRKMLTYVPSMRIS----ARDALDHEWIQTYT 289
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-37
Identities = 41/163 (25%), Positives = 73/163 (44%), Gaps = 10/163 (6%)
Query: 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILG 149
P ++ +L +G G G + + K +D S+ K +E +L
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLR 60
Query: 150 LLDHPFLPTLYSYF--ETDKFYCLVMEFCSGGNLHSL--RQKQPNKYFTEDAARFFASEV 205
L HP + Y T+ +VME+C GG+L S+ + + +Y E+ +++
Sbjct: 61 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 206 LLALEYLH-----MLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
LAL+ H +++RDLKP NV + + ++ L DF L+
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 27/114 (23%), Positives = 48/114 (42%), Gaps = 9/114 (7%)
Query: 315 MAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRAT 374
+ + +FVGT Y++PE + + D W+ G LYEL PF ++
Sbjct: 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-SQKE 223
Query: 375 LFNVV--GQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
L + G+ R P + S ++I +L + + R + EI ++P
Sbjct: 224 LAGKIREGKFRRIPY--RYSDELNEIITRMLNLKDYHRPS----VEEILENPLI 271
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 7e-37
Identities = 40/160 (25%), Positives = 70/160 (43%), Gaps = 9/160 (5%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
+ L LG G +V+ + T FA+KV + S + E E+L
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM--REFEVLKK 63
Query: 151 LDHPFLPTLYSYFE--TDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLL 207
L+H + L++ E T + L+MEFC G+L++ L + E +V+
Sbjct: 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 208 ALEYLHMLGIVYRDLKPENVLVR----DEGHIMLSDFDLS 243
+ +L GIV+R++KP N++ + L+DF +
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 21/127 (16%), Positives = 46/127 (36%), Gaps = 35/127 (27%)
Query: 324 MSFVGTHEYLAPEIIRG--------EGHGSAVDWWTFGIFLYELLHGTTPFK----GQGN 371
+S GT EYL P++ + +G+ VD W+ G+ Y G+ PF+ + N
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 372 RATLFNV-------------------VGQPLRFPETPQVSFVARD----LIRGLLVKEPH 408
+ ++ + + P + +S + ++ +L +
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
Query: 409 KRIAYKR 415
K + +
Sbjct: 293 KCWGFDQ 299
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-37
Identities = 39/154 (25%), Positives = 75/154 (48%), Gaps = 2/154 (1%)
Query: 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILG 149
P + + LG G + + T FA K++ K+ L ++ + E I
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 150 LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLAL 209
L H + + +FE + F +V+E C +L L +++ K TE AR++ +++L
Sbjct: 97 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGC 154
Query: 210 EYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+YLH +++RDLK N+ + ++ + + DF L+
Sbjct: 155 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 9e-21
Identities = 35/124 (28%), Positives = 54/124 (43%), Gaps = 10/124 (8%)
Query: 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE 387
GT Y+APE++ +GH VD W+ G +Y LL G PF+ + T + P
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP- 261
Query: 388 TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPH-IPEPV 446
++ VA LI+ +L +P R E+ FF + + LP + P
Sbjct: 262 -KHINPVAASLIQKMLQTDPTARPTIN----ELLNDEFF---TSGYIPARLPITCLTIPP 313
Query: 447 DFSV 450
FS+
Sbjct: 314 RFSI 317
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-37
Identities = 54/154 (35%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
F ++ LG G V+LV+ R T FA+K + K+ + L E +L + H
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKH 65
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
+ TL +E+ Y LVM+ SGG L + ++ +TE A +VL A++YL
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYL 122
Query: 213 HMLGIVYRDLKPENVLVR---DEGHIMLSDFDLS 243
H GIV+RDLKPEN+L + IM++DF LS
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 33/109 (30%), Positives = 52/109 (47%), Gaps = 10/109 (9%)
Query: 324 MSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV--GQ 381
+ GT Y+APE++ + + AVD W+ G+ Y LL G PF + + LF + G
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE-TESKLFEKIKEGY 223
Query: 382 PLRFPETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428
F +S A+D I LL K+P++R + HP+ +G
Sbjct: 224 -YEFESPFWDDISESAKDFICHLLEKDPNERYT----CEKALSHPWIDG 267
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 40/153 (26%), Positives = 68/153 (44%), Gaps = 2/153 (1%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD 152
L+NFR+ K++G G VY A+K + L E ++L L+
Sbjct: 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSL--RQKQPNKYFTEDAARFFASEVLLALE 210
HP + Y+ F D +V+E G+L + K+ + E + ++ ALE
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++H +++RD+KP NV + G + L D L
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 8e-15
Identities = 30/104 (28%), Positives = 43/104 (41%), Gaps = 8/104 (7%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQ-GNRATLFNVVGQPL 383
S VGT Y++PE I G+ D W+ G LYE+ +PF G N +L + Q
Sbjct: 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-C 253
Query: 384 RFPETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425
+P P S R L+ + +P KR T +
Sbjct: 254 DYPPLPSDHYSEELRQLVNMCINPDPEKRPD----VTYVYDVAK 293
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 7/155 (4%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE--ILGLLDH 153
+ L + +G G V R T FA+K++D A S L +RE I +L H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNL--HSLRQKQPNKYFTEDAARFFASEVLLALEY 211
P + L + +D +V EF G +L +++ ++E A + ++L AL Y
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 212 LHMLGIVYRDLKPENVLV--RDEGH-IMLSDFDLS 243
H I++RD+KP VL+ ++ + L F ++
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 39/130 (30%), Positives = 60/130 (46%), Gaps = 18/130 (13%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
FG + + E V VGT ++APE+++ E +G VD W G+ L+ LL
Sbjct: 175 GGFG------VAIQLGESGLVAG-GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILL 227
Query: 361 HGTTPFKGQGNRATLFNVV--GQPLRFPETP--QVSFVARDLIRGLLVKEPHKRIAYKRG 416
G PF G R LF + G+ + +S A+DL+R +L+ +P +RI
Sbjct: 228 SGCLPFYGTKER--LFEGIIKGK-YKMNPRQWSHISESAKDLVRRMLMLDPAERIT---- 280
Query: 417 ATEIKQHPFF 426
E HP+
Sbjct: 281 VYEALNHPWL 290
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-36
Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 11/158 (6%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRN----KLLRAQTEREI-- 147
N+ + LG G V + T +A+K++D S + + LR T +E+
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 148 -LGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAARFFASEV 205
+ HP + L +ET+ F+ LV + G L L +K +E R +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRAL 133
Query: 206 LLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
L + LH L IV+RDLKPEN+L+ D+ +I L+DF S
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 39/118 (33%), Positives = 52/118 (44%), Gaps = 12/118 (10%)
Query: 326 FVGTHEYLAPEIIRG------EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV 379
GT YLAPEII G+G VD W+ G+ +Y LL G+ PF + L ++
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242
Query: 380 GQPLRFPETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVR 435
+F S +DL+ LV +P KR A E HPFF+ VR
Sbjct: 243 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT----AEEALAHPFFQQYVVEEVR 296
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 51/154 (33%), Positives = 73/154 (47%), Gaps = 10/154 (6%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+ L +G G G V + +GT A K + K + ++ + E EI+ LDH
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ---EIEIMKSLDH 65
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
P + LY FE + LVME C+GG L + K + F E A +VL A+ Y
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYC 122
Query: 213 HMLGIVYRDLKPENVLVRDEGH---IMLSDFDLS 243
H L + +RDLKPEN L + + L DF L+
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 7/106 (6%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR 384
+ VGT Y++P+++ G +G D W+ G+ +Y LL G PF + + +
Sbjct: 167 TKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT 225
Query: 385 FPETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428
FPE VS A LIR LL K P +RI + + +H +FE
Sbjct: 226 FPEKDWLNVSPQAESLIRRLLTKSPKQRIT----SLQALEHEWFEK 267
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 39/154 (25%), Positives = 68/154 (44%), Gaps = 6/154 (3%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+ +L+ LG G G V+ + T F K ++ + + E I+ L H
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLHH 107
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
P L L+ FE L++EF SGG L R + +E + + L+++H
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFD-RIAAEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 214 MLGIVYRDLKPENVLV--RDEGHIMLSDFDLSLR 245
IV+ D+KPEN++ + + + DF L+ +
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 47/142 (33%), Positives = 64/142 (45%), Gaps = 15/142 (10%)
Query: 290 ILPSKKNRKSK-SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVD 348
+ +KK K DFG L + V+ T E+ APEI+ E G D
Sbjct: 181 MCETKKASSVKIIDFG------LATKLNPDEIVKVT--TATAEFAAPEIVDREPVGFYTD 232
Query: 349 WWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPET--PQVSFVARDLIRGLLVKE 406
W G+ Y LL G +PF G+ + TL NV F E VS A+D I+ LL KE
Sbjct: 233 MWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKE 292
Query: 407 PHKRIAYKRGATEIKQHPFFEG 428
P KR+ + +HP+ +G
Sbjct: 293 PRKRLT----VHDALEHPWLKG 310
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 17/209 (8%)
Query: 49 HGSSNCSSRSDSLESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIG 108
H + S R + P I+ + + ++ +K+LG G G
Sbjct: 3 HHHHHSSGRENLYFQGDLQATPGM----------FITSKKGHLS-EMYQRVKKLGSGAYG 51
Query: 109 SVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKF 168
V L + T+ A+K++ K S+ S + + E +L LLDHP + LY +FE +
Sbjct: 52 EVLLCRDKVTHVERAIKIIRKTSV-STSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN 110
Query: 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVL 228
Y LVME GG L + F E A +VL + YLH IV+RDLKPEN+L
Sbjct: 111 YYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLL 168
Query: 229 VR---DEGHIMLSDFDLSLRCSVSPTLVK 254
+ + I + DF LS + +
Sbjct: 169 LESKEKDALIKIVDFGLSAVFENQKKMKE 197
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 4e-20
Identities = 34/122 (27%), Positives = 57/122 (46%), Gaps = 7/122 (5%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR 384
+GT Y+APE++R + + D W+ G+ L+ LL G PF GQ ++ L V
Sbjct: 197 ERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT 255
Query: 385 FPETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHI 442
F VS A+DLI+ +L + +RI+ A + +HP+ + + P +
Sbjct: 256 FDSPEWKNVSEGAKDLIKQMLQFDSQRRIS----AQQALEHPWIKEMCSKKESGIELPSL 311
Query: 443 PE 444
Sbjct: 312 AN 313
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 52/169 (30%), Positives = 80/169 (47%), Gaps = 12/169 (7%)
Query: 83 MISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASL-ASRNKLLRA 141
M + + + + + + LG G V + T +A K + K ASR + R
Sbjct: 2 METFKQQKV-EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCRE 60
Query: 142 QTERE--ILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAA 198
+ ERE IL + HP + TL+ +E L++E SGG L L QK+ +E+ A
Sbjct: 61 EIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEA 117
Query: 199 RFFASEVLLALEYLHMLGIVYRDLKPENVLVR----DEGHIMLSDFDLS 243
F ++L + YLH I + DLKPEN+++ HI L DF L+
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 40/105 (38%), Positives = 53/105 (50%), Gaps = 6/105 (5%)
Query: 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF 385
GT E++APEI+ E G D W+ G+ Y LL G +PF G + TL N+ F
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237
Query: 386 PETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428
E Q S +A+D IR LLVKE KR+ E +HP+
Sbjct: 238 DEEFFSQTSELAKDFIRKLLVKETRKRLT----IQEALRHPWITP 278
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 51/158 (32%), Positives = 83/158 (52%), Gaps = 13/158 (8%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLAS-----RNKLLRAQTEREILG 149
+ + K LG G G V L R T A+K++ K A + L +TE EIL
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 150 LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAARFFASEVLLA 208
L+HP + + ++F+ + +Y +V+E GG L + + E + + ++LLA
Sbjct: 71 KLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLA 126
Query: 209 LEYLHMLGIVYRDLKPENVLVR---DEGHIMLSDFDLS 243
++YLH GI++RDLKPENVL+ ++ I ++DF S
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 39/135 (28%), Positives = 65/135 (48%), Gaps = 20/135 (14%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRG---EGHGSAVDWWTFGIFLY 357
+DFG +++ E + +R++ GT YLAPE++ G+ AVD W+ G+ L+
Sbjct: 159 TDFG------HSKILGETSLMRTL--CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210
Query: 358 ELLHGTTPFKGQGNRATLFNVV--GQPLRFPETP--QVSFVARDLIRGLLVKEPHKRIAY 413
L G PF + +L + + G+ F +VS A DL++ LLV +P R
Sbjct: 211 ICLSGYPPFSEHRTQVSLKDQITSGK-YNFIPEVWAEVSEKALDLVKKLLVVDPKARFT- 268
Query: 414 KRGATEIKQHPFFEG 428
E +HP+ +
Sbjct: 269 ---TEEALRHPWLQD 280
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-36
Identities = 46/155 (29%), Positives = 73/155 (47%), Gaps = 7/155 (4%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
F ++LG G G V+LVE R + +K ++K + + E E+L LDH
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE--AEIEVLKSLDH 79
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNL--HSLRQKQPNKYFTEDAARFFASEVLLALEY 211
P + ++ FE +VME C GG L + + K +E +++ AL Y
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 212 LHMLGIVYRDLKPENVLVR---DEGHIMLSDFDLS 243
H +V++DLKPEN+L + I + DF L+
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 26/103 (25%), Positives = 48/103 (46%), Gaps = 6/103 (5%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR 384
+ GT Y+APE+ + + D W+ G+ +Y LL G PF G +
Sbjct: 185 NAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN 243
Query: 385 FPETPQ-VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
+ + ++ A DL++ +L K+P +R + A ++ H +F
Sbjct: 244 YAVECRPLTPQAVDLLKQMLTKDPERRPS----AAQVLHHEWF 282
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 12/156 (7%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRN--KLLRAQTEREILGLL 151
N+ + + LG G V + T FA K+++ L++R+ KL R E I L
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKL 62
Query: 152 DHPFLPTLYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAARFFASEVLLALE 210
HP + L+ + + F+ LV + +GG L + + ++++E A ++L ++
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIA 119
Query: 211 YLHMLGIVYRDLKPENVLVRDEG---HIMLSDFDLS 243
Y H GIV+R+LKPEN+L+ + + L+DF L+
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 3e-21
Identities = 35/124 (28%), Positives = 52/124 (41%), Gaps = 10/124 (8%)
Query: 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF 385
F GT YL+PE+++ + + VD W G+ LY LL G PF + + +
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 226
Query: 386 PETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIP 443
P V+ A+ LI +L P KRI A + + P+ R A H
Sbjct: 227 PSPEWDTVTPEAKSLIDSMLTVNPKKRIT----ADQALKVPWICNRE----RVASAIHRQ 278
Query: 444 EPVD 447
+ VD
Sbjct: 279 DTVD 282
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 53/158 (33%), Positives = 80/158 (50%), Gaps = 11/158 (6%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASL-ASRNKLLRAQTERE--ILGL 150
++ + + LG G V +GT +A K + K L +SR + R + ERE IL
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAARFFASEVLLAL 209
+ HP + TL+ FE L++E SGG L L +K + TED A F ++L +
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGV 121
Query: 210 EYLHMLGIVYRDLKPENVLVRDE----GHIMLSDFDLS 243
YLH I + DLKPEN+++ D+ I L DF ++
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 9e-21
Identities = 36/105 (34%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF 385
GT E++APEI+ E G D W+ G+ Y LL G +PF G+ + TL N+ F
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF 230
Query: 386 PETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428
E S +A+D IR LLVK+P +R+ + +H + +
Sbjct: 231 DEEYFSNTSELAKDFIRRLLVKDPKRRMT----IAQSLEHSWIKA 271
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 49/154 (31%), Positives = 78/154 (50%), Gaps = 8/154 (5%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+ ++ LG G G V + R T +A+KV++KAS +++ E E+L LDH
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDH 80
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
P + L+ E + +V E +GG L + ++ K F+E A +V + Y+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYM 137
Query: 213 HMLGIVYRDLKPENVLVR---DEGHIMLSDFDLS 243
H IV+RDLKPEN+L+ + I + DF LS
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 38/122 (31%), Positives = 56/122 (45%), Gaps = 7/122 (5%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR 384
+GT Y+APE++RG + D W+ G+ LY LL GT PF G+ L V
Sbjct: 182 DRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA 240
Query: 385 FPETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHI 442
F +S A+DLIR +L P RI AT+ +HP+ + + + P +
Sbjct: 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRIT----ATQCLEHPWIQKYSSETPTISDLPSL 296
Query: 443 PE 444
Sbjct: 297 ES 298
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-35
Identities = 51/173 (29%), Positives = 78/173 (45%), Gaps = 12/173 (6%)
Query: 83 MISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASL-ASRNKLLRA 141
M + + + + + LG G V + T +A K + K ASR + R
Sbjct: 2 MEPFKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60
Query: 142 QTERE--ILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAA 198
+ ERE IL + H + TL+ +E L++E SGG L L QK+ +E+ A
Sbjct: 61 EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEA 117
Query: 199 RFFASEVLLALEYLHMLGIVYRDLKPENVLVR----DEGHIMLSDFDLSLRCS 247
F ++L + YLH I + DLKPEN+++ HI L DF L+
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 39/105 (37%), Positives = 52/105 (49%), Gaps = 6/105 (5%)
Query: 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF 385
GT E++APEI+ E G D W+ G+ Y LL G +PF G + TL N+ F
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237
Query: 386 PETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428
E S +A+D IR LLVKE KR+ E +HP+
Sbjct: 238 DEEFFSHTSELAKDFIRKLLVKETRKRLT----IQEALRHPWITP 278
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-35
Identities = 33/167 (19%), Positives = 65/167 (38%), Gaps = 23/167 (13%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD 152
+F+ ++ +G G G V+ + R + +K + + + E + L LD
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER-------EVKALAKLD 62
Query: 153 HPFLPTLYSYFE----------------TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTED 196
H + ++ K + MEFC G L +K+ + +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 197 AARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
A ++ ++Y+H ++ RDLKP N+ + D + + DF L
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLV 169
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 24/103 (23%), Positives = 38/103 (36%), Gaps = 10/103 (9%)
Query: 324 MSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL 383
GT Y++PE I + +G VD + G+ L ELLH + F +
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF---ETSKFFTDLRDG- 234
Query: 384 RFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
+ L++ LL K+P R +EI +
Sbjct: 235 IIS--DIFDKKEKTLLQKLLSKKPEDRPN----TSEILRTLTV 271
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 4e-35
Identities = 49/154 (31%), Positives = 78/154 (50%), Gaps = 8/154 (5%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+ ++ LG G G V + R T +A+KV++KAS +++ E E+L LDH
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDH 80
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
P + L+ E + +V E +GG L + ++ K F+E A +V + Y+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYM 137
Query: 213 HMLGIVYRDLKPENVLVR---DEGHIMLSDFDLS 243
H IV+RDLKPEN+L+ + I + DF LS
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 9e-18
Identities = 37/104 (35%), Positives = 51/104 (49%), Gaps = 7/104 (6%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR 384
+GT Y+APE++RG + D W+ G+ LY LL GT PF G+ L V
Sbjct: 182 DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA 240
Query: 385 FPETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
F +S A+DLIR +L P RI AT+ +HP+
Sbjct: 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRIT----ATQCLEHPWI 280
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-35
Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 11/162 (6%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASL-ASRNKLLRAQTERE--ILGL 150
+ + LG G V + T +A K + K +SR + R ERE IL
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAARFFASEVLLAL 209
+ HP + TL+ +E L++E +GG L L +K + TE+ A F ++L +
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGV 127
Query: 210 EYLHMLGIVYRDLKPENVLVRDE----GHIMLSDFDLSLRCS 247
YLH L I + DLKPEN+++ D I + DF L+ +
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 6/115 (5%)
Query: 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF 385
GT E++APEI+ E G D W+ G+ Y LL G +PF G + TL NV F
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 386 PETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSAL 438
+ S +A+D IR LLVK+P KR+ + QHP+ + + S
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMT----IQDSLQHPWIKPKDTQQALSRK 287
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-35
Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 15/174 (8%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRA----------QT 143
++ +++LG G G V L + + ++ A+KV+ K+
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 144 EREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFAS 203
E +L LDHP + L+ FE K++ LV EF GG L + F E A
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMK 153
Query: 204 EVLLALEYLHMLGIVYRDLKPENVLVR---DEGHIMLSDFDLSLRCSVSPTLVK 254
++L + YLH IV+RD+KPEN+L+ +I + DF LS S L
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 33/152 (21%), Positives = 59/152 (38%), Gaps = 21/152 (13%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG L ++ + + +GT Y+APE+++ + + D W+ G+ +Y LL
Sbjct: 192 DFG------LSSFFSK--DYKLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLC 242
Query: 362 GTTPFKGQGNRATLFNVVGQPLRFPETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATE 419
G PF GQ ++ + V F +S A++LI+ +L + +KR A E
Sbjct: 243 GYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCT----AEE 298
Query: 420 IKQHPFFEGVNWALVRSALPPHIPEPVDFSVF 451
W + +
Sbjct: 299 ALNSR------WIKKYANNINKSDQKTLCGAL 324
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 51/158 (32%), Positives = 83/158 (52%), Gaps = 13/158 (8%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASR-----NKLLRAQTEREILG 149
+ + K LG G G V L R T A++++ K A + L +TE EIL
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 150 LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAARFFASEVLLA 208
L+HP + + ++F+ + +Y +V+E GG L + K E + + ++LLA
Sbjct: 196 KLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLA 251
Query: 209 LEYLHMLGIVYRDLKPENVLVR---DEGHIMLSDFDLS 243
++YLH GI++RDLKPENVL+ ++ I ++DF S
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 39/135 (28%), Positives = 64/135 (47%), Gaps = 20/135 (14%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRG---EGHGSAVDWWTFGIFLY 357
+DFG +++ E + +R+ GT YLAPE++ G+ AVD W+ G+ L+
Sbjct: 284 TDFG------HSKILGETSLMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 335
Query: 358 ELLHGTTPFKGQGNRATLFNVV--GQPLRFPETP--QVSFVARDLIRGLLVKEPHKRIAY 413
L G PF + +L + + G+ F +VS A DL++ LLV +P R
Sbjct: 336 ICLSGYPPFSEHRTQVSLKDQITSGK-YNFIPEVWAEVSEKALDLVKKLLVVDPKARFT- 393
Query: 414 KRGATEIKQHPFFEG 428
E +HP+ +
Sbjct: 394 ---TEEALRHPWLQD 405
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 48/192 (25%), Positives = 72/192 (37%), Gaps = 42/192 (21%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE--ILGLL 151
+ L +G G G V + T A+K+M+K + N + + E ++ L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 152 DHPFLPTLYSYFETDKFYCLVMEFCSGGNL------------------------------ 181
HP + LY +E +++ CLVME C GG+L
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 182 --------HSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLV--RD 231
++ + E ++ AL YLH GI +RD+KPEN L
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 232 EGHIMLSDFDLS 243
I L DF LS
Sbjct: 206 SFEIKLVDFGLS 217
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 39/142 (27%), Positives = 61/142 (42%), Gaps = 14/142 (9%)
Query: 291 LPSKKNRKSK-SDFGPCVGGALPELMAEPTNVRSMS-FVGTHEYLAPEIIRGEGH--GSA 346
+ K+ + K DFG + M+ GT ++APE++ G
Sbjct: 201 FSTNKSFEIKLVDFGL----SKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256
Query: 347 VDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF--PETPQVSFVARDLIRGLLV 404
D W+ G+ L+ LL G PF G + T+ V+ + L F P +S +ARDL+ LL
Sbjct: 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLN 316
Query: 405 KEPHKRIAYKRGATEIKQHPFF 426
+ +R A QHP+
Sbjct: 317 RNVDERF----DAMRALQHPWI 334
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-34
Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 8/161 (4%)
Query: 85 SLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTE 144
+ + + +LK++G G V+ V L +A+K ++ L + E
Sbjct: 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEA-DNQTLDSYRNE 76
Query: 145 REILGLLDHPFLP--TLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFA 202
L L LY Y TD++ +VME C +L+S +K K + +
Sbjct: 77 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYW 133
Query: 203 SEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+L A+ +H GIV+ DLKP N L+ +G + L DF ++
Sbjct: 134 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIA 173
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 32/138 (23%), Positives = 56/138 (40%), Gaps = 21/138 (15%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG-----------HGSAVDW 349
DFG ++ + T+V S VGT Y+ PE I+ D
Sbjct: 168 IDFGIAN-----QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 222
Query: 350 WTFGIFLYELLHGTTPFKGQGNR-ATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408
W+ G LY + +G TPF+ N+ + L ++ +D+++ L ++P
Sbjct: 223 WSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK 282
Query: 409 KRIAYKRGATEIKQHPFF 426
+RI+ E+ HP+
Sbjct: 283 QRIS----IPELLAHPYV 296
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 14/206 (6%)
Query: 46 NHGHGSSNCSSRSDSLESSSAP------VKPHTGGDVRWDAINMISLRGPPIGLSNFRLL 99
+H H SS R ++ ++A + G D + + + + +L
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL 61
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLP-- 157
K++G G V+ V L +A+K ++ L + E L L
Sbjct: 62 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKII 119
Query: 158 TLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGI 217
LY Y TD++ +VME C +L+S +K K + + +L A+ +H GI
Sbjct: 120 RLYDYEITDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGI 176
Query: 218 VYRDLKPENVLVRDEGHIMLSDFDLS 243
V+ DLKP N L+ +G + L DF ++
Sbjct: 177 VHSDLKPANFLI-VDGMLKLIDFGIA 201
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 31/138 (22%), Positives = 55/138 (39%), Gaps = 21/138 (15%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG-----------HGSAVDW 349
DFG ++ + T+V S VG Y+ PE I+ D
Sbjct: 196 IDFGIAN-----QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 250
Query: 350 WTFGIFLYELLHGTTPFKGQGNR-ATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408
W+ G LY + +G TPF+ N+ + L ++ +D+++ L ++P
Sbjct: 251 WSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK 310
Query: 409 KRIAYKRGATEIKQHPFF 426
+RI+ E+ HP+
Sbjct: 311 QRIS----IPELLAHPYV 324
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 32/152 (21%), Positives = 64/152 (42%), Gaps = 7/152 (4%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+ + + LG G+ G V+ + + K + + + + E IL + H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKK---EISILNIARH 60
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
+ L+ FE+ + ++ EF SG ++ R E + +V AL++LH
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFE-RINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 214 MLGIVYRDLKPENVLV--RDEGHIMLSDFDLS 243
I + D++PEN++ R I + +F +
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 38/137 (27%), Positives = 61/137 (44%), Gaps = 15/137 (10%)
Query: 291 LPSKKNRKSK-SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDW 349
++++ K +FG + N R + EY APE+ + + +A D
Sbjct: 135 YQTRRSSTIKIIEFG------QARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVSTATDM 186
Query: 350 WTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETP--QVSFVARDLIRGLLVKEP 407
W+ G +Y LL G PF + N+ + N++ F E ++S A D + LLVKE
Sbjct: 187 WSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKER 246
Query: 408 HKRIAYKRGATEIKQHP 424
R+ A+E QHP
Sbjct: 247 KSRMT----ASEALQHP 259
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 42/154 (27%), Positives = 79/154 (51%), Gaps = 8/154 (5%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
N+ + + LG G V + T FA K+++ L++R+ + + E I L H
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQH 87
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
P + L+ + + F+ LV + +GG L + + ++++E A ++L ++ Y
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYC 144
Query: 213 HMLGIVYRDLKPENVLVRDEG---HIMLSDFDLS 243
H GIV+R+LKPEN+L+ + + L+DF L+
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 30/105 (28%), Positives = 46/105 (43%), Gaps = 6/105 (5%)
Query: 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF 385
F GT YL+PE+++ + + VD W G+ LY LL G PF + + +
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 249
Query: 386 PETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428
P V+ A+ LI +L P KRI A + + P+
Sbjct: 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRIT----ADQALKVPWICN 290
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-34
Identities = 41/157 (26%), Positives = 70/157 (44%), Gaps = 12/157 (7%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASL--ASRNKLLRAQTEREIL 148
+ + +LK++G G V+ V L +A+K ++ + + E L
Sbjct: 6 VKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRN---EIAYL 61
Query: 149 GLLDHPFLP--TLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVL 206
L LY Y TD++ +VME C +L+S +K K + + +L
Sbjct: 62 NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNML 118
Query: 207 LALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
A+ +H GIV+ DLKP N L+ +G + L DF ++
Sbjct: 119 EAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIA 154
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 37/196 (18%), Positives = 72/196 (36%), Gaps = 26/196 (13%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG-----------HGSAVDW 349
DFG ++ + T+V S VGT Y+ PE I+ D
Sbjct: 149 IDFGIAN-----QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 203
Query: 350 WTFGIFLYELLHGTTPFKGQGNR-ATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408
W+ G LY + +G TPF+ N+ + L ++ +D+++ L ++P
Sbjct: 204 WSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK 263
Query: 409 KRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEPVDFSVFAGKDQASAAAEKKVVAA 468
+RI+ E+ HP+ + + + + + ++ A
Sbjct: 264 QRIS----IPELLAHPYV-----QIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKA 314
Query: 469 AEAAVDHKNGDSPKDS 484
A+ +H +G +S
Sbjct: 315 AKTLYEHYSGGESHNS 330
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILG-LLDHPFLPT 158
LG G V T+ +A+K+++K R+++ R E E+L H +
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR---EVEMLYQCQGHRNVLE 75
Query: 159 LYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGI 217
L +FE + + LV E GG++ + ++ ++F E A +V AL++LH GI
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKGI 132
Query: 218 VYRDLKPENVLVRDEGH---IMLSDFDLS 243
+RDLKPEN+L + + DFDL
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLG 161
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 37/150 (24%), Positives = 63/150 (42%), Gaps = 26/150 (17%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRG-----EGHGSAVDWWTFGIF 355
DF G L + + ++ G+ EY+APE++ + D W+ G+
Sbjct: 156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
Query: 356 LYELLHGTTPFKGQGNRATLFNVVGQP---------------LRFPETP--QVSFVARDL 398
LY LL G PF G+ ++ FP+ +S A+DL
Sbjct: 216 LYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDL 275
Query: 399 IRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428
I LLV++ +R++ A ++ QHP+ +G
Sbjct: 276 ISKLLVRDAKQRLS----AAQVLQHPWVQG 301
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 38/154 (24%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
++L + LG G V +A +++ L S + + E I LL H
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKH 69
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
P + L+ + + L+ + +GG L + + +Y++E A ++L A+ +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHC 126
Query: 213 HMLGIVYRDLKPENVLVRDEG---HIMLSDFDLS 243
H +G+V+R+LKPEN+L+ + + L+DF L+
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 38/107 (35%), Positives = 54/107 (50%), Gaps = 10/107 (9%)
Query: 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV--GQPL 383
F GT YL+PE++R + +G VD W G+ LY LL G PF + ++ L+ + G
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE-DQHRLYQQIKAGA-Y 230
Query: 384 RFPETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428
FP V+ A+DLI +L P KRI A E +HP+
Sbjct: 231 DFPSPEWDTVTPEAKDLINKMLTINPSKRIT----AAEALKHPWISH 273
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 6e-33
Identities = 42/194 (21%), Positives = 77/194 (39%), Gaps = 26/194 (13%)
Query: 57 RSDSLESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKR-LGYGDIGSVYLVEL 115
S ++ + + + + + + L + LG G V
Sbjct: 7 HSSGVDLGTENLYFQSMENFN----------------NFYILTSKELGRGKFAVVRQCIS 50
Query: 116 RGTNTYFAMKVMDKASLASRNKLLRAQTERE--ILGLLDH-PFLPTLYSYFETDKFYCLV 172
+ T +A K + K RA+ E +L L P + L+ +E L+
Sbjct: 51 KSTGQEYAAKFLKKRRRGQDC---RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107
Query: 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE 232
+E+ +GG + SL + + +E+ ++L + YLH IV+ DLKP+N+L+
Sbjct: 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSI 167
Query: 233 ---GHIMLSDFDLS 243
G I + DF +S
Sbjct: 168 YPLGDIKIVDFGMS 181
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 44/139 (31%), Positives = 66/139 (47%), Gaps = 7/139 (5%)
Query: 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF 385
+GT EYLAPEI+ + +A D W GI Y LL T+PF G+ N+ T N+ + +
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDY 252
Query: 386 PETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIP 443
E VS +A D I+ LLVK P KR A H + + ++ +
Sbjct: 253 SEETFSSVSQLATDFIQSLLVKNPEKRPT----AEICLSHSWLQQWDFENLFHPEETSSS 308
Query: 444 EPV-DFSVFAGKDQASAAA 461
D SV + +D+ S ++
Sbjct: 309 SQTQDHSVRSSEDKTSKSS 327
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-33
Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 14/204 (6%)
Query: 46 NHGHGSSNCSSRSDSLESSSAPVKPHTGGDVRWDAINMISLRGPPIG--LSNFRLLKRLG 103
+H H SS +++L S + + + G F + LG
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELG 62
Query: 104 YGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYF 163
G VY + +GT +A+KV+ K +TE +L L HP + L F
Sbjct: 63 RGATSIVYRCKQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 164 ETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDL 222
ET LV+E +GG L + +K Y++E A ++L A+ YLH GIV+RDL
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENGIVHRDL 174
Query: 223 KPENVLVRDEG---HIMLSDFDLS 243
KPEN+L + ++DF LS
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLS 198
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 9e-21
Identities = 38/110 (34%), Positives = 54/110 (49%), Gaps = 9/110 (8%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV--GQP 382
+ GT Y APEI+RG +G VD W+ GI Y LL G PF + +F + +
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE- 267
Query: 383 LRFPETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430
F +VS A+DL+R L+V +P KR+ + QHP+ G
Sbjct: 268 YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLT----TFQALQHPWVTGKA 313
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 56/186 (30%), Positives = 86/186 (46%), Gaps = 30/186 (16%)
Query: 84 ISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLR--- 140
G + L+ + L +G G G V L NTY+AMKV+ K L + R
Sbjct: 3 SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 141 ------------------AQTEREI--LGLLDHPFLPTLYSYFET---DKFYCLVMEFCS 177
Q +EI L LDHP + L + D Y +V E +
Sbjct: 63 PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLY-MVFELVN 121
Query: 178 GGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIML 237
G + + +P +ED ARF+ +++ +EYLH I++RD+KP N+LV ++GHI +
Sbjct: 122 QGPVMEVPTLKP---LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKI 178
Query: 238 SDFDLS 243
+DF +S
Sbjct: 179 ADFGVS 184
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 7e-22
Identities = 38/130 (29%), Positives = 59/130 (45%), Gaps = 16/130 (12%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG---HGSAVDWWTFGIFLY 357
+DFG + + ++ + VGT ++APE + G A+D W G+ LY
Sbjct: 179 ADFG------VSNEF-KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231
Query: 358 ELLHGTTPFKGQGNRATLFN-VVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRG 416
+ G PF + L + + Q L FP+ P ++ +DLI +L K P RI
Sbjct: 232 CFVFGQCPFMDE-RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVP-- 288
Query: 417 ATEIKQHPFF 426
EIK HP+
Sbjct: 289 --EIKLHPWV 296
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-32
Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 14/160 (8%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLA-SRNKLLRAQTEREILGLLDH 153
+ + +RLG G G V + T A+K + +R + E +I+ L+H
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL---EIQIMKKLNH 71
Query: 154 PFLPTLYSYFET------DKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVL 206
P + + + + L ME+C GG+L L Q + E R S++
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 207 LALEYLHMLGIVYRDLKPENVLVRDEGH---IMLSDFDLS 243
AL YLH I++RDLKPEN++++ + D +
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 6e-16
Identities = 27/188 (14%), Positives = 59/188 (31%), Gaps = 33/188 (17%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR 384
FVGT +YLAPE++ + + VD+W+FG +E + G PF V +
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241
Query: 385 FPETPQVSFV----------------------ARDLIRGLLVKEPHKRIAYKRGATEIKQ 422
++ +L+ +R +
Sbjct: 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG----TDPQNPN 297
Query: 423 HPFFEGVNWALVRSALPPHIPEPVDFSVFAGKDQASAAAEKKVVAAAEAAVDHKNGDSPK 482
F+ ++ L L + ++ +G+ E + + ++ + G +
Sbjct: 298 VGCFQALDSILSLKLL--SV-----MNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEE 350
Query: 483 DSYVEFEY 490
+ +
Sbjct: 351 EQELLQAS 358
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPT 158
K LG G + +N FA+K++ K Q E L L + HP +
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLCEGHPNIVK 70
Query: 159 LYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGI 217
L+ F LVME +GG L +++K K+F+E A + +++ A+ ++H +G+
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVGV 127
Query: 218 VYRDLKPENVLVRDEGH---IMLSDFDLS 243
V+RDLKPEN+L DE I + DF +
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFA 156
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 36/153 (23%), Positives = 62/153 (40%), Gaps = 14/153 (9%)
Query: 317 EPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRAT-- 374
P N + T Y APE++ G+ + D W+ G+ LY +L G PF+ T
Sbjct: 160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT 219
Query: 375 ----LFNVVGQ-PLRFPETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427
+ + + F VS A+DLI+GLL +P+KR+ + ++ + + +
Sbjct: 220 SAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK----MSGLRYNEWLQ 275
Query: 428 GVNWALVRSALPPHIPEPVDFSVFAG-KDQASA 459
+ + P I +V K A
Sbjct: 276 DGSQLSSNPLMTPDILGSSGAAVHTCVKATFHA 308
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 45/154 (29%), Positives = 70/154 (45%), Gaps = 16/154 (10%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILG-LLDHP 154
+ + + +G G + TN FA+K++DK E EIL HP
Sbjct: 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK-------SKRDPTEEIEILLRYGQHP 76
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
+ TL ++ K+ +V E GG L + ++ K+F+E A + +EYLH
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLH 133
Query: 214 MLGIVYRDLKPENVLVRDEGH----IMLSDFDLS 243
G+V+RDLKP N+L DE I + DF +
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 31/117 (26%), Positives = 53/117 (45%), Gaps = 9/117 (7%)
Query: 317 EPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQG--NRAT 374
N M+ T ++APE++ +G+ +A D W+ G+ LY +L G TPF
Sbjct: 171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE 230
Query: 375 LFNVVGQ-PLRFPETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428
+ +G VS A+DL+ +L +PH+R+ A + +HP+
Sbjct: 231 ILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLT----AALVLRHPWIVH 283
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 50/151 (33%), Positives = 81/151 (53%), Gaps = 3/151 (1%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD 152
+ N+RLLK +G G+ V L T A+K++DK L + L + E I+ +L+
Sbjct: 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS-LQKLFREVRIMKILN 72
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
HP + L+ ET+K L+ME+ SGG + + E AR +++ A++Y
Sbjct: 73 HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYC 130
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
H IV+RDLK EN+L+ + +I ++DF S
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFS 161
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 34/122 (27%), Positives = 54/122 (44%), Gaps = 10/122 (8%)
Query: 326 FVGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR 384
F G Y APE+ +G+ G VD W+ G+ LY L+ G+ PF GQ N L V + +
Sbjct: 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ-NLKELRERVLRG-K 230
Query: 385 FPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE 444
+ +S +L++ LV P KR + +I + + N L P +
Sbjct: 231 YRIPFYMSTDCENLLKRFLVLNPIKRGTLE----QIMKDRWI---NAGHEEDELKPFVEP 283
Query: 445 PV 446
+
Sbjct: 284 EL 285
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 6e-32
Identities = 62/395 (15%), Positives = 114/395 (28%), Gaps = 62/395 (15%)
Query: 56 SRSDSLESSSAPVKPHTGGDVRWDA-INMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVE 114
R ++L+ +A V+ T +A + SL +L++ L GD V+LV
Sbjct: 25 CREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGE--RKLKLVEPLRVGDRSVVFLVR 82
Query: 115 LRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174
FA+KV + SR++L R L V
Sbjct: 83 DVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA- 141
Query: 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEG 233
++ + P + + + LL + + L +++ L D
Sbjct: 142 ---------VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL--------DFV 184
Query: 234 HIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPS 293
++ D + ++ L++ L + VHG P +
Sbjct: 185 YVFRGDEGILALHILTAQLIR------------LAANLQSKGLVHGHFTPDN----LFIM 228
Query: 294 KKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG--HGSAVDWWT 351
R D R + Y E + A++ W
Sbjct: 229 PDGRLMLGDVS----------ALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQ 278
Query: 352 FGIFLYELLHGTTPFKGQGN-------RATLFNVVGQPLRFPETPQVSFVARDLIRGLLV 404
G+ +Y + PF R +L L F + + LI L
Sbjct: 279 LGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLN 338
Query: 405 KEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALP 439
+ +R+ E + P F + + S+L
Sbjct: 339 FDRRRRL----LPLEAMETPEFLQLQ-NEISSSLS 368
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-31
Identities = 49/159 (30%), Positives = 81/159 (50%), Gaps = 2/159 (1%)
Query: 85 SLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTE 144
S + + ++ L LG G G V + E + T A+K++++ + S + + + + E
Sbjct: 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE 61
Query: 145 REILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASE 204
+ L L HP + LY T + +VME+ SGG L K + E AR +
Sbjct: 62 IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK--HGRVEEMEARRLFQQ 119
Query: 205 VLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+L A++Y H +V+RDLKPENVL+ + ++DF LS
Sbjct: 120 ILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 158
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 5e-17
Identities = 34/101 (33%), Positives = 50/101 (49%), Gaps = 9/101 (8%)
Query: 328 GTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFN-VVGQPLRF 385
G+ Y APE+I G G VD W+ G+ LY LL GT PF + + TLF + G
Sbjct: 172 GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE-HVPTLFKKIRGGVFYI 230
Query: 386 PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
P ++ L+ +L +P KR K +I++H +F
Sbjct: 231 P--EYLNRSVATLLMHMLQVDPLKRATIK----DIREHEWF 265
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-31
Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 6/153 (3%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLLD 152
+ + LG G G V V T A+K++ K L R A ++EI L L
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKL-RRIPNGEANVKKEIQLLRRLR 64
Query: 153 HPFLPTLYS--YFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
H + L Y E + +VME+C G + + P K F A + +++ LE
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
YLH GIV++D+KP N+L+ G + +S ++
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA 156
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 39/154 (25%), Positives = 57/154 (37%), Gaps = 26/154 (16%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFV----GTHEYLAPEIIRGEG--HGSAVDWWTFGI 354
S G + + G+ + PEI G G VD W+ G+
Sbjct: 151 SALG---------VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGV 201
Query: 355 FLYELLHGTTPFKGQGNRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY 413
LY + G PF+G N LF N+ P DL++G+L EP KR +
Sbjct: 202 TLYNITTGLYPFEGD-NIYKLFENIGKGSYAIP--GDCGPPLSDLLKGMLEYEPAKRFSI 258
Query: 414 KRGATEIKQHPFFEGVNWALVRSALPPHIPEPVD 447
+ +I+QH +F + P IP D
Sbjct: 259 R----QIRQHSWF---RKKHPPAEAPVPIPPSPD 285
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-31
Identities = 39/163 (23%), Positives = 70/163 (42%), Gaps = 10/163 (6%)
Query: 87 RGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASR---NKLLRAQT 143
G + + LG G G V+ + N +K + K + +
Sbjct: 19 EGEYSQ--KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV 76
Query: 144 EREI--LGLLDHPFLPTLYSYFETDKFYCLVMEF-CSGGNLHSLRQKQPNKYFTEDAARF 200
EI L ++H + + FE F+ LVME SG +L + + P E A +
Sbjct: 77 TLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASY 134
Query: 201 FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+++ A+ YL + I++RD+K EN+++ ++ I L DF +
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 36/154 (23%), Positives = 57/154 (37%), Gaps = 16/154 (10%)
Query: 326 FVGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR 384
F GT EY APE++ G G ++ W+ G+ LY L+ PF L V +
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIH 242
Query: 385 FPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF-EGVNWA--LVRSALPPH 441
P VS L+ GLL P +R + ++ P+ + VN A +
Sbjct: 243 PP--YLVSKELMSLVSGLLQPVPERRTTLE----KLVTDPWVTQPVNLADYTWEEVFRVN 296
Query: 442 IPEPVDFSVFAGKDQASAAAEKKVVAAAEAAVDH 475
PE S + + + ++ H
Sbjct: 297 KPESGVLSAASLEMGNRSLSDVAQAQELCGGEGH 330
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 10/157 (6%)
Query: 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI- 147
P + ++ L++ LG G G V L R T A+K++D ++EI
Sbjct: 4 PFVE--DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEIC 57
Query: 148 -LGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVL 206
+L+H + Y + L +E+CSGG L + + E A+ F +++
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLM 115
Query: 207 LALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ YLH +GI +RD+KPEN+L+ + ++ +SDF L+
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA 152
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 6e-18
Identities = 28/128 (21%), Positives = 49/128 (38%), Gaps = 11/128 (8%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYEL 359
SDFG + + GT Y+APE+++ H VD W+ GI L +
Sbjct: 147 SDFGLA---TVFRYNNRERLLNK--MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201
Query: 360 LHGTTPFKGQGNR-ATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGAT 418
L G P+ + + + ++ L+ +LV+ P RI
Sbjct: 202 LAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP---- 257
Query: 419 EIKQHPFF 426
+IK+ ++
Sbjct: 258 DIKKDRWY 265
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 38/152 (25%), Positives = 67/152 (44%), Gaps = 16/152 (10%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILG-LLDHPFLPT 158
+ LG G G V R T A+K++ + A + E + P +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ--------EVDHHWQASGGPHIVC 86
Query: 159 LYSYFET----DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
+ +E + ++ME GG L S Q++ ++ FTE A ++ A+++LH
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 215 LGIVYRDLKPENVLVRDEGH---IMLSDFDLS 243
I +RD+KPEN+L + + L+DF +
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 40/162 (24%), Positives = 67/162 (41%), Gaps = 21/162 (12%)
Query: 324 MSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRAT---LFNVVG 380
+ T Y+APE++ E + + D W+ G+ +Y LL G PF +A + +
Sbjct: 187 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 246
Query: 381 Q-PLRFPETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSA 437
FP +VS A+ LIR LL +P +R+ T+ HP W
Sbjct: 247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLT----ITQFMNHP------WINQSMV 296
Query: 438 LPPHIPEPVDFSVFAGKDQASAAAEKKVVAAAEAA--VDHKN 477
+P P+ + +D+ K+ + +A A VD+
Sbjct: 297 VPQT---PLHTARVLQEDKDHWDEVKEEMTSALATMRVDYDQ 335
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 35/165 (21%), Positives = 72/165 (43%), Gaps = 17/165 (10%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLA-SRNKLLRAQTEREILGLL 151
L++F ++ LG G G V+ + + + +A+K + + +R K++R E + L L
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR---EVKALAKL 60
Query: 152 DHPFLPTLYSYFETDKFY------------CLVMEFCSGGNLHS-LRQKQPNKYFTEDAA 198
+HP + ++ + + M+ C NL + + +
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 199 RFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++ A+E+LH G+++RDLKP N+ + + + DF L
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 165
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 34/118 (28%), Positives = 53/118 (44%), Gaps = 9/118 (7%)
Query: 314 LMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRA 373
L P R VGT Y++PE I G + VD ++ G+ L+ELL+ PF Q R
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV 234
Query: 374 TLFNVVGQPLRFPETP-QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430
V + L+FP Q +++ +L P +R A I ++ FE ++
Sbjct: 235 RTLTDV-RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPE----AINIIENAVFEDLD 287
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 46/155 (29%), Positives = 77/155 (49%), Gaps = 2/155 (1%)
Query: 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL 148
+ + ++ L LG G G V + + T A+K++++ + S + + + + E + L
Sbjct: 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL 70
Query: 149 GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLA 208
L HP + LY T +VME+ SGG L K N E +R ++L
Sbjct: 71 KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSG 128
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++Y H +V+RDLKPENVL+ + ++DF LS
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 163
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 7e-16
Identities = 36/133 (27%), Positives = 55/133 (41%), Gaps = 17/133 (12%)
Query: 326 FVGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFN-VVGQPL 383
G+ Y APE+I G G VD W+ G+ LY LL GT PF + TLF +
Sbjct: 175 SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD-HVPTLFKKICDGIF 233
Query: 384 RFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIP 443
P ++ L++ +L +P KR K +I++H +F + LP ++
Sbjct: 234 YTP--QYLNPSVISLLKHMLQVDPMKRATIK----DIREHEWF--------KQDLPKYLF 279
Query: 444 EPVDFSVFAGKDQ 456
D
Sbjct: 280 PEDPSYSSTMIDD 292
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 52/243 (21%), Positives = 87/243 (35%), Gaps = 36/243 (14%)
Query: 19 PSQKKPPNSEPSTVTMPGDIKHANSLTNHGHGSSNCSSRSDSLESSSAPVKPHTGGDVRW 78
+ PP P+ P A S +K + D
Sbjct: 5 SQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID--- 61
Query: 79 DAINMISLRGPPIGLSNFRLLKR-LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNK 137
++++ + LG G G V + + T FA+K++ A R
Sbjct: 62 ----------------DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-- 103
Query: 138 LLRAQTEREILG-LLDHPFLPTLYSYFET----DKFYCLVMEFCSGGNLHSLRQKQPNKY 192
E E+ P + + +E K +VME GG L S Q + ++
Sbjct: 104 ------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA 157
Query: 193 FTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGH---IMLSDFDLSLRCSVS 249
FTE A + A++YLH + I +RD+KPEN+L + + L+DF + +
Sbjct: 158 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217
Query: 250 PTL 252
+L
Sbjct: 218 NSL 220
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 40/155 (25%), Positives = 64/155 (41%), Gaps = 19/155 (12%)
Query: 324 MSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRAT---LFNVVG 380
+ T Y+APE++ E + + D W+ G+ +Y LL G PF A + +
Sbjct: 221 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280
Query: 381 Q-PLRFPETP--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSA 437
FP +VS + LIR LL EP +R+ TE HP W + +
Sbjct: 281 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT----ITEFMNHP------WIMQSTK 330
Query: 438 LPPHIPEPVDFSVFAGKDQASAAAEKKVVAAAEAA 472
+P P+ S +D+ K+ + +A A
Sbjct: 331 VPQT---PLHTSRVLKEDKERWEDVKEEMTSALAT 362
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-30
Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 10/157 (6%)
Query: 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI- 147
P + ++ L++ LG G G V L R T A+K++D ++EI
Sbjct: 4 PFVE--DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEIC 57
Query: 148 -LGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVL 206
+L+H + Y + L +E+CSGG L + + E A+ F +++
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLM 115
Query: 207 LALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ YLH +GI +RD+KPEN+L+ + ++ +SDF L+
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA 152
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 32/184 (17%), Positives = 64/184 (34%), Gaps = 16/184 (8%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYEL 359
SDFG + + GT Y+APE+++ H VD W+ GI L +
Sbjct: 147 SDFGLA---TVFRYNNRERLLNK--MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201
Query: 360 LHGTTPFKGQGN-RATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGAT 418
L G P+ + + + ++ L+ +LV+ P RI
Sbjct: 202 LAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP---- 257
Query: 419 EIKQHPFF-EGVNWALVRSALPP----HIPEPVDFSVFAGKDQASAAAEKKVVAAAEAAV 473
+IK+ ++ + + R + P + + D + + + + +
Sbjct: 258 DIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKE 317
Query: 474 DHKN 477
H +
Sbjct: 318 HHHH 321
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 43/151 (28%), Positives = 67/151 (44%), Gaps = 16/151 (10%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILG-LLDHPFLPT 158
+ LG G G V + + T FA+K++ A R E E+ P +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVR 75
Query: 159 LYSYFET----DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
+ +E K +VME GG L S Q + ++ FTE A + A++YLH
Sbjct: 76 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 215 LGIVYRDLKPENVLVRDEGH---IMLSDFDL 242
+ I +RD+KPEN+L + + L+DF
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 7e-17
Identities = 38/146 (26%), Positives = 58/146 (39%), Gaps = 20/146 (13%)
Query: 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRAT---LFNVVGQ-PLRFPET 388
A E GE + + D W+ G+ +Y LL G PF A + + FP
Sbjct: 166 FAKET-TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224
Query: 389 P--QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEPV 446
+VS + LIR LL EP +R+ TE HP W + + +P P+
Sbjct: 225 EWSEVSEEVKMLIRNLLKTEPTQRMT----ITEFMNHP------WIMQSTKVPQT---PL 271
Query: 447 DFSVFAGKDQASAAAEKKVVAAAEAA 472
S +D+ K+ + +A A
Sbjct: 272 HTSRVLKEDKERWEDVKEEMTSALAT 297
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 12/153 (7%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLLD 152
+ +K +G G+ G L+ + T A+K +++ + +REI L
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER------GAAIDENVQREIINHRSLR 74
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
HP + T ++ME+ SGG L+ F+ED ARFF ++L + Y
Sbjct: 75 HPNIVRFKEVILTPTHLAIIMEYASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYC 132
Query: 213 HMLGIVYRDLKPENVLV--RDEGHIMLSDFDLS 243
H + I +RDLK EN L+ + + DF S
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYS 165
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 34/140 (24%), Positives = 55/140 (39%), Gaps = 19/140 (13%)
Query: 325 SFVGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL 383
S VGT Y+APE++ + G D W+ G+ LY +L G PF+ + Q +
Sbjct: 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPRDYRKTIQRI 234
Query: 384 -----RFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSAL 438
P+ ++S LI + V +P RI+ EIK H +F L
Sbjct: 235 LSVKYSIPDDIRISPECCHLISRIFVADPATRISIP----EIKTHSWF--------LKNL 282
Query: 439 PPHIPEPVDFSVFAGKDQAS 458
P + + + +
Sbjct: 283 PADLMNESNTGSQFQEPEQP 302
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 46/198 (23%), Positives = 80/198 (40%), Gaps = 13/198 (6%)
Query: 55 SSRSDSLESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVE 114
S S P H A + + S +++ LG G GSVY
Sbjct: 4 SHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGI 63
Query: 115 LRGTNTYFAMKVMDKASLASRNKLLR-AQTEREI--LGLLDHPFLP---TLYSYFETDKF 168
N A+K ++K ++ +L + E+ L + F L +FE
Sbjct: 64 RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF-SGVIRLLDWFERPDS 122
Query: 169 YCLVMEFCSG-GNLHS-LRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPEN 226
+ L++E +L + ++ E+ AR F +VL A+ + H G+++RD+K EN
Sbjct: 123 FVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 179
Query: 227 VLV-RDEGHIMLSDFDLS 243
+L+ + G + L DF
Sbjct: 180 ILIDLNRGELKLIDFGSG 197
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 35/123 (28%), Positives = 51/123 (41%), Gaps = 15/123 (12%)
Query: 326 FVGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR 384
F GT Y PE IR HG + W+ GI LY+++ G PF+ ++ +
Sbjct: 208 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF 261
Query: 385 FPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN--WALVRSALPPHI 442
F +VS + LIR L P R ++ EI+ HP+ + V L
Sbjct: 262 FR--QRVSSECQHLIRWCLALRPSDRPTFE----EIQNHPWMQDVLLPQETAEIHLHSLS 315
Query: 443 PEP 445
P P
Sbjct: 316 PGP 318
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 37/251 (14%), Positives = 61/251 (24%), Gaps = 42/251 (16%)
Query: 35 PGDIKHANSLTNHGH-GSSNCSSRSDSLESSSAPVKPHTGGDVRWDAINMISLRGPPIGL 93
PGD+ S S S G + S G
Sbjct: 19 PGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQ----PFRVESELGERP-- 72
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-- 151
LG D + + T F + V N + + + E L LL
Sbjct: 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 132
Query: 152 -----------------------DHPFLPTLYSYFETDKF--YCLVMEFCS------GGN 180
+ + + G
Sbjct: 133 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 192
Query: 181 LHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240
L S K A +V+ L LH G+V+ L+P ++++ G + L+ F
Sbjct: 193 LLSHSSTH--KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF 250
Query: 241 DLSLRCSVSPT 251
+ +R
Sbjct: 251 EHLVRDGARVV 261
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 96.6 bits (240), Expect = 5e-22
Identities = 20/154 (12%), Positives = 38/154 (24%), Gaps = 37/154 (24%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG-----------HGSAVDW 349
+ F R + + PE+ + D
Sbjct: 248 TGFE----------HLVRDGARV-VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDA 296
Query: 350 WTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409
W G+ +Y + P + P+ R L+ G L
Sbjct: 297 WALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQP------VRALLEGFLRYPKED 350
Query: 410 RIAYKRGATEIKQHPFFEGVNWALVRSALPPHIP 443
R+ + + P +E +R+ L +P
Sbjct: 351 RL----LPLQAMETPEYEQ-----LRTELSAALP 375
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 52/153 (33%), Positives = 77/153 (50%), Gaps = 5/153 (3%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
IG + + + LG G G V L T A+K + + L + +R + E L L
Sbjct: 8 IG--PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKL 65
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
L HP + LY T +V+E+ GG L + K TED R F +++ A+E
Sbjct: 66 LRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIE 122
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
Y H IV+RDLKPEN+L+ D ++ ++DF LS
Sbjct: 123 YCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS 155
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 7/100 (7%)
Query: 328 GTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP 386
G+ Y APE+I G+ G VD W+ GI LY +L G PF + V P
Sbjct: 169 GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP 228
Query: 387 ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
+S A+ LIR ++V +P +RI + EI++ P+F
Sbjct: 229 --DFLSPGAQSLIRRMIVADPMQRITIQ----EIRRDPWF 262
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 65/414 (15%), Positives = 121/414 (29%), Gaps = 126/414 (30%)
Query: 82 NMISLRGPPIGLSNFRLLKRLGYG--DIGSVYLVELRGTNTYFAMKVMDKASLASRNKLL 139
M S + LL +G G D+ +V L + T Y ++ ++ + S +
Sbjct: 16 GMSSFLPEG---GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA-CSNEMVT 71
Query: 140 RAQTEREILGLLDHPFLPTLY-SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAA 198
Q E + L +HP + ++ ++ + +V F + G+ L E A
Sbjct: 72 FLQGELHVSKLFNHPNIVPYRATFIADNELW-VVTSFMAYGSAKDLICTHFMDGMNELAI 130
Query: 199 RFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258
+ VL AL+Y+H +G V+R +K ++L+ +G + LS + +++
Sbjct: 131 AYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGL------RSNLSMISHGQ- 183
Query: 259 SVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGAL----PEL 314
++ DF L PE+
Sbjct: 184 -------------------------------------RQRVVHDFPKYSVKVLPWLSPEV 206
Query: 315 MAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPF-------- 366
+ + +G+ + D ++ GI EL +G PF
Sbjct: 207 LQQ---------------------NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 245
Query: 367 ------------------------------------KGQGNRATLFNVVGQPLRFPETPQ 390
+T G P
Sbjct: 246 LLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRT 305
Query: 391 VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE 444
S + L + P R A+ + H FF+ + ALP +
Sbjct: 306 FSPHFHHFVEQCLQRNPDAR----PSASTLLNHSFFKQIK-RRASEALPELLRP 354
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 3e-28
Identities = 64/390 (16%), Positives = 114/390 (29%), Gaps = 92/390 (23%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL---- 151
+ ++++LG+G +V+L + AMKV+ K++ A E +L +
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTE---TALDEIRLLKSVRNSD 94
Query: 152 -DHP---FLPTLYSYFETD----KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFAS 203
+ P + L F+ C+V E G +L K + +
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 204 EVLLALEYLHM-LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNN 262
+VL L+YLH I++ D+KPEN+L+ + + S S S
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 263 GSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322
++K + +D G A +
Sbjct: 214 P--------------ATAGNFLVNPLEPKNAEKLKVKIADLG----------NACWVHKH 249
Query: 323 SMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGN----------- 371
+ T +Y + E++ G G+ + D W+ +EL G F+
Sbjct: 250 FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIA 309
Query: 372 -------------------RATLFNVVGQPLRFPETPQVSFVAR---------------- 396
F G +
Sbjct: 310 LIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFT 369
Query: 397 DLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
D + +L P KR A E +HP+
Sbjct: 370 DFLLPMLELIPEKRAT----AAECLRHPWL 395
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 59/300 (19%), Positives = 99/300 (33%), Gaps = 60/300 (20%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
S+ + LG G G V R T MK + + ++ L+ E +++
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK---EVKVMRC 63
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
L+HP + DK + E+ GG L + + + + FA ++ +
Sbjct: 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMA 122
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGI 270
YLH + I++RDL N LVR+ +++++DF L+ R L+
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENKNVVVADFGLA-R------LMVDEKTQPEGLRSLKKPD 175
Query: 271 LNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330
Y V G P MA
Sbjct: 176 RKKRYTVVGN-------------------------------PYWMA-------------- 190
Query: 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQ 390
PE+I G + VD ++FGI L E++ R F + + P
Sbjct: 191 ----PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPP 246
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-27
Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 13/161 (8%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQT-EREI--LG 149
+ +RL LG G G+V+ A+KV+ + + + L + T E+ L
Sbjct: 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89
Query: 150 LLD----HPFLPTLYSYFETDKFYCLVMEF-CSGGNLHS-LRQKQPNKYFTEDAARFFAS 203
+ HP + L +FET + + LV+E +L + +K P E +R F
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFG 146
Query: 204 EVLLALEYLHMLGIVYRDLKPENVLV-RDEGHIMLSDFDLS 243
+V+ A+++ H G+V+RD+K EN+L+ G L DF
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 33/125 (26%), Positives = 45/125 (36%), Gaps = 16/125 (12%)
Query: 326 FVGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR 384
F GT Y PE I H W+ GI LY+++ G PF+ ++ L
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELH 251
Query: 385 FPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE 444
FP VS LIR L +P R + + EI P+ L P
Sbjct: 252 FP--AHVSPDCCALIRRCLAPKPSSRPSLE----EILLDPWM---QTPAEDVPLNPSKGG 302
Query: 445 PVDFS 449
P +
Sbjct: 303 PAPLA 307
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 48/146 (32%), Positives = 76/146 (52%), Gaps = 6/146 (4%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
+ ++ LG G G VY + + T A KV++ S +L E EIL DHP+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCDHPY 77
Query: 156 LPTLY-SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
+ L +Y+ K + +++EFC GG + ++ + TE + ++L AL +LH
Sbjct: 78 IVKLLGAYYHDGKLW-IMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQMLEALNFLHS 135
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDF 240
I++RDLK NVL+ EG I L+DF
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADF 161
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 36/160 (22%), Positives = 57/160 (35%), Gaps = 42/160 (26%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII-----RGEGHGSAVDWWTFGIFL 356
DFG V T + SF+GT ++APE++ + + D W+ GI L
Sbjct: 160 DFG--VSAKN-----LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 212
Query: 357 YELLHGTTPFKGQGNRATLFNVVGQPLR------------FPETPQVSFVARDLIRGLLV 404
E+ P + P+R + S RD ++ L
Sbjct: 213 IEMAQIEPP---------HHEL--NPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALD 261
Query: 405 KEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE 444
K P R + A ++ +HPF V+ AL + E
Sbjct: 262 KNPETRPS----AAQLLEHPF---VSSITSNKALRELVAE 294
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 63/325 (19%), Positives = 108/325 (33%), Gaps = 86/325 (26%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE--IL 148
I + + +G G G V + R + A+K + ++ R E L
Sbjct: 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDV--AIKQI-------ESESERKAFIVELRQL 55
Query: 149 GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLL 207
++HP + LY CLVME+ GG+L++ L +P Y+T A + +
Sbjct: 56 SRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 208 ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGG 267
+ YLH ++P+ ++ RD +K
Sbjct: 114 GVAYLH-------SMQPKALIHRD---------------------LKP------------ 133
Query: 268 GGILNDEYAVHGCMQPSTFFPRILPSKKNRKSK-SDFGPCVGGALPELMAEPTNVRSMSF 326
P +L K DFG A +
Sbjct: 134 --------------------PNLLLVAGGTVLKICDFG----------TACDIQTHMTNN 163
Query: 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRA-TLFNVVGQPLRF 385
G+ ++APE+ G + D +++GI L+E++ PF G A + V R
Sbjct: 164 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP 223
Query: 386 PETPQVSFVARDLIRGLLVKEPHKR 410
P + L+ K+P +R
Sbjct: 224 PLIKNLPKPIESLMTRCWSKDPSQR 248
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 44/181 (24%), Positives = 82/181 (45%), Gaps = 12/181 (6%)
Query: 79 DAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKL 138
+ + I G P + +++G G G+VY T A++ M+ L + K
Sbjct: 7 EKLRSIVSVGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKK 61
Query: 139 LRAQTEREILGLLDHPFLPTLY-SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDA 197
E ++ +P + SY D+ + +VME+ +GG+L + + E
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELW-VVMEYLAGGSLTDVVTETC---MDEGQ 117
Query: 198 ARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSS 257
E L ALE+LH +++RD+K +N+L+ +G + L+DF ++P K S+
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRST 175
Query: 258 V 258
+
Sbjct: 176 M 176
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 9/160 (5%)
Query: 82 NMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRA 141
M +L+ P L F L+++G G G V+ T A+K++D + +
Sbjct: 12 GMQNLKADPEEL--FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-- 67
Query: 142 QTEREILGLLDHPFLPTLY-SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARF 200
Q E +L D P++ Y SY + K + ++ME+ GG+ L + P E
Sbjct: 68 QQEITVLSQCDSPYVTKYYGSYLKDTKLW-IIMEYLGGGSALDLLEPGP---LDETQIAT 123
Query: 201 FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240
E+L L+YLH ++RD+K NVL+ + G + L+DF
Sbjct: 124 ILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADF 163
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 41/147 (27%), Positives = 58/147 (39%), Gaps = 22/147 (14%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG V G L + T ++ +FVGT ++APE+I+ + S D W+ GI EL
Sbjct: 162 DFG--VAGQLTD-----TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAR 214
Query: 362 GTTPFKGQGNRATLFNVVGQPLRFPETPQV----SFVARDLIRGLLVKEPHKRIAYKRGA 417
G P LF + P + S ++ + L KEP R A
Sbjct: 215 GEPPHSELHPMKVLFLIPKNN-----PPTLEGNYSKPLKEFVEACLNKEPSFRPT----A 265
Query: 418 TEIKQHPFFEGVNWALVRSALPPHIPE 444
E+ +H F A S L I
Sbjct: 266 KELLKHKFIL--RNAKKTSYLTELIDR 290
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 47/225 (20%), Positives = 78/225 (34%), Gaps = 32/225 (14%)
Query: 24 PPNSEPSTVTMPGDIKHANSLTNHGHGSSNCSSRSDSLESSSAPVKPHTGGDVRWDAINM 83
+ + ++ + S G + L PV +V W
Sbjct: 5 VSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHW----- 59
Query: 84 ISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQT 143
R+G G G V+ ++ + T A+K + L
Sbjct: 60 ------------MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----------LEVFR 97
Query: 144 EREI--LGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFF 201
E+ L P + LY + + ME GG+L L ++ ED A ++
Sbjct: 98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYY 155
Query: 202 ASEVLLALEYLHMLGIVYRDLKPENVLVRDEG-HIMLSDFDLSLR 245
+ L LEYLH I++ D+K +NVL+ +G L DF +L
Sbjct: 156 LGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC 200
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 5e-19
Identities = 33/162 (20%), Positives = 60/162 (37%), Gaps = 8/162 (4%)
Query: 290 ILPSKKNRKSK-SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVD 348
+L S ++ DFG L + + GT ++APE++ G+ + VD
Sbjct: 181 VLLSSDGSRAALCDFG--HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVD 238
Query: 349 WWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETP-QVSFVARDLIRGLLVKEP 407
W+ + +L+G P+ + +P E P + + I+ L KEP
Sbjct: 239 IWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEP 298
Query: 408 HKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEPVDFS 449
R + A E+++ ++S EP S
Sbjct: 299 VHRAS----AMELRRKVGKALQEVGGLKSPWKGEYKEPRGNS 336
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 37/158 (23%), Positives = 70/158 (44%), Gaps = 10/158 (6%)
Query: 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILG 149
I ++ L + +G G V A+K ++ + + E + +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAMS 68
Query: 150 LLDHPFLPTLY-SYFETDKFYCLVMEFCSGGNLHSL------RQKQPNKYFTEDAARFFA 202
HP + + Y S+ D+ + LVM+ SGG++ + + + + E
Sbjct: 69 QCHHPNIVSYYTSFVVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 203 SEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240
EVL LEYLH G ++RD+K N+L+ ++G + ++DF
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 37/135 (27%), Positives = 53/135 (39%), Gaps = 17/135 (12%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII-RGEGHGSAVDWWTFGIFLYELL 360
DFG V L N +FVGT ++APE++ + G+ D W+FGI EL
Sbjct: 164 DFG--VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221
Query: 361 HGTTPF-KGQGNRATLFNVV--------GQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411
G P+ K + L + + R +I L K+P KR
Sbjct: 222 TGAAPYHKYPPMKV-LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280
Query: 412 AYKRGATEIKQHPFF 426
A E+ +H FF
Sbjct: 281 T----AAELLRHKFF 291
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-26
Identities = 73/322 (22%), Positives = 113/322 (35%), Gaps = 69/322 (21%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRA-QTEREILG 149
I + L + +G G G VY G A+K ++ + + E ++
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEV--AVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 150 LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLAL 209
+L HP + L + CLVMEF GG L+ + + D +A ++ +
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGM 118
Query: 210 EYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGG 269
YLH D ++ RD +KSS N
Sbjct: 119 NYLH-------DEAIVPIIHRD---------------------LKSS-----N------- 138
Query: 270 ILNDEYAVHGCMQPSTFFPRILPSKKNRKSK-SDFGPCVGGALPELMAEPTNVRSMSFVG 328
IL + +G + N+ K +DFG L E MS G
Sbjct: 139 ILILQKVENGDLS-------------NKILKITDFG---------LAREWHRTTKMSAAG 176
Query: 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPET 388
+ ++APE+IR D W++G+ L+ELL G PF+G A + V L P
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236
Query: 389 PQVSFVARDLIRGLLVKEPHKR 410
L+ +PH R
Sbjct: 237 STCPEPFAKLMEDCWNPDPHSR 258
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 16/216 (7%)
Query: 44 LTNHGHGSSNCSSRSDSLESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLG 103
+ +H H SS +++L S V T + A+ M+ +G P L ++G
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSGVV---THEQFK-AALRMVVDQGDPRLL--LDSYVKIG 54
Query: 104 YGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLY-SY 162
G G V L + + A+K+MD L + + E I+ H + +Y SY
Sbjct: 55 EGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 163 FETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDL 222
++ + ++MEF GG L + + E+ VL AL YLH G+++RD+
Sbjct: 112 LVGEELW-VLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHAQGVIHRDI 167
Query: 223 KPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258
K +++L+ +G + LSDF +S + K S+
Sbjct: 168 KSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSL 201
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 29/197 (14%), Positives = 57/197 (28%), Gaps = 33/197 (16%)
Query: 80 AINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLL 139
+ S G LG D + + T F + V N +
Sbjct: 66 PFRVESELGERPRT--LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 123
Query: 140 RAQTEREILGLL----------------------DHPFLPTLYSYFETDKFYCLVMEF-- 175
+ + E L LL P + ++ ++ F
Sbjct: 124 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 183
Query: 176 -----CSGGNLHSL--RQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVL 228
+ + +K A +V+ L LH G+V+ L+P +++
Sbjct: 184 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 243
Query: 229 VRDEGHIMLSDFDLSLR 245
+ G + L+ F+ +R
Sbjct: 244 LDQRGGVFLTGFEHLVR 260
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 27/176 (15%), Positives = 45/176 (25%), Gaps = 24/176 (13%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHG-----SAVDWWTFGIF 355
+ F V E A ++ H A D WT G+
Sbjct: 253 TGFEHLV------RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306
Query: 356 LYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKR 415
+Y + P + P+ R L+ G L R+
Sbjct: 307 IYWIWCADLPNTDDAALGGSEWIFRSCKNIPQP------VRALLEGFLRYPKEDRL---- 356
Query: 416 GATEIKQHPFFEGVNWAL---VRSALPPHIPEPVDFSVFAGKDQASAAAEKKVVAA 468
+ + P +E + L + P + +G Q A + V A
Sbjct: 357 LPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGAAEAVTA 412
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 10/178 (5%)
Query: 64 SSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFA 123
S V+ + ++ SL P + F +L++LG G GSVY + T A
Sbjct: 1 SLETVQLRNPPRRQLKKLDEDSLTKQPEEV--FDVLEKLGEGSYGSVYKAIHKETGQIVA 58
Query: 124 MKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLY-SYFETDKFYCLVMEFCSGGNLH 182
+K + + S + + E I+ D P + Y SYF+ + +VME+C G++
Sbjct: 59 IKQVP---VESDLQEI--IKEISIMQQCDSPHVVKYYGSYFKNTDLW-IVMEYCGAGSVS 112
Query: 183 SLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240
+ + + TED L LEYLH + ++RD+K N+L+ EGH L+DF
Sbjct: 113 DIIRLRNKT-LTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADF 169
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 39/128 (30%), Positives = 57/128 (44%), Gaps = 16/128 (12%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG V G L T + + +GT ++APE+I+ G+ D W+ GI E+
Sbjct: 168 DFG--VAGQL-----TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE 220
Query: 362 GTTPFKGQGNRATLFNVVGQP---LRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGAT 418
G P+ +F + P R PE S D ++ LVK P +R AT
Sbjct: 221 GKPPYADIHPMRAIFMIPTNPPPTFRKPE--LWSDNFTDFVKQCLVKSPEQRAT----AT 274
Query: 419 EIKQHPFF 426
++ QHPF
Sbjct: 275 QLLQHPFV 282
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 37/173 (21%), Positives = 70/173 (40%), Gaps = 18/173 (10%)
Query: 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI-- 147
+ + L +G G GSV + + + A+K + ++ ++ + Q ++
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR----STVDEKEQKQLLMDLDV 73
Query: 148 -LGLLDHPFLPTLY-SYFETDKFYCLVMEFCSGGNLHSLRQ--KQPNKYFTEDAARFFAS 203
+ D P++ Y + F + + ME S + + E+
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCW-ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITL 132
Query: 204 EVLLALEYLH-MLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKS 255
+ AL +L L I++RD+KP N+L+ G+I L DF +S LV S
Sbjct: 133 ATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF------GISGQLVDS 179
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 49/217 (22%), Positives = 81/217 (37%), Gaps = 14/217 (6%)
Query: 45 TNHGHGSSNCSSRSDSLESSSAPVKPHTG--GDVRWDAINMISLRGPPIGLSNFRLLKRL 102
+H H + + + + P G G ++ + + + P L F L+ +
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKL--FSDLREI 62
Query: 103 GYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLY-S 161
G+G G+VY + A+K M + S K E L L HP
Sbjct: 63 GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 122
Query: 162 YFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRD 221
Y + LVME+C G L + K E L L YLH +++RD
Sbjct: 123 YLREHTAW-LVMEYCLGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 179
Query: 222 LKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258
+K N+L+ + G + L DF + + ++S
Sbjct: 180 VKAGNILLSEPGLVKLGDF------GSASIMAPANSF 210
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 30/132 (22%), Positives = 47/132 (35%), Gaps = 32/132 (24%)
Query: 325 SFVGTHEYLAPEIIRGE---GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ 381
SFVGT ++APE+I + VD W+ GI EL P LFN+
Sbjct: 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---------LFNM--N 257
Query: 382 PLR--F-------P--ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430
+ + P ++ S R+ + L K P R + + +H F
Sbjct: 258 AMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT----SEVLLKHRFVLR-- 311
Query: 431 WALVRSALPPHI 442
+ + I
Sbjct: 312 -ERPPTVIMDLI 322
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 41/190 (21%), Positives = 74/190 (38%), Gaps = 18/190 (9%)
Query: 73 GGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASL 132
G + I + +++ L +G G G V+ + R T A+K M
Sbjct: 4 GSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR---- 59
Query: 133 ASRNKLLRAQTEREI---LGLLDHPFLPTLY-SYFETDKFYCLVMEFCSGGNLHSLRQKQ 188
S NK + ++ L D P++ + ++ + + ME L+++
Sbjct: 60 RSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF-IAMELMGTC-AEKLKKRM 117
Query: 189 PNKYFTEDAARFFASEVLLALEYLH-MLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247
E ++ AL YL G+++RD+KP N+L+ + G I L DF
Sbjct: 118 QGP-IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDF------G 170
Query: 248 VSPTLVKSSS 257
+S LV +
Sbjct: 171 ISGRLVDDKA 180
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 34/132 (25%), Positives = 50/132 (37%), Gaps = 19/132 (14%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII-----RGEGHGSAVDWWTFGIFL 356
DFG + G L + A+ G Y+APE I + D W+ GI L
Sbjct: 168 DFG--ISGRLVDDKAKDR------SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISL 219
Query: 357 YELLHGTTPFKGQGNR-ATLFNVV-GQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK 414
EL G P+K L V+ +P P S + ++ L K+ KR Y
Sbjct: 220 VELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYN 279
Query: 415 RGATEIKQHPFF 426
++ +H F
Sbjct: 280 ----KLLEHSFI 287
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 49/181 (27%), Positives = 81/181 (44%), Gaps = 13/181 (7%)
Query: 77 RWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMD-KASLASR 135
R +A + + +F + LG G+ G V+ V + + A K++ + A R
Sbjct: 16 RLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR 75
Query: 136 NKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTE 195
N+++R E ++L + P++ Y F +D + ME GG+L + +K E
Sbjct: 76 NQIIR---ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPE 130
Query: 196 DAARFFASEVLLALEYLH-MLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254
+ V+ L YL I++RD+KP N+LV G I L DF VS L+
Sbjct: 131 QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF------GVSGQLID 184
Query: 255 S 255
S
Sbjct: 185 S 185
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 48/187 (25%), Positives = 77/187 (41%), Gaps = 26/187 (13%)
Query: 70 PHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDK 129
D I++ +LR P F L++ +G G G VY T A+KVMD
Sbjct: 3 ASDSPARSLDEIDLSALRDP---AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD- 58
Query: 130 ASLASRNKLLRAQTEREILG-------LLDHPFLPTLY-SYFETDKFYC-----LVMEFC 176
+ E EI H + T Y ++ + + LVMEFC
Sbjct: 59 ---------VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC 109
Query: 177 SGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIM 236
G++ L + E+ + E+L L +LH +++RD+K +NVL+ + +
Sbjct: 110 GAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVK 169
Query: 237 LSDFDLS 243
L DF +S
Sbjct: 170 LVDFGVS 176
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 36/131 (27%), Positives = 55/131 (41%), Gaps = 18/131 (13%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGE-----GHGSAVDWWTFGIFL 356
DFG V L + T R +F+GT ++APE+I + + D W+ GI
Sbjct: 172 DFG--VSAQL-----DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA 224
Query: 357 YELLHGTTP-FKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKR 415
E+ G P RA LF + P ++ + S + I LVK +R A
Sbjct: 225 IEMAEGAPPLCDMHPMRA-LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPA--- 280
Query: 416 GATEIKQHPFF 426
++ +HPF
Sbjct: 281 -TEQLMKHPFI 290
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 39/171 (22%), Positives = 68/171 (39%), Gaps = 15/171 (8%)
Query: 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI-- 147
+ + + LG G G V + + A+K + A+ N + + ++
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR----ATVNSQEQKRLLMDLDI 58
Query: 148 -LGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQ-KQPNKYFTEDAARFFASEV 205
+ +D PF T Y + + ME +Q + ED A +
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 206 LLALEYLHM-LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKS 255
+ ALE+LH L +++RD+KP NVL+ G + + DF +S LV
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDF------GISGYLVDD 163
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 9e-12
Identities = 37/131 (28%), Positives = 50/131 (38%), Gaps = 19/131 (14%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSA----VDWWTFGIFLY 357
DFG + G L + +A+ G Y+APE I E + D W+ GI +
Sbjct: 153 DFG--ISGYLVDDVAKDI------DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMI 204
Query: 358 ELLHGTTPFKGQGN-RATLFNVV-GQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKR 415
EL P+ G L VV + P + S D L K +R Y
Sbjct: 205 ELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA-DKFSAEFVDFTSQCLKKNSKERPTYP- 262
Query: 416 GATEIKQHPFF 426
E+ QHPFF
Sbjct: 263 ---ELMQHPFF 270
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 41/156 (26%), Positives = 65/156 (41%), Gaps = 5/156 (3%)
Query: 102 LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYS 161
LG G G VY A+K + + L E + L H +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL---HEEIALHKHLKHKNIVQYLG 86
Query: 162 YFETDKFYCLVMEFCSGGNLHSLRQKQPNKY-FTEDAARFFASEVLLALEYLHMLGIVYR 220
F + F + ME GG+L +L + + E F+ ++L L+YLH IV+R
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 221 DLKPENVLV-RDEGHIMLSDFDLSLRCSVSPTLVKS 255
D+K +NVL+ G + +SDF S R + ++
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 9e-13
Identities = 42/141 (29%), Positives = 60/141 (42%), Gaps = 17/141 (12%)
Query: 290 ILPSKKNRKSK-SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRG--EGHGSA 346
+L + + K SDFG L + + +F GT +Y+APEII G+G A
Sbjct: 153 VLINTYSGVLKISDFG--TSKRLAGINP-----CTETFTGTLQYMAPEIIDKGPRGYGKA 205
Query: 347 VDWWTFGIFLYELLHGTTPFKGQGNR-ATLFNVVGQPLRFPETP-QVSFVARDLIRGLLV 404
D W+ G + E+ G PF G A +F VG PE P +S A+ I
Sbjct: 206 ADIWSLGCTIIEMATGKPPFYELGEPQAAMFK-VGMFKVHPEIPESMSAEAKAFILKCFE 264
Query: 405 KEPHKRIAYKRGATEIKQHPF 425
+P KR A ++ F
Sbjct: 265 PDPDKRAC----ANDLLVDEF 281
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 8e-23
Identities = 39/169 (23%), Positives = 72/169 (42%), Gaps = 12/169 (7%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP- 154
+ +G G +VY T A + L ++++ R + E E+L L HP
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPN 86
Query: 155 ---FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEY 211
F + S + K LV E + G L + ++ K R + ++L L++
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQF 144
Query: 212 LH--MLGIVYRDLKPENVLV-RDEGHIMLSDFDLS--LRCSVSPTLVKS 255
LH I++RDLK +N+ + G + + D L+ R S + ++ +
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGT 193
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 28/141 (19%), Positives = 54/141 (38%), Gaps = 20/141 (14%)
Query: 290 ILPSKKNRKSK-SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVD 348
I + K D G + + +GT E++APE+ E + +VD
Sbjct: 162 IFITGPTGSVKIGDLGLA---------TLKRASFAKAVIGTPEFMAPEMYE-EKYDESVD 211
Query: 349 WWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---PLRFPETPQVSFVARDLIRGLLVK 405
+ FG+ + E+ P+ N A ++ V P F + +++I G + +
Sbjct: 212 VYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV--AIPEVKEIIEGCIRQ 269
Query: 406 EPHKRIAYKRGATEIKQHPFF 426
+R + ++ H FF
Sbjct: 270 NKDERYS----IKDLLNHAFF 286
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 4e-21
Identities = 48/194 (24%), Positives = 77/194 (39%), Gaps = 27/194 (13%)
Query: 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI- 147
P + L N +LL+ +G G G+VY L A+KV A+ + E+ I
Sbjct: 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDER--PVAVKVFSFANRQN------FINEKNIY 59
Query: 148 -LGLLDHPFLPTLYSY-----FETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFF 201
+ L++H + + Y LVME+ G+L ++
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRL 116
Query: 202 ASEVLLALEYLHM---------LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252
A V L YLH I +RDL NVLV+++G ++SDF LS+R + + +
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 253 VKSSSVSVNNGSGG 266
+ G
Sbjct: 177 RPGEEDNAAISEVG 190
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 7e-21
Identities = 35/164 (21%), Positives = 65/164 (39%), Gaps = 14/164 (8%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRA----QTERE 146
+ + K++G G G V+ L + A+K + +++ Q E
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 147 ILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVL 206
I+ L+HP + LY +VMEF G+L+ + + ++
Sbjct: 76 IMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIA 132
Query: 207 LALEYLHMLG--IVYRDLKPENVLVRDEG-----HIMLSDFDLS 243
L +EY+ IV+RDL+ N+ ++ ++DF LS
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 26/115 (22%), Positives = 47/115 (40%), Gaps = 16/115 (13%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG--HGSAVDWWTFGIFLYE 358
+DFG +++ + +G +++APE I E + D ++F + LY
Sbjct: 171 ADFG----------LSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYT 220
Query: 359 LLHGTTPFKGQGNR--ATLFNVVGQPLRFPETPQ-VSFVARDLIRGLLVKEPHKR 410
+L G PF + + + LR P P+ R++I +P KR
Sbjct: 221 ILTGEGPFDEYSYGKIKFINMIREEGLR-PTIPEDCPPRLRNVIELCWSGDPKKR 274
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 70/393 (17%), Positives = 124/393 (31%), Gaps = 130/393 (33%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNK---LLRAQTEREILGLL- 151
F +++++G G G V L + Y+A+KV+ RN A+ E +IL +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-------RNIKKYTRSAKIEADILKKIQ 89
Query: 152 -----DHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVL 206
++ + + F CL+ E G +L+ + + F + + + E+L
Sbjct: 90 NDDINNNNIV-KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 207 LALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGG 266
AL YL + + + DLKPEN+L+ D + + ++ S +
Sbjct: 148 KALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI------ 201
Query: 267 GGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326
+++ DFG +F
Sbjct: 202 ----------------------KLI----------DFG------------------CATF 211
Query: 327 VGTHEYL--------APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATL--- 375
+ APE+I G + D W+FG L EL G+ F+ + L
Sbjct: 212 KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMM 271
Query: 376 -----------------------FNVVGQPLRFPET--------------PQVSFVAR-- 396
N L +PE P +
Sbjct: 272 ESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331
Query: 397 --DLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427
D + +L +P R + E+ +H F E
Sbjct: 332 FCDFLYSILQIDPTLRPS----PAELLKHKFLE 360
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 6/156 (3%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
I + + +++G G G+V+ E G++ A+K++ + ++ E I+
Sbjct: 34 IPWCDLNIKEKIGAGSFGTVHRAEWHGSDV--AVKILMEQDF-HAERVNEFLREVAIMKR 90
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLAL 209
L HP + +V E+ S G+L+ L + + E A +V +
Sbjct: 91 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 210 EYLHMLG--IVYRDLKPENVLVRDEGHIMLSDFDLS 243
YLH IV+R+LK N+LV + + + DF LS
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 32/110 (29%), Positives = 47/110 (42%), Gaps = 7/110 (6%)
Query: 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL 360
DFG L L A T + S S GT E++APE++R E D ++FG+ L+EL
Sbjct: 181 CDFG------LSRLKAS-TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233
Query: 361 HGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410
P+ + V + R ++ +I G EP KR
Sbjct: 234 TLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKR 283
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 27/145 (18%), Positives = 50/145 (34%), Gaps = 4/145 (2%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
+RLL G + + A+ +D + + L + L +D P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML 215
+ + T +V E+ GG+L + P+ A R + A + H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPS---PVGAIRA-MQSLAAAADAAHRA 148
Query: 216 GIVYRDLKPENVLVRDEGHIMLSDF 240
G+ P V V +G ++L+
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYP 173
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 14/91 (15%), Positives = 21/91 (23%), Gaps = 12/91 (13%)
Query: 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVVGQPL 383
+ + D G LY LL P G R+ L
Sbjct: 170 LAYPATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
Query: 384 RFPET--PQVSFVARDLIRGLLVKEPHKRIA 412
P + F + + + R A
Sbjct: 223 IEPADIDRDIPFQISAVAARSVQGDGGIRSA 253
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-20
Identities = 28/160 (17%), Positives = 58/160 (36%), Gaps = 11/160 (6%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGT--NTYFAMKVMDKASLASRNKLLRAQTEREIL 148
I L +L G ++ +G +KV+ ++R K E L
Sbjct: 7 IDFKQLNFLTKLNENHSGELW----KGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPRL 61
Query: 149 GLLDHPFLPTLY--SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVL 206
+ HP + + L+ + G+L+++ + N + A FA ++
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMA 121
Query: 207 LALEYLHMLG--IVYRDLKPENVLVRDEGHIMLSDFDLSL 244
+ +LH L I L +V++ ++ +S D+
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 5e-11
Identities = 22/91 (24%), Positives = 41/91 (45%), Gaps = 3/91 (3%)
Query: 323 SMSFVGTHEYLAPEIIRGEGHGS---AVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV 379
S + ++APE ++ + + + D W+F + L+EL+ PF N V
Sbjct: 165 SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA 224
Query: 380 GQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410
+ LR P +S L++ + ++P KR
Sbjct: 225 LEGLRPTIPPGISPHVSKLMKICMNEDPAKR 255
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 3e-20
Identities = 37/151 (24%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 96 FRLLKRLGYGDIGSVYL-VELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+ + + +G +G +YL ++ +K + + A ER+ L + HP
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHP 139
Query: 155 FLPTLYSYFETDKFYC-----LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLAL 209
+ ++++ E + +VME+ G +L + ++ A + E+L AL
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPAL 195
Query: 210 EYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240
YLH +G+VY DLKPEN+++ +E + L D
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEEQ-LKLIDL 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 20/94 (21%), Positives = 31/94 (32%), Gaps = 13/94 (13%)
Query: 321 VRSM----SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLF 376
V + GT + APEI+R G A D +T G L L G+ +
Sbjct: 228 VSRINSFGYLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNGR----YVD 282
Query: 377 NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410
+ L+R + +P +R
Sbjct: 283 GLPEDDPVLKTYDSY----GRLLRRAIDPDPRQR 312
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 10/177 (5%)
Query: 69 KPHTGGDVRWDAINMISLRGPPIG--LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKV 126
H + +M G +RL + +G G +G VY E A+K+
Sbjct: 7 HHHHSSGLVPRGSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKL 66
Query: 127 MDKASLASRNKLLRAQTERE--ILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS- 183
M +L+ + + R + +RE G L P + ++ + E D + M +G +L +
Sbjct: 67 M-SETLS-SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAM 124
Query: 184 LRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240
LR++ P A ++ AL+ H G +RD+KPEN+LV + L DF
Sbjct: 125 LRRQGP---LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDF 178
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 6e-07
Identities = 26/111 (23%), Positives = 42/111 (37%), Gaps = 9/111 (8%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG + + + + VGT Y+APE D + LYE L
Sbjct: 177 DFG------IASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLT 230
Query: 362 GTTPFKGQGNRATLFNVVGQPLRFPET--PQVSFVARDLIRGLLVKEPHKR 410
G+ P++G + + + Q + P T P + +I + K P R
Sbjct: 231 GSPPYQGD-QLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 37/174 (21%), Positives = 70/174 (40%), Gaps = 6/174 (3%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
I + + +G G G VY G A++++D + ++L + E
Sbjct: 30 IPFEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERD-NEDQLKAFKREVMAYRQ 85
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
H + + ++ C G L+S+ + + R A E++ +
Sbjct: 86 TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGMG 144
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGS 264
YLH GI+++DLK +NV D G ++++DF L V + + + NG
Sbjct: 145 YLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGW 197
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 28/127 (22%), Positives = 43/127 (33%), Gaps = 27/127 (21%)
Query: 301 SDFG------PCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGS--------- 345
+DFG G + + G +LAPEIIR +
Sbjct: 171 TDFGLFSISGVLQAGRREDKLRIQN--------GWLCHLAPEIIRQLSPDTEEDKLPFSK 222
Query: 346 AVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSF--VARDLIRGLL 403
D + G YEL PFK Q A ++ +G ++ P Q+ D++
Sbjct: 223 HSDVFALGTIWYELHAREWPFKTQPAEAIIW-QMGTGMK-PNLSQIGMGKEISDILLFCW 280
Query: 404 VKEPHKR 410
E +R
Sbjct: 281 AFEQEER 287
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 42/165 (25%), Positives = 79/165 (47%), Gaps = 7/165 (4%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLAS-RNKLLRAQTEREILGLLDHP 154
++++ +LG G + +VYL E N A+K + L R + E L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALEYLH 213
+ ++ E D Y LVME+ G L + P + D A F +++L +++ H
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH 128
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258
+ IV+RD+KP+N+L+ + + DF ++ + +L +++ V
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIA-KALSETSLTQTNHV 172
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 26/112 (23%), Positives = 48/112 (42%), Gaps = 9/112 (8%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG + + ++E + ++ +GT +Y +PE +GE D ++ GI LYE+L
Sbjct: 154 DFG------IAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLV 207
Query: 362 GTTPFKGQGNRATLFNVVGQPLRFPET---PQVSFVARDLIRGLLVKEPHKR 410
G PF G+ + + + T + ++I K+ R
Sbjct: 208 GEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 5e-20
Identities = 84/477 (17%), Positives = 137/477 (28%), Gaps = 137/477 (28%)
Query: 47 HGHGSSNCSSRSDSLESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGD 106
+ S ++ S + +M + + +G G
Sbjct: 6 AAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGS 65
Query: 107 IGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLLDHP--------FL 156
G V + A+K K + + + REI L L+H +
Sbjct: 66 YGHVCEAYDKLEKRVVAIK---KILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122
Query: 157 PTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALEYLHML 215
P F D+ Y +V+E + R TE + +L+ ++Y+H
Sbjct: 123 PKDVEKF--DELY-VVLEIA-DSDFKKLFRTPVY---LTELHIKTLLYNLLVGVKYVHSA 175
Query: 216 GIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEY 275
GI++RDLKP N LV + + + DF L+
Sbjct: 176 GILHRDLKPANCLVNQDCSVKVCDFGLA-------------------------------- 203
Query: 276 AVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM--SFVGTHEYL 333
R + +N S+ P N++ V T Y
Sbjct: 204 -------------RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYR 250
Query: 334 APEIIRGEGH-GSAVDWWTFGIFLYELL-HGTTPFKGQGNRATLF--------------- 376
APE+I + + A+D W+ G ELL +R LF
Sbjct: 251 APELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAG 310
Query: 377 ------------------NVVGQP-----------------LRFPETPQVSFV------- 394
N++G P FP+
Sbjct: 311 NDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS 370
Query: 395 --ARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEPVDFS 449
A L++ +LV P+KRI E HPFF+ V + + + E V
Sbjct: 371 ADAIHLLKRMLVFNPNKRIT----INECLAHPFFKEVR----IAEVETNATEKVRLP 419
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 8e-20
Identities = 46/219 (21%), Positives = 74/219 (33%), Gaps = 34/219 (15%)
Query: 62 ESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNF---------RLLKRLGYGDIGSVYL 112
E S + G D I ++ G GL L + +G G G V+
Sbjct: 1 EDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWR 60
Query: 113 VELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLLDHPFLPTLY----SYFETD 166
+ RG A+K+ S E EI +L H + T
Sbjct: 61 GKWRGEE--VAVKIFSSREERS------WFREAEIYQTVMLRHENILGFIAADNKDNGTW 112
Query: 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM--------LGIV 218
LV ++ G+L + T + A L +LHM I
Sbjct: 113 TQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 169
Query: 219 YRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSS 257
+RDLK +N+LV+ G ++D L++R + + +
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 36/161 (22%), Positives = 72/161 (44%), Gaps = 11/161 (6%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH- 153
+RL +++G G G +YL A+K+ + +++ L E +I ++
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE---CVKTKHPQLHI--ESKIYKMMQGG 64
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
+PT+ + +VME G +L L K F+ A +++ +EY+H
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEYIH 122
Query: 214 MLGIVYRDLKPENVLV---RDEGHIMLSDFDLSLRCSVSPT 251
++RD+KP+N L+ + + + DF L+ + + T
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 74/426 (17%), Positives = 128/426 (30%), Gaps = 135/426 (31%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGL 150
N+ + +G G G VYL + T A+K K + + + + REI L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK---KVNRMFEDLIDCKRILREITILNR 81
Query: 151 LDHP--------FLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFF 201
L +P F+ Y +V+E +L + TE+ +
Sbjct: 82 LKSDYIIRLYDLIIPDDLLKFDE--LY-IVLEIA-DSDLKKLFKTPIF---LTEEHIKTI 134
Query: 202 ASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVN 261
+LL ++H GI++RDLKP N L+ + + + DF L+ R
Sbjct: 135 LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA-R---------------- 177
Query: 262 NGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNV 321
T + N +++ L + +
Sbjct: 178 -----------------------TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS---- 210
Query: 322 RSMSFVGTHEYLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTP-----------FKGQ 369
V T Y APE+I + + ++D W+ G ELL+ F G
Sbjct: 211 ----HVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGS 266
Query: 370 GNRATL--------------------FNVVGQP-----------------LRFPETPQVS 392
FN++G P FP ++
Sbjct: 267 SCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPIN 326
Query: 393 FV---------ARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIP 443
+L+ +L P+KRI + HP+ + V + L
Sbjct: 327 LKQKYPSISDDGINLLESMLKFNPNKRIT----IDQALDHPYLKDVR----KKKLENFST 378
Query: 444 EPVDFS 449
+ +
Sbjct: 379 KKIILP 384
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 35/174 (20%), Positives = 65/174 (37%), Gaps = 25/174 (14%)
Query: 98 LLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLLDHP- 154
LL+ +G G G V+ +G A+K+ S E E+ +L H
Sbjct: 12 LLECVGKGRYGEVWRGSWQGE--NVAVKIFSSRDEKS------WFRETELYNTVMLRHEN 63
Query: 155 ---FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEY 211
F+ + + + L+ + G+L+ Q + + L +
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAH 120
Query: 212 LHML--------GIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSS 257
LH+ I +RDLK +N+LV+ G ++D L++ S S + +
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 35/191 (18%), Positives = 63/191 (32%), Gaps = 27/191 (14%)
Query: 84 ISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQT 143
+ +LL+ G G V+ +L A+K+ S Q
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYV--AVKIFPIQDKQS------WQN 65
Query: 144 EREI--LGLLDHPFLPTLYSY----FETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDA 197
E E+ L + H + D L+ F G+L + + +
Sbjct: 66 EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNE 122
Query: 198 ARFFASEVLLALEYLHM----------LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247
A + L YLH I +RD+K +NVL+++ ++DF L+L+
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 248 VSPTLVKSSSV 258
+ +
Sbjct: 183 AGKSAGDTHGQ 193
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 68/395 (17%), Positives = 121/395 (30%), Gaps = 136/395 (34%)
Query: 96 FRLLKRLGYGDIGSVYLV-ELRGTNTYFAMKVMDKASLASRNK---LLRAQTEREILGLL 151
+ ++ LG G G V + + + A+K++ +N A++E ++L L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-------KNVDRYCEAARSEIQVLEHL 68
Query: 152 -------DHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASE 204
+ + +FE C+V E G + + ++ F D R A +
Sbjct: 69 NTTDPNSTFRCV-QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQ 126
Query: 205 VLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGS 264
+ ++ +LH + + DLKPEN+L + + + + + + V
Sbjct: 127 ICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT----LINPDIKV---- 178
Query: 265 GGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324
+ DFG S
Sbjct: 179 -------------------------V-----------DFG------------------SA 184
Query: 325 SFVGTHE--------YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR---A 373
++ H Y APE+I G D W+ G L E G T F ++ A
Sbjct: 185 TYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244
Query: 374 TLFNVVGQP------------------LRFPETPQVSFVAR------------------- 396
+ ++G L + E
Sbjct: 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304
Query: 397 --DLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429
DLI+ +L +P KRI E +HPFF+ +
Sbjct: 305 LFDLIQKMLEYDPAKRIT----LREALKHPFFDLL 335
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 40/192 (20%), Positives = 70/192 (36%), Gaps = 30/192 (15%)
Query: 85 SLRGPP-----IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLL 139
S G P +++K++G G G V++ + RG A+KV AS
Sbjct: 23 SGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEK--VAVKVFFTTEEASW---- 76
Query: 140 RAQTEREI--LGLLDHP----FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYF 193
E EI L+ H F+ + L+ ++ G+L+ +
Sbjct: 77 --FRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---L 131
Query: 194 TEDAARFFASEVLLALEYLHML--------GIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245
+ A + L +LH I +RDLK +N+LV+ G ++D L+++
Sbjct: 132 DAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK 191
Query: 246 CSVSPTLVKSSS 257
V
Sbjct: 192 FISDTNEVDIPP 203
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 35/153 (22%), Positives = 67/153 (43%), Gaps = 6/153 (3%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
I + +R+G G G+VY + G A+K+++ + + +L + E +L
Sbjct: 21 IPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP-TPQQLQAFKNEVGVLRK 76
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
H + Y T +V ++C G +L+ K F A + ++
Sbjct: 77 TRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMD 134
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
YLH I++RDLK N+ + ++ + + DF L+
Sbjct: 135 YLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 29/125 (23%), Positives = 52/125 (41%), Gaps = 15/125 (12%)
Query: 295 KNRKSK-SDFGPCVGGALPELMAEPTNVRSM-SFVGTHEYLAPEIIRGEGHG---SAVDW 349
++ K DFG L + + G+ ++APE+IR + D
Sbjct: 155 EDNTVKIGDFG------LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDV 208
Query: 350 WTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVK---- 405
+ FGI LYEL+ G P+ NR + +VG+ P+ +V ++ L+ +
Sbjct: 209 YAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKK 268
Query: 406 EPHKR 410
+ +R
Sbjct: 269 KRDER 273
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 36/157 (22%), Positives = 67/157 (42%), Gaps = 13/157 (8%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH- 153
++++ +R+G G G ++ N A+K S LR E LL
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE---PRRSDAPQLR--DEYRTYKLLAGC 65
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
+P +Y + + LV++ G +L L K+ + A A ++L ++ +H
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMA-AKQMLARVQSIH 123
Query: 214 MLGIVYRDLKPENVLV-----RDEGHIMLSDFDLSLR 245
+VYRD+KP+N L+ ++ I + DF +
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 36/169 (21%), Positives = 64/169 (37%), Gaps = 19/169 (11%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGT--------NTYFAMKV--MDKASLASRNKLLRAQTE 144
++L + G +Y T F++K+ D +N RA
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 145 REI-----LGLLDHPFLPTLYSY-FETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAA 198
++ L +PT + DK+ LV+ G +L S P +E +
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSV 161
Query: 199 RFFASEVLLALEYLHMLGIVYRDLKPENVLV--RDEGHIMLSDFDLSLR 245
A +L ALE+LH V+ ++ EN+ V D+ + L+ + + R
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 30/114 (26%), Positives = 50/114 (43%), Gaps = 9/114 (7%)
Query: 317 EPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLF 376
P VGT Y++PE I G + VD ++ G+ L+ELL+ F Q R +
Sbjct: 227 MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRII 283
Query: 377 NVVGQPLRFPETPQVSF-VARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429
V +FP + +++ +L P +R AT+I ++ FE +
Sbjct: 284 TDVRNL-KFPLLFTQKYPQEHMMVQDMLSPSPTERP----EATDIIENAIFENL 332
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 21/126 (16%), Positives = 45/126 (35%), Gaps = 1/126 (0%)
Query: 119 NTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSG 178
+ + L+S + + + + + + M+ C
Sbjct: 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRK 145
Query: 179 GNLHSLRQKQPNKYFTE-DAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIML 237
NL ++ + E ++ A+E+LH G+++RDLKP N+ + + +
Sbjct: 146 ENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 205
Query: 238 SDFDLS 243
DF L
Sbjct: 206 GDFGLV 211
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 84/412 (20%), Positives = 140/412 (33%), Gaps = 123/412 (29%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL- 151
L + L+K+LG G G V+ R T A+K K A +N +T REI+ +L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---KIFDAFQNSTDAQRTFREIM-ILT 63
Query: 152 ---DHPFLPTLYSYFETDKF---YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEV 205
H + L + D Y LV ++ +LH++ + ++ ++
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVY-LVFDYM-ETDLHAVIRANI---LEPVHKQYVVYQL 118
Query: 206 LLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSG 265
+ ++YLH G+++RD+KP N+L+ E H+ ++DF LS R V+
Sbjct: 119 IKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLS-RSFVNIR-------------- 163
Query: 266 GGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325
+ I + +N + +
Sbjct: 164 ---------------RVTNNIPLSINENTENFDDDQPI-----------LTD-------- 189
Query: 326 FVGTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKG-----QGNRATLFNVV 379
+V T Y APEI+ G + +D W+ G L E+L G F G Q R + V+
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER--IIGVI 247
Query: 380 GQP-----------------LRFPETPQVSFV-------------------------ARD 397
P E ++ A D
Sbjct: 248 DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALD 307
Query: 398 LIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEPVDFS 449
L+ LL P+KRI+ A + +HPF P+ +
Sbjct: 308 LLDKLLQFNPNKRIS----ANDALKHPFVSI----FHNPNEEPNCDHIITIP 351
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 9e-18
Identities = 38/157 (24%), Positives = 67/157 (42%), Gaps = 12/157 (7%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRG----TNTYFAMKVMDKASLASRNKLLRAQTEREILG 149
+ + L++LG G+ GSV + T A+K + ++ R E EIL
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER---EIEILK 97
Query: 150 LLDHPFLPTLY--SYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVL 206
L H + Y + L+ME+ G+L L++ + + S++
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQIC 155
Query: 207 LALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+EYL ++RDL N+LV +E + + DF L+
Sbjct: 156 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 55/284 (19%), Positives = 98/284 (34%), Gaps = 82/284 (28%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
++ + +LG G G VY + + A+K + K + L+ E ++ + H
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLK---EAAVMKEIKH 68
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALEYL 212
P L L + + ++ EF + GNL LR+ + + + A+++ A+EYL
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYL 127
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILN 272
++RDL N LV + + ++DF LS R +
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLS-RL-----------------------MTG 163
Query: 273 DEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332
D Y H G P ++
Sbjct: 164 DTYTAHA----------------------------GAKFP--------IKWT-------- 179
Query: 333 LAPEIIRGEGHG---SAVDWWTFGIFLYELL-HGTTPFKGQGNR 372
APE + + D W FG+ L+E+ +G +P+ G
Sbjct: 180 -APESLA---YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 219
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 44/155 (28%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH- 153
NFR+ K++G G+ G + L + TN Y A+K+ S A + L E L
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL-----EYRFYKQLGSG 64
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
+P +Y + K+ +V+E G +L L F+ A +++ +EY+H
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRT-FSLKTVLMIAIQLISRMEYVH 122
Query: 214 MLGIVYRDLKPENVLVRDEGH-----IMLSDFDLS 243
++YRD+KPEN L+ G+ I + DF L+
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 38/157 (24%), Positives = 67/157 (42%), Gaps = 12/157 (7%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRG----TNTYFAMKVMDKASLASRNKLLRAQTEREILG 149
+ + L++LG G+ GSV + T A+K + ++ R E EIL
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER---EIEILK 66
Query: 150 LLDHPFLPTLY--SYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVL 206
L H + Y + L+ME+ G+L L++ + + S++
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQIC 124
Query: 207 LALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+EYL ++RDL N+LV +E + + DF L+
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 9e-17
Identities = 38/158 (24%), Positives = 61/158 (38%), Gaps = 13/158 (8%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELR----GTNTYFAMKVM-DKASLASRNKLLRAQTEREIL 148
+ ++ LG G G V L T A+K + ++ L + E EIL
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK---EIEIL 77
Query: 149 GLLDHPFLPTLY--SYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEV 205
L H + + L+MEF G+L L + + +A ++
Sbjct: 78 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--INLKQQLKYAVQI 135
Query: 206 LLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++YL V+RDL NVLV E + + DF L+
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 40/151 (26%), Positives = 71/151 (47%), Gaps = 10/151 (6%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLAS-RNKLLRAQTEREILGLLDHP 154
+ L + LG+G + V+L + A+KV+ +A LA + LR + E + L+HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHP 72
Query: 155 FLPTLYSYFETD----KFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLAL 209
+ +Y E + +VME+ G L + + P T A ++ AL
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQAL 129
Query: 210 EYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240
+ H GI++RD+KP N+++ + + DF
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDF 160
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 8e-08
Identities = 25/88 (28%), Positives = 40/88 (45%), Gaps = 2/88 (2%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR 384
+ +GT +YL+PE RG+ + D ++ G LYE+L G PF G + + V +
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 237
Query: 385 FPET--PQVSFVARDLIRGLLVKEPHKR 410
P +S ++ L K P R
Sbjct: 238 PPSARHEGLSADLDAVVLKALAKNPENR 265
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 39/152 (25%), Positives = 64/152 (42%), Gaps = 7/152 (4%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVM-DKASLASRNKLLRAQTEREILGLLD 152
+ L +++G G+ G V+ LR NT A+K + + K L+ E IL
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQ---EARILKQYS 170
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALEY 211
HP + L + +VME GG+ + LR + + +EY
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR--LRVKTLLQMVGDAAAGMEY 228
Query: 212 LHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
L ++RDL N LV ++ + +SDF +S
Sbjct: 229 LESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 39/155 (25%), Positives = 67/155 (43%), Gaps = 13/155 (8%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGL 150
+ + + ++G G G V+ R T A+K K + + +++ REI L
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQ 58
Query: 151 LDHPFLPTLYSYFETD-KFYCLVMEFCSGGNLHSLRQ--KQPNKYFTEDAARFFASEVLL 207
L HP L L F + + LV E+C H++ + + E + + L
Sbjct: 59 LKHPNLVNLLEVFRRKRRLH-LVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQTLQ 113
Query: 208 ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242
A+ + H ++RD+KPEN+L+ I L DF
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGF 148
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 30/137 (21%), Positives = 52/137 (37%), Gaps = 39/137 (28%)
Query: 329 THE-----YLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVV 379
E Y +PE++ G+ G VD W G ELL G + G+ + L +
Sbjct: 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL 219
Query: 380 GQP----------------LRFPET----------PQVSFVARDLIRGLLVKEPHKRIAY 413
G ++ P+ P +S+ A L++G L +P +R+
Sbjct: 220 GDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT- 278
Query: 414 KRGATEIKQHPFFEGVN 430
++ HP+FE +
Sbjct: 279 ---CEQLLHHPYFENIR 292
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 42/250 (16%), Positives = 93/250 (37%), Gaps = 21/250 (8%)
Query: 1 MDPLTKPRTNSITNQRPLPSQK-KPPNSEPSTVTMPGDIKHANSLTNHGHGSSNCSSRSD 59
+DP+ + +R + P P + + + SL + ++
Sbjct: 4 IDPM-GHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGAN 62
Query: 60 SLESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVY---LVELR 116
++ + + P V+ I + +G G G VY L++
Sbjct: 63 TVHIDLSALNPELVQAVQHVVI--------GPSSLIVHFNEVIGRGHFGCVYHGTLLDND 114
Query: 117 GTNTYFAMKVM-DKASLASRNKLLRAQTEREILGLLDHPFLPTLYSY-FETDKFYCLVME 174
G + A+K + + ++ L E I+ HP + +L ++ +V+
Sbjct: 115 GKKIHCAVKSLNRITDIGEVSQFLT---EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171
Query: 175 FCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG 233
+ G+L + +R + N T F +V +++L V+RDL N ++ ++
Sbjct: 172 YMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF 229
Query: 234 HIMLSDFDLS 243
+ ++DF L+
Sbjct: 230 TVKVADFGLA 239
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 34/150 (22%), Positives = 68/150 (45%), Gaps = 4/150 (2%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
++ + +LG G G VY + + A+K + K + L+ E ++ + H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLK---EAAVMKEIKH 275
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
P L L + + ++ EF + GNL ++ + + + A+++ A+EYL
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++R+L N LV + + ++DF LS
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLS 365
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 3e-16
Identities = 37/155 (23%), Positives = 72/155 (46%), Gaps = 11/155 (7%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DH 153
FRL +++G G G +YL TN A+K+ ++ +++ L E +I +L
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLE---NVKTKHPQLLY--ESKIYRILQGG 62
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
+P + + + LVM+ G +L L K + A +++ +E++H
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVH 120
Query: 214 MLGIVYRDLKPENVLV---RDEGHIMLSDFDLSLR 245
++RD+KP+N L+ R + + DF L+ +
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 38/158 (24%), Positives = 61/158 (38%), Gaps = 15/158 (9%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTN----TYFAMKVM-DKASLASRNKLLRAQTEREIL 148
+ ++ LG G G V L TN A+K + A R+ + E +IL
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ---EIDIL 87
Query: 149 GLLDHPFLPTLY--SYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEV 205
L H + LVME+ G+L L + FA ++
Sbjct: 88 RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQI 143
Query: 206 LLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ YLH ++RDL NVL+ ++ + + DF L+
Sbjct: 144 CEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 12/157 (7%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRG----TNTYFAMKVMDKASLASRNKLLRAQTEREILG 149
+ + + +LG G+ GSV L T A+K + + + R E +IL
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR---EIQILK 79
Query: 150 LLDHPFLPTLY--SYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVL 206
L F+ SY + LVME+ G L L++ + ++S++
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYSSQIC 137
Query: 207 LALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+EYL V+RDL N+LV E H+ ++DF L+
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 43/157 (27%), Positives = 69/157 (43%), Gaps = 21/157 (13%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNK---LLRAQTEREILGLL- 151
+ +LK +G G G V + + A+K++ RN+ +A E IL L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-------RNEKRFHRQAAEEIRILEHLR 151
Query: 152 ------DHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEV 205
+ + F C+ E S NL+ L +K + F+ R FA +
Sbjct: 152 KQDKDNTMNVI-HMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 206 LLALEYLHMLGIVYRDLKPENVLVRDEGH--IMLSDF 240
L L+ LH I++ DLKPEN+L++ +G I + DF
Sbjct: 210 LQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 16/41 (39%), Positives = 21/41 (51%)
Query: 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR 372
Y APE+I G +G +D W+ G L ELL G G+
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 32/171 (18%), Positives = 66/171 (38%), Gaps = 23/171 (13%)
Query: 95 NFRLLKRLGYGDIGSVYLVELR-GTNTYFAMKVMDKASLASRNKLL--------RAQTER 145
+++ +G G G +YL ++ + + K S N L RA
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVE-PSDNGPLFTELKFYQRAAKPE 94
Query: 146 EI-----LGLLDHPFLPTLYSY----FETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTED 196
+I L + +P + + ++M+ G +L + + + F+
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKR-FSRK 152
Query: 197 AARFFASEVLLALEYLHMLGIVYRDLKPENVLV--RDEGHIMLSDFDLSLR 245
+ +L LEY+H V+ D+K N+L+ ++ + L D+ L+ R
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 42/163 (25%), Positives = 71/163 (43%), Gaps = 28/163 (17%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTE-------- 144
+ + L +LG G +VY + + T+ A+K +R + E
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKE------------IRLEHEEGAPCTAI 48
Query: 145 REI--LGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQ--KQPNKYFTEDAARF 200
RE+ L L H + TL+ T+K LV E+ L+Q +
Sbjct: 49 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKL 104
Query: 201 FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
F ++L L Y H +++RDLKP+N+L+ + G + L+DF L+
Sbjct: 105 FLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA 147
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 3e-08
Identities = 37/161 (22%), Positives = 55/161 (34%), Gaps = 48/161 (29%)
Query: 329 THE-----YLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVV 379
+E Y P+I+ G + +D W G YE+ G F G L F ++
Sbjct: 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRIL 217
Query: 380 GQP----------------LRFPETPQVSF---------VARDLIRGLLVKEPHKRIAYK 414
G P +P+ + DL+ LL E RI+
Sbjct: 218 GTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS-- 275
Query: 415 RGATEIKQHPFFEGVNWALVRSALPPHIPE-PVDFSVFAGK 454
A + +HPFF +L I + P S+FA K
Sbjct: 276 --AEDAMKHPFF---------LSLGERIHKLPDTTSIFALK 305
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 43/163 (26%), Positives = 70/163 (42%), Gaps = 25/163 (15%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTE--------R 145
S F+ L++LG G +VY + T Y A+K ++ +E R
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKE------------VKLDSEEGTPSTAIR 52
Query: 146 EI--LGLLDHPFLPTLYSYFETDKFYCLVMEFCS---GGNLHSLRQKQPNKYFTEDAARF 200
EI + L H + LY T+ LV EF + S + + ++
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 201 FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
F ++L L + H I++RDLKP+N+L+ G + L DF L+
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 29/155 (18%), Positives = 51/155 (32%), Gaps = 51/155 (32%)
Query: 329 THE-----YLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVV 379
+ E Y AP+++ G +++D W+ G L E++ G F G + L F+++
Sbjct: 166 SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM 225
Query: 380 GQP-----------------------------LRFPETPQVSFVARDLIRGLLVKEPHKR 410
G P L+ + D + GLL P R
Sbjct: 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMR 285
Query: 411 IAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEP 445
++ A + HP+F + H
Sbjct: 286 LS----AKQALHHPWF---------AEYYHHASMG 307
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 58/290 (20%), Positives = 98/290 (33%), Gaps = 84/290 (28%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
S ++ +G G G V+L + A+K + + S + E E++ L H
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTI-REGAMSEEDFIE---EAEVMMKLSH 62
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALEYL 212
P L LY CLV EF G L LR ++ F + +V + YL
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYL 120
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILN 272
+++RDL N LV + I +SDF ++ R +L+
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMT-RF-----------------------VLD 156
Query: 273 DEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332
D+Y G P V+
Sbjct: 157 DQYTSST----------------------------GTKFP--------VKWA-------- 172
Query: 333 LAPEIIRGEGHG---SAVDWWTFGIFLYELL-HGTTPFKGQGNRATLFNV 378
+PE+ S D W+FG+ ++E+ G P++ + N + ++
Sbjct: 173 -SPEVFS---FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 39/153 (25%), Positives = 66/153 (43%), Gaps = 7/153 (4%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGL 150
+ + L +G G G V + T A+K K + +K+++ REI L
Sbjct: 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQ 80
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
L H L L + K + LV EF + + PN + + +++ +
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNG-LDYQVVQKYLFQIINGIG 138
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ H I++RD+KPEN+LV G + L DF +
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 34/135 (25%), Positives = 48/135 (35%), Gaps = 41/135 (30%)
Query: 329 THE-----YLAPEIIRGEGH-GSAVDWWTFG-IFLYELLHGTTPFKGQGNRATL---FNV 378
E Y APE++ G+ G AVD W G + E+ G F G + L
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLV-TEMFMGEPLFPGDSDIDQLYHIMMC 240
Query: 379 VGQP----------------LRFPET----------PQVSFVARDLIRGLLVKEPHKRIA 412
+G +R PE P++S V DL + L +P KR
Sbjct: 241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF 300
Query: 413 YKRGATEIKQHPFFE 427
E+ H FF+
Sbjct: 301 ----CAELLHHDFFQ 311
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 58/284 (20%), Positives = 92/284 (32%), Gaps = 84/284 (29%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
LLK LG G G V L + +G A+K++ K S ++ + E + + L H
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMI-KEGSMSEDEFFQ---EAQTMMKLSH 62
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALEYL 212
P L Y + +V E+ S G L + LR +V + +L
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFL 120
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILN 272
++RDL N LV + + +SDF ++ R +L+
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMT-RY-----------------------VLD 156
Query: 273 DEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332
D+Y G P V+
Sbjct: 157 DQYVSSV----------------------------GTKFP--------VKWS-------- 172
Query: 333 LAPEIIRGEGHG---SAVDWWTFGIFLYELL-HGTTPFKGQGNR 372
APE+ + S D W FGI ++E+ G P+ N
Sbjct: 173 -APEVFH---YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS 212
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 41/168 (24%), Positives = 68/168 (40%), Gaps = 20/168 (11%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVM-----DKASLASRNKLL-RAQTEREI- 147
+ L K++G G G +YL A V+ + L S K R + I
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 148 ----LGLLDHPFLPTLYSY----FETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAAR 199
LD+ +P Y F+ + +VME G +L + + N F +
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ--NGTFKKSTVL 154
Query: 200 FFASEVLLALEYLHMLGIVYRDLKPENVLV--RDEGHIMLSDFDLSLR 245
+L LEY+H V+ D+K N+L+ ++ + L+D+ LS R
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 21/158 (13%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNK---LLRAQTEREILGLL- 151
+ + +G G G V R + A+K++ +NK L +AQ E +L L+
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-------KNKKAFLNQAQIEVRLLELMN 108
Query: 152 -----DHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVL 206
++ L +F CLV E S NL+ L + + + + R FA ++
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 207 LALEYLHM--LGIVYRDLKPENVLVRDEGH--IMLSDF 240
AL +L L I++ DLKPEN+L+ + I + DF
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 13/41 (31%), Positives = 20/41 (48%)
Query: 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR 372
Y +PE++ G + A+D W+ G L E+ G F G
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 34/150 (22%), Positives = 65/150 (43%), Gaps = 6/150 (4%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+ +L K+LG G G V++ +T A+K M K S L E ++ L H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTM-KPGSMSVEAFLA---EANVMKTLQH 242
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
L L++ + Y ++ EF + G+L + F++++ + ++
Sbjct: 243 DKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++RDL+ N+LV ++DF L+
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLA 331
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 37/156 (23%), Positives = 69/156 (44%), Gaps = 12/156 (7%)
Query: 94 SNFRLLKRLGYGDIGSVY----LVELRGTNTYFAMKVM-DKASLASRNKLLRAQTEREIL 148
+ F+ +K LG G G+VY + E A+K + + S + ++L E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD---EAYVM 71
Query: 149 GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLL 207
+D+P + L T L+ + G L +R+ + N + ++
Sbjct: 72 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 128
Query: 208 ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ YL +V+RDL NVLV+ H+ ++DF L+
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLL 151
++ L +G G GSV T A+K K S ++ + +T RE+ L +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 152 DHP--------FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFAS 203
H F P S E + Y LV G +L+++ + Q T+D +F
Sbjct: 86 KHENVIGLLDVFTPA-RSLEEFNDVY-LVTHLM-GADLNNIVKCQK---LTDDHVQFLIY 139
Query: 204 EVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++L L+Y+H I++RDLKP N+ V ++ + + DF L+
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 41/158 (25%), Positives = 58/158 (36%), Gaps = 48/158 (30%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGH-GSAVDWWTFGIFLYELL 360
DFG +A T +V T Y APEI+ H VD W+ G + ELL
Sbjct: 175 DFG----------LARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
Query: 361 HGTTPFKG-----QGNRATLFNVVGQP-----------------LRFPETPQVSF----- 393
G T F G Q + +VG P + P+++F
Sbjct: 225 TGRTLFPGTDHIDQLKL--ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 282
Query: 394 ----VARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427
+A DL+ +LV + KRI A + H +F
Sbjct: 283 GANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFA 316
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 47/212 (22%), Positives = 77/212 (36%), Gaps = 25/212 (11%)
Query: 50 GSSNCSSRSDSLESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGS 109
G+ S E + ++ H + ++ I + L LG G G
Sbjct: 1 GAMGSGSSLSPTEGKGSGLQGHIIENPQY----FSDACVHHIKRRDIVLKWELGEGAFGK 56
Query: 110 VYLVELRGT-----NTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE 164
V+L E A+K + +AS ++R R E E+L +L H + +
Sbjct: 57 VFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTMLQHQHIVRFFGVCT 113
Query: 165 TDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARF------------FASEVLLALEY 211
+ +V E+ G+L+ LR P+ AS+V + Y
Sbjct: 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVY 173
Query: 212 LHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
L L V+RDL N LV + + DF +S
Sbjct: 174 LAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+ RL +LG G G V++ G T A+K + K S L+ E +++ L H
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQ---EAQVMKKLRH 238
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
L LY+ + Y +V E+ S G+L + + KY A+++ + Y+
Sbjct: 239 EKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ V+RDL+ N+LV + ++DF L+
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLA 327
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 7e-15
Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 6/153 (3%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGL 150
+ NF+ ++++G G G VY + T A+K K L + + + + REI L
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK---KIRLDTETEGVPSTAIREISLLKE 58
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
L+HP + L T+ LV EF +L + + ++L L
Sbjct: 59 LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ H +++RDLKP+N+L+ EG I L+DF L+
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 8e-15
Identities = 33/161 (20%), Positives = 67/161 (41%), Gaps = 11/161 (6%)
Query: 89 PPIGLSNFRLLKRLGYGDIGSVY---LVELRGTNTYFAMKVM-DKASLASRNKLLRAQTE 144
+ +G G G VY L++ G + A+K + + ++ L E
Sbjct: 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT---E 76
Query: 145 REILGLLDHPFLPTLYSY-FETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFA 202
I+ HP + +L ++ +V+ + G+L + +R + N T F
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFG 134
Query: 203 SEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+V ++YL V+RDL N ++ ++ + ++DF L+
Sbjct: 135 LQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLL 151
+ +R L+ +G G G+V T A+K K +++L + RE+ L +
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHM 81
Query: 152 DHP--------FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFAS 203
H F P + + FY LVM F G +L L + + ED +F
Sbjct: 82 RHENVIGLLDVFTPD-ETLDDFTDFY-LVMPFM-GTDLGKLMKHEK---LGEDRIQFLVY 135
Query: 204 EVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++L L Y+H GI++RDLKP N+ V ++ + + DF L+
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 39/159 (24%), Positives = 57/159 (35%), Gaps = 48/159 (30%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGH-GSAVDWWTFGIFLYELL 360
DFG +A + +V T Y APE+I VD W+ G + E++
Sbjct: 171 DFG----------LARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 220
Query: 361 HGTTPFKG-----QGNRATLFNVVGQP-----------------LRFPETPQVSF----- 393
G T FKG Q + V G P PE + F
Sbjct: 221 TGKTLFKGSDHLDQLKE--IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT 278
Query: 394 ----VARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428
+A +L+ +LV + +R+ A E HP+FE
Sbjct: 279 NASPLAVNLLEKMLVLDAEQRVT----AGEALAHPYFES 313
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 64/290 (22%), Positives = 103/290 (35%), Gaps = 84/290 (28%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+ LK LG G G V + RG A+K++ K S ++ + E +++ L H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMI-KEGSMSEDEFIE---EAKVMMNLSH 78
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALEYL 212
L LY + ++ E+ + G L + LR+ + F +V A+EYL
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYL 136
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILN 272
++RDL N LV D+G + +SDF LS R +L+
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLS-RY-----------------------VLD 172
Query: 273 DEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332
DEY G P VR
Sbjct: 173 DEYTSSV----------------------------GSKFP--------VRWS-------- 188
Query: 333 LAPEIIRGEGHG---SAVDWWTFGIFLYELL-HGTTPFKGQGNRATLFNV 378
PE++ + S D W FG+ ++E+ G P++ N T ++
Sbjct: 189 -PPEVLM---YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 37/164 (22%), Positives = 66/164 (40%), Gaps = 17/164 (10%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGT-----NTYFAMKVM-DKASLASRNKLLRAQTEREI 147
+ + LG G G VY +G T A+K + + AS+ R + L E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN---EASV 81
Query: 148 LGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARF------ 200
+ + + L + ++ME + G+L S LR +P A
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 201 -FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
A E+ + YL+ V+RDL N +V ++ + + DF ++
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 21/156 (13%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQ-TEREIL---G 149
+++L+++LG G V+ N +K++ K ++ + +REI
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---------KPVKKKKIKREIKILEN 86
Query: 150 LLDHPFLPTLYSYF--ETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLL 207
L P + TL + LV E + + L Q T+ RF+ E+L
Sbjct: 87 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILK 141
Query: 208 ALEYLHMLGIVYRDLKPENVLV-RDEGHIMLSDFDL 242
AL+Y H +GI++RD+KP NV++ + + L D+ L
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 25/140 (17%), Positives = 42/140 (30%), Gaps = 41/140 (29%)
Query: 327 VGTHEYLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTP-FKGQGNRATL---FNVVGQ 381
V + + PE++ ++D W+ G L ++ P F G N L V+G
Sbjct: 191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 250
Query: 382 P------------------LRFPETPQVSF--------------VARDLIRGLLVKEPHK 409
+ + A D + LL +
Sbjct: 251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQS 310
Query: 410 RIAYKRGATEIKQHPFFEGV 429
R+ A E +HP+F V
Sbjct: 311 RLT----AREAMEHPYFYTV 326
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 36/156 (23%), Positives = 65/156 (41%), Gaps = 12/156 (7%)
Query: 94 SNFRLLKRLGYGDIGSVY----LVELRGTNTYFAMKVM-DKASLASRNKLLRAQTEREIL 148
+ R LK LG G G+V+ + E +KV+ DK+ S + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD---HMLAI 69
Query: 149 GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLL 207
G LDH + L LV ++ G+L +RQ + + ++
Sbjct: 70 GSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQIAK 126
Query: 208 ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ YL G+V+R+L NVL++ + ++DF ++
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+ RL +LG G G V++ G T A+K + K S L+ E +++ L H
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQ---EAQVMKKLRH 321
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
L LY+ + Y +V E+ S G+L + + KY A+++ + Y+
Sbjct: 322 EKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ V+RDL+ N+LV + ++DF L+
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLA 410
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 40/155 (25%), Positives = 66/155 (42%), Gaps = 11/155 (7%)
Query: 94 SNFRLLKRLGYGDIGSVY---LVELRGTNTYFAMKVM-DKASLASRNKLLRAQTEREILG 149
L + +G G G V+ + A+K + S + R K L+ E +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ---EALTMR 71
Query: 150 LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLA 208
DHP + L + + ++ME C+ G L S L+ ++ + + +A ++ A
Sbjct: 72 QFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTA 128
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
L YL V+RD+ NVLV + L DF LS
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 22/161 (13%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLL 151
+ +G G GSV + + A+K K S ++++ + RE+ L +
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK---KLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 152 DHP--------FLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFA 202
H F P S FY LVM F +L + K F+E+ ++
Sbjct: 81 QHENVIGLLDVFTPA-SSLRNFYDFY-LVMPFM-QTDLQKIMGLK-----FSEEKIQYLV 132
Query: 203 SEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++L L+Y+H G+V+RDLKP N+ V ++ + + DF L+
Sbjct: 133 YQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 46/180 (25%), Positives = 63/180 (35%), Gaps = 52/180 (28%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGH-GSAVDWWTFGIFLYELL 360
DFG +A + +V T Y APE+I H VD W+ G + E+L
Sbjct: 169 DFG----------LARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 218
Query: 361 HGTTPFKG-----QGNRATLFNVVGQP-----------------LRFPETPQVSF----- 393
G T FKG Q + + V G P P+TP+ F
Sbjct: 219 TGKTLFKGKDYLDQLTQ--ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFP 276
Query: 394 ----VARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEPVDFS 449
A DL+ +L + KR+ A + HPFFE +P D S
Sbjct: 277 RASPQAADLLEKMLELDVDKRLT----AAQALTHPFFEP----FRDPEEETEAQQPFDDS 328
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 47/157 (29%), Positives = 66/157 (42%), Gaps = 14/157 (8%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKL---LRAQTEREI-- 147
+ L LG G +VY + TN A+K K L R++ + REI
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIK---KIKLGHRSEAKDGINRTALREIKL 65
Query: 148 LGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQ--KQPNKYFTEDAARFFASEV 205
L L HP + L F LV +F L K + T + +
Sbjct: 66 LQELSHPNIIGLLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 206 LLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242
L LEYLH I++RDLKP N+L+ + G + L+DF L
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 5e-07
Identities = 41/168 (24%), Positives = 58/168 (34%), Gaps = 41/168 (24%)
Query: 329 THE-----YLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVV 379
TH+ Y APE++ G G VD W G L ELL G + L F +
Sbjct: 170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 229
Query: 380 GQP--------------LRFPETPQVSF---------VARDLIRGLLVKEPHKRIAYKRG 416
G P + F P + DLI+GL + P RI
Sbjct: 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT---- 285
Query: 417 ATEIKQHPFFEGVNWALVRSALPPHIPEPVDFSVFAGKDQASAAAEKK 464
AT+ + +F +P P + V K+Q++ A K
Sbjct: 286 ATQALKMKYF----SNRPGPTPGCQLPRP-NCPVETLKEQSNPALAIK 328
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 3e-14
Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 11/155 (7%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGL 150
+ + L+++G G G+V+ + R T+ A+K + L ++ + + REI L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSSALREICLLKE 57
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQ--KQPNKYFTEDAARFFASEVLLA 208
L H + L+ +DK LV EFC L++ N + + F ++L
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
L + H +++RDLKP+N+L+ G + L++F L+
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA 148
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 3e-06
Identities = 32/132 (24%), Positives = 52/132 (39%), Gaps = 38/132 (28%)
Query: 329 THE-----YLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTP-FKGQGNRATL---FNV 378
+ E Y P+++ G +++D W+ G EL + P F G L F +
Sbjct: 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218
Query: 379 VGQP--------------LRFPET----------PQVSFVARDLIRGLLVKEPHKRIAYK 414
+G P +P P+++ RDL++ LL P +RI+
Sbjct: 219 LGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS-- 276
Query: 415 RGATEIKQHPFF 426
A E QHP+F
Sbjct: 277 --AEEALQHPYF 286
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 41/170 (24%), Positives = 74/170 (43%), Gaps = 33/170 (19%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNK---LLRAQTEREILGLL- 151
+ L+++LG+G +V+L + NT+ AMK++ R A+ E ++L +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-------RGDKVYTEAAEDEIKLLQRVN 73
Query: 152 -------DHPFLP---TLYSYFE----TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDA 197
D L +F +V E G NL +L +K ++
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIY 132
Query: 198 ARFFASEVLLALEYLH-MLGIVYRDLKPENVLVRDEGH------IMLSDF 240
+ + ++LL L+Y+H GI++ D+KPENVL+ I ++D
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 182
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 25/152 (16%), Positives = 46/152 (30%), Gaps = 54/152 (35%)
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQ--------------- 369
+ + T EY +PE++ G G D W+ ++EL+ G F+
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 370 --------------GNRATLF-------------------NVVGQPLRFPETPQVSFVAR 396
G F +V+ + +F +
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS-- 311
Query: 397 DLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428
D + +L +P KR A + HP+ +
Sbjct: 312 DFLSPMLQLDPRKRAD----AGGLVNHPWLKD 339
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 40/168 (23%), Positives = 74/168 (44%), Gaps = 16/168 (9%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGL 150
L ++ LK +G G G V + A+K K S +N+ + RE+ +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK---KLSRPFQNQTHAKRAYRELVLMKC 117
Query: 151 LDHPFLPTLY------SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASE 204
++H + +L E + LVME NL + Q + + + +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME----LDHERMSYLLYQ 172
Query: 205 VLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252
+L +++LH GI++RDLKP N++V+ + + + DF L+ S +
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 220
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 38/166 (22%), Positives = 60/166 (36%), Gaps = 51/166 (30%)
Query: 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKG-----QGNRATLFNVVG 380
+V T Y APE+I G G+ VD W+ G + E++ F G Q N+ + +G
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK--VIEQLG 280
Query: 381 QP----------------LRFPETPQVSF---------------------VARDLIRGLL 403
P P+ ++F ARDL+ +L
Sbjct: 281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 340
Query: 404 VKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEPVDFS 449
V +P KRI+ + QHP+ W + + P+ D
Sbjct: 341 VIDPAKRIS----VDDALQHPYINV--WY-DPAEVEAPPPQIYDKQ 379
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 44/164 (26%), Positives = 68/164 (41%), Gaps = 27/164 (16%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMK---VMDKASLASRNKLLRAQTEREI-- 147
S+F+L LG G G V + T A+K DK A R T REI
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR-------TLREIKI 62
Query: 148 LGLLDHP--------FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAAR 199
L H P + F Y ++ E +LH + Q ++D +
Sbjct: 63 LKHFKHENIITIFNIQRPDSFENFNE--VY-IIQELM-QTDLHRVISTQM---LSDDHIQ 115
Query: 200 FFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+F + L A++ LH +++RDLKP N+L+ + + DF L+
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 36/156 (23%), Positives = 52/156 (33%), Gaps = 39/156 (25%)
Query: 327 VGTHEYLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKG-----QGNRATLFNVVG 380
V T Y APE++ A+D W+ G L EL F G Q +F ++G
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL--IFGIIG 240
Query: 381 QP------------------LRFPETPQVSF---------VARDLIRGLLVKEPHKRIAY 413
P P P DL++ +LV +P KRI
Sbjct: 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT- 299
Query: 414 KRGATEIKQHPFFEGVNWALVRSALPPHIPEPVDFS 449
A E +HP+ + + P P +F
Sbjct: 300 ---AKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFD 332
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 38/151 (25%), Positives = 70/151 (46%), Gaps = 8/151 (5%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+L++RLG G G V++ G +T A+K + K S + L E ++ L H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLA---EANLMKQLQH 67
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALEYL 212
L LY+ + Y ++ E+ G+L L+ K T + A+++ + ++
Sbjct: 68 QRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFI 125
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++RDL+ N+LV D ++DF L+
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 41/154 (26%), Positives = 62/154 (40%), Gaps = 7/154 (4%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELR---GTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
+ RLL++LG G G V E G A+K + L+ + E +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLAL 209
LDH L LY T +V E G+L LR+ Q + F +A +V +
Sbjct: 78 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGM 134
Query: 210 EYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
YL ++RDL N+L+ + + DF L
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 37/155 (23%), Positives = 70/155 (45%), Gaps = 17/155 (10%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
++ K +G G G VY +L + A+K K R K R E +I+ LDH
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK---KVLQDKRFKN-R---ELQIMRKLDHC 107
Query: 155 FLPTLYSYF------ETDKFYCLVMEFCSGGNLHSL--RQKQPNKYFTEDAARFFASEVL 206
+ L +F + + + LV+++ ++ + + + + + ++
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 207 LALEYLHMLGIVYRDLKPENVLV-RDEGHIMLSDF 240
+L Y+H GI +RD+KP+N+L+ D + L DF
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF 201
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 36/146 (24%), Positives = 50/146 (34%), Gaps = 32/146 (21%)
Query: 332 YLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVVGQP----- 382
Y APE+I G S++D W+ G L ELL G F G L V+G P
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281
Query: 383 ---------LRFPETPQVSF----------VARDLIRGLLVKEPHKRIAYKRGATEIKQH 423
+FP+ + A L LL P R+ E H
Sbjct: 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEACAH 337
Query: 424 PFFEGVNWALVRSALPPHIPEPVDFS 449
FF+ + V+ P +F+
Sbjct: 338 SFFDELRDPNVKLPNGRDTPALFNFT 363
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 40/155 (25%), Positives = 66/155 (42%), Gaps = 11/155 (7%)
Query: 94 SNFRLLKRLGYGDIGSVY---LVELRGTNTYFAMKVM-DKASLASRNKLLRAQTEREILG 149
L + +G G G V+ + A+K + S + R K L+ E +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ---EALTMR 446
Query: 150 LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLA 208
DHP + L + + ++ME C+ G L S L+ ++ + + +A ++ A
Sbjct: 447 QFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTA 503
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
L YL V+RD+ NVLV + L DF LS
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 37/156 (23%), Positives = 69/156 (44%), Gaps = 12/156 (7%)
Query: 94 SNFRLLKRLGYGDIGSVY----LVELRGTNTYFAMKVM-DKASLASRNKLLRAQTEREIL 148
+ F+ +K LG G G+VY + E A+K + + S + ++L E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD---EAYVM 71
Query: 149 GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLL 207
+D+P + L T L+ + G L +R+ + N + ++
Sbjct: 72 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 128
Query: 208 ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ YL +V+RDL NVLV+ H+ ++DF L+
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 5e-14
Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 100 KRLGYGDIGSVYLVELRGTNTYF--AMKVM--DKASLASRNKLLRAQTEREILGLLDHPF 155
K LG G+ G+V + A+K++ + A +++LL E ++ LD+P+
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA---EANVMQQLDNPY 79
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
+ + E + + LVME G L+ L+Q N++ + +V + ++YL
Sbjct: 80 IVRMIGICEAESWM-LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
V+RDL NVL+ + + +SDF LS
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 46/153 (30%), Positives = 69/153 (45%), Gaps = 12/153 (7%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+LL+ +G G+ G V L + RG A+K + K A+ L E ++ L H
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCI-KND-ATAQAFLA---EASVMTQLRH 245
Query: 154 PFLPTLY--SYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALE 210
L L E Y +V E+ + G+L LR + D F+ +V A+E
Sbjct: 246 SNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAME 303
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
YL V+RDL NVLV ++ +SDF L+
Sbjct: 304 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 8e-14
Identities = 42/162 (25%), Positives = 68/162 (41%), Gaps = 26/162 (16%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTE-------R 145
+ + L+++G G G VY + FA+K + L + E R
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI----------RLEKEDEGIPSTTIR 49
Query: 146 EI--LGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQ--KQPNKYFTEDAARFF 201
EI L L H + LY T K LV E L++ A+ F
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSF 105
Query: 202 ASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++L + Y H +++RDLKP+N+L+ EG + ++DF L+
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA 147
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 30/135 (22%), Positives = 52/135 (38%), Gaps = 37/135 (27%)
Query: 329 THE-----YLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVV 379
THE Y AP+++ G + +D W+ G E+++GT F G L F ++
Sbjct: 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217
Query: 380 GQP---------------LRFPETPQVSF---------VARDLIRGLLVKEPHKRIAYKR 415
G P F + + DL+ +L +P++RI
Sbjct: 218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT--- 274
Query: 416 GATEIKQHPFFEGVN 430
A + +H +F+ N
Sbjct: 275 -AKQALEHAYFKENN 288
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 8e-14
Identities = 46/153 (30%), Positives = 69/153 (45%), Gaps = 12/153 (7%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+LL+ +G G+ G V L + RG A+K + K A+ L E ++ L H
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCI-KND-ATAQAFLA---EASVMTQLRH 73
Query: 154 PFLPTLYS--YFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALE 210
L L E Y +V E+ + G+L LR + D F+ +V A+E
Sbjct: 74 SNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAME 131
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
YL V+RDL NVLV ++ +SDF L+
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 35/163 (21%), Positives = 60/163 (36%), Gaps = 27/163 (16%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMK---VMDKASLASRNKLLRAQTEREI--L 148
+ L +G G G V A+K + + R T REI L
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR-------TLREIKIL 79
Query: 149 GLLDHP--------FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARF 200
H + Y +V + +L+ L + Q + D +
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKD--VY-IVQDLM-ETDLYKLLKTQH---LSNDHICY 132
Query: 201 FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
F ++L L+Y+H +++RDLKP N+L+ + + DF L+
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 37/155 (23%), Positives = 52/155 (33%), Gaps = 42/155 (27%)
Query: 327 VGTHEYLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKG-----QGNRATLFNVVG 380
V T Y APEI+ ++D W+ G L E+L F G Q N + ++G
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH--ILGILG 249
Query: 381 QP-----------------LRFPETPQVSF---------VARDLIRGLLVKEPHKRIAYK 414
P L P +V + A DL+ +L PHKRI
Sbjct: 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE-- 307
Query: 415 RGATEIKQHPFFEGVNWALVRSALPPHIPEPVDFS 449
+ HP+ E + P P F
Sbjct: 308 --VEQALAHPYLEQ----YYDPSDEPIAEAPFKFD 336
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 9e-14
Identities = 43/172 (25%), Positives = 64/172 (37%), Gaps = 22/172 (12%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGT-----NTYFAMKVMDKASLASRNKLLRAQTER 145
I + L + LG G G V+L E A+K + +LA+R R E
Sbjct: 12 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EA 68
Query: 146 EILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAAR----- 199
E+L L H + Y +V E+ G+L+ LR P+ D
Sbjct: 69 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 200 --------FFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
AS++ + YL V+RDL N LV + + DF +S
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 40/162 (24%), Positives = 71/162 (43%), Gaps = 22/162 (13%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGL 150
L ++ LK +G G G V A+K K S +N+ + RE+ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK---KLSRPFQNQTHAKRAYRELVLMKC 80
Query: 151 LDHP--------FLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFF 201
++H F P S E Y +VME NL ++ + + +
Sbjct: 81 VNHKNIIGLLNVFTPQ-KSLEEFQDVY-IVMELM-DANLCQVIQME-----LDHERMSYL 132
Query: 202 ASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++L +++LH GI++RDLKP N++V+ + + + DF L+
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 41/169 (24%), Positives = 58/169 (34%), Gaps = 56/169 (33%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 361
DFG +M +V T Y APE+I G G+ VD W+ G + E++
Sbjct: 170 DFGLARTAGTSFMMTP--------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 221
Query: 362 GTTPFKG-----QGNRATLFNVVGQP----------------LRFPETPQVSF------- 393
G F G Q N+ + +G P P+ SF
Sbjct: 222 GGVLFPGTDHIDQWNK--VIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDV 279
Query: 394 --------------VARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428
ARDL+ +LV + KRI+ E QHP+
Sbjct: 280 LFPADSEHNKLKASQARDLLSKMLVIDASKRIS----VDEALQHPYINV 324
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 39/156 (25%), Positives = 60/156 (38%), Gaps = 11/156 (7%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDK-----ASLASRNKLLRAQTEREIL 148
S K +G G+ G VY L+ ++ + V K + R L E I+
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG---EAGIM 100
Query: 149 GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLL 207
G H + L K ++ E+ G L LR+K F+ +
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAA 158
Query: 208 ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++YL + V+RDL N+LV +SDF LS
Sbjct: 159 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 44/154 (28%), Positives = 62/154 (40%), Gaps = 8/154 (5%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELR---GTNTYFAMKVM-DKASLASRNKLLRAQTEREILG 149
S + K +G GD G V LR + A+K + + R L E I+G
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLS---EASIMG 105
Query: 150 LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLAL 209
DHP + L + +V E+ G+L + + + FT V +
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGM 164
Query: 210 EYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
YL LG V+RDL NVLV +SDF LS
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 39/165 (23%), Positives = 73/165 (44%), Gaps = 32/165 (19%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRG---TNTYFAMKVMDKASLASRNKLLRAQTE----- 144
+ ++ L+++G G G VY + A+K + L A+ E
Sbjct: 20 MEKYQKLEKVGEGTYGVVY----KAKDSQGRIVALKRI----------RLDAEDEGIPST 65
Query: 145 --REI--LGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQ--KQPNKYFTEDAA 198
REI L L HP + +L +++ LV EF L++ + +
Sbjct: 66 AIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQI 121
Query: 199 RFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ + ++L + + H I++RDLKP+N+L+ +G + L+DF L+
Sbjct: 122 KIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA 166
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 34/148 (22%), Positives = 55/148 (37%), Gaps = 47/148 (31%)
Query: 329 THE-----YLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVV 379
THE Y AP+++ G ++VD W+ G E++ G F G + L F+++
Sbjct: 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL 236
Query: 380 GQP----------------LRFPETPQVSF---------VARDLIRGLLVKEPHKRIAYK 414
G P F + + DL+ +L +P+KRI+
Sbjct: 237 GTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS-- 294
Query: 415 RGATEIKQHPFFEGVNWALVRSALPPHI 442
A + HP+F L P I
Sbjct: 295 --ARDAMNHPYF---------KDLDPQI 311
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 39/155 (25%), Positives = 66/155 (42%), Gaps = 11/155 (7%)
Query: 94 SNFRLLKRLGYGDIGSVY---LVELRGTNTYFAMKVM-DKASLASRNKLLRAQTEREILG 149
+ L + LG G G VY +G A+K +L ++ K + E I+
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS---EAVIMK 68
Query: 150 LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLA 208
LDHP + L E + + ++ME G L L + + + ++ ++ A
Sbjct: 69 NLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKA 125
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ YL + V+RD+ N+LV + L DF LS
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 44/173 (25%), Positives = 69/173 (39%), Gaps = 23/173 (13%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGT-----NTYFAMKVM-DKASLASRNKLLRAQTE 144
I LS R ++ LG G VY L G A+K + DKA R + E
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH---E 62
Query: 145 REILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARF--- 200
+ L HP + L D+ ++ +CS G+LH L + P+
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 201 ----------FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+++ +EYL +V++DL NVLV D+ ++ +SD L
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 36/158 (22%), Positives = 66/158 (41%), Gaps = 13/158 (8%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMK-VMDKASLASRN----KLLRAQTEREI 147
+ F++ + G G G+V L + + T A+K V+ +R + L I
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNI 81
Query: 148 LGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSL--RQKQPNKYFTEDAARFFASEV 205
+ L + F D + +VME+ LH + + F ++
Sbjct: 82 VQLQSY-FYTLGERDRR-DIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 206 LLALEYLHM--LGIVYRDLKPENVLV-RDEGHIMLSDF 240
+ ++ LH+ + + +RD+KP NVLV +G + L DF
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 31/127 (24%), Positives = 48/127 (37%), Gaps = 35/127 (27%)
Query: 332 YLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVVGQP----- 382
Y APE+I G H +AVD W+ G E++ G F+G + L V+G P
Sbjct: 197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256
Query: 383 ---------LRFPETPQVSF-------------VARDLIRGLLVKEPHKRIAYKRGATEI 420
+ + + + A DL+ LL P +R+ E
Sbjct: 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK----PYEA 312
Query: 421 KQHPFFE 427
HP+F+
Sbjct: 313 LCHPYFD 319
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 45/169 (26%), Positives = 68/169 (40%), Gaps = 20/169 (11%)
Query: 90 PIG---LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKV--MDKASLASRNKLLRAQTE 144
P+G S + + +G G G+VY + + A+K + L T
Sbjct: 2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGG--LPISTV 59
Query: 145 REI-----LGLLDHPFLPTLY------SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYF 193
RE+ L +HP + L K LV E +L + K P
Sbjct: 60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVT-LVFEHVDQ-DLRTYLDKAPPPGL 117
Query: 194 TEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242
+ + + L L++LH IV+RDLKPEN+LV G + L+DF L
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 28/128 (21%), Positives = 41/128 (32%), Gaps = 34/128 (26%)
Query: 329 THE-----YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVVG 380
T Y APE++ + + VD W+ G E+ F G L F+++G
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236
Query: 381 QP-------------LRFPETPQVSF---------VARDLIRGLLVKEPHKRIAYKRGAT 418
P FP L+ +L PHKRI+ A
Sbjct: 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS----AF 292
Query: 419 EIKQHPFF 426
QH +
Sbjct: 293 RALQHSYL 300
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 38/154 (24%), Positives = 73/154 (47%), Gaps = 18/154 (11%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
+ K +G G G V+ +L ++ A+K K R K R E +I+ ++ HP
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIK---KVLQDKRFKN-R---ELQIMRIVKHPN 93
Query: 156 LPTLYSYF------ETDKFYCLVMEFCSGGNLHSL--RQKQPNKYFTEDAARFFASEVLL 207
+ L ++F + + F LV+E+ ++ + + + + ++L
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 208 ALEYLHMLGIVYRDLKPENVLV-RDEGHIMLSDF 240
+L Y+H +GI +RD+KP+N+L+ G + L DF
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 37/146 (25%), Positives = 55/146 (37%), Gaps = 32/146 (21%)
Query: 332 YLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVVGQP----- 382
Y APE+I G + + +D W+ G + EL+ G F G+ L V+G P
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266
Query: 383 ---------LRFPETPQVSF----------VARDLIRGLLVKEPHKRIAYKRGATEIKQH 423
+FP+ F A DLI LL P R+ A E H
Sbjct: 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT----AIEALCH 322
Query: 424 PFFEGVNWALVRSALPPHIPEPVDFS 449
PFF+ + R +P +++
Sbjct: 323 PFFDELRTGEARMPNGRELPPLFNWT 348
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 33/153 (21%), Positives = 61/153 (39%), Gaps = 11/153 (7%)
Query: 97 RLLKRLGYGDIGSVY---LVELRGTNTYFAMKVM-DKASLASRNKLLRAQTEREILGLLD 152
+ +G G G VY ++ A+K + + LR E ++ L+
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLR---EGLLMRGLN 80
Query: 153 HPFLPTLYSY-FETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLALE 210
HP + L + +++ + G+L +R Q N T F +V +E
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGME 138
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
YL V+RDL N ++ + + ++DF L+
Sbjct: 139 YLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 34/167 (20%), Positives = 64/167 (38%), Gaps = 17/167 (10%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVM-DKASLASRNKLLRAQTE 144
+ N L++ LG+G G VY ++ G + A+K + + S L E
Sbjct: 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM---E 124
Query: 145 REILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQP----NKYFTEDAAR 199
I+ +H + +++E +GG+L S LR+ +P
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184
Query: 200 FFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIML---SDFDLS 243
A ++ +YL ++RD+ N L+ G + DF ++
Sbjct: 185 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 46/182 (25%), Positives = 70/182 (38%), Gaps = 14/182 (7%)
Query: 67 PVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGT---NTYFA 123
V PHT D + + +N + K +G G+ G V L+ A
Sbjct: 22 FVDPHTFED----PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVA 77
Query: 124 MKVM-DKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLH 182
+K + + R L E I+G DHP + L K +V E+ G+L
Sbjct: 78 IKTLKVGYTEKQRRDFLG---EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 183 S-LRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFD 241
S LR+ FT + ++YL +G V+RDL N+L+ +SDF
Sbjct: 135 SFLRKHDAQ--FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFG 192
Query: 242 LS 243
L
Sbjct: 193 LG 194
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 40/178 (22%), Positives = 70/178 (39%), Gaps = 31/178 (17%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVM-DKASLASRNKLLRAQTEREI 147
+N ++ +G G G V+ G T A+K++ ++AS + R E +
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR---EAAL 103
Query: 148 LGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARF------ 200
+ D+P + L K CL+ E+ + G+L+ LR P+ + +
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 201 ---------------FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
A +V + YL V+RDL N LV + + ++DF LS
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 7e-13
Identities = 41/168 (24%), Positives = 68/168 (40%), Gaps = 21/168 (12%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELR--GTNTYFAMKVM-DKASLASRNKLLRAQTEREILG- 149
++ + +G G+ G V ++ G A+K M + AS E E+L
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG---ELEVLCK 81
Query: 150 LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARF-------- 200
L HP + L E + L +E+ GNL LR+ + + A
Sbjct: 82 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 201 -----FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
FA++V ++YL ++RDL N+LV + ++DF LS
Sbjct: 142 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 7e-13
Identities = 40/169 (23%), Positives = 69/169 (40%), Gaps = 33/169 (19%)
Query: 94 SNFRLLKRLGYGDIGSVYL-VELRGTNTYFAMKVMDKASLASRNKL-LRAQTE------- 144
+ + +G G G V+ +L+ + A+K ++ ++ E
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALK-----------RVRVQTGEEGMPLSTI 59
Query: 145 REI-----LGLLDHPFLPTLY------SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYF 193
RE+ L +HP + L+ K LV E +L + K P
Sbjct: 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT-LVFEHVDQ-DLTTYLDKVPEPGV 117
Query: 194 TEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242
+ + ++L L++LH +V+RDLKP+N+LV G I L+DF L
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 31/145 (21%), Positives = 50/145 (34%), Gaps = 36/145 (24%)
Query: 329 THE-----YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVVG 380
T Y APE++ + + VD W+ G E+ F+G + L +V+G
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 381 QP-------------LRFPETPQVSF---------VARDLIRGLLVKEPHKRIAYKRGAT 418
P F + +DL+ L P KRI+ A
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AY 292
Query: 419 EIKQHPFFEGVNWALVRSALPPHIP 443
HP+F+ + + L H+P
Sbjct: 293 SALSHPYFQDLE--RCKENLDSHLP 315
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 7e-13
Identities = 35/167 (20%), Positives = 64/167 (38%), Gaps = 17/167 (10%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVM-DKASLASRNKLLRAQTE 144
+ N L++ LG+G G VY ++ G + A+K + + S L E
Sbjct: 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM---E 83
Query: 145 REILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQP----NKYFTEDAAR 199
I+ +H + ++ME +GG+L S LR+ +P
Sbjct: 84 ALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 143
Query: 200 FFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIML---SDFDLS 243
A ++ +YL ++RD+ N L+ G + DF ++
Sbjct: 144 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 44/155 (28%), Positives = 68/155 (43%), Gaps = 11/155 (7%)
Query: 94 SNFRLLK-RLGYGDIGSVYLVELRGTN--TYFAMKVM-DKASLASRNKLLRAQTEREILG 149
N + LG G+ GSV R A+KV+ A +++R E +I+
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR---EAQIMH 65
Query: 150 LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEVLLA 208
LD+P++ L + + LVME GG LH L K+ +V +
Sbjct: 66 QLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMG 122
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++YL V+RDL NVL+ + + +SDF LS
Sbjct: 123 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 31/166 (18%), Positives = 57/166 (34%), Gaps = 21/166 (12%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYF-------AMKVMDKASLASRNKLLRAQTERE 146
+ + LG G ++ R Y +KV+DKA
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE---AAS 64
Query: 147 ILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARFFASEV 205
++ L H L Y LV EF G+L + L++ + A ++
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC--INILWKLEVAKQL 122
Query: 206 LLALEYLHMLGIVYRDLKPENVLVRDEGHIM--------LSDFDLS 243
A+ +L +++ ++ +N+L+ E LSD +S
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 31/155 (20%), Positives = 58/155 (37%), Gaps = 20/155 (12%)
Query: 96 FRLLKRLGYGDIGSVYLV-ELRGTNTYFAMKVMDKASLASRNK---LLRAQTEREILGLL 151
+ ++ LG G G V + + A+K++ RN A+ E +L +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKII-------RNVGKYREAARLEINVLKKI 73
Query: 152 -------DHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASE 204
+ + +F C+ E G N ++ + + R A +
Sbjct: 74 KEKDKENKFLCV-LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 205 VLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSD 239
+ AL +LH + + DLKPEN+L + L +
Sbjct: 132 LCHALRFLHENQLTHTDLKPENILFVNSEFETLYN 166
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 31/140 (22%), Positives = 45/140 (32%), Gaps = 46/140 (32%)
Query: 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR---ATLFNVVGQP------ 382
Y PE+I G D W+ G L+E G T F+ NR + ++G
Sbjct: 205 YRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIH 264
Query: 383 ------------LRFPETPQVSFVAR---------------------DLIRGLLVKEPHK 409
L + E + DL+R +L +P +
Sbjct: 265 RTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324
Query: 410 RIAYKRGATEIKQHPFFEGV 429
RI E HPFF G+
Sbjct: 325 RIT----LAEALLHPFFAGL 340
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 42/164 (25%), Positives = 70/164 (42%), Gaps = 17/164 (10%)
Query: 94 SNFRLLKRLGYGDIGSVY---LVELRGTNTYFAMKVM--DKASLASRNKLLRAQTEREIL 148
+ L K LG G+ GSV L + GT+ A+K M D +S + L E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS---EAACM 90
Query: 149 GLLDHPFLPTLY-----SYFETDKFYCLVMEFCSGGNLHS-LRQKQPN---KYFTEDAAR 199
HP + L + +++ F G+LH+ L + K+
Sbjct: 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150
Query: 200 FFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
F ++ L +EYL ++RDL N ++RD+ + ++DF LS
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 39/164 (23%), Positives = 71/164 (43%), Gaps = 18/164 (10%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMK--VMDKASLASRN----KLLRAQTERE 146
S + LK LG G G V+ + A+K V+ K++R
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 147 ILGLLD------HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARF 200
I+ + + + S E + Y +V E+ +L ++ ++ P E+ AR
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVY-IVQEYM-ETDLANVLEQGP---LLEEHARL 124
Query: 201 FASEVLLALEYLHMLGIVYRDLKPENVLVRDEG-HIMLSDFDLS 243
F ++L L+Y+H +++RDLKP N+ + E + + DF L+
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 24/133 (18%), Positives = 37/133 (27%), Gaps = 37/133 (27%)
Query: 327 VGTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKG-----QGNRATLFNVVG 380
+ T Y +P ++ + A+D W G E+L G T F G Q + +
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL--ILESIP 242
Query: 381 QP----------------LRFPETPQVSF---------VARDLIRGLLVKEPHKRIAYKR 415
P A D + +L P R+
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT--- 299
Query: 416 GATEIKQHPFFEG 428
A E HP+
Sbjct: 300 -AEEALSHPYMSI 311
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 41/160 (25%), Positives = 66/160 (41%), Gaps = 15/160 (9%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMK--VMDKA-----SLASRN-KLLRAQTE 144
+S + L ++G G G V+ R T A+K +M+ A R K+L+
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 145 REILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQ--KQPNKYFTEDAARFFA 202
++ L++ Y LV +FC H L FT +
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIY-LVFDFCE----HDLAGLLSNVLVKFTLSEIKRVM 130
Query: 203 SEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242
+L L Y+H I++RD+K NVL+ +G + L+DF L
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 33/178 (18%), Positives = 53/178 (29%), Gaps = 48/178 (26%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHE-----YLAPEIIRGEGH-GSAVDWWTFGIF 355
DFG L + N + + T+ Y PE++ GE G +D W G
Sbjct: 167 DFG------LARAFSLAKNSQPNRY--TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 218
Query: 356 LYELLHGTTPFKGQGNRATL---FNVVGQP----------------LRFPETPQVSF--- 393
+ E+ + +G + L + G L + +
Sbjct: 219 MAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDR 278
Query: 394 --------VARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIP 443
A DLI LLV +P +RI + + H FF +
Sbjct: 279 LKAYVRDPYALDLIDKLLVLDPAQRID----SDDALNHDFFWSDPMPSDLKGMLSTHL 332
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 37/165 (22%), Positives = 68/165 (41%), Gaps = 18/165 (10%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYF---AMKVM--DKASLASRNKLLRAQTEREIL 148
F L + LG G+ GSV +L+ + F A+K++ D + + + LR E +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR---EAACM 79
Query: 149 GLLDHPFLPTLY------SYFETDKFYCLVMEFCSGGNLHS-LRQKQPN---KYFTEDAA 198
DHP + L +++ F G+LH+ L +
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 199 RFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
F ++ +EYL ++RDL N ++ ++ + ++DF LS
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 49/245 (20%), Positives = 90/245 (36%), Gaps = 11/245 (4%)
Query: 3 PLTKPRTNSITNQRPLPSQKKPPNSEPSTVTMPGDIKHANSLTNHGHGSSNCSSRSDSLE 62
+ + + S P T+ + ++L + G+ +
Sbjct: 246 LIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARIT-SPDK 304
Query: 63 SSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLK-RLGYGDIGSVYLVELRGTNTY 121
P+ D + + + N + LG G+ GSV R
Sbjct: 305 PRPMPMDTSVFESPFSDP-EELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQ 363
Query: 122 F--AMKVM-DKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSG 178
A+KV+ A +++R E +I+ LD+P++ L + + LVME G
Sbjct: 364 IDVAIKVLKQGTEKADTEEMMR---EAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGG 419
Query: 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLS 238
G LH + + + A +V + ++YL V+R+L NVL+ + + +S
Sbjct: 420 GPLHKFLVGKREEIPVSNVAEL-LHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKIS 478
Query: 239 DFDLS 243
DF LS
Sbjct: 479 DFGLS 483
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 40/175 (22%), Positives = 64/175 (36%), Gaps = 22/175 (12%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRN-----KLLRAQ-TEREI 147
S + + + + G G+V + A+K + R + REI
Sbjct: 22 SPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 148 --LGLLDHP--------FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDA 197
L HP F+ K Y LV E +L + Q +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMH--KLY-LVTELM-RTDLAQVIHDQ-RIVISPQH 135
Query: 198 ARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252
++F +LL L LH G+V+RDL P N+L+ D I + DF+L+ +
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 34/160 (21%), Positives = 52/160 (32%), Gaps = 47/160 (29%)
Query: 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGH-GSAVDWWTFGIFLYELL 360
DF +V Y APE++ VD W+ G + E+
Sbjct: 177 DFNLAREDTADANKTH--------YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228
Query: 361 HGTTPFKG-----QGNRATLFNVVGQP------------------LRFPETPQVSF---- 393
+ F+G Q N+ + VVG P P ++
Sbjct: 229 NRKALFRGSTFYNQLNK--IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVV 286
Query: 394 -----VARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428
VA DLI +L P +RI+ + +HP+FE
Sbjct: 287 PTADPVALDLIAKMLEFNPQRRIS----TEQALRHPYFES 322
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 42/159 (26%), Positives = 63/159 (39%), Gaps = 22/159 (13%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
NF +G+G G VY LR A+K S + +TE E L HP
Sbjct: 40 NFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEEF---ETEIETLSFCRHP 95
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNL--HSLRQKQPNKYFT--------EDAARFFASE 204
L +L + + L+ ++ GNL H P + AAR
Sbjct: 96 HLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR----- 150
Query: 205 VLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
L YLH I++RD+K N+L+ + ++DF +S
Sbjct: 151 ---GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 40/173 (23%), Positives = 67/173 (38%), Gaps = 26/173 (15%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRG-------TNTYFAMKVM-DKASLASRNKLLRAQTER 145
L K LG G G V + E G A+K++ D A+ + L+ E
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS---EM 91
Query: 146 EIL-GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARF--- 200
E++ + H + L D +++E+ S GNL LR ++P
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 201 ----------FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++ +EYL ++RDL NVLV + + ++DF L+
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 8e-12
Identities = 44/178 (24%), Positives = 72/178 (40%), Gaps = 31/178 (17%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVM-DKASLASRNKLLRAQTEREI 147
N L K LG G+ G V T A+K++ + AS + LL E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS---EFNV 79
Query: 148 LGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARF------ 200
L ++HP + LY D L++E+ G+L LR+ + +
Sbjct: 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 201 ---------------FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
FA ++ ++YL + +V+RDL N+LV + + +SDF LS
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 9e-12
Identities = 39/172 (22%), Positives = 73/172 (42%), Gaps = 25/172 (14%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVM-DKASLASRNKLLRAQTEREI 147
+L K LG G G V + G T A+K++ + A+ + L+ E +I
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS---ELKI 83
Query: 148 LGLLD-HPFLPTLY-SYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARF---- 200
L + H + L + + +++EFC GNL + LR K+ + A
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 201 ---------FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++ +V +E+L ++RDL N+L+ ++ + + DF L+
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 37/166 (22%), Positives = 66/166 (39%), Gaps = 31/166 (18%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTE-------- 144
+ +R + +LG G G VY TN A+K +R + E
Sbjct: 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKR------------IRLEHEEEGVPGTA 80
Query: 145 -REI--LGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFF 201
RE+ L L H + L S + L+ E+ +L K P+ + + F
Sbjct: 81 IREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSF 137
Query: 202 ASEVLLALEYLHMLGIVYRDLKPENVLV-----RDEGHIMLSDFDL 242
+++ + + H ++RDLKP+N+L+ + + + DF L
Sbjct: 138 LYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 7e-07
Identities = 35/132 (26%), Positives = 49/132 (37%), Gaps = 38/132 (28%)
Query: 329 THE-----YLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVV 379
THE Y PEI+ G H ++VD W+ E+L T F G L F V+
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL 254
Query: 380 GQP---------------LRFPETPQVSFV----------ARDLIRGLLVKEPHKRIAYK 414
G P FP+ + DL+ +L +P KRI+
Sbjct: 255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS-- 312
Query: 415 RGATEIKQHPFF 426
A +HP+F
Sbjct: 313 --AKNALEHPYF 322
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 38/174 (21%), Positives = 68/174 (39%), Gaps = 28/174 (16%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVM-DKASLASRNKLLRAQTEREI 147
+ K LG G G V G A+K++ A L R L+ E ++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKV 79
Query: 148 L-GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARF----- 200
L L +H + L ++ E+C G+L + LR+K+ + ++ +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 201 ----------FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIM-LSDFDLS 243
F+ +V + +L ++RDL N+L+ G I + DF L+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL-THGRITKICDFGLA 192
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 40/173 (23%), Positives = 67/173 (38%), Gaps = 26/173 (15%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRG-------TNTYFAMKVM-DKASLASRNKLLRAQTER 145
L K LG G G V + E G A+K++ D A+ + L+ E
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS---EM 137
Query: 146 EIL-GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARF--- 200
E++ + H + L D +++E+ S GNL LR ++P
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 201 ----------FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
++ +EYL ++RDL NVLV + + ++DF L+
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 42/173 (24%), Positives = 69/173 (39%), Gaps = 26/173 (15%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRG-------TNTYFAMKVM-DKASLASRNKLLRAQTER 145
L K LG G G V L E G T A+K++ A+ + L+ E
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS---EM 125
Query: 146 EIL-GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARF--- 200
E++ + H + L D +++E+ S GNL L+ ++P
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 201 ----------FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
A +V +EYL ++RDL NVLV ++ + ++DF L+
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 39/170 (22%), Positives = 66/170 (38%), Gaps = 24/170 (14%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVM-DKASLASRNKLLRAQTEREI 147
+N + K LG G G V G A+K++ A + L+ E +I
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS---ELKI 102
Query: 148 L-GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARF----- 200
+ L H + L ++ E+C G+L + LR+K A
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 201 ------FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIM-LSDFDLS 243
F+S+V + +L ++RD+ NVL+ GH+ + DF L+
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL-TNGHVAKIGDFGLA 211
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 42/195 (21%), Positives = 73/195 (37%), Gaps = 51/195 (26%)
Query: 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMK-VMDKASLASRNKLLRAQTERE 146
G + L K LG G G V V + FA+K V+ +R E +
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR--------ELD 52
Query: 147 ILGLLDHPFLPTLYSYF--------------------------------------ETDKF 168
I+ +LDH + L YF +K+
Sbjct: 53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY 112
Query: 169 YCLVMEFCSGGNLHSL--RQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPEN 226
++ME+ LH + + + + + ++ A+ ++H LGI +RD+KP+N
Sbjct: 113 LNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQN 171
Query: 227 VLVRDEGHIM-LSDF 240
+LV + + + L DF
Sbjct: 172 LLVNSKDNTLKLCDF 186
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 32/131 (24%), Positives = 52/131 (39%), Gaps = 32/131 (24%)
Query: 325 SFVGTHEYLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVVG 380
+++ + Y APE++ G ++D W+ G EL+ G F G+ + L ++G
Sbjct: 200 AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMG 259
Query: 381 QP--------------LRFPETPQVSF----------VARDLIRGLLVKEPHKRIAYKRG 416
P +RFP + +A DL+ +L EP RI
Sbjct: 260 TPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN---- 315
Query: 417 ATEIKQHPFFE 427
E HPFF+
Sbjct: 316 PYEAMAHPFFD 326
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 44/179 (24%), Positives = 68/179 (37%), Gaps = 33/179 (18%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVM-DKASLASRNKLLRAQTEREI 147
N K LG G G V G + A+K++ +KA + R L+ E ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS---ELKM 101
Query: 148 L-GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTEDAARF----- 200
+ L H + L L+ E+C G+L + LR K+ E
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 201 ---------------FASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIM-LSDFDLS 243
FA +V +E+L V+RDL NVLV G ++ + DF L+
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV-THGKVVKICDFGLA 219
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 5e-10
Identities = 37/166 (22%), Positives = 62/166 (37%), Gaps = 30/166 (18%)
Query: 95 NFR------LLKRLGYGDIGSVYLVELRGT--NTYFAMKVMDKASLASRNKLLRA-QTER 145
NF ++G G G VY +G NT A+K + + +L + E
Sbjct: 26 NFDERPISVGGNKMGEGGFGVVY----KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEI 81
Query: 146 EILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGN----LHSLRQKQPNKYFT-----ED 196
+++ H L L + CLV + G+ L L P + +
Sbjct: 82 KVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQG 141
Query: 197 AARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242
AA + +LH ++RD+K N+L+ + +SDF L
Sbjct: 142 AAN--------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGL 179
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 42/164 (25%), Positives = 68/164 (41%), Gaps = 30/164 (18%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGT---NTYFAMKVMDKASLASRNKLLRAQTEREILGLL 151
NF LG G G VY +G T A+K + + QTE E++ +
Sbjct: 31 NFSNKNILGRGGFGKVY----KGRLADGTLVAVKRLKEERTQGGELQF--QTEVEMISMA 84
Query: 152 DHPFLPTLYSYFETDKFYCLVMEFCSGGNLHS-LRQKQPNKYFTE---------DAARFF 201
H L L + T LV + + G++ S LR++ ++ + +AR
Sbjct: 85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR-- 142
Query: 202 ASEVLLALEYLH---MLGIVYRDLKPENVLVRDEGHIMLSDFDL 242
L YLH I++RD+K N+L+ +E ++ DF L
Sbjct: 143 ------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 7e-09
Identities = 26/196 (13%), Positives = 54/196 (27%), Gaps = 52/196 (26%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVM--------------DKASLASRNKLL 139
+ +++G G G V+ +T A+K++ + +
Sbjct: 20 EKLQRCEKIGEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 140 RAQTEREILGLLDHPFLPTLY-------------------------------SYFETDKF 168
+ + L +F+ D+
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH-MLGIVYRDLKPENV 227
+ +V+EF GG + K + A+ ++ +L L +RDL NV
Sbjct: 138 F-IVLEFEFGGIDLE---QMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 228 LVRDEGHIMLSDFDLS 243
L++ L
Sbjct: 194 LLKKTSLKKLHYTLNG 209
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 8e-09
Identities = 33/161 (20%), Positives = 64/161 (39%), Gaps = 21/161 (13%)
Query: 97 RLLKRLGYGDIGSVYLVELR--GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
++G G G VY + + + +A+K ++ + + A E +L L HP
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHP 78
Query: 155 FLPTLYSYF---ETDKFYCLVMEFCS---GGNLHSLRQKQ---PNKYFTEDAARFFASEV 205
+ +L F K + L+ ++ + R + + ++
Sbjct: 79 NVISLQKVFLSHADRKVW-LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 206 LLALEYLHMLGIVYRDLKPENVLVRDE----GHIMLSDFDL 242
L + YLH +++RDLKP N+LV E G + ++D
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 26/107 (24%), Positives = 44/107 (41%), Gaps = 14/107 (13%)
Query: 134 SRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYF 193
S + A+ E L L +P +Y++ ++ME L+ +R + P++
Sbjct: 144 SVLAIRSARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRVRVENPDEVL 199
Query: 194 TEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240
+L + + GIV+ DL NVLV E I + DF
Sbjct: 200 ---------DMILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDF 236
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 1e-04
Identities = 35/287 (12%), Positives = 74/287 (25%), Gaps = 89/287 (31%)
Query: 163 FETDKFYCLVMEFCSGGNLHSLRQ---KQPNKYFTEDAARFFASEVLLALEYLHMLGI-- 217
FET + ++ L + +D + +L E H++
Sbjct: 9 FETGE-----HQYQYKDILSVFEDAFVDNFDCKDVQDMPK----SILSKEEIDHIIMSKD 59
Query: 218 ----VYR-----DLKPENVLVRDEGHIMLSDFD-----LSLRCSVSPTLVKSSSVSVNNG 263
R K E ++ + ++ ++ + P+++ + +
Sbjct: 60 AVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR-QPSMMTRMYIEQRDR 118
Query: 264 SGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323
+ +Y V R+ P K R+ AL EL R
Sbjct: 119 LYNDNQVF-AKYNV----------SRLQPYLKLRQ-----------ALLEL-------RP 149
Query: 324 MSFVGTH-------EYLAPEIIRGEG----HGSAVDWWTFG---------IFLYELLHGT 363
V ++A ++ + W L +LL+
Sbjct: 150 AKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQI 209
Query: 364 TPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410
P N + + +R LL +P++
Sbjct: 210 DP-----------NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN 245
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 491 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.95 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.81 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.51 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.32 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.21 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.04 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.9 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.8 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.71 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.52 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.48 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.46 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.41 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.13 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.97 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.88 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.85 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.73 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.7 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.69 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.64 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.63 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.56 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.55 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.48 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.44 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.2 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.71 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.75 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 89.81 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.3 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.2 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 85.09 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 81.73 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-73 Score=552.10 Aligned_cols=278 Identities=33% Similarity=0.625 Sum_probs=250.2
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+++|+.|+|||||+++++|++++.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999999999999999999987766666778899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
||||+||+|.+++++. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 111 mEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~-- 186 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-- 186 (311)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT--
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC--
Confidence 9999999999999875 569999999999999999999999999999999999999999999999999997643211
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......++|||+.|
T Consensus 187 ------------------------------------------------------------------~~~~~~~~~GTp~Y 200 (311)
T 4aw0_A 187 ------------------------------------------------------------------KQARANSFVGTAQY 200 (311)
T ss_dssp ------------------------------------------------------------------TCCCBCCCCSCGGG
T ss_pred ------------------------------------------------------------------CcccccCcccCccc
Confidence 11123457999999
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCC
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIA 412 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 412 (491)
||||++.+..|+.++|||||||+||||++|++||.+.+..+.+.+|+...+.+|. .+++++++||.+||++||++|+|
T Consensus 201 mAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~dli~~lL~~dp~~R~t 278 (311)
T 4aw0_A 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE--KFFPKARDLVEKLLVLDATKRLG 278 (311)
T ss_dssp CCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--TCCHHHHHHHHHHSCSSGGGSTT
T ss_pred CCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--ccCHHHHHHHHHHccCCHhHCcC
Confidence 9999999999999999999999999999999999999999999999999888875 49999999999999999999999
Q ss_pred cCC--ChHHhhcCCCcCCCChhhhhccCCCCC
Q 035713 413 YKR--GATEIKQHPFFEGVNWALVRSALPPHI 442 (491)
Q Consensus 413 ~~~--~~~ell~hpff~~~~~~~~~~~~~~~~ 442 (491)
..+ ...+|++||||++++|+.+++..||.+
T Consensus 279 ~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~l 310 (311)
T 4aw0_A 279 CEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310 (311)
T ss_dssp SGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCC
T ss_pred hHHHcCCHHHHCCCCcCCCCHHHhcCCCCCCC
Confidence 321 223479999999999999988777664
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-70 Score=530.74 Aligned_cols=278 Identities=41% Similarity=0.762 Sum_probs=238.4
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEe---CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELR---GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
+..++|++++.||+|+||+||+|++. .+++.||||++++...... ...++.+|+++|+.++|||||+++++|++++
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 34578999999999999999999984 4678999999987644322 2235678999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+|||||||+||+|.+++.+. +.+++.+++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999999999875 569999999999999999999999999999999999999999999999999996432
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
.. .....+++
T Consensus 178 ~~----------------------------------------------------------------------~~~~~~~~ 187 (304)
T 3ubd_A 178 DH----------------------------------------------------------------------EKKAYSFC 187 (304)
T ss_dssp -------------------------------------------------------------------------CCCCSCC
T ss_pred CC----------------------------------------------------------------------Cccccccc
Confidence 11 01223468
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP 407 (491)
||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.+|+...+.+|. .+|+++++||.+||++||
T Consensus 188 GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP 265 (304)
T 3ubd_A 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ--FLSPEAQSLLRMLFKRNP 265 (304)
T ss_dssp CCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSG
T ss_pred cCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC--cCCHHHHHHHHHHcccCH
Confidence 999999999999999999999999999999999999999999999999999988887775 499999999999999999
Q ss_pred CCCCCcC-CChHHhhcCCCcCCCChhhh--hccCCCCCC
Q 035713 408 HKRIAYK-RGATEIKQHPFFEGVNWALV--RSALPPHIP 443 (491)
Q Consensus 408 ~~R~t~~-~~~~ell~hpff~~~~~~~~--~~~~~~~~p 443 (491)
++|+|.. .+++||++||||+++||+.+ ++..||++|
T Consensus 266 ~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 266 ANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp GGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred HHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence 9999943 34689999999999999987 345677765
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-68 Score=524.21 Aligned_cols=262 Identities=23% Similarity=0.432 Sum_probs=230.0
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
.+++|+++++||+|+||+||+|+++.+|+.||||++++.... .....++.+|+++|+.|+|||||+++++|++++.+||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 357999999999999999999999999999999999876544 3456788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
|||||+||+|.+++...+...+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 178 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-- 178 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence 999999999999998776677899999999999999999999999999999999999999999999999999653210
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
.....+++||+.
T Consensus 179 --------------------------------------------------------------------~~~~~~~~GT~~ 190 (350)
T 4b9d_A 179 --------------------------------------------------------------------VELARACIGTPY 190 (350)
T ss_dssp --------------------------------------------------------------------HHHHHHHHSCCT
T ss_pred --------------------------------------------------------------------cccccccCCCcc
Confidence 112235689999
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.+++...+. +....+++++++||.+||++||++||
T Consensus 191 YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~ 269 (350)
T 4b9d_A 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSLHYSYDLRSLVSQLFKRNPRDRP 269 (350)
T ss_dssp TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred ccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHccCChhHCc
Confidence 99999999999999999999999999999999999999998888898877653 23356999999999999999999999
Q ss_pred CcCCChHHhhcCCCcCCC
Q 035713 412 AYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 412 t~~~~~~ell~hpff~~~ 429 (491)
| ++|||+||||+..
T Consensus 270 s----~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 270 S----VNSILEKGFIAKR 283 (350)
T ss_dssp C----HHHHHTSHHHHTT
T ss_pred C----HHHHhcCHHhhcC
Confidence 9 9999999999753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-67 Score=516.89 Aligned_cols=257 Identities=27% Similarity=0.440 Sum_probs=228.7
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.+.|+++++||+|+||+||+|+++.+|+.||||++++..... .+.+.+|+++|+.++|||||+++++|++++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999999999999999997654332 34567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
||||+||+|.+++.. +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 150 mEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--- 223 (346)
T 4fih_A 150 MEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--- 223 (346)
T ss_dssp ECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS---
T ss_pred EeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC---
Confidence 999999999999986 35999999999999999999999999999999999999999999999999999654211
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.....++|||+.|
T Consensus 224 -------------------------------------------------------------------~~~~~~~~GTp~Y 236 (346)
T 4fih_A 224 -------------------------------------------------------------------VPRRKSLVGTPYW 236 (346)
T ss_dssp -------------------------------------------------------------------SCCBCCCCSCGGG
T ss_pred -------------------------------------------------------------------CCcccccccCcCc
Confidence 1122356999999
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC-CcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP-LRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
||||++.+..|+.++|||||||+||||++|++||.+.+..+.+..|.... ..++....+++++++||.+||++||++||
T Consensus 237 mAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ 316 (346)
T 4fih_A 237 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 316 (346)
T ss_dssp CCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred CCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCc
Confidence 99999999999999999999999999999999999998888887776553 33444567999999999999999999999
Q ss_pred CcCCChHHhhcCCCcCCC
Q 035713 412 AYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 412 t~~~~~~ell~hpff~~~ 429 (491)
| ++|||+||||+..
T Consensus 317 t----a~e~l~Hp~~~~~ 330 (346)
T 4fih_A 317 T----AAELLKHPFLAKA 330 (346)
T ss_dssp C----HHHHTTCGGGGGC
T ss_pred C----HHHHhcCHhhcCC
Confidence 9 9999999999743
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-66 Score=501.08 Aligned_cols=255 Identities=31% Similarity=0.501 Sum_probs=217.6
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
+++|++++.||+|+||+||+|+++.+|+.||||++++..........++.+|+++|+.++|||||+++++|++++.+|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 47899999999999999999999999999999999887666666677889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+ +|+|.+++... +.+++.+++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.....
T Consensus 92 mEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--- 165 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--- 165 (275)
T ss_dssp EECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC---
Confidence 9999 78999998875 56999999999999999999999999999999999999999999999999999643210
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
....+.+||+.|
T Consensus 166 --------------------------------------------------------------------~~~~~~~GT~~Y 177 (275)
T 3hyh_A 166 --------------------------------------------------------------------NFLKTSCGSPNY 177 (275)
T ss_dssp -----------------------------------------------------------------------------CTT
T ss_pred --------------------------------------------------------------------CccCCeeECccc
Confidence 012246899999
Q ss_pred cCcchhcCCCC-CCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 333 LAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 333 ~aPE~l~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
||||++.+..| +.++|||||||+||||++|+.||.+.+....+.++....+.+|. .+++++++||.+||++||++||
T Consensus 178 ~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~ 255 (275)
T 3hyh_A 178 AAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK--FLSPGAAGLIKRMLIVNPLNRI 255 (275)
T ss_dssp SCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHSCSSGGGSC
T ss_pred CChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHccCChhHCc
Confidence 99999999887 57999999999999999999999998888888888888877775 4999999999999999999999
Q ss_pred CcCCChHHhhcCCCcC
Q 035713 412 AYKRGATEIKQHPFFE 427 (491)
Q Consensus 412 t~~~~~~ell~hpff~ 427 (491)
| ++|+|+||||+
T Consensus 256 s----~~eil~hpw~k 267 (275)
T 3hyh_A 256 S----IHEIMQDDWFK 267 (275)
T ss_dssp C----HHHHHHCHHHH
T ss_pred C----HHHHHcCcccc
Confidence 9 99999999996
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-66 Score=524.24 Aligned_cols=257 Identities=27% Similarity=0.440 Sum_probs=229.1
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.+.|+++++||+|+||+||+|+++.+|+.||||++.+..... .+.+.+|+++|+.|+|||||+++++|.+++.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 467999999999999999999999999999999997654332 34567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
||||+||+|.++++. +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 227 mEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--- 300 (423)
T 4fie_A 227 MEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--- 300 (423)
T ss_dssp EECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS---
T ss_pred EeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC---
Confidence 999999999999976 35999999999999999999999999999999999999999999999999999654211
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.....++|||+.|
T Consensus 301 -------------------------------------------------------------------~~~~~~~~GTp~Y 313 (423)
T 4fie_A 301 -------------------------------------------------------------------VPRRKSLVGTPYW 313 (423)
T ss_dssp -------------------------------------------------------------------CCCBCCCEECTTT
T ss_pred -------------------------------------------------------------------CccccccccCcCc
Confidence 1122356999999
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC-CcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP-LRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
||||++.+..|+.++|||||||+||||++|++||.+.+..+.+..|.... ..++....+++++++||.+||++||++|+
T Consensus 314 mAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ 393 (423)
T 4fie_A 314 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 393 (423)
T ss_dssp CCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSC
T ss_pred CCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCc
Confidence 99999999999999999999999999999999999998888887776553 34445567999999999999999999999
Q ss_pred CcCCChHHhhcCCCcCCC
Q 035713 412 AYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 412 t~~~~~~ell~hpff~~~ 429 (491)
| ++|||+||||+..
T Consensus 394 t----a~ell~Hp~~~~~ 407 (423)
T 4fie_A 394 T----AAELLKHPFLAKA 407 (423)
T ss_dssp C----HHHHTTCGGGGGC
T ss_pred C----HHHHhcCHHhcCC
Confidence 9 9999999999743
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-65 Score=536.66 Aligned_cols=280 Identities=31% Similarity=0.605 Sum_probs=242.1
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHH---HHHHhhcCCCCccceeeeEEe
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTE---REILGLLDHPFLPTLYSYFET 165 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E---~~il~~l~hp~iv~l~~~~~~ 165 (491)
..+.+++|+++++||+|+||+||+|+++.+|+.||||++++..+........+.+| +.+++.++|||||+++++|++
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 46778999999999999999999999999999999999988765544433444444 566677899999999999999
Q ss_pred CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
.+.+|||||||+||+|..++.+. +.|++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999999999875 5699999999999999999999999999999999999999999999999999965
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
+.. ....+
T Consensus 342 ~~~------------------------------------------------------------------------~~~~t 349 (689)
T 3v5w_A 342 FSK------------------------------------------------------------------------KKPHA 349 (689)
T ss_dssp CSS------------------------------------------------------------------------CCCCS
T ss_pred cCC------------------------------------------------------------------------CCCCC
Confidence 321 11234
Q ss_pred cccccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCc---HHHHHHHHcCCCcCCCCCCCCHHHHHHHHh
Q 035713 326 FVGTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGN---RATLFNVVGQPLRFPETPQVSFVARDLIRG 401 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 401 (491)
+|||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+. ......++...+.+|. .+|+++++||.+
T Consensus 350 ~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~--~~S~~a~dLI~~ 427 (689)
T 3v5w_A 350 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD--SFSPELRSLLEG 427 (689)
T ss_dssp CCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCT--TSCHHHHHHHHH
T ss_pred ccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCc--cCCHHHHHHHHH
Confidence 699999999999974 5799999999999999999999999976432 3445567777777765 499999999999
Q ss_pred hhccCCCCCCCc-CCChHHhhcCCCcCCCChhhh--hccCCCCCCC
Q 035713 402 LLVKEPHKRIAY-KRGATEIKQHPFFEGVNWALV--RSALPPHIPE 444 (491)
Q Consensus 402 ~L~~dP~~R~t~-~~~~~ell~hpff~~~~~~~~--~~~~~~~~p~ 444 (491)
||++||.+|+++ ..+++||++||||+++||+.+ +...||++|.
T Consensus 428 lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~ 473 (689)
T 3v5w_A 428 LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPP 473 (689)
T ss_dssp HTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred HccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCC
Confidence 999999999995 457899999999999999987 4567888885
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-64 Score=485.35 Aligned_cols=255 Identities=23% Similarity=0.400 Sum_probs=218.8
Q ss_pred CCc-eEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe----Cce
Q 035713 94 SNF-RLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET----DKF 168 (491)
Q Consensus 94 ~~y-~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~----~~~ 168 (491)
.+| ++.++||+|+||+||+|+++.+++.||||++.+.... .....++.+|+++|+.|+|||||+++++|++ ++.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 344 7888999999999999999999999999999876543 3456778999999999999999999999975 457
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccccCCCCCEEEcc-CCcEEEeecccccc
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG--IVYRDLKPENVLVRD-EGHIMLSDFDLSLR 245 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~NILl~~-~g~vkL~DFGla~~ 245 (491)
+|||||||+||+|.+++++. +.+++..++.|+.||+.||+|||++| ||||||||+||||+. +|.+||+|||+|+.
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 89999999999999999874 56999999999999999999999998 999999999999984 89999999999853
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
... ....+
T Consensus 182 ~~~------------------------------------------------------------------------~~~~~ 189 (290)
T 3fpq_A 182 KRA------------------------------------------------------------------------SFAKA 189 (290)
T ss_dssp CCT------------------------------------------------------------------------TSBEE
T ss_pred CCC------------------------------------------------------------------------CccCC
Confidence 210 11235
Q ss_pred cccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcC-CCCCCCCHHHHHHHHhhhc
Q 035713 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF-PETPQVSFVARDLIRGLLV 404 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~s~~~~~li~~~L~ 404 (491)
++||+.|||||++.+ .|+.++|||||||+||||+||+.||.+......+.+.+...... .....+++++++||.+||+
T Consensus 190 ~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~ 268 (290)
T 3fpq_A 190 VIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268 (290)
T ss_dssp SCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSC
T ss_pred cccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHcc
Confidence 689999999999875 59999999999999999999999998877766666655443322 2224578999999999999
Q ss_pred cCCCCCCCcCCChHHhhcCCCcCC
Q 035713 405 KEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 405 ~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
+||++||| ++|+|+||||+.
T Consensus 269 ~dP~~R~s----~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 269 QNKDERYS----IKDLLNHAFFQE 288 (290)
T ss_dssp SSGGGSCC----HHHHHTSGGGC-
T ss_pred CChhHCcC----HHHHhcCccccC
Confidence 99999999 999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-64 Score=495.86 Aligned_cols=259 Identities=24% Similarity=0.343 Sum_probs=223.7
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
..+.|++.++||+|+||+||+|+++.+|+.||||++++.... .+|+++|+.|+|||||+++++|++++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 456799999999999999999999999999999999865332 369999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC-cEEEeecccccccCCCC
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG-HIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g-~vkL~DFGla~~~~~~~ 250 (491)
|||||+||+|.++++.. +.|++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+....
T Consensus 128 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp EECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999999999875 5699999999999999999999999999999999999999988 69999999997643211
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
... ......+++||+
T Consensus 206 ~~~-----------------------------------------------------------------~~~~~~~~~GT~ 220 (336)
T 4g3f_A 206 LGK-----------------------------------------------------------------SLLTGDYIPGTE 220 (336)
T ss_dssp -------------------------------------------------------------------------CCCCCCG
T ss_pred ccc-----------------------------------------------------------------ceecCCccccCc
Confidence 000 001123468999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCC-CCCCCCHHHHHHHHhhhccCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP-ETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
.|||||++.+..|+.++|||||||+||||++|++||.+.+....+.+|......+. ..+.+++++++||.+||++||++
T Consensus 221 ~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 300 (336)
T 4g3f_A 221 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVH 300 (336)
T ss_dssp GGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGG
T ss_pred cccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhH
Confidence 99999999999999999999999999999999999999888777888887765432 23569999999999999999999
Q ss_pred CCCcCCChHHh-------------hcCCCcCCC
Q 035713 410 RIAYKRGATEI-------------KQHPFFEGV 429 (491)
Q Consensus 410 R~t~~~~~~el-------------l~hpff~~~ 429 (491)
||| +.|| |+|||+...
T Consensus 301 R~s----a~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 301 RAS----AMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp SCC----HHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred CcC----HHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 999 8887 578998754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-62 Score=495.58 Aligned_cols=265 Identities=25% Similarity=0.370 Sum_probs=223.5
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe------Cc
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET------DK 167 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~------~~ 167 (491)
++|+++++||+|+||+||+|+++.+|+.||||+|++.. .......++.+|+++|+.|+|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 57999999999999999999999999999999997653 334455678899999999999999999998764 36
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+|||||||+ |+|.+++... +.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 8999999995 7899988764 579999999999999999999999999999999999999999999999999996542
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
..... ......+++
T Consensus 210 ~~~~~------------------------------------------------------------------~~~~~~~~~ 223 (398)
T 4b99_A 210 TSPAE------------------------------------------------------------------HQYFMTEYV 223 (398)
T ss_dssp ------------------------------------------------------------------------CCCCCSSC
T ss_pred cCccc------------------------------------------------------------------cccccccce
Confidence 21100 011233569
Q ss_pred cccCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCc--------------------CC
Q 035713 328 GTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR--------------------FP 386 (491)
Q Consensus 328 gt~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~--------------------~~ 386 (491)
||++|||||++.+.. |+.++||||||||+|||++|++||.+.+..+++..|+..... ++
T Consensus 224 GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 303 (398)
T 4b99_A 224 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLP 303 (398)
T ss_dssp CCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSC
T ss_pred eChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCC
Confidence 999999999999865 599999999999999999999999999988888776532111 01
Q ss_pred C---------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 387 E---------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 387 ~---------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
. .+.++++++|||.+||++||++|+| ++|+|+||||+...+.
T Consensus 304 ~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~f~~~~~p 354 (398)
T 4b99_A 304 PRQPVPWETVYPGADRQALSLLGRMLRFEPSARIS----AAAALRHPFLAKYHDP 354 (398)
T ss_dssp CCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCC----HHHHTTSGGGTTTCCG
T ss_pred CcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcC----HHHHhcCHhhCcCCCC
Confidence 0 1357899999999999999999999 9999999999977543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-63 Score=481.68 Aligned_cols=271 Identities=24% Similarity=0.387 Sum_probs=205.5
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc------
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK------ 167 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~------ 167 (491)
++|++++.||+|+||+||+|+++.+|+.||||+++... .....+++.+|+++|+.|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 57999999999999999999999999999999997653 3345567889999999999999999999997543
Q ss_pred ------eEEEEEeccCCCchHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeec
Q 035713 168 ------FYCLVMEFCSGGNLHSLRQKQPN-KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240 (491)
Q Consensus 168 ------~~~lV~E~~~gg~L~~~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DF 240 (491)
++|||||||+||+|.+++..... ...++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 47999999999999999986522 22556778999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCC
Q 035713 241 DLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTN 320 (491)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (491)
|+|+.+.......... ......
T Consensus 163 Gla~~~~~~~~~~~~~----------------------------------------------------------~~~~~~ 184 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVL----------------------------------------------------------TPMPAY 184 (299)
T ss_dssp CCC-----------------------------------------------------------------------------
T ss_pred ccceecCCCccccccc----------------------------------------------------------cccccc
Confidence 9997654322110000 000011
Q ss_pred ccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHH-HHHHHHcCCCcCCCCCCCCHHHHHHH
Q 035713 321 VRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRA-TLFNVVGQPLRFPETPQVSFVARDLI 399 (491)
Q Consensus 321 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~s~~~~~li 399 (491)
.+.++.+||+.|||||++.+..|+.++|||||||+||||++ ||.+..... .+..+....++ +.....++.+.+||
T Consensus 185 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p-~~~~~~~~~~~~li 260 (299)
T 4g31_A 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFP-PLFTQKYPCEYVMV 260 (299)
T ss_dssp -------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCC-HHHHHHCHHHHHHH
T ss_pred cccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCC-CCCcccCHHHHHHH
Confidence 23345699999999999999999999999999999999996 886543322 22333332221 11234567789999
Q ss_pred HhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 400 RGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 400 ~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
.+||++||++||+ +.|||+||||++++|.
T Consensus 261 ~~~L~~dP~~Rps----~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 261 QDMLSPSPMERPE----AINIIENAVFEDLDFP 289 (299)
T ss_dssp HHHTCSSGGGSCC----HHHHHTSGGGCCC---
T ss_pred HHHcCCChhHCcC----HHHHhcCHhhCCCCCC
Confidence 9999999999999 9999999999999984
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-60 Score=476.21 Aligned_cols=282 Identities=23% Similarity=0.352 Sum_probs=212.1
Q ss_pred CCCceEeeeeeccCceEEEEEEEe---CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCce
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELR---GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKF 168 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~ 168 (491)
.++|+++++||+|+||+||+|+++ .+++.||||++.+.. ...++.+|+++|+.+ +|||||+++++|++.++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 368999999999999999999986 467899999986542 223567899999998 69999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC-CcEEEeecccccccC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE-GHIMLSDFDLSLRCS 247 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~-g~vkL~DFGla~~~~ 247 (491)
+|||||||+||+|.++++ .+++.+++.|+.||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+...
T Consensus 95 ~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 999999999999999884 39999999999999999999999999999999999999876 899999999997654
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
............. ...... ....+ ...........+.+
T Consensus 170 ~~~~~~~~~~~~~----------------------------------~~~~~~-~~~~~-------~~~~~~~~~~~~~~ 207 (361)
T 4f9c_A 170 DTKIELLKFVQSE----------------------------------AQQERC-SQNKC-------SICLSRRQQVAPRA 207 (361)
T ss_dssp TCSCGGGGGC--------------------------------------------------------------------CC
T ss_pred Ccccccccccccc----------------------------------cccccc-ccccc-------cccccccccccccc
Confidence 3221110000000 000000 00000 00001112334569
Q ss_pred cccCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCC-CcHHHHHHHHcC------------------------
Q 035713 328 GTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQ-GNRATLFNVVGQ------------------------ 381 (491)
Q Consensus 328 gt~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~-~~~~~~~~i~~~------------------------ 381 (491)
||++|||||++.+.. |+.++||||||||+|||++|+.||.+. +..+++.+|...
T Consensus 208 GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p 287 (361)
T 4f9c_A 208 GTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVP 287 (361)
T ss_dssp CCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCC
T ss_pred cCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCc
Confidence 999999999998865 899999999999999999999999654 444444433210
Q ss_pred ----------------------------CCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 382 ----------------------------PLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 382 ----------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
....+....++++++|||.+||++||++|+| ++|+|+||||++++
T Consensus 288 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~t----a~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 288 AQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRIT----AEEALLHPFFKDMS 360 (361)
T ss_dssp CCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCC----HHHHHTSGGGTTC-
T ss_pred chhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcCcccCCCC
Confidence 0011123468999999999999999999999 99999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=469.04 Aligned_cols=288 Identities=38% Similarity=0.712 Sum_probs=250.9
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
+.+++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+++|+.++||||++++++|.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 35689999999999999999999999999999999998765555556677889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
|||||++||+|..++... +.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++.....
T Consensus 82 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 158 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence 999999999999988764 56999999999999999999999999999999999999999999999999998542110
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
.....+.+||+
T Consensus 159 ---------------------------------------------------------------------~~~~~~~~gt~ 169 (337)
T 1o6l_A 159 ---------------------------------------------------------------------GATMKTFCGTP 169 (337)
T ss_dssp ---------------------------------------------------------------------TCCBCCCEECG
T ss_pred ---------------------------------------------------------------------CCcccccccCh
Confidence 01122458999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.......++...+.+|. .+++++++||.+||+.||.+|
T Consensus 170 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R 247 (337)
T 1o6l_A 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQR 247 (337)
T ss_dssp GGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSTTTS
T ss_pred hhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHHHh
Confidence 999999999999999999999999999999999999998888888888888777775 499999999999999999999
Q ss_pred CCcC-CChHHhhcCCCcCCCChhhh--hccCCCCCCC---CCCCCCCC
Q 035713 411 IAYK-RGATEIKQHPFFEGVNWALV--RSALPPHIPE---PVDFSVFA 452 (491)
Q Consensus 411 ~t~~-~~~~ell~hpff~~~~~~~~--~~~~~~~~p~---~~~~~~~~ 452 (491)
++.. ..+++|++||||++++|..+ +...||+.|. +.|...|.
T Consensus 248 ~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~~d~~~f~ 295 (337)
T 1o6l_A 248 LGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295 (337)
T ss_dssp TTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSC
T ss_pred cCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCcchhhccc
Confidence 9321 12999999999999999977 3456777775 34555554
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-60 Score=502.66 Aligned_cols=264 Identities=29% Similarity=0.446 Sum_probs=236.1
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
+++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+|+++|+.|+|||||+|+++|++++.+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 5789999999999999999999999999999999976542 3345678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC--CcEEEeecccccccCCCC
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE--GHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~--g~vkL~DFGla~~~~~~~ 250 (491)
||||+||+|.+++... .+.|++.+++.|+.||+.||+|||++||+||||||+||||+.+ |.+||+|||+|+.+...
T Consensus 233 ~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 233 YEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp EECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred EeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 9999999999988654 3569999999999999999999999999999999999999854 89999999999754321
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
....+.+||+
T Consensus 311 ----------------------------------------------------------------------~~~~~~~GT~ 320 (573)
T 3uto_A 311 ----------------------------------------------------------------------QSVKVTTGTA 320 (573)
T ss_dssp ----------------------------------------------------------------------SEEEEECSSG
T ss_pred ----------------------------------------------------------------------CceeeeEECc
Confidence 1123468999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCC--CCCCHHHHHHHHhhhccCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPET--PQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~ 408 (491)
.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+.+|....+.++.. ..+++++++||.+||++||.
T Consensus 321 ~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~ 400 (573)
T 3uto_A 321 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPN 400 (573)
T ss_dssp GGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGG
T ss_pred cccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChh
Confidence 9999999999999999999999999999999999999999999999998877666543 57999999999999999999
Q ss_pred CCCCcCCChHHhhcCCCcCCCChhhhh
Q 035713 409 KRIAYKRGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 409 ~R~t~~~~~~ell~hpff~~~~~~~~~ 435 (491)
+||+ +.|+|+||||+..+|....
T Consensus 401 ~R~t----~~e~l~Hpw~~~~~~~~~~ 423 (573)
T 3uto_A 401 TRMT----IHQALEHPWLTPGNAPGRD 423 (573)
T ss_dssp GSCC----HHHHHHSTTTSCCCCTTTT
T ss_pred HCcC----HHHHhcCcCcCCCCCCCch
Confidence 9999 9999999999998886443
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-59 Score=457.40 Aligned_cols=257 Identities=23% Similarity=0.350 Sum_probs=213.6
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
.+++..++|++.++||+|+||+||+|+++. .||||+++... ......+.+.+|+++|++++|||||++++++.. +
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D 104 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence 356778899999999999999999998653 49999987543 334566789999999999999999999998754 5
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+|||||||+||+|.+++... ...+++.++..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+|+...
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred eEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 689999999999999999765 3569999999999999999999999999999999999999999999999999996532
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
... ......+.+
T Consensus 184 ~~~--------------------------------------------------------------------~~~~~~~~~ 195 (307)
T 3omv_A 184 RWS--------------------------------------------------------------------GSQQVEQPT 195 (307)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred cCC--------------------------------------------------------------------cceeecccc
Confidence 110 011123458
Q ss_pred cccCccCcchhcCC---CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC----CCCCCHHHHHHHH
Q 035713 328 GTHEYLAPEIIRGE---GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE----TPQVSFVARDLIR 400 (491)
Q Consensus 328 gt~~y~aPE~l~~~---~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~s~~~~~li~ 400 (491)
||+.|||||++.+. .|+.++|||||||+||||+||+.||.+.+....+..++......|. ...+++++.+||.
T Consensus 196 GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~ 275 (307)
T 3omv_A 196 GSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVA 275 (307)
T ss_dssp CCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHH
T ss_pred cCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHH
Confidence 99999999999753 5899999999999999999999999988887777776655444332 2468999999999
Q ss_pred hhhccCCCCCCCcCCChHHhhc
Q 035713 401 GLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 401 ~~L~~dP~~R~t~~~~~~ell~ 422 (491)
+||+.||++||| +.+|++
T Consensus 276 ~cl~~dP~~RPs----~~ei~~ 293 (307)
T 3omv_A 276 DCVKKVKEERPL----FPQILS 293 (307)
T ss_dssp HHTCSSSTTSCC----HHHHHH
T ss_pred HHcCCCHhHCcC----HHHHHH
Confidence 999999999999 776643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-59 Score=462.22 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=215.6
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEe-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELR-----GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE 164 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 164 (491)
.+..++|.+.++||+|+||+||+|+++ .+++.||||+++... ....+.+.+|+++|++|+|||||++++++.
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 355678999999999999999999975 368899999997542 345567889999999999999999999999
Q ss_pred eCceEEEEEeccCCCchHHHHHhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc
Q 035713 165 TDKFYCLVMEFCSGGNLHSLRQKQP-------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD 231 (491)
Q Consensus 165 ~~~~~~lV~E~~~gg~L~~~~~~~~-------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~ 231 (491)
+++.+|||||||++|+|.++++... .+.+++.++..|+.||+.||.|||+++||||||||+||||+.
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 9999999999999999999987642 245999999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCC
Q 035713 232 EGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGAL 311 (491)
Q Consensus 232 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (491)
++.+||+|||+|+.......
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~------------------------------------------------------------ 213 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDY------------------------------------------------------------ 213 (329)
T ss_dssp TTEEEECCCC----------------------------------------------------------------------
T ss_pred CCcEEEcccccceeccCCCc------------------------------------------------------------
Confidence 99999999999965421110
Q ss_pred CccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCC
Q 035713 312 PELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQ 390 (491)
Q Consensus 312 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 390 (491)
.....+.+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+..+. +.+....
T Consensus 214 --------~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~-~~~~p~~ 284 (329)
T 4aoj_A 214 --------YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR-ELERPRA 284 (329)
T ss_dssp --------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC-CCCCCTT
T ss_pred --------ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCccc
Confidence 011223579999999999999999999999999999999999 999999988887777776542 3333456
Q ss_pred CCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 391 VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 391 ~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
+++++.+||.+||+.||++||| ++||+++
T Consensus 285 ~~~~~~~li~~cl~~dP~~RPs----~~ei~~~ 313 (329)
T 4aoj_A 285 CPPEVYAIMRGCWQREPQQRHS----IKDVHAR 313 (329)
T ss_dssp CCHHHHHHHHHHCCSSTTTSCC----HHHHHHH
T ss_pred ccHHHHHHHHHHcCcChhHCcC----HHHHHHH
Confidence 9999999999999999999999 8888764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-59 Score=467.78 Aligned_cols=288 Identities=36% Similarity=0.702 Sum_probs=248.3
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~ 169 (491)
+.+++|++++.||+|+||+||+|+++.+++.||||++++...........+.+|+++|+.+ +||||++++++|.+.+.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 4568999999999999999999999999999999999887666666777788999999988 699999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
||||||++||+|..++... +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++....
T Consensus 100 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~- 176 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC- 176 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc-
Confidence 9999999999999998874 5699999999999999999999999999999999999999999999999999853211
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
......+.+||
T Consensus 177 ---------------------------------------------------------------------~~~~~~~~~gt 187 (353)
T 3txo_A 177 ---------------------------------------------------------------------NGVTTATFCGT 187 (353)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred ---------------------------------------------------------------------CCccccccCCC
Confidence 01122346899
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+.+++...+.+|.. ++.++.+||++||++||.+
T Consensus 188 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~lL~~dP~~ 265 (353)
T 3txo_A 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW--LHEDATGILKSFMTKNPTM 265 (353)
T ss_dssp GGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--SCHHHHHHHHHHTCSSGGG
T ss_pred cCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHHhhhCHHH
Confidence 99999999999999999999999999999999999999999999999999988887754 9999999999999999999
Q ss_pred CCCc--CCChHHhhcCCCcCCCChhhh--hccCCCCCCC---CCCCCCCC
Q 035713 410 RIAY--KRGATEIKQHPFFEGVNWALV--RSALPPHIPE---PVDFSVFA 452 (491)
Q Consensus 410 R~t~--~~~~~ell~hpff~~~~~~~~--~~~~~~~~p~---~~~~~~~~ 452 (491)
|++. ..++++|++||||++++|..+ +...||+.|. +.|...|.
T Consensus 266 R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~~~~~f~ 315 (353)
T 3txo_A 266 RLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFD 315 (353)
T ss_dssp STTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSC
T ss_pred ccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCCCcccccccC
Confidence 9994 234499999999999999977 4556777765 34455543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-59 Score=457.38 Aligned_cols=260 Identities=22% Similarity=0.327 Sum_probs=220.0
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEe-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELR-----GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE 164 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 164 (491)
.+..++|.+.++||+|+||+||+|++. .++..||||+++... ....+.+.+|+++|++|+|||||++++++.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 455688999999999999999999975 367899999997542 345567889999999999999999999999
Q ss_pred eCceEEEEEeccCCCchHHHHHhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC
Q 035713 165 TDKFYCLVMEFCSGGNLHSLRQKQP-----------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG 233 (491)
Q Consensus 165 ~~~~~~lV~E~~~gg~L~~~~~~~~-----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g 233 (491)
+++.+|||||||+||+|.++++... ...+++.++..|+.||+.||.|||+++||||||||+||||+.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 9999999999999999999997642 34699999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCc
Q 035713 234 HIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPE 313 (491)
Q Consensus 234 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (491)
.+||+|||+|+.......
T Consensus 166 ~~Ki~DFGla~~~~~~~~-------------------------------------------------------------- 183 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDY-------------------------------------------------------------- 183 (299)
T ss_dssp CEEECCCSCHHHHTGGGC--------------------------------------------------------------
T ss_pred cEEECCcccceecCCCCc--------------------------------------------------------------
Confidence 999999999965421110
Q ss_pred cccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCC
Q 035713 314 LMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVS 392 (491)
Q Consensus 314 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 392 (491)
.......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+..+.. .+....++
T Consensus 184 ------~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~-~~~p~~~~ 256 (299)
T 4asz_A 184 ------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV-LQRPRTCP 256 (299)
T ss_dssp ------EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC-CCCCTTCC
T ss_pred ------eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-CCCCccch
Confidence 001123479999999999999999999999999999999999 9999999888887777766542 23334699
Q ss_pred HHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcC
Q 035713 393 FVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 393 ~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~ 427 (491)
+++.+||.+||+.||++||+ +++|. +|++
T Consensus 257 ~~~~~li~~cl~~dP~~RPs----~~~i~--~~L~ 285 (299)
T 4asz_A 257 QEVYELMLGCWQREPHMRKN----IKGIH--TLLQ 285 (299)
T ss_dssp HHHHHHHHHHTCSSGGGSCC----HHHHH--HHHH
T ss_pred HHHHHHHHHHcCCChhHCcC----HHHHH--HHHH
Confidence 99999999999999999999 88884 4554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-59 Score=479.64 Aligned_cols=296 Identities=35% Similarity=0.637 Sum_probs=253.4
Q ss_pred CCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 87 RGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 87 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
....+..++|+++++||+|+||+||+|+++.+++.||||++++...........+.+|+.+|+.++||||++++++|.++
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 34456678999999999999999999999999999999999876554444445578899999999999999999999999
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
+.+||||||++||+|.+++... .+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+..
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 9999999999999999999874 356999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
..... ......
T Consensus 226 ~~~~~---------------------------------------------------------------------~~~~~~ 236 (437)
T 4aw2_A 226 MEDGT---------------------------------------------------------------------VQSSVA 236 (437)
T ss_dssp CTTSC---------------------------------------------------------------------EECCSC
T ss_pred ccCCC---------------------------------------------------------------------cccccc
Confidence 21110 112235
Q ss_pred ccccCccCcchhc-----CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC--CcCCCC-CCCCHHHHHH
Q 035713 327 VGTHEYLAPEIIR-----GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP--LRFPET-PQVSFVARDL 398 (491)
Q Consensus 327 ~gt~~y~aPE~l~-----~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~-~~~s~~~~~l 398 (491)
+||+.|+|||++. ...|+.++|||||||++|||++|+.||.+.+..+.+.+++... +.+|.. ..+++++++|
T Consensus 237 ~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dL 316 (437)
T 4aw2_A 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDL 316 (437)
T ss_dssp CSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHH
T ss_pred cCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHH
Confidence 8999999999997 4568999999999999999999999999998888888887532 444443 4589999999
Q ss_pred HHhhhccCCCC--CCCcCCChHHhhcCCCcCCCChhhhhccCCCCCCC---CCCCCCCCCCch
Q 035713 399 IRGLLVKEPHK--RIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE---PVDFSVFAGKDQ 456 (491)
Q Consensus 399 i~~~L~~dP~~--R~t~~~~~~ell~hpff~~~~~~~~~~~~~~~~p~---~~~~~~~~~~~~ 456 (491)
|++||+.+|++ |++ ++|+++||||++++|+.++...||++|. +.|.+.|...+.
T Consensus 317 i~~lL~~~~~r~~r~~----~~eil~Hpff~~i~w~~l~~~~~p~~P~~~~~~d~~~fd~~~~ 375 (437)
T 4aw2_A 317 IRRLICSREHRLGQNG----IEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDD 375 (437)
T ss_dssp HHTTSSCGGGCTTTTT----THHHHTSGGGTTCCTTTGGGSCCSCCCCCSSTTCCTTSCCC--
T ss_pred HHHHhcccccccCCCC----HHHHhCCCccCCCCHHHHhhCCCCCCCcCCCccchhhcCCccc
Confidence 99999998888 888 9999999999999999998888888875 556777766543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=463.38 Aligned_cols=286 Identities=36% Similarity=0.724 Sum_probs=240.3
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCce
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKF 168 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~ 168 (491)
.+..++|++++.||+|+||.||+|+++.+|+.||||++++...........+.+|+++|+.+ +||||++++++|++.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 34668999999999999999999999999999999999876554455566778899999877 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
+||||||++||+|.+++... +.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999999998874 4699999999999999999999999999999999999999999999999999853211
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
. .....+.+|
T Consensus 171 ~----------------------------------------------------------------------~~~~~~~~g 180 (345)
T 1xjd_A 171 G----------------------------------------------------------------------DAKTNTFCG 180 (345)
T ss_dssp T----------------------------------------------------------------------TCCBCCCCS
T ss_pred C----------------------------------------------------------------------CCcccCCCC
Confidence 0 011234689
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCC
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 408 (491)
|+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+....+..+......+|. .++.++++||.+||+.||+
T Consensus 181 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dp~ 258 (345)
T 1xjd_A 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--WLEKEAKDLLVKLFVREPE 258 (345)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHSCSSGG
T ss_pred CcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc--ccCHHHHHHHHHHhcCCHh
Confidence 99999999999999999999999999999999999999999888888888887777765 4999999999999999999
Q ss_pred CCCCcCCChH-HhhcCCCcCCCChhhhh--ccCCCCCCC---CCCCCCCCC
Q 035713 409 KRIAYKRGAT-EIKQHPFFEGVNWALVR--SALPPHIPE---PVDFSVFAG 453 (491)
Q Consensus 409 ~R~t~~~~~~-ell~hpff~~~~~~~~~--~~~~~~~p~---~~~~~~~~~ 453 (491)
+||+ +. +|++||||++++|+.+. ...||+.|. +.|.+.|..
T Consensus 259 ~R~~----~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~d~~~f~~ 305 (345)
T 1xjd_A 259 KRLG----VRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDK 305 (345)
T ss_dssp GSBT----TBSCGGGSGGGTTCCHHHHHTTCSCC-----------------
T ss_pred HcCC----ChHHHHcCccccCCCHHHHhhCCCCCCcCCCCCCcchhhhcch
Confidence 9999 66 99999999999999873 456666664 445555543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-58 Score=467.61 Aligned_cols=288 Identities=38% Similarity=0.677 Sum_probs=238.4
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHH-HhhcCCCCccceeeeEEeCceEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI-LGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~i-l~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
..++|++++.||+|+||+||+|+++.+++.||||++++...........+.+|..+ ++.++||||++++++|.+.+.+|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 45789999999999999999999999999999999988766655666677778877 57789999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
|||||++||+|..++... +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++.....
T Consensus 116 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~- 192 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH- 192 (373)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC-
Confidence 999999999999998874 56999999999999999999999999999999999999999999999999998542110
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
.....+++||+
T Consensus 193 ---------------------------------------------------------------------~~~~~~~~gt~ 203 (373)
T 2r5t_A 193 ---------------------------------------------------------------------NSTTSTFCGTP 203 (373)
T ss_dssp ---------------------------------------------------------------------CCCCCSBSCCC
T ss_pred ---------------------------------------------------------------------CCccccccCCc
Confidence 01123468999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+.+++...+.++. .++.++++||.+||+.||.+|
T Consensus 204 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~lL~~dp~~R 281 (373)
T 2r5t_A 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP--NITNSARHLLEGLLQKDRTKR 281 (373)
T ss_dssp CCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCS--SSCHHHHHHHHHHTCSSGGGS
T ss_pred cccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHHHHHHcccCHHhC
Confidence 999999999999999999999999999999999999999888888889888777764 599999999999999999999
Q ss_pred CCcCCChHHhhcCCCcCCCChhhh--hccCCCCCCC---CCCCCCCCC
Q 035713 411 IAYKRGATEIKQHPFFEGVNWALV--RSALPPHIPE---PVDFSVFAG 453 (491)
Q Consensus 411 ~t~~~~~~ell~hpff~~~~~~~~--~~~~~~~~p~---~~~~~~~~~ 453 (491)
++...++.+|++||||++++|+.+ +...||++|. +.|...|..
T Consensus 282 ~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~d~~~f~~ 329 (373)
T 2r5t_A 282 LGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDP 329 (373)
T ss_dssp TTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCCC---------
T ss_pred CCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCCCcchhhhcCc
Confidence 997777899999999999999977 4456777774 345555553
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-58 Score=467.52 Aligned_cols=289 Identities=36% Similarity=0.715 Sum_probs=244.4
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCce
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKF 168 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~ 168 (491)
.+.+++|+++++||+|+||+||+|+++.+++.||||++++...........+.+|+.+|+.+ +||||++++++|.+.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 35668999999999999999999999999999999999987666666667788999999887 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
+||||||++||+|..++... +.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++....
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999999998874 5699999999999999999999999999999999999999999999999999853211
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
. .....+++|
T Consensus 206 ~----------------------------------------------------------------------~~~~~~~~g 215 (396)
T 4dc2_A 206 P----------------------------------------------------------------------GDTTSTFCG 215 (396)
T ss_dssp T----------------------------------------------------------------------TCCBCCCCB
T ss_pred C----------------------------------------------------------------------CCccccccC
Confidence 0 012234689
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCC---------cHHHHHHHHcCCCcCCCCCCCCHHHHHHH
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQG---------NRATLFNVVGQPLRFPETPQVSFVARDLI 399 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---------~~~~~~~i~~~~~~~~~~~~~s~~~~~li 399 (491)
|+.|+|||++.+..|+.++|||||||++|||++|+.||.+.. .......++...+.+|. .++.++++||
T Consensus 216 t~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li 293 (396)
T 4dc2_A 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASVL 293 (396)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT--TSCHHHHHHH
T ss_pred CcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC--cCCHHHHHHH
Confidence 999999999999999999999999999999999999996432 22344567777777775 4999999999
Q ss_pred HhhhccCCCCCCCcC--CChHHhhcCCCcCCCChhhhh--ccCCCCCCCC---CCCCCCC
Q 035713 400 RGLLVKEPHKRIAYK--RGATEIKQHPFFEGVNWALVR--SALPPHIPEP---VDFSVFA 452 (491)
Q Consensus 400 ~~~L~~dP~~R~t~~--~~~~ell~hpff~~~~~~~~~--~~~~~~~p~~---~~~~~~~ 452 (491)
.+||+.||.+|++.. .+++||++||||++++|+.+. ...||++|.. .|.+.|.
T Consensus 294 ~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~~~d~~~fd 353 (396)
T 4dc2_A 294 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFD 353 (396)
T ss_dssp HHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCSSTTGGGSC
T ss_pred HHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCCccchhhcC
Confidence 999999999999942 246899999999999999873 4567777753 3444554
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-59 Score=475.07 Aligned_cols=292 Identities=33% Similarity=0.653 Sum_probs=252.5
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
...+..++|+++++||+|+||+||+|+++.+++.||||++++...........+.+|+.+|+.++|||||+++++|.+++
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 44567789999999999999999999999999999999998765444444456778999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+||||||++||+|.++++.. .+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++...
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 999999999999999998763 59999999999999999999999999999999999999999999999999986532
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
... .....+.+
T Consensus 220 ~~~---------------------------------------------------------------------~~~~~~~~ 230 (410)
T 3v8s_A 220 KEG---------------------------------------------------------------------MVRCDTAV 230 (410)
T ss_dssp TTS---------------------------------------------------------------------EEECCSCC
T ss_pred cCC---------------------------------------------------------------------cccccCCc
Confidence 110 01122458
Q ss_pred cccCccCcchhcCCC----CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC--CcCCCCCCCCHHHHHHHHh
Q 035713 328 GTHEYLAPEIIRGEG----HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP--LRFPETPQVSFVARDLIRG 401 (491)
Q Consensus 328 gt~~y~aPE~l~~~~----~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~s~~~~~li~~ 401 (491)
||+.|+|||++.+.. |+.++|||||||+||||++|+.||.+.+....+.+|+... +.+|....++.++++||.+
T Consensus 231 gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~ 310 (410)
T 3v8s_A 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA 310 (410)
T ss_dssp SCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred CCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHH
Confidence 999999999998766 7899999999999999999999999998888888887643 5666666799999999999
Q ss_pred hhccCCCC--CCCcCCChHHhhcCCCcCCCChhh--hhccCCCCCCC---CCCCCCCCCCc
Q 035713 402 LLVKEPHK--RIAYKRGATEIKQHPFFEGVNWAL--VRSALPPHIPE---PVDFSVFAGKD 455 (491)
Q Consensus 402 ~L~~dP~~--R~t~~~~~~ell~hpff~~~~~~~--~~~~~~~~~p~---~~~~~~~~~~~ 455 (491)
||+.+|.+ |++ ++||++||||++++|+. .+...||++|. +.|.+.|....
T Consensus 311 lL~~~~~rlgR~~----~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~~~d~~~fd~~~ 367 (410)
T 3v8s_A 311 FLTDREVRLGRNG----VEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLE 367 (410)
T ss_dssp HSSCGGGCTTSSC----HHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSSTTCCTTSCCCC
T ss_pred HccChhhhCCCCC----HHHHhcCccccCCCHHHHhhcccCCCCCCcCCCccchhhcCCcc
Confidence 99998988 999 99999999999999874 46677888875 55666666543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-58 Score=452.90 Aligned_cols=277 Identities=34% Similarity=0.695 Sum_probs=246.0
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
+.+++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|+.++||||++++++|.+.+.+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 35688999999999999999999999999999999998765555455667889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 83 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred EEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 999999999999999874 5699999999999999999999999999999999999999999999999999854211
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
...+.+||+
T Consensus 159 -----------------------------------------------------------------------~~~~~~gt~ 167 (318)
T 1fot_A 159 -----------------------------------------------------------------------VTYTLCGTP 167 (318)
T ss_dssp -----------------------------------------------------------------------CBCCCCSCT
T ss_pred -----------------------------------------------------------------------ccccccCCc
Confidence 112358999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
.|+|||++.+..++.++|||||||++|||++|+.||.+.+....+.+++...+.+|. .++.++.+||.+||+.||.+|
T Consensus 168 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~lL~~dp~~R 245 (318)
T 1fot_A 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP--FFNEDVKDLLSRLITRDLSQR 245 (318)
T ss_dssp TTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSCTTTC
T ss_pred cccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhccCHHHc
Confidence 999999999999999999999999999999999999999888888889888877775 489999999999999999999
Q ss_pred CCcC-CChHHhhcCCCcCCCChhhhh--ccCCCCCCC
Q 035713 411 IAYK-RGATEIKQHPFFEGVNWALVR--SALPPHIPE 444 (491)
Q Consensus 411 ~t~~-~~~~ell~hpff~~~~~~~~~--~~~~~~~p~ 444 (491)
++.. .++++|++||||++++|+.+. ...||+.|.
T Consensus 246 ~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~ 282 (318)
T 1fot_A 246 LGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPP 282 (318)
T ss_dssp TTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCC
T ss_pred CCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCC
Confidence 9432 239999999999999999773 445666664
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-58 Score=453.92 Aligned_cols=259 Identities=21% Similarity=0.315 Sum_probs=219.3
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEe-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELR-----GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE 164 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 164 (491)
++..++++++++||+|+||+||+|++. .+++.||||+++... .....+.+.+|+.+|++++|||||++++++.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 456688999999999999999999964 367899999997542 2233457889999999999999999999999
Q ss_pred eCceEEEEEeccCCCchHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEc
Q 035713 165 TDKFYCLVMEFCSGGNLHSLRQKQP--------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVR 230 (491)
Q Consensus 165 ~~~~~~lV~E~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~ 230 (491)
+++.+|||||||++|+|.+++.... ...+++..+..|+.||+.||+|||+++||||||||+||||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 9999999999999999999997532 23589999999999999999999999999999999999999
Q ss_pred cCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCC
Q 035713 231 DEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGA 310 (491)
Q Consensus 231 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (491)
.++.+||+|||+|+.......
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~----------------------------------------------------------- 200 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADY----------------------------------------------------------- 200 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGC-----------------------------------------------------------
T ss_pred CCCCEEECCcccceeccCCCc-----------------------------------------------------------
Confidence 999999999999965421100
Q ss_pred CCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCC
Q 035713 311 LPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETP 389 (491)
Q Consensus 311 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 389 (491)
.....+.+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+..+. ..+...
T Consensus 201 ---------~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~p~ 270 (308)
T 4gt4_A 201 ---------YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ-VLPCPD 270 (308)
T ss_dssp ---------BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTC-CCCCCT
T ss_pred ---------eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCcc
Confidence 011223589999999999999999999999999999999998 899999998887777766543 344455
Q ss_pred CCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 390 QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 390 ~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
.++.++.+||.+||+.||++||+ +.||+++
T Consensus 271 ~~~~~~~~li~~C~~~dP~~RPs----~~ei~~~ 300 (308)
T 4gt4_A 271 DCPAWVYALMIECWNEFPSRRPR----FKDIHSR 300 (308)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred cchHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 79999999999999999999999 8888765
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=456.98 Aligned_cols=281 Identities=35% Similarity=0.682 Sum_probs=247.7
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~ 169 (491)
+..++|++++.||+|+||+||+|+++.+++.||||++++...........+.+|+++|..+ +||||++++++|++.+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 4568999999999999999999999999999999999887655555667788999999988 799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
||||||++||+|.+++... +.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++.....
T Consensus 97 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 9999999999999998864 45999999999999999999999999999999999999999999999999998532110
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.....+.+||
T Consensus 175 ----------------------------------------------------------------------~~~~~~~~gt 184 (353)
T 2i0e_A 175 ----------------------------------------------------------------------GVTTKTFCGT 184 (353)
T ss_dssp ----------------------------------------------------------------------TCCBCCCCSC
T ss_pred ----------------------------------------------------------------------CcccccccCC
Confidence 0112245899
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+.+++...+.+|. .++.++++||.+||+.||.+
T Consensus 185 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~ 262 (353)
T 2i0e_A 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAICKGLMTKHPGK 262 (353)
T ss_dssp GGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSCTTS
T ss_pred ccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhhcCHHH
Confidence 9999999999999999999999999999999999999999888888899988887775 59999999999999999999
Q ss_pred CCCc-CCChHHhhcCCCcCCCChhhh--hccCCCCCCCC
Q 035713 410 RIAY-KRGATEIKQHPFFEGVNWALV--RSALPPHIPEP 445 (491)
Q Consensus 410 R~t~-~~~~~ell~hpff~~~~~~~~--~~~~~~~~p~~ 445 (491)
|+++ ..++++|++||||++++|+.+ +...||++|..
T Consensus 263 R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~ 301 (353)
T 2i0e_A 263 RLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKA 301 (353)
T ss_dssp CTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred cCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCC
Confidence 9974 234899999999999999987 45567777753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-58 Score=459.24 Aligned_cols=261 Identities=21% Similarity=0.324 Sum_probs=222.6
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCCC-----cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCC-CCccceeee
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTN-----TYFAMKVMDKASLASRNKLLRAQTEREILGLLDH-PFLPTLYSY 162 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~l~~~ 162 (491)
+++..++|+++++||+|+||+||+|++..++ +.||||+++... .......+.+|+++|+.++| ||||+++++
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 4677789999999999999999999987643 679999997653 23445678899999999975 899999999
Q ss_pred EEe-CceEEEEEeccCCCchHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCE
Q 035713 163 FET-DKFYCLVMEFCSGGNLHSLRQKQP--------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENV 227 (491)
Q Consensus 163 ~~~-~~~~~lV~E~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NI 227 (491)
|.. ++.+|||||||++|+|.++++... ...+++..+..|+.||+.||+|||+++||||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 865 467999999999999999997642 24589999999999999999999999999999999999
Q ss_pred EEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCC
Q 035713 228 LVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCV 307 (491)
Q Consensus 228 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (491)
||+.++.+||+|||+|+.+.....
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~-------------------------------------------------------- 240 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPD-------------------------------------------------------- 240 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT--------------------------------------------------------
T ss_pred eeCCCCCEEECcchhhhhcccCCC--------------------------------------------------------
Confidence 999999999999999975432111
Q ss_pred CCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCC
Q 035713 308 GGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFP 386 (491)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 386 (491)
.....+.+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+.+++....+++
T Consensus 241 ------------~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~ 308 (353)
T 4ase_A 241 ------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 308 (353)
T ss_dssp ------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC
T ss_pred ------------ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCC
Confidence 112334689999999999999999999999999999999998 9999998776666666665555555
Q ss_pred CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 387 ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 387 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
....+++++.+||.+||+.||++||| +.+|++|
T Consensus 309 ~p~~~~~~~~~li~~c~~~dP~~RPt----~~eil~~ 341 (353)
T 4ase_A 309 APDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 341 (353)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCcChhHCcC----HHHHHHH
Confidence 55679999999999999999999999 9999987
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-57 Score=452.56 Aligned_cols=281 Identities=37% Similarity=0.733 Sum_probs=243.0
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCce
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKF 168 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~ 168 (491)
.+..++|++++.||+|+||.||+|+++.+++.||||++++...........+.+|+.+|+.+ +||||++++++|.+.+.
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 34568999999999999999999999999999999999987666667777888999999988 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
+||||||++||+|..++... +.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999999998864 4699999999999999999999999999999999999999999999999999853211
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
. .....+.+|
T Consensus 163 ~----------------------------------------------------------------------~~~~~~~~g 172 (345)
T 3a8x_A 163 P----------------------------------------------------------------------GDTTSTFCG 172 (345)
T ss_dssp T----------------------------------------------------------------------TCCBCCCCS
T ss_pred C----------------------------------------------------------------------CCcccccCC
Confidence 0 011224589
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCC---------CcHHHHHHHHcCCCcCCCCCCCCHHHHHHH
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQ---------GNRATLFNVVGQPLRFPETPQVSFVARDLI 399 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~~s~~~~~li 399 (491)
|+.|+|||++.+..|+.++|||||||++|||++|+.||... ........+....+.+|. .++.++++||
T Consensus 173 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li 250 (345)
T 3a8x_A 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASVL 250 (345)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT--TSCHHHHHHH
T ss_pred CccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC--CCCHHHHHHH
Confidence 99999999999999999999999999999999999999752 223344566677777665 5999999999
Q ss_pred HhhhccCCCCCCCcC--CChHHhhcCCCcCCCChhhh--hccCCCCCCC
Q 035713 400 RGLLVKEPHKRIAYK--RGATEIKQHPFFEGVNWALV--RSALPPHIPE 444 (491)
Q Consensus 400 ~~~L~~dP~~R~t~~--~~~~ell~hpff~~~~~~~~--~~~~~~~~p~ 444 (491)
.+||+.||.+|++.. .++++|++||||++++|+.+ +...||+.|.
T Consensus 251 ~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~ 299 (345)
T 3a8x_A 251 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPN 299 (345)
T ss_dssp HHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred HHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCC
Confidence 999999999999942 23589999999999999977 3456677665
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-57 Score=454.24 Aligned_cols=286 Identities=36% Similarity=0.669 Sum_probs=253.9
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
...+++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+++|+.++||||++++++|.+.+.+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 45678999999999999999999999999999999999877655555667788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
||||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~- 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC-
Confidence 9999999999999998874 4599999999999999999999999999999999999999999999999999854311
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
...+.+||
T Consensus 194 ------------------------------------------------------------------------~~~~~~gt 201 (350)
T 1rdq_E 194 ------------------------------------------------------------------------RTWTLCGT 201 (350)
T ss_dssp ------------------------------------------------------------------------CBCCCEEC
T ss_pred ------------------------------------------------------------------------CcccccCC
Confidence 11235899
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
+.|+|||++.+..++.++|||||||++|||++|+.||.+.+....+.++....+.+|. .++.++.+||.+||+.||.+
T Consensus 202 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~lL~~dp~~ 279 (350)
T 1rdq_E 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVDLTK 279 (350)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TCCHHHHHHHHHHSCSCTTT
T ss_pred ccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHHh
Confidence 9999999999999999999999999999999999999999888888888888777765 59999999999999999999
Q ss_pred CCCc-CCChHHhhcCCCcCCCChhhh--hccCCCCCCC---CCCCCCCC
Q 035713 410 RIAY-KRGATEIKQHPFFEGVNWALV--RSALPPHIPE---PVDFSVFA 452 (491)
Q Consensus 410 R~t~-~~~~~ell~hpff~~~~~~~~--~~~~~~~~p~---~~~~~~~~ 452 (491)
|++. ..++++|++||||++++|..+ +...||++|. +.|.+.|.
T Consensus 280 R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~f~ 328 (350)
T 1rdq_E 280 RFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328 (350)
T ss_dssp CTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSC
T ss_pred ccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCcccccccc
Confidence 9984 456899999999999999976 3456777764 45566665
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-58 Score=469.72 Aligned_cols=296 Identities=34% Similarity=0.646 Sum_probs=249.9
Q ss_pred cCCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 035713 86 LRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET 165 (491)
Q Consensus 86 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 165 (491)
+....+..++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+++|..++||||++++++|++
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 34455677999999999999999999999999999999999987655555555667899999999999999999999999
Q ss_pred CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
.+.+||||||++||+|.+++... +..+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++.
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLK 211 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhee
Confidence 99999999999999999999864 24699999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
..... ......
T Consensus 212 ~~~~~---------------------------------------------------------------------~~~~~~ 222 (412)
T 2vd5_A 212 LRADG---------------------------------------------------------------------TVRSLV 222 (412)
T ss_dssp CCTTS---------------------------------------------------------------------CEECSS
T ss_pred ccCCC---------------------------------------------------------------------ccccce
Confidence 32111 011223
Q ss_pred cccccCccCcchhc-------CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC--CcCCC-CCCCCHHH
Q 035713 326 FVGTHEYLAPEIIR-------GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP--LRFPE-TPQVSFVA 395 (491)
Q Consensus 326 ~~gt~~y~aPE~l~-------~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~-~~~~s~~~ 395 (491)
.+||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+..+.+.+|+... +.+|. ...++.++
T Consensus 223 ~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~ 302 (412)
T 2vd5_A 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEA 302 (412)
T ss_dssp CCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHH
T ss_pred eccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHH
Confidence 58999999999998 3568999999999999999999999999998888888877532 34443 24699999
Q ss_pred HHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhhhccCCCCCCC---CCCCCCCCC
Q 035713 396 RDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE---PVDFSVFAG 453 (491)
Q Consensus 396 ~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~~~~~~~~~p~---~~~~~~~~~ 453 (491)
++||.+||+ +|.+|++ +.+++||++||||++++|+.++...||++|. +.|...|..
T Consensus 303 ~dli~~lL~-~p~~Rlg-r~~~~ei~~Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~ 361 (412)
T 2vd5_A 303 RDFIQRLLC-PPETRLG-RGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFEGATDTCNFDL 361 (412)
T ss_dssp HHHHHTTSS-CGGGCTT-TTTHHHHHTSGGGTTCCSTTSTTSCCSCCCC-----CCSSCC-
T ss_pred HHHHHHHcC-ChhhcCC-CCCHHHHhcCCCcCCCCHHHHhhcCCCCCCcCCCcccccccCc
Confidence 999999999 9999963 1129999999999999999998888998886 345566654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-56 Score=450.05 Aligned_cols=279 Identities=29% Similarity=0.619 Sum_probs=242.0
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCce
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKF 168 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~ 168 (491)
..+..++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+++|+.++|||||+++++|.+.+.
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34567899999999999999999999999999999999988766666667788899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
+|+||||+.||+|..++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.+..
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999999998874 5699999999999999999999999999999999999999999999999999864321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
. ....+.+|
T Consensus 168 ~-----------------------------------------------------------------------~~~~~~~g 176 (384)
T 4fr4_A 168 E-----------------------------------------------------------------------TQITTMAG 176 (384)
T ss_dssp T-----------------------------------------------------------------------CCBCCCCS
T ss_pred C-----------------------------------------------------------------------CceeccCC
Confidence 0 11224589
Q ss_pred ccCccCcchhcC---CCCCCcccccchhhHHHhhhcCCCCCCCCC---cHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhh
Q 035713 329 THEYLAPEIIRG---EGHGSAVDWWTFGIFLYELLHGTTPFKGQG---NRATLFNVVGQPLRFPETPQVSFVARDLIRGL 402 (491)
Q Consensus 329 t~~y~aPE~l~~---~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~ 402 (491)
|+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.. ....+..+......+|. .++.++.+||.+|
T Consensus 177 t~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~--~~s~~~~~li~~l 254 (384)
T 4fr4_A 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS--AWSQEMVSLLKKL 254 (384)
T ss_dssp CGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHH
T ss_pred CccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCC--cCCHHHHHHHHHH
Confidence 999999999974 458999999999999999999999997543 33444555556566654 4899999999999
Q ss_pred hccCCCCCCCcCCChHHhhcCCCcCCCChhhh--hccCCCCCCCC
Q 035713 403 LVKEPHKRIAYKRGATEIKQHPFFEGVNWALV--RSALPPHIPEP 445 (491)
Q Consensus 403 L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~--~~~~~~~~p~~ 445 (491)
|+.||.+||+. ++++++||||++++|+.+ +...||++|..
T Consensus 255 L~~dP~~R~s~---~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~ 296 (384)
T 4fr4_A 255 LEPNPDQRFSQ---LSDVQNFPYMNDINWDAVFQKRLIPGFIPNK 296 (384)
T ss_dssp SCSSGGGSCCS---HHHHHTSGGGTTCCHHHHHTTCSCCCCCCSC
T ss_pred hcCCHhHhccc---HHHHHcChhhhcCCHHHHHhCCCCCCCCCCC
Confidence 99999999984 799999999999999977 45677887764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=464.25 Aligned_cols=285 Identities=31% Similarity=0.628 Sum_probs=248.2
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCce
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKF 168 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~ 168 (491)
..+..++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+++|+.++||||++++++|.+.+.
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 45677899999999999999999999999999999999988766555566778899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 169 YCLVMEFCSGGNLHSLRQKQP--NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
+||||||++||+|..++.... ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++..
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 999999999999999987643 346999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.... ....+.
T Consensus 340 ~~~~----------------------------------------------------------------------~~~~~~ 349 (543)
T 3c4z_A 340 KAGQ----------------------------------------------------------------------TKTKGY 349 (543)
T ss_dssp CTTC----------------------------------------------------------------------CCBCCC
T ss_pred cCCC----------------------------------------------------------------------cccccc
Confidence 2110 011235
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCC----cHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhh
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQG----NRATLFNVVGQPLRFPETPQVSFVARDLIRGL 402 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~ 402 (491)
+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+ .......++.....+|. .++.++++||.+|
T Consensus 350 ~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~l 427 (543)
T 3c4z_A 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFSPASKDFCEAL 427 (543)
T ss_dssp CSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHH
T ss_pred cCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc--ccCHHHHHHHHHh
Confidence 89999999999999999999999999999999999999998763 24455667777666664 5999999999999
Q ss_pred hccCCCCCCCcCC-ChHHhhcCCCcCCCChhhhh--ccCCCCCCCC
Q 035713 403 LVKEPHKRIAYKR-GATEIKQHPFFEGVNWALVR--SALPPHIPEP 445 (491)
Q Consensus 403 L~~dP~~R~t~~~-~~~ell~hpff~~~~~~~~~--~~~~~~~p~~ 445 (491)
|+.||.+||++.. ++++|++||||++++|..+. ...||++|.+
T Consensus 428 L~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~ 473 (543)
T 3c4z_A 428 LQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDS 473 (543)
T ss_dssp SCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCS
T ss_pred ccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCc
Confidence 9999999998643 57999999999999999874 4578888764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-56 Score=459.24 Aligned_cols=290 Identities=37% Similarity=0.704 Sum_probs=238.6
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
.+..++|+++++||+|+||.||+|+++.+|+.||||++.+...........+.+|+++|+.++||||++++++|.+.+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 35568999999999999999999999999999999999876555556667788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
||||||++||+|..++... +.+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+|+....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 9999999999999988764 569999999999999999999998 9999999999999999999999999999853211
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
. .....+.+|
T Consensus 302 ~----------------------------------------------------------------------~~~~~~~~g 311 (446)
T 4ejn_A 302 D----------------------------------------------------------------------GATMKTFCG 311 (446)
T ss_dssp ---------------------------------------------------------------------------CCSSS
T ss_pred C----------------------------------------------------------------------CcccccccC
Confidence 0 001123589
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCC
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 408 (491)
|+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+....+..+......+|. .+++++.+||.+||+.||.
T Consensus 312 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~ 389 (446)
T 4ejn_A 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLGPEAKSLLSGLLKKDPK 389 (446)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSTT
T ss_pred CccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHcccCHH
Confidence 99999999999999999999999999999999999999999888888888888777775 4899999999999999999
Q ss_pred CCCCc-CCChHHhhcCCCcCCCChhhh--hccCCCCCCCC---CCCCCCCC
Q 035713 409 KRIAY-KRGATEIKQHPFFEGVNWALV--RSALPPHIPEP---VDFSVFAG 453 (491)
Q Consensus 409 ~R~t~-~~~~~ell~hpff~~~~~~~~--~~~~~~~~p~~---~~~~~~~~ 453 (491)
+||+. ...++++++||||++++|..+ +...||+.|.. .|...|..
T Consensus 390 ~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~~~~~~~~~~ 440 (446)
T 4ejn_A 390 QRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDE 440 (446)
T ss_dssp TSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSSTTCCTTC--
T ss_pred HhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCCCCccchhhcch
Confidence 99921 011999999999999999876 34556666653 34555544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-55 Score=434.45 Aligned_cols=261 Identities=31% Similarity=0.497 Sum_probs=233.4
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
...++|++++.||+|+||.||+|++..+|+.||||++.+... ......++.+|+++|+.++||||+++++++.+.+.+|
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 346789999999999999999999999999999999987643 3445667889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 999999999999998764 569999999999999999999999999999999999999999999999999985432110
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
.....+||+
T Consensus 169 -----------------------------------------------------------------------~~~~~~gt~ 177 (328)
T 3fe3_A 169 -----------------------------------------------------------------------KLDAFCGAP 177 (328)
T ss_dssp -----------------------------------------------------------------------GGGTTSSSG
T ss_pred -----------------------------------------------------------------------ccccccCCc
Confidence 122358999
Q ss_pred CccCcchhcCCCCC-CcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 331 EYLAPEIIRGEGHG-SAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 331 ~y~aPE~l~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.......+....+.+|. .++.++.+||.+||+.||.+
T Consensus 178 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~ 255 (328)
T 3fe3_A 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF--YMSTDCENLLKRFLVLNPIK 255 (328)
T ss_dssp GGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHCCSSTTT
T ss_pred ceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHCCCChhH
Confidence 99999999998874 7999999999999999999999999888888888888777775 48999999999999999999
Q ss_pred CCCcCCChHHhhcCCCcCCCCh
Q 035713 410 RIAYKRGATEIKQHPFFEGVNW 431 (491)
Q Consensus 410 R~t~~~~~~ell~hpff~~~~~ 431 (491)
||| ++++++||||+...+
T Consensus 256 R~t----~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 256 RGT----LEQIMKDRWINAGHE 273 (328)
T ss_dssp SCC----HHHHTTCTTTTTTCT
T ss_pred CcC----HHHHhcCHhhcCCCc
Confidence 999 999999999986544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=478.24 Aligned_cols=283 Identities=35% Similarity=0.675 Sum_probs=250.0
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCce
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKF 168 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~ 168 (491)
.+.+++|+++++||+|+||.||+|+++.+++.||||++++...........+.+|+++|..+ +||||++++++|++.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 45678999999999999999999999999999999999887655556667788899999988 69999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
+||||||++||+|..+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 99999999999999998875 5699999999999999999999999999999999999999999999999999864211
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
. .....+++|
T Consensus 495 ~----------------------------------------------------------------------~~~~~~~~G 504 (674)
T 3pfq_A 495 D----------------------------------------------------------------------GVTTKTFCG 504 (674)
T ss_dssp T----------------------------------------------------------------------TCCBCCCCS
T ss_pred C----------------------------------------------------------------------CcccccccC
Confidence 0 012234689
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCC
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 408 (491)
|+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..|+...+.+|. .++.++++||.+||++||+
T Consensus 505 T~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~ 582 (674)
T 3pfq_A 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAICKGLMTKHPG 582 (674)
T ss_dssp CSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT--TSCHHHHHHHHHHSCSSST
T ss_pred CCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHccCCHH
Confidence 99999999999999999999999999999999999999999999999999998888876 4999999999999999999
Q ss_pred CCCCc-CCChHHhhcCCCcCCCChhhh--hccCCCCCCCCC
Q 035713 409 KRIAY-KRGATEIKQHPFFEGVNWALV--RSALPPHIPEPV 446 (491)
Q Consensus 409 ~R~t~-~~~~~ell~hpff~~~~~~~~--~~~~~~~~p~~~ 446 (491)
+|++. ..++++|++||||++++|+.+ +...||++|...
T Consensus 583 ~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~ 623 (674)
T 3pfq_A 583 KRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKAS 623 (674)
T ss_dssp TCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCC
T ss_pred HCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCC
Confidence 99994 234599999999999999987 445677877643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=465.20 Aligned_cols=285 Identities=34% Similarity=0.583 Sum_probs=245.7
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
...+..++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+++|+.++|||||+++++|.+.+
T Consensus 178 ~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257 (576)
T ss_dssp TSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence 44567789999999999999999999999999999999998876655556667889999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+||||||++||+|..++.......+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+++...
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999999999887655569999999999999999999999999999999999999999999999999986532
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
... ...+.+
T Consensus 338 ~~~-----------------------------------------------------------------------~~~~~~ 346 (576)
T 2acx_A 338 EGQ-----------------------------------------------------------------------TIKGRV 346 (576)
T ss_dssp TTC-----------------------------------------------------------------------CEECCC
T ss_pred cCc-----------------------------------------------------------------------cccccC
Confidence 110 112348
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCc----HHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhh
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGN----RATLFNVVGQPLRFPETPQVSFVARDLIRGLL 403 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L 403 (491)
||+.|+|||++.+..|+.++|||||||++|||++|+.||.+... ......+...+..++ ..++.++++||.+||
T Consensus 347 GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p--~~~s~~~~dLI~~lL 424 (576)
T 2acx_A 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSPQARSLCSQLL 424 (576)
T ss_dssp SCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHT
T ss_pred CCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC--ccCCHHHHHHHHHhc
Confidence 99999999999999999999999999999999999999987642 334445555555565 359999999999999
Q ss_pred ccCCCCCCCcC-CChHHhhcCCCcCCCChhhhh--ccCCCCCCCC
Q 035713 404 VKEPHKRIAYK-RGATEIKQHPFFEGVNWALVR--SALPPHIPEP 445 (491)
Q Consensus 404 ~~dP~~R~t~~-~~~~ell~hpff~~~~~~~~~--~~~~~~~p~~ 445 (491)
+.||.+|+++. .+++||++||||++++|..+. ...||++|.+
T Consensus 425 ~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~ 469 (576)
T 2acx_A 425 CKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDP 469 (576)
T ss_dssp CSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred cCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCc
Confidence 99999999432 138999999999999999874 4567777764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-55 Score=433.52 Aligned_cols=280 Identities=37% Similarity=0.682 Sum_probs=232.7
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEe---CCCcEEEEEEeecchhh-hHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELR---GTNTYFAMKVMDKASLA-SRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
+..++|++++.||+|+||.||+|++. .+++.||||++++.... .......+.+|+++|+.++||||+++++++.++
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 45588999999999999999999985 68999999999876432 223445677899999999999999999999999
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
+.+||||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++..
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred CEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 9999999999999999998864 46999999999999999999999999999999999999999999999999998532
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.... ......
T Consensus 172 ~~~~----------------------------------------------------------------------~~~~~~ 181 (327)
T 3a62_A 172 IHDG----------------------------------------------------------------------TVTHTF 181 (327)
T ss_dssp -----------------------------------------------------------------------------CTT
T ss_pred ccCC----------------------------------------------------------------------cccccc
Confidence 1100 011235
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+....+.++......++. .++.++++||.+||+.|
T Consensus 182 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~~d 259 (327)
T 3a62_A 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP--YLTQEARDLLKKLLKRN 259 (327)
T ss_dssp SSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHSCSC
T ss_pred CCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHHhcC
Confidence 7999999999999999999999999999999999999999999888888888887777664 58999999999999999
Q ss_pred CCCCCCcC-CChHHhhcCCCcCCCChhhhh--ccCCCCCCC
Q 035713 407 PHKRIAYK-RGATEIKQHPFFEGVNWALVR--SALPPHIPE 444 (491)
Q Consensus 407 P~~R~t~~-~~~~ell~hpff~~~~~~~~~--~~~~~~~p~ 444 (491)
|.+||+.. ..++++++||||++++|..+. ...||+.|.
T Consensus 260 p~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~ 300 (327)
T 3a62_A 260 AASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPL 300 (327)
T ss_dssp GGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC
T ss_pred HhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCCC
Confidence 99999532 238999999999999998763 345556554
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=436.10 Aligned_cols=264 Identities=32% Similarity=0.478 Sum_probs=233.7
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhH---HHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASR---NKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
.++|++++.||+|+||+||+|+++.+|+.||||++++...... .....+.+|+.+|+.++||||++++++|.+.+.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 3679999999999999999999999999999999987643221 1245678999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC----cEEEeecccccc
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG----HIMLSDFDLSLR 245 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g----~vkL~DFGla~~ 245 (491)
||||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 9999999999999998764 5699999999999999999999999999999999999998877 799999999865
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
..... ....
T Consensus 169 ~~~~~-----------------------------------------------------------------------~~~~ 177 (361)
T 2yab_A 169 IEDGV-----------------------------------------------------------------------EFKN 177 (361)
T ss_dssp CCTTC-----------------------------------------------------------------------CCCC
T ss_pred cCCCC-----------------------------------------------------------------------cccc
Confidence 32110 1123
Q ss_pred cccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCC--CCCCHHHHHHHHhhh
Q 035713 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPET--PQVSFVARDLIRGLL 403 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~~~~li~~~L 403 (491)
.+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+.+..+....+.++.. ..++.++++||.+||
T Consensus 178 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 257 (361)
T 2yab_A 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLL 257 (361)
T ss_dssp CCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHS
T ss_pred CCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHC
Confidence 479999999999999999999999999999999999999999998888888888877666532 468999999999999
Q ss_pred ccCCCCCCCcCCChHHhhcCCCcCCCChhh
Q 035713 404 VKEPHKRIAYKRGATEIKQHPFFEGVNWAL 433 (491)
Q Consensus 404 ~~dP~~R~t~~~~~~ell~hpff~~~~~~~ 433 (491)
..||.+||+ +.++|+||||+.++|..
T Consensus 258 ~~dP~~R~t----~~e~l~hp~~~~~~~~~ 283 (361)
T 2yab_A 258 VKETRKRLT----IQEALRHPWITPVDTQQ 283 (361)
T ss_dssp CSSTTTSCC----HHHHHTSTTTSCSSHHH
T ss_pred CCChhHCcC----HHHHhcCcCcCCCchhh
Confidence 999999999 99999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-54 Score=421.17 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=193.1
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc----eE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK----FY 169 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~----~~ 169 (491)
.+|.+.++||+|+||+||+|++ +|+.||||+++.... .......|+.++..++|||||++++++.+++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4689999999999999999987 488999999975421 1112234666667889999999999997653 68
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc--------CcccccCCCCCEEEccCCcEEEeecc
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML--------GIVYRDLKPENVLVRDEGHIMLSDFD 241 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------givHrDikp~NILl~~~g~vkL~DFG 241 (491)
|||||||+||+|.++++.. .++++.+..++.|++.||+|||++ +||||||||+||||+.++.+||+|||
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 9999999999999999874 499999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCc
Q 035713 242 LSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNV 321 (491)
Q Consensus 242 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (491)
+|+......... ..
T Consensus 154 la~~~~~~~~~~------------------------------------------------------------------~~ 167 (303)
T 3hmm_A 154 LAVRHDSATDTI------------------------------------------------------------------DI 167 (303)
T ss_dssp TCEEEETTTTEE------------------------------------------------------------------SC
T ss_pred CCccccCCCCce------------------------------------------------------------------ee
Confidence 997543211100 01
Q ss_pred cccccccccCccCcchhcCC------CCCCcccccchhhHHHhhhcCCCCCCCCC--------------cHHHHHH-HHc
Q 035713 322 RSMSFVGTHEYLAPEIIRGE------GHGSAVDWWTFGIFLYELLHGTTPFKGQG--------------NRATLFN-VVG 380 (491)
Q Consensus 322 ~~~~~~gt~~y~aPE~l~~~------~~~~~~DiwSlG~il~elltg~~Pf~~~~--------------~~~~~~~-i~~ 380 (491)
...+.+||+.|||||++.+. .|+.++|||||||+||||+||++||.... ....+.+ +..
T Consensus 168 ~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 3hmm_A 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 247 (303)
T ss_dssp C-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT
T ss_pred ecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhc
Confidence 12245899999999999875 36779999999999999999987664221 1233333 333
Q ss_pred CCCcC--CCC---CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 381 QPLRF--PET---PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 381 ~~~~~--~~~---~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
...+. |.. ..++..+.+||.+||+.||++||| +.+|++.
T Consensus 248 ~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~ei~~~ 291 (303)
T 3hmm_A 248 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKKT 291 (303)
T ss_dssp SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCC----HHHHHHH
T ss_pred ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcC----HHHHHHH
Confidence 33322 211 123357889999999999999999 8888764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-53 Score=412.94 Aligned_cols=257 Identities=23% Similarity=0.404 Sum_probs=224.3
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
..++|+++++||+|+||+||+|++..+++.||||++....... ...+.+|+.+++.++||||++++++|..++.+|+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 3478999999999999999999999999999999997654332 3456789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 95 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 170 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (297)
T ss_dssp EEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred EEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-
Confidence 99999999999999874 59999999999999999999999999999999999999999999999999985432110
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
......+||+.
T Consensus 171 ---------------------------------------------------------------------~~~~~~~gt~~ 181 (297)
T 3fxz_A 171 ---------------------------------------------------------------------SKRSTMVGTPY 181 (297)
T ss_dssp ---------------------------------------------------------------------CCBCCCCSCGG
T ss_pred ---------------------------------------------------------------------cccCCccCCcC
Confidence 01123479999
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc-CCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG-QPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
|+|||++.+..++.++|||||||++|||++|+.||.+.+....+..+.. ....+.....++..+.+||.+||+.||++|
T Consensus 182 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 261 (297)
T 3fxz_A 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 261 (297)
T ss_dssp GCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred ccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHC
Confidence 9999999999999999999999999999999999998877766665543 333344445689999999999999999999
Q ss_pred CCcCCChHHhhcCCCcCC
Q 035713 411 IAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 411 ~t~~~~~~ell~hpff~~ 428 (491)
|+ ++++++||||+.
T Consensus 262 ps----~~ell~h~~~~~ 275 (297)
T 3fxz_A 262 GS----AKELLQHQFLKI 275 (297)
T ss_dssp CC----HHHHTTCGGGGG
T ss_pred cC----HHHHhhChhhcc
Confidence 99 999999999974
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-53 Score=418.17 Aligned_cols=264 Identities=31% Similarity=0.489 Sum_probs=230.8
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhH---HHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASR---NKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
++|++.+.||+|+||.||+|+++.+|+.||||++.+...... .....+.+|+++|+.++||||++++++|.+.+.+|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 579999999999999999999999999999999986543221 12456788999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC----cEEEeeccccccc
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG----HIMLSDFDLSLRC 246 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g----~vkL~DFGla~~~ 246 (491)
+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999998764 5699999999999999999999999999999999999999887 8999999998653
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.... .....
T Consensus 169 ~~~~-----------------------------------------------------------------------~~~~~ 177 (326)
T 2y0a_A 169 DFGN-----------------------------------------------------------------------EFKNI 177 (326)
T ss_dssp CTTS-----------------------------------------------------------------------CCCCC
T ss_pred CCCC-----------------------------------------------------------------------ccccc
Confidence 2110 01124
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCC--CCCCHHHHHHHHhhhc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPET--PQVSFVARDLIRGLLV 404 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~~~~li~~~L~ 404 (491)
+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+.+..+......++.. ..++..+.+||.+||+
T Consensus 178 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 257 (326)
T 2y0a_A 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLV 257 (326)
T ss_dssp CSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSC
T ss_pred cCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHcc
Confidence 79999999999999999999999999999999999999999988888877777665554432 4689999999999999
Q ss_pred cCCCCCCCcCCChHHhhcCCCcCCCChhhh
Q 035713 405 KEPHKRIAYKRGATEIKQHPFFEGVNWALV 434 (491)
Q Consensus 405 ~dP~~R~t~~~~~~ell~hpff~~~~~~~~ 434 (491)
.||++||+ +.++|+||||+..+|...
T Consensus 258 ~dP~~Rpt----~~e~l~hp~~~~~~~~~~ 283 (326)
T 2y0a_A 258 KDPKKRMT----IQDSLQHPWIKPKDTQQA 283 (326)
T ss_dssp SSGGGSCC----HHHHHHSTTTSCCSHHHH
T ss_pred CChhhCCC----HHHHhcCCCccCCcchhh
Confidence 99999999 999999999999888643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=432.12 Aligned_cols=259 Identities=28% Similarity=0.483 Sum_probs=227.9
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.++|++++.||+|+||+||+|.++.+|+.||+|++.+.... ......+.+|+++|+.++||||+++++++.+++.+|+|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 36799999999999999999999999999999999876543 34456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEc---cCCcEEEeecccccccCCC
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVR---DEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~---~~g~vkL~DFGla~~~~~~ 249 (491)
|||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 89 ~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp ECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999999999988875 5699999999999999999999999999999999999998 4678999999998543211
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
. ......+||
T Consensus 167 ~----------------------------------------------------------------------~~~~~~~gt 176 (444)
T 3soa_A 167 Q----------------------------------------------------------------------QAWFGFAGT 176 (444)
T ss_dssp C----------------------------------------------------------------------CBCCCSCSC
T ss_pred C----------------------------------------------------------------------ceeecccCC
Confidence 0 011234799
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC--CCCCCHHHHHHHHhhhccCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE--TPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~li~~~L~~dP 407 (491)
+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+....+..+....+.++. ...+++++++||.+||+.||
T Consensus 177 ~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 256 (444)
T 3soa_A 177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINP 256 (444)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSST
T ss_pred cccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCCh
Confidence 9999999999999999999999999999999999999999888888888877666554 35789999999999999999
Q ss_pred CCCCCcCCChHHhhcCCCcCC
Q 035713 408 HKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 408 ~~R~t~~~~~~ell~hpff~~ 428 (491)
.+||+ +.|+|+||||+.
T Consensus 257 ~~Rpt----a~e~L~hp~~~~ 273 (444)
T 3soa_A 257 SKRIT----AAEALKHPWISH 273 (444)
T ss_dssp TTSCC----HHHHHHSCTTHH
T ss_pred hHCCC----HHHHhcCccccC
Confidence 99999 999999999964
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-54 Score=426.10 Aligned_cols=257 Identities=33% Similarity=0.506 Sum_probs=221.6
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
..++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+++|+.++||||+++++++.+.+.+|+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45789999999999999999999999999999999987654444445578899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||+ +|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 87 v~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~- 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN- 162 (336)
T ss_dssp EECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred EEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence 99999 78998888764 469999999999999999999999999999999999999999999999999985432110
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
...+.+||+.
T Consensus 163 ----------------------------------------------------------------------~~~~~~gt~~ 172 (336)
T 3h4j_B 163 ----------------------------------------------------------------------FLKTSCGSPN 172 (336)
T ss_dssp ----------------------------------------------------------------------TTCCCTTSTT
T ss_pred ----------------------------------------------------------------------ccccccCCcC
Confidence 1123479999
Q ss_pred ccCcchhcCCCC-CCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 332 YLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 332 y~aPE~l~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
|+|||++.+..+ +.++|||||||++|+|++|+.||.+.........+......+| ..+++++.+||.+||+.||.+|
T Consensus 173 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~R 250 (336)
T 3h4j_B 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP--DFLSPGAQSLIRRMIVADPMQR 250 (336)
T ss_dssp TSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC--TTSCHHHHHHHHTTSCSSGGGS
T ss_pred cCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc--ccCCHHHHHHHHHHcCCChhHC
Confidence 999999998887 7899999999999999999999987655443333333333444 3589999999999999999999
Q ss_pred CCcCCChHHhhcCCCcCC
Q 035713 411 IAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 411 ~t~~~~~~ell~hpff~~ 428 (491)
|| ++||++||||+.
T Consensus 251 pt----~~eil~hp~~~~ 264 (336)
T 3h4j_B 251 IT----IQEIRRDPWFNV 264 (336)
T ss_dssp CC----HHHHTTCHHHHT
T ss_pred cC----HHHHHhChhhcc
Confidence 99 999999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=423.30 Aligned_cols=258 Identities=28% Similarity=0.491 Sum_probs=228.0
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.++|++++.||+|+||.||+|+++.+|+.||+|++...... ......+.+|+++|+.++||||+++++++.+++.+|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36799999999999999999999999999999999876443 34556788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC---CcEEEeecccccccCCC
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE---GHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~---g~vkL~DFGla~~~~~~ 249 (491)
|||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 107 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp ECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999999999988764 569999999999999999999999999999999999999865 45999999998543211
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
. .....+||
T Consensus 185 ~-----------------------------------------------------------------------~~~~~~gt 193 (362)
T 2bdw_A 185 E-----------------------------------------------------------------------AWHGFAGT 193 (362)
T ss_dssp C-----------------------------------------------------------------------SCCCSCSC
T ss_pred c-----------------------------------------------------------------------ccccCCCC
Confidence 0 01134799
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCC--CCCCHHHHHHHHhhhccCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPET--PQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~~~~li~~~L~~dP 407 (491)
+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+....+..+....+.++.. ..+++++++||.+||+.||
T Consensus 194 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 273 (362)
T 2bdw_A 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNP 273 (362)
T ss_dssp TTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSG
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCCh
Confidence 99999999999999999999999999999999999999988888888888776666543 4689999999999999999
Q ss_pred CCCCCcCCChHHhhcCCCcCC
Q 035713 408 HKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 408 ~~R~t~~~~~~ell~hpff~~ 428 (491)
++||+ +.++|+||||..
T Consensus 274 ~~R~t----~~e~l~hp~~~~ 290 (362)
T 2bdw_A 274 KKRIT----ADQALKVPWICN 290 (362)
T ss_dssp GGSCC----HHHHTTSHHHHT
T ss_pred hhCcC----HHHHhcCcccCC
Confidence 99999 999999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-53 Score=418.28 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=228.0
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.++|++++.||+|+||+||+|++..+++.||+|++.... .....+.+|+++|+.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 478999999999999999999999999999999987542 2334577899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc--CCcEEEeecccccccCCCC
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD--EGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~--~g~vkL~DFGla~~~~~~~ 250 (491)
|||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus 80 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 80 FEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp ECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 9999999999998764 346999999999999999999999999999999999999987 7899999999986542110
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
.....+||+
T Consensus 159 -----------------------------------------------------------------------~~~~~~gt~ 167 (321)
T 1tki_A 159 -----------------------------------------------------------------------NFRLLFTAP 167 (321)
T ss_dssp -----------------------------------------------------------------------EEEEEESCG
T ss_pred -----------------------------------------------------------------------ccccccCCh
Confidence 112347999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC--CCCCCHHHHHHHHhhhccCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE--TPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~ 408 (491)
.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+......++. ...++.++.+||.+||..||.
T Consensus 168 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~ 247 (321)
T 1tki_A 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERK 247 (321)
T ss_dssp GGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGG
T ss_pred hhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChh
Confidence 999999999988999999999999999999999999999888888888887766553 246899999999999999999
Q ss_pred CCCCcCCChHHhhcCCCcCCC
Q 035713 409 KRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 409 ~R~t~~~~~~ell~hpff~~~ 429 (491)
+||+ +.|+|+||||+..
T Consensus 248 ~Rpt----~~e~l~hp~~~~~ 264 (321)
T 1tki_A 248 SRMT----ASEALQHPWLKQK 264 (321)
T ss_dssp GSCC----HHHHHHSHHHHSC
T ss_pred HCcC----HHHHhcChhhccC
Confidence 9999 9999999999754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=435.06 Aligned_cols=294 Identities=26% Similarity=0.372 Sum_probs=208.4
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe-----Cc
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET-----DK 167 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~-----~~ 167 (491)
.++|++++.||+|+||+||+|+++.+++.||||++.+. ........++.+|+++|+.++|||||++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 37899999999999999999999999999999999654 3445566778899999999999999999999943 35
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+||||||+ +++|..++... ..+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+...
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred eEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 799999998 68999988764 569999999999999999999999999999999999999999999999999997654
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
............ ..........++. ...........+
T Consensus 208 ~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~----------~~~~~~~~~~~~ 244 (458)
T 3rp9_A 208 YPENGNSQLPIS---------------------------------PREDDMNLVTFPH----------TKNLKRQLTGHV 244 (458)
T ss_dssp SCTTCCCCCC----------------------------------------------------------------------
T ss_pred CccccccccccC---------------------------------ccccccccccccc----------cccccccccCCc
Confidence 221110000000 0000000000000 000011233568
Q ss_pred cccCccCcchhc-CCCCCCcccccchhhHHHhhhc-----------CCCCCCCCCc--------------------HHHH
Q 035713 328 GTHEYLAPEIIR-GEGHGSAVDWWTFGIFLYELLH-----------GTTPFKGQGN--------------------RATL 375 (491)
Q Consensus 328 gt~~y~aPE~l~-~~~~~~~~DiwSlG~il~ellt-----------g~~Pf~~~~~--------------------~~~~ 375 (491)
||++|+|||++. +..|+.++||||||||||||++ |+++|.+.+. ..++
T Consensus 245 gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l 324 (458)
T 3rp9_A 245 VTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQL 324 (458)
T ss_dssp CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHH
T ss_pred ccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHH
Confidence 999999999874 5669999999999999999999 7888877542 1222
Q ss_pred H---HHHcCCC-----------------cC---------CCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 376 F---NVVGQPL-----------------RF---------PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 376 ~---~i~~~~~-----------------~~---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
. .+++.+. .+ ...+.++.++.+||.+||+.||++|+| ++|+|+||||
T Consensus 325 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----~~e~L~Hp~f 400 (458)
T 3rp9_A 325 NVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT----INECLAHPFF 400 (458)
T ss_dssp HHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGG
T ss_pred HHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCC----HHHHhcCHhh
Confidence 2 2222111 00 012357899999999999999999999 9999999999
Q ss_pred CCCChhhhhcc
Q 035713 427 EGVNWALVRSA 437 (491)
Q Consensus 427 ~~~~~~~~~~~ 437 (491)
++++|..+...
T Consensus 401 ~~~~~~~~e~~ 411 (458)
T 3rp9_A 401 KEVRIAEVETN 411 (458)
T ss_dssp TTTCCGGGCCC
T ss_pred hhcCCCccCCC
Confidence 99999876543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=425.72 Aligned_cols=274 Identities=23% Similarity=0.338 Sum_probs=224.3
Q ss_pred cCCCceEeeeeecc--CceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 92 GLSNFRLLKRLGYG--DIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 92 ~~~~y~~~~~iG~G--~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
..++|+++++||+| +||.||+|+++.+|+.||||+++.... .......+.+|+++|+.++|||||+++++|.+++.+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 34789999999999 999999999999999999999987643 345667788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
||||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 99999999999999998865567999999999999999999999999999999999999999999999999998543211
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
..... .........+||
T Consensus 182 ~~~~~---------------------------------------------------------------~~~~~~~~~~gt 198 (389)
T 3gni_B 182 GQRQR---------------------------------------------------------------VVHDFPKYSVKV 198 (389)
T ss_dssp TEECS---------------------------------------------------------------CBCCCCTTCTTT
T ss_pred ccccc---------------------------------------------------------------cccccccccccc
Confidence 10000 000011124799
Q ss_pred cCccCcchhcC--CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCc-----------------------
Q 035713 330 HEYLAPEIIRG--EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR----------------------- 384 (491)
Q Consensus 330 ~~y~aPE~l~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~----------------------- 384 (491)
+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..++.....
T Consensus 199 ~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (389)
T 3gni_B 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVAN 278 (389)
T ss_dssp GGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------------------------
T ss_pred ccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccc
Confidence 99999999998 57899999999999999999999999887666555443322111
Q ss_pred ---------------------CCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhh
Q 035713 385 ---------------------FPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWAL 433 (491)
Q Consensus 385 ---------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~ 433 (491)
.+....+++++.+||.+||+.||++||| ++|+|+||||+.+.|..
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----a~ell~hp~f~~~~~~~ 344 (389)
T 3gni_B 279 SGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS----ASTLLNHSFFKQIKRRA 344 (389)
T ss_dssp ---------------------------CCHHHHHHHHHHTCSCTTTSCC----HHHHTTSGGGGGC---C
T ss_pred cccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC----HHHHhcCHHHHHHhhcc
Confidence 1122457889999999999999999999 99999999999988753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-53 Score=430.00 Aligned_cols=254 Identities=29% Similarity=0.449 Sum_probs=209.5
Q ss_pred cCCCceEe-eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHH-hhcCCCCccceeeeEEe----
Q 035713 92 GLSNFRLL-KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL-GLLDHPFLPTLYSYFET---- 165 (491)
Q Consensus 92 ~~~~y~~~-~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il-~~l~hp~iv~l~~~~~~---- 165 (491)
..++|.++ +.||+|+||+||+|+++.+++.||||+++.. ..+.+|++++ +.++||||++++++|..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 34788887 7899999999999999999999999999643 1345788887 45589999999999876
Q ss_pred CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc---CCcEEEeeccc
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD---EGHIMLSDFDL 242 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~---~g~vkL~DFGl 242 (491)
.+.+||||||++||+|.+++.......+++..++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 678999999999999999998765567999999999999999999999999999999999999997 78999999999
Q ss_pred ccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcc
Q 035713 243 SLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322 (491)
Q Consensus 243 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (491)
++..... ..
T Consensus 211 a~~~~~~-----------------------------------------------------------------------~~ 219 (400)
T 1nxk_A 211 AKETTSH-----------------------------------------------------------------------NS 219 (400)
T ss_dssp CEECC---------------------------------------------------------------------------
T ss_pred ccccCCC-----------------------------------------------------------------------Cc
Confidence 8643210 01
Q ss_pred ccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHH----HHHHHHcCCCcCCC--CCCCCHHHH
Q 035713 323 SMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRA----TLFNVVGQPLRFPE--TPQVSFVAR 396 (491)
Q Consensus 323 ~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----~~~~i~~~~~~~~~--~~~~s~~~~ 396 (491)
..+.+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+..... ....+....+.++. ...++.+++
T Consensus 220 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 299 (400)
T 1nxk_A 220 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK 299 (400)
T ss_dssp -------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHH
Confidence 123589999999999999999999999999999999999999998764322 33445555554443 356999999
Q ss_pred HHHHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 397 DLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 397 ~li~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
+||.+||+.||++||+ +.+|++||||..
T Consensus 300 ~li~~~L~~dP~~Rpt----~~eil~hp~~~~ 327 (400)
T 1nxk_A 300 MLIRNLLKTEPTQRMT----ITEFMNHPWIMQ 327 (400)
T ss_dssp HHHHTTSCSSGGGSCC----HHHHHHSHHHHT
T ss_pred HHHHHHCCCChhHCcC----HHHHhcCccccC
Confidence 9999999999999999 999999999964
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-53 Score=412.52 Aligned_cols=259 Identities=34% Similarity=0.573 Sum_probs=220.1
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhh-----------------------HHHHHHHHHHHHHH
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLAS-----------------------RNKLLRAQTEREIL 148 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~-----------------------~~~~~~~~~E~~il 148 (491)
..++|++++.||+|+||.||+|++..+++.||||++.+..... ......+.+|+++|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 4578999999999999999999999999999999997654322 12245678999999
Q ss_pred hhcCCCCccceeeeEEe--CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCC
Q 035713 149 GLLDHPFLPTLYSYFET--DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPEN 226 (491)
Q Consensus 149 ~~l~hp~iv~l~~~~~~--~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~N 226 (491)
+.++||||+++++++.+ .+.+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 99999999999999986 6789999999999999876543 469999999999999999999999999999999999
Q ss_pred EEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCC
Q 035713 227 VLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPC 306 (491)
Q Consensus 227 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (491)
||++.++.+||+|||+++.......
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~------------------------------------------------------- 192 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDA------------------------------------------------------- 192 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSC-------------------------------------------------------
T ss_pred EEECCCCCEEEecCCCccccccccc-------------------------------------------------------
Confidence 9999999999999999865321100
Q ss_pred CCCCCCccccCCCCccccccccccCccCcchhcCCC---CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCC
Q 035713 307 VGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG---HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL 383 (491)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~ 383 (491)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 193 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 257 (298)
T 2zv2_A 193 ---------------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQAL 257 (298)
T ss_dssp ---------------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred ---------------cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccC
Confidence 011247999999999998765 37789999999999999999999998877777777777777
Q ss_pred cCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcC
Q 035713 384 RFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 384 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~ 427 (491)
.++....+++++.+||.+||+.||++||+ +.|+++||||+
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~R~s----~~e~l~hp~~~ 297 (298)
T 2zv2_A 258 EFPDQPDIAEDLKDLITRMLDKNPESRIV----VPEIKLHPWVT 297 (298)
T ss_dssp CCCSSSCCCHHHHHHHHHHTCSCTTTSCC----HHHHTTCHHHH
T ss_pred CCCCccccCHHHHHHHHHHhhcChhhCCC----HHHHhcCcccc
Confidence 77777789999999999999999999999 99999999995
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=412.45 Aligned_cols=263 Identities=24% Similarity=0.425 Sum_probs=217.0
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
..++|+++++||+|+||+||+|++. +|+.||||++.... ........+.+|+++|+.++||||+++++++.+++.+|+
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 3578999999999999999999986 58999999997553 233445677899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 97 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 97 VFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp EEECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred EEcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 999996 5888877764 35599999999999999999999999999999999999999999999999999865321100
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
.....+||+.
T Consensus 175 ----------------------------------------------------------------------~~~~~~~t~~ 184 (311)
T 3niz_A 175 ----------------------------------------------------------------------SYTHEVVTLW 184 (311)
T ss_dssp -------------------------------------------------------------------------CCCCCCT
T ss_pred ----------------------------------------------------------------------cccCCcccCC
Confidence 0112378999
Q ss_pred ccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CCCcC--C-------------------
Q 035713 332 YLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QPLRF--P------------------- 386 (491)
Q Consensus 332 y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~~~~--~------------------- 386 (491)
|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+.. .+... +
T Consensus 185 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (311)
T 3niz_A 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKK 264 (311)
T ss_dssp TCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCC
T ss_pred cCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCC
Confidence 999999987 4589999999999999999999999998777666555432 21100 0
Q ss_pred ----CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 387 ----ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 387 ----~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
..+.+++++.+||.+||+.||++||| ++|+|+||||++++++
T Consensus 265 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 265 PWSSIIPGFCQEGIDLLSNMLCFDPNKRIS----ARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp CHHHHSTTCCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTSCTT
T ss_pred cHHHhCcccCHHHHHHHHHHcCCChhHCCC----HHHHhcCcccccCCcc
Confidence 01347789999999999999999999 9999999999988764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=423.09 Aligned_cols=281 Identities=27% Similarity=0.428 Sum_probs=214.2
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeC--ceE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETD--KFY 169 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~--~~~ 169 (491)
.++|++++.||+|+||.||+|+++.+|+.||||++.+. ........++.+|+.+|+.+. ||||+++++++..+ ..+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 47899999999999999999999999999999998654 334455667789999999997 99999999999754 479
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
||||||+. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+...
T Consensus 87 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 99999996 689988876 35999999999999999999999999999999999999999999999999999765322
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
............ . . ..............+||
T Consensus 163 ~~~~~~~~~~~~-----------------------------------~-----~---------~~~~~~~~~~~~~~~gt 193 (388)
T 3oz6_A 163 RRVTNNIPLSIN-----------------------------------E-----N---------TENFDDDQPILTDYVAT 193 (388)
T ss_dssp CCCCCCGGGCCC----------------------------------------------------------------CCCG
T ss_pred cccccccccccc-----------------------------------c-----c---------ccccccccccccCCccc
Confidence 111000000000 0 0 00000011123346899
Q ss_pred cCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCC----------------------
Q 035713 330 HEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP---------------------- 386 (491)
Q Consensus 330 ~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---------------------- 386 (491)
++|+|||++.+ ..|+.++|||||||++|||++|++||.+.+....+.+++.. +..|
T Consensus 194 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~ 272 (388)
T 3oz6_A 194 RWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV-IDFPSNEDVESIQSPFAKTMIESLKE 272 (388)
T ss_dssp GGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCCCCHHHHHTSCCSSHHHHHHHHHH
T ss_pred CCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-cCCCCHHHHHhccCHHHHHHHHhCcc
Confidence 99999999987 56899999999999999999999999999888777766521 0000
Q ss_pred ------------------------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 387 ------------------------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 387 ------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
....+++++.+||.+||+.||++||| ++|+|+||||+.+...
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t----~~e~l~Hp~~~~~~~~ 338 (388)
T 3oz6_A 273 KVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS----ANDALKHPFVSIFHNP 338 (388)
T ss_dssp HCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC----HHHHTTSTTTTTTCCG
T ss_pred cccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC----HHHHhCCHHHHHhcCC
Confidence 11257899999999999999999999 9999999999876543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=405.93 Aligned_cols=260 Identities=27% Similarity=0.434 Sum_probs=214.9
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
+++|+++++||+|+||+||+|+++.+++.||||++..... .......+.+|+++|+.++||||+++++++.+++.+|||
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 3689999999999999999999999999999999976542 334456678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+.+ +|..++... .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 155 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-- 155 (292)
T ss_dssp EECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--
T ss_pred EecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--
Confidence 999965 565555543 3569999999999999999999999999999999999999999999999999986532110
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......+||+.|
T Consensus 156 --------------------------------------------------------------------~~~~~~~~t~~y 167 (292)
T 3o0g_A 156 --------------------------------------------------------------------RCYSAEVVTLWY 167 (292)
T ss_dssp --------------------------------------------------------------------SCCCSCCSCGGG
T ss_pred --------------------------------------------------------------------ccccCCccccCC
Confidence 011123789999
Q ss_pred cCcchhcCCC-CCCcccccchhhHHHhhhcCCCC-CCCCCcHHHHHHHHc---CCCc-----------------------
Q 035713 333 LAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTP-FKGQGNRATLFNVVG---QPLR----------------------- 384 (491)
Q Consensus 333 ~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~P-f~~~~~~~~~~~i~~---~~~~----------------------- 384 (491)
+|||++.+.. ++.++|||||||++|+|++|..| |.+.+....+..+.. .+..
T Consensus 168 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (292)
T 3o0g_A 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS 247 (292)
T ss_dssp CCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCC
T ss_pred cChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcc
Confidence 9999998876 79999999999999999987777 555555555555432 1100
Q ss_pred -CCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 385 -FPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 385 -~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
....+.++.++++||.+||+.||++||| ++|+|+||||+++
T Consensus 248 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 248 LVNVVPKLNATGRDLLQNLLKCNPVQRIS----AEEALQHPYFSDF 289 (292)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTC
T ss_pred hhhcccccChHHHHHHHHHhccChhhCCC----HHHHhcCcccccC
Confidence 0011357899999999999999999999 9999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=434.75 Aligned_cols=261 Identities=29% Similarity=0.451 Sum_probs=232.8
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCce
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKF 168 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~ 168 (491)
..+..++|.+++.||+|+||.||+|++..+|+.||||++.+...........+.+|+++|+.++||||+++++++.+.+.
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD 90 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 34556899999999999999999999999999999999987655544556678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
+||||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999999998764 5699999999999999999999999999999999999999999999999999864321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
.. ...+.+|
T Consensus 169 ~~-----------------------------------------------------------------------~~~~~~g 177 (476)
T 2y94_A 169 GE-----------------------------------------------------------------------FLRTSCG 177 (476)
T ss_dssp TC-----------------------------------------------------------------------CBCCCCS
T ss_pred cc-----------------------------------------------------------------------cccccCC
Confidence 10 1123489
Q ss_pred ccCccCcchhcCCCC-CCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCC
Q 035713 329 THEYLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 329 t~~y~aPE~l~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP 407 (491)
|+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+....+.++....+..|. .+++++.+||.+||+.||
T Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~Li~~~L~~dP 255 (476)
T 2y94_A 178 SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ--YLNPSVISLLKHMLQVDP 255 (476)
T ss_dssp CSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCT--TCCHHHHHHHHHHTCSST
T ss_pred CcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCc--cCCHHHHHHHHHHcCCCc
Confidence 999999999998876 78999999999999999999999998888888888877666554 489999999999999999
Q ss_pred CCCCCcCCChHHhhcCCCcCC
Q 035713 408 HKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 408 ~~R~t~~~~~~ell~hpff~~ 428 (491)
.+||+ +++|++||||+.
T Consensus 256 ~~Rpt----~~eil~hp~~~~ 272 (476)
T 2y94_A 256 MKRAT----IKDIREHEWFKQ 272 (476)
T ss_dssp TTSCC----HHHHHTCHHHHT
T ss_pred hhCcC----HHHHHhCHHhhh
Confidence 99999 999999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-53 Score=421.77 Aligned_cols=263 Identities=28% Similarity=0.467 Sum_probs=222.7
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhH--HHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASR--NKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~--~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
++|++++.||+|+||+||+|+++.+++.||||++.+...... .....+.+|+++|+.++||||+++++++.+++.+||
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 679999999999999999999999999999999976543221 134567899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCc---EEEeeccccccc
Q 035713 172 VMEFCSGGNLHSLRQKQ--PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGH---IMLSDFDLSLRC 246 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~---vkL~DFGla~~~ 246 (491)
||||++|++|.+++... .+..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 99999999998776542 2345899999999999999999999999999999999999987655 999999998654
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.... ......
T Consensus 184 ~~~~----------------------------------------------------------------------~~~~~~ 193 (351)
T 3c0i_A 184 GESG----------------------------------------------------------------------LVAGGR 193 (351)
T ss_dssp CTTS----------------------------------------------------------------------CBCCCC
T ss_pred cCCC----------------------------------------------------------------------eeecCC
Confidence 2110 011134
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC--CCCCCHHHHHHHHhhhc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE--TPQVSFVARDLIRGLLV 404 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~li~~~L~ 404 (491)
+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+. ....+..+......++. ...++.++++||.+||+
T Consensus 194 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 272 (351)
T 3c0i_A 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLM 272 (351)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTC
T ss_pred cCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCC
Confidence 7999999999999999999999999999999999999999875 34455566665554432 24689999999999999
Q ss_pred cCCCCCCCcCCChHHhhcCCCcCCCCh
Q 035713 405 KEPHKRIAYKRGATEIKQHPFFEGVNW 431 (491)
Q Consensus 405 ~dP~~R~t~~~~~~ell~hpff~~~~~ 431 (491)
.||++||+ +.++|+||||+..++
T Consensus 273 ~dP~~R~s----~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 273 LDPAERIT----VYEALNHPWLKERDR 295 (351)
T ss_dssp SSTTTSCC----HHHHHTSHHHHTHHH
T ss_pred CChhHCcC----HHHHhcChhhcCCcc
Confidence 99999999 999999999987654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=417.13 Aligned_cols=263 Identities=24% Similarity=0.368 Sum_probs=215.0
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
..++|+++++||+|+||+||+|++..+++.||||+++... ........+.+|+++|+.++||||+++++++.+++.+||
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc-cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3478999999999999999999999999999999997653 233445567789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEc-----cCCcEEEeeccccccc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVR-----DEGHIMLSDFDLSLRC 246 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~-----~~g~vkL~DFGla~~~ 246 (491)
||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++..
T Consensus 111 v~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 999996 5999998875 4599999999999999999999999999999999999994 4556999999998654
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.... ......
T Consensus 188 ~~~~----------------------------------------------------------------------~~~~~~ 197 (329)
T 3gbz_A 188 GIPI----------------------------------------------------------------------RQFTHE 197 (329)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred CCcc----------------------------------------------------------------------cccCCC
Confidence 2110 011123
Q ss_pred ccccCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---CC--cC-------------CC
Q 035713 327 VGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---PL--RF-------------PE 387 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~~--~~-------------~~ 387 (491)
+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+..+... +. .+ +.
T Consensus 198 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (329)
T 3gbz_A 198 IITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPK 277 (329)
T ss_dssp --CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred cCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhh
Confidence 7899999999998855 799999999999999999999999998887777666532 10 00 00
Q ss_pred C----------CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 388 T----------PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 388 ~----------~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
. ..++.++.+||.+||+.||.+||+ ++|+|+||||++++|+
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 278 FRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS----AKNALEHPYFSHNDFD 328 (329)
T ss_dssp CCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGSSSCSC
T ss_pred hccccHhhhcccccCHHHHHHHHHHccCChhhCCC----HHHHhCCcccCCCCCC
Confidence 0 117789999999999999999999 9999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-52 Score=415.02 Aligned_cols=258 Identities=34% Similarity=0.505 Sum_probs=211.5
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
..++|++.+.||+|+||.||+|++..+++.||||++++.. ....+.+|+++|+.++||||+++++++.+.+.+|+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 3478999999999999999999999999999999997642 23456789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc---CCcEEEeecccccccCC
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD---EGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~---~g~vkL~DFGla~~~~~ 248 (491)
||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||+++....
T Consensus 126 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp EECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999999988764 56999999999999999999999999999999999999975 88999999999854321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
. ......+|
T Consensus 204 ~-----------------------------------------------------------------------~~~~~~~g 212 (349)
T 2w4o_A 204 Q-----------------------------------------------------------------------VLMKTVCG 212 (349)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c-----------------------------------------------------------------------cccccccC
Confidence 0 01113479
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHH-HHHHHHcCCCcCC--CCCCCCHHHHHHHHhhhcc
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRA-TLFNVVGQPLRFP--ETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~--~~~~~s~~~~~li~~~L~~ 405 (491)
|+.|+|||++.+..++.++|||||||++|||++|+.||.+..... .+..+......++ ....++.++.+||.+||+.
T Consensus 213 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 292 (349)
T 2w4o_A 213 TPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVL 292 (349)
T ss_dssp CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCS
T ss_pred CCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccC
Confidence 999999999999999999999999999999999999998776655 4555666554433 2357899999999999999
Q ss_pred CCCCCCCcCCChHHhhcCCCcCCCCh
Q 035713 406 EPHKRIAYKRGATEIKQHPFFEGVNW 431 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~hpff~~~~~ 431 (491)
||++||+ +.++|+||||.+..+
T Consensus 293 dP~~Rpt----~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 293 DPKKRLT----TFQALQHPWVTGKAA 314 (349)
T ss_dssp SGGGSCC----HHHHHHSTTTTSTTC
T ss_pred ChhhCcC----HHHHhcCcccCCCcc
Confidence 9999999 999999999986543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=418.81 Aligned_cols=261 Identities=30% Similarity=0.447 Sum_probs=227.9
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.++|++++.||+|+||.||+|+++.+|+.||+|++..... .....+.+|+++|+.++||||++++++|.+...+|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 4689999999999999999999999999999999976532 2334678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc--CCcEEEeecccccccCCCC
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD--EGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~--~g~vkL~DFGla~~~~~~~ 250 (491)
|||+.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus 127 ~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 127 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp EECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 9999999999988764 346999999999999999999999999999999999999974 5789999999986532110
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
.....+||+
T Consensus 206 -----------------------------------------------------------------------~~~~~~gt~ 214 (387)
T 1kob_A 206 -----------------------------------------------------------------------IVKVTTATA 214 (387)
T ss_dssp -----------------------------------------------------------------------CEEEECSSG
T ss_pred -----------------------------------------------------------------------ceeeeccCC
Confidence 111247999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC--CCCCCHHHHHHHHhhhccCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE--TPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~ 408 (491)
.|+|||++.+..++.++|||||||++|||++|+.||.+.+....+..+....+.++. ...++.++.+||.+||+.||.
T Consensus 215 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 294 (387)
T 1kob_A 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPR 294 (387)
T ss_dssp GGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGG
T ss_pred CccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChh
Confidence 999999999999999999999999999999999999998888888887766554443 346899999999999999999
Q ss_pred CCCCcCCChHHhhcCCCcCCCChh
Q 035713 409 KRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 409 ~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
+||+ +.++|+||||++..+.
T Consensus 295 ~Rpt----~~ell~hp~~~~~~~~ 314 (387)
T 1kob_A 295 KRLT----VHDALEHPWLKGDHSN 314 (387)
T ss_dssp GSCC----HHHHHTSTTTSSCCTT
T ss_pred HCcC----HHHHhhCccccCCccc
Confidence 9999 9999999999876543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=412.14 Aligned_cols=262 Identities=25% Similarity=0.419 Sum_probs=220.3
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.++|++++.||+|+||+||+|++..+++.||||++...... .....+.+|+.+++.++||||+++++++.+++..|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 47899999999999999999999999999999999755322 2334577899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 160 (323)
T 3tki_A 84 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR- 160 (323)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE-
T ss_pred EEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc-
Confidence 9999999999988754 5699999999999999999999999999999999999999999999999999864321100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.......+||+.|
T Consensus 161 -------------------------------------------------------------------~~~~~~~~gt~~y 173 (323)
T 3tki_A 161 -------------------------------------------------------------------ERLLNKMCGTLPY 173 (323)
T ss_dssp -------------------------------------------------------------------ECCBCSCCSCGGG
T ss_pred -------------------------------------------------------------------ccccCCCccCcCc
Confidence 0011234899999
Q ss_pred cCcchhcCCCC-CCcccccchhhHHHhhhcCCCCCCCCCcHH-HHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 333 LAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRA-TLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 333 ~aPE~l~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
+|||++.+..+ +.++|||||||++|+|++|+.||.+..... .+..+.......+....++.++.+||.+||+.||.+|
T Consensus 174 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 253 (323)
T 3tki_A 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSAR 253 (323)
T ss_dssp SCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred cCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhC
Confidence 99999998776 778999999999999999999998766543 3333444444444446789999999999999999999
Q ss_pred CCcCCChHHhhcCCCcCCCC
Q 035713 411 IAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 411 ~t~~~~~~ell~hpff~~~~ 430 (491)
|+ ++|+++||||+...
T Consensus 254 ~t----~~eil~h~~~~~~~ 269 (323)
T 3tki_A 254 IT----IPDIKKDRWYNKPL 269 (323)
T ss_dssp CC----HHHHTTCTTTTCCC
T ss_pred cC----HHHHhhChhhcccc
Confidence 99 99999999998653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=406.54 Aligned_cols=263 Identities=26% Similarity=0.407 Sum_probs=214.0
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhh--HHHHHHHHHHHHHHhhc---CCCCccceeeeEEe
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLAS--RNKLLRAQTEREILGLL---DHPFLPTLYSYFET 165 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~E~~il~~l---~hp~iv~l~~~~~~ 165 (491)
+..++|+++++||+|+||+||+|++..+++.||||++....... ......+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 34579999999999999999999999999999999997543211 11122345677777666 49999999999987
Q ss_pred Cc-----eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeec
Q 035713 166 DK-----FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240 (491)
Q Consensus 166 ~~-----~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DF 240 (491)
.. .+|+||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 54 6899999995 69999998876566999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCC
Q 035713 241 DLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTN 320 (491)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (491)
|+++.....
T Consensus 165 g~a~~~~~~----------------------------------------------------------------------- 173 (308)
T 3g33_A 165 GLARIYSYQ----------------------------------------------------------------------- 173 (308)
T ss_dssp SCTTTSTTC-----------------------------------------------------------------------
T ss_pred ccccccCCC-----------------------------------------------------------------------
Confidence 998543210
Q ss_pred ccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---CC--cCC---------
Q 035713 321 VRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---PL--RFP--------- 386 (491)
Q Consensus 321 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~~--~~~--------- 386 (491)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.++... +. .++
T Consensus 174 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (308)
T 3g33_A 174 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA 253 (308)
T ss_dssp CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGG
T ss_pred cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 0112358999999999999999999999999999999999999999998888777666431 10 000
Q ss_pred -----------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 387 -----------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 387 -----------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
..+.++.++.+||.+||+.||++||| +.|+|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~h~~~~~~ 303 (308)
T 3g33_A 254 FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS----AFRALQHSYLHKD 303 (308)
T ss_dssp SCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSTTC---
T ss_pred cCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCC----HHHHhcCccccCC
Confidence 01357899999999999999999999 9999999999854
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-52 Score=416.55 Aligned_cols=255 Identities=29% Similarity=0.468 Sum_probs=214.1
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
..++|++++.||+|+||+||+|+++.+++.||||++.+..... ..+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 3578999999999999999999999999999999997654322 346689999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCc--EEEeecccccccCCC
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGH--IMLSDFDLSLRCSVS 249 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~--vkL~DFGla~~~~~~ 249 (491)
||||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++.....
T Consensus 94 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 94 IMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999999999998764 46999999999999999999999999999999999999987765 999999998532110
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
......+||
T Consensus 172 -----------------------------------------------------------------------~~~~~~~gt 180 (361)
T 3uc3_A 172 -----------------------------------------------------------------------SQPKSTVGT 180 (361)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -----------------------------------------------------------------------CCCCCCcCC
Confidence 011234799
Q ss_pred cCccCcchhcCCCCCCc-ccccchhhHHHhhhcCCCCCCCCCc----HHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhc
Q 035713 330 HEYLAPEIIRGEGHGSA-VDWWTFGIFLYELLHGTTPFKGQGN----RATLFNVVGQPLRFPETPQVSFVARDLIRGLLV 404 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~ 404 (491)
+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+... ...+..+......++....+++++++||.+||+
T Consensus 181 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 260 (361)
T 3uc3_A 181 PAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFV 260 (361)
T ss_dssp CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSC
T ss_pred CCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHcc
Confidence 99999999998887655 8999999999999999999987543 345556677777777777799999999999999
Q ss_pred cCCCCCCCcCCChHHhhcCCCcC
Q 035713 405 KEPHKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 405 ~dP~~R~t~~~~~~ell~hpff~ 427 (491)
.||.+||+ +.+|++||||.
T Consensus 261 ~dP~~Rps----~~ell~hp~f~ 279 (361)
T 3uc3_A 261 ADPATRIS----IPEIKTHSWFL 279 (361)
T ss_dssp SCTTTSCC----HHHHHTSHHHH
T ss_pred CChhHCcC----HHHHHhCcchh
Confidence 99999999 99999999994
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=418.87 Aligned_cols=283 Identities=40% Similarity=0.748 Sum_probs=228.1
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEe---CCCcEEEEEEeecchhh-hHHHHHHHHHHHHHHhhc-CCCCccceeeeE
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELR---GTNTYFAMKVMDKASLA-SRNKLLRAQTEREILGLL-DHPFLPTLYSYF 163 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~ 163 (491)
..+..++|++++.||+|+||.||+|++. .+++.||||++++.... .......+.+|+++|+.+ +||||+++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 3456689999999999999999999985 48999999999764321 112233456799999999 699999999999
Q ss_pred EeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccc
Q 035713 164 ETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243 (491)
Q Consensus 164 ~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla 243 (491)
...+.+||||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999999998864 46999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (491)
+.+.... ....
T Consensus 207 ~~~~~~~---------------------------------------------------------------------~~~~ 217 (355)
T 1vzo_A 207 KEFVADE---------------------------------------------------------------------TERA 217 (355)
T ss_dssp EECCGGG---------------------------------------------------------------------GGGG
T ss_pred eecccCC---------------------------------------------------------------------CCcc
Confidence 6432110 0112
Q ss_pred cccccccCccCcchhcCC--CCCCcccccchhhHHHhhhcCCCCCCCCCc----HHHHHHHHcCCCcCCCCCCCCHHHHH
Q 035713 324 MSFVGTHEYLAPEIIRGE--GHGSAVDWWTFGIFLYELLHGTTPFKGQGN----RATLFNVVGQPLRFPETPQVSFVARD 397 (491)
Q Consensus 324 ~~~~gt~~y~aPE~l~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~s~~~~~ 397 (491)
...+||+.|+|||++.+. .++.++|||||||+||||++|+.||..... ......+......++ ..++..+.+
T Consensus 218 ~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 295 (355)
T 1vzo_A 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKD 295 (355)
T ss_dssp CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--TTSCHHHHH
T ss_pred cCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC--cccCHHHHH
Confidence 245899999999999863 478999999999999999999999975432 233344555544444 358999999
Q ss_pred HHHhhhccCCCCCCCcC-CChHHhhcCCCcCCCChhhhhc--cCCCCCCC
Q 035713 398 LIRGLLVKEPHKRIAYK-RGATEIKQHPFFEGVNWALVRS--ALPPHIPE 444 (491)
Q Consensus 398 li~~~L~~dP~~R~t~~-~~~~ell~hpff~~~~~~~~~~--~~~~~~p~ 444 (491)
||.+||..||.+||++. ..++++++||||+.++|..+.. ..+|+.|.
T Consensus 296 li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p~ 345 (355)
T 1vzo_A 296 LIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPV 345 (355)
T ss_dssp HHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred HHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCCCCCCCc
Confidence 99999999999999211 1199999999999999997743 23444443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-52 Score=401.62 Aligned_cols=259 Identities=33% Similarity=0.559 Sum_probs=229.9
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
.+.+++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+++++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 45678999999999999999999999999999999999876555555566788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 9999999999999998765 45999999999999999999999999999999999999999999999999987432110
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.....+||
T Consensus 163 ------------------------------------------------------------------------~~~~~~~~ 170 (279)
T 3fdn_A 163 ------------------------------------------------------------------------RRTDLCGT 170 (279)
T ss_dssp -----------------------------------------------------------------------------CCC
T ss_pred ------------------------------------------------------------------------cccccCCC
Confidence 11124789
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......++. .++.++.+||.+||+.||.+
T Consensus 171 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~ 248 (279)
T 3fdn_A 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--FVTEGARDLISRLLKHNPSQ 248 (279)
T ss_dssp CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHCCSSGGG
T ss_pred CCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC--cCCHHHHHHHHHHhccChhh
Confidence 9999999999999999999999999999999999999998888877777776666664 48999999999999999999
Q ss_pred CCCcCCChHHhhcCCCcCC
Q 035713 410 RIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 410 R~t~~~~~~ell~hpff~~ 428 (491)
||+ +.+|++||||+.
T Consensus 249 Rps----~~e~l~h~~~~~ 263 (279)
T 3fdn_A 249 RPM----LREVLEHPWITA 263 (279)
T ss_dssp SCC----HHHHHHCHHHHH
T ss_pred CCC----HHHHhhCccccC
Confidence 999 999999999974
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-52 Score=403.90 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=214.6
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
+++|++++.||+|+||+||+|++ .+++.||||++..... .......+.+|+++|+.++||||+++++++.+.+.+|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 36899999999999999999998 5789999999976532 222335667899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+.+ +|.+++... .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 79 ~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (288)
T ss_dssp EECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--
Confidence 999964 999888764 3569999999999999999999999999999999999999999999999999985432100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......+||+.|
T Consensus 155 --------------------------------------------------------------------~~~~~~~~t~~y 166 (288)
T 1ob3_A 155 --------------------------------------------------------------------RKYTHEIVTLWY 166 (288)
T ss_dssp ---------------------------------------------------------------------------CCCTT
T ss_pred --------------------------------------------------------------------cccccccccccc
Confidence 001123789999
Q ss_pred cCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CCC--cCC--------------------
Q 035713 333 LAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QPL--RFP-------------------- 386 (491)
Q Consensus 333 ~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~~--~~~-------------------- 386 (491)
+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+.++.. .+. .++
T Consensus 167 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
T 1ob3_A 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPW 246 (288)
T ss_dssp CCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCG
T ss_pred cCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccH
Confidence 999999875 489999999999999999999999999887776665542 110 000
Q ss_pred --CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 387 --ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 387 --~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
....++.++.+||.+||+.||++||+ ++++|+||||++.|
T Consensus 247 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~n 288 (288)
T 1ob3_A 247 ESFLKGLDESGIDLLSKMLKLDPNQRIT----AKQALEHAYFKENN 288 (288)
T ss_dssp GGTCCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGGC--
T ss_pred HHHhhhcCHHHHHHHHHHcCCCcccCCC----HHHHhcCcchhhcC
Confidence 01357899999999999999999999 99999999998653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=413.60 Aligned_cols=265 Identities=26% Similarity=0.397 Sum_probs=224.3
Q ss_pred hhhcccCCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-----CCC
Q 035713 81 INMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-----HPF 155 (491)
Q Consensus 81 ~~~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----hp~ 155 (491)
...+++....+..++|+++++||+|+||+||+|++..+++.||||+++.. ......+.+|+++|+.+. |||
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 44566777777889999999999999999999999999999999999753 233445667999999986 999
Q ss_pred ccceeeeEEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc----
Q 035713 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD---- 231 (491)
Q Consensus 156 iv~l~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~---- 231 (491)
|+++++++...+.+||||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCC
T ss_pred eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccc
Confidence 999999999999999999999 999999998876667999999999999999999999999999999999999975
Q ss_pred ---------------------CCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcc
Q 035713 232 ---------------------EGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRI 290 (491)
Q Consensus 232 ---------------------~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (491)
++.+||+|||++.....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~------------------------------------------ 214 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD------------------------------------------ 214 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS------------------------------------------
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCC------------------------------------------
Confidence 78999999999854211
Q ss_pred cccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCC
Q 035713 291 LPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQG 370 (491)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 370 (491)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 215 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 215 -------------------------------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp -------------------------------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -------------------------------CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 0112479999999999999999999999999999999999999999887
Q ss_pred cHHHHHHHHcCCCcC--------------------------CCC------------------CCCCHHHHHHHHhhhccC
Q 035713 371 NRATLFNVVGQPLRF--------------------------PET------------------PQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 371 ~~~~~~~i~~~~~~~--------------------------~~~------------------~~~s~~~~~li~~~L~~d 406 (491)
..+.+..+......+ +.. ...++.+.+||.+||+.|
T Consensus 264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 343 (360)
T 3llt_A 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID 343 (360)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence 766655443211111 110 012367889999999999
Q ss_pred CCCCCCcCCChHHhhcCCCcC
Q 035713 407 PHKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 407 P~~R~t~~~~~~ell~hpff~ 427 (491)
|.+||| ++|||+||||+
T Consensus 344 P~~Rpt----a~elL~hp~f~ 360 (360)
T 3llt_A 344 PTLRPS----PAELLKHKFLE 360 (360)
T ss_dssp GGGSCC----HHHHTTSGGGC
T ss_pred hhhCCC----HHHHhcCcccC
Confidence 999999 99999999996
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-51 Score=419.12 Aligned_cols=288 Identities=26% Similarity=0.392 Sum_probs=217.3
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC-----c
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD-----K 167 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~-----~ 167 (491)
.++|++++.||+|+||+||+|+++.+++.||||++.+. ........++.+|+++|+.++||||+++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 37899999999999999999999999999999999754 34455667888999999999999999999999766 6
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+||||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred eEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 7999999995 6999998764 569999999999999999999999999999999999999999999999999997653
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
............. ...+..............+
T Consensus 181 ~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~~~~~~~ 212 (432)
T 3n9x_A 181 SEKDTNIVNDLEE------------------------------------------------NEEPGPHNKNLKKQLTSHV 212 (432)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred ccccccccccccc------------------------------------------------cccccccccchhccccCCC
Confidence 2211100000000 0000000000011234568
Q ss_pred cccCccCcchhc-CCCCCCcccccchhhHHHhhhc-----------CCCCCCCCCc-----------------HHHHHHH
Q 035713 328 GTHEYLAPEIIR-GEGHGSAVDWWTFGIFLYELLH-----------GTTPFKGQGN-----------------RATLFNV 378 (491)
Q Consensus 328 gt~~y~aPE~l~-~~~~~~~~DiwSlG~il~ellt-----------g~~Pf~~~~~-----------------~~~~~~i 378 (491)
||++|+|||++. +..|+.++||||||||||||++ |+++|.+.+. ..++..+
T Consensus 213 gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i 292 (432)
T 3n9x_A 213 VTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNII 292 (432)
T ss_dssp CCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHH
T ss_pred CCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHH
Confidence 999999999974 5568999999999999999998 5555655431 1222221
Q ss_pred ---HcCC---------------------CcCCC-----CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 379 ---VGQP---------------------LRFPE-----TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 379 ---~~~~---------------------~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
++.+ ...+. .+.+++++.+||.+||+.||++||| ++|+|+||||+++
T Consensus 293 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 293 FNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRIT----IDQALDHPYLKDV 368 (432)
T ss_dssp HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHTCGGGTTT
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCC----HHHHhcChhhhhc
Confidence 2211 11110 1458999999999999999999999 9999999999999
Q ss_pred Chhhhhc
Q 035713 430 NWALVRS 436 (491)
Q Consensus 430 ~~~~~~~ 436 (491)
+|.....
T Consensus 369 ~~~~~e~ 375 (432)
T 3n9x_A 369 RKKKLEN 375 (432)
T ss_dssp CCTTTC-
T ss_pred cCcccCc
Confidence 9986643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=411.05 Aligned_cols=264 Identities=26% Similarity=0.418 Sum_probs=206.1
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.++|++++.||+|+||.||+|+++.+|+.||||+++.... ......+.+|+++|+.++||||+++++++.+++.+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 4689999999999999999999999999999999976532 22334567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 173 MEFCSGGNLHSLRQKQP----NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
|||++ ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99997 69998876531 23599999999999999999999999999999999999999999999999999865321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
... .....+|
T Consensus 161 ~~~----------------------------------------------------------------------~~~~~~~ 170 (317)
T 2pmi_A 161 PVN----------------------------------------------------------------------TFSSEVV 170 (317)
T ss_dssp CCC----------------------------------------------------------------------CCCCCCS
T ss_pred Ccc----------------------------------------------------------------------cCCCCcc
Confidence 100 0112378
Q ss_pred ccCccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CCCc---------------C----
Q 035713 329 THEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QPLR---------------F---- 385 (491)
Q Consensus 329 t~~y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~~~---------------~---- 385 (491)
|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+.. .+.. +
T Consensus 171 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (317)
T 2pmi_A 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRP 250 (317)
T ss_dssp CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCC
T ss_pred cccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhccccccccc
Confidence 9999999999874 589999999999999999999999999887776665542 1100 0
Q ss_pred ----------CCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhh
Q 035713 386 ----------PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWAL 433 (491)
Q Consensus 386 ----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~ 433 (491)
.....++.++.+||.+||+.||++||+ ++|+|+||||+...|..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 251 PRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS----AKQALHHPWFAEYYHHA 304 (317)
T ss_dssp CCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGGGGCC--
T ss_pred chhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCC----HHHHhCChhhhcccchh
Confidence 011257889999999999999999999 99999999999877653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-52 Score=429.30 Aligned_cols=255 Identities=28% Similarity=0.443 Sum_probs=211.2
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC------
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD------ 166 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~------ 166 (491)
.++|++++.||+|+||+||+|++..+++.||||++.+. ........++.+|+.+|+.++||||++++++|...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG-GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc-ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 57899999999999999999999999999999999765 33455667788999999999999999999999654
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
..+||||||+.+ +|.+++.. .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+..
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred CeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 468999999965 56666543 3999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
... ......
T Consensus 215 ~~~-----------------------------------------------------------------------~~~~~~ 223 (464)
T 3ttj_A 215 GTS-----------------------------------------------------------------------FMMTPY 223 (464)
T ss_dssp --C-----------------------------------------------------------------------CCC---
T ss_pred CCC-----------------------------------------------------------------------cccCCC
Confidence 210 011235
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---C-------------------Cc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---P-------------------LR 384 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~-------------------~~ 384 (491)
+||++|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+++.+++.. + ..
T Consensus 224 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~ 303 (464)
T 3ttj_A 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 303 (464)
T ss_dssp -CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCC
T ss_pred cccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccc
Confidence 8999999999999999999999999999999999999999999887777665431 1 00
Q ss_pred CCCC------C------------CCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 385 FPET------P------------QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 385 ~~~~------~------------~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
+... + ..+.++++||.+||+.||++||| ++|+|+||||+.
T Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~~~~ 361 (464)
T 3ttj_A 304 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDDALQHPYINV 361 (464)
T ss_dssp CCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC----HHHHHTSTTTGG
T ss_pred cCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCC----HHHHhcChhhhh
Confidence 0000 0 01567999999999999999999 999999999984
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=407.56 Aligned_cols=265 Identities=31% Similarity=0.466 Sum_probs=231.5
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhH---HHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASR---NKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
.++|++++.||+|+||.||+|+++.+|+.||||++.+...... .....+.+|+++|+.++||||+++++++.+.+.+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 3679999999999999999999999999999999976543221 1245678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC----cEEEeecccccc
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG----HIMLSDFDLSLR 245 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g----~vkL~DFGla~~ 245 (491)
|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999999864 5699999999999999999999999999999999999999888 799999999854
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
..... ....
T Consensus 169 ~~~~~-----------------------------------------------------------------------~~~~ 177 (321)
T 2a2a_A 169 IEDGV-----------------------------------------------------------------------EFKN 177 (321)
T ss_dssp CCTTC-----------------------------------------------------------------------CCCC
T ss_pred cCccc-----------------------------------------------------------------------cccc
Confidence 32110 0112
Q ss_pred cccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCC--CCCCHHHHHHHHhhh
Q 035713 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPET--PQVSFVARDLIRGLL 403 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~~~~li~~~L 403 (491)
.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......++.. ..++..+.+||.+||
T Consensus 178 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l 257 (321)
T 2a2a_A 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLL 257 (321)
T ss_dssp CCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTS
T ss_pred cCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHc
Confidence 379999999999999999999999999999999999999999988888888877665554421 468899999999999
Q ss_pred ccCCCCCCCcCCChHHhhcCCCcCCCChhhh
Q 035713 404 VKEPHKRIAYKRGATEIKQHPFFEGVNWALV 434 (491)
Q Consensus 404 ~~dP~~R~t~~~~~~ell~hpff~~~~~~~~ 434 (491)
+.||++||+ +.++++||||..++|...
T Consensus 258 ~~dp~~Rps----~~e~l~hp~~~~~~~~~~ 284 (321)
T 2a2a_A 258 VKETRKRLT----IQEALRHPWITPVDNQQA 284 (321)
T ss_dssp CSSTTTSCC----HHHHHHSTTTSCSSHHHH
T ss_pred CCChhhCcC----HHHHhcCccccCCCcccc
Confidence 999999999 999999999999998753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=414.49 Aligned_cols=257 Identities=30% Similarity=0.503 Sum_probs=218.9
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~~l 171 (491)
.++|++++.||+|+||+||+|+++.+++.||||++.+.... ..+|+++|.++ +||||++++++|.+++.+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 36799999999999999999999999999999999765322 23588888887 79999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC----CcEEEeecccccccC
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE----GHIMLSDFDLSLRCS 247 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~----g~vkL~DFGla~~~~ 247 (491)
||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+..+ +.+||+|||+++...
T Consensus 94 v~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999999998764 569999999999999999999999999999999999998543 359999999986532
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
... ....+.+
T Consensus 172 ~~~----------------------------------------------------------------------~~~~~~~ 181 (342)
T 2qr7_A 172 AEN----------------------------------------------------------------------GLLMTPC 181 (342)
T ss_dssp CTT----------------------------------------------------------------------CCBCCSS
T ss_pred CCC----------------------------------------------------------------------CceeccC
Confidence 110 0112348
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCC---CcHHHHHHHHcCCCcCCC--CCCCCHHHHHHHHhh
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQ---GNRATLFNVVGQPLRFPE--TPQVSFVARDLIRGL 402 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~---~~~~~~~~i~~~~~~~~~--~~~~s~~~~~li~~~ 402 (491)
||+.|+|||++.+..|+.++|||||||++|||++|+.||.+. ...+.+..+....+.++. ...+++++++||.+|
T Consensus 182 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 261 (342)
T 2qr7_A 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKM 261 (342)
T ss_dssp CCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHH
T ss_pred CCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHH
Confidence 999999999999888999999999999999999999999863 344556667666655543 356899999999999
Q ss_pred hccCCCCCCCcCCChHHhhcCCCcCCCChhhh
Q 035713 403 LVKEPHKRIAYKRGATEIKQHPFFEGVNWALV 434 (491)
Q Consensus 403 L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~ 434 (491)
|..||++||+ +.++++||||. +|..+
T Consensus 262 L~~dP~~R~t----~~~il~hp~~~--~~~~~ 287 (342)
T 2qr7_A 262 LHVDPHQRLT----AALVLRHPWIV--HWDQL 287 (342)
T ss_dssp TCSSTTTSCC----HHHHTTSHHHH--TGGGS
T ss_pred CCCChhHCcC----HHHHhcCCeec--Ccccc
Confidence 9999999999 99999999995 56644
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-51 Score=395.11 Aligned_cols=264 Identities=28% Similarity=0.473 Sum_probs=231.1
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.++|++++.||+|+||.||+|.++.+++.||+|++..... .......+.+|+++++.++||||+++++++..++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4789999999999999999999999999999999976643 334556788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCc---EEEeecccccccCCC
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGH---IMLSDFDLSLRCSVS 249 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~---vkL~DFGla~~~~~~ 249 (491)
|||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 84 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999999999888764 56999999999999999999999999999999999999986655 999999998543211
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
. ......||
T Consensus 162 ~-----------------------------------------------------------------------~~~~~~~~ 170 (284)
T 3kk8_A 162 E-----------------------------------------------------------------------AWHGFAGT 170 (284)
T ss_dssp C-----------------------------------------------------------------------BCCCSCSC
T ss_pred c-----------------------------------------------------------------------cccCCCCC
Confidence 0 01124789
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC--CCCCCHHHHHHHHhhhccCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE--TPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~li~~~L~~dP 407 (491)
+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......++. ...+++++.+||.+||+.||
T Consensus 171 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp 250 (284)
T 3kk8_A 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNP 250 (284)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSST
T ss_pred cCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccCh
Confidence 9999999999999999999999999999999999999998888877777766655543 34689999999999999999
Q ss_pred CCCCCcCCChHHhhcCCCcCCCChhhh
Q 035713 408 HKRIAYKRGATEIKQHPFFEGVNWALV 434 (491)
Q Consensus 408 ~~R~t~~~~~~ell~hpff~~~~~~~~ 434 (491)
++||+ ++++++||||+...+...
T Consensus 251 ~~Rps----~~~~l~h~~~~~~~~~~~ 273 (284)
T 3kk8_A 251 KKRIT----ADQALKVPWICNRERVAS 273 (284)
T ss_dssp TTSCC----HHHHTTSHHHHSCCCGGG
T ss_pred hhCCC----HHHHhcCccccCChhHHh
Confidence 99999 999999999988766543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=400.14 Aligned_cols=259 Identities=32% Similarity=0.555 Sum_probs=230.5
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
.+..++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+++++.++||||+++++++.+.+.+
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 45568999999999999999999999999999999999876544444456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999999999998874 45999999999999999999999999999999999999999999999999987432110
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.....+||
T Consensus 168 ------------------------------------------------------------------------~~~~~~~~ 175 (284)
T 2vgo_A 168 ------------------------------------------------------------------------RRRTMCGT 175 (284)
T ss_dssp ------------------------------------------------------------------------CBCCCCSC
T ss_pred ------------------------------------------------------------------------ccccccCC
Confidence 01124789
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+......++. .++.++.+||.+||+.||.+
T Consensus 176 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~ 253 (284)
T 2vgo_A 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP--FLSDGSKDLISKLLRYHPPQ 253 (284)
T ss_dssp GGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT--TSCHHHHHHHHHHSCSSGGG
T ss_pred CCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCC--cCCHHHHHHHHHHhhcCHhh
Confidence 9999999999999999999999999999999999999988888777778777666654 58999999999999999999
Q ss_pred CCCcCCChHHhhcCCCcCC
Q 035713 410 RIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 410 R~t~~~~~~ell~hpff~~ 428 (491)
||+ ++++++||||+.
T Consensus 254 Rps----~~~ll~h~~~~~ 268 (284)
T 2vgo_A 254 RLP----LKGVMEHPWVKA 268 (284)
T ss_dssp SCC----HHHHHTCHHHHH
T ss_pred CCC----HHHHhhCHHHHh
Confidence 999 999999999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=403.22 Aligned_cols=264 Identities=27% Similarity=0.452 Sum_probs=218.1
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
+++|+++++||+|+||+||+|++..+|+.||||++.... ........+.+|+++++.++||||+++++++...+.+|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 478999999999999999999999999999999986653 3344556678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+++++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 157 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD- 157 (311)
T ss_dssp EECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence 9999999999887764 5599999999999999999999999999999999999999999999999999865321100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.....+||+.|
T Consensus 158 ---------------------------------------------------------------------~~~~~~~~~~y 168 (311)
T 4agu_A 158 ---------------------------------------------------------------------YYDDEVATRWY 168 (311)
T ss_dssp -----------------------------------------------------------------------------GGG
T ss_pred ---------------------------------------------------------------------ccCCCcCCccc
Confidence 01124789999
Q ss_pred cCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---C----------------CCcCCC-----
Q 035713 333 LAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---Q----------------PLRFPE----- 387 (491)
Q Consensus 333 ~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~----------------~~~~~~----- 387 (491)
+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.. . ....+.
T Consensus 169 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (311)
T 4agu_A 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDME 248 (311)
T ss_dssp CCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCC
T ss_pred cChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccc
Confidence 99999987 5679999999999999999999999998877766554332 1 011111
Q ss_pred -----CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhh
Q 035713 388 -----TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWAL 433 (491)
Q Consensus 388 -----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~ 433 (491)
.+.++.++.+||.+||+.||.+||| ++++++||||+++.+..
T Consensus 249 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 249 PLELKFPNISYPALGLLKGCLHMDPTERLT----CEQLLHHPYFENIREIE 295 (311)
T ss_dssp CHHHHCTTCCHHHHHHHHHHCCSSTTTSCC----HHHHHTSGGGTTCC---
T ss_pred hhhhhcccccHHHHHHHHHHccCChhhcCC----HHHHhcChHHHhccCHH
Confidence 1358889999999999999999999 99999999999987753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=416.17 Aligned_cols=259 Identities=30% Similarity=0.460 Sum_probs=221.1
Q ss_pred CceE--eeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 95 NFRL--LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 95 ~y~~--~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.|.+ .+.||+|+||.||+|++..+|+.||+|+++.... .....+.+|+++|+.++||||+++++++.+.+.+|||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3444 6789999999999999999999999999986543 3345678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEE--ccCCcEEEeecccccccCCCC
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLV--RDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl--~~~g~vkL~DFGla~~~~~~~ 250 (491)
|||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 165 ~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 9999999999888764 2459999999999999999999999999999999999999 567889999999986532110
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
.....+||+
T Consensus 244 -----------------------------------------------------------------------~~~~~~gt~ 252 (373)
T 2x4f_A 244 -----------------------------------------------------------------------KLKVNFGTP 252 (373)
T ss_dssp -----------------------------------------------------------------------BCCCCCSSC
T ss_pred -----------------------------------------------------------------------ccccccCCC
Confidence 011237999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC--CCCCCHHHHHHHHhhhccCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE--TPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~ 408 (491)
.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+.+++...+.++. ...+++++++||.+||+.||.
T Consensus 253 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 332 (373)
T 2x4f_A 253 EFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKS 332 (373)
T ss_dssp TTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGG
T ss_pred cEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChh
Confidence 999999999999999999999999999999999999999888888888877655543 246899999999999999999
Q ss_pred CCCCcCCChHHhhcCCCcCCCChh
Q 035713 409 KRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 409 ~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
+||+ +.++|+||||+...|.
T Consensus 333 ~Rps----~~e~l~hp~~~~~~~~ 352 (373)
T 2x4f_A 333 WRIS----ASEALKHPWLSDHKLH 352 (373)
T ss_dssp GSCC----HHHHHHSHHHHCHHHH
T ss_pred hCCC----HHHHhcCcCcCCCchh
Confidence 9999 9999999999987765
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=397.29 Aligned_cols=260 Identities=32% Similarity=0.574 Sum_probs=202.9
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+++++.++||||+++++++.+.+.+|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 47899999999999999999999999999999999866544444556788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-- 166 (278)
T ss_dssp EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--
Confidence 9999999999998864 3569999999999999999999999999999999999999999999999999985432100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......+||+.|
T Consensus 167 --------------------------------------------------------------------~~~~~~~~~~~y 178 (278)
T 3cok_A 167 --------------------------------------------------------------------EKHYTLCGTPNY 178 (278)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------CcceeccCCCCc
Confidence 011134789999
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCC
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIA 412 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 412 (491)
+|||++.+..++.++|||||||++|+|++|+.||........+..+.......+ ..++.++.+||.+||+.||++||+
T Consensus 179 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps 256 (278)
T 3cok_A 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP--SFLSIEAKDLIHQLLRRNPADRLS 256 (278)
T ss_dssp -------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCC--TTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCc--cccCHHHHHHHHHHcccCHhhCCC
Confidence 999999998899999999999999999999999988776665555544444444 358999999999999999999999
Q ss_pred cCCChHHhhcCCCcCCC
Q 035713 413 YKRGATEIKQHPFFEGV 429 (491)
Q Consensus 413 ~~~~~~ell~hpff~~~ 429 (491)
++++++||||...
T Consensus 257 ----~~~~l~h~~~~~~ 269 (278)
T 3cok_A 257 ----LSSVLDHPFMSRN 269 (278)
T ss_dssp ----HHHHTTSTTTC--
T ss_pred ----HHHHhcCccccCC
Confidence 9999999999854
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=407.71 Aligned_cols=266 Identities=29% Similarity=0.442 Sum_probs=228.8
Q ss_pred CCceEe-eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCceEEE
Q 035713 94 SNFRLL-KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 94 ~~y~~~-~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~~l 171 (491)
++|.+. +.||+|+||.||+|+++.+++.||||++.+.... ......+.+|+.+++.+. ||||+++++++.+.+.+|+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 568888 8999999999999999999999999999865433 233456778999999995 6999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc---CCcEEEeecccccccCC
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD---EGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~---~g~vkL~DFGla~~~~~ 248 (491)
||||+.||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 999999999999987655577999999999999999999999999999999999999997 78999999999865321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
.. .....+|
T Consensus 187 ~~-----------------------------------------------------------------------~~~~~~g 195 (327)
T 3lm5_A 187 AC-----------------------------------------------------------------------ELREIMG 195 (327)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred cc-----------------------------------------------------------------------ccccccC
Confidence 10 1112479
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCC--CCCCCCHHHHHHHHhhhccC
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP--ETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~~~~li~~~L~~d 406 (491)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+......++ ....++..+.+||.+||+.|
T Consensus 196 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 275 (327)
T 3lm5_A 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKN 275 (327)
T ss_dssp CGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSS
T ss_pred CcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCC
Confidence 9999999999999999999999999999999999999999888887777766544443 33568999999999999999
Q ss_pred CCCCCCcCCChHHhhcCCCcCCCChhhhh
Q 035713 407 PHKRIAYKRGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 407 P~~R~t~~~~~~ell~hpff~~~~~~~~~ 435 (491)
|.+||+ +++||+||||++.+|+.+.
T Consensus 276 P~~Rpt----~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 276 PEKRPT----AEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp GGGSCC----HHHHTTCGGGCCCCTTCC-
T ss_pred hhhCcC----HHHHhCCHhhccccccccc
Confidence 999999 9999999999999998653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=412.81 Aligned_cols=259 Identities=29% Similarity=0.439 Sum_probs=214.4
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC------
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD------ 166 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~------ 166 (491)
.++|++++.||+|+||.||+|++..+|+.||||++.... .......++.+|+++|+.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 368999999999999999999999999999999996542 3445567788999999999999999999999765
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
..+|+||||+ +++|.++++. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 3569999999 8999999887 35999999999999999999999999999999999999999999999999998542
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.. .....
T Consensus 179 ~~-------------------------------------------------------------------------~~~~~ 185 (367)
T 1cm8_A 179 DS-------------------------------------------------------------------------EMTGY 185 (367)
T ss_dssp CS-------------------------------------------------------------------------SCCSS
T ss_pred cc-------------------------------------------------------------------------ccCcC
Confidence 11 01124
Q ss_pred ccccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---CC-------------------
Q 035713 327 VGTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---PL------------------- 383 (491)
Q Consensus 327 ~gt~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~~------------------- 383 (491)
+||++|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+++..++.. +.
T Consensus 186 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 265 (367)
T 1cm8_A 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 265 (367)
T ss_dssp CSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHS
T ss_pred cCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhC
Confidence 78999999999988 67899999999999999999999999998877776655421 10
Q ss_pred ------cC-CCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhh
Q 035713 384 ------RF-PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWAL 433 (491)
Q Consensus 384 ------~~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~ 433 (491)
.+ .....+++++.+||.+||+.||.+|+| ++++|+||||+.+.+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t----~~e~l~hp~f~~~~~~~ 318 (367)
T 1cm8_A 266 PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT----AGEALAHPYFESLHDTE 318 (367)
T ss_dssp CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGTTTC---
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCC----HHHHhcChHHHhhcCCc
Confidence 00 011357899999999999999999999 99999999999876654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=409.64 Aligned_cols=263 Identities=27% Similarity=0.424 Sum_probs=214.5
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
+++|+++++||+|+||+||+|++..+++.||||++..... ......+.+|+++|+.++||||+++++++.+++.+|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 3689999999999999999999999999999999975431 11222345799999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 79 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-- 154 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 154 (324)
T ss_dssp EECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred ecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--
Confidence 99996 6898888775 3569999999999999999999999999999999999999999999999999985432100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......+||+.|
T Consensus 155 --------------------------------------------------------------------~~~~~~~~t~~y 166 (324)
T 3mtl_A 155 --------------------------------------------------------------------KTYDNEVVTLWY 166 (324)
T ss_dssp ----------------------------------------------------------------------------CGGG
T ss_pred --------------------------------------------------------------------cccccccCcccc
Confidence 011123789999
Q ss_pred cCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CCCc----------------CC------
Q 035713 333 LAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QPLR----------------FP------ 386 (491)
Q Consensus 333 ~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~~~----------------~~------ 386 (491)
+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.. .+.. ++
T Consensus 167 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (324)
T 3mtl_A 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEA 246 (324)
T ss_dssp CCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCC
T ss_pred cChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchh
Confidence 99999987 5689999999999999999999999999887776655542 2110 00
Q ss_pred ---CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhh
Q 035713 387 ---ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWAL 433 (491)
Q Consensus 387 ---~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~ 433 (491)
....++.++.+||.+||+.||.+||| ++|+|+||||..+....
T Consensus 247 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~ 292 (324)
T 3mtl_A 247 LLSHAPRLDSDGADLLTKLLQFEGRNRIS----AEDAMKHPFFLSLGERI 292 (324)
T ss_dssp HHHHCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGGGGCSTT
T ss_pred hhhhcCCCCHHHHHHHHHHcCcCcccCCC----HHHHhcChhhhhccccc
Confidence 01357889999999999999999999 99999999999776543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-52 Score=432.60 Aligned_cols=263 Identities=32% Similarity=0.491 Sum_probs=231.1
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
..++|+++++||+|+||.||+|+++.+|+.||||++.+...........+.+|+++|+.++||||+++++++.+.+.+|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 34689999999999999999999999999999999987655444456678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEE---ccCCcEEEeecccccccCC
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLV---RDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl---~~~g~vkL~DFGla~~~~~ 248 (491)
||||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 104 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 99999999999988764 569999999999999999999999999999999999999 5678999999999865421
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
.. .....+|
T Consensus 182 ~~-----------------------------------------------------------------------~~~~~~g 190 (484)
T 3nyv_A 182 SK-----------------------------------------------------------------------KMKDKIG 190 (484)
T ss_dssp CC-----------------------------------------------------------------------SHHHHTT
T ss_pred cc-----------------------------------------------------------------------ccccCCC
Confidence 11 1123479
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCC--CCCCCCHHHHHHHHhhhccC
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP--ETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~~~~li~~~L~~d 406 (491)
|+.|+|||++.+ .|+.++|||||||++|+|++|++||.+.+..+.+..+....+.++ ....+++++++||.+||+.|
T Consensus 191 t~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 269 (484)
T 3nyv_A 191 TAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYV 269 (484)
T ss_dssp GGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSS
T ss_pred CccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCC
Confidence 999999999987 689999999999999999999999999988888888887765544 33568999999999999999
Q ss_pred CCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 407 PHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 407 P~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
|.+||| +.++|+||||+...+.
T Consensus 270 p~~R~s----~~e~l~h~~~~~~~~~ 291 (484)
T 3nyv_A 270 PSMRIS----ARDALDHEWIQTYTKE 291 (484)
T ss_dssp GGGSCC----HHHHHTSHHHHHHTC-
T ss_pred hhHCcC----HHHHhhChhhcccccc
Confidence 999999 9999999999865543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-51 Score=404.60 Aligned_cols=261 Identities=26% Similarity=0.481 Sum_probs=232.1
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
...+|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 34789999999999999999999999999999999987765566677788899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 119 v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~- 195 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG- 195 (335)
T ss_dssp EECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred EEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-
Confidence 99999999999988764 469999999999999999999999999999999999999999999999999986432110
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
......+||+.
T Consensus 196 ---------------------------------------------------------------------~~~~~~~gt~~ 206 (335)
T 2owb_A 196 ---------------------------------------------------------------------ERKKVLCGTPN 206 (335)
T ss_dssp ---------------------------------------------------------------------CCBCCCCSCCS
T ss_pred ---------------------------------------------------------------------ccccccCCCcc
Confidence 01112479999
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
|+|||++.+..++.++|||||||++|+|++|+.||.+....+.+..+......++. .++.++.+||.+||+.||++||
T Consensus 207 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rp 284 (335)
T 2owb_A 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTDPTARP 284 (335)
T ss_dssp SCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHTCSSGGGSC
T ss_pred ccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc--cCCHHHHHHHHHHccCChhHCc
Confidence 99999999999999999999999999999999999988877777777777666654 5899999999999999999999
Q ss_pred CcCCChHHhhcCCCcCCCC
Q 035713 412 AYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 412 t~~~~~~ell~hpff~~~~ 430 (491)
+ ++++++||||....
T Consensus 285 s----~~ell~~~~~~~~~ 299 (335)
T 2owb_A 285 T----INELLNDEFFTSGY 299 (335)
T ss_dssp C----GGGGGGSHHHHTSC
T ss_pred C----HHHHhcCccccCCC
Confidence 9 99999999997543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=418.60 Aligned_cols=258 Identities=25% Similarity=0.434 Sum_probs=211.7
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC------c
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD------K 167 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~------~ 167 (491)
.+|++++.||+|+||+||+|++..+|+.||||++.+... ...+|+++|+.++|||||+++++|... .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 479999999999999999999999999999999875421 123699999999999999999998532 3
Q ss_pred eEEEEEeccCCCchHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC-CcEEEeeccccc
Q 035713 168 FYCLVMEFCSGGNLHSLRQK--QPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE-GHIMLSDFDLSL 244 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~-g~vkL~DFGla~ 244 (491)
++++||||+.+ +|..++.. .....+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 57899999965 66655542 224569999999999999999999999999999999999999965 568999999986
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
.+.... ...
T Consensus 206 ~~~~~~-----------------------------------------------------------------------~~~ 214 (420)
T 1j1b_A 206 QLVRGE-----------------------------------------------------------------------PNV 214 (420)
T ss_dssp ECCTTC-----------------------------------------------------------------------CCC
T ss_pred hcccCC-----------------------------------------------------------------------Cce
Confidence 532110 111
Q ss_pred ccccccCccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC-----------------CCcCC
Q 035713 325 SFVGTHEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ-----------------PLRFP 386 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~-----------------~~~~~ 386 (491)
..+||+.|+|||++.+. .|+.++|||||||+||||++|+.||.+.+..+.+.+++.. .+.++
T Consensus 215 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p 294 (420)
T 1j1b_A 215 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 294 (420)
T ss_dssp SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCC
T ss_pred eeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccC
Confidence 34789999999999875 6899999999999999999999999998877777665431 12222
Q ss_pred C----------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhh
Q 035713 387 E----------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALV 434 (491)
Q Consensus 387 ~----------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~ 434 (491)
. ...++.++++||.+||++||.+|++ +.|+++||||+.+.+...
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~ 348 (420)
T 1j1b_A 295 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEACAHSFFDELRDPNV 348 (420)
T ss_dssp CCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGGGGCTTC
T ss_pred ccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC----HHHHhCCHhhcccccccc
Confidence 1 1357899999999999999999999 999999999988766543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=394.53 Aligned_cols=260 Identities=27% Similarity=0.484 Sum_probs=231.4
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
..++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+++++.++||||+++++++.+.+.+|+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 34789999999999999999999999999999999987665556667788899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 93 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 169 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG- 169 (294)
T ss_dssp EEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc-
Confidence 99999999999988764 469999999999999999999999999999999999999999999999999985432110
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
......+||+.
T Consensus 170 ---------------------------------------------------------------------~~~~~~~~~~~ 180 (294)
T 2rku_A 170 ---------------------------------------------------------------------ERKKVLCGTPN 180 (294)
T ss_dssp ---------------------------------------------------------------------CCBCCCCSCCS
T ss_pred ---------------------------------------------------------------------cccccccCCCC
Confidence 00112478999
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
|+|||++.+..++.++|||||||++|+|++|+.||.+....+.+..+......++. .++..+.+||.+||+.||++||
T Consensus 181 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp 258 (294)
T 2rku_A 181 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTDPTARP 258 (294)
T ss_dssp SCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT--TSCHHHHHHHHHHTCSSGGGSC
T ss_pred cCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcc--ccCHHHHHHHHHHcccChhhCc
Confidence 99999999998999999999999999999999999998887777777777666554 5899999999999999999999
Q ss_pred CcCCChHHhhcCCCcCCC
Q 035713 412 AYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 412 t~~~~~~ell~hpff~~~ 429 (491)
+ ++++++||||...
T Consensus 259 s----~~~ll~~~~~~~~ 272 (294)
T 2rku_A 259 T----INELLNDEFFTSG 272 (294)
T ss_dssp C----GGGGGGSHHHHTS
T ss_pred C----HHHHhhChheecC
Confidence 9 9999999999754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=411.00 Aligned_cols=269 Identities=30% Similarity=0.476 Sum_probs=226.1
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhh--hHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLA--SRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
++|++++.||+|+||+||+|++..+++.||||++.+.... .......+.+|+++|+.++||||+++++++.+.+.+||
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 6799999999999999999999999999999999865432 23456678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCC--------------------------------------CCCCCHHHHHHHHHHHHHHHHHHH
Q 035713 172 VMEFCSGGNLHSLRQKQP--------------------------------------NKYFTEDAARFFASEVLLALEYLH 213 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~--------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH 213 (491)
||||++||+|.+++.... ...+++..++.++.||+.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 999999999999885210 112468889999999999999999
Q ss_pred HcCcccccCCCCCEEEccCC--cEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCccc
Q 035713 214 MLGIVYRDLKPENVLVRDEG--HIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRIL 291 (491)
Q Consensus 214 ~~givHrDikp~NILl~~~g--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (491)
++||+||||||+||||+.++ .+||+|||+++.+......
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~--------------------------------------- 226 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG--------------------------------------- 226 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------------------------------------
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCcc---------------------------------------
Confidence 99999999999999998776 8999999998654211100
Q ss_pred ccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcC--CCCCCcccccchhhHHHhhhcCCCCCCCC
Q 035713 292 PSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRG--EGHGSAVDWWTFGIFLYELLHGTTPFKGQ 369 (491)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~ 369 (491)
........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 227 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 279 (345)
T 3hko_A 227 ---------------------------EYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGV 279 (345)
T ss_dssp -----------------------------------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ---------------------------ccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 0001123479999999999976 56899999999999999999999999999
Q ss_pred CcHHHHHHHHcCCCcCCCC--CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 370 GNRATLFNVVGQPLRFPET--PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 370 ~~~~~~~~i~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
+..+.+.+++.....++.. ..+++++.+||.+||+.||.+||+ +.++|+||||+++.|.
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 280 NDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD----AMRALQHPWISQFSDK 340 (345)
T ss_dssp SHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC----HHHHHHSHHHHTTSSC
T ss_pred ChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCC----HHHHhcChhhccChHh
Confidence 8888888888776655433 358999999999999999999999 9999999999987664
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=394.00 Aligned_cols=266 Identities=31% Similarity=0.463 Sum_probs=227.4
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchh------hhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEe
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASL------ASRNKLLRAQTEREILGLLD-HPFLPTLYSYFET 165 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~------~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~ 165 (491)
.++|++++.||+|+||.||+|+++.+++.||||++..... ........+.+|+++|+.+. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 4789999999999999999999999999999999975431 12334566789999999996 9999999999999
Q ss_pred CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
.+.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999998864 4699999999999999999999999999999999999999999999999999854
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
..... ....
T Consensus 174 ~~~~~-----------------------------------------------------------------------~~~~ 182 (298)
T 1phk_A 174 LDPGE-----------------------------------------------------------------------KLRE 182 (298)
T ss_dssp CCTTC-----------------------------------------------------------------------CBCC
T ss_pred cCCCc-----------------------------------------------------------------------cccc
Confidence 32110 0112
Q ss_pred cccccCccCcchhc------CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC--CCCCCHHHHH
Q 035713 326 FVGTHEYLAPEIIR------GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE--TPQVSFVARD 397 (491)
Q Consensus 326 ~~gt~~y~aPE~l~------~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~ 397 (491)
.+||+.|+|||++. ...++.++|||||||++|+|++|+.||.+.+.......+......++. ...++..+.+
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 262 (298)
T 1phk_A 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD 262 (298)
T ss_dssp CCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHH
T ss_pred ccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHH
Confidence 47899999999986 456789999999999999999999999988877777777766655443 2468999999
Q ss_pred HHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhhh
Q 035713 398 LIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 398 li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~~ 435 (491)
||.+||+.||.+||+ +.++++||||+...|+.++
T Consensus 263 li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 263 LVSRFLVVQPQKRYT----AEEALAHPFFQQYVVEEVR 296 (298)
T ss_dssp HHHHHCCSSGGGSCC----HHHHTTSGGGCTTC-----
T ss_pred HHHHHccCCcccCCC----HHHHHhChHhhhccchhhc
Confidence 999999999999999 9999999999999887765
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=405.38 Aligned_cols=255 Identities=26% Similarity=0.369 Sum_probs=223.7
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
+.|++++.||+|+||+||+|++..+++.||||++.............+.+|+++|+.++||||+++++++.+++..||||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 56999999999999999999999999999999998765555566678889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206 (348)
T ss_dssp ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----
Confidence 9996 6788777643 35699999999999999999999999999999999999999999999999999854210
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
....+||+.|+
T Consensus 207 ---------------------------------------------------------------------~~~~~gt~~y~ 217 (348)
T 1u5q_A 207 ---------------------------------------------------------------------ANSFVGTPYWM 217 (348)
T ss_dssp ---------------------------------------------------------------------BCCCCSCGGGC
T ss_pred ---------------------------------------------------------------------CCcccCCccee
Confidence 01247999999
Q ss_pred Ccchhc---CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 334 APEIIR---GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 334 aPE~l~---~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
|||++. +..++.++|||||||++|||++|+.||.+.+....+..+............++..+.+||.+||+.||++|
T Consensus 218 aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 297 (348)
T 1u5q_A 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 297 (348)
T ss_dssp CHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred CHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhC
Confidence 999995 46689999999999999999999999998887777777766554444445689999999999999999999
Q ss_pred CCcCCChHHhhcCCCcCC
Q 035713 411 IAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 411 ~t~~~~~~ell~hpff~~ 428 (491)
|+ ++++++||||..
T Consensus 298 ps----~~~ll~h~~~~~ 311 (348)
T 1u5q_A 298 PT----SEVLLKHRFVLR 311 (348)
T ss_dssp CC----HHHHTTCHHHHS
T ss_pred cC----HHHHhhChhhhc
Confidence 99 999999999964
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=399.11 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=222.1
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
.|...+.||+|+||.||+|+++.+|+.||||++..... .....+.+|+.+|+.++||||+++++++...+.+|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 48889999999999999999999999999999975432 234457789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|++|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 123 ~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 195 (321)
T 2c30_A 123 FLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV---- 195 (321)
T ss_dssp CCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS----
T ss_pred cCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc----
Confidence 9999999998875 359999999999999999999999999999999999999999999999999985432110
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
......+||+.|+|
T Consensus 196 ------------------------------------------------------------------~~~~~~~gt~~y~a 209 (321)
T 2c30_A 196 ------------------------------------------------------------------PKRKSLVGTPYWMA 209 (321)
T ss_dssp ------------------------------------------------------------------CCBCCCCSCGGGCC
T ss_pred ------------------------------------------------------------------cccccccCCccccC
Confidence 01113479999999
Q ss_pred cchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCC-cCCCCCCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 335 PEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL-RFPETPQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 335 PE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
||++.+..++.++|||||||++|||++|+.||.+.+....+..+..... .+.....++.++.+||.+||+.||++||+
T Consensus 210 PE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps- 288 (321)
T 2c30_A 210 PEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT- 288 (321)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCC-
T ss_pred HhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcC-
Confidence 9999999999999999999999999999999998877776666655432 23333468999999999999999999999
Q ss_pred CCChHHhhcCCCcCCCC
Q 035713 414 KRGATEIKQHPFFEGVN 430 (491)
Q Consensus 414 ~~~~~ell~hpff~~~~ 430 (491)
+.++++||||....
T Consensus 289 ---~~ell~hp~~~~~~ 302 (321)
T 2c30_A 289 ---AQELLDHPFLLQTG 302 (321)
T ss_dssp ---HHHHHTSGGGGGCC
T ss_pred ---HHHHhcChhhccCC
Confidence 99999999997543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=392.25 Aligned_cols=261 Identities=31% Similarity=0.475 Sum_probs=221.6
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCce
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKF 168 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~ 168 (491)
..+..++|++.+.||+|+||.||+|++..+|+.||||++.............+.+|+++++.++||||+++++++...+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 34566899999999999999999999999999999999987654444556678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
+|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999999998764 4599999999999999999999999999999999999999999999999999854321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
.. .....+|
T Consensus 164 ~~-----------------------------------------------------------------------~~~~~~~ 172 (276)
T 2h6d_A 164 GE-----------------------------------------------------------------------FLRTSCG 172 (276)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred Cc-----------------------------------------------------------------------ceecccC
Confidence 00 0112378
Q ss_pred ccCccCcchhcCCCC-CCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCC
Q 035713 329 THEYLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 329 t~~y~aPE~l~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP 407 (491)
|+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+......+..+......++. .++..+.+||.+||+.||
T Consensus 173 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p 250 (276)
T 2h6d_A 173 SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE--YLNRSVATLLMHMLQVDP 250 (276)
T ss_dssp ----CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSG
T ss_pred CccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCch--hcCHHHHHHHHHHccCCh
Confidence 999999999998776 68999999999999999999999988777777777666555553 489999999999999999
Q ss_pred CCCCCcCCChHHhhcCCCcCC
Q 035713 408 HKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 408 ~~R~t~~~~~~ell~hpff~~ 428 (491)
.+||+ ++++++||||+.
T Consensus 251 ~~Rps----~~~~l~h~~~~~ 267 (276)
T 2h6d_A 251 LKRAT----IKDIREHEWFKQ 267 (276)
T ss_dssp GGSCC----HHHHHHSHHHHT
T ss_pred hhCCC----HHHHHhChhhcc
Confidence 99999 999999999964
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=404.54 Aligned_cols=254 Identities=30% Similarity=0.479 Sum_probs=198.7
Q ss_pred CCceEe---eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCceE
Q 035713 94 SNFRLL---KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKFY 169 (491)
Q Consensus 94 ~~y~~~---~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~ 169 (491)
++|++. +.||+|+||+||+|+++.+++.||||++.+.. ...+.+|+.+|+.+. ||||+++++++.++...
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 457765 78999999999999999999999999997542 234568999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC---cEEEeeccccccc
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG---HIMLSDFDLSLRC 246 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g---~vkL~DFGla~~~ 246 (491)
||||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999999875 5699999999999999999999999999999999999998766 8999999998543
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.... ....+.
T Consensus 160 ~~~~----------------------------------------------------------------------~~~~~~ 169 (325)
T 3kn6_A 160 PPDN----------------------------------------------------------------------QPLKTP 169 (325)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred CCCC----------------------------------------------------------------------Cccccc
Confidence 2110 011234
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCc-------HHHHHHHHcCCCcCCCC--CCCCHHHHH
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGN-------RATLFNVVGQPLRFPET--PQVSFVARD 397 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~~~~i~~~~~~~~~~--~~~s~~~~~ 397 (491)
+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+. .+.+..+....+.++.. ..+++++++
T Consensus 170 ~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 249 (325)
T 3kn6_A 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKD 249 (325)
T ss_dssp --------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHH
T ss_pred CCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHH
Confidence 789999999999999999999999999999999999999986543 34455565555544432 358999999
Q ss_pred HHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 398 LIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 398 li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
||.+||+.||.+||+ ++++++||||++.
T Consensus 250 li~~~L~~dP~~Rpt----~~ell~h~w~~~~ 277 (325)
T 3kn6_A 250 LIQGLLTVDPNKRLK----MSGLRYNEWLQDG 277 (325)
T ss_dssp HHHHHHCCCTTTCCC----TTTSTTCGGGCTT
T ss_pred HHHHHCCCChhHCCC----HHHHhcChhhccC
Confidence 999999999999999 9999999999853
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=404.22 Aligned_cols=263 Identities=24% Similarity=0.370 Sum_probs=221.8
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc----
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK---- 167 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~---- 167 (491)
..++|++++.||+|+||.||+|++..+++.||||++.............+.+|+++++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4578999999999999999999999999999999998776666667778899999999999999999999987654
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred ccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 459999999999999999864 469999999999999999999999999999999999999999999999999986532
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
..... .......+
T Consensus 168 ~~~~~-------------------------------------------------------------------~~~~~~~~ 180 (311)
T 3ork_A 168 DSGNS-------------------------------------------------------------------VTQTAAVI 180 (311)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccc-------------------------------------------------------------------cccccccC
Confidence 11100 01112357
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC--CCCCCHHHHHHHHhhhcc
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE--TPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~li~~~L~~ 405 (491)
||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.......+. ...++.++.+||.+||+.
T Consensus 181 gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 260 (311)
T 3ork_A 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAK 260 (311)
T ss_dssp -CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCS
T ss_pred cCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhc
Confidence 999999999999999999999999999999999999999998887777776655443321 245899999999999999
Q ss_pred CCCCCCCcCCChHHhhcCCCcC
Q 035713 406 EPHKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~hpff~ 427 (491)
||.+||+ +.+++.|+|++
T Consensus 261 dP~~R~~----~~~~l~~~l~~ 278 (311)
T 3ork_A 261 NPENRYQ----TAAEMRADLVR 278 (311)
T ss_dssp SGGGSCS----SHHHHHHHHHH
T ss_pred CHhhChh----hHHHHHHHHHH
Confidence 9999999 89999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=401.52 Aligned_cols=267 Identities=30% Similarity=0.475 Sum_probs=214.1
Q ss_pred CCceEe-eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceEEE
Q 035713 94 SNFRLL-KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 94 ~~y~~~-~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~~l 171 (491)
++|++. +.||+|+||.||+|++..+++.||||++.+... .....+.+|+++|+++ +||||+++++++.+++.+|+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 679996 789999999999999999999999999976532 2344677899999885 79999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCc---EEEeecccccccCC
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGH---IMLSDFDLSLRCSV 248 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~---vkL~DFGla~~~~~ 248 (491)
||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 99999999999998874 46999999999999999999999999999999999999998776 99999999854321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
...... .........+|
T Consensus 167 ~~~~~~---------------------------------------------------------------~~~~~~~~~~g 183 (316)
T 2ac3_A 167 NGDCSP---------------------------------------------------------------ISTPELLTPCG 183 (316)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred CCcccc---------------------------------------------------------------ccccccccccC
Confidence 110000 00001123479
Q ss_pred ccCccCcchhcC-----CCCCCcccccchhhHHHhhhcCCCCCCCCCc---------------HHHHHHHHcCCCcCCCC
Q 035713 329 THEYLAPEIIRG-----EGHGSAVDWWTFGIFLYELLHGTTPFKGQGN---------------RATLFNVVGQPLRFPET 388 (491)
Q Consensus 329 t~~y~aPE~l~~-----~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---------------~~~~~~i~~~~~~~~~~ 388 (491)
|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+... ...+..+......++..
T Consensus 184 t~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 263 (316)
T 2ac3_A 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDK 263 (316)
T ss_dssp SGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHH
T ss_pred CcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCch
Confidence 999999999986 4578999999999999999999999987642 23345555565555532
Q ss_pred --CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 389 --PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 389 --~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
..++.++++||.+||+.||.+||+ ++++|+||||++..+.
T Consensus 264 ~~~~~~~~~~~li~~~L~~dP~~Rps----~~e~l~hp~~~~~~~~ 305 (316)
T 2ac3_A 264 DWAHISCAAKDLISKLLVRDAKQRLS----AAQVLQHPWVQGCAPE 305 (316)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHHSTTCC-----
T ss_pred hcccCCHHHHHHHHHHhhCChhhCCC----HHHHhcChhhcCCCCc
Confidence 458999999999999999999999 9999999999987654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=392.79 Aligned_cols=254 Identities=34% Similarity=0.543 Sum_probs=224.0
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++.+.||+|+||.||+|++..++..||+|++.+.... ....+.+|+++|+.++||||+++++++.+.+.+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 5799999999999999999999999999999999765432 2456778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEE---ccCCcEEEeecccccccCCCC
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLV---RDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl---~~~g~vkL~DFGla~~~~~~~ 250 (491)
||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 86 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 86 ELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp ECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred eccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 999999999988764 559999999999999999999999999999999999999 788999999999985432111
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
.....+||+
T Consensus 164 -----------------------------------------------------------------------~~~~~~~t~ 172 (277)
T 3f3z_A 164 -----------------------------------------------------------------------MMRTKVGTP 172 (277)
T ss_dssp -----------------------------------------------------------------------CBCCCCSCT
T ss_pred -----------------------------------------------------------------------chhccCCCC
Confidence 111237999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCC--CCCCHHHHHHHHhhhccCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPET--PQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~ 408 (491)
.|+|||++.+. ++.++|||||||++|+|++|+.||.+....+....+......++.. ..+++++.+||.+||+.||.
T Consensus 173 ~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 251 (277)
T 3f3z_A 173 YYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPK 251 (277)
T ss_dssp TTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTT
T ss_pred CccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChh
Confidence 99999999765 8999999999999999999999999988888888887776666542 36899999999999999999
Q ss_pred CCCCcCCChHHhhcCCCcCC
Q 035713 409 KRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 409 ~R~t~~~~~~ell~hpff~~ 428 (491)
+||+ +.++|+||||+.
T Consensus 252 ~R~s----~~~~l~h~~~~~ 267 (277)
T 3f3z_A 252 QRIT----SLQALEHEWFEK 267 (277)
T ss_dssp TSCC----HHHHTTSHHHHH
T ss_pred hCcC----HHHHhcCHHHhc
Confidence 9999 999999999964
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=393.09 Aligned_cols=257 Identities=28% Similarity=0.460 Sum_probs=217.0
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++.++||+|+||.||+|+++.+++.||+|++.+... ......+.+|+++|+.++||||+++++++.+.+.+|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 679999999999999999999999999999999976532 223456788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEE---ccCCcEEEeecccccccCC
Q 035713 174 EFCSGGNLHSLRQKQ--PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLV---RDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 174 E~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl---~~~g~vkL~DFGla~~~~~ 248 (491)
||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 999999999887542 23569999999999999999999999999999999999999 4568899999999854321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
.. .....+|
T Consensus 180 ~~-----------------------------------------------------------------------~~~~~~~ 188 (285)
T 3is5_A 180 DE-----------------------------------------------------------------------HSTNAAG 188 (285)
T ss_dssp ------------------------------------------------------------------------------CT
T ss_pred cc-----------------------------------------------------------------------cCcCccc
Confidence 10 1113479
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC-CCCCCHHHHHHHHhhhccCC
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE-TPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~s~~~~~li~~~L~~dP 407 (491)
|+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+.......+......+.. ...+++++.+||.+||+.||
T Consensus 189 t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 267 (285)
T 3is5_A 189 TALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDP 267 (285)
T ss_dssp TGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCT
T ss_pred ccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCCh
Confidence 99999999986 46889999999999999999999999988777766665544443332 23488999999999999999
Q ss_pred CCCCCcCCChHHhhcCCCcCC
Q 035713 408 HKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 408 ~~R~t~~~~~~ell~hpff~~ 428 (491)
++||+ +.|+|+||||+.
T Consensus 268 ~~Rps----~~e~l~hp~f~~ 284 (285)
T 3is5_A 268 ERRPS----AAQVLHHEWFKQ 284 (285)
T ss_dssp TTSCC----HHHHHTSGGGGC
T ss_pred hhCcC----HHHHhcCHHhhc
Confidence 99999 999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-51 Score=426.13 Aligned_cols=260 Identities=33% Similarity=0.519 Sum_probs=221.4
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|+++++||+|+||+||+|+++.++..||||++.+..... .....+.+|+++|+.++||||++++++|.+.+.+|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999999999999999998754322 23456788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc---CCcEEEeecccccccCCCC
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD---EGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~---~g~vkL~DFGla~~~~~~~ 250 (491)
||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++.......
T Consensus 116 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 116 ECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 999999999888764 45999999999999999999999999999999999999976 4559999999986532110
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
.....+||+
T Consensus 194 -----------------------------------------------------------------------~~~~~~gt~ 202 (494)
T 3lij_A 194 -----------------------------------------------------------------------KMKERLGTA 202 (494)
T ss_dssp -----------------------------------------------------------------------CBCCCCSCT
T ss_pred -----------------------------------------------------------------------cccccCCCc
Confidence 111347999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC--CCCCCHHHHHHHHhhhccCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE--TPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~ 408 (491)
.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..+.+..+....+.++. ...++.++++||.+||+.||.
T Consensus 203 ~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~ 281 (494)
T 3lij_A 203 YYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQ 281 (494)
T ss_dssp TTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTT
T ss_pred CeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChh
Confidence 9999999874 6899999999999999999999999999888888888877665543 356899999999999999999
Q ss_pred CCCCcCCChHHhhcCCCcCCCChh
Q 035713 409 KRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 409 ~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
+||| +.++|+||||+...+.
T Consensus 282 ~R~s----~~e~l~hp~~~~~~~~ 301 (494)
T 3lij_A 282 RRIS----AQQALEHPWIKEMCSK 301 (494)
T ss_dssp TSCC----HHHHHTCHHHHHHHHH
T ss_pred hCcc----HHHHhcCcccccCccc
Confidence 9999 9999999999865443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-51 Score=426.00 Aligned_cols=258 Identities=34% Similarity=0.517 Sum_probs=224.7
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|+++++||+|+||+||+|+++.+++.||||++.+.... ......+.+|+++|+.++||||+++++++.+.+.+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 6799999999999999999999999999999999765432 223456789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEc---cCCcEEEeecccccccCCCC
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVR---DEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~---~~g~vkL~DFGla~~~~~~~ 250 (491)
||+.|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++......
T Consensus 101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 999999999888764 4699999999999999999999999999999999999995 45679999999985432110
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
.....+||+
T Consensus 179 -----------------------------------------------------------------------~~~~~~gt~ 187 (486)
T 3mwu_A 179 -----------------------------------------------------------------------KMKDRIGTA 187 (486)
T ss_dssp --------------------------------------------------------------------------CCTTGG
T ss_pred -----------------------------------------------------------------------ccCCCcCCC
Confidence 111347999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCC--CCCCCCHHHHHHHHhhhccCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP--ETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~ 408 (491)
.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..+.+..+....+.++ ....+++++++||.+||+.||.
T Consensus 188 ~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~ 266 (486)
T 3mwu_A 188 YYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPS 266 (486)
T ss_dssp GGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTT
T ss_pred CCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChh
Confidence 9999999986 489999999999999999999999999988888888877765543 3456899999999999999999
Q ss_pred CCCCcCCChHHhhcCCCcCCCC
Q 035713 409 KRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 409 ~R~t~~~~~~ell~hpff~~~~ 430 (491)
+||| +.++|+||||+...
T Consensus 267 ~R~t----~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 267 LRIT----ATQCLEHPWIQKYS 284 (486)
T ss_dssp TSCC----HHHHHHCHHHHHTC
T ss_pred hCcC----HHHHhcCHhhccCc
Confidence 9999 99999999997543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=405.95 Aligned_cols=266 Identities=27% Similarity=0.383 Sum_probs=215.7
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhh--HHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLAS--RNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
.++|++++.||+|+||.||+|++..+|+.||||++....... ......+.+|+++|+.++||||++++++|.+.+.+|
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 478999999999999999999999999999999997543221 122345778999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
+||||+++ +|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 89 lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 99999975 888887764 3569999999999999999999999999999999999999999999999999985432110
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
......+||+
T Consensus 167 ----------------------------------------------------------------------~~~~~~~~t~ 176 (346)
T 1ua2_A 167 ----------------------------------------------------------------------RAYTHQVVTR 176 (346)
T ss_dssp ----------------------------------------------------------------------CCCCCSCCCC
T ss_pred ----------------------------------------------------------------------ccCCcccccc
Confidence 0111247899
Q ss_pred CccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---CC--cCCC-----------------
Q 035713 331 EYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---PL--RFPE----------------- 387 (491)
Q Consensus 331 ~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~~--~~~~----------------- 387 (491)
.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+.+.++... +. .++.
T Consensus 177 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (346)
T 1ua2_A 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIP 256 (346)
T ss_dssp TTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCC
T ss_pred cccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCC
Confidence 999999998754 789999999999999999999999998888777766532 10 0110
Q ss_pred ----CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhh
Q 035713 388 ----TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALV 434 (491)
Q Consensus 388 ----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~ 434 (491)
...++.++.+||.+||+.||.+||| ++|+|+||||....+...
T Consensus 257 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 257 LHHIFSAAGDDLLDLIQGLFLFNPCARIT----ATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp HHHHCTTCCHHHHHHHHHHHCSSTTTSCC----HHHHHTSGGGTSSSCCCC
T ss_pred hHHhhccCCHHHHHHHHHHhccChhhCCC----HHHHhcChhhhcCCCCCC
Confidence 1346789999999999999999999 999999999998766543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=396.92 Aligned_cols=255 Identities=24% Similarity=0.321 Sum_probs=207.6
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhh-cCCCCccceeeeEEeCceEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL-LDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~-l~hp~iv~l~~~~~~~~~~~ 170 (491)
..++|+++++||+|+||+||+|++..+|+.||||++......... ......|+..+.. ++||||++++++|.+++.+|
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 346799999999999999999999999999999998664333333 3334445555544 48999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
|||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 134 lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 999999 77998887765 3569999999999999999999999999999999999999999999999999985432110
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
.....+||+
T Consensus 212 -----------------------------------------------------------------------~~~~~~gt~ 220 (311)
T 3p1a_A 212 -----------------------------------------------------------------------AGEVQEGDP 220 (311)
T ss_dssp --------------------------------------------------------------------------CCCCCG
T ss_pred -----------------------------------------------------------------------CCcccCCCc
Confidence 111236999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
.|+|||++.+ .++.++|||||||++|||++|..||.+... ...+............++.++.+||.+||+.||++|
T Consensus 221 ~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 296 (311)
T 3p1a_A 221 RYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLR 296 (311)
T ss_dssp GGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTS
T ss_pred cccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhC
Confidence 9999999987 689999999999999999999877765422 233333322211224589999999999999999999
Q ss_pred CCcCCChHHhhcCCCcCC
Q 035713 411 IAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 411 ~t~~~~~~ell~hpff~~ 428 (491)
|+ ++++|+||||+.
T Consensus 297 pt----~~ell~hp~~~~ 310 (311)
T 3p1a_A 297 AT----AEALLALPVLRQ 310 (311)
T ss_dssp CC----HHHHHTSGGGSC
T ss_pred cC----HHHHHhCccccC
Confidence 99 999999999974
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=424.87 Aligned_cols=259 Identities=30% Similarity=0.456 Sum_probs=223.0
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhH----------HHHHHHHHHHHHHhhcCCCCccceeee
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASR----------NKLLRAQTEREILGLLDHPFLPTLYSY 162 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~----------~~~~~~~~E~~il~~l~hp~iv~l~~~ 162 (491)
.++|+++++||+|+||+||+|+++.+++.||||++.+...... .....+.+|+++|+.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4789999999999999999999999999999999987643321 334578899999999999999999999
Q ss_pred EEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC---cEEEee
Q 035713 163 FETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG---HIMLSD 239 (491)
Q Consensus 163 ~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g---~vkL~D 239 (491)
+.+.+.+||||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999999988764 5699999999999999999999999999999999999999776 699999
Q ss_pred cccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCC
Q 035713 240 FDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPT 319 (491)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (491)
||++.......
T Consensus 193 fg~a~~~~~~~--------------------------------------------------------------------- 203 (504)
T 3q5i_A 193 FGLSSFFSKDY--------------------------------------------------------------------- 203 (504)
T ss_dssp CTTCEECCTTS---------------------------------------------------------------------
T ss_pred CCCCEEcCCCC---------------------------------------------------------------------
Confidence 99986532110
Q ss_pred CccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC--CCCCCHHHHH
Q 035713 320 NVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE--TPQVSFVARD 397 (491)
Q Consensus 320 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~ 397 (491)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..+.+..+....+.++. ...+++++++
T Consensus 204 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 280 (504)
T 3q5i_A 204 --KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKE 280 (504)
T ss_dssp --CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred --ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHH
Confidence 1113479999999999874 5899999999999999999999999999888888888877665542 2568999999
Q ss_pred HHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 398 LIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 398 li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
||.+||+.||.+||| ++++|+||||+..
T Consensus 281 li~~~L~~dp~~R~t----~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 281 LIKLMLTYDYNKRCT----AEEALNSRWIKKY 308 (504)
T ss_dssp HHHHHTCSSTTTSCC----HHHHHTSHHHHHT
T ss_pred HHHHHcCCChhHCCC----HHHHhcCHhhhhc
Confidence 999999999999999 9999999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=406.33 Aligned_cols=271 Identities=28% Similarity=0.397 Sum_probs=216.3
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc-----
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK----- 167 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~----- 167 (491)
.++|++++.||+|+||.||+|++..+++.||||++.... ........+.+|+.+|+.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 478999999999999999999999999999999997643 33455667889999999999999999999997654
Q ss_pred -eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 168 -FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 168 -~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
.+|+||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred cceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 7899999996 578887763 3999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.... .....
T Consensus 178 ~~~~-----------------------------------------------------------------------~~~~~ 186 (371)
T 2xrw_A 178 GTSF-----------------------------------------------------------------------MMTPY 186 (371)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccc-----------------------------------------------------------------------ccCCc
Confidence 2100 11134
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcC-------------------CC
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF-------------------PE 387 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~-------------------~~ 387 (491)
+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..++...... +.
T Consensus 187 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (371)
T 2xrw_A 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 266 (371)
T ss_dssp ---CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCC
T ss_pred eecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCcc
Confidence 79999999999999999999999999999999999999999988877777665431100 00
Q ss_pred C---------------------CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhhhccCCCCCCC
Q 035713 388 T---------------------PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPE 444 (491)
Q Consensus 388 ~---------------------~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~~~~~~~~~p~ 444 (491)
. ...+.++++||.+||+.||++||| ++|+|+||||+...........+|.+|.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~~~~~~~~~~~~~~~~~ 340 (371)
T 2xrw_A 267 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS----VDEALQHPYINVWYDPSEAEAPPPKIPD 340 (371)
T ss_dssp CCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHSHHHHTTCCHHHHTCCCCCCCT
T ss_pred ccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCC----HHHHhCCcchhhhcCccccCCCCCCCCC
Confidence 0 001567899999999999999999 9999999999865443333444444443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=396.79 Aligned_cols=255 Identities=25% Similarity=0.388 Sum_probs=210.8
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEe--Cce
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFET--DKF 168 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~--~~~ 168 (491)
..++|+++++||+|+||+||+|++..+++.||||+++... ...+.+|+++|+.++ ||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 3478999999999999999999999999999999997532 235678999999997 9999999999987 678
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC-cEEEeecccccccC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG-HIMLSDFDLSLRCS 247 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g-~vkL~DFGla~~~~ 247 (491)
.++||||+.+++|.++++. +++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++...
T Consensus 108 ~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999999988754 89999999999999999999999999999999999999777 89999999986432
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
... .....+
T Consensus 183 ~~~-----------------------------------------------------------------------~~~~~~ 191 (330)
T 3nsz_A 183 PGQ-----------------------------------------------------------------------EYNVRV 191 (330)
T ss_dssp TTC-----------------------------------------------------------------------CCCSCC
T ss_pred CCC-----------------------------------------------------------------------cccccc
Confidence 111 011237
Q ss_pred cccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCC-CcHHHHHHHHc-------------CCCc--------
Q 035713 328 GTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQ-GNRATLFNVVG-------------QPLR-------- 384 (491)
Q Consensus 328 gt~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~-~~~~~~~~i~~-------------~~~~-------- 384 (491)
||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... ...+.+..+.. ....
T Consensus 192 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (330)
T 3nsz_A 192 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI 271 (330)
T ss_dssp SCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHH
T ss_pred ccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhh
Confidence 8999999999988 56899999999999999999999999543 33333222211 1110
Q ss_pred --------------CCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 385 --------------FPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 385 --------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
......++.++.+||.+||+.||.+||| ++|+|+||||+++.|+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----a~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 272 LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT----AREAMEHPYFYTVVKD 329 (330)
T ss_dssp HCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCC----HHHHHTSGGGTTCC--
T ss_pred hhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCC----HHHHhcCccHhhhccC
Confidence 0111237899999999999999999999 9999999999998775
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-51 Score=408.62 Aligned_cols=268 Identities=25% Similarity=0.377 Sum_probs=225.6
Q ss_pred CCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 87 RGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 87 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
....+..++|++++.||+|+||+||+|++..+++.||+|++.... .......+.+|+++|+.++||||+++++++.++
T Consensus 26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103 (360)
T ss_dssp TCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred cccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence 344566789999999999999999999999999999999997652 344556788999999999999999999999999
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML-GIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
+.+||||||++|++|.+++... +.+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++..
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred CEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 9999999999999999999875 4599999999999999999999996 999999999999999999999999999854
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
.... ....
T Consensus 182 ~~~~------------------------------------------------------------------------~~~~ 189 (360)
T 3eqc_A 182 LIDS------------------------------------------------------------------------MANS 189 (360)
T ss_dssp HHHH------------------------------------------------------------------------C---
T ss_pred cccc------------------------------------------------------------------------cccC
Confidence 2100 0112
Q ss_pred cccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHH------------------------------
Q 035713 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATL------------------------------ 375 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~------------------------------ 375 (491)
.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.....
T Consensus 190 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (360)
T 3eqc_A 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269 (360)
T ss_dssp -CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------------
T ss_pred CCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccccc
Confidence 47999999999999999999999999999999999999999876543321
Q ss_pred ------------HHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhh
Q 035713 376 ------------FNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALV 434 (491)
Q Consensus 376 ------------~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~ 434 (491)
..+............++.++.+||.+||+.||++||| ++++|+||||+..+|..+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~~~~ 336 (360)
T 3eqc_A 270 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRSDAEEV 336 (360)
T ss_dssp ----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCC----HHHHHTSHHHHHHHHSCC
T ss_pred CCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCC----HHHHhhChHhhcchHhhh
Confidence 1122222222222357899999999999999999999 999999999988776543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=392.68 Aligned_cols=261 Identities=24% Similarity=0.369 Sum_probs=220.4
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
+..++|++++.||+|+||.||+|++..+++.||+|++............++.+|+.+++.++||||+++++++.+++.+|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 34578999999999999999999999999999999997765566667788899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 88 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 999999999999999875 469999999999999999999999999999999999999999999999999985432110
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
.......+||+
T Consensus 166 ---------------------------------------------------------------------~~~~~~~~gt~ 176 (294)
T 4eqm_A 166 ---------------------------------------------------------------------LTQTNHVLGTV 176 (294)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred ---------------------------------------------------------------------ccccCccccCc
Confidence 01112357999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcC---CCCCCCCHHHHHHHHhhhccCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF---PETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~s~~~~~li~~~L~~dP 407 (491)
.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......+.+...... .....+++.+.++|.+||+.||
T Consensus 177 ~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 256 (294)
T 4eqm_A 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDK 256 (294)
T ss_dssp SSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSG
T ss_pred cccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCH
Confidence 9999999999999999999999999999999999999988777766666554322 1234689999999999999999
Q ss_pred CCCCCcCCChHHhhcCCCc
Q 035713 408 HKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 408 ~~R~t~~~~~~ell~hpff 426 (491)
.+||+ ..+.+.+.|.
T Consensus 257 ~~R~~----~~~~l~~~l~ 271 (294)
T 4eqm_A 257 ANRYK----TIQEMKDDLS 271 (294)
T ss_dssp GGSCS----SHHHHHHHHH
T ss_pred hHccc----cHHHHHHHHH
Confidence 99996 4455555444
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=411.42 Aligned_cols=261 Identities=27% Similarity=0.472 Sum_probs=211.4
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc----
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK---- 167 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~---- 167 (491)
...+|++++.||+|+||+||+|++..+++ ||+|++...... ..+|+++|+.++||||++++++|...+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 34679999999999999999999987766 888877543211 126999999999999999999995433
Q ss_pred --eEEEEEeccCCCchHHHHH-hCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEc-cCCcEEEeecccc
Q 035713 168 --FYCLVMEFCSGGNLHSLRQ-KQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVR-DEGHIMLSDFDLS 243 (491)
Q Consensus 168 --~~~lV~E~~~gg~L~~~~~-~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~-~~g~vkL~DFGla 243 (491)
.+|+||||+.++.+..+.. ......+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+|
T Consensus 110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 4899999997654443332 11235699999999999999999999999999999999999999 7999999999998
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (491)
+...... ..
T Consensus 190 ~~~~~~~-----------------------------------------------------------------------~~ 198 (394)
T 4e7w_A 190 KILIAGE-----------------------------------------------------------------------PN 198 (394)
T ss_dssp EECCTTC-----------------------------------------------------------------------CC
T ss_pred ccccCCC-----------------------------------------------------------------------CC
Confidence 6532110 11
Q ss_pred cccccccCccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---C--------------CcC
Q 035713 324 MSFVGTHEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---P--------------LRF 385 (491)
Q Consensus 324 ~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~--------------~~~ 385 (491)
...+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+..++.. + ..+
T Consensus 199 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~ 278 (394)
T 4e7w_A 199 VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKF 278 (394)
T ss_dssp CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCC
T ss_pred cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhcc
Confidence 134789999999999876 4899999999999999999999999998887777665431 0 111
Q ss_pred CC----------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhhh
Q 035713 386 PE----------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 386 ~~----------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~~ 435 (491)
+. ...+++++.+||.+||+.||.+||+ +.++++||||+.++|...+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~~ 334 (394)
T 4e7w_A 279 PQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT----AIEALCHPFFDELRTGEAR 334 (394)
T ss_dssp CCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSGGGSTTTSSCCC
T ss_pred ccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC----HHHHhcChhhhhhcccccc
Confidence 11 1348899999999999999999999 9999999999999886543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=407.92 Aligned_cols=258 Identities=27% Similarity=0.400 Sum_probs=204.7
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC------c
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD------K 167 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~------~ 167 (491)
++|++++.||+|+||.||+|++..+|+.||||++.... .......++.+|+++|+.++||||+++++++... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 78999999999999999999999999999999996542 3345566788999999999999999999999654 5
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 689999999 8999998875 459999999999999999999999999999999999999999999999999985421
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
. .....+
T Consensus 184 ~-------------------------------------------------------------------------~~~~~~ 190 (367)
T 2fst_X 184 D-------------------------------------------------------------------------EMTGYV 190 (367)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c-------------------------------------------------------------------------cCCCcC
Confidence 0 011347
Q ss_pred cccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CC--------------------C
Q 035713 328 GTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QP--------------------L 383 (491)
Q Consensus 328 gt~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~--------------------~ 383 (491)
||++|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..++. .+ .
T Consensus 191 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 270 (367)
T 2fst_X 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 270 (367)
T ss_dssp CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSC
T ss_pred cCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccC
Confidence 9999999999987 6789999999999999999999999999887776655542 11 0
Q ss_pred cCCC------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhh
Q 035713 384 RFPE------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWAL 433 (491)
Q Consensus 384 ~~~~------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~ 433 (491)
..+. ...+++++.+||.+||+.||.+||| +.++|+||||+......
T Consensus 271 ~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t----~~e~L~hp~~~~~~~~~ 322 (367)
T 2fst_X 271 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQYHDPD 322 (367)
T ss_dssp CCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTTCCGG
T ss_pred CCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcC----HHHHhcChhhhhccCCC
Confidence 0011 1356889999999999999999999 99999999999776543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=403.11 Aligned_cols=257 Identities=32% Similarity=0.495 Sum_probs=223.1
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchh-----hhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCc
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASL-----ASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDK 167 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~-----~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~ 167 (491)
++|++.+.||+|+||.||+|+++.+|+.||||++..... ........+.+|+.+++.+ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 579999999999999999999999999999999975431 1223455678999999999 7999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
..||||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+.
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 999999999999999998764 469999999999999999999999999999999999999999999999999985532
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
... .....+
T Consensus 252 ~~~-----------------------------------------------------------------------~~~~~~ 260 (365)
T 2y7j_A 252 PGE-----------------------------------------------------------------------KLRELC 260 (365)
T ss_dssp TTC-----------------------------------------------------------------------CBCCCC
T ss_pred CCc-----------------------------------------------------------------------ccccCC
Confidence 110 111347
Q ss_pred cccCccCcchhcC------CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC--CCCCCHHHHHHH
Q 035713 328 GTHEYLAPEIIRG------EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE--TPQVSFVARDLI 399 (491)
Q Consensus 328 gt~~y~aPE~l~~------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~li 399 (491)
||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..+......++. ...++.++.+||
T Consensus 261 gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 340 (365)
T 2y7j_A 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLI 340 (365)
T ss_dssp SCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHH
T ss_pred CCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHH
Confidence 9999999999974 35789999999999999999999999988877777777766555432 246889999999
Q ss_pred HhhhccCCCCCCCcCCChHHhhcCCCcC
Q 035713 400 RGLLVKEPHKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 400 ~~~L~~dP~~R~t~~~~~~ell~hpff~ 427 (491)
.+||+.||++||+ ++++|+||||+
T Consensus 341 ~~~L~~dP~~Rps----~~ell~hp~f~ 364 (365)
T 2y7j_A 341 SRLLQVDPEARLT----AEQALQHPFFE 364 (365)
T ss_dssp HHHSCSSTTTSCC----HHHHHHSGGGC
T ss_pred HHHcCCChhHCcC----HHHHhcCcccC
Confidence 9999999999999 99999999997
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=409.75 Aligned_cols=258 Identities=28% Similarity=0.483 Sum_probs=212.5
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe-----
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET----- 165 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~----- 165 (491)
...++|++++.||+|+||+||+|++..+|+.||||++...... ..+|+++|+.++||||++++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 3457899999999999999999999999999999998754221 2369999999999999999999843
Q ss_pred ---------------------------------CceEEEEEeccCCCchHHHHHh--CCCCCCCHHHHHHHHHHHHHHHH
Q 035713 166 ---------------------------------DKFYCLVMEFCSGGNLHSLRQK--QPNKYFTEDAARFFASEVLLALE 210 (491)
Q Consensus 166 ---------------------------------~~~~~lV~E~~~gg~L~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~ 210 (491)
...+|+||||++ ++|.+++.. ..+..+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 345899999997 587776653 23467999999999999999999
Q ss_pred HHHHcCcccccCCCCCEEEc-cCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCc
Q 035713 211 YLHMLGIVYRDLKPENVLVR-DEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPR 289 (491)
Q Consensus 211 ~LH~~givHrDikp~NILl~-~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (491)
|||++||+||||||+|||++ .++.+||+|||+|+......
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--------------------------------------- 196 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--------------------------------------- 196 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---------------------------------------
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---------------------------------------
Confidence 99999999999999999998 68999999999986532111
Q ss_pred ccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCC
Q 035713 290 ILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKG 368 (491)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~ 368 (491)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+
T Consensus 197 --------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 244 (383)
T 3eb0_A 197 --------------------------------PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG 244 (383)
T ss_dssp --------------------------------CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --------------------------------CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence 111347899999999998765 89999999999999999999999999
Q ss_pred CCcHHHHHHHHc---C--------------CCcCCC----------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhh
Q 035713 369 QGNRATLFNVVG---Q--------------PLRFPE----------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIK 421 (491)
Q Consensus 369 ~~~~~~~~~i~~---~--------------~~~~~~----------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell 421 (491)
.+..+.+.+++. . ...++. ...++.++.+||.+||+.||.+||| +.|+|
T Consensus 245 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l 320 (383)
T 3eb0_A 245 ETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN----PYEAM 320 (383)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC----HHHHH
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC----HHHHh
Confidence 888877766643 1 111111 1347899999999999999999999 99999
Q ss_pred cCCCcCCCCh
Q 035713 422 QHPFFEGVNW 431 (491)
Q Consensus 422 ~hpff~~~~~ 431 (491)
+||||+.+.+
T Consensus 321 ~hp~f~~~~~ 330 (383)
T 3eb0_A 321 AHPFFDHLRN 330 (383)
T ss_dssp TSGGGHHHHH
T ss_pred cCHHHHHHHh
Confidence 9999987654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=393.89 Aligned_cols=264 Identities=32% Similarity=0.519 Sum_probs=227.2
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhH---HHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASR---NKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
++|++++.||+|+||.||+|++..+++.||+|++++...... .....+.+|+++|+.++||||+++++++.+.+..|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 579999999999999999999999999999999986543321 12456788999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC----cEEEeeccccccc
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG----HIMLSDFDLSLRC 246 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g----~vkL~DFGla~~~ 246 (491)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999999999998764 4699999999999999999999999999999999999998877 8999999998543
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.... .....
T Consensus 163 ~~~~-----------------------------------------------------------------------~~~~~ 171 (283)
T 3bhy_A 163 EAGN-----------------------------------------------------------------------EFKNI 171 (283)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred cCCC-----------------------------------------------------------------------ccccc
Confidence 2110 01123
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC--CCCCCHHHHHHHHhhhc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE--TPQVSFVARDLIRGLLV 404 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~li~~~L~ 404 (491)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+......++. ...++..+.+||.+||+
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 251 (283)
T 3bhy_A 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLV 251 (283)
T ss_dssp CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSC
T ss_pred CCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHcc
Confidence 6899999999999999999999999999999999999999998887777777665544432 14688999999999999
Q ss_pred cCCCCCCCcCCChHHhhcCCCcCCCChhhh
Q 035713 405 KEPHKRIAYKRGATEIKQHPFFEGVNWALV 434 (491)
Q Consensus 405 ~dP~~R~t~~~~~~ell~hpff~~~~~~~~ 434 (491)
.||.+||+ +.++++||||+.+++..+
T Consensus 252 ~dp~~Rps----~~~~l~h~~~~~~~~~~~ 277 (283)
T 3bhy_A 252 KDPKRRMT----IAQSLEHSWIKAIRRRNV 277 (283)
T ss_dssp SSGGGSCC----HHHHHHCHHHHHHHHCCC
T ss_pred CCHhHCcC----HHHHHhCHHHHHHHHHhh
Confidence 99999999 999999999988766544
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=412.35 Aligned_cols=256 Identities=27% Similarity=0.395 Sum_probs=215.9
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc------CCCCccceeeeEEe
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL------DHPFLPTLYSYFET 165 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l------~hp~iv~l~~~~~~ 165 (491)
...+|+++++||+|+||+||+|++..+++.||||+++... .....+.+|+++|+.+ .|+||+++++++..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 4578999999999999999999999999999999997542 3334566788888877 57799999999999
Q ss_pred CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCc--EEEeecccc
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGH--IMLSDFDLS 243 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~--vkL~DFGla 243 (491)
.+.+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 171 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 RNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999999999 469999988876567999999999999999999999999999999999999999887 999999998
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (491)
+.... ..
T Consensus 250 ~~~~~-------------------------------------------------------------------------~~ 256 (429)
T 3kvw_A 250 CYEHQ-------------------------------------------------------------------------RV 256 (429)
T ss_dssp EETTC-------------------------------------------------------------------------CC
T ss_pred eecCC-------------------------------------------------------------------------cc
Confidence 43210 11
Q ss_pred cccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---CC-----------------
Q 035713 324 MSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---PL----------------- 383 (491)
Q Consensus 324 ~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~~----------------- 383 (491)
.+.+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+..+.+..++.. +.
T Consensus 257 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~ 336 (429)
T 3kvw_A 257 YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSK 336 (429)
T ss_dssp CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTT
T ss_pred cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCC
Confidence 1347999999999999999999999999999999999999999998887766555421 00
Q ss_pred cCC-----------------------------C--------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 384 RFP-----------------------------E--------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 384 ~~~-----------------------------~--------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
.++ . ....++++.+||.+||+.||++||| ++|+|+||||
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt----a~e~L~Hpw~ 412 (429)
T 3kvw_A 337 GYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT----PGQALRHPWL 412 (429)
T ss_dssp SCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSTTT
T ss_pred CCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC----HHHHhCChhh
Confidence 000 0 0124788999999999999999999 9999999999
Q ss_pred CCC
Q 035713 427 EGV 429 (491)
Q Consensus 427 ~~~ 429 (491)
+..
T Consensus 413 ~~~ 415 (429)
T 3kvw_A 413 RRR 415 (429)
T ss_dssp C--
T ss_pred ccC
Confidence 853
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-51 Score=405.61 Aligned_cols=256 Identities=27% Similarity=0.455 Sum_probs=217.1
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhH-----HHHHHHHHHHHHHhhcCCCCccceeeeEEeCce
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASR-----NKLLRAQTEREILGLLDHPFLPTLYSYFETDKF 168 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~ 168 (491)
++|++++.||+|+||+||+|+++.+++.||||++++...... .....+.+|+++|+.++||||++++++|.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 689999999999999999999999999999999987543221 123345679999999999999999999999999
Q ss_pred EEEEEeccCCC-chHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 169 YCLVMEFCSGG-NLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 169 ~~lV~E~~~gg-~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
+|+||||+.+| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 99999999776 999998874 469999999999999999999999999999999999999999999999999986432
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
... ...+.+
T Consensus 182 ~~~-----------------------------------------------------------------------~~~~~~ 190 (335)
T 3dls_A 182 RGK-----------------------------------------------------------------------LFYTFC 190 (335)
T ss_dssp TTC-----------------------------------------------------------------------CBCEEC
T ss_pred CCC-----------------------------------------------------------------------ceeccC
Confidence 110 112357
Q ss_pred cccCccCcchhcCCCC-CCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 328 GTHEYLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ........+ ..++.++.+||.+||+.|
T Consensus 191 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~--~~~~~~l~~li~~~L~~d 262 (335)
T 3dls_A 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPP--YLVSKELMSLVSGLLQPV 262 (335)
T ss_dssp SCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCS--SCCCHHHHHHHHHHTCSS
T ss_pred CCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCC--cccCHHHHHHHHHHccCC
Confidence 9999999999998887 7899999999999999999999976322 222222333 348999999999999999
Q ss_pred CCCCCCcCCChHHhhcCCCcCC------CChhhh
Q 035713 407 PHKRIAYKRGATEIKQHPFFEG------VNWALV 434 (491)
Q Consensus 407 P~~R~t~~~~~~ell~hpff~~------~~~~~~ 434 (491)
|++||+ ++++++||||+. .+|+.+
T Consensus 263 P~~Rps----~~ell~hp~~~~~~~~~~~~~~~~ 292 (335)
T 3dls_A 263 PERRTT----LEKLVTDPWVTQPVNLADYTWEEV 292 (335)
T ss_dssp GGGSCC----HHHHHHCTTTTCCCCGGGCCHHHH
T ss_pred hhhCcC----HHHHhcCccccCCccccccCHHHH
Confidence 999999 999999999965 456554
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=401.05 Aligned_cols=270 Identities=21% Similarity=0.343 Sum_probs=210.2
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc-----
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK----- 167 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~----- 167 (491)
.++|++++.||+|+||.||+|+++.+|+.||||++.... .......+.+|+++|+.++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 367999999999999999999999999999999997643 2345567889999999999999999999986543
Q ss_pred ----------------------------------------------------eEEEEEeccCCCchHHHHHhCCC-CCCC
Q 035713 168 ----------------------------------------------------FYCLVMEFCSGGNLHSLRQKQPN-KYFT 194 (491)
Q Consensus 168 ----------------------------------------------------~~~lV~E~~~gg~L~~~~~~~~~-~~l~ 194 (491)
.+|+||||++|++|.+++..... ...+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 38999999999999999987532 2356
Q ss_pred HHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcc
Q 035713 195 EDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDE 274 (491)
Q Consensus 195 ~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (491)
+..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++............
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~------------------ 224 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL------------------ 224 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-------------------------
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccc------------------
Confidence 77899999999999999999999999999999999999999999999997654221110000
Q ss_pred cccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhh
Q 035713 275 YAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGI 354 (491)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~ 354 (491)
............+||+.|+|||++.+..++.++|||||||
T Consensus 225 ----------------------------------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 264 (332)
T 3qd2_B 225 ----------------------------------------TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGL 264 (332)
T ss_dssp -----------------------------------------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHH
T ss_pred ----------------------------------------ccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHH
Confidence 0000001122357999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 355 FLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 355 il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
++|||++|..|+... ......+...... ......++++.+||.+||+.||++||+ ++++++||||+++
T Consensus 265 il~el~~~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 265 ILFELLYSFSTQMER--VRIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPTERPE----ATDIIENAIFENL 332 (332)
T ss_dssp HHHHHHSCCCCHHHH--HHHHHHHHTTCCC-HHHHHHCHHHHHHHHHHHCSSGGGSCC----HHHHHHSTTCCCC
T ss_pred HHHHHHHcCCChhHH--HHHHHHhhccCCC-cccccCChhHHHHHHHHccCCCCcCCC----HHHHhhchhhhcC
Confidence 999999987775321 1222222222111 111346778899999999999999999 9999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=404.59 Aligned_cols=270 Identities=22% Similarity=0.378 Sum_probs=230.9
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHH--------------HHHHHHHHHHHHhhcCC
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRN--------------KLLRAQTEREILGLLDH 153 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~--------------~~~~~~~E~~il~~l~h 153 (491)
...+..++|++++.||+|+||.||+|++ +++.||||++......... ....+.+|+++|+.++|
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN 102 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence 3445568999999999999999999999 8999999999765433211 12677899999999999
Q ss_pred CCccceeeeEEeCceEEEEEeccCCCchHHH------HHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCC
Q 035713 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSL------RQKQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPEN 226 (491)
Q Consensus 154 p~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~------~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~N 226 (491)
|||+++++++.+.+.+|+||||+++++|.++ +.......+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus 103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9999999999999999999999999999998 655445679999999999999999999999 999999999999
Q ss_pred EEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCC
Q 035713 227 VLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPC 306 (491)
Q Consensus 227 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (491)
||++.++.+||+|||++......
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~--------------------------------------------------------- 205 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK--------------------------------------------------------- 205 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT---------------------------------------------------------
T ss_pred EEEcCCCcEEEeccccccccccc---------------------------------------------------------
Confidence 99999999999999998543211
Q ss_pred CCCCCCccccCCCCccccccccccCccCcchhcCC-CCCC-cccccchhhHHHhhhcCCCCCCCCCc-HHHHHHHHcCCC
Q 035713 307 VGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGE-GHGS-AVDWWTFGIFLYELLHGTTPFKGQGN-RATLFNVVGQPL 383 (491)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~-~~DiwSlG~il~elltg~~Pf~~~~~-~~~~~~i~~~~~ 383 (491)
......||+.|+|||++.+. .++. ++|||||||++|||++|+.||.+... .+.+..+.....
T Consensus 206 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~ 270 (348)
T 2pml_X 206 ---------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI 270 (348)
T ss_dssp ---------------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCC
T ss_pred ---------------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCc
Confidence 01123789999999999987 5666 99999999999999999999998877 666666666655
Q ss_pred cCCCC-----------------CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhhh
Q 035713 384 RFPET-----------------PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 384 ~~~~~-----------------~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~~ 435 (491)
.++.. ..++.++.+||.+||+.||.+||+ +.++++||||++.+|..+.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps----~~e~l~hp~f~~~~~~~~~ 335 (348)
T 2pml_X 271 EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT----SEDALKHEWLADTNIEDLR 335 (348)
T ss_dssp CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSGGGTTCCHHHHH
T ss_pred CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCC----HHHHhcCccccCCCHHHHH
Confidence 55532 468999999999999999999999 9999999999999998654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=415.76 Aligned_cols=263 Identities=32% Similarity=0.527 Sum_probs=211.9
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhh-----hHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLA-----SRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
.++|.+.+.||+|+||+||+|+++.+++.||||++.+.... .......+.+|+++|+.++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 47899999999999999999999999999999999875432 12223357789999999999999999999865 4
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC---cEEEeeccccc
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG---HIMLSDFDLSL 244 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g---~vkL~DFGla~ 244 (491)
.+||||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred ceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 578999999999999887654 5699999999999999999999999999999999999997554 59999999986
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
..... ....
T Consensus 291 ~~~~~-----------------------------------------------------------------------~~~~ 299 (419)
T 3i6u_A 291 ILGET-----------------------------------------------------------------------SLMR 299 (419)
T ss_dssp SCC-----------------------------------------------------------------------------
T ss_pred ecCCC-----------------------------------------------------------------------cccc
Confidence 43210 0112
Q ss_pred ccccccCccCcchhcC---CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHH-HHHHcCCCcCCC--CCCCCHHHHHH
Q 035713 325 SFVGTHEYLAPEIIRG---EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATL-FNVVGQPLRFPE--TPQVSFVARDL 398 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~---~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-~~i~~~~~~~~~--~~~~s~~~~~l 398 (491)
+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+......+ ..+......+.. ...++..+.+|
T Consensus 300 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 379 (419)
T 3i6u_A 300 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDL 379 (419)
T ss_dssp -----CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHH
T ss_pred ccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHH
Confidence 3589999999999864 56788999999999999999999999876544333 334444333321 24689999999
Q ss_pred HHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhh
Q 035713 399 IRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWAL 433 (491)
Q Consensus 399 i~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~ 433 (491)
|.+||+.||.+||+ ++++|+||||++.+|..
T Consensus 380 i~~~L~~dP~~Rps----~~e~l~hp~~~~~~~~~ 410 (419)
T 3i6u_A 380 VKKLLVVDPKARFT----TEEALRHPWLQDEDMKR 410 (419)
T ss_dssp HHHHSCSSTTTSCC----HHHHHHSGGGCCHHHHH
T ss_pred HHHHccCChhHCcC----HHHHhCCcccCChhHHH
Confidence 99999999999999 99999999999888764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=399.04 Aligned_cols=265 Identities=27% Similarity=0.397 Sum_probs=221.6
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
..++|++++.||+|+||.||+|++..+|+.||||++.... ........+.+|+++|+.++||||+++++++.+.+.+|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 3578999999999999999999999999999999987653 333445567889999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||+.+++|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 102 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999999998876653 4599999999999999999999999999999999999999999999999999854321100
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
.....+||+.
T Consensus 180 ----------------------------------------------------------------------~~~~~~~t~~ 189 (331)
T 4aaa_A 180 ----------------------------------------------------------------------VYDDEVATRW 189 (331)
T ss_dssp --------------------------------------------------------------------------CCCCCT
T ss_pred ----------------------------------------------------------------------ccCCCcCCcc
Confidence 0112378999
Q ss_pred ccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC-------------------CCcCCC----
Q 035713 332 YLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ-------------------PLRFPE---- 387 (491)
Q Consensus 332 y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~-------------------~~~~~~---- 387 (491)
|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+... ....+.
T Consensus 190 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
T 4aaa_A 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKER 269 (331)
T ss_dssp TCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSC
T ss_pred ccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCcccccc
Confidence 9999999876 6899999999999999999999999998877666554321 111111
Q ss_pred ------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhh
Q 035713 388 ------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWAL 433 (491)
Q Consensus 388 ------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~ 433 (491)
.+.+++++.+||.+||+.||++||+ +.|||+||||+...+..
T Consensus 270 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~~ 317 (331)
T 4aaa_A 270 EPLERRYPKLSEVVIDLAKKCLHIDPDKRPF----CAELLHHDFFQMDGFAE 317 (331)
T ss_dssp CCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC----GGGGGGSHHHHGGGHHH
T ss_pred chhhhcccchhHHHHHHHHHHhccCcccCCC----HHHHhcCchhccCChhh
Confidence 1357899999999999999999999 99999999999777653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=392.84 Aligned_cols=265 Identities=27% Similarity=0.412 Sum_probs=223.3
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhh-HHHHHHHHHHHHHHhhcCCCCccceeeeEE--eCceE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLAS-RNKLLRAQTEREILGLLDHPFLPTLYSYFE--TDKFY 169 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~~E~~il~~l~hp~iv~l~~~~~--~~~~~ 169 (491)
.++|++++.||+|+||.||+|++..+++.||+|++++..... ......+.+|+++|+.++||||+++++++. +.+.+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999999999999999998654332 244567889999999999999999999984 45689
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+.++ |.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999766 777777765677999999999999999999999999999999999999999999999999998643211
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.. ........||
T Consensus 163 ~~--------------------------------------------------------------------~~~~~~~~~~ 174 (305)
T 2wtk_C 163 AA--------------------------------------------------------------------DDTCRTSQGS 174 (305)
T ss_dssp CS--------------------------------------------------------------------SCEECCCCSC
T ss_pred cc--------------------------------------------------------------------ccccccCCCC
Confidence 00 0011134689
Q ss_pred cCccCcchhcCCCC--CCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCC
Q 035713 330 HEYLAPEIIRGEGH--GSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 330 ~~y~aPE~l~~~~~--~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP 407 (491)
+.|+|||++.+... +.++|||||||++|+|++|+.||.+.+....+..+......++. .++..+.+||.+||..||
T Consensus 175 ~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--~~~~~l~~li~~~l~~dp 252 (305)
T 2wtk_C 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG--DCGPPLSDLLKGMLEYEP 252 (305)
T ss_dssp GGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCS--SSCHHHHHHHHHHTCSST
T ss_pred CCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCC--ccCHHHHHHHHHHccCCh
Confidence 99999999987543 77999999999999999999999998877777777776655553 589999999999999999
Q ss_pred CCCCCcCCChHHhhcCCCcCCCChh
Q 035713 408 HKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 408 ~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
.+||+ ++++++||||+.....
T Consensus 253 ~~Rps----~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 253 AKRFS----IRQIRQHSWFRKKHPP 273 (305)
T ss_dssp TTSCC----HHHHHHSHHHHSCCCC
T ss_pred hhCCC----HHHHhcCcccccCCCC
Confidence 99999 9999999999876543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-50 Score=396.44 Aligned_cols=266 Identities=27% Similarity=0.396 Sum_probs=221.8
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEe-
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFET- 165 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~- 165 (491)
......++|++++.||+|+||.||+|++..+++.||||++...... ...+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3344568999999999999999999999999999999999754322 24567899999999 79999999999976
Q ss_pred -----CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeec
Q 035713 166 -----DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240 (491)
Q Consensus 166 -----~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DF 240 (491)
.+.+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence 568999999999999999998765567999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCC
Q 035713 241 DLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTN 320 (491)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (491)
|++.......
T Consensus 174 g~~~~~~~~~---------------------------------------------------------------------- 183 (326)
T 2x7f_A 174 GVSAQLDRTV---------------------------------------------------------------------- 183 (326)
T ss_dssp TTTC----------------------------------------------------------------------------
T ss_pred cCceecCcCc----------------------------------------------------------------------
Confidence 9985432100
Q ss_pred ccccccccccCccCcchhc-----CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHH
Q 035713 321 VRSMSFVGTHEYLAPEIIR-----GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVA 395 (491)
Q Consensus 321 ~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~ 395 (491)
......+||+.|+|||++. +..++.++|||||||++|+|++|+.||.+......+..+............++..+
T Consensus 184 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 263 (326)
T 2x7f_A 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKF 263 (326)
T ss_dssp -------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHH
T ss_pred cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCHHH
Confidence 0111347999999999997 45689999999999999999999999998877777766665554444445689999
Q ss_pred HHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCCh
Q 035713 396 RDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNW 431 (491)
Q Consensus 396 ~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~ 431 (491)
.+||.+||..||.+||+ +.++++||||+...+
T Consensus 264 ~~li~~~l~~dp~~Rps----~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 264 QSFIESCLVKNHSQRPA----TEQLMKHPFIRDQPN 295 (326)
T ss_dssp HHHHHHHCCSSGGGSCC----HHHHHTSHHHHCCTT
T ss_pred HHHHHHHhccChhhCCC----HHHHhhChHHhhCcc
Confidence 99999999999999999 999999999986544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=402.15 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=216.9
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC-----ce
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD-----KF 168 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~-----~~ 168 (491)
++|++++.||+|+||.||+|++..+++.||||++... ........+.+|+++|+.++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 6899999999999999999999999999999999753 2344556788999999999999999999999755 47
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
+|+||||+. ++|.++++. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 105 ~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 899999995 699998876 3599999999999999999999999999999999999999999999999999865321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
.... .......+|
T Consensus 181 ~~~~-------------------------------------------------------------------~~~~~~~~g 193 (364)
T 3qyz_A 181 DHDH-------------------------------------------------------------------TGFLTEYVA 193 (364)
T ss_dssp GGCB-------------------------------------------------------------------CCTTCCCCS
T ss_pred CCCc-------------------------------------------------------------------ccccccccc
Confidence 1000 001123489
Q ss_pred ccCccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CCC-----------------cCC-
Q 035713 329 THEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QPL-----------------RFP- 386 (491)
Q Consensus 329 t~~y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~~-----------------~~~- 386 (491)
|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..++. .+. ..+
T Consensus 194 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (364)
T 3qyz_A 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPH 273 (364)
T ss_dssp CGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCC
T ss_pred ccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCC
Confidence 9999999987654 489999999999999999999999998877766655542 110 000
Q ss_pred --------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 387 --------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 387 --------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
....++.++.+||.+||+.||.+||+ +.|+|+||||+..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 274 KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE----VEQALAHPYLEQY 320 (364)
T ss_dssp CCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGTTT
T ss_pred ccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCcchhhc
Confidence 01357899999999999999999999 9999999999876
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=392.60 Aligned_cols=255 Identities=33% Similarity=0.510 Sum_probs=222.2
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++++.||+|+||.||+|++..+|+.||||++...... ....+.+|+++|+.++||||+++++++.+.+.+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 6799999999999999999999999999999999765322 2345778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEE---ccCCcEEEeecccccccCCCC
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLV---RDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl---~~~g~vkL~DFGla~~~~~~~ 250 (491)
||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 86 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-- 161 (304)
T 2jam_A 86 QLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-- 161 (304)
T ss_dssp CCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--
T ss_pred EcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--
Confidence 999999999988764 469999999999999999999999999999999999999 7789999999999743210
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
......+||+
T Consensus 162 ----------------------------------------------------------------------~~~~~~~~~~ 171 (304)
T 2jam_A 162 ----------------------------------------------------------------------GIMSTACGTP 171 (304)
T ss_dssp ----------------------------------------------------------------------BTTHHHHSCC
T ss_pred ----------------------------------------------------------------------CccccccCCC
Confidence 0111347999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC--CCCCCHHHHHHHHhhhccCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE--TPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~ 408 (491)
.|+|||++.+..++.++|||||||++|+|++|+.||.+......+..+......++. ...++.++.+||.+||..||+
T Consensus 172 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 251 (304)
T 2jam_A 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPN 251 (304)
T ss_dssp CBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTT
T ss_pred CccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChh
Confidence 999999999999999999999999999999999999988887777777776554433 356899999999999999999
Q ss_pred CCCCcCCChHHhhcCCCcCCC
Q 035713 409 KRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 409 ~R~t~~~~~~ell~hpff~~~ 429 (491)
+||+ ++++++||||++.
T Consensus 252 ~Rps----~~~~l~h~~~~~~ 268 (304)
T 2jam_A 252 ERYT----CEKALSHPWIDGN 268 (304)
T ss_dssp TSCC----HHHHHTSHHHHSS
T ss_pred HCcC----HHHHhcCccccCC
Confidence 9999 9999999999753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=401.36 Aligned_cols=259 Identities=20% Similarity=0.298 Sum_probs=218.4
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeC-------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceee
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRG-------TNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYS 161 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~ 161 (491)
.+..++|++++.||+|+||.||+|++.. ++..||||+++.. ........+.+|+++|+.+ +||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 4566899999999999999999999863 4567999999765 2345566788999999999 8999999999
Q ss_pred eEEeCceEEEEEeccCCCchHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCE
Q 035713 162 YFETDKFYCLVMEFCSGGNLHSLRQKQP--------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENV 227 (491)
Q Consensus 162 ~~~~~~~~~lV~E~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NI 227 (491)
++.+.+.+|+||||++||+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999999999999998653 23589999999999999999999999999999999999
Q ss_pred EEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCC
Q 035713 228 LVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCV 307 (491)
Q Consensus 228 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (491)
||+.+|.+||+|||+++........
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~------------------------------------------------------- 259 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYY------------------------------------------------------- 259 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTT-------------------------------------------------------
T ss_pred EECCCCCEEEccccCCcccCcccce-------------------------------------------------------
Confidence 9999999999999998654211100
Q ss_pred CCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCC
Q 035713 308 GGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFP 386 (491)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 386 (491)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+... ...+
T Consensus 260 -------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~ 325 (370)
T 2psq_A 260 -------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-HRMD 325 (370)
T ss_dssp -------------CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCC
T ss_pred -------------ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCC
Confidence 01112367899999999999999999999999999999999 99999988776655555443 3333
Q ss_pred CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 387 ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 387 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
....++.++.+||.+||+.||.+||+ +.+++++
T Consensus 326 ~~~~~~~~l~~li~~~l~~dP~~Rpt----~~ell~~ 358 (370)
T 2psq_A 326 KPANCTNELYMMMRDCWHAVPSQRPT----FKQLVED 358 (370)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 44568999999999999999999999 8888864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=401.65 Aligned_cols=266 Identities=27% Similarity=0.367 Sum_probs=216.0
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe-------
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET------- 165 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~------- 165 (491)
.++|+++++||+|+||+||+|++..+|+.||||++...... ......+.+|+++|+.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 47899999999999999999999999999999998665322 2233456789999999999999999999976
Q ss_pred -CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 166 -DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 166 -~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
.+.+||||||+.+ +|...+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 4578999999964 777776654 3469999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
.+...... ......
T Consensus 173 ~~~~~~~~------------------------------------------------------------------~~~~~~ 186 (351)
T 3mi9_A 173 AFSLAKNS------------------------------------------------------------------QPNRYT 186 (351)
T ss_dssp ECCCCSSS------------------------------------------------------------------SCCCCC
T ss_pred cccccccc------------------------------------------------------------------cccccC
Confidence 54321100 001112
Q ss_pred ccccccCccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC--CCcCCCCCC-----------
Q 035713 325 SFVGTHEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ--PLRFPETPQ----------- 390 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~----------- 390 (491)
..+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+... .......+.
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (351)
T 3mi9_A 187 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLE 266 (351)
T ss_dssp SSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSC
T ss_pred CcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccc
Confidence 34789999999999874 5799999999999999999999999998877766655431 111111111
Q ss_pred -----------------CCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCCh
Q 035713 391 -----------------VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNW 431 (491)
Q Consensus 391 -----------------~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~ 431 (491)
.++++.+||.+||+.||++||+ ++|+|+||||....+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 267 LVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID----SDDALNHDFFWSDPM 320 (351)
T ss_dssp CCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGSSSC
T ss_pred cccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC----HHHHhCCCCcCCCCC
Confidence 2678999999999999999999 999999999986544
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=384.85 Aligned_cols=260 Identities=25% Similarity=0.421 Sum_probs=220.5
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|++++.||+|+||.||+|+++.+++.||||++..... ......+.+|+++++.++||||+++++++.+++..|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 679999999999999999999999999999999975532 234456789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 160 (276)
T 2yex_A 85 EYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-- 160 (276)
T ss_dssp ECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE--
T ss_pred EecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc--
Confidence 999999999988653 4699999999999999999999999999999999999999999999999999854321100
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.......+||+.|+
T Consensus 161 ------------------------------------------------------------------~~~~~~~~~~~~y~ 174 (276)
T 2yex_A 161 ------------------------------------------------------------------ERLLNKMCGTLPYV 174 (276)
T ss_dssp ------------------------------------------------------------------ECCBCCCCSCGGGC
T ss_pred ------------------------------------------------------------------hhcccCCccccCcc
Confidence 00111347899999
Q ss_pred CcchhcCCCC-CCcccccchhhHHHhhhcCCCCCCCCCcHH-HHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 334 APEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRA-TLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 334 aPE~l~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
|||++.+..+ +.++|||||||++|+|++|+.||.+..... .+..+.......+....++..+.+||.+||+.||.+||
T Consensus 175 aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 254 (276)
T 2yex_A 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI 254 (276)
T ss_dssp CGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred ChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCC
Confidence 9999998775 779999999999999999999998765542 33344444333444456899999999999999999999
Q ss_pred CcCCChHHhhcCCCcCCC
Q 035713 412 AYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 412 t~~~~~~ell~hpff~~~ 429 (491)
+ ++++++||||+..
T Consensus 255 s----~~~il~~~~~~~~ 268 (276)
T 2yex_A 255 T----IPDIKKDRWYNKP 268 (276)
T ss_dssp C----HHHHTTCTTTTCC
T ss_pred C----HHHHhcCccccCh
Confidence 9 9999999999854
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=388.77 Aligned_cols=262 Identities=25% Similarity=0.320 Sum_probs=207.1
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
++..++|++++.||+|+||+||+|++..+|+.||||+++... ........+.++..+++.++||||+++++++.+++..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 455689999999999999999999999999999999997653 2233344455566668889999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 170 CLVMEFCSGGNLHSLRQK--QPNKYFTEDAARFFASEVLLALEYLHML-GIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
|+||||++ |+|.+++.. .....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999996 588776653 1245699999999999999999999998 9999999999999999999999999998543
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.... .....
T Consensus 161 ~~~~-----------------------------------------------------------------------~~~~~ 169 (290)
T 3fme_A 161 VDDV-----------------------------------------------------------------------AKDID 169 (290)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccc-----------------------------------------------------------------------ccccc
Confidence 2110 01123
Q ss_pred ccccCccCcchh----cCCCCCCcccccchhhHHHhhhcCCCCCCCCC-cHHHHHHHHcCCCcCCCCCCCCHHHHHHHHh
Q 035713 327 VGTHEYLAPEII----RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQG-NRATLFNVVGQPLRFPETPQVSFVARDLIRG 401 (491)
Q Consensus 327 ~gt~~y~aPE~l----~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 401 (491)
.||+.|+|||++ .+..++.++|||||||++|+|++|+.||.... ....+...............++.++.+||.+
T Consensus 170 ~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 249 (290)
T 3fme_A 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQ 249 (290)
T ss_dssp CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHH
T ss_pred CCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHH
Confidence 689999999997 45568899999999999999999999998643 3444444444443333335689999999999
Q ss_pred hhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 402 LLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 402 ~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
||+.||++||+ +.++++||||+.
T Consensus 250 ~l~~~p~~Rpt----~~e~l~hp~f~~ 272 (290)
T 3fme_A 250 CLKKNSKERPT----YPELMQHPFFTL 272 (290)
T ss_dssp HTCSSGGGSCC----HHHHTTSHHHHH
T ss_pred HhhcChhhCcC----HHHHHhCccccc
Confidence 99999999999 999999999964
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=398.09 Aligned_cols=260 Identities=27% Similarity=0.410 Sum_probs=214.9
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCC--CCccceeeeEEeCce
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH--PFLPTLYSYFETDKF 168 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h--p~iv~l~~~~~~~~~ 168 (491)
+..++|++++.||+|+||.||+|.+. +++.||||++.... ........+.+|+++|+.++| +||+++++++.+++.
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 34578999999999999999999985 68899999997654 334556678899999999986 999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
+|||||+ .+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++....
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 9999995 588999999875 5699999999999999999999999999999999999996 68899999999865321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
... .......+|
T Consensus 160 ~~~--------------------------------------------------------------------~~~~~~~~g 171 (343)
T 3dbq_A 160 DTT--------------------------------------------------------------------SVVKDSQVG 171 (343)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred ccc--------------------------------------------------------------------cccCCCCcC
Confidence 110 001123479
Q ss_pred ccCccCcchhcC-----------CCCCCcccccchhhHHHhhhcCCCCCCCCCcH-HHHHHHHcCCCcCCCCCCCCHHHH
Q 035713 329 THEYLAPEIIRG-----------EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR-ATLFNVVGQPLRFPETPQVSFVAR 396 (491)
Q Consensus 329 t~~y~aPE~l~~-----------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~~~~ 396 (491)
|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.... ..+..++............+.++.
T Consensus 172 t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 251 (343)
T 3dbq_A 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 251 (343)
T ss_dssp CCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHH
T ss_pred CcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHH
Confidence 999999999975 56788999999999999999999999875444 444555555444444455788999
Q ss_pred HHHHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 397 DLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 397 ~li~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
+||.+||+.||.+||+ +.++|+||||+.
T Consensus 252 ~li~~~L~~dp~~Rpt----~~e~l~hp~~~~ 279 (343)
T 3dbq_A 252 DVLKCCLKRDPKQRIS----IPELLAHPYVQI 279 (343)
T ss_dssp HHHHHHTCSSTTTSCC----HHHHHTSHHHHS
T ss_pred HHHHHHcCCChhHCCC----HHHHHhCccccc
Confidence 9999999999999999 999999999974
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=384.47 Aligned_cols=256 Identities=23% Similarity=0.384 Sum_probs=217.7
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe----Cce
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET----DKF 168 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~----~~~ 168 (491)
...|++.+.||+|+||.||+|.+..++..||+|++...... ......+.+|+.+|+.++||||+++++++.. ...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 35699999999999999999999999999999999765433 3456778899999999999999999999875 467
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccccCCCCCEEEc-cCCcEEEeecccccc
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG--IVYRDLKPENVLVR-DEGHIMLSDFDLSLR 245 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~NILl~-~~g~vkL~DFGla~~ 245 (491)
+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999999874 45999999999999999999999999 99999999999998 789999999999843
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
.... ....
T Consensus 182 ~~~~------------------------------------------------------------------------~~~~ 189 (290)
T 1t4h_A 182 KRAS------------------------------------------------------------------------FAKA 189 (290)
T ss_dssp CCTT------------------------------------------------------------------------SBEE
T ss_pred cccc------------------------------------------------------------------------cccc
Confidence 2110 1112
Q ss_pred cccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcC-CCCCCCCHHHHHHHHhhhc
Q 035713 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF-PETPQVSFVARDLIRGLLV 404 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~s~~~~~li~~~L~ 404 (491)
.+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..........+...... ......++++.+||.+||+
T Consensus 190 ~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 268 (290)
T 1t4h_A 190 VIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268 (290)
T ss_dssp SCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSC
T ss_pred ccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHcc
Confidence 478999999998875 48999999999999999999999999876666665555443322 2223577899999999999
Q ss_pred cCCCCCCCcCCChHHhhcCCCcCC
Q 035713 405 KEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 405 ~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
.||.+||+ ++++++||||++
T Consensus 269 ~dp~~Rps----~~ell~h~~f~~ 288 (290)
T 1t4h_A 269 QNKDERYS----IKDLLNHAFFQE 288 (290)
T ss_dssp SSGGGSCC----HHHHHTSGGGC-
T ss_pred CChhhCCC----HHHHhhCccccc
Confidence 99999999 999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=404.00 Aligned_cols=260 Identities=27% Similarity=0.412 Sum_probs=216.5
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC--CCCccceeeeEEeCceEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD--HPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~--hp~iv~l~~~~~~~~~~~ 170 (491)
..+|++++.||+|+||+||+|.+.. ++.||||++.+... .......+.+|+++|+.++ ||||+++++++..++.+|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 3569999999999999999999875 88999999976543 3455677889999999997 599999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
|||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.+....
T Consensus 133 lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9999 5589999999875 4699999999999999999999999999999999999995 6899999999986542111
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
. .....+.+||+
T Consensus 209 ~--------------------------------------------------------------------~~~~~~~~gt~ 220 (390)
T 2zmd_A 209 T--------------------------------------------------------------------SVVKDSQVGAV 220 (390)
T ss_dssp -------------------------------------------------------------------------CCSCCCG
T ss_pred c--------------------------------------------------------------------cccCCCCCcCC
Confidence 0 00112347999
Q ss_pred CccCcchhcC-----------CCCCCcccccchhhHHHhhhcCCCCCCCCCcH-HHHHHHHcCCCcCCCCCCCCHHHHHH
Q 035713 331 EYLAPEIIRG-----------EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR-ATLFNVVGQPLRFPETPQVSFVARDL 398 (491)
Q Consensus 331 ~y~aPE~l~~-----------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~~~~~l 398 (491)
.|+|||++.+ ..++.++|||||||+||||++|+.||.+.... ..+..++.....++.....+.++.+|
T Consensus 221 ~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 300 (390)
T 2zmd_A 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDV 300 (390)
T ss_dssp GGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHH
T ss_pred CccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHH
Confidence 9999999976 35888999999999999999999999876543 45566666555544445578999999
Q ss_pred HHhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 399 IRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 399 i~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
|.+||..||.+||+ +.++|+||||+...
T Consensus 301 i~~~L~~dP~~Rps----~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 301 LKCCLKRDPKQRIS----IPELLAHPYVQIQT 328 (390)
T ss_dssp HHHHTCSSTTTSCC----HHHHHTSHHHHSCC
T ss_pred HHHHcccChhhCCC----HHHHhhCcCccccC
Confidence 99999999999999 99999999997543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=399.83 Aligned_cols=258 Identities=28% Similarity=0.419 Sum_probs=217.3
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE----
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY---- 169 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~---- 169 (491)
++|.+.+.||+|+||.||+|+++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 68999999999999999999999999999999997643 3445567788999999999999999999999877654
Q ss_pred --EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 170 --CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 170 --~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
|+||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999995 688877643 49999999999999999999999999999999999999999999999999985321
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
. .....+
T Consensus 196 ~-------------------------------------------------------------------------~~~~~~ 202 (371)
T 4exu_A 196 A-------------------------------------------------------------------------EMTGYV 202 (371)
T ss_dssp -----------------------------------------------------------------------------CTT
T ss_pred c-------------------------------------------------------------------------CcCCcc
Confidence 1 011247
Q ss_pred cccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---C--------------------C
Q 035713 328 GTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---P--------------------L 383 (491)
Q Consensus 328 gt~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~--------------------~ 383 (491)
||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..++.. + .
T Consensus 203 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (371)
T 4exu_A 203 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLP 282 (371)
T ss_dssp CCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSC
T ss_pred cCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccC
Confidence 8999999999988 67899999999999999999999999998877666655421 0 0
Q ss_pred cCCC------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhh
Q 035713 384 RFPE------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALV 434 (491)
Q Consensus 384 ~~~~------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~ 434 (491)
..+. .+.+++++.+||.+||+.||++||+ +.++|+||||+.+.....
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~~~ 335 (371)
T 4exu_A 283 QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT----AAQALTHPFFEPFRDPEE 335 (371)
T ss_dssp CCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTTCCGGG
T ss_pred CCcchhHHHhccccChHHHHHHHHHCCCChhhcCC----HHHHhcCcccccCCCccc
Confidence 0000 1357899999999999999999999 999999999998776543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=413.37 Aligned_cols=263 Identities=19% Similarity=0.236 Sum_probs=204.8
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc--CCCCcccee-------eeE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL--DHPFLPTLY-------SYF 163 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l--~hp~iv~l~-------~~~ 163 (491)
..+|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34699999999999999999999999999999999987655666677788886655555 699987755 455
Q ss_pred EeC-----------------ceEEEEEeccCCCchHHHHHhCCCCCCCHHHH------HHHHHHHHHHHHHHHHcCcccc
Q 035713 164 ETD-----------------KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAA------RFFASEVLLALEYLHMLGIVYR 220 (491)
Q Consensus 164 ~~~-----------------~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~------~~~~~qi~~aL~~LH~~givHr 220 (491)
... ..+||||||++ |+|.+++.... ..+++..+ ..++.||+.||.|||++||+||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr 218 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence 433 34899999997 89999988642 23455555 5777999999999999999999
Q ss_pred cCCCCCEEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCC
Q 035713 221 DLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSK 300 (491)
Q Consensus 221 Dikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (491)
||||+||||+.+|.+||+|||+|+....
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~---------------------------------------------------- 246 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGT---------------------------------------------------- 246 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTC----------------------------------------------------
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCC----------------------------------------------------
Confidence 9999999999999999999999864321
Q ss_pred CCCCCCCCCCCCccccCCCCccccccccccCccCcchhcC--CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHH--H-
Q 035713 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRG--EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRAT--L- 375 (491)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--~- 375 (491)
......||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+...... +
T Consensus 247 ---------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~ 305 (371)
T 3q60_A 247 ---------------------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK 305 (371)
T ss_dssp ---------------------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCC
T ss_pred ---------------------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchh
Confidence 0112367799999999988 6789999999999999999999999987643210 0
Q ss_pred ----HHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhh
Q 035713 376 ----FNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALV 434 (491)
Q Consensus 376 ----~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~ 434 (491)
.......+.++....+++++.+||.+||+.||++||+ +.++|+||||+.++|...
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~~~ 364 (371)
T 3q60_A 306 RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL----PLEAMETPEFLQLQNEIS 364 (371)
T ss_dssp BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCC----HHHHTTSHHHHHHHHHHH
T ss_pred hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCHHHHHHHHHHh
Confidence 0111223445555679999999999999999999999 999999999998888643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=394.13 Aligned_cols=272 Identities=27% Similarity=0.408 Sum_probs=219.8
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC-----c
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD-----K 167 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~-----~ 167 (491)
.++|++.+.||+|+||.||+|++..+|+.||||++... ........+.+|+++|+.++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 47899999999999999999999999999999999653 2344556678999999999999999999988654 6
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 8999999995 699998876 359999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
........ ...........+
T Consensus 164 ~~~~~~~~------------------------------------------------------------~~~~~~~~~~~~ 183 (353)
T 2b9h_A 164 ESAADNSE------------------------------------------------------------PTGQQSGMVEFV 183 (353)
T ss_dssp ----------------------------------------------------------------------------CCCC
T ss_pred cccccccC------------------------------------------------------------ccccccchhhcc
Confidence 21110000 000001112358
Q ss_pred cccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CCC--------------------
Q 035713 328 GTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QPL-------------------- 383 (491)
Q Consensus 328 gt~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~~-------------------- 383 (491)
||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.. .+.
T Consensus 184 gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (353)
T 2b9h_A 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSL 263 (353)
T ss_dssp CCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTS
T ss_pred ccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcc
Confidence 9999999999875 6689999999999999999999999998877665544331 111
Q ss_pred -cCCC------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhh
Q 035713 384 -RFPE------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALV 434 (491)
Q Consensus 384 -~~~~------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~ 434 (491)
..+. .+.++.++.+||.+||+.||++||+ +.++++||||+...+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~~~~ 317 (353)
T 2b9h_A 264 PMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT----AKEALEHPYLQTYHDPND 317 (353)
T ss_dssp CCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTTCCTTS
T ss_pred cCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCC----HHHHhcCccccccCCccc
Confidence 0110 1368899999999999999999999 999999999998877643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=388.02 Aligned_cols=258 Identities=25% Similarity=0.336 Sum_probs=214.0
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
...+..++|++++.||+|+||+||+|++ +|+.||||++..... .......+.+|+++|+.++||||+++++++.+.+
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 4456678999999999999999999987 478899999976543 3445667889999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcC--cccccCCCCCEEEccCCcEEEeeccccc
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPN-KYFTEDAARFFASEVLLALEYLHMLG--IVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
.+|+||||+++|+|.+++..... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 99999999999999999886421 23999999999999999999999999 9999999999999999999999999985
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
...... ....
T Consensus 188 ~~~~~~----------------------------------------------------------------------~~~~ 197 (309)
T 3p86_A 188 LKASTF----------------------------------------------------------------------LSSK 197 (309)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccccc----------------------------------------------------------------------cccc
Confidence 321100 0112
Q ss_pred ccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhc
Q 035713 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLV 404 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~ 404 (491)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.......+....+++++.+||.+||+
T Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 277 (309)
T 3p86_A 198 SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWT 277 (309)
T ss_dssp ----CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTC
T ss_pred cCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcc
Confidence 34799999999999999999999999999999999999999998887777666654444444445699999999999999
Q ss_pred cCCCCCCCcCCChHHhhc
Q 035713 405 KEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 405 ~dP~~R~t~~~~~~ell~ 422 (491)
.||.+||+ +.++++
T Consensus 278 ~dP~~Rps----~~~ll~ 291 (309)
T 3p86_A 278 NEPWKRPS----FATIMD 291 (309)
T ss_dssp SSGGGSCC----HHHHHH
T ss_pred CChhhCcC----HHHHHH
Confidence 99999999 888886
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=390.96 Aligned_cols=273 Identities=25% Similarity=0.376 Sum_probs=201.6
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
.+..++|++++.||+|+||.||+|++..+++.||||++..... ......+.+|+++++.++||||+++++++...+..
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 4566899999999999999999999998999999999865432 23455678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccc
Q 035713 170 CLVMEFCSGGNLHSLRQK------QPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~------~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla 243 (491)
|+||||++|++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999998874 12356999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (491)
.......... .....
T Consensus 169 ~~~~~~~~~~-----------------------------------------------------------------~~~~~ 183 (303)
T 2vwi_A 169 AFLATGGDIT-----------------------------------------------------------------RNKVR 183 (303)
T ss_dssp HHCC----------------------------------------------------------------------------
T ss_pred heeccCCCcc-----------------------------------------------------------------chhhh
Confidence 6542211000 00011
Q ss_pred cccccccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcC--------CCCCCCCHH
Q 035713 324 MSFVGTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF--------PETPQVSFV 394 (491)
Q Consensus 324 ~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~--------~~~~~~s~~ 394 (491)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+.......... .....++.+
T Consensus 184 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (303)
T 2vwi_A 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKS 263 (303)
T ss_dssp ----CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHH
T ss_pred cccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHH
Confidence 23479999999999976 568999999999999999999999999877766655554432211 112457899
Q ss_pred HHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhh
Q 035713 395 ARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWAL 433 (491)
Q Consensus 395 ~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~ 433 (491)
+.+||.+||+.||.+||+ +.++++||||+...+..
T Consensus 264 ~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~~ 298 (303)
T 2vwi_A 264 FRKMISLCLQKDPEKRPT----AAELLRHKFFQKAKNKE 298 (303)
T ss_dssp HHHHHHHHCCSSGGGSCC----HHHHHTSTTC-------
T ss_pred HHHHHHHHccCChhhCcC----HHHHhhChhhhcCCCCc
Confidence 999999999999999999 99999999999876653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=388.13 Aligned_cols=263 Identities=28% Similarity=0.447 Sum_probs=220.7
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
..++|++++.||+|+||.||+|++..+++.||+|++.... ......+.+|+++|+.++||||+++++++..++.+|+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 3478999999999999999999999999999999987542 2334567789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 170 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-- 170 (302)
T ss_dssp EEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--
T ss_pred EEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--
Confidence 99999999999988764 245999999999999999999999999999999999999999999999999987431100
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
.......+||+.
T Consensus 171 --------------------------------------------------------------------~~~~~~~~~~~~ 182 (302)
T 2j7t_A 171 --------------------------------------------------------------------LQKRDSFIGTPY 182 (302)
T ss_dssp --------------------------------------------------------------------HHC-----CCGG
T ss_pred --------------------------------------------------------------------ccccccccCChh
Confidence 000112479999
Q ss_pred ccCcchhc-----CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCC-cCCCCCCCCHHHHHHHHhhhcc
Q 035713 332 YLAPEIIR-----GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL-RFPETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 332 y~aPE~l~-----~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~~~~li~~~L~~ 405 (491)
|+|||++. +..++.++|||||||++|+|++|+.||...+....+..+..... .......++.++.+||.+||+.
T Consensus 183 y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 262 (302)
T 2j7t_A 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDK 262 (302)
T ss_dssp GCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCS
T ss_pred hcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHccc
Confidence 99999984 56789999999999999999999999998887777666655433 2233356899999999999999
Q ss_pred CCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 406 EPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
||.+||+ +.++++||||+.+.|.
T Consensus 263 dp~~Rps----~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 263 NPETRPS----AAQLLEHPFVSSITSN 285 (302)
T ss_dssp CTTTSCC----HHHHTTSTTTTTCCCC
T ss_pred ChhhCCC----HHHHhcChHHhhhccc
Confidence 9999999 9999999999988765
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=381.87 Aligned_cols=253 Identities=20% Similarity=0.310 Sum_probs=209.6
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~~lV 172 (491)
++|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+.++..+ +||||+++++++.+++.+|+|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 6799999999999999999999999999999999865333 23445677899999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC-----------------
Q 035713 173 MEFCSGGNLHSLRQKQP--NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG----------------- 233 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g----------------- 233 (491)
|||++|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 99999999999987532 25599999999999999999999999999999999999998544
Q ss_pred --cEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCC
Q 035713 234 --HIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGAL 311 (491)
Q Consensus 234 --~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (491)
.+||+|||++......
T Consensus 170 ~~~~kl~Dfg~~~~~~~~-------------------------------------------------------------- 187 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSP-------------------------------------------------------------- 187 (289)
T ss_dssp CCCEEECCCTTCEETTCS--------------------------------------------------------------
T ss_pred ceEEEEcccccccccCCc--------------------------------------------------------------
Confidence 7999999998543210
Q ss_pred CccccCCCCccccccccccCccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCC
Q 035713 312 PELMAEPTNVRSMSFVGTHEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQ 390 (491)
Q Consensus 312 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 390 (491)
....||+.|+|||++.+. .++.++|||||||++|+|++|.+++.... ....+...... .....
T Consensus 188 ------------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~~-~~~~~ 251 (289)
T 1x8b_A 188 ------------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGRLP-RIPQV 251 (289)
T ss_dssp ------------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTTCCC-CCSSC
T ss_pred ------------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcCCCC-CCCcc
Confidence 012589999999999876 46789999999999999999998876442 23344433321 22246
Q ss_pred CCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 391 VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 391 ~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
++.++.+||.+||+.||++||+ +.++++||||...
T Consensus 252 ~~~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 252 LSQEFTELLKVMIHPDPERRPS----AMALVKHSVLLSA 286 (289)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCC----HHHHHTCTTC---
T ss_pred cCHHHHHHHHHHhCCCcccCCC----HHHHhhChHhhhh
Confidence 8999999999999999999999 9999999999854
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=404.53 Aligned_cols=258 Identities=22% Similarity=0.352 Sum_probs=209.6
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC--------CCCcccee
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD--------HPFLPTLY 160 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~--------hp~iv~l~ 160 (491)
..+..++|+++++||+|+||+||+|++..+++.||||+++.. ......+.+|+++|+.++ |+||++++
T Consensus 32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 344468999999999999999999999999999999999754 234456778999999985 78899999
Q ss_pred eeEE----eCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccccCCCCCEEEccCC--
Q 035713 161 SYFE----TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML-GIVYRDLKPENVLVRDEG-- 233 (491)
Q Consensus 161 ~~~~----~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~NILl~~~g-- 233 (491)
++|. ....+||||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+||||+.++
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHH
T ss_pred cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchh
Confidence 9997 566899999999 66777666655456799999999999999999999998 999999999999999775
Q ss_pred -----------------------------------------------cEEEeecccccccCCCCcccccccccccCCCCC
Q 035713 234 -----------------------------------------------HIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGG 266 (491)
Q Consensus 234 -----------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 266 (491)
.+||+|||++......
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----------------- 249 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----------------- 249 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----------------
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----------------
Confidence 7999999998543210
Q ss_pred CCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCCCCCc
Q 035713 267 GGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSA 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~ 346 (491)
....+||+.|+|||++.+..++.+
T Consensus 250 --------------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~ 273 (397)
T 1wak_A 250 --------------------------------------------------------FTEDIQTRQYRSLEVLIGSGYNTP 273 (397)
T ss_dssp --------------------------------------------------------SCSCCSCGGGCCHHHHHTSCCCTH
T ss_pred --------------------------------------------------------CccCCCCCcccCChhhcCCCCCcH
Confidence 112378999999999999999999
Q ss_pred ccccchhhHHHhhhcCCCCCCCCCc------HHHHHH---HHcCCC---------c------------------------
Q 035713 347 VDWWTFGIFLYELLHGTTPFKGQGN------RATLFN---VVGQPL---------R------------------------ 384 (491)
Q Consensus 347 ~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~---i~~~~~---------~------------------------ 384 (491)
+|||||||+||||++|+.||.+.+. ...+.. +++... .
T Consensus 274 ~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (397)
T 1wak_A 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353 (397)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHH
T ss_pred HHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHh
Confidence 9999999999999999999986542 222222 221110 0
Q ss_pred ----CCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 385 ----FPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 385 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
+......+.++.+||.+||+.||++||+ ++|||+||||++
T Consensus 354 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~~~~ 397 (397)
T 1wak_A 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT----AAECLRHPWLNS 397 (397)
T ss_dssp HHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCC----HHHHHTSGGGGC
T ss_pred hhhhcccchhhHHHHHHHHHHHhccChhhcCC----HHHHhhCccccC
Confidence 0011123467889999999999999999 999999999963
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=392.52 Aligned_cols=261 Identities=24% Similarity=0.336 Sum_probs=216.2
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEE-eCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCC------Ccccee
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVEL-RGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP------FLPTLY 160 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~-~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp------~iv~l~ 160 (491)
...+..++|++++.||+|+||.||+|.+ ..+++.||||+++.. ......+.+|+++++.++|+ +|++++
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 3445568999999999999999999998 567899999999754 23445677899999988655 499999
Q ss_pred eeEEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc---------
Q 035713 161 SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD--------- 231 (491)
Q Consensus 161 ~~~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~--------- 231 (491)
+++...+.+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999999999 999999998875557999999999999999999999999999999999999987
Q ss_pred ----------CCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCC
Q 035713 232 ----------EGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKS 301 (491)
Q Consensus 232 ----------~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (491)
++.+||+|||+++....
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~----------------------------------------------------- 189 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDE----------------------------------------------------- 189 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTS-----------------------------------------------------
T ss_pred ccccccccccCCCceEeeCcccccCcc-----------------------------------------------------
Confidence 67899999999854211
Q ss_pred CCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC
Q 035713 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ 381 (491)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~ 381 (491)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 190 --------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 249 (339)
T 1z57_A 190 --------------------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249 (339)
T ss_dssp --------------------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHH
T ss_pred --------------------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 011247899999999999999999999999999999999999999988766544333211
Q ss_pred CCcC------------------------------------------CCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHH
Q 035713 382 PLRF------------------------------------------PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATE 419 (491)
Q Consensus 382 ~~~~------------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~e 419 (491)
...+ ......++++.+||.+||+.||.+||+ +.|
T Consensus 250 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~e 325 (339)
T 1z57_A 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT----LRE 325 (339)
T ss_dssp HCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC----HHH
T ss_pred hCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC----HHH
Confidence 0000 001123567899999999999999999 999
Q ss_pred hhcCCCcCCCC
Q 035713 420 IKQHPFFEGVN 430 (491)
Q Consensus 420 ll~hpff~~~~ 430 (491)
+++||||+.++
T Consensus 326 ll~hp~f~~~~ 336 (339)
T 1z57_A 326 ALKHPFFDLLK 336 (339)
T ss_dssp HTTSGGGGGGG
T ss_pred HhcCHHHHHHh
Confidence 99999998653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=413.02 Aligned_cols=251 Identities=16% Similarity=0.207 Sum_probs=204.5
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHH---HHhhcCCCCcccee-------ee
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE---ILGLLDHPFLPTLY-------SY 162 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~---il~~l~hp~iv~l~-------~~ 162 (491)
.++|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|++ +|+.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 578999999999999999999999999999999998665555556678889995 45555799999998 66
Q ss_pred EEeCc-----------------eEEEEEeccCCCchHHHHHhCCCCCCC-------HHHHHHHHHHHHHHHHHHHHcCcc
Q 035713 163 FETDK-----------------FYCLVMEFCSGGNLHSLRQKQPNKYFT-------EDAARFFASEVLLALEYLHMLGIV 218 (491)
Q Consensus 163 ~~~~~-----------------~~~lV~E~~~gg~L~~~~~~~~~~~l~-------~~~~~~~~~qi~~aL~~LH~~giv 218 (491)
+.+.+ ..||||||+ +|+|.+++... +.++ +..+..|+.||+.||+|||++||+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~--~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL--LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH--HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc--cccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 66553 389999999 78999998864 2244 488888999999999999999999
Q ss_pred cccCCCCCEEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccC
Q 035713 219 YRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRK 298 (491)
Q Consensus 219 HrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (491)
||||||+||||+.+|.+||+|||+++....
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-------------------------------------------------- 258 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-------------------------------------------------- 258 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC--------------------------------------------------
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC--------------------------------------------------
Confidence 999999999999999999999999853210
Q ss_pred CCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCC-----------CCCCcccccchhhHHHhhhcCCCCCC
Q 035713 299 SKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGE-----------GHGSAVDWWTFGIFLYELLHGTTPFK 367 (491)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~~~DiwSlG~il~elltg~~Pf~ 367 (491)
...+.+| +.|+|||++.+. .++.++|||||||+||||++|+.||.
T Consensus 259 -----------------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~ 314 (377)
T 3byv_A 259 -----------------------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT 314 (377)
T ss_dssp -----------------------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred -----------------------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCc
Confidence 1123478 999999999988 89999999999999999999999998
Q ss_pred CCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 368 GQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 368 ~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
+......+..+.. ....+++++.+||.+||+.||++||+ +.++++||||+.+.
T Consensus 315 ~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt----~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 315 KDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLL----PLQAMETPEYEQLR 367 (377)
T ss_dssp -----CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCC----HHHHHTSHHHHHHH
T ss_pred ccccccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCC----HHHHhhChHHHHHH
Confidence 7654333322221 22468999999999999999999999 99999999998653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=389.06 Aligned_cols=264 Identities=25% Similarity=0.409 Sum_probs=219.3
Q ss_pred cCCCceEeeeeeccCceEEEEEEEe-CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc---CCCCccceeeeEE---
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELR-GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL---DHPFLPTLYSYFE--- 164 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l---~hp~iv~l~~~~~--- 164 (491)
..++|++++.||+|+||.||+|++. .+++.||||++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3478999999999999999999995 678999999997543221 1122345677777766 8999999999987
Q ss_pred --eCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccc
Q 035713 165 --TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242 (491)
Q Consensus 165 --~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGl 242 (491)
....+|+||||+. |+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 5678999999996 6999999887656699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcc
Q 035713 243 SLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322 (491)
Q Consensus 243 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (491)
++...... .
T Consensus 167 ~~~~~~~~-----------------------------------------------------------------------~ 175 (326)
T 1blx_A 167 ARIYSFQM-----------------------------------------------------------------------A 175 (326)
T ss_dssp CCCCCGGG-----------------------------------------------------------------------G
T ss_pred cccccCCC-----------------------------------------------------------------------C
Confidence 85432100 1
Q ss_pred ccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---C--CcCC-----------
Q 035713 323 SMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---P--LRFP----------- 386 (491)
Q Consensus 323 ~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~--~~~~----------- 386 (491)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..++.. + ..++
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 1blx_A 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH 255 (326)
T ss_dssp GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSC
T ss_pred ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhc
Confidence 11247899999999999999999999999999999999999999998887777666531 0 0000
Q ss_pred ---------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 387 ---------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 387 ---------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
....++..+.+||.+||..||.+||+ +.++++||||+.+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 256 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYFQDLERC 306 (326)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTCCCC
T ss_pred ccCcchhhhccccCCHHHHHHHHHHcCCCcccCCC----HHHHhcCccccccchh
Confidence 11358899999999999999999999 9999999999998875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=394.13 Aligned_cols=266 Identities=24% Similarity=0.344 Sum_probs=218.7
Q ss_pred CCCCccCCCceEeeeeeccCceEEEEEEEeCCC-cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCC------ccce
Q 035713 87 RGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTN-TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF------LPTL 159 (491)
Q Consensus 87 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~------iv~l 159 (491)
.......++|++++.||+|+||+||+|++..++ +.||||+++... .....+.+|+++|+.++|++ ++.+
T Consensus 12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLM 87 (355)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence 334455689999999999999999999998777 689999997542 33456778999999987655 8999
Q ss_pred eeeEEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEE----------
Q 035713 160 YSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLV---------- 229 (491)
Q Consensus 160 ~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl---------- 229 (491)
++++...+.+||||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence 99999999999999999 6777777776555679999999999999999999999999999999999999
Q ss_pred ---------ccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCC
Q 035713 230 ---------RDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSK 300 (491)
Q Consensus 230 ---------~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (491)
+.++.+||+|||+++....
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---------------------------------------------------- 194 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHE---------------------------------------------------- 194 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTS----------------------------------------------------
T ss_pred ccccccccccCCCcEEEeecCccccccc----------------------------------------------------
Confidence 5678999999999854211
Q ss_pred CCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc
Q 035713 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG 380 (491)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~ 380 (491)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+....+..+..
T Consensus 195 ---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 253 (355)
T 2eu9_A 195 ---------------------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253 (355)
T ss_dssp ---------------------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ---------------------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 01124799999999999999999999999999999999999999998876655443321
Q ss_pred CCCcCC------------------------------------------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChH
Q 035713 381 QPLRFP------------------------------------------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGAT 418 (491)
Q Consensus 381 ~~~~~~------------------------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ 418 (491)
....+| .....+.++.+||.+||+.||++||| +.
T Consensus 254 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~ 329 (355)
T 2eu9_A 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT----LA 329 (355)
T ss_dssp HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC----HH
T ss_pred HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC----HH
Confidence 100000 01122457889999999999999999 99
Q ss_pred HhhcCCCcCCCChhhh
Q 035713 419 EIKQHPFFEGVNWALV 434 (491)
Q Consensus 419 ell~hpff~~~~~~~~ 434 (491)
++|+||||++++|...
T Consensus 330 e~l~hp~f~~~~~~~~ 345 (355)
T 2eu9_A 330 EALLHPFFAGLTPEER 345 (355)
T ss_dssp HHTTSGGGGGCCHHHH
T ss_pred HHhcChhhcCCChhhc
Confidence 9999999999998754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=393.06 Aligned_cols=261 Identities=33% Similarity=0.546 Sum_probs=213.8
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhh-----hHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCce
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLA-----SRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKF 168 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~ 168 (491)
++|++++.||+|+||.||+|++..+++.||||++.+.... .......+.+|+++|+.++||||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 6799999999999999999999999999999999765332 1223345778999999999999999999997765
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCc---EEEeecccccc
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGH---IMLSDFDLSLR 245 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~---vkL~DFGla~~ 245 (491)
+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 89999999999999988754 56999999999999999999999999999999999999987665 99999999854
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
.... .....
T Consensus 167 ~~~~-----------------------------------------------------------------------~~~~~ 175 (322)
T 2ycf_A 167 LGET-----------------------------------------------------------------------SLMRT 175 (322)
T ss_dssp CCCC-----------------------------------------------------------------------HHHHH
T ss_pred cccc-----------------------------------------------------------------------ccccc
Confidence 3210 01123
Q ss_pred cccccCccCcchhc---CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHH-HHHHcCCCcCCC--CCCCCHHHHHHH
Q 035713 326 FVGTHEYLAPEIIR---GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATL-FNVVGQPLRFPE--TPQVSFVARDLI 399 (491)
Q Consensus 326 ~~gt~~y~aPE~l~---~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-~~i~~~~~~~~~--~~~~s~~~~~li 399 (491)
.+||+.|+|||++. ...++.++|||||||++|+|++|+.||.+......+ ..+......+.. ...++.++.+||
T Consensus 176 ~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 255 (322)
T 2ycf_A 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLV 255 (322)
T ss_dssp HHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred ccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHH
Confidence 47999999999985 456889999999999999999999999876543222 333333333221 145899999999
Q ss_pred HhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 400 RGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 400 ~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
.+||+.||++||+ +.++|+||||+..+|.
T Consensus 256 ~~~l~~dP~~Rps----~~~~l~h~~~~~~~~~ 284 (322)
T 2ycf_A 256 KKLLVVDPKARFT----TEEALRHPWLQDEDMK 284 (322)
T ss_dssp HHHSCSSTTTSCC----HHHHHTSGGGCCHHHH
T ss_pred HHHcccCHhhCCC----HHHHhhCcCcCCHHHH
Confidence 9999999999999 9999999999998875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=399.20 Aligned_cols=263 Identities=27% Similarity=0.390 Sum_probs=215.9
Q ss_pred CCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CC-----Ccccee
Q 035713 87 RGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HP-----FLPTLY 160 (491)
Q Consensus 87 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp-----~iv~l~ 160 (491)
.......++|++++.||+|+||+||+|++..+++.||||+++.. ......+.+|+++++.++ |+ +|++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 44455578999999999999999999999999999999999754 233456677898988885 45 499999
Q ss_pred eeEEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HcCcccccCCCCCEEEc--cCCcEE
Q 035713 161 SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH--MLGIVYRDLKPENVLVR--DEGHIM 236 (491)
Q Consensus 161 ~~~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~givHrDikp~NILl~--~~g~vk 236 (491)
+++...+.+||||||+. ++|.+++.....+.+++..++.++.||+.||.||| +.||+||||||+||||+ .++.+|
T Consensus 123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence 99999999999999995 59999998765567999999999999999999999 57999999999999995 478899
Q ss_pred EeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCcccc
Q 035713 237 LSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMA 316 (491)
Q Consensus 237 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (491)
|+|||+++....
T Consensus 202 L~DFG~a~~~~~-------------------------------------------------------------------- 213 (382)
T 2vx3_A 202 IVDFGSSCQLGQ-------------------------------------------------------------------- 213 (382)
T ss_dssp ECCCTTCEETTC--------------------------------------------------------------------
T ss_pred EEeccCceeccc--------------------------------------------------------------------
Confidence 999999854311
Q ss_pred CCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcC-----------
Q 035713 317 EPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF----------- 385 (491)
Q Consensus 317 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~----------- 385 (491)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..++......
T Consensus 214 -----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (382)
T 2vx3_A 214 -----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288 (382)
T ss_dssp -----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTH
T ss_pred -----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHH
Confidence 0112478999999999999999999999999999999999999999988877776654310000
Q ss_pred -------CC-------------------CCC-------------------------CCHHHHHHHHhhhccCCCCCCCcC
Q 035713 386 -------PE-------------------TPQ-------------------------VSFVARDLIRGLLVKEPHKRIAYK 414 (491)
Q Consensus 386 -------~~-------------------~~~-------------------------~s~~~~~li~~~L~~dP~~R~t~~ 414 (491)
+. ... ...++++||.+||+.||++|||
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt-- 366 (382)
T 2vx3_A 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ-- 366 (382)
T ss_dssp HHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC--
T ss_pred HHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC--
Confidence 00 000 0137899999999999999999
Q ss_pred CChHHhhcCCCcCCCCh
Q 035713 415 RGATEIKQHPFFEGVNW 431 (491)
Q Consensus 415 ~~~~ell~hpff~~~~~ 431 (491)
++|+|+||||+...+
T Consensus 367 --a~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 367 --PYYALQHSFFKKTAD 381 (382)
T ss_dssp --HHHHTTSGGGCC---
T ss_pred --HHHHhcCcccccCCC
Confidence 999999999987544
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=390.76 Aligned_cols=258 Identities=28% Similarity=0.421 Sum_probs=216.2
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCce-----
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKF----- 168 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~----- 168 (491)
++|.+.+.||+|+||.||+|+++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 68999999999999999999999999999999997643 344556678899999999999999999999987653
Q ss_pred -EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 169 -YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 169 -~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
+|+||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 599999996 688877643 49999999999999999999999999999999999999999999999999985321
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
. .....+
T Consensus 178 ~-------------------------------------------------------------------------~~~~~~ 184 (353)
T 3coi_A 178 A-------------------------------------------------------------------------EMTGYV 184 (353)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred C-------------------------------------------------------------------------Cccccc
Confidence 0 011247
Q ss_pred cccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---C---------------------
Q 035713 328 GTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---P--------------------- 382 (491)
Q Consensus 328 gt~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~--------------------- 382 (491)
||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..++.. +
T Consensus 185 ~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (353)
T 3coi_A 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLP 264 (353)
T ss_dssp CSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSC
T ss_pred cCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCc
Confidence 8999999999987 56899999999999999999999999988776665554321 0
Q ss_pred ----CcCC-CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhh
Q 035713 383 ----LRFP-ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALV 434 (491)
Q Consensus 383 ----~~~~-~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~ 434 (491)
..+. ....++.++.+||.+||+.||++||+ ++++|+||||+.+.....
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt----~~e~l~hp~f~~~~~~~~ 317 (353)
T 3coi_A 265 QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT----AAQALTHPFFEPFRDPEE 317 (353)
T ss_dssp BCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTTCCGGG
T ss_pred CCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCC----HHHHhcCcchhhccCccc
Confidence 0111 12357899999999999999999999 999999999998766543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=384.49 Aligned_cols=260 Identities=33% Similarity=0.507 Sum_probs=223.9
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.++|++++.||+|+||.||+|++..+++.||||++.+.... ......+.+|+++++.++||||+++++++.+.+.+|+|
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 36899999999999999999999999999999999765432 23445678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC---CcEEEeecccccccCCC
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE---GHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~---g~vkL~DFGla~~~~~~ 249 (491)
|||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 100 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 100 GELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 9999999999887764 459999999999999999999999999999999999999754 46999999998543210
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
. ......||
T Consensus 178 ~-----------------------------------------------------------------------~~~~~~~~ 186 (287)
T 2wei_A 178 T-----------------------------------------------------------------------KMKDRIGT 186 (287)
T ss_dssp S-----------------------------------------------------------------------SCSCHHHH
T ss_pred C-----------------------------------------------------------------------ccccccCc
Confidence 0 01124689
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCC--CCCCCCHHHHHHHHhhhccCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP--ETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~~~~li~~~L~~dP 407 (491)
+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+....+..+......++ ....++.++.+||.+||+.||
T Consensus 187 ~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp 265 (287)
T 2wei_A 187 AYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHP 265 (287)
T ss_dssp HTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSG
T ss_pred ccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccCh
Confidence 999999999865 89999999999999999999999999888777777776655433 335689999999999999999
Q ss_pred CCCCCcCCChHHhhcCCCcCCCCh
Q 035713 408 HKRIAYKRGATEIKQHPFFEGVNW 431 (491)
Q Consensus 408 ~~R~t~~~~~~ell~hpff~~~~~ 431 (491)
++||+ +.++++||||+...|
T Consensus 266 ~~Rps----~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 266 SLRIT----ATQCLEHPWIQKYSS 285 (287)
T ss_dssp GGSCC----HHHHHHSHHHHHHCC
T ss_pred hhCcC----HHHHhcCHHHhcccc
Confidence 99999 999999999986554
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=385.81 Aligned_cols=261 Identities=29% Similarity=0.476 Sum_probs=219.2
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
..++|++++.||+|+||.||+|++..+|+.||||++.... ....+.+|+++|+.++||||+++++++...+.+|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3478999999999999999999999999999999997642 23456789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 102 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp EEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred EeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 99999999999998743 3569999999999999999999999999999999999999999999999999985432110
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
.......||+.
T Consensus 180 ---------------------------------------------------------------------~~~~~~~~~~~ 190 (314)
T 3com_A 180 ---------------------------------------------------------------------AKRNTVIGTPF 190 (314)
T ss_dssp ---------------------------------------------------------------------SCBCCCCSCGG
T ss_pred ---------------------------------------------------------------------cccCccCCCCC
Confidence 01112478999
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCC-CcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP-LRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.... ..+.....++..+.+||.+||..||.+|
T Consensus 191 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 270 (314)
T 3com_A 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQR 270 (314)
T ss_dssp GCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTS
T ss_pred ccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhC
Confidence 999999999999999999999999999999999999877666555554332 2333334589999999999999999999
Q ss_pred CCcCCChHHhhcCCCcCCCChh
Q 035713 411 IAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 411 ~t~~~~~~ell~hpff~~~~~~ 432 (491)
|+ +.++++||||+...+.
T Consensus 271 pt----~~~ll~~~~~~~~~~~ 288 (314)
T 3com_A 271 AT----ATQLLQHPFVRSAKGV 288 (314)
T ss_dssp CC----HHHHTTSHHHHTCCCG
T ss_pred cC----HHHHHhCHHHhcCCcc
Confidence 99 9999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=388.05 Aligned_cols=259 Identities=26% Similarity=0.332 Sum_probs=217.9
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCc---EEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNT---YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
.+..++|++++.||+|+||+||+|++..+++ .||||+++... .......+.+|+++|+.++||||+++++++.++
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3456889999999999999999999986555 49999997542 334556788999999999999999999999999
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
+.+||||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999999998764 356999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
....... ......
T Consensus 202 ~~~~~~~-------------------------------------------------------------------~~~~~~ 214 (325)
T 3kul_A 202 EDDPDAA-------------------------------------------------------------------YTTTGG 214 (325)
T ss_dssp C----CC-------------------------------------------------------------------EECC--
T ss_pred ccCccce-------------------------------------------------------------------eeccCC
Confidence 3211100 001122
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhcc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~ 405 (491)
.+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+... ...+....++.++.+||.+||..
T Consensus 215 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~ 293 (325)
T 3kul_A 215 KIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPAPMGCPHALHQLMLDCWHK 293 (325)
T ss_dssp -CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CCCCCCCCcCHHHHHHHHHHccC
Confidence 57889999999999999999999999999999999 99999988777766665544 44455567999999999999999
Q ss_pred CCCCCCCcCCChHHhhcC
Q 035713 406 EPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~h 423 (491)
||.+||+ +.+|++.
T Consensus 294 dp~~Rps----~~eil~~ 307 (325)
T 3kul_A 294 DRAQRPR----FSQIVSV 307 (325)
T ss_dssp SGGGSCC----HHHHHHH
T ss_pred ChhhCcC----HHHHHHH
Confidence 9999999 8887763
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=382.79 Aligned_cols=254 Identities=27% Similarity=0.427 Sum_probs=220.9
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
+.|++++.||+|+||.||+|++..+++.||||++..... ......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999976532 234567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 100 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 173 (303)
T 3a7i_A 100 EYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--- 173 (303)
T ss_dssp ECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB---
T ss_pred EeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc---
Confidence 99999999999875 459999999999999999999999999999999999999999999999999985432110
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
......+||+.|+
T Consensus 174 -------------------------------------------------------------------~~~~~~~~~~~y~ 186 (303)
T 3a7i_A 174 -------------------------------------------------------------------IKRNTFVGTPFWM 186 (303)
T ss_dssp -------------------------------------------------------------------CCBCCCCSCGGGC
T ss_pred -------------------------------------------------------------------cccCccCCCcCcc
Confidence 0111347899999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCc
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAY 413 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 413 (491)
|||++.+..++.++|||||||++|+|++|+.||...........+..... ......++..+.+||.+||+.||.+||+
T Consensus 187 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps- 264 (303)
T 3a7i_A 187 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFVEACLNKEPSFRPT- 264 (303)
T ss_dssp CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCCSSCCHHHHHHHHHHCCSSGGGSCC-
T ss_pred CHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC-CCCccccCHHHHHHHHHHcCCChhhCcC-
Confidence 99999999999999999999999999999999998777666655544322 1223468999999999999999999999
Q ss_pred CCChHHhhcCCCcC
Q 035713 414 KRGATEIKQHPFFE 427 (491)
Q Consensus 414 ~~~~~ell~hpff~ 427 (491)
+.++++||||.
T Consensus 265 ---~~~ll~~~~~~ 275 (303)
T 3a7i_A 265 ---AKELLKHKFIL 275 (303)
T ss_dssp ---HHHHTTCHHHH
T ss_pred ---HHHHhhChhhh
Confidence 99999999995
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=400.17 Aligned_cols=271 Identities=18% Similarity=0.239 Sum_probs=223.1
Q ss_pred CccCCCceEeeeeeccCceEEEEEE-----EeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVE-----LRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE 164 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 164 (491)
.+..++|++++.||+|+||+||+|+ +..+++.||||+++.. ........+.+|+.+|+.++||||+++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3456889999999999999999999 4557889999998653 22344456788999999999999999999999
Q ss_pred eCceEEEEEeccCCCchHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC---cEE
Q 035713 165 TDKFYCLVMEFCSGGNLHSLRQKQP-----NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG---HIM 236 (491)
Q Consensus 165 ~~~~~~lV~E~~~gg~L~~~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g---~vk 236 (491)
+....||||||++||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||||+.+| .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999988642 23599999999999999999999999999999999999999655 499
Q ss_pred EeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCcccc
Q 035713 237 LSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMA 316 (491)
Q Consensus 237 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (491)
|+|||+++......
T Consensus 225 L~DFG~a~~~~~~~------------------------------------------------------------------ 238 (367)
T 3l9p_A 225 IGDFGMARDIYRAG------------------------------------------------------------------ 238 (367)
T ss_dssp ECCCHHHHHHHHHS------------------------------------------------------------------
T ss_pred ECCCcccccccccc------------------------------------------------------------------
Confidence 99999986432100
Q ss_pred CCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHH
Q 035713 317 EPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVA 395 (491)
Q Consensus 317 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~ 395 (491)
........+||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+.+..+.... ..+....++..+
T Consensus 239 --~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~l 315 (367)
T 3l9p_A 239 --YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPPKNCPGPV 315 (367)
T ss_dssp --SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHHH
T ss_pred --ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCccCCHHH
Confidence 0011123478999999999999999999999999999999998 999999888777766665543 233345689999
Q ss_pred HHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhhh
Q 035713 396 RDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVR 435 (491)
Q Consensus 396 ~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~~ 435 (491)
.+||.+||+.||.+||+ +.+|++|.++-.-+...+.
T Consensus 316 ~~li~~~l~~dP~~Rps----~~eil~~l~~~~~~~~~~~ 351 (367)
T 3l9p_A 316 YRIMTQCWQHQPEDRPN----FAIILERIEYCTQDPDVIN 351 (367)
T ss_dssp HHHHHHHTCSSGGGSCC----HHHHHHHHHHHHHCHHHHT
T ss_pred HHHHHHHcCCCHhHCcC----HHHHHHHHHHHhhChhhcc
Confidence 99999999999999999 9999999877544444333
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=388.70 Aligned_cols=256 Identities=23% Similarity=0.387 Sum_probs=210.8
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc--eE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK--FY 169 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~--~~ 169 (491)
..++|+++++||+|+||+||+|++..+++.||||++...... .....+.+|+++|+.++||||+++++++.... .+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 347899999999999999999999999999999999765332 23455678999999999999999999998654 88
Q ss_pred EEEEeccCCCchHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEE----ccCCcEEEeeccccc
Q 035713 170 CLVMEFCSGGNLHSLRQKQPN-KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLV----RDEGHIMLSDFDLSL 244 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl----~~~g~vkL~DFGla~ 244 (491)
||||||++|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999999886432 339999999999999999999999999999999999999 778889999999986
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
...... ...
T Consensus 165 ~~~~~~-----------------------------------------------------------------------~~~ 173 (319)
T 4euu_A 165 ELEDDE-----------------------------------------------------------------------QFV 173 (319)
T ss_dssp ECCTTC-----------------------------------------------------------------------CBC
T ss_pred ecCCCC-----------------------------------------------------------------------cee
Confidence 542111 111
Q ss_pred ccccccCccCcchhc--------CCCCCCcccccchhhHHHhhhcCCCCCCCCC----cHHHHHHHHcCCC---------
Q 035713 325 SFVGTHEYLAPEIIR--------GEGHGSAVDWWTFGIFLYELLHGTTPFKGQG----NRATLFNVVGQPL--------- 383 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~--------~~~~~~~~DiwSlG~il~elltg~~Pf~~~~----~~~~~~~i~~~~~--------- 383 (491)
..+||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+.+.+++....
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 253 (319)
T 4euu_A 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQK 253 (319)
T ss_dssp CCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEEC
T ss_pred ecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhc
Confidence 347999999999987 5678999999999999999999999997533 3444555554322
Q ss_pred ----------cCCCC----CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCC
Q 035713 384 ----------RFPET----PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHP 424 (491)
Q Consensus 384 ----------~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hp 424 (491)
.++.. ..++..+.+||.+||+.||++||+ ++|+|+||
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s----~~ell~h~ 304 (319)
T 4euu_A 254 AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG----FDQFFAET 304 (319)
T ss_dssp STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC----HHHHHHHH
T ss_pred ccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhcc----HHHhhhcc
Confidence 11111 234457889999999999999999 99999996
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=395.18 Aligned_cols=261 Identities=21% Similarity=0.322 Sum_probs=218.3
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEE-----eCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeee
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVEL-----RGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSY 162 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~ 162 (491)
+.+..++|++++.||+|+||.||+|++ ..+++.||||+++... .......+.+|+++|+.+ +||||++++++
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 345678999999999999999999994 4566899999997642 234456788999999999 78999999999
Q ss_pred EEeCc-eEEEEEeccCCCchHHHHHhCCC---------------------------------------------------
Q 035713 163 FETDK-FYCLVMEFCSGGNLHSLRQKQPN--------------------------------------------------- 190 (491)
Q Consensus 163 ~~~~~-~~~lV~E~~~gg~L~~~~~~~~~--------------------------------------------------- 190 (491)
+.+.+ .+|+||||++||+|.+++.....
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 98754 58999999999999999986532
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccccc
Q 035713 191 -------------KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSS 257 (491)
Q Consensus 191 -------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 257 (491)
..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~------ 248 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD------ 248 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT------
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc------
Confidence 1289999999999999999999999999999999999999999999999999864321110
Q ss_pred ccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcch
Q 035713 258 VSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEI 337 (491)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 337 (491)
........||+.|+|||+
T Consensus 249 --------------------------------------------------------------~~~~~~~~~t~~y~aPE~ 266 (359)
T 3vhe_A 249 --------------------------------------------------------------YVRKGDARLPLKWMAPET 266 (359)
T ss_dssp --------------------------------------------------------------CEEC--CEECGGGCCHHH
T ss_pred --------------------------------------------------------------chhccccCCCceeEChhh
Confidence 011123478999999999
Q ss_pred hcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCC
Q 035713 338 IRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRG 416 (491)
Q Consensus 338 l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~ 416 (491)
+.+..++.++|||||||++|||++ |+.||.+......+...+......+....+++++.+||.+||+.||.+||+
T Consensus 267 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---- 342 (359)
T 3vhe_A 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT---- 342 (359)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----
T ss_pred hcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCC----
Confidence 999999999999999999999998 999999887666665555444444444568999999999999999999999
Q ss_pred hHHhhcC
Q 035713 417 ATEIKQH 423 (491)
Q Consensus 417 ~~ell~h 423 (491)
+.++++|
T Consensus 343 ~~ell~~ 349 (359)
T 3vhe_A 343 FSELVEH 349 (359)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999886
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=388.71 Aligned_cols=279 Identities=20% Similarity=0.308 Sum_probs=206.6
Q ss_pred cCCCCccCCCceEeeeeeccCceEEEEEEEeCCCc---EEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeee
Q 035713 86 LRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNT---YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSY 162 (491)
Q Consensus 86 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 162 (491)
+....+..++|++++.||+|+||+||+|++..++. .||||+++..... ......+.+|+++++.++||||++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 34455677899999999999999999999887765 8999999765332 3446678899999999999999999999
Q ss_pred EEeCceE------EEEEeccCCCchHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC
Q 035713 163 FETDKFY------CLVMEFCSGGNLHSLRQKQP----NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE 232 (491)
Q Consensus 163 ~~~~~~~------~lV~E~~~gg~L~~~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~ 232 (491)
+...... |+||||+.+|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED 173 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC
Confidence 9877654 99999999999999886432 1259999999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCC
Q 035713 233 GHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALP 312 (491)
Q Consensus 233 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (491)
+.+||+|||+++........
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~------------------------------------------------------------ 193 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYY------------------------------------------------------------ 193 (323)
T ss_dssp SCEEECCCCC----------------------------------------------------------------------
T ss_pred CCEEEeeccccccccccccc------------------------------------------------------------
Confidence 99999999998653211100
Q ss_pred ccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCC
Q 035713 313 ELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQV 391 (491)
Q Consensus 313 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 391 (491)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+.... ..+....+
T Consensus 194 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 264 (323)
T 3qup_A 194 --------RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-RLKQPPEC 264 (323)
T ss_dssp ---------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTC
T ss_pred --------cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-CCCCCCcc
Confidence 00112357889999999999999999999999999999999 999999988877776666543 23334568
Q ss_pred CHHHHHHHHhhhccCCCCCCCcC---CChHHhhcCCCcCCCChhhh
Q 035713 392 SFVARDLIRGLLVKEPHKRIAYK---RGATEIKQHPFFEGVNWALV 434 (491)
Q Consensus 392 s~~~~~li~~~L~~dP~~R~t~~---~~~~ell~hpff~~~~~~~~ 434 (491)
+.++.+||.+||+.||.+||++. +.++++++|||+....++.+
T Consensus 265 ~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl 310 (323)
T 3qup_A 265 MEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310 (323)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence 99999999999999999999943 23678899999987665544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=401.02 Aligned_cols=263 Identities=24% Similarity=0.365 Sum_probs=196.6
Q ss_pred CCceE-eeeeeccCceEEEEEEEe--CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe--Cce
Q 035713 94 SNFRL-LKRLGYGDIGSVYLVELR--GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET--DKF 168 (491)
Q Consensus 94 ~~y~~-~~~iG~G~~g~V~~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~--~~~ 168 (491)
+.|++ .++||+|+||+||+|+++ .+++.||||++...... ..+.+|+++|+.++||||++++++|.. +..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 45777 457999999999999976 56889999999765332 246689999999999999999999954 678
Q ss_pred EEEEEeccCCCchHHHHHhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEE----ccCCcEEE
Q 035713 169 YCLVMEFCSGGNLHSLRQKQ-------PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLV----RDEGHIML 237 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~-------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl----~~~g~vkL 237 (491)
+||||||+. ++|.+++... ....+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999999995 5887776532 12249999999999999999999999999999999999999 67889999
Q ss_pred eecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccC
Q 035713 238 SDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAE 317 (491)
Q Consensus 238 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (491)
+|||+++.+.....
T Consensus 174 ~Dfg~a~~~~~~~~------------------------------------------------------------------ 187 (405)
T 3rgf_A 174 ADMGFARLFNSPLK------------------------------------------------------------------ 187 (405)
T ss_dssp CCTTCCC-------------------------------------------------------------------------
T ss_pred EECCCceecCCCCc------------------------------------------------------------------
Confidence 99999865421100
Q ss_pred CCCccccccccccCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcH---------HHHHHHH---cCCCc
Q 035713 318 PTNVRSMSFVGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNR---------ATLFNVV---GQPLR 384 (491)
Q Consensus 318 ~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~---------~~~~~i~---~~~~~ 384 (491)
........+||+.|+|||++.+.. ++.++|||||||+||||++|++||.+.... +.+..++ +.+..
T Consensus 188 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~ 266 (405)
T 3rgf_A 188 -PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPAD 266 (405)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCT
T ss_pred -ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCCh
Confidence 000112358999999999998854 899999999999999999999999876542 3333332 21110
Q ss_pred C--C-------------------------------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCCh
Q 035713 385 F--P-------------------------------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNW 431 (491)
Q Consensus 385 ~--~-------------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~ 431 (491)
. + .....+.++.+||.+||+.||.+||| ++|||+||||....|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t----a~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 267 KDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT----SEQAMQDPYFLEDPL 342 (405)
T ss_dssp TTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTSSSC
T ss_pred hhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC----HHHHhcChhhccCCC
Confidence 0 0 00123778999999999999999999 999999999998766
Q ss_pred hh
Q 035713 432 AL 433 (491)
Q Consensus 432 ~~ 433 (491)
..
T Consensus 343 ~~ 344 (405)
T 3rgf_A 343 PT 344 (405)
T ss_dssp CC
T ss_pred Cc
Confidence 54
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=386.79 Aligned_cols=262 Identities=23% Similarity=0.342 Sum_probs=211.7
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEE--------
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE-------- 164 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~-------- 164 (491)
.++|++++.||+|+||.||+|++..+++.||||++... .......+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 47899999999999999999999999999999998754 2345567889999999999999999999873
Q ss_pred ------eCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEc-cCCcEEE
Q 035713 165 ------TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVR-DEGHIML 237 (491)
Q Consensus 165 ------~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~-~~g~vkL 237 (491)
....+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 4468999999996 699998865 4599999999999999999999999999999999999997 5679999
Q ss_pred eecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccC
Q 035713 238 SDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAE 317 (491)
Q Consensus 238 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (491)
+|||+++........
T Consensus 163 ~Dfg~~~~~~~~~~~----------------------------------------------------------------- 177 (320)
T 2i6l_A 163 GDFGLARIMDPHYSH----------------------------------------------------------------- 177 (320)
T ss_dssp CCCTTCBCC-----------------------------------------------------------------------
T ss_pred ccCccccccCCCccc-----------------------------------------------------------------
Confidence 999998643211000
Q ss_pred CCCccccccccccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCc------------
Q 035713 318 PTNVRSMSFVGTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR------------ 384 (491)
Q Consensus 318 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~------------ 384 (491)
........||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..++.....
T Consensus 178 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (320)
T 2i6l_A 178 --KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSV 255 (320)
T ss_dssp ----CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTT
T ss_pred --ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhc
Confidence 001112368999999999876 66899999999999999999999999988877666655432110
Q ss_pred ----------CC------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 385 ----------FP------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 385 ----------~~------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
.+ ....++.++.+||.+||+.||++||+ ++++|+||||+..+|.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 256 IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT----AEEALSHPYMSIYSFP 315 (320)
T ss_dssp SCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC----HHHHHTSHHHHTTCC-
T ss_pred CcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC----HHHHhCCcccccccCc
Confidence 00 01358999999999999999999999 9999999999987765
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=378.97 Aligned_cols=261 Identities=25% Similarity=0.386 Sum_probs=221.5
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEE--eCceE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE--TDKFY 169 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~--~~~~~ 169 (491)
..++|++++.||+|+||.||+|+++.+++.||+|++...... ......+.+|+++++.++||||+++++++. ..+.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 347899999999999999999999999999999999765433 345667889999999999999999999885 46789
Q ss_pred EEEEeccCCCchHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcC-----cccccCCCCCEEEccCCcEEEeeccc
Q 035713 170 CLVMEFCSGGNLHSLRQKQ--PNKYFTEDAARFFASEVLLALEYLHMLG-----IVYRDLKPENVLVRDEGHIMLSDFDL 242 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDikp~NILl~~~g~vkL~DFGl 242 (491)
|+||||+++++|.+++... ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999999998753 2345999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcc
Q 035713 243 SLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322 (491)
Q Consensus 243 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (491)
+....... ..
T Consensus 163 ~~~~~~~~----------------------------------------------------------------------~~ 172 (279)
T 2w5a_A 163 ARILNHDT----------------------------------------------------------------------SF 172 (279)
T ss_dssp HHHC---C----------------------------------------------------------------------HH
T ss_pred heeecccc----------------------------------------------------------------------cc
Confidence 85432110 01
Q ss_pred ccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhh
Q 035713 323 SMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGL 402 (491)
Q Consensus 323 ~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~ 402 (491)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...... .....++.++.+||.+|
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~~ 251 (279)
T 2w5a_A 173 AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYRYSDELNEIITRM 251 (279)
T ss_dssp HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHH
T ss_pred ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc-cCCcccCHHHHHHHHHH
Confidence 11347899999999999999999999999999999999999999988777666666655432 22235899999999999
Q ss_pred hccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 403 LVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 403 L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
|..||.+||+ +++|++|+|+.+
T Consensus 252 l~~~p~~Rps----~~~ll~~~~~~~ 273 (279)
T 2w5a_A 252 LNLKDYHRPS----VEEILENPLILE 273 (279)
T ss_dssp TCSSGGGSCC----HHHHHTSTTCCG
T ss_pred cCCCcccCCC----HHHHHhChhhhh
Confidence 9999999999 999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=393.97 Aligned_cols=262 Identities=27% Similarity=0.428 Sum_probs=201.2
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc----
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK---- 167 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~---- 167 (491)
.+++|++++.||+|+||+||+|++..+|+.||||++....... .+..+|++.++.++||||++++++|...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 3478999999999999999999999999999999986543222 23456788888999999999999996533
Q ss_pred ---eEEEEEeccCCCchHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHH--HcCcccccCCCCCEEEcc-CCcEEEee
Q 035713 168 ---FYCLVMEFCSGGNLHSLRQK--QPNKYFTEDAARFFASEVLLALEYLH--MLGIVYRDLKPENVLVRD-EGHIMLSD 239 (491)
Q Consensus 168 ---~~~lV~E~~~gg~L~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH--~~givHrDikp~NILl~~-~g~vkL~D 239 (491)
.+|+||||+.++ |...+.. .....+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+|
T Consensus 97 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred cceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 389999999764 4433321 23456999999999999999999999 999999999999999996 89999999
Q ss_pred cccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCC
Q 035713 240 FDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPT 319 (491)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (491)
||+++......
T Consensus 176 fg~a~~~~~~~--------------------------------------------------------------------- 186 (360)
T 3e3p_A 176 FGSAKKLSPSE--------------------------------------------------------------------- 186 (360)
T ss_dssp CTTCBCCCTTS---------------------------------------------------------------------
T ss_pred CCCceecCCCC---------------------------------------------------------------------
Confidence 99986432110
Q ss_pred CccccccccccCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---C-------------
Q 035713 320 NVRSMSFVGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---P------------- 382 (491)
Q Consensus 320 ~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~------------- 382 (491)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+....+..++.. +
T Consensus 187 --~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3e3p_A 187 --PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHT 264 (360)
T ss_dssp --CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCC
T ss_pred --CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchh
Confidence 111347899999999997765 799999999999999999999999998877766665431 0
Q ss_pred -CcC-------------CCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhh
Q 035713 383 -LRF-------------PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWAL 433 (491)
Q Consensus 383 -~~~-------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~ 433 (491)
..+ ......+.++.+||.+||+.||.+||+ +.|+|+||||+.+.+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~~ 325 (360)
T 3e3p_A 265 DVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK----PYEALCHPYFDELHDPA 325 (360)
T ss_dssp CGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCC----HHHHTTSGGGGGGGCTT
T ss_pred hccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCC----HHHHhcCccccccCCcc
Confidence 000 011225678999999999999999999 99999999999876543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=391.54 Aligned_cols=262 Identities=26% Similarity=0.391 Sum_probs=211.5
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchh--------hhHHHHHHHHHHHHHHhhcCCCCccceeeeE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASL--------ASRNKLLRAQTEREILGLLDHPFLPTLYSYF 163 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~--------~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 163 (491)
..++|++++.||+|+||.||+|++.. |+.||||++..... ........+.+|+++|+.++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 45789999999999999999999875 89999999865322 2334457788999999999999999999998
Q ss_pred Ee-----CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEe
Q 035713 164 ET-----DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLS 238 (491)
Q Consensus 164 ~~-----~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~ 238 (491)
.. ...+|+||||+. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 53 347899999996 6888887754 3569999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCC
Q 035713 239 DFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEP 318 (491)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (491)
|||+++.....
T Consensus 177 Dfg~~~~~~~~--------------------------------------------------------------------- 187 (362)
T 3pg1_A 177 DFNLAREDTAD--------------------------------------------------------------------- 187 (362)
T ss_dssp CTTC----------------------------------------------------------------------------
T ss_pred ecCcccccccc---------------------------------------------------------------------
Confidence 99998532110
Q ss_pred CCccccccccccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---C------------
Q 035713 319 TNVRSMSFVGTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---P------------ 382 (491)
Q Consensus 319 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~------------ 382 (491)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+... +
T Consensus 188 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 265 (362)
T 3pg1_A 188 --ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPS 265 (362)
T ss_dssp ----------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHH
T ss_pred --cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchh
Confidence 01113478999999999987 66899999999999999999999999988776666555321 0
Q ss_pred ---------CcCCC------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCCh
Q 035713 383 ---------LRFPE------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNW 431 (491)
Q Consensus 383 ---------~~~~~------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~ 431 (491)
...+. .+.+++.+.+||.+||+.||.+||+ +.++|+||||+.+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 266 ARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS----TEQALRHPYFESLFD 325 (362)
T ss_dssp HHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGTTTCC
T ss_pred hhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCC----HHHHHcCchhhhccC
Confidence 00110 1356889999999999999999999 999999999998743
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=392.86 Aligned_cols=258 Identities=24% Similarity=0.406 Sum_probs=209.0
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-----------CCCccc
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-----------HPFLPT 158 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----------hp~iv~ 158 (491)
.+..++|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+++++.++ |+||++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 345689999999999999999999999999999999997543 23345678999998886 899999
Q ss_pred eeeeEEeCc----eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccccCCCCCEEEcc--
Q 035713 159 LYSYFETDK----FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML-GIVYRDLKPENVLVRD-- 231 (491)
Q Consensus 159 l~~~~~~~~----~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~NILl~~-- 231 (491)
+++++...+ .+++||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+||||+.
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999998654 899999999 99999999886666799999999999999999999998 9999999999999953
Q ss_pred ----CCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCC
Q 035713 232 ----EGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCV 307 (491)
Q Consensus 232 ----~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (491)
.+.+||+|||++......
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~---------------------------------------------------------- 191 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH---------------------------------------------------------- 191 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC----------------------------------------------------------
T ss_pred CCcCcceEEEcccccccccCCC----------------------------------------------------------
Confidence 347999999998543210
Q ss_pred CCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCc------HHHHHHHH--
Q 035713 308 GGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGN------RATLFNVV-- 379 (491)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~-- 379 (491)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+. ...+..+.
T Consensus 192 ---------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (373)
T 1q8y_A 192 ---------------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256 (373)
T ss_dssp ---------------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred ---------------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHh
Confidence 1123789999999999999999999999999999999999999986542 22222221
Q ss_pred -cCCC-------------------------------------cCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhh
Q 035713 380 -GQPL-------------------------------------RFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIK 421 (491)
Q Consensus 380 -~~~~-------------------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell 421 (491)
+... .+.....++.++.+||.+||+.||++||+ +++||
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell 332 (373)
T 1q8y_A 257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD----AGGLV 332 (373)
T ss_dssp HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC----HHHHH
T ss_pred cCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC----HHHHh
Confidence 1100 00011235678899999999999999999 99999
Q ss_pred cCCCcCCC
Q 035713 422 QHPFFEGV 429 (491)
Q Consensus 422 ~hpff~~~ 429 (491)
+||||++.
T Consensus 333 ~hp~f~~~ 340 (373)
T 1q8y_A 333 NHPWLKDT 340 (373)
T ss_dssp TCGGGTTC
T ss_pred hChhhhcc
Confidence 99999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=373.16 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=217.4
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
.+..++|++++.||+|+||.||+|++. +++.||+|++....... ..+.+|+++|+.++||||+++++++.+++.+
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 456689999999999999999999987 57789999997654332 3567899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999999999765 356999999999999999999999999999999999999999999999999998643211
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.. .......||
T Consensus 160 ~~---------------------------------------------------------------------~~~~~~~~~ 170 (269)
T 4hcu_A 160 QY---------------------------------------------------------------------TSSTGTKFP 170 (269)
T ss_dssp HH---------------------------------------------------------------------HSTTSTTCC
T ss_pred cc---------------------------------------------------------------------ccccCcccc
Confidence 00 001123578
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 408 (491)
+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+... ........++.++.+||.+||+.||+
T Consensus 171 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~ 249 (269)
T 4hcu_A 171 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHCWRERPE 249 (269)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred cccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-ccCCCCCcCCHHHHHHHHHHccCCcc
Confidence 89999999999999999999999999999999 99999988877776666554 33333346899999999999999999
Q ss_pred CCCCcCCChHHhhcC
Q 035713 409 KRIAYKRGATEIKQH 423 (491)
Q Consensus 409 ~R~t~~~~~~ell~h 423 (491)
+||+ +.++++|
T Consensus 250 ~Rps----~~~ll~~ 260 (269)
T 4hcu_A 250 DRPA----FSRLLRQ 260 (269)
T ss_dssp GSCC----HHHHHHH
T ss_pred cCcC----HHHHHHH
Confidence 9999 8999876
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=388.14 Aligned_cols=261 Identities=20% Similarity=0.292 Sum_probs=220.6
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEe-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeee
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELR-----GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSY 162 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~ 162 (491)
+.+..++|++.+.||+|+||.||+|++. .++..||||++.... .......+.+|+++|+.+ +||||++++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3456789999999999999999999984 356789999997542 233456788999999999 89999999999
Q ss_pred EEeCceEEEEEeccCCCchHHHHHhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 035713 163 FETDKFYCLVMEFCSGGNLHSLRQKQPN---------------------KYFTEDAARFFASEVLLALEYLHMLGIVYRD 221 (491)
Q Consensus 163 ~~~~~~~~lV~E~~~gg~L~~~~~~~~~---------------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrD 221 (491)
+...+.+|+||||+++|+|.+++..... ..+++..++.++.||+.||.|||++||+|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 9999999999999999999999986532 2389999999999999999999999999999
Q ss_pred CCCCCEEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCC
Q 035713 222 LKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKS 301 (491)
Q Consensus 222 ikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (491)
|||+||||+.++.+||+|||++........
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-------------------------------------------------- 227 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSN-------------------------------------------------- 227 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTT--------------------------------------------------
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCcc--------------------------------------------------
Confidence 999999999999999999999864421110
Q ss_pred CCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHc
Q 035713 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVG 380 (491)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~ 380 (491)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+......+..++.
T Consensus 228 ------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 289 (344)
T 1rjb_A 228 ------------------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ 289 (344)
T ss_dssp ------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH
T ss_pred ------------------ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHh
Confidence 001123468899999999999999999999999999999998 9999998877777777776
Q ss_pred CCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 381 QPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 381 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
.....+....+++++.+||.+||..||.+||+ +.+|++|
T Consensus 290 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~~ 328 (344)
T 1rjb_A 290 NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS----FPNLTSF 328 (344)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcC----HHHHHHH
Confidence 66666556678999999999999999999999 9999886
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=373.64 Aligned_cols=253 Identities=27% Similarity=0.454 Sum_probs=210.3
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhh-HHHHHHHHHHHHHHhhcCCCCccceeeeEEeCce
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLAS-RNKLLRAQTEREILGLLDHPFLPTLYSYFETDKF 168 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~ 168 (491)
.+..++|++.+.||+|+||.||+|++. ++.||||+++...... ......+.+|+++++.++||||+++++++.+++.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 355689999999999999999999975 7889999987653322 2334678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC---cccccCCCCCEEEcc--------CCcEEE
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG---IVYRDLKPENVLVRD--------EGHIML 237 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~NILl~~--------~g~vkL 237 (491)
+|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred eEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 9999999999999998864 46999999999999999999999999 899999999999986 778999
Q ss_pred eecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccC
Q 035713 238 SDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAE 317 (491)
Q Consensus 238 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (491)
+|||++......
T Consensus 158 ~Dfg~~~~~~~~-------------------------------------------------------------------- 169 (271)
T 3dtc_A 158 TDFGLAREWHRT-------------------------------------------------------------------- 169 (271)
T ss_dssp CCCCC---------------------------------------------------------------------------
T ss_pred ccCCcccccccc--------------------------------------------------------------------
Confidence 999998543210
Q ss_pred CCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHH
Q 035713 318 PTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARD 397 (491)
Q Consensus 318 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~ 397 (491)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.......+....+++.+.+
T Consensus 170 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (271)
T 3dtc_A 170 ----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAK 245 (271)
T ss_dssp ----------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHH
T ss_pred ----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHH
Confidence 0112368999999999999999999999999999999999999999988877777777776666666679999999
Q ss_pred HHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 398 LIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 398 li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
||.+||+.||.+||+ +.++++|
T Consensus 246 li~~~l~~~p~~Rps----~~e~l~~ 267 (271)
T 3dtc_A 246 LMEDCWNPDPHSRPS----FTNILDQ 267 (271)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHhcCCcccCcC----HHHHHHH
Confidence 999999999999999 8998875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=384.90 Aligned_cols=265 Identities=22% Similarity=0.326 Sum_probs=213.8
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~~l 171 (491)
.++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+++|+.+ +||||+++++++..++..|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 47899999999999999999999999999999998754322 2466899999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCc-----EEEeeccccccc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGH-----IMLSDFDLSLRC 246 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~-----vkL~DFGla~~~ 246 (491)
||||+ +++|.+++... .+.+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++.+
T Consensus 83 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99999 99999999875 356999999999999999999999999999999999999998887 999999999754
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
........ .........
T Consensus 161 ~~~~~~~~---------------------------------------------------------------~~~~~~~~~ 177 (330)
T 2izr_A 161 IDPETKKH---------------------------------------------------------------IPYREHKSL 177 (330)
T ss_dssp BCTTTCCB---------------------------------------------------------------CCCCCCCCC
T ss_pred ecCCCCcc---------------------------------------------------------------ccccccCCc
Confidence 32111000 000112245
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCc---HHHHHHHHcCCCcCCC---CCCCCHHHHHHHH
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGN---RATLFNVVGQPLRFPE---TPQVSFVARDLIR 400 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~~~~~~~~~---~~~~s~~~~~li~ 400 (491)
+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+. .+.+..+.......+. ...++ ++.+||.
T Consensus 178 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~ 256 (330)
T 2izr_A 178 TGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLR 256 (330)
T ss_dssp CSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHH
T ss_pred CCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHH
Confidence 899999999999999999999999999999999999999987533 2333344332222221 12244 9999999
Q ss_pred hhhccCCCCCCCcCCChHHhhc----------CCCcCCCChh
Q 035713 401 GLLVKEPHKRIAYKRGATEIKQ----------HPFFEGVNWA 432 (491)
Q Consensus 401 ~~L~~dP~~R~t~~~~~~ell~----------hpff~~~~~~ 432 (491)
.||..||.+||+ +++|++ ..+...++|.
T Consensus 257 ~~l~~~p~~RP~----~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 257 YVRRLDFFEKPD----YDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp HHHHCCTTCCCC----HHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred HHHhCCCCCCCC----HHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 999999999999 665554 3455678887
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=376.07 Aligned_cols=273 Identities=25% Similarity=0.411 Sum_probs=211.5
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe--------
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET-------- 165 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~-------- 165 (491)
++|++++.||+|+||.||+|++..+++.||||++... ......+.+|+++++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 5799999999999999999999999999999999653 3445678899999999999999999998864
Q ss_pred -----CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeec
Q 035713 166 -----DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240 (491)
Q Consensus 166 -----~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DF 240 (491)
.+.+|+||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 46789999999999999999864 345889999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCC
Q 035713 241 DLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTN 320 (491)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (491)
|++............... ......
T Consensus 161 g~~~~~~~~~~~~~~~~~--------------------------------------------------------~~~~~~ 184 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQ--------------------------------------------------------NLPGSS 184 (303)
T ss_dssp CCCSCTTC------------------------------------------------------------------------
T ss_pred cchhhcccccchhccccc--------------------------------------------------------cccccc
Confidence 998654321110000000 000000
Q ss_pred ccccccccccCccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCc-HHHHHHHHcCCCcCCC--CCCCCHHHH
Q 035713 321 VRSMSFVGTHEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGN-RATLFNVVGQPLRFPE--TPQVSFVAR 396 (491)
Q Consensus 321 ~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~-~~~~~~i~~~~~~~~~--~~~~s~~~~ 396 (491)
......+||+.|+|||++.+. .++.++|||||||++|+|++ ||..... ...+..+......++. ....+..+.
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (303)
T 1zy4_A 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEK 261 (303)
T ss_dssp ---------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHH
T ss_pred cccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHH
Confidence 112245799999999999875 58999999999999999998 5653322 3333444444333332 245778899
Q ss_pred HHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhh
Q 035713 397 DLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALV 434 (491)
Q Consensus 397 ~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~ 434 (491)
+||.+||+.||.+||+ +.++++||||+...+...
T Consensus 262 ~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~~~ 295 (303)
T 1zy4_A 262 KIIRLLIDHDPNKRPG----ARTLLNSGWLPVKHQDEV 295 (303)
T ss_dssp HHHHHHTCSSGGGSCC----HHHHHHSSCSCCCCHHHH
T ss_pred HHHHHHHhcCcccCcC----HHHHhCCCCcCCCChHHH
Confidence 9999999999999999 999999999998777643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=380.59 Aligned_cols=261 Identities=23% Similarity=0.316 Sum_probs=219.8
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEe-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeee
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELR-----GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSY 162 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 162 (491)
...+..++|++.+.||+|+||.||+|++. .+++.||||++.... .......+.+|+++|+.++||||++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 44566789999999999999999999984 455889999997542 34556678899999999999999999999
Q ss_pred EEeCceEEEEEeccCCCchHHHHHhCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 035713 163 FETDKFYCLVMEFCSGGNLHSLRQKQPN----------------------KYFTEDAARFFASEVLLALEYLHMLGIVYR 220 (491)
Q Consensus 163 ~~~~~~~~lV~E~~~gg~L~~~~~~~~~----------------------~~l~~~~~~~~~~qi~~aL~~LH~~givHr 220 (491)
+.+.+.+|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 9999999999999999999999987532 348999999999999999999999999999
Q ss_pred cCCCCCEEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCC
Q 035713 221 DLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSK 300 (491)
Q Consensus 221 Dikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (491)
||||+|||++.++.+||+|||+++.........
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~----------------------------------------------- 207 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYV----------------------------------------------- 207 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEE-----------------------------------------------
T ss_pred ccchheEEEcCCCCEEEccccccccccccccce-----------------------------------------------
Confidence 999999999999999999999986543211100
Q ss_pred CCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHH
Q 035713 301 SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVV 379 (491)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~ 379 (491)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+.
T Consensus 208 ---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 266 (314)
T 2ivs_A 208 ---------------------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK 266 (314)
T ss_dssp ---------------------CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred ---------------------eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhh
Confidence 0112357889999999999989999999999999999999 999999887766555444
Q ss_pred cCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 380 GQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 380 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
.. ...+....++.++.+||.+||+.||.+||+ +.+++++
T Consensus 267 ~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~l~~~ 305 (314)
T 2ivs_A 267 TG-HRMERPDNCSEEMYRLMLQCWKQEPDKRPV----FADISKD 305 (314)
T ss_dssp TT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred cC-CcCCCCccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 33 333444579999999999999999999999 8888875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=382.46 Aligned_cols=264 Identities=22% Similarity=0.320 Sum_probs=212.2
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
+..++|++.++||+|+||+||+|++..+++.||+|++... .......+.+|+++|+.++||||+++++++.+++.+|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 4458899999999999999999999999999999988653 3445567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
+||||++|++|.++++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 84 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999999875 3569999999999999999999999999999999999999999999999999997653221
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
...... ............+.+||+
T Consensus 163 ~~~~~~--------------------------------------------------------~~~~~~~~~~~~~~~gt~ 186 (310)
T 3s95_A 163 TQPEGL--------------------------------------------------------RSLKKPDRKKRYTVVGNP 186 (310)
T ss_dssp -------------------------------------------------------------------------CCCCSCG
T ss_pred cccccc--------------------------------------------------------ccccccccccccccCCCc
Confidence 110000 000000111223468999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHH-----HHHHHHcCCCcCCCCCCCCHHHHHHHHhhhcc
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRA-----TLFNVVGQPLRFPETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-----~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~ 405 (491)
.|+|||++.+..++.++|||||||++|||++|..||....... ........ .....+++.+.+||.+||+.
T Consensus 187 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~ 262 (310)
T 3s95_A 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR----YCPPNCPPSFFPITVRCCDL 262 (310)
T ss_dssp GGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH----TCCTTCCTTHHHHHHHHTCS
T ss_pred ceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc----cCCCCCCHHHHHHHHHHccC
Confidence 9999999999999999999999999999999999987542211 01111111 11235888999999999999
Q ss_pred CCCCCCCcCCChHHhhc
Q 035713 406 EPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~ 422 (491)
||++||+ +.++++
T Consensus 263 dP~~Rps----~~~l~~ 275 (310)
T 3s95_A 263 DPEKRPS----FVKLEH 275 (310)
T ss_dssp SGGGSCC----HHHHHH
T ss_pred ChhhCcC----HHHHHH
Confidence 9999999 888887
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=387.24 Aligned_cols=259 Identities=22% Similarity=0.317 Sum_probs=219.0
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCC-------cEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceee
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTN-------TYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYS 161 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~-------~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~ 161 (491)
.+..++|++.++||+|+||+||+|++..++ ..||||+++.. ........+.+|+++++.+ +||||+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 455689999999999999999999986433 57999999765 2344566788999999999 8999999999
Q ss_pred eEEeCceEEEEEeccCCCchHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCE
Q 035713 162 YFETDKFYCLVMEFCSGGNLHSLRQKQP--------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENV 227 (491)
Q Consensus 162 ~~~~~~~~~lV~E~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NI 227 (491)
++..++.+|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 9999999999999999999999998753 24599999999999999999999999999999999999
Q ss_pred EEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCC
Q 035713 228 LVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCV 307 (491)
Q Consensus 228 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (491)
||+.++.+||+|||+++........
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~------------------------------------------------------- 247 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYY------------------------------------------------------- 247 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTT-------------------------------------------------------
T ss_pred EEcCCCcEEEcccCccccccccccc-------------------------------------------------------
Confidence 9999999999999998643211100
Q ss_pred CCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCC
Q 035713 308 GGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFP 386 (491)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 386 (491)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+... ....
T Consensus 248 -------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~ 313 (382)
T 3tt0_A 248 -------------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMD 313 (382)
T ss_dssp -------------CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCC
T ss_pred -------------ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCC
Confidence 01112367899999999999999999999999999999999 99999988766655554433 3444
Q ss_pred CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 387 ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 387 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
....++.++.+||.+||+.||++||+ +.+|+++
T Consensus 314 ~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 346 (382)
T 3tt0_A 314 KPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVED 346 (382)
T ss_dssp CCSSCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 44579999999999999999999999 8998886
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=379.82 Aligned_cols=261 Identities=20% Similarity=0.295 Sum_probs=221.9
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEE-----eCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeee
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVEL-----RGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSY 162 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~ 162 (491)
..+..++|++.+.||+|+||.||+|++ ..+++.||||+++... .......+.+|+++|+.+ +||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 345668999999999999999999996 3467899999997653 233456788999999999 89999999999
Q ss_pred EEeCceEEEEEeccCCCchHHHHHhCCCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCC
Q 035713 163 FETDKFYCLVMEFCSGGNLHSLRQKQPNK----------------YFTEDAARFFASEVLLALEYLHMLGIVYRDLKPEN 226 (491)
Q Consensus 163 ~~~~~~~~lV~E~~~gg~L~~~~~~~~~~----------------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~N 226 (491)
+.+++..|+||||+++|+|.+++...... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 99999999999999999999999875322 48999999999999999999999999999999999
Q ss_pred EEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCC
Q 035713 227 VLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPC 306 (491)
Q Consensus 227 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (491)
||++.++.+||+|||++.........
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~------------------------------------------------------ 201 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNY------------------------------------------------------ 201 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTS------------------------------------------------------
T ss_pred EEEcCCCCEEEccccccccccccccc------------------------------------------------------
Confidence 99999999999999998654321100
Q ss_pred CCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcC
Q 035713 307 VGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRF 385 (491)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 385 (491)
.......||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+......+...+......
T Consensus 202 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 267 (313)
T 1t46_A 202 --------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM 267 (313)
T ss_dssp --------------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC
T ss_pred --------------eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCC
Confidence 01112368899999999999999999999999999999999 999999887766666666555555
Q ss_pred CCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 386 PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 386 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
.....++.++.+||.+||+.||.+||+ +.+++++
T Consensus 268 ~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 301 (313)
T 1t46_A 268 LSPEHAPAEMYDIMKTCWDADPLKRPT----FKQIVQL 301 (313)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCcccCCHHHHHHHHHHcCCCchhCcC----HHHHHHH
Confidence 555679999999999999999999999 8888875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=386.69 Aligned_cols=253 Identities=28% Similarity=0.414 Sum_probs=186.5
Q ss_pred CCCceEee-eeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe----Cc
Q 035713 93 LSNFRLLK-RLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET----DK 167 (491)
Q Consensus 93 ~~~y~~~~-~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~----~~ 167 (491)
.++|++++ .||+|+||+||+|+++.+++.||||++.... ... ......++.++||||+++++++.. ..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KAR---QEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 47899976 5999999999999999999999999997542 111 122334677799999999999976 55
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc---CCcEEEeeccccc
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD---EGHIMLSDFDLSL 244 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~---~g~vkL~DFGla~ 244 (491)
.+||||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||+++
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 6899999999999999998876567999999999999999999999999999999999999986 4559999999985
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
..... ...
T Consensus 180 ~~~~~------------------------------------------------------------------------~~~ 187 (336)
T 3fhr_A 180 ETTQN------------------------------------------------------------------------ALQ 187 (336)
T ss_dssp EC------------------------------------------------------------------------------
T ss_pred ecccc------------------------------------------------------------------------ccc
Confidence 43210 011
Q ss_pred ccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHH----HHHHcCCC--cCCCCCCCCHHHHHH
Q 035713 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATL----FNVVGQPL--RFPETPQVSFVARDL 398 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~----~~i~~~~~--~~~~~~~~s~~~~~l 398 (491)
..+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....... ..+..... ..+....++.++.+|
T Consensus 188 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (336)
T 3fhr_A 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQL 267 (336)
T ss_dssp ----------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHH
T ss_pred cCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHH
Confidence 247899999999999888999999999999999999999999876544321 12222222 233335789999999
Q ss_pred HHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 399 IRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 399 i~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
|.+||+.||.+||+ ++++++||||+.
T Consensus 268 i~~~L~~dP~~Rpt----~~ell~hp~~~~ 293 (336)
T 3fhr_A 268 IRLLLKTDPTERLT----ITQFMNHPWINQ 293 (336)
T ss_dssp HHHHSCSSGGGSCC----HHHHHHSHHHHT
T ss_pred HHHHCCCChhHCcC----HHHHhcCccccc
Confidence 99999999999999 999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=384.43 Aligned_cols=260 Identities=21% Similarity=0.314 Sum_probs=219.9
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeE
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYF 163 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 163 (491)
..+..++|++++.||+|+||.||+|++.. +++.||||++++.. .......+.+|+++|+.++||||+++++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34566899999999999999999999983 55899999997643 334556788999999999999999999999
Q ss_pred EeCceEEEEEeccCCCchHHHHHhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 035713 164 ETDKFYCLVMEFCSGGNLHSLRQKQP----------------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRD 221 (491)
Q Consensus 164 ~~~~~~~lV~E~~~gg~L~~~~~~~~----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrD 221 (491)
.+.+.+|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 99999999999999999999998742 15699999999999999999999999999999
Q ss_pred CCCCCEEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCC
Q 035713 222 LKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKS 301 (491)
Q Consensus 222 ikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (491)
|||+|||++.++.+||+|||+++........
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~------------------------------------------------- 230 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYY------------------------------------------------- 230 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCB-------------------------------------------------
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccc-------------------------------------------------
Confidence 9999999999999999999998653211000
Q ss_pred CCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHc
Q 035713 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVG 380 (491)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~ 380 (491)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+..
T Consensus 231 -------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 291 (343)
T 1luf_A 231 -------------------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 291 (343)
T ss_dssp -------------------C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred -------------------cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhC
Confidence 00112368999999999999999999999999999999999 9999998887777766665
Q ss_pred CCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 381 QPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 381 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
.... +....++.++.+||.+||+.||.+||+ +.+++++
T Consensus 292 ~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~~~~~ 329 (343)
T 1luf_A 292 GNIL-ACPENCPLELYNLMRLCWSKLPADRPS----FCSIHRI 329 (343)
T ss_dssp TCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCcC-CCCCCCCHHHHHHHHHHcccCcccCCC----HHHHHHH
Confidence 5432 223468999999999999999999999 8888764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=370.50 Aligned_cols=252 Identities=20% Similarity=0.293 Sum_probs=219.2
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC--
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD-- 166 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~-- 166 (491)
..+..++|++++.||+|+||.||+|++. ++.||||+++.... .......+.+|+.+|+.++||||+++++++.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 3456789999999999999999999986 78899999976533 334456788999999999999999999999877
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccccCCCCCEEEccCCcEEEeeccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG--IVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
+.+|+||||+++|+|.+++.......+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 78999999999999999998765556999999999999999999999999 9999999999999999999999998763
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
... ..
T Consensus 162 ~~~---------------------------------------------------------------------------~~ 166 (271)
T 3kmu_A 162 SFQ---------------------------------------------------------------------------SP 166 (271)
T ss_dssp TTS---------------------------------------------------------------------------CT
T ss_pred eec---------------------------------------------------------------------------cc
Confidence 210 01
Q ss_pred ccccccCccCcchhcCCCCCC---cccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHh
Q 035713 325 SFVGTHEYLAPEIIRGEGHGS---AVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRG 401 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~~~~~---~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 401 (491)
..+||+.|+|||++.+..++. ++|||||||++|||++|+.||.+.+.......+............++.++.+||.+
T Consensus 167 ~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 246 (271)
T 3kmu_A 167 GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKI 246 (271)
T ss_dssp TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHH
T ss_pred CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 236899999999999876655 79999999999999999999999888887777776665555556799999999999
Q ss_pred hhccCCCCCCCcCCChHHhhc
Q 035713 402 LLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 402 ~L~~dP~~R~t~~~~~~ell~ 422 (491)
||+.||++||+ ++++++
T Consensus 247 ~l~~~p~~Rps----~~~il~ 263 (271)
T 3kmu_A 247 CMNEDPAKRPK----FDMIVP 263 (271)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HcCCChhhCcC----HHHHHH
Confidence 99999999999 888875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=369.69 Aligned_cols=254 Identities=21% Similarity=0.279 Sum_probs=216.8
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
.+..++|++++.||+|+||.||+|+++ ++..||+|++....... ..+.+|+++++.++||||+++++++.+++.+
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 456689999999999999999999877 57789999997654332 3567899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999999998764 245999999999999999999999999999999999999999999999999998653221
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
... ......||
T Consensus 158 ~~~---------------------------------------------------------------------~~~~~~~~ 168 (268)
T 3sxs_A 158 QYV---------------------------------------------------------------------SSVGTKFP 168 (268)
T ss_dssp CEE---------------------------------------------------------------------ECCSCCCC
T ss_pred hhh---------------------------------------------------------------------cccCCCcC
Confidence 100 00112567
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 408 (491)
+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+..... ......+++.+.+||.+||+.||.
T Consensus 169 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~ 247 (268)
T 3sxs_A 169 VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR-LYRPHLASDTIYQIMYSCWHELPE 247 (268)
T ss_dssp GGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-CCCCTTSCHHHHHHHHHTTCSSGG
T ss_pred cccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC-CCCCCcChHHHHHHHHHHcCCChh
Confidence 88999999999899999999999999999999 9999998887777766655432 223345899999999999999999
Q ss_pred CCCCcCCChHHhhcC
Q 035713 409 KRIAYKRGATEIKQH 423 (491)
Q Consensus 409 ~R~t~~~~~~ell~h 423 (491)
+||+ +.++++|
T Consensus 248 ~Rps----~~~ll~~ 258 (268)
T 3sxs_A 248 KRPT----FQQLLSS 258 (268)
T ss_dssp GSCC----HHHHHHH
T ss_pred hCcC----HHHHHHH
Confidence 9999 9999876
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=382.73 Aligned_cols=271 Identities=20% Similarity=0.272 Sum_probs=225.8
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEe-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeee
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELR-----GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSY 162 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 162 (491)
.+.+..++|++.+.||+|+||.||+|++. .+++.||||++.... .......+.+|+++|+.++||||++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 44566789999999999999999999987 357889999997543 23445568899999999999999999999
Q ss_pred EEeCceEEEEEeccCCCchHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCc
Q 035713 163 FETDKFYCLVMEFCSGGNLHSLRQKQP--------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGH 234 (491)
Q Consensus 163 ~~~~~~~~lV~E~~~gg~L~~~~~~~~--------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~ 234 (491)
+.+.+..|+||||+++|+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 999999999999999999999987531 135799999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCcc
Q 035713 235 IMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPEL 314 (491)
Q Consensus 235 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (491)
+||+|||+++.......
T Consensus 177 ~kl~Dfg~~~~~~~~~~--------------------------------------------------------------- 193 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDY--------------------------------------------------------------- 193 (322)
T ss_dssp EEECCTTCCCGGGGGGC---------------------------------------------------------------
T ss_pred EEECcCccccccccccc---------------------------------------------------------------
Confidence 99999999854321100
Q ss_pred ccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCH
Q 035713 315 MAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSF 393 (491)
Q Consensus 315 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 393 (491)
........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.......+..... .+....++.
T Consensus 194 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 267 (322)
T 1p4o_A 194 -----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-LDKPDNCPD 267 (322)
T ss_dssp -----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-CCCCTTCCH
T ss_pred -----cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc-CCCCCCCCH
Confidence 001112368899999999999999999999999999999999 8999998877776666665443 233356899
Q ss_pred HHHHHHHhhhccCCCCCCCcCCChHHhhcC------CCcCCCChhh
Q 035713 394 VARDLIRGLLVKEPHKRIAYKRGATEIKQH------PFFEGVNWAL 433 (491)
Q Consensus 394 ~~~~li~~~L~~dP~~R~t~~~~~~ell~h------pff~~~~~~~ 433 (491)
.+.+||.+||+.||.+||+ +.++++| ++|+.++|..
T Consensus 268 ~l~~li~~~l~~dp~~Rps----~~e~l~~L~~~~~~~~~~~~~~~ 309 (322)
T 1p4o_A 268 MLFELMRMCWQYNPKMRPS----FLEIISSIKEEMEPGFREVSFYY 309 (322)
T ss_dssp HHHHHHHHHTCSSGGGSCC----HHHHHHHHGGGSCTTHHHHCSTT
T ss_pred HHHHHHHHHcCCCcccCcC----HHHHHHHHHHhhccCCccccccc
Confidence 9999999999999999999 8888876 6776666553
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=391.96 Aligned_cols=259 Identities=23% Similarity=0.299 Sum_probs=218.7
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
.+.+..++|++.+.||+|+||.||+|+++.+++.||||+++.. ........+.+|+++|+.++||||+++++++..++
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 4456778999999999999999999999999999999998754 22344556788999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+||||||+++|+|.+++... +..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred CcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 999999999999999998764 2459999999999999999999999999999999999999999999999999986432
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
..... .......
T Consensus 265 ~~~~~--------------------------------------------------------------------~~~~~~~ 276 (377)
T 3cbl_A 265 DGVYA--------------------------------------------------------------------ASGGLRQ 276 (377)
T ss_dssp TSEEE--------------------------------------------------------------------CCSSCCE
T ss_pred CCcee--------------------------------------------------------------------ecCCCCC
Confidence 10000 0001124
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+.......+. .....+....++.++.+||.+||+.|
T Consensus 277 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~d 355 (377)
T 3cbl_A 277 VPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDAVFRLMEQCWAYE 355 (377)
T ss_dssp EEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 6788999999999899999999999999999998 999999887665554443 33444545568999999999999999
Q ss_pred CCCCCCcCCChHHhhc
Q 035713 407 PHKRIAYKRGATEIKQ 422 (491)
Q Consensus 407 P~~R~t~~~~~~ell~ 422 (491)
|++||+ +.+|++
T Consensus 356 P~~Rps----~~~i~~ 367 (377)
T 3cbl_A 356 PGQRPS----FSTIYQ 367 (377)
T ss_dssp GGGSCC----HHHHHH
T ss_pred chhCcC----HHHHHH
Confidence 999999 888775
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=373.28 Aligned_cols=258 Identities=21% Similarity=0.298 Sum_probs=222.4
Q ss_pred CCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 87 RGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 87 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
..+.+..++|++.+.||+|+||+||+|++..+++.||+|++.... .....+.+|+++++.++||||+++++++.++
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 345667789999999999999999999999999999999997543 2345677899999999999999999999999
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
+.+|+||||++|++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999999999998876677999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
..... ......
T Consensus 162 ~~~~~---------------------------------------------------------------------~~~~~~ 172 (288)
T 3kfa_A 162 TGDTY---------------------------------------------------------------------TAHAGA 172 (288)
T ss_dssp CSSSS---------------------------------------------------------------------EEETTE
T ss_pred cCCcc---------------------------------------------------------------------ccccCC
Confidence 21110 011123
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhcc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~ 405 (491)
.||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+. .....+....+++.+.+||.+||..
T Consensus 173 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~ 251 (288)
T 3kfa_A 173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKVYELMRACWQW 251 (288)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred ccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHhCC
Confidence 67889999999999999999999999999999999 999999877665544443 3444444567999999999999999
Q ss_pred CCCCCCCcCCChHHhhc
Q 035713 406 EPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~ 422 (491)
||.+||+ +.++++
T Consensus 252 dp~~Rps----~~~~~~ 264 (288)
T 3kfa_A 252 NPSDRPS----FAEIHQ 264 (288)
T ss_dssp SGGGSCC----HHHHHH
T ss_pred ChhhCcC----HHHHHH
Confidence 9999999 888876
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=374.54 Aligned_cols=261 Identities=27% Similarity=0.377 Sum_probs=213.8
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
+..++|.....||+|+||.||+|++..+++.||||++.... ......+.+|+.+++.++||||+++++++...+.++
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence 34466777789999999999999999999999999987643 234456788999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc-CCcEEEeecccccccCC
Q 035713 171 LVMEFCSGGNLHSLRQKQP-NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD-EGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~-~g~vkL~DFGla~~~~~ 248 (491)
+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999999999988653 235779999999999999999999999999999999999987 89999999999854321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
.. .......|
T Consensus 176 ~~----------------------------------------------------------------------~~~~~~~~ 185 (295)
T 2clq_A 176 IN----------------------------------------------------------------------PCTETFTG 185 (295)
T ss_dssp ---------------------------------------------------------------------------CCCCC
T ss_pred CC----------------------------------------------------------------------CcccccCC
Confidence 00 00112478
Q ss_pred ccCccCcchhcCCC--CCCcccccchhhHHHhhhcCCCCCCCCCcHHH-HHHH--HcCCCcCCCCCCCCHHHHHHHHhhh
Q 035713 329 THEYLAPEIIRGEG--HGSAVDWWTFGIFLYELLHGTTPFKGQGNRAT-LFNV--VGQPLRFPETPQVSFVARDLIRGLL 403 (491)
Q Consensus 329 t~~y~aPE~l~~~~--~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-~~~i--~~~~~~~~~~~~~s~~~~~li~~~L 403 (491)
|+.|+|||++.+.. ++.++|||||||++|+|++|+.||........ .... ......++ ..++.++.+||.+||
T Consensus 186 ~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l 263 (295)
T 2clq_A 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP--ESMSAEAKAFILKCF 263 (295)
T ss_dssp CGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC--TTSCHHHHHHHHHTT
T ss_pred CccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccccc--ccCCHHHHHHHHHHc
Confidence 99999999998754 78899999999999999999999976544332 2222 22222333 458999999999999
Q ss_pred ccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 404 VKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 404 ~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
+.||++||+ ++++++||||+...
T Consensus 264 ~~dp~~Rps----~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 264 EPDPDKRAC----ANDLLVDEFLKVSS 286 (295)
T ss_dssp CSSTTTSCC----HHHHHTSGGGCC--
T ss_pred cCChhhCCC----HHHHhcChhhhhcc
Confidence 999999999 99999999998543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=372.37 Aligned_cols=255 Identities=22% Similarity=0.309 Sum_probs=214.5
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCce
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKF 168 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~ 168 (491)
+.+..++|++++.||+|+||+||+|++. ++..||||++....... ..+.+|+++|+.++||||+++++++.+.+.
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence 4556789999999999999999999887 67789999997654332 356789999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
+|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred eEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999999998764 24599999999999999999999999999999999999999999999999999864321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
... .......|
T Consensus 173 ~~~---------------------------------------------------------------------~~~~~~~~ 183 (283)
T 3gen_A 173 DEY---------------------------------------------------------------------TSSVGSKF 183 (283)
T ss_dssp HHH---------------------------------------------------------------------HSTTSTTS
T ss_pred ccc---------------------------------------------------------------------ccccCCcc
Confidence 100 00011257
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCC
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP 407 (491)
|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.......+... ........+++.+.+||.+||+.||
T Consensus 184 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p 262 (283)
T 3gen_A 184 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYRPHLASEKVYTIMYSCWHEKA 262 (283)
T ss_dssp CGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHTTCSSG
T ss_pred CcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc-cCCCCCCcCCHHHHHHHHHHccCCh
Confidence 889999999999999999999999999999998 99999988877776666554 3333334689999999999999999
Q ss_pred CCCCCcCCChHHhhcC
Q 035713 408 HKRIAYKRGATEIKQH 423 (491)
Q Consensus 408 ~~R~t~~~~~~ell~h 423 (491)
.+||+ +.++++|
T Consensus 263 ~~Rps----~~~ll~~ 274 (283)
T 3gen_A 263 DERPT----FKILLSN 274 (283)
T ss_dssp GGSCC----HHHHHHH
T ss_pred hHCcC----HHHHHHH
Confidence 99999 8999876
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=371.31 Aligned_cols=257 Identities=25% Similarity=0.345 Sum_probs=208.2
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCC---CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGT---NTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET 165 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 165 (491)
..+..++|++.+.||+|+||.||+|++..+ +..||+|++... ........+.+|+.+|+.++||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 455668999999999999999999998653 457999998653 23445567889999999999999999999985
Q ss_pred CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
++..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred cCccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 55788999999999999999865 34699999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
...... .....
T Consensus 166 ~~~~~~---------------------------------------------------------------------~~~~~ 176 (281)
T 1mp8_A 166 MEDSTY---------------------------------------------------------------------YKASK 176 (281)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCcccc---------------------------------------------------------------------ccccc
Confidence 321100 00112
Q ss_pred cccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhc
Q 035713 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLV 404 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~ 404 (491)
..+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+.... ..+....++.++.+||.+||+
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~~l~ 255 (281)
T 1mp8_A 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLMTKCWA 255 (281)
T ss_dssp --CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcc
Confidence 257889999999999999999999999999999997 999999888777766665543 233445699999999999999
Q ss_pred cCCCCCCCcCCChHHhhcC
Q 035713 405 KEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 405 ~dP~~R~t~~~~~~ell~h 423 (491)
.||++||+ +.+++++
T Consensus 256 ~~p~~Rps----~~~l~~~ 270 (281)
T 1mp8_A 256 YDPSRRPR----FTELKAQ 270 (281)
T ss_dssp SSGGGSCC----HHHHHHH
T ss_pred CChhhCcC----HHHHHHH
Confidence 99999999 8888764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=369.77 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=210.7
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHH----HHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNK----LLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~----~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
+..++|++.+.||+|+||+||+|++..+++.||||++.......... ...+.+|+++++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 45589999999999999999999999999999999987654332222 25788999999999999999999999776
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccccCCCCCEEEccCCc-----EEEee
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG--IVYRDLKPENVLVRDEGH-----IMLSD 239 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~g~-----vkL~D 239 (491)
. ++||||+++++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred C--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 6 6999999999999888764 356999999999999999999999999 999999999999988876 99999
Q ss_pred cccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCC
Q 035713 240 FDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPT 319 (491)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (491)
||+++....
T Consensus 173 fg~~~~~~~----------------------------------------------------------------------- 181 (287)
T 4f0f_A 173 FGLSQQSVH----------------------------------------------------------------------- 181 (287)
T ss_dssp CTTCBCCSS-----------------------------------------------------------------------
T ss_pred CCccccccc-----------------------------------------------------------------------
Confidence 999853211
Q ss_pred CccccccccccCccCcchhc--CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHH--HHHHHcCCCcCCCCCCCCHHH
Q 035713 320 NVRSMSFVGTHEYLAPEIIR--GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRAT--LFNVVGQPLRFPETPQVSFVA 395 (491)
Q Consensus 320 ~~~~~~~~gt~~y~aPE~l~--~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~s~~~ 395 (491)
.....+||+.|+|||++. ...++.++|||||||++|||++|+.||.+...... ...+............+++++
T Consensus 182 --~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 259 (287)
T 4f0f_A 182 --SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRL 259 (287)
T ss_dssp --CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred --cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHH
Confidence 011247999999999994 44578899999999999999999999987654433 344444444444455799999
Q ss_pred HHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 396 RDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 396 ~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
.+||.+||+.||.+||+ ++++++
T Consensus 260 ~~li~~~l~~dp~~Rps----~~~ll~ 282 (287)
T 4f0f_A 260 RNVIELCWSGDPKKRPH----FSYIVK 282 (287)
T ss_dssp HHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHHhcCChhhCcC----HHHHHH
Confidence 99999999999999999 888875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=373.56 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=207.7
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.++|++++.||+|+||.||+|++..+++.||||++.............+.+|+++++.++||||+++++++..++.+|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 57899999999999999999999999999999999876555566677889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-- 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK-- 188 (309)
T ss_dssp EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc--
Confidence 9999999999998874 469999999999999999999999999999999999999999999999999985432100
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.......+||+.|
T Consensus 189 -------------------------------------------------------------------~~~~~~~~~~~~y 201 (309)
T 2h34_A 189 -------------------------------------------------------------------LTQLGNTVGTLYY 201 (309)
T ss_dssp ---------------------------------------------------------------------------CCGGG
T ss_pred -------------------------------------------------------------------cccccccCCCcCc
Confidence 0011134789999
Q ss_pred cCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcC--CCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF--PETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 333 ~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
+|||++.+..++.++|||||||++|+|++|+.||.+.... .+...+...... .....++.++.+||.+||..||++|
T Consensus 202 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 280 (309)
T 2h34_A 202 MAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDR 280 (309)
T ss_dssp CCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGS
T ss_pred cCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHH
Confidence 9999999999999999999999999999999999887554 333333332221 1234689999999999999999999
Q ss_pred C-CcCCChHHhhc
Q 035713 411 I-AYKRGATEIKQ 422 (491)
Q Consensus 411 ~-t~~~~~~ell~ 422 (491)
| + ++++++
T Consensus 281 p~s----~~~l~~ 289 (309)
T 2h34_A 281 YVT----CGDLSA 289 (309)
T ss_dssp CSS----HHHHHH
T ss_pred HHh----HHHHHH
Confidence 9 6 666654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=382.49 Aligned_cols=256 Identities=18% Similarity=0.236 Sum_probs=210.0
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcE----EEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTY----FAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
+..++|++++.||+|+||+||+|++..+++. ||+|++.... .......+.+|+.+++.++||||+++++++. +
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 4568999999999999999999999988876 6666664332 1222334567999999999999999999986 4
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
+..++||||+.+|+|.+++... .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred CccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 5688999999999999998764 346999999999999999999999999999999999999999999999999999654
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
...... ......
T Consensus 166 ~~~~~~--------------------------------------------------------------------~~~~~~ 177 (325)
T 3kex_A 166 PPDDKQ--------------------------------------------------------------------LLYSEA 177 (325)
T ss_dssp CCCTTC--------------------------------------------------------------------CC----
T ss_pred Cccccc--------------------------------------------------------------------ccccCC
Confidence 321100 011124
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhcc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~ 405 (491)
.||..|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+... ...+....++.++.+||.+||+.
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~ 256 (325)
T 3kex_A 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-ERLAQPQICTIDVYMVMVKCWMI 256 (325)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT-CBCCCCTTBCTTTTHHHHHHTCS
T ss_pred CCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC-CCCCCCCcCcHHHHHHHHHHcCC
Confidence 68889999999999999999999999999999999 99999987766655555443 23333345888999999999999
Q ss_pred CCCCCCCcCCChHHhhcC
Q 035713 406 EPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~h 423 (491)
||.+||+ +.++++|
T Consensus 257 dp~~Rps----~~el~~~ 270 (325)
T 3kex_A 257 DENIRPT----FKELANE 270 (325)
T ss_dssp CTTTSCC----HHHHHHH
T ss_pred ChhhCcC----HHHHHHH
Confidence 9999999 8888886
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=373.46 Aligned_cols=249 Identities=21% Similarity=0.246 Sum_probs=210.0
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCC-------cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTN-------TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYF 163 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~-------~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 163 (491)
+..++|++.+.||+|+||+||+|++..++ ..||+|++.+.. ......+.+|+++|+.++||||+++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 45689999999999999999999999877 469999986543 23445678999999999999999999999
Q ss_pred EeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCc--------E
Q 035713 164 ETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGH--------I 235 (491)
Q Consensus 164 ~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~--------v 235 (491)
.+++..|+||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999999875 234999999999999999999999999999999999999998887 9
Q ss_pred EEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccc
Q 035713 236 MLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELM 315 (491)
Q Consensus 236 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (491)
||+|||++....
T Consensus 161 kl~Dfg~~~~~~-------------------------------------------------------------------- 172 (289)
T 4fvq_A 161 KLSDPGISITVL-------------------------------------------------------------------- 172 (289)
T ss_dssp EECCCCSCTTTS--------------------------------------------------------------------
T ss_pred eeccCccccccc--------------------------------------------------------------------
Confidence 999999974321
Q ss_pred cCCCCccccccccccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHH
Q 035713 316 AEPTNVRSMSFVGTHEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFV 394 (491)
Q Consensus 316 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 394 (491)
......||+.|+|||++.+ ..++.++|||||||++|||++|..|+...........+......++. ..+.+
T Consensus 173 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 244 (289)
T 4fvq_A 173 ------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA--PKAAE 244 (289)
T ss_dssp ------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC--CSSCT
T ss_pred ------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCC--CCCHH
Confidence 0112468999999999998 66899999999999999999955444444444444455555444444 36888
Q ss_pred HHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 395 ARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 395 ~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
+.+||.+||+.||.+||+ +.++++|
T Consensus 245 l~~li~~~l~~dp~~Rps----~~~ll~~ 269 (289)
T 4fvq_A 245 LANLINNCMDYEPDHRPS----FRAIIRD 269 (289)
T ss_dssp THHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 999999999999999999 9999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=381.69 Aligned_cols=265 Identities=23% Similarity=0.319 Sum_probs=195.3
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHH-HHhhcCCCCccceeeeEEeCce
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE-ILGLLDHPFLPTLYSYFETDKF 168 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~-il~~l~hp~iv~l~~~~~~~~~ 168 (491)
.+..++|++++.||+|+||.||+|+++.+|+.||||++..... ......+.+|+. +++.++||||+++++++..++.
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 4566899999999999999999999999999999999976532 223334445555 7788899999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 169 YCLVMEFCSGGNLHSLRQK---QPNKYFTEDAARFFASEVLLALEYLHML-GIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~---~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
.|+||||+.+ +|.+++.. .....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999999965 77776653 2246699999999999999999999998 99999999999999999999999999985
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
...... ...
T Consensus 175 ~~~~~~-----------------------------------------------------------------------~~~ 183 (327)
T 3aln_A 175 QLVDSI-----------------------------------------------------------------------AKT 183 (327)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred eccccc-----------------------------------------------------------------------ccc
Confidence 432100 011
Q ss_pred ccccccCccCcchh----cCCCCCCcccccchhhHHHhhhcCCCCCCCCCcH-HHHHHHHcCC-CcCC--CCCCCCHHHH
Q 035713 325 SFVGTHEYLAPEII----RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR-ATLFNVVGQP-LRFP--ETPQVSFVAR 396 (491)
Q Consensus 325 ~~~gt~~y~aPE~l----~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~-~~~~--~~~~~s~~~~ 396 (491)
...||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.... +.+..+.... ..++ ....++.++.
T Consensus 184 ~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 263 (327)
T 3aln_A 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFI 263 (327)
T ss_dssp ----------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHH
T ss_pred cCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHH
Confidence 23689999999999 4566899999999999999999999999875432 2222222211 1122 1245899999
Q ss_pred HHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 397 DLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 397 ~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
+||.+||+.||.+||+ +.+|++||||....+.
T Consensus 264 ~li~~~l~~dp~~Rps----~~ell~hp~~~~~~~~ 295 (327)
T 3aln_A 264 NFVNLCLTKDESKRPK----YKELLKHPFILMYEER 295 (327)
T ss_dssp HHHHHHTCSSGGGSCC----HHHHTTSHHHHHHHHS
T ss_pred HHHHHHhhCChhhCcC----HHHHHhChHHHHhHhh
Confidence 9999999999999999 9999999999765544
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=381.65 Aligned_cols=261 Identities=19% Similarity=0.288 Sum_probs=221.2
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCCCc-----EEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeee
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNT-----YFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSY 162 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~ 162 (491)
..+..++|++.+.||+|+||.||+|++..+++ .||+|++.... .......+.+|+++|+.+ +||||++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34566899999999999999999999987664 79999997643 234456788999999999 89999999999
Q ss_pred EEeCceEEEEEeccCCCchHHHHHhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEc
Q 035713 163 FETDKFYCLVMEFCSGGNLHSLRQKQP------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVR 230 (491)
Q Consensus 163 ~~~~~~~~lV~E~~~gg~L~~~~~~~~------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~ 230 (491)
+...+.+|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 999999999999999999999987531 34589999999999999999999999999999999999999
Q ss_pred cCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCC
Q 035713 231 DEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGA 310 (491)
Q Consensus 231 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (491)
.++.+||+|||++.........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~---------------------------------------------------------- 220 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNY---------------------------------------------------------- 220 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTS----------------------------------------------------------
T ss_pred CCCeEEECccccccccccccce----------------------------------------------------------
Confidence 9999999999998643211100
Q ss_pred CCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCC
Q 035713 311 LPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETP 389 (491)
Q Consensus 311 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 389 (491)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||.+......+..++......+...
T Consensus 221 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (333)
T 2i1m_A 221 ----------IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPA 290 (333)
T ss_dssp ----------EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCT
T ss_pred ----------eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCC
Confidence 01112368899999999999999999999999999999999 9999998877766666666555555556
Q ss_pred CCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 390 QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 390 ~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
.++..+.+||.+||+.||.+||+ +.+++++
T Consensus 291 ~~~~~l~~li~~~l~~~p~~Rps----~~~l~~~ 320 (333)
T 2i1m_A 291 FAPKNIYSIMQACWALEPTHRPT----FQQICSF 320 (333)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCHHHHHHHHHHhccChhhCcC----HHHHHHH
Confidence 68999999999999999999999 8888874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=379.90 Aligned_cols=255 Identities=20% Similarity=0.263 Sum_probs=206.8
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEE----EEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYF----AMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~v----aiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
..++|+++++||+|+||+||+|++..+++.+ |+|.+... ........+.+|+++|+.++||||+++++++.++.
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 4578999999999999999999998887765 66666433 22334467889999999999999999999998765
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred -eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 779999999999999988753 569999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
..... .......
T Consensus 169 ~~~~~--------------------------------------------------------------------~~~~~~~ 180 (327)
T 3poz_A 169 AEEKE--------------------------------------------------------------------YHAEGGK 180 (327)
T ss_dssp TTCC---------------------------------------------------------------------------C
T ss_pred CCccc--------------------------------------------------------------------ccccCCC
Confidence 21100 0011235
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
||+.|+|||++.+..++.++|||||||++|||++ |+.||.+......... +......+....++.++.+||.+||+.|
T Consensus 181 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~ 259 (327)
T 3poz_A 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-LEKGERLPQPPICTIDVYMIMVKCWMID 259 (327)
T ss_dssp CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-HHTTCCCCCCTTBCHHHHHHHHHHTCSC
T ss_pred ccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH-HHcCCCCCCCccCCHHHHHHHHHHcCCC
Confidence 7889999999999999999999999999999999 9999998766654444 4444445555679999999999999999
Q ss_pred CCCCCCcCCChHHhhcC
Q 035713 407 PHKRIAYKRGATEIKQH 423 (491)
Q Consensus 407 P~~R~t~~~~~~ell~h 423 (491)
|.+||+ +.+++++
T Consensus 260 p~~Rps----~~ell~~ 272 (327)
T 3poz_A 260 ADSRPK----FRELIIE 272 (327)
T ss_dssp GGGSCC----HHHHHHH
T ss_pred hhhCCC----HHHHHHH
Confidence 999999 8888876
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=384.28 Aligned_cols=258 Identities=28% Similarity=0.393 Sum_probs=217.0
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhH---HHHHHHHHHHHHHhhcC--CCCccceeeeEE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASR---NKLLRAQTEREILGLLD--HPFLPTLYSYFE 164 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~il~~l~--hp~iv~l~~~~~ 164 (491)
....++|++++.||+|+||.||+|++..+++.||||++........ .....+.+|+.+++.++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 3456889999999999999999999999999999999976543221 11234567999999996 599999999999
Q ss_pred eCceEEEEEeccCC-CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEc-cCCcEEEeeccc
Q 035713 165 TDKFYCLVMEFCSG-GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVR-DEGHIMLSDFDL 242 (491)
Q Consensus 165 ~~~~~~lV~E~~~g-g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~-~~g~vkL~DFGl 242 (491)
.++.+++||||+.+ ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 99999999999976 8999998864 5699999999999999999999999999999999999999 789999999999
Q ss_pred ccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcc
Q 035713 243 SLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322 (491)
Q Consensus 243 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (491)
++..... .
T Consensus 197 ~~~~~~~------------------------------------------------------------------------~ 204 (320)
T 3a99_A 197 GALLKDT------------------------------------------------------------------------V 204 (320)
T ss_dssp CEECCSS------------------------------------------------------------------------C
T ss_pred ccccccc------------------------------------------------------------------------c
Confidence 8543210 0
Q ss_pred ccccccccCccCcchhcCCCC-CCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHh
Q 035713 323 SMSFVGTHEYLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRG 401 (491)
Q Consensus 323 ~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 401 (491)
.....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .+......++ ..++.++.+||.+
T Consensus 205 ~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~--~~~~~~~~~li~~ 276 (320)
T 3a99_A 205 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR--QRVSSECQHLIRW 276 (320)
T ss_dssp BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS--SCCCHHHHHHHHH
T ss_pred ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc--ccCCHHHHHHHHH
Confidence 112368999999999988776 788999999999999999999997532 2333333333 3589999999999
Q ss_pred hhccCCCCCCCcCCChHHhhcCCCcCCCChhh
Q 035713 402 LLVKEPHKRIAYKRGATEIKQHPFFEGVNWAL 433 (491)
Q Consensus 402 ~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~ 433 (491)
||+.||++||+ +++|++||||+.+.+..
T Consensus 277 ~l~~dp~~Rps----~~~ll~hp~~~~~~~~~ 304 (320)
T 3a99_A 277 CLALRPSDRPT----FEEIQNHPWMQDVLLPQ 304 (320)
T ss_dssp HTCSSGGGSCC----HHHHHTSGGGSSCCCHH
T ss_pred HccCChhhCcC----HHHHhcCHhhcCccCcc
Confidence 99999999999 99999999999887653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=373.78 Aligned_cols=258 Identities=21% Similarity=0.291 Sum_probs=209.7
Q ss_pred CccCCCceEeeeeeccCceEEEEEE----EeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVE----LRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET 165 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 165 (491)
.+..++|+++++||+|+||+||+|+ +..+++.||||++... .......+.+|+++|+.++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3456899999999999999999999 5678999999998754 23455678899999999999999999999864
Q ss_pred --CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccc
Q 035713 166 --DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243 (491)
Q Consensus 166 --~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla 243 (491)
...+|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 356899999999999999998753 45999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (491)
+......... ...
T Consensus 162 ~~~~~~~~~~-------------------------------------------------------------------~~~ 174 (295)
T 3ugc_A 162 KVLPQDKEFF-------------------------------------------------------------------KVK 174 (295)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred ccccCCccee-------------------------------------------------------------------eec
Confidence 6542211000 001
Q ss_pred cccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcH---------------HHHHHHHcCCCcCCCC
Q 035713 324 MSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR---------------ATLFNVVGQPLRFPET 388 (491)
Q Consensus 324 ~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~ 388 (491)
....||..|+|||++.+..++.++|||||||++|||++|..||...... ..+...+......+..
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (295)
T 3ugc_A 175 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 254 (295)
T ss_dssp -CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCC
T ss_pred cCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCC
Confidence 1235788899999999999999999999999999999999998643211 0122233334445555
Q ss_pred CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 389 PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 389 ~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
..+++++.+||.+||+.||++||+ +.++++
T Consensus 255 ~~~~~~l~~li~~~l~~dp~~Rps----~~el~~ 284 (295)
T 3ugc_A 255 DGCPDEIYMIMTECWNNNVNQRPS----FRDLAL 284 (295)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSCC----HHHHHH
T ss_pred cCcCHHHHHHHHHHcCCChhhCCC----HHHHHH
Confidence 679999999999999999999999 888875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=373.84 Aligned_cols=262 Identities=24% Similarity=0.363 Sum_probs=203.4
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
.+..++|++++.||+|+||.||+|+++.+|+.||||++...... ......+..+..+++.++||||+++++++.+++.+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 34568999999999999999999999999999999999765322 23333445566678889999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML-GIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
|+||||+ ++.+..++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 100 ~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 9999999 66666665543 35699999999999999999999995 999999999999999999999999999854321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
.. ......|
T Consensus 178 ~~-----------------------------------------------------------------------~~~~~~~ 186 (318)
T 2dyl_A 178 DK-----------------------------------------------------------------------AKDRSAG 186 (318)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred Cc-----------------------------------------------------------------------cccccCC
Confidence 00 0112368
Q ss_pred ccCccCcchhc-----CCCCCCcccccchhhHHHhhhcCCCCCCCCC-cHHHHHHHHcCC-CcCCCCCCCCHHHHHHHHh
Q 035713 329 THEYLAPEIIR-----GEGHGSAVDWWTFGIFLYELLHGTTPFKGQG-NRATLFNVVGQP-LRFPETPQVSFVARDLIRG 401 (491)
Q Consensus 329 t~~y~aPE~l~-----~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-~~~~~~~i~~~~-~~~~~~~~~s~~~~~li~~ 401 (491)
|+.|+|||++. +..++.++|||||||++|+|++|+.||.... ....+..++... ..++....++.++.+||.+
T Consensus 187 ~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 266 (318)
T 2dyl_A 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKD 266 (318)
T ss_dssp CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHH
T ss_pred CccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHH
Confidence 99999999995 4567899999999999999999999998743 344455555443 3344445689999999999
Q ss_pred hhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 402 LLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 402 ~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
||+.||.+||+ +++|++||||+..
T Consensus 267 ~l~~dp~~Rps----~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 267 CLTKDHRKRPK----YNKLLEHSFIKRY 290 (318)
T ss_dssp HTCSCTTTSCC----HHHHTTSHHHHHH
T ss_pred HccCChhHCcC----HHHHhhCHHHHhc
Confidence 99999999999 9999999999754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=385.64 Aligned_cols=258 Identities=23% Similarity=0.320 Sum_probs=208.0
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEe---CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELR---GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
.+...+|++.+.||+|+||.||+|+++ .++..||||+++... .......+.+|+++|+.++||||+++++++...
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 456679999999999999999999987 567789999997542 334556788999999999999999999999999
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
+.+||||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999999999865 346999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
....... ......
T Consensus 198 ~~~~~~~-------------------------------------------------------------------~~~~~~ 210 (373)
T 2qol_A 198 EDDPEAA-------------------------------------------------------------------YTTRGG 210 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccCCccc-------------------------------------------------------------------eeccCC
Confidence 3211000 000112
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhcc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~ 405 (491)
.+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+.......+. .....+....++..+.+||.+||+.
T Consensus 211 ~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~ 289 (373)
T 2qol_A 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMDCPAALYQLMLDCWQK 289 (373)
T ss_dssp ---CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-TTEECCCCTTCBHHHHHHHHHHTCS
T ss_pred CcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCccccHHHHHHHHHHhCc
Confidence 46789999999999999999999999999999998 999999887766555544 3445555567899999999999999
Q ss_pred CCCCCCCcCCChHHhhc
Q 035713 406 EPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~ 422 (491)
||.+||+ +.+|++
T Consensus 290 dp~~RPs----~~~i~~ 302 (373)
T 2qol_A 290 DRNNRPK----FEQIVS 302 (373)
T ss_dssp SGGGSCC----HHHHHH
T ss_pred ChhhCcC----HHHHHH
Confidence 9999999 777765
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=369.12 Aligned_cols=258 Identities=18% Similarity=0.229 Sum_probs=209.8
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~ 169 (491)
+..++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+++++.+ +|+||+++++++......
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 3457899999999999999999999999999999998754322 2456799999999 799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCc-----EEEeeccccc
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGH-----IMLSDFDLSL 244 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~-----vkL~DFGla~ 244 (491)
|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++
T Consensus 82 ~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 9999999 99999999875 345999999999999999999999999999999999999987776 9999999996
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
.......... .......
T Consensus 160 ~~~~~~~~~~---------------------------------------------------------------~~~~~~~ 176 (298)
T 1csn_A 160 FYRDPVTKQH---------------------------------------------------------------IPYREKK 176 (298)
T ss_dssp ESBCTTTCCB---------------------------------------------------------------CCCCCCC
T ss_pred cccccccccc---------------------------------------------------------------ccccCcc
Confidence 5432111000 0001122
Q ss_pred ccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCC---cHHHHHHHHcCCCcCC---CCCCCCHHHHHH
Q 035713 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQG---NRATLFNVVGQPLRFP---ETPQVSFVARDL 398 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~---~~~~~s~~~~~l 398 (491)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ....+..+.......+ ....+++++.+|
T Consensus 177 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 256 (298)
T 1csn_A 177 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKY 256 (298)
T ss_dssp CCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHH
T ss_pred CCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHH
Confidence 3579999999999999999999999999999999999999998743 3333333332221111 123589999999
Q ss_pred HHhhhccCCCCCCCcCCChHHhhc
Q 035713 399 IRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 399 i~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
|.+||+.||++||+ +++|++
T Consensus 257 i~~~l~~dp~~RP~----~~~l~~ 276 (298)
T 1csn_A 257 MHYARNLAFDATPD----YDYLQG 276 (298)
T ss_dssp HHHHHHCCTTCCCC----HHHHHH
T ss_pred HHHHhcCCcccCCC----HHHHHH
Confidence 99999999999999 666654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=399.17 Aligned_cols=257 Identities=20% Similarity=0.303 Sum_probs=221.0
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
.+.+..++|++.++||+|+||.||+|+++.++..||||+++.... ....+.+|+++|+.++||||+++++++...+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 455667889999999999999999999999999999999976532 2456788999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+||||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999999999999987655679999999999999999999999999999999999999999999999999986542
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
..... ......
T Consensus 370 ~~~~~---------------------------------------------------------------------~~~~~~ 380 (495)
T 1opk_A 370 GDTYT---------------------------------------------------------------------AHAGAK 380 (495)
T ss_dssp TCCEE---------------------------------------------------------------------CCTTCC
T ss_pred CCcee---------------------------------------------------------------------ecCCCc
Confidence 11000 001125
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
+|..|+|||++.+..++.++|||||||+||||++ |+.||.+.+....... +......+....++.++.+||.+||+.|
T Consensus 381 ~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~d 459 (495)
T 1opk_A 381 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKDYRMERPEGCPEKVYELMRACWQWN 459 (495)
T ss_dssp CCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcCcC
Confidence 6789999999999999999999999999999999 9999998876655444 4444555555679999999999999999
Q ss_pred CCCCCCcCCChHHhhc
Q 035713 407 PHKRIAYKRGATEIKQ 422 (491)
Q Consensus 407 P~~R~t~~~~~~ell~ 422 (491)
|++||+ +.+|++
T Consensus 460 P~~RPs----~~el~~ 471 (495)
T 1opk_A 460 PSDRPS----FAEIHQ 471 (495)
T ss_dssp GGGSCC----HHHHHH
T ss_pred hhHCcC----HHHHHH
Confidence 999999 888875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=374.61 Aligned_cols=263 Identities=27% Similarity=0.411 Sum_probs=214.7
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC--CCCccceeeeEEeC
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD--HPFLPTLYSYFETD 166 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~--hp~iv~l~~~~~~~ 166 (491)
..+..++|++++.||+|+||.||+|++. +++.||||++..... .......+.+|+++|+.++ |+||+++++++..+
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 3455678999999999999999999986 588999999976533 3445667889999999997 59999999999999
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
+.+|+||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 176 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred CEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccc
Confidence 99999999 4589999999875 4699999999999999999999999999999999999996 589999999998543
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
..... .......
T Consensus 177 ~~~~~--------------------------------------------------------------------~~~~~~~ 188 (313)
T 3cek_A 177 QPDTT--------------------------------------------------------------------SVVKDSQ 188 (313)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCccc--------------------------------------------------------------------cccccCC
Confidence 21110 0011134
Q ss_pred ccccCccCcchhcC-----------CCCCCcccccchhhHHHhhhcCCCCCCCCCcH-HHHHHHHcCCCcCCCCCCCCHH
Q 035713 327 VGTHEYLAPEIIRG-----------EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR-ATLFNVVGQPLRFPETPQVSFV 394 (491)
Q Consensus 327 ~gt~~y~aPE~l~~-----------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~~ 394 (491)
+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ..+..++............+.+
T Consensus 189 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (313)
T 3cek_A 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKD 268 (313)
T ss_dssp -CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHH
T ss_pred CCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHH
Confidence 79999999999986 46788999999999999999999999876443 3444555544444444457899
Q ss_pred HHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 395 ARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 395 ~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
+.+||.+||+.||.+||+ +.++++||||+..
T Consensus 269 l~~li~~~l~~dp~~Rps----~~ell~h~~~~~~ 299 (313)
T 3cek_A 269 LQDVLKCCLKRDPKQRIS----IPELLAHPYVQIQ 299 (313)
T ss_dssp HHHHHHHHTCSSTTTSCC----HHHHHTSHHHHCC
T ss_pred HHHHHHHHccCCcccCcC----HHHHhcCccccCC
Confidence 999999999999999999 9999999999743
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=376.58 Aligned_cols=260 Identities=22% Similarity=0.326 Sum_probs=216.6
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEe-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELR-----GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYF 163 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~ 163 (491)
.+..++|++++.||+|+||+||+|++. .+++.||||++.... .......+.+|+++|+.+ +||||+++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 455689999999999999999999964 467899999997653 234455788999999999 699999999998
Q ss_pred EeC-ceEEEEEeccCCCchHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEE
Q 035713 164 ETD-KFYCLVMEFCSGGNLHSLRQKQPN--------------KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVL 228 (491)
Q Consensus 164 ~~~-~~~~lV~E~~~gg~L~~~~~~~~~--------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NIL 228 (491)
... +.+|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 765 459999999999999999987532 12899999999999999999999999999999999999
Q ss_pred EccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCC
Q 035713 229 VRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVG 308 (491)
Q Consensus 229 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (491)
++.++.+||+|||+++.......
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~--------------------------------------------------------- 203 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPD--------------------------------------------------------- 203 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTT---------------------------------------------------------
T ss_pred ECCCCCEEECCCccccccccCcc---------------------------------------------------------
Confidence 99999999999999864321110
Q ss_pred CCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCC
Q 035713 309 GALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPE 387 (491)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 387 (491)
........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+......+...+......+.
T Consensus 204 -----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 272 (316)
T 2xir_A 204 -----------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 272 (316)
T ss_dssp -----------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCC
T ss_pred -----------ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCC
Confidence 011123478999999999999999999999999999999998 99999887765555554443333444
Q ss_pred CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 388 TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 388 ~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
...+++++.+||.+||+.||.+||+ +.++++|
T Consensus 273 ~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 304 (316)
T 2xir_A 273 PDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 304 (316)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 4568999999999999999999999 9999886
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=376.84 Aligned_cols=255 Identities=23% Similarity=0.338 Sum_probs=213.4
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEE--EEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCc
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYF--AMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDK 167 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~v--aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~ 167 (491)
+..++|++.+.||+|+||.||+|++..++..+ |+|++... ........+.+|+++|+.+ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 45589999999999999999999999988865 99988753 2334455678999999999 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQP--------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG 233 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g 233 (491)
.+|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999987642 24699999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCc
Q 035713 234 HIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPE 313 (491)
Q Consensus 234 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (491)
.+||+|||+++.....
T Consensus 180 ~~kL~Dfg~~~~~~~~---------------------------------------------------------------- 195 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY---------------------------------------------------------------- 195 (327)
T ss_dssp CEEECCTTCEESSCEE----------------------------------------------------------------
T ss_pred eEEEcccCcCcccccc----------------------------------------------------------------
Confidence 9999999998532100
Q ss_pred cccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCC
Q 035713 314 LMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVS 392 (491)
Q Consensus 314 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 392 (491)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+... ...+....++
T Consensus 196 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~ 267 (327)
T 1fvr_A 196 -------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPLNCD 267 (327)
T ss_dssp -------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-CCCCCCTTBC
T ss_pred -------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC-CCCCCCCCCC
Confidence 00012257889999999999889999999999999999998 99999988776655555433 3344445689
Q ss_pred HHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 393 FVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 393 ~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
.++.+||.+||+.||.+||+ +++++++
T Consensus 268 ~~l~~li~~~l~~dp~~Rps----~~ell~~ 294 (327)
T 1fvr_A 268 DEVYDLMRQCWREKPYERPS----FAQILVS 294 (327)
T ss_dssp HHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 99999999999999999999 8999886
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=369.96 Aligned_cols=258 Identities=25% Similarity=0.361 Sum_probs=207.2
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
..++|++++.||+|+||.||+|++..+|+.||||++.............+.+|+++|+.++||||+++++++...+.+|+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 34689999999999999999999999999999999986554555666778899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 172 VMEFCSGGNLHSLRQKQ--PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 99999999999988642 2356999999999999999999999999999999999999999999999999998543210
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
. .......||
T Consensus 190 ~----------------------------------------------------------------------~~~~~~~~~ 199 (310)
T 2wqm_A 190 T----------------------------------------------------------------------TAAHSLVGT 199 (310)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred C----------------------------------------------------------------------ccccccCCC
Confidence 0 001124789
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCc--HHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGN--RATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP 407 (491)
+.|+|||++.+..++.++|||||||++|+|++|+.||.+... ......+............++.++.+||.+||..||
T Consensus 200 ~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 279 (310)
T 2wqm_A 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDP 279 (310)
T ss_dssp CSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSG
T ss_pred eeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCCh
Confidence 999999999999999999999999999999999999976532 223333444333322235689999999999999999
Q ss_pred CCCCCcCCChHHhhcC
Q 035713 408 HKRIAYKRGATEIKQH 423 (491)
Q Consensus 408 ~~R~t~~~~~~ell~h 423 (491)
.+||+ +.+++++
T Consensus 280 ~~Rps----~~~il~~ 291 (310)
T 2wqm_A 280 EKRPD----VTYVYDV 291 (310)
T ss_dssp GGSCC----HHHHHHH
T ss_pred hhCCC----HHHHHHH
Confidence 99999 8888874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=370.94 Aligned_cols=258 Identities=24% Similarity=0.281 Sum_probs=210.3
Q ss_pred ccCCCceEeeeeeccCceEEEEEE----EeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVE----LRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
+...+|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+++|+.++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 345679999999999999999999 56789999999997553 233446678999999999999999999999876
Q ss_pred --ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 167 --KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 167 --~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
..+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 67899999999999999986542 459999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
......... ....
T Consensus 175 ~~~~~~~~~-------------------------------------------------------------------~~~~ 187 (302)
T 4e5w_A 175 AIETDKEYY-------------------------------------------------------------------TVKD 187 (302)
T ss_dssp ECCTTCCEE-------------------------------------------------------------------ECCC
T ss_pred cccCCCcce-------------------------------------------------------------------eccC
Confidence 543211100 0111
Q ss_pred ccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCC--------------CCcHHHHHHHHcCCCcCCCCCC
Q 035713 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKG--------------QGNRATLFNVVGQPLRFPETPQ 390 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~--------------~~~~~~~~~i~~~~~~~~~~~~ 390 (491)
...||..|+|||++.+..++.++|||||||++|+|++|+.|+.. ......+...+......+....
T Consensus 188 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (302)
T 4e5w_A 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPN 267 (302)
T ss_dssp CTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTT
T ss_pred CCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCC
Confidence 23688999999999999999999999999999999999987632 2222333344444445555567
Q ss_pred CCHHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 391 VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 391 ~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
+++++.+||.+||+.||.+||+ +.++++
T Consensus 268 ~~~~l~~li~~~l~~dp~~Rps----~~~ll~ 295 (302)
T 4e5w_A 268 CPDEVYQLMRKCWEFQPSNRTS----FQNLIE 295 (302)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCC----HHHHHH
T ss_pred CCHHHHHHHHHHcCCCCCCCCC----HHHHHH
Confidence 9999999999999999999999 888875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=377.67 Aligned_cols=253 Identities=27% Similarity=0.409 Sum_probs=205.6
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhH---HHHHHHHHHHHHHhhc----CCCCccceeeeEEe
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASR---NKLLRAQTEREILGLL----DHPFLPTLYSYFET 165 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~il~~l----~hp~iv~l~~~~~~ 165 (491)
.++|++++.||+|+||.||+|++..+++.||||++........ .....+.+|+.+++.+ +|+||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 4789999999999999999999999999999999976543221 1223456799999998 89999999999999
Q ss_pred CceEEEEEec-cCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEc-cCCcEEEeecccc
Q 035713 166 DKFYCLVMEF-CSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVR-DEGHIMLSDFDLS 243 (491)
Q Consensus 166 ~~~~~lV~E~-~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~-~~g~vkL~DFGla 243 (491)
.+..++|||| +.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred CCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 9999999999 7899999998874 4599999999999999999999999999999999999999 8899999999998
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (491)
...... ..
T Consensus 188 ~~~~~~------------------------------------------------------------------------~~ 195 (312)
T 2iwi_A 188 ALLHDE------------------------------------------------------------------------PY 195 (312)
T ss_dssp EECCSS------------------------------------------------------------------------CB
T ss_pred hhcccC------------------------------------------------------------------------cc
Confidence 543210 01
Q ss_pred cccccccCccCcchhcCCCC-CCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhh
Q 035713 324 MSFVGTHEYLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGL 402 (491)
Q Consensus 324 ~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~ 402 (491)
....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||... ..+......++ ..++.++.+||.+|
T Consensus 196 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~--~~~~~~~~~li~~~ 267 (312)
T 2iwi_A 196 TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFP--AHVSPDCCALIRRC 267 (312)
T ss_dssp CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHTCCCCC--TTSCHHHHHHHHHH
T ss_pred cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhhccCCc--ccCCHHHHHHHHHH
Confidence 12368999999999987776 45899999999999999999999753 22334444444 35899999999999
Q ss_pred hccCCCCCCCcCCChHHhhcCCCcCCCCh
Q 035713 403 LVKEPHKRIAYKRGATEIKQHPFFEGVNW 431 (491)
Q Consensus 403 L~~dP~~R~t~~~~~~ell~hpff~~~~~ 431 (491)
|+.||++||+ ++++++||||+....
T Consensus 268 l~~~p~~Rps----~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 268 LAPKPSSRPS----LEEILLDPWMQTPAE 292 (312)
T ss_dssp TCSSTTTSCC----HHHHHHSTTTCC---
T ss_pred ccCChhhCcC----HHHHhcChhhcCchh
Confidence 9999999999 999999999987543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=375.52 Aligned_cols=260 Identities=19% Similarity=0.281 Sum_probs=216.5
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEe-------CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCcccee
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELR-------GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLY 160 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~ 160 (491)
+.+..++|++++.||+|+||.||+|++. .++..||||+++... .......+.+|+++|+.+ +||||++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 3456689999999999999999999985 457789999997542 344566788999999999 899999999
Q ss_pred eeEEeCceEEEEEeccCCCchHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCC
Q 035713 161 SYFETDKFYCLVMEFCSGGNLHSLRQKQPN--------------KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPEN 226 (491)
Q Consensus 161 ~~~~~~~~~~lV~E~~~gg~L~~~~~~~~~--------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~N 226 (491)
+++...+.+|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 999999999999999999999999986531 348999999999999999999999999999999999
Q ss_pred EEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCC
Q 035713 227 VLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPC 306 (491)
Q Consensus 227 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (491)
||++.++.+||+|||+++.........
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~----------------------------------------------------- 214 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYK----------------------------------------------------- 214 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEE-----------------------------------------------------
T ss_pred EEEcCCCCEEEcccccccccccccccc-----------------------------------------------------
Confidence 999999999999999986542211000
Q ss_pred CCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcC
Q 035713 307 VGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRF 385 (491)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 385 (491)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+.... ..
T Consensus 215 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~ 278 (334)
T 2pvf_A 215 ---------------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-RM 278 (334)
T ss_dssp ---------------CCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC-CC
T ss_pred ---------------ccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCC-CC
Confidence 0112257889999999999889999999999999999999 999999887666555554432 33
Q ss_pred CCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 386 PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 386 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
+....++.++.+||.+||+.||.+||+ +.+++++
T Consensus 279 ~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 312 (334)
T 2pvf_A 279 DKPANCTNELYMMMRDCWHAVPSQRPT----FKQLVED 312 (334)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 334568999999999999999999999 8888875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=390.51 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=215.4
Q ss_pred cCCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 035713 86 LRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET 165 (491)
Q Consensus 86 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 165 (491)
...+.+..++|++++.||+|+||.||+|++. ++.||||+++... ....+.+|+++|+.++||||+++++++..
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 257 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVE 257 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEc
Confidence 3456778899999999999999999999886 6799999997653 23467789999999999999999999876
Q ss_pred Cc-eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 166 DK-FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 166 ~~-~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
.. .+||||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 258 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 337 (450)
T 1k9a_A 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337 (450)
T ss_dssp TTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence 54 79999999999999999987654558999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
..... ..
T Consensus 338 ~~~~~-------------------------------------------------------------------------~~ 344 (450)
T 1k9a_A 338 EASST-------------------------------------------------------------------------QD 344 (450)
T ss_dssp ECC-----------------------------------------------------------------------------
T ss_pred ccccc-------------------------------------------------------------------------cc
Confidence 32100 00
Q ss_pred ccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhh
Q 035713 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLL 403 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L 403 (491)
...+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+.+..+.+..+..+ ...+....+++++.+||.+||
T Consensus 345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl 423 (450)
T 1k9a_A 345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYDVMKNCW 423 (450)
T ss_dssp --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT-CCCCCCTTCCHHHHHHHHHHT
T ss_pred CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHHHc
Confidence 1256889999999999999999999999999999998 99999988776666555443 444455679999999999999
Q ss_pred ccCCCCCCCcCCChHHhhc
Q 035713 404 VKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 404 ~~dP~~R~t~~~~~~ell~ 422 (491)
..||.+||+ +.+|+.
T Consensus 424 ~~dp~~Rpt----~~~l~~ 438 (450)
T 1k9a_A 424 HLDAATRPT----FLQLRE 438 (450)
T ss_dssp CSSGGGSCC----HHHHHH
T ss_pred CCChhHCcC----HHHHHH
Confidence 999999999 777764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=377.55 Aligned_cols=262 Identities=18% Similarity=0.242 Sum_probs=214.7
Q ss_pred ccCCCceEeeeeeccCceEEEEEE-----EeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVE-----LRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET 165 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 165 (491)
+..++|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 345789999999999999999999 55678899999996442 33445578899999999999999999999999
Q ss_pred CceEEEEEeccCCCchHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc---CCcEEE
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPN-----KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD---EGHIML 237 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~---~g~vkL 237 (491)
.+..||||||++|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999999987532 34899999999999999999999999999999999999994 446999
Q ss_pred eecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccC
Q 035713 238 SDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAE 317 (491)
Q Consensus 238 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (491)
+|||++........
T Consensus 185 ~Dfg~~~~~~~~~~------------------------------------------------------------------ 198 (327)
T 2yfx_A 185 GDFGMARDIYRASY------------------------------------------------------------------ 198 (327)
T ss_dssp CCCHHHHHHHC---------------------------------------------------------------------
T ss_pred Cccccccccccccc------------------------------------------------------------------
Confidence 99999854321100
Q ss_pred CCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHH
Q 035713 318 PTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVAR 396 (491)
Q Consensus 318 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~ 396 (491)
........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+......+..+.... .......++..+.
T Consensus 199 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 275 (327)
T 2yfx_A 199 --YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPPKNCPGPVY 275 (327)
T ss_dssp -----CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHHHH
T ss_pred --cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC-CCCCCCCCCHHHH
Confidence 001113468999999999999999999999999999999998 999999887766666555443 2233346899999
Q ss_pred HHHHhhhccCCCCCCCcCCChHHhhcCCCcC
Q 035713 397 DLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 397 ~li~~~L~~dP~~R~t~~~~~~ell~hpff~ 427 (491)
+||.+||+.||.+||+ +.+|++|.|+-
T Consensus 276 ~li~~~l~~dp~~Rps----~~~ll~~l~~~ 302 (327)
T 2yfx_A 276 RIMTQCWQHQPEDRPN----FAIILERIEYC 302 (327)
T ss_dssp HHHHHHTCSSGGGSCC----HHHHHHHHHHH
T ss_pred HHHHHHhcCChhhCcC----HHHHHHHHHHH
Confidence 9999999999999999 99999998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=362.06 Aligned_cols=254 Identities=22% Similarity=0.335 Sum_probs=216.5
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
.+..++|++++.||+|+||.||+|++. +++.||+|++....... ..+.+|+++++.++||||+++++++.+++.+
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 455689999999999999999999987 67789999998654322 4577899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999999999875 356999999999999999999999999999999999999999999999999998543210
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.. .......||
T Consensus 158 ~~---------------------------------------------------------------------~~~~~~~~~ 168 (267)
T 3t9t_A 158 QY---------------------------------------------------------------------TSSTGTKFP 168 (267)
T ss_dssp HH---------------------------------------------------------------------HSTTSTTCC
T ss_pred cc---------------------------------------------------------------------ccccccccc
Confidence 00 000123578
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 408 (491)
..|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+... ........++..+.+||.+||..||+
T Consensus 169 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~l~~~p~ 247 (267)
T 3t9t_A 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHCWRERPE 247 (267)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred ccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC-CcCCCCccCcHHHHHHHHHHccCChh
Confidence 89999999999999999999999999999999 99999988777766666554 22333346899999999999999999
Q ss_pred CCCCcCCChHHhhcC
Q 035713 409 KRIAYKRGATEIKQH 423 (491)
Q Consensus 409 ~R~t~~~~~~ell~h 423 (491)
+||+ +.+++++
T Consensus 248 ~Rps----~~~ll~~ 258 (267)
T 3t9t_A 248 DRPA----FSRLLRQ 258 (267)
T ss_dssp GSCC----HHHHHHH
T ss_pred hCcC----HHHHHHH
Confidence 9999 8888864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=371.75 Aligned_cols=260 Identities=22% Similarity=0.289 Sum_probs=213.6
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCCC----cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEE
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTN----TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE 164 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 164 (491)
.++..++|++.+.||+|+||+||+|++..++ ..||||+++... .......+.+|+++++.++||||+++++++.
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3566789999999999999999999987654 359999997542 3344557889999999999999999999999
Q ss_pred eCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 165 TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 165 ~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
..+.+||||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 999999999999999999998864 3569999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
......... ....
T Consensus 196 ~~~~~~~~~-------------------------------------------------------------------~~~~ 208 (333)
T 1mqb_A 196 VLEDDPEAT-------------------------------------------------------------------YTTS 208 (333)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred hhccccccc-------------------------------------------------------------------cccC
Confidence 542211000 0001
Q ss_pred ccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhh
Q 035713 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLL 403 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L 403 (491)
...+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+... ...+....++..+.+||.+||
T Consensus 209 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l 287 (333)
T 1mqb_A 209 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPTPMDCPSAIYQLMMQCW 287 (333)
T ss_dssp --CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTCBHHHHHHHHHHT
T ss_pred CCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC-CcCCCcccCCHHHHHHHHHHc
Confidence 1256889999999999999999999999999999999 99999988776666555443 344445578999999999999
Q ss_pred ccCCCCCCCcCCChHHhhcC
Q 035713 404 VKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 404 ~~dP~~R~t~~~~~~ell~h 423 (491)
+.||.+||+ +.+++++
T Consensus 288 ~~~p~~Rps----~~~l~~~ 303 (333)
T 1mqb_A 288 QQERARRPK----FADIVSI 303 (333)
T ss_dssp CSSTTTSCC----HHHHHHH
T ss_pred CCChhhCcC----HHHHHHH
Confidence 999999999 8888765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=373.83 Aligned_cols=256 Identities=20% Similarity=0.276 Sum_probs=208.5
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEE----EEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYF----AMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~v----aiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
+..++|+++++||+|+||+||+|++..+++.| |+|.+... ........+.+|+.+|+.++||||+++++++..+
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 34588999999999999999999999888776 55555332 1223455678899999999999999999999876
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
. .++||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred C-ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 5 78999999999999998875 356999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
...... ......
T Consensus 168 ~~~~~~--------------------------------------------------------------------~~~~~~ 179 (327)
T 3lzb_A 168 GAEEKE--------------------------------------------------------------------YHAEGG 179 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCcccc--------------------------------------------------------------------ccccCC
Confidence 211100 001123
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhcc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~ 405 (491)
.||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+ ......+....++.++.+||.+||+.
T Consensus 180 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~ 258 (327)
T 3lzb_A 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVYMIMRKCWMI 258 (327)
T ss_dssp CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCCCCCCTTBCHHHHHHHHHHTCS
T ss_pred CccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCCccCCHHHHHHHHHHcCC
Confidence 57889999999999999999999999999999999 99999987766554444 34444555567999999999999999
Q ss_pred CCCCCCCcCCChHHhhcC
Q 035713 406 EPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~h 423 (491)
||.+||+ +.++++.
T Consensus 259 dp~~Rps----~~ell~~ 272 (327)
T 3lzb_A 259 DADSRPK----FRELIIE 272 (327)
T ss_dssp SGGGSCC----HHHHHHH
T ss_pred ChhHCcC----HHHHHHH
Confidence 9999999 8888874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=363.91 Aligned_cols=259 Identities=22% Similarity=0.311 Sum_probs=216.2
Q ss_pred CccCCCceEee-eeeccCceEEEEEEEe--CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 90 PIGLSNFRLLK-RLGYGDIGSVYLVELR--GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 90 ~~~~~~y~~~~-~iG~G~~g~V~~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
.+..++|.+++ .||+|+||.||+|.+. .++..||||+++... .......+.+|+++|+.++||||+++++++ ..
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 45567899988 9999999999999864 467889999997642 344566788999999999999999999999 45
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
+.+|+||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 5689999999999999998754 356999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
....... ......
T Consensus 161 ~~~~~~~-------------------------------------------------------------------~~~~~~ 173 (287)
T 1u59_A 161 GADDSYY-------------------------------------------------------------------TARSAG 173 (287)
T ss_dssp TTCSCEE-------------------------------------------------------------------CCCCSS
T ss_pred ccCccee-------------------------------------------------------------------eccccc
Confidence 3211100 001122
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhcc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~ 405 (491)
.||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+.... ..+....+++++.+||.+||..
T Consensus 174 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~~l~~ 252 (287)
T 1u59_A 174 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPECPPELYALMSDCWIY 252 (287)
T ss_dssp CCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCS
T ss_pred cccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC-cCCCCCCcCHHHHHHHHHHcCC
Confidence 57899999999998889999999999999999998 999999887777666655432 2233356899999999999999
Q ss_pred CCCCCCCcCCChHHhhcCC
Q 035713 406 EPHKRIAYKRGATEIKQHP 424 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~hp 424 (491)
||.+||+ +.++++|.
T Consensus 253 ~p~~Rps----~~~l~~~l 267 (287)
T 1u59_A 253 KWEDRPD----FLTVEQRM 267 (287)
T ss_dssp SGGGSCC----HHHHHHHH
T ss_pred ChhhCcC----HHHHHHHH
Confidence 9999999 99999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=369.52 Aligned_cols=259 Identities=22% Similarity=0.318 Sum_probs=210.7
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeC-CCc--EEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCce
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRG-TNT--YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKF 168 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~-~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~ 168 (491)
..++|++++.||+|+||+||+|++.. +++ .||||+++............+.+|+++++.++||||+++++++..+.
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 45789999999999999999999754 333 69999997765555566778889999999999999999999998765
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
.++||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 78999999999999988764 24599999999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
..... .......+
T Consensus 174 ~~~~~-------------------------------------------------------------------~~~~~~~~ 186 (291)
T 1u46_A 174 NDDHY-------------------------------------------------------------------VMQEHRKV 186 (291)
T ss_dssp -CCEE-------------------------------------------------------------------EC-----C
T ss_pred cccch-------------------------------------------------------------------hhhccCCC
Confidence 11000 00112367
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCC
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP 407 (491)
|..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+....+..+......++....++.++.+||.+||..||
T Consensus 187 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 266 (291)
T 1u46_A 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKP 266 (291)
T ss_dssp CGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCc
Confidence 889999999999889999999999999999999 9999999888888888877766666667899999999999999999
Q ss_pred CCCCCcCCChHHhhcC
Q 035713 408 HKRIAYKRGATEIKQH 423 (491)
Q Consensus 408 ~~R~t~~~~~~ell~h 423 (491)
.+||+ +.+++++
T Consensus 267 ~~Rps----~~~l~~~ 278 (291)
T 1u46_A 267 EDRPT----FVALRDF 278 (291)
T ss_dssp GGSCC----HHHHHHH
T ss_pred ccCcC----HHHHHHH
Confidence 99999 8898873
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=392.24 Aligned_cols=256 Identities=20% Similarity=0.294 Sum_probs=216.1
Q ss_pred CCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 87 RGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 87 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
..+.+..++|++.++||+|+||+||+|++. ++..||||+++.... ....+.+|+++|+.++||||+++++++. .
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-K 254 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence 345677789999999999999999999987 467899999976432 2456789999999999999999999986 5
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
+.+||||||+.+|+|.++++......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 67899999999999999998543346899999999999999999999999999999999999999999999999998653
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
..... ......
T Consensus 335 ~~~~~---------------------------------------------------------------------~~~~~~ 345 (454)
T 1qcf_A 335 EDNEY---------------------------------------------------------------------TAREGA 345 (454)
T ss_dssp CCHHH---------------------------------------------------------------------HTTCSS
T ss_pred CCCce---------------------------------------------------------------------eccCCC
Confidence 21000 000112
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhcc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~ 405 (491)
.+|..|+|||++.+..++.++|||||||+||||++ |+.||.+.+..+.+..+... ...+....+++++.+||.+||..
T Consensus 346 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~ 424 (454)
T 1qcf_A 346 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPRPENCPEELYNIMMRCWKN 424 (454)
T ss_dssp SSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-CCCCCCTTSCHHHHHHHHHHTCS
T ss_pred cccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHccC
Confidence 46789999999999999999999999999999999 99999988877766665543 45555567999999999999999
Q ss_pred CCCCCCCcCCChHHhhc
Q 035713 406 EPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~ 422 (491)
||++||+ +++|++
T Consensus 425 dp~~RPt----~~~i~~ 437 (454)
T 1qcf_A 425 RPEERPT----FEYIQS 437 (454)
T ss_dssp SGGGSCC----HHHHHH
T ss_pred ChhHCcC----HHHHHH
Confidence 9999999 777764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=375.72 Aligned_cols=251 Identities=22% Similarity=0.294 Sum_probs=200.2
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC----
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD---- 166 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~---- 166 (491)
+..++|+++++||+|+||+||+|++. ++.||||++.... .......+|+.+|+.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 45678999999999999999999876 7899999996542 2233445689999999999999999999874
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc----------CcccccCCCCCEEEccCCcEE
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML----------GIVYRDLKPENVLVRDEGHIM 236 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----------givHrDikp~NILl~~~g~vk 236 (491)
..+|+||||+++|+|.++++.. .+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+|
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred ceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 3589999999999999999874 499999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCcccc
Q 035713 237 LSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMA 316 (491)
Q Consensus 237 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (491)
|+|||+++........
T Consensus 172 L~DFg~a~~~~~~~~~---------------------------------------------------------------- 187 (322)
T 3soc_A 172 IADFGLALKFEAGKSA---------------------------------------------------------------- 187 (322)
T ss_dssp ECCCTTCEEECTTSCC----------------------------------------------------------------
T ss_pred EccCCcccccccccCc----------------------------------------------------------------
Confidence 9999998654321100
Q ss_pred CCCCccccccccccCccCcchhcCC-----CCCCcccccchhhHHHhhhcCCCCCCCCCc---------------HHHHH
Q 035713 317 EPTNVRSMSFVGTHEYLAPEIIRGE-----GHGSAVDWWTFGIFLYELLHGTTPFKGQGN---------------RATLF 376 (491)
Q Consensus 317 ~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~DiwSlG~il~elltg~~Pf~~~~~---------------~~~~~ 376 (491)
......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... ...+.
T Consensus 188 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (322)
T 3soc_A 188 ----GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQ 263 (322)
T ss_dssp ----CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHH
T ss_pred ----cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhh
Confidence 011124799999999999873 456789999999999999999999976432 12222
Q ss_pred HHHcCCCcCCCC------CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 377 NVVGQPLRFPET------PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 377 ~i~~~~~~~~~~------~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
..+......+.. ...+.++.+||.+||+.||++||+ +.+|++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ell~ 311 (322)
T 3soc_A 264 EVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS----AGCVGE 311 (322)
T ss_dssp HHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred hhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcC----HHHHHH
Confidence 222222222211 123356999999999999999999 888875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=365.93 Aligned_cols=257 Identities=24% Similarity=0.380 Sum_probs=203.8
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
..++..++|++.++||+|+||+||+|++.. .||||+++... ........+.+|+++|+.++||||+++++++ ...
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 345667899999999999999999998653 49999997553 3345567788999999999999999999965 556
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+++||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred ccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 689999999999999998754 3569999999999999999999999999999999999999999999999999985432
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
.... ........
T Consensus 172 ~~~~--------------------------------------------------------------------~~~~~~~~ 183 (289)
T 3og7_A 172 RWSG--------------------------------------------------------------------SHQFEQLS 183 (289)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccc--------------------------------------------------------------------cccccccC
Confidence 1000 00112347
Q ss_pred cccCccCcchhc---CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC----CCCCCHHHHHHHH
Q 035713 328 GTHEYLAPEIIR---GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE----TPQVSFVARDLIR 400 (491)
Q Consensus 328 gt~~y~aPE~l~---~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~s~~~~~li~ 400 (491)
||+.|+|||++. +..++.++|||||||++|+|++|+.||.+......+...+......+. ...+++++.+||.
T Consensus 184 gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 263 (289)
T 3og7_A 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMA 263 (289)
T ss_dssp CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHH
T ss_pred CCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHH
Confidence 999999999997 566788999999999999999999999987777666655533222111 2368899999999
Q ss_pred hhhccCCCCCCCcCCChHHhhc
Q 035713 401 GLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 401 ~~L~~dP~~R~t~~~~~~ell~ 422 (491)
+||+.||.+||+ +.++++
T Consensus 264 ~~l~~~p~~Rps----~~ell~ 281 (289)
T 3og7_A 264 ECLKKKRDERPS----FPRILA 281 (289)
T ss_dssp HHTCSSGGGSCC----HHHHHH
T ss_pred HHccCChhhCCC----HHHHHH
Confidence 999999999999 888875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=374.61 Aligned_cols=258 Identities=22% Similarity=0.342 Sum_probs=213.6
Q ss_pred ccCCCceEeeeeeccCceEEEEEE----EeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEE--
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVE----LRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE-- 164 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~-- 164 (491)
+..++|++++.||+|+||.||+|+ +..+++.||||++.... ......+.+|+++|+.++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 445789999999999999999999 46789999999997643 344566889999999999999999999886
Q ss_pred eCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 165 TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 165 ~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
....+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 4567999999999999999987642 359999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
......... ....
T Consensus 176 ~~~~~~~~~-------------------------------------------------------------------~~~~ 188 (327)
T 3lxl_A 176 LLPLDKDYY-------------------------------------------------------------------VVRE 188 (327)
T ss_dssp ECCTTCSEE-------------------------------------------------------------------ECSS
T ss_pred ecccCCccc-------------------------------------------------------------------eeec
Confidence 543211100 0111
Q ss_pred ccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcH--------------HHHHHHHcCCCcCCCCCC
Q 035713 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR--------------ATLFNVVGQPLRFPETPQ 390 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------------~~~~~i~~~~~~~~~~~~ 390 (491)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..+...+......+....
T Consensus 189 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (327)
T 3lxl_A 189 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPA 268 (327)
T ss_dssp CCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTT
T ss_pred cCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCc
Confidence 236889999999999999999999999999999999999999654321 223334444445555567
Q ss_pred CCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 391 VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 391 ~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
+++++.+||.+||+.||.+||+ +.+++++
T Consensus 269 ~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 297 (327)
T 3lxl_A 269 CPAEVHELMKLCWAPSPQDRPS----FSALGPQ 297 (327)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 9999999999999999999999 8888544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=364.54 Aligned_cols=267 Identities=17% Similarity=0.257 Sum_probs=209.4
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeE-EeCceEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYF-ETDKFYCLV 172 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~-~~~~~~~lV 172 (491)
++|++++.||+|+||+||+|++..+++.||||++...... ..+.+|+++++.++|++++..+..+ ...+..|+|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 6899999999999999999999999999999987654322 2466799999999988776666554 677889999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEE---ccCCcEEEeecccccccCCC
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLV---RDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl---~~~g~vkL~DFGla~~~~~~ 249 (491)
|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.....
T Consensus 84 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 9999 99999998864 3469999999999999999999999999999999999999 78999999999998654321
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
...... .........||
T Consensus 162 ~~~~~~---------------------------------------------------------------~~~~~~~~~gt 178 (296)
T 4hgt_A 162 RTHQHI---------------------------------------------------------------PYRENKNLTGT 178 (296)
T ss_dssp TTCCBC---------------------------------------------------------------CCCCSCCCCSC
T ss_pred ccCccC---------------------------------------------------------------CCCcccccCCC
Confidence 110000 00111235799
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcH---HHHHHHHcCCCcCCC---CCCCCHHHHHHHHhhh
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR---ATLFNVVGQPLRFPE---TPQVSFVARDLIRGLL 403 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~i~~~~~~~~~---~~~~s~~~~~li~~~L 403 (491)
+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... ..+..+.......+. ...+++++.+||.+||
T Consensus 179 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 258 (296)
T 4hgt_A 179 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCR 258 (296)
T ss_dssp GGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHH
T ss_pred ccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999874332 233333332222221 1357899999999999
Q ss_pred ccCCCCCCCcCCChHHhhc----------CCCcCCCChhhh
Q 035713 404 VKEPHKRIAYKRGATEIKQ----------HPFFEGVNWALV 434 (491)
Q Consensus 404 ~~dP~~R~t~~~~~~ell~----------hpff~~~~~~~~ 434 (491)
+.||++||+ ++++++ ..|...++|+.+
T Consensus 259 ~~~p~~Rpt----~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 259 SLRFDDKPD----YSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp TSCTTCCCC----HHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred hcCCCCCCC----HHHHHHHHHHHHHHhCCCccCccchhhc
Confidence 999999999 777665 355566677654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=363.82 Aligned_cols=259 Identities=20% Similarity=0.270 Sum_probs=212.2
Q ss_pred CCCccCCCceEee-eeeccCceEEEEEEE--eCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEE
Q 035713 88 GPPIGLSNFRLLK-RLGYGDIGSVYLVEL--RGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE 164 (491)
Q Consensus 88 ~~~~~~~~y~~~~-~iG~G~~g~V~~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 164 (491)
...+...+|++.+ .||+|+||+||+|.+ ..+++.||||+++... ........+.+|+++++.++||||+++++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 3345668899999 999999999999955 5667899999997653 2334466788999999999999999999999
Q ss_pred eCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 165 TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 165 ~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
..+.+|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 566789999999999999999874 559999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
.......... ...
T Consensus 166 ~~~~~~~~~~-------------------------------------------------------------------~~~ 178 (291)
T 1xbb_A 166 ALRADENYYK-------------------------------------------------------------------AQT 178 (291)
T ss_dssp ECCTTCSEEE-------------------------------------------------------------------C--
T ss_pred eeccCCCccc-------------------------------------------------------------------ccc
Confidence 5432111000 001
Q ss_pred ccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhh
Q 035713 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLL 403 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L 403 (491)
...||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+.... ..+....++.++.+||.+||
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l 257 (291)
T 1xbb_A 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGCPAGCPREMYDLMNLCW 257 (291)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHT
T ss_pred cCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHc
Confidence 1256789999999999889999999999999999999 999999887766555554432 23333568999999999999
Q ss_pred ccCCCCCCCcCCChHHhhc
Q 035713 404 VKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 404 ~~dP~~R~t~~~~~~ell~ 422 (491)
+.||.+||+ +.++++
T Consensus 258 ~~dp~~Rps----~~~l~~ 272 (291)
T 1xbb_A 258 TYDVENRPG----FAAVEL 272 (291)
T ss_dssp CSSTTTSCC----HHHHHH
T ss_pred CCChhhCcC----HHHHHH
Confidence 999999999 888775
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=375.90 Aligned_cols=260 Identities=21% Similarity=0.236 Sum_probs=209.8
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
......++|++.+.||+|+||.||+|++. +++.||||++.... ......+.+|+++|+.++||||+++++++...+
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34456689999999999999999999965 68899999887543 234556789999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQP--NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
.+|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999999999886543 23599999999999999999999999999999999999999999999999999854
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
...... ......
T Consensus 189 ~~~~~~--------------------------------------------------------------------~~~~~~ 200 (321)
T 2qkw_B 189 GTELDQ--------------------------------------------------------------------THLSTV 200 (321)
T ss_dssp CSSSSC--------------------------------------------------------------------CCCBCC
T ss_pred cccccc--------------------------------------------------------------------cccccc
Confidence 321000 001123
Q ss_pred cccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHH------HH-HHcCCC--------cCCCCCC
Q 035713 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATL------FN-VVGQPL--------RFPETPQ 390 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~------~~-i~~~~~--------~~~~~~~ 390 (491)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.+....... .. .....+ .......
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (321)
T 2qkw_B 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE 280 (321)
T ss_dssp CEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHH
T ss_pred cCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHH
Confidence 47999999999999999999999999999999999999999765432111 11 111111 1111123
Q ss_pred CCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 391 VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 391 ~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
++..+.+||.+||+.||++||+ +.++++|
T Consensus 281 ~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 309 (321)
T 2qkw_B 281 SLRKFGDTAVKCLALSSEDRPS----MGDVLWK 309 (321)
T ss_dssp HHHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHHHHcCCCcccCcC----HHHHHHH
Confidence 4567899999999999999999 9999876
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=366.93 Aligned_cols=264 Identities=21% Similarity=0.266 Sum_probs=211.4
Q ss_pred cCCCCccCCCceEeeeeeccCceEEEEEEEeC---CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeee
Q 035713 86 LRGPPIGLSNFRLLKRLGYGDIGSVYLVELRG---TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSY 162 (491)
Q Consensus 86 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 162 (491)
+....+..++|++.+.||+|+||.||+|++.. +++.||||++..... .......+.+|+++|+.++||||++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 34555677899999999999999999999875 456899999875532 34455678899999999999999999999
Q ss_pred EEeCc-----eEEEEEeccCCCchHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC
Q 035713 163 FETDK-----FYCLVMEFCSGGNLHSLRQKQ----PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG 233 (491)
Q Consensus 163 ~~~~~-----~~~lV~E~~~gg~L~~~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g 233 (491)
+.... ..|+||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence 97654 459999999999999988532 235699999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCc
Q 035713 234 HIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPE 313 (491)
Q Consensus 234 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (491)
.+||+|||+++........
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~------------------------------------------------------------- 203 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYY------------------------------------------------------------- 203 (313)
T ss_dssp CEEECSCSCC----------------------------------------------------------------------
T ss_pred cEEEeecCcceeccccccc-------------------------------------------------------------
Confidence 9999999998543211000
Q ss_pred cccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCC
Q 035713 314 LMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVS 392 (491)
Q Consensus 314 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 392 (491)
.......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+.... ..+....++
T Consensus 204 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 275 (313)
T 3brb_A 204 -------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-RLKQPEDCL 275 (313)
T ss_dssp --------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCCBTTCC
T ss_pred -------CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-CCCCCcccc
Confidence 00112357889999999999999999999999999999999 999999887777666665543 233335689
Q ss_pred HHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 393 FVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 393 ~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
.++.+||.+||..||.+||+ +.+++++
T Consensus 276 ~~l~~li~~~l~~dp~~Rps----~~~l~~~ 302 (313)
T 3brb_A 276 DELYEIMYSCWRTDPLDRPT----FSVLRLQ 302 (313)
T ss_dssp HHHHHHHHHTTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 99999999999999999999 8888875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=398.05 Aligned_cols=257 Identities=22% Similarity=0.304 Sum_probs=210.7
Q ss_pred CCccCCCceEee-eeeccCceEEEEEEEeC--CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 035713 89 PPIGLSNFRLLK-RLGYGDIGSVYLVELRG--TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET 165 (491)
Q Consensus 89 ~~~~~~~y~~~~-~iG~G~~g~V~~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 165 (491)
..+..+++.+.+ +||+|+||.||+|.++. ++..||||+++... .......+.+|+++|+.++|||||++++++..
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence 345567788877 89999999999998863 56679999997652 22345678899999999999999999999976
Q ss_pred CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
+.+||||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred -CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 5689999999999999998764 35699999999999999999999999999999999999999999999999999965
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
........ .....
T Consensus 486 ~~~~~~~~-------------------------------------------------------------------~~~~~ 498 (613)
T 2ozo_A 486 LGADDSYY-------------------------------------------------------------------TARSA 498 (613)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred ccCCCcee-------------------------------------------------------------------eeccC
Confidence 42111000 00011
Q ss_pred cccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhc
Q 035713 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLV 404 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~ 404 (491)
..+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+.+..+.+..+..+ ...+....+++++.+||.+||.
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~ 577 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPPECPPELYALMSDCWI 577 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHTTC
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHHHcC
Confidence 246789999999999999999999999999999998 99999998887777666544 3334445699999999999999
Q ss_pred cCCCCCCCcCCChHHhh
Q 035713 405 KEPHKRIAYKRGATEIK 421 (491)
Q Consensus 405 ~dP~~R~t~~~~~~ell 421 (491)
.||++||+ +.+|+
T Consensus 578 ~dP~~RPs----~~~l~ 590 (613)
T 2ozo_A 578 YKWEDRPD----FLTVE 590 (613)
T ss_dssp SSTTTSCC----HHHHH
T ss_pred CChhHCcC----HHHHH
Confidence 99999999 67664
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=380.16 Aligned_cols=261 Identities=16% Similarity=0.226 Sum_probs=201.7
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCC-----CcEEEEEEeecchhhhHHHH--------HHHHHHHHHHhhcCCCCccc
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGT-----NTYFAMKVMDKASLASRNKL--------LRAQTEREILGLLDHPFLPT 158 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~-----~~~vaiK~i~~~~~~~~~~~--------~~~~~E~~il~~l~hp~iv~ 158 (491)
..++|++++.||+|+||+||+|++..+ ++.||||++........... ..+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 346899999999999999999999765 57899999876532111111 12335666778889999999
Q ss_pred eeeeEEeC----ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEc--cC
Q 035713 159 LYSYFETD----KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVR--DE 232 (491)
Q Consensus 159 l~~~~~~~----~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~--~~ 232 (491)
+++++... ..+||||||+ |++|.+++... .+.+++..++.++.||+.||.|||++||+||||||+||||+ .+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 99998764 5689999999 99999999875 35699999999999999999999999999999999999999 88
Q ss_pred CcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCC
Q 035713 233 GHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALP 312 (491)
Q Consensus 233 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (491)
+.+||+|||+++.+........
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~---------------------------------------------------------- 212 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKA---------------------------------------------------------- 212 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCC----------------------------------------------------------
T ss_pred CeEEEEECCcceecccCCcccc----------------------------------------------------------
Confidence 9999999999966432110000
Q ss_pred ccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC----CC-----
Q 035713 313 ELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ----PL----- 383 (491)
Q Consensus 313 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~----~~----- 383 (491)
.........+||+.|+|||++.+..++.++|||||||+||||++|+.||.+............. .+
T Consensus 213 -----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (364)
T 3op5_A 213 -----YAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMD 287 (364)
T ss_dssp -----SSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHH
T ss_pred -----cccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHH
Confidence 0001112357999999999999999999999999999999999999999864333222211110 00
Q ss_pred -cCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 384 -RFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 384 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
.++ ...++.++.+||..||+.||.+||+ +.+|++
T Consensus 288 ~~~~-~~~~~~~~~~li~~cl~~~p~~RP~----~~~l~~ 322 (364)
T 3op5_A 288 KCFP-AANAPGEIAKYMETVKLLDYTEKPL----YENLRD 322 (364)
T ss_dssp HHSC-TTCCCHHHHHHHHHHHTCCTTCCCC----HHHHHH
T ss_pred Hhcc-cccCHHHHHHHHHHHhcCCCCCCCC----HHHHHH
Confidence 011 1357999999999999999999999 666654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=388.27 Aligned_cols=261 Identities=25% Similarity=0.362 Sum_probs=201.6
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~~ 170 (491)
...+|++.+.||+|+||+||. ....+++.||||++.+.... .+.+|+++|+.+ +|||||++++++.+.+.+|
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 94 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQY 94 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred ccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence 345799999999999999774 44567899999999764322 235799999999 7999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc-----CCcEEEeecccccc
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD-----EGHIMLSDFDLSLR 245 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~-----~g~vkL~DFGla~~ 245 (491)
|||||+. |+|.+++.... ..+.+..++.++.||+.||.|||++||+||||||+||||+. ...+||+|||+++.
T Consensus 95 lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 95 IAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 9999995 69999988653 34666677899999999999999999999999999999953 23588999999865
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
...... .......
T Consensus 173 ~~~~~~-------------------------------------------------------------------~~~~~~~ 185 (432)
T 3p23_A 173 LAVGRH-------------------------------------------------------------------SFSRRSG 185 (432)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred ccCCCc-------------------------------------------------------------------ceeeccc
Confidence 421110 0011223
Q ss_pred cccccCccCcchhcC---CCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCC-CCCCCCHHHHHHHH
Q 035713 326 FVGTHEYLAPEIIRG---EGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFP-ETPQVSFVARDLIR 400 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~---~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~s~~~~~li~ 400 (491)
.+||+.|+|||++.+ ..++.++|||||||++|||++ |..||...........+........ .....+..+.+||.
T Consensus 186 ~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 265 (432)
T 3p23_A 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIE 265 (432)
T ss_dssp CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHH
T ss_pred cCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHH
Confidence 579999999999984 556889999999999999999 9999976544433222211111111 11234566899999
Q ss_pred hhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 401 GLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 401 ~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
+||+.||.+||+ +++|++||||..++|.
T Consensus 266 ~~L~~dP~~Rps----~~evl~hp~f~~~~~~ 293 (432)
T 3p23_A 266 KMIAMDPQKRPS----AKHVLKHPFFWSLEKQ 293 (432)
T ss_dssp HHSCSSGGGSCC----HHHHHTSTTTCCHHHH
T ss_pred HHHhCCHhhCCC----HHHHHhCccccChHHH
Confidence 999999999999 9999999999998884
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=362.42 Aligned_cols=255 Identities=18% Similarity=0.218 Sum_probs=208.3
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCc---EEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE-E
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNT---YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY-C 170 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~-~ 170 (491)
.|++.++||+|+||+||+|++..+++ .||+|++... ........+.+|+++|+.++||||+++++++.+.+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 57778999999999999999876554 7999998753 3345567788999999999999999999999876554 9
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
+||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999998764 3569999999999999999999999999999999999999999999999999986432111
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
.. .........||+
T Consensus 179 ~~------------------------------------------------------------------~~~~~~~~~~~~ 192 (298)
T 3pls_A 179 YY------------------------------------------------------------------SVQQHRHARLPV 192 (298)
T ss_dssp GG------------------------------------------------------------------CSCCSSCTTCGG
T ss_pred cc------------------------------------------------------------------ccccCcCCCCCc
Confidence 00 000111246899
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcC-CCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHG-TTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHK 409 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 409 (491)
.|+|||++.+..++.++|||||||++|+|++| .+||...+.......+ ......+....++..+.+||.+||+.||.+
T Consensus 193 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 271 (298)
T 3pls_A 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-AQGRRLPQPEYCPDSLYQVMQQCWEADPAV 271 (298)
T ss_dssp GGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred cccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh-hcCCCCCCCccchHHHHHHHHHHccCChhh
Confidence 99999999999999999999999999999995 5555555554444444 333444455578999999999999999999
Q ss_pred CCCcCCChHHhhcC
Q 035713 410 RIAYKRGATEIKQH 423 (491)
Q Consensus 410 R~t~~~~~~ell~h 423 (491)
||+ +.++++.
T Consensus 272 Rps----~~~ll~~ 281 (298)
T 3pls_A 272 RPT----FRVLVGE 281 (298)
T ss_dssp SCC----HHHHHHH
T ss_pred CcC----HHHHHHH
Confidence 999 8888763
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=360.81 Aligned_cols=256 Identities=23% Similarity=0.291 Sum_probs=211.8
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCC---CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGT---NTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
.+..++|++.+.||+|+||+||+|++... +..||+|++.+.. .......+.+|+++|+.++||||+++++++.++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 45568999999999999999999997643 4469999987652 234456788999999999999999999998755
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
..|+||||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred -CCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 468999999999999998764 345999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
..... ......
T Consensus 164 ~~~~~---------------------------------------------------------------------~~~~~~ 174 (281)
T 3cc6_A 164 EDEDY---------------------------------------------------------------------YKASVT 174 (281)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred ccccc---------------------------------------------------------------------cccccC
Confidence 21100 001123
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhcc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~ 405 (491)
.+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+... ...+....+++.+.+||.+||..
T Consensus 175 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~ 253 (281)
T 3cc6_A 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-DRLPKPDLCPPVLYTLMTRCWDY 253 (281)
T ss_dssp CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHccC
Confidence 57889999999999999999999999999999998 99999877666655554433 23333456899999999999999
Q ss_pred CCCCCCCcCCChHHhhcC
Q 035713 406 EPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~h 423 (491)
||++||+ +.+++++
T Consensus 254 ~p~~Rps----~~ell~~ 267 (281)
T 3cc6_A 254 DPSDRPR----FTELVCS 267 (281)
T ss_dssp SGGGSCC----HHHHHHH
T ss_pred CchhCcC----HHHHHHH
Confidence 9999999 8898875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=361.11 Aligned_cols=255 Identities=21% Similarity=0.296 Sum_probs=213.1
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
++.+..++|++++.||+|+||.||+|++. ++..||||++...... ...+.+|+++|+.++||||+++++++.. +
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 34566689999999999999999999976 5678999999765322 3457789999999999999999999874 4
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
..|+||||+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 58899999999999999875433369999999999999999999999999999999999999999999999999986542
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
..... ......
T Consensus 161 ~~~~~---------------------------------------------------------------------~~~~~~ 171 (279)
T 1qpc_A 161 DNEYT---------------------------------------------------------------------AREGAK 171 (279)
T ss_dssp SSCEE---------------------------------------------------------------------CCTTCC
T ss_pred Ccccc---------------------------------------------------------------------cccCCC
Confidence 11100 001225
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
+|..|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+... ........++.++.+||.+||..|
T Consensus 172 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~ 250 (279)
T 1qpc_A 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRPDNCPEELYQLMRLCWKER 250 (279)
T ss_dssp CCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-cCCCCcccccHHHHHHHHHHhccC
Confidence 7889999999998889999999999999999999 99999988777666555443 333444578999999999999999
Q ss_pred CCCCCCcCCChHHhhc
Q 035713 407 PHKRIAYKRGATEIKQ 422 (491)
Q Consensus 407 P~~R~t~~~~~~ell~ 422 (491)
|++||+ ++++++
T Consensus 251 p~~Rps----~~~l~~ 262 (279)
T 1qpc_A 251 PEDRPT----FDYLRS 262 (279)
T ss_dssp GGGSCC----HHHHHH
T ss_pred hhhCCC----HHHHHH
Confidence 999999 888775
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=363.29 Aligned_cols=245 Identities=23% Similarity=0.376 Sum_probs=208.1
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe--------
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET-------- 165 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~-------- 165 (491)
.+|++++.||+|+||.||+|++..+++.||||++.... ..+.+|+++++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 57999999999999999999999999999999997643 134579999999999999999999864
Q ss_pred --------CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEE
Q 035713 166 --------DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIML 237 (491)
Q Consensus 166 --------~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL 237 (491)
...+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 456899999999999999998765567999999999999999999999999999999999999999999999
Q ss_pred eecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccC
Q 035713 238 SDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAE 317 (491)
Q Consensus 238 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (491)
+|||++.......
T Consensus 164 ~Dfg~~~~~~~~~------------------------------------------------------------------- 176 (284)
T 2a19_B 164 GDFGLVTSLKNDG------------------------------------------------------------------- 176 (284)
T ss_dssp CCCTTCEESSCCS-------------------------------------------------------------------
T ss_pred Ccchhheeccccc-------------------------------------------------------------------
Confidence 9999985532110
Q ss_pred CCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHH
Q 035713 318 PTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARD 397 (491)
Q Consensus 318 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~ 397 (491)
......||+.|+|||++.+..++.++|||||||++|+|++|..||... ......+.... ++ ..++..+.+
T Consensus 177 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~~--~~--~~~~~~~~~ 246 (284)
T 2a19_B 177 ----KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDGI--IS--DIFDKKEKT 246 (284)
T ss_dssp ----CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTTC--CC--TTSCHHHHH
T ss_pred ----cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhccc--cc--ccCCHHHHH
Confidence 011236899999999999999999999999999999999999988532 12222332222 22 358899999
Q ss_pred HHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 398 LIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 398 li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
||.+||..||.+||+ +.++++|.+.
T Consensus 247 li~~~l~~dp~~Rps----~~e~l~~l~~ 271 (284)
T 2a19_B 247 LLQKLLSKKPEDRPN----TSEILRTLTV 271 (284)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHHHHHH
T ss_pred HHHHHccCChhhCcC----HHHHHHHHHH
Confidence 999999999999999 9999999765
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=386.25 Aligned_cols=275 Identities=18% Similarity=0.254 Sum_probs=216.5
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCC-CCccceeeeEEeCceEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH-PFLPTLYSYFETDKFYC 170 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~l~~~~~~~~~~~ 170 (491)
..++|+++++||+|+||.||+|++..+++.||||++...... ..+.+|+++++.|+| ++|+.+..++...+..|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 347899999999999999999999999999999998754322 235679999999987 56666667777888999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEE---ccCCcEEEeecccccccC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLV---RDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl---~~~g~vkL~DFGla~~~~ 247 (491)
|||||+ +++|.+++... .+.+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.+.
T Consensus 80 lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 999999 99999999864 3569999999999999999999999999999999999999 688999999999997643
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
....... .........+
T Consensus 158 ~~~~~~~---------------------------------------------------------------~~~~~~~~~~ 174 (483)
T 3sv0_A 158 DTSTHQH---------------------------------------------------------------IPYRENKNLT 174 (483)
T ss_dssp CTTTCCB---------------------------------------------------------------CCCCCCCCCC
T ss_pred CCccccc---------------------------------------------------------------cccccccccC
Confidence 2111000 0001112458
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCc---HHHHHHHHcCCCcCC---CCCCCCHHHHHHHHh
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGN---RATLFNVVGQPLRFP---ETPQVSFVARDLIRG 401 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~~~~~~~~---~~~~~s~~~~~li~~ 401 (491)
||+.|+|||++.+..++.++|||||||+||||++|+.||.+... ...+..+........ ....++.++.+||.+
T Consensus 175 gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~ 254 (483)
T 3sv0_A 175 GTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHY 254 (483)
T ss_dssp SCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHH
T ss_pred CCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHH
Confidence 99999999999999999999999999999999999999987543 233333332221111 113588999999999
Q ss_pred hhccCCCCCCCcCC---ChH---HhhcCCCcCCCChhhhhc
Q 035713 402 LLVKEPHKRIAYKR---GAT---EIKQHPFFEGVNWALVRS 436 (491)
Q Consensus 402 ~L~~dP~~R~t~~~---~~~---ell~hpff~~~~~~~~~~ 436 (491)
||+.||++||++.+ .+. ..+.++|+..++|..++.
T Consensus 255 cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~ 295 (483)
T 3sv0_A 255 CRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKY 295 (483)
T ss_dssp HHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC
T ss_pred HhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhcc
Confidence 99999999999421 011 123489999999998753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=386.37 Aligned_cols=256 Identities=25% Similarity=0.335 Sum_probs=213.2
Q ss_pred CCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 87 RGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 87 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
..+.+..++|++.++||+|+||.||+|++.. +..||||+++..... ...+.+|+++|+.++||||+++++++.+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 3455677899999999999999999999985 467999999765322 2457789999999999999999999876
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
+.+||||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 67899999999999999987543456999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
..... ......
T Consensus 331 ~~~~~---------------------------------------------------------------------~~~~~~ 341 (452)
T 1fmk_A 331 EDNEY---------------------------------------------------------------------TARQGA 341 (452)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CCCce---------------------------------------------------------------------ecccCC
Confidence 21100 000122
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhcc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~ 405 (491)
.+|..|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+.. ....+....++..+.+||.+||+.
T Consensus 342 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~ 420 (452)
T 1fmk_A 342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRK 420 (452)
T ss_dssp -CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred cccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHccC
Confidence 57889999999999999999999999999999999 9999998887776666544 344555567999999999999999
Q ss_pred CCCCCCCcCCChHHhhc
Q 035713 406 EPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~ 422 (491)
||++||+ +++|++
T Consensus 421 dP~~Rpt----~~~l~~ 433 (452)
T 1fmk_A 421 EPEERPT----FEYLQA 433 (452)
T ss_dssp SGGGSCC----HHHHHH
T ss_pred ChhhCcC----HHHHHH
Confidence 9999999 888876
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=384.58 Aligned_cols=255 Identities=23% Similarity=0.394 Sum_probs=207.8
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc--eE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK--FY 169 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~--~~ 169 (491)
..++|++.++||+|+||+||+|++..+|+.||||++...... .....+.+|+++|+.++||||+++++++...+ ..
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 346899999999999999999999999999999999765332 23455678999999999999999999998754 78
Q ss_pred EEEEeccCCCchHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEE----ccCCcEEEeeccccc
Q 035713 170 CLVMEFCSGGNLHSLRQKQPN-KYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLV----RDEGHIMLSDFDLSL 244 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl----~~~g~vkL~DFGla~ 244 (491)
||||||++||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999999876422 339999999999999999999999999999999999999 777889999999986
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
...... ...
T Consensus 165 ~~~~~~-----------------------------------------------------------------------~~~ 173 (396)
T 4eut_A 165 ELEDDE-----------------------------------------------------------------------QFV 173 (396)
T ss_dssp ECCCGG-----------------------------------------------------------------------GSS
T ss_pred EccCCC-----------------------------------------------------------------------ccc
Confidence 532110 111
Q ss_pred ccccccCccCcchhcC--------CCCCCcccccchhhHHHhhhcCCCCCCC----CCcHHHHHHHHcCCCc--------
Q 035713 325 SFVGTHEYLAPEIIRG--------EGHGSAVDWWTFGIFLYELLHGTTPFKG----QGNRATLFNVVGQPLR-------- 384 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~--------~~~~~~~DiwSlG~il~elltg~~Pf~~----~~~~~~~~~i~~~~~~-------- 384 (491)
..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+ ....+.+.+++.+...
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 253 (396)
T 4eut_A 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQK 253 (396)
T ss_dssp CSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEEC
T ss_pred cccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhhee
Confidence 3479999999999975 4578899999999999999999999964 3344556666554321
Q ss_pred -----------CCCC----CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 385 -----------FPET----PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 385 -----------~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
++.. ..++..+.+||.+||+.||++|++ +++++++
T Consensus 254 ~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s----~~e~l~~ 303 (396)
T 4eut_A 254 AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG----FDQFFAE 303 (396)
T ss_dssp STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC----HHHHHHH
T ss_pred ccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhcc----HHHHHHH
Confidence 1111 124457889999999999999999 8887554
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=362.29 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=206.3
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe-C
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET-D 166 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~-~ 166 (491)
.+.+..++|++++.||+|+||.||+|++. |+.||||+++... ....+.+|+++++.++||||+++++++.. .
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34566789999999999999999999875 7899999987542 34567889999999999999999998754 4
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
+.+|+||||+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 57899999999999999988653334899999999999999999999999999999999999999999999999998532
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
... ....
T Consensus 168 ~~~-------------------------------------------------------------------------~~~~ 174 (278)
T 1byg_A 168 SST-------------------------------------------------------------------------QDTG 174 (278)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc-------------------------------------------------------------------------ccCC
Confidence 110 0012
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhcc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~ 405 (491)
.+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+... ........+++.+.+||.+||..
T Consensus 175 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~ 253 (278)
T 1byg_A 175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYEVMKNCWHL 253 (278)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCcccCCHHHHHHHHHHhcC
Confidence 57889999999999999999999999999999998 99999987766655555433 33444457899999999999999
Q ss_pred CCCCCCCcCCChHHhhc
Q 035713 406 EPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~ 422 (491)
||.+||+ +.++++
T Consensus 254 ~p~~Rps----~~~l~~ 266 (278)
T 1byg_A 254 DAAMRPS----FLQLRE 266 (278)
T ss_dssp SGGGSCC----HHHHHH
T ss_pred ChhhCCC----HHHHHH
Confidence 9999999 888775
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=361.55 Aligned_cols=256 Identities=17% Similarity=0.227 Sum_probs=209.5
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCC---CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeE-EeCce
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGT---NTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYF-ETDKF 168 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~-~~~~~ 168 (491)
..+|++.+.||+|+||+||+|++..+ +..||+|++... ........+.+|+.+|+.++||||+++++++ ..++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 45799999999999999999997543 346899998753 3345566788999999999999999999985 55678
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
.|+||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred eEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 89999999999999999764 35689999999999999999999999999999999999999999999999999865421
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
.... .........|
T Consensus 181 ~~~~------------------------------------------------------------------~~~~~~~~~~ 194 (298)
T 3f66_A 181 KEYY------------------------------------------------------------------SVHNKTGAKL 194 (298)
T ss_dssp GGGC------------------------------------------------------------------BC-----CCB
T ss_pred cchh------------------------------------------------------------------ccccccCCCC
Confidence 1100 0001112368
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCC
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP 407 (491)
|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+.......+...... .....++..+.+||.+||+.||
T Consensus 195 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p 273 (298)
T 3f66_A 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-LQPEYCPDPLYEVMLKCWHPKA 273 (298)
T ss_dssp CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSG
T ss_pred CccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHcCCCh
Confidence 899999999999999999999999999999999 77788877766666666554332 2234689999999999999999
Q ss_pred CCCCCcCCChHHhhc
Q 035713 408 HKRIAYKRGATEIKQ 422 (491)
Q Consensus 408 ~~R~t~~~~~~ell~ 422 (491)
.+||+ +.++++
T Consensus 274 ~~Rps----~~ell~ 284 (298)
T 3f66_A 274 EMRPS----FSELVS 284 (298)
T ss_dssp GGSCC----HHHHHH
T ss_pred hhCcC----HHHHHH
Confidence 99999 888876
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=379.92 Aligned_cols=267 Identities=24% Similarity=0.263 Sum_probs=210.3
Q ss_pred cccCCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeE
Q 035713 84 ISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYF 163 (491)
Q Consensus 84 ~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 163 (491)
++..+..+..++|++.+.||+|+||.||+|++. +++.||||++....... ....+.+|+++++.++||||+++++++
T Consensus 20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred ecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEE
Confidence 344444566789999999999999999999865 68899999997653221 222577899999999999999999999
Q ss_pred EeCceEEEEEeccCCCchHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHc---CcccccCCCCCEEEccCCcEEEe
Q 035713 164 ETDKFYCLVMEFCSGGNLHSLRQKQPN--KYFTEDAARFFASEVLLALEYLHML---GIVYRDLKPENVLVRDEGHIMLS 238 (491)
Q Consensus 164 ~~~~~~~lV~E~~~gg~L~~~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~NILl~~~g~vkL~ 238 (491)
.+.+..|+||||+.+|+|.+++..... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 999999999999999999999986532 3499999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCC
Q 035713 239 DFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEP 318 (491)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (491)
|||+++.......
T Consensus 177 Dfg~~~~~~~~~~------------------------------------------------------------------- 189 (326)
T 3uim_A 177 DFGLAKLMDYKDT------------------------------------------------------------------- 189 (326)
T ss_dssp CCSSCEECCSSSS-------------------------------------------------------------------
T ss_pred cCccccccCcccc-------------------------------------------------------------------
Confidence 9999865421110
Q ss_pred CCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCC----CCcHHHHHHHHcCCCc----------
Q 035713 319 TNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKG----QGNRATLFNVVGQPLR---------- 384 (491)
Q Consensus 319 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~----~~~~~~~~~i~~~~~~---------- 384 (491)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.. ......+...+.....
T Consensus 190 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (326)
T 3uim_A 190 --HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDV 267 (326)
T ss_dssp --CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCT
T ss_pred --cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcCh
Confidence 011234699999999999998899999999999999999999999952 1111111222211110
Q ss_pred ---CCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCc
Q 035713 385 ---FPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 385 ---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff 426 (491)
.......+..+.+||.+||+.||.+||+ +.+|++|-.-
T Consensus 268 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ell~~L~~ 308 (326)
T 3uim_A 268 DLQGNYKDEEVEQLIQVALLCTQSSPMERPK----MSEVVRMLEG 308 (326)
T ss_dssp TCTTSCCHHHHHHHHHHHHHHTCSCGGGSCC----HHHHHHHHHT
T ss_pred hhccccCHHHHHHHHHHHHHHhCcCCccCCC----HHHHHHHhcC
Confidence 0111123467999999999999999999 9999988543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=373.04 Aligned_cols=262 Identities=18% Similarity=0.182 Sum_probs=200.1
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeC---CCcEEEEEEeecchhhhHH--------HHHHHHHHHHHHhhcCCCCcccee
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRG---TNTYFAMKVMDKASLASRN--------KLLRAQTEREILGLLDHPFLPTLY 160 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~---~~~~vaiK~i~~~~~~~~~--------~~~~~~~E~~il~~l~hp~iv~l~ 160 (491)
..++|++++.||+|+||.||+|++.. ++..||||++......... ....+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 34789999999999999999999987 7889999998765321111 112356788899999999999999
Q ss_pred eeEEe----CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC--c
Q 035713 161 SYFET----DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG--H 234 (491)
Q Consensus 161 ~~~~~----~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g--~ 234 (491)
+++.. ...+||||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++ .
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTS
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCc
Confidence 99987 78999999999 99999998765 3699999999999999999999999999999999999999887 9
Q ss_pred EEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCcc
Q 035713 235 IMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPEL 314 (491)
Q Consensus 235 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (491)
+||+|||+++.+........
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~------------------------------------------------------------ 211 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQ------------------------------------------------------------ 211 (345)
T ss_dssp EEECCCTTCEESSGGGCCCC------------------------------------------------------------
T ss_pred EEEEeCCCceeccccccccc------------------------------------------------------------
Confidence 99999999965432110000
Q ss_pred ccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCc-HHHHHHHH-cCCCcCC------
Q 035713 315 MAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGN-RATLFNVV-GQPLRFP------ 386 (491)
Q Consensus 315 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-~~~~~~i~-~~~~~~~------ 386 (491)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ...+.... .....++
T Consensus 212 ---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (345)
T 2v62_A 212 ---YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKW 288 (345)
T ss_dssp ---CCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHH
T ss_pred ---chhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhh
Confidence 000111235799999999999999999999999999999999999999965322 22221111 1001111
Q ss_pred -CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 387 -ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 387 -~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
....++.++.+||.+||..||++||+ +++|++.
T Consensus 289 ~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~~ 322 (345)
T 2v62_A 289 APSGSSCCEIAQFLVCAHSLAYDEKPN----YQALKKI 322 (345)
T ss_dssp SCTTSCCHHHHHHHHHHHTCCTTCCCC----HHHHHHH
T ss_pred ccccccHHHHHHHHHHHhhcCcccCCC----HHHHHHH
Confidence 11268999999999999999999999 7877763
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=362.28 Aligned_cols=250 Identities=24% Similarity=0.318 Sum_probs=197.3
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhh--cCCCCccceeeeEEe----
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL--LDHPFLPTLYSYFET---- 165 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~--l~hp~iv~l~~~~~~---- 165 (491)
..++|++++.||+|+||+||+|++ +++.||||++.... ...+.+|.+++.. ++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~ 77 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHS 77 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence 457899999999999999999987 58899999986542 1234456777666 799999999998654
Q ss_pred CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------HcCcccccCCCCCEEEccCCcEEE
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH--------MLGIVYRDLKPENVLVRDEGHIML 237 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--------~~givHrDikp~NILl~~~g~vkL 237 (491)
...+|+||||+++|+|.++++. ..+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 3568999999999999999965 45999999999999999999999 999999999999999999999999
Q ss_pred eecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccC
Q 035713 238 SDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAE 317 (491)
Q Consensus 238 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (491)
+|||+++..........
T Consensus 155 ~Dfg~a~~~~~~~~~~~--------------------------------------------------------------- 171 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLD--------------------------------------------------------------- 171 (301)
T ss_dssp CCCTTCEEEETTTTEEE---------------------------------------------------------------
T ss_pred eeCCCeeeccccccccc---------------------------------------------------------------
Confidence 99999865432111000
Q ss_pred CCCccccccccccCccCcchhcCC------CCCCcccccchhhHHHhhhcC----------CCCCCCCC----cHHHHHH
Q 035713 318 PTNVRSMSFVGTHEYLAPEIIRGE------GHGSAVDWWTFGIFLYELLHG----------TTPFKGQG----NRATLFN 377 (491)
Q Consensus 318 ~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~~DiwSlG~il~elltg----------~~Pf~~~~----~~~~~~~ 377 (491)
......+||+.|+|||++.+. .++.++|||||||++|||++| +.||.... ....+..
T Consensus 172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 248 (301)
T 3q4u_A 172 ---VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRK 248 (301)
T ss_dssp ---CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred ---ccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhH
Confidence 011134799999999999887 455799999999999999999 88986532 2333444
Q ss_pred HHcCCCcCCCC------CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 378 VVGQPLRFPET------PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 378 i~~~~~~~~~~------~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
........+.. ..++.++.+||.+||+.||++||+ +.+|++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~~i~~ 295 (301)
T 3q4u_A 249 VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT----ALRIKK 295 (301)
T ss_dssp HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCC----HHHHHH
T ss_pred HHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCC----HHHHHH
Confidence 43322222211 124578999999999999999999 888875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=380.33 Aligned_cols=256 Identities=27% Similarity=0.358 Sum_probs=196.1
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~~lV 172 (491)
+.|.+.+.||+|+||+||.+ ...+|+.||||++.... ...+.+|+++|+.+ +|||||++++++.+++.+|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 34566788999999999875 45579999999986542 23456899999876 899999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCC-----CCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC-------------Cc
Q 035713 173 MEFCSGGNLHSLRQKQPNKY-----FTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE-------------GH 234 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~-------------g~ 234 (491)
|||+. |+|.+++....... .++..++.++.||+.||.|||++||+||||||+||||+.+ +.
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99995 69999998642211 1333467899999999999999999999999999999754 48
Q ss_pred EEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCcc
Q 035713 235 IMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPEL 314 (491)
Q Consensus 235 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (491)
+||+|||+++.........
T Consensus 167 ~kL~DFG~a~~~~~~~~~~------------------------------------------------------------- 185 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSF------------------------------------------------------------- 185 (434)
T ss_dssp EEECCCTTCEECCC------------------------------------------------------------------
T ss_pred EEEcccccceecCCCCccc-------------------------------------------------------------
Confidence 9999999986543211000
Q ss_pred ccCCCCccccccccccCccCcchhcC-------CCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCC
Q 035713 315 MAEPTNVRSMSFVGTHEYLAPEIIRG-------EGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFP 386 (491)
Q Consensus 315 ~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 386 (491)
.......+||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+..... ..++.....++
T Consensus 186 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~ 258 (434)
T 2rio_A 186 -----RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLD 258 (434)
T ss_dssp --------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCC
T ss_pred -----eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcc
Confidence 001123479999999999976 568999999999999999999 999998765443 34444443333
Q ss_pred CC-----CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 387 ET-----PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 387 ~~-----~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
.. ..++.++.+||.+||+.||.+||+ +.++++||||...
T Consensus 259 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~eil~hp~f~~~ 302 (434)
T 2rio_A 259 EMKCLHDRSLIAEATDLISQMIDHDPLKRPT----AMKVLRHPLFWPK 302 (434)
T ss_dssp CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGSCH
T ss_pred cccccccccchHHHHHHHHHHhhCChhhCCC----HHHHHhCCccCCc
Confidence 22 234578999999999999999999 9999999999754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=366.22 Aligned_cols=265 Identities=24% Similarity=0.364 Sum_probs=209.3
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEE----eC
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE----TD 166 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~----~~ 166 (491)
+..++|++++.||+|+||.||+|++..+++.||||++... .......+.+|+++++.++||||+++++++. ..
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 3457899999999999999999999999999999998653 2345567789999999999999999999987 34
Q ss_pred ceEEEEEeccCCCchHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQ--PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
...|+||||+.+++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 5889999999999999988752 24569999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
.......... .........
T Consensus 183 ~~~~~~~~~~-------------------------------------------------------------~~~~~~~~~ 201 (317)
T 2buj_A 183 QACIHVEGSR-------------------------------------------------------------QALTLQDWA 201 (317)
T ss_dssp ESCEEEESHH-------------------------------------------------------------HHHHHHHHH
T ss_pred hccccccccc-------------------------------------------------------------ccccccccc
Confidence 4321000000 000000112
Q ss_pred ccccccCccCcchhcCCC---CCCcccccchhhHHHhhhcCCCCCCCCCc-HHHHHHHHcCCCcCCCCCCCCHHHHHHHH
Q 035713 325 SFVGTHEYLAPEIIRGEG---HGSAVDWWTFGIFLYELLHGTTPFKGQGN-RATLFNVVGQPLRFPETPQVSFVARDLIR 400 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~~---~~~~~DiwSlG~il~elltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~s~~~~~li~ 400 (491)
...||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..... ...+...+.....++....++.++.+||.
T Consensus 202 ~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 281 (317)
T 2buj_A 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLN 281 (317)
T ss_dssp HHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHH
T ss_pred cccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHH
Confidence 346899999999998664 68899999999999999999999954110 01122223334556666679999999999
Q ss_pred hhhccCCCCCCCcCCChHHhhcC
Q 035713 401 GLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 401 ~~L~~dP~~R~t~~~~~~ell~h 423 (491)
+||+.||.+||+ +.+++++
T Consensus 282 ~~l~~dp~~Rps----~~~ll~~ 300 (317)
T 2buj_A 282 SMMTVDPHQRPH----IPLLLSQ 300 (317)
T ss_dssp HHTCSSGGGSCC----HHHHHHH
T ss_pred HHhhcChhhCCC----HHHHHHH
Confidence 999999999999 9999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=395.63 Aligned_cols=254 Identities=21% Similarity=0.279 Sum_probs=207.5
Q ss_pred CCCceEe-eeeeccCceEEEEEEE--eCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 93 LSNFRLL-KRLGYGDIGSVYLVEL--RGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 93 ~~~y~~~-~~iG~G~~g~V~~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
...+.+. ++||+|+||+||+|.+ +.+++.||||+++... ........+.+|+++|+.++|||||++++++.. +.+
T Consensus 367 ~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~ 444 (635)
T 4fl3_A 367 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESW 444 (635)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred chhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCE
Confidence 3445554 4899999999999965 4567889999997653 333445678899999999999999999999975 458
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
||||||+++|+|.+++... +.+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+...
T Consensus 445 ~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred EEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 8999999999999999874 56999999999999999999999999999999999999999999999999999654321
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.... .......||
T Consensus 523 ~~~~-------------------------------------------------------------------~~~~~~~~t 535 (635)
T 4fl3_A 523 ENYY-------------------------------------------------------------------KAQTHGKWP 535 (635)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred cccc-------------------------------------------------------------------ccccCCCCc
Confidence 1100 001123578
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 408 (491)
+.|+|||++.+..++.++|||||||+||||++ |+.||.+.+..+....+... ...+....++.++.+||.+||+.||+
T Consensus 536 ~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~dP~ 614 (635)
T 4fl3_A 536 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCPAGCPREMYDLMNLCWTYDVE 614 (635)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSTT
T ss_pred eeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCCHh
Confidence 89999999999999999999999999999998 99999998877666655544 33344456999999999999999999
Q ss_pred CCCCcCCChHHhhc
Q 035713 409 KRIAYKRGATEIKQ 422 (491)
Q Consensus 409 ~R~t~~~~~~ell~ 422 (491)
+||+ +++|++
T Consensus 615 ~RPs----~~~l~~ 624 (635)
T 4fl3_A 615 NRPG----FAAVEL 624 (635)
T ss_dssp TSCC----HHHHHH
T ss_pred HCcC----HHHHHH
Confidence 9999 777764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=365.73 Aligned_cols=251 Identities=22% Similarity=0.295 Sum_probs=207.3
Q ss_pred ceEeeeeeccCceEEEEEEE----eCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe--CceE
Q 035713 96 FRLLKRLGYGDIGSVYLVEL----RGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET--DKFY 169 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~--~~~~ 169 (491)
|+++++||+|+||+||+|.. ..+++.||||+++.. ........+.+|+++|+.++||||+++++++.+ ...+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 49999999999999988764 457899999999765 233456678899999999999999999999987 4689
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 111 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 9999999999999999874 3999999999999999999999999999999999999999999999999998654321
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.... .......||
T Consensus 188 ~~~~-------------------------------------------------------------------~~~~~~~~~ 200 (318)
T 3lxp_A 188 HEYY-------------------------------------------------------------------RVREDGDSP 200 (318)
T ss_dssp CSEE-------------------------------------------------------------------EC---CCCC
T ss_pred cccc-------------------------------------------------------------------ccccCCCCC
Confidence 1000 011123688
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcH--------------HHHHHHHcCCCcCCCCCCCCHHH
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR--------------ATLFNVVGQPLRFPETPQVSFVA 395 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------------~~~~~i~~~~~~~~~~~~~s~~~ 395 (491)
..|+|||++.+..++.++|||||||++|+|++|+.||...... ..+...+......+....++.++
T Consensus 201 ~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 280 (318)
T 3lxp_A 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEV 280 (318)
T ss_dssp GGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred ceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHH
Confidence 8999999999999999999999999999999999999753221 12233344444555556799999
Q ss_pred HHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 396 RDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 396 ~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
.+||.+||+.||.+||+ +.++++
T Consensus 281 ~~li~~~l~~dP~~Rps----~~ell~ 303 (318)
T 3lxp_A 281 YHLMKNCWETEASFRPT----FENLIP 303 (318)
T ss_dssp HHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHHcCCCcccCcC----HHHHHH
Confidence 99999999999999999 888885
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=357.27 Aligned_cols=256 Identities=18% Similarity=0.248 Sum_probs=205.2
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeE-EeCceEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYF-ETDKFYCL 171 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~-~~~~~~~l 171 (491)
.++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+++++.++|++++..+.++ ...+..|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 37899999999999999999999999999999998765322 2467899999999988766655554 67788999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEE---ccCCcEEEeecccccccCC
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLV---RDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl---~~~g~vkL~DFGla~~~~~ 248 (491)
||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 83 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99999 99999999854 3569999999999999999999999999999999999999 4889999999999865432
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
...... ..........|
T Consensus 161 ~~~~~~---------------------------------------------------------------~~~~~~~~~~g 177 (296)
T 3uzp_A 161 ARTHQH---------------------------------------------------------------IPYRENKNLTG 177 (296)
T ss_dssp TTTCCB---------------------------------------------------------------CCCCCSCCCCS
T ss_pred cccccc---------------------------------------------------------------ccccccccccc
Confidence 111000 00001123479
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCc---HHHHHHHHcCCCcCC---CCCCCCHHHHHHHHhh
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGN---RATLFNVVGQPLRFP---ETPQVSFVARDLIRGL 402 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~~~~~~~~---~~~~~s~~~~~li~~~ 402 (491)
|+.|+|||++.+..++.++|||||||++|||++|+.||.+... ...+..+.......+ ....+++++.+||.+|
T Consensus 178 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 257 (296)
T 3uzp_A 178 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFC 257 (296)
T ss_dssp CTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHH
T ss_pred ccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHH
Confidence 9999999999999999999999999999999999999987432 233333333222222 1135899999999999
Q ss_pred hccCCCCCCCcCCChHHhhc
Q 035713 403 LVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 403 L~~dP~~R~t~~~~~~ell~ 422 (491)
|+.||.+||+ ++++++
T Consensus 258 l~~dp~~Rps----~~~l~~ 273 (296)
T 3uzp_A 258 RSLRFDDKPD----YSYLRQ 273 (296)
T ss_dssp HTSCTTCCCC----HHHHHH
T ss_pred HhcCcCcCCC----HHHHHH
Confidence 9999999999 777665
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=374.47 Aligned_cols=256 Identities=17% Similarity=0.231 Sum_probs=203.6
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCC---cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEE-eCceE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTN---TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE-TDKFY 169 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~-~~~~~ 169 (491)
..|++.+.||+|+||+||+|++..++ ..||+|+++.. ........+.+|+.+|+.++||||+++++++. .++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 45889999999999999999986443 46899998653 33345667889999999999999999999864 45688
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~ 249 (491)
|+||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 167 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999999999764 356899999999999999999999999999999999999999999999999998654211
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
.... ........||
T Consensus 246 ~~~~------------------------------------------------------------------~~~~~~~~~~ 259 (373)
T 3c1x_A 246 EFDS------------------------------------------------------------------VHNKTGAKLP 259 (373)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred cccc------------------------------------------------------------------ccccCCCCCc
Confidence 1000 0011123678
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 408 (491)
+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+.... .......++..+.+||.+||+.||+
T Consensus 260 ~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~-~~~~p~~~~~~l~~li~~cl~~dp~ 338 (373)
T 3c1x_A 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWHPKAE 338 (373)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred ccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChh
Confidence 89999999999999999999999999999999 788998776666555555443 2333346899999999999999999
Q ss_pred CCCCcCCChHHhhcC
Q 035713 409 KRIAYKRGATEIKQH 423 (491)
Q Consensus 409 ~R~t~~~~~~ell~h 423 (491)
+||+ +.+++++
T Consensus 339 ~RPs----~~ell~~ 349 (373)
T 3c1x_A 339 MRPS----FSELVSR 349 (373)
T ss_dssp GSCC----HHHHHHH
T ss_pred hCcC----HHHHHHH
Confidence 9999 8888865
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=391.58 Aligned_cols=256 Identities=25% Similarity=0.336 Sum_probs=215.3
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
.+.+..++|++.++||+|+||.||+|++.. +..||||+++..... .+.+.+|+++|+.++||||+++++++.+ +
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 345667889999999999999999999975 467999999765422 2457789999999999999999999876 6
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+||||||+.+|+|.++++......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 78999999999999999975434569999999999999999999999999999999999999999999999999986432
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
.... .......
T Consensus 415 ~~~~---------------------------------------------------------------------~~~~~~~ 425 (535)
T 2h8h_A 415 DNEY---------------------------------------------------------------------TARQGAK 425 (535)
T ss_dssp CHHH---------------------------------------------------------------------HTTCSTT
T ss_pred CCce---------------------------------------------------------------------ecccCCc
Confidence 1000 0001125
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
+|..|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+.. ....+....++.++.+||.+||+.|
T Consensus 426 ~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~d 504 (535)
T 2h8h_A 426 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKE 504 (535)
T ss_dssp SCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 7889999999999999999999999999999999 9999998877776666543 3445555679999999999999999
Q ss_pred CCCCCCcCCChHHhhcC
Q 035713 407 PHKRIAYKRGATEIKQH 423 (491)
Q Consensus 407 P~~R~t~~~~~~ell~h 423 (491)
|++||+ +++|++.
T Consensus 505 P~~RPt----~~~l~~~ 517 (535)
T 2h8h_A 505 PEERPT----FEYLQAF 517 (535)
T ss_dssp GGGSCC----HHHHHHH
T ss_pred hhHCcC----HHHHHHH
Confidence 999999 8887763
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=371.08 Aligned_cols=254 Identities=19% Similarity=0.259 Sum_probs=203.9
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCC--------CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccc------
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGT--------NTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPT------ 158 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~--------~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~------ 158 (491)
.++|++++.||+|+||.||+|++..+ ++.||||++.+. ..+.+|+++++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 37899999999999999999999874 889999998754 24668999999999999987
Q ss_pred ---------eeeeEEe-CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEE
Q 035713 159 ---------LYSYFET-DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVL 228 (491)
Q Consensus 159 ---------l~~~~~~-~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NIL 228 (491)
+++++.. ++.+||||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 5677765 78899999999 999999998764567999999999999999999999999999999999999
Q ss_pred EccCC--cEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCC
Q 035713 229 VRDEG--HIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPC 306 (491)
Q Consensus 229 l~~~g--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (491)
++.++ .+||+|||+++.+........
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~---------------------------------------------------- 219 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVA---------------------------------------------------- 219 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCC----------------------------------------------------
T ss_pred EcCCCCceEEEecCcceeeccCCCcccc----------------------------------------------------
Confidence 99998 899999999965432110000
Q ss_pred CCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCC-cHHHHHHH----HcC
Q 035713 307 VGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQG-NRATLFNV----VGQ 381 (491)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-~~~~~~~i----~~~ 381 (491)
.........+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ....+... ...
T Consensus 220 -----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 288 (352)
T 2jii_A 220 -----------YVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDK 288 (352)
T ss_dssp -----------CCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHS
T ss_pred -----------ccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCC
Confidence 00001123479999999999999999999999999999999999999998764 33333222 222
Q ss_pred CCcCCC----CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 382 PLRFPE----TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 382 ~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
...+.. ...++.++.+||.+||..||++||+ +++|++
T Consensus 289 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~ 329 (352)
T 2jii_A 289 PGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPP----YAMLRN 329 (352)
T ss_dssp CCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCC----HHHHHH
T ss_pred hhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCC----HHHHHH
Confidence 222211 1257899999999999999999999 777765
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=361.32 Aligned_cols=247 Identities=25% Similarity=0.408 Sum_probs=200.4
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
+..++|++.+.||+|+||+||+|++. ++.||||++... .....+.+|+++|+.++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 45678999999999999999999875 778999998643 234567889999999999999999998874 478
Q ss_pred EEEeccCCCchHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHH---cCcccccCCCCCEEEccCCc-EEEeecccccc
Q 035713 171 LVMEFCSGGNLHSLRQKQPN-KYFTEDAARFFASEVLLALEYLHM---LGIVYRDLKPENVLVRDEGH-IMLSDFDLSLR 245 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~NILl~~~g~-vkL~DFGla~~ 245 (491)
+||||++|++|.+++..... ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 99999999999999986432 247899999999999999999999 89999999999999998887 79999999853
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
... ....
T Consensus 156 ~~~-------------------------------------------------------------------------~~~~ 162 (307)
T 2eva_A 156 IQT-------------------------------------------------------------------------HMTN 162 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc-------------------------------------------------------------------------cccc
Confidence 211 0012
Q ss_pred cccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHH-HHHHHHcCCCcCCCCCCCCHHHHHHHHhhhc
Q 035713 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRA-TLFNVVGQPLRFPETPQVSFVARDLIRGLLV 404 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~ 404 (491)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+..........+....++..+.+||.+||+
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 242 (307)
T 2eva_A 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWS 242 (307)
T ss_dssp --CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTC
T ss_pred CCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhc
Confidence 368999999999999999999999999999999999999998654322 2222222223333345689999999999999
Q ss_pred cCCCCCCCcCCChHHhhcC
Q 035713 405 KEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 405 ~dP~~R~t~~~~~~ell~h 423 (491)
.||.+||+ +++++++
T Consensus 243 ~dp~~Rps----~~ell~~ 257 (307)
T 2eva_A 243 KDPSQRPS----MEEIVKI 257 (307)
T ss_dssp SSGGGSCC----HHHHHHH
T ss_pred CChhhCcC----HHHHHHH
Confidence 99999999 8888873
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=360.94 Aligned_cols=232 Identities=30% Similarity=0.483 Sum_probs=192.1
Q ss_pred CCCceEe-eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHH-hhcCCCCccceeeeEEe----C
Q 035713 93 LSNFRLL-KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL-GLLDHPFLPTLYSYFET----D 166 (491)
Q Consensus 93 ~~~y~~~-~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il-~~l~hp~iv~l~~~~~~----~ 166 (491)
.++|.++ +.||+|+||.||+|++..+++.||||++... ..+.+|++++ +.++||||+++++++.. .
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 4779988 7899999999999999999999999999653 1345788887 66689999999999987 7
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc---CCcEEEeecccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD---EGHIMLSDFDLS 243 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~---~g~vkL~DFGla 243 (491)
..+||||||++|++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 78999999999999999999876667999999999999999999999999999999999999998 789999999987
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (491)
...
T Consensus 168 ~~~----------------------------------------------------------------------------- 170 (299)
T 3m2w_A 168 KET----------------------------------------------------------------------------- 170 (299)
T ss_dssp EEC-----------------------------------------------------------------------------
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 321
Q ss_pred cccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHH----cCCCcCCC--CCCCCHHHHH
Q 035713 324 MSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV----GQPLRFPE--TPQVSFVARD 397 (491)
Q Consensus 324 ~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~----~~~~~~~~--~~~~s~~~~~ 397 (491)
.+..++.++|||||||++|||++|+.||.+.........+. .....++. ...++.++.+
T Consensus 171 ---------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T 3m2w_A 171 ---------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 235 (299)
T ss_dssp ---------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHH
T ss_pred ---------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHH
Confidence 12346789999999999999999999998765433221111 11112221 1458999999
Q ss_pred HHHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 398 LIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 398 li~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
||.+||+.||.+||+ +.++++||||+.
T Consensus 236 li~~~l~~dP~~Rps----~~e~l~hp~~~~ 262 (299)
T 3m2w_A 236 LIRNLLKTEPTQRMT----ITEFMNHPWIMQ 262 (299)
T ss_dssp HHHHHTCSSTTTSCC----HHHHHTSHHHHT
T ss_pred HHHHHcccChhhCCC----HHHHhcChhhcc
Confidence 999999999999999 999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=366.90 Aligned_cols=263 Identities=25% Similarity=0.339 Sum_probs=191.6
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEE-----
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFE----- 164 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~----- 164 (491)
+...+|+++++||+|+||.||+|++..+++.||||++.... ......+.+|+.+|+.+. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 34468999999999999999999999999999999986542 344556788999999996 999999999983
Q ss_pred ---eCceEEEEEeccCCCchHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccccCCCCCEEEccCCcEEEe
Q 035713 165 ---TDKFYCLVMEFCSGGNLHSLRQK-QPNKYFTEDAARFFASEVLLALEYLHMLG--IVYRDLKPENVLVRDEGHIMLS 238 (491)
Q Consensus 165 ---~~~~~~lV~E~~~gg~L~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~g~vkL~ 238 (491)
....+|+||||+. |+|.+++.. ...+.+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence 4456899999995 789888764 22356999999999999999999999999 9999999999999999999999
Q ss_pred ecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCC
Q 035713 239 DFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEP 318 (491)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (491)
|||+++............ ....
T Consensus 181 Dfg~~~~~~~~~~~~~~~----------------------------------------------------------~~~~ 202 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSA----------------------------------------------------------QRRA 202 (337)
T ss_dssp CCTTCBCCSSCC--------------------------------------------------------------------
T ss_pred cCccceeccccCcccccc----------------------------------------------------------cccc
Confidence 999986543221110000 0000
Q ss_pred CCccccccccccCccCcchh---cCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHH
Q 035713 319 TNVRSMSFVGTHEYLAPEII---RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVA 395 (491)
Q Consensus 319 ~~~~~~~~~gt~~y~aPE~l---~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~ 395 (491)
........+||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+..... ++......+.....+..+
T Consensus 203 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~ 278 (337)
T 3ll6_A 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----IVNGKYSIPPHDTQYTVF 278 (337)
T ss_dssp ---------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------CCCCTTCCSSGGG
T ss_pred cchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----hhcCcccCCcccccchHH
Confidence 00111234799999999999 56668899999999999999999999997654432 333444455555688899
Q ss_pred HHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 396 RDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 396 ~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
.+||.+||+.||.+||+ +.++++|
T Consensus 279 ~~li~~~l~~~p~~Rps----~~e~l~~ 302 (337)
T 3ll6_A 279 HSLIRAMLQVNPEERLS----IAEVVHQ 302 (337)
T ss_dssp HHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHccCChhhCcC----HHHHHHH
Confidence 99999999999999999 9999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=371.34 Aligned_cols=243 Identities=18% Similarity=0.207 Sum_probs=196.4
Q ss_pred CccCCCceEeeeeeccCceEEEEE-----EEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC---CCCccceee
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLV-----ELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD---HPFLPTLYS 161 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a-----~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~---hp~iv~l~~ 161 (491)
.+..++|++.++||+|+||+||+| .+..+++.||||++.... ...+.+|+++++.++ |+||+.+++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 355688999999999999999999 467789999999997642 224566788888876 999999999
Q ss_pred eEEeCceEEEEEeccCCCchHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc-------
Q 035713 162 YFETDKFYCLVMEFCSGGNLHSLRQKQ---PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD------- 231 (491)
Q Consensus 162 ~~~~~~~~~lV~E~~~gg~L~~~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~------- 231 (491)
++...+..||||||++||+|.+++... ....+++..++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 999999999999999999999998742 2456999999999999999999999999999999999999998
Q ss_pred ----CCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCC
Q 035713 232 ----EGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCV 307 (491)
Q Consensus 232 ----~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (491)
++.+||+|||+|+.+....
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~--------------------------------------------------------- 237 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFP--------------------------------------------------------- 237 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSC---------------------------------------------------------
T ss_pred cccccCCEEEeeCchhhhhhccC---------------------------------------------------------
Confidence 8999999999996532110
Q ss_pred CCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC
Q 035713 308 GGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE 387 (491)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 387 (491)
........+||+.|+|||++.+..|+.++|||||||++|||++|+.||......... +.. .+..
T Consensus 238 -----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~--~~~~ 301 (365)
T 3e7e_A 238 -----------KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---PEG--LFRR 301 (365)
T ss_dssp -----------TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE---ECS--CCTT
T ss_pred -----------CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee---ech--hccc
Confidence 011122358999999999999999999999999999999999999999654321100 001 1111
Q ss_pred CCCCCHHHHHHHHhhhccCCCCCCC
Q 035713 388 TPQVSFVARDLIRGLLVKEPHKRIA 412 (491)
Q Consensus 388 ~~~~s~~~~~li~~~L~~dP~~R~t 412 (491)
...++.+.+++.+||..+|.+|+.
T Consensus 302 -~~~~~~~~~~~~~~l~~~p~~r~~ 325 (365)
T 3e7e_A 302 -LPHLDMWNEFFHVMLNIPDCHHLP 325 (365)
T ss_dssp -CSSHHHHHHHHHHHHCCCCTTCCC
T ss_pred -cCcHHHHHHHHHHHcCCCCCCcch
Confidence 135678999999999999999977
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=362.87 Aligned_cols=257 Identities=22% Similarity=0.298 Sum_probs=209.7
Q ss_pred ccCCCceEeeeeeccCceEEEEEEE----eCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVEL----RGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
+..++|++++.||+|+||.||+|++ ..+++.||||++... .......+.+|+++|+.++||||+++++++...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 4457899999999999999999994 568999999999764 234456788999999999999999999998754
Q ss_pred --ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 167 --KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 167 --~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
..+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 37899999999999999998753 459999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
.......... ...
T Consensus 194 ~~~~~~~~~~-------------------------------------------------------------------~~~ 206 (326)
T 2w1i_A 194 VLPQDKEYYK-------------------------------------------------------------------VKE 206 (326)
T ss_dssp ECCSSCSEEE-------------------------------------------------------------------CSS
T ss_pred hccccccccc-------------------------------------------------------------------ccc
Confidence 5432111000 001
Q ss_pred ccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCc------------H---HHHHHHHcCCCcCCCCC
Q 035713 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGN------------R---ATLFNVVGQPLRFPETP 389 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------------~---~~~~~i~~~~~~~~~~~ 389 (491)
...+|..|+|||++.+..++.++|||||||++|||++|..||..... . ..+...+......+...
T Consensus 207 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (326)
T 2w1i_A 207 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 286 (326)
T ss_dssp CCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCT
T ss_pred CCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCC
Confidence 12578889999999999899999999999999999999999864211 0 11223333334445556
Q ss_pred CCCHHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 390 QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 390 ~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
.++.++.+||.+||+.||.+||+ +.+|++
T Consensus 287 ~~~~~l~~li~~cl~~dP~~Rps----~~el~~ 315 (326)
T 2w1i_A 287 GCPDEIYMIMTECWNNNVNQRPS----FRDLAL 315 (326)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCC----HHHHHH
T ss_pred cccHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 79999999999999999999999 888875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=376.96 Aligned_cols=246 Identities=18% Similarity=0.177 Sum_probs=192.1
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhh-----hHHHHHHHHHHHHHHhhcC---------CCCcc
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLA-----SRNKLLRAQTEREILGLLD---------HPFLP 157 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~---------hp~iv 157 (491)
..++|+++++||+|+||+||+|++ +|+.||||++.+.... .......+.+|+++|+.++ |||||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 347899999999999999999998 6899999999865321 2223456778999998886 55555
Q ss_pred ceeee-----------------EEe-------------CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHH
Q 035713 158 TLYSY-----------------FET-------------DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLL 207 (491)
Q Consensus 158 ~l~~~-----------------~~~-------------~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~ 207 (491)
+++++ |.+ .+.+||||||+++|++.+.+.. +.+++..++.++.||+.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTA 172 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHH
Confidence 55554 443 7899999999999977665543 45899999999999999
Q ss_pred HHHHHH-HcCcccccCCCCCEEEccCC--------------------cEEEeecccccccCCCCcccccccccccCCCCC
Q 035713 208 ALEYLH-MLGIVYRDLKPENVLVRDEG--------------------HIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGG 266 (491)
Q Consensus 208 aL~~LH-~~givHrDikp~NILl~~~g--------------------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 266 (491)
||.||| ++||+||||||+||||+.++ .+||+|||+|+....
T Consensus 173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------------------ 234 (336)
T 2vuw_A 173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------------------ 234 (336)
T ss_dssp HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------------------
T ss_pred HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------------------
Confidence 999999 99999999999999999887 899999999864321
Q ss_pred CCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCCCCCc
Q 035713 267 GGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSA 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~ 346 (491)
...+||+.|||||++.+.. +.+
T Consensus 235 ---------------------------------------------------------~~~~gt~~y~aPE~~~g~~-~~~ 256 (336)
T 2vuw_A 235 ---------------------------------------------------------GIVVFCDVSMDEDLFTGDG-DYQ 256 (336)
T ss_dssp ---------------------------------------------------------TEEECCCCTTCSGGGCCCS-SHH
T ss_pred ---------------------------------------------------------CcEEEeecccChhhhcCCC-ccc
Confidence 1237999999999999876 889
Q ss_pred ccccchhhH-HHhhhcCCCCCCCCCcHH-HHHHHHcC-CCcCCC----CCCCCHHHHHHHHhhhccCCCCCCCcCCChHH
Q 035713 347 VDWWTFGIF-LYELLHGTTPFKGQGNRA-TLFNVVGQ-PLRFPE----TPQVSFVARDLIRGLLVKEPHKRIAYKRGATE 419 (491)
Q Consensus 347 ~DiwSlG~i-l~elltg~~Pf~~~~~~~-~~~~i~~~-~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~e 419 (491)
+||||||++ .+++++|..||.+..... ....+... ...... ...+++++++||.+||++| | ++|
T Consensus 257 ~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s----a~e 327 (336)
T 2vuw_A 257 FDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S----ATD 327 (336)
T ss_dssp HHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S----HHH
T ss_pred eehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C----HHH
Confidence 999998777 888999999995421111 12223311 111111 1247789999999999987 7 999
Q ss_pred hh-cCCCcC
Q 035713 420 IK-QHPFFE 427 (491)
Q Consensus 420 ll-~hpff~ 427 (491)
+| +||||+
T Consensus 328 ~l~~Hp~f~ 336 (336)
T 2vuw_A 328 LLCQHSLFK 336 (336)
T ss_dssp HHHHCGGGC
T ss_pred HHhcCCCcC
Confidence 99 999995
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=382.47 Aligned_cols=255 Identities=18% Similarity=0.205 Sum_probs=199.9
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCC-CCccc------------
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH-PFLPT------------ 158 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~------------ 158 (491)
...+|.+.+.||+|+||+||+|++..+|+.||||+++..........+.+.+|+.+++.++| .|+..
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34568999999999999999999999999999999985544444446678899999999987 32211
Q ss_pred ---------eeeeEEe-----CceEEEEEeccCCCchHHHHH-----hCCCCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 035713 159 ---------LYSYFET-----DKFYCLVMEFCSGGNLHSLRQ-----KQPNKYFTEDAARFFASEVLLALEYLHMLGIVY 219 (491)
Q Consensus 159 ---------l~~~~~~-----~~~~~lV~E~~~gg~L~~~~~-----~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH 219 (491)
++.++.. ...++++|+++ +++|.++++ ......+++..+..++.||+.||.|||++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 1111111 22467888877 789999885 222345888899999999999999999999999
Q ss_pred ccCCCCCEEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCC
Q 035713 220 RDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKS 299 (491)
Q Consensus 220 rDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (491)
|||||+||||+.++.+||+|||+++....
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~--------------------------------------------------- 263 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA--------------------------------------------------- 263 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTE---------------------------------------------------
T ss_pred CCcccceEEEecCCeEEEEeccceeecCC---------------------------------------------------
Confidence 99999999999999999999999854211
Q ss_pred CCCCCCCCCCCCCccccCCCCccccccccccCccCcchh----------cCCCCCCcccccchhhHHHhhhcCCCCCCCC
Q 035713 300 KSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEII----------RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQ 369 (491)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 369 (491)
...+.+| +.|+|||++ .+..++.++|||||||++|||++|+.||.+.
T Consensus 264 ----------------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~ 320 (413)
T 3dzo_A 264 ----------------------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320 (413)
T ss_dssp ----------------------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTT
T ss_pred ----------------------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0123478 999999999 5556888999999999999999999999876
Q ss_pred CcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCCh
Q 035713 370 GNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNW 431 (491)
Q Consensus 370 ~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~ 431 (491)
+.......+ +.....+++++.+||.+||+.||++||+ +.++++||||+.+..
T Consensus 321 ~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~~~l~~~~~~~~~~ 372 (413)
T 3dzo_A 321 AALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLL----PLQAMETPEYEQLRT 372 (413)
T ss_dssp GGGSCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGSCC----HHHHTTSHHHHHHHH
T ss_pred chhhhHHHH------HhhcccCCHHHHHHHHHHccCChhhCcC----HHHHHhCHHHHHHHH
Confidence 554333222 2223468899999999999999999999 999999999987654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=364.15 Aligned_cols=262 Identities=21% Similarity=0.258 Sum_probs=211.4
Q ss_pred CCCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 87 RGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 87 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
....+..++|++.+.||+|+||.||+|++.. .||+|+++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 3456677999999999999999999999864 399999875432 122334566799999999999999999999999
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
+.+|+||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred CceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 9999999999999999998764 34699999999999999999999999999999999999998 789999999998543
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
....... ........
T Consensus 180 ~~~~~~~-----------------------------------------------------------------~~~~~~~~ 194 (319)
T 2y4i_B 180 GVLQAGR-----------------------------------------------------------------REDKLRIQ 194 (319)
T ss_dssp -------------------------------------------------------------------------CCSCBCC
T ss_pred ccccccc-----------------------------------------------------------------cccccccC
Confidence 2110000 00011123
Q ss_pred ccccCccCcchhcC---------CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHH
Q 035713 327 VGTHEYLAPEIIRG---------EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARD 397 (491)
Q Consensus 327 ~gt~~y~aPE~l~~---------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~ 397 (491)
.||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+............++.++.+
T Consensus 195 ~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 274 (319)
T 2y4i_B 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISD 274 (319)
T ss_dssp SGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHH
T ss_pred CCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHH
Confidence 69999999999975 347889999999999999999999999888777776666554433333468899999
Q ss_pred HHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 398 LIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 398 li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
||.+||..||.+||+ +.++++.
T Consensus 275 li~~~l~~~p~~Rpt----~~~l~~~ 296 (319)
T 2y4i_B 275 ILLFCWAFEQEERPT----FTKLMDM 296 (319)
T ss_dssp HHHHHHCSSTTTSCC----HHHHHHH
T ss_pred HHHHHhcCChhhCcC----HHHHHHH
Confidence 999999999999999 8888873
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=396.09 Aligned_cols=262 Identities=24% Similarity=0.359 Sum_probs=209.8
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe------C
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET------D 166 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~------~ 166 (491)
.++|+++++||+|+||.||+|++..+|+.||||+++... .......+.+|+++|+.++||||+++++++.. .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 478999999999999999999999999999999987642 34455678899999999999999999998765 6
Q ss_pred ceEEEEEeccCCCchHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCc---EEEeeccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQP-NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGH---IMLSDFDL 242 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~---vkL~DFGl 242 (491)
+..|+||||++||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 78899999999999999998743 235999999999999999999999999999999999999997765 99999999
Q ss_pred ccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcc
Q 035713 243 SLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322 (491)
Q Consensus 243 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (491)
+....... .
T Consensus 171 a~~~~~~~-----------------------------------------------------------------------~ 179 (676)
T 3qa8_A 171 AKELDQGE-----------------------------------------------------------------------L 179 (676)
T ss_dssp CCBTTSCC-----------------------------------------------------------------------C
T ss_pred cccccccc-----------------------------------------------------------------------c
Confidence 85432110 1
Q ss_pred ccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHH--------------HcCCCcCCC-
Q 035713 323 SMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNV--------------VGQPLRFPE- 387 (491)
Q Consensus 323 ~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i--------------~~~~~~~~~- 387 (491)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......+... ..+...+..
T Consensus 180 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~ 259 (676)
T 3qa8_A 180 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSV 259 (676)
T ss_dssp CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSS
T ss_pred cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccc
Confidence 11247999999999999999999999999999999999999999765433221110 111111111
Q ss_pred -------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCCh
Q 035713 388 -------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNW 431 (491)
Q Consensus 388 -------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~ 431 (491)
...++..+.+||.+||..||++||+ +.++++||||+.++.
T Consensus 260 lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPT----a~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 260 LPTPNHLSGILAGKLERWLQCMLMWHQRQRGT----DPQNPNVGCFQALDS 306 (676)
T ss_dssp SCCSCCCCGGGHHHHHHHHHHHSCSSCC---C----CTTCCCCTTHHHHHH
T ss_pred cCCchhhchhhhHHHHHHHHHHccCCHhhCcC----HHHHhcCHHHHHHHH
Confidence 1236688999999999999999999 999999999987543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=358.71 Aligned_cols=250 Identities=22% Similarity=0.350 Sum_probs=196.5
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc--CCCCccceeeeEEeC----
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL--DHPFLPTLYSYFETD---- 166 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l--~hp~iv~l~~~~~~~---- 166 (491)
.++|++++.||+|+||.||+|++. ++.||||++..... ....+|.+++..+ +||||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc------chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 368999999999999999999886 88999999865421 2234456666554 899999999999877
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc--------CcccccCCCCCEEEccCCcEEEe
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML--------GIVYRDLKPENVLVRDEGHIMLS 238 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------givHrDikp~NILl~~~g~vkL~ 238 (491)
..+|+||||+++|+|.++++.. .+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 7899999999999999999764 599999999999999999999998 99999999999999999999999
Q ss_pred ecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCC
Q 035713 239 DFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEP 318 (491)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (491)
|||+++.+.......
T Consensus 185 Dfg~a~~~~~~~~~~----------------------------------------------------------------- 199 (337)
T 3mdy_A 185 DLGLAVKFISDTNEV----------------------------------------------------------------- 199 (337)
T ss_dssp CCTTCEECC-----------------------------------------------------------------------
T ss_pred eCCCceeeccccccc-----------------------------------------------------------------
Confidence 999986543211100
Q ss_pred CCccccccccccCccCcchhcCCCCCCc------ccccchhhHHHhhhcC----------CCCCCCCC----cHHHHHHH
Q 035713 319 TNVRSMSFVGTHEYLAPEIIRGEGHGSA------VDWWTFGIFLYELLHG----------TTPFKGQG----NRATLFNV 378 (491)
Q Consensus 319 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~------~DiwSlG~il~elltg----------~~Pf~~~~----~~~~~~~i 378 (491)
.....+.+||+.|+|||++.+..+... +|||||||++|||++| +.||.... ....+...
T Consensus 200 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 278 (337)
T 3mdy_A 200 -DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI 278 (337)
T ss_dssp ----CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHH
T ss_pred -cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHH
Confidence 001123479999999999998777665 9999999999999999 77775432 22333333
Q ss_pred HcC-CCc--CCC---CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 379 VGQ-PLR--FPE---TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 379 ~~~-~~~--~~~---~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
+.. ... ++. ...++.++.+||.+||+.||.+||+ +.+|++|
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 325 (337)
T 3mdy_A 279 VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT----ALRVKKT 325 (337)
T ss_dssp HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred HhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCC----HHHHHHH
Confidence 322 111 121 1245677999999999999999999 9999876
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=361.57 Aligned_cols=263 Identities=27% Similarity=0.381 Sum_probs=194.3
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHH--HhhcCCCCccceeeeEE--
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI--LGLLDHPFLPTLYSYFE-- 164 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~i--l~~l~hp~iv~l~~~~~-- 164 (491)
..+..++|++++.||+|+||+||+|++ +++.||||++..... ..+..|.++ +..++||||+++++.+.
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 345678999999999999999999976 588999999975421 122334444 45589999999998653
Q ss_pred ---eCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc---------CcccccCCCCCEEEccC
Q 035713 165 ---TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML---------GIVYRDLKPENVLVRDE 232 (491)
Q Consensus 165 ---~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---------givHrDikp~NILl~~~ 232 (491)
....+||||||+++|+|.+++... .+++..++.++.||+.||.|||++ ||+||||||+||||+.+
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence 234789999999999999999874 368999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCC
Q 035713 233 GHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALP 312 (491)
Q Consensus 233 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (491)
+.+||+|||+++.+........
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~---------------------------------------------------------- 178 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRP---------------------------------------------------------- 178 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC------------------------------------------------------------
T ss_pred CcEEEeeccceeecccccccCc----------------------------------------------------------
Confidence 9999999999966432111000
Q ss_pred ccccCCCCccccccccccCccCcchhcC-------CCCCCcccccchhhHHHhhhcCCCCCCCCCc--------------
Q 035713 313 ELMAEPTNVRSMSFVGTHEYLAPEIIRG-------EGHGSAVDWWTFGIFLYELLHGTTPFKGQGN-------------- 371 (491)
Q Consensus 313 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------------- 371 (491)
..........+||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 179 ----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 254 (336)
T 3g2f_A 179 ----GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGN 254 (336)
T ss_dssp -----------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCS
T ss_pred ----cccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCC
Confidence 000011223479999999999987 3456789999999999999999776533211
Q ss_pred ---HHHHHHHHcCC---CcCCC----CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhh------cCCCcCC
Q 035713 372 ---RATLFNVVGQP---LRFPE----TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIK------QHPFFEG 428 (491)
Q Consensus 372 ---~~~~~~i~~~~---~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell------~hpff~~ 428 (491)
...+...+... ..++. ...++.++.+||.+||+.||++||+ +.+++ .++|-++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 255 HPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT----AQXAEERMAELMMIWERN 323 (336)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHHHHHHHHCCCC-
T ss_pred CchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcc----hHHHHHHHHHHHHHHHhc
Confidence 11222222221 11221 1224457999999999999999999 88884 4566543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=386.58 Aligned_cols=257 Identities=25% Similarity=0.344 Sum_probs=213.7
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCC---CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGT---NTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET 165 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 165 (491)
..+..++|++.+.||+|+||.||+|++..+ +..||||++... ........+.+|+.+|+.++||||+++++++.
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 445668899999999999999999998653 457999988653 23445567889999999999999999999985
Q ss_pred CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
++.+|+||||+++|+|.++++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred cCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 45689999999999999999865 34599999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
...... .....
T Consensus 541 ~~~~~~---------------------------------------------------------------------~~~~~ 551 (656)
T 2j0j_A 541 MEDSTY---------------------------------------------------------------------YKASK 551 (656)
T ss_dssp CCC-----------------------------------------------------------------------------
T ss_pred cCCCcc---------------------------------------------------------------------eeccC
Confidence 321100 00112
Q ss_pred cccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhc
Q 035713 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLV 404 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~ 404 (491)
..||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+.... ..+....++..+.+||.+||.
T Consensus 552 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~~l~ 630 (656)
T 2j0j_A 552 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLMTKCWA 630 (656)
T ss_dssp --CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC-CCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCCCccccHHHHHHHHHHcC
Confidence 357889999999999999999999999999999997 999999988877776665543 233345699999999999999
Q ss_pred cCCCCCCCcCCChHHhhcC
Q 035713 405 KEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 405 ~dP~~R~t~~~~~~ell~h 423 (491)
.||.+||+ +.+|++.
T Consensus 631 ~dP~~RPs----~~el~~~ 645 (656)
T 2j0j_A 631 YDPSRRPR----FTELKAQ 645 (656)
T ss_dssp SSGGGSCC----HHHHHHH
T ss_pred CChhHCcC----HHHHHHH
Confidence 99999999 8888753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=355.79 Aligned_cols=253 Identities=20% Similarity=0.269 Sum_probs=202.1
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecch-hhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKAS-LASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
|...+.||+|+||.||+|++ +++.||||++.... .........+.+|+++|+.++||||+++++++.+.+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 55569999999999999986 57899999987543 2334456678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 175 FCSGGNLHSLRQKQP-NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
|+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 188 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ-- 188 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS--
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc--
Confidence 999999999887432 34599999999999999999999999999999999999999999999999999864321110
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.......+||+.|+
T Consensus 189 ------------------------------------------------------------------~~~~~~~~g~~~y~ 202 (307)
T 2nru_A 189 ------------------------------------------------------------------TVMTSRIVGTTAYM 202 (307)
T ss_dssp ------------------------------------------------------------------CEECSSCCSCGGGC
T ss_pred ------------------------------------------------------------------cccccccCCCcCcC
Confidence 00111247999999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHH----HHHHcCCC--------cC-CCCCCCCHHHHHHHH
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATL----FNVVGQPL--------RF-PETPQVSFVARDLIR 400 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~----~~i~~~~~--------~~-~~~~~~s~~~~~li~ 400 (491)
|||++.+ .++.++|||||||++|+|++|+.||.+......+ ..+..... .. ......+..+.+||.
T Consensus 203 aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 281 (307)
T 2nru_A 203 APEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVAS 281 (307)
T ss_dssp CHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHH
T ss_pred ChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHH
Confidence 9999876 4789999999999999999999999875443211 11111110 01 111234567899999
Q ss_pred hhhccCCCCCCCcCCChHHhhcC
Q 035713 401 GLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 401 ~~L~~dP~~R~t~~~~~~ell~h 423 (491)
+||+.||.+||+ +.+++++
T Consensus 282 ~cl~~~p~~Rps----~~~l~~~ 300 (307)
T 2nru_A 282 QCLHEKKNKRPD----IKKVQQL 300 (307)
T ss_dssp HHTCSSTTTSCC----HHHHHHH
T ss_pred HHcCCCcccCcC----HHHHHHH
Confidence 999999999999 8888864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=347.33 Aligned_cols=227 Identities=18% Similarity=0.157 Sum_probs=191.3
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
+..++|++++.||+|+||.||+|++..+++.||||++.............+.+|+++++.++||||+++++++.+++.+|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 34478999999999999999999999999999999998765555666778889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
|||||++|++|.++++.. ....++..++.||+.||.|||++||+||||||+||||+.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999998642 4566788899999999999999999999999999999999999998554
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
T Consensus 175 -------------------------------------------------------------------------------- 174 (286)
T 3uqc_A 175 -------------------------------------------------------------------------------- 174 (286)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHH---HHHcCCCcCC--CCCCCCHHHHHHHHhhhcc
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLF---NVVGQPLRFP--ETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~---~i~~~~~~~~--~~~~~s~~~~~li~~~L~~ 405 (491)
|++ .++.++|||||||++|||++|+.||.+.+....+. +.+......+ ....+++++.+||.+||+.
T Consensus 175 -~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 246 (286)
T 3uqc_A 175 -TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQG 246 (286)
T ss_dssp -CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCT
T ss_pred -ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHccc
Confidence 222 26889999999999999999999998876543221 1111211111 1246899999999999999
Q ss_pred CCCCCCCcCCChHHhhcC
Q 035713 406 EPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~h 423 (491)
||.+| + +.++++.
T Consensus 247 dP~~R-s----~~el~~~ 259 (286)
T 3uqc_A 247 DGGIR-S----ASTLLNL 259 (286)
T ss_dssp TSSCC-C----HHHHHHH
T ss_pred CCccC-C----HHHHHHH
Confidence 99999 9 8888874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=355.59 Aligned_cols=249 Identities=22% Similarity=0.300 Sum_probs=199.3
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhh--cCCCCccceeeeEEeCc----
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL--LDHPFLPTLYSYFETDK---- 167 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~--l~hp~iv~l~~~~~~~~---- 167 (491)
++|++.+.||+|+||.||+|++ +++.||||++.... ...+.+|+++++. ++||||+++++++....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 6899999999999999999998 48899999986542 2345678888887 78999999999998775
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------HcCcccccCCCCCEEEccCCcEEEee
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH--------MLGIVYRDLKPENVLVRDEGHIMLSD 239 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--------~~givHrDikp~NILl~~~g~vkL~D 239 (491)
.+|+||||+++|+|.+++... .+++..++.++.||+.||.||| ++||+||||||+||||+.++.+||+|
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred eeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 899999999999999999863 5999999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCC
Q 035713 240 FDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPT 319 (491)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (491)
||++..........
T Consensus 191 fg~~~~~~~~~~~~------------------------------------------------------------------ 204 (342)
T 1b6c_B 191 LGLAVRHDSATDTI------------------------------------------------------------------ 204 (342)
T ss_dssp CTTCEEEETTTTEE------------------------------------------------------------------
T ss_pred CCCceecccccccc------------------------------------------------------------------
Confidence 99986543211100
Q ss_pred CccccccccccCccCcchhcCCC------CCCcccccchhhHHHhhhcC----------CCCCCCCC----cHHHHHHHH
Q 035713 320 NVRSMSFVGTHEYLAPEIIRGEG------HGSAVDWWTFGIFLYELLHG----------TTPFKGQG----NRATLFNVV 379 (491)
Q Consensus 320 ~~~~~~~~gt~~y~aPE~l~~~~------~~~~~DiwSlG~il~elltg----------~~Pf~~~~----~~~~~~~i~ 379 (491)
.......+||+.|+|||++.+.. ++.++|||||||++|||++| ..||.... ....+...+
T Consensus 205 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 284 (342)
T 1b6c_B 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 284 (342)
T ss_dssp EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHH
T ss_pred ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHH
Confidence 00111347999999999998763 34689999999999999999 78987642 223333333
Q ss_pred -cCCCcCCCC-----CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 380 -GQPLRFPET-----PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 380 -~~~~~~~~~-----~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
......... ..++..+.+||.+||+.||++||+ +.+|++|
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~i~~~ 330 (342)
T 1b6c_B 285 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKKT 330 (342)
T ss_dssp TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC----HHHHHHH
T ss_pred HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCC----HHHHHHH
Confidence 332222111 134467899999999999999999 8998876
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=387.15 Aligned_cols=245 Identities=24% Similarity=0.328 Sum_probs=200.3
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeC-CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRG-TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
..+..++|++++.||+|+||+||+|++.. +++.||||++.... .......+.+|+++|+.++||||++++++|...+
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 34455899999999999999999999986 78999999986542 2345567789999999999999999999998765
Q ss_pred e-----EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccc
Q 035713 168 F-----YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242 (491)
Q Consensus 168 ~-----~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGl 242 (491)
. .||||||++|++|.+++.. .+++..++.|+.||+.||.|||++|||||||||+||||+.+ .+||+|||+
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEeccc
Confidence 4 7999999999999987654 59999999999999999999999999999999999999875 899999999
Q ss_pred ccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcc
Q 035713 243 SLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322 (491)
Q Consensus 243 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (491)
++.....
T Consensus 228 a~~~~~~------------------------------------------------------------------------- 234 (681)
T 2pzi_A 228 VSRINSF------------------------------------------------------------------------- 234 (681)
T ss_dssp CEETTCC-------------------------------------------------------------------------
T ss_pred chhcccC-------------------------------------------------------------------------
Confidence 8543210
Q ss_pred ccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhh
Q 035713 323 SMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGL 402 (491)
Q Consensus 323 ~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~ 402 (491)
...+||+.|+|||++.+. ++.++|||||||+||+|++|..||.+..... .........+++.+.+||.+|
T Consensus 235 -~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~ 304 (681)
T 2pzi_A 235 -GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------LPEDDPVLKTYDSYGRLLRRA 304 (681)
T ss_dssp -SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------CCTTCHHHHHCHHHHHHHHHH
T ss_pred -CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc--------ccccccccccCHHHHHHHhhh
Confidence 124799999999999875 4889999999999999999999987532110 000000012467899999999
Q ss_pred hccCCCCCCCcCCChHHhhcCCCcC
Q 035713 403 LVKEPHKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 403 L~~dP~~R~t~~~~~~ell~hpff~ 427 (491)
|+.||.+||+ ..+++.|+|+.
T Consensus 305 l~~dP~~R~~----~~~~l~~~l~~ 325 (681)
T 2pzi_A 305 IDPDPRQRFT----TAEEMSAQLTG 325 (681)
T ss_dssp TCSSGGGSCS----SHHHHHHHHHH
T ss_pred ccCChhhCCC----HHHHHHHHHHH
Confidence 9999999999 78888888875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=324.31 Aligned_cols=191 Identities=16% Similarity=0.085 Sum_probs=138.2
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchh-------hhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCceEEE
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASL-------ASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~-------~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~~~l 171 (491)
..++.|++|.+..++..-.|+.||+|++.+... ..+...+.+.+|+++|+++ .|+||+++++++++++.+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 356788888888888888899999999976421 2334556789999999999 69999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||++|++|.+++... +.+++. .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 320 VMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~-- 392 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD-- 392 (569)
T ss_dssp EEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred EEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC--
Confidence 99999999999999874 567764 47899999999999999999999999999999999999999998643211
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
.....+.+||+.
T Consensus 393 --------------------------------------------------------------------~~~~~t~vGTp~ 404 (569)
T 4azs_A 393 --------------------------------------------------------------------CSWPTNLVQSFF 404 (569)
T ss_dssp ---------------------------------------------------------------------CCSHHHHHHHH
T ss_pred --------------------------------------------------------------------CccccCceechh
Confidence 112335799999
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhcCCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPF 366 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf 366 (491)
|||||++.+. +..++|+||+|+++|+|.++..+|
T Consensus 405 YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 405 VFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp HHHHHHC------------------CCCCTTHHHH
T ss_pred hccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 9999999874 667899999999999998765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-30 Score=273.84 Aligned_cols=194 Identities=16% Similarity=0.137 Sum_probs=146.1
Q ss_pred eEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchh-----hhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 97 RLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASL-----ASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 97 ~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~-----~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
...+.||+|+||+||+|+ ..++.+|+|++..... ......+++.+|+++|+.++||||+++..++...+..||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 446789999999999994 4477899998654332 222335668999999999999999966666667777899
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||++|++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 9999999999998765 5689999999999999999999999999999998 999999999976432110
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
... .......+++||+.
T Consensus 485 ~~~---------------------------------------------------------------~~~~~~~~~~GT~~ 501 (540)
T 3en9_A 485 KAV---------------------------------------------------------------DLIVFKKAVLSTHH 501 (540)
T ss_dssp HHH---------------------------------------------------------------HHHHHHHHHHHHCG
T ss_pred ccc---------------------------------------------------------------chhhhhhhhcCCCC
Confidence 000 00001235689999
Q ss_pred ccCcchhcC--CCCCCcccccchhhHHHhhhcCCCCCC
Q 035713 332 YLAPEIIRG--EGHGSAVDWWTFGIFLYELLHGTTPFK 367 (491)
Q Consensus 332 y~aPE~l~~--~~~~~~~DiwSlG~il~elltg~~Pf~ 367 (491)
|||||++.+ ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 502 y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 502 EKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp GGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 999999987 568888999999988888877766653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=235.75 Aligned_cols=134 Identities=20% Similarity=0.129 Sum_probs=109.9
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhH---------------HHHHHHHHHHHHHhhcCCCCccce
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASR---------------NKLLRAQTEREILGLLDHPFLPTL 159 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~---------------~~~~~~~~E~~il~~l~hp~iv~l 159 (491)
.|.+.+.||+|+||.||+|++ .+|+.||||+++....... .....+.+|+++|+.++ | +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 355669999999999999999 7899999999975432111 23556889999999999 5 777
Q ss_pred eeeEEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEee
Q 035713 160 YSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSD 239 (491)
Q Consensus 160 ~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~D 239 (491)
++++.. +..|+||||++|++|.+ +.. .....++.||+.||.|||++||+||||||+||||+ +|.+||+|
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 776654 45699999999999987 321 23557999999999999999999999999999999 99999999
Q ss_pred cccc
Q 035713 240 FDLS 243 (491)
Q Consensus 240 FGla 243 (491)
||+|
T Consensus 236 FG~a 239 (282)
T 1zar_A 236 FPQS 239 (282)
T ss_dssp CTTC
T ss_pred CCCC
Confidence 9998
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=199.60 Aligned_cols=140 Identities=17% Similarity=0.190 Sum_probs=110.2
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcE--EEEEEeecchhh---------------------hHHHHHHHHHHHHHHhhcC
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTY--FAMKVMDKASLA---------------------SRNKLLRAQTEREILGLLD 152 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~--vaiK~i~~~~~~---------------------~~~~~~~~~~E~~il~~l~ 152 (491)
|++.+.||+|+||.||+|++..+|+. ||||+++..... .......+.+|+++|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999778999 999997653211 0112236788999999998
Q ss_pred CCCc--cceeeeEEeCceEEEEEeccCC-C----chHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCcccccCCC
Q 035713 153 HPFL--PTLYSYFETDKFYCLVMEFCSG-G----NLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH-MLGIVYRDLKP 224 (491)
Q Consensus 153 hp~i--v~l~~~~~~~~~~~lV~E~~~g-g----~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~givHrDikp 224 (491)
|++| +.++++ +..||||||+.+ | .|.++... +++..+..++.||+.||.||| ++||+||||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8764 444432 356899999932 3 66665432 345578899999999999999 99999999999
Q ss_pred CCEEEccCCcEEEeeccccccc
Q 035713 225 ENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 225 ~NILl~~~g~vkL~DFGla~~~ 246 (491)
+|||++. .++|+|||+|...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999988 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.81 E-value=4.3e-20 Score=183.85 Aligned_cols=139 Identities=14% Similarity=0.228 Sum_probs=101.6
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhh---------------hHH----HHHHHHHHHHHHhhcCCCCc
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLA---------------SRN----KLLRAQTEREILGLLDHPFL 156 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~---------------~~~----~~~~~~~E~~il~~l~hp~i 156 (491)
|++.++||+|+||.||+|.+. +|+.||||+++..... ... ......+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 999999999999999999986 6899999997642110 000 11123457777777755443
Q ss_pred cceeeeEEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCc--
Q 035713 157 PTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGH-- 234 (491)
Q Consensus 157 v~l~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~-- 234 (491)
. ....+.... .+|||||++|+.|..+.. ...+..++.||+.+|.+||++|||||||||.||||+.+|.
T Consensus 176 ~-vp~p~~~~~-~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 P-VPEPIAQSR-HTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp S-CCCEEEEET-TEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred C-CCeeeeccC-ceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 2 222222222 369999999999865422 2245678899999999999999999999999999998773
Q ss_pred --------EEEeecccccc
Q 035713 235 --------IMLSDFDLSLR 245 (491)
Q Consensus 235 --------vkL~DFGla~~ 245 (491)
+.|+||+-+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 89999997743
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=7.4e-14 Score=133.01 Aligned_cols=140 Identities=17% Similarity=0.181 Sum_probs=111.7
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCceEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~~l 171 (491)
+..|++...++.|+.+.||++... ++.+++|+........ ...+.+|+++|+.+. +..+.++++++.+.+..|+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 357999999999999999999754 6789999986432111 124678999999985 6778899999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM------------------------------------- 214 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~------------------------------------- 214 (491)
||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 88 v~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999999976521 122344678899999999998
Q ss_pred ----------------------cCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 215 ----------------------LGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 215 ----------------------~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999865556799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.38 E-value=6.9e-13 Score=125.75 Aligned_cols=135 Identities=15% Similarity=0.052 Sum_probs=100.4
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCC--ccceeeeEEeCceEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF--LPTLYSYFETDKFYC 170 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~--iv~l~~~~~~~~~~~ 170 (491)
..+|.+....+.|..+.||++.. .+|..+++|+..... ...+.+|+++|+.+.+.+ +.++++++..++..|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 35677655555677799999964 457789999976431 124567999999886444 567899888888899
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC----------------------------------
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG---------------------------------- 216 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---------------------------------- 216 (491)
+||||++|.+|. ... .. ...++.+++..|..||+..
T Consensus 92 ~v~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EEEECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EEEEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 999999999884 111 22 2245677777777777643
Q ss_pred ------------------------cccccCCCCCEEEccCCcEEEeeccccc
Q 035713 217 ------------------------IVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 217 ------------------------ivHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876666799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.32 E-value=3.8e-12 Score=127.05 Aligned_cols=142 Identities=16% Similarity=0.210 Sum_probs=107.1
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEee--cchhhhHHHHHHHHHHHHHHhhcC--CCCccceeeeEEeC---ce
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMD--KASLASRNKLLRAQTEREILGLLD--HPFLPTLYSYFETD---KF 168 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~--~~~~~~~~~~~~~~~E~~il~~l~--hp~iv~l~~~~~~~---~~ 168 (491)
...++.|+.|.++.||++... +..+++|+.. ..... .....+.+|.++|+.|. +..+++++.++.+. +.
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 445788999999999998765 4578899765 32211 12235678999999997 45578999888766 45
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM---------------------------------- 214 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---------------------------------- 214 (491)
.|+||||++|..+.+.. ...++......++.+++..|..||+
T Consensus 116 ~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp CEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred eEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 89999999998885311 1237888889999999999999997
Q ss_pred ------------------------cCcccccCCCCCEEEccCCc--EEEeecccccc
Q 035713 215 ------------------------LGIVYRDLKPENVLVRDEGH--IMLSDFDLSLR 245 (491)
Q Consensus 215 ------------------------~givHrDikp~NILl~~~g~--vkL~DFGla~~ 245 (491)
..++|+|+++.|||++.++. +.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997753 68999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.21 E-value=1.4e-11 Score=119.98 Aligned_cols=133 Identities=15% Similarity=0.119 Sum_probs=99.3
Q ss_pred eeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCC--ccceeeeEEeCc---eEEEE
Q 035713 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPF--LPTLYSYFETDK---FYCLV 172 (491)
Q Consensus 99 ~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~--iv~l~~~~~~~~---~~~lV 172 (491)
++.|+.|.+..||++. ..+++|+.... .....+.+|.++|+.+. +.. +.+++......+ ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568999999999864 45899986432 23456778999998884 333 445555443333 45899
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM-------------------------------------- 214 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-------------------------------------- 214 (491)
||+++|..|...... .++.++...++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp EECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred EcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 999999998754332 27888888899999999999996
Q ss_pred --------------------cCcccccCCCCCEEEcc--CCcEEEeecccccc
Q 035713 215 --------------------LGIVYRDLKPENVLVRD--EGHIMLSDFDLSLR 245 (491)
Q Consensus 215 --------------------~givHrDikp~NILl~~--~g~vkL~DFGla~~ 245 (491)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 13799999999999997 45678999998744
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.90 E-value=2.4e-08 Score=97.05 Aligned_cols=133 Identities=18% Similarity=0.150 Sum_probs=96.0
Q ss_pred eeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCC---CccceeeeEE-eCceEEEEEe
Q 035713 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP---FLPTLYSYFE-TDKFYCLVME 174 (491)
Q Consensus 99 ~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp---~iv~l~~~~~-~~~~~~lV~E 174 (491)
++.++.|....||+. +..+++|+-.. ......+.+|.++|+.|.+. .|.+.+.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456889999999988 45688998532 22345678999999999753 3567776664 4566789999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc---------------------------------------
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML--------------------------------------- 215 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------------------------------------- 215 (491)
|++|..|....-. .++..+...++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 94 KVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred ccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9999988763221 245566666666666666666642
Q ss_pred ---------------------CcccccCCCCCEEEcc---CCcE-EEeecccccc
Q 035713 216 ---------------------GIVYRDLKPENVLVRD---EGHI-MLSDFDLSLR 245 (491)
Q Consensus 216 ---------------------givHrDikp~NILl~~---~g~v-kL~DFGla~~ 245 (491)
.++|+|+++.|||++. ++.+ .|+||+.+..
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 4565 8999998743
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.80 E-value=5.7e-08 Score=92.36 Aligned_cols=132 Identities=17% Similarity=0.146 Sum_probs=94.8
Q ss_pred eeeccCce-EEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCceEEEEEeccCC
Q 035713 101 RLGYGDIG-SVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKFYCLVMEFCSG 178 (491)
Q Consensus 101 ~iG~G~~g-~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~~lV~E~~~g 178 (491)
.+..|..| .||+......+..+++|+-... ....+.+|..+|+.|. +--|.+++.++.+++..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34455555 6999888777888999986432 2335678999999885 33477899999999999999999999
Q ss_pred CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-------------------------------------------
Q 035713 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML------------------------------------------- 215 (491)
Q Consensus 179 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~------------------------------------------- 215 (491)
.++.+..... ......+..++...|.-||..
T Consensus 105 ~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 105 KTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp EEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 8887654432 111223444555555555521
Q ss_pred ---------------CcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 216 ---------------GIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 216 ---------------givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 17899999999999877767799999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=2.4e-07 Score=93.36 Aligned_cols=81 Identities=17% Similarity=0.173 Sum_probs=51.2
Q ss_pred eEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchh-hhH---HHHHHHHHHHHHHhhcCC--C-CccceeeeEEeCceE
Q 035713 97 RLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASL-ASR---NKLLRAQTEREILGLLDH--P-FLPTLYSYFETDKFY 169 (491)
Q Consensus 97 ~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~-~~~---~~~~~~~~E~~il~~l~h--p-~iv~l~~~~~~~~~~ 169 (491)
..++.||.|.++.||+++...+++.|+||....... ... ....++..|.++|+.+.. + .+.+++.+ +....
T Consensus 33 ~~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~ 110 (397)
T 2olc_A 33 LTCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA 110 (397)
T ss_dssp CEEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred eEEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence 346789999999999998766678899998653211 000 122355679999988742 3 34566644 34445
Q ss_pred EEEEeccCCC
Q 035713 170 CLVMEFCSGG 179 (491)
Q Consensus 170 ~lV~E~~~gg 179 (491)
++||||++|.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 7999999774
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.48 E-value=2.1e-06 Score=84.23 Aligned_cols=138 Identities=14% Similarity=0.137 Sum_probs=79.8
Q ss_pred EeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC--CCCccceee------eEEeCceE
Q 035713 98 LLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD--HPFLPTLYS------YFETDKFY 169 (491)
Q Consensus 98 ~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~--hp~iv~l~~------~~~~~~~~ 169 (491)
-++.|+.|..+.||++... +..+++|+.... . ..+..|.++++.|. .-.|++++. +....+..
T Consensus 36 ~~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~ 106 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHTD--SGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL 106 (346)
T ss_dssp EEEECC----CEEEEEEET--TEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred EeeeccccccCcEEEEEeC--CCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence 3456777789999998764 335899998652 1 12234555555553 113444443 22456788
Q ss_pred EEEEeccCCCchH---------------HHHHhCCCC--C---------CCHHH--------------------------
Q 035713 170 CLVMEFCSGGNLH---------------SLRQKQPNK--Y---------FTEDA-------------------------- 197 (491)
Q Consensus 170 ~lV~E~~~gg~L~---------------~~~~~~~~~--~---------l~~~~-------------------------- 197 (491)
++||||++|..+. .+......- . -.+..
T Consensus 107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 186 (346)
T 2q83_A 107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ 186 (346)
T ss_dssp EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence 9999999986542 111110000 0 01110
Q ss_pred -----HHHHHHHHHHHHHHHHH-------------cCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 198 -----ARFFASEVLLALEYLHM-------------LGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 198 -----~~~~~~qi~~aL~~LH~-------------~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
+..+..++..++.+|+. .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11122234445666652 579999999999999888899999999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=2.5e-07 Score=91.68 Aligned_cols=84 Identities=13% Similarity=0.128 Sum_probs=57.3
Q ss_pred ceEeeee-eccCceEEEEEEEe--C----CCcEEEEEEeecch---hhhHHHHHHHHHHHHHHhhcC-C--CCccceeee
Q 035713 96 FRLLKRL-GYGDIGSVYLVELR--G----TNTYFAMKVMDKAS---LASRNKLLRAQTEREILGLLD-H--PFLPTLYSY 162 (491)
Q Consensus 96 y~~~~~i-G~G~~g~V~~a~~~--~----~~~~vaiK~i~~~~---~~~~~~~~~~~~E~~il~~l~-h--p~iv~l~~~ 162 (491)
...++.| +.|....+|++... . ++..+++|+..... ... ...+.+|..+|+.|. + -.+.+++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~ 98 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWI 98 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 3456778 88999999998754 1 15678999865432 101 123567888888885 2 357788887
Q ss_pred EEeC---ceEEEEEeccCCCchH
Q 035713 163 FETD---KFYCLVMEFCSGGNLH 182 (491)
Q Consensus 163 ~~~~---~~~~lV~E~~~gg~L~ 182 (491)
..+. +..|+||||++|..+.
T Consensus 99 ~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 99 ETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp ECSSTTTSSCEEEEECCCCBCCC
T ss_pred ccCCCccCCceEEEEecCCCChh
Confidence 7655 4578999999987653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.13 E-value=2.6e-05 Score=75.65 Aligned_cols=78 Identities=15% Similarity=0.219 Sum_probs=61.1
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC---CCCccceeeeEEeCceEEEE
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD---HPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~---hp~iv~l~~~~~~~~~~~lV 172 (491)
..-++.|+.|.+..+|+... ++..+++|+.... ....+..|.+.|+.|. ...|++++.+....+..|+|
T Consensus 38 i~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv 109 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL 109 (312)
T ss_dssp CCEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred eeeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence 34567899999999999875 3667889987543 1345678999998884 35688999988888899999
Q ss_pred EeccCCCch
Q 035713 173 MEFCSGGNL 181 (491)
Q Consensus 173 ~E~~~gg~L 181 (491)
|||++|..+
T Consensus 110 me~l~G~~~ 118 (312)
T 3jr1_A 110 LEALNKSKN 118 (312)
T ss_dssp EECCCCCCC
T ss_pred EEeccCCCC
Confidence 999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.97 E-value=2.7e-05 Score=78.95 Aligned_cols=77 Identities=17% Similarity=0.219 Sum_probs=45.6
Q ss_pred EeeeeeccCceEEEEEEEeCCCcEEEEEEeecch--hhh--HHHHHHHHHHHHHHhhc---CCCCccceeeeEEeCceEE
Q 035713 98 LLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKAS--LAS--RNKLLRAQTEREILGLL---DHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 98 ~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~--~~~--~~~~~~~~~E~~il~~l---~hp~iv~l~~~~~~~~~~~ 170 (491)
-++.||.|..+.||++.. +++.++||...... ... .....+...|.+++..+ ....+++++.+. .+..+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 467889999999999954 46789999432110 000 00001122344444333 234567777765 45678
Q ss_pred EEEecc-CC
Q 035713 171 LVMEFC-SG 178 (491)
Q Consensus 171 lV~E~~-~g 178 (491)
+||||+ +|
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 77
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.88 E-value=3.3e-05 Score=74.48 Aligned_cols=133 Identities=11% Similarity=0.026 Sum_probs=75.6
Q ss_pred eeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCc-cceeeeEEeCceEEEEEecc-
Q 035713 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFL-PTLYSYFETDKFYCLVMEFC- 176 (491)
Q Consensus 99 ~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~i-v~l~~~~~~~~~~~lV~E~~- 176 (491)
++.|+.|....+|++ ..+++|+...... ......+|..+++.+...++ .+++.++ .+.-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 788999999999998 4588998754311 11112358888877753233 5666543 33346899999
Q ss_pred CCCchHHH------------------HHhCCCC---CCC-HHHHHHHHHH--------------HHHHHHHHHH------
Q 035713 177 SGGNLHSL------------------RQKQPNK---YFT-EDAARFFASE--------------VLLALEYLHM------ 214 (491)
Q Consensus 177 ~gg~L~~~------------------~~~~~~~---~l~-~~~~~~~~~q--------------i~~aL~~LH~------ 214 (491)
+|.+|... ++..... .+. ...+..+... +...+..|..
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 76555310 1111100 011 1122222111 1122222211
Q ss_pred --cCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 215 --LGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 215 --~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
..++|+|+.+.||| ..++.+.|+||..+.
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 13899999999999 567789999998874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.85 E-value=7.3e-05 Score=72.57 Aligned_cols=144 Identities=16% Similarity=0.127 Sum_probs=81.5
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCC--ccceeee------EEe
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF--LPTLYSY------FET 165 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~--iv~l~~~------~~~ 165 (491)
....-++.|+.|....||++... +| .+++|+..... ....+..|..+++.|.... +.+++.. ...
T Consensus 22 ~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~ 94 (322)
T 2ppq_A 22 GSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 94 (322)
T ss_dssp CCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred CcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence 34455678888999999999765 33 68899886521 1123445777777764212 3344321 233
Q ss_pred CceEEEEEeccCCCchHH-----------H---HHhC----CCC---CCC---HHHH-HH-----------HHHHHHHHH
Q 035713 166 DKFYCLVMEFCSGGNLHS-----------L---RQKQ----PNK---YFT---EDAA-RF-----------FASEVLLAL 209 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~-----------~---~~~~----~~~---~l~---~~~~-~~-----------~~~qi~~aL 209 (491)
.+..++||+|++|..+.. . ++.. ... ... +... .. +...+...+
T Consensus 95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~ 174 (322)
T 2ppq_A 95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI 174 (322)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence 467899999999865311 0 1110 000 011 1110 00 011244455
Q ss_pred HHHHH-------cCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 210 EYLHM-------LGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 210 ~~LH~-------~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
++++. .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 66653 369999999999999876656899998874
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.73 E-value=6.6e-05 Score=76.21 Aligned_cols=75 Identities=20% Similarity=0.249 Sum_probs=50.9
Q ss_pred EeeeeeccCceEEEEEEEeC-------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCceE
Q 035713 98 LLKRLGYGDIGSVYLVELRG-------TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKFY 169 (491)
Q Consensus 98 ~~~~iG~G~~g~V~~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~ 169 (491)
-++.|+.|....||++.... +++.|++|+...... ...+.+|..+++.|. +...+++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-----ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc-----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 45778889999999998753 257899998743211 123346888888885 3334677776543
Q ss_pred EEEEeccCCCch
Q 035713 170 CLVMEFCSGGNL 181 (491)
Q Consensus 170 ~lV~E~~~gg~L 181 (491)
.+||||++|..|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 289999987444
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00017 Score=68.83 Aligned_cols=80 Identities=20% Similarity=0.139 Sum_probs=55.6
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCC---CCccceeeeEEeCceEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH---PFLPTLYSYFETDKFYC 170 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h---p~iv~l~~~~~~~~~~~ 170 (491)
.+..-++.+|.|..+.||+++.. +|+.|++|+-....... ...+..|.+.|+.|.- --+++++.+. . -+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TE
T ss_pred CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ce
Confidence 35667889999999999999865 68899999864332111 1245679999998852 2345555542 2 36
Q ss_pred EEEeccCCCch
Q 035713 171 LVMEFCSGGNL 181 (491)
Q Consensus 171 lV~E~~~gg~L 181 (491)
+||||++++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999987653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00016 Score=65.24 Aligned_cols=59 Identities=15% Similarity=0.064 Sum_probs=45.3
Q ss_pred CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCCEEEccCCcEEEe
Q 035713 179 GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEGHIMLS 238 (491)
Q Consensus 179 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~NILl~~~g~vkL~ 238 (491)
.+|.++++.. +..++|+++|.++.|.+.+|.-+-. +.-..+=+-|..|+|..+|.|-+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~ 92 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLA 92 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEEC
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceecc
Confidence 4788888876 5789999999999999999877622 222233345689999999998875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.64 E-value=9.2e-05 Score=73.70 Aligned_cols=142 Identities=15% Similarity=0.213 Sum_probs=85.4
Q ss_pred CCceEeeeeeccCceEEEEEEEeC-------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEe
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRG-------TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFET 165 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~ 165 (491)
+.++ ++.|..|-...+|++.... +++.|++|+.-.. .. ....+.+|.++++.|. +.-..++++++.+
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~ 125 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQ---GVDSLVLESVMFAILAERSLGPQLYGVFPE 125 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC
Confidence 4454 3567778889999998742 3578999985321 11 1233457999998885 3334677776654
Q ss_pred CceEEEEEeccCCCchHH--------------HH---HhCC---CCCC--CHHHHHHHHHHHHH----------------
Q 035713 166 DKFYCLVMEFCSGGNLHS--------------LR---QKQP---NKYF--TEDAARFFASEVLL---------------- 207 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~--------------~~---~~~~---~~~l--~~~~~~~~~~qi~~---------------- 207 (491)
+ +||||++|..|.. .+ +... .+.. -+.++..|..++-.
T Consensus 126 g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
T 3feg_A 126 G----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS 201 (379)
T ss_dssp E----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred c----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence 2 9999999866531 11 1110 1112 24566666654422
Q ss_pred ---HHHHHHH--------cCcccccCCCCCEEEccC----CcEEEeeccccc
Q 035713 208 ---ALEYLHM--------LGIVYRDLKPENVLVRDE----GHIMLSDFDLSL 244 (491)
Q Consensus 208 ---aL~~LH~--------~givHrDikp~NILl~~~----g~vkL~DFGla~ 244 (491)
.+..|.+ ..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2344432 248999999999999876 789999999874
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00015 Score=70.88 Aligned_cols=138 Identities=12% Similarity=0.051 Sum_probs=71.7
Q ss_pred eeeeeccCceE-EEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCC--CCccceeeeEEeCceEEEEEec
Q 035713 99 LKRLGYGDIGS-VYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH--PFLPTLYSYFETDKFYCLVMEF 175 (491)
Q Consensus 99 ~~~iG~G~~g~-V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h--p~iv~l~~~~~~~~~~~lV~E~ 175 (491)
++.|+.|.... +|+.... ++..+++|....... ..+..|+.+++.+.. -.+.+++.+....+ ++|||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEECT-TCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEcC-CCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 34565554444 6676532 256677776543210 123457777777742 23566776643333 689999
Q ss_pred cCCCchHHHHHhC---------------------CC---CCCCHHHHH--------HHH------------HHHHHHHHH
Q 035713 176 CSGGNLHSLRQKQ---------------------PN---KYFTEDAAR--------FFA------------SEVLLALEY 211 (491)
Q Consensus 176 ~~gg~L~~~~~~~---------------------~~---~~l~~~~~~--------~~~------------~qi~~aL~~ 211 (491)
+.+..+.+++... .. ..+...... .+. ..+...+..
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9776654333211 00 112221110 000 111222333
Q ss_pred HH------HcCcccccCCCCCEEEccC----CcEEEeecccccc
Q 035713 212 LH------MLGIVYRDLKPENVLVRDE----GHIMLSDFDLSLR 245 (491)
Q Consensus 212 LH------~~givHrDikp~NILl~~~----g~vkL~DFGla~~ 245 (491)
+. ...++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 31 2369999999999999874 6799999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.0004 Score=67.45 Aligned_cols=137 Identities=15% Similarity=0.125 Sum_probs=77.9
Q ss_pred eeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCC--Cccceeee-----EEeCceEEEE
Q 035713 100 KRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP--FLPTLYSY-----FETDKFYCLV 172 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp--~iv~l~~~-----~~~~~~~~lV 172 (491)
..|+ |....||++... +|+.+++|+....... ...+..|..+++.|... .+++++.. ...++..++|
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 888899987653 4667999998643211 12345688888777421 24444442 2335677899
Q ss_pred EeccCCCchH-----H------H---HHh----CC---CCCCCHHHH----HHH---------------HHHHHHHHHHH
Q 035713 173 MEFCSGGNLH-----S------L---RQK----QP---NKYFTEDAA----RFF---------------ASEVLLALEYL 212 (491)
Q Consensus 173 ~E~~~gg~L~-----~------~---~~~----~~---~~~l~~~~~----~~~---------------~~qi~~aL~~L 212 (491)
|||++|..+. . . ++. .. ...+..... ..+ ...+-..++.+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999885432 0 0 111 00 011221110 011 11111223333
Q ss_pred H-------HcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 213 H-------MLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 213 H-------~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
. ...++|+|+++.|||++ + .+.|+||+.+.
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 2 23589999999999998 4 89999998774
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00014 Score=72.15 Aligned_cols=76 Identities=20% Similarity=0.262 Sum_probs=45.9
Q ss_pred EeeeeeccCceEEEEEEEeC--------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCC-ccceeeeEEeCce
Q 035713 98 LLKRLGYGDIGSVYLVELRG--------TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF-LPTLYSYFETDKF 168 (491)
Q Consensus 98 ~~~~iG~G~~g~V~~a~~~~--------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~-iv~l~~~~~~~~~ 168 (491)
-++.|+.|....+|++.... .+..+++|+..... . . ......|.++|+.|...+ +.++++.+ .+
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~--~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~- 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-D--E-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG- 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-G--G-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-c--c-eecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence 35678888889999998753 13678899875421 1 1 111246888888875333 45777654 22
Q ss_pred EEEEEeccCCCch
Q 035713 169 YCLVMEFCSGGNL 181 (491)
Q Consensus 169 ~~lV~E~~~gg~L 181 (491)
++||||++|..+
T Consensus 110 -~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 -GRIEEWLYGDPL 121 (369)
T ss_dssp -EEEEECCCSEEC
T ss_pred -cEEEEEecCCcC
Confidence 689999988643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00078 Score=68.75 Aligned_cols=76 Identities=14% Similarity=0.256 Sum_probs=49.9
Q ss_pred EeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCc-cceeeeEEeCceEEEEEecc
Q 035713 98 LLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFL-PTLYSYFETDKFYCLVMEFC 176 (491)
Q Consensus 98 ~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~i-v~l~~~~~~~~~~~lV~E~~ 176 (491)
-++.|+.|-...+|++.....+..|++|+..... . ..+ ...+|..+|+.|...++ .++++++. + .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~--~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-D--EII-NREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C-C--SCS-CHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-h--hhc-CHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEee
Confidence 4567888999999999876445789999874321 1 111 11468999998864444 67787773 2 2599999
Q ss_pred CCCch
Q 035713 177 SGGNL 181 (491)
Q Consensus 177 ~gg~L 181 (491)
+|..|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 88554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.44 E-value=0.0011 Score=65.03 Aligned_cols=72 Identities=13% Similarity=0.072 Sum_probs=45.7
Q ss_pred eeee--eccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC---CCCccceeee------EEeCc
Q 035713 99 LKRL--GYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD---HPFLPTLYSY------FETDK 167 (491)
Q Consensus 99 ~~~i--G~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~---hp~iv~l~~~------~~~~~ 167 (491)
++.| |.|....||++... +| .+++|+...... ..|..+++.|. -++|++.+.. ....+
T Consensus 26 ~~~l~~G~g~~N~vy~v~~~-~g-~~vLK~~~~~~~---------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g 94 (339)
T 3i1a_A 26 AQFIQGGADTNAFAYQADSE-SK-SYFIKLKYGYHD---------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKH 94 (339)
T ss_dssp EEEETTTSCSSCEEEEEECS-SC-EEEEEEEECSSC---------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSS
T ss_pred eEEeeccCccccceEEEEeC-CC-CEEEEEecCccc---------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECC
Confidence 3445 33446899998754 34 899998765431 24666666553 2335555432 24467
Q ss_pred eEEEEEeccCCCch
Q 035713 168 FYCLVMEFCSGGNL 181 (491)
Q Consensus 168 ~~~lV~E~~~gg~L 181 (491)
..++||+|++|..+
T Consensus 95 ~~~~l~~~i~G~~~ 108 (339)
T 3i1a_A 95 FKIIAYPFIHAPNG 108 (339)
T ss_dssp EEEEEEECCCCCBT
T ss_pred EEEEEEeccCCCcC
Confidence 88999999998765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0031 Score=63.52 Aligned_cols=76 Identities=16% Similarity=0.280 Sum_probs=49.7
Q ss_pred EeeeeeccCceEEEEEEEeCC-------CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCceE
Q 035713 98 LLKRLGYGDIGSVYLVELRGT-------NTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKFY 169 (491)
Q Consensus 98 ~~~~iG~G~~g~V~~a~~~~~-------~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~ 169 (491)
-++.|..|-...+|++..... ++.|++|+..... ...+ ...+|.++++.|. +.-..++++.+. +
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~~--~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFY-DSKVELDVFRYLSNINIAPNIIADFP--E-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCC-CHHHHHHHHHHHHHTTSSCCEEEEET--T--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhc-CHHHHHHHHHHHHhcCCCCCEEEEcC--C--
Confidence 456677788899999987631 5779999864321 1111 1246888888875 333567776442 2
Q ss_pred EEEEeccCCCch
Q 035713 170 CLVMEFCSGGNL 181 (491)
Q Consensus 170 ~lV~E~~~gg~L 181 (491)
++||||++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 689999998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.75 E-value=0.027 Score=56.24 Aligned_cols=28 Identities=29% Similarity=0.504 Sum_probs=24.3
Q ss_pred cccccCCCCCEEE------ccCCcEEEeeccccc
Q 035713 217 IVYRDLKPENVLV------RDEGHIMLSDFDLSL 244 (491)
Q Consensus 217 ivHrDikp~NILl------~~~g~vkL~DFGla~ 244 (491)
++|.|+.+.|||+ +.++.++|+||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6899999999999 446779999999874
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=89.81 E-value=0.025 Score=57.72 Aligned_cols=64 Identities=6% Similarity=0.017 Sum_probs=18.4
Q ss_pred eEeeeeeccCceEEEEEEEeCCCcEEEE------EEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEE
Q 035713 97 RLLKRLGYGDIGSVYLVELRGTNTYFAM------KVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFE 164 (491)
Q Consensus 97 ~~~~~iG~G~~g~V~~a~~~~~~~~vai------K~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 164 (491)
.+.++|| ||+||++........||+ |..+... ...+....+.+|..+++.++|||+++.+.+..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~-~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDG-VSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCcccccccc-ccccccccccccccccccccccccCCCcceEE
Confidence 4456676 999999999865567888 6654332 22344456778999999999999999988653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.30 E-value=0.75 Score=41.34 Aligned_cols=83 Identities=11% Similarity=-0.048 Sum_probs=60.1
Q ss_pred CCCCccceeeeEEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHH-HHHHcCcccccCCCCCEEEc
Q 035713 152 DHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE-YLHMLGIVYRDLKPENVLVR 230 (491)
Q Consensus 152 ~hp~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~-~LH~~givHrDikp~NILl~ 230 (491)
.||++ -..+-.+++.+.|.++.-+++.=+.-++. ++....+.++.+|+.... +++ .-+|--|.|+||+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-----~~~~eKlrll~nl~~L~~~~~~--~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-----TTLLSRIRAAIHLVSKVKHHSA--RRLIFIVCPENLMFN 118 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-----SCHHHHHHHHHHHHHHHSSCCS--SSEECCCCGGGEEEC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-----cCHHHHHHHHHHHHHHHHHhhh--CceeEEEeCceEEEe
Confidence 57777 44444677888787776544433333433 788888888888777665 443 447778899999999
Q ss_pred cCCcEEEeecccc
Q 035713 231 DEGHIMLSDFDLS 243 (491)
Q Consensus 231 ~~g~vkL~DFGla 243 (491)
.++.++|.-.|+-
T Consensus 119 ~~~~p~i~hRGi~ 131 (219)
T 4ano_A 119 RALEPFFLHVGVK 131 (219)
T ss_dssp TTCCEEESCCEET
T ss_pred CCCcEEEEEcCCc
Confidence 9999999999975
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.20 E-value=0.41 Score=42.89 Aligned_cols=83 Identities=11% Similarity=0.124 Sum_probs=61.9
Q ss_pred CCCCccceeeeEEeCceEEEEEeccC-CCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEc
Q 035713 152 DHPFLPTLYSYFETDKFYCLVMEFCS-GGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVR 230 (491)
Q Consensus 152 ~hp~iv~l~~~~~~~~~~~lV~E~~~-gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~ 230 (491)
.||+++.. .+-.+++.+.+.++.-. +-++.. ++. ++....+.++.+|+....+++ .-+|--|.|+||+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~-----~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~ 113 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS-----FTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFT 113 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG-----SCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh-----cCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEc
Confidence 58888877 56667777777777654 233333 333 788888899988888775443 347778899999999
Q ss_pred cCCcEEEeecccc
Q 035713 231 DEGHIMLSDFDLS 243 (491)
Q Consensus 231 ~~g~vkL~DFGla 243 (491)
.++.+++.-.|+-
T Consensus 114 ~~~~p~i~~RGik 126 (215)
T 4ann_A 114 RDGLPIAKTRGLQ 126 (215)
T ss_dssp TTSCEEESCCEET
T ss_pred CCCCEEEEEccCc
Confidence 9999999999875
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=85.09 E-value=2.9 Score=39.94 Aligned_cols=139 Identities=17% Similarity=0.236 Sum_probs=74.0
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeee------------
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSY------------ 162 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~------------ 162 (491)
+++.++.+-.|..|.++... ++..|+||-. ..+ ..+.+-.++...-.+.-|+.--+...
T Consensus 70 ~v~~I~~s~~Gstgvff~~t---d~~~~VVK~s--~~l----~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~~~L~ 140 (342)
T 1cja_A 70 QFKGIERSEKGTEGLFFVET---ESGVFIVKRS--TNI----ESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLA 140 (342)
T ss_dssp GEEEEEECCSTTSCEEEEEE---SSCEEEEECC--TTH----HHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHH
T ss_pred CeeEEEeccCCCCCeEEEEe---CCCEEEEeCc--HHH----HHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHHHHHH
Confidence 47788888788765555444 3668899943 122 22222233333333444442111100
Q ss_pred -----E-----EeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC----ccc-ccCCCCCE
Q 035713 163 -----F-----ETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG----IVY-RDLKPENV 227 (491)
Q Consensus 163 -----~-----~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g----ivH-rDikp~NI 227 (491)
+ ...+..+++|||.+|..|..+-...-...+.++..+.+. -+.+++.+..++ .+. .--.++||
T Consensus 141 ~~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~LG--~Ii~FDi~InN~DR~Pl~W~n~GN~~NI 218 (342)
T 1cja_A 141 AIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLG--SLMALDVIVNNSDRLPIAWTNEGNLDNI 218 (342)
T ss_dssp HHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHH--HHHHHHHHHTCCSSSCSSSCSCCCGGGE
T ss_pred HhhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHHHHhhc--hhheehhhhcCCccCcccccCCCChhhe
Confidence 0 012356799999998777643211100114444433322 144566666653 222 23578999
Q ss_pred EEccCC-cEEEeeccccc
Q 035713 228 LVRDEG-HIMLSDFDLSL 244 (491)
Q Consensus 228 Ll~~~g-~vkL~DFGla~ 244 (491)
|++.++ .+.++|-+++.
T Consensus 219 L~~~~n~~~~~IDhn~af 236 (342)
T 1cja_A 219 MLSERGATVVPIDSKIIP 236 (342)
T ss_dssp EEESBTTCEEECSCCCCC
T ss_pred EEeCCCCeEEEEcCCccc
Confidence 998654 48899999884
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=81.73 E-value=37 Score=35.90 Aligned_cols=82 Identities=15% Similarity=0.301 Sum_probs=48.0
Q ss_pred cceeeeEEeCceEEEEEeccCCCchHHHHHhCC-----------C--CCC--CHHHHHHHHHHHH--HHHHHHHHcCccc
Q 035713 157 PTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQP-----------N--KYF--TEDAARFFASEVL--LALEYLHMLGIVY 219 (491)
Q Consensus 157 v~l~~~~~~~~~~~lV~E~~~gg~L~~~~~~~~-----------~--~~l--~~~~~~~~~~qi~--~aL~~LH~~givH 219 (491)
++.|.+.......-| .|+++..+|.+++...+ . ..+ .......++.+++ +-+.|+= ||
T Consensus 476 i~~Y~Vipls~~~GL-IE~V~s~tl~~i~~~~~~l~~~f~~~~p~~~~~~~~~~~ar~nF~~SlA~~Svv~YIL--Gl-- 550 (696)
T 2x6h_A 476 LTPYKVLATSSKHGF-LQYVDSCTVAEVLAREGNIHNFFRKHHPCDNGPYGISAEVMDTYIKSCAGYCVITYLL--GV-- 550 (696)
T ss_dssp CCCCCEEESSTTCEE-EECCCCEEHHHHHHHSSSHHHHHHHHSBCTTSSSSBCHHHHHHHHHHHHHHHHHHHHH--TC--
T ss_pred EeccEEEeccCCCCe-eeeCCCccHHHHHHhcChHHHHHHHHCCCccchhhhHHHHHHHHHHHHHHHHHHHHHc--cC--
Confidence 445555544433323 46666666666655431 0 011 1233444554443 3344443 33
Q ss_pred ccCCCCCEEEccCCcEEEeecccc
Q 035713 220 RDLKPENVLVRDEGHIMLSDFDLS 243 (491)
Q Consensus 220 rDikp~NILl~~~g~vkL~DFGla 243 (491)
+|=+++||||+.+|++.=+|||.+
T Consensus 551 GDRH~~NILid~tG~v~HIDFG~~ 574 (696)
T 2x6h_A 551 GDRHLDNLLLTTNGKLFHIDFGYI 574 (696)
T ss_dssp CCCCTTTEEECTTSCEEECCCCSC
T ss_pred CCCCCcceEEeCCCCEEEEeehhh
Confidence 688899999999999999999986
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 491 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-53 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-47 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-45 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-44 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-44 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-24 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-28 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-41 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-24 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-41 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-30 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-27 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-26 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-24 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-23 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-23 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-39 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-27 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-37 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-16 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-33 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-20 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-36 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-36 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-16 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-36 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-36 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-18 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-21 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-36 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-35 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-35 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-28 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-24 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-34 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-16 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-34 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-34 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-18 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-33 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-29 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-32 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-20 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-32 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-16 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-32 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-31 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-30 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-14 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-18 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-28 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-26 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-16 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 9e-53
Identities = 68/344 (19%), Positives = 112/344 (32%), Gaps = 45/344 (13%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+F + LG G+ G V+ V + + A K++ + + E ++L + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNSP 64
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH- 213
++ Y F +D + ME GG+L + +K E + V+ L YL
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 214 MLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILND 273
I++RD+KP N+LV G I L DF +S G L D
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-------------------------GQLID 157
Query: 274 EYAVHGCMQPSTFFPRILPSKKNRKSKSD---FGPCVGGALPELMAEPTNVRSMSFVGTH 330
A S P L +SD G L E+ +
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSV-QSDIWSMG-LS---LVEMA---VGRYPIPPPDAK 209
Query: 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQ 390
E + EG + +G L +V +P +
Sbjct: 210 ELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGV 269
Query: 391 VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALV 434
S +D + L+K P +R ++ H F + + V
Sbjct: 270 FSLEFQDFVNKCLIKNPAERA----DLKQLMVHAFIKRSDAEEV 309
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 162 bits (412), Expect = 8e-47
Identities = 76/358 (21%), Positives = 137/358 (38%), Gaps = 80/358 (22%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD 152
L +F++L+ LG G G V+L+ R Y+AMKV+ K + ++ ER +L ++
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
HPF+ ++ F + + + +A Y
Sbjct: 63 HPFIIRMWGT------------FQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA 110
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILN 272
+ + L ++++ RD +K +
Sbjct: 111 AEVCLALEYLHSKDIIYRD---------------------LKPEN--------------- 134
Query: 273 DEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332
IL K +DFG A+ + + GT +Y
Sbjct: 135 -----------------ILLDKNGHIKITDFG----------FAKYVPDVTYTLCGTPDY 167
Query: 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVS 392
+APE++ + + ++DWW+FGI +YE+L G TPF T ++ LRFP P +
Sbjct: 168 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--PFFN 225
Query: 393 FVARDLIRGLLVKEPHKRIAYKR-GATEIKQHPFFEGVNWA--LVRSALPPHIPEPVD 447
+DL+ L+ ++ +R+ + G ++K HP+F+ V W L R+ P+ P
Sbjct: 226 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQ 283
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 9e-45
Identities = 60/340 (17%), Positives = 113/340 (33%), Gaps = 85/340 (25%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
I + +R+G G G+VY + G A+K+++ + + +L + E +L
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP-TPQQLQAFKNEVGVLRK 60
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
H + + T +V ++C G +L+ K F A + ++
Sbjct: 61 TRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMD 118
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGI 270
YLH I++ RD +KS+++ ++
Sbjct: 119 YLHAKSIIH----------RD---------------------LKSNNIFLH--------- 138
Query: 271 LNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330
+I DFG + + G+
Sbjct: 139 -------------EDLTVKI----------GDFGLAT-----VKSRWSGSHQFEQLSGSI 170
Query: 331 EYLAPEIIRGEGHG---SAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE 387
++APE+IR + D + FGI LYEL+ G P+ NR + +VG+ P+
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230
Query: 388 TPQ----VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423
+ + L+ L K+ +R +I
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPL----FPQILAS 266
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 156 bits (394), Expect = 4e-44
Identities = 68/341 (19%), Positives = 118/341 (34%), Gaps = 53/341 (15%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILG-LLDH 153
+++L+++LG G V+ N +K++ + + E +IL L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK------KIKREIKILENLRGG 89
Query: 154 PFLPTLYSYFE--TDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEY 211
P + TL + + LV E + + L Q T+ RF+ E+L AL+Y
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDY 144
Query: 212 LHMLGIVYRDLKPENVLVRDEG-HIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGI 270
H +GI++RD+KP NV++ E + L D+ L+
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH----------------------- 181
Query: 271 LNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330
+ P +L + D +L ++A + F G
Sbjct: 182 -PGQEYNVRVASRYFKGPELLVDYQMYDYSLDM-----WSLGCMLASMIFRKEPFFHGHD 235
Query: 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQ 390
Y I + G+ + + EL G+ +R V +
Sbjct: 236 NYDQLVRIA-KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQ----HL 290
Query: 391 VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNW 431
VS A D + LL + R+ A E +HP+F V
Sbjct: 291 VSPEALDFLDKLLRYDHQSRL----TAREAMEHPYFYTVVK 327
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 5e-44
Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 4/149 (2%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+ ++ LG G G VY + + T+ A KV+D S + E +IL DHP
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV---EIDILASCDHP 69
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
+ L F + +++EFC+GG + ++ + + TE + + L AL YLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD 128
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
I++RDLK N+L +G I L+DF +S
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVS 157
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.7 bits (248), Expect = 5e-24
Identities = 33/156 (21%), Positives = 57/156 (36%), Gaps = 21/156 (13%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336
+H ++ IL + +DFG T R SF+GT ++APE
Sbjct: 132 IHRDLKAGN----ILFTLDGDIKLADFGVSA-------KNTRTIQRRDSFIGTPYWMAPE 180
Query: 337 II-----RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV-GQPLRFPETPQ 390
++ + + D W+ GI L E+ P L + +P + +
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR 240
Query: 391 VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
S +D ++ L K R +++ QHPF
Sbjct: 241 WSSNFKDFLKKCLEKNVDARW----TTSQLLQHPFV 272
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 1e-43
Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 2/159 (1%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD 152
L +F + + LG G G+VYL + + A+KV+ KA L + + E EI L
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
HP + LY YF L++E+ G ++ QK F E + +E+ AL Y
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYC 122
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251
H +++RD+KPEN+L+ G + ++DF S+ S
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 161
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 4e-28
Identities = 42/150 (28%), Positives = 61/150 (40%), Gaps = 19/150 (12%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336
+H ++P +L +DFG + R + GT +YL PE
Sbjct: 128 IHRDIKPEN----LLLGSAGELKIADFG---------WSVHAPSSRRTTLCGTLDYLPPE 174
Query: 337 IIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVAR 396
+I G H VD W+ G+ YE L G PF+ + T + FP V+ AR
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGAR 232
Query: 397 DLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
DLI LL P +R E+ +HP+
Sbjct: 233 DLISRLLKHNPSQRP----MLREVLEHPWI 258
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 3e-43
Identities = 54/164 (32%), Positives = 89/164 (54%), Gaps = 2/164 (1%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+F+ K LG G +V L T+ +A+K+++K + NK+ ER+++ LDHP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
F LY F+ D+ + + G L +K F E RF+ +E++ ALEYLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 126
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258
GI++RDLKPEN+L+ ++ HI ++DF + S +++S
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 170
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 5e-35
Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 271 LNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330
L+ + +H ++P IL ++ +DFG L E R+ SFVGT
Sbjct: 124 LHGKGIIHRDLKPEN----ILLNEDMHIQITDFGTAK-----VLSPESKQARANSFVGTA 174
Query: 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQ 390
+Y++PE++ + + D W G +Y+L+ G PF+ ++ FPE +
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--K 232
Query: 391 VSFVARDLIRGLLVKEPHKRIAYK--RGATEIKQHPFFEGVNWALVRSALPPHIP 443
ARDL+ LLV + KR+ + G +K HPFFE V W + PP +
Sbjct: 233 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 4e-43
Identities = 71/377 (18%), Positives = 114/377 (30%), Gaps = 108/377 (28%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD 152
+ NF+ ++++G G G VY + T A+K + + + A E +L L+
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN 59
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
HP + L T+ LV EF +L + + ++L L +
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILN 272
H +++RDLKP+N+L+ EG I L+DF L+ V
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-----------------------P 155
Query: 273 DEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332
H + P IL K + D
Sbjct: 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVD------------------------------ 185
Query: 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPET---- 388
W+ G E++ F G LF + E
Sbjct: 186 ----------------IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 389 -----------------------PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425
P + R L+ +L +P+KRI A HPF
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI----SAKAALAHPF 285
Query: 426 FEGVNWALVRSALPPHI 442
F+ V + PH+
Sbjct: 286 FQDVTKPV------PHL 296
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 4e-42
Identities = 63/364 (17%), Positives = 114/364 (31%), Gaps = 64/364 (17%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
++ K +G G G VY +L + A+K + + E +I+ LDH
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHC 73
Query: 155 FLPTLYSYFET------DKFYCLVMEFCSGGNLHSLRQ-KQPNKYFTEDAARFFASEVLL 207
+ L +F + + + LV+++ R + + + + ++
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 208 ALEYLHMLGIVYRDLKPENVLVRDEGHIM-LSDFDLSLRCSVSPTLVKSSSVSVNNGSGG 266
+L Y+H GI +RD+KP+N+L+ + ++ L DF + +
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV------------------- 174
Query: 267 GGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326
E V P ++ + S D G L EL+ + F
Sbjct: 175 -----RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSA-GCVLAELL-----LGQPIF 223
Query: 327 VGTHEY-LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF 385
G EII+ G + + P
Sbjct: 224 PGDSGVDQLVEIIKVLGTPTREQIRE--------------MNPNYTEFKFPQIKAHPWTK 269
Query: 386 PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEP 445
P+ A L LL P R+ E H FF+ + V+ P
Sbjct: 270 VFRPRTPPEAIALCSRLLEYTPTARL----TPLEACAHSFFDELRDPNVKLPNGRDTPAL 325
Query: 446 VDFS 449
+F+
Sbjct: 326 FNFT 329
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 9e-42
Identities = 73/335 (21%), Positives = 118/335 (35%), Gaps = 50/335 (14%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD 152
+ + L+++G G G+V+ + R T+ A+K + A E +L L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK 59
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
H + L+ +DK LV EFC N + + F ++L L +
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKY--FDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILN 272
H +++RDLKP+N+L+ G + L++F L+ +
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP----------------------- 154
Query: 273 DEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332
+ P +L K + D G EL N F G
Sbjct: 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMW-SAGCIFAELA----NAGRPLFPGNDVD 209
Query: 333 -LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQV 391
I R G + W + L P+ +L NVV P++
Sbjct: 210 DQLKRIFRLLGTPTEEQWPSM-----TKLPDYKPYPMYPATTSLVNVV---------PKL 255
Query: 392 SFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
+ RDL++ LL P +RI A E QHP+F
Sbjct: 256 NATGRDLLQNLLKCNPVQRI----SAEEALQHPYF 286
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (376), Expect = 1e-41
Identities = 41/158 (25%), Positives = 63/158 (39%), Gaps = 2/158 (1%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
F L+ +G+G G+VY + A+K M + S K E L L HP
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML 215
+ + LVME+C G L K E L L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 216 GIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253
+++RD+K N+L+ + G + L DF + + + + V
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV 172
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 100 bits (250), Expect = 3e-24
Identities = 36/175 (20%), Positives = 58/175 (33%), Gaps = 25/175 (14%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336
+H ++ IL S+ DFG + SFVGT ++APE
Sbjct: 137 IHRDVKAGN----ILLSEPGLVKLGDFGSAS-----------IMAPANSFVGTPYWMAPE 181
Query: 337 IIRGEGHG---SAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSF 393
+I G VD W+ GI EL P + L+++ ++ S
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 241
Query: 394 VARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEPVDF 448
R+ + L K P R + + +H F + + I D
Sbjct: 242 YFRNFVDSCLQKIPQDRP----TSEVLLKHRFVLR---ERPPTVIMDLIQRTKDA 289
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 149 bits (376), Expect = 3e-41
Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 6/153 (3%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD 152
L ++ + + LG G G V+ V R T FA K + + + + + E + + +L
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVLR 81
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
HP L L+ FE D ++ EF SGG L + NK +ED A + +V L ++
Sbjct: 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHM 140
Query: 213 HMLGIVYRDLKPENVLV--RDEGHIMLSDFDLS 243
H V+ DLKPEN++ + + L DF L+
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 173
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 118 bits (296), Expect = 4e-30
Identities = 42/172 (24%), Positives = 66/172 (38%), Gaps = 16/172 (9%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336
VH ++P + N DFG GT E+ APE
Sbjct: 146 VHLDLKPENIM--FTTKRSNELKLIDFGLTA--------HLDPKQSVKVTTGTAEFAAPE 195
Query: 337 IIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPET--PQVSFV 394
+ G+ G D W+ G+ Y LL G +PF G+ + TL NV ++ +S
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255
Query: 395 ARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEPV 446
+D IR LL+ +P+ R+ + +HP+ N S +P +
Sbjct: 256 GKDFIRKLLLADPNTRM----TIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 303
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 149 bits (377), Expect = 3e-41
Identities = 51/164 (31%), Positives = 87/164 (53%), Gaps = 5/164 (3%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
+ +++F + + +G G G VY T +AMK +DK + + A ER +L L
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 151 L---DHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLL 207
+ D PF+ + F T +++ +GG+LH + + F+E RF+A+E++L
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIIL 118
Query: 208 ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251
LE++H +VYRDLKP N+L+ + GH+ +SD L+ S
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 162
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 109 bits (272), Expect = 9e-27
Identities = 48/174 (27%), Positives = 85/174 (48%), Gaps = 18/174 (10%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336
V+ ++P+ IL + SD G L + + + + VGTH Y+APE
Sbjct: 129 VYRDLKPAN----ILLDEHGHVRISDLG---------LACDFSKKKPHASVGTHGYMAPE 175
Query: 337 II-RGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATL-FNVVGQPLRFPETPQVSFV 394
++ +G + S+ DW++ G L++LL G +PF+ + + + + S
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235
Query: 395 ARDLIRGLLVKEPHKRI-AYKRGATEIKQHPFFEGVNWALV--RSALPPHIPEP 445
R L+ GLL ++ ++R+ RGA E+K+ PFF ++W +V + PP IP
Sbjct: 236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPR 289
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 147 bits (373), Expect = 8e-41
Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 6/155 (3%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+ +L+ LG G G V+ + T F K ++ + + E I+ L HP
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLHHP 86
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
L L+ FE L++EF SGG L + K +E + + L+++H
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE 145
Query: 215 LGIVYRDLKPENVLVR--DEGHIMLSDFDLSLRCS 247
IV+ D+KPEN++ + + DF L+ + +
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 106 bits (266), Expect = 4e-26
Identities = 48/166 (28%), Positives = 69/166 (41%), Gaps = 17/166 (10%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336
VH ++P K + DFG + T E+ APE
Sbjct: 149 VHLDIKPENIM--CETKKASSVKIIDFGLAT--------KLNPDEIVKVTTATAEFAAPE 198
Query: 337 IIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPET--PQVSFV 394
I+ E G D W G+ Y LL G +PF G+ + TL NV F E VS
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 258
Query: 395 ARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPP 440
A+D I+ LL KEP KR+ + +HP+ +G + + + S +P
Sbjct: 259 AKDFIKNLLQKEPRKRL----TVHDALEHPWLKG-DHSNLTSRIPS 299
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-40
Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 4/166 (2%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD 152
+ ++ L++ LG G G V L R T A+K++D + + E I +L+
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLN 61
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
H + Y + L +E+CSGG L + + E A+ F +++ + YL
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYL 119
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258
H +GI +RD+KPEN+L+ + ++ +SDF L+ + + +
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 165
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.3 bits (247), Expect = 4e-24
Identities = 32/158 (20%), Positives = 59/158 (37%), Gaps = 15/158 (9%)
Query: 271 LNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330
L+ H ++P +L +++ SDFG GT
Sbjct: 119 LHGIGITHRDIKPEN----LLLDERDNLKISDFGLAT-----VFRYNNRERLLNKMCGTL 169
Query: 331 EYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLF-NVVGQPLRFPET 388
Y+APE+++ H VD W+ GI L +L G P+ + + + +
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 229
Query: 389 PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
++ L+ +LV+ P RI +IK+ ++
Sbjct: 230 KKIDSAPLALLHKILVENPSARI----TIPDIKKDRWY 263
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (363), Expect = 3e-40
Identities = 40/170 (23%), Positives = 77/170 (45%), Gaps = 10/170 (5%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
++ +L +G G G + + K +D S+ + + +E +L L HP
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHP 63
Query: 155 FLPTLYSYF--ETDKFYCLVMEFCSGGNLHSL--RQKQPNKYFTEDAARFFASEVLLALE 210
+ Y T+ +VME+C GG+L S+ + + +Y E+ +++ LAL+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 211 YLHMLG-----IVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKS 255
H +++RDLKP NV + + ++ L DF L+ + + K+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (238), Expect = 6e-23
Identities = 32/150 (21%), Positives = 56/150 (37%), Gaps = 18/150 (12%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336
+H ++P+ + K DFG + + +FVGT Y++PE
Sbjct: 136 LHRDLKPAN----VFLDGKQNVKLGDFGLAR-------ILNHDTSFAKAFVGTPYYMSPE 184
Query: 337 IIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV-GQPLRFPETPQVSFVA 395
+ + D W+ G LYEL PF + + G+ R P + S
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP--YRYSDEL 242
Query: 396 RDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425
++I +L + + R EI ++P
Sbjct: 243 NEIITRMLNLKDYHRP----SVEEILENPL 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 5e-40
Identities = 69/347 (19%), Positives = 104/347 (29%), Gaps = 57/347 (16%)
Query: 98 LLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE--ILGLLDHPF 155
L LG G +VY + TN A+K + + + RE +L L HP
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML 215
+ L F LV +F ++ + T + + L LEYLH
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 216 GIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEY 275
I++RDLKP N+L+ + G + L+DF G
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADF-------------------------GLAKSFGSPN 154
Query: 276 AVHGCMQPSTFF--PRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY- 332
+ + ++ P +L + D VG L EL+ R G +
Sbjct: 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMW-AVGCILAELLL-----RVPFLPGDSDLD 208
Query: 333 LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVS 392
I G + W P F
Sbjct: 209 QLTRIFETLGTPTEEQW---------------PDMCSLPDYVTFKSFPGIPLHHIFSAAG 253
Query: 393 FVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALP 439
DLI+GL + P RI AT+ + +F LP
Sbjct: 254 DDLLDLIQGLFLFNPCARI----TATQALKMKYFSNRPGPTPGCQLP 296
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (359), Expect = 2e-39
Identities = 64/364 (17%), Positives = 124/364 (34%), Gaps = 80/364 (21%)
Query: 68 VKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGSVYLVELRGTN---TYFAM 124
+ P T D +A+ + I +S ++ + +G G+ G V L+ + A+
Sbjct: 4 IDPFTFEDPN-EAVREFA---KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAI 59
Query: 125 KVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSL 184
K + + + +E I+G DHP + L ++ EF G+L S
Sbjct: 60 KTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF 117
Query: 185 RQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244
+Q + FT + ++YL + N + RD
Sbjct: 118 -LRQNDGQFTVIQLVGMLRGIAAGMKYLADM----------NYVHRD------------- 153
Query: 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFG 304
+ + ++ VN S ++ SDFG
Sbjct: 154 --------LAARNILVN----------------------SNLVCKV----------SDFG 173
Query: 305 PCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL-HGT 363
L + ++PT ++ + APE I+ SA D W++GI ++E++ +G
Sbjct: 174 LSR--FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
Query: 364 TPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYK---RGATEI 420
P+ + N + Q R P L+ K+ + R + ++
Sbjct: 232 RPYWDM-TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
Query: 421 KQHP 424
++P
Sbjct: 291 IRNP 294
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (360), Expect = 2e-39
Identities = 69/353 (19%), Positives = 122/353 (34%), Gaps = 84/353 (23%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
+ LG G V L E + T A+K + K +L + + E +L + HP
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG--SMENEIAVLHKIKHPN 68
Query: 156 LPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHML 215
+ L + SGG+L+ L ++ +
Sbjct: 69 IVALDDI------------YESGGHLY------------------------LIMQLVSG- 91
Query: 216 GIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEY 275
G ++ + + + ++ +++ L+D
Sbjct: 92 GELFDRIVEKGFYTERDASRLIFQVLDAVKY------------------------LHDLG 127
Query: 276 AVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAP 335
VH ++P + ++ SDFG E + GT Y+AP
Sbjct: 128 IVHRDLKPENLL-YYSLDEDSKIMISDFGLS--------KMEDPGSVLSTACGTPGYVAP 178
Query: 336 EIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF--PETPQVSF 393
E++ + + AVD W+ G+ Y LL G PF + + ++ F P +S
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238
Query: 394 VARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEPV 446
A+D IR L+ K+P KR + QHP+ G +AL +I + V
Sbjct: 239 SAKDFIRHLMEKDPEKRF----TCEQALQHPWIAG------DTALDKNIHQSV 281
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-39
Identities = 62/340 (18%), Positives = 101/340 (29%), Gaps = 54/340 (15%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+ L +G G G V A+K + + R E +IL H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65
Query: 154 PFLPTLYSYFETDKF-----YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLA 208
+ + LV L+ ++ + D +F ++L
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRG 121
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGG 268
L+Y+H +++RDLKP N+L+ + + DF L+
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD----------------- 164
Query: 269 GILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328
+ + P I+ + K D G L E+++ F G
Sbjct: 165 ---HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV-GCILAEMLS-----NRPIFPG 215
Query: 329 THEY-LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE 387
H I+ G S D + P K + LF
Sbjct: 216 KHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF----------- 264
Query: 388 TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427
P A DL+ +L PHKRI + HP+ E
Sbjct: 265 -PNADSKALDLLDKMLTFNPHKRI----EVEQALAHPYLE 299
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-39
Identities = 67/361 (18%), Positives = 125/361 (34%), Gaps = 58/361 (16%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH 153
+ +R L+ +G G G+V T A+K + + S RA E +L + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRH 76
Query: 154 PFLPTLYSYFETDKF------YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLL 207
+ L F D+ + LVM F ++ ++ ED +F ++L
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----LGEDRIQFLVYQMLK 132
Query: 208 ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGG 267
L Y+H GI++RDLKP N+ V ++ + + DF L+
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------------------------ 168
Query: 268 GGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327
D + P ++ + D ++ +MAE +++
Sbjct: 169 --RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDI-----WSVGCIMAEMITGKTLFKG 221
Query: 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE 387
H EI++ G A + P + + A++
Sbjct: 222 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL----------- 270
Query: 388 TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEPVD 447
S +A +L+ +LV + +R+ A E HP+FE ++ + + D
Sbjct: 271 -TNASPLAVNLLEKMLVLDAEQRV----TAGEALAHPYFESLHDTEDEPQVQKYDDSFDD 325
Query: 448 F 448
Sbjct: 326 V 326
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 141 bits (356), Expect = 3e-39
Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 9/156 (5%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLL------RAQTEREIL 148
N+ + LG G V + T +A+K++D S + E +IL
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 149 GLL-DHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLL 207
+ HP + L +ET+ F+ LV + G L + +E R +L
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLE 121
Query: 208 ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ LH L IV+RDLKPEN+L+ D+ +I L+DF S
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 157
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 98.2 bits (244), Expect = 1e-23
Identities = 46/158 (29%), Positives = 63/158 (39%), Gaps = 24/158 (15%)
Query: 278 HGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEI 337
H ++P IL +DFG + GT YLAPEI
Sbjct: 133 HRDLKPE----NILLDDDMNIKLTDFGFSC--------QLDPGEKLREVCGTPSYLAPEI 180
Query: 338 IRGE------GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF--PETP 389
I G+G VD W+ G+ +Y LL G+ PF + L ++ +F PE
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 390 QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427
S +DL+ LV +P KR A E HPFF+
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRY----TAEEALAHPFFQ 274
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 6e-39
Identities = 33/153 (21%), Positives = 68/153 (44%), Gaps = 6/153 (3%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+ +++G G G+VY T A++ M+ + ++ E ++ +P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRENKNP 77
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
+ + +VME+ +GG+L + + E E L ALE+LH
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHS 134
Query: 215 LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247
+++RD+K +N+L+ +G + L+DF + +
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (272), Expect = 3e-27
Identities = 40/170 (23%), Positives = 68/170 (40%), Gaps = 19/170 (11%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336
+H ++ L + K +DFG C P + + VGT ++APE
Sbjct: 138 IHRDIKSDNIL---LGMDGSVK-LTDFGFCA-------QITPEQSKRSTMVGTPYWMAPE 186
Query: 337 IIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV-GQPLRFPETPQVSFVA 395
++ + +G VD W+ GI E++ G P+ + L+ + ++S +
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 396 RDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEP 445
RD + L + KR A E+ QH F + A S+L P I
Sbjct: 247 RDFLNRCLDMDVEKRG----SAKELLQHQFLKI---AKPLSSLTPLIAAA 289
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 140 bits (354), Expect = 6e-39
Identities = 66/337 (19%), Positives = 113/337 (33%), Gaps = 54/337 (16%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD 152
+ + L+++G G G VY + FA+K + E IL L
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELK 58
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
H + LY T K LV E L + A+ F ++L + Y
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYC 116
Query: 213 HMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILN 272
H +++RDLKP+N+L+ EG + ++DF L+ +
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP----------------------- 153
Query: 273 DEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332
H + P +L K + D G + M + F G E
Sbjct: 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSV--GCIFAEMVN----GTPLFPGVSEA 207
Query: 333 -LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE-TPQ 390
I R G ++ +W P + + V +PL +
Sbjct: 208 DQLMRIFRILGTPNSKNW---------------PNVTELPKYDPNFTVYEPLPWESFLKG 252
Query: 391 VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427
+ DL+ +L +P++RI A + +H +F+
Sbjct: 253 LDESGIDLLSKMLKLDPNQRI----TAKQALEHAYFK 285
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 8e-39
Identities = 76/342 (22%), Positives = 122/342 (35%), Gaps = 50/342 (14%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD 152
+S + L ++G G G V+ R T A+K + + + A E +IL LL
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK 67
Query: 153 HPFLPTLYSYFETDKFY--------CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASE 204
H + L T LV +FC L FT +
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQM 125
Query: 205 VLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGS 264
+L L Y+H I++RD+K NVL+ +G + L+DF L+ S++ + +
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR---- 181
Query: 265 GGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324
+ P +L +++ D G + E+ RS
Sbjct: 182 ---------------VVTLWYRPPELLLGERDYGPPIDL-WGAGCIMAEMW-----TRSP 220
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR 384
G E +I + GS + YEL KGQ + + + + +R
Sbjct: 221 IMQGNTEQHQLALIS-QLCGSITPEVWPNVDNYELYEKLELVKGQKRK--VKDRLKAYVR 277
Query: 385 FPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF 426
P A DLI LLV +P +RI + + H FF
Sbjct: 278 DPY-------ALDLIDKLLVLDPAQRI----DSDDALNHDFF 308
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-38
Identities = 64/359 (17%), Positives = 115/359 (32%), Gaps = 47/359 (13%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD 152
L ++ LK +G G G V + A+K + + ++ RA E ++ ++
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74
Query: 153 HPFLPTLYSYFETDKF------YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVL 206
H + +L + F K LVME ++ + + + ++L
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQML 129
Query: 207 LALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGG 266
+++LH GI++RDLKP N++V+ + + + DF L+ S
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--------------- 174
Query: 267 GGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326
+ P K D G + E++ + F
Sbjct: 175 ----MTPYVVTRYYRAPEVI------LGMGYKENVDIWSV-GCIMGEMVR-----HKILF 218
Query: 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP 386
G + + ++ P LF P
Sbjct: 219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSE 278
Query: 387 ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEP 445
+ ARDL+ +LV +P KRI + QHP+ A PP I +
Sbjct: 279 HNKLKASQARDLLSKMLVIDPAKRI----SVDDALQHPYINVWYDPAEVEAPPPQIYDK 333
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 4e-38
Identities = 56/152 (36%), Positives = 89/152 (58%), Gaps = 3/152 (1%)
Query: 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL-L 151
+ +F L K LG G G V+L E + TN +FA+K + K + + + E+ +L L
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 152 DHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEY 211
+HPFL ++ F+T + VME+ +GG+L Q F A F+A+E++L L++
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQF 118
Query: 212 LHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
LH GIVYRDLK +N+L+ +GHI ++DF +
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 150
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 7e-35
Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336
V+ ++ IL K +DFG C + ++ +F GT +Y+APE
Sbjct: 125 VYRDLKLDN----ILLDKDGHIKIADFGMCK-------ENMLGDAKTNTFCGTPDYIAPE 173
Query: 337 IIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVAR 396
I+ G+ + +VDWW+FG+ LYE+L G +PF GQ ++ +P + A+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--WLEKEAK 231
Query: 397 DLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALV--RSALPPHIPE---PVDFSVF 451
DL+ L V+EP KR+ +I+QHP F +NW + + PP P+ P D S F
Sbjct: 232 DLLVKLFVREPEKRLGV---RGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNF 288
Query: 452 AGKDQASAAAEKKVVAAAEAAVDHKNGDSPKDSYVEFEY 490
D+ + ++ A A ++ + ++ + F +
Sbjct: 289 ---DKEFLNEKPRLSFADRALINSMD----QNMFRNFSF 320
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (346), Expect = 4e-37
Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 6/197 (3%)
Query: 50 GSSNCSSRSDSLESSSAPVKPHTGGDVRWDAINMISLRGPPIGLSNFRLLKRLGYGDIGS 109
G++ + + ES VK + L F +K LG G G
Sbjct: 1 GNAAAAKKGSEQES----VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGR 56
Query: 110 VYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169
V LV+ + + ++AMK++DK + ++ E+ IL ++ PFL L F+ +
Sbjct: 57 VMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLV 229
+VME+ +GG + S ++ F+E ARF+A++++L EYLH L ++YRDLKPEN+L+
Sbjct: 117 YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI 174
Query: 230 RDEGHIMLSDFDLSLRC 246
+G+I ++DF + R
Sbjct: 175 DQQGYIQVTDFGFAKRV 191
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 109 bits (272), Expect = 6e-27
Identities = 49/143 (34%), Positives = 68/143 (47%), Gaps = 8/143 (5%)
Query: 315 MAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRAT 374
A+ R+ + GT E LAPEII +G+ AVDWW G+ +YE+ G PF
Sbjct: 187 FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 375 LFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKR-GATEIKQHPFFEGVNWAL 433
+V +RFP S +DL+R LL + KR + G +IK H +F +W
Sbjct: 247 YEKIVSGKVRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304
Query: 434 V--RSALPPHIPE---PVDFSVF 451
+ R P IP+ P D S F
Sbjct: 305 IYQRKVEAPFIPKFKGPGDTSNF 327
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 5e-37
Identities = 33/168 (19%), Positives = 70/168 (41%), Gaps = 6/168 (3%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
+ +L++RLG G G V++ G A+K + + S++ E ++
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPD----AFLAEANLMKQ 64
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
L H L LY+ + Y ++ E+ G+L + T + A+++ +
Sbjct: 65 LQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258
++ ++RDL+ N+LV D ++DF L+ + + +
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.2 bits (187), Expect = 4e-16
Identities = 27/152 (17%), Positives = 46/152 (30%), Gaps = 16/152 (10%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336
+H ++ + IL S +DFG L L+ + ++ APE
Sbjct: 131 IHRDLRAA----NILVSDTLSCKIADFG------LARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 337 IIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVAR 396
I D W+FGI L E++ + + + R
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY 240
Query: 397 DLIRGLLVKEPHKRIAYKRGATEIKQ--HPFF 426
L+R + P R ++ FF
Sbjct: 241 QLMRLCWKERPEDRPT----FDYLRSVLEDFF 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 8e-37
Identities = 53/340 (15%), Positives = 110/340 (32%), Gaps = 60/340 (17%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTN-----TYFAMKVMDKASLASRNKLLRAQTER 145
N K LG G G V G + A+K++ + + ++ +E
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSEL 91
Query: 146 EILG-LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASE 204
+++ L H + L L+ E+C G+L + + + K F+ED + +
Sbjct: 92 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREK-FSEDEIEYENQK 150
Query: 205 VLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGS 264
L E L++L + + K
Sbjct: 151 RLEEEEDLNVL-------------------------TFEDLLCFAYQVAK---------- 175
Query: 265 GGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324
G L + VH + +L + DFG ++M++ V
Sbjct: 176 --GMEFLEFKSCVHRDLAARN----VLVTHGKVVKICDFGLAR-----DIMSDSNYVVRG 224
Query: 325 SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL-HGTTPFKGQGNRATLFNVVGQPL 383
+ +++APE + + D W++GI L+E+ G P+ G A + ++
Sbjct: 225 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGF 284
Query: 384 RFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423
+ + + +++ + KR + +
Sbjct: 285 KMDQPFYATEEIYIIMQSCWAFDSRKRPS----FPNLTSF 320
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-36
Identities = 59/153 (38%), Positives = 92/153 (60%), Gaps = 2/153 (1%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
+ +++F LK LG G G V LV + T Y+AMK++ K + +++++ TE +L
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
HPFL L F+T C VME+ +GG L + + FTE+ ARF+ +E++ ALE
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALE 119
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
YLH +VYRD+K EN+++ +GHI ++DF L
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 3e-33
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 19/220 (8%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336
V+ ++ ++ K +DFG C G +F GT EYLAPE
Sbjct: 127 VYRDIKLE----NLMLDKDGHIKITDFGLCKEG-------ISDGATMKTFCGTPEYLAPE 175
Query: 337 IIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVAR 396
++ +G AVDWW G+ +YE++ G PF Q + ++ + +RFP +S A+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAK 233
Query: 397 DLIRGLLVKEPHKRIAYKR-GATEIKQHPFFEGVNWALV--RSALPPHIPE---PVDFSV 450
L+ GLL K+P +R+ A E+ +H FF +NW V + LPP P+ VD
Sbjct: 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRY 293
Query: 451 FAGKDQASAAAEKKVVAAAEAAVDHKNGDSPKDSYVEFEY 490
F + A + + + ++ + +F+Y
Sbjct: 294 FDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDY 333
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 134 bits (338), Expect = 1e-36
Identities = 38/169 (22%), Positives = 74/169 (43%), Gaps = 6/169 (3%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF 155
+ L + LG+G + V+L + A+KV+ + LR + E + L+HP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 156 LPTLYSYFETD----KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEY 211
+ +Y E + +VME+ G L + + T A ++ AL +
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNF 126
Query: 212 LHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSV 260
H GI++RD+KP N+++ + + DF ++ + S V ++ +
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 88.6 bits (219), Expect = 2e-20
Identities = 30/140 (21%), Positives = 53/140 (37%), Gaps = 3/140 (2%)
Query: 276 AVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM-SFVGTHEYLA 334
A++ Q + P+ + + G + +V + +GT +YL+
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 335 PEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPET--PQVS 392
PE RG+ + D ++ G LYE+L G PF G + + V + P +S
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242
Query: 393 FVARDLIRGLLVKEPHKRIA 412
++ L K P R
Sbjct: 243 ADLDAVVLKALAKNPENRYQ 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (338), Expect = 1e-36
Identities = 33/168 (19%), Positives = 71/168 (42%), Gaps = 4/168 (2%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
+ ++ + +LG G G VY + + A+K + + ++ E ++
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLKEAAVMKE 69
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
+ HP L L + + ++ EF + GNL ++ + + + A+++ A+E
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258
YL ++RDL N LV + + ++DF LS + + +
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-36
Identities = 45/189 (23%), Positives = 77/189 (40%), Gaps = 13/189 (6%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
I + LK LG G G V + RG A+K++ + S++ E +++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSED----EFIEEAKVMMN 55
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
L H L LY + ++ E+ + G L + ++ ++ F +V A+E
Sbjct: 56 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAME 114
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGI 270
YL ++RDL N LV D+G + +SDF LS V + + GS
Sbjct: 115 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS-------RYVLDDEYTSSVGSKFPVRW 167
Query: 271 LNDEYAVHG 279
E ++
Sbjct: 168 SPPEVLMYS 176
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.3 bits (187), Expect = 3e-16
Identities = 25/148 (16%), Positives = 50/148 (33%), Gaps = 16/148 (10%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336
+H + L + + SDFG L + + S+ + PE
Sbjct: 122 LHRDLAAR----NCLVNDQGVVKVSDFG------LSRYVLDDEYTSSVGSKFPVRWSPPE 171
Query: 337 IIRGEGHGSAVDWWTFGIFLYELL-HGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVA 395
++ S D W FG+ ++E+ G P++ N T ++ Q LR S
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKV 230
Query: 396 RDLIRGLLVKEPHKRIAYKRGATEIKQH 423
++ ++ +R + +
Sbjct: 231 YTIMYSCWHEKADERPT----FKILLSN 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-36
Identities = 50/336 (14%), Positives = 100/336 (29%), Gaps = 62/336 (18%)
Query: 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREIL 148
P + ++ + +G G+ G V ++ + AS++ E E+L
Sbjct: 5 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 64
Query: 149 G-LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLL 207
L HP + L E + L +E+ GNL +K ++ D A A+
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK--SRVLETDPAFAIANSTAS 122
Query: 208 ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGG 267
L +L + + +
Sbjct: 123 TLSSQQLLHFAADVARG-------------------MDYLSQKQFI-------------- 149
Query: 268 GGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327
H + IL + +DFG + V+
Sbjct: 150 ----------HRDLAARN----ILVGENYVAKIADFGLS--------RGQEVYVKKTMGR 187
Query: 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE 387
++A E + + + D W++G+ L+E++ A L+ + Q R +
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247
Query: 388 TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423
DL+R ++P++R + +I
Sbjct: 248 PLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 279
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 3e-36
Identities = 42/162 (25%), Positives = 69/162 (42%), Gaps = 8/162 (4%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
+ + +LL+ +G G+ G V L + RG A+K + + A E ++
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA-----FLAEASVMTQ 56
Query: 151 LDHPFLPTLYSYF-ETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLAL 209
L H L L E +V E+ + G+L + + D F+ +V A+
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 210 EYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251
EYL V+RDL NVLV ++ +SDF L+ S +
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 158
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.4 bits (203), Expect = 2e-18
Identities = 22/147 (14%), Positives = 51/147 (34%), Gaps = 18/147 (12%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336
VH + +L S+ N SDFG + + + + ++ APE
Sbjct: 125 VHRDLAAR----NVLVSEDNVAKVSDFG----------LTKEASSTQDTGKLPVKWTAPE 170
Query: 337 IIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVAR 396
+R + + D W+FGI L+E+ + + V + +
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 230
Query: 397 DLIRGLLVKEPHKRIAYKRGATEIKQH 423
++++ + R + ++++
Sbjct: 231 EVMKNCWHLDAAMRPS----FLQLREQ 253
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 6e-36
Identities = 67/347 (19%), Positives = 111/347 (31%), Gaps = 63/347 (18%)
Query: 95 NFRLLKRLGYGDIGSVYLV-ELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-- 151
+ + +G G G V+ +L+ + A+K + + L E +L L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLRHLET 66
Query: 152 -DHPFLPTLYSYFETDKF-----YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEV 205
+HP + L+ + LV E + K P + + ++
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMMFQL 125
Query: 206 LLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSG 265
L L++LH +V+RDLKP+N+LV G I L+DF L+ S
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS------------------ 167
Query: 266 GGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325
+ P +L D VG E+ R
Sbjct: 168 ------FQMALTSVVVTLWYRAPEVLLQSSYAT-PVDLW-SVGCIFAEMFR-----RKPL 214
Query: 326 FVGTHEY-LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLR 384
F G+ + +I+ G DW P R + QP+
Sbjct: 215 FRGSSDVDQLGKILDVIGLPGEEDW---------------PRDVALPRQAFHSKSAQPIE 259
Query: 385 FPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNW 431
+ + +DL+ L P KRI A HP+F+ +
Sbjct: 260 -KFVTDIDELGKDLLLKCLTFNPAKRI----SAYSALSHPYFQDLER 301
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 6e-36
Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 17/160 (10%)
Query: 93 LSNFRLLKR-LGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILG-L 150
+ ++++ + LG G G V + + T FA+K++ +A+ E E+
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRA 61
Query: 151 LDHPFLPTLYSYFET----DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVL 206
P + + +E K +VME GG L S Q + ++ FTE A +
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 121
Query: 207 LALEYLHMLGIVYRDLKPENVLV---RDEGHIMLSDFDLS 243
A++YLH + I +RD+KPEN+L R + L+DF +
Sbjct: 122 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.5 bits (229), Expect = 3e-21
Identities = 48/208 (23%), Positives = 78/208 (37%), Gaps = 28/208 (13%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSK-SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAP 335
H ++P + N K +DFG ++ + T Y+AP
Sbjct: 133 AHRDVKPENLL--YTSKRPNAILKLTDFGFA--------KETTSHNSLTTPCYTPYYVAP 182
Query: 336 EIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ------PLRFPETP 389
E++ E + + D W+ G+ +Y LL G PF A + + PE
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 390 QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEPVDFS 449
+VS + LIR LL EP +R+ TE HP+ ++S P P
Sbjct: 243 EVSEEVKMLIRNLLKTEPTQRM----TITEFMNHPWI-------MQSTKVPQTPLHTSRV 291
Query: 450 VFAGKDQASAAAEKKVVAAAEAAVDHKN 477
+ K++ E+ A A VD++
Sbjct: 292 LKEDKERWEDVKEEMTSALATMRVDYEQ 319
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 9e-36
Identities = 41/156 (26%), Positives = 61/156 (39%), Gaps = 5/156 (3%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELR---GTNTYFAMKVMDKASLASRNKLLRAQTEREI 147
IG + RLL++LG G G V E G A+K + L+ + E
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 148 LGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLL 207
+ LDH L LY T +V E G+L +K F +A +V
Sbjct: 65 MHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAE 122
Query: 208 ALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+ YL ++RDL N+L+ + + DF L
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 158
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-35
Identities = 60/355 (16%), Positives = 109/355 (30%), Gaps = 89/355 (25%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
I + RL +LG G G V++ GT A+K + +++ E +++
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE----AFLQEAQVMKK 68
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
L H L LY+ + Y +V E+ S G+L + + KY ++
Sbjct: 69 LRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLP----------QLVD 117
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGI 270
+ ++ N + RD ++++++ V
Sbjct: 118 MAAQIASGMAYVERMNYVHRD---------------------LRAANILVG--------- 147
Query: 271 LNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330
++ +DFG L L+ +
Sbjct: 148 -------------ENLVCKV----------ADFG------LARLIEDNEYTARQGAKFPI 178
Query: 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQ 390
++ APE D W+FGI L EL + + V + R P P+
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 238
Query: 391 VSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ--HPFFEGVNWALVRSALPPHIP 443
DL+ KEP +R ++ +F S P + P
Sbjct: 239 CPESLHDLMCQCWRKEPEERPT----FEYLQAFLEDYF--------TSTEPQYQP 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 2e-35
Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 14/164 (8%)
Query: 91 IGLSN----FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTERE 146
+G+SN + +G G +VY T A + L ++++ R + E E
Sbjct: 2 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAE 60
Query: 147 ILGLLDHPFLPTLYSYFET----DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFA 202
+L L HP + Y +E+ K LV E + G L + ++ K R +
Sbjct: 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWC 118
Query: 203 SEVLLALEYLHMLG--IVYRDLKPENVLVRDE-GHIMLSDFDLS 243
++L L++LH I++RDLK +N+ + G + + D L+
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 4e-26
Identities = 27/153 (17%), Positives = 58/153 (37%), Gaps = 20/153 (13%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSK-SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAP 335
+H ++ I + K D G L + + +GT E++AP
Sbjct: 136 IHRDLKCDN----IFITGPTGSVKIGDLG---------LATLKRASFAKAVIGTPEFMAP 182
Query: 336 EIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQ-VSFV 394
E+ + +VD + FG+ + E+ P+ N A ++ V ++ +
Sbjct: 183 EMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241
Query: 395 ARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427
+++I G + + +R ++ H FF+
Sbjct: 242 VKEIIEGCIRQNKDERY----SIKDLLNHAFFQ 270
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 5e-35
Identities = 66/174 (37%), Positives = 102/174 (58%), Gaps = 9/174 (5%)
Query: 85 SLRGPP--IGLSNFRLLKRLGYGDIGSVYLVEL---RGTNTYFAMKVMDKASLASRNKLL 139
+L G +G+ NF LLK LG G G V+LV T +AMKV+ KA++ + K
Sbjct: 13 NLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT 72
Query: 140 -RAQTEREILGLLDH-PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDA 197
+TER++L + PFL TL+ F+T+ L++++ +GG L + ++ FTE
Sbjct: 73 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHE 130
Query: 198 ARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251
+ + E++LALE+LH LGI+YRD+K EN+L+ GH++L+DF LS T
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 184
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 8e-28
Identities = 56/162 (34%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 290 ILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRG--EGHGSAV 347
IL +DFG + R+ F GT EY+AP+I+RG GH AV
Sbjct: 160 ILLDSNGHVVLTDFGLS------KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV 213
Query: 348 DWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPET--PQVSFVARDLIRGLLVK 405
DWW+ G+ +YELL G +PF G + + + + L+ ++S +A+DLI+ LL+K
Sbjct: 214 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMK 273
Query: 406 EPHKRI-AYKRGATEIKQHPFFEGVNWALV--RSALPPHIPE 444
+P KR+ R A EIK+H FF+ +NW + + P P
Sbjct: 274 DPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPV 315
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 5e-35
Identities = 31/151 (20%), Positives = 63/151 (41%), Gaps = 7/151 (4%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
+ + + LG G+ G V+ + + K + + + E IL + H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHR 61
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
+ L+ FE+ + ++ EF SG ++ + E + +V AL++LH
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS 120
Query: 215 LGIVYRDLKPENVLV--RDEGHIMLSDFDLS 243
I + D++PEN++ R I + +F +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 1e-24
Identities = 42/192 (21%), Positives = 74/192 (38%), Gaps = 19/192 (9%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSK-SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAP 335
H ++P I ++++ K +FG EY AP
Sbjct: 124 GHFDIRPENI---IYQTRRSSTIKIIEFGQAR--------QLKPGDNFRLLFTAPEYYAP 172
Query: 336 EIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPET--PQVSF 393
E+ + + +A D W+ G +Y LL G PF + N+ + N++ F E ++S
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232
Query: 394 VARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEPVDFSVFAG 453
A D + LLVKE R+ A+E QHP+ + V + + + +
Sbjct: 233 EAMDFVDRLLVKERKSRM----TASEALQHPWLKQ-KIERVSTKVIRTLKHRRYYHTLIK 287
Query: 454 KDQASAAAEKKV 465
KD + ++
Sbjct: 288 KDLNMVVSAARI 299
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-34
Identities = 41/169 (24%), Positives = 68/169 (40%), Gaps = 7/169 (4%)
Query: 95 NFRLLKR-LGYGDIGSVYLVELRGTNT--YFAMKVMDKASLASRNKLLRAQTEREILGLL 151
N + LG G+ GSV R A+KV+ + + + E +I+ L
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQL 66
Query: 152 DHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEY 211
D+P++ L + + LVME GG LH + + +V + ++Y
Sbjct: 67 DNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKY 124
Query: 212 LHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSV 260
L V+RDL NVL+ + + +SDF LS + + S
Sbjct: 125 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.1 bits (189), Expect = 2e-16
Identities = 25/152 (16%), Positives = 51/152 (33%), Gaps = 11/152 (7%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336
VH + +L ++ SDFG + + ++ APE
Sbjct: 131 VHRDLAARN----VLLVNRHYAKISDFGLSK----ALGADDSYYTARSAGKWPLKWYAPE 182
Query: 337 IIRGEGHGSAVDWWTFGIFLYELL-HGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVA 395
I S D W++G+ ++E L +G P+K + + Q R P+
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRMECPPECPPEL 241
Query: 396 RDLIRGLLVKEPHKRIAYKRGATEIKQHPFFE 427
L+ + + R + + + ++
Sbjct: 242 YALMSDCWIYKWEDRPDFLT-VEQRMRACYYS 272
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 3e-34
Identities = 69/362 (19%), Positives = 118/362 (32%), Gaps = 63/362 (17%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
++ L +G G GSV T A+K + + S R E +L + H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHE 77
Query: 155 FLPTLYSYFET-----DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLAL 209
+ L F + ++ G +L+++ + Q T+D +F ++L L
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGL 134
Query: 210 EYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGG 269
+Y+H I++RDLKP N+ V ++ + + DF L+ T
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT------------------ 176
Query: 270 ILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329
P I+ + + D VG + EL+ F GT
Sbjct: 177 --------GYVATRWYRAPEIMLNWMHYNQTVDIW-SVGCIMAELL-----TGRTLFPGT 222
Query: 330 HEY-LAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPET 388
I+R G A + + N A +F
Sbjct: 223 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF------------ 270
Query: 389 PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPHIPEPVDF 448
+ +A DL+ +LV + KRI A + H +F + +P D
Sbjct: 271 IGANPLAVDLLEKMLVLDSDKRI----TAAQALAHAYFAQ-----YHDPDDEPVADPYDQ 321
Query: 449 SV 450
S
Sbjct: 322 SF 323
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 3e-34
Identities = 38/152 (25%), Positives = 62/152 (40%), Gaps = 6/152 (3%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL 150
I S ++ +G G G V+L + A+K + + +++ E E++
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEE----DFIEEAEVMMK 56
Query: 151 LDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
L HP L LY CLV EF G L + Q + + +V +
Sbjct: 57 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMA 115
Query: 211 YLHMLGIVYRDLKPENVLVRDEGHIMLSDFDL 242
YL +++RDL N LV + I +SDF +
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGM 147
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.3 bits (200), Expect = 7e-18
Identities = 20/147 (13%), Positives = 47/147 (31%), Gaps = 14/147 (9%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336
+H + L + SDFG + + + S ++ +PE
Sbjct: 123 IHRDLAARN----CLVGENQVIKVSDFG------MTRFVLDDQYTSSTGTKFPVKWASPE 172
Query: 337 IIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVAR 396
+ + S D W+FG+ ++E+ + + + + R + S
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY 232
Query: 397 DLIRGLLVKEPHKRIAYKRGATEIKQH 423
++ + P R A + + +
Sbjct: 233 QIMNHCWKERPEDRPA----FSRLLRQ 255
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 6e-33
Identities = 52/367 (14%), Positives = 113/367 (30%), Gaps = 81/367 (22%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKA--SLASRNKLLRAQTEREIL 148
+ + F+ +K LG G G+VY + V K S E ++
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 149 GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLA 208
+D+P + L T L+ + G L ++ + ++
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKG 123
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGG 268
+ Y L+ ++ RD + + +V V
Sbjct: 124 MNY----------LEDRRLVHRD---------------------LAARNVLVKTP----- 147
Query: 269 GILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328
+I +DFG L AE +
Sbjct: 148 -----------------QHVKI----------TDFGLA-----KLLGAEEKEYHAEGGKV 175
Query: 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELL-HGTTPFKGQGNRATLFNVVGQPLRFPE 387
+++A E I + D W++G+ ++EL+ G+ P+ G + + +++ + R P+
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 234
Query: 388 TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF---EGVNWALVRSALPPHIPE 444
P + ++ + + R E+ + + +++ H+P
Sbjct: 235 PPICTIDVYMIMVKCWMIDADSRPK----FRELIIEFSKMARDPQRYLVIQGDERMHLPS 290
Query: 445 PVDFSVF 451
P D + +
Sbjct: 291 PTDSNFY 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 7e-33
Identities = 30/190 (15%), Positives = 65/190 (34%), Gaps = 24/190 (12%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVMDKASLASRNKLLRAQTER 145
+ K LG G G V G A+K++ ++ + + +E
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE--ALMSEL 77
Query: 146 EILG-LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKY------------ 192
++L L +H + L ++ E+C G+L + +++ + +
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 193 ----FTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248
+ F+ +V + +L ++RDL N+L+ + DF L+
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 249 SPTLVKSSSV 258
V +
Sbjct: 198 DSNYVVKGNA 207
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-32
Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 9/164 (5%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLL---RAQTEREILGLLD 152
+ + LG G V + T +A K + K S + + + E IL +
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 153 HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYL 212
HP + TL+ +E L++E +GG L + + TE+ A F ++L + YL
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYL 129
Query: 213 HMLGIVYRDLKPENVLVRDEG----HIMLSDFDLSLRCSVSPTL 252
H L I + DLKPEN+++ D I + DF L+ +
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 2e-29
Identities = 42/125 (33%), Positives = 60/125 (48%), Gaps = 8/125 (6%)
Query: 322 RSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ 381
+ GT E++APEI+ E G D W+ G+ Y LL G +PF G + TL NV
Sbjct: 172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231
Query: 382 PLRFPET--PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNW--ALVRSA 437
F + S +A+D IR LLVK+P KR+ + QHP+ + + AL +
Sbjct: 232 NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM----TIQDSLQHPWIKPKDTQQALSSAW 287
Query: 438 LPPHI 442
P
Sbjct: 288 SHPQF 292
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 2e-32
Identities = 38/188 (20%), Positives = 71/188 (37%), Gaps = 11/188 (5%)
Query: 100 KRLGYGDIGSVYLVELRGTNT--YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLP 157
K LG G+ G+V + A+K++ + E ++ LD+P++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIV 71
Query: 158 TLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGI 217
+ E + + LVME G L+ Q+ N++ + +V + ++YL
Sbjct: 72 RMIGICEAESWM-LVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 218 VYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAV 277
V+RDL NVL+ + + +SDF LS K+ + E
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK-----WPVKWYAPECIN 183
Query: 278 HGCMQPST 285
+ +
Sbjct: 184 YYKFSSKS 191
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.9 bits (217), Expect = 5e-20
Identities = 27/156 (17%), Positives = 53/156 (33%), Gaps = 11/156 (7%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336
VH + +L ++ SDFG E ++ APE
Sbjct: 129 VHRDLAAR----NVLLVTQHYAKISDFGLSKALR----ADENYYKAQTHGKWPVKWYAPE 180
Query: 337 IIRGEGHGSAVDWWTFGIFLYELL-HGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVA 395
I S D W+FG+ ++E +G P++G + + ++ + R
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-KGSEVTAMLEKGERMGCPAGCPREM 239
Query: 396 RDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNW 431
DL+ + R + ++ +++ VN
Sbjct: 240 YDLMNLCWTYDVENRPGFAA-VELRLRNYYYDVVNE 274
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-32
Identities = 41/169 (24%), Positives = 63/169 (37%), Gaps = 3/169 (1%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGT-NTYFAMKVMDKASLASRNKLLRAQTEREILG 149
I L + +G G G V+ N A+ + + S + + E +
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63
Query: 150 LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLAL 209
DHP + L T+ ++ME C+ G L S Q + + +A ++ AL
Sbjct: 64 QFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTAL 121
Query: 210 EYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSV 258
YL V+RD+ NVLV + L DF LS S S
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 170
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.9 bits (191), Expect = 1e-16
Identities = 31/147 (21%), Positives = 50/147 (34%), Gaps = 14/147 (9%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPE 336
VH + +L S + DFG L M + T ++ +++APE
Sbjct: 130 VHRDIAAR----NVLVSSNDCVKLGDFG------LSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 337 IIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVAR 396
I SA D W FG+ ++E+L + + R P P
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239
Query: 397 DLIRGLLVKEPHKRIAYKRGATEIKQH 423
L+ +P +R TE+K
Sbjct: 240 SLMTKCWAYDPSRRPR----FTELKAQ 262
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 4e-32
Identities = 62/346 (17%), Positives = 106/346 (30%), Gaps = 91/346 (26%)
Query: 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKL---LRAQTERE 146
P+ S +++ LG G GSVY N A+K ++K ++ +L R E
Sbjct: 1 PLE-SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 59
Query: 147 ILGLLD--HPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASE 204
+L + + L +FE
Sbjct: 60 LLKKVSSGFSGVIRLLDWFERP------------------------------------DS 83
Query: 205 VLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGS 264
+L LE + ++ + L + ++R
Sbjct: 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH------------------ 125
Query: 265 GGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324
++ +H ++ + + DFG A +
Sbjct: 126 ------CHNCGVLHRDIKDENIL---IDLNRGELKLIDFG---------SGALLKDTVYT 167
Query: 325 SFVGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL 383
F GT Y PE IR HG + W+ GI LY+++ G PF+ ++ +
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQV 221
Query: 384 RFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429
F +VS + LIR L P R EI+ HP+ + V
Sbjct: 222 FFR--QRVSSECQHLIRWCLALRPSDRP----TFEEIQNHPWMQDV 261
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (306), Expect = 7e-32
Identities = 55/325 (16%), Positives = 102/325 (31%), Gaps = 57/325 (17%)
Query: 94 SNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVMDKASLASRNKLLRAQTEREIL 148
+N ++ +G G G V+ G T A+K++ + + S + Q E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALM 70
Query: 149 GLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLA 208
D+P + L K CL+ E+ + G+L+
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN-------------------------- 104
Query: 209 LEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGG 268
E+L + + L LS + + G
Sbjct: 105 -EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA----------EQLCIARQVAAGM 153
Query: 269 GILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328
L++ VH + L + +DFG + + +
Sbjct: 154 AYLSERKFVHRDLATRN----CLVGENMVVKIADFGLSR-----NIYSADYYKADGNDAI 204
Query: 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVV-GQPLRFP 386
++ PE I + + D W +G+ L+E+ G P+ G + ++ V G L P
Sbjct: 205 PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACP 264
Query: 387 ETPQVSFVARDLIRGLLVKEPHKRI 411
E +L+R K P R
Sbjct: 265 E--NCPLELYNLMRLCWSKLPADRP 287
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 7e-31
Identities = 50/349 (14%), Positives = 101/349 (28%), Gaps = 73/349 (20%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVMDKASLASRNKLLRAQTER 145
+ + + LG G G VY +G T A+K +++A AS + + E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEA 74
Query: 146 EILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEV 205
++ + + L + ++ME + G+L
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLK----------------------- 111
Query: 206 LLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSG 265
YL L + + M + +
Sbjct: 112 ----SYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAY------------------- 148
Query: 266 GGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVG--GALPELMAEPTNVRS 323
LN VH + N DF +G G ++ +
Sbjct: 149 -----LNANKFVHRDLAAR-----------NCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 324 MSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL 383
+ +++PE ++ + D W+FG+ L+E+ + + V +
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252
Query: 384 RFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ--HPFFEGVN 430
+ + +L+R P R ++ + IK+ P F V+
Sbjct: 253 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 6e-30
Identities = 52/325 (16%), Positives = 93/325 (28%), Gaps = 74/325 (22%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTN----TYFAMKVMDKASLASRNKLLRAQTERE 146
I S K +G G+ G VY L+ ++ A+K + + + + E
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAG 61
Query: 147 ILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVL 206
I+G H + L K ++ E+ G L +++ + F+ +
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIA 120
Query: 207 LALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGG 266
++YL + V+RDL N+LV +SDF LS +++ + SGG
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS-------RVLEDDPEATYTTSGG 173
Query: 267 GGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326
I P S + S SD G + E+M
Sbjct: 174 KIPI--------RWTAPEAI------SYRKFTSASDVWSF-GIVMWEVMT---------- 208
Query: 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP 386
+ + + + R P
Sbjct: 209 -----------------------------------YGERPYWELSNHEVMKAINDGFRLP 233
Query: 387 ETPQVSFVARDLIRGLLVKEPHKRI 411
L+ +E +R
Sbjct: 234 TPMDCPSAIYQLMMQCWQQERARRP 258
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-29
Identities = 50/330 (15%), Positives = 96/330 (29%), Gaps = 66/330 (20%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTN-------TYFAMKVMDKASLASRNKLLRAQT 143
+ L K LG G G V L E G + T A+K++ A+ L +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLIS 67
Query: 144 EREILG-LLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFA 202
E E++ + H + L D +++E+ S GNL
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR-------------------- 107
Query: 203 SEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNN 262
EYL P + H S + + +
Sbjct: 108 -------EYLQARR------PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVAR-------- 146
Query: 263 GSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322
+ + + G ++ +
Sbjct: 147 -------------GMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 323 SMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELL-HGTTPFKGQGNRATLFNVVGQ 381
+ + +++APE + + D W+FG+ L+E+ G +P+ G LF ++ +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKE 252
Query: 382 PLRFPETPQVSFVARDLIRGLLVKEPHKRI 411
R + + ++R P +R
Sbjct: 253 GHRMDKPSNCTNELYMMMRDCWHAVPSQRP 282
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-29
Identities = 37/189 (19%), Positives = 75/189 (39%), Gaps = 23/189 (12%)
Query: 91 IGLSNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVMDKASLASRNKLLRAQTER 145
+L K LG G G V + G T A+K++ + + S ++ +E
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR--ALMSEL 67
Query: 146 EILGLLDHPFLPTLY--SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKY----------- 192
+IL + H + + +++EFC GNL + + + N++
Sbjct: 68 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 127
Query: 193 ---FTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVS 249
T + ++ +V +E+L ++RDL N+L+ ++ + + DF L+
Sbjct: 128 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187
Query: 250 PTLVKSSSV 258
P V+
Sbjct: 188 PDYVRKGDA 196
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 114 bits (286), Expect = 3e-29
Identities = 35/177 (19%), Positives = 67/177 (37%), Gaps = 13/177 (7%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH- 153
++++ +R+G G G ++ N A+K + R+ + + E LL
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGC 60
Query: 154 PFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH 213
+P +Y + + LV++ L + F+ A ++L ++ +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIH 118
Query: 214 MLGIVYRDLKPENVLVRD-----EGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSG 265
+VYRD+KP+N L+ I + DF + T N SG
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 70.6 bits (172), Expect = 4e-14
Identities = 22/145 (15%), Positives = 32/145 (22%), Gaps = 7/145 (4%)
Query: 277 VHGCMQPSTFFPRILPSKKNRKSK-SDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAP 335
V+ ++P F SK DFG P + GT Y++
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 336 EIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVV-----GQPLRFPETPQ 390
G D G L G+ P++G Q E
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 391 -VSFVARDLIRGLLVKEPHKRIAYK 414
+ Y
Sbjct: 243 GFPEEFYKYMHYARNLAFDATPDYD 267
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (279), Expect = 3e-28
Identities = 34/174 (19%), Positives = 69/174 (39%), Gaps = 11/174 (6%)
Query: 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP- 154
+RL +++G G G +YL A+K+ + K + E +I ++
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQGGV 63
Query: 155 FLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM 214
+PT+ + +VME ++ F+ A +++ +EY+H
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLED--LFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 215 LGIVYRDLKPENVLVRDEGH---IMLSDFDLSLRCSVSPTLVKSSSVSVNNGSG 265
++RD+KP+N L+ + + DF L+ + + T N +G
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 82.6 bits (203), Expect = 4e-18
Identities = 24/168 (14%), Positives = 47/168 (27%), Gaps = 9/168 (5%)
Query: 271 LNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330
++ + +H ++P F L K N DFG + + GT
Sbjct: 119 IHSKNFIHRDVKPDNFLMG-LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETP- 389
Y + G D + G L G+ P++G + TP
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237
Query: 390 -----QVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFF-EGVNW 431
+ + Y ++ ++ F +G ++
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSY-LRQLFRNLFHRQGFSY 284
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 4e-28
Identities = 53/340 (15%), Positives = 97/340 (28%), Gaps = 65/340 (19%)
Query: 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHP 154
L + +G G G V+ + RG A+K+ + + E +L H
Sbjct: 4 TIVLQESIGKGRFGEVWRGKWRGE--EVAVKIFSS----REERSWFREAEIYQTVMLRHE 57
Query: 155 FLPTLYSYFETD----KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALE 210
+ + D LV ++ G+L + T + A L
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLA 114
Query: 211 YLHM--------LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNN 262
+LHM I +RDLK +N+LV+ G ++D L++R + + +
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-- 172
Query: 263 GSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVR 322
M P I ++D +G E+ R
Sbjct: 173 ------------VGTKRYMAPEVLDDSINMKHFESFKRADIY-AMGLVFWEIAR-----R 214
Query: 323 SMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQP 382
+Y P S + + + L P +
Sbjct: 215 CSIGGIHEDYQLPYYDLVPSDPSVEEM--RKVVCEQKLRPNIPNR--------------- 257
Query: 383 LRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422
++ + V ++R R+ A IK+
Sbjct: 258 ---WQSCEALRVMAKIMRECWYANGAARLT----ALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (280), Expect = 6e-28
Identities = 53/356 (14%), Positives = 117/356 (32%), Gaps = 42/356 (11%)
Query: 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREI 147
G P + + L+++LG+G +V+L + NT+ AMK++ + + + + +
Sbjct: 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 66
Query: 148 -------LGLLDHPFLPTLYSYFET---DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDA 197
+ + L +F + + +++ G NL +L +K ++
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 198 ARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSS 256
+ + ++LL L+Y+H GI++ D+KPENVL+ + + +
Sbjct: 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE-NLIQIKIAD---------- 175
Query: 257 SVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMA 316
G + + + +D + EL+
Sbjct: 176 -------LGNACWYDEHYTNSIQTRE---YRSPEVLLGAPWGCGADI-WSTACLIFELIT 224
Query: 317 --EPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFL-YELLHGTTPFKGQGNRA 373
+ +II G + + G +
Sbjct: 225 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 284
Query: 374 TLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429
L +V+ + +F + D + +L +P KR A + HP+ +
Sbjct: 285 PLEDVLTEKYKFS--KDEAKEISDFLSPMLQLDPRKRA----DAGGLVNHPWLKDT 334
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 8e-26
Identities = 34/188 (18%), Positives = 74/188 (39%), Gaps = 11/188 (5%)
Query: 102 LGYGDIGSVYLVELR---GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPT 158
+G G G VY L G + A+K +++ + ++ + TE I+ HP + +
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 159 LYSY-FETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGI 217
L ++ +V+ + G+L + + + + T F +V +++L
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 218 VYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAV 277
V+RDL N ++ ++ + ++DF L+ + SV G+ + E
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDK----EFDSVHNKTGAKLPVKWMALESLQ 207
Query: 278 HGCMQPST 285
+
Sbjct: 208 TQKFTTKS 215
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.2 bits (184), Expect = 2e-15
Identities = 15/105 (14%), Positives = 37/105 (35%), Gaps = 4/105 (3%)
Query: 319 TNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNV 378
+ +++A E ++ + + D W+FG+ L+EL+ P N +
Sbjct: 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 246
Query: 379 VGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423
+ Q R + +++ + R + +E+
Sbjct: 247 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPS----FSELVSR 287
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 73.7 bits (180), Expect = 7e-16
Identities = 29/161 (18%), Positives = 52/161 (32%), Gaps = 30/161 (18%)
Query: 98 LLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRN---------------KLLRAQ 142
+ K +G G +V+ +K + + + A+
Sbjct: 4 IGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 143 TEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFA 202
E L L +P +Y++ ++ME + +
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEG----NAVLMELI---------DAKELYRVRVENPDEVL 109
Query: 203 SEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243
+L + + GIV+ DL NVLV +EG I + DF S
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS 149
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 491 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.69 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.23 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.18 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.44 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.4 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.73 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-68 Score=523.55 Aligned_cols=280 Identities=38% Similarity=0.719 Sum_probs=251.1
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
+.+++|++++.||+|+||+||+|+++.+|+.||||++++..........++.+|+.+|+.++|||||+++++|++++.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 45789999999999999999999999999999999999877666667778899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
+|||||+||+|..++... +.+++..++.|++||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 82 iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~- 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred cceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC-
Confidence 999999999999998875 56999999999999999999999999999999999999999999999999998643211
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
.....+++||+
T Consensus 159 ---------------------------------------------------------------------~~~~~~~~GT~ 169 (337)
T d1o6la_ 159 ---------------------------------------------------------------------GATMKTFCGTP 169 (337)
T ss_dssp ---------------------------------------------------------------------TCCBCCCEECG
T ss_pred ---------------------------------------------------------------------CcccccceeCH
Confidence 01123469999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+....+.+|. .+++++++||.+||++||.+|
T Consensus 170 ~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~dli~~~L~~dP~~R 247 (337)
T d1o6la_ 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQR 247 (337)
T ss_dssp GGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSTTTS
T ss_pred HHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc--cCCHHHHHHHHhhccCCchhh
Confidence 999999999999999999999999999999999999999998888889888888876 499999999999999999999
Q ss_pred CCcC-CChHHhhcCCCcCCCChhhh--hccCCCCCCC
Q 035713 411 IAYK-RGATEIKQHPFFEGVNWALV--RSALPPHIPE 444 (491)
Q Consensus 411 ~t~~-~~~~ell~hpff~~~~~~~~--~~~~~~~~p~ 444 (491)
++.. ..++||++||||++++|..+ +...||+.|.
T Consensus 248 ~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~ 284 (337)
T d1o6la_ 248 LGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQ 284 (337)
T ss_dssp TTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred cccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCC
Confidence 9643 24899999999999999977 3455666664
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-68 Score=513.00 Aligned_cols=280 Identities=33% Similarity=0.618 Sum_probs=247.1
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
..++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+++|++++|||||+++++|.+++.+||
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 34789999999999999999999999999999999988766666667788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||++||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 86 vmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~- 162 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES- 162 (288)
T ss_dssp EECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC-
Confidence 99999999999988875 569999999999999999999999999999999999999999999999999996543111
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
......+.+||+.
T Consensus 163 -------------------------------------------------------------------~~~~~~~~~GT~~ 175 (288)
T d1uu3a_ 163 -------------------------------------------------------------------KQARANSFVGTAQ 175 (288)
T ss_dssp --------------------------------------------------------------------------CCCCGG
T ss_pred -------------------------------------------------------------------cccccccccCCcc
Confidence 0112234589999
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.+++...+.+|. .+++++++||.+||+.||++||
T Consensus 176 Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~ 253 (288)
T d1uu3a_ 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLLVLDATKRL 253 (288)
T ss_dssp GCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT--TCCHHHHHHHHTTSCSSGGGST
T ss_pred ccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc--cCCHHHHHHHHHHccCCHhHCc
Confidence 99999999999999999999999999999999999999888888999988887775 5999999999999999999999
Q ss_pred CcCC--ChHHhhcCCCcCCCChhhhhccCCCCCC
Q 035713 412 AYKR--GATEIKQHPFFEGVNWALVRSALPPHIP 443 (491)
Q Consensus 412 t~~~--~~~ell~hpff~~~~~~~~~~~~~~~~p 443 (491)
|.++ ....|++||||++++|+.++...||.+|
T Consensus 254 t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 254 GCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp TSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred CHHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCC
Confidence 9321 1223799999999999999988888776
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.5e-65 Score=500.91 Aligned_cols=276 Identities=35% Similarity=0.706 Sum_probs=247.0
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
.+++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|+.++|||||+++++|.+++.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 35789999999999999999999999999999999988766666667788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
|||||.||+|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 82 vmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--- 156 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--- 156 (316)
T ss_dssp EECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred EeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc---
Confidence 99999999999988875 5699999999999999999999999999999999999999999999999999865321
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
...+.+||+.
T Consensus 157 ----------------------------------------------------------------------~~~~~~Gt~~ 166 (316)
T d1fota_ 157 ----------------------------------------------------------------------VTYTLCGTPD 166 (316)
T ss_dssp ----------------------------------------------------------------------CBCCCCSCTT
T ss_pred ----------------------------------------------------------------------ccccccCccc
Confidence 1123589999
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.+++.....+|. .+++++++||.+||.+||.+|+
T Consensus 167 Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dp~~R~ 244 (316)
T d1fota_ 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP--FFNEDVKDLLSRLITRDLSQRL 244 (316)
T ss_dssp TCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSCTTTCT
T ss_pred ccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhhCHHhcc
Confidence 99999999999999999999999999999999999999988888999988877764 5999999999999999999997
Q ss_pred CcC-CChHHhhcCCCcCCCChhhh--hccCCCCCCC
Q 035713 412 AYK-RGATEIKQHPFFEGVNWALV--RSALPPHIPE 444 (491)
Q Consensus 412 t~~-~~~~ell~hpff~~~~~~~~--~~~~~~~~p~ 444 (491)
+.. ..+++||+||||++++|+.+ +...+|++|.
T Consensus 245 ~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~ 280 (316)
T d1fota_ 245 GNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPP 280 (316)
T ss_dssp TSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCC
T ss_pred ccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCCC
Confidence 422 23999999999999999977 3455666654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-65 Score=488.13 Aligned_cols=256 Identities=33% Similarity=0.564 Sum_probs=234.3
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
.+++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+++|+.++|||||++++++.+++.+||
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 45789999999999999999999999999999999988766666667788899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
|||||+||+|.+++... +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 84 vmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--- 158 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 158 (263)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---
T ss_pred EEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC---
Confidence 99999999999998874 4699999999999999999999999999999999999999999999999999854321
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
......+||+.
T Consensus 159 ---------------------------------------------------------------------~~~~~~~Gt~~ 169 (263)
T d2j4za1 159 ---------------------------------------------------------------------SRRTTLCGTLD 169 (263)
T ss_dssp ---------------------------------------------------------------------CCCEETTEEGG
T ss_pred ---------------------------------------------------------------------CcccccCCCCc
Confidence 01123589999
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++....+.+|. .+++++++||.+||+.||++||
T Consensus 170 Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dp~~R~ 247 (263)
T d2j4za1 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--FVTEGARDLISRLLKHNPSQRP 247 (263)
T ss_dssp GCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT--TSCHHHHHHHHHHTCSSGGGSC
T ss_pred ccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc--cCCHHHHHHHHHHccCCHhHCc
Confidence 99999999999999999999999999999999999999888888888888877775 4999999999999999999999
Q ss_pred CcCCChHHhhcCCCcC
Q 035713 412 AYKRGATEIKQHPFFE 427 (491)
Q Consensus 412 t~~~~~~ell~hpff~ 427 (491)
| ++|+|+||||.
T Consensus 248 t----~~eil~hp~~~ 259 (263)
T d2j4za1 248 M----LREVLEHPWIT 259 (263)
T ss_dssp C----HHHHHTCHHHH
T ss_pred C----HHHHHcCcCcC
Confidence 9 99999999996
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-64 Score=502.61 Aligned_cols=285 Identities=36% Similarity=0.666 Sum_probs=251.0
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
..+++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+++|+.++|||||+++++|.+...+|
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 34589999999999999999999999999999999998776666666778899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCC
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~ 250 (491)
+||||+.||+|..++... +.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 118 ~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-- 193 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred cccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--
Confidence 999999999999988775 4699999999999999999999999999999999999999999999999999965321
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
...+.+||+
T Consensus 194 -----------------------------------------------------------------------~~~~~~Gt~ 202 (350)
T d1rdqe_ 194 -----------------------------------------------------------------------RTWTLCGTP 202 (350)
T ss_dssp -----------------------------------------------------------------------CBCCCEECG
T ss_pred -----------------------------------------------------------------------ccccccCcc
Confidence 112358999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
.|||||++.+..|+.++|||||||+||||++|+.||.+.+....+.++....+.++. .+++++.+||++||++||.+|
T Consensus 203 ~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~kR 280 (350)
T d1rdqe_ 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVDLTKR 280 (350)
T ss_dssp GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TCCHHHHHHHHHHSCSCTTTC
T ss_pred ccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCc--cCCHHHHHHHHHHhhhCHHhc
Confidence 999999999999999999999999999999999999999888888889888777765 599999999999999999999
Q ss_pred CC-cCCChHHhhcCCCcCCCChhhhh--ccCCCCCCC---CCCCCCCC
Q 035713 411 IA-YKRGATEIKQHPFFEGVNWALVR--SALPPHIPE---PVDFSVFA 452 (491)
Q Consensus 411 ~t-~~~~~~ell~hpff~~~~~~~~~--~~~~~~~p~---~~~~~~~~ 452 (491)
+. .+..+++||+||||++++|..+. ...||++|. +.|.+.|.
T Consensus 281 ~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~~d~s~~~ 328 (350)
T d1rdqe_ 281 FGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328 (350)
T ss_dssp TTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSC
T ss_pred cccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCCcchhhhcC
Confidence 62 12239999999999999999763 345677775 33444443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-64 Score=493.94 Aligned_cols=281 Identities=37% Similarity=0.728 Sum_probs=238.5
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHh-hcCCCCccceeeeEEeCceEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILG-LLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~-~l~hp~iv~l~~~~~~~~~~~l 171 (491)
+++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.++. .++|||||+++++|.+++.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 378999999999999999999999999999999998776555555666777777765 6899999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
|||||+||+|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 vmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~- 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 157 (320)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc-
Confidence 99999999999999874 569999999999999999999999999999999999999999999999999986432111
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
......+||+.
T Consensus 158 ---------------------------------------------------------------------~~~~~~~gt~~ 168 (320)
T d1xjda_ 158 ---------------------------------------------------------------------AKTNTFCGTPD 168 (320)
T ss_dssp ---------------------------------------------------------------------CCBCCCCSCGG
T ss_pred ---------------------------------------------------------------------ccccccCCCCC
Confidence 01123489999
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
|+|||++.+..|+.++|||||||++|||++|+.||.+.+....+.++....+.+|. .+++++++||.+||++||++||
T Consensus 169 y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~dli~~~L~~dP~~R~ 246 (320)
T d1xjda_ 169 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--WLEKEAKDLLVKLFVREPEKRL 246 (320)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHSCSSGGGSB
T ss_pred cCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--cCCHHHHHHHHHhcccCCCCCc
Confidence 99999999999999999999999999999999999999988888888888777765 4899999999999999999999
Q ss_pred CcCCChH-HhhcCCCcCCCChhhhh--ccCCCCCCC---CCCCCCC
Q 035713 412 AYKRGAT-EIKQHPFFEGVNWALVR--SALPPHIPE---PVDFSVF 451 (491)
Q Consensus 412 t~~~~~~-ell~hpff~~~~~~~~~--~~~~~~~p~---~~~~~~~ 451 (491)
+ +. ++++||||++++|+.+. ...||..|. +.|...|
T Consensus 247 s----~~~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~~~d~~~f 288 (320)
T d1xjda_ 247 G----VRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNF 288 (320)
T ss_dssp T----TBSCGGGSGGGTTCCHHHHHTTCSCC---------------
T ss_pred C----HHHHHHhCchhccCCHHHHHhcCCCCCCCCCCCCccchhhc
Confidence 9 74 89999999999999763 334555553 3444444
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-64 Score=480.81 Aligned_cols=259 Identities=25% Similarity=0.438 Sum_probs=220.2
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.++|+++++||+|+||+||+|+++.+|+.||||++++.... +..+.+.+|+++|+.++|||||++++++.+++.+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 47899999999999999999999999999999999865322 2345678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||++||+|.++++.. +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.......
T Consensus 82 mEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~- 158 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR- 158 (271)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE-
T ss_pred EeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc-
Confidence 9999999999998753 5699999999999999999999999999999999999999999999999999965421110
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
.....+.+||+.|
T Consensus 159 -------------------------------------------------------------------~~~~~~~~GT~~Y 171 (271)
T d1nvra_ 159 -------------------------------------------------------------------ERLLNKMCGTLPY 171 (271)
T ss_dssp -------------------------------------------------------------------ECCBCCCCSCGGG
T ss_pred -------------------------------------------------------------------cccccceeeCcCc
Confidence 0112245899999
Q ss_pred cCcchhcCCCC-CCcccccchhhHHHhhhcCCCCCCCCCcHHHHH-HHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 333 LAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATLF-NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 333 ~aPE~l~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~-~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
||||++.+..+ +.++|||||||+||||++|++||.+........ .+.......+....+++++++||.+||+.||++|
T Consensus 172 ~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 251 (271)
T d1nvra_ 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSAR 251 (271)
T ss_dssp SCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred cCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHC
Confidence 99999998886 678999999999999999999998765544433 3334444444445789999999999999999999
Q ss_pred CCcCCChHHhhcCCCcC
Q 035713 411 IAYKRGATEIKQHPFFE 427 (491)
Q Consensus 411 ~t~~~~~~ell~hpff~ 427 (491)
|| ++|+|+||||+
T Consensus 252 ~t----~~eil~hpwf~ 264 (271)
T d1nvra_ 252 IT----IPDIKKDRWYN 264 (271)
T ss_dssp CC----HHHHTTCTTTT
T ss_pred cC----HHHHhcCHhhC
Confidence 99 99999999996
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-63 Score=481.12 Aligned_cols=254 Identities=24% Similarity=0.420 Sum_probs=225.6
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
++|+++++||+|+||+||+|+++.+|+.||||++++..... .+.+.+|+++|+.++|||||+++++|.+++.+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 57999999999999999999999999999999997654332 356789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
|||+||+|.+++.. +.+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 97 Ey~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--- 170 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 170 (293)
T ss_dssp ECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT---
T ss_pred EecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc---
Confidence 99999999998876 359999999999999999999999999999999999999999999999999996542111
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
......+||+.||
T Consensus 171 -------------------------------------------------------------------~~~~~~~gt~~Y~ 183 (293)
T d1yhwa1 171 -------------------------------------------------------------------SKRSTMVGTPYWM 183 (293)
T ss_dssp -------------------------------------------------------------------CCBCCCCSCGGGC
T ss_pred -------------------------------------------------------------------ccccccccCCCcc
Confidence 1122348999999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC-CCcCCCCCCCCHHHHHHHHhhhccCCCCCCC
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ-PLRFPETPQVSFVARDLIRGLLVKEPHKRIA 412 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 412 (491)
|||++.+..|+.++|||||||++|||++|+.||.+.+....+..+... ...++....+++++++||.+||+.||++|||
T Consensus 184 aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s 263 (293)
T d1yhwa1 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS 263 (293)
T ss_dssp CHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCC
T ss_pred ChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcC
Confidence 999999999999999999999999999999999998887777766543 3344445679999999999999999999999
Q ss_pred cCCChHHhhcCCCcC
Q 035713 413 YKRGATEIKQHPFFE 427 (491)
Q Consensus 413 ~~~~~~ell~hpff~ 427 (491)
++|+|+||||+
T Consensus 264 ----~~eil~Hp~~~ 274 (293)
T d1yhwa1 264 ----AKELLQHQFLK 274 (293)
T ss_dssp ----HHHHTTCGGGG
T ss_pred ----HHHHhcCHhhC
Confidence 99999999997
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-62 Score=491.77 Aligned_cols=277 Identities=31% Similarity=0.612 Sum_probs=231.5
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHH---HHHHHHHhhcCCCCccceeeeEEeCce
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRA---QTEREILGLLDHPFLPTLYSYFETDKF 168 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~---~~E~~il~~l~hp~iv~l~~~~~~~~~ 168 (491)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+...........+ .+|+++++.++|||||+++++|.+++.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 56899999999999999999999999999999999987655443333333 345677778889999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
+|||||||+||+|.+++... ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999999998875 5699999999999999999999999999999999999999999999999999865321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
. .....+|
T Consensus 160 ~------------------------------------------------------------------------~~~~~~G 167 (364)
T d1omwa3 160 K------------------------------------------------------------------------KPHASVG 167 (364)
T ss_dssp S------------------------------------------------------------------------CCCSCCS
T ss_pred C------------------------------------------------------------------------ccccccc
Confidence 1 1123489
Q ss_pred ccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHH---HHHHcCCCcCCCCCCCCHHHHHHHHhhhc
Q 035713 329 THEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATL---FNVVGQPLRFPETPQVSFVARDLIRGLLV 404 (491)
Q Consensus 329 t~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~~i~~~~~~~~~~~~~s~~~~~li~~~L~ 404 (491)
|+.|||||++.+ ..|+.++|||||||+||||++|+.||.+.+..... ..+......++ ..+++++++||.+||+
T Consensus 168 T~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~ 245 (364)
T d1omwa3 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP--DSFSPELRSLLEGLLQ 245 (364)
T ss_dssp CGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCC--SSSCHHHHHHHHHHTC
T ss_pred ccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCC--CCCCHHHHHHHHHHcc
Confidence 999999999975 56899999999999999999999999876543222 22223333333 4699999999999999
Q ss_pred cCCCCCCCc-CCChHHhhcCCCcCCCChhhh--hccCCCCCCC
Q 035713 405 KEPHKRIAY-KRGATEIKQHPFFEGVNWALV--RSALPPHIPE 444 (491)
Q Consensus 405 ~dP~~R~t~-~~~~~ell~hpff~~~~~~~~--~~~~~~~~p~ 444 (491)
+||++|||+ ...|+|||+||||++++|..+ +...||.+|.
T Consensus 246 ~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~ 288 (364)
T d1omwa3 246 RDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPP 288 (364)
T ss_dssp SSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred cCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCC
Confidence 999999995 345899999999999999876 3445666664
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-63 Score=491.90 Aligned_cols=264 Identities=25% Similarity=0.386 Sum_probs=222.1
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFY 169 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 169 (491)
++..++|+++++||+|+||+||+|+++.+|+.||+|++++.. ......++.+|+++|+.++|||||+++++|.+++++
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 345689999999999999999999999999999999997653 234456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
||||||++||+|.+++.+. +.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|+....
T Consensus 80 ~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999999999874 569999999999999999999997 5999999999999999999999999999864321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
....+++|
T Consensus 158 ------------------------------------------------------------------------~~~~~~~G 165 (322)
T d1s9ja_ 158 ------------------------------------------------------------------------SMANSFVG 165 (322)
T ss_dssp ------------------------------------------------------------------------HTC---CC
T ss_pred ------------------------------------------------------------------------CccccccC
Confidence 01224589
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHH--------------------------------
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLF-------------------------------- 376 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~-------------------------------- 376 (491)
|+.|||||++.+..|+.++|||||||++|||++|+.||.+.+......
T Consensus 166 T~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (322)
T d1s9ja_ 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSR 245 (322)
T ss_dssp SSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------
T ss_pred CccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccc
Confidence 999999999999999999999999999999999999998765432111
Q ss_pred ----------HHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhh
Q 035713 377 ----------NVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWAL 433 (491)
Q Consensus 377 ----------~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~ 433 (491)
.+............++.++++||.+||+.||++||| ++|+|+||||+..+|+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t----a~e~L~Hpf~~~~~~~~ 308 (322)
T d1s9ja_ 246 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRSDAEE 308 (322)
T ss_dssp CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHHHHHSC
T ss_pred cchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcC----HHHHhhCHhhCcCCccc
Confidence 011111111111247899999999999999999999 99999999998777653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.2e-62 Score=485.96 Aligned_cols=262 Identities=29% Similarity=0.453 Sum_probs=233.1
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
+++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+++|+.++|||||+++++|.+++.+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 5789999999999999999999999999999999976543 3345678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc--CCcEEEeecccccccCCCC
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD--EGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~--~g~vkL~DFGla~~~~~~~ 250 (491)
||||+||+|.+++... .+.+++..++.|+.||+.||.|||++|||||||||+||||+. +|.+||+|||+|+.+....
T Consensus 102 mE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 102 YEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp ECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999999999988654 356999999999999999999999999999999999999964 6889999999986542111
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
...+.+||+
T Consensus 181 -----------------------------------------------------------------------~~~~~~gT~ 189 (350)
T d1koaa2 181 -----------------------------------------------------------------------SVKVTTGTA 189 (350)
T ss_dssp -----------------------------------------------------------------------CEEEECSCT
T ss_pred -----------------------------------------------------------------------ccceecCcc
Confidence 122458999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCC--CCCCHHHHHHHHhhhccCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPET--PQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~ 408 (491)
.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+.++......++.. ..+++++++||.+||+.||+
T Consensus 190 ~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 269 (350)
T d1koaa2 190 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPN 269 (350)
T ss_dssp TTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGG
T ss_pred cccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChh
Confidence 9999999999999999999999999999999999999998888888888877665543 46899999999999999999
Q ss_pred CCCCcCCChHHhhcCCCcCCCChhh
Q 035713 409 KRIAYKRGATEIKQHPFFEGVNWAL 433 (491)
Q Consensus 409 ~R~t~~~~~~ell~hpff~~~~~~~ 433 (491)
+||| ++|||+||||+..+|..
T Consensus 270 ~R~t----~~eil~hp~~~~~~~~~ 290 (350)
T d1koaa2 270 TRMT----IHQALEHPWLTPGNAPG 290 (350)
T ss_dssp GSCC----HHHHHHSTTTSCTTCCS
T ss_pred HCcC----HHHHhcCcccCCCCCCC
Confidence 9999 99999999999887654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-62 Score=478.11 Aligned_cols=257 Identities=33% Similarity=0.508 Sum_probs=215.1
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.+.|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+++|+.++|||||+++++|.+++.+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367999999999999999999999999999999998765432 335678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEc---cCCcEEEeecccccccCCC
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVR---DEGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~---~~g~vkL~DFGla~~~~~~ 249 (491)
||||+||+|.+++... +.+++..++.|+.||+.||+|||++|||||||||+|||+. .+|.+||+|||+|+.....
T Consensus 86 mE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp ECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred EeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999999999999864 5699999999999999999999999999999999999995 5789999999998543210
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
....+.+||
T Consensus 164 -----------------------------------------------------------------------~~~~~~~GT 172 (307)
T d1a06a_ 164 -----------------------------------------------------------------------SVLSTACGT 172 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -----------------------------------------------------------------------CeeeeeeeC
Confidence 112245899
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCC--CCCCCCHHHHHHHHhhhccCC
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP--ETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~~~~li~~~L~~dP 407 (491)
+.|||||++.+..|+.++|||||||+||||++|+.||.+........+++.....++ ....+|+++++||.+||++||
T Consensus 173 ~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 252 (307)
T d1a06a_ 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDP 252 (307)
T ss_dssp CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSG
T ss_pred ccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCH
Confidence 999999999999999999999999999999999999999988888888887766554 335799999999999999999
Q ss_pred CCCCCcCCChHHhhcCCCcCC
Q 035713 408 HKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 408 ~~R~t~~~~~~ell~hpff~~ 428 (491)
++||| ++|+|+||||++
T Consensus 253 ~~R~s----~~eil~hp~~~~ 269 (307)
T d1a06a_ 253 EKRFT----CEQALQHPWIAG 269 (307)
T ss_dssp GGSCC----HHHHHHSTTTTS
T ss_pred hHCcC----HHHHhcCHhhCC
Confidence 99999 999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-62 Score=476.34 Aligned_cols=258 Identities=28% Similarity=0.438 Sum_probs=225.5
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVM 173 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~ 173 (491)
+.|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+++|+.++|||||+++++|.+++.+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 46999999999999999999999999999999997653 233456778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
|||+||+|.+++... .+.+++.+++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.....
T Consensus 89 Ey~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~---- 163 (288)
T d2jfla1 89 EFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---- 163 (288)
T ss_dssp ECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH----
T ss_pred ecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC----
Confidence 999999999987654 356999999999999999999999999999999999999999999999999998543110
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
.....+.+||+.||
T Consensus 164 ------------------------------------------------------------------~~~~~~~~Gt~~y~ 177 (288)
T d2jfla1 164 ------------------------------------------------------------------IQRRDSFIGTPYWM 177 (288)
T ss_dssp ------------------------------------------------------------------HHHHTCCCSCCTTC
T ss_pred ------------------------------------------------------------------cccccccccccccC
Confidence 00122458999999
Q ss_pred Ccchhc-----CCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCC-cCCCCCCCCHHHHHHHHhhhccCC
Q 035713 334 APEIIR-----GEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL-RFPETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 334 aPE~l~-----~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~~~~li~~~L~~dP 407 (491)
|||++. +..|+.++|||||||+||||++|+.||.+.+..+.+.++..... .++....+++++++||.+||+.||
T Consensus 178 APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp 257 (288)
T d2jfla1 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNV 257 (288)
T ss_dssp CHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSST
T ss_pred CHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCCh
Confidence 999995 45578999999999999999999999999988888888876643 334445799999999999999999
Q ss_pred CCCCCcCCChHHhhcCCCcCCC
Q 035713 408 HKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 408 ~~R~t~~~~~~ell~hpff~~~ 429 (491)
++||| ++|||+||||+.-
T Consensus 258 ~~R~t----~~ell~hp~~~~~ 275 (288)
T d2jfla1 258 DARWT----TSQLLQHPFVTVD 275 (288)
T ss_dssp TTSCC----HHHHTTSGGGCCC
T ss_pred hHCcC----HHHHhcCcccCCC
Confidence 99999 9999999999743
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-62 Score=477.30 Aligned_cols=253 Identities=26% Similarity=0.372 Sum_probs=228.6
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
.|+++++||+|+||+||+|+++.+|+.||||++++...........+.+|+++|+.++|||||+++++|.+++.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999988766667777889999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
||.||+|..++... +.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------ 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 167 (309)
T ss_dssp CCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------
Confidence 99999998766654 5699999999999999999999999999999999999999999999999999854211
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
....+||+.|||
T Consensus 168 --------------------------------------------------------------------~~~~~GT~~Y~A 179 (309)
T d1u5ra_ 168 --------------------------------------------------------------------ANSFVGTPYWMA 179 (309)
T ss_dssp --------------------------------------------------------------------BCCCCSCGGGCC
T ss_pred --------------------------------------------------------------------CCccccCccccC
Confidence 113479999999
Q ss_pred cchhcC---CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCC
Q 035713 335 PEIIRG---EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRI 411 (491)
Q Consensus 335 PE~l~~---~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 411 (491)
||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+.++............+++++++||.+||+.||.+||
T Consensus 180 PE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 259 (309)
T d1u5ra_ 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRP 259 (309)
T ss_dssp HHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCc
Confidence 999975 35899999999999999999999999998888888888877655555567999999999999999999999
Q ss_pred CcCCChHHhhcCCCcC
Q 035713 412 AYKRGATEIKQHPFFE 427 (491)
Q Consensus 412 t~~~~~~ell~hpff~ 427 (491)
| ++|||+||||.
T Consensus 260 t----~~ell~Hp~~~ 271 (309)
T d1u5ra_ 260 T----SEVLLKHRFVL 271 (309)
T ss_dssp C----HHHHTTCHHHH
T ss_pred C----HHHHHhCHHhc
Confidence 9 99999999996
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-62 Score=474.31 Aligned_cols=264 Identities=31% Similarity=0.487 Sum_probs=230.1
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhH---HHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASR---NKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYC 170 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 170 (491)
++|++++.||+|+||+||+|+++.+|+.||||++++...... ...+.+.+|+++|+.++|||||+++++|.+++.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 579999999999999999999999999999999987544322 23567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC----cEEEeeccccccc
Q 035713 171 LVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG----HIMLSDFDLSLRC 246 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g----~vkL~DFGla~~~ 246 (491)
||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|...
T Consensus 90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999998875 4699999999999999999999999999999999999998776 5999999998654
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.... ...+.
T Consensus 168 ~~~~-----------------------------------------------------------------------~~~~~ 176 (293)
T d1jksa_ 168 DFGN-----------------------------------------------------------------------EFKNI 176 (293)
T ss_dssp TTSC-----------------------------------------------------------------------BCSCC
T ss_pred CCCc-----------------------------------------------------------------------ccccc
Confidence 2110 11234
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC--CCCCCHHHHHHHHhhhc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE--TPQVSFVARDLIRGLLV 404 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~li~~~L~ 404 (491)
+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++......++. ...++.++++||++||+
T Consensus 177 ~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 256 (293)
T d1jksa_ 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLV 256 (293)
T ss_dssp CCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSC
T ss_pred CCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHcc
Confidence 7999999999999999999999999999999999999999999998888888887766543 24689999999999999
Q ss_pred cCCCCCCCcCCChHHhhcCCCcCCCChhhh
Q 035713 405 KEPHKRIAYKRGATEIKQHPFFEGVNWALV 434 (491)
Q Consensus 405 ~dP~~R~t~~~~~~ell~hpff~~~~~~~~ 434 (491)
.||++||| ++|+|+||||+..+|...
T Consensus 257 ~dP~~R~s----~~eil~hp~~~~~~~~~~ 282 (293)
T d1jksa_ 257 KDPKKRMT----IQDSLQHPWIKPKDTQQA 282 (293)
T ss_dssp SSGGGSCC----HHHHHHSTTTCC------
T ss_pred CChhHCcC----HHHHhcCcccCCCChhHh
Confidence 99999999 999999999999999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-62 Score=469.39 Aligned_cols=258 Identities=24% Similarity=0.390 Sum_probs=216.6
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe--CceEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET--DKFYC 170 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~--~~~~~ 170 (491)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.... +.....+.+|+++|+.++|||||++++++.+ ++.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 37899999999999999999999999999999999876543 4456678899999999999999999999864 56789
Q ss_pred EEEeccCCCchHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcC-----cccccCCCCCEEEccCCcEEEeecccc
Q 035713 171 LVMEFCSGGNLHSLRQKQ--PNKYFTEDAARFFASEVLLALEYLHMLG-----IVYRDLKPENVLVRDEGHIMLSDFDLS 243 (491)
Q Consensus 171 lV~E~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDikp~NILl~~~g~vkL~DFGla 243 (491)
||||||+||+|.+++... ....+++..++.++.||+.||.|||++| ||||||||+||||+.+|.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 999999999999988642 2356999999999999999999999976 999999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (491)
+.+.... ...
T Consensus 162 ~~~~~~~----------------------------------------------------------------------~~~ 171 (269)
T d2java1 162 RILNHDT----------------------------------------------------------------------SFA 171 (269)
T ss_dssp HHC-----------------------------------------------------------------------------
T ss_pred eecccCC----------------------------------------------------------------------Ccc
Confidence 6543211 012
Q ss_pred cccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhh
Q 035713 324 MSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLL 403 (491)
Q Consensus 324 ~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L 403 (491)
.+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+.++....... ....+++++.+||.+||
T Consensus 172 ~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~l~~li~~~L 250 (269)
T d2java1 172 KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR-IPYRYSDELNEIITRML 250 (269)
T ss_dssp ----CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHT
T ss_pred ccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-CCcccCHHHHHHHHHHc
Confidence 24589999999999999999999999999999999999999999988888888887765532 22469999999999999
Q ss_pred ccCCCCCCCcCCChHHhhcCCCc
Q 035713 404 VKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 404 ~~dP~~R~t~~~~~~ell~hpff 426 (491)
+.||++||+ ++|||+|||+
T Consensus 251 ~~dp~~Rps----~~ell~hp~i 269 (269)
T d2java1 251 NLKDYHRPS----VEEILENPLI 269 (269)
T ss_dssp CSSGGGSCC----HHHHHTSTTC
T ss_pred CCChhHCcC----HHHHHhCCcC
Confidence 999999999 9999999995
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.4e-61 Score=480.04 Aligned_cols=258 Identities=30% Similarity=0.457 Sum_probs=230.2
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.++|++++.||+|+||+||+|+++.+|+.||||++++.... ....+.+|+++|+.|+|||||+++++|.+++.+|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 36799999999999999999999999999999999875432 335677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEc--cCCcEEEeecccccccCCCC
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVR--DEGHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~--~~g~vkL~DFGla~~~~~~~ 250 (491)
||||+||+|.+++... ...|++.+++.|+.||+.||.|||++|||||||||+||||+ .+|.+||+|||+|+.+...
T Consensus 105 mE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 105 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp EECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 9999999999877654 34699999999999999999999999999999999999998 5789999999999654321
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
....+.+||+
T Consensus 183 ----------------------------------------------------------------------~~~~~~~gt~ 192 (352)
T d1koba_ 183 ----------------------------------------------------------------------EIVKVTTATA 192 (352)
T ss_dssp ----------------------------------------------------------------------SCEEEECSSG
T ss_pred ----------------------------------------------------------------------CceeeccCcc
Confidence 1122458999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC--CCCCCHHHHHHHHhhhccCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE--TPQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~ 408 (491)
.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++....+.++. ...+++++++||.+||++||.
T Consensus 193 ~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~ 272 (352)
T d1koba_ 193 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPR 272 (352)
T ss_dssp GGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGG
T ss_pred cccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChh
Confidence 999999999999999999999999999999999999999998888888887766554 357999999999999999999
Q ss_pred CCCCcCCChHHhhcCCCcCCC
Q 035713 409 KRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 409 ~R~t~~~~~~ell~hpff~~~ 429 (491)
+||| ++|+|+||||++.
T Consensus 273 ~R~s----~~eil~Hp~~~~~ 289 (352)
T d1koba_ 273 KRLT----VHDALEHPWLKGD 289 (352)
T ss_dssp GSCC----HHHHHTSTTTSSC
T ss_pred HCcC----HHHHhcCHhhCCC
Confidence 9999 9999999999874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-61 Score=460.09 Aligned_cols=252 Identities=23% Similarity=0.397 Sum_probs=216.2
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe----CceEEE
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET----DKFYCL 171 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~----~~~~~l 171 (491)
|++.++||+|+||+||+|+++.+++.||+|++...... ....+.+.+|+++|+.++|||||+++++|.+ +..+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 47888999999999999999999999999999876543 3456678899999999999999999999875 457899
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccccCCCCCEEEc-cCCcEEEeecccccccCC
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLG--IVYRDLKPENVLVR-DEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~NILl~-~~g~vkL~DFGla~~~~~ 248 (491)
||||++||+|.+++.+. ..+++..++.|+.||+.||+|||++| |+||||||+||||+ .++.+||+|||+|+....
T Consensus 90 vmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999998874 56999999999999999999999998 99999999999997 579999999999853211
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
....+.+|
T Consensus 168 ------------------------------------------------------------------------~~~~~~~G 175 (270)
T d1t4ha_ 168 ------------------------------------------------------------------------SFAKAVIG 175 (270)
T ss_dssp ------------------------------------------------------------------------TSBEESCS
T ss_pred ------------------------------------------------------------------------CccCCccc
Confidence 11224589
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcC-CCCCCCCHHHHHHHHhhhccCC
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRF-PETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~s~~~~~li~~~L~~dP 407 (491)
|+.|||||++.+ .|+.++|||||||+||||++|+.||.+......+.+.+...... .....+++++++||.+||+.||
T Consensus 176 T~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp 254 (270)
T d1t4ha_ 176 TPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNK 254 (270)
T ss_dssp SCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSG
T ss_pred CccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCH
Confidence 999999999876 59999999999999999999999998877666665554433322 2234588999999999999999
Q ss_pred CCCCCcCCChHHhhcCCCcC
Q 035713 408 HKRIAYKRGATEIKQHPFFE 427 (491)
Q Consensus 408 ~~R~t~~~~~~ell~hpff~ 427 (491)
++||| ++|||+||||+
T Consensus 255 ~~R~s----~~ell~Hp~fk 270 (270)
T d1t4ha_ 255 DERYS----IKDLLNHAFFQ 270 (270)
T ss_dssp GGSCC----HHHHHTSGGGC
T ss_pred hHCcC----HHHHhCCcccC
Confidence 99999 99999999996
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.9e-60 Score=454.95 Aligned_cols=260 Identities=32% Similarity=0.477 Sum_probs=228.8
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhh------HHHHHHHHHHHHHHhhcC-CCCccceeeeEEe
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLAS------RNKLLRAQTEREILGLLD-HPFLPTLYSYFET 165 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~------~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~ 165 (491)
.++|++++.||+|+||+||+|+++.+|+.||||++.+..... ......+.+|+.+|++++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 378999999999999999999999999999999998654321 234456889999999997 9999999999999
Q ss_pred CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
++++|||||||+||+|.++++.. +.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 99999999999999999999875 5699999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
..... ....
T Consensus 160 ~~~~~-----------------------------------------------------------------------~~~~ 168 (277)
T d1phka_ 160 LDPGE-----------------------------------------------------------------------KLRE 168 (277)
T ss_dssp CCTTC-----------------------------------------------------------------------CBCC
T ss_pred ccCCC-----------------------------------------------------------------------ceee
Confidence 42110 1123
Q ss_pred cccccCccCcchhcC------CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC--CCCCCHHHHH
Q 035713 326 FVGTHEYLAPEIIRG------EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE--TPQVSFVARD 397 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~ 397 (491)
.+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+....+..++.....++. ...+|+++++
T Consensus 169 ~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 248 (277)
T d1phka_ 169 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD 248 (277)
T ss_dssp CCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHH
T ss_pred eeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHH
Confidence 479999999999974 34688999999999999999999999999888888888877665443 3579999999
Q ss_pred HHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 398 LIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 398 li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
||.+||+.||++||+ ++|||+||||+..
T Consensus 249 li~~~L~~~p~~R~s----~~eil~h~~~~~~ 276 (277)
T d1phka_ 249 LVSRFLVVQPQKRYT----AEEALAHPFFQQY 276 (277)
T ss_dssp HHHHHCCSSGGGSCC----HHHHTTSGGGCTT
T ss_pred HHHHHccCChhHCcC----HHHHHcCHHHHHh
Confidence 999999999999999 9999999999853
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-60 Score=464.92 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=228.3
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
.++|++++.||+|+||+||+|+++.+|+.||||++++.... ...+.+|+++|+.++|||||+++++|++++.+|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 47899999999999999999999999999999999875422 23567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccC--CcEEEeecccccccCCCC
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDE--GHIMLSDFDLSLRCSVSP 250 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~--g~vkL~DFGla~~~~~~~ 250 (491)
||||+||+|.+++... +..+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 80 mE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 80 FEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp ECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 9999999999998765 3469999999999999999999999999999999999999854 48999999998653211
Q ss_pred cccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccccc
Q 035713 251 TLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTH 330 (491)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 330 (491)
....+.+||+
T Consensus 158 ----------------------------------------------------------------------~~~~~~~~t~ 167 (321)
T d1tkia_ 158 ----------------------------------------------------------------------DNFRLLFTAP 167 (321)
T ss_dssp ----------------------------------------------------------------------CEEEEEESCG
T ss_pred ----------------------------------------------------------------------Cccccccccc
Confidence 1122458999
Q ss_pred CccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCC--CCCCHHHHHHHHhhhccCCC
Q 035713 331 EYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPET--PQVSFVARDLIRGLLVKEPH 408 (491)
Q Consensus 331 ~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~ 408 (491)
.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+.+|....+.++.. ..+++++++||.+||++||+
T Consensus 168 ~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~ 247 (321)
T d1tkia_ 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERK 247 (321)
T ss_dssp GGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGG
T ss_pred ccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChh
Confidence 9999999999999999999999999999999999999999998899998887766542 46899999999999999999
Q ss_pred CCCCcCCChHHhhcCCCcCC
Q 035713 409 KRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 409 ~R~t~~~~~~ell~hpff~~ 428 (491)
+||| ++|+|+||||+.
T Consensus 248 ~R~s----~~eil~hp~~~~ 263 (321)
T d1tkia_ 248 SRMT----ASEALQHPWLKQ 263 (321)
T ss_dssp GSCC----HHHHHHSHHHHS
T ss_pred HCcC----HHHHhcCHhhcc
Confidence 9999 999999999964
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-59 Score=458.80 Aligned_cols=258 Identities=28% Similarity=0.378 Sum_probs=212.7
Q ss_pred eEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhh--HHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEe
Q 035713 97 RLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLAS--RNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVME 174 (491)
Q Consensus 97 ~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 174 (491)
+.+++||+|+||+||+|+++.+|+.||||++++..... ......+.+|+++|+.++|||||+++++|.+++++|||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 35789999999999999999999999999997654322 2223567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcccc
Q 035713 175 FCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVK 254 (491)
Q Consensus 175 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 254 (491)
|+.|+++..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 81 ~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~---- 154 (299)
T d1ua2a_ 81 FMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN---- 154 (299)
T ss_dssp CCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC----
T ss_pred hhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc----
Confidence 9988877766543 4669999999999999999999999999999999999999999999999999985432110
Q ss_pred cccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccC
Q 035713 255 SSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLA 334 (491)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 334 (491)
....+.+||+.|||
T Consensus 155 ------------------------------------------------------------------~~~~~~~gt~~y~a 168 (299)
T d1ua2a_ 155 ------------------------------------------------------------------RAYTHQVVTRWYRA 168 (299)
T ss_dssp ------------------------------------------------------------------CCCCCSCCCCTTCC
T ss_pred ------------------------------------------------------------------ccccceecChhhcc
Confidence 01123489999999
Q ss_pred cchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---CC-----------------cCCC------
Q 035713 335 PEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---PL-----------------RFPE------ 387 (491)
Q Consensus 335 PE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~~-----------------~~~~------ 387 (491)
||++.+. .|+.++|||||||++|||++|++||.+.+..+.+.++... +. .++.
T Consensus 169 PE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
T d1ua2a_ 169 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHI 248 (299)
T ss_dssp HHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHH
T ss_pred HHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHh
Confidence 9999765 5799999999999999999999999999888877766531 10 0000
Q ss_pred CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 388 TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 388 ~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
...+++++++||.+||+.||++||| ++|+|+||||++..
T Consensus 249 ~~~~s~~~~dll~~~L~~dP~~R~s----a~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 249 FSAAGDDLLDLIQGLFLFNPCARIT----ATQALKMKYFSNRP 287 (299)
T ss_dssp CTTCCHHHHHHHHHHHCSSTTTSCC----HHHHHTSGGGTSSS
T ss_pred cccCCHHHHHHHHHHccCChhhCcC----HHHHhCCHhhCCCC
Confidence 1257889999999999999999999 99999999998654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-59 Score=452.79 Aligned_cols=261 Identities=29% Similarity=0.451 Sum_probs=218.0
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
+++|+++++||+|+||+||+|+++.+|+.||||+++... ..+.....+.+|+++|+.++|||||+++++|.+++.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 478999999999999999999999999999999997653 2233456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+.+ .+..++.......+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus 80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-- 156 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 156 (298)
T ss_dssp EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc--
Confidence 999954 55555555445679999999999999999999999999999999999999999999999999986542111
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......+||+.|
T Consensus 157 --------------------------------------------------------------------~~~~~~~gt~~y 168 (298)
T d1gz8a_ 157 --------------------------------------------------------------------RTYTHEVVTLWY 168 (298)
T ss_dssp --------------------------------------------------------------------BCTTCCBCCCTT
T ss_pred --------------------------------------------------------------------ccceeeccccee
Confidence 111234799999
Q ss_pred cCcchhcCCCC-CCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---CC---------------cCCC------
Q 035713 333 LAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---PL---------------RFPE------ 387 (491)
Q Consensus 333 ~aPE~l~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~~---------------~~~~------ 387 (491)
+|||++....+ +.++|||||||++|+|++|+.||.+.+..+.+.++... +. .++.
T Consensus 169 ~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
T d1gz8a_ 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDF 248 (298)
T ss_dssp CCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCH
T ss_pred eehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccch
Confidence 99999888775 78999999999999999999999998888777665421 10 0000
Q ss_pred ---CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 388 ---TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 388 ---~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
...++.++++||++||++||++||| ++|||+||||+++
T Consensus 249 ~~~~~~~s~~~~dll~~mL~~dP~~R~t----~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 249 SKVVPPLDEDGRSLLSQMLHYDPNKRIS----AKAALAHPFFQDV 289 (298)
T ss_dssp HHHSTTCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGTTC
T ss_pred hhhccCCCHHHHHHHHHHccCChhHCcC----HHHHhCCHhhccC
Confidence 1357889999999999999999999 9999999999866
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-59 Score=461.67 Aligned_cols=253 Identities=29% Similarity=0.452 Sum_probs=212.9
Q ss_pred CCCceEee-eeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhh-cCCCCccceeeeEEe----C
Q 035713 93 LSNFRLLK-RLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGL-LDHPFLPTLYSYFET----D 166 (491)
Q Consensus 93 ~~~y~~~~-~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~-l~hp~iv~l~~~~~~----~ 166 (491)
+++|+++. .||+|+||+||+|+++.+++.||||++++. ..+.+|++++.+ ++|||||+++++|++ +
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 57899986 599999999999999999999999999753 235679988655 589999999999976 4
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc---CCcEEEeecccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD---EGHIMLSDFDLS 243 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~---~g~vkL~DFGla 243 (491)
.++|||||||+||+|.+++.......|++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 67999999999999999998765567999999999999999999999999999999999999985 567999999998
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (491)
+...... ..
T Consensus 162 ~~~~~~~-----------------------------------------------------------------------~~ 170 (335)
T d2ozaa1 162 KETTSHN-----------------------------------------------------------------------SL 170 (335)
T ss_dssp EECCCCC-----------------------------------------------------------------------CC
T ss_pred eeccCCC-----------------------------------------------------------------------cc
Confidence 6542211 11
Q ss_pred cccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHH----HcCCCcCCCC--CCCCHHHHH
Q 035713 324 MSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNV----VGQPLRFPET--PQVSFVARD 397 (491)
Q Consensus 324 ~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i----~~~~~~~~~~--~~~s~~~~~ 397 (491)
.+.+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+.......+ ....+.+|.. ..+++++++
T Consensus 171 ~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 250 (335)
T d2ozaa1 171 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 250 (335)
T ss_dssp CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHH
T ss_pred ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHH
Confidence 2348999999999999999999999999999999999999999887655444333 3334444432 358999999
Q ss_pred HHHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 398 LIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 398 li~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
||.+||+.||++||+ +.|||+||||..
T Consensus 251 li~~~L~~dP~~R~s----~~eil~hp~~~~ 277 (335)
T d2ozaa1 251 LIRNLLKTEPTQRMT----ITEFMNHPWIMQ 277 (335)
T ss_dssp HHHHHSCSSTTTSCC----HHHHHHSHHHHT
T ss_pred HHHHHccCChhHCcC----HHHHHcCHHhhC
Confidence 999999999999999 999999999963
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-58 Score=446.41 Aligned_cols=258 Identities=19% Similarity=0.277 Sum_probs=224.4
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
.+++..++|++.++||+|+||+||+|+++.+++.||||++++.... .+.+.+|+++|+.++|||||+++++|.+++
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 4556778999999999999999999999999999999999765332 346789999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+|||||||++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecC
Confidence 99999999999999999987666789999999999999999999999999999999999999999999999999996542
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
.... .......
T Consensus 167 ~~~~---------------------------------------------------------------------~~~~~~~ 177 (287)
T d1opja_ 167 GDTY---------------------------------------------------------------------TAHAGAK 177 (287)
T ss_dssp SSSS---------------------------------------------------------------------EEETTEE
T ss_pred CCCc---------------------------------------------------------------------eeecccc
Confidence 2110 0111236
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP 407 (491)
||+.|||||++.+..|+.++|||||||++|||++|..||........+.+++......+....+++++.+||.+||+.||
T Consensus 178 g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP 257 (287)
T d1opja_ 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 257 (287)
T ss_dssp ECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred ccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCH
Confidence 89999999999999999999999999999999997776665556666666666666666666799999999999999999
Q ss_pred CCCCCcCCChHHhhc
Q 035713 408 HKRIAYKRGATEIKQ 422 (491)
Q Consensus 408 ~~R~t~~~~~~ell~ 422 (491)
++||| +++|++
T Consensus 258 ~~Rps----~~ei~~ 268 (287)
T d1opja_ 258 SDRPS----FAEIHQ 268 (287)
T ss_dssp GGSCC----HHHHHH
T ss_pred hHCcC----HHHHHH
Confidence 99999 889876
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-58 Score=444.41 Aligned_cols=251 Identities=28% Similarity=0.410 Sum_probs=214.3
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHH---HHHHHHHHHHHHhhcC--CCCccceeeeEEeCce
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRN---KLLRAQTEREILGLLD--HPFLPTLYSYFETDKF 168 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~---~~~~~~~E~~il~~l~--hp~iv~l~~~~~~~~~ 168 (491)
++|++.++||+|+||+||+|+++.+|+.||||++++....... ...++.+|+.+|+.++ |||||+++++|.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 6899999999999999999999999999999999875433211 1223567999999997 8999999999999999
Q ss_pred EEEEEeccCC-CchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc-CCcEEEeeccccccc
Q 035713 169 YCLVMEFCSG-GNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD-EGHIMLSDFDLSLRC 246 (491)
Q Consensus 169 ~~lV~E~~~g-g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~-~g~vkL~DFGla~~~ 246 (491)
+|+||||+.+ +++.+++... ..+++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+..
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 9999999976 5777777764 56999999999999999999999999999999999999985 479999999998543
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.. ....+.
T Consensus 162 ~~------------------------------------------------------------------------~~~~~~ 169 (273)
T d1xwsa_ 162 KD------------------------------------------------------------------------TVYTDF 169 (273)
T ss_dssp CS------------------------------------------------------------------------SCBCCC
T ss_pred cc------------------------------------------------------------------------cccccc
Confidence 11 011235
Q ss_pred ccccCccCcchhcCCCC-CCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhcc
Q 035713 327 VGTHEYLAPEIIRGEGH-GSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~ 405 (491)
+||+.|||||++.+..+ +.++|||||||+||||++|+.||.+. ..+......++. .+|+++++||.+||+.
T Consensus 170 ~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~--~~s~~~~~li~~~L~~ 241 (273)
T d1xwsa_ 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQ--RVSSECQHLIRWCLAL 241 (273)
T ss_dssp CSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSS--CCCHHHHHHHHHHTCS
T ss_pred ccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCC--CCCHHHHHHHHHHccC
Confidence 89999999999988776 67899999999999999999999763 235555555554 5999999999999999
Q ss_pred CCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 406 EPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
||++||| ++|+|+||||+++.
T Consensus 242 dp~~R~s----~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 242 RPSDRPT----FEEIQNHPWMQDVL 262 (273)
T ss_dssp SGGGSCC----HHHHHTSGGGSSCC
T ss_pred CHhHCcC----HHHHhcCHhhCCCC
Confidence 9999999 99999999998754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-58 Score=446.88 Aligned_cols=262 Identities=25% Similarity=0.391 Sum_probs=215.1
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCC-CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc---CCCCccceeeeEEe---
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGT-NTYFAMKVMDKASLASRNKLLRAQTEREILGLL---DHPFLPTLYSYFET--- 165 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l---~hp~iv~l~~~~~~--- 165 (491)
.++|+++++||+|+||+||+|++..+ ++.||||+++..... ......+.+|+++|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 37899999999999999999999765 678999999765322 22222345677777766 79999999999853
Q ss_pred --CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccc
Q 035713 166 --DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLS 243 (491)
Q Consensus 166 --~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla 243 (491)
...+|++|||+.++.+...... ....+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred ccCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 3578999999988777644443 3567999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccc
Q 035713 244 LRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRS 323 (491)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (491)
+..... ...
T Consensus 164 ~~~~~~-----------------------------------------------------------------------~~~ 172 (305)
T d1blxa_ 164 RIYSFQ-----------------------------------------------------------------------MAL 172 (305)
T ss_dssp CCCCGG-----------------------------------------------------------------------GGG
T ss_pred hhhccc-----------------------------------------------------------------------ccC
Confidence 532110 112
Q ss_pred cccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC---CC--cC-------------
Q 035713 324 MSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ---PL--RF------------- 385 (491)
Q Consensus 324 ~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~~--~~------------- 385 (491)
.+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+.+++.. +. .+
T Consensus 173 ~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (305)
T d1blxa_ 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS 252 (305)
T ss_dssp CCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCC
T ss_pred CCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhcc
Confidence 2358999999999999999999999999999999999999999999888777766421 10 00
Q ss_pred -------CCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCCh
Q 035713 386 -------PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNW 431 (491)
Q Consensus 386 -------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~ 431 (491)
.....+++++++||.+||++||++||| ++|+|+||||+++++
T Consensus 253 ~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s----a~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 253 KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYFQDLER 301 (305)
T ss_dssp CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTCCC
T ss_pred ccccchhhccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcChhhcCchh
Confidence 012357899999999999999999999 999999999998865
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=449.56 Aligned_cols=260 Identities=20% Similarity=0.300 Sum_probs=222.7
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCc-----EEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNT-----YFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYF 163 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~ 163 (491)
++..++|+++++||+|+||+||+|++..+++ .||+|++.... .......+.+|+.+|+.+ +|||||++++++
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 4566899999999999999999999986654 69999986543 233445678999999998 899999999999
Q ss_pred EeCceEEEEEeccCCCchHHHHHhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcccccC
Q 035713 164 ETDKFYCLVMEFCSGGNLHSLRQKQPN---------------------KYFTEDAARFFASEVLLALEYLHMLGIVYRDL 222 (491)
Q Consensus 164 ~~~~~~~lV~E~~~gg~L~~~~~~~~~---------------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDi 222 (491)
.+.+.+|||||||+||+|.++++.... ..+++..++.|+.||+.||.|||++|||||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 999999999999999999999976432 35899999999999999999999999999999
Q ss_pred CCCCEEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCC
Q 035713 223 KPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSD 302 (491)
Q Consensus 223 kp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (491)
||+|||++.++.+||+|||+|+.......
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~--------------------------------------------------- 219 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSN--------------------------------------------------- 219 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTT---------------------------------------------------
T ss_pred chhccccccCCeEEEeeccccccccCCCc---------------------------------------------------
Confidence 99999999999999999999965432111
Q ss_pred CCCCCCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcC
Q 035713 303 FGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQ 381 (491)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~ 381 (491)
.....+.+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+....+.+++..
T Consensus 220 -----------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~ 282 (325)
T d1rjba_ 220 -----------------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN 282 (325)
T ss_dssp -----------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHT
T ss_pred -----------------eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 111224579999999999999999999999999999999998 89999998888888888888
Q ss_pred CCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 382 PLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 382 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
..+++....+++++++||.+||+.||++||| ++||++|
T Consensus 283 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt----~~ei~~~ 320 (325)
T d1rjba_ 283 GFKMDQPFYATEEIYIIMQSCWAFDSRKRPS----FPNLTSF 320 (325)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 7777776789999999999999999999999 9999876
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-57 Score=440.14 Aligned_cols=261 Identities=25% Similarity=0.394 Sum_probs=218.1
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc----e
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK----F 168 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~----~ 168 (491)
.++|++++.||+|+||+||+|+++.+|+.||||++++....+.....++.+|+++|+.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367999999999999999999999999999999998876666777788999999999999999999999997643 4
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
+||||||++|++|..++... +.+++.+++.|+.||+.||+|||++|||||||||+||||+.++.++|+|||++.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 89999999999999988775 5699999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
... ......+.+|
T Consensus 164 ~~~-------------------------------------------------------------------~~~~~~~~~G 176 (277)
T d1o6ya_ 164 SGN-------------------------------------------------------------------SVTQTAAVIG 176 (277)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc-------------------------------------------------------------------cccccccccC
Confidence 110 0112234589
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCC--CCCCCCHHHHHHHHhhhccC
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP--ETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~~~~li~~~L~~d 406 (491)
|+.|||||++.+..|+.++|||||||++|||+||++||.+.+..+.+.+++.....++ ....+|+++.+||.+||++|
T Consensus 177 t~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d 256 (277)
T d1o6ya_ 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN 256 (277)
T ss_dssp --TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSS
T ss_pred cccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCC
Confidence 9999999999999999999999999999999999999999988888888877655443 23579999999999999999
Q ss_pred CCCCCCcCCChHHhhcCCCc
Q 035713 407 PHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 407 P~~R~t~~~~~~ell~hpff 426 (491)
|.+||+. ++++ .|+|.
T Consensus 257 p~~R~~s---a~~l-~~~l~ 272 (277)
T d1o6ya_ 257 PENRYQT---AAEM-RADLV 272 (277)
T ss_dssp GGGSCSS---HHHH-HHHHH
T ss_pred HhHCHhH---HHHH-HHHHH
Confidence 9999951 5554 45444
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-58 Score=449.16 Aligned_cols=281 Identities=40% Similarity=0.747 Sum_probs=231.4
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEe---CCCcEEEEEEeecchhh-hHHHHHHHHHHHHHHhhcCC-CCccceeeeEEe
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELR---GTNTYFAMKVMDKASLA-SRNKLLRAQTEREILGLLDH-PFLPTLYSYFET 165 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h-p~iv~l~~~~~~ 165 (491)
+.+++|+++++||+|+||+||+|++. .+|+.||||++++.... .....+++.+|+++|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 45689999999999999999999984 46899999999765432 22334557789999999976 899999999999
Q ss_pred CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
...+|+||||+.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999998875 5689999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
+.... .....+
T Consensus 179 ~~~~~---------------------------------------------------------------------~~~~~~ 189 (322)
T d1vzoa_ 179 FVADE---------------------------------------------------------------------TERAYD 189 (322)
T ss_dssp CCGGG---------------------------------------------------------------------GGGGCG
T ss_pred hcccc---------------------------------------------------------------------cccccc
Confidence 42111 011224
Q ss_pred cccccCccCcchhcCCC--CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHH----HcCCCcCCCCCCCCHHHHHHH
Q 035713 326 FVGTHEYLAPEIIRGEG--HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNV----VGQPLRFPETPQVSFVARDLI 399 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~~~--~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i----~~~~~~~~~~~~~s~~~~~li 399 (491)
..||+.|+|||.+.+.. ++.++|||||||+||||++|+.||.+.+.......+ ......++ ..+++++.+||
T Consensus 190 ~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~--~~~s~~~~~li 267 (322)
T d1vzoa_ 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDLI 267 (322)
T ss_dssp GGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHH
T ss_pred cccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc--ccCCHHHHHHH
Confidence 58999999999998754 578999999999999999999999876554433333 33334444 35999999999
Q ss_pred HhhhccCCCCCCCcCC-ChHHhhcCCCcCCCChhhhh--ccCCCCCCC
Q 035713 400 RGLLVKEPHKRIAYKR-GATEIKQHPFFEGVNWALVR--SALPPHIPE 444 (491)
Q Consensus 400 ~~~L~~dP~~R~t~~~-~~~ell~hpff~~~~~~~~~--~~~~~~~p~ 444 (491)
.+||.+||++|+++.. .++|+|+||||++++|..+. ...+|.+|.
T Consensus 268 ~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~ 315 (322)
T d1vzoa_ 268 QRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPV 315 (322)
T ss_dssp HHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred HHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCC
Confidence 9999999999997532 48999999999999998763 344555553
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-57 Score=436.61 Aligned_cols=258 Identities=23% Similarity=0.331 Sum_probs=213.6
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
++++..++|+++++||+|+||+||+|+++ ..||||+++..... ....+.+.+|+++|++++|||||++++++. +.
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~ 76 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYST-AP 76 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-cc
Confidence 34677789999999999999999999764 35999999765433 345678899999999999999999999865 45
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+|||||||+||+|.+++... ...+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+...
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 689999999999999998765 3569999999999999999999999999999999999999999999999999986532
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
.... .....+.+
T Consensus 156 ~~~~--------------------------------------------------------------------~~~~~~~~ 167 (276)
T d1uwha_ 156 RWSG--------------------------------------------------------------------SHQFEQLS 167 (276)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred ccCC--------------------------------------------------------------------cccccccc
Confidence 1110 01122457
Q ss_pred cccCccCcchhcCC---CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCC----CCCCCCHHHHHHHH
Q 035713 328 GTHEYLAPEIIRGE---GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFP----ETPQVSFVARDLIR 400 (491)
Q Consensus 328 gt~~y~aPE~l~~~---~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~s~~~~~li~ 400 (491)
||+.|||||++.+. .|+.++|||||||+||||+||+.||.+.+....+..++......| ....+++++.+||.
T Consensus 168 gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~ 247 (276)
T d1uwha_ 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMA 247 (276)
T ss_dssp CCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHH
T ss_pred cCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHH
Confidence 99999999999753 478899999999999999999999998887776666654433332 23468999999999
Q ss_pred hhhccCCCCCCCcCCChHHhhcC
Q 035713 401 GLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 401 ~~L~~dP~~R~t~~~~~~ell~h 423 (491)
+||..||++||| +++|+++
T Consensus 248 ~cl~~dp~~RPt----~~~il~~ 266 (276)
T d1uwha_ 248 ECLKKKRDERPL----FPQILAS 266 (276)
T ss_dssp HHTCSSGGGSCC----HHHHHHH
T ss_pred HHcCCCHhHCcC----HHHHHHH
Confidence 999999999999 9999886
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-56 Score=436.17 Aligned_cols=261 Identities=22% Similarity=0.315 Sum_probs=210.3
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCCc---EEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTNT---YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD 166 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 166 (491)
.+..++|++.++||+|+||+||+|+++.+++ .||||++.... .....+.+.+|+++|+.++|||||++++++.++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4567899999999999999999999987664 58889886542 334556788999999999999999999999999
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
+.+|||||||+||+|.+++... .+.+++.++..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999999999988765 356999999999999999999999999999999999999999999999999999764
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
....... ........
T Consensus 179 ~~~~~~~-----------------------------------------------------------------~~~~~~~~ 193 (299)
T d1jpaa_ 179 EDDTSDP-----------------------------------------------------------------TYTSALGG 193 (299)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCCCCcc-----------------------------------------------------------------eeeecccc
Confidence 3211100 00011123
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhcc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~ 405 (491)
.||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+... ...+....++.++.+||.+||+.
T Consensus 194 ~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~ 272 (299)
T d1jpaa_ 194 KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD-YRLPPPMDCPSALHQLMLDCWQK 272 (299)
T ss_dssp --CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCS
T ss_pred cCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCccchHHHHHHHHHHcCC
Confidence 68999999999999999999999999999999998 89999988877766666543 44555567999999999999999
Q ss_pred CCCCCCCcCCChHHhhcC
Q 035713 406 EPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~h 423 (491)
||++||+ +.+|+++
T Consensus 273 ~P~~RPs----~~ei~~~ 286 (299)
T d1jpaa_ 273 DRNHRPK----FGQIVNT 286 (299)
T ss_dssp STTTSCC----HHHHHHH
T ss_pred CHhHCcC----HHHHHHH
Confidence 9999999 7777754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.9e-57 Score=436.30 Aligned_cols=258 Identities=25% Similarity=0.394 Sum_probs=215.8
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
+++|+++++||+|+||+||+|+++ +|+.||||+++.... .+....++.+|+.+|+.++|||||+++++|.+++..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 478999999999999999999986 789999999976543 334456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
|||+.++.+..+.+.. +.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|.......
T Consensus 79 ~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-- 154 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (286)
T ss_dssp EECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc--
Confidence 9999877776665543 679999999999999999999999999999999999999999999999999986532110
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......+||+.|
T Consensus 155 --------------------------------------------------------------------~~~~~~~~~~~y 166 (286)
T d1ob3a_ 155 --------------------------------------------------------------------RKYTHEIVTLWY 166 (286)
T ss_dssp ---------------------------------------------------------------------------CCCTT
T ss_pred --------------------------------------------------------------------cccceecccchh
Confidence 011234789999
Q ss_pred cCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CCC--------c-------C--------
Q 035713 333 LAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QPL--------R-------F-------- 385 (491)
Q Consensus 333 ~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~~--------~-------~-------- 385 (491)
+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+.++.. .+. . +
T Consensus 167 ~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (286)
T d1ob3a_ 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPW 246 (286)
T ss_dssp CCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCG
T ss_pred hhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcch
Confidence 9999998755 68999999999999999999999999888777766542 100 0 0
Q ss_pred -CCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 386 -PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 386 -~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
.....++++++|||++||+.||++||| ++|||+||||+.
T Consensus 247 ~~~~~~~s~~~~dli~~~L~~dP~~R~s----~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 247 ESFLKGLDESGIDLLSKMLKLDPNQRIT----AKQALEHAYFKE 286 (286)
T ss_dssp GGTCCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGGC
T ss_pred hhhcccCCHHHHHHHHHHccCChhHCcC----HHHHhcCcccCc
Confidence 011357889999999999999999999 999999999973
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-57 Score=434.46 Aligned_cols=260 Identities=21% Similarity=0.301 Sum_probs=216.4
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
.+++..++|+++++||+|+||+||+|+++ +++.||||+++..... .+.+.+|+++|++++|||||++++++.+ +
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 34566789999999999999999999986 5778999999765432 2457899999999999999999998754 5
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+||||||+++|+|.+++.......+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+.
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 67899999999999988765444569999999999999999999999999999999999999999999999999997543
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
.... .......
T Consensus 161 ~~~~---------------------------------------------------------------------~~~~~~~ 171 (272)
T d1qpca_ 161 DNEY---------------------------------------------------------------------TAREGAK 171 (272)
T ss_dssp SSCE---------------------------------------------------------------------ECCTTCC
T ss_pred CCcc---------------------------------------------------------------------ccccccC
Confidence 2110 0111247
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhcC-CCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHG-TTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
||+.|||||++.+..|+.++|||||||+||||+|| ++||...+..+.+..+. .....+....+++++.+||.+||+.|
T Consensus 172 gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~~ 250 (272)
T d1qpca_ 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEELYQLMRLCWKER 250 (272)
T ss_dssp CCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccChHHHHHHHHHHcCCC
Confidence 89999999999999999999999999999999995 55566655555555554 34444455679999999999999999
Q ss_pred CCCCCCcCCChHHhhc--CCCcC
Q 035713 407 PHKRIAYKRGATEIKQ--HPFFE 427 (491)
Q Consensus 407 P~~R~t~~~~~~ell~--hpff~ 427 (491)
|++||| +++|++ |+||.
T Consensus 251 P~~Rpt----~~ei~~~L~~~ft 269 (272)
T d1qpca_ 251 PEDRPT----FDYLRSVLEDFFT 269 (272)
T ss_dssp GGGSCC----HHHHHHHHHHHHH
T ss_pred HhHCcC----HHHHHHHhhhhhh
Confidence 999999 999987 77774
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-56 Score=426.68 Aligned_cols=252 Identities=22% Similarity=0.339 Sum_probs=207.9
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
..++|+++++||+|+||+||+|+++ +++.||||++++..... +.+.+|+++|+.++|||||++++++..++.+||
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcH----HHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 4578999999999999999999987 56789999997654332 357789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||+++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.......
T Consensus 78 v~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 99999999999988765 35699999999999999999999999999999999999999999999999999865421110
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
.......||+.
T Consensus 157 ---------------------------------------------------------------------~~~~~~~gt~~ 167 (263)
T d1sm2a_ 157 ---------------------------------------------------------------------TSSTGTKFPVK 167 (263)
T ss_dssp -----------------------------------------------------------------------------CTT
T ss_pred ---------------------------------------------------------------------eeecceecCcc
Confidence 01123479999
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
|||||++.+..|+.++|||||||+||||+| |++||...+..+.+..+... ...+....+++++.+||.+||+.||++|
T Consensus 168 y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~~p~~R 246 (263)
T d1sm2a_ 168 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHCWKERPEDR 246 (263)
T ss_dssp SCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT-CCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred cCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc-CCCCCccccCHHHHHHHHHHccCCHhHC
Confidence 999999999999999999999999999999 57777776666666655543 3333445689999999999999999999
Q ss_pred CCcCCChHHhhcC
Q 035713 411 IAYKRGATEIKQH 423 (491)
Q Consensus 411 ~t~~~~~~ell~h 423 (491)
|+ +++|++|
T Consensus 247 ps----~~~il~~ 255 (263)
T d1sm2a_ 247 PA----FSRLLRQ 255 (263)
T ss_dssp CC----HHHHHHH
T ss_pred cC----HHHHHHH
Confidence 99 9999886
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-56 Score=430.65 Aligned_cols=261 Identities=22% Similarity=0.316 Sum_probs=217.0
Q ss_pred ccCCCceEeee-eeccCceEEEEEEEeC--CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 91 IGLSNFRLLKR-LGYGDIGSVYLVELRG--TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 91 ~~~~~y~~~~~-iG~G~~g~V~~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
+..++|.+.+. ||+|+||+||+|.++. ++..||||++++.. ......++.+|+++|++++|||||++++++.++
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~- 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE- 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-
Confidence 44577888884 9999999999998764 45579999997642 344566789999999999999999999998754
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+|||||||+||+|.+++... ...+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+.
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred eEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 588999999999999987654 3569999999999999999999999999999999999999999999999999997653
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
...... ......+
T Consensus 161 ~~~~~~-------------------------------------------------------------------~~~~~~~ 173 (285)
T d1u59a_ 161 ADDSYY-------------------------------------------------------------------TARSAGK 173 (285)
T ss_dssp TCSCEE-------------------------------------------------------------------CCCCSSC
T ss_pred cccccc-------------------------------------------------------------------ccccccc
Confidence 211100 0111347
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..+.+..+..+ .+.+....+++++.+||.+||+.|
T Consensus 174 gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~~ 252 (285)
T d1u59a_ 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPPECPPELYALMSDCWIYK 252 (285)
T ss_dssp CCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHTTCSS
T ss_pred cCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHHHcCCC
Confidence 8999999999999999999999999999999998 99999988877766666543 333444579999999999999999
Q ss_pred CCCCCCcCCChHHh---hcCCCcC
Q 035713 407 PHKRIAYKRGATEI---KQHPFFE 427 (491)
Q Consensus 407 P~~R~t~~~~~~el---l~hpff~ 427 (491)
|++||+ +.+| |+|+|+.
T Consensus 253 p~~RPs----~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 253 WEDRPD----FLTVEQRMRACYYS 272 (285)
T ss_dssp GGGSCC----HHHHHHHHHHHHHH
T ss_pred HhHCcC----HHHHHHHHHHHHHH
Confidence 999999 5555 6787763
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-56 Score=444.10 Aligned_cols=259 Identities=29% Similarity=0.417 Sum_probs=213.0
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc-----
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK----- 167 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~----- 167 (491)
.++|+++++||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 478999999999999999999999999999999997653 34556678889999999999999999999997654
Q ss_pred -eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 168 -FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 168 -~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
++||||||+ |.+|..+++. +.|++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+..
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 579999999 7788887765 45999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.. ..+..
T Consensus 172 ~~-------------------------------------------------------------------------~~~~~ 178 (346)
T d1cm8a_ 172 DS-------------------------------------------------------------------------EMTGY 178 (346)
T ss_dssp CS-------------------------------------------------------------------------SCCSS
T ss_pred CC-------------------------------------------------------------------------ccccc
Confidence 21 01134
Q ss_pred ccccCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCC----------------------
Q 035713 327 VGTHEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL---------------------- 383 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~---------------------- 383 (491)
+||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+....+..+.....
T Consensus 179 ~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (346)
T d1cm8a_ 179 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 258 (346)
T ss_dssp CSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHS
T ss_pred cccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccC
Confidence 7999999999998754 68999999999999999999999998877666544332100
Q ss_pred -cC------CCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhh
Q 035713 384 -RF------PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWAL 433 (491)
Q Consensus 384 -~~------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~ 433 (491)
.. .....+++++++||.+||..||.+||| ++|||+||||+++.+..
T Consensus 259 ~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~eiL~Hp~f~~~~~~~ 311 (346)
T d1cm8a_ 259 PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT----AGEALAHPYFESLHDTE 311 (346)
T ss_dssp CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGTTTC---
T ss_pred CcccccchHHhccCCCHHHHHHHHHHCcCChhHCcC----HHHHhcChhhCcCCCcc
Confidence 00 011457899999999999999999999 99999999999887653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.4e-56 Score=437.89 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=210.2
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEe--CceE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFET--DKFY 169 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~--~~~~ 169 (491)
.++|+++++||+|+||+||+|+++.+|+.||||++++.. ..++.+|+++|+.++ ||||++++++|.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 468999999999999999999999999999999997542 235678999999995 9999999999984 4579
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC-cEEEeecccccccCC
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG-HIMLSDFDLSLRCSV 248 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g-~vkL~DFGla~~~~~ 248 (491)
|+||||+.+++|..+. +.+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+....
T Consensus 108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999999997653 3499999999999999999999999999999999999998655 699999999865321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
.. .....+|
T Consensus 183 ~~-----------------------------------------------------------------------~~~~~~~ 191 (328)
T d3bqca1 183 GQ-----------------------------------------------------------------------EYNVRVA 191 (328)
T ss_dssp TC-----------------------------------------------------------------------CCCSCCS
T ss_pred CC-----------------------------------------------------------------------ccccccc
Confidence 11 1123479
Q ss_pred ccCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHH-HHHHH---HcC----------C-----------
Q 035713 329 THEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRA-TLFNV---VGQ----------P----------- 382 (491)
Q Consensus 329 t~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~i---~~~----------~----------- 382 (491)
|+.|+|||++.+.. ++.++|||||||++|||++|+.||....... ....+ ++. .
T Consensus 192 t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 271 (328)
T d3bqca1 192 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL 271 (328)
T ss_dssp CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTC
T ss_pred CccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhc
Confidence 99999999998765 7999999999999999999999997654432 22111 110 0
Q ss_pred -----------CcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChh
Q 035713 383 -----------LRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWA 432 (491)
Q Consensus 383 -----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~ 432 (491)
...+....++++++|||++||++||++|+| ++|||+||||+++.|+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 272 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT----AREAMEHPYFYTVVKD 328 (328)
T ss_dssp CCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTSCCC
T ss_pred ccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcC----HHHHhcCcccCCCCCC
Confidence 011112357899999999999999999999 9999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-56 Score=429.87 Aligned_cols=254 Identities=21% Similarity=0.293 Sum_probs=209.3
Q ss_pred eeeeccCceEEEEEEEeC--CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEEEeccC
Q 035713 100 KRLGYGDIGSVYLVELRG--TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLVMEFCS 177 (491)
Q Consensus 100 ~~iG~G~~g~V~~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E~~~ 177 (491)
++||+|+||+||+|.++. +++.||||+++... ......+++.+|+++|++++|||||++++++.++ ..||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 479999999999998754 45789999997543 3344566789999999999999999999999755 5789999999
Q ss_pred CCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccccccc
Q 035713 178 GGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSS 257 (491)
Q Consensus 178 gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 257 (491)
+|+|.++++.. ..+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+.......
T Consensus 91 ~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~---- 164 (277)
T d1xbba_ 91 LGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY---- 164 (277)
T ss_dssp TEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE----
T ss_pred CCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc----
Confidence 99999998875 569999999999999999999999999999999999999999999999999997543211110
Q ss_pred ccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCccCcch
Q 035713 258 VSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEI 337 (491)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 337 (491)
.......||+.|||||+
T Consensus 165 ---------------------------------------------------------------~~~~~~~gt~~y~APE~ 181 (277)
T d1xbba_ 165 ---------------------------------------------------------------KAQTHGKWPVKWYAPEC 181 (277)
T ss_dssp ---------------------------------------------------------------EC----CCCGGGCCHHH
T ss_pred ---------------------------------------------------------------ccccccCCCceecCchh
Confidence 01123478999999999
Q ss_pred hcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCC
Q 035713 338 IRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRG 416 (491)
Q Consensus 338 l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~ 416 (491)
+.+..++.++|||||||++|||++ |+.||.+.+..+....+..+ .+.+....+++++.+||.+||+.||++||+
T Consensus 182 l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~~~~li~~cl~~dp~~RPs---- 256 (277)
T d1xbba_ 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCPAGCPREMYDLMNLCWTYDVENRPG---- 256 (277)
T ss_dssp HHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSTTTSCC----
T ss_pred hcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC-CCCCCCcccCHHHHHHHHHHcCCCHhHCcC----
Confidence 999999999999999999999998 99999988777666555543 334444569999999999999999999999
Q ss_pred hHHh---hcCCCcCCC
Q 035713 417 ATEI---KQHPFFEGV 429 (491)
Q Consensus 417 ~~el---l~hpff~~~ 429 (491)
+++| |+|+|++.+
T Consensus 257 ~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 257 FAAVELRLRNYYYDVV 272 (277)
T ss_dssp HHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhhCHHhhcC
Confidence 7776 677776543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=440.11 Aligned_cols=254 Identities=26% Similarity=0.453 Sum_probs=209.9
Q ss_pred CceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe------Cce
Q 035713 95 NFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET------DKF 168 (491)
Q Consensus 95 ~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~------~~~ 168 (491)
+|+.+++||+|+||+||+|+++.+|+.||||++.+.... ..+|+++|+.++|||||+++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 699999999999999999999999999999999765321 2369999999999999999999853 346
Q ss_pred EEEEEeccCCCchHHHHH-hCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC-cEEEeeccccccc
Q 035713 169 YCLVMEFCSGGNLHSLRQ-KQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG-HIMLSDFDLSLRC 246 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~-~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g-~vkL~DFGla~~~ 246 (491)
+|||||||.++.+..+.. ......+++.+++.|+.||+.||+|||++||+||||||+||||+.++ .+||+|||+++.+
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 899999997665444432 12345699999999999999999999999999999999999999775 8999999998654
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.... ...+.
T Consensus 174 ~~~~-----------------------------------------------------------------------~~~~~ 182 (350)
T d1q5ka_ 174 VRGE-----------------------------------------------------------------------PNVSY 182 (350)
T ss_dssp CTTS-----------------------------------------------------------------------CCCSC
T ss_pred cCCc-----------------------------------------------------------------------ccccc
Confidence 2111 11234
Q ss_pred ccccCccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CC--------------CcCC--
Q 035713 327 VGTHEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QP--------------LRFP-- 386 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~--------------~~~~-- 386 (491)
+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+.+++. .+ ..++
T Consensus 183 ~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
T d1q5ka_ 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 262 (350)
T ss_dssp CSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCC
T ss_pred cccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhcccccc
Confidence 899999999998865 589999999999999999999999999888777766542 10 1111
Q ss_pred --------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCC
Q 035713 387 --------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVN 430 (491)
Q Consensus 387 --------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~ 430 (491)
....+++++.+||.+||.+||++||| +.|+|+||||+.+.
T Consensus 263 ~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 263 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEACAHSFFDELR 310 (350)
T ss_dssp CCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGGGG
T ss_pred ccCchhhhcccCCCHHHHHHHHHHccCChhHCcC----HHHHhcCHhhcccc
Confidence 12357899999999999999999999 99999999998654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=419.77 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=218.9
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 171 (491)
..++|+++++||+|+||+||+|+++ +++.||||++++..... ..+.+|+.+++.++|||||++++++.+++.+|+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~----~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH----HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH----HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 3478999999999999999999985 78899999998765433 357789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCc
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPT 251 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~ 251 (491)
||||+++|+|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 77 v~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp EEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred EEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999999999887654 34699999999999999999999999999999999999999999999999999865422110
Q ss_pred ccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccC
Q 035713 252 LVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHE 331 (491)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 331 (491)
.......||+.
T Consensus 156 ---------------------------------------------------------------------~~~~~~~~t~~ 166 (258)
T d1k2pa_ 156 ---------------------------------------------------------------------TSSVGSKFPVR 166 (258)
T ss_dssp ---------------------------------------------------------------------CCCCCSCCCGG
T ss_pred ---------------------------------------------------------------------eeecccCCCCC
Confidence 01112378999
Q ss_pred ccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCC
Q 035713 332 YLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKR 410 (491)
Q Consensus 332 y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 410 (491)
|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..+...++... ...+....++.++.+||.+||+.||++|
T Consensus 167 y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~dP~~R 245 (258)
T d1k2pa_ 167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYRPHLASEKVYTIMYSCWHEKADER 245 (258)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHTTCSSGGGS
T ss_pred cCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC-CCCCCcccccHHHHHHHHHHccCCHhHC
Confidence 999999999999999999999999999998 89999999887777766653 3444555799999999999999999999
Q ss_pred CCcCCChHHhhcC
Q 035713 411 IAYKRGATEIKQH 423 (491)
Q Consensus 411 ~t~~~~~~ell~h 423 (491)
|| +++|++|
T Consensus 246 Pt----~~eil~~ 254 (258)
T d1k2pa_ 246 PT----FKILLSN 254 (258)
T ss_dssp CC----HHHHHHH
T ss_pred cC----HHHHHHH
Confidence 99 9999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-55 Score=421.58 Aligned_cols=259 Identities=21% Similarity=0.256 Sum_probs=210.6
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCCC----cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGTN----TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET 165 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 165 (491)
++..+.|++.++||+|+||+||+|.++.++ ..||||+++... .......+.+|+++|+.++|||||++++++.+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 456678999999999999999999988655 469999997543 23445568899999999999999999999999
Q ss_pred CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
.+.+++||||+.+++|.+++... ...+++.++..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999999999887765 35699999999999999999999999999999999999999999999999999965
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
........ .....
T Consensus 160 ~~~~~~~~-------------------------------------------------------------------~~~~~ 172 (283)
T d1mqba_ 160 LEDDPEAT-------------------------------------------------------------------YTTSG 172 (283)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccCCCccc-------------------------------------------------------------------eEecc
Confidence 43211100 01112
Q ss_pred cccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhcc
Q 035713 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVK 405 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~ 405 (491)
..||+.|||||++.+..++.++|||||||+||||++|..||........+.+.+....+.+....++.++.+||.+||..
T Consensus 173 ~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~ 252 (283)
T d1mqba_ 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQ 252 (283)
T ss_dssp -CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCS
T ss_pred CCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcC
Confidence 36899999999999999999999999999999999965555444444445555555566666667999999999999999
Q ss_pred CCCCCCCcCCChHHhhc
Q 035713 406 EPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 406 dP~~R~t~~~~~~ell~ 422 (491)
||++||+ +.+|++
T Consensus 253 ~p~~RPt----~~eil~ 265 (283)
T d1mqba_ 253 ERARRPK----FADIVS 265 (283)
T ss_dssp STTTSCC----HHHHHH
T ss_pred CHhHCcC----HHHHHH
Confidence 9999999 888876
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-55 Score=423.36 Aligned_cols=260 Identities=25% Similarity=0.412 Sum_probs=218.2
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCceEEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV 172 (491)
+++|+++++||+|+||+||+|+++.+|+.||||+++... .......++.+|+.+|+.++||||++++++|.+...+++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 468999999999999999999999999999999997654 3445677889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCcc
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTL 252 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~ 252 (491)
||++.|++|..++... +.+++..++.++.|++.||+|||++|||||||||+||||+.++.+||+|||+|+.......
T Consensus 80 ~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~- 156 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp EECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred eeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence 9999999998877654 6699999999999999999999999999999999999999999999999999865432110
Q ss_pred cccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCc
Q 035713 253 VKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEY 332 (491)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 332 (491)
......+++.|
T Consensus 157 ---------------------------------------------------------------------~~~~~~~~~~~ 167 (292)
T d1unla_ 157 ---------------------------------------------------------------------CYSAEVVTLWY 167 (292)
T ss_dssp ---------------------------------------------------------------------CCCSCCSCGGG
T ss_pred ---------------------------------------------------------------------cceeeccccch
Confidence 01123578899
Q ss_pred cCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCC-CCCcHHHHHHHHc---CCC------------------------
Q 035713 333 LAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFK-GQGNRATLFNVVG---QPL------------------------ 383 (491)
Q Consensus 333 ~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~-~~~~~~~~~~i~~---~~~------------------------ 383 (491)
+|||++.+.. ++.++|||||||++|||++|+.||. +.+..+.+.++.. .+.
T Consensus 168 ~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (292)
T d1unla_ 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS 247 (292)
T ss_dssp CCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCC
T ss_pred hhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccch
Confidence 9999998776 5899999999999999999998864 4444444444321 110
Q ss_pred cCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 384 RFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 384 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
.......+++++++||.+||+.||.+||| |+|||+||||+++
T Consensus 248 ~~~~~~~~s~~~~dll~~mL~~dP~~R~s----a~e~L~Hp~f~~~ 289 (292)
T d1unla_ 248 LVNVVPKLNATGRDLLQNLLKCNPVQRIS----AEEALQHPYFSDF 289 (292)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGSSC
T ss_pred hhhccccCCHHHHHHHHHHccCChhHCcC----HHHHhcChhhcCC
Confidence 00011357889999999999999999999 9999999999854
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=425.43 Aligned_cols=261 Identities=25% Similarity=0.337 Sum_probs=214.3
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
.+++..++|++.+.||+|+||+||+|+++.+ +.||||+++..... .+.+.+|+.+|++++|||||++++++.+ +
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 84 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence 4456678999999999999999999998754 57999999765432 2457889999999999999999999865 4
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+|+||||+++|+|..++.......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence 57899999999999988776544569999999999999999999999999999999999999999999999999986532
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
.... ......+
T Consensus 165 ~~~~---------------------------------------------------------------------~~~~~~~ 175 (285)
T d1fmka3 165 DNEY---------------------------------------------------------------------TARQGAK 175 (285)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CCCc---------------------------------------------------------------------eeecccc
Confidence 1110 0111247
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhcC-CCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHG-TTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
||+.|+|||++.+..++.++|||||||+||||++| ++||.+....+.+..+.. ....+....++.++++||.+||+.|
T Consensus 176 gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~d 254 (285)
T d1fmka3 176 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKE 254 (285)
T ss_dssp CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred ccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh-cCCCCCCcccCHHHHHHHHHHcccC
Confidence 99999999999999999999999999999999995 555565555555555543 4455555679999999999999999
Q ss_pred CCCCCCcCCChHHhhc--CCCcCC
Q 035713 407 PHKRIAYKRGATEIKQ--HPFFEG 428 (491)
Q Consensus 407 P~~R~t~~~~~~ell~--hpff~~ 428 (491)
|++||+ +++|++ |+||..
T Consensus 255 P~~Rps----~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 255 PEERPT----FEYLQAFLEDYFTS 274 (285)
T ss_dssp GGGSCC----HHHHHHHHHTTTSC
T ss_pred HhHCcC----HHHHHHHHhhhhcC
Confidence 999999 999987 888864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=433.11 Aligned_cols=263 Identities=27% Similarity=0.341 Sum_probs=210.5
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe-------
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET------- 165 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~------- 165 (491)
.++|+++++||+|+||+||+|+++.+|+.||||++.+... .+....++.+|+++|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 4789999999999999999999999999999999876543 23445567899999999999999999999854
Q ss_pred -CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 166 -DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 166 -~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
.+++|+||||+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 4568999999977766544333 4669999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccc
Q 035713 245 RCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSM 324 (491)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (491)
........ ......
T Consensus 166 ~~~~~~~~------------------------------------------------------------------~~~~~~ 179 (318)
T d3blha1 166 AFSLAKNS------------------------------------------------------------------QPNRYT 179 (318)
T ss_dssp ECCC-----------------------------------------------------------------------CCCCC
T ss_pred eccccccc------------------------------------------------------------------cccccc
Confidence 54321100 001112
Q ss_pred ccccccCccCcchhcCC-CCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCCcCCC--C-------------
Q 035713 325 SFVGTHEYLAPEIIRGE-GHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPLRFPE--T------------- 388 (491)
Q Consensus 325 ~~~gt~~y~aPE~l~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~------------- 388 (491)
+.+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+....+..+......++. .
T Consensus 180 ~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T d3blha1 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLE 259 (318)
T ss_dssp SCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------
T ss_pred ceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhc
Confidence 34899999999999876 5899999999999999999999999988877766554321110000 0
Q ss_pred ---------------CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCC
Q 035713 389 ---------------PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEG 428 (491)
Q Consensus 389 ---------------~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~ 428 (491)
...+++++|||.+||++||++|+| ++|||+||||+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~s----a~elL~Hpff~~ 310 (318)
T d3blha1 260 LVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID----SDDALNHDFFWS 310 (318)
T ss_dssp CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGSS
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcC----HHHHHcChhhcc
Confidence 013678899999999999999999 999999999973
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-55 Score=421.31 Aligned_cols=257 Identities=25% Similarity=0.347 Sum_probs=210.6
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCCC---cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTN---TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET 165 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 165 (491)
+++..++|++++.||+|+||+||+|++..++ ..||||+++.. ........+.+|+++|+.++|||||++++++.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4566789999999999999999999987543 46888887543 33455667889999999999999999999996
Q ss_pred CceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 166 DKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
++.+||||||+++|+|..++... ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred cCeEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhee
Confidence 46789999999999999987765 35699999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccc
Q 035713 246 CSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMS 325 (491)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (491)
+..... .....
T Consensus 158 ~~~~~~---------------------------------------------------------------------~~~~~ 168 (273)
T d1mp8a_ 158 MEDSTY---------------------------------------------------------------------YKASK 168 (273)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccCCcc---------------------------------------------------------------------eeccc
Confidence 421110 11223
Q ss_pred cccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhc
Q 035713 326 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLV 404 (491)
Q Consensus 326 ~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~ 404 (491)
.+||+.|+|||++.+..|+.++|||||||+||||++ |.+||.+.+..+.+.++..+. ..+....+++++.+||.+||+
T Consensus 169 ~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~~cl~ 247 (273)
T d1mp8a_ 169 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLMTKCWA 247 (273)
T ss_dssp --CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTC
T ss_pred eecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcC
Confidence 478999999999999999999999999999999998 899999988888777776543 334456799999999999999
Q ss_pred cCCCCCCCcCCChHHhhcC
Q 035713 405 KEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 405 ~dP~~R~t~~~~~~ell~h 423 (491)
.||++||| ++||++|
T Consensus 248 ~dp~~Rps----~~ei~~~ 262 (273)
T d1mp8a_ 248 YDPSRRPR----FTELKAQ 262 (273)
T ss_dssp SSGGGSCC----HHHHHHH
T ss_pred CCHhHCcC----HHHHHHH
Confidence 99999999 9999876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=431.20 Aligned_cols=259 Identities=26% Similarity=0.397 Sum_probs=210.0
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc-----e
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK-----F 168 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~-----~ 168 (491)
++|+++++||+|+||+||+|+++.+|+.||||++.+.. .....+++++|+++|+.++||||+++++++.... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 57999999999999999999999999999999997643 3455667889999999999999999999997543 3
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
+||+ +|+.||+|.++++.. .+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 86 ~~l~-~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 86 VYLV-THLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEE-EECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEE-EeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 5555 556699999999763 599999999999999999999999999999999999999999999999999865421
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
... ........+|
T Consensus 162 ~~~-------------------------------------------------------------------~~~~~~~~~g 174 (345)
T d1pmea_ 162 DHD-------------------------------------------------------------------HTGFLTEYVA 174 (345)
T ss_dssp GGC-------------------------------------------------------------------BCCTTCCCCS
T ss_pred CCc-------------------------------------------------------------------cceeeccccc
Confidence 110 0011223589
Q ss_pred ccCccCcchhcC-CCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHc---CC-----------------CcCC-
Q 035713 329 THEYLAPEIIRG-EGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVG---QP-----------------LRFP- 386 (491)
Q Consensus 329 t~~y~aPE~l~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~-----------------~~~~- 386 (491)
|+.|+|||++.. ..++.++||||+||++|||++|+.||.+.+.......... .+ ...+
T Consensus 175 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (345)
T d1pmea_ 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPH 254 (345)
T ss_dssp CGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCC
T ss_pred cceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCc
Confidence 999999999855 4578999999999999999999999998876655544321 00 0000
Q ss_pred --------CCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 387 --------ETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 387 --------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
..+.++.++++||.+||++||.+||| ++|+|+||||+..
T Consensus 255 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----a~e~L~hpf~~~~ 301 (345)
T d1pmea_ 255 KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE----VEQALAHPYLEQY 301 (345)
T ss_dssp CCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTT
T ss_pred cCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcC----HHHHhcCHhhccC
Confidence 01357889999999999999999999 9999999999855
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-55 Score=420.91 Aligned_cols=259 Identities=23% Similarity=0.318 Sum_probs=212.6
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCC-C--cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGT-N--TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK 167 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~-~--~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 167 (491)
+..++|++++.||+|+||+||+|++..+ + ..||||++++.........+.+.+|+++|+.++|||||++++++.++
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~- 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP- 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence 3457899999999999999999997643 2 36899999877666666777899999999999999999999999764
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+++||||+++|+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred chheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 678999999999999877654 2459999999999999999999999999999999999999999999999999997543
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
...... .......
T Consensus 163 ~~~~~~-------------------------------------------------------------------~~~~~~~ 175 (273)
T d1u46a_ 163 QNDDHY-------------------------------------------------------------------VMQEHRK 175 (273)
T ss_dssp C-CCEE-------------------------------------------------------------------EC-----
T ss_pred cCCCcc-------------------------------------------------------------------eecCccc
Confidence 211100 0112346
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
||..|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+.+.++......++....++.++.+||.+||..|
T Consensus 176 ~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~d 255 (273)
T d1u46a_ 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHK 255 (273)
T ss_dssp CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred cCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCC
Confidence 8899999999999999999999999999999998 899999999999889998888777777789999999999999999
Q ss_pred CCCCCCcCCChHHhhc
Q 035713 407 PHKRIAYKRGATEIKQ 422 (491)
Q Consensus 407 P~~R~t~~~~~~ell~ 422 (491)
|++||| +.+|+.
T Consensus 256 p~~RPt----~~ei~~ 267 (273)
T d1u46a_ 256 PEDRPT----FVALRD 267 (273)
T ss_dssp GGGSCC----HHHHHH
T ss_pred hhHCcC----HHHHHH
Confidence 999999 888753
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-55 Score=436.47 Aligned_cols=268 Identities=26% Similarity=0.377 Sum_probs=210.9
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe------C
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET------D 166 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~------~ 166 (491)
+++|+++++||+|+||+||+|+++.+|+.||||++.+... ......++.+|+.+|+.++|||||+++++|.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 4789999999999999999999999999999999987643 45566678899999999999999999999963 4
Q ss_pred ceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeeccccccc
Q 035713 167 KFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRC 246 (491)
Q Consensus 167 ~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~ 246 (491)
.++|+||||+.++.+ ..+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++..
T Consensus 95 ~~~~iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 95 QDVYLVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp CEEEEEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred ceeEEEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence 789999999966544 4443 34999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccc
Q 035713 247 SVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSF 326 (491)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (491)
.. .......
T Consensus 170 ~~-----------------------------------------------------------------------~~~~~~~ 178 (355)
T d2b1pa1 170 GT-----------------------------------------------------------------------SFMMTPY 178 (355)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc-----------------------------------------------------------------------ccccccc
Confidence 21 0112234
Q ss_pred ccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcC----------------------CCc
Q 035713 327 VGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQ----------------------PLR 384 (491)
Q Consensus 327 ~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~----------------------~~~ 384 (491)
+||+.|+|||++.+..++.++||||+||++|||++|++||.+.+......+++.. ...
T Consensus 179 ~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (355)
T d2b1pa1 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 258 (355)
T ss_dssp --CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCC
T ss_pred cccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcc
Confidence 7999999999999999999999999999999999999999988776665554321 000
Q ss_pred CCC------------------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCCChhhhhccCCCC
Q 035713 385 FPE------------------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGVNWALVRSALPPH 441 (491)
Q Consensus 385 ~~~------------------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~~~~~~~~~~~~~ 441 (491)
... ....+.++++||++||+.||++||| |+|||+||||+...+..-....+|.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t----a~elL~Hpw~~~~~~~~~~~~~~~~ 329 (355)
T d2b1pa1 259 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDDALQHPYINVWYDPAEVEAPPPQ 329 (355)
T ss_dssp CCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC----HHHHHTSTTTGGGCCHHHHTCCCC-
T ss_pred ccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcCcccCCCCCcccccCCCCC
Confidence 000 0124567899999999999999999 9999999999975443333333433
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-55 Score=434.05 Aligned_cols=255 Identities=26% Similarity=0.375 Sum_probs=212.8
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeC-----ce
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETD-----KF 168 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~-----~~ 168 (491)
++|+++++||+|+||+||+|+++.+|+.||||++.+.. .......++.+|+++|+.++|||||+++++|... ..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 68999999999999999999999999999999998653 3344556788999999999999999999999633 33
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
.++||+|+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~- 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD- 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT-
T ss_pred eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC-
Confidence 4566777789999999865 459999999999999999999999999999999999999999999999999984321
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
....+.+|
T Consensus 173 ------------------------------------------------------------------------~~~~~~~g 180 (348)
T d2gfsa1 173 ------------------------------------------------------------------------DEMTGYVA 180 (348)
T ss_dssp ------------------------------------------------------------------------GGGSSSCH
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 01123479
Q ss_pred ccCccCcchhcCCC-CCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHHHcCCC-----------------------c
Q 035713 329 THEYLAPEIIRGEG-HGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNVVGQPL-----------------------R 384 (491)
Q Consensus 329 t~~y~aPE~l~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-----------------------~ 384 (491)
|+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+.......++.... .
T Consensus 181 ~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (348)
T d2gfsa1 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 260 (348)
T ss_dssp HHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCC
T ss_pred cccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhccc
Confidence 99999999988765 58899999999999999999999999887766665543211 1
Q ss_pred CCC------CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCCcCCC
Q 035713 385 FPE------TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPFFEGV 429 (491)
Q Consensus 385 ~~~------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpff~~~ 429 (491)
.+. ...+++++++||.+||+.||.+|+| ++|||+||||+..
T Consensus 261 ~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~elL~Hp~f~~~ 307 (348)
T d2gfsa1 261 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQY 307 (348)
T ss_dssp CCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTT
T ss_pred CCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcC----HHHHhcCHhhCCC
Confidence 111 1357899999999999999999999 9999999999865
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=422.12 Aligned_cols=260 Identities=21% Similarity=0.309 Sum_probs=208.6
Q ss_pred CccCCCceEeeeeeccCceEEEEEEEeCC-----CcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeE
Q 035713 90 PIGLSNFRLLKRLGYGDIGSVYLVELRGT-----NTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYF 163 (491)
Q Consensus 90 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~ 163 (491)
++..++|+++++||+|+||+||+|++... ++.||||+++.... ......+.+|..++.++ +|+|||.+++++
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 45568899999999999999999998653 46899999875432 33445667787777776 689999999987
Q ss_pred Ee-CceEEEEEeccCCCchHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEE
Q 035713 164 ET-DKFYCLVMEFCSGGNLHSLRQKQP--------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVL 228 (491)
Q Consensus 164 ~~-~~~~~lV~E~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NIL 228 (491)
.. +..+|+|||||++|+|.++++... ...+++..++.|+.||+.||.|||++|||||||||+|||
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 65 457899999999999999987542 235899999999999999999999999999999999999
Q ss_pred EccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCC
Q 035713 229 VRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVG 308 (491)
Q Consensus 229 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (491)
|+.++.+||+|||+|+.......
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~--------------------------------------------------------- 189 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPD--------------------------------------------------------- 189 (299)
T ss_dssp ECGGGCEEECC------CCSCTT---------------------------------------------------------
T ss_pred ECCCCcEEEccCcchhhcccccc---------------------------------------------------------
Confidence 99999999999999965432111
Q ss_pred CCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcC-CCCCCCCCcHHHHHHHHcCCCcCCC
Q 035713 309 GALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHG-TTPFKGQGNRATLFNVVGQPLRFPE 387 (491)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~~ 387 (491)
.....+.+||+.|||||++.+..++.++|||||||++|||++| .+||.+......+..++.....++.
T Consensus 190 -----------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~ 258 (299)
T d1ywna1 190 -----------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 258 (299)
T ss_dssp -----------SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCC
T ss_pred -----------ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 1112245799999999999999999999999999999999986 5789887776667666665555555
Q ss_pred CCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 388 TPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 388 ~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
...+++++.+||.+||+.||++||| ++||++|
T Consensus 259 ~~~~~~~l~~li~~cl~~dP~~Rpt----~~eil~~ 290 (299)
T d1ywna1 259 PDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 290 (299)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 5679999999999999999999999 9999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-54 Score=422.86 Aligned_cols=254 Identities=20% Similarity=0.258 Sum_probs=208.2
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCc----EEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCce
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNT----YFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDKF 168 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~ 168 (491)
.++|+++++||+|+||+||+|++..+|+ .||+|.++.. ......+.+.+|+++|+.++|||||++++++.++ .
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 3679999999999999999999988876 4777777543 2333456788999999999999999999999865 4
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCC
Q 035713 169 YCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSV 248 (491)
Q Consensus 169 ~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~ 248 (491)
.+++|||+.+|+|.+++... ...+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+....
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 67888999999999887765 45699999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCcccccccc
Q 035713 249 SPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVG 328 (491)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 328 (491)
.... .......|
T Consensus 164 ~~~~--------------------------------------------------------------------~~~~~~~g 175 (317)
T d1xkka_ 164 EEKE--------------------------------------------------------------------YHAEGGKV 175 (317)
T ss_dssp TCC----------------------------------------------------------------------------C
T ss_pred cccc--------------------------------------------------------------------cccccccc
Confidence 1110 01122468
Q ss_pred ccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCC
Q 035713 329 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEP 407 (491)
Q Consensus 329 t~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP 407 (491)
|+.|||||++.+..|+.++|||||||+||||+| |.+||.+.+..+....+.. ..+.+....+++++.+||.+||+.||
T Consensus 176 t~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~-~~~~~~p~~~~~~~~~li~~cl~~dP 254 (317)
T d1xkka_ 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GERLPQPPICTIDVYMIMVKCWMIDA 254 (317)
T ss_dssp CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH-TCCCCCCTTBCHHHHHHHHHHTCSSG
T ss_pred CccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHHHHHHHHhCCCCh
Confidence 999999999999999999999999999999998 8999998776665444433 34445556799999999999999999
Q ss_pred CCCCCcCCChHHhhcC
Q 035713 408 HKRIAYKRGATEIKQH 423 (491)
Q Consensus 408 ~~R~t~~~~~~ell~h 423 (491)
++||| +.+|++|
T Consensus 255 ~~RPs----~~eil~~ 266 (317)
T d1xkka_ 255 DSRPK----FRELIIE 266 (317)
T ss_dssp GGSCC----HHHHHHH
T ss_pred hhCcC----HHHHHHH
Confidence 99999 9999988
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=412.52 Aligned_cols=250 Identities=22% Similarity=0.331 Sum_probs=209.2
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe-Cc
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET-DK 167 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~-~~ 167 (491)
+++..++|+++++||+|+||.||+|+++ |..||||++++.. ..+.+.+|+++|++++|||||++++++.+ .+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 5678899999999999999999999985 6789999997643 33467899999999999999999998854 56
Q ss_pred eEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCS 247 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~ 247 (491)
.+||||||+++|+|.+++.......+++..++.++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 78999999999999999876433459999999999999999999999999999999999999999999999999985432
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
. ......
T Consensus 155 ~-------------------------------------------------------------------------~~~~~~ 161 (262)
T d1byga_ 155 S-------------------------------------------------------------------------TQDTGK 161 (262)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred C-------------------------------------------------------------------------CCcccc
Confidence 1 011236
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccC
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRFPETPQVSFVARDLIRGLLVKE 406 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 406 (491)
+|..|+|||++.+..++.++|||||||++|||+| |++||.+.+..+.+..+.. ....+....+++++.+||.+||+.|
T Consensus 162 ~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~cl~~d 240 (262)
T d1byga_ 162 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVYEVMKNCWHLD 240 (262)
T ss_dssp CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred ccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCCCCCccCCHHHHHHHHHHcccC
Confidence 8899999999999999999999999999999998 7999988877766666544 3444445569999999999999999
Q ss_pred CCCCCCcCCChHHhhcC
Q 035713 407 PHKRIAYKRGATEIKQH 423 (491)
Q Consensus 407 P~~R~t~~~~~~ell~h 423 (491)
|++||| +.+|+++
T Consensus 241 P~~Rps----~~~l~~~ 253 (262)
T d1byga_ 241 AAMRPS----FLQLREQ 253 (262)
T ss_dssp GGGSCC----HHHHHHH
T ss_pred HhHCcC----HHHHHHH
Confidence 999999 8888764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=416.78 Aligned_cols=255 Identities=22% Similarity=0.313 Sum_probs=213.0
Q ss_pred ccCCCceEeeeeeccCceEEEEEEEeCCCcE--EEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeeeEEeCc
Q 035713 91 IGLSNFRLLKRLGYGDIGSVYLVELRGTNTY--FAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSYFETDK 167 (491)
Q Consensus 91 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~--vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~ 167 (491)
+..++|++.++||+|+||+||+|+++.+|.. ||||+++.. ......+.+.+|+++|+.+ +|||||++++++.+++
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 5568999999999999999999999988875 667776543 2334456788999999998 7999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCC
Q 035713 168 FYCLVMEFCSGGNLHSLRQKQ--------------PNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEG 233 (491)
Q Consensus 168 ~~~lV~E~~~gg~L~~~~~~~--------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g 233 (491)
.+|+||||++||+|.++++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999998753 235699999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCc
Q 035713 234 HIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPE 313 (491)
Q Consensus 234 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (491)
.+||+|||+|+......
T Consensus 165 ~~kl~DfG~a~~~~~~~--------------------------------------------------------------- 181 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYV--------------------------------------------------------------- 181 (309)
T ss_dssp CEEECCTTCEESSCEEC---------------------------------------------------------------
T ss_pred ceEEccccccccccccc---------------------------------------------------------------
Confidence 99999999985432100
Q ss_pred cccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCC-CCCCCCCcHHHHHHHHcCCCcCCCCCCCC
Q 035713 314 LMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGT-TPFKGQGNRATLFNVVGQPLRFPETPQVS 392 (491)
Q Consensus 314 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~-~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 392 (491)
......||..|+|||.+.+..|+.++|||||||++|||++|. +||.+.+..+.+..+..+ ..++....++
T Consensus 182 --------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~ 252 (309)
T d1fvra_ 182 --------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPLNCD 252 (309)
T ss_dssp --------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-CCCCCCTTBC
T ss_pred --------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc-CCCCCCccCC
Confidence 111246899999999999999999999999999999999965 678877766666655443 4445556799
Q ss_pred HHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 393 FVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 393 ~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
+++++||.+||+.||++||+ +++|++|
T Consensus 253 ~~~~~li~~cl~~dP~~RPs----~~eil~~ 279 (309)
T d1fvra_ 253 DEVYDLMRQCWREKPYERPS----FAQILVS 279 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 99999999999999999999 9999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-53 Score=413.85 Aligned_cols=259 Identities=20% Similarity=0.302 Sum_probs=218.6
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeE
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYF 163 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 163 (491)
+++..++|++++.||+|+||+||+|+++. +++.||||++++.. ......++.+|+++|+.++||||+++++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 45566889999999999999999999874 56789999997643 334566789999999999999999999999
Q ss_pred EeCceEEEEEeccCCCchHHHHHhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 035713 164 ETDKFYCLVMEFCSGGNLHSLRQKQP----------------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRD 221 (491)
Q Consensus 164 ~~~~~~~lV~E~~~gg~L~~~~~~~~----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrD 221 (491)
...+.+++||||+++|+|.+++.... ...+++..+..|+.||+.||+|||+++|||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999999999999987532 22489999999999999999999999999999
Q ss_pred CCCCCEEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCC
Q 035713 222 LKPENVLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKS 301 (491)
Q Consensus 222 ikp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (491)
|||+||||+.++.+||+|||+|+.......
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~-------------------------------------------------- 195 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADY-------------------------------------------------- 195 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGC--------------------------------------------------
T ss_pred EcccceEECCCCcEEEccchhheeccCCcc--------------------------------------------------
Confidence 999999999999999999999865421110
Q ss_pred CCCCCCCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCC-CCCCCCCcHHHHHHHHc
Q 035713 302 DFGPCVGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGT-TPFKGQGNRATLFNVVG 380 (491)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~-~Pf~~~~~~~~~~~i~~ 380 (491)
....++.+||+.|+|||++.+..|+.++|||||||+||||++|. +||.+.+..+.+..+..
T Consensus 196 ------------------~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~ 257 (301)
T d1lufa_ 196 ------------------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 257 (301)
T ss_dssp ------------------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred ------------------ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHc
Confidence 01122457999999999999999999999999999999999985 78988888877777665
Q ss_pred CCCcCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 381 QPLRFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 381 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
+. ..+....+++++.+||.+||+.||++||| +.||++
T Consensus 258 ~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt----~~ev~~ 294 (301)
T d1lufa_ 258 GN-ILACPENCPLELYNLMRLCWSKLPADRPS----FCSIHR 294 (301)
T ss_dssp TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CC-CCCCCccchHHHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 54 33344569999999999999999999999 888865
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=409.02 Aligned_cols=259 Identities=22% Similarity=0.310 Sum_probs=213.9
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEeCCC-------cEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCcccee
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELRGTN-------TYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLY 160 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~-------~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~ 160 (491)
+.+..++|++++.||+|+||.||+|++..++ ..||||++++.. .......+.+|..++.++ +|||||+++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 4567789999999999999999999987654 379999997653 234456678898888888 799999999
Q ss_pred eeEEeCceEEEEEeccCCCchHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCC
Q 035713 161 SYFETDKFYCLVMEFCSGGNLHSLRQKQP--------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPEN 226 (491)
Q Consensus 161 ~~~~~~~~~~lV~E~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~N 226 (491)
++|.+++.+|+||||+++|+|.+++.... ...+++.++..++.||+.||+|||++|||||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 99999999999999999999999997543 2458999999999999999999999999999999999
Q ss_pred EEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCC
Q 035713 227 VLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPC 306 (491)
Q Consensus 227 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (491)
||++.++.+||+|||+++.......
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~------------------------------------------------------- 190 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDY------------------------------------------------------- 190 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCT-------------------------------------------------------
T ss_pred eeecCCCCeEeccchhhcccccccc-------------------------------------------------------
Confidence 9999999999999999865432110
Q ss_pred CCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcC
Q 035713 307 VGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRF 385 (491)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 385 (491)
.......+||+.|+|||++.+..|+.++|||||||++|||++ |++||.+.+....+.. +.....+
T Consensus 191 -------------~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~-i~~~~~~ 256 (299)
T d1fgka_ 191 -------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL-LKEGHRM 256 (299)
T ss_dssp -------------TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHTTCCC
T ss_pred -------------ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH-HHcCCCC
Confidence 011223579999999999999999999999999999999998 7999987776655444 4444555
Q ss_pred CCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 386 PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 386 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
+....+++++.+||.+||+.||.+||| +.||++
T Consensus 257 ~~p~~~~~~l~~li~~cl~~dP~~Rps----~~eil~ 289 (299)
T d1fgka_ 257 DKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVE 289 (299)
T ss_dssp CCCSSCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCCccchHHHHHHHHHHccCCHhHCcC----HHHHHH
Confidence 556679999999999999999999999 899886
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=411.51 Aligned_cols=260 Identities=20% Similarity=0.292 Sum_probs=222.8
Q ss_pred CCccCCCceEeeeeeccCceEEEEEEEe-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhc-CCCCccceeee
Q 035713 89 PPIGLSNFRLLKRLGYGDIGSVYLVELR-----GTNTYFAMKVMDKASLASRNKLLRAQTEREILGLL-DHPFLPTLYSY 162 (491)
Q Consensus 89 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~ 162 (491)
+++..++|++.++||+|+||.||+|++. .+++.||||++++.. .......+.+|+.+++.+ +|||||+++++
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3456689999999999999999999975 356789999997653 234556788999999999 69999999999
Q ss_pred EEeCceEEEEEeccCCCchHHHHHhCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCC
Q 035713 163 FETDKFYCLVMEFCSGGNLHSLRQKQP----------------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPEN 226 (491)
Q Consensus 163 ~~~~~~~~lV~E~~~gg~L~~~~~~~~----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~N 226 (491)
+.+++.+|||||||++|+|.++++... ...+++..+..|+.||+.||.|||++|||||||||+|
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 999999999999999999999987642 2258999999999999999999999999999999999
Q ss_pred EEEccCCcEEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCC
Q 035713 227 VLVRDEGHIMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPC 306 (491)
Q Consensus 227 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (491)
||++.++.+||+|||+++.+......
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~------------------------------------------------------ 201 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNY------------------------------------------------------ 201 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTS------------------------------------------------------
T ss_pred ccccccCcccccccchheeccCCCcc------------------------------------------------------
Confidence 99999999999999998654321110
Q ss_pred CCCCCCccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhc-CCCCCCCCCcHHHHHHHHcCCCcC
Q 035713 307 VGGALPELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH-GTTPFKGQGNRATLFNVVGQPLRF 385 (491)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 385 (491)
......+||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+....+.+++....+.
T Consensus 202 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~ 267 (311)
T d1t46a_ 202 --------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM 267 (311)
T ss_dssp --------------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC
T ss_pred --------------eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 11123589999999999999999999999999999999998 777788877777777877776666
Q ss_pred CCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhc
Q 035713 386 PETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQ 422 (491)
Q Consensus 386 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~ 422 (491)
.....++.++.+||.+||+.||++||+ +++|++
T Consensus 268 ~~~~~~~~~l~~Li~~cl~~dP~~RPs----~~~il~ 300 (311)
T d1t46a_ 268 LSPEHAPAEMYDIMKTCWDADPLKRPT----FKQIVQ 300 (311)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCcccccHHHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 666679999999999999999999999 888885
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=409.82 Aligned_cols=266 Identities=20% Similarity=0.266 Sum_probs=224.0
Q ss_pred CCCccCCCceEeeeeeccCceEEEEEEEeC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeee
Q 035713 88 GPPIGLSNFRLLKRLGYGDIGSVYLVELRG-----TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSY 162 (491)
Q Consensus 88 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 162 (491)
.+++..++|+++++||+|+||+||+|+++. ++..||||++++.. .......+.+|+++|++++|||||+++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 346677899999999999999999999863 35789999997643 33455678899999999999999999999
Q ss_pred EEeCceEEEEEeccCCCchHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCc
Q 035713 163 FETDKFYCLVMEFCSGGNLHSLRQKQP--------NKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGH 234 (491)
Q Consensus 163 ~~~~~~~~lV~E~~~gg~L~~~~~~~~--------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~ 234 (491)
+..++.+++||||+.+|+|.+++.... ...+++..+..++.||+.||.|||+++|+||||||+||||+.++.
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 999999999999999999999876421 134789999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCcc
Q 035713 235 IMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPEL 314 (491)
Q Consensus 235 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (491)
+||+|||+|+.......
T Consensus 172 ~Kl~DFGla~~~~~~~~--------------------------------------------------------------- 188 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDY--------------------------------------------------------------- 188 (308)
T ss_dssp EEECCTTCCCGGGGGGC---------------------------------------------------------------
T ss_pred EEEeecccceeccCCcc---------------------------------------------------------------
Confidence 99999999965432111
Q ss_pred ccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcC-CCCCCCCCcHHHHHHHHcCCCcCCCCCCCCH
Q 035713 315 MAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHG-TTPFKGQGNRATLFNVVGQPLRFPETPQVSF 393 (491)
Q Consensus 315 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 393 (491)
.......+||+.|+|||.+.+..++.++|||||||+||||+|| ++||.+.+..+.+..+..+. ..+....++.
T Consensus 189 -----~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~-~~~~p~~~~~ 262 (308)
T d1p4oa_ 189 -----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKPDNCPD 262 (308)
T ss_dssp -----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-CCCCCTTCCH
T ss_pred -----eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC-CCCCcccchH
Confidence 0112234799999999999999999999999999999999997 58888888877777776543 3444457999
Q ss_pred HHHHHHHhhhccCCCCCCCcCCChHHhhc------CCCcCC
Q 035713 394 VARDLIRGLLVKEPHKRIAYKRGATEIKQ------HPFFEG 428 (491)
Q Consensus 394 ~~~~li~~~L~~dP~~R~t~~~~~~ell~------hpff~~ 428 (491)
.+.+||.+||+.||++||+ +++|++ +|+|+.
T Consensus 263 ~l~~li~~cl~~~P~~RPs----~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 263 MLFELMRMCWQYNPKMRPS----FLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp HHHHHHHHHTCSSGGGSCC----HHHHHHHHGGGSCTTHHH
T ss_pred HHHHHHHHHcCCChhHCcC----HHHHHHHHHHhcCCCCcC
Confidence 9999999999999999999 888887 666653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-51 Score=398.88 Aligned_cols=252 Identities=17% Similarity=0.212 Sum_probs=204.2
Q ss_pred EeeeeeccCceEEEEEEEeCCC---cEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEe-CceEEEEE
Q 035713 98 LLKRLGYGDIGSVYLVELRGTN---TYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFET-DKFYCLVM 173 (491)
Q Consensus 98 ~~~~iG~G~~g~V~~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~-~~~~~lV~ 173 (491)
+.++||+|+||+||+|++..++ ..||||++++. .......++.+|+++|++++|||||++++++.. ++.+++||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 3678999999999999986543 36999998753 345566789999999999999999999999765 56899999
Q ss_pred eccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeecccccccCCCCccc
Q 035713 174 EFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDFDLSLRCSVSPTLV 253 (491)
Q Consensus 174 E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 253 (491)
|||++|+|.+++... ...+++..+..++.||+.||.|||+.+|+||||||+||||+.++.+||+|||+++.........
T Consensus 109 E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp ECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999999988764 3558899999999999999999999999999999999999999999999999996543211100
Q ss_pred ccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccccCcc
Q 035713 254 KSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGTHEYL 333 (491)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 333 (491)
........||+.|+
T Consensus 188 ------------------------------------------------------------------~~~~~~~~gt~~y~ 201 (311)
T d1r0pa_ 188 ------------------------------------------------------------------VHNKTGAKLPVKWM 201 (311)
T ss_dssp ------------------------------------------------------------------TTCTTCSSCCGGGS
T ss_pred ------------------------------------------------------------------ceeccccccccccc
Confidence 00111247899999
Q ss_pred CcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHH-HHHHHHcCCCcCCCCCCCCHHHHHHHHhhhccCCCCCCC
Q 035713 334 APEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRA-TLFNVVGQPLRFPETPQVSFVARDLIRGLLVKEPHKRIA 412 (491)
Q Consensus 334 aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 412 (491)
|||++....++.++|||||||+||||++|..||....... ....+..+ ...+....+++++.+||.+||+.||++||+
T Consensus 202 aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-~~~~~p~~~~~~l~~li~~cl~~dP~~RPs 280 (311)
T d1r0pa_ 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQPEYCPDPLYEVMLKCWHPKAEMRPS 280 (311)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCcccCcHHHHHHHHHHcCCCHhHCcC
Confidence 9999999999999999999999999999777776544333 33334333 344444578999999999999999999999
Q ss_pred cCCChHHhhcC
Q 035713 413 YKRGATEIKQH 423 (491)
Q Consensus 413 ~~~~~~ell~h 423 (491)
+.||++|
T Consensus 281 ----~~ei~~~ 287 (311)
T d1r0pa_ 281 ----FSELVSR 287 (311)
T ss_dssp ----HHHHHHH
T ss_pred ----HHHHHHH
Confidence 9999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-51 Score=399.69 Aligned_cols=262 Identities=18% Similarity=0.250 Sum_probs=202.0
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCC-ccceeeeEEeCceEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPF-LPTLYSYFETDKFYCLV 172 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~-iv~l~~~~~~~~~~~lV 172 (491)
++|++++.||+|+||+||+|++..+|+.||||++...... .++.+|+++++.++|+| |+.+.+++.+.+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 5799999999999999999999999999999998765322 24567999999998766 55556667888999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc---CCcEEEeecccccccCCC
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD---EGHIMLSDFDLSLRCSVS 249 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~---~g~vkL~DFGla~~~~~~ 249 (491)
|||+ +++|...+... .+.+++..+..++.||+.||+|||++|||||||||+|||++. +..+||+|||+|+.....
T Consensus 82 me~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9999 66776665553 356999999999999999999999999999999999999863 557999999999765422
Q ss_pred CcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccccc
Q 035713 250 PTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFVGT 329 (491)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 329 (491)
..... .......+.+||
T Consensus 160 ~~~~~---------------------------------------------------------------~~~~~~~~~~gt 176 (299)
T d1ckia_ 160 RTHQH---------------------------------------------------------------IPYRENKNLTGT 176 (299)
T ss_dssp TTCCB---------------------------------------------------------------CCCCBCCSCCCC
T ss_pred ccccc---------------------------------------------------------------eeccccCCcCCC
Confidence 11100 001122346899
Q ss_pred cCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcHHHHHHH---HcCCCcCC---CCCCCCHHHHHHHHhhh
Q 035713 330 HEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLFNV---VGQPLRFP---ETPQVSFVARDLIRGLL 403 (491)
Q Consensus 330 ~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i---~~~~~~~~---~~~~~s~~~~~li~~~L 403 (491)
+.|||||++.+..++.++|||||||++|||++|+.||.+.........+ .......+ ....+|+++.+||.+||
T Consensus 177 ~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl 256 (299)
T d1ckia_ 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCR 256 (299)
T ss_dssp SSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHH
T ss_pred ccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHc
Confidence 9999999999999999999999999999999999999876554333221 11111111 12468999999999999
Q ss_pred ccCCCCCCCcCCChHHhhcCCCc
Q 035713 404 VKEPHKRIAYKRGATEIKQHPFF 426 (491)
Q Consensus 404 ~~dP~~R~t~~~~~~ell~hpff 426 (491)
+.||++||++.. +.++|+|+|.
T Consensus 257 ~~~p~~RP~~~~-i~~~l~~~~~ 278 (299)
T d1ckia_ 257 SLRFDDKPDYSY-LRQLFRNLFH 278 (299)
T ss_dssp HSCTTCCCCHHH-HHHHHHHHHH
T ss_pred cCChhHCcCHHH-HHHHHHHHHH
Confidence 999999999422 3466777654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-49 Score=386.22 Aligned_cols=250 Identities=19% Similarity=0.244 Sum_probs=203.2
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCC-CCccceeeeEEeCceEEEE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH-PFLPTLYSYFETDKFYCLV 172 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~l~~~~~~~~~~~lV 172 (491)
++|+++++||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.|+| +||+.+++++..+...|+|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 6899999999999999999999999999999998664322 235678999999975 8999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEcc-----CCcEEEeecccccccC
Q 035713 173 MEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRD-----EGHIMLSDFDLSLRCS 247 (491)
Q Consensus 173 ~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~-----~g~vkL~DFGla~~~~ 247 (491)
|||+ +++|.+++... +..+++..+..++.|++.||+|||++|||||||||+||||+. ++.+||+|||+|+...
T Consensus 80 me~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9999 89999988765 356999999999999999999999999999999999999974 5789999999997653
Q ss_pred CCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCccccccc
Q 035713 248 VSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNVRSMSFV 327 (491)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (491)
....... .......+++
T Consensus 158 ~~~~~~~---------------------------------------------------------------~~~~~~~~~~ 174 (293)
T d1csna_ 158 DPVTKQH---------------------------------------------------------------IPYREKKNLS 174 (293)
T ss_dssp CTTTCCB---------------------------------------------------------------CCCCCCCCCC
T ss_pred cCccccc---------------------------------------------------------------eeecccCceE
Confidence 2211000 0011223468
Q ss_pred cccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcH---HHHHHHHcCCCcCC---CCCCCCHHHHHHHHh
Q 035713 328 GTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR---ATLFNVVGQPLRFP---ETPQVSFVARDLIRG 401 (491)
Q Consensus 328 gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~i~~~~~~~~---~~~~~s~~~~~li~~ 401 (491)
||+.|||||++.+..++.++|||||||++|||++|+.||.+.... ..+.++.......+ ....+++++.+|+..
T Consensus 175 GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~ 254 (293)
T d1csna_ 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHY 254 (293)
T ss_dssp SCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHH
T ss_pred EchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHH
Confidence 999999999999999999999999999999999999999865432 22233322111111 113588999999999
Q ss_pred hhccCCCCCCCc
Q 035713 402 LLVKEPHKRIAY 413 (491)
Q Consensus 402 ~L~~dP~~R~t~ 413 (491)
|+..+|++||++
T Consensus 255 ~~~~~~~~rP~y 266 (293)
T d1csna_ 255 ARNLAFDATPDY 266 (293)
T ss_dssp HHHCCTTCCCCH
T ss_pred HhcCCcccCcCH
Confidence 999999999983
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=383.25 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=191.9
Q ss_pred CCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCccceeeeEEeCc----eE
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFLPTLYSYFETDK----FY 169 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~----~~ 169 (491)
++|.+.++||+|+||+||+|++ +|+.||||+++.... .......|+..+..++|||||++++++.+.+ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 5799999999999999999986 588999999865421 1111224555556789999999999997643 68
Q ss_pred EEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--------cCcccccCCCCCEEEccCCcEEEeecc
Q 035713 170 CLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHM--------LGIVYRDLKPENVLVRDEGHIMLSDFD 241 (491)
Q Consensus 170 ~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--------~givHrDikp~NILl~~~g~vkL~DFG 241 (491)
|||||||++|+|.+++++. .+++..+..++.|++.||.|||+ +|||||||||+||||+.+|.+||+|||
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 9999999999999999874 49999999999999999999996 599999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCCCccccCCCCc
Q 035713 242 LSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGALPELMAEPTNV 321 (491)
Q Consensus 242 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (491)
+++......... ..
T Consensus 154 l~~~~~~~~~~~------------------------------------------------------------------~~ 167 (303)
T d1vjya_ 154 LAVRHDSATDTI------------------------------------------------------------------DI 167 (303)
T ss_dssp TCEEEETTTTEE------------------------------------------------------------------CC
T ss_pred ccccccCCCcce------------------------------------------------------------------ec
Confidence 987543211110 01
Q ss_pred cccccccccCccCcchhcCCC------CCCcccccchhhHHHhhhcCCCCCCCCC--------------cHHHHHHHH-c
Q 035713 322 RSMSFVGTHEYLAPEIIRGEG------HGSAVDWWTFGIFLYELLHGTTPFKGQG--------------NRATLFNVV-G 380 (491)
Q Consensus 322 ~~~~~~gt~~y~aPE~l~~~~------~~~~~DiwSlG~il~elltg~~Pf~~~~--------------~~~~~~~i~-~ 380 (491)
.....+||+.|||||++.+.. ++.++|||||||+||||+||..||.... ....+...+ .
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (303)
T d1vjya_ 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 247 (303)
T ss_dssp ----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT
T ss_pred cccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhc
Confidence 122358999999999998753 5678999999999999999998874321 122233332 2
Q ss_pred CCCcC--CCC---CCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcC
Q 035713 381 QPLRF--PET---PQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQH 423 (491)
Q Consensus 381 ~~~~~--~~~---~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~h 423 (491)
...+. +.. ......+.+||.+||+.||++||| +.||+++
T Consensus 248 ~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~ei~~~ 291 (303)
T d1vjya_ 248 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKKT 291 (303)
T ss_dssp SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCC----HHHHHHH
T ss_pred cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcC----HHHHHHH
Confidence 22221 111 112345889999999999999999 8888764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-47 Score=383.98 Aligned_cols=258 Identities=23% Similarity=0.376 Sum_probs=198.7
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-----------CCCccceee
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-----------HPFLPTLYS 161 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----------hp~iv~l~~ 161 (491)
.++|+++++||+|+||+||+|+++.+|+.||||++++... ....+.+|+++|+.++ |+||+++++
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 3579999999999999999999999999999999987532 2345667888888775 578999999
Q ss_pred eEEe--CceEEEEEeccCCCch-HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccCCCCCEEEccCCc---
Q 035713 162 YFET--DKFYCLVMEFCSGGNL-HSLRQKQPNKYFTEDAARFFASEVLLALEYLHM-LGIVYRDLKPENVLVRDEGH--- 234 (491)
Q Consensus 162 ~~~~--~~~~~lV~E~~~gg~L-~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~NILl~~~g~--- 234 (491)
++.. ....+++|+++..+.. ...........+++..++.++.||+.||.|||+ +||+||||||+||||+.++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence 8864 4566677776655443 334444455779999999999999999999998 89999999999999987653
Q ss_pred ---EEEeecccccccCCCCcccccccccccCCCCCCCCccCcccccccCCCCCccCCcccccccccCCCCCCCCCCCCCC
Q 035713 235 ---IMLSDFDLSLRCSVSPTLVKSSSVSVNNGSGGGGGILNDEYAVHGCMQPSTFFPRILPSKKNRKSKSDFGPCVGGAL 311 (491)
Q Consensus 235 ---vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (491)
+||+|||.|.....
T Consensus 168 ~~~~kl~dfg~s~~~~~--------------------------------------------------------------- 184 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE--------------------------------------------------------------- 184 (362)
T ss_dssp EEEEEECCCTTCEETTB---------------------------------------------------------------
T ss_pred cceeeEeeccccccccc---------------------------------------------------------------
Confidence 99999999853211
Q ss_pred CccccCCCCccccccccccCccCcchhcCCCCCCcccccchhhHHHhhhcCCCCCCCCCcH------HHHH---HHHcCC
Q 035713 312 PELMAEPTNVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNR------ATLF---NVVGQP 382 (491)
Q Consensus 312 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~---~i~~~~ 382 (491)
.....+||+.|+|||++.+..|+.++|||||||++++|++|+.||.+.... ..+. .+++..
T Consensus 185 ----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~ 254 (362)
T d1q8ya_ 185 ----------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254 (362)
T ss_dssp ----------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSC
T ss_pred ----------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCC
Confidence 111347999999999999999999999999999999999999999765321 1111 111110
Q ss_pred ---------------------C----------------cCCCCCCCCHHHHHHHHhhhccCCCCCCCcCCChHHhhcCCC
Q 035713 383 ---------------------L----------------RFPETPQVSFVARDLIRGLLVKEPHKRIAYKRGATEIKQHPF 425 (491)
Q Consensus 383 ---------------------~----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~~ell~hpf 425 (491)
. .+......+++++|||.+||++||.+||| ++|||+|||
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt----a~e~L~Hp~ 330 (362)
T d1q8ya_ 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD----AGGLVNHPW 330 (362)
T ss_dssp CHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC----HHHHHTCGG
T ss_pred CHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC----HHHHhcCcc
Confidence 0 00011234577999999999999999999 999999999
Q ss_pred cCCCCh
Q 035713 426 FEGVNW 431 (491)
Q Consensus 426 f~~~~~ 431 (491)
|+++.+
T Consensus 331 f~~~~~ 336 (362)
T d1q8ya_ 331 LKDTLG 336 (362)
T ss_dssp GTTCTT
T ss_pred cCCCCC
Confidence 996654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=1.1e-27 Score=216.36 Aligned_cols=136 Identities=22% Similarity=0.212 Sum_probs=108.1
Q ss_pred ceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhh---------------hHHHHHHHHHHHHHHhhcCCCCcccee
Q 035713 96 FRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLA---------------SRNKLLRAQTEREILGLLDHPFLPTLY 160 (491)
Q Consensus 96 y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~---------------~~~~~~~~~~E~~il~~l~hp~iv~l~ 160 (491)
+.+.++||+|+||+||+|++. +|+.||||+++..... .........+|..+|.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 467899999999999999986 6899999987632111 111233456788999999999999988
Q ss_pred eeEEeCceEEEEEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccCCCCCEEEccCCcEEEeec
Q 035713 161 SYFETDKFYCLVMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDEGHIMLSDF 240 (491)
Q Consensus 161 ~~~~~~~~~~lV~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~NILl~~~g~vkL~DF 240 (491)
++.. .+|||||+++..+.. +++..+..++.||+.+|.|||++||+||||||+|||++.+ .++|+||
T Consensus 81 ~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred EecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence 6532 269999998876643 4555677899999999999999999999999999999865 5999999
Q ss_pred cccccc
Q 035713 241 DLSLRC 246 (491)
Q Consensus 241 Gla~~~ 246 (491)
|+|+..
T Consensus 147 G~a~~~ 152 (191)
T d1zara2 147 PQSVEV 152 (191)
T ss_dssp TTCEET
T ss_pred CCcccC
Confidence 998543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.69 E-value=5.6e-08 Score=89.66 Aligned_cols=140 Identities=16% Similarity=0.177 Sum_probs=92.8
Q ss_pred CCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEeCceEEE
Q 035713 93 LSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 93 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~~l 171 (491)
++.|++++..+-++.+.||+.. .+++.++||+....... ....+.+|..+|+.+. +--+.+++.++..++..|+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 3678888876666668999875 34666888987543222 1223557888888775 4346888888888999999
Q ss_pred EEeccCCCchHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 035713 172 VMEFCSGGNLHSLRQKQPNKYFTEDAARFFASEVLLALEYLH-------------------------------------- 213 (491)
Q Consensus 172 V~E~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-------------------------------------- 213 (491)
||++++|..+....... .. ...++.++...|..||
T Consensus 88 v~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 99999998775432110 01 1112222222233333
Q ss_pred ---------------Hc------CcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 214 ---------------ML------GIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 214 ---------------~~------givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
.. .++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 21 27999999999999876666799999874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.23 E-value=2e-06 Score=78.43 Aligned_cols=137 Identities=13% Similarity=0.021 Sum_probs=83.2
Q ss_pred eeeccC-ceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCC--CCccceeeeEEeCceEEEEEeccC
Q 035713 101 RLGYGD-IGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDH--PFLPTLYSYFETDKFYCLVMEFCS 177 (491)
Q Consensus 101 ~iG~G~-~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h--p~iv~l~~~~~~~~~~~lV~E~~~ 177 (491)
.+..|. .+.||+.... ++..+++|....... ..+..|..+|+.|.. -.+.+++.+..+++..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 334444 4689988765 466688997654321 134568888887743 336788888888889999999999
Q ss_pred CCchHH--------------HHHhCC-----CCCCC--HHHH-----HHHH---------------HHHHHHHHHHHHc-
Q 035713 178 GGNLHS--------------LRQKQP-----NKYFT--EDAA-----RFFA---------------SEVLLALEYLHML- 215 (491)
Q Consensus 178 gg~L~~--------------~~~~~~-----~~~l~--~~~~-----~~~~---------------~qi~~aL~~LH~~- 215 (491)
|.++.. ++.+.. ...+. .... ..+. ......+..+...
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 876532 111100 00000 0000 0000 0122233444332
Q ss_pred ------CcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 216 ------GIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 216 ------givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
.++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 37999999999999877667899999874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.18 E-value=2.4e-06 Score=83.49 Aligned_cols=81 Identities=17% Similarity=0.180 Sum_probs=50.5
Q ss_pred eeeeeccCceEEEEEEEeCCCcEEEEEEeecc-hhh---hHHHHHHHHHHHHHHhhcC-C--CCccceeeeEEeCceEEE
Q 035713 99 LKRLGYGDIGSVYLVELRGTNTYFAMKVMDKA-SLA---SRNKLLRAQTEREILGLLD-H--PFLPTLYSYFETDKFYCL 171 (491)
Q Consensus 99 ~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~-~~~---~~~~~~~~~~E~~il~~l~-h--p~iv~l~~~~~~~~~~~l 171 (491)
.+.||.|....||++++..+++.|+||.-... ... ......+...|.++|+.+. + ..+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 56789999999999998878888999964321 110 0112334567888887763 2 345666654 3444568
Q ss_pred EEeccCCCch
Q 035713 172 VMEFCSGGNL 181 (491)
Q Consensus 172 V~E~~~gg~L 181 (491)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.44 E-value=0.00017 Score=70.00 Aligned_cols=78 Identities=21% Similarity=0.308 Sum_probs=52.7
Q ss_pred CCceEeeeeeccCceEEEEEEEeC-------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcC-CCCccceeeeEEe
Q 035713 94 SNFRLLKRLGYGDIGSVYLVELRG-------TNTYFAMKVMDKASLASRNKLLRAQTEREILGLLD-HPFLPTLYSYFET 165 (491)
Q Consensus 94 ~~y~~~~~iG~G~~g~V~~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~ 165 (491)
+++++ +.|+.|-.-.+|++.... ..+.|.+++.-... ..+ ...+|..+++.+. +.-..+++++|.+
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~~i-dr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TES-HLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CHH-HHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----hhh-HHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 44554 678889999999998753 34567777764221 112 2347888998885 4445688887753
Q ss_pred CceEEEEEeccCCCch
Q 035713 166 DKFYCLVMEFCSGGNL 181 (491)
Q Consensus 166 ~~~~~lV~E~~~gg~L 181 (491)
.+||||++|..|
T Consensus 117 ----g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ----GRLEEYIPSRPL 128 (395)
T ss_dssp ----EEEECCCCEEEC
T ss_pred ----ceEEEEeccccC
Confidence 589999988654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.40 E-value=0.0003 Score=66.15 Aligned_cols=134 Identities=16% Similarity=0.155 Sum_probs=76.5
Q ss_pred cCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCc-----ccee--eeEEeCceEEEEEeccC
Q 035713 105 GDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFL-----PTLY--SYFETDKFYCLVMEFCS 177 (491)
Q Consensus 105 G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~i-----v~l~--~~~~~~~~~~lV~E~~~ 177 (491)
+.--.||+++.. +|..|++|+.+...... ..+..|...|..|....| +..- ..+..++..+.|++++.
T Consensus 33 s~EN~vy~v~~~-dg~~~VlK~~rp~~~s~----~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 33 SYENRVYQFQDE-DRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp CSSSEEEEECCT-TCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred cccceeEEEEcC-CCCEEEEEEeCCCCCCH----HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 334689999875 67889999987543222 234568888877742222 1111 23456778899999998
Q ss_pred CCchH-----H------HH---Hh----CC---CC-------------------CCCHHHHHHHHHHHHHHHHHHHH---
Q 035713 178 GGNLH-----S------LR---QK----QP---NK-------------------YFTEDAARFFASEVLLALEYLHM--- 214 (491)
Q Consensus 178 gg~L~-----~------~~---~~----~~---~~-------------------~l~~~~~~~~~~qi~~aL~~LH~--- 214 (491)
|..+. . .+ +. .. .. .++......+...+-..++.+..
T Consensus 108 G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~ 187 (325)
T d1zyla1 108 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 187 (325)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcc
Confidence 75431 0 00 00 00 00 11112122222223333334432
Q ss_pred ----cCcccccCCCCCEEEccCCcEEEeecccccc
Q 035713 215 ----LGIVYRDLKPENVLVRDEGHIMLSDFDLSLR 245 (491)
Q Consensus 215 ----~givHrDikp~NILl~~~g~vkL~DFGla~~ 245 (491)
.++||+|+.+.|||++. + ..++||+-+..
T Consensus 188 ~~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 188 EDFTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp SCSCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred ccCCceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 36899999999999963 3 45899998743
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.73 E-value=0.0059 Score=56.43 Aligned_cols=146 Identities=14% Similarity=0.063 Sum_probs=77.7
Q ss_pred cCCCceEeeeeeccCceEEEEEEEeCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHhhcCCCCc-----ccee-e--eE
Q 035713 92 GLSNFRLLKRLGYGDIGSVYLVELRGTNTYFAMKVMDKASLASRNKLLRAQTEREILGLLDHPFL-----PTLY-S--YF 163 (491)
Q Consensus 92 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~i-----v~l~-~--~~ 163 (491)
.++...-++.|..|---+.|+.+.. +| .|++|++.+... . ..+..|+++|..|...++ +... + +.
T Consensus 16 ~lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~~--~---~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~ 88 (316)
T d2ppqa1 16 DVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVE--K---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLG 88 (316)
T ss_dssp CCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCE
T ss_pred CCCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCCC--H---HHHHHHHHHHHhhhhccccccccceecCCCcce
Confidence 4456666777888888999998765 34 489999865321 1 233456667776642222 2111 1 12
Q ss_pred EeCceEEEEEeccCCCchHH--------------HHHhC----C---CCCCCH------------------HHHHHHHHH
Q 035713 164 ETDKFYCLVMEFCSGGNLHS--------------LRQKQ----P---NKYFTE------------------DAARFFASE 204 (491)
Q Consensus 164 ~~~~~~~lV~E~~~gg~L~~--------------~~~~~----~---~~~l~~------------------~~~~~~~~q 204 (491)
...+..+.++.++.|..... .++.. . ...... ......+..
T Consensus 89 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 168 (316)
T d2ppqa1 89 ELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRP 168 (316)
T ss_dssp EETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHH
T ss_pred eeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHH
Confidence 33456677777776654311 00000 0 000001 111111222
Q ss_pred HHHHHHHHH----HcCcccccCCCCCEEEccCCcEEEeeccccc
Q 035713 205 VLLALEYLH----MLGIVYRDLKPENVLVRDEGHIMLSDFDLSL 244 (491)
Q Consensus 205 i~~aL~~LH----~~givHrDikp~NILl~~~g~vkL~DFGla~ 244 (491)
+...+.-.+ ..|+||+|+.++|||++.+...-|+||+.+.
T Consensus 169 ~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 169 EIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 222222222 1479999999999999988777899999874
|